Citrus Sinensis ID: 002094
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 967 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LRT1 | 1016 | Probably inactive leucine | no | no | 0.956 | 0.910 | 0.447 | 0.0 | |
| C0LGE4 | 882 | Probable LRR receptor-lik | no | no | 0.858 | 0.941 | 0.349 | 1e-129 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.914 | 0.872 | 0.320 | 1e-123 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.898 | 0.867 | 0.330 | 1e-121 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.947 | 0.831 | 0.318 | 1e-120 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.884 | 0.749 | 0.346 | 1e-119 | |
| Q42371 | 976 | LRR receptor-like serine/ | no | no | 0.901 | 0.893 | 0.320 | 1e-119 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.882 | 0.681 | 0.324 | 1e-118 | |
| Q6XAT2 | 967 | LRR receptor-like serine/ | no | no | 0.884 | 0.884 | 0.302 | 1e-118 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.902 | 0.903 | 0.304 | 1e-117 |
| >sp|Q9LRT1|Y3804_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At3g28040 OS=Arabidopsis thaliana GN=At3g28040 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 784 bits (2025), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/987 (44%), Positives = 612/987 (62%), Gaps = 62/987 (6%)
Query: 25 FNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSGH 84
NDDVLGLIVFK+ L DP L SW+EDD+ PC+W VKC+PKT RV+ L+LDG +L+G
Sbjct: 33 LNDDVLGLIVFKSDLNDPFSHLESWTEDDNTPCSWSYVKCNPKTSRVIELSLDGLALTGK 92
Query: 85 IGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIP---------- 134
I RG+ +LQ L+VLSLSNNNFTG INA L++ LQ +D S NNLSG IP
Sbjct: 93 INRGIQKLQRLKVLSLSNNNFTGNINA-LSNNNHLQKLDLSHNNLSGQIPSSLGSITSLQ 151
Query: 135 --------------DEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSG 180
D+ F C SLR +S ++N+L G IP +L CS L S+N S NR SG
Sbjct: 152 HLDLTGNSFSGTLSDDLFNNCSSLRYLSLSHNHLEGQIPSTLFRCSVLNSLNLSRNRFSG 211
Query: 181 QLPY--GIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCS 238
+ GIW L L++LDLS+N L G I GI +L++L+ ++L +N+FSG LP DIG C
Sbjct: 212 NPSFVSGIWRLERLRALDLSSNSLSGSIPLGILSLHNLKELQLQRNQFSGALPSDIGLCP 271
Query: 239 MLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQF 298
L +D N SG LP +LQ+L S + + N +G+ P WIG + L LD S N+
Sbjct: 272 HLNRVDLSSNHFSGELPRTLQKLKSLNHFDVSNNLLSGDFPPWIGDMTGLVHLDFSSNEL 331
Query: 299 SGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMG 358
+G++PSSI NL LK+LN+S N+ +G +PES+ +C L+ + + N +GNIP F +G
Sbjct: 332 TGKLPSSISNLRSLKDLNLSENKLSGEVPESLESCKELMIVQLKGNDFSGNIPDGFFDLG 391
Query: 359 LQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMS 418
LQ + SGN L S+ S ++ L LDLS N+L+G IP +G + LN+S
Sbjct: 392 LQEMDFSGNGLTGSIPRGS----SRLFESLIRLDLSHNSLTGSIPGEVGLFIHMRYLNLS 447
Query: 419 MNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQI 478
N+ +P I L+ + VLD ++ L G++P I + SL+ L+L+ N L+G IP I
Sbjct: 448 WNHFNTRVPPEIEFLQNLTVLDLRNSALIGSVPADICESQSLQILQLDGNSLTGSIPEGI 507
Query: 479 KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNIS 538
NCSSL L LS NNLTGP+P +++NL LK + L N LSG +PKEL +L +LL N+S
Sbjct: 508 GNCSSLKLLSLSHNNLTGPIPKSLSNLQELKILKLEANKLSGEIPKELGDLQNLLLVNVS 567
Query: 539 HNHLHGELPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSS 598
N L G LP+G F ++ S++ GN +C ++ C KP+V+NPNS GN+
Sbjct: 568 FNRLIGRLPLGDVFQSLDQSAIQGNLGICSPLLRGPCTLNVPKPLVINPNSYG--NGNNM 625
Query: 599 PNHR---------RKIVLSISALIAIGAAAFIAIGVIAVTVLNIRVRSSMSRAAAALS-- 647
P +R R++ LS+S ++AI AA I GVI +T+LN VR ++ AL
Sbjct: 626 PGNRASGGSGTFHRRMFLSVSVIVAISAAILIFSGVIIITLLNASVRRRLAFVDNALESI 685
Query: 648 FSGGEDYSCSPTKDPNYGKLVMFS--------GDAEFAAGANALLNKDCELGRGGFGVVY 699
FSG S + GKLV+ + EF +LLNK +G G FG VY
Sbjct: 686 FSG----SSKSGRSLMMGKLVLLNSRTSRSSSSSQEFERNPESLLNKASRIGEGVFGTVY 741
Query: 700 RTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758
+ L + GR++A+KKL S ++++ EDF++E++ L K +H NLV+++GY+WTP L LL+
Sbjct: 742 KAPLGEQGRNLAVKKLVPSPILQNLEDFDREVRILAKAKHPNLVSIKGYFWTPDLHLLVS 801
Query: 759 EFISSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHT---NIIHYNLKSTNVL 814
E+I +G+L LH+ S LSW R+ IILG AKGLAYLHHT IH+NLK TN+L
Sbjct: 802 EYIPNGNLQSKLHEREPSTPPLSWDVRYKIILGTAKGLAYLHHTFRPTTIHFNLKPTNIL 861
Query: 815 IDSSGEPKVGDFGLARLLPMLD-RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGV 873
+D PK+ DFGL+RLL D + +++ Q+ALGY+APE C+ +++ EKCDVYGFGV
Sbjct: 862 LDEKNNPKISDFGLSRLLTTQDGNTMNNNRFQNALGYVAPELECQNLRVNEKCDVYGFGV 921
Query: 874 LVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGL 933
L+LE+VTG+RPVEY ED V+L D VR LE G V +C+D + + DE +PV+KL L
Sbjct: 922 LILELVTGRRPVEYGEDSFVILSDHVRVMLEQGNVLECIDPVMEEQYSEDEVLPVLKLAL 981
Query: 934 ICASQVPSNRPDMEEVVNILELIQSPL 960
+C SQ+PSNRP M E+V IL++I SP+
Sbjct: 982 VCTSQIPSNRPTMAEIVQILQVINSPV 1008
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGE4|Y1124_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g12460 OS=Arabidopsis thaliana GN=At1g12460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 463 bits (1191), Expect = e-129, Method: Compositional matrix adjust.
Identities = 331/946 (34%), Positives = 497/946 (52%), Gaps = 116/946 (12%)
Query: 32 LIVFKAGL-EDPKEKLTSWSEDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLL 90
L+ FK + +DP L SW D D ++ G+ C+P+ V + L SL+G + GL
Sbjct: 30 LLQFKGSISDDPYNSLASWVSDGDLCNSFNGITCNPQ-GFVDKIVLWNTSLAGTLAPGLS 88
Query: 91 RLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFA 150
L+F++VL+L N F +G +P ++F+
Sbjct: 89 NLKFIRVLNLFGNRF------------------------TGNLPLDYFK----------- 113
Query: 151 NNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGI 210
+L ++N SSN LSG +P I L SL+ LDLS N GEI +
Sbjct: 114 --------------LQTLWTINVSSNALSGPIPEFISELSSLRFLDLSKNGFTGEIPVSL 159
Query: 211 SNLYD-LRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSL 269
D + + L N G +P I C+ L DF N+L G LP + + +S+
Sbjct: 160 FKFCDKTKFVSLAHNNIFGSIPASIVNCNNLVGFDFSYNNLKGVLPPRICDIPVLEYISV 219
Query: 270 KGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPES 329
+ N +G+V + I K L +DL N F G P ++ + N+S N+F G + E
Sbjct: 220 RNNLLSGDVSEEIQKCQRLILVDLGSNLFHGLAPFAVLTFKNITYFNVSWNRFGGEIGEI 279
Query: 330 MMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQ 389
+ +L +D S N+LTG IPT + MG ++ L+
Sbjct: 280 VDCSESLEFLDASSNELTGRIPTGV--MGCKS--------------------------LK 311
Query: 390 VLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGT 449
+LDL SN L+G IP +IG + SL ++ + N + G IP IG L+ +QVL+ + L G
Sbjct: 312 LLDLESNKLNGSIPGSIGKMESLSVIRLGNNSIDGVIPRDIGSLEFLQVLNLHNLNLIGE 371
Query: 450 IPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLK 509
+P I L EL + N L G+I ++ N +++ L L +N L G +P + NLS ++
Sbjct: 372 VPEDISNCRVLLELDVSGNDLEGKISKKLLNLTNIKILDLHRNRLNGSIPPELGNLSKVQ 431
Query: 510 YVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGS 569
++DLS N LSG +P L +L+ L FN+S+N+L G +P S+ S NP LCG
Sbjct: 432 FLDLSQNSLSGPIPSSLGSLNTLTHFNVSYNNLSGVIPPVPMIQAFGSSAFSNNPFLCGD 491
Query: 570 VVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNHRRKIVLSISALIAIGAAAFIAIGVIAVT 629
P+V NS ++ R LSIS +I I AAA I GV V
Sbjct: 492 ------------PLVTPCNSR-----GAAAKSRNSDALSISVIIVIIAAAVILFGVCIVL 534
Query: 630 VLNIRVRSSMSRAAAALSFSGGEDYSCSPTKDPNYGKLVMFSGD-----AEFAAGANALL 684
LN+R R + L+ S + GKLV+FS + ++ AG ALL
Sbjct: 535 ALNLRARKR-RKDEEILTVETTPLASSIDSSGVIIGKLVLFSKNLPSKYEDWEAGTKALL 593
Query: 685 NKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+K+ +G G G VYR + G S+A+KKL G I++QE+FE+E+ LG ++H NL +
Sbjct: 594 DKENIIGMGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFEQEIGRLGGLQHPNLSSF 653
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLH----DGSSRNC----LSWRQRFNIILGMAKGLA 796
+GYY++ ++QL++ EF+ +GSLY +LH G+S + L+W +RF I LG AK L+
Sbjct: 654 QGYYFSSTMQLILSEFVPNGSLYDNLHLRIFPGTSSSYGNTDLNWHRRFQIALGTAKALS 713
Query: 797 YLHHT---NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAP 853
+LH+ I+H N+KSTN+L+D E K+ D+GL + LP++D L+ K +A+GY+AP
Sbjct: 714 FLHNDCKPAILHLNVKSTNILLDERYEAKLSDYGLEKFLPVMDSFGLTKKFHNAVGYIAP 773
Query: 854 EFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEY-MEDDVVVLCDMVRGALEDGRVEDCV 912
E A ++++ +EKCDVY +GV++LE+VTG++PVE E+ V++L D VR LE G DC
Sbjct: 774 ELAQQSLRASEKCDVYSYGVVLLELVTGRKPVESPSENQVLILRDYVRDLLETGSASDCF 833
Query: 913 DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958
D RLR F +E I V+KLGL+C S+ P RP M EVV +LE I++
Sbjct: 834 DRRLR-EFEENELIQVMKLGLLCTSENPLKRPSMAEVVQVLESIRN 878
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1143), Expect = e-123, Method: Compositional matrix adjust.
Identities = 314/981 (32%), Positives = 500/981 (50%), Gaps = 97/981 (9%)
Query: 32 LIVFKAGLEDPKEKLTSWS-EDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLL 90
L+ K+ L DP L W D + CNW GV+C+ V L L G +L+G I +
Sbjct: 34 LLSVKSTLVDPLNFLKDWKLSDTSDHCNWTGVRCN-SNGNVEKLDLAGMNLTGKISDSIS 92
Query: 91 RLQFLQV---------------------------------------------LSLSNNNF 105
+L L L+ S NN
Sbjct: 93 QLSSLVSFNISCNGFESLLPKSIPPLKSIDISQNSFSGSLFLFSNESLGLVHLNASGNNL 152
Query: 106 TGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFC 165
+G + DL + +L+V+D N G +P F + LR + + NNLTG +P L
Sbjct: 153 SGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSF-KNLQKLRFLGLSGNNLTGELPSVLGQL 211
Query: 166 SSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNK 225
SLE+ N G +P + SL+ LDL+ L GEI + L L + L +N
Sbjct: 212 PSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENN 271
Query: 226 FSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKL 285
F+G +P +IG + LKVLDF N+L+G +P + +L + L+L N +G +P I L
Sbjct: 272 FTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSL 331
Query: 286 ANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNK 345
A L+ L+L N SG +PS +G L+ L++S N F+G +P ++ N GNL + + N
Sbjct: 332 AQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNT 391
Query: 346 LTGNIPTWIFK-MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPS 404
TG IP + L V + N L S+ F + + LQ L+L+ N LSG IP
Sbjct: 392 FTGQIPATLSTCQSLVRVRMQNNLLNGSIPI-GFGKL----EKLQRLELAGNRLSGGIPG 446
Query: 405 NIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELK 464
+I D SL ++ S N + S+P++I + +Q +DN+++G +P Q SL L
Sbjct: 447 DISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLD 506
Query: 465 LEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPK 524
L N L+G IPS I +C L SL L NNLTG +P I +S L +DLS N L+G+LP+
Sbjct: 507 LSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPE 566
Query: 525 ELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIV 584
+ L N+S+N L G +P+ GF TI+P + GN LCG V+ C Q
Sbjct: 567 SIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGVL-PPCSKFQRA--- 622
Query: 585 LNPNSSNPYTGNSSPNHRRKIVLSISALIAIGAAAFIAIGVIAVTVLNIRVRSSMSRAAA 644
T + S H ++IV A IG A+ +A+G++ + V ++ +
Sbjct: 623 ---------TSSHSSLHGKRIV----AGWLIGIASVLALGILTI------VTRTLYKKWY 663
Query: 645 ALSFSGGEDYSCSPTKDPNYGKLVMFSGDAEFAAGANALLNKDCELGRGGFGVVYRTILQ 704
+ F G E + +K +L+ F A+ A + + +G G G+VY+ +
Sbjct: 664 SNGFCGDE----TASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMS 719
Query: 705 DGRSV-AIKKLTVSGL---IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760
+V A+KKL S + DF E+ LGK+RH N+V L G+ + +++YEF
Sbjct: 720 RSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEF 779
Query: 761 ISSGSLYKHLH--DGSSRNCLSWRQRFNIILGMAKGLAYLHHT---NIIHYNLKSTNVLI 815
+ +G+L +H + + R + W R+NI LG+A GLAYLHH +IH ++KS N+L+
Sbjct: 780 MLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILL 839
Query: 816 DSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLV 875
D++ + ++ DFGLAR++ + S + + GY+APE+ T+K+ EK D+Y +GV++
Sbjct: 840 DANLDARIADFGLARMMARKKETV--SMVAGSYGYIAPEYG-YTLKVDEKIDIYSYGVVL 896
Query: 876 LEVVTGKRPVEYMEDDVVVLCDMVRGALEDG-RVEDCVDARLRGN--FPADEAIPVIKLG 932
LE++TG+RP+E + V + + VR + D +E+ +D + GN + +E + V+++
Sbjct: 897 LELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEEALDPNV-GNCRYVQEEMLLVLQIA 955
Query: 933 LICASQVPSNRPDMEEVVNIL 953
L+C +++P +RP M +V+++L
Sbjct: 956 LLCTTKLPKDRPSMRDVISML 976
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1121), Expect = e-121, Method: Compositional matrix adjust.
Identities = 325/983 (33%), Positives = 485/983 (49%), Gaps = 114/983 (11%)
Query: 46 LTSWSEDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNF 105
LTSW+ C+W GV CD + V L L G +LSG + + L LQ LSL+ N
Sbjct: 47 LTSWNLSTTF-CSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSDVAHLPLLQNLSLAANQI 105
Query: 106 TGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFC 165
+G I +++ L+ ++ S N +G PDE +LR + NNNLTG +P SL+
Sbjct: 106 SGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNL 165
Query: 166 SSLESVNFSSNRLSGQLP--YGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGK 223
+ L ++ N SG++P YG W + L+ L +S N L G+I I NL LR + +G
Sbjct: 166 TQLRHLHLGGNYFSGKIPATYGTWPV--LEYLAVSGNELTGKIPPEIGNLTTLRELYIGY 223
Query: 224 -NKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWI 282
N F LP +IG S L D L+G +P + +L +L L+ N+FTG + +
Sbjct: 224 YNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQEL 283
Query: 283 GKLANLESLDLSLNQFSGRIPSS------------------------IGNLVFLKELNIS 318
G +++L+S+DLS N F+G IP+S IG + L+ L +
Sbjct: 284 GLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLW 343
Query: 319 MNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFK----MGLQTV------------ 362
N FTG +P+ + G L+ +D+S NKLTG +P + M L T+
Sbjct: 344 ENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSL 403
Query: 363 ----SLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLS-SLMLLNM 417
SL+ R+GE+ S L ++L N L+G +P + G +S L +++
Sbjct: 404 GKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQISL 463
Query: 418 SMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQ 477
S N L GS+PA+IG L +Q L N +G+IPP+IG L +L N SGRI +
Sbjct: 464 SNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPE 523
Query: 478 IKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNI 537
I C LT + LS+N L+G +P + + L Y++LS N L G +P + ++ L S +
Sbjct: 524 ISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDF 583
Query: 538 SHNHLHGELPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNS 597
S+N+L G +P G F+ + +S GN LCG PY G
Sbjct: 584 SYNNLSGLVPSTGQFSYFNYTSFVGNSHLCG-----------------------PYLGPC 620
Query: 598 SPNHRRKIVLSISALIA---IGAAAFIAIGVIAVTVLNIR-VRSSMSRAAAALSFSGGED 653
+ V +SA + F ++ V ++ R +R++ A L+ D
Sbjct: 621 GKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQRLD 680
Query: 654 YSCSPTKDPNYGKLVMFSGDAEFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKK 713
++C D L +D +G+GG G+VY+ + G VA+K+
Sbjct: 681 FTCDDVLDS---------------------LKEDNIIGKGGAGIVYKGTMPKGDLVAVKR 719
Query: 714 L-TVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHD 772
L T+S F E++TLG+IRH ++V L G+ LL+YE++ +GSL + LH
Sbjct: 720 LATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLH- 778
Query: 773 GSSRNCLSWRQRFNIILGMAKGLAYLHHTN---IIHYNLKSTNVLIDSSGEPKVGDFGLA 829
G L W R+ I L AKGL YLHH I+H ++KS N+L+DS+ E V DFGLA
Sbjct: 779 GKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLA 838
Query: 830 RLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYME 889
+ L S I + GY+APE+A T+K+ EK DVY FGV++LE++TGK+PV
Sbjct: 839 KFLQDSGTSECMSAIAGSYGYIAPEYA-YTLKVDEKSDVYSFGVVLLELITGKKPVGEFG 897
Query: 890 DDVVVLCDMVRGALEDGRVEDCV----DARLRGNFPADEAIPVIKLGLICASQVPSNRPD 945
D V ++ VR + + DCV D RL + P E V + L+C + RP
Sbjct: 898 DGVDIV-QWVRSMTDSNK--DCVLKVIDLRL-SSVPVHEVTHVFYVALLCVEEQAVERPT 953
Query: 946 MEEVVNIL-ELIQSPLDGQEELE 967
M EVV IL E+ + PL Q+ E
Sbjct: 954 MREVVQILTEIPKIPLSKQQAAE 976
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 434 bits (1115), Expect = e-120, Method: Compositional matrix adjust.
Identities = 350/1098 (31%), Positives = 522/1098 (47%), Gaps = 182/1098 (16%)
Query: 5 LKLIFLLVLAPVFVRSLDPTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKC 64
L ++ L + + VRSL N++ L+ FKA L D L SW++ D NPCNW G+ C
Sbjct: 8 LAIVILCSFSFILVRSL----NEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIAC 63
Query: 65 DPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDF 124
+ V + L+G +LSG + + +L L+ L++S N +G I DL+ +L+V+D
Sbjct: 64 T-HLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDL 122
Query: 125 SENNLSGLIPDEFF--------------------RQCG---SLREVSFANNNLTGPIPES 161
N G+IP + RQ G SL+E+ +NNLTG IP S
Sbjct: 123 CTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPS 182
Query: 162 LSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKL 221
++ L + N SG +P I SL+ L L+ NLLEG + K + L +L + L
Sbjct: 183 MAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLIL 242
Query: 222 GKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDW 281
+N+ SG++P +G S L+VL N +GS+P + +L L L N TGE+P
Sbjct: 243 WQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPRE 302
Query: 282 IGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDV 341
IG L + +D S NQ +G IP G+++ LK L++ N G +P + L +D+
Sbjct: 303 IGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDL 362
Query: 342 SQNKLTGNIPTWI-FKMGLQTVSLSGNRLGESMQ-----YPSFASMKDS----------- 384
S N+L G IP + F L + L N+L + Y +F+ + S
Sbjct: 363 SINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAH 422
Query: 385 ---YQGLQVLDLSSNALSGVIPSNI-----------GD-------------LSSLMLLNM 417
+Q L +L L SN LSG IP ++ GD L +L L +
Sbjct: 423 FCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALEL 482
Query: 418 SMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQ 477
N+L G+I A +GKLK ++ L ++N G IPP+IG + + N L+G IP +
Sbjct: 483 HQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKE 542
Query: 478 IKNCSS------------------------LTSLILSQNNLTGPVPAAIANLSNLKYVDL 513
+ +C + L L LS N LTG +P + +L+ L + L
Sbjct: 543 LGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQL 602
Query: 514 SFNDLSGILPKELINLSHL-LSFNISHNHLHGELP------------------------- 547
N LS +P EL L+ L +S NISHN+L G +P
Sbjct: 603 GGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPA 662
Query: 548 ------------------VG-----GFFNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIV 584
VG F + S+ +GN LC S RS +P+V
Sbjct: 663 SIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNS--QRS----HCQPLV 716
Query: 585 LNPNSSNPYTGNSSPNHRRKIVLSISALIAIGAAAFIAIGVIAVTVLNIRVRSSMSRAAA 644
+ +S + N S +R+ +L+I+ I IG+ I + T+ R
Sbjct: 717 PHSDSKLNWLINGS---QRQKILTITC-IVIGSVFLITFLGLCWTI---------KRREP 763
Query: 645 ALSFSGGEDYSCSPTKDPNYGKLVMFSGDAEFAAGANALLNKDCELGRGGFGVVYRTILQ 704
A F ED + D Y F+ A N ++D LGRG G VY+ +
Sbjct: 764 A--FVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRN--FSEDVVLGRGACGTVYKAEMS 819
Query: 705 DGRSVAIKKLTVSGLIKSQED-FEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763
G +A+KKL G S ++ F E+ TLGKIRH N+V L G+ + + LL+YE++S
Sbjct: 820 GGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSK 879
Query: 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT---NIIHYNLKSTNVLIDSSGE 820
GSL + L G L W R+ I LG A+GL YLHH I+H ++KS N+L+D +
Sbjct: 880 GSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQ 939
Query: 821 PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT 880
VGDFGLA+L+ L S + + GY+APE+A T+K+TEKCD+Y FGV++LE++T
Sbjct: 940 AHVGDFGLAKLID-LSYSKSMSAVAGSYGYIAPEYA-YTMKVTEKCDIYSFGVVLLELIT 997
Query: 881 GKRPVEYMED--DVVVLCDMVRGALEDG-RVEDCVDARLRGN--FPADEAIPVIKLGLIC 935
GK PV+ +E D+V + VR ++ + + DARL N E V+K+ L C
Sbjct: 998 GKPPVQPLEQGGDLV---NWVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFC 1054
Query: 936 ASQVPSNRPDMEEVVNIL 953
S P++RP M EVV ++
Sbjct: 1055 TSNSPASRPTMREVVAMI 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 431 bits (1108), Expect = e-119, Method: Compositional matrix adjust.
Identities = 330/953 (34%), Positives = 481/953 (50%), Gaps = 98/953 (10%)
Query: 67 KTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSE 126
K + + L L+ L+G I + + L+ L L +N TG+I +L L+V+
Sbjct: 151 KLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGG 210
Query: 127 NN-LSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYG 185
N +SG IP E C +L + A +++G +P SL LE+++ + +SG++P
Sbjct: 211 NKEISGQIPSEI-GDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSD 269
Query: 186 IWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDF 245
+ L L L N L G I + I L L + L +N G +PE+IG CS LK++D
Sbjct: 270 LGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDL 329
Query: 246 GVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSS 305
+N LSGS+P S+ RL+ + N F+G +P I ++L L L NQ SG IPS
Sbjct: 330 SLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSE 389
Query: 306 IGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIF------KMGL 359
+G L L NQ G +P + +C +L A+D+S+N LTG IP+ +F K+ L
Sbjct: 390 LGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLL 449
Query: 360 QTVSLSGN--------------RLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSN 405
+ SLSG RLG + S S + + LD SSN L G +P
Sbjct: 450 ISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDE 509
Query: 406 IGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKL 465
IG S L ++++S N L GS+P + L +QVLD S N +G IP +G VSL +L L
Sbjct: 510 IGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLIL 569
Query: 466 EKNFLSGRIPSQIKNCSSLT-------------------------SLILSQNNLTGPVPA 500
KN SG IP+ + CS L +L LS N LTG +P+
Sbjct: 570 SKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPS 629
Query: 501 AIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSV 560
IA+L+ L +DLS N L G L L N+ +L+S NIS+N G LP F +SP +
Sbjct: 630 KIASLNKLSILDLSHNMLEGDL-APLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDL 688
Query: 561 SGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNHRRKIVLSISALIAIGAAAF 620
GN LC S + SC K L G+ R + + AL+
Sbjct: 689 EGNKKLCSSTQD-SCFLTYRKGNGL---------GDDGDASRTRKLRLTLALLITLTVVL 738
Query: 621 IAIGVIAVTVLNIRVRSSMSRAAAALSFSGGEDYSCSPTKDPNYGKLVMFSGDAEFAAGA 680
+ +G +AV IR R ++ + GE Y T + KL FS D
Sbjct: 739 MILGAVAV----IRARRNIDNERDS---ELGETYKWQFTP---FQKL-NFSVDQIIRC-- 785
Query: 681 NALLNKDCELGRGGFGVVYRTILQDGRSVAIKKL---TVSG-----LIKSQEDFEKEMKT 732
L + +G+G GVVYR + +G +A+KKL V+G ++ F E+KT
Sbjct: 786 ---LVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKT 842
Query: 733 LGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHD--GSSRNCLSWRQRFNIILG 790
LG IRH N+V G W + +LL+Y+++ +GSL LH+ GSS L W R+ I+LG
Sbjct: 843 LGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGSS---LDWDLRYRILLG 899
Query: 791 MAKGLAYLHHT---NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA 847
A+GLAYLHH I+H ++K+ N+LI EP + DFGLA+L+ D S+ + +
Sbjct: 900 AAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGS 959
Query: 848 LGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMV---RGALE 904
GY+APE+ ++KITEK DVY +GV+VLEV+TGK+P++ + + L D V RG+LE
Sbjct: 960 YGYIAPEYG-YSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLE 1018
Query: 905 DGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957
V D R R ADE + V+ L+C + P RP M++V +L+ I+
Sbjct: 1019 ---VLDST-LRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLKEIK 1067
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 430 bits (1105), Expect = e-119, Method: Compositional matrix adjust.
Identities = 300/935 (32%), Positives = 472/935 (50%), Gaps = 63/935 (6%)
Query: 32 LIVFKAGLEDPKEKLTSWSED-DDNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLL 90
L+ K +D L W+ + C W GV C+ T VV L L +L G I +
Sbjct: 30 LLEIKKSFKDVNNVLYDWTTSPSSDYCVWRGVSCENVTFNVVALNLSDLNLDGEISPAIG 89
Query: 91 RLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFA 150
L+ L + L N +G I ++ +LQ +D S N LSG IP + L ++
Sbjct: 90 DLKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDLSFNELSGDIPFSI-SKLKQLEQLILK 148
Query: 151 NNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGI 210
NN L GPIP +LS +L+ ++ + N+LSG++P I++ LQ L L N L G I +
Sbjct: 149 NNQLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRLIYWNEVLQYLGLRGNNLVGNISPDL 208
Query: 211 SNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLK 270
L L + N +G +PE IG C+ +VLD N L+G +P + L ++LSL+
Sbjct: 209 CQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQLTGEIPFDIGFL-QVATLSLQ 267
Query: 271 GNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESM 330
GN +G++P IG + L LDLS N SG IP +GNL F ++L + N+ TG +P +
Sbjct: 268 GNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGNLTFTEKLYLHSNKLTGSIPPEL 327
Query: 331 MNCGNLLAIDVSQNKLTGNIPTWIFKM-GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQ 389
N L ++++ N LTG+IP + K+ L ++++ N L + P S S L
Sbjct: 328 GNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLEGPI--PDHLS---SCTNLN 382
Query: 390 VLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGT 449
L++ N SG IP L S+ LN+S N + G IP + ++ + LD S+N +NG
Sbjct: 383 SLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGI 442
Query: 450 IPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLK 509
IP +G L ++ L +N ++G +P N S+ + LS N+++GP+P + L N+
Sbjct: 443 IPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNII 502
Query: 510 YVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGS 569
+ L N+L+G + L N L N+SHN+L G++P F+ SP S GNP LCGS
Sbjct: 503 LLRLENNNLTGNV-GSLANCLSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCGS 561
Query: 570 VVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNHRRKIVLSISALIAIGAAAFIAIG--VIA 627
+N C + RR + +SIS +G IAIG VI
Sbjct: 562 WLNSPCH-----------------------DSRRTVRVSISRAAILG----IAIGGLVIL 594
Query: 628 VTVLNIRVRSSMSRAAAALSFSGGEDYSCSPTKDPNYGKLVMFSGDAEFAAGANAL---- 683
+ VL R S YS KLV+ + + +
Sbjct: 595 LMVLIAACRPHNPPPFLDGSLDKPVTYSTP--------KLVILHMNMALHVYEDIMRMTE 646
Query: 684 -LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
L++ +G G VY+ +L++ + VAIK+L S +S + FE E++ L I+H NLV
Sbjct: 647 NLSEKYIIGHGASSTVYKCVLKNCKPVAIKRL-YSHNPQSMKQFETELEMLSSIKHRNLV 705
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT- 801
+L+ Y + LL Y+++ +GSL+ LH + + L W R I G A+GLAYLHH
Sbjct: 706 SLQAYSLSHLGSLLFYDYLENGSLWDLLHGPTKKKTLDWDTRLKIAYGAAQGLAYLHHDC 765
Query: 802 --NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRT 859
IIH ++KS+N+L+D E ++ DFG+A+ L + + S+ + +GY+ PE+A RT
Sbjct: 766 SPRIIHRDVKSSNILLDKDLEARLTDFGIAKSL-CVSKSHTSTYVMGTIGYIDPEYA-RT 823
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919
++TEK DVY +G+++LE++T ++ V DD L ++ + V + D +
Sbjct: 824 SRLTEKSDVYSYGIVLLELLTRRKAV----DDESNLHHLIMSKTGNNEVMEMADPDITST 879
Query: 920 FPADEAI-PVIKLGLICASQVPSNRPDMEEVVNIL 953
+ V +L L+C + P++RP M +V +L
Sbjct: 880 CKDLGVVKKVFQLALLCTKRQPNDRPTMHQVTRVL 914
|
Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 427 bits (1097), Expect = e-118, Method: Compositional matrix adjust.
Identities = 322/991 (32%), Positives = 488/991 (49%), Gaps = 138/991 (13%)
Query: 74 LTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133
L L G L G I + L L LQ L LS+NN TG I+ + L+ + ++N LSG +
Sbjct: 269 LNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSL 328
Query: 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQ 193
P SL+++ + L+G IP +S C SL+ ++ S+N L+GQ+P ++ L L
Sbjct: 329 PKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELT 388
Query: 194 SLDLSNNLLEGEIVKGISNLYDLRAIKL------GK------------------NKFSGQ 229
+L L+NN LEG + ISNL +L+ L GK N+FSG+
Sbjct: 389 NLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGE 448
Query: 230 LPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLE 289
+P +IG C+ L+ +D+ N LSG +P S+ RL + L L+ N G +P +G +
Sbjct: 449 MPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMT 508
Query: 290 SLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGN 349
+DL+ NQ SG IPSS G L L+ I N G LP+S++N NL I+ S NK G+
Sbjct: 509 VIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGS 568
Query: 350 IPTWIFKMGLQTVSLSGN--------RLGESMQYPSFASMKDSYQG-----------LQV 390
I + ++ N LG+S K+ + G L +
Sbjct: 569 ISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSL 628
Query: 391 LDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNW----- 445
LD+S N+LSG+IP +G L ++++ NYL G IP +GKL + L S N
Sbjct: 629 LDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSL 688
Query: 446 -------------------LNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTS 486
LNG+IP +IG +L L LE+N LSG +PS I S L
Sbjct: 689 PTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFE 748
Query: 487 LILSQNNLTGPVPAAIANLSNLK-YVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGE 545
L LS+N LTG +P I L +L+ +DLS+N+ +G +P + L L S ++SHN L GE
Sbjct: 749 LRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGE 808
Query: 546 LP--VGGF--------------------FNTISPSSVSGNPSLCGSVVNRSCPAVQNKPI 583
+P +G F+ + GN LCGS ++ A
Sbjct: 809 VPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQR 868
Query: 584 VLNPNSSNPYTGNSSPNHRRKIVLSISALIAIGAAAFIAIGVIAVTVLN----IRVRSSM 639
L+P K V+ ISA+ ++ A A + + +I N +VR
Sbjct: 869 SLSP----------------KTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGN 912
Query: 640 SRAAAALSFSGGEDYSCSPTKDPNYGKLVMFSGDAEFAAGANALLNKDCELGRGGFGVVY 699
S ++ S S +S K +M A LN++ +G GG G VY
Sbjct: 913 SAFSSNSSSSQAPLFSNGGAKSDIKWDDIM---------EATHYLNEEFMIGSGGSGKVY 963
Query: 700 RTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS--LQLLI 757
+ L++G ++A+KK+ + S + F +E+KTLG IRH +LV L GY + + L LLI
Sbjct: 964 KAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLI 1023
Query: 758 YEFISSGSLYKHLH---DGSSRNCLSWRQRFNIILGMAKGLAYLHHT---NIIHYNLKST 811
YE++++GS++ LH + + L W R I LG+A+G+ YLH+ I+H ++KS+
Sbjct: 1024 YEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSS 1083
Query: 812 NVLIDSSGEPKVGDFGLARLLP-MLDRCILSSKI-QSALGYMAPEFACRTVKITEKCDVY 869
NVL+DS+ E +GDFGLA++L D S+ + + GY+APE+A ++K TEK DVY
Sbjct: 1084 NVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYA-YSLKATEKSDVY 1142
Query: 870 GFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE-----DGRVEDCVDARLRGNFPADE 924
G++++E+VTGK P E M D+ + V L+ + R E +D+ L+ P +E
Sbjct: 1143 SMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAR-EKLIDSELKSLLPCEE 1201
Query: 925 --AIPVIKLGLICASQVPSNRPDMEEVVNIL 953
A V+++ L C P RP + L
Sbjct: 1202 EAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1094), Expect = e-118, Method: Compositional matrix adjust.
Identities = 292/964 (30%), Positives = 474/964 (49%), Gaps = 109/964 (11%)
Query: 25 FNDDVLGLIVFKAGLEDPKEKLTSWSE-DDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSG 83
N++ L+ KA + L W + + + C+W GV CD + VV L L +L G
Sbjct: 28 MNNEGKALMAIKASFSNVANMLLDWDDVHNHDFCSWRGVFCDNVSLNVVSLNLSNLNLGG 87
Query: 84 HIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGS 143
I L L LQ + L N G I ++ + +L VDFS N L G IP +
Sbjct: 88 EISSALGDLMNLQSIDLQGNKLGGQIPDEIGNCVSLAYVDFSTNLLFGDIPFSI-SKLKQ 146
Query: 144 LREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLE 203
L ++ NN LTGPIP +L+ +L++++ + N+L+G++P +++ LQ L L N+L
Sbjct: 147 LEFLNLKNNQLTGPIPATLTQIPNLKTLDLARNQLTGEIPRLLYWNEVLQYLGLRGNMLT 206
Query: 204 GEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNS 263
G + + L L + N +G +PE IG C+ ++LD N ++G +P ++ L
Sbjct: 207 GTLSPDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFEILDVSYNQITGVIPYNIGFL-Q 265
Query: 264 CSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFT 323
++LSL+GN TG +P+ IG + L LDLS N+ +G IP +GNL F +L + N+ T
Sbjct: 266 VATLSLQGNKLTGRIPEVIGLMQALAVLDLSDNELTGPIPPILGNLSFTGKLYLHGNKLT 325
Query: 324 GGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKD 383
G +P + N L + ++ N+L G IP P ++
Sbjct: 326 GQIPPELGNMSRLSYLQLNDNELVGKIP------------------------PELGKLEQ 361
Query: 384 SYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSD 443
++ L+L++N L G+IPSNI ++L N+ N+L G++P L ++ L+ S
Sbjct: 362 LFE----LNLANNNLVGLIPSNISSCAALNQFNVHGNFLSGAVPLEFRNLGSLTYLNLSS 417
Query: 444 NWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIA 503
N G IP ++G ++L L L N SG IP + + L L LS+N+L G +PA
Sbjct: 418 NSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPAEFG 477
Query: 504 NLSNLKYVDLSFNDLSGILPKEL------------------------INLSHLLSFNISH 539
NL +++ +D+SFN L+G++P EL N L + NIS
Sbjct: 478 NLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLANLNISF 537
Query: 540 NHLHGELPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSSP 599
N+L G +P F SP+S GNP LCG+ V C P
Sbjct: 538 NNLSGIIPPMKNFTRFSPASFFGNPFLCGNWVGSIC----------------------GP 575
Query: 600 NHRRKIVLSISALIAIGAAAFIAIGVIAVTVLNIRVRSSMSRAAAALSFSGGEDYSCSPT 659
+ + V + A+I + I +I + V + + + + ++
Sbjct: 576 SLPKSQVFTRVAVICMVLGFITLICMIFIAVYKSKQQKPVLKGSS--------------- 620
Query: 660 KDPN-YGKLVMFSGDAEFAAGANAL-----LNKDCELGRGGFGVVYRTILQDGRSVAIKK 713
K P KLV+ D + + L++ +G G VY+ + R +AIK+
Sbjct: 621 KQPEGSTKLVILHMDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKR 680
Query: 714 LTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDG 773
+ + + +FE E++T+G IRH N+V+L GY +P LL Y+++ +GSL+ LH
Sbjct: 681 I-YNQYPSNFREFETELETIGSIRHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGP 739
Query: 774 SSRNCLSWRQRFNIILGMAKGLAYLHHT---NIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
+ L W R I +G A+GLAYLHH IIH ++KS+N+L+D + E ++ DFG+A+
Sbjct: 740 GKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNFEARLSDFGIAK 799
Query: 831 LLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMED 890
+P + S+ + +GY+ PE+A RT ++ EK D+Y FG+++LE++TGK+ V D
Sbjct: 800 SIPA-TKTYASTYVLGTIGYIDPEYA-RTSRLNEKSDIYSFGIVLLELLTGKKAV----D 853
Query: 891 DVVVLCDMVRGALEDGRVEDCVDARLRGN-FPADEAIPVIKLGLICASQVPSNRPDMEEV 949
+ L M+ +D V + VDA + + +L L+C + P RP M+EV
Sbjct: 854 NEANLHQMILSKADDNTVMEAVDAEVSVTCMDSGHIKKTFQLALLCTKRNPLERPTMQEV 913
Query: 950 VNIL 953
+L
Sbjct: 914 SRVL 917
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 424 bits (1089), Expect = e-117, Method: Compositional matrix adjust.
Identities = 299/983 (30%), Positives = 478/983 (48%), Gaps = 110/983 (11%)
Query: 6 KLIFLLVLAPVFVRSLDPTFNDDVLGLIVFKAGLEDPKEKLTSWSE-DDDNPCNWVGVKC 64
+++ L + V + N++ L+ K + L W + + + C+W GV C
Sbjct: 7 RMVLSLAMVGFMVFGVASAMNNEGKALMAIKGSFSNLVNMLLDWDDVHNSDLCSWRGVFC 66
Query: 65 DPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDF 124
D + VV L L +L G I + L+ LQ + L N G I ++ + +L +D
Sbjct: 67 DNVSYSVVSLNLSSLNLGGEISPAIGDLRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDL 126
Query: 125 SENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPY 184
SEN L G IP + L ++ NN LTGP+P +L+ +L+ ++ + N L+G++
Sbjct: 127 SENLLYGDIPFSI-SKLKQLETLNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEISR 185
Query: 185 GIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLD 244
+++ LQ L L N+L G + + L L + N +G +PE IG C+ ++LD
Sbjct: 186 LLYWNEVLQYLGLRGNMLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILD 245
Query: 245 FGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPS 304
N ++G +P ++ L ++LSL+GN TG +P+ IG + L LDLS N+ G IP
Sbjct: 246 ISYNQITGEIPYNIGFL-QVATLSLQGNRLTGRIPEVIGLMQALAVLDLSDNELVGPIPP 304
Query: 305 SIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSL 364
+GNL F +L + N TG +P + N L + ++ NKL G IP
Sbjct: 305 ILGNLSFTGKLYLHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIP------------- 351
Query: 365 SGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFG 424
P ++ ++ L+L++N L G IPSNI ++L N+ N L G
Sbjct: 352 -----------PELGKLEQLFE----LNLANNRLVGPIPSNISSCAALNQFNVHGNLLSG 396
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSL 484
SIP + L ++ L+ S N G IP ++G ++L +L L N SG IP + + L
Sbjct: 397 SIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHL 456
Query: 485 TSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKEL------------------ 526
L LS+N+L+G +PA NL +++ +D+SFN LSG++P EL
Sbjct: 457 LILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHG 516
Query: 527 ------INLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAVQN 580
N L++ N+S N+L G +P F+ +P+S GNP LCG+ V C +
Sbjct: 517 KIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPYLCGNWVGSICGPL-- 574
Query: 581 KPIVLNPNSSNPYTGNSSPNHRRKIVLSISALIAIGAAAFIAIGVIA-VTVLNIRVRSSM 639
P R V S ALI I +GVI + ++ + V SM
Sbjct: 575 ------------------PKSR---VFSRGALIC------IVLGVITLLCMIFLAVYKSM 607
Query: 640 SRAAAALSFSGGEDYSCSPTKDPNYGKLVMFSGDAEFAAGANAL-----LNKDCELGRGG 694
+ S + KLV+ D + + LN+ +G G
Sbjct: 608 QQKKI---------LQGSSKQAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGA 658
Query: 695 FGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQ 754
VY+ L+ R +AIK+L + + +FE E++T+G IRH N+V+L GY +P+
Sbjct: 659 SSTVYKCALKSSRPIAIKRL-YNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPTGN 717
Query: 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT---NIIHYNLKST 811
LL Y+++ +GSL+ LH + L W R I +G A+GLAYLHH IIH ++KS+
Sbjct: 718 LLFYDYMENGSLWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSS 777
Query: 812 NVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGF 871
N+L+D + E + DFG+A+ +P + S+ + +GY+ PE+A RT +I EK D+Y F
Sbjct: 778 NILLDENFEAHLSDFGIAKSIPA-SKTHASTYVLGTIGYIDPEYA-RTSRINEKSDIYSF 835
Query: 872 GVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN-FPADEAIPVIK 930
G+++LE++TGK+ V D+ L ++ +D V + VD + +
Sbjct: 836 GIVLLELLTGKKAV----DNEANLHQLILSKADDNTVMEAVDPEVTVTCMDLGHIRKTFQ 891
Query: 931 LGLICASQVPSNRPDMEEVVNIL 953
L L+C + P RP M EV +L
Sbjct: 892 LALLCTKRNPLERPTMLEVSRVL 914
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 967 | ||||||
| 255575584 | 968 | Brassinosteroid LRR receptor kinase prec | 0.995 | 0.994 | 0.791 | 0.0 | |
| 224140605 | 965 | predicted protein [Populus trichocarpa] | 0.976 | 0.978 | 0.781 | 0.0 | |
| 224091114 | 965 | predicted protein [Populus trichocarpa] | 0.994 | 0.996 | 0.765 | 0.0 | |
| 356530171 | 962 | PREDICTED: probably inactive leucine-ric | 0.991 | 0.996 | 0.727 | 0.0 | |
| 449439801 | 959 | PREDICTED: probably inactive leucine-ric | 0.988 | 0.996 | 0.715 | 0.0 | |
| 359481232 | 966 | PREDICTED: probably inactive leucine-ric | 0.991 | 0.992 | 0.736 | 0.0 | |
| 357506675 | 948 | Receptor-like protein kinase [Medicago t | 0.968 | 0.988 | 0.683 | 0.0 | |
| 225448703 | 969 | PREDICTED: probably inactive leucine-ric | 0.983 | 0.981 | 0.701 | 0.0 | |
| 356495131 | 969 | PREDICTED: probably inactive leucine-ric | 0.982 | 0.980 | 0.703 | 0.0 | |
| 255559719 | 963 | ATP binding protein, putative [Ricinus c | 0.985 | 0.989 | 0.667 | 0.0 |
| >gi|255575584|ref|XP_002528692.1| Brassinosteroid LRR receptor kinase precursor, putative [Ricinus communis] gi|223531864|gb|EEF33681.1| Brassinosteroid LRR receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1509 bits (3906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 762/963 (79%), Positives = 853/963 (88%)
Query: 5 LKLIFLLVLAPVFVRSLDPTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKC 64
K L+L P FV S DPTFNDDVLGLIVFKAGL+DP+ KLTSW+ED +NPCNWVGVKC
Sbjct: 6 FKFCIFLLLVPFFVHSSDPTFNDDVLGLIVFKAGLQDPESKLTSWNEDSENPCNWVGVKC 65
Query: 65 DPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDF 124
DPKT+RV L LDGF LSGHIGRGL+RLQFLQ+LSLSNNNFTGTIN DL+ G LQV+D
Sbjct: 66 DPKTQRVTELALDGFFLSGHIGRGLIRLQFLQILSLSNNNFTGTINPDLSQLGGLQVIDL 125
Query: 125 SENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPY 184
S N LSG IPDEFF+QCGSLR VSFA NNL+G IPESLS+C SL +VNFSSN+LSG+LP
Sbjct: 126 SRNKLSGFIPDEFFKQCGSLRSVSFAKNNLSGQIPESLSWCPSLAAVNFSSNQLSGELPS 185
Query: 185 GIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLD 244
G+WFLR LQSLDLS+NLL+G+I GI+N+YDLRAI L KN+FSGQLP DIGGC +LK+LD
Sbjct: 186 GLWFLRGLQSLDLSDNLLDGQIPGGIANVYDLRAIHLQKNRFSGQLPVDIGGCVLLKMLD 245
Query: 245 FGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPS 304
F NSLSGSLP+SLQRL SC++L L+GNSF GE+P WIG+L LESLDLS N+FSGRIP+
Sbjct: 246 FSENSLSGSLPESLQRLGSCTTLRLRGNSFAGEIPGWIGELPTLESLDLSANKFSGRIPT 305
Query: 305 SIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSL 364
SIGNL LKELN+SMN GGLPESM NC NLL +D+SQN+L+G +PTWIFKMGL ++S+
Sbjct: 306 SIGNLNTLKELNLSMNHLIGGLPESMENCANLLVLDISQNRLSGTLPTWIFKMGLHSISI 365
Query: 365 SGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFG 424
SGNRLG SM YPS AS+ S QGL+VLDLSSNALSG IP++IG +SSL+L N+S N LFG
Sbjct: 366 SGNRLGWSMHYPSVASLASSLQGLKVLDLSSNALSGEIPADIGVISSLLLFNISRNRLFG 425
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSL 484
SIP+SIG+LK IQVLDFS+N LNG IP +IGGA SL EL+LEKN L+G IP+QIKNCSSL
Sbjct: 426 SIPSSIGELKMIQVLDFSNNKLNGRIPSEIGGAASLVELRLEKNSLTGNIPTQIKNCSSL 485
Query: 485 TSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHG 544
TSLILS NNLTGPVPAAIANLSNL+YVDLSFN+LSG LPKEL NLS L+SFNISHN+LHG
Sbjct: 486 TSLILSHNNLTGPVPAAIANLSNLEYVDLSFNNLSGSLPKELTNLSRLVSFNISHNNLHG 545
Query: 545 ELPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNHRRK 604
ELP+GGFFNTISPSSVS NPSLCGSVVNRSCP+V KPIVLNPNSS G+S ++ RK
Sbjct: 546 ELPLGGFFNTISPSSVSVNPSLCGSVVNRSCPSVHPKPIVLNPNSSTSAHGSSLNSNHRK 605
Query: 605 IVLSISALIAIGAAAFIAIGVIAVTVLNIRVRSSMSRAAAALSFSGGEDYSCSPTKDPNY 664
I LSISALIAIGAAAFIA+GVIA+++LNI VRSSM + A + SGGED+SCSPT DPNY
Sbjct: 606 IALSISALIAIGAAAFIALGVIAISLLNIHVRSSMMQTPVAFTLSGGEDFSCSPTNDPNY 665
Query: 665 GKLVMFSGDAEFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQE 724
GKLVMFSGDA+F AGA+ALLNKDCELGRGGFGVVYRTIL+DGRSVAIKKLTVS LIKSQE
Sbjct: 666 GKLVMFSGDADFVAGAHALLNKDCELGRGGFGVVYRTILRDGRSVAIKKLTVSSLIKSQE 725
Query: 725 DFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQR 784
+FE+E+K LG+IRHHNLVALEGYYWTPSLQLLIYE+ISSG LYKHLHDG + NCLSWR+R
Sbjct: 726 EFEREVKRLGQIRHHNLVALEGYYWTPSLQLLIYEYISSGCLYKHLHDGPNINCLSWRRR 785
Query: 785 FNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI 844
FNIILGMAKGL++LH N+IHYNLKSTN+L+D SGEPKVGDFGLARLLPMLDRCILSSKI
Sbjct: 786 FNIILGMAKGLSHLHQMNVIHYNLKSTNILLDDSGEPKVGDFGLARLLPMLDRCILSSKI 845
Query: 845 QSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE 904
QSALGYMAPEFACRTVKITEKCDVYGFG+LVLEVVTGKRPVEYMEDDVVVLCDMVRGALE
Sbjct: 846 QSALGYMAPEFACRTVKITEKCDVYGFGILVLEVVTGKRPVEYMEDDVVVLCDMVRGALE 905
Query: 905 DGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQE 964
+GRVE+CVD RL GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ P +GQE
Sbjct: 906 NGRVEECVDGRLLGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQCPAEGQE 965
Query: 965 ELE 967
ELE
Sbjct: 966 ELE 968
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224140605|ref|XP_002323672.1| predicted protein [Populus trichocarpa] gi|222868302|gb|EEF05433.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1495 bits (3870), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 738/944 (78%), Positives = 826/944 (87%)
Query: 24 TFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSG 83
+ NDDVLGLIVFKAGL+DP+ KL+SW+EDDD+PCNWVGVKCDP T RV L LDGFSLSG
Sbjct: 22 SINDDVLGLIVFKAGLQDPESKLSSWNEDDDSPCNWVGVKCDPNTHRVTELVLDGFSLSG 81
Query: 84 HIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGS 143
HIGRGLLRLQFLQVLSL+NNNF GTIN DL G LQV+D SEN LSG IPD FF+QCGS
Sbjct: 82 HIGRGLLRLQFLQVLSLANNNFNGTINPDLPRLGGLQVIDLSENGLSGSIPDGFFQQCGS 141
Query: 144 LREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLE 203
LR VSFA N+LTG IP SLSFC SL VNFSSN LSG+LP G+W+LR LQSLDLS+NLLE
Sbjct: 142 LRSVSFARNDLTGMIPGSLSFCMSLSVVNFSSNGLSGELPSGLWYLRGLQSLDLSDNLLE 201
Query: 204 GEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNS 263
GEI +GI+NLY LRAI L +N+F+GQLP DIGGC +LK+LDF N+LSG LP+SLQRL+S
Sbjct: 202 GEIPEGIANLYALRAINLRRNRFTGQLPVDIGGCQVLKLLDFSENALSGGLPESLQRLSS 261
Query: 264 CSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFT 323
C+++ L GNSFTGEVP WIG+L +LESLDLS+N+ SGRIP SIGNL LKELN+SMNQ T
Sbjct: 262 CATVRLGGNSFTGEVPGWIGELTSLESLDLSVNRLSGRIPVSIGNLNVLKELNLSMNQLT 321
Query: 324 GGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKD 383
GGLPESM NC NLLAIDVS N+LTGN+P+WIFK GL++VSLSGN+L ES+++PS S+
Sbjct: 322 GGLPESMANCVNLLAIDVSHNRLTGNLPSWIFKTGLKSVSLSGNKLDESIEHPSGVSLAA 381
Query: 384 SYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSD 443
S + LQVLDLSSN SG IPS+IG LSSL L N+S N LFGSIP S+G+L IQ LD SD
Sbjct: 382 SLESLQVLDLSSNVFSGEIPSDIGVLSSLQLFNVSRNQLFGSIPPSVGELTMIQALDLSD 441
Query: 444 NWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIA 503
N L G+IP +IGGAVSLKEL+LE NFL+G+IP+QIK CSSLTSLI+S NNL+GP+P AIA
Sbjct: 442 NRLTGSIPSEIGGAVSLKELRLEMNFLTGKIPTQIKKCSSLTSLIISGNNLSGPIPVAIA 501
Query: 504 NLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGN 563
NL+NL+YVDLSFN SG LPKEL NLSHLLSFNISHN+L G+LP+GGFFNTISPSSVS N
Sbjct: 502 NLTNLQYVDLSFNRFSGSLPKELANLSHLLSFNISHNNLKGDLPLGGFFNTISPSSVSRN 561
Query: 564 PSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNHRRKIVLSISALIAIGAAAFIAI 623
PSLCGSVVNRSCP+V KPIVLNPNSS G S H RKI LSISALIAIGAAA I +
Sbjct: 562 PSLCGSVVNRSCPSVHQKPIVLNPNSSGSSNGTSFNLHHRKIALSISALIAIGAAACITL 621
Query: 624 GVIAVTVLNIRVRSSMSRAAAALSFSGGEDYSCSPTKDPNYGKLVMFSGDAEFAAGANAL 683
GV+AVT+LNIR RSSM+R+ AA +FSGGED+SCSPT DPNYGKLVMFSGDA+F AGA AL
Sbjct: 622 GVVAVTLLNIRARSSMARSPAAFTFSGGEDFSCSPTNDPNYGKLVMFSGDADFVAGAQAL 681
Query: 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
LNKD ELGRGGFGVVYRTIL+DGRSVAIKKLTVS LIKSQ++FE+E+K LG++RHHNLV
Sbjct: 682 LNKDSELGRGGFGVVYRTILRDGRSVAIKKLTVSSLIKSQDEFEREVKKLGEVRHHNLVT 741
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
LEGYYWTPSLQLLIYE++SSGSLYKHLHDG +N LSWR RFNIILGMA+GLA+LHH NI
Sbjct: 742 LEGYYWTPSLQLLIYEYVSSGSLYKHLHDGPDKNYLSWRHRFNIILGMARGLAHLHHMNI 801
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
HYNLKSTN+LID SGEPKVGDFGLA+LLP LDRCILSSKIQSALGYMAPEFACRTVKIT
Sbjct: 802 THYNLKSTNILIDDSGEPKVGDFGLAKLLPTLDRCILSSKIQSALGYMAPEFACRTVKIT 861
Query: 864 EKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923
EKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE+C+D RLRGNFPAD
Sbjct: 862 EKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEECIDGRLRGNFPAD 921
Query: 924 EAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEELE 967
EAIPV+KLGLIC+SQVPSNRPDMEEVVNILELIQ P GQEELE
Sbjct: 922 EAIPVVKLGLICSSQVPSNRPDMEEVVNILELIQCPAGGQEELE 965
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224091114|ref|XP_002309183.1| predicted protein [Populus trichocarpa] gi|222855159|gb|EEE92706.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1472 bits (3812), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 738/964 (76%), Positives = 830/964 (86%), Gaps = 2/964 (0%)
Query: 5 LKLIFLLVLAPVFV-RSLDPTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVK 63
LK +FL+ LAP+ V + LD TFNDDVLGLIVFKAGL+DP+ KL+SW+EDDD+PC+WVGVK
Sbjct: 3 LKFLFLVGLAPLLVVQCLDSTFNDDVLGLIVFKAGLQDPESKLSSWNEDDDSPCSWVGVK 62
Query: 64 CDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVD 123
C+P T RV L LDGFSLSGHIGRGLLRLQFLQVLSL+NN F GTIN DL G LQV+D
Sbjct: 63 CEPNTHRVTELFLDGFSLSGHIGRGLLRLQFLQVLSLANNKFNGTINPDLPRLGGLQVID 122
Query: 124 FSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLP 183
S+N+LSG IPD FF+QCGSLR VSFA N+LTG IP SLS C +L VNFSSN L G+LP
Sbjct: 123 LSDNSLSGSIPDGFFQQCGSLRSVSFARNDLTGMIPGSLSSCMTLSLVNFSSNGLCGELP 182
Query: 184 YGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVL 243
G+W+LR LQSLDLS+NLLEGEI +GI+NLYDLR I L N+F+GQLP DIGG +LK+L
Sbjct: 183 SGLWYLRGLQSLDLSDNLLEGEIPEGIANLYDLRVINLKNNRFTGQLPVDIGGSQVLKLL 242
Query: 244 DFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIP 303
DF NSLSGSLP+SL+RL+SC+++ L GNSFTGEVP WIG+L +LESLDLS N+FSGRIP
Sbjct: 243 DFSENSLSGSLPESLRRLSSCATVRLGGNSFTGEVPGWIGELTDLESLDLSANRFSGRIP 302
Query: 304 SSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVS 363
SIGNL LKELN+SMNQ TGGLPESMMNC NLLAIDVS N+LTGN+P+WIFK GL VS
Sbjct: 303 VSIGNLNVLKELNLSMNQLTGGLPESMMNCLNLLAIDVSHNRLTGNLPSWIFKSGLNRVS 362
Query: 364 LSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLF 423
SGNR ES Q+PS S+ S QGLQVLDLSSN SG IPS+IG LSSL+LLN+S N LF
Sbjct: 363 PSGNRFDESKQHPSGVSLAVSIQGLQVLDLSSNVFSGEIPSDIGVLSSLLLLNVSRNQLF 422
Query: 424 GSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSS 483
GSIP+SIG L I+ LD SDN LNG+IP +IGGA+SL EL+LEKN L+G+IP+QIK CSS
Sbjct: 423 GSIPSSIGDLTMIRALDLSDNRLNGSIPSEIGGAISLTELRLEKNLLTGKIPTQIKKCSS 482
Query: 484 LTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLH 543
L SLILS NNLTGP+P A+ANL NL+YVDLSFN LSG LPKEL NLSHLLSFNISHN+L
Sbjct: 483 LASLILSWNNLTGPIPVAVANLINLQYVDLSFNRLSGSLPKELTNLSHLLSFNISHNNLQ 542
Query: 544 GELPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNHRR 603
G+LP+GGFFNT+SPSSVSGNPSLCGSVVN SCP+ KPIVLNPNSS+ G S H
Sbjct: 543 GDLPLGGFFNTVSPSSVSGNPSLCGSVVNLSCPSDHQKPIVLNPNSSDSSNGTSLDRH-H 601
Query: 604 KIVLSISALIAIGAAAFIAIGVIAVTVLNIRVRSSMSRAAAALSFSGGEDYSCSPTKDPN 663
KIVLSISALIAIGAAA I +GV+AV LNI +SSM+R+ AA +FSGGED+SCSPT DPN
Sbjct: 602 KIVLSISALIAIGAAACITLGVVAVIFLNIHAQSSMARSPAAFAFSGGEDFSCSPTNDPN 661
Query: 664 YGKLVMFSGDAEFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQ 723
YGKLVMFSGDA+F AGA ALLNKD ELGRGGFGVVYRTIL+DGRSVAIKKLTVS LIKSQ
Sbjct: 662 YGKLVMFSGDADFVAGARALLNKDSELGRGGFGVVYRTILRDGRSVAIKKLTVSSLIKSQ 721
Query: 724 EDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQ 783
++FE+E+K LGK+RHHNLVALEGYYWTP+LQLLIYE++SSGSLYKHLHDG + LSWR
Sbjct: 722 DEFEREVKELGKVRHHNLVALEGYYWTPTLQLLIYEYVSSGSLYKHLHDGPDKKYLSWRH 781
Query: 784 RFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843
RFNIILGMA+ LA+LHH NI+HYNLKSTN+LID SGEPKVGDFGLA+LLP LDRCILSSK
Sbjct: 782 RFNIILGMARALAHLHHMNIVHYNLKSTNILIDDSGEPKVGDFGLAKLLPTLDRCILSSK 841
Query: 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGAL 903
IQSALGYMAPEFACRTVKITEKCDVYGFG+LVLEVVTGKRPVEYMEDDVVVLCDMVRGAL
Sbjct: 842 IQSALGYMAPEFACRTVKITEKCDVYGFGILVLEVVTGKRPVEYMEDDVVVLCDMVRGAL 901
Query: 904 EDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQ 963
EDGRVE+C+D +L G PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ P +G
Sbjct: 902 EDGRVEECIDGKLGGKVPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQCPAEGH 961
Query: 964 EELE 967
EELE
Sbjct: 962 EELE 965
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356530171|ref|XP_003533657.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1366 bits (3535), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 700/962 (72%), Positives = 805/962 (83%), Gaps = 3/962 (0%)
Query: 7 LIFLLVLAPV-FVRSLDPTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKCD 65
++FL++LAPV V S+D FNDDVLGLIVFKAGL+DPK KL+SW+EDD++PCNW GVKCD
Sbjct: 3 VLFLILLAPVMLVFSVDTGFNDDVLGLIVFKAGLDDPKRKLSSWNEDDNSPCNWEGVKCD 62
Query: 66 PKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFS 125
P + RV L LDGFSLSGH+ RGLLRLQ LQ+LSLS NNFTG+IN DL G+LQVVD S
Sbjct: 63 PSSNRVTALVLDGFSLSGHVDRGLLRLQSLQILSLSRNNFTGSINPDLPLLGSLQVVDLS 122
Query: 126 ENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYG 185
+NNLSG IP+ FF+QCGSLR VSFA NNLTG IPESLS CS+L SVNFSSN+L G+LP G
Sbjct: 123 DNNLSGEIPEGFFQQCGSLRTVSFAKNNLTGKIPESLSSCSNLASVNFSSNQLHGELPNG 182
Query: 186 IWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDF 245
+WFLR LQSLDLS+N LEGEI +GI NLYD+R + L +N+FSG+LP DIGGC +LK LD
Sbjct: 183 VWFLRGLQSLDLSDNFLEGEIPEGIQNLYDMRELSLQRNRFSGRLPGDIGGCILLKSLDL 242
Query: 246 GVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSS 305
N LS LP S+QRL SC+S+SL+GNSFTG +P+WIG+L NLE LDLS N FSG IP S
Sbjct: 243 SGNFLS-ELPQSMQRLTSCTSISLQGNSFTGGIPEWIGELKNLEVLDLSANGFSGWIPKS 301
Query: 306 IGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLS 365
+GNL L LN+S N+ TG +P+SMMNC LLA+D+S N L G++P+WIFKMG+Q++SLS
Sbjct: 302 LGNLDSLHRLNLSRNRLTGNMPDSMMNCTKLLALDISHNHLAGHVPSWIFKMGVQSISLS 361
Query: 366 GNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGS 425
G+ + YPS SY GL+VLDLSSNA SGV+PS IG L SL +LN S N + GS
Sbjct: 362 GDGFSKG-NYPSLKPTPASYHGLEVLDLSSNAFSGVLPSGIGGLGSLQVLNFSTNNISGS 420
Query: 426 IPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLT 485
IP IG LK++ ++D SDN LNG+IP +I GA SL EL+L+KNFL GRIP+QI CSSLT
Sbjct: 421 IPVGIGDLKSLYIVDLSDNKLNGSIPSEIEGATSLSELRLQKNFLGGRIPAQIDKCSSLT 480
Query: 486 SLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGE 545
LILS N LTG +PAAIANL+NL+YVDLS+N+LSG LPKEL NLSHL SFN+S+NHL GE
Sbjct: 481 FLILSHNKLTGSIPAAIANLTNLQYVDLSWNELSGSLPKELTNLSHLFSFNVSYNHLEGE 540
Query: 546 LPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNHRRKI 605
LPVGGFFNTIS SSVSGNP LCGSVVN SCP+V KPIVLNPNSS + S NHR KI
Sbjct: 541 LPVGGFFNTISFSSVSGNPLLCGSVVNHSCPSVHPKPIVLNPNSSGSNSSISLQNHRHKI 600
Query: 606 VLSISALIAIGAAAFIAIGVIAVTVLNIRVRSSMSRAAAALSFSGGEDYSCSPTKDPNYG 665
+LSISALIAIGAAAFIA+GV+AVTVLNI VRSSM AA SFSGGEDYS SP DPNYG
Sbjct: 601 ILSISALIAIGAAAFIAVGVVAVTVLNIHVRSSMEHTAAPFSFSGGEDYSGSPANDPNYG 660
Query: 666 KLVMFSGDAEFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQED 725
KLVMFSGDA+FA GA+ +LNK+ E+GRGGFGVVYRT L+DGR+VAIKKLTVS LIKSQE+
Sbjct: 661 KLVMFSGDADFADGAHNILNKESEIGRGGFGVVYRTFLRDGRAVAIKKLTVSSLIKSQEE 720
Query: 726 FEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF 785
FE+E+K LGK+RH NLVALEGYYWT SLQLLIY+++SSGSL+K LHD +S+N SW QRF
Sbjct: 721 FEREIKKLGKVRHPNLVALEGYYWTSSLQLLIYDYLSSGSLHKLLHDDNSKNVFSWPQRF 780
Query: 786 NIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQ 845
+ILGMAKGLA+LH NIIHYNLKSTNVLID SGEPKVGDFGL +LLPMLD C+LSSKIQ
Sbjct: 781 KVILGMAKGLAHLHQMNIIHYNLKSTNVLIDCSGEPKVGDFGLVKLLPMLDHCVLSSKIQ 840
Query: 846 SALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALED 905
SALGYMAPEFACRTVKIT+KCDVYGFG+LVLE+VTGKRPVEYMEDDVVVLCDMVRGALE+
Sbjct: 841 SALGYMAPEFACRTVKITKKCDVYGFGILVLEIVTGKRPVEYMEDDVVVLCDMVRGALEE 900
Query: 906 GRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEE 965
G+VE CVD RL GNF A+EAIPVIKLGLICASQVPSNRPDM EVVNILELIQ P +GQEE
Sbjct: 901 GKVEQCVDGRLLGNFAAEEAIPVIKLGLICASQVPSNRPDMAEVVNILELIQCPSEGQEE 960
Query: 966 LE 967
LE
Sbjct: 961 LE 962
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439801|ref|XP_004137674.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Cucumis sativus] gi|449497163|ref|XP_004160330.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1363 bits (3528), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 690/964 (71%), Positives = 798/964 (82%), Gaps = 8/964 (0%)
Query: 5 LKLIFLLVLAPVFVRSLDPTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKC 64
KL +LVLA V ++D FNDDVLGLIVFKAGL+DP KL +W+EDD+ PCNW GVKC
Sbjct: 3 FKLFLILVLAAAGVSAVDTAFNDDVLGLIVFKAGLQDPMGKLVTWNEDDETPCNWFGVKC 62
Query: 65 DPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDF 124
+PKT RV L LDGFSLSGHIGRGLLRLQFLQ+LSL+NNNFTGTIN+ L+ G LQV+D
Sbjct: 63 NPKTNRVSELVLDGFSLSGHIGRGLLRLQFLQILSLANNNFTGTINSALSHLGNLQVIDL 122
Query: 125 SENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPY 184
S+N+LSG IP++ F QCGS+R +SFA NNL G IP+SL+ C SLE +NFSSN LSG LP
Sbjct: 123 SDNSLSGPIPEQLFLQCGSIRVLSFARNNLIGNIPQSLTSCFSLELLNFSSNHLSGTLPS 182
Query: 185 GIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLD 244
G+W+LR LQSLDLS+NLLEG+I GI NLYDLR + L KN+ SG+LPEDIGGC +LK LD
Sbjct: 183 GLWYLRELQSLDLSDNLLEGQIPTGIQNLYDLRFVSLHKNRLSGKLPEDIGGCLLLKSLD 242
Query: 245 FGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPS 304
F N LSG LP+S+Q L+SC+ L+L+GN TGEVP WIG+L NL++LDLS N FSG++PS
Sbjct: 243 FSENILSGGLPESMQMLSSCTYLNLRGNFLTGEVPRWIGELKNLDTLDLSANNFSGQLPS 302
Query: 305 SIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSL 364
SIGNL FLK+ N+S N T LPESM NC NLL+ID S N+LTGN+P WIFK + +V
Sbjct: 303 SIGNLQFLKKFNVSTNYLTRNLPESMENCNNLLSIDASHNRLTGNLPIWIFKAAMPSVPF 362
Query: 365 SGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFG 424
S RL E++ P+ S+QGLQVLDLSSN SG IPSN+G+L +L LLN+S N+L G
Sbjct: 363 SSYRLEENLSSPA------SFQGLQVLDLSSNIFSGHIPSNVGELGNLQLLNISRNHLVG 416
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSL 484
SIP SIG+LK+ LDFSDN L+G+IP +IGGA+SLKEL+LEKNFL+G IP +I C L
Sbjct: 417 SIPRSIGELKSAYALDFSDNQLSGSIPAEIGGAISLKELRLEKNFLTGEIPVKIGKCPLL 476
Query: 485 TSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHG 544
TSLILS NNLTG +PAA+ANLSNL VDLSFN LSG LPKEL NLSHLLSFNISHNHL G
Sbjct: 477 TSLILSHNNLTGSIPAAVANLSNLVDVDLSFNKLSGSLPKELTNLSHLLSFNISHNHLEG 536
Query: 545 ELPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNHRRK 604
ELPVGGFFN ISP S+S NPSLCG+VVNRSCP+V KPIVLNPNSS+ + S NH +
Sbjct: 537 ELPVGGFFNAISPLSISHNPSLCGAVVNRSCPSVHPKPIVLNPNSSDANGNSPSHNHHHE 596
Query: 605 IVLSISALIAIGAAAFIAIGVIAVTVLNIRVRSSMSRAAAALSFSGGEDYSCSPTKDPNY 664
I+LSIS++IAIGAA+FI +GV+AVT+LNIR RSS SR +AAL S ED+SCSP + +Y
Sbjct: 597 IILSISSIIAIGAASFILLGVVAVTILNIRARSSQSR-SAALVLSVREDFSCSPKTNSDY 655
Query: 665 GKLVMFSGDAEFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQE 724
GKLVMFSGDAEF GA ALLNKDCELGRGGFGVVY+T+L+DG VAIKKLTV+ LIKS+E
Sbjct: 656 GKLVMFSGDAEFVVGAQALLNKDCELGRGGFGVVYKTVLRDGYLVAIKKLTVTSLIKSRE 715
Query: 725 DFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRN-CLSWRQ 783
DFE E+K LG+IRHHNLVALEGYYWT SLQLLIYE++ +GSLYKHLHD + N CLSWRQ
Sbjct: 716 DFESEVKKLGQIRHHNLVALEGYYWTTSLQLLIYEYVPNGSLYKHLHDRTGDNYCLSWRQ 775
Query: 784 RFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843
RF I+LGMAKGLAYLHH NIIHYNLKSTNVLIDSSG+PKVGD+GLA LLPMLDRCILSSK
Sbjct: 776 RFKIVLGMAKGLAYLHHNNIIHYNLKSTNVLIDSSGKPKVGDYGLAMLLPMLDRCILSSK 835
Query: 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGAL 903
IQSALGYMAPEFAC+TV ITEKCDVYGFG+LVLEVVTGKRPVEYMEDDV+VLCDMVR AL
Sbjct: 836 IQSALGYMAPEFACKTVTITEKCDVYGFGILVLEVVTGKRPVEYMEDDVIVLCDMVRVAL 895
Query: 904 EDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQ 963
++G VE CVD RL+ NF +EAIPV+KLGLICASQVPSNRPDM EVVNILELIQSP +
Sbjct: 896 DEGTVERCVDERLQLNFRVEEAIPVMKLGLICASQVPSNRPDMNEVVNILELIQSPSEVD 955
Query: 964 EELE 967
EELE
Sbjct: 956 EELE 959
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359481232|ref|XP_002267737.2| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1362 bits (3526), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 708/961 (73%), Positives = 807/961 (83%), Gaps = 2/961 (0%)
Query: 5 LKLIFLLVLAPVFVRSLDPTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKC 64
+ L +L + PV + SLDP FNDDVLGLIVFKAGL+DP+ KL SW+EDD+NPCNW GVKC
Sbjct: 3 VTLFAVLFIVPVVLGSLDPGFNDDVLGLIVFKAGLQDPESKLISWNEDDNNPCNWAGVKC 62
Query: 65 DPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDF 124
D +T RV L LD FSLSG IGRGLLRLQFL++LSLS NNFTGTIN LA +L+V+D
Sbjct: 63 DRQTNRVSELLLDNFSLSGRIGRGLLRLQFLRILSLSKNNFTGTINPSLARIASLRVIDL 122
Query: 125 SENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPY 184
SENNLSG IPDEFFRQCGSL VS A N L+G IP++LS C +L VNFSSN+LSGQLP
Sbjct: 123 SENNLSGPIPDEFFRQCGSLIVVSLAGNKLSGQIPDTLSLCKTLRGVNFSSNQLSGQLPD 182
Query: 185 GIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLD 244
GIW L L+SLDLSNN LEGEI +GI +LY LRAI LGKNKFSG++P+ IG C +L++LD
Sbjct: 183 GIWSLYGLRSLDLSNNFLEGEIPEGIGSLYSLRAINLGKNKFSGRIPDSIGSCLLLRLLD 242
Query: 245 FGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPS 304
N SG LP+S+QRL C+ LSL+GN TGEVP WI + NL +LDLS N FSG+IP+
Sbjct: 243 LSENLFSGGLPESMQRLRMCNYLSLRGNLLTGEVPAWIWGMRNLGTLDLSANVFSGQIPN 302
Query: 305 SIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSL 364
SIGNL+ LKELN+S NQF G LPESM C NL+A+DVS N LTGN+P WIF +GLQT+SL
Sbjct: 303 SIGNLLLLKELNLSSNQFGGSLPESMTKCTNLVAMDVSHNLLTGNLPAWIFSLGLQTISL 362
Query: 365 SGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFG 424
+GN+L S++Y SM SYQ LQVLDLSSNALSG I S I SSL LNMS N L G
Sbjct: 363 AGNKLNGSVEYSPLTSMAASYQRLQVLDLSSNALSGEILSGIAAFSSLQFLNMSRNSLIG 422
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSL 484
SIP SIG+LK + VLD S+N LNG+IP +I GAV LKELKLEKNFL+G+IP+QI+ C SL
Sbjct: 423 SIPESIGELKTLHVLDLSNNQLNGSIPFEIRGAVLLKELKLEKNFLTGKIPTQIEKCKSL 482
Query: 485 TSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHG 544
TSLILSQN+LTGP+PAAIANL++++ VDLSFN+LSG LPKEL NLSHLLSFNISHN++ G
Sbjct: 483 TSLILSQNHLTGPIPAAIANLTSIENVDLSFNNLSGSLPKELTNLSHLLSFNISHNNIQG 542
Query: 545 ELPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPN--SSNPYTGNSSPNHR 602
ELP GGFFNTISPSSVSGNPSLCGSVVNRSCP+V KPIVLNP+ S++ G+ N R
Sbjct: 543 ELPSGGFFNTISPSSVSGNPSLCGSVVNRSCPSVHPKPIVLNPDSSSNSSNAGSFPSNRR 602
Query: 603 RKIVLSISALIAIGAAAFIAIGVIAVTVLNIRVRSSMSRAAAALSFSGGEDYSCSPTKDP 662
KI+LSISALIAIGAA FIA+GV+A+T+LNI RSSMS AAA+ SGG+D+S SPT D
Sbjct: 603 HKIILSISALIAIGAAIFIAVGVLAITILNIHARSSMSHAAASPILSGGDDFSHSPTNDA 662
Query: 663 NYGKLVMFSGDAEFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKS 722
YGKLVMFSGDA+F AGA+ALLNKDCELGRGGFG VYRTIL+DGRSVAIKKLTVS LIKS
Sbjct: 663 QYGKLVMFSGDADFVAGAHALLNKDCELGRGGFGAVYRTILRDGRSVAIKKLTVSSLIKS 722
Query: 723 QEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWR 782
QEDFE+E+K LGKIRHHNLVALEGYYWT SLQLLIYE+ISSGSLYKHLH+ ++CLSWR
Sbjct: 723 QEDFEREVKNLGKIRHHNLVALEGYYWTSSLQLLIYEYISSGSLYKHLHEVPGKSCLSWR 782
Query: 783 QRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842
+RFNI+LG AKGLA+LH NIIHYNLKSTN+LIDS GEPKVGDF LARLLPMLDR +LSS
Sbjct: 783 ERFNIVLGTAKGLAHLHQLNIIHYNLKSTNILIDSGGEPKVGDFALARLLPMLDRYVLSS 842
Query: 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGA 902
KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTG+RPVEYMEDDVVVLCDMVRGA
Sbjct: 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGRRPVEYMEDDVVVLCDMVRGA 902
Query: 903 LEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962
L++G+VE+CVD RL+G FPADEAIPVIKLGLICASQVPSNRPDM EVVNILELIQ P +G
Sbjct: 903 LDEGKVEECVDRRLQGEFPADEAIPVIKLGLICASQVPSNRPDMGEVVNILELIQCPSEG 962
Query: 963 Q 963
Q
Sbjct: 963 Q 963
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357506675|ref|XP_003623626.1| Receptor-like protein kinase [Medicago truncatula] gi|355498641|gb|AES79844.1| Receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1342 bits (3473), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 660/965 (68%), Positives = 780/965 (80%), Gaps = 28/965 (2%)
Query: 5 LKLIFLLVLAPVFVRSL---DPTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVG 61
+ L+F++ V ++ DP FNDD+LGLIVFKAGL+DPK KL SW+EDD PCNW G
Sbjct: 7 IYLLFVIFFGSVMLQVFSVDDPVFNDDILGLIVFKAGLQDPKHKLISWNEDDYTPCNWEG 66
Query: 62 VKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQV 121
VKCD RV + LDGFSLSGHI RGLLRLQFLQ LSLS NNFTG IN DL G+LQV
Sbjct: 67 VKCDSSNNRVTSVILDGFSLSGHIDRGLLRLQFLQTLSLSGNNFTGFINPDLPKLGSLQV 126
Query: 122 VDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQ 181
VDFS+NNL G IP+ FF+QCGSL+ V+FA NNLTG IP SL C++L +VNFS N++ G+
Sbjct: 127 VDFSDNNLKGTIPEGFFQQCGSLKTVNFAKNNLTGNIPVSLGTCNTLANVNFSYNQIDGK 186
Query: 182 LPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLK 241
LP +WFLR LQSLD+SNNLL+GEI +GI NLYD+R + L KN+FSG++P+DIGGC +LK
Sbjct: 187 LPSEVWFLRGLQSLDVSNNLLDGEIPEGIQNLYDMRELSLKKNRFSGRIPQDIGGCIVLK 246
Query: 242 VLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGR 301
LD N LSG +P S+QRLNSC+SLSL+GNSFTG +PDWIG+L +LE+LDLS N+FSG
Sbjct: 247 SLDLSGNLLSGGIPQSMQRLNSCNSLSLQGNSFTGNIPDWIGELKDLENLDLSANRFSGW 306
Query: 302 IPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQT 361
IP S+GNL L+ LN S NQ TG LP+SMMNC LLA+D+S N+L G +P+WIF+ G
Sbjct: 307 IPKSLGNLNMLQRLNFSRNQLTGNLPDSMMNCTKLLALDISNNQLNGYLPSWIFRNG--- 363
Query: 362 VSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNY 421
+Y GL+VLDLSSN+ SG IPS+IG LSSL + NMS NY
Sbjct: 364 ----------------------NYHGLEVLDLSSNSFSGEIPSDIGGLSSLKIWNMSTNY 401
Query: 422 LFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNC 481
GS+P IG+LK++ ++D SDN LNG+IP ++ GA+SL EL+L+KN + GRIP QI C
Sbjct: 402 FSGSVPVGIGELKSLCIVDLSDNKLNGSIPFELEGAISLGELRLQKNSIGGRIPDQIAKC 461
Query: 482 SSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNH 541
S+LTSL LS N LTG +P AIANL+NL++VDLS+N+LSG LPKEL NLS+LLSF++S+NH
Sbjct: 462 SALTSLDLSHNKLTGSIPGAIANLTNLQHVDLSWNELSGTLPKELTNLSNLLSFDVSYNH 521
Query: 542 LHGELPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNH 601
L GELPVGGFFNTI SSV+GN LCGSVVN SCP+V KPIVLNPNSS P + S H
Sbjct: 522 LQGELPVGGFFNTIPSSSVTGNSLLCGSVVNHSCPSVHPKPIVLNPNSSAPNSSVPSNYH 581
Query: 602 RRKIVLSISALIAIGAAAFIAIGVIAVTVLNIRVRSSMSRAAAALSFSGGEDYSCSPTKD 661
R KI+LSISAL+AIGAAA IA+GV+A+T LN+R RS+M R+A +FSGGEDYS SP D
Sbjct: 582 RHKIILSISALVAIGAAALIAVGVVAITFLNMRARSAMERSAVPFAFSGGEDYSNSPAND 641
Query: 662 PNYGKLVMFSGDAEFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIK 721
PNYGKLVMFSGDA+FA GA+ LLNKD E+GRGGFGVVYRT L+DG +VAIKKLTVS LIK
Sbjct: 642 PNYGKLVMFSGDADFADGAHNLLNKDSEIGRGGFGVVYRTFLRDGHAVAIKKLTVSSLIK 701
Query: 722 SQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSW 781
SQ++FEKE+K GKIRH NLVALEGYYWT SLQLLIYE++SSGSL+K LHD +++N LSW
Sbjct: 702 SQDEFEKEVKRFGKIRHQNLVALEGYYWTSSLQLLIYEYLSSGSLHKLLHDANNKNVLSW 761
Query: 782 RQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841
RQRF +ILGMAKGL++LH TNIIHYNLKSTNVLID SGE K+GDFGL +LLPMLD C+LS
Sbjct: 762 RQRFKVILGMAKGLSHLHETNIIHYNLKSTNVLIDCSGEAKIGDFGLVKLLPMLDHCVLS 821
Query: 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRG 901
SKIQSALGYMAPEFACRTVKITEKCDVYGFG+L+LE+VTGKRPVEYMEDDVVVLCDMVRG
Sbjct: 822 SKIQSALGYMAPEFACRTVKITEKCDVYGFGILILEIVTGKRPVEYMEDDVVVLCDMVRG 881
Query: 902 ALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961
+LE+G VE CVD RL GNF A+EAIPVIKLGLICASQVPSNRPDM EV+NILELIQ P +
Sbjct: 882 SLEEGNVEHCVDERLLGNFAAEEAIPVIKLGLICASQVPSNRPDMSEVINILELIQCPSE 941
Query: 962 GQEEL 966
GQEEL
Sbjct: 942 GQEEL 946
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225448703|ref|XP_002275275.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1327 bits (3433), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 669/954 (70%), Positives = 789/954 (82%), Gaps = 3/954 (0%)
Query: 15 PVFVRSLDPTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKCDPKTKRVVGL 74
P V+SL+P+ NDDVLGLIVFKA ++DP KL SW+EDDD+PCNWVGVKC+P++ RV L
Sbjct: 16 PSCVKSLNPSLNDDVLGLIVFKADIQDPNSKLASWNEDDDSPCNWVGVKCNPRSNRVTDL 75
Query: 75 TLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIP 134
LDGFSLSG IGRGLL+LQFL+ LSL+ NN TG+I +LA L+ +D SEN+LSG IP
Sbjct: 76 VLDGFSLSGKIGRGLLQLQFLRKLSLAKNNITGSIGPNLARLQNLRFIDLSENSLSGTIP 135
Query: 135 DEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQS 194
D+FF+QCGSL +S A N +G IPES+ CS+L +++FSSN+ SG LP GIW L L+S
Sbjct: 136 DDFFKQCGSLHAISLAKNKFSGKIPESVGSCSTLAAIDFSSNQFSGPLPSGIWSLNGLRS 195
Query: 195 LDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSL 254
LDLS+NLLEG+I KGI +LY+LRAI L KN+FSG LP+ IGGC +L+++DF NSLSGSL
Sbjct: 196 LDLSDNLLEGDIPKGIDSLYNLRAINLSKNRFSGPLPDGIGGCLLLRLIDFSENSLSGSL 255
Query: 255 PDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKE 314
P ++Q+L C+ ++L GNSF GEVP+WIG++ +LE+LDLS N+FSGR+P+SIGNL LK
Sbjct: 256 PGTMQKLTLCNYMNLHGNSFEGEVPEWIGEMKSLETLDLSANKFSGRVPTSIGNLKSLKV 315
Query: 315 LNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQ 374
LN S+N F+G LPESM+NC LL +DVSQN L G++P WIFK+GLQ V LS N L +M
Sbjct: 316 LNFSVNVFSGSLPESMINCEQLLVLDVSQNSLLGDLPAWIFKLGLQKVLLSKNSLSGNMD 375
Query: 375 YPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLK 434
P +S++ S QGLQVLDLS N LSG S+IG SL LN+S N L G+IPASIG LK
Sbjct: 376 SPFSSSVEKSRQGLQVLDLSYNELSGDFTSSIGVFRSLQFLNISRNSLVGAIPASIGDLK 435
Query: 435 AIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNL 494
A+ VLD S+N LNG+IP +IGGA SLK+L+L+ NFL+G+IP ++NCSSLT+LILS NNL
Sbjct: 436 ALDVLDLSENQLNGSIPLEIGGAFSLKDLRLKNNFLAGKIPVSLENCSSLTTLILSHNNL 495
Query: 495 TGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNT 554
+GP+P I+ LSNL+ VDLS N L+G LPK+L NL HL+SFNISHN L GELP GGFFNT
Sbjct: 496 SGPIPMGISKLSNLENVDLSLNKLTGSLPKQLANLPHLISFNISHNQLQGELPAGGFFNT 555
Query: 555 ISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNH--RRKIVLSISAL 612
ISPSSVSGNPSLCGS N+SCPAV KPIVLNPNSS+ T + P +KI+LSISAL
Sbjct: 556 ISPSSVSGNPSLCGSAANKSCPAVLPKPIVLNPNSSSDTTAGAFPRSLAHKKIILSISAL 615
Query: 613 IAIGAAAFIAIGVIAVTVLNIRVRSSMSRAAAALSFSGGEDYSCSPTKDPNYGKLVMFSG 672
IAIGAAA I IGVIA+TVLN+RVRSS SR+AAAL+ SGG+DYS SPT D N GKLVMFSG
Sbjct: 616 IAIGAAAVIVIGVIAITVLNLRVRSSASRSAAALALSGGDDYSHSPTTDANSGKLVMFSG 675
Query: 673 DAEFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKT 732
D +F+ GA+ALLNKDCELGRGGFG VYRT+L+DG VAIKKLTVS L+KSQEDFE+E+K
Sbjct: 676 DPDFSMGAHALLNKDCELGRGGFGAVYRTVLRDGHPVAIKKLTVSSLVKSQEDFEREVKK 735
Query: 733 LGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMA 792
LGKIRH NLVALEGYYWTPSLQLLIYEFIS GSLYKHLH+G+ N +W +RFNIILG A
Sbjct: 736 LGKIRHQNLVALEGYYWTPSLQLLIYEFISGGSLYKHLHEGAGGN-FTWNERFNIILGTA 794
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMA 852
K LA+LH +IIHYNLKS+NVLID SGEPKV DFGLARLLPMLDR +LSSKIQSALGYMA
Sbjct: 795 KSLAHLHQMSIIHYNLKSSNVLIDPSGEPKVADFGLARLLPMLDRYVLSSKIQSALGYMA 854
Query: 853 PEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV 912
PEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE+G+VE+CV
Sbjct: 855 PEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEEGKVEECV 914
Query: 913 DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEEL 966
D RL+G FPA+EAIPV+KLGLIC SQVPSNRPDM EVVNILELI+ P +GQEEL
Sbjct: 915 DGRLQGKFPAEEAIPVMKLGLICTSQVPSNRPDMAEVVNILELIRCPSEGQEEL 968
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495131|ref|XP_003516434.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1293 bits (3347), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 673/956 (70%), Positives = 779/956 (81%), Gaps = 6/956 (0%)
Query: 14 APVFVRSLD-PTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKCDPKTKRVV 72
P+ V S+D +FNDDVLGLIVFKAGLEDPK KL++W+EDD +PCNWVGVKCD RV
Sbjct: 18 GPILVISIDLSSFNDDVLGLIVFKAGLEDPKGKLSTWNEDDYSPCNWVGVKCDLANNRVS 77
Query: 73 GLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGL 132
L LDGFSLSGHI RGLLRLQFLQ+LSLS NNFTGTI DL S G LQVVD SENNL G
Sbjct: 78 SLVLDGFSLSGHIDRGLLRLQFLQILSLSRNNFTGTIAPDLLSIGDLQVVDLSENNLYGP 137
Query: 133 IPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSL 192
IPD F+QC SLR VSFANNNLTG IP+SLS C SL VNFSSN+L G+LP G+WFLR L
Sbjct: 138 IPDGIFQQCWSLRVVSFANNNLTGKIPDSLSSCYSLAVVNFSSNQLHGELPSGMWFLRGL 197
Query: 193 QSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSG 252
QS+DLSNN LEGEI +GI NL DLR ++LG N F+G++PE IG C +LK++DF NS+SG
Sbjct: 198 QSIDLSNNFLEGEIPEGIQNLIDLRELRLGSNHFTGRVPEHIGDCLLLKLVDFSDNSISG 257
Query: 253 SLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFL 312
LP+S+Q+L SC+ LSL+GNSFTG +P WIG++ +LE LDLS N+FSG IP SIGNL L
Sbjct: 258 RLPESMQKLTSCTFLSLQGNSFTGGIPHWIGEMKSLEVLDLSANRFSGWIPKSIGNLDLL 317
Query: 313 KELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGES 372
LN+S NQ TG LPE M+NC LL +D+S N L G++P+WIF+MGLQ+VSLSGNR ES
Sbjct: 318 SRLNLSRNQITGNLPELMVNCIKLLTLDISHNHLAGHLPSWIFRMGLQSVSLSGNRFSES 377
Query: 373 MQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGK 432
YPS S+ S+ GLQVLDLSSNA G +PS IG LSSL +LN+S N + GSIP SIG+
Sbjct: 378 -NYPSLTSIPVSFHGLQVLDLSSNAFFGQLPSGIGGLSSLQVLNLSTNNISGSIPMSIGE 436
Query: 433 LKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQN 492
LK++ +LD SDN LNG+IP ++ GA+SL E++L+KNFL GRIP+QI+ CS LT L LS N
Sbjct: 437 LKSLYILDLSDNKLNGSIPSEVEGAISLSEMRLQKNFLGGRIPAQIEKCSELTFLNLSHN 496
Query: 493 NLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFF 552
L G +P+AIANL+NL+Y D S+N+LSG LPKEL NLS+L SFN+S+N L GELPVGGFF
Sbjct: 497 KLIGSIPSAIANLTNLQYADFSWNELSGSLPKELTNLSNLFSFNVSYNRLQGELPVGGFF 556
Query: 553 NTISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNHRRKIVLSISAL 612
NTISP SVSGNP LCGSVVN SCP+V KPIVLNPNSS +G+S N+ K++LSIS +
Sbjct: 557 NTISPLSVSGNPLLCGSVVNHSCPSVHPKPIVLNPNSSYSNSGSSLQNNHHKMMLSISVI 616
Query: 613 IAIGAAAFIAIGVIAVTVLNIRVRSSMSRAAAALSFSGGEDYSCSPTKDPNYGKLVMFSG 672
IAIGAA FI IGV+ VTVLNI RSSM +AA FSGGEDYS SP DPNYGKLVMFSG
Sbjct: 617 IAIGAAIFIVIGVVVVTVLNIHARSSMLSSAAPFVFSGGEDYSGSPANDPNYGKLVMFSG 676
Query: 673 DAEFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKT 732
DAEF GA+ +LNKD E+GRGGFGVVY T+L+DG VAIKKLTVS L KSQEDFE+E+K
Sbjct: 677 DAEFVDGAHNILNKDSEIGRGGFGVVYCTVLRDGHCVAIKKLTVSTLTKSQEDFEREVKM 736
Query: 733 LGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLH-DGSSRNCLSWRQRFNIILGM 791
LGKI+H NLVALEGYYWTPSLQLLIYE+++ GSL K LH D SS+N LSWRQRF IILGM
Sbjct: 737 LGKIKHQNLVALEGYYWTPSLQLLIYEYLARGSLQKLLHDDDSSKNLLSWRQRFKIILGM 796
Query: 792 AKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYM 851
AKGLAYLH +IHYNLKSTNV ID S EPK+GDFGL RLLPMLD C+LSSKIQSALGYM
Sbjct: 797 AKGLAYLHQMELIHYNLKSTNVFIDCSDEPKIGDFGLVRLLPMLDHCVLSSKIQSALGYM 856
Query: 852 APEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911
APEFACRTVKITEKCD+Y FG+L+LEVVTGKRPVEYMEDDVVVLCD VR AL+DG+VE C
Sbjct: 857 APEFACRTVKITEKCDIYSFGILILEVVTGKRPVEYMEDDVVVLCDKVRSALDDGKVEQC 916
Query: 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEELE 967
VD +L+GNF A+EAIPVIKLGL+CASQVPSNRPDM EV+NILELIQ P EEL+
Sbjct: 917 VDEKLKGNFAAEEAIPVIKLGLVCASQVPSNRPDMAEVINILELIQCP---SEELQ 969
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255559719|ref|XP_002520879.1| ATP binding protein, putative [Ricinus communis] gi|223540010|gb|EEF41588.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1286 bits (3329), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 643/964 (66%), Positives = 771/964 (79%), Gaps = 11/964 (1%)
Query: 5 LKLIFLLVLAPVFVRSLDPTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKC 64
L L LL V SL P+ NDDVLGLIVFKA L+DPK KL+SW++DDD PCNWVGVKC
Sbjct: 8 LSLFALLGFVLQCVGSLTPSLNDDVLGLIVFKADLQDPKGKLSSWNQDDDTPCNWVGVKC 67
Query: 65 DPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDF 124
+P++ RV LTLD FSLSG IGRGLL+LQFL LSL+ NN +G I+ +LA L+++D
Sbjct: 68 NPRSNRVTELTLDDFSLSGRIGRGLLQLQFLHKLSLARNNLSGNISPNLARLANLRIIDL 127
Query: 125 SENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPY 184
SEN+LSG IPD+FF+QCGSLR +S A N +G IP SL C++L SV+ SSN+ SG LP
Sbjct: 128 SENSLSGPIPDDFFQQCGSLRVISLAKNKFSGKIPASLGSCATLASVDLSSNQFSGSLPP 187
Query: 185 GIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLD 244
GIW L L+SLDLSNNLLEGEI KGI L +LR I L KN+F+G +P+ IG C +L+ +D
Sbjct: 188 GIWGLSGLRSLDLSNNLLEGEIPKGIEVLNNLRGINLSKNQFTGIVPDGIGSCLLLRSID 247
Query: 245 FGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPS 304
NSLSG P+++Q+L+ C+ +SL N TGEVP+WIG++ LE+LD+S N+ SG+IP+
Sbjct: 248 LSGNSLSGEFPETIQKLSLCNFMSLSNNLLTGEVPNWIGEMKRLETLDISGNKISGQIPT 307
Query: 305 SIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSL 364
SIGNL LK LN S N +G LPESM NCG+LLA+D+S+N + G++P W+F GL+ V
Sbjct: 308 SIGNLQSLKVLNFSSNDLSGSLPESMANCGSLLALDLSRNSMNGDLPAWVFSPGLEKVLH 367
Query: 365 SGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFG 424
++LG S +S LQVLDLS N SG I S+IG LSSL LN+S N L G
Sbjct: 368 LDSKLGGSF---------NSVPKLQVLDLSENEFSGKIASSIGVLSSLQFLNLSGNSLEG 418
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSL 484
+P +IG LK + VLD S N LNG+IP +IGGA SLKEL+LE+N LSG+IPS + NC+SL
Sbjct: 419 PLPGTIGDLKELDVLDLSGNSLNGSIPLEIGGAFSLKELRLERNLLSGQIPSSVGNCTSL 478
Query: 485 TSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHG 544
T++ILS+NNLTG +PAAIA L++LK VDLSFN L+G LPK+L NL +L SFNISHN L G
Sbjct: 479 TTMILSRNNLTGLIPAAIAKLTSLKDVDLSFNSLTGGLPKQLANLPNLSSFNISHNQLQG 538
Query: 545 ELPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNH--R 602
ELP GGFFNTISP SVSGNPSLCG+ VN+SCPAV KPIVLNPNSS+ P
Sbjct: 539 ELPAGGFFNTISPYSVSGNPSLCGAAVNKSCPAVLPKPIVLNPNSSSDSAPGEIPQDIGH 598
Query: 603 RKIVLSISALIAIGAAAFIAIGVIAVTVLNIRVRSSMSRAAAALSFSGGEDYSCSPTKDP 662
++I+LSISALIAIGAAA I +GVIA+TVLN+RVRSS SR+AAAL+FS G+D+S SPT D
Sbjct: 599 KRIILSISALIAIGAAAVIVVGVIAITVLNLRVRSSTSRSAAALTFSAGDDFSHSPTTDA 658
Query: 663 NYGKLVMFSGDAEFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKS 722
N GKLVMFSGD +F+ GA+ALLNKDCELGRGGFG VYRT+L++G VAIKKLTVS L+KS
Sbjct: 659 NSGKLVMFSGDPDFSTGAHALLNKDCELGRGGFGAVYRTVLRNGHPVAIKKLTVSSLVKS 718
Query: 723 QEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWR 782
Q+DFE+E+K LGK+RH NLV LEGYYWTPSLQLLIYEF+S GSLYKHLH+GS + LSW
Sbjct: 719 QDDFEREVKKLGKVRHQNLVGLEGYYWTPSLQLLIYEFVSGGSLYKHLHEGSGGHFLSWN 778
Query: 783 QRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842
+RFNIILG AK LA+LH +NIIHYN+KS+NVL+DSSGEPKVGD+GLARLLPMLDR +LSS
Sbjct: 779 ERFNIILGTAKSLAHLHQSNIIHYNIKSSNVLLDSSGEPKVGDYGLARLLPMLDRYVLSS 838
Query: 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGA 902
KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLE+VTGKRPVEYMEDDV VLCDMVRGA
Sbjct: 839 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEIVTGKRPVEYMEDDVAVLCDMVRGA 898
Query: 903 LEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962
LE+GRVE+C+D RL+GNFPADE +PV+KLGLIC SQVPSNRPDM EVVNILELI+ P +G
Sbjct: 899 LEEGRVEECIDDRLQGNFPADEVVPVMKLGLICTSQVPSNRPDMGEVVNILELIRCPSEG 958
Query: 963 QEEL 966
Q+EL
Sbjct: 959 QDEL 962
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 967 | ||||||
| TAIR|locus:2181042 | 967 | AT5G01890 [Arabidopsis thalian | 0.976 | 0.976 | 0.597 | 5.9e-302 | |
| TAIR|locus:2102499 | 964 | AT3G56370 [Arabidopsis thalian | 0.968 | 0.971 | 0.588 | 6.9e-292 | |
| TAIR|locus:2091353 | 1016 | AT3G28040 [Arabidopsis thalian | 0.868 | 0.826 | 0.364 | 2e-136 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.502 | 0.479 | 0.332 | 3.8e-115 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.555 | 0.487 | 0.323 | 3.2e-114 | |
| TAIR|locus:2034725 | 882 | AT1G12460 [Arabidopsis thalian | 0.302 | 0.332 | 0.450 | 7.8e-114 | |
| TAIR|locus:2015504 | 890 | AT1G62950 [Arabidopsis thalian | 0.293 | 0.319 | 0.447 | 4.3e-113 | |
| TAIR|locus:2005507 | 976 | ER "ERECTA" [Arabidopsis thali | 0.570 | 0.565 | 0.310 | 1e-111 | |
| TAIR|locus:2182855 | 967 | ERL2 "ERECTA-like 2" [Arabidop | 0.574 | 0.574 | 0.301 | 2.3e-111 | |
| TAIR|locus:2122239 | 1136 | AT4G36180 [Arabidopsis thalian | 0.482 | 0.411 | 0.354 | 2.4e-111 |
| TAIR|locus:2181042 AT5G01890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2898 (1025.2 bits), Expect = 5.9e-302, P = 5.9e-302
Identities = 568/951 (59%), Positives = 685/951 (72%)
Query: 14 APVFVRSLDPTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKCDPKTKRVVG 73
A V R+ DPTFNDDVLGLIVFKAGL+DP KL+SW+ +D +PCNWVG CDP T RV
Sbjct: 14 AVVSARA-DPTFNDDVLGLIVFKAGLDDPLSKLSSWNSEDYDPCNWVGCTCDPATNRVSE 72
Query: 74 LTLDGFSLSGHIXXXXXXXXXXXXXXXXNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133
L LD FSLSGHI NNN TGT+N + G+LQVVDFS NNLSG I
Sbjct: 73 LRLDAFSLSGHIGRGLLRLQFLHTLVLSNNNLTGTLNPEFPHLGSLQVVDFSGNNLSGRI 132
Query: 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFXXXXX 193
PD FF QCGSLR VS ANN LTG IP SLS+CS+L +N SSN+LSG+LP IWF
Sbjct: 133 PDGFFEQCGSLRSVSLANNKLTGSIPVSLSYCSTLTHLNLSSNQLSGRLPRDIWFLKSLK 192
Query: 194 XXXXXXXXXEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGS 253
+G+I G+ LYDLR I L +N FSG +P DIG CS LK LD N SG+
Sbjct: 193 SLDFSHNFLQGDIPDGLGGLYDLRHINLSRNWFSGDVPSDIGRCSSLKSLDLSENYFSGN 252
Query: 254 LPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLK 313
LPDS++ L SCSS+ L+GNS GE+PDWIG +A LE LDLS N F+G +P S+GNL FLK
Sbjct: 253 LPDSMKSLGSCSSIRLRGNSLIGEIPDWIGDIATLEILDLSANNFTGTVPFSLGNLEFLK 312
Query: 314 ELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESM 373
+LN+S N G LP+++ NC NL++IDVS+N TG++ W+F ++ SLS L +
Sbjct: 313 DLNLSANMLAGELPQTLSNCSNLISIDVSKNSFTGDVLKWMFTGNSESSSLSRFSLHKRS 372
Query: 374 QYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDXXXXXXXXXXXXYLFGSIPASIGKL 433
+ + QGL+VLDLSSN +G +PSNI LFGSIP IG L
Sbjct: 373 GNDTIMPIVGFLQGLRVLDLSSNGFTGELPSNIWILTSLLQLNMSTNSLFGSIPTGIGGL 432
Query: 434 KAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNN 493
K ++LD S N LNGT+P +IGGAVSLK+L L +N LSG+IP++I NCS+L ++ LS+N
Sbjct: 433 KVAEILDLSSNLLNGTLPSEIGGAVSLKQLHLHRNRLSGQIPAKISNCSALNTINLSENE 492
Query: 494 LTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFN 553
L+G +P +I +LSNL+Y+DLS N+LSG LPKE+ LSHLL+FNISHN++ GELP GGFFN
Sbjct: 493 LSGAIPGSIGSLSNLEYIDLSRNNLSGSLPKEIEKLSHLLTFNISHNNITGELPAGGFFN 552
Query: 554 TISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNHRRKXXXXXXXXX 613
TI S+V+GNPSLCGSVVNRSC +V KPIVLNPNSSNP G + RK
Sbjct: 553 TIPLSAVTGNPSLCGSVVNRSCLSVHPKPIVLNPNSSNPTNGPALTGQIRKSVLSISALI 612
Query: 614 XXXXXXXXXXXXXXVTVLNIXXXXXXXX--XXXXXXXXGGEDYSCSPTKDPNYGKLVMFS 671
VT+LN+ GE +SCSP+KD +GKLVMFS
Sbjct: 613 AIGAAAVIAIGVVAVTLLNVHARSSVSRHDAAAALALSVGETFSCSPSKDQEFGKLVMFS 672
Query: 672 GDAEF--AAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKE 729
G+ + GA+ALLNKD ELGRGGFGVVY+T LQDGR VA+KKLTVSGLIKSQE+FE+E
Sbjct: 673 GEVDVFDTTGADALLNKDSELGRGGFGVVYKTSLQDGRPVAVKKLTVSGLIKSQEEFERE 732
Query: 730 MKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIIL 789
M+ LGK+RH N+V ++GYYWT SLQLLI+EF+S GSLY+HLH G CL+WRQRF+IIL
Sbjct: 733 MRKLGKLRHKNVVEIKGYYWTQSLQLLIHEFVSGGSLYRHLH-GDESVCLTWRQRFSIIL 791
Query: 790 GMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM-LDRCILSSKIQSAL 848
G+A+GLA+LH +NI HYN+K+TNVLID++GE KV DFGLARLL LDRC+LS K+QSAL
Sbjct: 792 GIARGLAFLHSSNITHYNMKATNVLIDAAGEAKVSDFGLARLLASALDRCVLSGKVQSAL 851
Query: 849 GYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV 908
GY APEFACRTVKIT++CDVYGFG+LVLEVVTGKRPVEY EDDVVVLC+ VR LE+GRV
Sbjct: 852 GYTAPEFACRTVKITDRCDVYGFGILVLEVVTGKRPVEYAEDDVVVLCETVREGLEEGRV 911
Query: 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959
E+CVD RLRGNFPA+EAIPVIKLGL+C SQVPSNRP+MEEVV ILELIQ P
Sbjct: 912 EECVDPRLRGNFPAEEAIPVIKLGLVCGSQVPSNRPEMEEVVKILELIQCP 962
|
|
| TAIR|locus:2102499 AT3G56370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2803 (991.8 bits), Expect = 6.9e-292, P = 6.9e-292
Identities = 563/956 (58%), Positives = 671/956 (70%)
Query: 18 VRSLDPTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKCDPKTKRVVGLTLD 77
VRSLDP NDDVLGLIVFKA L DP++KL SW+EDD PC+W GVKC P+T RV L LD
Sbjct: 18 VRSLDPPLNDDVLGLIVFKADLRDPEQKLASWNEDDYTPCSWNGVKCHPRTNRVTELNLD 77
Query: 78 GFSLSGHIXXXXXXXXXXXXXXXXNNNFTGTINAD-LASFGTLQVVDFSENNLSGLIPDE 136
GFSLSG I NNN TG IN + L S L+VVD S N LSG +PDE
Sbjct: 78 GFSLSGRIGRGLLQLQFLHKLSLSNNNLTGIINPNMLLSLVNLKVVDLSSNGLSGSLPDE 137
Query: 137 FFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFXXXXXXXX 196
FFRQCGSLR +S A N LTG IP S+S CSSL ++N SSN SG +P GIW
Sbjct: 138 FFRQCGSLRVLSLAKNKLTGKIPVSISSCSSLAALNLSSNGFSGSMPLGIWSLNTLRSLD 197
Query: 197 XXXXXXEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPD 256
EGE + I L +LRA+ L +N+ SG +P +IG C +LK +D NSLSGSLP+
Sbjct: 198 LSRNELEGEFPEKIDRLNNLRALDLSRNRLSGPIPSEIGSCMLLKTIDLSENSLSGSLPN 257
Query: 257 SLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELN 316
+ Q+L+ C SL+L N+ GEVP WIG++ +LE+LDLS+N+FSG++P SIGNL+ LK LN
Sbjct: 258 TFQQLSLCYSLNLGKNALEGEVPKWIGEMRSLETLDLSMNKFSGQVPDSIGNLLALKVLN 317
Query: 317 ISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYP 376
S N G LP S NC NLLA+D+S N LTG +P W+F+ G + VS N
Sbjct: 318 FSGNGLIGSLPVSTANCINLLALDLSGNSLTGKLPMWLFQDGSRDVSALKND-------N 370
Query: 377 SFASMKDSYQGLQVLDLSSNALSGVIPSNIGDXXXXXXXXXXXXYLFGSIPASIGKLKAI 436
S +K +QVLDLS NA SG I + +GD L G IP++IG+LK +
Sbjct: 371 STGGIKK----IQVLDLSHNAFSGEIGAGLGDLRDLEGLHLSRNSLTGPIPSTIGELKHL 426
Query: 437 QVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTG 496
VLD S N LNG IP + GGAVSL+EL+LE N L G IPS IKNCSSL SLILS N L G
Sbjct: 427 SVLDVSHNQLNGMIPRETGGAVSLEELRLENNLLEGNIPSSIKNCSSLRSLILSHNKLLG 486
Query: 497 PVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTIS 556
+P +A L+ L+ VDLSFN+L+G LPK+L NL +L +FNISHNHL GELP GG FN +S
Sbjct: 487 SIPPELAKLTRLEEVDLSFNELAGTLPKQLANLGYLHTFNISHNHLFGELPAGGIFNGLS 546
Query: 557 PSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSS-NPYTGNSSP---NHRRKXXXXXXXX 612
PSSVSGNP +CG+VVN+SCPA+ KPIVLNPN++ +PY G P H+R
Sbjct: 547 PSSVSGNPGICGAVVNKSCPAISPKPIVLNPNATFDPYNGEIVPPGAGHKR-ILLSISSL 605
Query: 613 XXXXXXXXXXXXXXXVTVLNIXXXXXXXXXXXX-XXXXGGEDYSCSPTKDPNYGKLVMFS 671
+TVLN+ GG+D+S SPT D N GKLVMFS
Sbjct: 606 IAISAAAAIVVGVIAITVLNLRVRASTVSRSAVPLTFSGGDDFSRSPTTDSNSGKLVMFS 665
Query: 672 GDAEFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMK 731
G+ +F+ G +ALLNKDCELGRGGFG VYRT+++DG VAIKKLTVS L+KSQ++FE+E+K
Sbjct: 666 GEPDFSTGTHALLNKDCELGRGGFGAVYRTVIRDGYPVAIKKLTVSSLVKSQDEFEREVK 725
Query: 732 TLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNC-LSWRQRFNIILG 790
LGK+RH NLV LEGYYWT SLQLLIYEF+S GSLYK LH+ N LSW RFNIILG
Sbjct: 726 KLGKLRHSNLVKLEGYYWTTSLQLLIYEFLSGGSLYKQLHEAPGGNSSLSWNDRFNIILG 785
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGY 850
AK LAYLH +NIIHYN+KS+NVL+DSSGEPKVGD+GLARLLPMLDR +LSSKIQSALGY
Sbjct: 786 TAKCLAYLHQSNIIHYNIKSSNVLLDSSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGY 845
Query: 851 MAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVED 910
MAPEFACRTVKITEKCDVYGFGVLVLEVVTGK+PVEYMEDDVVVLCDMVR ALEDGR ++
Sbjct: 846 MAPEFACRTVKITEKCDVYGFGVLVLEVVTGKKPVEYMEDDVVVLCDMVREALEDGRADE 905
Query: 911 CVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEEL 966
C+D RL+G FP +EA+ VIKLGLIC SQVPS+RP M E VNIL +I+ P +EL
Sbjct: 906 CIDPRLQGKFPVEEAVAVIKLGLICTSQVPSSRPHMGEAVNILRMIRCPSGSSDEL 961
|
|
| TAIR|locus:2091353 AT3G28040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1336 (475.4 bits), Expect = 2.0e-136, P = 2.0e-136
Identities = 338/927 (36%), Positives = 483/927 (52%)
Query: 74 LTLDGFSLSGHIXXXXXXXXXXXXXXXXNNNFTGTINADLAS-FGTLQVVDFSENNLSGL 132
L L +LSG I N+F+GT++ DL + +L+ + S N+L G
Sbjct: 129 LDLSHNNLSGQIPSSLGSITSLQHLDLTGNSFSGTLSDDLFNNCSSLRYLSLSHNHLEGQ 188
Query: 133 IPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLE---SVNFSSNRLSGQLPYGIWFX 189
IP FR C L ++ + N +G P +S LE +++ SSN LSG +P GI
Sbjct: 189 IPSTLFR-CSVLNSLNLSRNRFSGN-PSFVSGIWRLERLRALDLSSNSLSGSIPLGIL-- 244
Query: 190 XXXXXXXXXXXXXEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNS 249
+L++L+ ++L +N+FSG LP DIG C L +D N
Sbjct: 245 ----------------------SLHNLKELQLQRNQFSGALPSDIGLCPHLNRVDLSSNH 282
Query: 250 LSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNL 309
SG LP +LQ+L S + + N +G+ P WIG + L LD S N+ +G++PSSI NL
Sbjct: 283 FSGELPRTLQKLKSLNHFDVSNNLLSGDFPPWIGDMTGLVHLDFSSNELTGKLPSSISNL 342
Query: 310 VFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRL 369
LK+LN+S N+ +G +PES+ +C L+ + + N +GNIP F +GLQ + SGN L
Sbjct: 343 RSLKDLNLSENKLSGEVPESLESCKELMIVQLKGNDFSGNIPDGFFDLGLQEMDFSGNGL 402
Query: 370 ------GESMQYPSFA-------SMKDSYQG-------LQVLDLSSNALSGVIPSNIGDX 409
G S + S S+ S G ++ L+LS N + +P I
Sbjct: 403 TGSIPRGSSRLFESLIRLDLSHNSLTGSIPGEVGLFIHMRYLNLSWNHFNTRVPPEIEFL 462
Query: 410 XXXXXXXXXXXYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNF 469
L GS+PA I + +++Q+L N L G+IP IG SLK L L N
Sbjct: 463 QNLTVLDLRNSALIGSVPADICESQSLQILQLDGNSLTGSIPEGIGNCSSLKLLSLSHNN 522
Query: 470 LSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINL 529
L+G IP + N L L L N L+G +P + +L NL V++SFN L G LP L
Sbjct: 523 LTGPIPKSLSNLQELKILKLEANKLSGEIPKELGDLQNLLLVNVSFNRLIGRLP-----L 577
Query: 530 SHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNS 589
+ ++ + + G L + SP + G P C +N P V N N N+
Sbjct: 578 GDVFQ-SLDQSAIQGNLGI------CSPL-LRG-P--C--TLNVPKPLVINPNSYGNGNN 624
Query: 590 --SNPYTGNSSPNHRRKXXXXXXXXXXXXXXXXXXXXXXXVTVLNIXXXXXXXXXXXXXX 647
N +G S HRR +T+LN
Sbjct: 625 MPGNRASGGSGTFHRRMFLSVSVIVAISAAILIFSGVII-ITLLNASVRRRLAFVDNALE 683
Query: 648 XXGGEDYSCSPTKDPNYGKLVMF--------SGDAEFAAGANALLNKDCELGRGGFGVVY 699
S + GKLV+ S EF +LLNK +G G FG VY
Sbjct: 684 SIFSG--SSKSGRSLMMGKLVLLNSRTSRSSSSSQEFERNPESLLNKASRIGEGVFGTVY 741
Query: 700 RTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758
+ L + GR++A+KKL S ++++ EDF++E++ L K +H NLV+++GY+WTP L LL+
Sbjct: 742 KAPLGEQGRNLAVKKLVPSPILQNLEDFDREVRILAKAKHPNLVSIKGYFWTPDLHLLVS 801
Query: 759 EFISSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHT---NIIHYNLKSTNVL 814
E+I +G+L LH+ S LSW R+ IILG AKGLAYLHHT IH+NLK TN+L
Sbjct: 802 EYIPNGNLQSKLHEREPSTPPLSWDVRYKIILGTAKGLAYLHHTFRPTTIHFNLKPTNIL 861
Query: 815 IDSSGEPKVGDFGLARLLPMLD-RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGV 873
+D PK+ DFGL+RLL D + +++ Q+ALGY+APE C+ +++ EKCDVYGFGV
Sbjct: 862 LDEKNNPKISDFGLSRLLTTQDGNTMNNNRFQNALGYVAPELECQNLRVNEKCDVYGFGV 921
Query: 874 LVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGL 933
L+LE+VTG+RPVEY ED V+L D VR LE G V +C+D + + DE +PV+KL L
Sbjct: 922 LILELVTGRRPVEYGEDSFVILSDHVRVMLEQGNVLECIDPVMEEQYSEDEVLPVLKLAL 981
Query: 934 ICASQVPSNRPDMEEVVNILELIQSPL 960
+C SQ+PSNRP M E+V IL++I SP+
Sbjct: 982 VCTSQIPSNRPTMAEIVQILQVINSPV 1008
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 704 (252.9 bits), Expect = 3.8e-115, Sum P(2) = 3.8e-115
Identities = 164/493 (33%), Positives = 242/493 (49%)
Query: 80 SLSGHIXXXXXXXXXXXXXXXXNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFR 139
S SG + NN +G + DL + +L+V+D N G +P F +
Sbjct: 127 SFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSF-K 185
Query: 140 QCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFXXXXXXXXXXX 199
LR + + NNLTG +P L SLE+ N G +P
Sbjct: 186 NLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAI 245
Query: 200 XXXEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQ 259
GEI + L L + L +N F+G +P +IG + LKVLDF N+L+G +P +
Sbjct: 246 GKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEIT 305
Query: 260 RLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISM 319
+L + L+L N +G +P I LA L+ L+L N SG +PS +G L+ L++S
Sbjct: 306 KLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSS 365
Query: 320 NQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFK-MGLQTVSLSGNRLGESMQYPSF 378
N F+G +P ++ N GNL + + N TG IP + L V + N L S+ F
Sbjct: 366 NSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPI-GF 424
Query: 379 ASMKDSYQGLQVLDLSSNALSGVIPSNIGDXXXXXXXXXXXXYLFGSIPASIGKLKAIQV 438
++ LQ L+L+ N LSG IP +I D + S+P++I + +Q
Sbjct: 425 GKLEK----LQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQA 480
Query: 439 LDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPV 498
+DN+++G +P Q SL L L N L+G IPS I +C L SL L NNLTG +
Sbjct: 481 FLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEI 540
Query: 499 PAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPS 558
P I +S L +DLS N L+G+LP+ + L N+S+N L G +P+ GF TI+P
Sbjct: 541 PRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPD 600
Query: 559 SVSGNPSLCGSVV 571
+ GN LCG V+
Sbjct: 601 DLRGNSGLCGGVL 613
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 652 (234.6 bits), Expect = 3.2e-114, Sum P(2) = 3.2e-114
Identities = 178/550 (32%), Positives = 266/550 (48%)
Query: 16 VFVRSLDPTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKCDPKTKRVVGLT 75
+ VRSL N++ L+ FKA L D L SW++ D NPCNW G+ C + V +
Sbjct: 19 ILVRSL----NEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACT-HLRTVTSVD 73
Query: 76 LDGFSLSGHIXXXXXXXXXXXXXXXXNNNFTGTINADLASFGTLQVVDFSENNLSGLIPD 135
L+G +LSG + N +G I DL+ +L+V+D N G+IP
Sbjct: 74 LNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPI 133
Query: 136 EFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFXXXXXXX 195
+ +L+++ N L G IP + SSL+ + SN L+G +P +
Sbjct: 134 QL-TMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRII 192
Query: 196 XXXXXXXEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLP 255
G I IS L+ + L +N G LP+ + L L N LSG +P
Sbjct: 193 RAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIP 252
Query: 256 DSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKEL 315
S+ ++ L+L N FTG +P IGKL ++ L L NQ +G IP IGNL+ E+
Sbjct: 253 PSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEI 312
Query: 316 NISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGL-QTVSLSGNRLGESMQ 374
+ S NQ TG +P+ + NL + + +N L G IP + ++ L + + LS NRL ++
Sbjct: 313 DFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTI- 371
Query: 375 YPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDXXXXXXXXXXXXYLFGSIPASIGKLK 434
P LQ+ D N L G IP IG L G IPA + +
Sbjct: 372 -PQELQFLPYLVDLQLFD---NQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQ 427
Query: 435 AIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNL 494
+ +L N L+G IP + SL +L L N L+G +P ++ N +LT+L L QN L
Sbjct: 428 TLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWL 487
Query: 495 TGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVG-GFFN 553
+G + A + L NL+ + L+ N+ +G +P E+ NL+ ++ FNIS N L G +P G
Sbjct: 488 SGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCV 547
Query: 554 TISPSSVSGN 563
TI +SGN
Sbjct: 548 TIQRLDLSGN 557
|
|
| TAIR|locus:2034725 AT1G12460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 672 (241.6 bits), Expect = 7.8e-114, Sum P(2) = 7.8e-114
Identities = 140/311 (45%), Positives = 209/311 (67%)
Query: 665 GKLVMFSGDA-----EFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL 719
GKLV+FS + ++ AG ALL+K+ +G G G VYR + G S+A+KKL G
Sbjct: 569 GKLVLFSKNLPSKYEDWEAGTKALLDKENIIGMGSIGSVYRASFEGGVSIAVKKLETLGR 628
Query: 720 IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLH----DGSS 775
I++QE+FE+E+ LG ++H NL + +GYY++ ++QL++ EF+ +GSLY +LH G+S
Sbjct: 629 IRNQEEFEQEIGRLGGLQHPNLSSFQGYYFSSTMQLILSEFVPNGSLYDNLHLRIFPGTS 688
Query: 776 RNC----LSWRQRFNIILGMAKGLAYLHHT---NIIHYNLKSTNVLIDSSGEPKVGDFGL 828
+ L+W +RF I LG AK L++LH+ I+H N+KSTN+L+D E K+ D+GL
Sbjct: 689 SSYGNTDLNWHRRFQIALGTAKALSFLHNDCKPAILHLNVKSTNILLDERYEAKLSDYGL 748
Query: 829 ARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEY- 887
+ LP++D L+ K +A+GY+APE A ++++ +EKCDVY +GV++LE+VTG++PVE
Sbjct: 749 EKFLPVMDSFGLTKKFHNAVGYIAPELAQQSLRASEKCDVYSYGVVLLELVTGRKPVESP 808
Query: 888 MEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDME 947
E+ V++L D VR LE G DC D RLR F +E I V+KLGL+C S+ P RP M
Sbjct: 809 SENQVLILRDYVRDLLETGSASDCFDRRLR-EFEENELIQVMKLGLLCTSENPLKRPSMA 867
Query: 948 EVVNILELIQS 958
EVV +LE I++
Sbjct: 868 EVVQVLESIRN 878
|
|
| TAIR|locus:2015504 AT1G62950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 655 (235.6 bits), Expect = 4.3e-113, Sum P(2) = 4.3e-113
Identities = 135/302 (44%), Positives = 206/302 (68%)
Query: 675 EFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLG 734
++ AG ALL+KD +G G G VYR + G S+A+KKL G I++QE+FE+E+ LG
Sbjct: 591 DWEAGTKALLDKDNIIGIGSIGAVYRASFEGGVSIAVKKLETLGRIRNQEEFEQEIGRLG 650
Query: 735 KIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHD------GSSRNC-----LSWRQ 783
+ H NL + +GYY++ ++QL++ EF+++GSLY +LH SS + L+W +
Sbjct: 651 SLSHPNLASFQGYYFSSTMQLILSEFVTNGSLYDNLHPRVSHRTSSSSSSHGNTELNWHR 710
Query: 784 RFNIILGMAKGLAYLHHT---NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840
RF I +G AK L++LH+ I+H N+KSTN+L+D E K+ D+GL + LP+L+ L
Sbjct: 711 RFQIAVGTAKALSFLHNDCKPAILHLNVKSTNILLDERYEAKLSDYGLEKFLPVLNSSGL 770
Query: 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEY-MEDDVVVLCDMV 899
+ K +A+GY+APE A +++++++KCDVY +GV++LE+VTG++PVE E++VV+L D V
Sbjct: 771 T-KFHNAVGYIAPELA-QSLRVSDKCDVYSYGVVLLELVTGRKPVESPSENEVVILRDHV 828
Query: 900 RGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959
R LE G DC D RLRG F +E I V+KLGLIC ++ P RP + EVV +LELI++
Sbjct: 829 RNLLETGSASDCFDRRLRG-FEENELIQVMKLGLICTTENPLKRPSIAEVVQVLELIRNG 887
Query: 960 LD 961
++
Sbjct: 888 ME 889
|
|
| TAIR|locus:2005507 ER "ERECTA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 710 (255.0 bits), Expect = 1.0e-111, Sum P(2) = 1.0e-111
Identities = 175/563 (31%), Positives = 273/563 (48%)
Query: 16 VFVRSLDPTF-NDDVLGLIVFKAGLEDPKEKLTSWSEDDDNP-CNWVGVKCDPKTKRVVG 73
+F SL T +++ L+ K +D L W+ + C W GV C+ T VV
Sbjct: 13 LFCLSLVATVTSEEGATLLEIKKSFKDVNNVLYDWTTSPSSDYCVWRGVSCENVTFNVVA 72
Query: 74 LTLDGFSLSGHIXXXXXXXXXXXXXXXXNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133
L L +L G I N +G I ++ +LQ +D S N LSG I
Sbjct: 73 LNLSDLNLDGEISPAIGDLKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDLSFNELSGDI 132
Query: 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFXXXXX 193
P + L ++ NN L GPIP +LS +L+ ++ + N+LSG++P I++
Sbjct: 133 PFSISK-LKQLEQLILKNNQLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRLIYWNEVLQ 191
Query: 194 XXXXXXXXXEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGS 253
G I + L L + N +G +PE IG C+ +VLD N L+G
Sbjct: 192 YLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQLTGE 251
Query: 254 LPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLK 313
+P + L ++LSL+GN +G++P IG + L LDLS N SG IP +GNL F +
Sbjct: 252 IPFDIGFLQ-VATLSLQGNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGNLTFTE 310
Query: 314 ELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM-GLQTVSLSGNRLGES 372
+L + N+ TG +P + N L ++++ N LTG+IP + K+ L ++++ N L
Sbjct: 311 KLYLHSNKLTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLEGP 370
Query: 373 MQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDXXXXXXXXXXXXYLFGSIPASIGK 432
+ P S S L L++ N SG IP + G IP + +
Sbjct: 371 I--PDHLS---SCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSR 425
Query: 433 LKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQN 492
+ + LD S+N +NG IP +G L ++ L +N ++G +P N S+ + LS N
Sbjct: 426 IGNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNN 485
Query: 493 NLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFF 552
+++GP+P + L N+ + L N+L+G + L N L N+SHN+L G++P F
Sbjct: 486 DISGPIPEELNQLQNIILLRLENNNLTGNVGS-LANCLSLTVLNVSHNNLVGDIPKNNNF 544
Query: 553 NTISPSSVSGNPSLCGSVVNRSC 575
+ SP S GNP LCGS +N C
Sbjct: 545 SRFSPDSFIGNPGLCGSWLNSPC 567
|
|
| TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 671 (241.3 bits), Expect = 2.3e-111, Sum P(2) = 2.3e-111
Identities = 171/567 (30%), Positives = 275/567 (48%)
Query: 20 SLDPTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNP-CNWVGVKCDPKTKRVVGLTLDG 78
S+ P N++ L+ KA + L W + ++ C+W GV CD + VV L L
Sbjct: 24 SVSP-MNNEGKALMAIKASFSNVANMLLDWDDVHNHDFCSWRGVFCDNVSLNVVSLNLSN 82
Query: 79 FSLSGHIXXXXXXXXXXXXXXXXNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFF 138
+L G I N G I ++ + +L VDFS N L G IP
Sbjct: 83 LNLGGEISSALGDLMNLQSIDLQGNKLGGQIPDEIGNCVSLAYVDFSTNLLFGDIPFSIS 142
Query: 139 RQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFXXXXXXXXXX 198
+ L ++ NN LTGPIP +L+ +L++++ + N+L+G++P +++
Sbjct: 143 K-LKQLEFLNLKNNQLTGPIPATLTQIPNLKTLDLARNQLTGEIPRLLYWNEVLQYLGLR 201
Query: 199 XXXXEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSL 258
G + + L L + N +G +PE IG C+ ++LD N ++G +P ++
Sbjct: 202 GNMLTGTLSPDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFEILDVSYNQITGVIPYNI 261
Query: 259 QRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNIS 318
L ++LSL+GN TG +P+ IG + L LDLS N+ +G IP +GNL F +L +
Sbjct: 262 GFLQ-VATLSLQGNKLTGRIPEVIGLMQALAVLDLSDNELTGPIPPILGNLSFTGKLYLH 320
Query: 319 MNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMG-LQTVSLSGNRLGESMQYPS 377
N+ TG +P + N L + ++ N+L G IP + K+ L ++L+ N L + PS
Sbjct: 321 GNKLTGQIPPELGNMSRLSYLQLNDNELVGKIPPELGKLEQLFELNLANNNLVGLI--PS 378
Query: 378 FASMKDSYQGLQVLDLSSNALSGVIPSNIGDXXXXXXXXXXXXYLFGSIPASIGKLKAIQ 437
S S L ++ N LSG +P + G IPA +G + +
Sbjct: 379 NIS---SCAALNQFNVHGNFLSGAVPLEFRNLGSLTYLNLSSNSFKGKIPAELGHIINLD 435
Query: 438 VLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGP 497
LD S N +G+IP +G L L L +N L+G +P++ N S+ + +S N L G
Sbjct: 436 TLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGV 495
Query: 498 VPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISP 557
+P + L N+ + L+ N + G +P +L N L + NIS N+L G +P F SP
Sbjct: 496 IPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKNFTRFSP 555
Query: 558 SSVSGNPSLCGSVVNRSC-PAVQNKPI 583
+S GNP LCG+ V C P++ +
Sbjct: 556 ASFFGNPFLCGNWVGSICGPSLPKSQV 582
|
|
| TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 2.4e-111, Sum P(2) = 2.4e-111
Identities = 170/479 (35%), Positives = 247/479 (51%)
Query: 102 NNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGS-LREVSFANNNLTGPIPE 160
NNNF+GT+ L +L +V N S ++ E C + L+ + N ++G P
Sbjct: 267 NNNFSGTVPFSLFCNTSLTIVQLGFNAFSDIVRPETTANCRTGLQVLDLQENRISGRFPL 326
Query: 161 SLSFCSSLESVNFSSNRLSGQLPYGIWFXXXXXXXXXXXXXXEGEIVKGISNLYDLRAIK 220
L+ SL++++ S N SG++P I GEI I L +
Sbjct: 327 WLTNILSLKNLDVSGNLFSGEIPPDIGNLKRLEELKLANNSLTGEIPVEIKQCGSLDVLD 386
Query: 221 LGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPD 280
N GQ+PE +G LKVL G NS SG +P S+ L L+L N+ G P
Sbjct: 387 FEGNSLKGQIPEFLGYMKALKVLSLGRNSFSGYVPSSMVNLQQLERLNLGENNLNGSFPV 446
Query: 281 WIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAID 340
+ L +L LDLS N+FSG +P SI NL L LN+S N F+G +P S+ N L A+D
Sbjct: 447 ELMALTSLSELDLSGNRFSGAVPVSISNLSNLSFLNLSGNGFSGEIPASVGNLFKLTALD 506
Query: 341 VSQNKLTGNIPTWIFKM-GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALS 399
+S+ ++G +P + + +Q ++L GN + F+S+ L+ ++LSSN+ S
Sbjct: 507 LSKQNMSGEVPVELSGLPNVQVIALQGNNFSGVVP-EGFSSLVS----LRYVNLSSNSFS 561
Query: 400 GVIPSNIGDXXXXXXXXXXXXYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVS 459
G IP G ++ GSIP IG A++VL+ N L G IP +
Sbjct: 562 GEIPQTFGFLRLLVSLSLSDNHISGSIPPEIGNCSALEVLELRSNRLMGHIPADLSRLPR 621
Query: 460 LKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLS 519
LK L L +N LSG IP +I SSL SL L N+L+G +P + + LSNL +DLS N+L+
Sbjct: 622 LKVLDLGQNNLSGEIPPEISQSSSLNSLSLDHNHLSGVIPGSFSGLSNLTKMDLSVNNLT 681
Query: 520 GILPKELINLS-HLLSFNISHNHLHGELP--VGGFFNTISPSSVSGNPSLCGSVVNRSC 575
G +P L +S +L+ FN+S N+L GE+P +G N + S SGN LCG +NR C
Sbjct: 682 GEIPASLALISSNLVYFNVSSNNLKGEIPASLGSRIN--NTSEFSGNTELCGKPLNRRC 738
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| eugene3.00161317 | hypothetical protein (966 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 967 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-117 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-31 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-29 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-05 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 7e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 5e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 9e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 9e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.001 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.003 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 381 bits (979), Expect = e-117
Identities = 309/987 (31%), Positives = 464/987 (47%), Gaps = 135/987 (13%)
Query: 32 LIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKCDPKTKRVVG------------------ 73
L+ FK+ + DP + L++W+ D C W G+ C+ + RVV
Sbjct: 34 LLSFKSSINDPLKYLSNWNSSAD-VCLWQGITCN-NSSRVVSIDLSGKNISGKISSAIFR 91
Query: 74 -------------------------------LTLDGFSLSGHIGRGLLRLQFLQVLSLSN 102
L L + +G I RG + L+ L LSN
Sbjct: 92 LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN--LETLDLSN 149
Query: 103 NNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESL 162
N +G I D+ SF +L+V+D N L G IP+ SL ++ A+N L G IP L
Sbjct: 150 NMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN-SLTNLTSLEFLTLASNQLVGQIPREL 208
Query: 163 SFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLG 222
SL+ + N LSG++PY I L SL LDL N L G I + NL +L+ + L
Sbjct: 209 GQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLY 268
Query: 223 KNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWI 282
+NK SG +P I L LD NSLSG +P+ + +L + L L N+FTG++P +
Sbjct: 269 QNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL 328
Query: 283 GKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVS 342
L L+ L L N+FSG IP ++G L L++S N TG +PE + + GNL + +
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILF 388
Query: 343 QNKLTGNIP------TWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSN 396
N L G IP + ++ LQ S SG E + P + LD+S+N
Sbjct: 389 SNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL----------VYFLDISNN 438
Query: 397 ALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGG 456
L G I S D+ SL +L+++ N FG +P S G K ++ LD S N +G +P ++G
Sbjct: 439 NLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGS 497
Query: 457 AVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFN 516
L +LKL +N LSG IP ++ +C L SL LS N L+G +PA+ + + L +DLS N
Sbjct: 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQN 557
Query: 517 DLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGSVVNRSCP 576
LSG +PK L N+ L+ NISHNHLHG LP G F I+ S+V+GN LCG
Sbjct: 558 QLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG------- 610
Query: 577 AVQNKPIVLNPNSSNPYTGNSSPNHRRKIVLSISALIAIGAAAFIAIGVIAVTVLNIRVR 636
+ S P P R + S I AF+ + ++A + IR R
Sbjct: 611 ---------DTTSGLP------PCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGR 655
Query: 637 SSMSRAAAALSFSGGEDYSCSPTKDPNYGKLVMFSGDAEFAAGANALLNKDCE---LGRG 693
+++ L ED +L F + N +L+ E + RG
Sbjct: 656 NNLE-----LKRVENED---------GTWELQFFDSKVSKSITINDILSSLKEENVISRG 701
Query: 694 GFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS 752
G Y+ +++G +K++ I E+ +GK++H N+V L G +
Sbjct: 702 KKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEK 756
Query: 753 LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH---HTNIIHYNLK 809
LI+E+I +L + L LSW +R I +G+AK L +LH ++ NL
Sbjct: 757 GAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810
Query: 810 STNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVY 869
++ID EP + L LL +C +SS Y+APE T ITEK D+Y
Sbjct: 811 PEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS------AYVAPE-TRETKDITEKSDIY 862
Query: 870 GFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD--EAIP 927
GFG++++E++TGK P + + + R D ++ +D +RG+ + E +
Sbjct: 863 GFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE 922
Query: 928 VIKLGLICASQVPSNRPDMEEVVNILE 954
V+ L L C + P+ RP +V+ LE
Sbjct: 923 VMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-46
Identities = 67/190 (35%), Positives = 104/190 (54%), Gaps = 6/190 (3%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
LG GGFG VY + G+ VAIK + E+ +E++ L K+ H N+V L G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL 808
+ L+ E+ GSL L + + LS + I+L + +GL YLH IIH +L
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 809 KSTNVLIDS-SGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCD 867
K N+L+DS +G+ K+ DFGL++LL D+ +L + + + YMAPE +EK D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGT-PAYMAPEVLLGKGYYSEKSD 176
Query: 868 VYGFGVLVLE 877
++ GV++ E
Sbjct: 177 IWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 3e-42
Identities = 80/276 (28%), Positives = 126/276 (45%), Gaps = 24/276 (8%)
Query: 684 LNKDCELGRGGFGVVYRTIL-----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRH 738
L +LG G FG VY+ L VA+K L + +E+F +E + K+ H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 739 HNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
N+V L G ++ E++ G L L L+ + + L +AKG+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK--HGEKLTLKDLLQMALQIAKGMEYL 118
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR 858
N +H +L + N L+ + K+ DFGL+R + D + + +MAPE + +
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE-SLK 177
Query: 859 TVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917
K T K DV+ FGVL+ E+ T G++P M ++ V+ LEDG RL
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE------LLEDGY-------RLP 224
Query: 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953
P + + +L L C + P +RP E+V L
Sbjct: 225 --RPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 79/282 (28%), Positives = 123/282 (43%), Gaps = 36/282 (12%)
Query: 684 LNKDCELGRGGFGVVYRTILQDGRS-----VAIKKLTVSGLIKSQEDFEKEMKTLGKIRH 738
L +LG G FG VY+ L+ VA+K L + E+F +E + + K+ H
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 739 HNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
N+V L G +++ E++ G L +L + LS + L +A+G+ YL
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYL 119
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG------YMA 852
N IH +L + N L+ + K+ DFGL+R L G +MA
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-------DDDYYKVKGGKLPIRWMA 172
Query: 853 PEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911
PE + + K T K DV+ FGVL+ E+ T G+ P M + V+ L + +C
Sbjct: 173 PE-SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLP--KPPNC 229
Query: 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953
+ KL L C ++ P +RP E+V IL
Sbjct: 230 PPE-------------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 4e-41
Identities = 77/277 (27%), Positives = 122/277 (44%), Gaps = 27/277 (9%)
Query: 689 ELGRGGFGVVYRTILQDG----RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+LG G FG VY+ L+ VA+K L + ++DF KE + + K+ H N+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHL------HDGSSRNCLSWRQRFNIILGMAKGLAYL 798
G L+ E++ G L +L ++ LS + + + +AKG+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR 858
+H +L + N L+ K+ DFGL+R + D + + + +MAPE + +
Sbjct: 122 ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE-SLK 180
Query: 859 TVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917
T K DV+ FGVL+ E+ T G P + ++ V L G RL
Sbjct: 181 DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------VLEYLRKGY-------RL- 226
Query: 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
P + +L L C P +RP E+V LE
Sbjct: 227 -PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 81/282 (28%), Positives = 127/282 (45%), Gaps = 37/282 (13%)
Query: 684 LNKDCELGRGGFGVVYRTILQD-----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRH 738
L +LG G FG VY+ L+ VA+K L + E+F +E + + K+ H
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 739 HNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
N+V L G ++ E++ G L +L +R LS + L +A+G+ YL
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYL 118
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG------YMA 852
N IH +L + N L+ + K+ DFGL+R L G +MA
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-------DDDYYRKRGGKLPIRWMA 171
Query: 853 PEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911
PE + + K T K DV+ FGVL+ E+ T G++P M ++ V+ L++G
Sbjct: 172 PE-SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL------EYLKNGYRLPQ 224
Query: 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953
N P + + L L C ++ P +RP E+V IL
Sbjct: 225 PP-----NCPPE----LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 73/264 (27%), Positives = 120/264 (45%), Gaps = 20/264 (7%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+LG G FG VY + G+ VAIK + + K +E +E+K L K++H N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+ L+ E+ G L+ L R LS + + + L YLH I+H +
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLHSKGIVHRD 122
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCD 867
LK N+L+D G K+ DFGLAR L ++ L++ + + YMAPE + D
Sbjct: 123 LKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGT-PEYMAPE-VLLGKGYGKAVD 178
Query: 868 VYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIP 927
++ GV++ E++TGK P + + + + + E + EA
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDIS---------PEAKD 229
Query: 928 VIKLGLICASQVPSNRPDMEEVVN 951
+I+ L+ + P R EE +
Sbjct: 230 LIR-KLLV--KDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 81/267 (30%), Positives = 126/267 (47%), Gaps = 22/267 (8%)
Query: 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEK--EMKTLGKIRHHNLVALEG 746
LG G FG VY+ + G+ VA+K L KS++D E++ L ++ H N+V L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ L+ E+ G L+ +L S LS + I L + +GL YLH IIH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSNGIIHR 122
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
+LK N+L+D +G K+ DFGLA+ L + YMAPE K
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSS--SLTTFVGTPWYMAPEVLLGGNGYGPKV 180
Query: 867 DVYGFGVLVLEVVTGKRPV--EYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADE 924
DV+ GV++ E++TGK P E + D + ++ ++ LE + ++E
Sbjct: 181 DVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSS--------GSEE 232
Query: 925 AIPVIKLGLICASQVPSNRPDMEEVVN 951
A +IK + + PS RP EE++
Sbjct: 233 AKDLIK-KCLN--KDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 69/217 (31%), Positives = 110/217 (50%), Gaps = 20/217 (9%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALEGY 747
LGRG FG VY + +D G +A+K + +SG + + E E+E++ L ++H N+V G
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 748 YWTPSL-QLLIY-EFISSGSL------YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
L I+ E++S GSL + L + R RQ IL +GLAYLH
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYT--RQ----IL---EGLAYLH 118
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRT 859
I+H ++K N+L+DS G K+ DFG A+ L ++ + ++ +MAPE R
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE-VIRG 177
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLC 896
+ D++ G V+E+ TGK P + + + L
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
++G+GGFG VY+ + G+ VAIK + + + +E E++ L K +H N+V G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN------IILGMAKGLAYLHHT 801
Y ++ EF S GSL L S Q + + KGL YLH
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLK--------STNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLA-RLLPMLDRCILSSKIQSALGYMAPEFACRTV 860
IIH ++K+ N+L+ S GE K+ DFGL+ +L R + + +MAPE
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR----NTMVGTPYWMAPEVINGK- 172
Query: 861 KITEKCDVYGFGVLVLEVVTGKRP 884
K D++ G+ +E+ GK P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 83/273 (30%), Positives = 131/273 (47%), Gaps = 27/273 (9%)
Query: 689 ELGRGGFGVVYRTILQ----DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+G G FG V R L+ VAIK L K + DF E +G+ H N++ L
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHL--HDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
EG ++I E++ +GSL K L +DG + Q ++ G+A G+ YL N
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSEMN 126
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKI 862
+H +L + N+L++S+ KV DFGL+R L + + + + + APE A K
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE-AIAYRKF 185
Query: 863 TEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921
T DV+ FG+++ EV++ G+RP M + V A+EDG RL P
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERPYWDMSN------QDVIKAVEDG-------YRLPP--P 230
Query: 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
D + +L L C + + RP ++V+ L+
Sbjct: 231 MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 84/289 (29%), Positives = 136/289 (47%), Gaps = 37/289 (12%)
Query: 689 ELGRGGFGVVYR---TILQD--GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
+LG G FG V L D G VA+K L SG + + DFE+E++ L + H N+V
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 744 LEGYYWTP---SLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
+G P SL+L I E++ SGSL +L + L F+ + KG+ YL
Sbjct: 71 YKGVCEKPGGRSLRL-IMEYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICKGMDYLGS 127
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM-LDRCILSSKIQSALGYMAPEFACRT 859
IH +L + N+L++S K+ DFGLA++LP D + +S + + APE RT
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE-CLRT 186
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRP----------VEYMEDDVVVLCDMVRGALEDGRVE 909
K + DV+ FGV + E+ T P + + +++ ++ L++G
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE-LLKEGE-- 243
Query: 910 DCVDARLRGNFPADEAIP--VIKLGLICASQVPSNRPDMEEVVNILELI 956
RL P + P V L +C P +RP +++ I++ +
Sbjct: 244 -----RL----PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 8e-29
Identities = 93/275 (33%), Positives = 140/275 (50%), Gaps = 32/275 (11%)
Query: 690 LGRGGFGVVYRTILQ-DGRS---VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745
+G G FG V+R IL+ GR VAIK L K ++DF E +G+ HHN++ LE
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHL--HDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
G ++I E++ +G+L K+L HDG S Q ++ G+A G+ YL N
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGE----FSSYQLVGMLRGIAAGMKYLSDMNY 128
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLL---PMLDRCILSSKIQSALGYMAPEFACRTV 860
+H +L + N+L++S+ E KV DFGL+R+L P KI + + APE A
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPE-AIAYR 185
Query: 861 KITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919
K T DV+ FG+++ EV++ G+RP M + V+ A+ DG R
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM------KAINDG---------FRLP 230
Query: 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
P D V +L L C Q + RP ++VN+L+
Sbjct: 231 APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 688 CELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALE 745
+GRG FGVVY+ + L+ G VAIK++++ + + + +E+ L ++H N+V
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
G T +I E+ +GSL + + + + +GLAYLH +IH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIK---KFGPFPESLVAVYVYQVLQGLAYLHEQGVIH 122
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKI 862
++K+ N+L G K+ DFG+A L +S S +G +MAPE
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLN-----DVSKDDASVVGTPYWMAPE-VIEMSGA 176
Query: 863 TEKCDVYGFGVLVLEVVTGKRP 884
+ D++ G V+E++TG P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-27
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKS--QEDFEKEMKTLGKIRHH-NLVALE 745
+LG G FG VY +D + VA+K L KS E F +E++ L + H N+V L
Sbjct: 7 KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
++ L+ E++ GSL L + LS + I+ + L YLH IIH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIH 124
Query: 806 YNLKSTNVLIDSSG-EPKVGDFGLARLLP----MLDRCILSSKIQSALGYMAPEFA--CR 858
++K N+L+D G K+ DFGLA+LLP L S GYMAPE
Sbjct: 125 RDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS 184
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRPVE 886
+ D++ G+ + E++TG P E
Sbjct: 185 LAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEG 746
++G+G FG VY DG+ +K++ +S + K +ED E+K L K+ H N++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF------NIILGMAKGLAYLHH 800
+ ++ E+ G L + + + F + + + L YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEG-----KPFPEEQILDWFVQLCLALKYLHS 121
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA---LG---YMAPE 854
I+H ++K N+ + S+G K+GDFG+++ +LSS + A +G Y++PE
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISK--------VLSSTVDLAKTVVGTPYYLSPE 173
Query: 855 FACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
C+ K D++ G ++ E+ T K P
Sbjct: 174 -LCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 82/265 (30%), Positives = 125/265 (47%), Gaps = 35/265 (13%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL---- 744
+LG G FG V+ + ++ VAIK L L+K Q+DF+KE++ L ++RH +L++L
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK-QQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 745 ---EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
E Y +I E + GSL L + L ++ +A+G+AYL
Sbjct: 72 SVGEPVY-------IITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ 123
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVK 861
N IH +L + N+L+ KV DFGLARL+ + LSS + + APE A
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYKWTAPEAASHG-T 180
Query: 862 ITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920
+ K DV+ FG+L+ E+ T G+ P M + V D + A R
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGM---------------NNHEVYDQITAGYRMPC 225
Query: 921 PADEAIPVIKLGLICASQVPSNRPD 945
PA + K+ L C + P +RP
Sbjct: 226 PAKCPQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 80/269 (29%), Positives = 122/269 (45%), Gaps = 27/269 (10%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW 749
LG G FG V+ + + VA+K L + +DF E + + K+RH L+ L Y
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQL---YA 68
Query: 750 TPSLQLLIY---EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+L+ IY E + GSL ++L G+ R Q ++ +A G+AYL N IH
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQNYIHR 127
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
+L + NVL+ + KV DFGLAR++ D + + + APE A + + K
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPE-AALYNRFSIKS 185
Query: 867 DVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEA 925
DV+ FG+L+ E+VT G+ P M + V VD R P
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGM---------------TNAEVLQQVDQGYRMPCPPGCP 230
Query: 926 IPVIKLGLICASQVPSNRPDMEEVVNILE 954
+ + L C + P +RP E + LE
Sbjct: 231 KELYDIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 690 LGRGGFGVVYRTI-LQDGRS----VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
LG G FG VY+ + + +G VAIK L K+ ++ E + + H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGS----SRNCLSW-RQRFNIILGMAKGLAYLH 799
G + +QL I + + G L ++ + S+ L+W Q +AKG++YL
Sbjct: 75 LGICLSSQVQL-ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ-------IAKGMSYLE 126
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRT 859
++H +L + NVL+ + K+ DFGLA+LL + ++ + + + +MA E +
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE-SILH 185
Query: 860 VKITEKCDVYGFGVLVLEVVT-GKRPVE 886
T K DV+ +GV V E++T G +P E
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 83/273 (30%), Positives = 123/273 (45%), Gaps = 35/273 (12%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW 749
LG G FG V+ VA+K L + S E F +E + + K+RH LV L Y
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQL---YA 68
Query: 750 TPSLQLLIY---EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGM----AKGLAYLHHTN 802
S + IY E++S GSL L G + R ++ M A+G+AYL N
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-----LRLPQLVDMAAQIAEGMAYLESRN 123
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKI 862
IH +L + N+L+ + K+ DFGLARL+ D + + + APE A +
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPE-AANYGRF 181
Query: 863 TEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921
T K DV+ FG+L+ E+VT G+ P M + V+ + V+ R P
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL---------------EQVERGYRMPRP 226
Query: 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
+ + L L C + P RP E + + LE
Sbjct: 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 7/207 (3%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
E+G G FG+V+ + R VAIK T+ S+EDF +E + + K+ H LV L G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIK--TIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL 808
S L++EF+ G L +L + R S + L + +G+AYL +N+IH +L
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 809 KSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDV 868
+ N L+ + KV DFG+ R + + D+ S+ + + + +PE K + K DV
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPE-VFSFSKYSSKSDV 184
Query: 869 YGFGVLVLEVVT-GKRPVEYMEDDVVV 894
+ FGVL+ EV + GK P E + VV
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 689 ELGRGGFGVVYR----TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+LG G FGVV R T VA+K L L +DF KE + + H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGS------SRNCLSWRQRFNIILGMAKGLAYL 798
G T L +++ E GSL L + S C Q +A G+ YL
Sbjct: 62 YGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ-------IANGMRYL 113
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-ILSSKIQSALGYMAPEFAC 857
IH +L + N+L+ S + K+GDFGL R LP + ++ ++ + APE +
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE-SL 172
Query: 858 RTVKITEKCDVYGFGVLVLEVVT-GKRP 884
RT + DV+ FGV + E+ T G+ P
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 69/268 (25%), Positives = 119/268 (44%), Gaps = 23/268 (8%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW 749
+G+G FG VY+ +L+ VA+K + + F +E + L + H N+V L G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 750 TPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLK 809
++ E + GSL L +N L+ ++ + L A G+ YL N IH +L
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLR--KKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120
Query: 810 STNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVY 869
+ N L+ + K+ DFG++R + Q + + APE A + T + DV+
Sbjct: 121 ARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE-ALNYGRYTSESDVW 179
Query: 870 GFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIP- 927
+G+L+ E + G P M + + + +++ R PA + P
Sbjct: 180 SYGILLWETFSLGDTPYPGMSNQ---------------QTRERIESGYR--MPAPQLCPE 222
Query: 928 -VIKLGLICASQVPSNRPDMEEVVNILE 954
+ +L L C + P NRP E+ N L+
Sbjct: 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 85/269 (31%), Positives = 126/269 (46%), Gaps = 26/269 (9%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+LG G FG V+ VA+K L + S E F +E + + K+RH LV L Y
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQL---Y 67
Query: 749 WTPSLQ--LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
S + ++ E++S GSL L DG R L ++ +A G+AY+ N IH
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERMNYIHR 126
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
+L+S N+L+ K+ DFGLARL+ + + + + APE A + T K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFTIKS 184
Query: 867 DVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEA 925
DV+ FG+L+ E+VT G+ P M + R LE V+ R P D
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMNN---------REVLEQ------VERGYRMPCPQDCP 229
Query: 926 IPVIKLGLICASQVPSNRPDMEEVVNILE 954
I + +L L C + P RP E + + LE
Sbjct: 230 ISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 30/214 (14%)
Query: 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
L + LG+G GVVY+ + G+ A+KK+ V G + ++ +E+KTL +V
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 743 ALEGYYWTPSLQLLIYEFISSGSL----YKHLHDGSSRNCLSW--RQRFNIILGMAKGLA 796
G ++ ++ E++ GSL K L++ RQ + KGL
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQ-------ILKGLD 113
Query: 797 YLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP-MLDRCILSSKIQSALG---YM 851
YLH +IIH ++K +N+LI+S GE K+ DFG++++L LD+C + +G YM
Sbjct: 114 YLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC------NTFVGTVTYM 167
Query: 852 APE-FACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
+PE + + D++ G+ +LE GK P
Sbjct: 168 SPERIQGESY--SYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 67/261 (25%), Positives = 121/261 (46%), Gaps = 27/261 (10%)
Query: 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+G+G FGVV++ + + D R A+K++ +S + + +E+ E + L K+ ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNC---LSWRQRFNIILGMAKGLAYLHHTNII 804
+ ++ E+ +G L+K L R WR I+LG LA+LH I+
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLHSKKIL 123
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITE 864
H ++KS N+ +D+ K+GD G+A+LL D ++ I Y++PE C E
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPEL-CEDKPYNE 180
Query: 865 KCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADE 924
K DV+ GV++ E TGK P + + ++ ++RG + +
Sbjct: 181 KSDVWALGVVLYECCTGKHPFD-ANNQGALILKIIRGVFPP----------VSQMYSQQ- 228
Query: 925 AIPVIKLGLICASQVPSNRPD 945
+ +L C ++ RPD
Sbjct: 229 ---LAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 84/275 (30%), Positives = 132/275 (48%), Gaps = 32/275 (11%)
Query: 690 LGRGGFGVVY--RTILQDGR--SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745
+G G FG V R L R VAIK L K + DF E +G+ H N++ LE
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHL--HDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
G +++ E++ +GSL L HDG + Q ++ G+A G+ YL
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ----FTVIQLVGMLRGIASGMKYLSDMGY 127
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLL---PMLDRCILSSKIQSALGYMAPEFACRTV 860
+H +L + N+L++S+ KV DFGL+R+L P KI + + APE A
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPE-AIAYR 184
Query: 861 KITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919
K T DV+ +G+++ EV++ G+RP M + V+ A+E+G R
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK------AIEEG---------YRLP 229
Query: 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
P D + +L L C + + RP E++V+IL+
Sbjct: 230 APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+G G G VY+ G+ VAIKK+ + +++E E+ + +H N+V Y
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 749 WTPSLQLLIYEFISSGSL----YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
++ E++ GSL ++ ++ Q + + +GL YLH N+I
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIITQN------FVRMNEPQIAYVCREVLQGLEYLHSQNVI 138
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQ---SALG---YMAPEFACR 858
H ++KS N+L+ G K+ DFG A L+ + S +G +MAPE R
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGFA--------AQLTKEKSKRNSVVGTPYWMAPEVIKR 190
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRPVEYMED 890
K D++ G++ +E+ G+ P Y+ +
Sbjct: 191 K-DYGPKVDIWSLGIMCIEMAEGEPP--YLRE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 82/291 (28%), Positives = 137/291 (47%), Gaps = 41/291 (14%)
Query: 690 LGRGGFGVV----YRTILQD--GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
LG+G FG V Y LQD G VA+KKL S + DFE+E++ L ++H N+V
Sbjct: 12 LGKGNFGSVELCRYDP-LQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVK 69
Query: 744 LEGYYWTP---SLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
+G ++ +L+L + E++ GSL +L R L R+ + KG+ YL
Sbjct: 70 YKGVCYSAGRRNLRL-VMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYLGS 126
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM-LDRCILSSKIQSALGYMAPEFACRT 859
+H +L + N+L++S K+GDFGL ++LP + + +S + + APE +
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE-SLTE 185
Query: 860 VKITEKCDVYGFGVLVLEVVT-----GKRPVEYME------DDVVVLCDMVRGALEDGRV 908
K + DV+ FGV++ E+ T P E+M +++ ++ L++
Sbjct: 186 SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE-LLKNNG- 243
Query: 909 EDCVDARLRGNFPADEAIP--VIKLGLICASQVPSNRPDMEEVVNILELIQ 957
RL PA P + + C + PS RP E+ +E I+
Sbjct: 244 ------RL----PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 83/283 (29%), Positives = 126/283 (44%), Gaps = 33/283 (11%)
Query: 690 LGRGGFGVVYR----TILQDGRS---VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
LG G FG VY IL G VA+K L + +++F KE + H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNC----LSWRQRFNIILGMAKGLAYL 798
L G Q +I E + G L +L D L+ ++ +I L +AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 799 HHTNIIHYNLKSTNVLIDSSGEP-----KVGDFGLARLLPMLDRCILSSKIQSALGYMAP 853
+ IH +L + N L+ G K+GDFGLAR + D + + +MAP
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP 182
Query: 854 EFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV 912
E + K T + DV+ FGVL+ E++T G++P + + V+ V GR++
Sbjct: 183 E-SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL--QHVT---AGGRLQK-- 234
Query: 913 DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955
N P + +L C +Q PS RP + + IL+
Sbjct: 235 ----PENCPDK----IYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKL-TVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+G G FG VY + L G +A+K++ K+ ++ EMK L ++H NLV Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV---KY 64
Query: 748 YWTP--SLQLLIY-EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
Y ++ I+ E+ S G+L + L G + R +L +GLAYLH I+
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL---EGLAYLHSHGIV 121
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLA-RLLPMLDRCILSSKIQSALG---YMAPEFACRTV 860
H ++K N+ +D +G K+GDFG A +L ++QS G YMAPE
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM--GEEVQSLAGTPAYMAPEVITGG- 178
Query: 861 KITEK---CDVYGFGVLVLEVVTGKRPVEYMED 890
K D++ G +VLE+ TGKRP +++
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 77/266 (28%), Positives = 122/266 (45%), Gaps = 22/266 (8%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
ELG G FGVV+ + VAIK + + S+EDF +E K + K+ H LV L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL 808
++ EF+ +G L +L + LS ++ + +G+ YL + IH +L
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 809 KSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDV 868
+ N L+ S+G KV DFG+ R + + D SS + + + PE + K + K DV
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDV 184
Query: 869 YGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIP 927
+ FGVL+ EV T GK P E + VV + + R P ++
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYEVV---------------EMISRGFRLYRPKLASMT 229
Query: 928 VIKLGLICASQVPSNRPDMEEVVNIL 953
V ++ C + P RP E++ +
Sbjct: 230 VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 70/207 (33%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKK-LTVSGLIKSQE---DFEKEMKTLGKIRHHNLVAL 744
LG G FG VY + L DG A+K+ QE E+E+ L K++H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ- 66
Query: 745 EGYYWTPSLQ--LLIY-EFISSGSLYKHLHD-GSSRNC---LSWRQRFNIILGMAKGLAY 797
Y T + L I+ E + GSL K L GS L RQ IL GL Y
Sbjct: 67 --YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ----IL---LGLEY 117
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFAC 857
LH N +H ++K N+L+D++G K+ DFG+A+ + S S +MAPE
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPY-WMAPEVIA 174
Query: 858 RTVKITEKCDVYGFGVLVLEVVTGKRP 884
+ D++ G VLE+ TGK P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 19/214 (8%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
ELG G FGVV + VAIK + + S+++F +E K + K+ H LV L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL 808
++ E++S+G L +L + R Q + + +G+AYL IH +L
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESKQFIHRDL 126
Query: 809 KSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG------YMAPEFACRTVKI 862
+ N L+D G KV DFGL+R +L + S++G + PE + K
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRY-------VLDDEYTSSVGSKFPVRWSPPEVLLYS-KF 178
Query: 863 TEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVL 895
+ K DV+ FGVL+ EV + GK P E + V
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE 212
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 77/272 (28%), Positives = 121/272 (44%), Gaps = 34/272 (12%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW 749
+G+G FG V + G+ VA+K L F E + +RH NLV L G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA--FLAEASVMTTLRHPNLVQLLGVVL 70
Query: 750 TPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLK 809
+ ++ E+++ GSL +L R ++ Q+ L + +G+ YL N +H +L
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRS-RGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 810 STNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVY 869
+ NVL+ KV DFGLA+ + + + + APE A R K + K DV+
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPE-ALREKKFSTKSDVW 183
Query: 870 GFGVLVLEVVT-GKRPVEYME-DDVVVLCDMVRGALEDG-RVEDCVDARLRGNFPADEAI 926
FG+L+ E+ + G+ P + DVV +E G R+E A E
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKDVV-------PHVEKGYRME------------APEGC 224
Query: 927 P--VIKLGLICASQVPSNRPDMEEVVNILELI 956
P V K+ C P+ RP +++ L LI
Sbjct: 225 PPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
ELG G FGVV+ + VAIK + + S++DF +E K + K+ H NLV L G
Sbjct: 11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN--IILGMA----KGLAYLHHTN 802
++ E++++G L +L + + + +L M + + YL
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRER--------KGKLGTEWLLDMCSDVCEAMEYLESNG 120
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKI 862
IH +L + N L+ KV DFGLAR + + D+ S + + + PE + +
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSSQGTKFPVKWAPPEVFDYS-RF 178
Query: 863 TEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVV 894
+ K DV+ FGVL+ EV + GK P E + VV
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 84/278 (30%), Positives = 132/278 (47%), Gaps = 36/278 (12%)
Query: 690 LGRGGFGVVYRTIL-QDGRS---VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745
+G G FG V R L G+ VAIK L K + DF E +G+ H N++ LE
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 746 GYYWTPSLQLLIYEFISSGSL--YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
G ++I EF+ +G+L + +DG + Q ++ G+A G+ YL N
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQ----FTVIQLVGMLRGIAAGMKYLSEMNY 127
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLL------PMLDRCILSSKIQSALGYMAPEFAC 857
+H +L + N+L++S+ KV DFGL+R L P L KI + + APE A
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS-LGGKI--PIRWTAPE-AI 183
Query: 858 RTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916
K T DV+ +G+++ EV++ G+RP M + V+ A+E D RL
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI------NAIEQ-------DYRL 230
Query: 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
P D + +L L C + + RP ++V+ L+
Sbjct: 231 PP--PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 687 DCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745
+LG G +G VY+ I + G+ VAIK + V + ++ KE+ L + +V
Sbjct: 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL---QEIIKEISILKQCDSPYIVKYY 64
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
G Y+ + ++ E+ +GS+ + + L+ + I+ KGL YLH IH
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH 122
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLL--PMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
++K+ N+L++ G+ K+ DFG++ L M R ++ I + +MAPE +
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR---NTVIGTPF-WMAPEVIQE-IGYN 177
Query: 864 EKCDVYGFGVLVLEVVTGKRP 884
K D++ G+ +E+ GK P
Sbjct: 178 NKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 65/202 (32%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKS--QEDFEKEMKTLGKIRHHNLVALEG 746
LG+G FG V G+ A+K L +IK E E L +I H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLS-WRQRFNIILGMAKGLAYLHHTNIIH 805
+ T L+ E+ G L+ HL S S R RF + L YLH II+
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARF-YAAEIVLALEYLHSLGIIY 116
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKI 862
+LK N+L+D+ G K+ DFGLA+ L S+ + G Y+APE
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEG-----SRTNTFCGTPEYLAPEVLLGK-GY 170
Query: 863 TEKCDVYGFGVLVLEVVTGKRP 884
+ D + GVL+ E++TGK P
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 69/280 (24%), Positives = 128/280 (45%), Gaps = 30/280 (10%)
Query: 689 ELGRGGFGVVYRTILQD------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG+G FG+VY + + VAIK + + ++ + +F E + + H++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHL--HDGSSRNC-----LSWRQRFNIILGMAKGL 795
L G T L++ E ++ G L +L + N + ++ + +A G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEF 855
AYL +H +L + N ++ K+GDFG+ R + D K + +MAPE
Sbjct: 133 AYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE- 191
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914
+ + T K DV+ FGV++ E+ T ++P + + ++ V+ + G L+ E+C D
Sbjct: 192 SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD--LPENCPD- 248
Query: 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
+++L +C P RP E+V+ L+
Sbjct: 249 ------------KLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 8e-21
Identities = 81/274 (29%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
L D +LG+G FG V+ VAIK L + E F +E + + K+RH LV
Sbjct: 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVP 65
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
L + ++ EF+ GSL L +G + L Q ++ +A G+AY+ N
Sbjct: 66 LYAVVSEEPI-YIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERMNY 123
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
IH +L++ N+L+ + K+ DFGLARL+ + + + + APE A + T
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 181
Query: 864 EKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922
K DV+ FG+L+ E+VT G+ P M + R LE V+ R P
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVN---------REVLEQ------VERGYR--MPC 224
Query: 923 DEAIP--VIKLGLICASQVPSNRPDMEEVVNILE 954
+ P + +L +C + P RP E + + LE
Sbjct: 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 688 CELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEG 746
+G G VVY I L + VAIK++ + S ++ KE++ + + H N+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV---K 63
Query: 747 YY--WTPSLQL-LIYEFISSGSL-----YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
YY + +L L+ ++S GSL + G ++ ++ + KGL YL
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA-----TVLKEVLKGLEYL 118
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEF 855
H IH ++K+ N+L+ G K+ DFG++ L ++ +G +MAPE
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
+ K D++ FG+ +E+ TG P
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 78/272 (28%), Positives = 122/272 (44%), Gaps = 22/272 (8%)
Query: 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
L + +LG+G FG V+ VAIK L + S E F +E + + K+RH LV
Sbjct: 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 65
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
L + ++ E++S GSL L G L Q ++ +A G+AY+ N
Sbjct: 66 LYAVVSEEPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
+H +L++ N+L+ + KV DFGLARL+ + + + + APE A + T
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 181
Query: 864 EKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922
K DV+ FG+L+ E+ T G+ P M + V+ D V+ R P
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGMVNREVL---------------DQVERGYRMPCPP 226
Query: 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
+ + L C + P RP E + LE
Sbjct: 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 76/286 (26%), Positives = 133/286 (46%), Gaps = 38/286 (13%)
Query: 689 ELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG G FG VY+ L SVAIK L + K Q++F +E + + ++H N+V
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHL-------------HDGSSRNCLSWRQRFNIIL 789
L G +++E+++ G L++ L D + ++ L +I +
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 790 GMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG 849
+A G+ YL + +H +L + N L+ K+ DFGL+R + D + SK +
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR 191
Query: 850 YMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRP-VEYMEDDVVVLCDMVRGALEDGR 907
+M PE A K T + D++ FGV++ E+ + G +P + +V+ +M+R
Sbjct: 192 WMPPE-AILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI---EMIRSRQLLPC 247
Query: 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953
EDC PA V L + C +++P+ RP +++ L
Sbjct: 248 PEDC---------PAR----VYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 30/210 (14%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIK--KLTVSGLIKSQEDFE---KEMKTLGKIRHHNLV 742
+G G +G VY+ + G VAIK KL +DFE +E+ L + RH N+V
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLE------PGDDFEIIQQEISMLKECRHPNIV 63
Query: 743 ALEGYYWTPSLQLLIYEFISSGSL---YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
A G Y ++ E+ GSL Y+ S +++ R + KGLAYLH
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLH 118
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFA 856
T IH ++K N+L+ G+ K+ DFG++ L I +K +S +G +MAPE A
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSAQ---LTATI--AKRKSFIGTPYWMAPEVA 173
Query: 857 C--RTVKITEKCDVYGFGVLVLEVVTGKRP 884
R KCD++ G+ +E+ + P
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 11/215 (5%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVALEGY 747
+G G G+V++ + G +VA+KK+ + L +E+K L +H +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+ S +L+ E++ S L + L D L Q + + + KG+AY+H I+H +
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHANGIMHRD 124
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPE--FACRTVKITEK 865
LK N+LI + G K+ DFGLARL + + S ++ + Y APE + R K
Sbjct: 125 LKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVAT-RWYRAPELLYGAR--KYDPG 181
Query: 866 CDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVR 900
D++ G + E++ G P+ E+D+ L + R
Sbjct: 182 VDLWAVGCIFAELLNG-SPLFPGENDIEQLAIVFR 215
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (225), Expect = 9e-20
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGKIRHHNL 741
LG G +GVVY+ + G VA+KK I+ + E +E+ L +++H N+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKK------IRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
V L T L++E+ L K+L LS +I+ + +GLAY H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP--LSPNLIKSIMYQLLRGLAYCHSH 117
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVK 861
I+H +LK N+LI+ G K+ DFGLAR + R + ++ + L Y APE +
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVVT-LWYRAPEILLGSKH 175
Query: 862 ITEKCDVYGFGVLVLEVVTGK 882
+ D++ G + E++TGK
Sbjct: 176 YSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH---NLVALE 745
+GRG +G VYR + GR VA+K + + D ++E+ L ++R N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
G Y +I E+ GS+ + G ++ + II + L Y+H +IH
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVGVIH 124
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKI 862
++K+ N+L+ ++G K+ DFG+A LL SSK + +G +MAPE
Sbjct: 125 RDIKAANILVTNTGNVKLCDFGVAALLN-----QNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 863 TEKCDVYGFGVLVLEVVTGKRP 884
K D++ G+ + E+ TG P
Sbjct: 180 DTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 10/205 (4%)
Query: 690 LGRGGFGVVYRTI-LQDGRS----VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
LG G FG V++ I + +G S VAIK + ++ ++ M +G + H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
G SLQL + + GSL H+ R+ L ++ N + +AKG+ YL ++
Sbjct: 75 LGICPGASLQL-VTQLSPLGSLLDHVR--QHRDSLDPQRLLNWCVQIAKGMYYLEEHRMV 131
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITE 864
H NL + N+L+ S ++ DFG+A LL D+ S+ ++ + +MA E + + T
Sbjct: 132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE-SILFGRYTH 190
Query: 865 KCDVYGFGVLVLEVVT-GKRPVEYM 888
+ DV+ +GV V E+++ G P M
Sbjct: 191 QSDVWSYGVTVWEMMSYGAEPYAGM 215
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 63/195 (32%), Positives = 100/195 (51%), Gaps = 21/195 (10%)
Query: 686 KDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQE--DFE--KEMKTLGKIRHHN 740
K +LG G + VVY+ + GR VAIKK+ + ++++ +F +E+K L +++H N
Sbjct: 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN 63
Query: 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
++ L + S L++EF+ + L K + D S L+ + +L +GL YLH
Sbjct: 64 IIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIV--LTPADIKSYMLMTLRGLEYLHS 120
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPE--FACR 858
I+H +LK N+LI S G K+ DFGLAR +R ++ ++ Y APE F R
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQV-VTRWYRAPELLFGAR 178
Query: 859 TVKITEKCDVYGFGV 873
YG GV
Sbjct: 179 H---------YGVGV 184
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 65/232 (28%), Positives = 106/232 (45%), Gaps = 45/232 (19%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIK-SQEDFEKEMKTLGKIRHH-NLVALE 745
+G G +G VY+ + G+ VAIK + +I+ +E+ ++E L K +H N+
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK---IMDIIEDEEEEIKEEYNILRKYSNHPNIATFY 69
Query: 746 GYYWTPSL-----QL-LIYEFISSGS---LYKHLHDGSSR---NCLSWRQRFNIILGMAK 793
G + + QL L+ E GS L K L R +++ I+ +
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-----ILRETLR 124
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---Y 850
GLAYLH +IH ++K N+L+ + E K+ DFG++ LD + + + +G +
Sbjct: 125 GLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA---QLDSTL--GRRNTFIGTPYW 179
Query: 851 MAPE-FAC---RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDM 898
MAPE AC + DV+ G+ +E+ GK P LCDM
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP----------LCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 74/285 (25%), Positives = 132/285 (46%), Gaps = 43/285 (15%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALEG 746
+G+G F VVY+ I L DGR VA+KK+ + ++ K+++D KE+ L ++ H N++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 747 YYWTPSLQLLIYEFISSGSLYKHL-HDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
+ + ++ E +G L + + H + + R + + + L ++H I+H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMH 129
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI---QSALG---YMAPEFACRT 859
++K NV I ++G K+GD GL R SSK S +G YM+PE
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGR--------FFSSKTTAAHSLVGTPYYMSPE----- 176
Query: 860 VKITE-----KCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914
+I E K D++ G L+ E+ + P + ++ LC ++E C
Sbjct: 177 -RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---------KIEKCDYP 226
Query: 915 RLRGNFPADE-AIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958
L PAD + + L C + P RPD+ V+ + + + +
Sbjct: 227 PL----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 5e-19
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 26/211 (12%)
Query: 689 ELGRGGFGVVYRTILQDGRS---VAIKKLTVSGLIKSQ--EDFEKEMKTLGKIRHHNLVA 743
E+G G FG VY +D R+ VAIKK++ SG ++ +D KE++ L K+RH N +
Sbjct: 22 EIGHGSFGAVY--FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 744 LEGYYWTPSLQLLIYEF-ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
G Y L+ E+ + S S +H + L + + G +GLAYLH N
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE--FAC 857
+IH ++K+ N+L+ G K+GDFG A ++ + +G +MAPE A
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM---------APANXFVGTPYWMAPEVILAM 186
Query: 858 RTVKITEKCDVYGFGVLVLEVVTGKRPVEYM 888
+ K DV+ G+ +E+ K P+ M
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 76/267 (28%), Positives = 123/267 (46%), Gaps = 22/267 (8%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+LG G FG V+ VAIK L + S E F E + +++H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL 808
T +I E++ +GSL L L+ + ++ +A+G+A++ N IH +L
Sbjct: 71 -TQEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKNYIHRDL 128
Query: 809 KSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDV 868
++ N+L+ + K+ DFGLARL+ + + + + APE A T K DV
Sbjct: 129 RAANILVSETLCCKIADFGLARLIED-NEYTAREGAKFPIKWTAPE-AINYGTFTIKSDV 186
Query: 869 YGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIP 927
+ FG+L+ E+VT G+ P M + V+ LE G D N P +
Sbjct: 187 WSFGILLTEIVTYGRIPYPGMTNPEVI------QNLERGYRMPRPD-----NCPEE---- 231
Query: 928 VIKLGLICASQVPSNRPDMEEVVNILE 954
+ +L +C + P RP E + ++LE
Sbjct: 232 LYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 63/266 (23%), Positives = 124/266 (46%), Gaps = 29/266 (10%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALEGY 747
LG+G +G VY+ L D + A+K++ + + + + ED E++ L + H N+++ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSS-RNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ + ++ E+ G L K + R + ++ + I + + +GL LH I+H
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHR 127
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
+LKS N+L+ ++ K+GD G++++ L + + ++I + YMAPE + K
Sbjct: 128 DLKSANILLVANDLVKIGDLGISKV---LKKNMAKTQIGTPH-YMAPEVWKGR-PYSYKS 182
Query: 867 DVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAI 926
D++ G L+ E+ T P E +++D R + RG +P I
Sbjct: 183 DIWSLGCLLYEMATFAPPFEAR-------------SMQDLRYKVQ-----RGKYPPIPPI 224
Query: 927 PVIKLGLICAS---QVPSNRPDMEEV 949
L S P RP+ +++
Sbjct: 225 YSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 62/203 (30%), Positives = 108/203 (53%), Gaps = 10/203 (4%)
Query: 690 LGRGGFGVVYRTI-LQDGRSV----AIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
LG G FG VY+ I + +G +V AIK L + K+ +F E + + H +LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
G +P++QL + + + G L ++H+ ++ + + N + +AKG+ YL ++
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERRLV 131
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITE 864
H +L + NVL+ S K+ DFGLARLL ++ + + + +MA E K T
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE-CIHYRKFTH 190
Query: 865 KCDVYGFGVLVLEVVT-GKRPVE 886
+ DV+ +GV + E++T G +P +
Sbjct: 191 QSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 30/267 (11%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW 749
+G G FG V + G+ VA+K + + + F +E + K+ H NLV L G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 750 TPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLK 809
L +++ E +S G+L L R +S Q L +A+G+ YL ++H +L
Sbjct: 70 HNGLYIVM-ELMSKGNLVNFLRT-RGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLA 127
Query: 810 STNVLIDSSGEPKVGDFGLARLLPM-LDRCILSSKIQSALGYMAPEFACRTVKITEKCDV 868
+ N+L+ G KV DFGLAR+ M +D L K + APE A + K + K DV
Sbjct: 128 ARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPE-ALKHKKFSSKSDV 180
Query: 869 YGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIP 927
+ +GVL+ EV + G+ P M +L++ V++CV+ R P
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKM-------------SLKE--VKECVEKGYRMEPPEGCPAD 225
Query: 928 VIKLGLICASQVPSNRPDMEEVVNILE 954
V L C P RP ++ LE
Sbjct: 226 VYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 2e-18
Identities = 76/240 (31%), Positives = 115/240 (47%), Gaps = 33/240 (13%)
Query: 660 KDPNYGKLVMFSGDAEFAAGANALLNKDCELGRGGFGVVYRTILQDGRS---VAIKKLTV 716
KDP +L F D E L E+G G FG VY +D R+ VAIKK++
Sbjct: 10 KDPEIAEL-FFKEDPE------KLFTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSY 60
Query: 717 SGLIKSQ--EDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF-ISSGSLYKHLHDG 773
SG ++ +D KE+K L +I+H N + +G Y L+ E+ + S S +H
Sbjct: 61 SGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH-- 118
Query: 774 SSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833
+ L + I G +GLAYLH N+IH ++K+ N+L+ G+ K+ DFG A
Sbjct: 119 --KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS--- 173
Query: 834 MLDRCILSSKIQSALG---YMAPE--FACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYM 888
++S S +G +MAPE A + K DV+ G+ +E+ K P+ M
Sbjct: 174 ------IASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 13/279 (4%)
Query: 684 LNKDCELGRGGFGVV--YR---TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRH 738
L K LG G FG V Y G VA+K L ++ ++KE+ L + H
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65
Query: 739 HNLVALEGYYWTPSLQ--LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLA 796
N+V +G + LI E++ GSL +L ++ L+ Q + +G+A
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMA 121
Query: 797 YLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI-LSSKIQSALGYMAPEF 855
YLH + IH +L + NVL+D+ K+GDFGLA+ +P + S + + A E
Sbjct: 122 YLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE- 180
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915
+ K + DV+ FGV + E++T + + +G + R+ + ++
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240
Query: 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
+R P + V L C RP ++ IL+
Sbjct: 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 52/206 (25%), Positives = 103/206 (50%), Gaps = 20/206 (9%)
Query: 690 LGRGGFG--VVYRTILQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALEG 746
LG+G FG +YR +D V K++ ++ L + + D E+ L ++H N++A
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
++ + L+ E+ + G+LY + + + ++Y+H I+H
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR 125
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI---QSALG---YMAPEFACRTV 860
++K+ N+ + +G K+GDFG+++ IL S+ ++ +G YM+PE C+ V
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISK--------ILGSEYSMAETVVGTPYYMSPEL-CQGV 176
Query: 861 KITEKCDVYGFGVLVLEVVTGKRPVE 886
K K D++ G ++ E++T KR +
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 77/275 (28%), Positives = 126/275 (45%), Gaps = 37/275 (13%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+LG G FG V+ + VA+K L + S + F +E + ++H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 749 WTPSLQLLIYEFISSGSLYKHLH-DGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+I E+++ GSL L D + L F+ +A+G+AY+ N IH +
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA--QIAEGMAYIERKNYIHRD 128
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPE---FACRTVKITE 864
L++ NVL+ S K+ DFGLAR++ + + + + APE F T+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTI---- 183
Query: 865 KCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVDARLRGN 919
K DV+ FG+L+ E+VT GK P M + V+ AL+ G R+E+C
Sbjct: 184 KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS------ALQRGYRMPRMENC-------- 229
Query: 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
DE ++K C + RP + + ++L+
Sbjct: 230 --PDELYDIMKT---CWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQED---------FEKEMKTLGKIRHH 739
+G+G +G VY + + G +A+K++ + I + D E++TL + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIIL------GMAK 793
N+V G+ T + E++ GS+ GS CL RF L + +
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSI------GS---CLRTYGRFEEQLVRFFTEQVLE 119
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAP 853
GLAYLH I+H +LK+ N+L+D+ G K+ DFG+++ + + +Q ++ +MAP
Sbjct: 120 GLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 854 EFACRTVK-ITEKCDVYGFGVLVLEVVTGKRPVEYME 889
E + + K D++ G +VLE+ G+RP E
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 6e-18
Identities = 77/285 (27%), Positives = 131/285 (45%), Gaps = 37/285 (12%)
Query: 689 ELGRGGFGVVYR------TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG G FG V+ + +D VA+K L L +++DF++E + L ++H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIV 70
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLH----------DGSSRNC---LSWRQRFNIIL 789
G ++++E++ G L K L DG R L Q +I
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 790 GMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG 849
+A G+ YL + +H +L + N L+ ++ K+GDFG++R + D + +
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190
Query: 850 YMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRV 908
+M PE + K T + DV+ FGV++ E+ T GK+P + + V+ C LE RV
Sbjct: 191 WMPPE-SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV 249
Query: 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953
C P + V + L C + P R +++E+ IL
Sbjct: 250 --C---------PKE----VYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 9e-18
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL-EGY 747
ELG G FG VY+ ++ A K+ + EDF E+ L + +H N+V L E Y
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
++ L +LI EF G+L + R L+ Q + M + L +LH +IH +
Sbjct: 72 FYENKLWILI-EFCDGGAL-DSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE-FACRTVKIT 863
LK+ N+L+ G+ K+ DFG++ + K + +G +MAPE AC T K
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQ-----KRDTFIGTPYWMAPEVVACETFKDN 183
Query: 864 E---KCDVYGFGVLVLEVVTGKRP 884
K D++ G+ ++E+ + P
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 46/216 (21%)
Query: 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALEG 746
LG GGFG V ++ R+ A+K + ++ QE E + L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 747 YYWTPSLQLLIY---EFISSGSLYKHLHDGSSRNCLS-WRQRFNIILGMAKGLAYLHHTN 802
Y T + IY E+ G L+ L D R + RF I + YLH+
Sbjct: 59 -YRTFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARF-YIACVVLAFEYLHNRG 113
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA---------LGYMAP 853
II+ +LK N+L+DS+G K+ DFG A+ K++S Y+AP
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAK------------KLKSGQKTWTFCGTPEYVAP 161
Query: 854 EFACRTVKITEK-----CDVYGFGVLVLEVVTGKRP 884
E I K D + G+L+ E++TG+ P
Sbjct: 162 EI------ILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK----EMKTLGKIRHHNLVAL 744
+G G +GVVY+ G VAIKK+ + E K E+K L ++ H N++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLR---FESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
+ L++EF+ + LYK + D + L + + + +GLA+ H I+
Sbjct: 64 LDVFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLL-----PMLDRCILSSKIQSALGYMAPEFACRT 859
H +LK N+LI++ G K+ DFGLAR P Y APE
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-------VTRWYRAPELLLGD 173
Query: 860 VKITEKCDVYGFGVLVLEVVTGK 882
+ D++ G + E+++ +
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 67/210 (31%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 689 ELGRGGFGVVY-RTILQDGRSVAIKKLTVSGLIKSQE---DFEKEMKTLGKIRHHNLVAL 744
E+G G FG VY ++ VAIKK++ SG +S E D KE++ L ++RH N +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 745 EGYYWTPSLQLLIYEF-ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
+G Y L+ E+ + S S +H + L + I G +GLAYLH
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE--FACR 858
IH ++K+ N+L+ G K+ DFG A L+ S S +G +MAPE A
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLV---------SPANSFVGTPYWMAPEVILAMD 187
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRPVEYM 888
+ K DV+ G+ +E+ K P+ M
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTV----SGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
LG+G FG VY D GR +A+K++ K E E++ L ++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHD-GSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
G + E++ GS+ L G+ ++ + I+ +G+ YLH I
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHSNMI 125
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTV 860
+H ++K N+L DS+G K+GDFG ++ L + C + ++S G +M+PE V
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTI--CSSGTGMKSVTGTPYWMSPE-----V 178
Query: 861 KITE----KCDVYGFGVLVLEVVTGKRP 884
E K DV+ G V+E++T K P
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 30/278 (10%)
Query: 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNL 741
L + +LG G FG V+ VA+K + + S E F E + ++H L
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKL 63
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
V L T +I EF++ GSL L + + + +A+G+A++
Sbjct: 64 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVK 861
N IH +L++ N+L+ +S K+ DFGLAR++ + + + + APE A
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPE-AINFGS 179
Query: 862 ITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVDARL 916
T K DV+ FG+L++E+VT G+ P M + V+ ALE G R E+C
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR------ALERGYRMPRPENC----- 228
Query: 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
+E ++ + C P RP E + ++L+
Sbjct: 229 -----PEELYNIM---MRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 36/215 (16%)
Query: 686 KDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE----KEMKTLGKIRHHN 740
K ++G G +G VY+ + G VA+KK+ + +E F +E+K L K+RH N
Sbjct: 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPN 59
Query: 741 LVALE---------GYYWTPSLQLLIYEFIS---SGSLYKHLHDGSSRNCLSW-RQRFNI 787
+V L+ Y +++E++ +G L + + +Q
Sbjct: 60 IVRLKEIVTSKGKGSIY-------MVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQ---- 108
Query: 788 ILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA 847
+ +GL YLH I+H ++K +N+LI++ G K+ DFGLAR + ++++ +
Sbjct: 109 ---LLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVIT- 164
Query: 848 LGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
L Y PE + + D++ G ++ E+ GK
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 70/279 (25%), Positives = 128/279 (45%), Gaps = 41/279 (14%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALE 745
++GRG F VYR T L DG VA+KK+ + L+ K++ D KE+ L ++ H N++
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHL-HDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
+ + ++ E +G L + + H + + + + + + L ++H ++
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVM 128
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG------YMAPEFACR 858
H ++K NV I ++G K+GD GL R SSK +A YM+PE
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRF--------FSSKTTAAHSLVGTPYYMSPE---- 176
Query: 859 TVKITE-----KCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913
+I E K D++ G L+ E+ + P + ++ LC ++E C
Sbjct: 177 --RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---------KIEQCDY 225
Query: 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952
L + ++E + +L +C + P RPD+ V ++
Sbjct: 226 PPLPSDHYSEE---LRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 77/288 (26%), Positives = 118/288 (40%), Gaps = 45/288 (15%)
Query: 690 LGRGGFGVVYRTIL--QDGRS----VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
LG G FG VY + +DG + VA+K L S + + DF E + K H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSR----NCLSWRQRFNIILGMAKGLAYLH 799
L G + + ++ E ++ G L L + R + L+ + +AKG YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 800 HTNIIHYNLKSTNVLIDSSGE---PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFA 856
+ IH ++ + N L+ G K+ DFG+AR + + + +M PE
Sbjct: 134 ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF 193
Query: 857 CRTVKITEKCDVYGFGVLVLEVV-------TGKRPVEYMEDDVVVLCDMVRGALEDGRVE 909
+ T K DV+ FGVL+ E+ G+ E ME V G GR++
Sbjct: 194 LDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME--------FVTGG---GRLD 241
Query: 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957
P PV ++ C P +RP+ ILE IQ
Sbjct: 242 ----------PPKGCPGPVYRIMTDCWQHTPEDRPNF---ATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 69/268 (25%), Positives = 121/268 (45%), Gaps = 25/268 (9%)
Query: 690 LGRGGFGVVYRTI-LQDGRS----VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
LG G FG VY+ I + DG + VAIK L + K+ ++ E + + + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
G T ++QL + + + G L ++ + R + + N + +AKG++YL ++
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDR--IGSQDLLNWCVQIAKGMSYLEEVRLV 131
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITE 864
H +L + NVL+ S K+ DFGLARLL + + + + + +MA E + T
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR-RFTH 190
Query: 865 KCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923
+ DV+ +GV V E++T G +P + + + D ++ R P
Sbjct: 191 QSDVWSYGVTVWELMTFGAKPYD---------------GIPAREIPDLLEKGERLPQPPI 235
Query: 924 EAIPVIKLGLICASQVPSNRPDMEEVVN 951
I V + + C RP E+V+
Sbjct: 236 CTIDVYMIMVKCWMIDSECRPRFRELVD 263
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 76/272 (27%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 690 LGRGGFGVVYRTILQ-DGRS---VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745
LG G FG + R L+ + VAI L K + F E TLG+ H N+V LE
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHL--HDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
G + +++ E++S+G+L L H+G L Q ++ G+A G+ YL
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLSEMGY 128
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS-KIQSALGYMAPEFACRTVKI 862
+H L + VL++S K+ F RL I ++ +S + + APE A +
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPE-AIQYHHF 185
Query: 863 TEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921
+ DV+ FG+++ EV++ G+RP M V+ A+EDG R P
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI------KAVEDG---------FRLPAP 230
Query: 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953
+ + +L L C + RP ++ +IL
Sbjct: 231 RNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 75/280 (26%), Positives = 124/280 (44%), Gaps = 33/280 (11%)
Query: 690 LGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
LGRG FG V+ + V +K L + Q +F +E+ K+ H N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNC------LSWRQRFNIILGMAKGLAY 797
L G +I E+ G L + L S++ LS +Q+ + +A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFAC 857
L + +H +L + N L+ S E KV L++ + + L + + L ++APE A
Sbjct: 133 LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL-IPLRWLAPE-AV 190
Query: 858 RTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916
+ + K DV+ FGVL+ EV T G+ P + D+ V+ L+ G++E
Sbjct: 191 QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL------NRLQAGKLE------- 237
Query: 917 RGNFPADEAIP--VIKLGLICASQVPSNRPDMEEVVNILE 954
P E P + KL C + P +RP E+V+ L
Sbjct: 238 ---LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 76/292 (26%), Positives = 128/292 (43%), Gaps = 42/292 (14%)
Query: 689 ELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
++G+G FG V++ + VA+K L Q DF++E + + H N+V
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNC-------------------LSWRQ 783
L G L++E+++ G L + L S R LS +
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 784 RFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843
+ I +A G+AYL +H +L + N L+ + K+ DFGL+R + D S
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191
Query: 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGA 902
+ +M PE + + T + DV+ +GV++ E+ + G +P M + V+ VR
Sbjct: 192 DAIPIRWMPPE-SIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY--YVR-- 246
Query: 903 LEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
DG V C D N P + + L +C S++PS+RP + IL+
Sbjct: 247 --DGNVLSCPD-----NCPLE----LYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKK--LTVSGLIKSQEDFEK---EMKTLGKIRHHNLVAL 744
LG+G +G VY + G+ +A+K+ L S ++ +++++EK E+ L ++H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
G + + EF+ GS+ L+ + + IL G+AYLH+ ++
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL---DGVAYLHNNCVV 124
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI-QSALG---YMAPEFACRTV 860
H ++K NV++ +G K+ DFG AR L + S + +S G +MAPE
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-VINES 183
Query: 861 KITEKCDVYGFGVLVLEVVTGKRPVEYME 889
K D++ G V E+ TGK P+ M+
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 67/277 (24%), Positives = 125/277 (45%), Gaps = 30/277 (10%)
Query: 689 ELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG+G FG+VY I + VAIK + + ++ + +F E + + H++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHL-------HDGSSRNCLSWRQRFNIILGMAKGL 795
L G L+I E ++ G L +L + + S ++ + +A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEF 855
AYL+ +H +L + N ++ K+GDFG+ R + D K + +M+PE
Sbjct: 133 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE- 191
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914
+ + T DV+ FGV++ E+ T ++P + M ++ V+ M G L+ + ++C D
Sbjct: 192 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD--KPDNCPDM 249
Query: 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951
+ +L +C P RP E+++
Sbjct: 250 -------------LFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 7e-17
Identities = 37/88 (42%), Positives = 55/88 (62%)
Query: 391 LDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTI 450
L L + L G IP++I L L +N+S N + G+IP S+G + +++VLD S N NG+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 451 PPQIGGAVSLKELKLEKNFLSGRIPSQI 478
P +G SL+ L L N LSGR+P+ +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 40/283 (14%)
Query: 689 ELGRGGFGVVYRTIL-----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
ELG FG +Y+ L + VAIK L + +F++E + ++ H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHL--------------HDGSSRNCLSWRQRFNIIL 789
L G +++E+++ G L++ L DG+ ++ L +I +
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 790 GMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG 849
+A G+ YL +H +L + N+LI K+ D GL+R + D + K +
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191
Query: 850 YMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRV 908
+M PE A K + D++ FGV++ E+ + G +P + V+ +MVR
Sbjct: 192 WMPPE-AIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI--EMVRK------- 241
Query: 909 EDCVDARLRGNFPADEAIPVIKLGLI--CASQVPSNRPDMEEV 949
R P E P L+ C + PS RP +++
Sbjct: 242 --------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-16
Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 689 ELGRGGFGVVY-RTILQDGRSVAIKKLTVSGLIKSQ--EDFEKEMKTLGKIRHHNLVALE 745
E+G G FG VY T VA+KK++ SG ++ +D KE+K L +++H N + +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 746 GYYWTPSLQLLIYEF-ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
G Y L+ E+ + S S +H + L + I G +GLAYLH N+I
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE--FACRT 859
H ++K+ N+L+ G+ K+ DFG A SS S +G +MAPE A
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSAS---------KSSPANSFVGTPYWMAPEVILAMDE 194
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRPVEYM 888
+ K DV+ G+ +E+ K P+ M
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 83/278 (29%), Positives = 124/278 (44%), Gaps = 42/278 (15%)
Query: 689 ELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+LG G +G VY + + +VA+K L + E+F KE + +I+H NLV L G
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN--IILGMAK----GLAYLHHT 801
+I EF++ G+L +L + + RQ N ++L MA + YL
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECN-------RQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVK 861
N IH +L + N L+ + KV DFGL+RL+ D + + + + APE + K
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNK 181
Query: 862 ITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVDARL 916
+ K DV+ FGVL+ E+ T G P ++ L V LE G R E C
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQ-VYELLEKGYRMERPEGC----- 230
Query: 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
P V +L C PS+RP E+ E
Sbjct: 231 ----PPK----VYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 689 ELGRGGFGVVYRT-ILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
ELG G GVV + G+ +A+K + + Q+ +E+ L K +V G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHY 806
++ + E++ GSL K L + R + R I + + KGL YLH IIH
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGR--IPERILGKIAVAVLKGLTYLHEKHKIIHR 125
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTV--K 861
++K +N+L++S G+ K+ DFG++ L ++S ++ +G YMAPE R
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQL-------VNSLAKTFVGTSSYMAPE---RIQGND 175
Query: 862 ITEKCDVYGFGVLVLEVVTGKRPV 885
+ K D++ G+ ++E+ TG+ P
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-16
Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 19/225 (8%)
Query: 689 ELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG G FG V+ QD VA+K L + +++DF +E + L ++H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIV 70
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLH----------DGSSRNCLSWRQRFNIILGMA 792
G ++++E++ G L K L +G+ L+ Q +I +A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMA 852
G+ YL + +H +L + N L+ + K+GDFG++R + D + + +M
Sbjct: 131 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190
Query: 853 PEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLC 896
PE + K T + DV+ GV++ E+ T GK+P + ++ V+ C
Sbjct: 191 PE-SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+G+G FG VY+ I + + VAIK + + ED ++E++ L + R + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN------IILGMAKGLAYLHHT 801
+ S +I E+ GS L G + + I+ + GL YLH
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPG----------KLDETYIAFILREVLLGLEYLHEE 117
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACR 858
IH ++K+ N+L+ G+ K+ DFG++ L SK + +G +MAPE +
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS-----TMSKRNTFVGTPFWMAPEVIKQ 172
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRP 884
+ EK D++ G+ +E+ G+ P
Sbjct: 173 S-GYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 63/212 (29%), Positives = 109/212 (51%), Gaps = 25/212 (11%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQED--------FEKEMKTLGKIRHHN 740
+G G FG VY + G +A+K++ + + S +D +E+ L +++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLHD-GSSRNCLSWRQRFNIILGMAKGLAYLH 799
+V G + E++ GS+ L++ G+ L N + + KGL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR----NFVRQILKGLNYLH 123
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK-------IQSALGYMA 852
+ IIH ++K N+L+D+ G K+ DFG+++ L+ LS+K +Q ++ +MA
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISK---KLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 853 PEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
PE +T T K D++ G LV+E++TGK P
Sbjct: 181 PEVVKQTSY-TRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 52/224 (23%), Positives = 88/224 (39%), Gaps = 38/224 (16%)
Query: 689 ELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQ-EDF---EKEMKTLGKIRHH-NLV 742
+G G F V + + AIK L LIK + + EKE L ++ H ++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE--VLTRLNGHPGII 65
Query: 743 ALEGYYWT---PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
L Y+T + E+ +G L +++ L + + L YLH
Sbjct: 66 KL---YYTFQDEENLYFVLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLH 119
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---------- 849
IIH +LK N+L+D K+ DFG A++L S+K +
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS-SPESNKGDATNIDSQIEKNRRR 178
Query: 850 ---------YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
Y++PE + D++ G ++ +++TGK P
Sbjct: 179 FASFVGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 689 ELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG G FG V+ D VA+K L + +++DFE+E + L +H N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHL--HD---------GSSRNCLSWRQRFNIILGM 791
G ++++E++ G L K L H S L+ Q I + +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 792 AKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYM 851
A G+ YL + +H +L + N L+ K+GDFG++R + D + + +M
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM 191
Query: 852 APEFACRTVKITEKCDVYGFGVLVLEVVT-GKRP 884
PE + K T + DV+ FGV++ E+ T GK+P
Sbjct: 192 PPE-SIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 16/220 (7%)
Query: 689 ELGRGGFGVVYRTILQDGRSVA---IKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745
E+G G FG V G S A +K+L S Q F +E++ ++ H N++
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMA----KGLAYLHHT 801
G LL+ EF G L +L S+R ++ + +++ MA GL +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLR--SNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFA----- 856
+ IH +L N + + K+GD+GLA D I L ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 857 -CRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVV 894
T+K +++ GV + E+ T +P + D+ V+
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL 219
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 71/294 (24%), Positives = 134/294 (45%), Gaps = 45/294 (15%)
Query: 680 ANALLNKDCELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKI 736
AN + K ++GRG F VYR T L D + VA+KK+ + ++ K+++D KE+ L ++
Sbjct: 2 ANFQIEK--KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL 59
Query: 737 RHHNLVA-LEGYYWTPSLQLLIYEFISSGSLYKHL-HDGSSRNCLSWRQRFNIILGMAKG 794
H N++ L+ + L +++ E +G L + + + + + R + + +
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVL-ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 795 LAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG----- 849
+ ++H ++H ++K NV I ++G K+GD GL R SSK +A
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--------FSSKTTAAHSLVGTP 170
Query: 850 -YMAPEFACRTVKITE-----KCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGAL 903
YM+PE +I E K D++ G L+ E+ + P + ++ LC
Sbjct: 171 YYMSPE------RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ------ 218
Query: 904 EDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957
++E C L +++ ++ + C P RPD+ V I + +
Sbjct: 219 ---KIEQCDYPPLPTEHYSEKLRELVSM---CIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 3e-16
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 44/214 (20%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKS-QED-FEKEMKTLGKIRHHNLVALEG 746
LG G FG V + G+ A+K L+ + ++K Q + E + L IRH LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAK--------GLAYL 798
+ S L+ E++ G L+ HL R RF +A+ L YL
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHL-----RKS----GRFP--EPVARFYAAQVVLALEYL 117
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEF 855
H +I++ +LK N+L+DS G K+ DFG A+ + + + G Y+APE
Sbjct: 118 HSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK--------GRTYTLCGTPEYLAPE- 168
Query: 856 ACRTVKITEK-----CDVYGFGVLVLEVVTGKRP 884
I K D + G+L+ E++ G P
Sbjct: 169 -----IILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 690 LGRGGFGVV----YRTILQDGRSVAIKKLTV-SGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+G+G +G V +R DG+ IKKL + + + ++ E+E + L +++H N+VA
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 745 -EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
E + L ++ F G LY L + + L Q + +A L YLH +I
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGK-LLPENQVVEWFVQIAMALQYLHEKHI 123
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPE-FACRTVKI 862
+H +LK+ NV + + KVGD G+AR+L ++C ++S + YM+PE F+ +
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLE--NQCDMASTLIGTPYYMSPELFSNKPYNY 181
Query: 863 TEKCDVYGFGVLVLEVVTGK 882
K DV+ G V E+ T K
Sbjct: 182 --KSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 67/279 (24%), Positives = 113/279 (40%), Gaps = 42/279 (15%)
Query: 689 ELGRGGFGVVYRTILQ--DGRS--VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
ELG G FG V + + G+ VA+K L + +++F +E + ++ H +V L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGM---AKGLAYLHHT 801
G L +L+ E G L K+L ++ A G+AYL
Sbjct: 62 IGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVS------DLKELAHQVAMGMAYLESK 114
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG------YMAPEF 855
+ +H +L + NVL+ + + K+ DFG++R L S ++ + APE
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALG-----AGSDYYRATTAGRWPLKWYAPE- 168
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914
K + K DV+ +GV + E + G +P M+ V+ LE G
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI------AMLESG-------- 214
Query: 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953
R P + + + L C P +RP E+ +
Sbjct: 215 -ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 81/280 (28%), Positives = 128/280 (45%), Gaps = 32/280 (11%)
Query: 690 LGRGGFGVVYRTIL--QDGRSV--AIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745
+G+G FG VY L DG+ + A+K L ++ E F KE + H N+++L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 746 GYYWTPS-LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
G L++ ++ G L ++ + N + + L +AKG+ YL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDL-RNFIRSETHNP-TVKDLIGFGLQVAKGMEYLASKKFV 120
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA----LGYMAPEFACRTV 860
H +L + N ++D S KV DFGLAR + D+ S + + +MA E + +T
Sbjct: 121 HRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHTGAKLPVKWMALE-SLQTQ 177
Query: 861 KITEKCDVYGFGVLVLEVVT-GKRPVEYMED-DVVVLCDMVRGALEDGRVEDCVDARLRG 918
K T K DV+ FGVL+ E++T G P ++ D+ V L GR RL
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY-------LLQGR-------RLLQ 223
Query: 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958
P P+ ++ L C P RP E+V+ +E I S
Sbjct: 224 --PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 48/225 (21%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE----KEMKTLGKIRHHNLVAL 744
LG G FG VY+ ++ GR VA+KK+ + ++ F +E+K L K++H N+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMH---NEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHL----------HD-----GSSRNCLSWRQRFNIIL 789
+ E S K HD + L+ Q +L
Sbjct: 73 ID---------MAVER-PDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML 122
Query: 790 GMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG 849
+ +G+ YLH +I+H ++K+ N+LID+ G K+ DFGLAR D + K G
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP---YDGPPPNPKGGGGGG 179
Query: 850 ------------YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
Y PE + T D++G G + E+ T +
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 27/271 (9%)
Query: 683 LLNKDCELGRGGFGVVYRTILQDGRS---VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH 739
L K ++G+G FG V++ I D R+ VAIK + + ED ++E+ L +
Sbjct: 5 LFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
+ G Y + +I E++ GS L G L Q I+ + KGL YLH
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLH 118
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRT 859
IH ++K+ NVL+ GE K+ DFG+A L D I + +MAPE +
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPE-VIKQ 175
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919
K D++ G+ +E+ G+ P + V+ + L GN
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-----------IPKNNPPTLEGN 224
Query: 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVV 950
+ P+ + C ++ PS RP +E++
Sbjct: 225 YSK----PLKEFVEACLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 71/263 (26%), Positives = 109/263 (41%), Gaps = 24/263 (9%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW 749
LG+G FG V++ L+D VA+K + + F E + L + H N+V L G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 750 TPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLK 809
++ E + G L ++ L +Q L A G+AYL N IH +L
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR--KKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLA 120
Query: 810 STNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK--IQSALGYMAPEFACRTVKITEKCD 867
+ N L+ + K+ DFG++R D I SS Q + + APE A + + + D
Sbjct: 121 ARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPE-ALNYGRYSSESD 176
Query: 868 VYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAI 926
V+ +G+L+ E + G P M + R +E G C P
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTN------QQAREQVEKGYRMSC---------PQKCPD 221
Query: 927 PVIKLGLICASQVPSNRPDMEEV 949
V K+ C P NRP E+
Sbjct: 222 DVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 689 ELGRGGFGVVY----RTIL--QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG G FG V+ +L QD VA+K L + +++DF++E + L ++H ++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTVLQHQHIV 70
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLH------------DGSSRNCLSWRQRFNIILG 790
G L+++E++ G L + L + + L+ Q I
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGY 850
+A G+ YL + +H +L + N L+ K+GDFG++R + D + + + +
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190
Query: 851 MAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRP 884
M PE + K T + D++ FGV++ E+ T GK+P
Sbjct: 191 MPPE-SILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 688 CELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGKIRHH 739
+G G +GVV + + G VAIKK K ED E +E+K L ++RH
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKF------KESEDDEDVKKTALREVKVLRQLRHE 60
Query: 740 NLVAL-EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
N+V L E + L L++E++ +L + L +S L + I + + +AY
Sbjct: 61 NIVNLKEAFRRKGRL-YLVFEYVER-TLLELLE--ASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR 858
H NIIH ++K N+L+ SG K+ DFG AR L L+ + + Y APE
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVG 175
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRP 884
+ DV+ G ++ E++ G P
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG-EP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEG-Y 747
ELG G FG VY+ ++ ++A K+ + + ED+ E++ L H +V L G +
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 748 YWTPSLQLLIYEFISSGS---LYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
YW L ++I EF G+ + L G L+ Q I M + L YLH II
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIMLELDRG-----LTEPQIQVICRQMLEALQYLHSMKII 132
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGL-ARLLPMLDRCILSSKIQSALG---YMAPEFA-CRT 859
H +LK+ NVL+ G+ K+ DFG+ A+ + L R S +G +MAPE C T
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR------RDSFIGTPYWMAPEVVMCET 186
Query: 860 VKITE---KCDVYGFGVLVLEVVTGKRP 884
+K T K D++ G+ ++E+ + P
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 71/240 (29%), Positives = 112/240 (46%), Gaps = 25/240 (10%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQED------FEKEMKTLGKIRHHNLV 742
LGRG FG VY D GR +A+K++ SQE E E++ L +RH +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDP--DSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 743 ALEGYYWTPSLQLL--IYEFISSGSLYKHLHD-GSSRNCLSWRQRFNIILGMAKGLAYLH 799
G P + L E++ GS+ L G+ ++ R I+ +G++YLH
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGVSYLH 123
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFA 856
I+H ++K N+L DS+G K+GDFG ++ + + C+ + I+S G +M+PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI--CMSGTGIKSVTGTPYWMSPE-V 180
Query: 857 CRTVKITEKCDVYGFGVLVLEVVTGKRP---VEYMEDDVVVLCDMVRGALEDGRVEDCVD 913
K DV+ V+E++T K P E M + + L DG + C D
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 688 CELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFE-----KEMKTLGKIRHH-N 740
+LG G FG VY + G VAIKK+ K +E +E+K+L K+ H N
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMK-----KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 741 LVAL-EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
+V L E + L ++E++ G+LY+ + D + S +II + +GLA++H
Sbjct: 60 IVKLKEVFRENDELYF-VFEYME-GNLYQLMKDRKGK-PFSESVIRSIIYQILQGLAHIH 116
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRT 859
H +LK N+L+ K+ DFGLAR + R + + S Y APE R+
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYV-STRWYRAPEILLRS 173
Query: 860 VKITEKCDVYGFGVLVLEVVTGK 882
+ D++ G ++ E+ T +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 5e-15
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 690 LGRGGFGVVY--RTILQDGRSVAIKKLTVSGLIKSQ-----EDFEKEMKTLGKIRHHNLV 742
LG G F Y R + + G +A+K++T S+ E KE++ + ++ H +++
Sbjct: 8 LGTGAFSSCYQARDV-KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHD-GSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
+ G S L E+++ GS+ L G+ + + N + +GL+YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI----INYTEQLLRGLSYLHEN 122
Query: 802 NIIHYNLKSTNVLIDSSGEP-KVGDFGLA-RLLPMLDRC-ILSSKIQSALGYMAPEFACR 858
IIH ++K N+LIDS+G+ ++ DFG A RL ++ + +MAPE R
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE-VLR 181
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRP 884
+ CDV+ G +++E+ T K P
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 32/211 (15%)
Query: 691 GRGGFGVVYRTILQDGRSV-AIKKLTVSGLIKSQE--DFEKEMKTLGKIRHHNLVALEGY 747
G+G FG V +D + + A+K + ++ + E + L ++ H LV L +
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL--W 66
Query: 748 YWTPSLQ-----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN------IILGMAKGLA 796
Y S Q L+ + + G L HL S + +F+ I + L
Sbjct: 67 Y---SFQDEENMYLVVDLLLGGDLRYHL---------SQKVKFSEEQVKFWICEIVLALE 114
Query: 797 YLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFA 856
YLH IIH ++K N+L+D G + DF +A + L++ GYMAPE
Sbjct: 115 YLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT---PDTLTTSTSGTPGYMAPEVL 171
Query: 857 CRTVKITEKCDVYGFGVLVLEVVTGKRPVEY 887
CR D + GV E + GKRP
Sbjct: 172 CRQGYSVA-VDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-15
Identities = 67/280 (23%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 689 ELGRGGFGVVYRTILQD------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG+G FG+VY +D VA+K + S ++ + +F E + H++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHL-------HDGSSRNCLSWRQRFNIILGMAKGL 795
L G L++ E ++ G L +L + R + ++ + +A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEF 855
AYL+ +H +L + N ++ K+GDFG+ R + D K + +MAPE
Sbjct: 133 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE- 191
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914
+ + T D++ FGV++ E+ + ++P + + ++ V+ M G L+ + ++C
Sbjct: 192 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD--QPDNC-PE 248
Query: 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
R+ L +C P RP E+VN+L+
Sbjct: 249 RVT------------DLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 43/212 (20%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE------KEMKTLGKIRHHNLV 742
+G G +G+V + ++ G+ VAIKK ++S++D +E++ L ++RH NLV
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKF-----LESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 743 ALEGYYWTPSLQLLIYEFISSGSL--YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
L + L++EF+ L + +G + + F I+ +G+ + H
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDES-RVRKYLFQIL----RGIEFCHS 118
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG----------- 849
NIIH ++K N+L+ SG K+ DFG AR L +A G
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTL-------------AAPGEVYTDYVATRW 165
Query: 850 YMAPEFACRTVKITEKCDVYGFGVLVLEVVTG 881
Y APE K D++ G LV E++TG
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 38/286 (13%)
Query: 689 ELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG FG VY+ L + ++VAIK L +E+F+ E +++H N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHL-------------HDGSSRNCLSWRQRFNIIL 789
L G +I+ + S L++ L D + ++ L +I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 790 GMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG 849
+A G+ +L +++H +L + NVL+ K+ D GL R + D L +
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR 191
Query: 850 YMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRP-VEYMEDDVVVLCDMVRGALEDGR 907
+M+PE A K + D++ +GV++ EV + G +P Y DV+ +M+R + +
Sbjct: 192 WMSPE-AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI---EMIR----NRQ 243
Query: 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953
V C P D V L L C ++ PS RP +++ + L
Sbjct: 244 VLPC---------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 62/245 (25%), Positives = 116/245 (47%), Gaps = 44/245 (17%)
Query: 689 ELGRGGFGVVYRTIL----QDGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVA 743
++G G FG + IL +DG+ IK++ +S + K +E+ KE+ L ++H N+V
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCL-SWRQRFNIILGMAKGLAYLHHTN 802
+ + ++ ++ G LYK ++ + R L Q + + + L ++H
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKIN--AQRGVLFPEDQILDWFVQICLALKHVHDRK 121
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA---LG---YMAPEFA 856
I+H ++KS N+ + G K+GDFG+AR +L+S ++ A +G Y++PE
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIAR--------VLNSTVELARTCIGTPYYLSPEI- 172
Query: 857 CRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916
C K D++ G ++ E+ T K A E G +++ V +
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKH------------------AFEAGNMKNLVLKII 214
Query: 917 RGNFP 921
RG++P
Sbjct: 215 RGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 71/274 (25%), Positives = 120/274 (43%), Gaps = 29/274 (10%)
Query: 690 LGRGGFGVVYRTILQDGRS----VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745
+G G FG VY+ + + VA+K +E F +E + + H ++V L
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
G T + ++ E G L +L ++ L ++ LAYL +H
Sbjct: 74 GVI-TENPVWIVMELAPLGELRSYLQ--VNKYSLDLASLILYSYQLSTALAYLESKRFVH 130
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
++ + NVL+ S K+GDFGL+R L + +SK + + +MAPE + + T
Sbjct: 131 RDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLPIKWMAPE-SINFRRFTSA 188
Query: 866 CDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADE 924
DV+ FGV + E++ G +P + ++++ V+ G +E+G RL P
Sbjct: 189 SDVWMFGVCMWEILMLGVKPFQGVKNNDVI------GRIENGE-------RL----PMPP 231
Query: 925 AIPVIKLGLI--CASQVPSNRPDMEEVVNILELI 956
P L+ C + PS RP E+ L I
Sbjct: 232 NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 9e-15
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 32/224 (14%)
Query: 686 KDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-------------KEMK 731
K LG G +G V + G+ VAIKK+ + + +E+K
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 732 TLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGM 791
+ +I+H N++ L Y L+ + I + L K + + L+ Q I+L +
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVV---DRKIRLTESQVKCILLQI 128
Query: 792 AKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR---LLPMLDRCI--------- 839
GL LH +H +L N+ I+S G K+ DFGLAR P D
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 840 -LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
++SK+ + L Y APE K D++ G + E++TGK
Sbjct: 189 EMTSKVVT-LWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 56/205 (27%), Positives = 102/205 (49%), Gaps = 10/205 (4%)
Query: 686 KDCELGRGGFGVVYRTI-LQDGRS----VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHN 740
K LG G FG VY+ + + +G VAIK+L + K+ ++ E + + + +
Sbjct: 11 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 70
Query: 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
+ L G T ++QL I + + G L ++ + + N + +AKG+ YL
Sbjct: 71 VCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAKGMNYLEE 127
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTV 860
++H +L + NVL+ + K+ DFGLA+LL ++ + + + +MA E +
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI 187
Query: 861 KITEKCDVYGFGVLVLEVVT-GKRP 884
T + DV+ +GV V E++T G +P
Sbjct: 188 -YTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEK--EMKTLGKIRHHN---LVA 743
+G+G FG VY+ +D R A+K L+ ++ +E E L + +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHL-HDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
L+ + T S L+ +++S G L+ HL +G R +F I + L +LH +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKF-YIAELVLALEHLHKYD 116
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKI 862
I++ +LK N+L+D++G + DFGL++ L ++ Y+APE
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 863 TEKCDVYGFGVLVLEVVTGKRPVEYMED 890
T+ D + GVLV E+ G P Y ED
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPF-YAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGKIRHHN 740
++G G +GVVY+ G VA+KK I+ + E +E+ L ++ H N
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKK------IRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
+V L T + L++EF+ L K + D S + + + + + +GLA+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTV 860
++H +LK N+LI++ G K+ DFGLAR + R + L Y APE
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCK 176
Query: 861 KITEKCDVYGFGVLVLEVVTGK 882
+ D++ G + E+VT +
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
LG+G +G+VY L +AIK++ Q E E+ ++H N+V G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE-EIALHSYLKHRNIVQYLGSD 74
Query: 749 WTPSLQLLIYEFISSGSL-------YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
+ E + GSL + L D +Q IL +GL YLH
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ----IL---EGLKYLHDN 127
Query: 802 NIIHYNLKSTNVLIDS-SGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTV 860
I+H ++K NVL+++ SG K+ DFG ++ L ++ C + L YMAPE +
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKGP 185
Query: 861 K-ITEKCDVYGFGVLVLEVVTGKRP 884
+ D++ G ++E+ TGK P
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 690 LGRGGFGVV----YRTILQDGRSVAIKKLTVSGLIKSQEDFEKEM------KTLGKIRHH 739
LGRG FG V Y+ G AIK L G I ++++ E M +T RH
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALK-KGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDG--SSRNCLSWRQRF---NIILGMAKG 794
LV L + T + E+ + G L H+H S R F ++LG
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVLG---- 113
Query: 795 LAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YM 851
L YLH I++ +LK N+L+D+ G K+ DFGL + + + + G ++
Sbjct: 114 LQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCGTPEFL 168
Query: 852 APEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
APE T T D +G GVL+ E++ G+ P
Sbjct: 169 APEVLTET-SYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+G G FG +Y + D IK++ ++ + +K +E +KE+ L K++H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDG-----SSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
+ ++ E+ G L K ++ S LSW + ++ GL ++H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIHDRK 121
Query: 803 IIHYNLKSTNVLIDSSGE-PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVK 861
I+H ++KS N+ + +G K+GDFG+AR L D L+ Y++PE C+
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEI-CQNRP 178
Query: 862 ITEKCDVYGFGVLVLEVVTGKRPVE 886
K D++ G ++ E+ T K P E
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 43/221 (19%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEM-----KTLGKIRHHNLV 742
+G+G FG V + DG+ + K++ + +E K+ L +++H N+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKE---KQQLVSEVNILRELKHPNIV 62
Query: 743 ALEGYYW----TPSLQLLIY-EFISSGSLYKHLHDGSSRNCLSWRQRF------NIILGM 791
YY + L I E+ G L + + + C R+ I+ +
Sbjct: 63 ---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLI-----QKCKKERKYIEEEFIWRILTQL 114
Query: 792 AKGLAYLHH-----TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQS 846
L H+ ++H +LK N+ +D++ K+GDFGLA++L SS ++
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-----HDSSFAKT 169
Query: 847 ALG---YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
+G YM+PE + EK D++ G L+ E+ P
Sbjct: 170 YVGTPYYMSPEQ-LNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 77/287 (26%), Positives = 124/287 (43%), Gaps = 36/287 (12%)
Query: 690 LGRGGFGVVY--------RTILQDGRS---------VAIKKLTVSGLIKSQEDFEKEMKT 732
LG G FG V+ + VA+K L ++EDF KE+K
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 733 LGKIRHHNLVALEGYYWTPSLQLLIYEFISSGS----LYKHLHDGSSRNCLSWRQRFNII 788
L ++ N+ L G +I E++ +G L KH+ + S C S F+ +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 789 LGM----AKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI 844
L M A G+ YL N +H +L + N L+ + K+ DFG++R L D + +
Sbjct: 133 LYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRA 192
Query: 845 QSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT--GKRPVEYMEDDVVVLCDMVRGA 902
+ +MA E K T K DV+ FGV + E++T ++P E++ D V+ +
Sbjct: 193 PLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIE-NAGHFF 250
Query: 903 LEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEV 949
+DGR + N P D + +L L C + +RP E+
Sbjct: 251 RDDGRQI-YLP--RPPNCPKD----IYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQED----FEKEMKTLGKIRHHNLVAL 744
LG+GGFG V ++ G+ A KKL L K + + EK++ L K+ +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHHT 801
+ T L+ ++ G L H+++ R F II G L +LH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQR 114
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSAL---GYMAPEFACR 858
I++ +LK NVL+D G ++ D GLA L KI+ GYMAPE
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------GKKIKGRAGTPGYMAPEVLQG 168
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRP 884
V D + G + E++ G+ P
Sbjct: 169 EV-YDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 683 LLNKDCELGRGGFGVVYRTILQDGRS---VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH 739
L K +G+G FG VY+ I D R+ VAIK + + ED ++E+ L +
Sbjct: 5 LFTKLERIGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
+ G Y + +I E++ GS L G L I+ + KGL YLH
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLH 118
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRT 859
IH ++K+ NVL+ G+ K+ DFG+A L D I + +MAPE +
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPE-VIKQ 175
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRP 884
K D++ G+ +E+ G+ P
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 683 LLNKDCELGRGGFGVVYRTILQDGRS---VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH 739
L K +G+G FG V++ I D R+ VAIK + + ED ++E+ L +
Sbjct: 5 LFTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
+ G Y + +I E++ GS L G Q ++ + KGL YLH
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP----FDEFQIATMLKEILKGLDYLH 118
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRT 859
IH ++K+ NVL+ G+ K+ DFG+A L D I + +MAPE ++
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRP 884
K D++ G+ +E+ G+ P
Sbjct: 177 A-YDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 76/293 (25%), Positives = 131/293 (44%), Gaps = 33/293 (11%)
Query: 683 LLNKDCELGRGGFGVVY---------RTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTL 733
L + +LG G FG V T G VA+K L D +KE++ L
Sbjct: 5 FLKRIRDLGEGHFGKVELCRYDPEGDNT----GEQVAVKSLKPESGGNHIADLKKEIEIL 60
Query: 734 GKIRHHNLVALEGYYWTPSLQ--LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGM 791
+ H N+V +G LI EF+ SGSL ++L ++N ++ +Q+ + +
Sbjct: 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQI 118
Query: 792 AKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK--IQSALG 849
KG+ YL +H +L + NVL++S + K+GDFGL + + D+ + K + S +
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET-DKEYYTVKDDLDSPVF 177
Query: 850 YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD---VVVLCDMV---RGAL 903
+ APE ++ K DV+ FGV + E++T Y + + + + M+ G +
Sbjct: 178 WYAPECLIQS-KFYIASDVWSFGVTLYELLT------YCDSESSPMTLFLKMIGPTHGQM 230
Query: 904 EDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956
R+ ++ R P + V +L C PS R + ++ E I
Sbjct: 231 TVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 16/149 (10%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGKIRHHNL 741
+G G +GVVY+ G VA+KK I+ + + E +E+ L ++ H N+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKK------IRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
V L + + L++EF+ L K++ D S L + + + +G+AY H
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDL-DLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
++H +LK N+LID G K+ DFGLAR
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-14
Identities = 41/99 (41%), Positives = 55/99 (55%), Gaps = 3/99 (3%)
Query: 185 GIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLD 244
G WF+ L L N L G I IS L L++I L N G +P +G + L+VLD
Sbjct: 416 GKWFI---DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLD 472
Query: 245 FGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIG 283
NS +GS+P+SL +L S L+L GNS +G VP +G
Sbjct: 473 LSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQED-----FEKEMKTLGKIRHHNLV 742
++G G +GVVY+ + G+ VA+KK+ ++S+E+ +E+ L +++H N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIR----LESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
L+ S LI+EF+S L K+L + + + + +G+ + H
Sbjct: 63 CLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKI 862
++H +LK N+LID+ G K+ DFGLAR + R + L Y APE + +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGSPRY 179
Query: 863 TEKCDVYGFGVLVLEVVTGKRPV 885
+ D++ G + E+ T K+P+
Sbjct: 180 STPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 29/205 (14%)
Query: 690 LGRGGFGVV----YRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745
+G+G FG V YR G VA+K + + + F E + ++RH NLV L
Sbjct: 14 IGKGEFGDVMLGDYR-----GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLL 65
Query: 746 GYYWTPSLQLLIY-EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
G L I E+++ GSL +L R+ L L + + + YL N +
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA----LGYMAPEFACRTV 860
H +L + NVL+ KV DFGL + +S Q + + APE A R
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPE-ALREK 174
Query: 861 KITEKCDVYGFGVLVLEVVT-GKRP 884
K + K DV+ FG+L+ E+ + G+ P
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 5e-14
Identities = 75/290 (25%), Positives = 123/290 (42%), Gaps = 39/290 (13%)
Query: 690 LGRGGFGVVYRT----ILQDGR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHN 740
LG G FG V R I + +VA+K L + K D EM+ + I +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLH-----------DG--SSRNCLSWRQRFNI 787
++ L G +I E+ + G+L + L D LS++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 788 ILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA 847
+A+G+ YL IH +L + NVL+ K+ DFGLAR + +D +S +
Sbjct: 140 AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP 199
Query: 848 LGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG 906
+ +MAPE V T + DV+ FG+L+ E+ T G P + + + L +G
Sbjct: 200 VKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYP------GIPVEELFKLLREG 252
Query: 907 RVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956
D P++ + L C VP+ RP +++V L+ +
Sbjct: 253 HRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVS----GLIKSQEDFEKEMKTLGKIRHHNLVAL 744
LG+G FG VY D GR +A+K++ K E E++ L + H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 745 EGYYWTPSLQLL--IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
G P + L E + GS+ L + R+ IL +G++YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL---EGVSYLHSNM 126
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRT 859
I+H ++K N+L DS G K+GDFG ++ L + C+ + ++S G +M+PE
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI--CLSGTGMKSVTGTPYWMSPE-VISG 183
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRP 884
K D++ G V+E++T K P
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-13
Identities = 32/81 (39%), Positives = 51/81 (62%)
Query: 250 LSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNL 309
L G +P+ + +L S++L GNS G +P +G + +LE LDLS N F+G IP S+G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 310 VFLKELNISMNQFTGGLPESM 330
L+ LN++ N +G +P ++
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVS----GLIKSQEDFEKEMKTLGKIRHHNLVAL 744
LG+G FG VY D GR +A K++ K E E++ L ++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 745 EGYYWTPSLQLL--IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
G + + L E++ GS+ L + R+ IL +G++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL---EGMSYLHSNM 126
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRT 859
I+H ++K N+L DS+G K+GDFG ++ L + C+ + I+S G +M+PE
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI--CMSGTGIRSVTGTPYWMSPE-VISG 183
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRP-VEY 887
K DV+ G V+E++T K P EY
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 689 ELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFE----KEMKTLGKIRHHNLVA 743
+LG G + VY+ I + +G+ VA+K ++ +K++E +E L ++H N+V
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVIS----MKTEEGVPFTAIREASLLKGLKHANIVL 67
Query: 744 LEGYYWTPSLQLLIYEFISSG-SLYKHLHDGSSRNCLSWRQRFNIILGM---AKGLAYLH 799
L T ++E++ + + Y H G N+ L M +GLAY+H
Sbjct: 68 LHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY-------NVRLFMFQLLRGLAYIH 120
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQS---ALGYMAPEFA 856
+I+H +LK N+LI GE K+ DFGLAR + I S S L Y P+
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLAR-----AKSIPSQTYSSEVVTLWYRPPDVL 175
Query: 857 CRTVKITEKCDVYGFGVLVLEVVTGK 882
+ D++G G + +E++ G+
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 78/298 (26%), Positives = 131/298 (43%), Gaps = 39/298 (13%)
Query: 690 LGRGGFG-VVYRTIL-------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHN 740
LG G FG VV L ++ +VA+K L K D EM+ + I +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLH-------------DGSSRNCLSWRQRFNI 787
++ L G +I E+ S G+L ++L ++++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 788 ILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA 847
+A+G+ YL IH +L + NVL+ + K+ DFGLAR + +D ++ +
Sbjct: 143 TYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202
Query: 848 LGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG 906
+ +MAPE V T + DV+ FGVL+ E+ T G P Y V L + L++G
Sbjct: 203 VKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEELFKL----LKEG 255
Query: 907 RVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQE 964
R + PA+ + + C +PS+RP +++V L+ I + +E
Sbjct: 256 H---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTNEE 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 689 ELGRGGFGVVYRTILQDGRS------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
+LG G + V++ GRS VA+K++ + + +E+ L ++H N+V
Sbjct: 12 KLGEGTYATVFK-----GRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGM---AKGLAYLH 799
L T L++E++ S K D NC + N+ + M +GL+Y H
Sbjct: 67 TLHDIIHTERCLTLVFEYLDSD--LKQYLD----NCGNLMSMHNVKIFMFQLLRGLSYCH 120
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRT 859
I+H +LK N+LI+ GE K+ DFGLAR + + + + L Y P+ +
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGS 178
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRPV 885
+ + D++G G ++ E+ TG RP+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATG-RPM 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 43/214 (20%)
Query: 690 LGRGGFGVVYRTILQDGRS---VAIKK---------LTVSGLIKSQEDFEKEMKTLGKIR 737
+G G +G+VYR +D S VA+KK + +S L +E+ L +R
Sbjct: 15 IGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISSL--------REITLLLNLR 64
Query: 738 HHNLVALEGYYWTPSLQ--LLIYEFISSGSLYKHLHDGSS-----RNCLSWRQRFNIILG 790
H N+V L+ L L+ E+ D +S S Q ++L
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYCE--------QDLASLLDNMPTPFSESQVKCLMLQ 116
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGY 850
+ +GL YLH IIH +LK +N+L+ G K+ DFGLAR + + ++ K+ + L Y
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-MTPKVVT-LWY 174
Query: 851 MAPE--FACRTVKITEKCDVYGFGVLVLEVVTGK 882
APE C T T D++ G ++ E++ K
Sbjct: 175 RAPELLLGCTTY--TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 37/226 (16%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+G G +G VY+ ++ G+ AIK + V+G +E+ ++E+ L K HH +A YY
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIAT--YY 69
Query: 749 WT------PSL--QL-LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
P + QL L+ EF +GS+ L + N L I + +GL++LH
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLH 128
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE-F 855
+IH ++K NVL+ + E K+ DFG++ LDR + + + +G +MAPE
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTV--GRRNTFIGTPYWMAPEVI 183
Query: 856 ACRT---VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDM 898
AC K D++ G+ +E+ G P LCDM
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPP----------LCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 690 LGRGGFGVVY--RTIL--QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVAL 744
LG+G FG V+ R I G+ A+K L + L ++ + + E L ++ H +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILG-MAKGLAYLHHTNI 803
+ T LI +F+ G L+ L S+ + + L +A L +LH I
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTV 860
I+ +LK N+L+D G K+ DFGL++ +D K S G YMAPE R
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK--ESIDH---EKKAYSFCGTVEYMAPEVVNRRG 174
Query: 861 KITEKCDVYGFGVLVLEVVTGKRP 884
T+ D + FGVL+ E++TG P
Sbjct: 175 H-TQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-13
Identities = 28/71 (39%), Positives = 51/71 (71%)
Query: 386 QGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNW 445
+ LQ ++LS N++ G IP ++G ++SL +L++S N GSIP S+G+L ++++L+ + N
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501
Query: 446 LNGTIPPQIGG 456
L+G +P +GG
Sbjct: 502 LSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 23/204 (11%)
Query: 689 ELGRGGFGVV-YRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
++G G G+V T G+ VA+KK+ + + + F E+ + H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHENVVDMYNS 87
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
Y ++ EF+ G+L D + ++ Q + L + + L+YLH+ +IH +
Sbjct: 88 YLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 808 LKSTNVLIDSSGEPKVGDFG----LARLLPMLDRCILSSKIQSALG---YMAPEFACRTV 860
+KS ++L+ S G K+ DFG +++ +P K +S +G +MAPE R
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVP---------KRKSLVGTPYWMAPEVISRLP 194
Query: 861 KITEKCDVYGFGVLVLEVVTGKRP 884
TE D++ G++V+E++ G+ P
Sbjct: 195 YGTE-VDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 50/166 (30%), Positives = 76/166 (45%), Gaps = 38/166 (22%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVS--------------GLIKSQEDFEKEMKTL 733
E+G G +G VY+ L GR VA+KK+ V L+K E FE
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE------ 59
Query: 734 GKIRHHNLVAL----EGYYWTPSLQL-LIYEFIS---SGSLYKHLHDGSSRNCLSWRQRF 785
H N+V L G L+L L++E + + L K G L
Sbjct: 60 ----HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-----LPPETIK 110
Query: 786 NIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831
+++ + +G+ +LH I+H +LK N+L+ S G+ K+ DFGLAR+
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 690 LGRGGFGVVYRTILQ-DGRSVAIKKLT--VSGLIKSQEDFEKEMKTLGKIRHHNLVALEG 746
+G G FG+V Q G++VAIKK+ S + ++ + +E+K L +RH N+++L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSD 76
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ +P + + L++ L + Q F + + +GL Y+H ++H
Sbjct: 77 IFISPLEDIYFVTELLGTDLHRLLTSRPLEK--QFIQYF--LYQILRGLKYVHSAGVVHR 132
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
+LK +N+LI+ + + K+ DFGLAR+ +S++ Y APE K +
Sbjct: 133 DLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKYDVEV 187
Query: 867 DVYGFGVLVLEVVTGK 882
D++ G + E++ GK
Sbjct: 188 DIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 689 ELGRGGFGVVYRTILQDGRS------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
+LG G + VY+ GRS VA+K++ + + +E+ L ++H N+V
Sbjct: 13 KLGEGTYATVYK-----GRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
L T L++E++ L ++L D N ++ + + +GL Y H
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKI 862
++H +LK N+LI+ GE K+ DFGLAR + + + + L Y P+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDY 182
Query: 863 TEKCDVYGFGVLVLEVVTGKRPV 885
+ + D++G G + E+ TG RP+
Sbjct: 183 STQIDMWGVGCIFYEMSTG-RPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 690 LGRGGFG-VVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKE--------MKTLGKIRHHN 740
LG G FG VV T +S A+ K+ V L + E+E M LG H N
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN--HEN 100
Query: 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
+V L G L+I E+ G L L + L+ + +AKG+A+L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRR-KRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPE--FACR 858
N IH +L + NVL+ K+ DFGLAR + ++ + + +MAPE F C
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC- 218
Query: 859 TVKITEKCDVYGFGVLVLEVVT 880
T + DV+ +G+L+ E+ +
Sbjct: 219 --VYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 8/198 (4%)
Query: 690 LGRGGFG-VVYRTILQDGRSVAIKKLTVSGLIKSQEDFE--KEMKTLGKIRHHNLVALEG 746
LG+GGFG V + G+ A K+L + K + + E + L K+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
Y T L+ ++ G L H+++ + R F + GL LH N ++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF-YAAEILCGLEDLHRENTVYR 126
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
+LK N+L+D G ++ D GLA +P + + ++ +GYMAPE + T
Sbjct: 127 DLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGRV-GTVGYMAPE-VLNNQRYTLSP 182
Query: 867 DVYGFGVLVLEVVTGKRP 884
D +G G L+ E++ G+ P
Sbjct: 183 DYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 74/293 (25%), Positives = 121/293 (41%), Gaps = 44/293 (15%)
Query: 690 LGRGGFGVVYRTILQD--GR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
LG G FG V + GR +VA+K L + D E L ++ H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHD-----------GSSRNC----------LSWR 782
L G LLI E+ GSL L + +RN L+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 783 QRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842
+ +++G+ YL ++H +L + NVL+ + K+ DFGL+R + D + S
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRG 901
K + + +MA E + T + DV+ FGVL+ E+VT G P + + L ++++
Sbjct: 188 KGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE--RLFNLLKT 244
Query: 902 ALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
R E+C + + L L C Q P RP ++ LE
Sbjct: 245 GYRMERPENCSEE-------------MYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 28/208 (13%)
Query: 688 CELGRGGFGVVYRTILQDGRS---VAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLV 742
+G G FG V+ +++D S A+K + + +I K ++ E + L ++ H ++
Sbjct: 7 KTVGTGTFGRVH--LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFII 64
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILG------MAKGLA 796
L ++ E++ G L+ +L RN RF+ G + L
Sbjct: 65 RLFWTEHDQRFLYMLMEYVPGGELFSYL-----RN----SGRFSNSTGLFYASEIVCALE 115
Query: 797 YLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFA 856
YLH I++ +LK N+L+D G K+ DFG A+ L DR + + Y+APE
Sbjct: 116 YLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL--RDR---TWTLCGTPEYLAPEVI 170
Query: 857 CRTVKITEKCDVYGFGVLVLEVVTGKRP 884
+ D + G+L+ E++ G P
Sbjct: 171 QSKGH-NKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-13
Identities = 49/148 (33%), Positives = 72/148 (48%), Gaps = 15/148 (10%)
Query: 24 TFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPC-----NWVGVKC--DPKTKR--VVGL 74
T ++V L K+ L P W+ D PC W G C D + + GL
Sbjct: 369 TLLEEVSALQTLKSSLGLPLR--FGWNGD---PCVPQQHPWSGADCQFDSTKGKWFIDGL 423
Query: 75 TLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIP 134
LD L G I + +L+ LQ ++LS N+ G I L S +L+V+D S N+ +G IP
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 135 DEFFRQCGSLREVSFANNNLTGPIPESL 162
E Q SLR ++ N+L+G +P +L
Sbjct: 484 -ESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-13
Identities = 74/275 (26%), Positives = 123/275 (44%), Gaps = 31/275 (11%)
Query: 708 SVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEFISSGSL 766
+VA+K L K D EM+ + I +H N++ L G ++ E+ S G+L
Sbjct: 46 TVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105
Query: 767 YKHLH-------DGSSRNC------LSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNV 813
++L D S C L+++ + +A+G+ YL IH +L + NV
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165
Query: 814 LIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGV 873
L+ K+ DFGLAR + +D ++ + + +MAPE V T + DV+ FGV
Sbjct: 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGV 224
Query: 874 LVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLG 932
L+ E+ T G P Y V L + L++G R + PA+ + +
Sbjct: 225 LLWEIFTLGGSP--YPGIPVEELFKL----LKEGH---------RMDKPANCTHELYMIM 269
Query: 933 LICASQVPSNRPDMEEVVNILELIQSPLDGQEELE 967
C VPS RP +++V L+ + + E L+
Sbjct: 270 RECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLD 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 6e-13
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 689 ELGRGGFGVVYRTILQDGRS---VAIKKLT---VSGLIKSQEDFEKEMKTLGKIRHHNLV 742
++G G +G V + D R+ VAIKKL S L + +E++ L ++H N++
Sbjct: 22 QVGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRA--YRELRLLKHMKHENVI 77
Query: 743 ALEGYYWTPSLQL-------LIYEFISS--GSLYKHLHDGSSRNCLSWRQRFNIILGMAK 793
L + TP L L L+ F+ + G L KH R +F ++ M K
Sbjct: 78 GLLDVF-TPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR------IQF-LVYQMLK 129
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAP 853
GL Y+H IIH +LK N+ ++ E K+ DFGLAR D + + Y AP
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTR--WYRAP 184
Query: 854 EFACRTVKITEKCDVYGFGVLVLEVVTGK 882
E + T+ D++ G ++ E++TGK
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 74/294 (25%), Positives = 121/294 (41%), Gaps = 37/294 (12%)
Query: 684 LNKDCELGRGGFGVVYR-----TILQDGRS-VAIKKLTVSGLIKSQEDFEKEMKTLGKI- 736
L LG G FG V + + S VA+K L K D EM+ + I
Sbjct: 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 73
Query: 737 RHHNLVALEGYYWTPSLQLLIYEFISSGSL-------------YKHLHDGSSRNCLSWRQ 783
+H N++ L G ++ E+ + G+L L+ +
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 784 RFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843
+ +A+G+ +L IH +L + NVL+ K+ DFGLAR + +D ++
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGA 902
+ + +MAPE V T + DV+ FGVL+ E+ T G P Y V L +++
Sbjct: 194 GRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSP--YPGIPVEELFKLLK-- 248
Query: 903 LEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956
E R+E P + + L C +VPS RP +++V L+ +
Sbjct: 249 -EGYRMEK----------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 52/202 (25%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 689 ELGRGGFGVVYRTILQDGRS------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
+LG G + VY+ GR+ VA+K++ + + +E+ + +++H N+V
Sbjct: 7 KLGEGTYATVYK-----GRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
L T + +L++E++ L K++ R L + + KG+A+ H
Sbjct: 62 RLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARL--LPMLDRCILSSKIQSALGYMAPEFACRTV 860
++H +LK N+LI+ GE K+ DFGLAR +P+ S+++ + L Y AP+ +
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVVT-LWYRAPDVLLGSR 176
Query: 861 KITEKCDVYGFGVLVLEVVTGK 882
+ D++ G ++ E++TG+
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
++G+G G V+ + G+ VAIK++ + K +E E+ + ++++ N+V
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK-KELIINEILVMKELKNPNIVNFLDS 84
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+ ++ E+++ GSL D + C+ Q + + L +LH +IH +
Sbjct: 85 FLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140
Query: 808 LKSTNVLIDSSGEPKVGDFGL-ARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKIT 863
+KS NVL+ G K+ DFG A++ P SK + +G +MAPE R
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPE------QSKRSTMVGTPYWMAPEVVTRKA-YG 193
Query: 864 EKCDVYGFGVLVLEVVTGKRP 884
K D++ G++ +E+V G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 79/298 (26%), Positives = 126/298 (42%), Gaps = 39/298 (13%)
Query: 690 LGRGGFG--VVYRTILQDGRS------VAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHN 740
LG G FG V+ I D VA+K L K D EM+ + I +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLH-------------DGSSRNCLSWRQRFNI 787
++ L G +I E+ S G+L ++L LS++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 788 ILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA 847
+A+G+ YL IH +L + NVL+ K+ DFGLAR + +D ++ +
Sbjct: 146 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205
Query: 848 LGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG 906
+ +MAPE A T + DV+ FGVL+ E+ T G P Y V L +++
Sbjct: 206 VKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEELFKLLKEGHRMD 262
Query: 907 RVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQE 964
+ +C +E +++ C VPS RP +++V L+ I + QE
Sbjct: 263 KPSNC----------TNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRILALTSNQE 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQED----FE--KEMKTLGKIRHHNLV 742
+LG G + VY+ G+S KL +I+ QE+ F +E L ++H N+V
Sbjct: 12 KLGEGSYATVYK-----GKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 743 ALEGYYWTPSLQLLIYEFISSG-SLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
L T L++E++ + Y H G L + + +GL+Y+H
Sbjct: 67 LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG----LHPENVKLFLFQLLRGLSYIHQR 122
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVK 861
I+H +LK N+LI +GE K+ DFGLAR + + + L Y P+ + +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTE 180
Query: 862 ITEKCDVYGFGVLVLEVVTGKRPVEYMED 890
+ D++G G + +E++ G M+D
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
++G+G G VY I + G+ VAIK++ + K +E E+ + + +H N+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK-KELIINEILVMRENKHPNIVNYLDS 84
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
Y ++ E+++ GSL D + C+ Q + + L +LH +IH +
Sbjct: 85 YLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 140
Query: 808 LKSTNVLIDSSGEPKVGDFGL-ARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKIT 863
+KS N+L+ G K+ DFG A++ P SK + +G +MAPE R
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPE------QSKRSTMVGTPYWMAPEVVTRK-AYG 193
Query: 864 EKCDVYGFGVLVLEVVTGKRP 884
K D++ G++ +E+V G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 2e-12
Identities = 47/152 (30%), Positives = 78/152 (51%), Gaps = 19/152 (12%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK----EMKTLGKIRHHNLVAL 744
+G G +GVV + + GR VAIKK++ + K E+K L +RH N++ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS---NVFDDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 745 EGYYWTPSLQ-----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN-IILGMAKGLAYL 798
PS + ++ E + + L+K + S L+ + + +GL YL
Sbjct: 65 LDILRPPSPEDFNDVYIVTELMET-DLHKVIK---SPQPLT-DDHIQYFLYQILRGLKYL 119
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
H N+IH +LK +N+L++S+ + K+ DFGLAR
Sbjct: 120 HSANVIHRDLKPSNILVNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 33/224 (14%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALEGY 747
+G G +G VY+ ++ G+ AIK + V+ +E+ + E+ L K HH N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 748 YWTPSL-----QL-LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
+ S QL L+ EF +GS+ L + N L I + +GLA+LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE-FAC 857
+IH ++K NVL+ + E K+ DFG++ LDR + + + +G +MAPE AC
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTV--GRRNTFIGTPYWMAPEVIAC 195
Query: 858 RT---VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDM 898
+ D++ G+ +E+ G P LCDM
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPP----------LCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 683 LLNKDCELGRGGFGVVYRTILQD---GRSVAIKKLTVSGLIKSQ--EDFEKEMKTLGKIR 737
LL ++G G G+V I ++ GR VA+K + L K Q E E+ + +
Sbjct: 22 LLENYIKIGEGSTGIV--CIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQ 76
Query: 738 HHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAY 797
H N+V + Y ++ EF+ G+L D S+ L+ Q + + + L Y
Sbjct: 77 HQNVVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCY 132
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFG----LARLLPMLDRCILSSKIQSALG---Y 850
LH +IH ++KS ++L+ G K+ DFG +++ +P K +S +G +
Sbjct: 133 LHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP---------KRKSLVGTPYW 183
Query: 851 MAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVV 893
MAPE RT TE D++ G++V+E+V G+ P Y D V
Sbjct: 184 MAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPP--YFSDSPV 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 29/212 (13%)
Query: 690 LGRGGFGVVY----RTILQDGRSVAIK---KLTVSGLIKSQEDFEKEMKTLGKIRHHN-L 741
LG G +G V+ G+ A+K K T+ K+ E E + L +R L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN------IILGMAKGL 795
V L + T + LI ++++ G L+ HL+ R+ F I + L
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQ---------REHFTESEVRVYIAEIVLAL 118
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLL--PMLDRCILSSKIQSALGYMAP 853
+LH II+ ++K N+L+DS G + DFGL++ +R + + YMAP
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER---AYSFCGTIEYMAP 175
Query: 854 EFACRTVKITEKC-DVYGFGVLVLEVVTGKRP 884
E +K D + GVL E++TG P
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 48/221 (21%)
Query: 684 LNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE----KEMKTLGKIRH 738
LN+ E G +GVVYR + G VA+KKL + K +E F +E+ L K++H
Sbjct: 10 LNRIEE---GTYGVVYRARDKKTGEIVALKKLKME---KEKEGFPITSLREINILLKLQH 63
Query: 739 HNLVALE----GYYWTPSLQLLIY---EFISSG--SLYKHLHDG---SSRNCLSWRQRFN 786
N+V ++ G S IY E++ SL + + S CL
Sbjct: 64 PNIVTVKEVVVG-----SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL------- 111
Query: 787 IILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR-----LLPMLDRCILS 841
+L + G+A+LH I+H +LK++N+L+++ G K+ DFGLAR L P
Sbjct: 112 -MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY------- 163
Query: 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
+++ L Y APE + + D++ G + E++T K
Sbjct: 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQED-FEKEMKTLGKIRHHNLVALEGY 747
+GRG FG+V+ D + V IK++ V + K + + E + L + H N++ Y
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---EY 64
Query: 748 Y--WTPSLQLLI-YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
Y + L+I E+ G+L +++ + L + + + L ++H I+
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 805 HYNLKSTNVLIDSSGEP-KVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTV 860
H +LK+ N+L+D K+GDFG++++L SK + +G Y++PE C
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSS------KSKAYTVVGTPCYISPEL-CEGK 176
Query: 861 KITEKCDVYGFGVLVLEVVTGKRPVE 886
+K D++ G ++ E+ + KR E
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 54/212 (25%), Positives = 103/212 (48%), Gaps = 18/212 (8%)
Query: 689 ELGRGGFGVVYRTILQDGRS------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
+LG G + V++ GRS VA+K++ + + +E+ L ++H N+V
Sbjct: 13 KLGEGTYATVFK-----GRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
L T L++E++ L +++ D N +S + + +GLAY H
Sbjct: 68 TLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKI 862
++H +LK N+LI+ GE K+ DFGLAR + + + + L Y P+ + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEY 182
Query: 863 TEKCDVYGFGVLVLEVVTGKR--PVEYMEDDV 892
+ + D++G G + E+ +G+ P +ED++
Sbjct: 183 STQIDMWGVGCIFFEMASGRPLFPGSTVEDEL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 686 KDCELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE------KEMKTLGKIRH 738
K ++G G +GVV++ ++ G+ VAIKK ++S++D +E++ L +++H
Sbjct: 5 KLSKIGEGSYGVVFKCRNRETGQIVAIKKF-----VESEDDPVIKKIALREIRMLKQLKH 59
Query: 739 HNLVAL-EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAY 797
NLV L E + L L ++E+ L + + + R + II + + +
Sbjct: 60 PNLVNLIEVFRRKRKLHL-VFEYCDHTVL--NELEKNPRGVPEHLIK-KIIWQTLQAVNF 115
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLL----PMLDRCILSSKIQSALGYMAP 853
H N IH ++K N+LI G+ K+ DFG AR+L + + Y AP
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR------WYRAP 169
Query: 854 EFACRTVKITEKCDVYGFGVLVLEVVTG 881
E + DV+ G + E++TG
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 37/214 (17%)
Query: 690 LGRGGFGVVYRTILQDGRS----VAIKKLTVSGLIKSQEDF---EKEMKTLGKIRHHNLV 742
LG+GG+G V++ G A+K L + ++++Q+D + E L ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIIL-GMAK-------- 793
L + T LI E++S G L+ HL +R I + A
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL------------EREGIFMEDTACFYLSEISL 111
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---Y 850
L +LH II+ +LK N+L+D+ G K+ DFGL + + + + G Y
Sbjct: 112 ALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK-----ESIHEGTVTHTFCGTIEY 166
Query: 851 MAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
MAPE R+ + D + G L+ +++TG P
Sbjct: 167 MAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 25/228 (10%)
Query: 684 LNKDCELGRGGFGVV-YRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
L+ ++G G G+V T+ G+ VA+KK+ + + + F E+ + +H N+V
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVV 80
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
+ Y ++ EF+ G+L D + ++ Q + L + K L+ LH
Sbjct: 81 EMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG 136
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK----IQSALG---YMAPEF 855
+IH ++KS ++L+ G K+ DFG C SK +S +G +MAPE
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGF---------CAQVSKEVPRRKSLVGTPYWMAPEL 187
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGAL 903
R + + D++ G++V+E+V G+ P Y + + M+R L
Sbjct: 188 ISR-LPYGPEVDIWSLGIMVIEMVDGEPP--YFNEPPLKAMKMIRDNL 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 689 ELGRGGFGVV-YRTILQDGRSVAIKKLTVSGLIKSQ--EDFEKEMKTLGKIRHHNLVALE 745
++G G G+V T GR VA+KK+ L K Q E E+ + +H N+V +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMY 82
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
Y ++ EF+ G+L D + ++ Q + L + K L++LH +IH
Sbjct: 83 SSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIH 138
Query: 806 YNLKSTNVLIDSSGEPKVGDFG----LARLLPMLDRCILSSKIQSALG---YMAPEFACR 858
++KS ++L+ S G K+ DFG +++ +P + +S +G +MAPE R
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP---------RRKSLVGTPYWMAPEVISR 189
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRP 884
TE D++ G++V+E+V G+ P
Sbjct: 190 LPYGTE-VDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-12
Identities = 37/115 (32%), Positives = 64/115 (55%), Gaps = 2/115 (1%)
Query: 463 LKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGIL 522
L L+ L G IP+ I L S+ LS N++ G +P ++ ++++L+ +DLS+N +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 523 PKELINLSHLLSFNISHNHLHGELP--VGGFFNTISPSSVSGNPSLCGSVVNRSC 575
P+ L L+ L N++ N L G +P +GG + + + N LCG R+C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC 537
|
Length = 623 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
++G+G G VY I + G+ VAIK++ + K +E E+ + + ++ N+V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 84
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
Y ++ E+++ GSL D + C+ Q + + L +LH +IH +
Sbjct: 85 YLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRD 140
Query: 808 LKSTNVLIDSSGEPKVGDFGL-ARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKIT 863
+KS N+L+ G K+ DFG A++ P SK + +G +MAPE R
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPE------QSKRSTMVGTPYWMAPEVVTRKA-YG 193
Query: 864 EKCDVYGFGVLVLEVVTGKRP 884
K D++ G++ +E+V G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL-EGY 747
ELG G FG VY+ ++ +A K+ + + ED+ E+ L H N+V L + +
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
Y+ +L +LI EF + G++ + + L+ Q + + L YLH IIH +
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENKIIHRD 128
Query: 808 LKSTNVLIDSSGEPKVGDFGLA----RLLPMLDRCILSSKIQSALGYMAPEFA-CRTVK- 861
LK+ N+L G+ K+ DFG++ R + D I + +MAPE C T K
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY------WMAPEVVMCETSKD 182
Query: 862 --ITEKCDVYGFGVLVLEVVTGKRP 884
K DV+ G+ ++E+ + P
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-12
Identities = 41/109 (37%), Positives = 64/109 (58%), Gaps = 7/109 (6%)
Query: 338 AIDVSQNKLTGNIPTWIFKM-GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSN 396
+ + L G IP I K+ LQ+++LSGN + PS S+ L+VLDLS N
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSI-RGNIPPSLGSIT----SLEVLDLSYN 476
Query: 397 ALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIG-KLKAIQVLDFSDN 444
+ +G IP ++G L+SL +LN++ N L G +PA++G +L +F+DN
Sbjct: 477 SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQ--EDF---EKEMKTLGKIRHHNLVAL 744
+G G +G VY+ R++ +L +IK + +DF ++E+ + + +H N+VA
Sbjct: 17 VGSGTYGDVYK-----ARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
G Y + + E+ GSL H LS Q + +GLAYLH +
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLAYLHSKGKM 128
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFAC--RT 859
H ++K N+L+ +G+ K+ DFG+A + +K +S +G +MAPE A +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITA-----TIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRPV 885
+ CD++ G+ +E+ + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 43/222 (19%)
Query: 689 ELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE----KEMKTLGKIRHHNLVA 743
++G G +G VY+ +D G VA+KK+ L +E F +E+K L ++ H N+V
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNHRNIVN 70
Query: 744 L-----------------EGYYWTPSLQLLIYEFISS---GSLYKHLHDGSSRNCLSWRQ 783
L +Y L++E++ G L L S + S+ +
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFY-------LVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 784 RFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843
+ + +GL Y H N +H ++K +N+L+++ G+ K+ DFGLARL + ++K
Sbjct: 124 Q------LLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPV 885
+ + L Y PE + DV+ G ++ E+ T K+P+
Sbjct: 178 VIT-LWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-----RHHNLVA 743
LG+G FG V L+ A+K L +I +D E M T ++ +H L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLK-KDVILQDDDVECTM-TEKRVLALAGKHPFLTQ 60
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHH 800
L + T + E+++ G L H+ S R RF I+LG L +LH
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQ--RSGRFDEPRARFYAAEIVLG----LQFLHE 114
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTV 860
II+ +LK NVL+DS G K+ DFG+ + +L + +S Y+APE
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGG-VTTSTFCGTPDYIAPEI-LSYQ 171
Query: 861 KITEKCDVYGFGVLVLEVVTGKRPVEYMEDD 891
D + GVL+ E++ G+ P E ++D
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 5e-12
Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLT-VSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+G G +GVV I + G+ VAIKK+ + + +E+K L +H N++A+
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 748 YWTPSLQLLIYEFIS--------SGSLYKHLHDGSSRNCLSWRQRFNIILG-MAKGLAYL 798
P +F L+ +H S L+ + L + +GL Y+
Sbjct: 73 LRPPG-----ADFKDVYVVMDLMESDLHHIIH---SDQPLT-EEHIRYFLYQLLRGLKYI 123
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQ---------SALG 849
H N+IH +LK +N+L++ E ++GDFG+A R + SS + +
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMA-------RGLSSSPTEHKYFMTEYVATRW 176
Query: 850 YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPV 885
Y APE + T D++ G + E++ G+R +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 690 LGRGGFGVVYRTILQ-DG--RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALE 745
+G G FG V + ++ DG AIK++ DF E++ L K+ HH N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLH-------------DGSSRNCLSWRQRFNIILGMA 792
G L E+ G+L L S+ + LS +Q + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMA 852
+G+ YL IH +L + N+L+ + K+ DFGL+R + + + + + +MA
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG---RLPVRWMA 179
Query: 853 PEFACRTVKITEKCDVYGFGVLVLEVVT 880
E +V T DV+ +GVL+ E+V+
Sbjct: 180 IESLNYSV-YTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 690 LGRGGFGVVYRTILQDGRSV-AIKKLTVSGLIKSQEDFEKEM---KTLG-KIRHHNLVAL 744
LG+G FG V L+ AIK L ++ +D E M + L H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALK-KDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHHT 801
+ T + E+++ G L H+ S R + R RF II G L +LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEA-RARFYAAEIICG----LQFLHKK 115
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVK 861
II+ +LK NVL+D G K+ DFG+ + + +S Y+APE + K
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPEI-LKGQK 172
Query: 862 ITEKCDVYGFGVLVLEVVTGKRP 884
E D + FGVL+ E++ G+ P
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 16/220 (7%)
Query: 689 ELGRGGFGVVYRTILQDGRS---VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745
E+G G FG V + G + V +K+L VS ++ Q F +E + ++H NL+
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMA----KGLAYLHHT 801
G + LL+ EF G L +L S R + MA GL +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLR--SCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFA----- 856
N IH +L N L+ + K+GD+GL+ D + ++ L ++APE
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 857 -CRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVV 894
V T++ +V+ GV + E+ G +P ++ D+ V+
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL 219
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-12
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 21/197 (10%)
Query: 704 QDGRSVAIKKLTVSGLIKSQE--DFEKEMKTLGKIRHHNLVAL--EGYYWTPSLQLLIYE 759
G VAIK L + + F +E ++ H N+VAL G P L ++E
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59
Query: 760 FISSGSLYKHL-HDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS 818
++ +L + L DG+ L + ++L + LA H+ I+H +LK N+++ +
Sbjct: 60 YVPGRTLREVLAADGA----LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQT 115
Query: 819 G-EP--KVGDFGLARLLPMLDRCILSSKIQSA---LG---YMAPEFACRTVKITEKCDVY 869
G P KV DFG+ LLP + R + + LG Y APE R +T D+Y
Sbjct: 116 GVRPHAKVLDFGIGTLLPGV-RDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLY 173
Query: 870 GFGVLVLEVVTGKRPVE 886
+G++ LE +TG+R V+
Sbjct: 174 AWGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 8/206 (3%)
Query: 690 LGRGGFG-VVYRTILQDGRSVAIKKLTVSGLIKSQEDFE--KEMKTLGKIRHHNLVALEG 746
LG+GGFG V + G+ A KKL + K + + E + L K+ +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
Y T L+ ++ G L H+++ + R F + GL L I++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF-YAAELCCGLEDLQRERIVYR 126
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
+LK N+L+D G ++ D GLA +P + + ++ +GYMAPE K T
Sbjct: 127 DLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPE-VINNEKYTFSP 182
Query: 867 DVYGFGVLVLEVVTGKRPVEYMEDDV 892
D +G G L+ E++ G+ P ++ V
Sbjct: 183 DWWGLGCLIYEMIQGQSPFRKRKERV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 690 LGRGGFG-VVYRTILQDGRSVAIKKLTVSGLIKSQEDFE--KEMKTLGKIRHHNLVALEG 746
LG+GGFG V + G+ A KKL + K + + E + L K+ +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHHTNI 803
Y T L+ ++ G L H+++ + R F I G L LH I
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG----LEDLHRERI 123
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
++ +LK N+L+D G ++ D GLA +P + + ++ +GYMAPE + + T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVV-KNERYT 179
Query: 864 EKCDVYGFGVLVLEVVTGKRP 884
D +G G L+ E++ GK P
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 8/200 (4%)
Query: 690 LGRGGFG-VVYRTILQDGRSVAIKKLTVSGLIKSQEDFE--KEMKTLGKIRHHNLVALEG 746
LG+GGFG V + G+ A KKL + K + + E + L K+ +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
Y T L+ ++ G L H++ R F + GL LH I++
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDLHQERIVYR 126
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
+LK N+L+D G ++ D GLA +P + + ++ +GYMAPE + + T
Sbjct: 127 DLKPENILLDDHGHIRISDLGLAVHVP--EGQTIKGRV-GTVGYMAPE-VVKNERYTFSP 182
Query: 867 DVYGFGVLVLEVVTGKRPVE 886
D + G L+ E++ G+ P +
Sbjct: 183 DWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 690 LGRGGFGVVYRTILQDGRSVA-------IKKLTVSGLIKSQEDFEKEMKTLGKIRHHN-L 741
LG G +G V+ G +KK T+ K+ E E + L IR L
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN-----IILG-MAKGL 795
V L + T + LI ++I+ G L+ HL S R+RF I G + L
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHL---------SQRERFKEQEVQIYSGEIVLAL 118
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEF 855
+LH II+ ++K N+L+DS+G + DFGL++ D + + YMAP+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYSFCGTIEYMAPDI 177
Query: 856 ACRTVKITEKC-DVYGFGVLVLEVVTGKRP 884
+K D + GVL+ E++TG P
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 690 LGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
LG G G V + L G A+K +T Q+ +E++ + +V G +
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 749 WTPSLQLL--IYEFISSGSL---YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
S + E+ GSL YK + R + + I + KGL+YLH I
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR--IGEKVLGKIAESVLKGLSYLHSRKI 126
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTV 860
IH ++K +N+L+ G+ K+ DFG++ L ++S + G YMAPE
Sbjct: 127 IHRDIKPSNILLTRKGQVKLCDFGVSGEL-------VNSLAGTFTGTSFYMAPE------ 173
Query: 861 KITEK-----CDVYGFGVLVLEVVTGKRP 884
+I K DV+ G+ +LEV + P
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 8e-12
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 690 LGRGGFGVVY--RTILQDGRSVAIKKLTVSGLIK--SQEDFEKEMKTLGKIRHHNLVALE 745
+ +G +G V+ + G AIK + + +I+ + E L + + +V L
Sbjct: 1 ISKGAYGRVFLAKKK-STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL- 58
Query: 746 GYYWTPSLQ-----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
YY S Q L+ E++ G L L + L I + L YLH
Sbjct: 59 -YY---SFQGKKNLYLVMEYLPGGDLASLLE---NVGSLDEDVARIYIAEIVLALEYLHS 111
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLA------RLLPMLDRCILSSKIQSALGYMAPE 854
IIH +LK N+LIDS+G K+ DFGL+ R + + D +I Y+APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 855 FACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
++ D + G ++ E + G P
Sbjct: 172 VILGQ-GHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEM---KTLGKIRHHNLVALE 745
LG+GGFG V ++ G+ A KKL L K ++ +E M + L K+ +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL-KKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRN--------CLSWRQRFNIILGMAKGLAY 797
+ T + L+ ++ G L H+++ N C Q II G L +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ---IISG----LEH 112
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFAC 857
LH II+ +LK NVL+D+ G ++ D GLA + + D + G+MAPE
Sbjct: 113 LHQRRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPEL-L 169
Query: 858 RTVKITEKCDVYGFGVLVLEVVTGKRP 884
+ + D + GV + E++ + P
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQ--EDF---EKEMKTLGKIRHHNLVAL 744
+G G +G VY+ R+V +L +IK + EDF ++E+ + +H N+VA
Sbjct: 17 IGSGTYGDVYK-----ARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
G Y + EF GSL H LS Q + +GL YLH +
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGL-ARLLPMLDRCILSSKIQSALG---YMAPEFAC--R 858
H ++K N+L+ +G K+ DFG+ A++ + +K +S +G +MAPE A R
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATI------AKRKSFIGTPYWMAPEVAAVER 182
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRPV 885
+ CD++ G+ +E+ + P+
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 1e-11
Identities = 50/198 (25%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
++G+G G VY + + G+ VAI+++ + K +E E+ + + ++ N+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 85
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
Y ++ E+++ GSL D + C+ Q + + L +LH +IH +
Sbjct: 86 YLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 808 LKSTNVLIDSSGEPKVGDFGL-ARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
+KS N+L+ G K+ DFG A++ P + S + +MAPE R K
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKA-YGPKV 197
Query: 867 DVYGFGVLVLEVVTGKRP 884
D++ G++ +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 51/204 (25%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 704 QDGRS--VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761
DG+ VA+K L ++ DF KE+K + ++++ N++ L G + +I E++
Sbjct: 40 FDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYM 99
Query: 762 SSGSLYKHLHDGSSRN---------CLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTN 812
+G L + L + +S + + +A G+ YL N +H +L + N
Sbjct: 100 ENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159
Query: 813 VLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFG 872
L+ + K+ DFG++R L D + + + +MA E + K T DV+ FG
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE-SILLGKFTTASDVWAFG 218
Query: 873 VLVLEVVT--GKRPVEYMEDDVVV 894
V + E+ T ++P + D+ V+
Sbjct: 219 VTLWEMFTLCKEQPYSLLSDEQVI 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 48/196 (24%), Positives = 89/196 (45%), Gaps = 24/196 (12%)
Query: 705 DGRSVAIKKLTVS--GLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL----LIY 758
+ + V I+ G + E E+K L +I +N++ + G+ L LI
Sbjct: 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101
Query: 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH-HTNIIHYNLKSTNVLIDS 817
E+ + G L + L LS++ + ++ + KGL L+ +TN + NL S + L+
Sbjct: 102 EYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE 158
Query: 818 SGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPE-----FACRTVKITEKCDVYGFG 872
+ + K+ GL ++L K + + Y + + F+ + T K D+Y G
Sbjct: 159 NYKLKIICHGLEKILS-----SPPFKNVNFMVYFSYKMLNDIFS----EYTIKDDIYSLG 209
Query: 873 VLVLEVVTGKRPVEYM 888
V++ E+ TGK P E +
Sbjct: 210 VVLWEIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 690 LGRGGFGVVYRTILQ-DGR--SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALE 745
+G G FG V R +++ DG + AIK L DF E++ L K+ HH N++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLH-------------DGSSRNCLSWRQRFNIILGMA 792
G + E+ G+L L + + + L+ +Q +A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMA 852
G+ YL IH +L + NVL+ + K+ DFGL+R + + + + + +MA
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG---RLPVRWMA 186
Query: 853 PEFACRTVKITEKCDVYGFGVLVLEVVT 880
E +V T K DV+ FGVL+ E+V+
Sbjct: 187 IESLNYSV-YTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 40/215 (18%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLT-----VSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
+ +G FG VY +A K+ T + L KS + ++ + R ++
Sbjct: 3 PISKGAFGSVY---------LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQ 53
Query: 744 LEGYYWTPSLQLLIYEFISSGSLY---KHLHDGSSRNCLSWRQRF---------NIILGM 791
E P + L Y F S LY ++L+ G +C S + I +
Sbjct: 54 GES----PYVAKLYYSFQSKDYLYLVMEYLNGG---DCASLIKTLGGLPEDWAKQYIAEV 106
Query: 792 AKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYM 851
G+ LH IIH ++K N+LID +G K+ DFGL+R + + K Y+
Sbjct: 107 VLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYL 160
Query: 852 APEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVE 886
APE V + D + G ++ E + G P
Sbjct: 161 APE-TILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 73/280 (26%), Positives = 123/280 (43%), Gaps = 42/280 (15%)
Query: 693 GGFGVVYRTILQDG-----RSVAIKKLTVSGLIKSQED-FEKEMKTLGKIRHHNL----- 741
G FG ++ IL D V +K + + Q +E L + H N+
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGS-----SRNCLSWRQRFNIILGMAKGLA 796
V +E P ++Y +++ G+L L + LS +Q ++ + +A G++
Sbjct: 76 VCIEDGE-PP---FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 797 YLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR-LLPMLDRCILSSKIQSALGYMAPEF 855
YLH +IH ++ + N +ID + K+ D L+R L PM C L + +MA E
Sbjct: 132 YLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC-LGDNENRPVKWMALE- 189
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG-RVEDCVD 913
+ + + DV+ FGVL+ E++T G+ P Y+E D + L+DG R+ +
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELMTLGQTP--YVEIDPFEMAAY----LKDGYRLAQPI- 242
Query: 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953
N P DE V+ C + P RP ++V L
Sbjct: 243 -----NCP-DELFAVM---ACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 13/209 (6%)
Query: 690 LGRGGFG-VVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEM---KTLGKIRHHN-LVAL 744
LG+G FG V+ + + GR A+K L +I +D E M + L R+H L L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLK-KDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
+ TP + EF++ G L H+ SR R RF + L +LH II
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQ--KSRRFDEARARF-YAAEITSALMFLHDKGII 118
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITE 864
+ +LK NVL+D G K+ DFG+ + + +S Y+APE + +
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEI-LQEMLYGP 175
Query: 865 KCDVYGFGVLVLEVVTGKRPVEY-MEDDV 892
D + GVL+ E++ G P E EDD+
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-11
Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 687 DCELGRGGFGVVYR-TILQDGRSVAIKKL--TVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
D +G G FGVV+ T +DG+ VA+KK+ L+ + F +E+K L +H N+++
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN------IILGMAKGLAY 797
P + ++ + + LH Q + + + +GL Y
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKY 118
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFAC 857
LH I+H ++K N+L++S+ K+ DFGLAR+ + ++ ++ + Y APE
Sbjct: 119 LHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILM 177
Query: 858 RTVKITEKCDVYGFGVLVLEVVTGK 882
+ T D++ G + E++ +
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 690 LGRGGFG-VVYRTILQDGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGK-IRHHNLVALE 745
+G+G FG V+ DG+ A+K L ++ K Q+ E L K ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
+ T + +F++ G L+ HL R+ R RF +A L YLH NI++
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQ--RERSFPEPRARF-YAAEIASALGYLHSINIVY 119
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKI 862
+LK N+L+DS G + DFGL + + S + G Y+APE R
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK-----EGIAQSDTTTTFCGTPEYLAPE-VIRKQPY 173
Query: 863 TEKCDVYGFGVLVLEVVTGKRP 884
D + G ++ E++ G P
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 689 ELGRGGFGVVYRTILQD---GRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGKIRH 738
++G G +GVVY+ +D ++A+KK+ + QED E +E+ L +++H
Sbjct: 9 KIGEGTYGVVYKA--RDRVTNETIALKKIRLE-----QED-EGVPSTAIREISLLKEMQH 60
Query: 739 HNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
N+V L+ + L++E++ L KH+ D S + R + + +G+AY
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHM-DSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 799 HHTNIIHYNLKSTNVLID-SSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFAC 857
H ++H +LK N+LID + K+ DFGLAR + R + L Y APE
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILL 176
Query: 858 RTVKITEKCDVYGFGVLVLEVVTGK 882
+ + D++ G + E+V K
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 75/295 (25%), Positives = 116/295 (39%), Gaps = 57/295 (19%)
Query: 690 LGRGGFGVVYR-TILQDGRS---VAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVAL 744
LG G FG V + QD S VA+K + + S+ E+F E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 745 EGYYWT------PSLQLLIYEFISSGSL-----YKHLHDGSSRNCLSWRQRFNIILGMAK 793
G + ++I F+ G L Y L + L +F ++ +A
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF--MVDIAL 124
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAP 853
G+ YL + N IH +L + N ++ V DFGL++ KI S Y
Sbjct: 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK------------KIYSGDYYRQG 172
Query: 854 EFACRTVK-----------ITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRG 901
A VK T K DV+ FGV + E+ T G+ P +E+ + D +R
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY--DYLRH 230
Query: 902 ALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956
+ EDC+D + L C P +RP ++ +LE I
Sbjct: 231 GNRLKQPEDCLDE-------------LYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 70/298 (23%), Positives = 135/298 (45%), Gaps = 61/298 (20%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
LG G G VY+ L R +A+K + + ++ Q+ E++ L K ++ G +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 749 WTPSLQLLIYEFISSGSL--YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ + + EF+ GSL Y+ + + + L I + + KGL YL I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPE----HVLG-----RIAVAVVKGLTYLWSLKILHR 119
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKIT 863
++K +N+L+++ G+ K+ DFG++ L ++S ++ +G YMAPE +I+
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQL-------VNSIAKTYVGTNAYMAPE------RIS 166
Query: 864 EK-----CDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918
+ DV+ G+ +E+ G+ P ++ + +G+L ++ C+
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKN--------QGSLMPLQLLQCI------ 212
Query: 919 NFPADEAIPVIKLGLI----------CASQVPSNRPDMEEVVNILELIQSPLDGQEEL 966
DE PV+ +G C + P RP E +++ ++Q DG E+
Sbjct: 213 ---VDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN-DGNAEV 266
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 53/212 (25%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+LG G G V + + G +A K + + ++ +E++ + + R +V+ G
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF--NIILGMAKGLAYL---HHTN 802
+ + + EF+ GSL D + I + + +GL YL H
Sbjct: 72 FLNENNICMCMEFMDCGSL-----DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR-- 124
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRT 859
I+H ++K +N+L++S G+ K+ DFG++ L ++S + +G YM+PE +
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGEL-------INSIADTFVGTSTYMSPE-RIQG 176
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD 891
K T K DV+ G+ ++E+ GK P + D
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNID 208
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 64/236 (27%), Positives = 102/236 (43%), Gaps = 27/236 (11%)
Query: 690 LGRGGFG-VVYRTILQDGRSVAIKKLTVSGLIKSQED---FEKEMKTLGKIRHHNLVALE 745
+G+G FG V+ DG A+K L ++K +E + L ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
+ T + ++++ G L+ HL R L R RF +A + YLH NII+
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQ--RERCFLEPRARF-YAAEVASAIGYLHSLNIIY 119
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
+LK N+L+DS G + DFGL + ++ +S Y+APE R
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPE-VLRKEPYDRT 176
Query: 866 CDVYGFGVLVLEVVTG-----KRPVEYMEDDV------------VVLCDMVRGALE 904
D + G ++ E++ G R V M D++ V CD++ G L
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLH 232
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 690 LGRGGFGVVYRT-ILQDG--RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALE 745
+G G FG V + I +DG AIK++ DF E++ L K+ HH N++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDG-------------SSRNCLSWRQRFNIILGMA 792
G L E+ G+L L S+ + LS +Q + +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG--Y 850
+G+ YL IH +L + N+L+ + K+ DFGL+R + + K L +
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRW 189
Query: 851 MAPEFACRTVKITEKCDVYGFGVLVLEVVT 880
MA E +V T DV+ +GVL+ E+V+
Sbjct: 190 MAIESLNYSVYTTNS-DVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKT-----LGKIRHHNLVA 743
+G+G FG V + + + A+K L ++K +E EK + + L ++H LV
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE--EKHIMSERNVLLKNVKHPFLVG 60
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
L + T + ++I+ G L+ HL R L R RF +A L YLH NI
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQ--RERCFLEPRARF-YAAEIASALGYLHSLNI 117
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
++ +LK N+L+DS G + DFGL + ++ +S Y+APE +
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQ-PYD 174
Query: 864 EKCDVYGFGVLVLEVVTGKRP 884
D + G ++ E++ G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 96/356 (26%), Positives = 144/356 (40%), Gaps = 56/356 (15%)
Query: 261 LNSCSSLSLKGNSFTGEVPDWIGKLANL---ESLDLSLNQFSGRIPSSIGNLVFLKELNI 317
L+ SL L S D L NL SLDL+LN+ I S + L L L++
Sbjct: 66 LSRLLSLDLLSPSGISS-LDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDL 123
Query: 318 SMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM--GLQTVSLSGNRLGESMQY 375
N T +IP I + L+ + LS N +
Sbjct: 124 DNNNIT-------------------------DIPPLIGLLKSNLKELDLSDN------KI 152
Query: 376 PSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKA 435
S S + L+ LDLS N LS +P + +LS+L L++S N +P I L A
Sbjct: 153 ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGN-KISDLPPEIELLSA 210
Query: 436 IQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLT 495
++ LD S+N + + + +L L+L N L +P I N S+L +L LS N ++
Sbjct: 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268
Query: 496 GPVPAAIANLSNLKYVDLSFNDLSGILP----------KELINLSHLLSFNISHNHLHGE 545
+ +L+NL+ +DLS N LS LP L L L + + N +
Sbjct: 269 SISS--LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLN 326
Query: 546 LPVGGFFNTISPSSVSGNPSLCGS--VVNRSCPAVQNKPIVLNPNSSNPYTGNSSP 599
+ T SP ++S SL + N + N+ IV NPN+
Sbjct: 327 NNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYIVKNPNAIGSLLDLVKK 382
|
Length = 394 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 66/231 (28%), Positives = 112/231 (48%), Gaps = 38/231 (16%)
Query: 671 SGDAEFAAGANALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKE 729
SG A AA + + L + +G G G VY+ I + GR A+K + + + +E
Sbjct: 63 SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE 122
Query: 730 MKTLGKIRHHNLVALEGYY-WTPSLQLLIYEFISSGSLY-KHLHDGSSRNCLSWRQRFNI 787
++ L + H N+V + +Q+L+ EF+ GSL H+ D ++ RQ +
Sbjct: 123 IEILRDVNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSLEGTHIADEQFLADVA-RQILS- 179
Query: 788 ILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM-LDRCILSSKIQS 846
G+AYLH +I+H ++K +N+LI+S+ K+ DFG++R+L +D C S
Sbjct: 180 ------GIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC------NS 227
Query: 847 ALG---YMAPEFACRTVKITEKC----------DVYGFGVLVLEVVTGKRP 884
++G YM+PE +I D++ GV +LE G+ P
Sbjct: 228 SVGTIAYMSPE------RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 67/270 (24%), Positives = 123/270 (45%), Gaps = 32/270 (11%)
Query: 689 ELGRGGFGVVYRTILQDGR---SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745
ELG G FG V + + + + VAIK L +++ +E + + ++ + +V +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
G +L +L+ E S G L K L ++ ++ ++ ++ G+ YL N +H
Sbjct: 62 GVCEAEAL-MLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA----LGYMAPEFACRTV- 860
+L + NVL+ + K+ DFGL++ L D K +SA L + APE C
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDS---YYKARSAGKWPLKWYAPE--CINFR 173
Query: 861 KITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919
K + + DV+ +G+ + E + G++P + M+ V+ +E G+ DC
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM------SFIEQGKRLDC-------- 219
Query: 920 FPADEAIPVIKLGLICASQVPSNRPDMEEV 949
PA+ + L C +RP+ +V
Sbjct: 220 -PAECPPEMYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 690 LGRGGFGVVYRTIL----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745
+G G FG R +L + A+K++ + + ED KE L K++H N+VA +
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSR-----NCLSWRQRFNIILGMAKGLAYLHH 800
+ ++ E+ G L + + + L W + M G+ ++H
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHE 118
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLL--PMLDRCILSSKIQSALGYMAPEFACR 858
++H ++KS N+ + +G+ K+GDFG ARLL P C Y P
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGT-----PYYVPPEIWE 173
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRPVE 886
+ K D++ G ++ E+ T K P +
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-11
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 30/208 (14%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+G G FGVVY I D VAIKK+ ++ + +E+ + + H N++ L+ YY
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKV-----LQDPQYKNRELLIMKNLNHINIIFLKDYY 128
Query: 749 WTPSLQL--------LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIIL------GMAKG 794
+T + ++ EFI +++K++ + N + L + +
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNN-----HALPLFLVKLYSYQLCRA 182
Query: 795 LAYLHHTNIIHYNLKSTNVLIDSSGEP-KVGDFGLARLLPMLDRCILSSKIQSALGYMAP 853
LAY+H I H +LK N+LID + K+ DFG A+ L R + S I S Y AP
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV--SYICSRF-YRAP 239
Query: 854 EFACRTVKITEKCDVYGFGVLVLEVVTG 881
E T D++ G ++ E++ G
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 54/225 (24%), Positives = 105/225 (46%), Gaps = 28/225 (12%)
Query: 688 CELGRGGFGVVYRTILQDGR---SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
C++GRG +G VY+ +DG+ A+K++ +G+ S +E+ L +++H N++AL
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC---REIALLRELKHPNVIAL 63
Query: 745 EGYYWTPSLQ--LLIYEFISSGSLYK--HLHDGSSRN----CLSWRQRFNIILGMAKGLA 796
+ + + S + L++++ + L+ H S N L +++ + G+
Sbjct: 64 QKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 797 YLHHTNIIHYNLKSTNVLI----DSSGEPKVGDFGLARLL-----PMLDRCILSSKIQSA 847
YLH ++H +LK N+L+ G K+ D G ARL P+ D +
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL----DPVVVT 178
Query: 848 LGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDV 892
Y APE T+ D++ G + E++T + ++D+
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 54/229 (23%), Positives = 106/229 (46%), Gaps = 36/229 (15%)
Query: 688 CELGRGGFGVVYRTILQDGRS---VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
C++GRG +G VY+ +DG+ A+K++ +G+ S +E+ L +++H N+++L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC---REIALLRELKHPNVISL 63
Query: 745 EGYYWTPSLQ--LLIYEFISSGSLYK--HLHDGSSRNCLSWRQRFNIILGMAK------- 793
+ + + + + L++++ + L+ H S N ++ + GM K
Sbjct: 64 QKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKAN----KKPVQLPRGMVKSLLYQIL 118
Query: 794 -GLAYLHHTNIIHYNLKSTNVLI----DSSGEPKVGDFGLARLL-----PMLDRCILSSK 843
G+ YLH ++H +LK N+L+ G K+ D G ARL P+ D
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL----DP 174
Query: 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDV 892
+ Y APE T+ D++ G + E++T + ++D+
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGL-IKSQEDF---EKEMKTLGKIRHHNLVAL 744
+GRGGFG VY D G+ A+K L + +K E E+ M +L +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 745 EGY-YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQ-RF---NIILGMAKGLAYLH 799
Y + TP I + ++ G L+ HL S S + RF IILG L ++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEAEMRFYAAEIILG----LEHMH 114
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSAL----GYMAPEF 855
+ +++ +LK N+L+D G ++ D GLA C S K A GYMAPE
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLA--------CDFSKKKPHASVGTHGYMAPEV 166
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
+ V D + G ++ +++ G P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLT-VSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+G+G +GVV I G VAIKK+ V + +E+K L +RH ++V ++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 748 YWTPSLQ-----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIIL-GMAKGLAYLHHT 801
PS + +++E + S LH N + L + + L Y+H
Sbjct: 68 MLPPSRREFKDIYVVFELMES-----DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA 122
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR---CILSSKIQSALGYMAPEF-AC 857
N+ H +LK N+L ++ + K+ DFGLAR + I + + Y APE
Sbjct: 123 NVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 858 RTVKITEKCDVYGFGVLVLEVVTGK 882
K T D++ G + EV+TGK
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 51/226 (22%)
Query: 688 CELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQE------DFEKEMKTLG---KIR 737
ELGRG +GVV + + G +A+K++ + + SQE D + M+++ +
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRAT--VNSQEQKRLLMDLDISMRSVDCPYTVT 64
Query: 738 HHNLVALEGYYWTPSLQLLIYEFISSGSL---YKHLHDGSSR---NCLSWRQRFNIILGM 791
+ + EG W I + SL YK ++D + L I + +
Sbjct: 65 FYGALFREGDVW-------ICMEVMDTSLDKFYKKVYDKGLTIPEDILG-----KIAVSI 112
Query: 792 AKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQS-ALG 849
K L YLH ++IH ++K +NVLI+ +G+ K+ DFG++ L +D ++ I +
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDS--VAKTIDAGCKP 168
Query: 850 YMAPEFACRTVKITE---------KCDVYGFGVLVLEVVTGKRPVE 886
YMAPE +I K DV+ G+ ++E+ TG+ P +
Sbjct: 169 YMAPE------RINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLT--VSGLIKSQEDFEKEMKTLGKIRHHNLVALEG 746
+G G +G V + G VA+KKL+ +I ++ + +E++ L ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN-----IILGMAKGLAYLHHT 801
+ TP+ L E + L HL N + ++ + +I + +GL Y+H
Sbjct: 84 VF-TPARSL---EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 139
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVK 861
+IIH +LK +N+ ++ E K+ DFGLAR ++++ Y APE +
Sbjct: 140 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMH 194
Query: 862 ITEKCDVYGFGVLVLEVVTGK 882
+ D++ G ++ E++TG+
Sbjct: 195 YNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 37/216 (17%)
Query: 686 KDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGKIRH 738
K +LG G + VY+ GRS +L I+ + + E +E L ++H
Sbjct: 9 KLDKLGEGSYATVYK-----GRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKH 62
Query: 739 HNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGM---AKGL 795
N+V L T L++E++ + L +++ D C N+ L + +GL
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDD-----CGGGLSMHNVRLFLFQLLRGL 116
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL--LPMLDRCILSSKIQS----ALG 849
AY H ++H +LK N+LI GE K+ DFGLAR +P SK S L
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--------SKTYSNEVVTLW 168
Query: 850 YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPV 885
Y P+ + + + D++G G + E+ TG RP+
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG-RPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDF----EKEMKTLGKIRHHNLVAL 744
+GRGGFG VY D G+ A+K L + Q + E+ M +L +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 745 EGY-YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQ-RF---NIILGMAKGLAYLH 799
Y + TP I + ++ G L+ HL S S ++ RF IILG L ++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILG----LEHMH 114
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSAL----GYMAPEF 855
+ +++ +LK N+L+D G ++ D GLA C S K A GYMAPE
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLA--------CDFSKKKPHASVGTHGYMAPEV 166
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
+ D + G ++ +++ G P
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 13/221 (5%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQED----FEKEMKTLGKIRHHNLVAL 744
LG+GGFG V +++ G+ A KKL L K + EKE+ L K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
+ + + L+ ++ G L H+++ R L + + + G+ +LH +I+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHSMDIV 117
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITE 864
+ ++K NVL+D G ++ D GLA L D ++ + + GYMAPE
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTN-GYMAPEILKEEPYSY- 173
Query: 865 KCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALED 905
D + G + E+V G+ P + ++ V ++ R LED
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE-ELKRRTLED 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 36/106 (33%), Positives = 55/106 (51%), Gaps = 1/106 (0%)
Query: 436 IQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLT 495
I L + L G IP I L+ + L N + G IP + + +SL L LS N+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 496 GPVPAAIANLSNLKYVDLSFNDLSGILPKEL-INLSHLLSFNISHN 540
G +P ++ L++L+ ++L+ N LSG +P L L H SFN + N
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 32/90 (35%), Positives = 47/90 (52%)
Query: 147 VSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEI 206
+ N L G IP +S L+S+N S N + G +P + + SL+ LDLS N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 207 VKGISNLYDLRAIKLGKNKFSGQLPEDIGG 236
+ + L LR + L N SG++P +GG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 52/227 (22%)
Query: 686 KDC-ELGRGGFGVVYRTILQD-GRSVAIKK--LTVSGLIKSQEDFEKEMKTLGK------ 735
KD E+GRG FG V + + + G +A+K+ TV K Q+ ++ + +
Sbjct: 7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPY 64
Query: 736 -IRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNI---ILG- 790
++ + + EG W ++L+ IS YK++++ + I ILG
Sbjct: 65 IVKFYGALFREGDCWI-CMELMD---ISLDKFYKYVYE---------VLKSVIPEEILGK 111
Query: 791 ----MAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQ 845
K L YL IIH ++K +N+L+D +G K+ DFG++ L I ++
Sbjct: 112 IAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKTRDA 168
Query: 846 SALGYMAPEFACRTVKITE--------KCDVYGFGVLVLEVVTGKRP 884
YMAPE +I + DV+ G+ + EV TGK P
Sbjct: 169 GCRPYMAPE------RIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 30/264 (11%)
Query: 689 ELGRGGFGVVYRTILQDGRS---VAIKKLTVSGLIKSQED-FEKEMKTLGKIRHHNLVAL 744
ELG G FG V + + + +S VA+K L + +D +E + ++ + +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
G S +L+ E G L K L +++ ++ + ++ ++ G+ YL TN +
Sbjct: 62 IGICEAESW-MLVMELAELGPLNKFLQ--KNKH-VTEKNITELVHQVSMGMKYLEETNFV 117
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA--LGYMAPEFACRTVKI 862
H +L + NVL+ + K+ DFGL++ L D +K + + APE K
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGA-DENYYKAKTHGKWPVKWYAPE-CMNYYKF 175
Query: 863 TEKCDVYGFGVLVLEVVT-GKRPVEYME-DDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920
+ K DV+ FGVL+ E + G++P + M+ ++V + +E G +C
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM-------IESGERMEC--------- 219
Query: 921 PADEAIPVIKLGLICASQVPSNRP 944
P + L +C + RP
Sbjct: 220 PQRCPPEMYDLMKLCWTYGVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 689 ELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
ELG+G +G VY+ + + G ++A+K++ + E+ L K +V G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHY 806
++ + E++ +GSL K G + + I + KGL +L NIIH
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHR 127
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI--QSALGYMAPE-----FACRT 859
++K TNVL++ +G+ K+ DFG++ L + + I QS YMAPE +
Sbjct: 128 DVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQS---YMAPERIKSGGPNQN 181
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRP 884
T + DV+ G+ +LE+ G+ P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 65/272 (23%), Positives = 117/272 (43%), Gaps = 28/272 (10%)
Query: 689 ELGRGGFGVVY--RTILQDGRSVAIKKLTVS----GLIKSQEDFEKEMKTLGKIRHHNLV 742
E+G G +G V+ R + GR VA+K++ V G+ S ++ L H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 743 ALEGYYWTPSLQ-----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAY 797
L L++E + L +L D + +++ + +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFAC 857
LH ++H +LK N+L+ SSG+ K+ DFGLAR+ + + + L Y APE
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLL 182
Query: 858 RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917
++ T D++ G + E+ ++P+ DV L G++ D +
Sbjct: 183 QSSYAT-PVDLWSVGCIFAEMFR-RKPLFRGSSDVDQL----------GKILDVIGLPGE 230
Query: 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEV 949
++P D A+P A + D++E+
Sbjct: 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL 262
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALEGY 747
+G+G +G VY+ T +DG A+K L + E+ E E L + +H N+V G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 748 YWTPSL----QL-LIYEFISSGSLYKHLHDGSSRNCLSWRQRFN------IILGMAKGLA 796
++ QL L+ E + GS+ + + + L QR + I+ G GL
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 797 YLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQ--SALG---YM 851
+LH+ IIH ++K N+L+ + G K+ DFG++ L S++++ +++G +M
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-------STRLRRNTSVGTPFWM 195
Query: 852 APE-FACRT---VKITEKCDVYGFGVLVLEVVTGKRPVEYM 888
APE AC +CDV+ G+ +E+ G P+ M
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 40/212 (18%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE---------KEMKTLGKIRHH 739
+G G +G V GR VAIKKL+ F+ +E++ L + H
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS--------RPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN------IILGMAK 793
N++ L + TP+ L E L HL G+ N + Q+ + ++ + +
Sbjct: 75 NVIGLLDVF-TPASSL---EDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---Y 850
GL Y+H IIH +LK +N+ ++ E K+ DFGLAR ++ + Y
Sbjct: 130 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH--------TDDEMTGYVATRWY 181
Query: 851 MAPEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
APE + + D++ G ++ E++TGK
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 64/235 (27%), Positives = 110/235 (46%), Gaps = 21/235 (8%)
Query: 690 LGRGGFGVVYRTILQDGRSV-AIKKLTVSGLI-KSQEDFE-KEMKTLGKIRHHNLVALEG 746
+G+G FG V + +D + + A+K + + ++ +S+ E L ++ +V L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ +P L+ FI+ G L+ HL + R RF + L LH N+I+
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFD--LSRARF-YTAELLCALENLHKFNVIYR 117
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKIT 863
+LK N+L+D G + DFGL + L M D K + G Y+APE T
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCK-LNMKD----DDKTNTFCGTPEYLAPELLL-GHGYT 171
Query: 864 EKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG-RVEDCVDARLR 917
+ D + GVL+ E++TG P + +++V +M R L++ R D D +
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP--FYDENVN---EMYRKILQEPLRFPDGFDRDAK 221
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 11/147 (7%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKT-----LGKIRHHNLVA 743
+G+G FG V DG+ A+K L ++K +E +K + L ++H LV
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE--QKHIMAERNVLLKNVKHPFLVG 60
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
L + T + ++++ G L+ HL R+ R RF +A L YLH NI
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQ--RERSFPEPRARF-YAAEIASALGYLHSLNI 117
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLAR 830
I+ +LK N+L+DS G + DFGL +
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 47/217 (21%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK---EMKTLGKIRHHNLVALE 745
+GRG +G+V + VAIKK ++ ++ D ++ E+K L + H N++A++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKK--IANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 746 GYYWTPSLQ-----LLIYEFI---------SSGSLYKHLHDGSSRNCLSWRQRFNIILGM 791
P + ++YE + SS +L S +C Q F + +
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTL-------SDDHC----QYF--LYQL 117
Query: 792 AKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYM 851
+GL Y+H N++H +LK +N+L++++ + K+ DFGLAR S K Y+
Sbjct: 118 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKGDFMTEYV 169
Query: 852 ------APEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
APE + T DV+ G + E++ K
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-10
Identities = 19/41 (46%), Positives = 25/41 (60%), Gaps = 1/41 (2%)
Query: 26 NDDVLGLIVFKAGL-EDPKEKLTSWSEDDDNPCNWVGVKCD 65
NDD L+ FK+ L DP L+SW+ +PC+W GV CD
Sbjct: 2 NDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 36/215 (16%)
Query: 690 LGRGGFGVVY--RTIL--QDGRSVAIKKLTVSGLI---KSQEDFEKEMKTLGKIRHHN-L 741
LG G +G V+ R + G+ A+K L + L+ K+ E E L +R L
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN----------IILGM 791
V L + T + LI +++S G ++ HL+ R F+ IIL
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ---------RDNFSEDEVRFYSGEIILA- 117
Query: 792 AKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR--LLPMLDRCILSSKIQSALG 849
L +LH I++ ++K N+L+DS G + DFGL++ L +R + +
Sbjct: 118 ---LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER---TYSFCGTIE 171
Query: 850 YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
YMAPE + D + G+L+ E++TG P
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
LG G G+V+ + D + VA+KK+ ++ +S + +E+K + ++ H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 749 WTPS--LQLLIYEFISSGSLY--KHLHDGSSRNCLSWRQRFN-----IILGMAKGLAYLH 799
L + S+Y + + N L + + +GL Y+H
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIH 131
Query: 800 HTNIIHYNLKSTNVLIDSSGEP-KVGDFGLARLL-PMLDRCILSSKIQSALGYMAPEFAC 857
N++H +LK NV I++ K+GDFGLAR++ P S+ Y +P
Sbjct: 132 SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL 191
Query: 858 RTVKITEKCDVYGFGVLVLEVVTGK 882
T+ D++ G + E++TGK
Sbjct: 192 SPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-10
Identities = 73/290 (25%), Positives = 116/290 (40%), Gaps = 12/290 (4%)
Query: 89 LLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVS 148
LL L L L L+ N I+ L L +D NN++ + P +L+E+
Sbjct: 89 LLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGL-LKSNLKELD 146
Query: 149 FANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVK 208
++N + +P L +L++++ S N LS LP + L +L +LDLS N + ++
Sbjct: 147 LSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPP 203
Query: 209 GISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLS 268
I L L + L N +L + L L+ N L LP+S+ L++ +L
Sbjct: 204 EIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLD 261
Query: 269 LKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPE 328
L N +G L NL LDLS N S +P L+ L+ L + +
Sbjct: 262 LSNN--QISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELK 319
Query: 329 SMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSF 378
LL ++ N T + L + N L ES
Sbjct: 320 L---NSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYI 366
|
Length = 394 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 68/271 (25%), Positives = 107/271 (39%), Gaps = 28/271 (10%)
Query: 689 ELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+GRG FG V+ L+ D VA+K + + F +E + L + H N+V L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
++ E + G L R L ++ ++ A G+ YL + IH +
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLESKHCIHRD 119
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK--IQSALGYMAPEFACRTVKITEK 865
L + N L+ K+ DFG++R D S+ Q + + APE A + + +
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPE-ALNYGRYSSE 176
Query: 866 CDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADE 924
DV+ FG+L+ E + G P + + R A+E G P E
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSN------QQTREAIEQG-----------VRLPCPE 219
Query: 925 AIP--VIKLGLICASQVPSNRPDMEEVVNIL 953
P V +L C P RP V L
Sbjct: 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 10/201 (4%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDF---EKEMKTLGKIRHHN-LVALE 745
+GRG + V L+ + K+ L+ ED + E + +H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
+ T S + E+++ G L H+ R RF ++ L YLH II+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARF-YSAEISLALNYLHERGIIY 119
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
+LK NVL+DS G K+ D+G+ + L +S Y+APE R
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEI-LRGEDYGFS 176
Query: 866 CDVYGFGVLVLEVVTGKRPVE 886
D + GVL+ E++ G+ P +
Sbjct: 177 VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 57/203 (28%), Positives = 85/203 (41%), Gaps = 18/203 (8%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDF-----EKEMKTLGKIRHHNLVAL 744
+GRG + V L+ R + K+ L+ ED EK + H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-NHPFLVGL 61
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHHT 801
+ T S + EF+S G L H+ R RF I L L +LH
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQ--RQRKLPEEHARFYSAEISLA----LNFLHER 115
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVK 861
II+ +LK NVL+D+ G K+ D+G+ + + +S Y+APE R
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEI-LRGED 172
Query: 862 ITEKCDVYGFGVLVLEVVTGKRP 884
D + GVL+ E++ G+ P
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 38/242 (15%)
Query: 689 ELGRGGFGVVYR---------TILQ------DGRS--VAIKKLTVSGLIKSQEDFEKEMK 731
+LG G FG V+ LQ GR VA+K L ++ DF KE+K
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 732 TLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSL-----YKHLHDGSSRN--------- 777
L +++ N++ L G +I E++ +G L HL D
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 778 --CLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835
+S+ ++ L +A G+ YL N +H +L + N L+ + K+ DFG++R L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAG 191
Query: 836 DRCILSSKIQSALGYMAPEFACRTV-KITEKCDVYGFGVLVLEV--VTGKRPVEYMEDDV 892
D + + + +MA E C + K T DV+ FGV + E+ + ++P + D+
Sbjct: 192 DYYRIQGRAVLPIRWMAWE--CILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249
Query: 893 VV 894
V+
Sbjct: 250 VI 251
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 73/283 (25%), Positives = 118/283 (41%), Gaps = 38/283 (13%)
Query: 690 LGRGGFGVVYRTILQDGRS---VAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVAL- 744
LG G FG V L S VA+K + ++ +S+ EDF E + + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 745 ---------EGYYWTPSLQLLIYEFISSGSLYKHL---HDGSSRNCLSWRQRFNIILGMA 792
EGY PS ++I F+ G L+ L G L + + +A
Sbjct: 67 GVCLQTVESEGY---PS-PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMA 852
G+ YL + IH +L + N +++ + V DFGL++ + D + + ++A
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 853 PEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911
E V T K DV+ FGV + E+ T G+ P +E+ + D +R + DC
Sbjct: 183 IESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY--DYLRQGNRLKQPPDC 239
Query: 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
+D + L C P +RP E + LE
Sbjct: 240 LDG-------------LYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 690 LGRGGFG-VVYRTILQDGRSVAIKKLTVSGLIKSQEDFEK--EMKTLGKIRHHNLVALEG 746
LG+G FG V+ G+ A+K L +I E E + L RH L +L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ T + E+++ G L+ HL R R RF + L YLH I++
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHL--SRERVFSEDRTRF-YGAEIVSALDYLHSGKIVYR 119
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKIT 863
+LK N+++D G K+ DFGL + + ++ +++ G Y+APE
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCK-----EGITDAATMKTFCGTPEYLAPE-VLEDNDYG 173
Query: 864 EKCDVYGFGVLVLEVVTGKRPVEYMED 890
D +G GV++ E++ G+ P Y +D
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPF-YNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-10
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 690 LGRGGFGVV---YRTILQDGRSVAIKKLT--VSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+G G +G V Y T L+ + VA+KKL+ LI ++ + +E++ L ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGL 79
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN------IILGMAKGLAYL 798
+ TP+ + E + L +L G+ N + Q+ + +I + +GL Y+
Sbjct: 80 LDVF-TPATSI---ENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR 858
H IIH +LK +NV ++ E ++ DFGLAR ++++ Y APE
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLN 189
Query: 859 TVKITEKCDVYGFGVLVLEVVTGK 882
+ + D++ G ++ E++ GK
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-10
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEM--KTLGKIRHHN--LVAL 744
LG+G FG V L+ G A+K L ++ +D E M K + + N L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALK-KDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILG------MAKGLAYL 798
+ T + EF++ G L H+ D + RF++ + GL +L
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQD---------KGRFDLYRATFYAAEIVCGLQFL 112
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEF 855
H II+ +LK NV++D G K+ DFG+ + + ++ + G Y+APE
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK-----ENVFGDNRASTFCGTPDYIAPEI 167
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD 891
+ +K T D + FGVL+ E++ G+ P ++D
Sbjct: 168 -LQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 50/205 (24%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 688 CELGRGGFGVVYRTILQDGRSVAIKKLT---VSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
ELG G GVV + + + +KL + I++Q +E++ L + +V
Sbjct: 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGF 68
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN-I 803
G +++ + E + GSL + L + + + + + +GLAYL + I
Sbjct: 69 YGAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREKHQI 125
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTV 860
+H ++K +N+L++S GE K+ DFG++ L + S S +G YM+PE +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPE-RLQGT 177
Query: 861 KITEKCDVYGFGVLVLEVVTGKRPV 885
+ + D++ G+ ++E+ G+ P+
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 31/87 (35%), Positives = 52/87 (59%)
Query: 265 SSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTG 324
L L G +P+ I KL +L+S++LS N G IP S+G++ L+ L++S N F G
Sbjct: 421 DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480
Query: 325 GLPESMMNCGNLLAIDVSQNKLTGNIP 351
+PES+ +L ++++ N L+G +P
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 10/206 (4%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFE--KEMKTLGKIRHHN--LVALE 745
+GRG + V L+ + K+ L+ ED + + K + + N LV L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
+ T S L+ E+++ G L H+ R RF + L +LH II+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQ--RQRKLPEEHARF-YAAEICIALNFLHERGIIY 119
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
+LK NVL+D+ G K+ D+G+ + L +S Y+APE R +
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEI-LRGEEYGFS 176
Query: 866 CDVYGFGVLVLEVVTGKRPVEYMEDD 891
D + GVL+ E++ G+ P + + D+
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 34/211 (16%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK---------EMKTLGKIRHH 739
+G G +G+V G VAIKK+ FE E+K L + +H
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKI---------SPFEHQTFCQRTLREIKILRRFKHE 63
Query: 740 NLVALEGYYWTPSLQ-----LLIYEFISSGSLYKHL--HDGSSRNCLSWRQRFNIILGMA 792
N++ + PS + ++ E + + LYK + S+ + Q F + +
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHI----QYF--LYQIL 116
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL-LPMLDRCILSSKIQSALGYM 851
+GL Y+H N++H +LK +N+L++++ + K+ DFGLAR+ P D ++ + Y
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 852 APEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
APE + T+ D++ G ++ E+++ +
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 37/212 (17%)
Query: 690 LGRGGFGVVYRTIL----QDGRSVAIKKLTVSGLIKSQEDFEK--EMKTLGKIRHHNLVA 743
LG+G FG V IL G+ A+K L +I E E + L RH L A
Sbjct: 3 LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHH 800
L+ + T + E+ + G L+ HL R R RF I+ L YLH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSA----LGYLHS 113
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFA- 856
++++ +LK N+++D G K+ DFGL + + + +++ G Y+APE
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLE 168
Query: 857 ----CRTVKITEKCDVYGFGVLVLEVVTGKRP 884
R V D +G GV++ E++ G+ P
Sbjct: 169 DNDYGRAV------DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 31/208 (14%)
Query: 690 LGRGGFGVVYRTILQDGR--SVAIKKLTVSGLIKSQE--DFEKEMKTLGKIRHHNLVALE 745
LG G FG V ++ VAIK+ S +IK ++ E K L I H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILG------MAKGLAYLH 799
G + S L+ EF+ G + L RN +RF +G + YL
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLR----RN-----KRFPNDVGCFYAAQIVLIFEYLQ 148
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFA 856
NI++ +LK N+L+D G K+ DFG A+ ++ ++ + G Y+APE
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--------VVDTRTYTLCGTPEYIAPEIL 200
Query: 857 CRTVKITEKCDVYGFGVLVLEVVTGKRP 884
V + D + G+ + E++ G P
Sbjct: 201 L-NVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 65/282 (23%), Positives = 115/282 (40%), Gaps = 48/282 (17%)
Query: 690 LGRGGFGVVYRTILQDGRS--VAIKKLTVSGLI---------KSQEDFEKEMKTLGK-IR 737
LG G FG VY+ ++ +A+K++ V KS D E+ + + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 738 HHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF------NIILGM 791
H N+V + ++ + I L +H + + +QRF NI + M
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK-----KQRFTEERIWNIFVQM 122
Query: 792 AKGLAYLH-HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG- 849
L YLH I+H +L N+++ + + DFGLA+ + SK+ S +G
Sbjct: 123 VLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------QKQPESKLTSVVGT 176
Query: 850 --YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR 907
Y PE + EK DV+ FG ++ ++ T + P + +++ L + A+ +
Sbjct: 177 ILYSCPEIV-KNEPYGEKADVWAFGCILYQMCTLQPP--FYSTNMLSLATKIVEAVYEPL 233
Query: 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEV 949
E + VI C + RPD+ +V
Sbjct: 234 PEGMYSEDVTD---------VITS---CLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 690 LGRGGFG-VVYRTILQDGRSVAIKKLTVSGLIKSQEDFEK--EMKTLGKIRHHNLVALEG 746
LG+G FG V+ GR A+K L +I E E + L RH L AL+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILG--MAKGLAYLHHTNII 804
+ T + E+ + G L+ HL R R RF G + L YLH +++
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARF---YGAEIVSALEYLHSRDVV 117
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVK 861
+ ++K N+++D G K+ DFGL + + + +++ G Y+APE
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPE-VLEDND 171
Query: 862 ITEKCDVYGFGVLVLEVVTGKRPVEYMED 890
D +G GV++ E++ G+ P Y +D
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF-YNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 25/215 (11%)
Query: 690 LGRGGFGVVYRTILQDGRSV-AIKKLTVSGLIKSQED------FEKEMKTLGKIRHHNLV 742
LG+G FG V L+ V AIK L ++ Q+D EK + L +H L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL--QDDDVDCTMTEKRILALAA-KHPFLT 59
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
AL + T + E+++ G L + SR R RF + L +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQ--RSRKFDEPRSRF-YAAEVTLALMFLHRHG 116
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSAL----GYMAPEFACR 858
+I+ +LK N+L+D+ G K+ DFG M IL+ + Y+APE +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFG------MCKEGILNGVTTTTFCGTPDYIAPEI-LQ 169
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRPVEY-MEDDV 892
++ D + GVL+ E++ G+ P E EDD+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 19/217 (8%)
Query: 689 ELGRGGFGVVYRTILQDGRSVA---IKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745
E+G G FG V + + VA +K+L + K Q +F ++ ++H N++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHL-----HDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
G LL++E+ G L +L H +S+ L R I A G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI----AAGVTHMHK 117
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR-- 858
N +H +L N + S KVGD+G+ D L ++APE
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 859 ----TVKITEKCDVYGFGVLVLEVV-TGKRPVEYMED 890
T + T+ +V+ GV + E+ +P ++ D
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 3e-09
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 39/216 (18%)
Query: 688 CELGRGGFGVVYRTI-LQDGRSVAIKKL--TVSGLIKSQEDFEKEMKTLGKIRHH-NLVA 743
+LG+G +G+V++ I + VA+KK+ +Q F +E+ L ++ H N+V
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIVK 71
Query: 744 L----------EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAK 793
L + Y L++E++ + LH N L + I+ + K
Sbjct: 72 LLNVIKAENDKDIY--------LVFEYMET-----DLHAVIRANILEDVHKRYIMYQLLK 118
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---- 849
L Y+H N+IH +LK +N+L++S K+ DFGLAR L + + L
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL----SELEENPENPVLTDYVA 174
Query: 850 ---YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
Y APE + + T+ D++ G ++ E++ GK
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 49/185 (26%), Positives = 88/185 (47%), Gaps = 29/185 (15%)
Query: 691 GRGGFGVVYRTILQ---DGRSVAIKKL-----TVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
GRG +G VY+ + DG+ AIKK +G+ SQ +E+ L +++H N+V
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGI--SQSAC-REIALLRELKHENVV 65
Query: 743 ALEGYYWTPSLQL--LIYEFISSGSLYK--HLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
+L + + + L++++ + L++ H + R + +++ + G+ YL
Sbjct: 66 SLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 799 HHTNIIHYNLKSTNVLIDSSGEP----KVGDFGLAR-----LLPMLDRCILSSKIQSALG 849
H ++H +LK N+L+ G K+GD GLAR L P+ D + +
Sbjct: 125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD----LDPVVVTIW 180
Query: 850 YMAPE 854
Y APE
Sbjct: 181 YRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 35/162 (21%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE----KEMKTLGKIRHHNLVAL 744
+G+G FG V++ + + VA+KK+ + +E F +E+K L ++H N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLME---NEKEGFPITALREIKILQLLKHENVVNL 76
Query: 745 EGYYWTPSLQ--------LLIYEFISSGSLYKHLHD--GSSRNCLSWRQRFN------II 788
T + L++EF HD G N +F ++
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNV---KFTLSEIKKVM 125
Query: 789 LGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
+ GL Y+H I+H ++K+ N+LI G K+ DFGLAR
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 46/208 (22%), Positives = 85/208 (40%), Gaps = 30/208 (14%)
Query: 690 LGRGGFGVVYRTILQ-------DGRSVAIKKLTVSGLIKSQEDFE---KEMKTLGKIRHH 739
LG+G F +Y+ +L+ G + + + L D + + ++ H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVS-VVLKVLGSDHRDSLAFFETASLMSQLSHK 61
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
+LV L G + + E++ G L LH +N +S + ++ +A L YL
Sbjct: 62 HLVKLYGVCVRDENIM-VEEYVKFGPLDVFLH--REKNNVSLHWKLDVAKQLASALHYLE 118
Query: 800 HTNIIHYNLKSTNVLI-----DSSGEP--KVGDFGLARLLPMLDRCILSSKIQSALGYMA 852
++H N+ N+L+ + P K+ D G+ +L R +I ++A
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERIP----WIA 172
Query: 853 PEFACR--TVKITEKCDVYGFGVLVLEV 878
PE R +T D + FG +LE+
Sbjct: 173 PEC-IRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 39/213 (18%)
Query: 688 CELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK----EMKTLGKIRHHNLV 742
++G G +G V I + G VAIKKL S +S E F K E+ L ++H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQS-EIFAKRAYRELTLLKHMQHENVI 77
Query: 743 ALEGYYWTPSLQL-------LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGL 795
L + T ++ L+ ++ + L K + S + + + ++ M GL
Sbjct: 78 GLLDVF-TSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQY-----LVYQMLCGL 130
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYM---- 851
Y+H IIH +LK N+ ++ E K+ DFGLAR GY+
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----------HADAEMTGYVVTRW 179
Query: 852 --APEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
APE + + D++ G ++ E++TGK
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 31/282 (10%)
Query: 690 LGRGGFGVVYRTILQ----DGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVAL 744
LG+G FG V L+ + VA+K L S E+F +E + + H N++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 745 EGYYWTPSLQ------LLIYEFISSGSLYKHL---HDGSSRNCLSWRQRFNIILGMAKGL 795
G + ++I F+ G L+ L G L + ++ +A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEF 855
YL N IH +L + N +++ + V DFGL++ + D + + ++A E
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914
V T DV+ FGV + E++T G+ P +E+ + + +
Sbjct: 187 LADNVYTTHS-DVWAFGVTMWEIMTRGQTPY---------------AGVENSEIYNYLIK 230
Query: 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956
R P D V +L C S P RP + + + LELI
Sbjct: 231 GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 689 ELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGKIRHHN 740
++G G +G V++ ++ VA+K+ ++ +D E +E+ L +++H N
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKR------VRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
+V L + L++E+ L K+ + + F + + KGLA+ H
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSF--MFQLLKGLAFCHS 117
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTV 860
N++H +LK N+LI+ +GE K+ DFGLAR + RC S+++ + L Y P+
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVT-LWYRPPDVLFGAK 175
Query: 861 KITEKCDVYGFGVLVLEVVTGKRPV 885
+ D++ G + E+ RP+
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 48/196 (24%), Positives = 93/196 (47%), Gaps = 11/196 (5%)
Query: 709 VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYK 768
VA+K L ++ DF KE+K + +++ N++ L T +I E++ +G L +
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 769 HLH--------DGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE 820
L + + +S+ + +A G+ YL N +H +L + N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT 168
Query: 821 PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT 880
K+ DFG++R L D + + + +M+ E + K T DV+ FGV + E++T
Sbjct: 169 IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE-SILLGKFTTASDVWAFGVTLWEILT 227
Query: 881 --GKRPVEYMEDDVVV 894
++P + D+ V+
Sbjct: 228 LCKEQPYSQLSDEQVI 243
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-09
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 24/205 (11%)
Query: 689 ELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQE----DFEKEMKTLGKIRHHNLVA 743
++G+GG+G V+ +D G VA+K++ S L K E E+++ T K LV
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK--SEWLVK 65
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQ-RFNIILGMAKGLAYLHHTN 802
L + L E++ G L ++ LS RF + M + + LH
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMA-EMFEAVDALHELG 121
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRT 859
IH +LK N LID+SG K+ DFGL++ + + S +G YMAPE R
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKG--------IVTYANSVVGSPDYMAPE-VLRG 172
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRP 884
D + G ++ E + G P
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-08
Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 46/231 (19%)
Query: 690 LGRGGFGVVYRTILQD---GRSVAIKK----LTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
+G+GG G VY + D R VA+KK L+ + L+K + F +E K + H +V
Sbjct: 10 IGKGGMGEVY--LAYDPVCSRRVALKKIREDLSENPLLKKR--FLREAKIAADLIHPGIV 65
Query: 743 AL-----EG---YYWTP-----SLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIIL 789
+ +G YY P +L+ L+ SL K L + +S +I
Sbjct: 66 PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF-----LSIFH 120
Query: 790 GMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM-------LD---RCI 839
+ + Y+H ++H +LK N+L+ GE + D+G A + +D R I
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 840 LSS------KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
S KI YMAPE V +E D+Y GV++ +++T P
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERL-LGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKK---LTVSGLIKSQEDFEKEMKTLGKIRHHN 740
K ELG G GVV + + + + +K L + I++Q +E+K L +
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQ--IIRELKVLHECNSPY 60
Query: 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILG-----MAKGL 795
+V G +++ + E + GSL + L + ILG + +GL
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK--------KAGRIPENILGKISIAVLRGL 112
Query: 796 AYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YM 851
YL I+H ++K +N+L++S GE K+ DFG++ L + S S +G YM
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYM 165
Query: 852 APEFACRTVKITEKCDVYGFGVLVLEVVTGKRPV 885
+PE T T + D++ G+ ++E+ G+ P+
Sbjct: 166 SPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 24/204 (11%)
Query: 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALEG 746
LG G FG V + G AIK L ++ K + +E L ++ H +V +
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHD-GSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
+ + + EF+ G L+ HL G N ++ ++L YLH +II+
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FEYLHSKDIIY 141
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
+LK N+L+D+ G KV DFG A+ +P DR + + Y+APE I K
Sbjct: 142 RDLKPENLLLDNKGHVKVTDFGFAKKVP--DR---TFTLCGTPEYLAPEV------IQSK 190
Query: 866 -----CDVYGFGVLVLEVVTGKRP 884
D + GVL+ E + G P
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 24/202 (11%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTV-----SGLIKSQEDFE--KEMKTLGKIRHHNLV 742
LG+G FG VY +++D ++VA ++L V G + E + +E + L K+ H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 743 ALEGYYWTPSLQLLIYEFISSGSL------YKHLHDGSSRNCLSWRQRFNIILGMAKGLA 796
+ +I E+ L KH S N Q + + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSEN-----QVCEWFIQLLLGVH 120
Query: 797 YLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFA 856
Y+H I+H +LK+ N+ + ++ K+GDFG++RLL + C L++ YM+PE A
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL--MGSCDLATTFTGTPYYMSPE-A 176
Query: 857 CRTVKITEKCDVYGFGVLVLEV 878
+ K D++ G ++ E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 33/114 (28%), Positives = 55/114 (48%), Gaps = 6/114 (5%)
Query: 766 LYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGD 825
LY +L S L Q I + +GL YLH IIH ++K+ N+ I+ + +GD
Sbjct: 143 LYTYLTKRSRP--LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGD 200
Query: 826 FGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVV 879
G A+ P++ L + + APE R K K D++ G+++ E++
Sbjct: 201 LGAAQ-FPVVAPAFLG--LAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 42/222 (18%)
Query: 690 LGRGGFGVVYRTILQDGRSV----AIKKLTVSGLIKSQED------FEKEMKTLGKIRHH 739
LG+G FG V +L + + AIK L +I Q+D EK + L +
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVII--QDDDVECTMVEKRVLALPG-KPP 61
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHD-GSSRNCLSWRQRFNIILGMAKGLAYL 798
L L + T + E+++ G L H+ G + + I A GL +L
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI----AIGLFFL 117
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSAL----GYMAPE 854
H II+ +LK NV++D+ G K+ DFG M I K Y+APE
Sbjct: 118 HSKGIIYRDLKLDNVMLDAEGHIKIADFG------MCKENIFGGKTTRTFCGTPDYIAPE 171
Query: 855 FAC-----RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD 891
++V D + FGVL+ E++ G+ P + ++D
Sbjct: 172 IIAYQPYGKSV------DWWAFGVLLYEMLAGQPPFDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEM---KTLGKIRHHN-LVAL 744
LG+G FG V+ L+ + AIK L ++ +D E M + L H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSW---RQRF---NIILGMAKGLAYL 798
+ T + E+++ G L H+ ++C + R F II G L +L
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHI-----QSCHKFDLPRATFYAAEIICG----LQFL 112
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEF 855
H I++ +LK N+L+D+ G K+ DFG+ + + + +K + G Y+APE
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCK-----ENMLGDAKTCTFCGTPDYIAPEI 167
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
K D + FGVL+ E++ G+ P
Sbjct: 168 LLGQ-KYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-08
Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 17/153 (11%)
Query: 689 ELGRGGFGVVYR---TILQDGRSVAIKKLTVSGLIKSQEDFEK----EMKTLGKIRHH-- 739
ELG+G +G+V + +VAIKK+T + S++ K E+K L R H
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITN---VFSKKILAKRALRELKLLRHFRGHKN 63
Query: 740 --NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAY 797
L ++ + +L +YE + L++ + G L+ + I + GL Y
Sbjct: 64 ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP---LTDAHFQSFIYQILCGLKY 120
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
+H N++H +LK N+L+++ E K+ DFGLAR
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 25/173 (14%)
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGY 850
+A+G+ +L IH +L + N+L+ + K+ DFGLAR + + + L +
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242
Query: 851 MAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRP---VEYMEDDVVVLCDMVRGALEDG 906
MAPE V T + DV+ FGVL+ E+ + G P V+ E+ C ++ DG
Sbjct: 243 MAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE----FCQRLK----DG 293
Query: 907 RVEDCVDARLRGNFPADEAIPVI-KLGLICASQVPSNRPDMEEVVNIL-ELIQ 957
R+R + A P I ++ L C P RP +V IL +L+Q
Sbjct: 294 -------TRMRA---PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALEGY 747
+G+G +G V++ + ++G A+K L I E+ E E L + H N+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI--DEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 748 YWTPSL----QL-LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMA-KGLAYLHHT 801
Y+ + QL L+ E + GS+ + R IL A GL +LH
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPE-FACRT- 859
IH ++K N+L+ + G K+ DFG++ L R ++ + + +MAPE AC
Sbjct: 144 KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-TRLRRNTSVGTPF-WMAPEVIACEQQ 201
Query: 860 --VKITEKCDVYGFGVLVLEVVTGKRPV 885
+CDV+ G+ +E+ G P+
Sbjct: 202 LDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 3/101 (2%)
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGY 850
+A GL +LH II+ +LK NV++DS G K+ DFG+ + M D + + Y
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDG-VTTKTFCGTPDY 167
Query: 851 MAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD 891
+APE + D + FGVL+ E++ G+ P E ++D
Sbjct: 168 IAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 51/207 (24%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 686 KDCELGRGGFGVVYRTILQDGRSVAIKKLT---VSGLIKSQEDFEKEMKTLGKIRHHNLV 742
K ELG G GVV++ + + +KL + I++Q +E++ L + +V
Sbjct: 9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIV 66
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
G +++ + E + GSL + L + + + + + KGL YL +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH 123
Query: 803 -IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACR 858
I+H ++K +N+L++S GE K+ DFG++ L + S S +G YM+PE +
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPE-RLQ 175
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRPV 885
+ + D++ G+ ++E+ G+ P+
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 56/239 (23%), Positives = 85/239 (35%), Gaps = 62/239 (25%)
Query: 690 LGRGGFGVVY--RTILQDGRSVAIKKLTVSGLIKS-QEDF---EKEMKTLGKIRHHNLVA 743
+GRG FG V+ R G+ A+K L S +IK Q E+++
Sbjct: 9 IGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP------ 61
Query: 744 LEGYYWTPSLQL---------LIYEFISSGSLYKHLHDGSSRNCL--SWRQRFNIILGMA 792
W L L+ E++ G L L ++ RF I +
Sbjct: 62 -----WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEET-ARF-YIAELV 111
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLA-------RLLPMLDRCILSSKIQ 845
L +H IH ++K N+LID+ G K+ DFGL L+
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 846 -----------------SALG---YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
S +G Y+APE T +CD + GV++ E++ G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTV----SGLIKSQEDFEKEMKTLGKIRHHNLVA 743
E+G G +G VY+ G VA+K + V GL S +K L H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 744 LEGYYWTPSLQ-----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
L T L++E + L +L D L +++ +GL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS-SKIQSALGYMAPEFAC 857
H I+H +LK N+L+ S G+ K+ DFGLAR+ C ++ + + L Y APE
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYRAPEVLL 180
Query: 858 RTVKITEKCDVYGFGVLVLEVVTGK 882
++ T D++ G + E+ K
Sbjct: 181 QSTYAT-PVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-07
Identities = 26/60 (43%), Positives = 34/60 (56%)
Query: 483 SLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHL 542
+L SL LS N LT A L NLK +DLS N+L+ I P+ L L S ++S N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 690 LGRGGFG-VVYRTILQDGRSVAIKKLTVSGLIKSQEDFEK--EMKTLGKIRHHNLVALEG 746
LG+G FG V+ GR A+K L ++ E E + L RH L AL+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH-HTNIIH 805
+ T + E+ + G L+ HL R R RF + L YLH N+++
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARF-YGAEIVSALDYLHSEKNVVY 119
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKI 862
+LK N+++D G K+ DFGL + + + +++ G Y+APE
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAPE-VLEDNDY 173
Query: 863 TEKCDVYGFGVLVLEVVTGKRPVEYMED 890
D +G GV++ E++ G+ P Y +D
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLPF-YNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 26/85 (30%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 122 VDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQ 181
+ L G IP++ + L+ ++ + N++ G IP SL +SLE ++ S N +G
Sbjct: 423 LGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 182 LPYGIWFLRSLQSLDLSNNLLEGEI 206
+P + L SL+ L+L+ N L G +
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 33/104 (31%), Positives = 59/104 (56%), Gaps = 19/104 (18%)
Query: 797 YLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG------- 849
++H ++IH ++KS N+L+ S+G K+GDFG +++ ++ + +G
Sbjct: 158 HVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM--------YAATVSDDVGRTFCGTP 209
Query: 850 -YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPV--EYMED 890
Y+APE R ++K D++ GVL+ E++T KRP E ME+
Sbjct: 210 YYVAPEI-WRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE 252
|
Length = 496 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 5e-07
Identities = 20/60 (33%), Positives = 31/60 (51%)
Query: 143 SLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLL 202
+L+ + +NN LT + +L+ ++ S N L+ P L SL+SLDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGY 850
+A+G+ +L N IH ++ + NVL+ K+ DFGLAR + ++ + + +
Sbjct: 221 VAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKW 280
Query: 851 MAPE--FACRTVKITEKCDVYGFGVLVLEVVT-GKRP 884
MAPE F C T + DV+ +G+L+ E+ + GK P
Sbjct: 281 MAPESIFDC---VYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 6e-07
Identities = 24/60 (40%), Positives = 32/60 (53%)
Query: 459 SLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDL 518
+LK L L N L+ K +L L LS NNLT P A + L +L+ +DLS N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 8e-07
Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGY 850
+AKG+ +L IH +L + N+L+ + K+ DFGLAR + + + L +
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247
Query: 851 MAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVE 909
MAPE V T + DV+ FGVL+ E+ + G P ++ D + G
Sbjct: 248 MAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-------- 298
Query: 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNIL-ELIQS 958
R+R P + + L C PS RP E+V L L+Q+
Sbjct: 299 ----TRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 21/114 (18%)
Query: 793 KGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLA-RLLPMLDRCILSSKIQSALGY 850
K L YL +IH ++K +N+L+D+SG K+ DFG++ RL+ + ++ Y
Sbjct: 125 KALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK----TRSAGCAAY 180
Query: 851 MAPEFACRTVKITEK---------CDVYGFGVLVLEVVTGKRPVEYMEDDVVVL 895
MAPE +I DV+ G+ ++E+ TG+ P + + + VL
Sbjct: 181 MAPE------RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 10/206 (4%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEM--KTLGKIRHHN--LVALE 745
LG+G FG V + + K+ ++ +D E M K + ++ L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
+ T + E+++ G L H+ Q ++ GL +LH II+
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFLHRRGIIY 124
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
+LK NV++DS G K+ DFG+ + M+D + + Y+APE +
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCK-EHMVDG-VTTRTFCGTPDYIAPEIIAYQ-PYGKS 181
Query: 866 CDVYGFGVLVLEVVTGKRPVEYMEDD 891
D + +GVL+ E++ G+ P + ++D
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 52/173 (30%), Positives = 80/173 (46%), Gaps = 23/173 (13%)
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGY 850
+A+G+ +L IH +L + N+L+ + K+ DFGLAR + + + L +
Sbjct: 182 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241
Query: 851 MAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRP---VEYMEDDVVVLCDMVRGALEDG 906
MAPE V T + DV+ FGVL+ E+ + G P V+ E+ C L++G
Sbjct: 242 MAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE----FCR----RLKEG 292
Query: 907 RVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNIL-ELIQS 958
R+R A I I L C P +RP E+V IL +L+Q
Sbjct: 293 -------TRMRAPEYATPEIYSIMLD--CWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 50/211 (23%), Positives = 95/211 (45%), Gaps = 31/211 (14%)
Query: 690 LGRGGFGVVYRTI---LQDGRSVAIKKLTVSGLIKSQ----EDFEKEMKTLGKIRHHNLV 742
LG+G F +++ I + D + ++ + L KS E F + + ++ H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAY-LHH- 800
G +++ E++ GSL +L + +SW+ L +AK LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALHFL 116
Query: 801 --TNIIHYNLKSTNVLI-----DSSGEP---KVGDFGLARLLPMLDRCILSSKIQSALGY 850
+ H N+ + NVL+ +G P K+ D G++ + +L + IL +I +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERIP----W 170
Query: 851 MAPEFACRTVKITEKCDVYGFGVLVLEVVTG 881
+ PE ++ D + FG + E+ +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 40/177 (22%), Positives = 76/177 (42%), Gaps = 14/177 (7%)
Query: 712 KKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV-ALEGYYWTPSLQLLIYEFISSGSLYKHL 770
KK+ V + + +E+ L I H ++ + Y W ++ +++ ++ L+ ++
Sbjct: 120 KKVIVKAVTGGK-TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY--KCDLFTYV 176
Query: 771 HDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
D S L Q I + + LAYLH IIH ++K+ N+ +D +GDFG A
Sbjct: 177 -DRSGP--LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA- 232
Query: 831 LLPMLDRCILSSKIQSALGYM---APEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
LD + + G + +PE K D++ G+++ E+
Sbjct: 233 --CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 34/208 (16%)
Query: 690 LGRGGFGVV---YRTILQDGRSVAIKKLTVSGLIKSQEDFEK---EMKTLGKIRHHNLVA 743
+G G G+V + T+L G +VA+KKL S ++Q ++ E+ L + H N+++
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKL--SRPFQNQTHAKRAYRELVLLKCVNHKNIIS 84
Query: 744 LEGYYWTPSLQL-------LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLA 796
L + TP L L+ E + + +L + +H +S+ ++ M G+
Sbjct: 85 LLNVF-TPQKSLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSY-----LLYQMLCGIK 137
Query: 797 YLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP---MLDRCILSSKIQSALGYMAP 853
+LH IIH +LK +N+++ S K+ DFGLAR M+ +++ Y AP
Sbjct: 138 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY------YRAP 191
Query: 854 EFACRTVKITEKCDVYGFGVLVLEVVTG 881
E + E D++ G ++ E+V G
Sbjct: 192 EVIL-GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 4e-06
Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 23/170 (13%)
Query: 738 HHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAY 797
+ N + L T +LI ++I G L+ L LS + II + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK---KEGKLSEAEVKKIIRQLVEALND 124
Query: 798 LHHTNIIHYNLKSTNVLID-SSGEPKVGDFGLARLLPMLDRCI-LSSKIQSALGYMAPEF 855
LH NIIH ++K NVL D + + D+GL + I S L Y +PE
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC-------KIIGTPSCYDGTLDYFSPE- 176
Query: 856 ACRTVKIT-EKCDV----YGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVR 900
KI DV + GVL E++TGK P + ED+ + L +++
Sbjct: 177 -----KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221
|
Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 37/225 (16%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQED---FEKEMKTLGKIRHHNLVALE 745
+GRG FG V G A+K + S L+ +QE FE+E +++++
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQETVSFFEEE---------RDILSIS 58
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIIL--GMAK--------GL 795
W P LQ Y F +LY + + LS R+ MA+ +
Sbjct: 59 NSPWIPQLQ---YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI 115
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEF 855
+H +H ++K NVLID +G K+ DFG A L ++ + S Y+APE
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA-NKMVNSKLPVGTPDYIAPEV 174
Query: 856 ACRTVKITEK------CDVYGFGVLVLEVVTGKRPVEYMEDDVVV 894
T+ K CD + GV+ E++ G+ P E
Sbjct: 175 -LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH--EGTSAK 216
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-06
Identities = 26/83 (31%), Positives = 46/83 (55%), Gaps = 1/83 (1%)
Query: 288 LESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLT 347
++ L L G IP+ I L L+ +N+S N G +P S+ + +L +D+S N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 348 GNIPTWIFKM-GLQTVSLSGNRL 369
G+IP + ++ L+ ++L+GN L
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSL 502
|
Length = 623 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 45/196 (22%), Positives = 88/196 (44%), Gaps = 20/196 (10%)
Query: 706 GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALEGYYWTPSLQLLIYEFISSG 764
G V ++++ + F + + K+ +H N+V + + ++ F++ G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 765 S----LYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE 820
S + H DG S +++ I+ G+ K L Y+HH +H ++K++++LI G
Sbjct: 85 SAKDLICTHFMDGMSELAIAY-----ILQGVLKALDYIHHMGYVHRSVKASHILISVDG- 138
Query: 821 PKVGDFGLARLLPMLD-----RCILSSKIQSA--LGYMAPEFACRTVK-ITEKCDVYGFG 872
KV GL L M++ R + S L +++PE + ++ K D+Y G
Sbjct: 139 -KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 197
Query: 873 VLVLEVVTGKRPVEYM 888
+ E+ G P + M
Sbjct: 198 ITACELANGHVPFKDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-06
Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 6/104 (5%)
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGY 850
+AKG+++L N IH +L + N+L+ K+ DFGLAR + ++ + + +
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKW 282
Query: 851 MAPE--FACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDD 891
MAPE F C T + DV+ +G+L+ E+ + G P M D
Sbjct: 283 MAPESIFNC---VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 19/175 (10%)
Query: 726 FEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGS----LYKHLHDGSSRNCLSW 781
+ E+ RH N++ + T S +I F++ GS L + +G S +
Sbjct: 46 LQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG- 104
Query: 782 RQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841
NI+ G +GL YLH IH N+K++++LI SG+ V GL+ L ++ +
Sbjct: 105 ----NILFGALRGLNYLHQNGYIHRNIKASHILI--SGDGLVSLSGLSHLYSLVRNGQKA 158
Query: 842 SKI-------QSALGYMAPEFACRTVK-ITEKCDVYGFGVLVLEVVTGKRPVEYM 888
+ S L +++PE + + K D+Y G+ E+ TG+ P + M
Sbjct: 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-05
Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 1/60 (1%)
Query: 119 LQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRL 178
L+ +D S N L+ IPD F+ +L+ + + NNLT PE+ S SL S++ S N L
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 690 LGRGGFGVV---YRTILQDGRSVAIKKLTVSGLIKSQEDFEK---EMKTLGKIRHHNLVA 743
+G G G+V Y IL+ R+VAIKKL S ++Q ++ E+ + + H N++
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWR---QRFNIIL-GMAKGLAYLH 799
L + TP L E + L D + + +R + +L M G+ +LH
Sbjct: 88 LLNVF-TPQKSL---EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP---MLDRCILSSKIQSALGYMAPEFA 856
IIH +LK +N+++ S K+ DFGLAR M+ +++ Y APE
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY------YRAPEVI 197
Query: 857 CRTVKITEKCDVYGFGVLVLEVVTGK 882
+ E D++ G ++ E++ G
Sbjct: 198 L-GMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 1/90 (1%)
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGY 850
+A G+ +L N +H +L + NVLI K+ DFGLAR + I L +
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW 307
Query: 851 MAPEFACRTVKITEKCDVYGFGVLVLEVVT 880
MAPE + T DV+ FG+L+ E+ T
Sbjct: 308 MAPESIFNNL-YTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 38/147 (25%), Positives = 72/147 (48%), Gaps = 9/147 (6%)
Query: 690 LGRGGFGVVYRTILQDGRS-VAIKKLTVS-GLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+G G +GVV + ++ + VAIKK S + +E +E+K L ++ N+V L+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 748 YWTPSLQLLIYEFISSG--SLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
+ L++E++ L + + +G + + I + K + + H +I+H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-----SYIYQLIKAIHWCHKNDIVH 123
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLL 832
++K N+LI + K+ DFG AR L
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 37/136 (27%), Positives = 69/136 (50%), Gaps = 12/136 (8%)
Query: 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQR------FNIILGMAKGLAYLHHTNIIHYNL 808
LLI E+ S G L K + + L +++ + I+L + + +H ++H +L
Sbjct: 141 LLIMEYGSGGDLNKQIKQ-RLKEHLPFQEYEVGLLFYQIVLALDE----VHSRKMMHRDL 195
Query: 809 KSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDV 868
KS N+ + +G K+GDFG ++ ++S Y+APE R + ++K D+
Sbjct: 196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK-RYSKKADM 254
Query: 869 YGFGVLVLEVVTGKRP 884
+ GV++ E++T RP
Sbjct: 255 WSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 690 LGRGGFGVV---YRTILQDGRSVAIKKLTVSGLIKSQEDFEK---EMKTLGKIRHHNLVA 743
+G G G+V Y +L R+VAIKKL S ++Q ++ E+ + + H N+++
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWR---QRFNIIL-GMAKGLAYLH 799
L + TP L E L L D + + +R + +L M G+ +LH
Sbjct: 81 LLNVF-TPQKSL---EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRT 859
IIH +LK +N+++ S K+ DFGLAR + + Y APE
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL-G 192
Query: 860 VKITEKCDVYGFGVLVLEVVTGK 882
+ E D++ G ++ E+V K
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 67/294 (22%), Positives = 113/294 (38%), Gaps = 44/294 (14%)
Query: 266 SLSLKGNSF-TGEVPDWIGKLANLESLDLSLNQFSGR----IPSSIGNLVFLKELNISMN 320
LSLKG T + + KL L+ L L N + S++ LKEL +S+N
Sbjct: 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLN 61
Query: 321 Q------FTGGLPESMMNCGNLLAIDVSQNKLT-GNIPTWI---FKMGLQTVSLSGNRLG 370
+ L + + L +D+S N L LQ + L+ N LG
Sbjct: 62 ETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLG 121
Query: 371 ESMQYPSFASMKDSYQGLQVLDLSSN--------ALSGVIPSNIGDLSSLMLLNMSMNYL 422
+ +KD L+ L L N AL+ + +N L LN++ N +
Sbjct: 122 DRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRAN----RDLKELNLANNGI 177
Query: 423 FGSIPASIGK----LKAIQVLDFSDNWLNGTIPPQIGGAV----SLKELKLEKNFLSGRI 474
+ ++ + ++VLD ++N L + + SL+ L L N L+
Sbjct: 178 GDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAG 237
Query: 475 PSQIKN-----CSSLTSLILSQNNLT----GPVPAAIANLSNLKYVDLSFNDLS 519
+ + + SL +L LS N++T + +A +L +DL N
Sbjct: 238 AAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-05
Identities = 44/149 (29%), Positives = 67/149 (44%), Gaps = 18/149 (12%)
Query: 692 RGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP 751
RG FG VY GR KL ++K + K M + +AL +P
Sbjct: 14 RGAFGKVYL-----GRKKNNSKLYAVKVVKKADMINKNM-VHQVQAERDALALSK---SP 64
Query: 752 SLQLLIYEFISSGSLY---KHLHDGSSRNCLSWRQRFN------IILGMAKGLAYLHHTN 802
+ L Y S+ ++Y ++L G ++ L F+ I +A L YLH
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG 124
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARL 831
IIH +LK N+LI + G K+ DFGL+++
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 38/215 (17%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGKIRHHNL 741
+G G +G VY+ G+ VA+KK + + D E +E+ L +
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK------TRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 742 VA-------LEGYYWTPSLQLLIYEFISSG-SLYKHLHDGSSRNCLSWRQRFNIILGMAK 793
+ +E PSL L++E++ S + + L + + + + K
Sbjct: 63 IVRLLDVEHVEEKNGKPSL-YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEP-KVGDFGLARLLPMLDRCILSSKIQS------ 846
G+A+ H ++H +LK N+L+D K+ D GL R S ++S
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR--------AFSIPVKSYTHEIV 173
Query: 847 ALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTG 881
L Y APE + + D++ G + E+
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 57/239 (23%), Positives = 91/239 (38%), Gaps = 56/239 (23%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEG-- 746
+GRG FG V +D G A+K +++ + EKE +G IR + +E
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMK------ILRKADMLEKEQ--VGHIRAERDILVEADS 60
Query: 747 -------YYWTPSLQL-LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
Y + L L LI EF+ G + L ++ L+ + I + +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDSI 117
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSAL---------- 848
H IH ++K N+L+DS G K+ DFGL L R + +L
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 849 -----------------------GYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
Y+APE +T + CD + GV++ E++ G P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 6e-05
Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 36/160 (22%)
Query: 690 LGRGGFGVV---YRTILQDGRSVAIKKLTVSGLIKSQEDFE---------KEMKTLGKIR 737
+G G G+V Y T+ G++VAIKKL F+ +E+ + +
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKL--------SRPFQNVTHAKRAYRELVLMKLVN 73
Query: 738 HHNLVALEGYYWTPSLQL-------LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILG 790
H N++ L + TP L L+ E + + +L + + +S+ ++
Sbjct: 74 HKNIIGLLNVF-TPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSY-----LLYQ 126
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
M G+ +LH IIH +LK +N+++ S K+ DFGLAR
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 7e-05
Identities = 36/152 (23%), Positives = 71/152 (46%), Gaps = 18/152 (11%)
Query: 688 CELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-----KEMKTLGKIRHH-N 740
++G G F V + + G+ AIK + K + E +E++ L ++ H N
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-----KKHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 741 LVAL-EGYYWTPSLQL-LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
++ L E + + +L L++E + +LY+ + + L ++ + + + K L ++
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
H I H ++K N+LI K+ DFG R
Sbjct: 117 HRNGIFHRDIKPENILIK-DDILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-05
Identities = 36/129 (27%), Positives = 51/129 (39%), Gaps = 42/129 (32%)
Query: 797 YLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGL------------------ARLLPM---- 834
+H IH ++K N+LID G K+ DFGL R M
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 835 ----LDRCILSS------------KIQSALG---YMAPEFACRTVKITEKCDVYGFGVLV 875
+DRC L S +G Y+APE RT T+ CD + GV++
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVIL 234
Query: 876 LEVVTGKRP 884
E++ G+ P
Sbjct: 235 YEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-05
Identities = 69/257 (26%), Positives = 109/257 (42%), Gaps = 60/257 (23%)
Query: 293 LSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPT 352
L L IP I L+ S LPE++ GN+ + + N+LT +IP
Sbjct: 188 LGLTTIPACIPEQITTLILDNNELKS-------LPENLQ--GNIKTLYANSNQLT-SIPA 237
Query: 353 WIFKMGLQTVSLSGNRLGESMQY-PSFASMKDSYQGLQVLDLSSNALSGVIPSNIGD-LS 410
+ +Q + LS NR+ E + PS LQ LDL N +S +P N+ + L
Sbjct: 238 TLPDT-IQEMELSINRITELPERLPS---------ALQSLDLFHNKIS-CLPENLPEELR 286
Query: 411 SLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFL 470
L + + S+ L +P+ I L V S L T+PP LK L+ +N L
Sbjct: 287 YLSVYDNSIRTLPAHLPSGITHL---NVQSNSLTALPETLPP------GLKTLEAGENAL 337
Query: 471 S---GRIPSQIKNCS---------------SLTSLILSQN---NLTGPVPAAIANLSNLK 509
+ +P +++ ++T+L +S+N NL +PAA L+
Sbjct: 338 TSLPASLPPELQVLDVSKNQITVLPETLPPTITTLDVSRNALTNLPENLPAA------LQ 391
Query: 510 YVDLSFNDLSGILPKEL 526
+ S N+L LP+ L
Sbjct: 392 IMQASRNNLVR-LPESL 407
|
Length = 754 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 19/58 (32%), Positives = 31/58 (53%)
Query: 387 GLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDN 444
L+ LDLS+N L+ + L +L +L++S N L P + L +++ LD S N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 54/231 (23%), Positives = 87/231 (37%), Gaps = 36/231 (15%)
Query: 89 LLRLQFLQVLSLSNNNFTGTINADLA-----SFGTLQVVDFSENNLSGLIPD---EFFRQ 140
LLR LQ L L+NN LA L+ + N L G + + R
Sbjct: 104 LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRA 163
Query: 141 CGSLREVSFANNNLTGP----IPESLSFCSSLESVNFSSNRL----SGQLPYGIWFLRSL 192
L+E++ ANN + + E L +LE ++ ++N L + L + L+SL
Sbjct: 164 NRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSL 223
Query: 193 QSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSG 252
+ L+L +N L +++ I L L + + D G L+
Sbjct: 224 EVLNLGDNNLTDAGAAALASALLSPNISL--------LTLSLSCN---DITDDGAKDLAE 272
Query: 253 SLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKL-----ANLESLDLSLNQF 298
L + L L L+GN F E + + LESL + + F
Sbjct: 273 VLAEKESLLE----LDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 65/275 (23%), Positives = 111/275 (40%), Gaps = 39/275 (14%)
Query: 690 LGRGGFGVVYRTILQDGRSV-AIKKLTVSGLIKSQED--FEKEMKTLGKIRHHNLVALEG 746
+GRG FG V + + V A+K L+ +IK + F +E + +V L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ ++ E++ G L + + W + + + +A L +H +IH
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KWAKFYTAEVVLA--LDAIHSMGLIHR 166
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPM--LDRCILSSKIQSALG---YMAPEFACRTVK 861
++K N+L+D G K+ DFG + + RC +A+G Y++PE
Sbjct: 167 DVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC------DTAVGTPDYISPEVLKSQGG 220
Query: 862 ---ITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918
+CD + GV + E++ G P + D +V G +D +
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTP--FYADSLV------------GTYSKIMDHKNSL 266
Query: 919 NFPADEAIPVIKLGLICA----SQVPSNRPDMEEV 949
NFP D I LICA +V R +EE+
Sbjct: 267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEI 301
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 61/305 (20%), Positives = 112/305 (36%), Gaps = 67/305 (21%)
Query: 687 DCELGR----GGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDF---EKEMKTLGKIRHH 739
+G+ + + VA+KK+ + S+ED ++E+ T +++H
Sbjct: 3 LTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDS--CSKEDLKLLQQEIITSRQLQHP 59
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLY---KHLHDGSSRNCLSWRQRF----------N 786
N++ Y T FI LY + GS + L + F
Sbjct: 60 NILP----YVT--------SFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAF 105
Query: 787 IILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD-----RCILS 841
I+ + L Y+H IH ++K++++L+ G KV GL + M+ R +
Sbjct: 106 ILKDVLNALDYIHSKGFIHRSVKASHILLSGDG--KVVLSGLRYSVSMIKHGKRQRVVHD 163
Query: 842 SKIQSA--LGYMAPEFACRTVK-ITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDM 898
S L +++PE + ++ EK D+Y G+ E+ G P + M +L +
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP-ATQMLLEK 222
Query: 899 VRGA-----------LEDGRVEDCVDARLRGNFPADEAIPVIK--------LGLICASQV 939
VRG L + + + N P + +C +
Sbjct: 223 VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRD 282
Query: 940 PSNRP 944
P +RP
Sbjct: 283 PESRP 287
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 12/157 (7%)
Query: 729 EMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNII 788
E L I H +++ L+G + LI + LY +L +++ ++ I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYL---AAKRNIAICDILAIE 188
Query: 789 LGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSAL 848
+ + + YLH IIH ++K+ N+ I+ G+ +GDFG A P+ I ++K
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPV---DINANKYYGWA 244
Query: 849 GYMA---PEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
G +A PE R D++ G+++ E+ T
Sbjct: 245 GTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 50/202 (24%), Positives = 85/202 (42%), Gaps = 10/202 (4%)
Query: 690 LGRGGFGVVYRTILQDGRSV-AIKKLTVSGLIKSQED--FEKEMKTLGKIRHHNLVALEG 746
+GRG FG V L++ V A+K L ++K E F +E L + + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ + L+ ++ G L L R L + M + +H + +H
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDR--LPEDMARFYLAEMVIAIDSVHQLHYVHR 126
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTV----KI 862
++K N+L+D +G ++ DFG L M D + SS Y++PE K
Sbjct: 127 DIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPEILQAMEDGKGKY 185
Query: 863 TEKCDVYGFGVLVLEVVTGKRP 884
+CD + GV + E++ G+ P
Sbjct: 186 GPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 28/113 (24%), Positives = 54/113 (47%), Gaps = 17/113 (15%)
Query: 726 FEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI---YEFISSGSLYKHLHDGSSRNCLSWR 782
E E+ LG++ H N++ +E + + +I Y+F LY ++D + W+
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEA----FDWK 261
Query: 783 ------QRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLA 829
Q I+ + + Y+H +IH ++K N+ ++ G+ +GDFG A
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
|
Length = 501 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 690 LGRGGFGVVYRTIL-------QDGRSVAIK-KLTVSGLIKSQED----FEKEMKTLGKIR 737
LGRG +Y IL DG S + K+ + L S D F + + ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 738 HHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAY 797
H ++V L G +++ EF+ G L +H S W+ F + +A L+Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--FKVAKQLASALSY 120
Query: 798 LHHTNIIHYNLKSTNVL-----IDSSGEP--KVGDFGLARLLPMLDRCILSSKIQSALGY 850
L +++H N+ + N+L ID P K+ D G+ + C+ + +
Sbjct: 121 LEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECV------ERIPW 174
Query: 851 MAPEFACRTVKITEKCDVYGFGVLVLEV 878
+APE + ++ D + FG + E+
Sbjct: 175 IAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 57/237 (24%), Positives = 91/237 (38%), Gaps = 41/237 (17%)
Query: 84 HIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGS 143
+ L L L+ L LS N+ L+ L + NNL
Sbjct: 154 SLPSPLRNLPNLKNLDLSFND--------LSDLPKLLSNLSNLNNLD------------- 192
Query: 144 LREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLE 203
+ N +P + S+LE ++ S+N + +L + L++L L+LSNN LE
Sbjct: 193 ------LSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE 245
Query: 204 GEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNS 263
++ + I NL +L + L N+ S + +G + L+ LD NSLS +LP L
Sbjct: 246 -DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIALLLLL 302
Query: 264 CSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFS---GRIPSSIGNLVFLKELNI 317
L + L S+ L+ N S P ++ L L L
Sbjct: 303 LELLLNL-------LLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWT 352
|
Length = 394 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-04
Identities = 34/133 (25%), Positives = 51/133 (38%), Gaps = 48/133 (36%)
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLA---------------------------- 829
+H IH ++K N+LID G K+ DFGL
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 830 -----------RLLPM-------LDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGF 871
RL P+ RC+ S + + Y+APE RT T+ CD +
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTP-NYIAPEVLLRT-GYTQLCDWWSV 234
Query: 872 GVLVLEVVTGKRP 884
GV++ E++ G+ P
Sbjct: 235 GVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 50/202 (24%), Positives = 83/202 (41%), Gaps = 10/202 (4%)
Query: 690 LGRGGFGVVYRTILQDG-RSVAIKKLTVSGLIKSQED--FEKEMKTLGKIRHHNLVALEG 746
+GRG FG V ++ R A+K L ++K E F +E L + L
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ + L+ ++ G L L R L I M + +H + +H
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDR--LPEDMARFYIAEMVLAIHSIHQLHYVHR 126
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTV----KI 862
++K NVL+D +G ++ DFG + L D + SS Y++PE K
Sbjct: 127 DIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKY 185
Query: 863 TEKCDVYGFGVLVLEVVTGKRP 884
+CD + GV + E++ G+ P
Sbjct: 186 GPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 5e-04
Identities = 59/264 (22%), Positives = 92/264 (34%), Gaps = 53/264 (20%)
Query: 189 LRSLQSLDLSNNLLEGEIVKGISN---------LYDLRAIKLGKN-KFSGQLPEDIGGCS 238
L LQ L L N L E K +++ L + G+ + L + +
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 239 MLKVLDFGVNSLSGSLPDSLQRLNSCSSL---SLKGNSFTGEVPDWIGK-----LANLES 290
L+ LD N+L L+ L SSL L N + K LE
Sbjct: 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141
Query: 291 LDLSLNQFSGRIPSSIGNLVF----LKELNISMNQFTG--------GLPESMMNCGNLLA 338
L L N+ G ++ + LKELN++ N GL NC NL
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLK---ANC-NLEV 197
Query: 339 IDVSQNKLT--------GNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQV 390
+D++ N LT + + L+ ++L N L ++ +++ L
Sbjct: 198 LDLNNNGLTDEGASALAETLASLKS---LEVLNLGDNNLTDAGAAALASALLSPNISLLT 254
Query: 391 LDLSSNALSGVIPSNIGDLSSLML 414
L LS N +I D + L
Sbjct: 255 LSLSCN--------DITDDGAKDL 270
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-04
Identities = 76/291 (26%), Positives = 119/291 (40%), Gaps = 43/291 (14%)
Query: 158 IPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLS--NNLLEGEIVKGISNLYD 215
IP+ LS ++LE++ S +LP I +L L+ LD+S NL + +LY
Sbjct: 650 IPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYR 708
Query: 216 LRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLP-DSLQRLNSCSSLSLKGNSF 274
L + K + +I S L + + + +L ++L L C S K
Sbjct: 709 LNLSGCSRLKSFPDISTNI---SWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWER 765
Query: 275 TGEVPDWIGKLA-NLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNC 333
+ + L+ +L L LS +PSSI NL L+ L I NC
Sbjct: 766 VQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEI-------------ENC 812
Query: 334 GNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSG-NRLGESMQYPSFASMKDSYQGLQVLD 392
NL +PT I L+++ LSG +RL + D + L+
Sbjct: 813 INLE-----------TLPTGINLESLESLDLSGCSRL---------RTFPDISTNISDLN 852
Query: 393 LSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSD 443
LS + V P I S+L L+M+ + +I KLK ++ +DFSD
Sbjct: 853 LSRTGIEEV-PWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSD 902
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 1/90 (1%)
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGY 850
+A+G+ +L N +H +L + NVL+ K+ DFGLAR + + + +
Sbjct: 246 VARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKW 305
Query: 851 MAPEFACRTVKITEKCDVYGFGVLVLEVVT 880
MAPE + T DV+ +G+L+ E+ +
Sbjct: 306 MAPESIFDNL-YTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 18/37 (48%), Positives = 26/37 (70%)
Query: 795 LAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831
L YLH+ I+H +LK N+LI S G K+ DFGL+++
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 8e-04
Identities = 56/256 (21%), Positives = 107/256 (41%), Gaps = 59/256 (23%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAI---KKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVAL 744
++G G FG V+ +++ R+ K ++ GL + + E+ + +++H N+V
Sbjct: 20 KIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 745 EGYYWTPSLQLL--IYEFISSGSLYKHLHDGSSRNCLSWRQRF---------NIILGMAK 793
+ + Q L + EF +G L SRN + F +I +
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDL--------SRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 794 GLAYLHH-------TNIIHYNLKSTNVLIDS---------------SGEP--KVGDFGLA 829
LAY H+ ++H +LK N+ + + +G P K+GDFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 830 RLLPMLDRCILSSKIQSALG---YMAPEFACRTVK-ITEKCDVYGFGVLVLEVVTGKRPV 885
+ + + S S +G Y +PE K +K D++ G ++ E+ +GK P
Sbjct: 190 KNIG------IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
Query: 886 EYMEDDVVVLCDMVRG 901
+ ++ ++ RG
Sbjct: 244 HKANNFSQLISELKRG 259
|
Length = 1021 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 9e-04
Identities = 68/315 (21%), Positives = 115/315 (36%), Gaps = 59/315 (18%)
Query: 119 LQVVDFSENNLSGL----IPDEFFRQCGSLREVSFANNNL------TGPIPESLSFCSSL 168
LQV+ N L + Q SL+E+ + N + + L+ L
Sbjct: 25 LQVLRLEGNTLGEEAAKALASALRPQ-PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGL 83
Query: 169 ESVNFSSNRLSGQLPYGIW--FLRS--LQSLDLSNNLLEGEIVKGI-----SNLYDLRAI 219
+ ++ S N L G+ LRS LQ L L+NN L ++ + L +
Sbjct: 84 QELDLSDNALGPDGC-GVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL 142
Query: 220 KLGKNKFSGQLPEDIGG----CSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFT 275
LG+N+ G E + LK L+ N + + +L LK N
Sbjct: 143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE-------GLKANC-- 193
Query: 276 GEVPDWIGKLANLESLDLSLNQF----SGRIPSSIGNLVFLKELNISMNQFTGG-----L 326
NLE LDL+ N + + ++ +L L+ LN+ N T
Sbjct: 194 -----------NLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA 242
Query: 327 PESMMNCGNLLAIDVSQNKLT----GNIPTWIF-KMGLQTVSLSGNRLGESMQYPSFASM 381
+ +LL + +S N +T ++ + K L + L GN+ GE S+
Sbjct: 243 SALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESL 302
Query: 382 KDSYQGLQVLDLSSN 396
+ L+ L + +
Sbjct: 303 LEPGNELESLWVKDD 317
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 9e-04
Identities = 51/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 388 LQVLDLSSNALSGV----IPSNIGDLSSLMLLNMSMNYLFGSIPASIG-------KLKAI 436
LQVL L N L + S + SL L +S+N G IP + K +
Sbjct: 25 LQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNET-GRIPRGLQSLLQGLTKGCGL 83
Query: 437 QVLDFSDNWLNGTIPPQIGGA---VSLKELKLEKNFLSGRIPSQIKNCS------SLTSL 487
Q LD SDN L + SL+ELKL N L R ++ +L L
Sbjct: 84 QELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRG-LRLLAKGLKDLPPALEKL 142
Query: 488 ILSQNNLTGPVPAAIANL----SNLKYVDLSFNDL--SGI--LPKELINLSHLLSFNISH 539
+L +N L G A+A +LK ++L+ N + +GI L + L +L ++++
Sbjct: 143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN 202
Query: 540 N 540
N
Sbjct: 203 N 203
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 45/158 (28%), Positives = 69/158 (43%), Gaps = 38/158 (24%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR---------HH 739
+GRG FG V +D G A+KKL + E EKE + +R +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKL------RKSEMLEKEQ--VAHVRAERDILAEADN 60
Query: 740 NLVALEGYYWTPSLQ-----LLIYEFISSGSLYKHLHDGSSRNCLSWRQ-RFNI---ILG 790
V ++ YY S Q LI E++ G + L ++ + + RF I IL
Sbjct: 61 PWV-VKLYY---SFQDENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIAETILA 113
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGL 828
+ +H IH ++K N+L+D+ G K+ DFGL
Sbjct: 114 ----IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 65/275 (23%), Positives = 110/275 (40%), Gaps = 39/275 (14%)
Query: 690 LGRGGFGVVYRTILQDGRSV-AIKKLTVSGLIKSQED--FEKEMKTLGKIRHHNLVALEG 746
+GRG FG V + R V A+K L+ +IK + F +E + +V L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ ++ E++ G L + + W + + + +A L +H IH
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE--KWARFYTAEVVLA--LDAIHSMGFIHR 166
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPM--LDRCILSSKIQSALG---YMAPEFACRTVK 861
++K N+L+D SG K+ DFG + + RC +A+G Y++PE
Sbjct: 167 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC------DTAVGTPDYISPEVLKSQGG 220
Query: 862 ---ITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918
+CD + GV + E++ G P + D +V G ++ +
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTP--FYADSLV------------GTYSKIMNHKNSL 266
Query: 919 NFPADEAIPVIKLGLICA----SQVPSNRPDMEEV 949
FP D I LICA +V R +EE+
Sbjct: 267 TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEI 301
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 58/237 (24%), Positives = 92/237 (38%), Gaps = 52/237 (21%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEG-- 746
+GRG FG V +D G A+K +++ + EKE + LV +G
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMK------ILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 747 -----YYWTPSLQL-LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
Y + L LI EF+ G + L ++ LS I + +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI-----------------LSSK 843
IH ++K N+L+D+ G K+ DFGL L R ++SK
Sbjct: 120 LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179
Query: 844 IQ-------------SALG---YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
+ S +G Y+APE +T + CD + GV++ E++ G P
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 16/154 (10%)
Query: 689 ELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIK----SQEDFEKEMKTLGKIRHHNLVA 743
LG+G G V+ L+ G+ A+K L +IK + E+E+ L + H L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDHPFLPT 65
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQ-RF---NIILGMAKGLAYLH 799
L + T + L+ ++ G L+ L CLS RF ++L L YLH
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELF-RLLQRQPGKCLSEEVARFYAAEVLLA----LEYLH 120
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833
I++ +LK N+L+ SG + DF L++
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 22/60 (36%), Positives = 30/60 (50%), Gaps = 10/60 (16%)
Query: 507 NLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSL 566
NLK +DLS N L+ I L +L ++S N+L +ISP + SG PSL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT----------SISPEAFSGLPSL 50
|
Length = 60 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.003
Identities = 64/267 (23%), Positives = 109/267 (40%), Gaps = 53/267 (19%)
Query: 690 LGRGGFGVVYRTILQDGRSV-AIKKLTVSGLIKSQED--FEKEMKTLGKIRHHNLVALEG 746
+GRG FG V + + V A+K L+ +IK + F +E + +V L
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110
Query: 747 YYWTPSLQLLIYEFISSGSLYKHL--HDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
+ ++ E++ G L + +D + W + + + +A L +H I
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----WARFYTAEVVLA--LDAIHSMGFI 164
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPM----LDRCILSSKIQSALG---YMAPEFAC 857
H ++K N+L+D SG K+ DFG + M + RC +A+G Y++PE
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTC--MKMDANGMVRC------DTAVGTPDYISPE--- 213
Query: 858 RTVKITE--------KCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE 909
V ++ +CD + GV + E++ G P + D +V G
Sbjct: 214 --VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP--FYADSLV------------GTYS 257
Query: 910 DCVDARLRGNFPADEAIPVIKLGLICA 936
+D + FP D I LICA
Sbjct: 258 KIMDHKNSLTFPDDIEISKQAKDLICA 284
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 34/157 (21%)
Query: 690 LGRGGFGVVYRTI--LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEG 746
+G+G FG V R + G+ A+K L +KS E F+K+ L ++ +++A
Sbjct: 9 IGKGAFGEV-RLVQKKDTGKIYAMKTL-----LKS-EMFKKDQ--LAHVKAERDVLAESD 59
Query: 747 YYWTPSLQ---------LLIYEFISSGSLYKHL--HDGSSRNCLSWRQRF---NIILGMA 792
W SL LI EF+ G L L +D S + RF +L
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLA-- 113
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLA 829
+ +H IH ++K N+LID G K+ DFGL+
Sbjct: 114 --IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 20/176 (11%)
Query: 716 VSGLIKSQEDFEKEMKTLGKIRHH--NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDG 773
+ GL KS E + +E T+ I H N+V L Y + L+ + G L+ H+
Sbjct: 23 LKGLRKSSE-YSRERLTI--IPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79
Query: 774 SS--RNCLS-WRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
+ C+ W M L LH I+ +L N+L+D G ++ F R
Sbjct: 80 LNIPEECVKRWAAE------MVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--R 131
Query: 831 LLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVE 886
+ D C +++ Y APE + + TE CD + G ++ E++TGK VE
Sbjct: 132 WSEVEDSCD-GEAVENM--YCAPEVGGIS-EETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 967 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.77 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.4 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.34 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.33 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.24 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.23 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.2 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.18 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.18 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.15 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.14 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.12 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.11 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.11 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.1 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.07 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.06 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.0 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.89 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.82 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.76 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.67 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.65 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.61 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.61 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.55 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.52 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.45 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-109 Score=1051.10 Aligned_cols=879 Identities=32% Similarity=0.531 Sum_probs=665.7
Q ss_pred CChhHHHHHHHHHhcCCCCccccCCCCCCCCCCCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCC
Q 002094 24 TFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNN 103 (967)
Q Consensus 24 ~~~~d~~all~~k~~~~~~~~~l~sw~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n 103 (967)
..++|+.||++||+++.||.+.+++|... ++||.|.||+|++ .++|+.|+|.+++++|.+++.+..+++|+.|+|++|
T Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 26 LHAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN 103 (968)
T ss_pred CCHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence 36789999999999999998889999765 4589999999985 579999999999999999999999999999999999
Q ss_pred ccCcccccccc-CCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeeccccccccc
Q 002094 104 NFTGTINADLA-SFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQL 182 (967)
Q Consensus 104 ~l~~~~~~~~~-~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 182 (967)
++++.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..++.+++|++|+|++|.+.+.+
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 180 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCc---cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccC
Confidence 99998887765 899999999999999988886 45788888888888888888888888888888888888888888
Q ss_pred CccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCC
Q 002094 183 PYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLN 262 (967)
Q Consensus 183 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~ 262 (967)
|..+.++++|++|+|++|.+++.+|..++++++|++|+|++|++++.+|..++++++|++|++++|++++.+|..+.+++
T Consensus 181 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 260 (968)
T PLN00113 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLK 260 (968)
T ss_pred ChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCC
Confidence 88888888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEcc
Q 002094 263 SCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVS 342 (967)
Q Consensus 263 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 342 (967)
+|+.|+|++|.+++.+|..+.++++|++|+|++|.+.+.+|..+.++++|+.|++++|.+++..|..+..+++|+.|+++
T Consensus 261 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~ 340 (968)
T PLN00113 261 NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLW 340 (968)
T ss_pred CCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECc
Confidence 88888888888887778778888888888888888877777777777778888888887777777777777777777777
Q ss_pred CCcCcCCCChhhhcc-cccEEeccCCCCCCCCCC-------------------CcccccccCCCCccEEEccCCcccCCC
Q 002094 343 QNKLTGNIPTWIFKM-GLQTVSLSGNRLGESMQY-------------------PSFASMKDSYQGLQVLDLSSNALSGVI 402 (967)
Q Consensus 343 ~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~~~-------------------~~~~~~~~~~~~L~~L~L~~N~l~~~~ 402 (967)
+|.+.+.+|..+... +|+.|++++|++...... ...+..+..+++|+.|++++|++++.+
T Consensus 341 ~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~ 420 (968)
T PLN00113 341 SNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420 (968)
T ss_pred CCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeEC
Confidence 777777777665543 577777777766421100 011122233455555555555555555
Q ss_pred CCCcccccccchhcccccccccccCCCcCC-----------------------cccccEEEecCCcccccCcccccCCCC
Q 002094 403 PSNIGDLSSLMLLNMSMNYLFGSIPASIGK-----------------------LKAIQVLDFSDNWLNGTIPPQIGGAVS 459 (967)
Q Consensus 403 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----------------------l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 459 (967)
|..+..+++|+.|++++|.+.+.+|..+.. .++|+.|++++|++++.+|..+..+++
T Consensus 421 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~ 500 (968)
T PLN00113 421 PSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSE 500 (968)
T ss_pred ChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhc
Confidence 555555555555555555544444433322 356677777777777788888888999
Q ss_pred CCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecC
Q 002094 460 LKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISH 539 (967)
Q Consensus 460 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~ 539 (967)
|++|+|++|++.+.+|..+.++++|+.|+|++|.+++.+|..|.++++|+.|||++|++++.+|..+..++.|+.|++++
T Consensus 501 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~ 580 (968)
T PLN00113 501 LMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISH 580 (968)
T ss_pred cCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCccCCCcccCCCCCCCccccCCCCCCCCCCcccCCCCCCCCCCCCCCCccceeehhhHHHHHHHHHH
Q 002094 540 NHLHGELPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNHRRKIVLSISALIAIGAAA 619 (967)
Q Consensus 540 N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~i~~~~ 619 (967)
|+++|.+|..+.+.++...++.|||.+|+...... . ++. .... ....+... +++++++
T Consensus 581 N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~------~---------~~c--~~~~-~~~~~~~~----~~~~~~~ 638 (968)
T PLN00113 581 NHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG------L---------PPC--KRVR-KTPSWWFY----ITCTLGA 638 (968)
T ss_pred CcceeeCCCcchhcccChhhhcCCccccCCccccC------C---------CCC--cccc-ccceeeee----hhHHHHH
Confidence 99999999988888899999999999998643111 0 000 0000 11111111 1112222
Q ss_pred HHHHHHHHHHhhheeecccchhhhhhcccCCCCCCCCCCCCCCCCCcceeccCcHHHHHHHhhccCCCCccCCCCceEEE
Q 002094 620 FIAIGVIAVTVLNIRVRSSMSRAAAALSFSGGEDYSCSPTKDPNYGKLVMFSGDAEFAAGANALLNKDCELGRGGFGVVY 699 (967)
Q Consensus 620 ~~~~~~~~~~~~~~r~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy 699 (967)
++++++++++++++|+|++.+...... ..+ .+ ....+.... ......... ...+...+.||+|+||.||
T Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~-----~~~~~~~~~--~~~~~~~~~-~~~~~~~~~ig~G~~g~Vy 707 (968)
T PLN00113 639 FLVLALVAFGFVFIRGRNNLELKRVEN--EDG-TW-----ELQFFDSKV--SKSITINDI-LSSLKEENVISRGKKGASY 707 (968)
T ss_pred HHHHHHHHHHHHHHHhhhccccccccc--ccc-cc-----ccccccccc--chhhhHHHH-HhhCCcccEEccCCCeeEE
Confidence 222222222233333222111110000 000 00 000000000 000111111 1235677899999999999
Q ss_pred EEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCchhhhhhcCCCCCC
Q 002094 700 RTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNC 778 (967)
Q Consensus 700 ~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~ 778 (967)
+|+. .++..||||++..... ....|++.+++++|||||++++++.+++..++||||+++|+|.++++.
T Consensus 708 ~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------ 776 (968)
T PLN00113 708 KGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------ 776 (968)
T ss_pred EEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------
Confidence 9996 5789999998864331 123568889999999999999999999999999999999999999963
Q ss_pred CCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccccccccccCccc
Q 002094 779 LSWRQRFNIILGMAKGLAYLH---HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEF 855 (967)
Q Consensus 779 ~~~~~~~~i~~~i~~aL~~LH---~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 855 (967)
++|.++.+++.|+|+|++||| +.+|+||||||+||+++.++.+++. ||...... ......+++.|+|||+
T Consensus 777 l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------~~~~~~~t~~y~aPE~ 849 (968)
T PLN00113 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPET 849 (968)
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------cCCCccccccccCccc
Confidence 789999999999999999999 6699999999999999999888875 66554321 1123367889999999
Q ss_pred ccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC--CChhhHHHHHHHHH
Q 002094 856 ACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN--FPADEAIPVIKLGL 933 (967)
Q Consensus 856 ~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 933 (967)
+ ....++.++|||||||++|||++|+.||+..........+|++..........++++.+... .+..+..++.+++.
T Consensus 850 ~-~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 928 (968)
T PLN00113 850 R-ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLAL 928 (968)
T ss_pred c-cCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHH
Confidence 8 66789999999999999999999999997544444556677776665555666666655432 34556678899999
Q ss_pred hhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 934 ICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 934 ~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
+|++.||++||||+|++++|+++.+.
T Consensus 929 ~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 929 HCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred hhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 99999999999999999999998763
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-56 Score=565.70 Aligned_cols=469 Identities=35% Similarity=0.545 Sum_probs=402.5
Q ss_pred CCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceee
Q 002094 93 QFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVN 172 (967)
Q Consensus 93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 172 (967)
.+++.|+|++|++++.++..|..+++|+.|+|++|++++.+|..+|..+++|++|+|++|++++.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 47999999999999999999999999999999999999999999988999999999999999998885 5789999999
Q ss_pred ecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCC
Q 002094 173 FSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSG 252 (967)
Q Consensus 173 L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 252 (967)
|++|.+++.+|..++.+++|++|+|++|.+.+..|..++++++|++|+|++|++++.+|..++.+++|++|++++|++++
T Consensus 147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 226 (968)
T PLN00113 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG 226 (968)
T ss_pred CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhc
Q 002094 253 SLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMN 332 (967)
Q Consensus 253 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 332 (967)
.+|..+.++++|++|+|++|.+++.+|..++++++|++|+|++|++.+.+|..+.++++|+.|++++|.+.+.+|..+.+
T Consensus 227 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~ 306 (968)
T PLN00113 227 EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306 (968)
T ss_pred cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcEEEccCCcCcCCCChhhhcc-cccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCC---------------
Q 002094 333 CGNLLAIDVSQNKLTGNIPTWIFKM-GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSN--------------- 396 (967)
Q Consensus 333 l~~L~~L~l~~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N--------------- 396 (967)
+++|+.|++++|.+.+.+|..+... +|+.|++++|.+.... +..+..+++|+.|++++|
T Consensus 307 l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~-----p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~ 381 (968)
T PLN00113 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI-----PKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGN 381 (968)
T ss_pred CCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcC-----ChHHhCCCCCcEEECCCCeeEeeCChhHhCcCC
Confidence 9999999999999999999877665 7999999999986432 122233444555555555
Q ss_pred ---------cccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCC--------
Q 002094 397 ---------ALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVS-------- 459 (967)
Q Consensus 397 ---------~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-------- 459 (967)
++.+.+|..+..+++|+.|++++|++.+.+|..+..++.|+.|++++|++++.+|..+..+++
T Consensus 382 L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 461 (968)
T PLN00113 382 LFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR 461 (968)
T ss_pred CCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcC
Confidence 444555555666667777777777777777777777777777777777777666654444443
Q ss_pred ---------------CCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCch
Q 002094 460 ---------------LKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPK 524 (967)
Q Consensus 460 ---------------L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 524 (967)
|+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|..+.++++|++|+|++|++++.+|.
T Consensus 462 n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 541 (968)
T PLN00113 462 NKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA 541 (968)
T ss_pred ceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCCh
Confidence 45555566666667777777888888888888888888888888889999999999999989999
Q ss_pred hhhhccCCceEEecCCcccccCCCC-CCCCccCCCcccCCCCCCC
Q 002094 525 ELINLSHLLSFNISHNHLHGELPVG-GFFNTISPSSVSGNPSLCG 568 (967)
Q Consensus 525 ~l~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~ 568 (967)
.|..+++|+.|+|++|+++|.+|.. ..+..+....+.+|+..+.
T Consensus 542 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~ 586 (968)
T PLN00113 542 SFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGS 586 (968)
T ss_pred hHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceee
Confidence 9999999999999999999888853 2234456666778876553
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=422.33 Aligned_cols=283 Identities=40% Similarity=0.687 Sum_probs=246.8
Q ss_pred cCcHHHHHHHhhccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEc
Q 002094 671 SGDAEFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT 750 (967)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 750 (967)
....++..+|++| ...+.||+|+||.||+|...+|+.||||++....... ..+|..|++++.+++|||+|+++|||.+
T Consensus 65 fs~~el~~AT~~F-s~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 65 FSYDELRKATNNF-SESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred eeHHHHHHHHhCC-chhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 3567888888777 8889999999999999999999999999887665332 5679999999999999999999999999
Q ss_pred CC-ceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCCCCEEeCCCCCeEEeec
Q 002094 751 PS-LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT---NIIHYNLKSTNVLIDSSGEPKVGDF 826 (967)
Q Consensus 751 ~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~---~ivH~Dik~~Nill~~~~~~kl~Df 826 (967)
.+ +.++|||||++|+|.++++..... +++|.+|++||.++|+||+|||+. .|+|||||++|||+|+++.+||+||
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 98 499999999999999999987654 599999999999999999999985 4999999999999999999999999
Q ss_pred ccccccCCCccccccccc-cccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCc-cchHhHHHHHHhhhc
Q 002094 827 GLARLLPMLDRCILSSKI-QSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYME-DDVVVLCDMVRGALE 904 (967)
Q Consensus 827 g~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~-~~~~~~~~~~~~~~~ 904 (967)
|+|+..+.. ....... .||.+|+|||++ ..+..|.|+|||||||+++|++||+.|.+... .....+.+|++..+.
T Consensus 222 GLa~~~~~~--~~~~~~~~~gt~gY~~PEy~-~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 222 GLAKLGPEG--DTSVSTTVMGTFGYLAPEYA-STGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCcccCCcc--ccceeeecCCCCccCChhhh-ccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 999765431 1111122 899999999999 66899999999999999999999999988543 445558999999999
Q ss_pred cCCchhhcchhhc-CCCCh-hhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 905 DGRVEDCVDARLR-GNFPA-DEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 905 ~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
..++.+++|+++. ..++. .+...+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 9999999999987 66664 5778899999999999999999999999999776643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=391.54 Aligned_cols=260 Identities=33% Similarity=0.513 Sum_probs=219.1
Q ss_pred CCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC-ceeEEEEecC
Q 002094 685 NKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS-LQLLIYEFIS 762 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~ 762 (967)
...+.+|+|+||+||+|.++....||||++..... ....++|.+|+.++.+++|||||+++|+|.++. ..++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 34455999999999999998555599999976543 222678999999999999999999999999887 7899999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-cccCCCCCCCEEeCCCC-CeEEeecccccccCCCccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN-IIHYNLKSTNVLIDSSG-EPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~-ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+|+|.++++.. ....+++..++++|.|||+||.|||+++ |||||+||+|||++.++ ++||+|||+++...... ..
T Consensus 124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~ 200 (362)
T KOG0192|consen 124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS 200 (362)
T ss_pred CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence 99999999885 2234999999999999999999999999 99999999999999997 99999999998664311 33
Q ss_pred cccccccccccCcccccC-cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 841 SSKIQSALGYMAPEFACR-TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~-~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
.+...||+.|||||++.. ...++.|+||||||+++|||+||+.||..... ....... +....+..
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v-------------~~~~~Rp~ 266 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAV-------------VVGGLRPP 266 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHH-------------HhcCCCCC
Confidence 445789999999999943 56899999999999999999999999987665 2222222 22334556
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 961 (967)
.+..++..+..++.+||+.||++||++.|++..|+.+.....
T Consensus 267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 677788999999999999999999999999999998876544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=370.10 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=210.2
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC-ceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS-LQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~ 761 (967)
.+..+.||+|..|+|||+.++ +++.+|+|.+.........+++.+|+++++..+||+||.+||.|..++ ...++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 466778999999999999976 688999999966655667789999999999999999999999999988 499999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++|||++++...+. +++...-+|+.+|++||.|||+ ++||||||||+|||++..|+|||||||.+..+.. + .
T Consensus 161 DgGSLd~~~k~~g~---i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn---S-~ 233 (364)
T KOG0581|consen 161 DGGSLDDILKRVGR---IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN---S-I 233 (364)
T ss_pred CCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh---h-h
Confidence 99999999987644 8899999999999999999995 8999999999999999999999999999987643 2 4
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....||..|||||.+ ++..|+.++||||||+.++|+.+|+.||...........+.+.-. ++ ...+..
T Consensus 234 a~tfvGT~~YMsPERi-~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---------v~-~ppP~l 302 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERI-SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---------VD-EPPPRL 302 (364)
T ss_pred cccccccccccChhhh-cCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---------hc-CCCCCC
Confidence 4567899999999999 777999999999999999999999999975422111111111111 11 112334
Q ss_pred Chh-hHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 921 PAD-EAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 921 ~~~-~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
|.+ ++.++.+++..|+++||.+|||++|+++.
T Consensus 303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 554 78889999999999999999999998763
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=386.52 Aligned_cols=258 Identities=31% Similarity=0.443 Sum_probs=225.9
Q ss_pred CCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCC
Q 002094 685 NKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSG 764 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 764 (967)
...+.||+|-||.||.|.++....||+|.++... ...++|.+|+.+|++++|++||+++++|..++..+||||||+.|
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3456899999999999999988899999998764 45678999999999999999999999999988999999999999
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccc
Q 002094 765 SLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI 844 (967)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 844 (967)
+|.++|+..... .+...+.+.++.|||+||+||+++++|||||.++|||++++..+||+|||+|+...+ +.+......
T Consensus 287 sLl~yLr~~~~~-~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~~~~~~ 364 (468)
T KOG0197|consen 287 SLLDYLRTREGG-LLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEYTASEGG 364 (468)
T ss_pred cHHHHhhhcCCC-ccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC-CceeecCCC
Confidence 999999973333 388899999999999999999999999999999999999999999999999995443 444444455
Q ss_pred cccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 845 QSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 845 ~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
.....|.|||.+ ..+.++.|+|||||||+||||+| |+.||+.+...+. -+.++.+.|.+.|..
T Consensus 365 kfPIkWtAPEa~-~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev---------------~~~le~GyRlp~P~~ 428 (468)
T KOG0197|consen 365 KFPIKWTAPEAL-NYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV---------------LELLERGYRLPRPEG 428 (468)
T ss_pred CCCceecCHHHH-hhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH---------------HHHHhccCcCCCCCC
Confidence 556779999999 77789999999999999999999 9999987765322 245667778888999
Q ss_pred hHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 924 EAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
|+.++.++|..||+.+|++|||++.+...|+++....++
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~~ 467 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTEG 467 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcccC
Confidence 999999999999999999999999999999998876554
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=403.25 Aligned_cols=262 Identities=27% Similarity=0.421 Sum_probs=225.4
Q ss_pred cCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
....++||+|+||+||+|+.. +...||||.++.....+.+.+|++|+++++.++|||||+++|+|.+++..++|
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 355778999999999999943 45689999999888776789999999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeec
Q 002094 758 YEFISSGSLYKHLHDGSSR-----------NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDF 826 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Df 826 (967)
+|||+.|||.++|...... .+++..+.+.||.|||.||+||-++.+||||+.++|+|++++..|||+||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDf 647 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDF 647 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEeccc
Confidence 9999999999999753221 23888999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhcc
Q 002094 827 GLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALED 905 (967)
Q Consensus 827 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 905 (967)
|+++..-..+.+.......-..+|||||.+ ..+.+|+++|||||||++||+++ |+.||.....++.+ ..++.
T Consensus 648 GLsRdiYssDYYk~~~~t~lPIRWMppEsI-ly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI------e~i~~ 720 (774)
T KOG1026|consen 648 GLSRDIYSSDYYKVRGNTLLPIRWMPPESI-LYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI------ECIRA 720 (774)
T ss_pred ccchhhhhhhhhcccCCceeeeecCCHHHh-hcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH------HHHHc
Confidence 999877655555555566667899999999 67799999999999999999999 99999876665332 12222
Q ss_pred CCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 002094 906 GRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961 (967)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 961 (967)
+ -.-+.|+++|.++++||..||+..|++||+++||-..|+...++-.
T Consensus 721 g---------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 721 G---------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred C---------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 2 2234689999999999999999999999999999999998765543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=367.06 Aligned_cols=257 Identities=22% Similarity=0.348 Sum_probs=209.3
Q ss_pred HHHhhccCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCccc------cHHHHHHHHHHHcCCCCCceeeeeeEEEc
Q 002094 678 AGANALLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIK------SQEDFEKEMKTLGKIRHHNLVALEGYYWT 750 (967)
Q Consensus 678 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 750 (967)
...+++|...+.||+|+||.|-+|. .++|+.||||++....... ....+++|+++|++++||+||++++++..
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 3456788899999999999999999 5579999999997654321 23457899999999999999999999999
Q ss_pred CCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC---CCeEEeecc
Q 002094 751 PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS---GEPKVGDFG 827 (967)
Q Consensus 751 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~---~~~kl~Dfg 827 (967)
++..|+||||++||+|.+.+-.... +.+..-..+++|++.|+.|||++||+||||||+|||+..+ ..+||+|||
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999999976554 6677778899999999999999999999999999999755 679999999
Q ss_pred cccccCCCccccccccccccccccCcccccCcc-c-CCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhcc
Q 002094 828 LARLLPMLDRCILSSKIQSALGYMAPEFACRTV-K-ITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALED 905 (967)
Q Consensus 828 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 905 (967)
+|+..+. ........|||.|.|||++...+ . +..++|+||+||++|-+++|.+||.....+.....++.++....
T Consensus 325 lAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 325 LAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF 401 (475)
T ss_pred hhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence 9997752 33455788999999999984432 2 34589999999999999999999985544432233333222211
Q ss_pred CCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 906 GRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+..+...+.+..++|.+|+..||++|||++|+++
T Consensus 402 -----------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 402 -----------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -----------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 12234566788999999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=376.97 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=213.5
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
..|...+.||+|||+.||+++. ..|+.||+|++..... ....+.+.+|+++.++++|||||+++++|++....|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4578899999999999999996 7899999999987543 345678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
|+|..++|.+++++... +++.++..+.+||+.|+.|||+++|+|||||..|++++++.++||+|||+|..... ..
T Consensus 98 ELC~~~sL~el~Krrk~---ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKP---LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DG 172 (592)
T ss_pred EecCCccHHHHHHhcCC---CCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--cc
Confidence 99999999999985443 99999999999999999999999999999999999999999999999999998763 23
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......|||.|+|||++ .....+..+||||+||++|-|+.|++||+...-.+ .+..+. .. ..
T Consensus 173 Erk~TlCGTPNYIAPEVl-~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-ty~~Ik-------------~~--~Y 235 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVL-NKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-TYNKIK-------------LN--EY 235 (592)
T ss_pred cccceecCCCcccChhHh-ccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-HHHHHH-------------hc--Cc
Confidence 445678899999999999 46678899999999999999999999997433211 111111 00 22
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+|...+.+..+||.++++++|.+|||+++|+.
T Consensus 236 ~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 356788889999999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=355.54 Aligned_cols=199 Identities=29% Similarity=0.454 Sum_probs=179.0
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCC-ccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSG-LIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|...+.||+|+||+||+|+++ ++..||||.+.... ..+..+-+..|+++++.++|||||++++++..++..|+|||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 566778999999999999965 58999999998775 3556778899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC------CCeEEeecccccccCCC
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS------GEPKVGDFGLARLLPML 835 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~------~~~kl~Dfg~a~~~~~~ 835 (967)
+||+|.++++.... +++..+..++.|+|.||++||+++||||||||.|||++.. -.+||+|||+|+...
T Consensus 92 ~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~-- 166 (429)
T KOG0595|consen 92 NGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ-- 166 (429)
T ss_pred CCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC--
Confidence 99999999998765 8999999999999999999999999999999999999764 357999999999885
Q ss_pred ccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCc
Q 002094 836 DRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYME 889 (967)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~ 889 (967)
.........|++-|||||++ +..+|+.|+|+||+|+++||+++|+.||+...
T Consensus 167 -~~~~a~tlcGSplYMAPEV~-~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 167 -PGSMAETLCGSPLYMAPEVI-MSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred -chhHHHHhhCCccccCHHHH-HhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 33445578899999999999 67799999999999999999999999997443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=340.25 Aligned_cols=246 Identities=24% Similarity=0.436 Sum_probs=201.6
Q ss_pred cCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeee-EEEcCCc-eeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEG-YYWTPSL-QLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~lv~e 759 (967)
|++.++||+|.||+|||+. ..+|..||.|.+..... .+...+...|+.++++++|||||++++ .+.++.+ .++|||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 5778899999999999999 56899999999985543 345677899999999999999999998 3444444 789999
Q ss_pred ecCCCchhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhc--CC--cccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 760 FISSGSLYKHLHDGSSR-NCLSWRQRFNIILGMAKGLAYLHH--TN--IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~-~~~~~~~~~~i~~~i~~aL~~LH~--~~--ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
||++|+|.++++..+.. ..+++..+|+++.|++.||+++|. .. |.||||||.||+++.+|.|||+|||+++.+..
T Consensus 101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 99999999999764433 358999999999999999999999 44 88999999999999999999999999998864
Q ss_pred CccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 835 LDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
.........|||-||+||.+ ....++.++||||+||++|||+.-++||....- ..+. ..+..+..
T Consensus 181 --~~tfA~S~VGTPyYMSPE~i-~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--~~L~----~KI~qgd~------ 245 (375)
T KOG0591|consen 181 --KTTFAHSLVGTPYYMSPERI-HESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL--LSLC----KKIEQGDY------ 245 (375)
T ss_pred --hhHHHHhhcCCCcccCHHHH-hcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--HHHH----HHHHcCCC------
Confidence 23344578899999999999 777899999999999999999999999975421 1111 12222211
Q ss_pred hhcCCCC-hhhHHHHHHHHHhhccCCCCCCCCHH
Q 002094 915 RLRGNFP-ADEAIPVIKLGLICASQVPSNRPDME 947 (967)
Q Consensus 915 ~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~ 947 (967)
++.| ...+..+..+|..|+..||+.||+.-
T Consensus 246 ---~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~ 276 (375)
T KOG0591|consen 246 ---PPLPDEHYSTDLRELINMCIAVDPEQRPDTV 276 (375)
T ss_pred ---CCCcHHHhhhHHHHHHHHHccCCcccCCCcc
Confidence 1234 56678899999999999999999853
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=369.42 Aligned_cols=384 Identities=23% Similarity=0.221 Sum_probs=205.5
Q ss_pred CCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeec
Q 002094 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFS 174 (967)
Q Consensus 95 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 174 (967)
-+.|++++|++..+-+..|.++++|+++.|.+|.++ .||.. .+...+|+.|+|.+|.|+.+-.+.++.++.|+.||||
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f-~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRF-GHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccc-cccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 345666666666555555555555555555555555 45542 1233345555555555555445555555555555555
Q ss_pred ccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCC
Q 002094 175 SNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSL 254 (967)
Q Consensus 175 ~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 254 (967)
.|.|+.+.-..|..-.++++|+|++|.|+......|.++.+|..|.|++|+++ ...
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit------------------------tLp 213 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT------------------------TLP 213 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc------------------------ccC
Confidence 55555333333433444555555555555444444444444444444444444 444
Q ss_pred ChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCC
Q 002094 255 PDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCG 334 (967)
Q Consensus 255 ~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 334 (967)
+..|.+|++|+.|+|..|+|.-.-.-.|.+|++|+.|.|..|.++..-...|..+.++++|+|+.|+++..-..++.+++
T Consensus 214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt 293 (873)
T KOG4194|consen 214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLT 293 (873)
T ss_pred HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccc
Confidence 44444444444444444444422233444555555555555555444444444555555555555555544444444555
Q ss_pred CCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccch
Q 002094 335 NLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLML 414 (967)
Q Consensus 335 ~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 414 (967)
.|+.||||+|.|...-++. ....++|++|+|++|+|+...+..|..+..|++
T Consensus 294 ~L~~L~lS~NaI~rih~d~----------------------------WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~ 345 (873)
T KOG4194|consen 294 SLEQLDLSYNAIQRIHIDS----------------------------WSFTQKLKELDLSSNRITRLDEGSFRVLSQLEE 345 (873)
T ss_pred hhhhhccchhhhheeecch----------------------------hhhcccceeEeccccccccCChhHHHHHHHhhh
Confidence 5555555555444211110 011245666666666666666777778888888
Q ss_pred hcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcC
Q 002094 415 LNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNL 494 (967)
Q Consensus 415 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 494 (967)
|+|++|++.......|..+++|+.|||++|.+...+.+. ...|..|++|+.|+|.+|+|
T Consensus 346 LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDa---------------------a~~f~gl~~LrkL~l~gNql 404 (873)
T KOG4194|consen 346 LNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDA---------------------AVAFNGLPSLRKLRLTGNQL 404 (873)
T ss_pred hcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecc---------------------hhhhccchhhhheeecCcee
Confidence 888888887666666777777777777777776544321 12345555566666666666
Q ss_pred cCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCCCCCCc
Q 002094 495 TGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNT 554 (967)
Q Consensus 495 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 554 (967)
..+.-.+|.++++|+.|||.+|.|..+.|++|..| +|+.|-++.-.+-+.+...++.+|
T Consensus 405 k~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl~qW 463 (873)
T KOG4194|consen 405 KSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWLAQW 463 (873)
T ss_pred eecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHHHHHH
Confidence 54444566666666666666666666666666666 566665555555444443333333
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=332.13 Aligned_cols=262 Identities=22% Similarity=0.284 Sum_probs=204.8
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|+...++|+|+||+|||++.+ +|+.||||++..... +.-.+-..+|++++++++|+|+|.++++|......++|+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 3667788999999999999966 599999999976653 33456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
|+..-|++. ...... .+.+.+.+++.|++.|+.|+|+++++||||||+||+++.+|.+||||||+|+.... ....
T Consensus 83 ~dhTvL~eL-e~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~ 157 (396)
T KOG0593|consen 83 CDHTVLHEL-ERYPNG--VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDN 157 (396)
T ss_pred cchHHHHHH-HhccCC--CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccch
Confidence 998555544 333322 78899999999999999999999999999999999999999999999999998863 3334
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhcc--CCchhhcch----
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALED--GRVEDCVDA---- 914 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~---- 914 (967)
.+....|-.|+|||.+.+..+|+..+||||.||++.||++|.+.|.+..+-.+.+ .+.. .+.. ++..+++..
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy-~I~k-tLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY-LIRK-TLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH-HHHH-HHcccCHHHHHHhccCCce
Confidence 5567778899999999888999999999999999999999999998655433321 1111 1100 001111110
Q ss_pred ------hh-----cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 915 ------RL-----RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 915 ------~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.. ....-+....-+.++++.|++.||++|++-+|++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 00 00011223446889999999999999999998763
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=343.36 Aligned_cols=242 Identities=24% Similarity=0.320 Sum_probs=203.8
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccc--cHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIK--SQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||.++.+ .++.+|+|++++....+ ..+...+|..++.+++||+||.++-.|++++..|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 34688999999999999999965 58899999998776533 4678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+.||.|..+|.+... +++..+.-++.+|+.||.|||++||||||+||+|||+|++|+++|+|||+++..-. ..
T Consensus 105 d~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~~ 179 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--DG 179 (357)
T ss_pred eccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--CC
Confidence 99999999999987665 89999999999999999999999999999999999999999999999999985432 22
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......||+.|||||++ ....++.++|+||+|+++|||++|.+||...+.. .+........ ..
T Consensus 180 ~~t~tfcGT~eYmAPEil-~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-----~~~~~I~~~k----------~~ 243 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEIL-LGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-----KMYDKILKGK----------LP 243 (357)
T ss_pred CccccccCCccccChHHH-hcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-----HHHHHHhcCc----------CC
Confidence 234458999999999999 5568999999999999999999999999644321 2222222111 12
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCC
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRP 944 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rp 944 (967)
..+...+.+..+++.+.++.||++|.
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 23444667899999999999999995
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=354.06 Aligned_cols=266 Identities=23% Similarity=0.312 Sum_probs=213.6
Q ss_pred hhccCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCC-ceeEE
Q 002094 681 NALLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPS-LQLLI 757 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~lv 757 (967)
.+.|...++||.|.||.||+|+ ..+|..||||+++..-...++-.=.+|++.+++++ ||||+++.+++.+.+ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4557788899999999999999 45789999999987764444445678999999998 999999999999888 89999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
||||+. +|.+.++++ ...+++..+..|+.||++||+|+|++|+.|||+||+|||+.....+||+|||+|+....
T Consensus 89 fE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S--- 162 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS--- 162 (538)
T ss_pred HHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc---
Confidence 999976 999999887 34599999999999999999999999999999999999999999999999999997743
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHh--HHHHHHhhhccCCch-hhcch
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVV--LCDMVRGALEDGRVE-DCVDA 914 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~ 914 (967)
....+....|-.|+|||++.+.+.|+.+.||||+||+++|+.+-++.|.+..+-.+. .++++.......+.. .-...
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 334567778889999999999999999999999999999999999999865543222 222222111111111 00011
Q ss_pred hhcCCC-----------ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 915 RLRGNF-----------PADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 915 ~~~~~~-----------~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.+.-.+ -+..+.+..++|.+|+.+||++||||+|+++.
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111 12367789999999999999999999998864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=348.44 Aligned_cols=264 Identities=22% Similarity=0.309 Sum_probs=212.4
Q ss_pred hccCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--CceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP--SLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 757 (967)
+.|+..+.||+|+||.||+|+ ..+|+.||+|+++.+.. .....-..+||.+++++.||||+++.+...++ +..|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 345777899999999999999 55799999999988764 44567788999999999999999999998876 789999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
+|||+. +|..++...... ++..++..+++|++.||+|+|++||+|||||.+|||+|.+|.+||+|||+|+++....
T Consensus 197 FeYMdh-DL~GLl~~p~vk--ft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~- 272 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVK--FTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG- 272 (560)
T ss_pred Eecccc-hhhhhhcCCCcc--cChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC-
Confidence 999988 888888765443 8999999999999999999999999999999999999999999999999999876532
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh-
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL- 916 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 916 (967)
....+...-|..|+|||.+.+...|+.++|+||.|||+.||++|++.|....+-++ + +.+......+....+...++
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ-l-~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ-L-HKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH-H-HHHHHHhCCCChhccccccCC
Confidence 23355667789999999999999999999999999999999999999976544222 2 22222222222222221111
Q ss_pred -------cCCC-------ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 917 -------RGNF-------PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 917 -------~~~~-------~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..++ -...+....+|+..++..||++|.||.++++
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1111 1234556889999999999999999999874
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=366.57 Aligned_cols=452 Identities=26% Similarity=0.387 Sum_probs=334.8
Q ss_pred eeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccc
Q 002094 72 VGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151 (967)
Q Consensus 72 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~ 151 (967)
..+.+.+|++.- +.+.+.+|..|.+|++++|+++ ..|++++.+.+++.|+.|+|+++ .+|.++ ..+.+|+.|+.++
T Consensus 48 ~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i-~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 48 QKLILSHNDLEV-LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQI-GSLISLVKLDCSS 123 (565)
T ss_pred hhhhhccCchhh-ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHH-hhhhhhhhhhccc
Confidence 345555555432 3456777777778888887777 55677777777777788887777 666664 6677777777777
Q ss_pred cccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCC
Q 002094 152 NNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLP 231 (967)
Q Consensus 152 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 231 (967)
|++. .+|+.++.+..|+.|+..+|+++ ..|..+.++.+|..|++.+|.++..++..+. ++.|++||..+|-+. .+|
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP 199 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLP 199 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCC
Confidence 7777 56667777777777777777777 5677777777777777777777766665555 777777777777776 677
Q ss_pred cCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccc
Q 002094 232 EDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVF 311 (967)
Q Consensus 232 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 311 (967)
..++++.+|..|+|..|+|. ..| .|.++..|++|+++.|+|+-...+...++.+|.+|||.+|+++ ..|..+.-+.+
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrs 276 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRS 276 (565)
T ss_pred hhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhh
Confidence 77777777777777777777 455 6777777777777777777333333447777777777777777 66777777777
Q ss_pred cceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCC-------------------------------------CChhh
Q 002094 312 LKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGN-------------------------------------IPTWI 354 (967)
Q Consensus 312 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-------------------------------------~p~~~ 354 (967)
|.+|++++|.|+ ..|.+++++ +|+.|-+.+|++... .|.+.
T Consensus 277 L~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~ 354 (565)
T KOG0472|consen 277 LERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSES 354 (565)
T ss_pred hhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCc
Confidence 777777777777 456677777 777777777777411 11111
Q ss_pred h-----cccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCC
Q 002094 355 F-----KMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPAS 429 (967)
Q Consensus 355 ~-----~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 429 (967)
+ ..+.+.|++++-.++..+. ..|..... .-.+.++++.|++. .+|..+..+..+.+.-+..|+..+.+|..
T Consensus 355 ~~~~~~~i~tkiL~~s~~qlt~VPd-EVfea~~~--~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~ 430 (565)
T KOG0472|consen 355 FPDIYAIITTKILDVSDKQLTLVPD-EVFEAAKS--EIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLE 430 (565)
T ss_pred ccchhhhhhhhhhcccccccccCCH-HHHHHhhh--cceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHH
Confidence 1 1134555555555544321 11211111 12567888888888 67777877777665444444444689999
Q ss_pred cCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCcc
Q 002094 430 IGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLK 509 (967)
Q Consensus 430 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 509 (967)
++.+++|..|+|++|-+. .+|.+++.+..|+.|+++.|++. .+|..+..+..|+.+-.++|++....|..+.+|.+|.
T Consensus 431 l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~ 508 (565)
T KOG0472|consen 431 LSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLT 508 (565)
T ss_pred HHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcc
Confidence 999999999999999997 78999999999999999999998 8999888888888888888999977777799999999
Q ss_pred EEeccCCccccCCchhhhhccCCceEEecCCccc
Q 002094 510 YVDLSFNDLSGILPKELINLSHLLSFNISHNHLH 543 (967)
Q Consensus 510 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 543 (967)
.|||.+|.+. .+|..+++|.+|+.|++++|++.
T Consensus 509 tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 509 TLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred eeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 9999999999 88999999999999999999998
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=367.74 Aligned_cols=259 Identities=28% Similarity=0.432 Sum_probs=224.9
Q ss_pred hccCCCCccCCCCceEEEEEEeC----CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ----DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
+...++++||.|.||.||+|+++ ....||||.++....++.+.+|..|+.+|.+++||||+++.|+.......+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34577889999999999999965 24679999999988888889999999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
.|||++|+|+.+|+....+ +++.+...+.++||.|++||-++++||||+..+|||++.+-..|++|||+++...+..
T Consensus 709 TEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~- 785 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP- 785 (996)
T ss_pred hhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence 9999999999999887654 8999999999999999999999999999999999999999999999999999875432
Q ss_pred cccccccc--ccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 838 CILSSKIQ--SALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 838 ~~~~~~~~--gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
....+... -..+|.|||.+ ..+.+|.++||||||++|||.++ |..||=.|..++. -..++.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAI-a~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV---------------IkaIe~ 849 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---------------IKAIEQ 849 (996)
T ss_pred CccccccCCccceeecChhHh-hhcccCchhhccccceEEEEecccCCCcccccchHHH---------------HHHHHh
Confidence 12222222 24679999999 78899999999999999999998 9999865554322 233455
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
.++-+.|.+|+..+.+||..||++|-.+||++.+++.+|+++...
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 667778899999999999999999999999999999999987643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=318.44 Aligned_cols=263 Identities=25% Similarity=0.314 Sum_probs=213.1
Q ss_pred ccCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCccc-cHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIK-SQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|...+.+|+|.||.||+|+ .++|+.||||+++.....+ -.....+|++.++.++|+||+.++++|...+...+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 36677899999999999999 5579999999998775432 245688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++. +|+..+++... .++..++..++.++++|++|+|++.|+||||||.|+|++++|.+||+|||+|+.+........
T Consensus 83 m~t-dLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred ccc-cHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 976 99999987654 389999999999999999999999999999999999999999999999999998875444332
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC-
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN- 919 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 919 (967)
....|-.|+|||.+.+...|+..+||||.||++.||+-|.+-|.+..+- ..+ ..+.+.+..+...++.+-...+.
T Consensus 160 --~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL-~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 160 --HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQL-SKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred --cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHH-HHHHHHcCCCCcccCccccccccH
Confidence 2356778999999989999999999999999999999988877654432 222 33444444443333333211110
Q ss_pred -------------CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 920 -------------FPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 920 -------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.-..+.....+++.+++..||.+|+|++|++++
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 112345567999999999999999999998864
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.78 Aligned_cols=382 Identities=24% Similarity=0.240 Sum_probs=278.6
Q ss_pred CCCCCccceEEeCCC--------------CCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCC
Q 002094 53 DDNPCNWVGVKCDPK--------------TKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGT 118 (967)
Q Consensus 53 ~~~~c~w~gv~c~~~--------------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 118 (967)
.+|+|.-.=..|+.. ...+..|++++|.++..-...|-++++|+.++|.+|.++ .||...+...+
T Consensus 48 a~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sgh 126 (873)
T KOG4194|consen 48 ATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGH 126 (873)
T ss_pred CcCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccc
Confidence 356788777888643 235778999999998887888999999999999999998 67877777888
Q ss_pred CcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeec
Q 002094 119 LQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLS 198 (967)
Q Consensus 119 L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 198 (967)
|+.|+|.+|.|+ .+..+-++-++.|+.|||+.|.|+.+.-.+|..-.++++|+|++|+|+..-...|..+.+|..|.|+
T Consensus 127 l~~L~L~~N~I~-sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLs 205 (873)
T KOG4194|consen 127 LEKLDLRHNLIS-SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLS 205 (873)
T ss_pred eeEEeeeccccc-cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecc
Confidence 999999999999 5666667899999999999999997777789888999999999999998888999999999999999
Q ss_pred CCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcC
Q 002094 199 NNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEV 278 (967)
Q Consensus 199 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 278 (967)
.|.++..++..|.+|++|+.|+|..|+|.-..--.|.++++|+.|.|..|.|...-...|-.+.++++|+|..|+++..-
T Consensus 206 rNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn 285 (873)
T KOG4194|consen 206 RNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVN 285 (873)
T ss_pred cCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhh
Confidence 99999999999999999999999999988443456777777777777777777655666666666666666666666666
Q ss_pred chhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhccc
Q 002094 279 PDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMG 358 (967)
Q Consensus 279 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 358 (967)
..++.+|+.|+.|+||+|.|..+.+++....++|+.|+|++|+|+...+.+|..+..|+.|+|++|.++
T Consensus 286 ~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~----------- 354 (873)
T KOG4194|consen 286 EGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID----------- 354 (873)
T ss_pred cccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH-----------
Confidence 666666666666666666666666666666666666666666666555555555555555555555443
Q ss_pred ccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCC---CcCCccc
Q 002094 359 LQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPA---SIGKLKA 435 (967)
Q Consensus 359 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~ 435 (967)
..-..+|..+++|+.|||++|.++..+-+ .|.++++
T Consensus 355 -----------------------------------------~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~ 393 (873)
T KOG4194|consen 355 -----------------------------------------HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPS 393 (873)
T ss_pred -----------------------------------------HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchh
Confidence 33445566677777777777777654432 3344444
Q ss_pred ccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEec
Q 002094 436 IQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDL 513 (967)
Q Consensus 436 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 513 (967)
|+.|+|.+|++. .....+|.++.+|+.|||.+|.|..+-|.+|..| +|+.|-+
T Consensus 394 LrkL~l~gNqlk------------------------~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~ 446 (873)
T KOG4194|consen 394 LRKLRLTGNQLK------------------------SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVM 446 (873)
T ss_pred hhheeecCceee------------------------ecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhh
Confidence 444444444444 3333345555555555555555555555555555 5555544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.88 Aligned_cols=261 Identities=29% Similarity=0.442 Sum_probs=211.7
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+++.....||+|.||+||+|.|. ..||||.+..... .+..+.|+.|+..+++-+|.||+-+.|||..+.. .||..|
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 34566788999999999999985 4799999988765 3456889999999999999999999999988877 999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
|+|.+|+.++|....+ ++..+.++||+|||+|+.|||.++|||||+|..||++.+++.|||+|||++...........
T Consensus 469 CeGsSLY~hlHv~etk--fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q 546 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQETK--FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ 546 (678)
T ss_pred ccCchhhhhccchhhh--hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccc
Confidence 9999999999987644 88999999999999999999999999999999999999999999999999976543322222
Q ss_pred cccccccccccCcccccC--cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 841 SSKIQSALGYMAPEFACR--TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~--~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.....|...|||||++.. ..+|++.+||||||+++|||++|..||.....+ +++...-+++. ..| ..
T Consensus 547 ~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-qIifmVGrG~l-------~pd---~s 615 (678)
T KOG0193|consen 547 LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-QIIFMVGRGYL-------MPD---LS 615 (678)
T ss_pred cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-heEEEeccccc-------Ccc---ch
Confidence 233446677999999843 456899999999999999999999999833222 21111111111 011 01
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
....+++.++.+|+..||..++++||.+.+++..|+.+..
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1245678899999999999999999999999998887765
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=349.11 Aligned_cols=248 Identities=22% Similarity=0.336 Sum_probs=211.5
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCcc--ccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 759 (967)
|..++.||+|+|++||+|+. ..+++||||++.+.... ...+.+..|-.+|.++ .||.|++++..|+++...|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 47788999999999999994 46899999999766542 3346688899999999 89999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc-
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC- 838 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 838 (967)
|+++|+|.+++++.+. +++.-+..+|.+|+.|++|||++|||||||||+|||+|+|++++|.|||.|..++.....
T Consensus 155 ~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred ecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence 9999999999998766 899999999999999999999999999999999999999999999999999888542222
Q ss_pred --------ccc--ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc
Q 002094 839 --------ILS--SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV 908 (967)
Q Consensus 839 --------~~~--~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 908 (967)
... ..+.||..|.+||++ .....+.++|+|+|||++|+|+.|.+||....+ ...+..++.
T Consensus 232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL-~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yliFqkI~~-------- 301 (604)
T KOG0592|consen 232 ENPVDPNQASSRRSSFVGTAEYVSPELL-NDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YLIFQKIQA-------- 301 (604)
T ss_pred cCccCcccccCcccceeeeecccCHHHh-cCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HHHHHHHHH--------
Confidence 111 458899999999999 777899999999999999999999999975543 222222221
Q ss_pred hhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+.-.++++.+..+.+|+++.+..||.+|+|.+||.+
T Consensus 302 -------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 302 -------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred -------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 234567778888999999999999999999988765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=343.98 Aligned_cols=256 Identities=26% Similarity=0.384 Sum_probs=206.9
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC--ceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS--LQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~ 760 (967)
|...+.||+|+||+||.+... +|+..|||.+....... .+.+.+|++++++++|||||+++|...... ..++.|||
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 567789999999999999965 48999999987664322 567999999999999999999999855444 58899999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC-CCCeEEeecccccccCC-Cccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS-SGEPKVGDFGLARLLPM-LDRC 838 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~-~~~~kl~Dfg~a~~~~~-~~~~ 838 (967)
+++|+|.+++.+... .+++..+..+.+||++||+|||++|||||||||+|||++. ++.+||+|||++..... ....
T Consensus 98 ~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred cCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 999999999998765 2899999999999999999999999999999999999999 79999999999986653 1222
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......||+.|||||++..+.....++||||+||++.||+||++||...... .+++..... ....+
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~----~~~~~~ig~---------~~~~P 242 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE----AEALLLIGR---------EDSLP 242 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch----HHHHHHHhc---------cCCCC
Confidence 33446889999999999944323345999999999999999999999743111 111111111 11123
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
.+|...+.+..+++.+|+..||++||||+++++.--.
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 5677788889999999999999999999999876543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.01 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=210.9
Q ss_pred ccCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..++||.|..++||+|+ ...++.||||++..+....+.+.+.+|+..++.++||||++++..|..+...|+||.||
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 46778899999999999999 45689999999988876666789999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc-cccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD-RCIL 840 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~ 840 (967)
.+||+.+.++..-... +++..+..|.+++++||.|||++|.||||||+.|||++.+|.|||+|||.+..+-... +...
T Consensus 107 a~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~ 185 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVT 185 (516)
T ss_pred cCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeE
Confidence 9999999998776655 8899999999999999999999999999999999999999999999999876553322 2222
Q ss_pred c-ccccccccccCccccc-CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 841 S-SKIQSALGYMAPEFAC-RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 841 ~-~~~~gt~~y~aPE~~~-~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
. ....||+.|||||+++ +-..|+.|+||||||++..||.+|..||.....-...+... .+...... -.....
T Consensus 186 rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~-----t~~~~~ 259 (516)
T KOG0582|consen 186 RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLL-----TSGLDK 259 (516)
T ss_pred eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCcc-----cccCCh
Confidence 2 4568999999999953 44569999999999999999999999998655433222211 11110000 000110
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.........+.+++..|+++||++|||++++++
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111122346889999999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=380.72 Aligned_cols=267 Identities=30% Similarity=0.440 Sum_probs=224.9
Q ss_pred hccCCCCccCCCCceEEEEEEeCC--Cc----EEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD--GR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
...+..+.||+|+||.||+|...+ |. .||||.+......+...+|.+|..+|+.++|||||+++|++.+.+..+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344667789999999999999653 33 499999988877778899999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCC----CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 756 LIYEFISSGSLYKHLHDGSSR----NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
+++|||+||+|..+|++.+.. ..++..+.+.++.|||+|+.||+++++|||||..+|+|+++...|||+|||+|+.
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHh
Confidence 999999999999999876332 2488999999999999999999999999999999999999999999999999996
Q ss_pred cCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchh
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVED 910 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (967)
....+.+.......-...|||||.+ ..+.+|.|+|||||||++||++| |..||......+. +..+. +.+
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl-~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-~~~~~----~gg---- 921 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESL-KDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-LLDVL----EGG---- 921 (1025)
T ss_pred hhhchheeccCccccceecCCHHHH-hhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-HHHHH----hCC----
Confidence 5543444333333344679999999 66899999999999999999999 9999976544321 11111 111
Q ss_pred hcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCcc
Q 002094 911 CVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQE 964 (967)
Q Consensus 911 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~ 964 (967)
|-+.|..|+..++++|..||+.+|++||++..+++.+..+.+.+.+.+
T Consensus 922 ------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 922 ------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred ------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 344688999999999999999999999999999999999988776643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=359.26 Aligned_cols=263 Identities=27% Similarity=0.391 Sum_probs=208.1
Q ss_pred hccCCCCccCCCCceEEEEEEe------CCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcC-Cc
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTP-SL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~ 753 (967)
+.|+..+.||+|+||.||+|.. .+++.||||++...........+.+|+++++.+ +||||+++++++..+ +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 4468889999999999999974 235789999997654344456799999999999 899999999988764 45
Q ss_pred eeEEEEecCCCchhhhhhcCCC----------------------------------------------------------
Q 002094 754 QLLIYEFISSGSLYKHLHDGSS---------------------------------------------------------- 775 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 775 (967)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 7899999999999999875321
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccccccccccCcc
Q 002094 776 -RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPE 854 (967)
Q Consensus 776 -~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 854 (967)
...+++.++.+++.||++||+|||++||+||||||+||+++.++.+||+|||+++...............+++.|+|||
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 1237788999999999999999999999999999999999999999999999997654322222233445667899999
Q ss_pred cccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHH
Q 002094 855 FACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGL 933 (967)
Q Consensus 855 ~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 933 (967)
++ ....++.++|||||||++|||++ |..||.......... .. +..+ .....+...+..+.+++.
T Consensus 247 ~~-~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~-~~----~~~~---------~~~~~~~~~~~~l~~li~ 311 (338)
T cd05102 247 SI-FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC-QR----LKDG---------TRMRAPENATPEIYRIML 311 (338)
T ss_pred Hh-hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH-HH----HhcC---------CCCCCCCCCCHHHHHHHH
Confidence 88 55678999999999999999997 999997543322111 11 1111 111234456677999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 934 ICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 934 ~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
+|++.||++|||+.|++++|+++..+
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=316.59 Aligned_cols=235 Identities=25% Similarity=0.361 Sum_probs=204.5
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||.|+||+|..++.+ +|..+|+|++..... .++.+...+|.++++.+.||+++++++.+.+.+..++||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 477789999999999999955 689999999987764 23557788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++||.|.+++++.++ +++..+.-+|.||+.|++|||+.+|++||+||+|||+|.+|.+||.|||+|+.+.. .
T Consensus 126 v~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-----r 197 (355)
T KOG0616|consen 126 VPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-----R 197 (355)
T ss_pred cCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC-----c
Confidence 999999999998766 89999999999999999999999999999999999999999999999999997653 2
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.-...|||.|+|||.+ +...+..++|.|||||++|||+.|.+||..... ...+..++.+.+ .+
T Consensus 198 T~TlCGTPeYLAPEii-~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~v---------------~f 260 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEII-QSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGKV---------------KF 260 (355)
T ss_pred EEEecCCccccChHHh-hcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCcc---------------cC
Confidence 3467899999999999 777899999999999999999999999975443 333333332222 35
Q ss_pred ChhhHHHHHHHHHhhccCCCCCC
Q 002094 921 PADEAIPVIKLGLICASQVPSNR 943 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~R 943 (967)
|......+.+|+.+.++.|-++|
T Consensus 261 P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcccCHHHHHHHHHHHhhhhHhh
Confidence 67777789999999999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=341.45 Aligned_cols=246 Identities=24% Similarity=0.394 Sum_probs=211.1
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|...+.||+|.||.||||+.+ +.+.||+|.+.+.+. .++.+.+.+|++++++++|||||.++++|+...+.|+|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 4667788999999999999955 578999999977654 44567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+.| +|..++..... ++++.+..++.+++.||.|||+.+|.|||+||.||+++..+.+|+||||+|+.+.. ....
T Consensus 83 a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 83 AVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred hhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 988 99999987665 89999999999999999999999999999999999999999999999999997764 4445
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.+...|||-|||||.. .+..++..+|+||+||++||++.|++||... .+.+.++....++ ...
T Consensus 157 ltsikGtPlYmAPElv-~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~-----------v~~ 219 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELV-EEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDP-----------VKP 219 (808)
T ss_pred eeeccCcccccCHHHH-cCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCC-----------CCC
Confidence 6678899999999998 7889999999999999999999999999522 1223333332211 123
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
|...+..+..++...+.+||.+|.|..+++.
T Consensus 220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 4566778999999999999999999988764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.80 Aligned_cols=245 Identities=29% Similarity=0.456 Sum_probs=208.4
Q ss_pred CCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCC
Q 002094 685 NKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSG 764 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 764 (967)
.+.+-||.|+.|.||.|+++ ++.||||+++.- -..+++.+++++||||+.+.|+|.....++||||||..|
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 44567999999999999987 799999977532 255788999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccc
Q 002094 765 SLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI 844 (967)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 844 (967)
-|...|+..+. ++......|.++||.|+.|||.+.|||||+|.-||||..+..|||+|||.++..... ...-.+
T Consensus 198 qL~~VLka~~~---itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 198 QLYEVLKAGRP---ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred cHHHHHhccCc---cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 99999987665 788999999999999999999999999999999999999999999999999866432 223468
Q ss_pred cccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhh
Q 002094 845 QSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADE 924 (967)
Q Consensus 845 ~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (967)
.||..|||||++ ++.+.++|+|||||||+||||+||..||...+.. .++++. -...+.-..|..+
T Consensus 272 aGTVaWMAPEvI-rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----AIIwGV---------GsNsL~LpvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVI-RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----AIIWGV---------GSNSLHLPVPSTC 336 (904)
T ss_pred hhhHhhhCHHHh-hcCCcccccceehhHHHHHHHHhcCCCccccchh-----eeEEec---------cCCcccccCcccC
Confidence 899999999999 7779999999999999999999999999644332 122221 1122334567888
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 925 AIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 925 ~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
+.-+.-|++.||+..|..||++.+++..|+-...+
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 88899999999999999999999999999865443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=345.55 Aligned_cols=256 Identities=24% Similarity=0.350 Sum_probs=209.3
Q ss_pred hhccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCcc----ccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCce
Q 002094 681 NALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLI----KSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 754 (967)
.+.|...+.||+|+||+||.|.. .+++.||+|.+...... ...+.+.+|+.++++++ ||||+++++++..+...
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 34578899999999999999984 46899999977654211 23556779999999998 99999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC-CCeEEeecccccccC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS-GEPKVGDFGLARLLP 833 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~-~~~kl~Dfg~a~~~~ 833 (967)
++||||+.||+|.+++..... +.+..+.++++|++.|++|+|++||+||||||+||+++.+ +.+||+|||++...+
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~---l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGR---LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEEecCCccHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999988333 7889999999999999999999999999999999999999 999999999998764
Q ss_pred CCccccccccccccccccCcccccCcc-cCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTV-KITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV 912 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (967)
..........||+.|+|||++.... .-+.++||||+||++|-|++|+.||+..... ..+.. +..+
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-~l~~k-----i~~~------ 238 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-NLYRK-----IRKG------ 238 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-HHHHH-----HhcC------
Confidence 2233455788999999999995555 3458999999999999999999999763221 11111 1111
Q ss_pred chhhcCCCChhh-HHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 913 DARLRGNFPADE-AIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 913 ~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.-.+|... +.++.+++.+|+..||.+|+|+.+++ .-.-++.
T Consensus 239 ----~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 239 ----EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred ----CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 12244555 78899999999999999999999998 4444443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.26 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=209.5
Q ss_pred hccCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
..|..-.+||+|+.|.||.+. ..+++.||||++.... +...+-+..|+.+|+..+|+|||.+++.|...++.|+||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 346677789999999999998 4568999999998776 34456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++||+|.+.+.... +++.++..|.+++++||+|||.+||+|||||.+|||++.+|.+||+|||++..+.... ..
T Consensus 352 m~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~K 425 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--SK 425 (550)
T ss_pred cCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc--Cc
Confidence 99999999987654 7899999999999999999999999999999999999999999999999998775422 24
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....|||-|||||+. ....|++++||||||++++||+.|.+||-.. .....+.-+.. .....-..
T Consensus 426 R~TmVGTPYWMAPEVv-trk~YG~KVDIWSLGIMaIEMveGEPPYlnE-~PlrAlyLIa~------------ng~P~lk~ 491 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVV-TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIAT------------NGTPKLKN 491 (550)
T ss_pred cccccCCCCccchhhh-hhcccCccccchhhhhHHHHHhcCCCCccCC-ChHHHHHHHhh------------cCCCCcCC
Confidence 5678899999999999 6678999999999999999999999999542 22222111111 11112234
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
++..+..+.+++.+|++.|+++|++++|+++
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 5667788999999999999999999999986
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=335.25 Aligned_cols=266 Identities=26% Similarity=0.349 Sum_probs=220.4
Q ss_pred hhccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.......++||+|-||.|..+....+..||||.++.........+|.+|+++|.+++|||||+++|+|..++..++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 33456678899999999999999888999999999887666678999999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
|++|+|.+++....... .......+|+.||+.|++||.+-.+||||+.++|+|+|.++++||+|||+++-.-..+....
T Consensus 617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 99999999998764432 34456677999999999999999999999999999999999999999999987665566666
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHc--CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT--GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.+...-..+|||||.+ --+.+|+|+|||+|||++||+++ ...||+...++... +-.....+.... ....
T Consensus 696 qgr~vlpiRwmawEsi-llgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv--en~~~~~~~~~~------~~~l 766 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESI-LLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV--ENAGEFFRDQGR------QVVL 766 (807)
T ss_pred ecceeeeeeehhHHHH-HhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH--HhhhhhcCCCCc------ceec
Confidence 6666677899999988 45589999999999999999887 78899866554221 111111111111 1122
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
..|.-++..+.+++.+||..|.++||+++++...|++.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 34778899999999999999999999999999888764
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=351.35 Aligned_cols=456 Identities=26% Similarity=0.364 Sum_probs=390.5
Q ss_pred CCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceee
Q 002094 93 QFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVN 172 (967)
Q Consensus 93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 172 (967)
..|+.|++++|.++ .+.+.+.++..|++|++++|+++ ..|+++ +.+..++.|+.++|++. .+|+.++.+.+|..|+
T Consensus 45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~ai-g~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~ 120 (565)
T KOG0472|consen 45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAI-GELEALKSLNVSHNKLS-ELPEQIGSLISLVKLD 120 (565)
T ss_pred cchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHH-HHHHHHHHhhcccchHh-hccHHHhhhhhhhhhh
Confidence 45889999999998 45667899999999999999999 677765 89999999999999999 7899999999999999
Q ss_pred ecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCC
Q 002094 173 FSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSG 252 (967)
Q Consensus 173 L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 252 (967)
+++|.+. .+|+.++.+..|..|+..+|+++ ..|..+.++.+|..|++.+|++....|+.+. ++.|++||+..|-+.
T Consensus 121 ~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~- 196 (565)
T KOG0472|consen 121 CSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE- 196 (565)
T ss_pred cccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-
Confidence 9999999 78889999999999999999998 5688889999999999999999965555555 999999999999998
Q ss_pred CCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCC-cccccceEEcccCcCCCCCChhhh
Q 002094 253 SLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIG-NLVFLKELNISMNQFTGGLPESMM 331 (967)
Q Consensus 253 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~ 331 (967)
.+|+.++.+.+|..|+|++|+|. ..| .|.++..|.+|+++.|+|. .+|.... +++++..|+|..|+++ ..|+.++
T Consensus 197 tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~c 272 (565)
T KOG0472|consen 197 TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEIC 272 (565)
T ss_pred cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHH
Confidence 88999999999999999999999 566 7999999999999999998 6666654 8999999999999999 7899999
Q ss_pred cCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCC------------------------------CCCcc---
Q 002094 332 NCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESM------------------------------QYPSF--- 378 (967)
Q Consensus 332 ~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~------------------------------~~~~~--- 378 (967)
.+.+|..||+|+|.|+ ..|..+....|+.|-+.||++.... .....
T Consensus 273 lLrsL~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~ 351 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDIS-SLPYSLGNLHLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLP 351 (565)
T ss_pred HhhhhhhhcccCCccc-cCCcccccceeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCC
Confidence 9999999999999999 5677777779999999999973200 00000
Q ss_pred ---cccccCCCCccEEEccCCcccCCCCCCccccc--ccchhcccccccccccCCCcCCcccccE-EEecCCcccccCcc
Q 002094 379 ---ASMKDSYQGLQVLDLSSNALSGVIPSNIGDLS--SLMLLNMSMNYLFGSIPASIGKLKAIQV-LDFSDNWLNGTIPP 452 (967)
Q Consensus 379 ---~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~~~~p~ 452 (967)
........+.+.|+++.-+++.++.+.|..-. -....+++.|++. ++|..+..++.+.+ +.+++|++. -+|.
T Consensus 352 ~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~ 429 (565)
T KOG0472|consen 352 SESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPL 429 (565)
T ss_pred CCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchH
Confidence 00111234578899999999966555554433 2778999999997 88998888887754 666666665 8899
Q ss_pred cccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCC
Q 002094 453 QIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHL 532 (967)
Q Consensus 453 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 532 (967)
.+..+++|..|+|++|.+. .+|..++.+..|+.||+|.|+|. .+|...-.+..|+.+-.++|++..+.|..+.+|.+|
T Consensus 430 ~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL 507 (565)
T KOG0472|consen 430 ELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNL 507 (565)
T ss_pred HHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhc
Confidence 9999999999999999998 89999999999999999999999 899999889999999999999998888889999999
Q ss_pred ceEEecCCcccccCCCCCCCCccCCCcccCCCC
Q 002094 533 LSFNISHNHLHGELPVGGFFNTISPSSVSGNPS 565 (967)
Q Consensus 533 ~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 565 (967)
..|||.+|.+....|.-+-...+...-+.|||.
T Consensus 508 ~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 508 TTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred ceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence 999999999996555555566666667788874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=347.25 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=215.0
Q ss_pred CCCCccCCCCceEEEEEEeCC--C---cEEEEEEeecC--CccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 685 NKDCELGRGGFGVVYRTILQD--G---RSVAIKKLTVS--GLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~--~---~~vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
...+.||+|+||.||+|+++. + ..||||..... .......+|.+|++++++++|||||+++|++......++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 345789999999999999553 2 23899998852 2355678999999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
||+|+||+|.++++.... .++..++..++.++|.||+|||+++++||||..+|+|++.++.+||+|||+++.-.. .
T Consensus 240 mEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~--~ 315 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ--Y 315 (474)
T ss_pred EEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc--e
Confidence 999999999999998765 389999999999999999999999999999999999999999999999999875431 1
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
........-...|+|||.+ ..+.+++++|||||||++||+++ |..||..+..... .. .+....+
T Consensus 316 ~~~~~~~klPirWLAPEtl-~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v--~~------------kI~~~~~ 380 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETL-NTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV--KA------------KIVKNGY 380 (474)
T ss_pred eeccccccCcceecChhhh-ccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH--HH------------HHHhcCc
Confidence 1111122345679999999 66699999999999999999999 8999986654311 11 1123345
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
+...+...+.++..++.+||..+|+.||||.++.+.++.+.+..+.
T Consensus 381 r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 381 RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 5666778888999999999999999999999999999998877653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.73 Aligned_cols=264 Identities=25% Similarity=0.343 Sum_probs=205.5
Q ss_pred ccCCCCccCCCCceEEEEEEeCC-----------------CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQD-----------------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 745 (967)
.|...+.||+|+||.||+|..++ +..||+|.+..........++.+|++++.+++||||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 46778899999999999998532 3369999987654344456899999999999999999999
Q ss_pred eEEEcCCceeEEEEecCCCchhhhhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Q 002094 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSS----------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLK 809 (967)
Q Consensus 746 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik 809 (967)
+++.+.+..++||||+++|+|.+++..... ...+++..+++++.||+.||+|||++||+|||||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlk 165 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcc
Confidence 999999999999999999999999864321 1236788999999999999999999999999999
Q ss_pred CCCEEeCCCCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc--CCCCCCC
Q 002094 810 STNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT--GKRPVEY 887 (967)
Q Consensus 810 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt--g~~p~~~ 887 (967)
|+||+++.++.+||+|||+++...............++..|+|||++ ..+.++.++||||||+++|||++ +..||..
T Consensus 166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI-LMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH-hcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 99999999999999999999765433322223344557789999988 55678999999999999999987 5667764
Q ss_pred CccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 888 MEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
.... .....+........ .......+..++..+.+++.+|++.||++|||+.|+.+.|++
T Consensus 245 ~~~~--~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 245 LTDE--QVIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCHH--HHHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 4322 11122222111110 001112244567789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=351.80 Aligned_cols=259 Identities=26% Similarity=0.389 Sum_probs=206.9
Q ss_pred ccCCCCccCCCCceEEEEEEe------CCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCcee
Q 002094 683 LLNKDCELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 755 (967)
.|+..+.||+|+||.||+|.. .++..||||+++........+.+.+|+++++.+ +||||+++++++...+..+
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 467889999999999999973 235689999997654444556789999999999 8999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCC------------------------------------------------------------
Q 002094 756 LIYEFISSGSLYKHLHDGSS------------------------------------------------------------ 775 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 775 (967)
+||||+++|+|.++++....
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 99999999999999865321
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 776 ------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 776 ------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
...+++..+.+++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++...........+.
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 275 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence 11378889999999999999999999999999999999999999999999999986643222222233
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
..++..|+|||.+ ....++.++||||||+++|||++ |..||.....+.. ..+++.. ..+...+.
T Consensus 276 ~~~~~~y~aPE~~-~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~~~~~-------------~~~~~~~~ 340 (375)
T cd05104 276 ARLPVKWMAPESI-FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKMIKE-------------GYRMLSPE 340 (375)
T ss_pred CCCCcceeChhHh-cCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHHHHHh-------------CccCCCCC
Confidence 4456679999998 56678999999999999999998 8999975433221 1122111 11112233
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
..+.++.+++.+|++.||++|||+.|++++|++.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 4456799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=334.89 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=203.0
Q ss_pred CCccCCCCceEEEEEEeCCCcEEEEEEeecCCccc--cHHHHHHHHHHHcCCCCCceeeeeeEEEc----CCceeEEEEe
Q 002094 687 DCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIK--SQEDFEKEMKTLGKIRHHNLVALEGYYWT----PSLQLLIYEF 760 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~ 760 (967)
...||+|++|.||+|.. +|+.||||++....... ..+.+.+|++++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 58999999997653211 14678899999999999999999999876 3467899999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
+++|+|.+++..... +++..+.+++.+++.|++|+|+. +++||||||+||+++.++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---- 176 (283)
T PHA02988 104 CTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---- 176 (283)
T ss_pred CCCCcHHHHHhhCCC---CChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----
Confidence 999999999986543 88999999999999999999985 9999999999999999999999999998765321
Q ss_pred ccccccccccccCcccccC-cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 840 LSSKIQSALGYMAPEFACR-TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~-~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.....++..|+|||.+.. ...++.++|||||||++|||++|+.||...... .....++. ...+.
T Consensus 177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-~~~~~i~~-------------~~~~~ 241 (283)
T PHA02988 177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-EIYDLIIN-------------KNNSL 241 (283)
T ss_pred -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHh-------------cCCCC
Confidence 123457788999999843 257899999999999999999999999754322 11111111 11122
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
..+..++..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 3444677889999999999999999999999999998865
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=351.11 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=207.1
Q ss_pred ccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCcee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 755 (967)
.|+..+.||+|+||.||+|+.. ++..||||++...........+.+|+++++.+ +|+|||++++++...+..+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 4688899999999999998742 34579999997655444556789999999999 8999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCC------------------------------------------------------------
Q 002094 756 LIYEFISSGSLYKHLHDGSS------------------------------------------------------------ 775 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 775 (967)
+||||+++|+|.++++....
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 99999999999999864211
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccccccc
Q 002094 776 -------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSAL 848 (967)
Q Consensus 776 -------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~ 848 (967)
...+++.++++++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...............++.
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~ 278 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcc
Confidence 1137888999999999999999999999999999999999999999999999997654322222222334566
Q ss_pred cccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHH
Q 002094 849 GYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIP 927 (967)
Q Consensus 849 ~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 927 (967)
.|+|||++ ....++.++|||||||++|||++ |+.||........ ....+ ........+...+.+
T Consensus 279 ~y~aPE~~-~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~-------------~~~~~~~~~~~~~~~ 343 (374)
T cd05106 279 KWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMV-------------KRGYQMSRPDFAPPE 343 (374)
T ss_pred ceeCHHHh-cCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHH-------------HcccCccCCCCCCHH
Confidence 79999998 56679999999999999999997 9999975433221 11111 111122223344677
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 928 VIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 928 l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
+.+++.+|++.||++|||+.+++++|+++.
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=325.99 Aligned_cols=261 Identities=23% Similarity=0.261 Sum_probs=202.9
Q ss_pred HhhccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-------------cccHHHHHHHHHHHcCCCCCceeeee
Q 002094 680 ANALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-------------IKSQEDFEKEMKTLGKIRHHNLVALE 745 (967)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-------------~~~~~~~~~E~~~l~~l~h~niv~~~ 745 (967)
+-+.|+..+.||+|.||.|-+|.. .+++.||||++.+... ....+.+.+|+.+++++.|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 345679999999999999999994 4689999999954321 11235899999999999999999999
Q ss_pred eEEEcC--CceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEE
Q 002094 746 GYYWTP--SLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKV 823 (967)
Q Consensus 746 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl 823 (967)
++..++ +..|+|+|||..|.+.+.-.... .++..++++++++++.||+|||.+|||||||||+|+|++++|+|||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~---els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKP---ELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcc---cccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 999765 67899999999887654432221 2889999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCcc---ccccccccccccccCcccccCc---ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHH
Q 002094 824 GDFGLARLLPMLDR---CILSSKIQSALGYMAPEFACRT---VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCD 897 (967)
Q Consensus 824 ~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~ 897 (967)
+|||.+...+.... ...-....|||.|+|||....+ ...+.+.||||+||+||.|+.|+.||-... ....+.
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-~~~l~~- 329 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-ELELFD- 329 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-HHHHHH-
Confidence 99999976632211 1112247899999999988552 235678999999999999999999994221 111111
Q ss_pred HHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 898 MVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
.++...+..+..++....+.++|++++++||++|.+..+|.......+
T Consensus 330 ------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 330 ------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred ------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 222333333333456778999999999999999999999877665443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=330.83 Aligned_cols=256 Identities=26% Similarity=0.362 Sum_probs=206.7
Q ss_pred hccCCCCccCCCCceEEEEEEeC----CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ----DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|+..+.||+|+||.||+|.++ .+..||+|.++..........+.+|+..+++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 34677889999999999999853 36789999998765444556799999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++|+|.+++..... .+++..++.++.|++.|++|||++|++||||||+||+++.++.++++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~- 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA- 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc-
Confidence 999999999999976432 38899999999999999999999999999999999999999999999999876432211
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
........++..|+|||.+ ....++.++||||||+++||+++ |+.||....... ..+.+ . ...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~----~---------~~~ 225 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAI-QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAV----E---------DGF 225 (266)
T ss_pred hhcccCCCCceeecCHHHH-hhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHH----H---------CCC
Confidence 1111123345679999988 56688999999999999999875 999997543321 11111 1 111
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
....+..++..+.+++.+||+.+|++|||++++.+.|+++
T Consensus 226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 2234556778899999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=329.93 Aligned_cols=248 Identities=27% Similarity=0.406 Sum_probs=209.8
Q ss_pred ccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..++||+|.||.||+|.. +.++.||+|++..+......+++++|+.++.+++++||.++|+.+..+...+++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 456678999999999999994 4689999999999887778899999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
.||++.+.++.... +.+..+.-+++++..|+.|+|.++.+|||||+.||++..+|.+|++|||.+..+.... ...
T Consensus 94 ~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--~rr 168 (467)
T KOG0201|consen 94 GGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--KRR 168 (467)
T ss_pred cCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh--hcc
Confidence 99999999976554 4677778899999999999999999999999999999999999999999998775422 233
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
..+.|||-|||||++ ....|+.|+||||+|++.+||.+|.+|+....... +.-.+-..-.+...
T Consensus 169 ~tfvGTPfwMAPEVI-~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------------vlflIpk~~PP~L~ 232 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVI-KQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------------VLFLIPKSAPPRLD 232 (467)
T ss_pred ccccccccccchhhh-ccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------------EEEeccCCCCCccc
Confidence 678899999999999 56689999999999999999999999997543311 11111111122233
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
......+.+++..|+++||+.||+|.++++
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 466777999999999999999999999875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=309.18 Aligned_cols=261 Identities=23% Similarity=0.253 Sum_probs=205.7
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCcc-ccHHHHHHHHHHHcCCCCCceeeeeeEEEc--CCceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVALEGYYWT--PSLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 759 (967)
|+..+.|++|+||.||+|+. ++++.||+|+++.+... .-.-...+|+.++.+++|||||.+-.+.+. -+..|+|||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 57778899999999999994 46899999999876532 123456899999999999999999888763 467899999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
||+. +|.+.++.... ++...++..++.|+++|++|||.+.|+|||+|++|+|++..|.+||+|||+|+.++.. ..
T Consensus 158 ~~Eh-DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~k 232 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--LK 232 (419)
T ss_pred HHHh-hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC--cc
Confidence 9987 89999987653 3889999999999999999999999999999999999999999999999999988643 33
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC---chhhcc---
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR---VEDCVD--- 913 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 913 (967)
..+...-|..|+|||.+.+...|+++.|+||+|||+.||+++++.|.+..+..+ +..++ ..+..+. +..+.+
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~~If-~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LDKIF-KLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HHHHH-HHhCCCccccCCCccccch
Confidence 455677789999999999999999999999999999999999999975443222 22222 2221111 111111
Q ss_pred -----------hhhcCCCChh-hHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 914 -----------ARLRGNFPAD-EAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 914 -----------~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..++..++.. ....-++++..++..||.+|.||+|.++
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1112222222 3466789999999999999999999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=339.13 Aligned_cols=240 Identities=26% Similarity=0.365 Sum_probs=202.1
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 759 (967)
|...++||+|.||+|+.+..+ +++.+|||.+++... .++.+....|.+++... +||.++.++.+|+.+++.++|||
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvme 449 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVME 449 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEE
Confidence 477889999999999999965 578999999998765 33456788888888777 59999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+.||++..+.+.. .+++..+.-+|..|+.||+|||++||||||+|.+|||+|.+|++||+|||+++.-. ....
T Consensus 450 y~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--~~g~ 523 (694)
T KOG0694|consen 450 YVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--GQGD 523 (694)
T ss_pred ecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC--CCCC
Confidence 99999944443322 28999999999999999999999999999999999999999999999999997543 2233
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
..+...|||.|+|||++ .+..|+.++|+|||||+||||+.|..||...+++ ..+..++.. ...
T Consensus 524 ~TsTfCGTpey~aPEil-~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-e~FdsI~~d---------------~~~ 586 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVL-TEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-EVFDSIVND---------------EVR 586 (694)
T ss_pred ccccccCChhhcChhhh-ccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcC---------------CCC
Confidence 56688999999999999 7779999999999999999999999999755443 222222211 234
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDM 946 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~ 946 (967)
||...+.+...++++++.++|++|.-+
T Consensus 587 yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCcccHHHHHHHHHHhccCcccccCC
Confidence 788889999999999999999999865
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=335.85 Aligned_cols=247 Identities=25% Similarity=0.340 Sum_probs=209.3
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|..++.||+|+.|.|-.|++ .+|+.+|||++..... ......+.+|+-+|+.+.||||+++++++....+.|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 67788999999999999994 4799999999976521 23456799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++||-|++++-..+. +++.++.++++||+.|+.|+|..+|+|||+||+|+++|..+.+||+|||+|..... ...
T Consensus 94 v~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---gkl 167 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP---GKL 167 (786)
T ss_pred cCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC---Ccc
Confidence 999999999987665 88999999999999999999999999999999999999999999999999976532 223
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
-....|+|.|.|||++++...-+.++||||.|||+|.|++|+.||+.. ....+.. .+..+ .-++
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--Nir~LLl----KV~~G----------~f~M 231 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--NIRVLLL----KVQRG----------VFEM 231 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--cHHHHHH----HHHcC----------cccC
Confidence 345779999999999966666788999999999999999999999732 2222111 11111 2235
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
|...+.++++|+.+|+..||++|.|++||++.
T Consensus 232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 77888899999999999999999999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=298.28 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=213.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+.++.||+|-||.||.|+.+ ++..||+|++.+.+. ..-..++.+|+++-+.++||||.+++++|.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 34688999999999999999954 678999999977654 234578999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||...|++...+....... +++.....++.|+|.|+.|+|.++|+||||||+|+|++.++..|++|||.+...+ .
T Consensus 102 Eya~~gel~k~L~~~~~~~-f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~ 176 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKR-FDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----S 176 (281)
T ss_pred EecCCchHHHHHHhccccc-ccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC----C
Confidence 9999999999999665544 8888999999999999999999999999999999999999999999999998653 3
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......||.-|.|||+. ++...+.++|+|++|++.||++.|.+||+.... ...+.++.+ .+-
T Consensus 177 ~kR~tlcgt~dyl~pEmv-~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI~k---------------~~~ 239 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMV-EGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRIRK---------------VDL 239 (281)
T ss_pred CCceeeecccccCCHhhc-CCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHHHH---------------ccc
Confidence 344567899999999998 777899999999999999999999999985542 222222221 123
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.+|...+..+.++|.+|+..+|.+|.+..|+++.
T Consensus 240 ~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 4567777889999999999999999999998763
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=344.32 Aligned_cols=262 Identities=24% Similarity=0.337 Sum_probs=209.2
Q ss_pred hccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCce
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 754 (967)
+.|+..+.||+|+||.||+|+.. .+..||||++.........+.+.+|+++++++. |||||++++++.+.+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 45678899999999999999853 234799999976554445578999999999996 99999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCC-----------------------------------------------------------
Q 002094 755 LLIYEFISSGSLYKHLHDGSS----------------------------------------------------------- 775 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 775 (967)
++||||+++|+|.++++....
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 999999999999998865321
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCe
Q 002094 776 ----------------------------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEP 821 (967)
Q Consensus 776 ----------------------------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~ 821 (967)
...+++..+..++.|++.|++|||+.+|+||||||+||+++.++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~ 276 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIV 276 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEE
Confidence 1136788889999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHH
Q 002094 822 KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVR 900 (967)
Q Consensus 822 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 900 (967)
||+|||+++...............+++.|+|||.+ ....++.++|||||||++|||++ |..||.....+.... ..+.
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~-~~~~ 354 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI-FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY-NKIK 354 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH-HHHh
Confidence 99999999765432222223344567789999988 55678999999999999999997 999997543321111 1111
Q ss_pred hhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 901 GALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
...+...+...+.++.+++.+|++.||++|||+.++.++|+++.+
T Consensus 355 -------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 355 -------------SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -------------cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111222344567789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.22 Aligned_cols=256 Identities=29% Similarity=0.438 Sum_probs=208.6
Q ss_pred ccCCCCccCCCCceEEEEEEeCC----CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQD----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
.|+..+.||+|+||.||+|.++. ...||||.+..........++.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 36788999999999999999642 45799999876554455678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++++|.+++..... .+++..+.+++.|++.|++|||+++|+||||||+||++++++.++++|||++.........
T Consensus 85 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 85 EYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred EcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 99999999999976443 3899999999999999999999999999999999999999999999999999876422222
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.......++..|+|||.. ....++.++||||||+++|||++ |..||....... ..+.+.. ..+
T Consensus 163 ~~~~~~~~~~~y~~Pe~~-~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~-------------~~~ 226 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAVED-------------GYR 226 (266)
T ss_pred eeccCCCCCccccChhhh-ccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHHHc-------------CCC
Confidence 222233445789999988 55678999999999999999998 999996443221 1111111 111
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
.+.+.+.+..+.+++.+|++.+|++||+++|++++|+++
T Consensus 227 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 123445667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.15 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=208.4
Q ss_pred cCCCCccCCCCceEEEEEEeCC------CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQD------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
|+..+.||+|+||.||+|.... ...||+|.+..........++.+|++.+++++||||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 5778899999999999998542 2579999987655444556799999999999999999999999988899999
Q ss_pred EEecCCCchhhhhhcCCCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEe
Q 002094 758 YEFISSGSLYKHLHDGSSR-------------NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVG 824 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~-------------~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~ 824 (967)
|||+++++|.+++...... ..+++..+..++.|++.|++|||+++++||||||+||+++.++.++|+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~ 166 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKIS 166 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEEC
Confidence 9999999999999754221 237889999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhh
Q 002094 825 DFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGAL 903 (967)
Q Consensus 825 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 903 (967)
|||++................+++.|+|||.+ ....++.++|||||||++|||++ |..||...... ...+.+.
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~~i~--- 240 (283)
T cd05048 167 DFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI-LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIEMIR--- 240 (283)
T ss_pred CCcceeeccccccccccCCCcccccccCHHHh-ccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH---
Confidence 99999765432222233344567889999988 55678999999999999999998 99999644322 1111111
Q ss_pred ccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 904 EDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
.......+..++.++.+++.+|++.||.+||+++|+++.|+.+
T Consensus 241 ----------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 241 ----------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ----------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1112234566778899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.74 Aligned_cols=250 Identities=34% Similarity=0.550 Sum_probs=198.8
Q ss_pred CCccCCCCceEEEEEEeC-----CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 687 DCELGRGGFGVVYRTILQ-----DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.+.||+|.||.||+|.+. .+..|+||.+.........+.+.+|++.+++++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999976 367899999976554455789999999999999999999999999888899999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++|+|.++++..... .+++..++.|+.||++||+|||+++++|+||+++||+++.++.+||+|||++............
T Consensus 84 ~~g~L~~~L~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~ 162 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKE-PLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKND 162 (259)
T ss_dssp TTEBHHHHHHHTCTT-TSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEES
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999987322 2899999999999999999999999999999999999999999999999999876322233333
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
........|+|||.+ ....++.++||||||+++||+++ |+.||....... ..+.+ ....+...
T Consensus 163 ~~~~~~~~~~aPE~~-~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--~~~~~-------------~~~~~~~~ 226 (259)
T PF07714_consen 163 SSQQLPLRYLAPEVL-KDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--IIEKL-------------KQGQRLPI 226 (259)
T ss_dssp TTSESGGGGS-HHHH-HHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--HHHHH-------------HTTEETTS
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccc--ccccc-------------ccccccee
Confidence 445567789999998 55668999999999999999999 789987553321 11111 11122334
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 953 (967)
+..++..+.+++.+||+.||++|||++++++.|
T Consensus 227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 556677899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.84 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=200.8
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCch
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSL 766 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 766 (967)
+.||+|+||.||+|... +++.||+|.+......+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999964 68999999886554344567899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccccc
Q 002094 767 YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQS 846 (967)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 846 (967)
.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+|++|||.+.................
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 999975432 378999999999999999999999999999999999999999999999999875432111111112223
Q ss_pred cccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhH
Q 002094 847 ALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEA 925 (967)
Q Consensus 847 t~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (967)
+..|+|||.+ ..+.++.++||||+|+++|||++ |..||....... .... .........+...+
T Consensus 159 ~~~y~aPE~~-~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~-------------~~~~~~~~~~~~~~ 222 (252)
T cd05084 159 PVKWTAPEAL-NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREA-------------IEQGVRLPCPELCP 222 (252)
T ss_pred ceeecCchhh-cCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHH-------------HHcCCCCCCcccCC
Confidence 4569999988 56678999999999999999998 999986443211 1111 11111223445567
Q ss_pred HHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 926 IPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 926 ~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
..+.+++.+|++.+|++|||+.|+.++|++
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=336.37 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=218.4
Q ss_pred CCCCccCCCCceEEEEEEe-CC----CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 685 NKDCELGRGGFGVVYRTIL-QD----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~-~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
..+++||+|+||+||+|.+ .+ .-+||+|++......+...++.+|+-+|.+++|||+++++|+|.... ..+|++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 5678999999999999994 33 34799999988877777889999999999999999999999997665 789999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|++.|.|.++++..+.. +.....+.|..|||+||.|||++++|||||-++|||+.+-..+|+.|||+++.....+...
T Consensus 778 ~mP~G~LlDyvr~hr~~--igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDN--IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred hcccchHHHHHHHhhcc--ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 99999999999886543 7888999999999999999999999999999999999999999999999999887655554
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
....-.-.+.|+|-|.+ ....+|.++|||||||++||++| |..|++....++ +.+.++...|-
T Consensus 856 ~~~~gK~pikwmale~i-~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------------I~dlle~geRL 919 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESI-RIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------------IPDLLEKGERL 919 (1177)
T ss_pred cccccccCcHHHHHHHh-hccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------------hhHHHhccccC
Confidence 44444445679999988 67789999999999999999999 999997655432 23344444455
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
+-|+.++.++..++.+||..|++.||+++++...+.++-.
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 6688999999999999999999999999999998877654
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.42 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=207.0
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCc----EEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
.|+..+.||+|+||.||+|++. ++. .||+|.+.........+++.+|+.+++.++||||+++++++... ..++|
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v 86 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 86 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceee
Confidence 3688899999999999999854 333 48999987554444567899999999999999999999998764 57799
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
+||+++|+|.+++..... .+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 87 TQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred eecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 999999999999986543 278899999999999999999999999999999999999999999999999987654333
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
........++..|+|||++ ....++.++||||||+++|||++ |+.||+...... ...+.. ...
T Consensus 165 ~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~-------------~~~ 228 (316)
T cd05108 165 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILE-------------KGE 228 (316)
T ss_pred ceeccCCccceeecChHHh-ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHh-------------CCC
Confidence 2222233346789999988 56678999999999999999998 999997543221 111111 111
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
....+..++.++.+++.+|++.+|++|||+.+++..+.++...
T Consensus 229 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 229 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 2223445667799999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.83 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=201.2
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||+|.. .+|+.||||.+..... ......+.+|++++++++|++|+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 45678899999999999985 4789999999875432 22345678999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++|+|.+++...... .+++..+..++.|++.|++|||+++|+||||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~~g~L~~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---T 157 (285)
T ss_pred cCCCcHHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---e
Confidence 9999999888654322 38899999999999999999999999999999999999999999999999997653321 1
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....|+..|+|||++ ....++.++||||+||++|||++|+.||........ ... +...+. .....+
T Consensus 158 ~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~-~~~~~~----------~~~~~~ 224 (285)
T cd05631 158 VRGRVGTVGYMAPEVI-NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REE-VDRRVK----------EDQEEY 224 (285)
T ss_pred ecCCCCCCCccCHhhh-cCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHH-HHHHhh----------cccccC
Confidence 2345689999999998 566889999999999999999999999975433211 001 111110 011234
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPD-----MEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~ 951 (967)
+...+..+.+++.+|++.||++||+ ++++++
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 4556678999999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.81 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=207.4
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+.|+..++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3467788999999999999998888899999886543 34578999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.++++..... .+++..+..++.|++.|++|||+.+++||||||+||+++.++.++|+|||.+........ ...
T Consensus 84 ~~~~L~~~l~~~~~~-~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 161 (261)
T cd05072 84 AKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAR 161 (261)
T ss_pred CCCcHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-ecc
Confidence 999999999764333 378899999999999999999999999999999999999999999999999986643221 112
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....++..|+|||+. ....++.++||||||+++|||++ |+.||....... ....+... .+.+.
T Consensus 162 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~-------------~~~~~ 225 (261)
T cd05072 162 EGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRG-------------YRMPR 225 (261)
T ss_pred CCCccceecCCHHHh-ccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcC-------------CCCCC
Confidence 233456789999988 55678899999999999999998 999996543221 11111111 11122
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
....+.++.+++.+|++.+|++||+++++.++|+++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 234566799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=329.00 Aligned_cols=255 Identities=25% Similarity=0.381 Sum_probs=219.2
Q ss_pred cCCCCccCCCCceEEEEEEeCC---C--cEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQD---G--RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+...+.||+|.||.||+|++.+ | -.||||.-+.+...++.+.|.+|+.+|+.++|||||+++|+|.+. ..|+||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 4556789999999999999542 3 358899998887778889999999999999999999999999764 679999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
|.++-|.|.++++..... ++......++.||+.||+|||+..+|||||..+|||+.+..-||++|||+++.+.+...+
T Consensus 470 EL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred ecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 999999999999876554 888899999999999999999999999999999999999999999999999998775444
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
... ...-...|||||-+ .-.++|.++|||.|||.+||++. |..||...+.... --.++.+-|
T Consensus 548 kaS-~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV---------------I~~iEnGeR 610 (974)
T KOG4257|consen 548 KAS-RGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV---------------IGHIENGER 610 (974)
T ss_pred hcc-ccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccce---------------EEEecCCCC
Confidence 333 34445679999998 77899999999999999999998 9999975443321 122334456
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.+.|+.|+..++.++.+||..||.+||++.|+...|.++.+
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 67899999999999999999999999999999999998875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=322.66 Aligned_cols=249 Identities=31% Similarity=0.443 Sum_probs=202.2
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
|+..+.||+|+||.||++..+++..+|+|.+.... ...+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 56678899999999999999888899999886443 3456789999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|.++++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||.+........ .....
T Consensus 84 ~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~ 160 (256)
T cd05114 84 GCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSG 160 (256)
T ss_pred CcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-eccCC
Confidence 999999875433 378999999999999999999999999999999999999999999999999876532111 11223
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
..++..|+|||.. ....++.++|+||||+++|||++ |+.||...... .. ...+. .. .+...+.
T Consensus 161 ~~~~~~y~aPE~~-~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-~~-~~~i~---~~----------~~~~~~~ 224 (256)
T cd05114 161 AKFPVKWSPPEVF-NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EV-VEMIS---RG----------FRLYRPK 224 (256)
T ss_pred CCCchhhCChhhc-ccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-HH-HHHHH---CC----------CCCCCCC
Confidence 3455679999998 55678899999999999999999 99999654322 11 11111 10 0111233
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 953 (967)
..+..+.+++.+|++.+|++||+++|+++.|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 3456799999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=328.60 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=201.7
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||.||+|..+ +++.||+|.++..........+.+|++++++++||||+++++++..++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 3677889999999999999965 688999999976543344567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++ +|.+++..... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 86 ~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~~ 160 (288)
T cd07871 86 DS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTY 160 (288)
T ss_pred Cc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--ccc
Confidence 85 89988865432 37889999999999999999999999999999999999999999999999987543211 122
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch------------
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE------------ 909 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------ 909 (967)
....+++.|+|||.+.+...++.++||||+||++|||++|+.||....... .+..+.. ....+...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFR-LLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HhCCCChHHhhccccchhhh
Confidence 345678899999988555678999999999999999999999997543321 1111111 11111000
Q ss_pred hhcchhhcCC----CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 910 DCVDARLRGN----FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 910 ~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+..+.. .....+.+..+++.+|++.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000 01234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.14 Aligned_cols=251 Identities=23% Similarity=0.250 Sum_probs=201.4
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||.|+.+ +|..+|+|++++... ....+.+..|-.+|....+|.||+++-.|++....|+|||
T Consensus 142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME 221 (550)
T KOG0605|consen 142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME 221 (550)
T ss_pred cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence 4577889999999999999965 599999999987654 3456788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC----
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML---- 835 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~---- 835 (967)
|++||++..+|..... +++..+..++.+++-|++.+|+.|+|||||||+|+|||..|++||+|||++.-....
T Consensus 222 ylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 222 YLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred ecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 9999999999987655 899999999999999999999999999999999999999999999999998433110
Q ss_pred ------------------ccc----cc-------------------cccccccccccCcccccCcccCCcccchhhHHHH
Q 002094 836 ------------------DRC----IL-------------------SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVL 874 (967)
Q Consensus 836 ------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvl 874 (967)
+.. .. .....|||-|+|||++. +..++..+|+||+|||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll-~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL-GKGYGKECDWWSLGCI 377 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh-cCCCCccccHHHHHHH
Confidence 000 00 01255999999999994 4469999999999999
Q ss_pred HHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCC---HHHHH
Q 002094 875 VLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPD---MEEVV 950 (967)
Q Consensus 875 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~evl 950 (967)
+|||+.|.+||...... ..+..++..... +..+-......+..++|.+|+. ||++|.- ++||.
T Consensus 378 myEmLvGyPPF~s~tp~-~T~rkI~nwr~~-----------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQ-ETYRKIVNWRET-----------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHHhCCCCCCCCCHH-HHHHHHHHHhhh-----------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 99999999999755443 333333322111 1111223345789999999999 9999975 55543
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=327.67 Aligned_cols=269 Identities=26% Similarity=0.343 Sum_probs=208.2
Q ss_pred cCCCCccCCCCceEEEEEEe-----CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--CceeE
Q 002094 684 LNKDCELGRGGFGVVYRTIL-----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP--SLQLL 756 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 756 (967)
|+..+.||+|+||+||++.. .+++.||+|.+.........+.+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47788999999999988652 357899999987654334567789999999999999999999988653 45789
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
||||+++++|.+++... .+++..+..++.|++.|++|||+++|+||||||+||+++.++.++|+|||++.......
T Consensus 86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 99999999999999753 28999999999999999999999999999999999999999999999999998664322
Q ss_pred cccc-cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 837 RCIL-SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 837 ~~~~-~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
.... .....++..|+|||.. ....++.++||||||+++|||++|+.||........................+..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECL-KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hhhccCCCCCCCceeeCHhHh-cccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 2111 1223345669999988 5567899999999999999999999998643322111111111111111222223333
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
.....+...+.++.+++.+|++.+|++|||+++++++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 333445667788999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=326.83 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=205.7
Q ss_pred cCCCCccCCCCceEEEEEEe-----CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 684 LNKDCELGRGGFGVVYRTIL-----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
|+..+.||+|+||.||+|.. .++..||+|.+..........++.+|++++++++||||+++++++..+...++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 46678899999999999984 2467899999976543444568999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEe
Q 002094 759 EFISSGSLYKHLHDGSS--------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVG 824 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~ 824 (967)
||+++++|.+++..... ...+++.++..++.|++.||+|||++|++||||||+||++++++.+||+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKIS 166 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEec
Confidence 99999999999863321 1237888999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhh
Q 002094 825 DFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGAL 903 (967)
Q Consensus 825 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 903 (967)
|||++................++..|+|||+. ....++.++||||||+++|||++ |..||...... ...+.+..
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~-- 241 (283)
T cd05090 167 DLGLSREIYSADYYRVQPKSLLPIRWMPPEAI-MYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVIEMVRK-- 241 (283)
T ss_pred cccccccccCCcceecccCCCccceecChHHh-ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc--
Confidence 99999765432222223344456789999988 55678999999999999999998 99998644321 11122211
Q ss_pred ccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 904 EDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
......+...+.++.+++.+|++.||++||++.++.++|+.
T Consensus 242 -----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 -----------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -----------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11112344566789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=323.03 Aligned_cols=253 Identities=27% Similarity=0.409 Sum_probs=206.6
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+..+.||+|++|.||+|..+ .++.||+|.+.... ...+++.+|++++++++|+||+++++++...+..++||||++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 466788999999999999965 58899999887543 345678999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.+++...... .+++..+..++.|++.|++|||++|++||||||+||++++++.+||+|||.+........ ....
T Consensus 86 ~~~L~~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~ 163 (263)
T cd05052 86 YGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHA 163 (263)
T ss_pred CCcHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-eccC
Confidence 99999999764432 388999999999999999999999999999999999999999999999999976643211 1112
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
...+++.|+|||.. ....++.++||||||+++|||++ |..||.....+. ....+ ....+...+
T Consensus 164 ~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~-------------~~~~~~~~~ 227 (263)
T cd05052 164 GAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELL-------------EKGYRMERP 227 (263)
T ss_pred CCCCccccCCHHHh-ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH-------------HCCCCCCCC
Confidence 23345679999988 56678999999999999999998 999987543221 11111 111223345
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
...+.++.+++.+|++.+|++|||+.++.++|+.+
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 56678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=310.22 Aligned_cols=268 Identities=25% Similarity=0.329 Sum_probs=209.3
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCc-eeeeeeEEEcCC------ce
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHN-LVALEGYYWTPS------LQ 754 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------~~ 754 (967)
|...+.||+|+||+||+|+. .+|+.||+|+++.... +.......+|+.++++++|+| ||++++++.... ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 45566799999999999994 4789999999987754 234456799999999999999 999999998776 77
Q ss_pred eEEEEecCCCchhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSR-NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
++||||++. +|..++...... ...+...+..++.||++|++|+|+++|+||||||.||+++++|.+||+|||+|+...
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 899999976 999999876532 236678899999999999999999999999999999999999999999999999665
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcc
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (967)
... ...+...+|..|+|||++.+...|+...||||+||+++||+++++.|....+. ..+..+ ...+..+....+..
T Consensus 172 ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~I-f~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 172 IPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRI-FRLLGTPNEKDWPG 247 (323)
T ss_pred CCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHH-HHHcCCCCccCCCC
Confidence 322 23557778889999999988888999999999999999999999999765542 222222 22332221111111
Q ss_pred ----hhhcCCCC------------hhhHHHHHHHHHhhccCCCCCCCCHHHHHHH--HHhh
Q 002094 914 ----ARLRGNFP------------ADEAIPVIKLGLICASQVPSNRPDMEEVVNI--LELI 956 (967)
Q Consensus 914 ----~~~~~~~~------------~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~~ 956 (967)
+.....++ +.......+++.+|++.+|.+|.|++.++.. +..+
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11111111 1112468899999999999999999999886 5444
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.20 Aligned_cols=242 Identities=23% Similarity=0.308 Sum_probs=197.6
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSG 764 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 764 (967)
+.||+|+||.||++..+ +|+.||+|++..... ......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999854 689999999975432 233456788999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccc
Q 002094 765 SLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI 844 (967)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 844 (967)
+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.... ........
T Consensus 81 ~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRERV---FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTF 155 (323)
T ss_pred cHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccce
Confidence 99999876543 78999999999999999999999999999999999999999999999999875322 11122345
Q ss_pred cccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhh
Q 002094 845 QSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADE 924 (967)
Q Consensus 845 ~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (967)
.||+.|+|||++ ....++.++||||+||++|||++|+.||...... .....+.. . ...++...
T Consensus 156 ~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~~~~-----~----------~~~~p~~~ 218 (323)
T cd05571 156 CGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILM-----E----------EIRFPRTL 218 (323)
T ss_pred ecCccccChhhh-cCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-HHHHHHHc-----C----------CCCCCCCC
Confidence 689999999998 5667899999999999999999999999643322 11111110 0 11234556
Q ss_pred HHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 925 AIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 925 ~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
+.++.+++.+|++.||++|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 67799999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=335.27 Aligned_cols=262 Identities=27% Similarity=0.399 Sum_probs=206.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcC-Cc
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTP-SL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~ 753 (967)
+.|+..+.||+|+||.||+|... +++.||+|+++........+.+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 34688899999999999999732 35789999987654334456788899999999 899999999988654 56
Q ss_pred eeEEEEecCCCchhhhhhcCCC----------------------------------------------------------
Q 002094 754 QLLIYEFISSGSLYKHLHDGSS---------------------------------------------------------- 775 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 775 (967)
.+++|||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999999864321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccccccccccCccc
Q 002094 776 RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEF 855 (967)
Q Consensus 776 ~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 855 (967)
...+++..+.+++.||+.||+|||++||+||||||+||+++.++.++|+|||++................++..|+|||+
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 11478999999999999999999999999999999999999999999999999987643222223334456678999998
Q ss_pred ccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHh
Q 002094 856 ACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLI 934 (967)
Q Consensus 856 ~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 934 (967)
+ ....++.++||||+||++|||++ |..||....... .+...+.. ..+...+.....++.+++.+
T Consensus 247 ~-~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~-------------~~~~~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 247 I-FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKE-------------GTRMRAPEYATPEIYSIMLD 311 (337)
T ss_pred h-cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhc-------------cCCCCCCccCCHHHHHHHHH
Confidence 8 56689999999999999999998 999996433221 11111111 11112234455679999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhhcC
Q 002094 935 CASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 935 cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
|++.+|++||++.|++++|+++.+
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=326.92 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=207.2
Q ss_pred cCCCCccCCCCceEEEEEEeCC------CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQD------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
|...+.||+|+||.||+|...+ ++.||||.+......+..+.+.+|++++++++|+||+++++++......++|
T Consensus 7 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 86 (280)
T cd05049 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMV 86 (280)
T ss_pred hhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEE
Confidence 5667889999999999998643 4789999987665444567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeec
Q 002094 758 YEFISSGSLYKHLHDGSS-----------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDF 826 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Df 826 (967)
|||+++++|.++++.... ...+++..+..++.|++.|++|||++|++||||||+||+++.++.++|+||
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~ 166 (280)
T cd05049 87 FEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDF 166 (280)
T ss_pred EecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCc
Confidence 999999999999975431 124788999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhcc
Q 002094 827 GLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALED 905 (967)
Q Consensus 827 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 905 (967)
|.+................+++.|+|||++ ....++.++||||+|+++|||++ |..||....... ..+.+. .
T Consensus 167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~~----~ 239 (280)
T cd05049 167 GMSRDVYTTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECIT----Q 239 (280)
T ss_pred ccceecccCcceecCCCCcccceecChhhh-ccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHH----c
Confidence 998755332222223344567789999998 56678999999999999999998 999986443321 111111 1
Q ss_pred CCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 906 GRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
......+...+..+.+++.+|++.||++|||++|+++.|++
T Consensus 240 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 240 ---------GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ---------CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11112234566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=325.60 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=204.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
+.|+..+.||+|+||.||+|..+ .+..||||++..........++.+|+.+++.++||||+++++++.+....+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 44688899999999999998753 356799999865443334567899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccc
Q 002094 756 LIYEFISSGSLYKHLHDGSS-------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGL 828 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~ 828 (967)
+||||+++++|.+++..... ....++..+..++.|++.|++|||+.+++||||||+||++++++.++++|||+
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCC
Confidence 99999999999999875332 12367889999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCC
Q 002094 829 ARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGR 907 (967)
Q Consensus 829 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (967)
+................+++.|+|||.+ ....++.++||||||+++|||++ |..||...... . ....+ . ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-~-~~~~~---~-~~- 237 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-Q-VLRFV---M-EG- 237 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHh-hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-H-HHHHH---H-cC-
Confidence 8755432222222233456789999998 56678999999999999999999 78898644322 1 11111 1 00
Q ss_pred chhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
.....+...+..+.+++.+|++.||++|||+.|+++.|++
T Consensus 238 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 --------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0112344556779999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=329.66 Aligned_cols=264 Identities=23% Similarity=0.313 Sum_probs=201.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|..+ +++.||||++...........+.+|+++++.++||||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 44688899999999999999965 68899999997654334455678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++ ++|.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 85 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 159 (303)
T cd07869 85 VH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HT 159 (303)
T ss_pred CC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--cc
Confidence 96 578777765432 37889999999999999999999999999999999999999999999999987543211 12
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh---------
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC--------- 911 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 911 (967)
.....+++.|+|||.+.....++.++||||+||++|||++|+.||....+....+...... ........+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV-LGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHH-hCCCChhhccchhhcccc
Confidence 2345678899999988555668899999999999999999999997654432322222211 111000000
Q ss_pred cchhhcCCCC---------hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 912 VDARLRGNFP---------ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 912 ~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.........+ ...+..+.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000 012346789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=321.40 Aligned_cols=254 Identities=29% Similarity=0.412 Sum_probs=206.8
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.|+..+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 357788999999999999998778899999987543 345679999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.+++..... ..+++..+..++.|++.|++|||++|++||||||+||++++++.++|+|||++........ ....
T Consensus 85 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 162 (261)
T cd05068 85 YGSLLEYLQGGAG-RALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EARE 162 (261)
T ss_pred CCcHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-cccC
Confidence 9999999976542 2389999999999999999999999999999999999999999999999999986642111 1111
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....+..|+|||+. ....++.++|+||||+++|||++ |+.||...... .....+. .......+
T Consensus 163 ~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~--------------~~~~~~~~ 226 (261)
T cd05068 163 GAKFPIKWTAPEAA-LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-EVLQQVD--------------QGYRMPCP 226 (261)
T ss_pred CCcCceeccCcccc-ccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHH--------------cCCCCCCC
Confidence 22234579999988 56678999999999999999999 99999654322 1111111 11112234
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
...+..+.+++.+|++.+|++||+++++++.|+++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 45667899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=315.07 Aligned_cols=257 Identities=24% Similarity=0.344 Sum_probs=197.1
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCc-----eeEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSL-----QLLI 757 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~~lv 757 (967)
|...+++|.|+||.||+|+.. ++..||||+.-.+.. .-.+|+.+|+.++|||||++.-+|..... ..+|
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 567789999999999999955 479999999865542 23578999999999999999988864322 2489
Q ss_pred EEecCCCchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC-CCeEEeecccccccCCC
Q 002094 758 YEFISSGSLYKHLHDGSS-RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS-GEPKVGDFGLARLLPML 835 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~-~~~kl~Dfg~a~~~~~~ 835 (967)
||||+. +|.+.++.... ...++.-.+.-+.+||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+.....
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 999987 89999885311 1236777788899999999999999999999999999999965 89999999999987543
Q ss_pred ccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh----
Q 002094 836 DRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC---- 911 (967)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 911 (967)
.. ......|--|+|||.+.+...||.+.||||.||++.||+-|++-|.+... ...+..+++ .+..+.-+++
T Consensus 180 ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik-~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 180 EP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIK-VLGTPTREDIKSMN 254 (364)
T ss_pred CC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHH-HhCCCCHHHHhhcC
Confidence 32 34455566699999999999999999999999999999999999976332 222333332 2222211111
Q ss_pred ------cchhhcC-----CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 912 ------VDARLRG-----NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 912 ------~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+.+.. -+....+.+..+++.+++..+|.+|.++.|++.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111111 133456778999999999999999999999874
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=310.99 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=205.5
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecC-CccccHHHHHHHHHHHcCCCCCceeeeeeEEEc-----CCceeE
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVS-GLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT-----PSLQLL 756 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~l 756 (967)
|...+.||+|+||.|+.+.. .+|+.||||++... ......++..+|+++++.++|+||+.+.+.+.. -...|+
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi 103 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL 103 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence 45567899999999999994 47899999999733 224567889999999999999999999998864 356799
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
|+|+| +.+|.+.++..+. ++..++.-++.|+++||.|+|+.+|+|||+||+|++++.+...||+|||+|+......
T Consensus 104 V~elM-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 104 VFELM-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred ehhHH-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99999 4599999987665 8899999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC----------
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG---------- 906 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 906 (967)
.....+....|-.|+|||.......||.+.||||.|||++||++|++.|.+.+.-.+ .+.+...+..+
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q--l~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ--LQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH--HHHHHHhcCCCCHHHHHHhcc
Confidence 233335566788899999998888999999999999999999999999975443222 11111111111
Q ss_pred -Cchhhcchhh-cCC-----CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 907 -RVEDCVDARL-RGN-----FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 907 -~~~~~~~~~~-~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+.+-. ... .-+.......+++.+|+..||.+|+|++|+++
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111111100 000 01245667899999999999999999999976
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=327.47 Aligned_cols=257 Identities=28% Similarity=0.406 Sum_probs=223.0
Q ss_pred CCCCccCCCCceEEEEEEeCC-CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 685 NKDCELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
....+||-|.||.||.|+|+. .-.||||.++.+. ...++|..|+.+|+.++|||+|+++|+|..+..+|||.|||..
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 556789999999999999874 5679999998765 5678999999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|.+|+++..... ++.--.+.+|.||+.|++||..+.+||||+..+|+|++++..||++|||+++.+.. +.+..+..
T Consensus 348 GNLLdYLRecnr~e-v~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg-DTYTAHAG 425 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSE-VPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG-DTYTAHAG 425 (1157)
T ss_pred ccHHHHHHHhchhh-cchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC-CceecccC
Confidence 99999998865543 66677789999999999999999999999999999999999999999999998865 44444445
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
......|.|||-+ ....++.|+|||+|||++||+.| |-.||...+.. ++.++++..++...|+
T Consensus 426 AKFPIKWTAPEsL-AyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS---------------qVY~LLEkgyRM~~Pe 489 (1157)
T KOG4278|consen 426 AKFPIKWTAPESL-AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------------QVYGLLEKGYRMDGPE 489 (1157)
T ss_pred ccCcccccCcccc-cccccccchhhHHHHHHHHHHHhcCCCCCCCccHH---------------HHHHHHhccccccCCC
Confidence 5566789999987 56678999999999999999999 88998755432 2234556677888899
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 961 (967)
.|+..+++||+.||+..|..||++.|+-+.++.+.+.-.
T Consensus 490 GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 490 GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 999999999999999999999999999999988765543
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=326.23 Aligned_cols=264 Identities=26% Similarity=0.395 Sum_probs=210.6
Q ss_pred ccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLL 756 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 756 (967)
.|...+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 3577889999999999999842 34568999886543 2345679999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeec
Q 002094 757 IYEFISSGSLYKHLHDGSS----------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDF 826 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Df 826 (967)
||||+++++|.+++..... ...+++..++.++.|++.||+|||++|++||||||+||++++++.++|+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccC
Confidence 9999999999999975431 123899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhcc
Q 002094 827 GLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALED 905 (967)
Q Consensus 827 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 905 (967)
|.+................+++.|+|||.+ ....++.++|+||||+++|||++ |..||....... ....+ ..
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~i-----~~ 237 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIECI-----TQ 237 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH-----Hc
Confidence 999765432222223334456789999988 55678999999999999999998 999986543321 11111 11
Q ss_pred CCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCc
Q 002094 906 GRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQ 963 (967)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~ 963 (967)
+. ....+...+.++.+++.+|++.||.+|||++|+.+.|+++.+..+..
T Consensus 238 ~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~~ 286 (288)
T cd05093 238 GR---------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVY 286 (288)
T ss_pred CC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcccc
Confidence 11 11123345567999999999999999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=323.28 Aligned_cols=258 Identities=27% Similarity=0.364 Sum_probs=203.6
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCc----EEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
.|+..+.||+|+||.||+|.+. +++ .|++|.+..........++..|+..+++++||||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 3577889999999999999964 344 4777877544323344678888999999999999999998754 457889
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
+||+++|+|.+++..... .+++..+..++.||+.|++|||+++++||||||+||++++++.+||+|||.++.......
T Consensus 87 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 999999999999976433 388999999999999999999999999999999999999999999999999986643333
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
........++..|+|||.. ..+.++.++||||||+++||+++ |+.||...... ...+++. . ..
T Consensus 165 ~~~~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~----~---------~~ 228 (279)
T cd05111 165 KYFYSEHKTPIKWMALESI-LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLE----K---------GE 228 (279)
T ss_pred ccccCCCCCcccccCHHHh-ccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH----C---------CC
Confidence 2233345567789999988 55678999999999999999998 99999754322 1122221 1 11
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
....+..++..+.+++.+|+..||++|||+.|+++.|..+...
T Consensus 229 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 229 RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 1122333556788999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=327.59 Aligned_cols=259 Identities=26% Similarity=0.399 Sum_probs=208.6
Q ss_pred ccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCcee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 755 (967)
.|+..+.||+|+||.||++... ....+|+|.+......+...++.+|++++.++ +|+||+++++++..++..+
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY 92 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence 4577889999999999999864 23679999987654444456789999999999 8999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeE
Q 002094 756 LIYEFISSGSLYKHLHDGS-------------SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPK 822 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~k 822 (967)
++|||+++|+|.++++... ....+++..+++++.|++.|++|||+++|+||||||+||+++.++.+|
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~k 172 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMK 172 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEE
Confidence 9999999999999997532 223488999999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHh
Q 002094 823 VGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRG 901 (967)
Q Consensus 823 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 901 (967)
|+|||.++...............++..|+|||.. ....++.++|||||||++||+++ |..||........ .+.
T Consensus 173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~--- 246 (293)
T cd05053 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--FKL--- 246 (293)
T ss_pred eCccccccccccccceeccCCCCCCccccCHHHh-ccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH--HHH---
Confidence 9999999866442222222233455679999987 56678999999999999999998 9999864432211 111
Q ss_pred hhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 902 ALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
.........+...+.++.+++.+|++.||++|||++|+++.|+.+.
T Consensus 247 ----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 ----------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111122334556678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=321.79 Aligned_cols=254 Identities=31% Similarity=0.458 Sum_probs=209.9
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.|+..+.||+|+||.||+|..+++..+|+|.+.... ......+..|+.+++.++|+||+++++++......++||||++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 357788999999999999998889999999987654 2345679999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.+++...... .+++..+..++.|++.|++|||++|++|+||+|+||+++.++.+||+|||.+........ ...
T Consensus 86 ~~~L~~~~~~~~~~-~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~--~~~ 162 (261)
T cd05148 86 KGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY--LSS 162 (261)
T ss_pred cCCHHHHHhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc--ccc
Confidence 99999999875432 389999999999999999999999999999999999999999999999999976643211 122
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
...++..|+|||.. ....++.++||||||+++|+|++ |+.||....... ... .+ ....+...+
T Consensus 163 ~~~~~~~~~~PE~~-~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-~~~-~~-------------~~~~~~~~~ 226 (261)
T cd05148 163 DKKIPYKWTAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-VYD-QI-------------TAGYRMPCP 226 (261)
T ss_pred CCCCceEecCHHHH-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-HHH-HH-------------HhCCcCCCC
Confidence 33456789999988 55678999999999999999998 899997543221 111 11 111222345
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
..++..+.+++.+|++.||++|||++++.+.|+.+
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 56677899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=313.01 Aligned_cols=268 Identities=24% Similarity=0.303 Sum_probs=202.1
Q ss_pred CCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcC--CCCCceeeeeeEEEcCC----ceeEEE
Q 002094 685 NKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGK--IRHHNLVALEGYYWTPS----LQLLIY 758 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~ 758 (967)
+..+.+|+|.||.||||.+. ++.||||++.. ++.+.|+.|-++.+. ++|+||++++++-.... ++++|+
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 44568999999999999986 69999999974 346678888888766 48999999999876655 889999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------CcccCCCCCCCEEeCCCCCeEEeecccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT---------NIIHYNLKSTNVLIDSSGEPKVGDFGLA 829 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~---------~ivH~Dik~~Nill~~~~~~kl~Dfg~a 829 (967)
||.+.|+|.++|.... .+|....+|+..+++||+|||+. +|+|||||++|||+..|++..|+|||+|
T Consensus 288 ~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999998754 79999999999999999999962 6999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCcccCC-----cccchhhHHHHHHHHHcCCCCCC-CC-ccchHhHHHHHHhh
Q 002094 830 RLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT-----EKCDVYGFGVLVLEVVTGKRPVE-YM-EDDVVVLCDMVRGA 902 (967)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t-----~~~Dv~slGvll~elltg~~p~~-~~-~~~~~~~~~~~~~~ 902 (967)
.++.........-...||.+|||||++.+...+. .+.||||+|.++|||++...-++ .. ++-.-.+..-+...
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 8886544444444588999999999984443444 36899999999999998544332 11 11011111112111
Q ss_pred hccCCchhhcc-hhhcCCCCh-----hhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 002094 903 LEDGRVEDCVD-ARLRGNFPA-----DEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961 (967)
Q Consensus 903 ~~~~~~~~~~~-~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 961 (967)
-..+++.+.+- .+.|+.++. .....+.+.+..||+.||+.|.|+.=+-+.+.++...-+
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 11112222222 233333332 345668899999999999999999999888887765443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.26 Aligned_cols=244 Identities=21% Similarity=0.322 Sum_probs=200.6
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||+|..+ +++.||+|++..... .+..+.+.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 577889999999999999965 689999999875432 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----- 154 (291)
T cd05612 83 VPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----- 154 (291)
T ss_pred CCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----
Confidence 999999999976543 788999999999999999999999999999999999999999999999998765321
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....|++.|+|||.+ ....++.++||||+||++|||++|+.||...... .....+... ...+
T Consensus 155 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~~~i~~~---------------~~~~ 217 (291)
T cd05612 155 TWTLCGTPEYLAPEVI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-GIYEKILAG---------------KLEF 217 (291)
T ss_pred cccccCChhhcCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhC---------------CcCC
Confidence 1234688999999988 5567899999999999999999999999754322 111111111 1123
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPD-----MEEVVNI 952 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~~ 952 (967)
+...+..+.+++.+|++.||.+||+ ++|+++.
T Consensus 218 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 4445667999999999999999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=325.42 Aligned_cols=259 Identities=27% Similarity=0.398 Sum_probs=207.1
Q ss_pred cCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
|+..+.||+|+||.||+|+.. ....+|+|.+..........++.+|+.+++.++||||+++++++...+..++|
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 466789999999999999853 23578888887654334456799999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC
Q 002094 758 YEFISSGSLYKHLHDGSS---------------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID 816 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~ 816 (967)
|||+.+++|.+++..... ...+++.+++.++.|++.|++|||+++++||||||+||+++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~ 161 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA 161 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEc
Confidence 999999999999864321 12478999999999999999999999999999999999999
Q ss_pred CCCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhH
Q 002094 817 SSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVL 895 (967)
Q Consensus 817 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~ 895 (967)
+++.++|+|||+++...............++..|+|||.. ....++.++||||||+++|||++ |..||...... ..
T Consensus 162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~ 238 (290)
T cd05045 162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE--RL 238 (290)
T ss_pred CCCcEEeccccccccccCccchhcccCCCCCccccCHHHH-ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH--HH
Confidence 9999999999998765332222222334456789999987 55678999999999999999998 99999654322 11
Q ss_pred HHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 896 CDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.+.+. ...+...+...+.++.+++.+|++.+|++||+++|+++.|+++..
T Consensus 239 ~~~~~-------------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 239 FNLLK-------------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHh-------------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 12111 111222344566789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=300.93 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=205.0
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|+..++||+|.|+.||++.. .+|+.+|+|.+..... ..+.+++.+|+++-+.++|||||++++.+.+.+..|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 3456677899999999999884 4689999998854432 3467889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC---CCCeEEeecccccccCCCc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS---SGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~---~~~~kl~Dfg~a~~~~~~~ 836 (967)
+|+|++|..-+-.+ ..+++..+-..++||++|+.|.|.++|||||+||+|+++.+ ...+||+|||+|..+.
T Consensus 91 ~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--- 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--- 164 (355)
T ss_pred cccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC---
Confidence 99999997666443 22677888899999999999999999999999999999953 3468999999998775
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.........|||+|+|||+. +..+++-.+|||+.||++|-++.|++||... +....+.+++.+... +
T Consensus 165 ~g~~~~G~~GtP~fmaPEvv-rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-~~~rlye~I~~g~yd-----------~ 231 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDE-DQHRLYEQIKAGAYD-----------Y 231 (355)
T ss_pred CccccccccCCCcccCHHHh-hcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-cHHHHHHHHhccccC-----------C
Confidence 23344577899999999998 7778999999999999999999999999542 233334444433221 2
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.++......++..+++++|+..||.+|.|+.|.++
T Consensus 232 ~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 23345566778999999999999999999999874
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=293.09 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=210.7
Q ss_pred HhhccCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC-----Cc
Q 002094 680 ANALLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP-----SL 753 (967)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 753 (967)
.+..|++.+.+|+|||+-||.+. ..+++.||+|++.... .++.+...+|++..++++|||+++++++...+ ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 35678999999999999999998 6678999999998776 56788999999999999999999999887543 34
Q ss_pred eeEEEEecCCCchhhhhhcCCCCC-CCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRN-CLSWRQRFNIILGMAKGLAYLHHTN--IIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~i~~~i~~aL~~LH~~~--ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
.|++++|...|+|.+.+.....++ .+++.++++|+.+|++||++||+.. ++||||||.||++.+.+.+++.|||.+.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 799999999999999998765544 6899999999999999999999986 9999999999999999999999999987
Q ss_pred ccCCCccccc-------cccccccccccCcccccC--cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHh
Q 002094 831 LLPMLDRCIL-------SSKIQSALGYMAPEFACR--TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRG 901 (967)
Q Consensus 831 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~--~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~ 901 (967)
..+-.-.... ......|..|+|||.+.- +...++++|||||||++|+|+.|..||+....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence 6643111100 113446788999998732 34578999999999999999999999963211
Q ss_pred hhccCCchhh-cchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 902 ALEDGRVEDC-VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 902 ~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
+.+.+.-. ....+..+-....++.+.+++++|++.||.+||++.+++..++.+.
T Consensus 247 --~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 --QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111111 1112222222336778999999999999999999999999988764
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=336.18 Aligned_cols=260 Identities=26% Similarity=0.346 Sum_probs=207.7
Q ss_pred ccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCcee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 755 (967)
.+...+.||+|+||.||+|++. .+..||||++.........+.+.+|++++.++. |||||++++++...+..+
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~ 117 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY 117 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence 3577889999999999999854 346899999976543334457889999999997 999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCC------------------------------------------------------------
Q 002094 756 LIYEFISSGSLYKHLHDGSS------------------------------------------------------------ 775 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 775 (967)
+||||+++|+|.++++....
T Consensus 118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (401)
T cd05107 118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG 197 (401)
T ss_pred EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence 99999999999999975321
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC
Q 002094 776 -----------------------------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE 820 (967)
Q Consensus 776 -----------------------------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~ 820 (967)
...+++..+++++.|++.||+|||+.+++||||||+||+++.++.
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~ 277 (401)
T cd05107 198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKL 277 (401)
T ss_pred hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCE
Confidence 013677888999999999999999999999999999999999999
Q ss_pred eEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHH
Q 002094 821 PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMV 899 (967)
Q Consensus 821 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~ 899 (967)
+||+|||+++...............++..|+|||.+ ....++.++||||||+++|||++ |..||........ ....+
T Consensus 278 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~~~~~ 355 (401)
T cd05107 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI-FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-FYNAI 355 (401)
T ss_pred EEEEecCcceecccccccccCCCcCCCCceeChHHh-cCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-HHHHH
Confidence 999999999765332222222334567889999988 55578899999999999999998 8999865433221 11111
Q ss_pred HhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 900 RGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
....+...+...+.++.+++.+||+.+|.+||+++|+++.|+++.
T Consensus 356 -------------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 356 -------------KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -------------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111222345556778999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=342.78 Aligned_cols=370 Identities=25% Similarity=0.337 Sum_probs=238.2
Q ss_pred CCCCcEEEcCCCCCC-CCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCe
Q 002094 116 FGTLQVVDFSENNLS-GLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQS 194 (967)
Q Consensus 116 l~~L~~L~Ls~n~~~-~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 194 (967)
|+-.+-+|+++|.++ +..|..+ ..+++++.|.|...++. .+|+.++.|.+|++|.+++|++. .+-..++.|+.|+.
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v-~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRs 82 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDV-EQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRS 82 (1255)
T ss_pred cceeecccccCCcCCCCcCchhH-HHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHH
Confidence 444555566666666 3455554 77778888888877777 67888888888888888888887 44556777888888
Q ss_pred EeecCCcCCC-cccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCC
Q 002094 195 LDLSNNLLEG-EIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNS 273 (967)
Q Consensus 195 L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 273 (967)
+++..|++.. -+|..+..+..|+.|||++|++. ..|..+..-+++-+|+||+|+|..+....|.+|+.|-+|+|++|+
T Consensus 83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~Nr 161 (1255)
T KOG0444|consen 83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNR 161 (1255)
T ss_pred HhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccch
Confidence 8888887763 35666667777777777777776 567777777777777777777764444445667777777777777
Q ss_pred CCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCC-CCCChhhhcCCCCcEEEccCCcCcCCCCh
Q 002094 274 FTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFT-GGLPESMMNCGNLLAIDVSQNKLTGNIPT 352 (967)
Q Consensus 274 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 352 (967)
+. .+|..+..+.+|++|+|++|.+...--..+..+++|+.|.+++.+=+ ..+|.++..+.||..+|+|.|.+.
T Consensus 162 Le-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp----- 235 (1255)
T KOG0444|consen 162 LE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP----- 235 (1255)
T ss_pred hh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-----
Confidence 76 55556677777777777777765443344555566666666665432 234555555555555555555544
Q ss_pred hhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCC
Q 002094 353 WIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGK 432 (967)
Q Consensus 353 ~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 432 (967)
..|+.+.++++|+.|+||+|+|+ .+....+.
T Consensus 236 ------------------------------------------------~vPecly~l~~LrrLNLS~N~it-eL~~~~~~ 266 (1255)
T KOG0444|consen 236 ------------------------------------------------IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGE 266 (1255)
T ss_pred ------------------------------------------------cchHHHhhhhhhheeccCcCcee-eeeccHHH
Confidence 34444555555555555555554 33333444
Q ss_pred cccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCc-CCccccccCccceeeccCCcCcCccchhhhcccCccEE
Q 002094 433 LKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGR-IPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYV 511 (967)
Q Consensus 433 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 511 (967)
..+|+.|+||.|+++ .+|+.++++++|+.|++.+|+++-. +|+.+++|.+|+.+..++|.+. .+|..++.+..|+.|
T Consensus 267 W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL 344 (1255)
T KOG0444|consen 267 WENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKL 344 (1255)
T ss_pred Hhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHh
Confidence 455556666666665 5566666666666666666665422 6666777777777777777666 667777777777777
Q ss_pred eccCCccccCCchhhhhccCCceEEecCCcccccCC
Q 002094 512 DLSFNDLSGILPKELINLSHLLSFNISHNHLHGELP 547 (967)
Q Consensus 512 ~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 547 (967)
.|+.|+|- .+|+++.-|+.|+.|||..|+=--..|
T Consensus 345 ~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 345 KLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred ccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 77777766 566667667777777777665443333
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=318.09 Aligned_cols=249 Identities=29% Similarity=0.418 Sum_probs=202.6
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
|+..+.||+|+||.||++..+++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 56788999999999999998878899999886443 3456788999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
++|.+++..... .+++..+..++.|++.|++|||++|++||||||+||+++.++.+|++|||.++....... .....
T Consensus 84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 160 (256)
T cd05059 84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQG 160 (256)
T ss_pred CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cccCC
Confidence 999999976443 388999999999999999999999999999999999999999999999999876532111 11122
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
..++..|+|||.. ....++.++|+||||+++||+++ |+.||....... .. ..+ ....+...+.
T Consensus 161 ~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~-~~~-------------~~~~~~~~~~ 224 (256)
T cd05059 161 TKFPVKWAPPEVF-DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VV-ESV-------------SAGYRLYRPK 224 (256)
T ss_pred CCCCccccCHHHh-ccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-HH-HHH-------------HcCCcCCCCC
Confidence 2344579999988 55678999999999999999999 899996443221 11 111 1111223344
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 953 (967)
..+.++.+++.+|++.+|++|||+.|+++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 5677899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=331.68 Aligned_cols=241 Identities=25% Similarity=0.340 Sum_probs=194.8
Q ss_pred cCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCch
Q 002094 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSL 766 (967)
Q Consensus 690 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 766 (967)
||+|+||.||+|+.. +++.||+|.+..... ......+.+|++++++++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 578999999875421 23446788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccccc
Q 002094 767 YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQS 846 (967)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 846 (967)
.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++...... .......|
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 155 (312)
T cd05585 81 FHHLQREGR---FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCG 155 (312)
T ss_pred HHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccC
Confidence 999976433 8899999999999999999999999999999999999999999999999987543211 12334568
Q ss_pred cccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHH
Q 002094 847 ALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAI 926 (967)
Q Consensus 847 t~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (967)
|+.|+|||.+ ....++.++||||+||++|||++|+.||...... ++....... ...++...+.
T Consensus 156 t~~y~aPE~~-~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~~~~~-----------~~~~~~~~~~ 218 (312)
T cd05585 156 TPEYLAPELL-LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRKILQE-----------PLRFPDGFDR 218 (312)
T ss_pred CcccCCHHHH-cCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcC-----------CCCCCCcCCH
Confidence 9999999998 5567899999999999999999999999643321 111111111 1123455667
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 927 PVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 927 ~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
++.+++.+|++.||++||++..+.++
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 79999999999999999865433333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.04 Aligned_cols=252 Identities=32% Similarity=0.466 Sum_probs=204.5
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.|+..+.||+|+||.||+|..+++..||+|.+.... ...+.+.+|+.++++++|++++++++++. ....+++|||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCC--CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 467788999999999999998888899999987644 24567999999999999999999999875 456899999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.++++..... .+++.++..++.|++.|++|||+++++||||||+||++++++.++|+|||.+........ ....
T Consensus 84 ~~~L~~~~~~~~~~-~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 161 (260)
T cd05070 84 KGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TARQ 161 (260)
T ss_pred CCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-cccc
Confidence 99999999764332 378999999999999999999999999999999999999999999999999976543221 1112
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
...++..|+|||.. ....++.++|+||||+++|||++ |+.||...... . ..... ......+.+
T Consensus 162 ~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~----~~~~~----------~~~~~~~~~ 225 (260)
T cd05070 162 GAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-E----VLEQV----------ERGYRMPCP 225 (260)
T ss_pred CCCCCccccChHHH-hcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-H----HHHHH----------HcCCCCCCC
Confidence 23345679999987 55678999999999999999999 89999654321 1 11111 111122334
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
.+.+..+.+++.+|++.+|++|||++++.+.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 5567789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=324.80 Aligned_cols=263 Identities=20% Similarity=0.242 Sum_probs=200.1
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|+..+.||+|+||.||+|+.+ +++.||||++..... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 3677889999999999999975 578999999976532 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++++.+..+.... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++....... ...
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (287)
T cd07848 82 VEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NAN 157 (287)
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-ccc
Confidence 9988776554332 238899999999999999999999999999999999999999999999999998664321 112
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHH--h---------hhccCCch
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVR--G---------ALEDGRVE 909 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~--~---------~~~~~~~~ 909 (967)
.....|++.|+|||++ .+..++.++||||+||++|||++|++||........ ...... + ........
T Consensus 158 ~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 158 YTEYVATRWYRSPELL-LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccCCcHHH-cCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccchhc
Confidence 2345688999999998 555789999999999999999999999975433211 111111 0 00000000
Q ss_pred hhcchhh------cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 910 DCVDARL------RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 910 ~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+.. ...+....+..+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00111234567999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=324.96 Aligned_cols=256 Identities=26% Similarity=0.360 Sum_probs=204.7
Q ss_pred cCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
|+..+.||+|+||.||+|... .+..||+|++.........+.+.+|+.+++.++||||+++++++..+...+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 455678999999999999853 25789999997654333456789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEe
Q 002094 758 YEFISSGSLYKHLHDGS-------------SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVG 824 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~ 824 (967)
+||+++++|.+++.... ....+++..+.+++.|++.||+|+|++||+||||||+||++++++.+||+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~ 166 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKIS 166 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEec
Confidence 99999999999985321 11237888999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhh
Q 002094 825 DFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGAL 903 (967)
Q Consensus 825 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 903 (967)
|||+++...............+++.|+|||.+ ..+.++.++||||+|+++|||++ |..||...... ++.....
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~i~ 240 (283)
T cd05091 167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAI-MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-----DVIEMIR 240 (283)
T ss_pred ccccccccccchheeeccCccCCccccCHHHH-hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHH
Confidence 99998765433322223344557789999988 55678999999999999999998 88888643321 1111111
Q ss_pred ccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 904 EDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
. ......+.+++..+.+++.+|++.+|++||+++|+++.|+.
T Consensus 241 ~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 N----------RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred c----------CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 11123456677889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=310.65 Aligned_cols=246 Identities=22% Similarity=0.362 Sum_probs=206.1
Q ss_pred cCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCcc--ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|.||.|-++. ...|+.||||.++++... ++.-.+.+|+++|..++||||+.++.+|...+...+||||
T Consensus 55 yE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEY 134 (668)
T KOG0611|consen 55 YEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEY 134 (668)
T ss_pred HHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEe
Confidence 5667789999999999998 478999999999877643 3445789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
..+|.|++++.+.+. +++.++..+++||+.|+.|+|+++++|||+|.+|||+|.++.+||+|||++-.+.. ...
T Consensus 135 aS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---~kf 208 (668)
T KOG0611|consen 135 ASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---KKF 208 (668)
T ss_pred cCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc---ccH
Confidence 999999999988766 89999999999999999999999999999999999999999999999999987743 334
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
-..+.|+|-|.+||...+...-.+.+|-||+||++|-|+.|..||++.+- ..+++.. ..+.+ .
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lvrQI-s~GaY-----------r 271 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLVRQI-SRGAY-----------R 271 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHHHHh-hcccc-----------c
Confidence 45788999999999984444457889999999999999999999975432 1222221 11111 1
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.+..+....-+|++|+..+|++|.|+.+|...
T Consensus 272 EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 272 EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 23334457789999999999999999998754
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=318.00 Aligned_cols=250 Identities=29% Similarity=0.417 Sum_probs=202.5
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
|+..+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++......++||||+.+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 46678899999999999998877789999887543 3456799999999999999999999999988889999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|.+++..... .+++..++.++.||+.|++|||++|++|+||||+||+++.++.+||+|||.+....... ......
T Consensus 84 ~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~~~ 160 (256)
T cd05113 84 GCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVG 160 (256)
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeecCC
Confidence 999999976433 38899999999999999999999999999999999999999999999999987654321 112223
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
..++..|+|||.. ....++.++||||||+++|||++ |+.||....... ....+ .. ..+...+.
T Consensus 161 ~~~~~~y~~pe~~-~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~---~~----------~~~~~~~~ 224 (256)
T cd05113 161 SKFPVRWSPPEVL-LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKV---SQ----------GLRLYRPH 224 (256)
T ss_pred CccChhhCCHHHH-hcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHH---hc----------CCCCCCCC
Confidence 3456779999988 55578899999999999999998 999996443321 11111 11 01112233
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
..+..+.+++.+|++.+|++|||+.++++.|+
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 34677999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=326.10 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=207.9
Q ss_pred hccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCce
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 754 (967)
+.|...+.||+|+||.||++... .+..||||.++........+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 44688899999999999999741 34579999887654334456799999999999 799999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
++||||+++|+|.++++..... .+++.++..++.|++.|++|||+++++|+||||+||+++.++.++++|||++.....
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRES-FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999999764432 379999999999999999999999999999999999999999999999999976543
Q ss_pred CccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcc
Q 002094 835 LDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913 (967)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (967)
...........++..|+|||.+ ....++.++||||+||++|||++ |..||........ ..... .
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~~-------------~ 258 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKLI-------------K 258 (302)
T ss_pred CCceeecCCCCcccccCCHhhh-ccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHHH-------------H
Confidence 3222222334456789999988 55678999999999999999998 9999975433211 11111 1
Q ss_pred hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 914 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
...+...+...+.++.+++.+|++++|++|||+.|+++.|++.
T Consensus 259 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111122334466799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.99 Aligned_cols=248 Identities=27% Similarity=0.371 Sum_probs=202.1
Q ss_pred CccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCchh
Q 002094 688 CELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLY 767 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 767 (967)
+.||+|+||.||+|..++++.||+|.+...........+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999876543444567899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccccccc
Q 002094 768 KHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA 847 (967)
Q Consensus 768 ~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 847 (967)
+++..... .+++..+..++.|++.|+.|+|++|++||||||+||+++.++.++++|||++....... ........++
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQIP 157 (250)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCCc
Confidence 99875432 37899999999999999999999999999999999999999999999999987543211 1111223445
Q ss_pred ccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHH
Q 002094 848 LGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAI 926 (967)
Q Consensus 848 ~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (967)
+.|+|||+. ....++.++||||||+++||+++ |..||........ .. .+. ...+...+...+.
T Consensus 158 ~~y~aPE~~-~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~--~~----~~~---------~~~~~~~~~~~~~ 221 (250)
T cd05085 158 IKWTAPEAL-NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA--RE----QVE---------KGYRMSCPQKCPD 221 (250)
T ss_pred ccccCHHHh-ccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH--HH----HHH---------cCCCCCCCCCCCH
Confidence 679999988 66678999999999999999998 9999975432211 11 111 1112233455677
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 927 PVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 927 ~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
.+.+++.+|++.+|++||++.|++++|+
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.79 Aligned_cols=254 Identities=28% Similarity=0.412 Sum_probs=205.9
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+.|+..++||+|+||.||+|..++++.||+|.+.... ...+++.+|+.++++++|+||+++++++ ..+..+++|||+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 3467788999999999999998889999999987544 3456899999999999999999999987 456789999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++...... .+++.++..++.|++.||+|||+.|++||||||+||+++.++.++++|||.+........ ...
T Consensus 83 ~~~~L~~~~~~~~~~-~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 160 (260)
T cd05067 83 ENGSLVDFLKTPEGI-KLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAR 160 (260)
T ss_pred CCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccc
Confidence 999999998764432 388999999999999999999999999999999999999999999999999976542111 112
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....++..|+|||++ ....++.++|+||||+++||+++ |+.||....... ....+ ....+.+.
T Consensus 161 ~~~~~~~~y~~pe~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~-------------~~~~~~~~ 224 (260)
T cd05067 161 EGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNL-------------ERGYRMPR 224 (260)
T ss_pred cCCcccccccCHHHh-ccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHH-------------HcCCCCCC
Confidence 233456789999988 56678899999999999999999 999997543221 11111 11112223
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
+...+.++.+++.+|++.+|++|||++++.+.|+.+
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 444567799999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=322.82 Aligned_cols=262 Identities=22% Similarity=0.319 Sum_probs=210.3
Q ss_pred hccCCCCccCCCCceEEEEEEeCC-----CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEc-CCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD-----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT-PSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 755 (967)
+.|+..+.||+|+||.||+|...+ +..||+|++...........+.+|+.++++++|+||+++++++.. +...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 346778899999999999999765 788999998755444556778999999999999999999998765 56788
Q ss_pred EEEEecCCCchhhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 756 LIYEFISSGSLYKHLHDGSSR-----NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
+++||+++++|.+++...... ..+++..+..++.|++.||+|||+++++|+||||+||+++.++.+|++|||+++
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~ 165 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence 999999999999999764322 348899999999999999999999999999999999999999999999999997
Q ss_pred ccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 831 LLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
.+.............++..|+|||++ ....++.++||||||+++||+++ |+.||..... .....++..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~-------- 234 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESL-VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKD-------- 234 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHH-hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHc--------
Confidence 65432222222334456779999988 55678999999999999999999 9999964432 222222211
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
......+..++.++.+++.+|+..||++|||+.++++.|+++.+.
T Consensus 235 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 -----GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -----CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 111112334566799999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=327.59 Aligned_cols=263 Identities=28% Similarity=0.379 Sum_probs=208.9
Q ss_pred ccCCCCccCCCCceEEEEEEeC--------CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCc
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ--------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSL 753 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 753 (967)
.|...+.||+|+||.||++... ++..+|+|.+..........++.+|+++++++ +||||+++++++...+.
T Consensus 19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (307)
T cd05098 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 98 (307)
T ss_pred HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 4688899999999999999742 23579999997654334456788999999999 79999999999999999
Q ss_pred eeEEEEecCCCchhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSS-------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE 820 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~ 820 (967)
.++||||+++|+|.+++..... ...+++.++.+++.|++.||+|||++|++||||||+||+++.++.
T Consensus 99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~ 178 (307)
T cd05098 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 178 (307)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCc
Confidence 9999999999999999976432 124789999999999999999999999999999999999999999
Q ss_pred eEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHH
Q 002094 821 PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMV 899 (967)
Q Consensus 821 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~ 899 (967)
++|+|||.+................+++.|+|||.. ....++.++||||+||++|||++ |..||.....+ .....+
T Consensus 179 ~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--~~~~~~ 255 (307)
T cd05098 179 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--ELFKLL 255 (307)
T ss_pred EEECCCcccccccccchhhccccCCCccceeChHHh-ccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHH
Confidence 999999998765432211112222344679999988 55678999999999999999998 88998643321 111111
Q ss_pred HhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 002094 900 RGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961 (967)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 961 (967)
. .......+...+.++.+++.+|++.+|++|||+.++++.|+++.....
T Consensus 256 ~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 256 K-------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred H-------------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 1 111223345567789999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.76 Aligned_cols=260 Identities=26% Similarity=0.434 Sum_probs=208.1
Q ss_pred cCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
|...+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|++++++++|+||+++++++...+..++|
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 466789999999999999742 35568899886543 33456799999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEe
Q 002094 758 YEFISSGSLYKHLHDGSS-------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVG 824 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~ 824 (967)
|||+++++|.+++..... ...+++..++.++.||+.|++|||++|++||||||+||+++.++.++|+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEEC
Confidence 999999999999975321 1237899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhh
Q 002094 825 DFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGAL 903 (967)
Q Consensus 825 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 903 (967)
|||.+................++..|+|||.+ ....++.++||||||+++|||++ |+.||....... ..+. +
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~----~ 238 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIEC----I 238 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----H
Confidence 99999765432222223345567889999988 55678899999999999999999 999986443321 1111 1
Q ss_pred ccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 904 EDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
..+. ....+...+..+.+++.+|+++||++|||+++++++|+++.+..
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 239 TQGR---------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred hCCC---------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 1111 11123345667999999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=333.87 Aligned_cols=243 Identities=24% Similarity=0.304 Sum_probs=199.2
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||+|+.+ +++.||+|.+..... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 3577889999999999999965 588999999975432 2344678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---- 171 (329)
T PTZ00263 99 FVVGGELFTHLRKAGR---FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---- 171 (329)
T ss_pred CCCCChHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----
Confidence 9999999999976543 788899999999999999999999999999999999999999999999999865331
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
.....|++.|+|||++ ....++.++||||+||++|||++|+.||...... ..... . ..+ +..
T Consensus 172 -~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~----i-~~~----------~~~ 233 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVI-QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-RIYEK----I-LAG----------RLK 233 (329)
T ss_pred -cceecCChhhcCHHHH-cCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-HHHHH----H-hcC----------CcC
Confidence 1235689999999998 5567899999999999999999999999643321 11111 1 111 112
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCC-----HHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPD-----MEEVV 950 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl 950 (967)
++...+..+.+++.+|++.||++||+ +++++
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 34445567899999999999999997 56665
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=308.81 Aligned_cols=251 Identities=22% Similarity=0.272 Sum_probs=203.9
Q ss_pred cCCCCccCCCCceEEEEEEeCC-CcEEEEEEeecCCcc--ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
++..+.||+|.-|+||.++.++ +..+|+|++.+.... +...+++.|-++|+.++||.++.+|+.+..+...|+||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 3556789999999999999774 589999999876542 3456788899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC-----
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML----- 835 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~----- 835 (967)
|+||+|....+++..+ ++++..+.-+|.+|+-||+|||..|||+||+||+|||+-++|++.|+||.++...+..
T Consensus 159 CpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~ 237 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK 237 (459)
T ss_pred CCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence 9999999998876554 5999999999999999999999999999999999999999999999999997543110
Q ss_pred ---------------------------c-c---------------------ccccccccccccccCcccccCcccCCccc
Q 002094 836 ---------------------------D-R---------------------CILSSKIQSALGYMAPEFACRTVKITEKC 866 (967)
Q Consensus 836 ---------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~t~~~ 866 (967)
. . ........||..|.|||++ .+...+.++
T Consensus 238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI-~G~GHgsAV 316 (459)
T KOG0610|consen 238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI-RGEGHGSAV 316 (459)
T ss_pred cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee-ecCCCCchh
Confidence 0 0 0111235688899999999 666788999
Q ss_pred chhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCC-
Q 002094 867 DVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPD- 945 (967)
Q Consensus 867 Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt- 945 (967)
|+|+|||++|||+.|.-||.+.... ..+.+++.. .+.-+..+..+..+.+||++.+.+||.+|.-
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~~~-~Tl~NIv~~-------------~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSNNK-ETLRNIVGQ-------------PLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCCch-hhHHHHhcC-------------CCcCCCCCcchhHHHHHHHHHhccChhhhhcc
Confidence 9999999999999999999765443 334433332 2222222355677999999999999999987
Q ss_pred ---HHHHH
Q 002094 946 ---MEEVV 950 (967)
Q Consensus 946 ---~~evl 950 (967)
+.||.
T Consensus 383 ~rGA~eIK 390 (459)
T KOG0610|consen 383 KRGAAEIK 390 (459)
T ss_pred ccchHHhh
Confidence 66654
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.13 Aligned_cols=254 Identities=30% Similarity=0.419 Sum_probs=204.9
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.|+..+.||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++. ....++||||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 468888999999999999998777789999987543 24567999999999999999999999874 456799999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+|+|.+++...... .+++..+..++.|++.||+|+|+.+++||||||+||+++.++.++|+|||.+........ ....
T Consensus 84 ~~~L~~~~~~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~~ 161 (262)
T cd05071 84 KGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQ 161 (262)
T ss_pred CCcHHHHHhhcccc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc-cccc
Confidence 99999999764322 378999999999999999999999999999999999999999999999999976643221 1222
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
...++..|+|||+. ....++.++|+||||+++|||++ |+.||........ . ..... ......+
T Consensus 162 ~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~----~~~~~----------~~~~~~~ 225 (262)
T cd05071 162 GAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-L----DQVER----------GYRMPCP 225 (262)
T ss_pred CCcccceecCHhHh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-H----HHHhc----------CCCCCCc
Confidence 34456779999987 56678999999999999999999 8889875433211 1 11100 1111233
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
...+..+.+++.+|++.||++||+++++++.|++..
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 456677999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=331.13 Aligned_cols=242 Identities=23% Similarity=0.309 Sum_probs=196.8
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSG 764 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 764 (967)
+.||+|+||.||++..+ +|..||+|++..... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999954 689999999976432 233456788999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccc
Q 002094 765 SLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI 844 (967)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 844 (967)
+|..++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... ........
T Consensus 81 ~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTF 155 (323)
T ss_pred cHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccc
Confidence 99988876543 88999999999999999999999999999999999999999999999999874322 11122345
Q ss_pred cccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhh
Q 002094 845 QSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADE 924 (967)
Q Consensus 845 ~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (967)
.|++.|+|||.+ ....++.++||||+||++|||++|+.||....... ....+... ...++...
T Consensus 156 ~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~~~~~---------------~~~~p~~~ 218 (323)
T cd05595 156 CGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILME---------------EIRFPRTL 218 (323)
T ss_pred cCCcCcCCcccc-cCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHhcC---------------CCCCCCCC
Confidence 689999999998 56678999999999999999999999996443221 11111100 11234556
Q ss_pred HHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 925 AIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 925 ~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
+.++.+++.+|++.||++|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 67799999999999999998 7887764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.15 Aligned_cols=261 Identities=27% Similarity=0.389 Sum_probs=209.2
Q ss_pred hccCCCCccCCCCceEEEEEEeC--------CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCC
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ--------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPS 752 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 752 (967)
+.|+..+.||+|+||.||++... ++..||+|.+..........++.+|+.+++.+ +||||+++++++...+
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 34678899999999999999731 34579999887554344567899999999999 8999999999999999
Q ss_pred ceeEEEEecCCCchhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC
Q 002094 753 LQLLIYEFISSGSLYKHLHDGSS-------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG 819 (967)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~ 819 (967)
..++||||+++|+|.+++..... ...+++.++..++.||+.||+|||++|++||||||+||+++.++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~ 174 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN 174 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence 99999999999999999976432 12478899999999999999999999999999999999999999
Q ss_pred CeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHH
Q 002094 820 EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDM 898 (967)
Q Consensus 820 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~ 898 (967)
.+||+|||.++...............+++.|+|||.. ....++.++||||||+++||+++ |..||...... ++
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~ 248 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-----EL 248 (304)
T ss_pred cEEECCCccceecccccccccccCCCCCceeeCchhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-----HH
Confidence 9999999999876543322223334456789999988 55678999999999999999998 88888643321 11
Q ss_pred HHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 899 VRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.... . ...+...+..++..+.+++.+|++.+|++|||+.|+++.|+++..
T Consensus 249 ~~~~-~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 249 FKLL-K---------EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHH-H---------cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1111 1 111122345567789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.05 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=199.2
Q ss_pred ccCCCCceEEEEEEeC---CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCc
Q 002094 689 ELGRGGFGVVYRTILQ---DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGS 765 (967)
Q Consensus 689 ~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 765 (967)
.||+|+||.||+|+++ .+..||+|.+.........+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999854 355799999876543444577999999999999999999999875 457899999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc-cccc
Q 002094 766 LYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL-SSKI 844 (967)
Q Consensus 766 L~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~ 844 (967)
|.+++..... .+++..+.+++.|++.|++|||++|++||||||+||+++.++.+||+|||++........... ....
T Consensus 81 L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 9999875432 388999999999999999999999999999999999999999999999999975543222111 1122
Q ss_pred cccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 845 QSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 845 ~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
.+++.|+|||.. ....++.++||||||+++||+++ |..||........ ...+ ....+...+..
T Consensus 159 ~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~-------------~~~~~~~~~~~ 222 (257)
T cd05115 159 KWPLKWYAPECI-NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV--MSFI-------------EQGKRLDCPAE 222 (257)
T ss_pred CCCcccCCHHHH-ccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH--HHHH-------------HCCCCCCCCCC
Confidence 235679999987 55578899999999999999996 9999975443211 1111 11122334556
Q ss_pred hHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 924 EAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.13 Aligned_cols=248 Identities=24% Similarity=0.390 Sum_probs=199.2
Q ss_pred ccCCCCceEEEEEEeC---CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCC
Q 002094 689 ELGRGGFGVVYRTILQ---DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSG 764 (967)
Q Consensus 689 ~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 764 (967)
+||+|+||.||+|.++ ++..||+|++..... ....+++.+|+.+++.++||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6999999999999743 578899999865432 234567899999999999999999999875 45678999999999
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc-cccc
Q 002094 765 SLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI-LSSK 843 (967)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~ 843 (967)
+|.+++.... .+++..+..++.|++.|++|+|++|++||||||+||+++.++.++|+|||++.......... ....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999997543 27899999999999999999999999999999999999999999999999997664322211 1122
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
..++..|+|||.. ....++.++|+||||+++|||++ |+.||...... ...+.+. .......+.
T Consensus 158 ~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~-------------~~~~~~~~~ 221 (257)
T cd05116 158 GKWPVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIE-------------SGERMECPQ 221 (257)
T ss_pred CCCCccccCHhHh-ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH-------------CCCCCCCCC
Confidence 2345789999988 56678889999999999999998 99999754332 1111111 111223455
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
..+.++.++|.+|++.||++||++++|.+.|+.+
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 6778899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=331.04 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=197.9
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSG 764 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 764 (967)
+.||+|+||.||++..+ +++.||+|++..... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999954 689999999976432 234567889999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccc
Q 002094 765 SLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI 844 (967)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 844 (967)
+|..++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.... ........
T Consensus 81 ~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRERV---FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTF 155 (328)
T ss_pred CHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccc
Confidence 99998876443 88999999999999999999999999999999999999999999999999875322 11122345
Q ss_pred cccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhh
Q 002094 845 QSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADE 924 (967)
Q Consensus 845 ~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (967)
.||+.|+|||.+ ....++.++||||+||++|||++|+.||....... ....... ....++...
T Consensus 156 ~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-----~~~~~~~-----------~~~~~p~~~ 218 (328)
T cd05593 156 CGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELILM-----------EDIKFPRTL 218 (328)
T ss_pred cCCcCccChhhh-cCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-----HHHHhcc-----------CCccCCCCC
Confidence 689999999998 56678999999999999999999999996433221 1111110 011234556
Q ss_pred HHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 002094 925 AIPVIKLGLICASQVPSNRP-----DMEEVVNI 952 (967)
Q Consensus 925 ~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 952 (967)
+.++.+++.+|++.||++|| ++.|+++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 67799999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.46 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=204.6
Q ss_pred hccCCCCccCCCCceEEEEEEeCC------CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
+.|+..+.||+|++|.||+|...+ +..||+|.+...........+..|+.++++++|+||+++++++.+....+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 346788899999999999999753 56789998865543444567999999999999999999999999989999
Q ss_pred EEEEecCCCchhhhhhcCCCC----CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC---CeEEeeccc
Q 002094 756 LIYEFISSGSLYKHLHDGSSR----NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG---EPKVGDFGL 828 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~---~~kl~Dfg~ 828 (967)
+||||+++++|.++++..... ..+++..+.+++.||+.|++|||+++++||||||+||+++.++ .+||+|||+
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence 999999999999999765321 2488999999999999999999999999999999999998654 589999999
Q ss_pred ccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCC
Q 002094 829 ARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGR 907 (967)
Q Consensus 829 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (967)
++................+..|+|||++ .+..++.++|||||||++|||++ |+.||+...... ....+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~------- 235 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAF-LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVT------- 235 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHH-hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH-------
Confidence 9765322211112223335679999998 55679999999999999999997 999997543321 111111
Q ss_pred chhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
...+...+...+.++.+++.+|++.+|++|||+.++++.|+
T Consensus 236 ------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 ------GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11122335556778999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.27 Aligned_cols=262 Identities=21% Similarity=0.339 Sum_probs=204.3
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+++.+ ++..||+|.+...........+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 34678889999999999999965 58889999987654334456899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
+++++|.+++..... +++..+..++.|++.|++|||++ +|+||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 157 (331)
T cd06649 85 MDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157 (331)
T ss_pred CCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc----
Confidence 999999999976543 78999999999999999999986 6999999999999999999999999998755321
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC------------
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR------------ 907 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 907 (967)
......|++.|+|||.+ .+..++.++||||+||++|||++|+.||...... .+...+........
T Consensus 158 ~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 MANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ccccCCCCcCcCCHhHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCcccc
Confidence 12345688999999998 5667899999999999999999999999644322 11111111000000
Q ss_pred ------------------chhhcchhh---cCCC-ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 002094 908 ------------------VEDCVDARL---RGNF-PADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953 (967)
Q Consensus 908 ------------------~~~~~~~~~---~~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 953 (967)
..+..+... .... ....+.++.+++.+|++.||++|||++|+++.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000000 0111 113456799999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=346.28 Aligned_cols=251 Identities=21% Similarity=0.280 Sum_probs=202.6
Q ss_pred cCCCCccCCCCceEEEEEEeC-C-CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-D-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|...+.||+|++|.||+|... + ++.||+|.+.... ......+.+|+++++.++|||||++++++..++..++||||+
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 677889999999999999854 3 5788888775443 334467888999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 762 SSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 762 ~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++|+|.++++... ....+++..+..++.||+.||+|+|+++|+||||||+||+++.++.+||+|||++...........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 227 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence 9999999886532 223488999999999999999999999999999999999999999999999999987644222223
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....||+.|+|||++ ....++.++||||+||++|||++|+.||...... +++..... + .....
T Consensus 228 ~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----~~~~~~~~-~---------~~~~~ 291 (478)
T PTZ00267 228 ASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----EIMQQVLY-G---------KYDPF 291 (478)
T ss_pred ccccCCCccccCHhHh-CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh-C---------CCCCC
Confidence 3456689999999988 5667899999999999999999999999643321 11111111 0 01123
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+...+..+.+++.+|++.||++||++++++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 3445677999999999999999999999864
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=318.44 Aligned_cols=257 Identities=26% Similarity=0.372 Sum_probs=204.0
Q ss_pred cCCCCccCCCCceEEEEEEeCC----CcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCc-----
Q 002094 684 LNKDCELGRGGFGVVYRTILQD----GRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSL----- 753 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 753 (967)
|+..+.||+|+||.||+|.... +..||+|++..... ......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998642 36799999876542 2334678999999999999999999998866544
Q ss_pred -eeEEEEecCCCchhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccc
Q 002094 754 -QLLIYEFISSGSLYKHLHDGS---SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLA 829 (967)
Q Consensus 754 -~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a 829 (967)
.++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 689999999999999986532 1224889999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCc
Q 002094 830 RLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRV 908 (967)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 908 (967)
+...............++..|+|||.. ....++.++||||||+++|||++ |..||....... ..+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~~~~------- 230 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDYLRH------- 230 (273)
T ss_pred eeccccccccccccccCCccccCHhhc-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc-------
Confidence 866433222222233346679999988 66678999999999999999999 999986543321 1111111
Q ss_pred hhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
......+...+.++.+++.+|++.||++|||+.|+++.|+++
T Consensus 231 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 ------GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ------CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111223455677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.87 Aligned_cols=259 Identities=26% Similarity=0.369 Sum_probs=204.8
Q ss_pred ccCCCCccCCCCceEEEEEEeCC-C--cEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQD-G--RSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 758 (967)
.|+..+.||+|+||.||+|..++ + ..+++|.++........+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 46788899999999999998653 3 347888877443334456789999999999 7999999999999999999999
Q ss_pred EecCCCchhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEee
Q 002094 759 EFISSGSLYKHLHDGSS-------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGD 825 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~D 825 (967)
||+++++|.++++.... ...+++..++.++.|++.|++|||++|++||||||+||++++++.+||+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~d 162 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIAD 162 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECC
Confidence 99999999999975331 12478899999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhc
Q 002094 826 FGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALE 904 (967)
Q Consensus 826 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 904 (967)
||++..... .........+..|+|||.. ....++.++|||||||++|||++ |..||....... ....
T Consensus 163 fg~~~~~~~---~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~~~~--- 230 (297)
T cd05089 163 FGLSRGEEV---YVKKTMGRLPVRWMAIESL-NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----LYEK--- 230 (297)
T ss_pred cCCCccccc---eeccCCCCcCccccCchhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHH---
Confidence 999864321 1111122234569999988 55678999999999999999997 999996543321 1111
Q ss_pred cCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 905 DGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
.........+...+..+.+++.+|++.+|.+|||++++++.|+.+....
T Consensus 231 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 -------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111222334456678999999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=318.49 Aligned_cols=256 Identities=26% Similarity=0.352 Sum_probs=199.8
Q ss_pred CCCCccCCCCceEEEEEEeCCC-c--EEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC------Cce
Q 002094 685 NKDCELGRGGFGVVYRTILQDG-R--SVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP------SLQ 754 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~~-~--~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 754 (967)
...+.||+|+||.||+|...+. . .||+|.+..... ....+.+.+|+++++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999997543 2 689998865432 23456789999999999999999999987432 246
Q ss_pred eEEEEecCCCchhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 755 LLIYEFISSGSLYKHLHDGS---SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
++||||+++|+|.+++.... ....+++..+..++.|++.|++|||+++|+||||||+||++++++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 89999999999999874322 122378999999999999999999999999999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchh
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVED 910 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (967)
..............+++.|+|||.. ....++.++||||||+++|||++ |+.||...... . ..+ .+..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~-~~~----~~~~~---- 230 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESL-ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-E-IYD----YLRQG---- 230 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHc-cCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-H-HHH----HHHcC----
Confidence 6432222222334456789999988 56678999999999999999999 89999653321 1 111 11111
Q ss_pred hcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 911 CVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 911 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
.....+...+..+.+++.+|++.||++|||++++++.|+++
T Consensus 231 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 -----NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11123445667799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.86 Aligned_cols=260 Identities=22% Similarity=0.368 Sum_probs=207.5
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||+|+.. +++.||||.+..... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 3677889999999999999954 689999998865332 2344678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 760 FISSGSLYKHLHDGSS-RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
|+++++|.+++..... ...+++..+..++.|++.||+|||+++++|+||||+||+++.++.++++|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~- 161 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT- 161 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH-
Confidence 9999999998864322 22378899999999999999999999999999999999999999999999999876643211
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
......+++.|+|||.. .+..++.++|+||+|+++|||++|+.||.....+.....+.+.. . ....
T Consensus 162 -~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~----~--------~~~~ 227 (267)
T cd08228 162 -AAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ----C--------DYPP 227 (267)
T ss_pred -HHhcCCCCccccChhhh-ccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc----C--------CCCC
Confidence 12234577889999988 55578899999999999999999999996443322222221111 0 0111
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
..+...+..+.+++.+|++.+|++||++.|+++.+++++
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 112345567999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=323.89 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=214.8
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCc-eeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSL-QLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e 759 (967)
.|...+.+|+|+||.++.++++ ++..|++|.+..... ........+|+.++++++|||||.+.+.+.+++. .+|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 4677889999999999998855 578999999987664 2334578999999999999999999999998888 899999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
||+||++.+.+.+.+.. .++++.+.+++.|++.|+.|||+++|+|||||+.||+++.++.|+|+|||+|+.+.... .
T Consensus 85 Y~eGg~l~~~i~~~k~~-~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~ 161 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGV-LFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--S 161 (426)
T ss_pred ecCCCCHHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch--h
Confidence 99999999999887743 38999999999999999999999999999999999999999999999999999886432 2
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
....+.||+-|+.||.+ .+.+|..|+||||+||++|||++-+++|...+...- ...+++. .-.+
T Consensus 162 ~a~tvvGTp~YmcPEil-~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-i~ki~~~--------------~~~P 225 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEIL-SDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-ILKINRG--------------LYSP 225 (426)
T ss_pred hhheecCCCcccCHHHh-CCCCCCccCcchhhcchHHHHHhcccccCccchHHH-HHHHhhc--------------cCCC
Confidence 45678899999999998 888999999999999999999999999975543211 1112211 1234
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.+.....++..++..|++.+|..||++.+++..
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 577788889999999999999999999999876
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=315.21 Aligned_cols=253 Identities=30% Similarity=0.452 Sum_probs=203.8
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.|...+.||+|++|.||+|...++..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 357788999999999999998877889999886543 33567899999999999999999999875 456889999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.++++..... .+++..+..++.|++.||+|||+.|++|+||||+||++++++.++|+|||.+........ ....
T Consensus 84 ~~~L~~~~~~~~~~-~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~~ 161 (260)
T cd05069 84 KGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQ 161 (260)
T ss_pred CCCHHHHHhhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cccC
Confidence 99999999764332 378999999999999999999999999999999999999999999999999976543221 1222
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
...++..|+|||.. ....++.++|+||||+++|||++ |+.||....... ..+++.. ......+
T Consensus 162 ~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~-------------~~~~~~~ 225 (260)
T cd05069 162 GAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVER-------------GYRMPCP 225 (260)
T ss_pred CCccchhhCCHHHh-ccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc-------------CCCCCCC
Confidence 33456779999988 55678999999999999999999 999997543321 1111111 1112234
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
.+.+..+.+++.+|++.||++||+++++++.|+++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 45667899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=319.47 Aligned_cols=260 Identities=27% Similarity=0.387 Sum_probs=206.8
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCc----EEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
.|+..+.||+|+||+||+|.+. +++ .||+|.+..........++.+|+.+++.++||||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~ 86 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLV 86 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEE
Confidence 3577889999999999999853 444 4899998765544556788999999999999999999999875 456799
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++|+|.++++.... .+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 87 TQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 999999999999976432 388999999999999999999999999999999999999999999999999987643222
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
........+++.|+|||.. ....++.++||||||+++|||++ |..||...... ....++.. ..
T Consensus 165 ~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~-------------~~ 228 (279)
T cd05109 165 EYHADGGKVPIKWMALESI-LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLLEK-------------GE 228 (279)
T ss_pred eeecCCCccchhhCCHHHh-ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC-------------CC
Confidence 2222223446679999988 55678999999999999999998 99998644321 12222211 11
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 961 (967)
....+...+..+.+++.+|++.||++||++.++++.|+.+...-.
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 112234456679999999999999999999999999998866543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=332.26 Aligned_cols=245 Identities=24% Similarity=0.300 Sum_probs=200.1
Q ss_pred ccCCCCccCCCCceEEEEEEeCC--CcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQD--GRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
.|+..+.||+|+||.||+|..+. +..||+|++..... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 36778899999999999998543 36899999865432 234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 111 Ey~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--- 184 (340)
T PTZ00426 111 EFVIGGEFFTFLRRNKR---FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--- 184 (340)
T ss_pred eCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC---
Confidence 99999999999976543 889999999999999999999999999999999999999999999999999765321
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.....||+.|+|||++ .+..++.++||||+||++|||++|+.||...... .....+.. + ..
T Consensus 185 --~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i~~-----~----------~~ 245 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEIL-LNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQKILE-----G----------II 245 (340)
T ss_pred --cceecCChhhcCHHHH-hCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHHHHHhc-----C----------CC
Confidence 2345689999999998 5567889999999999999999999999754321 11111111 0 11
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRP-----DMEEVVNI 952 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 952 (967)
.++...+..+.+++.+|++.||++|+ +++|+++.
T Consensus 246 ~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 23445566789999999999999995 88887653
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=316.68 Aligned_cols=256 Identities=26% Similarity=0.345 Sum_probs=196.1
Q ss_pred CccCCCCceEEEEEEeCC---CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCC
Q 002094 688 CELGRGGFGVVYRTILQD---GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSG 764 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 764 (967)
+.||+|+||.||+|...+ +..+|+|.++..........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998653 45799998876654444567899999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 765 SLYKHLHDGSSR--NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 765 sL~~~l~~~~~~--~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+|.++++..... ...++..+..++.|++.|++|||+++++|+||||+||+++.++.++++|||.+.............
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 999999754321 235677888999999999999999999999999999999999999999999987543322222233
Q ss_pred cccccccccCcccccCc------ccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 843 KIQSALGYMAPEFACRT------VKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~------~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
...++..|+|||++... ..++.++|+||||+++|||++ |+.||............ +. .. .....+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~----~~-~~~~~~-- 232 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VR----EQ-QLKLPK-- 232 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-hh----cc-cCCCCC--
Confidence 45567889999987321 235789999999999999996 99999754433221111 10 00 001111
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
+......+..+.+++.+|+ .+|++|||++|+++.|+
T Consensus 233 --~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 --PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred --CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1112234556889999999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=332.08 Aligned_cols=248 Identities=22% Similarity=0.322 Sum_probs=195.7
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+..+.||+|+||.||+|+.. +++.||||++...........+.+|++++++++|+||+++++++...+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 456778999999999999965 6899999999765433445779999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.+.. ...+..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...... ....
T Consensus 156 ~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 226 (353)
T PLN00034 156 GGSLEGTH-------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCN 226 (353)
T ss_pred CCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--cccc
Confidence 99986532 14567788999999999999999999999999999999999999999999997654211 1123
Q ss_pred cccccccccCcccccC----cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 843 KIQSALGYMAPEFACR----TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~----~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
...|+..|+|||++.. ....+.++|||||||++|||++|+.||........ ...+.... .....
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~----------~~~~~ 294 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW--ASLMCAIC----------MSQPP 294 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHHh----------ccCCC
Confidence 4568999999998732 22345689999999999999999999973322111 11111100 00112
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..+...+.++.+++.+|++.||++|||++|+++.
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2344566789999999999999999999999875
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=332.67 Aligned_cols=252 Identities=21% Similarity=0.276 Sum_probs=201.8
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||+|+.. +++.||||++..... ......+..|++++..++||||+++++++..++..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 577889999999999999976 589999999975432 22346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..... .
T Consensus 83 ~~g~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~ 154 (333)
T cd05600 83 VPGGDFRTLLNNLGV---LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----Y 154 (333)
T ss_pred CCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----c
Confidence 999999999976443 78899999999999999999999999999999999999999999999999975532 2
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....|++.|+|||++ ....++.++||||+||++|||++|+.||........ ... +.... ...........
T Consensus 155 ~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~-i~~~~------~~~~~~~~~~~ 225 (333)
T cd05600 155 ANSVVGSPDYMAPEVL-RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WEN-LKYWK------ETLQRPVYDDP 225 (333)
T ss_pred cCCcccCccccChhHh-cCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHH-HHhcc------ccccCCCCCcc
Confidence 3355689999999998 555889999999999999999999999975433211 111 11000 00000000000
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
....+.++.+++.+|+..+|.+||+++|+++.
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 12346678999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=319.68 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=206.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
+.|+..+.||+|+||.||+|..+ .+..||+|.+..........++.+|+.++++++||||+++++++.++...+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 45688899999999999998753 245899998875543344557889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccc
Q 002094 756 LIYEFISSGSLYKHLHDGSS-------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGL 828 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~ 828 (967)
+||||+++|+|.+++..... ....++..+.+++.|++.|++|||+++|+||||||+||++++++.++++|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~ 165 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM 165 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCc
Confidence 99999999999999975321 12356788899999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCC
Q 002094 829 ARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGR 907 (967)
Q Consensus 829 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (967)
++...............++..|+|||.. ..+.++.++|+|||||++|||++ |..||....... +.......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~-~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~~~~-- 237 (288)
T cd05061 166 TRDIYETDYYRKGGKGLLPVRWMAPESL-KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-----VLKFVMDG-- 237 (288)
T ss_pred cccccccccccccCCCcccccccCHHHh-ccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHcC--
Confidence 8755332222222233446779999988 55678999999999999999998 788986433221 11111110
Q ss_pred chhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
.....+...+..+.+++.+|++.||++|||+.++++.|+....+
T Consensus 238 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 238 --------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 01122344567899999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=338.83 Aligned_cols=257 Identities=21% Similarity=0.276 Sum_probs=210.0
Q ss_pred cCCCCccCCCCceEEEEEEeCCC-cEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeE-EEc------CCce
Q 002094 684 LNKDCELGRGGFGVVYRTILQDG-RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGY-YWT------PSLQ 754 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~------~~~~ 754 (967)
+++.+.|.+|||+.||.|....+ ..||+|++... .......+.+|+++|++|+ |+|||.+++. ... ..+.
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 57788999999999999997665 99999999877 3567788999999999996 9999999993 321 2466
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCEEeCCCCCeEEeeccccccc
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN--IIHYNLKSTNVLIDSSGEPKVGDFGLARLL 832 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~--ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 832 (967)
++.||||.||.|-+++..+.... +++.++++|+.|+|+|+++||..+ |||||||-+|||++.++..||||||.|.-.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 89999999999999998766555 999999999999999999999874 999999999999999999999999998643
Q ss_pred CCCcccc-------ccccccccccccCccccc--CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhh
Q 002094 833 PMLDRCI-------LSSKIQSALGYMAPEFAC--RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGAL 903 (967)
Q Consensus 833 ~~~~~~~-------~~~~~~gt~~y~aPE~~~--~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 903 (967)
-...... ..-....|+.|+|||++. ++...++|+||||+||+||-|+....||+....
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------------- 263 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------------- 263 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------------
Confidence 2111100 111355789999999872 466789999999999999999999999974321
Q ss_pred ccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 904 EDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
..+++..+..+-.+.....+.+||+.|+++||.+||++-+|+..+.+++..-
T Consensus 264 -----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 -----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1233333433333567888999999999999999999999999998887543
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=345.42 Aligned_cols=256 Identities=20% Similarity=0.324 Sum_probs=205.1
Q ss_pred hhccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC------
Q 002094 681 NALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS------ 752 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 752 (967)
.+.|+..+.||+|+||.||+|+. .+|+.||||.+..... ......+.+|+..+..++|+|++++++.+....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 34678889999999999999985 4689999999976543 334567889999999999999999988765332
Q ss_pred --ceeEEEEecCCCchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccc
Q 002094 753 --LQLLIYEFISSGSLYKHLHDGSS-RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLA 829 (967)
Q Consensus 753 --~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a 829 (967)
..++||||+++|+|.++++.... ...+++..+..++.|++.||+|+|+++|+||||||+||+++.++.+||+|||++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 35799999999999999975432 235889999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 830 RLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
+.+.............||+.|+|||++ ....++.++|||||||++|||++|+.||...... +++.....
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-----~~~~~~~~----- 259 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIW-RRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-----EVMHKTLA----- 259 (496)
T ss_pred eeccccccccccccccCCcceeCHHHh-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHhc-----
Confidence 866432222233456789999999998 5667899999999999999999999999744321 11111111
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
......+...+.++.+++.+|++.||++||++.++++.
T Consensus 260 -----~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 -----GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 01122455667789999999999999999999998763
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.96 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=206.5
Q ss_pred ccCCCCccCCCCceEEEEEEeCC------CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQD------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLL 756 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 756 (967)
.|+..+.||+|+||.||+|..+. +..||+|.+...........+.+|+.+++.++||||+++++++......++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 86 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV 86 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence 45778899999999999998642 468999998655433445678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccc
Q 002094 757 IYEFISSGSLYKHLHDGSSR-------NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLA 829 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a 829 (967)
||||+++|+|.+++...... ..+++..+..++.|++.|++|||+.+++||||||+||+++.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~ 166 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT 166 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccc
Confidence 99999999999999754321 23688999999999999999999999999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCc
Q 002094 830 RLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRV 908 (967)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 908 (967)
+...............++..|+|||.. ....++.++||||||+++||+++ |..||...... .....+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~-------- 235 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESL-KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFVI-------- 235 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHH-hcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHHh--------
Confidence 765432222223344567789999988 55678999999999999999998 99998643322 1111111
Q ss_pred hhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
.......+...+.++.+++.+|++.+|++|||+.++++.|++
T Consensus 236 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 -----DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -----cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111122345557789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=322.03 Aligned_cols=269 Identities=26% Similarity=0.363 Sum_probs=205.0
Q ss_pred hccCCCCccCCCCceEEEEEEe-----CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--Cce
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP--SLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 754 (967)
.+|+..+.||+|+||.||++.. .++..||+|.+...........+.+|++++++++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4568889999999999999974 357889999987654444557899999999999999999999998765 567
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
++||||+++++|.+++..... .+++..+..++.|++.||+|+|++|++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 899999999999999865432 378999999999999999999999999999999999999999999999999986643
Q ss_pred Cccc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch---h
Q 002094 835 LDRC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE---D 910 (967)
Q Consensus 835 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~ 910 (967)
.... .......++..|+|||+. .+..++.++||||||+++|||++++.|+...... ............... .
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECL-IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred CccceeecCCCCCCccccCHHHh-ccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhcccccccccHHHHHH
Confidence 2221 112234456679999988 5567899999999999999999988765321110 000000000000000 0
Q ss_pred hcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 911 CVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 911 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
......+.+.+...+..+.+++.+|++.+|++|||++++++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0111112223445677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.88 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=207.9
Q ss_pred ccCCCCccCCCCceEEEEEEeC--------CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCc
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ--------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSL 753 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 753 (967)
.|...+.||+|+||.||++... ....||+|.+..........++..|+++++++ +||||+++++++...+.
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 4577899999999999999742 24579999887654344456788999999999 69999999999999899
Q ss_pred eeEEEEecCCCchhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSS-------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE 820 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~ 820 (967)
.++||||+++|+|.+++..... ...+++.++.+++.|++.||+|||++|++||||||+||+++.++.
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~ 172 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV 172 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCc
Confidence 9999999999999999976421 124889999999999999999999999999999999999999999
Q ss_pred eEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHH
Q 002094 821 PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMV 899 (967)
Q Consensus 821 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~ 899 (967)
+||+|||.++...............++..|+|||.+ ....++.++||||||+++|||++ |..||....... ..+.+
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~ 249 (314)
T cd05099 173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--LFKLL 249 (314)
T ss_pred EEEccccccccccccccccccccCCCCccccCHHHH-ccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH
Confidence 999999999765432221112222344579999988 55678999999999999999999 899986543221 11111
Q ss_pred HhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 900 RGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
.. ......+..++.++.+++.+|++.+|++|||+.|+++.|+++...+
T Consensus 250 ----~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 250 ----RE---------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ----Hc---------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 11 1112234556678999999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=314.91 Aligned_cols=255 Identities=31% Similarity=0.443 Sum_probs=207.6
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+.|+..+.||+|+||.||+|..++++.||||.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 3467888999999999999998888899999987543 34578999999999999999999999999889999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++...... .+++.++..++.|++.|++|||+++++|+||||+||++++++.++++|||.+....... ....
T Consensus 84 ~~~~L~~~i~~~~~~-~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~ 161 (261)
T cd05034 84 SKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAR 161 (261)
T ss_pred CCCCHHHHHhccccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh-hhhh
Confidence 999999999775432 38999999999999999999999999999999999999999999999999987654311 1111
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....++..|+|||.. ....++.++|+||+|+++||+++ |+.||...... .....+. ...+...
T Consensus 162 ~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~--------------~~~~~~~ 225 (261)
T cd05034 162 EGAKFPIKWTAPEAA-NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQVE--------------RGYRMPR 225 (261)
T ss_pred hccCCCccccCHHHh-ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH--------------cCCCCCC
Confidence 223345679999988 55678999999999999999998 99999654322 1111111 1111223
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
+...+.++.+++.+|++.+|++||+++++.+.|+.+
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 344567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.77 Aligned_cols=265 Identities=25% Similarity=0.352 Sum_probs=204.2
Q ss_pred hccCCCCccCCCCceEEEEEEeCC---------------CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD---------------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEG 746 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 746 (967)
+.|+..+.||+|+||.||++.... ...||+|.++..........+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 346788899999999999987532 23589999876543444567999999999999999999999
Q ss_pred EEEcCCceeEEEEecCCCchhhhhhcCCCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC
Q 002094 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSR---------NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS 817 (967)
Q Consensus 747 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~ 817 (967)
++...+..++||||+++++|.+++...... ..+++..+..++.|++.|++|||+++++||||||+||+++.
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~ 164 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence 999999999999999999999998653211 13688999999999999999999999999999999999999
Q ss_pred CCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc--CCCCCCCCccchHhH
Q 002094 818 SGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT--GKRPVEYMEDDVVVL 895 (967)
Q Consensus 818 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt--g~~p~~~~~~~~~~~ 895 (967)
++.+||+|||++................++..|+|||.. ..+.++.++|+||||+++|||++ |..||....... ..
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-~~ 242 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI-LLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-VI 242 (295)
T ss_pred CCcEEecccccccccccCcceeccCcCcCceeecChhhh-ccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-HH
Confidence 999999999998765432222222334456789999988 55678999999999999999998 667776433221 11
Q ss_pred HHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 896 CDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
... ....... ........+...+..+.+++.+|++.||++|||+++|++.|++
T Consensus 243 ~~~-~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 243 ENT-GEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHH-HHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111 1111000 0111112234456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=323.11 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=203.4
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCc--EEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGR--SVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 758 (967)
.|+..+.||+|+||.||+|..+ ++. .+|+|.+...........+.+|++++.++ +||||+++++++...+..++||
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 4577889999999999999964 344 45777766443334456789999999999 8999999999999999999999
Q ss_pred EecCCCchhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEee
Q 002094 759 EFISSGSLYKHLHDGSS-------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGD 825 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~D 825 (967)
||+++++|.++++.... ...+++.+++.++.|++.|++|||++|++||||||+||+++.++.+||+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~d 167 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 167 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCc
Confidence 99999999999975431 12478999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhc
Q 002094 826 FGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALE 904 (967)
Q Consensus 826 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 904 (967)
||++..... ........++..|+|||.+ ....++.++|||||||++|||++ |..||....... ..+.+
T Consensus 168 fg~~~~~~~---~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~----- 236 (303)
T cd05088 168 FGLSRGQEV---YVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKL----- 236 (303)
T ss_pred cccCcccch---hhhcccCCCcccccCHHHH-hccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHHHH-----
Confidence 999863221 1111122345679999988 55678899999999999999998 999996443221 11111
Q ss_pred cCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 905 DGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
........+...+.++.+++.+|++.+|++||+++++++.|+++...-
T Consensus 237 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 237 --------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred --------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111112223345567899999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=328.71 Aligned_cols=263 Identities=28% Similarity=0.386 Sum_probs=204.7
Q ss_pred hccCCCCccCCCCceEEEEEEe------CCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcC-Cc
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTP-SL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~ 753 (967)
+.|+..+.||+|+||.||+|.. .+++.||||+++..........+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 3478899999999999999973 357899999997654333456788999999999 689999999988654 45
Q ss_pred eeEEEEecCCCchhhhhhcCCC----------------------------------------------------------
Q 002094 754 QLLIYEFISSGSLYKHLHDGSS---------------------------------------------------------- 775 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 775 (967)
.++||||+++|+|.++++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999865321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccccccccc
Q 002094 776 ------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG 849 (967)
Q Consensus 776 ------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 849 (967)
...+++..+.+++.|++.|++|||+++|+||||||+||+++.++.+|++|||++................+++.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 11367888999999999999999999999999999999999999999999999876533222222233445677
Q ss_pred ccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHH
Q 002094 850 YMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPV 928 (967)
Q Consensus 850 y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 928 (967)
|+|||.+ ....++.++||||||+++|||++ |..||........ ....+ .. ..+...+...+.++
T Consensus 247 y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~----~~---------~~~~~~~~~~~~~~ 311 (343)
T cd05103 247 WMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRL----KE---------GTRMRAPDYTTPEM 311 (343)
T ss_pred eECcHHh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHH----hc---------cCCCCCCCCCCHHH
Confidence 9999988 55678999999999999999997 9999975432211 11111 11 11111223345578
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 929 IKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 929 ~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
.+++.+|++.||++|||+.|+++.|+.+.+.
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=315.53 Aligned_cols=257 Identities=33% Similarity=0.493 Sum_probs=205.2
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CC---cEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DG---RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
.|+..+.||+|+||.||+|+.+ ++ ..+|+|.+.........+++..|++++++++|||++++.+++...+..++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 4577889999999999999965 23 3799999876543444567999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++++|.+++..... .+++.++..++.|++.|++|||+.+++||||||+||+++.++.++++|||++.........
T Consensus 86 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 86 EYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred EcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 99999999999976432 3789999999999999999999999999999999999999999999999998766432211
Q ss_pred cc-cccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 839 IL-SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 839 ~~-~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.. ......++.|+|||++ ....++.++||||||+++||+++ |+.||....... +..... ...
T Consensus 164 ~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-----~~~~i~----------~~~ 227 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-----VMKAIN----------DGF 227 (268)
T ss_pred ceeccCCCcCceecCHHHh-hcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----HHHHHh----------cCC
Confidence 11 1112234579999988 55678999999999999999998 999996443221 111111 111
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
+.+.+.+.+..+.+++.+|++.+|++||++.++++.|+++.
T Consensus 228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 22234456678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=326.06 Aligned_cols=242 Identities=26% Similarity=0.372 Sum_probs=195.9
Q ss_pred CccCCCCceEEEEEEe----CCCcEEEEEEeecCCc---cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 688 CELGRGGFGVVYRTIL----QDGRSVAIKKLTVSGL---IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.||+|+||.||+++. .+++.||||.+..... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 3578999999975432 22345678999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|.+++..... +.+..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..... ...
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 156 (323)
T cd05584 82 LSGGELFMHLEREGI---FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--GTV 156 (323)
T ss_pred CCCchHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--CCc
Confidence 999999999976543 778888999999999999999999999999999999999999999999998743221 112
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....|++.|+|||++ ....++.++||||+||++|||++|+.||...... .....+.. + ....
T Consensus 157 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-~~~~~~~~-----~----------~~~~ 219 (323)
T cd05584 157 THTFCGTIEYMAPEIL-MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-KTIDKILK-----G----------KLNL 219 (323)
T ss_pred ccccCCCccccChhhc-cCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-HHHHHHHc-----C----------CCCC
Confidence 2345689999999998 5557889999999999999999999999754322 11111111 0 1123
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
+...+..+.+++.+|++.||++|| +++++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 455567799999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=320.79 Aligned_cols=264 Identities=27% Similarity=0.368 Sum_probs=207.0
Q ss_pred ccCCCCccCCCCceEEEEEEeCC-----------------CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQD-----------------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 745 (967)
.|+..+.||+|+||.||+|...+ +..||+|.+.........+.+.+|++++++++||||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 46788999999999999988542 2468999987665445567899999999999999999999
Q ss_pred eEEEcCCceeEEEEecCCCchhhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC
Q 002094 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSS--------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS 817 (967)
Q Consensus 746 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~ 817 (967)
+++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+++++|+||||+||+++.
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~ 165 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecC
Confidence 999999999999999999999999976541 124789999999999999999999999999999999999999
Q ss_pred CCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc--CCCCCCCCccchHhH
Q 002094 818 SGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT--GKRPVEYMEDDVVVL 895 (967)
Q Consensus 818 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt--g~~p~~~~~~~~~~~ 895 (967)
++.++++|||.++...............+++.|+|||.. ....++.++||||||+++|||++ |..||....... .
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~-~- 242 (296)
T cd05051 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV-LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ-V- 242 (296)
T ss_pred CCceEEccccceeecccCcceeecCcCCCCceecCHHHh-hcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH-H-
Confidence 999999999998765432222233345567789999988 45578999999999999999998 777886443221 1
Q ss_pred HHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 896 CDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
........... ........+...+.++.+++.+|++.||++|||+.|+++.|++
T Consensus 243 ~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 243 IENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111110 0111112234456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=328.49 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=198.9
Q ss_pred cCCCCccCCCCceEEEEEEe----CCCcEEEEEEeecCCc---cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCcee
Q 002094 684 LNKDCELGRGGFGVVYRTIL----QDGRSVAIKKLTVSGL---IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 755 (967)
|+..+.||+|+||.||+++. .+++.||+|++..... ....+.+..|+.+++.+ +|++|+++++++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 56678899999999999885 3588999999875321 23345688899999999 5999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+||||+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 82 lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 99999999999999976443 889999999999999999999999999999999999999999999999998765332
Q ss_pred ccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 836 DRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
.. .......||+.|+|||.+.....++.++|||||||++|||++|+.||....... ....+......
T Consensus 159 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~----------- 225 (332)
T cd05614 159 EK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVSRRILK----------- 225 (332)
T ss_pred CC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHHHHHhc-----------
Confidence 21 122345689999999998544557889999999999999999999996332211 01111111111
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
....++...+..+.+++.+|++.||++|| +++++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11233445667789999999999999999 6667654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.07 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=205.3
Q ss_pred hccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
+.|+..+.||+|+||.||+|... ++..||+|.+..........++.+|+.++++++||||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 34678889999999999999853 467899999876554444577999999999999999999999999989999
Q ss_pred EEEEecCCCchhhhhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC
Q 002094 756 LIYEFISSGSLYKHLHDGSS-------------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID 816 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~-------------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~ 816 (967)
+||||+++|+|.+++..... ...+++..++.++.|++.||+|||+++++||||||+||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~ 164 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG 164 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence 99999999999999974321 11367889999999999999999999999999999999999
Q ss_pred CCCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhH
Q 002094 817 SSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVL 895 (967)
Q Consensus 817 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~ 895 (967)
.++.++|+|||.+.................+..|+|||.. ....++.++|||||||++|||++ |..||......
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~---- 239 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE---- 239 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHH-hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999998755332222222233446679999988 55678999999999999999998 88898644322
Q ss_pred HHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 896 CDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
++... +..+. ....+...+.++.+++.+|++.||++|||+.|+++.|++
T Consensus 240 -~~~~~-~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -EVIYY-VRDGN---------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -HHHHH-HhcCC---------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 11111 111234556789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=323.73 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=210.7
Q ss_pred CCCccCCCCceEEEEEEeCC--C--cEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 686 KDCELGRGGFGVVYRTILQD--G--RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 686 ~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
..++||+|.||+|++|.|.. | ..||||.++.........+|.+|+.+|.+++|||++++||++.+ ....+|||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 34679999999999999762 3 46999999887655567899999999999999999999999877 6778999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
+.|||.+.|++ ..+..+-......++.|||.||.||.++++||||+..+|+++-....|||+|||+.+-++..+..+..
T Consensus 193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm 271 (1039)
T KOG0199|consen 193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVM 271 (1039)
T ss_pred ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEe
Confidence 99999999998 33344888889999999999999999999999999999999999999999999999988765444322
Q ss_pred -ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 842 -SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 842 -~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
....-.+.|+|||.+ ++..++.++|||+|||++|||++ |..||..-... .+-+.+|.+.+-+
T Consensus 272 ~p~rkvPfAWCaPEsL-rh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---------------qIL~~iD~~erLp 335 (1039)
T KOG0199|consen 272 APQRKVPFAWCAPESL-RHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---------------QILKNIDAGERLP 335 (1039)
T ss_pred cCCCcCcccccCHhHh-ccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---------------HHHHhccccccCC
Confidence 233345679999999 88899999999999999999999 89999654331 1223445555666
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.|+.|++.++++++.||..+|.+|||+..+.+.
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 789999999999999999999999999999743
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=317.09 Aligned_cols=247 Identities=23% Similarity=0.329 Sum_probs=195.9
Q ss_pred cCCCCceEEEEEEeC-CCcEEEEEEeecCCcc--ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCch
Q 002094 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSL 766 (967)
Q Consensus 690 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 766 (967)
||+|+||+||++..+ +++.||+|.+...... ...+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999854 6889999998754321 2335678899999999999999999999999999999999999999
Q ss_pred hhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccccc
Q 002094 767 YKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQ 845 (967)
Q Consensus 767 ~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 845 (967)
..++.... ....+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||.+........ ......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccC
Confidence 98875432 223489999999999999999999999999999999999999999999999999876543221 223456
Q ss_pred ccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhH
Q 002094 846 SALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEA 925 (967)
Q Consensus 846 gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (967)
|++.|+|||.+ .+..++.++||||+|+++|||++|+.||........ ......... .. ...++...+
T Consensus 159 g~~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~---------~~--~~~~~~~~~ 225 (280)
T cd05608 159 GTPGFMAPELL-QGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRIL---------ND--SVTYPDKFS 225 (280)
T ss_pred CCcCccCHHHh-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhc---------cc--CCCCcccCC
Confidence 88999999998 566889999999999999999999999974332111 011111110 00 112344566
Q ss_pred HHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 926 IPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 926 ~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
..+.+++.+|++.||++|| |++++++
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 7799999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=290.30 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=207.6
Q ss_pred HHHhhccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccc-------cHHHHHHHHHHHcCC-CCCceeeeeeEE
Q 002094 678 AGANALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIK-------SQEDFEKEMKTLGKI-RHHNLVALEGYY 748 (967)
Q Consensus 678 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~-------~~~~~~~E~~~l~~l-~h~niv~~~~~~ 748 (967)
....+.|...+.+|.|..++|.++.. +.|..+|+|++....... -.+.-.+|+.+++++ .||+|+.+.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 33445567888999999999998874 468899999996654321 134567899999998 699999999999
Q ss_pred EcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccc
Q 002094 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGL 828 (967)
Q Consensus 749 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~ 828 (967)
..+...++|+|.|+.|.|.+++...-. +++....+|++|+.+|++|||.+.|||||+||+|||+|++.+++|+|||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~Vt---lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKVT---LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhee---ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccce
Confidence 999999999999999999999987654 88999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccC-----cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhh
Q 002094 829 ARLLPMLDRCILSSKIQSALGYMAPEFACR-----TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGAL 903 (967)
Q Consensus 829 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 903 (967)
++..+. ...-+...|||+|.|||.+.. +..|+..+|+||.||++|.++.|.+||-.... .. +-..+
T Consensus 170 a~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-ml-----MLR~I 240 (411)
T KOG0599|consen 170 ACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-ML-----MLRMI 240 (411)
T ss_pred eeccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-HH-----HHHHH
Confidence 998754 334567889999999998732 34578899999999999999999999942211 11 11122
Q ss_pred ccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 904 EDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
-++..+ .+.+-+.+.+....++|.+|++.||++|.|++|+++
T Consensus 241 meGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 241 MEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred Hhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 122111 123335677788999999999999999999999875
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=314.58 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=198.2
Q ss_pred CccCCCCceEEEEEEeCC-Cc--EEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQD-GR--SVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||+|..++ +. .+|+|.+...........+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999654 43 46888887544334556889999999999 799999999999999999999999999
Q ss_pred CchhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 764 GSLYKHLHDGSS-------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 764 gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
|+|.++++.... ...+++.++..++.|++.|++|||++|++||||||+||++++++.+|++|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 999999975431 1237899999999999999999999999999999999999999999999999985
Q ss_pred ccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 831 LLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
.... .........+..|+|||+. ....++.++||||||+++|||++ |..||....... .....
T Consensus 161 ~~~~---~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~~~------- 224 (270)
T cd05047 161 GQEV---YVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEKL------- 224 (270)
T ss_pred ccch---hhhccCCCCccccCChHHH-ccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-----HHHHH-------
Confidence 3221 1111122335679999988 56678999999999999999997 999996443221 11111
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
........+...+.++.+++.+|++.+|.+|||+.++++.|+++.
T Consensus 225 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 ---PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111111233445667999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=312.81 Aligned_cols=251 Identities=29% Similarity=0.450 Sum_probs=207.0
Q ss_pred CccCCCCceEEEEEEeCC----CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQD----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||+|.... +..||+|.+.........+.+.+|++.++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999654 8899999997765433467899999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 764 GSLYKHLHDGSS------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 764 gsL~~~l~~~~~------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
++|.+++..... ...+++..+++++.|++.|++|||+++++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 999999987621 13489999999999999999999999999999999999999999999999999987754332
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
........+++.|+|||.+ ....++.++||||+|+++|||++ |..||...... ...+.+.. ..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~-------------~~ 224 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESL-KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLEYLRK-------------GY 224 (262)
T ss_pred cccccCCCcCccccCHHHh-ccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc-------------CC
Confidence 2334455678889999988 44578999999999999999999 69999755322 11111110 11
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
+...+...+.++.+++.+|++.+|++|||+.|+++.|+
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 22345556778999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=317.25 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=203.0
Q ss_pred cCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
++..++||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++|+||+++++++...+..++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 566789999999999999732 35688999876543 34456899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEee
Q 002094 758 YEFISSGSLYKHLHDGSSR------------NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGD 825 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~D 825 (967)
|||+++++|.+++...... ..+++..+..++.|++.|++|||++|++||||||+||++++++.++|+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECC
Confidence 9999999999999764321 2378999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhc
Q 002094 826 FGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALE 904 (967)
Q Consensus 826 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 904 (967)
||++................+++.|+|||.. ....++.++|||||||++|||++ |++||........ .+.+
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~----- 237 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-LYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--IECI----- 237 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHh-ccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--HHHH-----
Confidence 9998755332221222334456789999988 55678999999999999999998 9999864332211 1101
Q ss_pred cCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 905 DGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
........+..++..+.+++.+|++.||.+||+++|+.+.|++
T Consensus 238 --------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 --------TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred --------HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111112334556779999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=315.70 Aligned_cols=255 Identities=29% Similarity=0.439 Sum_probs=204.3
Q ss_pred cCCCCccCCCCceEEEEEEeCC-C---cEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQD-G---RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
|+..+.||+|+||.||+|..+. + ..||||.+..........+|..|+.++++++||||+++++++......++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 5678899999999999999653 3 36999998765434456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++++|.+++..... .+++.+++.++.|++.|++|||++|++|+||||+||+++.++.++++|||.+..........
T Consensus 86 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 86 FMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred cCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 9999999999976433 37899999999999999999999999999999999999999999999999987654322111
Q ss_pred c-ccccc--ccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 840 L-SSKIQ--SALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 840 ~-~~~~~--gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
. ..... .+..|+|||.. ....++.++||||+|+++||+++ |..||...... ...+++.. .
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~-------------~ 227 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQ-------------D 227 (269)
T ss_pred ccccccCCCcceeecCHhHh-ccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHc-------------C
Confidence 1 11111 23579999998 66678999999999999999887 99999643321 12222211 1
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
.+...+.+++..+.+++.+|++.+|.+||++++++.+|+++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11223445667799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=311.37 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=200.8
Q ss_pred CccCCCCceEEEEEEeCC----CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQD----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
++||+|+||.||+|.... +..||+|.+.........+++.+|+++++++.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998432 26899999876654445678999999999999999999999875 4567999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc-cc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL-SS 842 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~ 842 (967)
++|.+++.... .+++..+..++.|++.|++|||+++++|+||||+||+++.++.+||+|||.++.......... ..
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999998655 388999999999999999999999999999999999999999999999999986643222111 11
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
...++..|+|||.. ....++.++||||||+++||+++ |+.||...... ....++.. . .....+
T Consensus 157 ~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~~----~---------~~~~~~ 220 (257)
T cd05060 157 AGRWPLKWYAPECI-NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLES----G---------ERLPRP 220 (257)
T ss_pred CccccccccCHHHh-cCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHc----C---------CcCCCC
Confidence 22234579999988 56678999999999999999998 99999754332 11222211 1 112234
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
...+..+.+++.+|++.+|++||++.+++++|+++-
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 556678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=310.18 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=202.7
Q ss_pred CccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCchh
Q 002094 688 CELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLY 767 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 767 (967)
+.||+|+||.||++...+++.||+|.+...........+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999999876654445678999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccccccc
Q 002094 768 KHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA 847 (967)
Q Consensus 768 ~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 847 (967)
+++..... .+++..+..++.+++.|++|||+++++||||+|+||+++.++.++|+|||.+................++
T Consensus 81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (251)
T cd05041 81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158 (251)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence 99976433 3788999999999999999999999999999999999999999999999998755421111111223345
Q ss_pred ccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHH
Q 002094 848 LGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAI 926 (967)
Q Consensus 848 ~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (967)
..|+|||.. ..+.++.++|+||+|+++|||++ |..||....... ..+.+ ........+...+.
T Consensus 159 ~~y~~PE~~-~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~~-------------~~~~~~~~~~~~~~ 222 (251)
T cd05041 159 IKWTAPEAL-NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRERI-------------ESGYRMPAPQLCPE 222 (251)
T ss_pred eccCChHhh-ccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHHH-------------hcCCCCCCCccCCH
Confidence 679999988 55678999999999999999999 889986543221 11111 11112223445667
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 927 PVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 927 ~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
.+.+++.+|++.+|.+|||+.|+++.|+.
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 89999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=318.81 Aligned_cols=268 Identities=26% Similarity=0.389 Sum_probs=203.3
Q ss_pred ccCCCCccCCCCceEEEEEEeC-----CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEc--CCcee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-----DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT--PSLQL 755 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~ 755 (967)
.|+..+.||+|+||.||++..+ +++.||+|.+.... ....+.+.+|++++++++||||+++++++.. ....+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 3567788999999999999742 57899999987543 3445688999999999999999999998754 34678
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+||||+++++|.+++..... .+++..+..++.|++.||+|||++|++||||||+||++++++.++|+|||++......
T Consensus 84 lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999999999975432 3789999999999999999999999999999999999999999999999999876542
Q ss_pred ccccc-cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc----cCCchh
Q 002094 836 DRCIL-SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE----DGRVED 910 (967)
Q Consensus 836 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~ 910 (967)
..... .....++..|+|||.. ....++.++|+||||+++|||++|..|+...... ..+.+..... ...+.+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred CcceeecCCCCCceEeeCHHHh-ccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHHH
Confidence 22111 1122234459999988 5667899999999999999999988776432211 0000000000 000111
Q ss_pred hcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 911 CVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 911 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
..........+...+.++.+++.+|++.+|++|||++|+++.|+.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 12222222334556778999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=317.92 Aligned_cols=261 Identities=23% Similarity=0.310 Sum_probs=195.3
Q ss_pred ccCCCCccCCCCceEEEEEEeC--CCcEEEEEEeecCCcc-ccHHHHHHHHHHHcCC---CCCceeeeeeEEE-----cC
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ--DGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKI---RHHNLVALEGYYW-----TP 751 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~ 751 (967)
.|+..+.||+|+||.||+|+.. +++.||+|+++..... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 3677889999999999999853 4688999998765432 2234566777776655 6999999999885 24
Q ss_pred CceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 752 SLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
...++||||++ ++|.+++...... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 56789999997 5899998764433 378999999999999999999999999999999999999999999999999976
Q ss_pred cCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (967)
.... .......|++.|+|||.+ ....++.++||||+||++|||++|++||....+. ..+..++.. .......++
T Consensus 160 ~~~~---~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~-~~~~~~~~~ 233 (290)
T cd07862 160 YSFQ---MALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDV-IGLPGEEDW 233 (290)
T ss_pred ccCC---cccccccccccccChHHH-hCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHH-hCCCChhhc
Confidence 5432 223455688999999988 5567889999999999999999999999754432 222222221 111100000
Q ss_pred cc------hhh----cC---CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 912 VD------ARL----RG---NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 912 ~~------~~~----~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.. ... .. ...++.+..+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 000 00 011234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=325.06 Aligned_cols=237 Identities=25% Similarity=0.353 Sum_probs=192.2
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||+|+.+ +++.||||++..... ....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 588999999875421 23445677888888776 699999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..... .......
T Consensus 81 g~L~~~i~~~~~---l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSRR---FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTST 155 (320)
T ss_pred chHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCcccc
Confidence 999999876543 88999999999999999999999999999999999999999999999999875322 1122334
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
..||+.|+|||.+ ....++.++||||+||++|||++|+.||...... .. ...... . ....+..
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~----~~~i~~-~----------~~~~~~~ 218 (320)
T cd05590 156 FCGTPDYIAPEIL-QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-DL----FEAILN-D----------EVVYPTW 218 (320)
T ss_pred cccCccccCHHHH-cCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-HH----HHHHhc-C----------CCCCCCC
Confidence 5689999999998 5667899999999999999999999999754332 11 111111 0 1123344
Q ss_pred hHHHHHHHHHhhccCCCCCCCCH
Q 002094 924 EAIPVIKLGLICASQVPSNRPDM 946 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~ 946 (967)
.+.++.+++.+|++.||++||++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCC
Confidence 56678999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=325.16 Aligned_cols=243 Identities=22% Similarity=0.297 Sum_probs=192.9
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||++..+ +++.||+|++..... ......+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 578999999976432 23345678888888776 899999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|..++..... +++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~~~~~---l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTST 155 (329)
T ss_pred CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCcccc
Confidence 999988865433 889999999999999999999999999999999999999999999999998753221 112234
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCcc---chHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMED---DVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
..||+.|+|||++ .+..++.++||||+||++|||++|+.||..... .......++...+... ...+
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----------~~~~ 224 (329)
T cd05618 156 FCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------QIRI 224 (329)
T ss_pred ccCCccccCHHHH-cCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC----------CCCC
Confidence 5689999999998 566789999999999999999999999963211 1111112222111111 1234
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDM 946 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~ 946 (967)
|...+..+.+++.+|++.||++||++
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 55667789999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.65 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=209.1
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||+|... +|+.||+|.++.... ....+.+.+|++++++++|++++++++++...+..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 4677889999999999999976 789999998864322 2345789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 760 FISSGSLYKHLHDGSS-RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
|+++++|.+++..... ...+++.++..++.+++.|++|||+.|++||||+|+||+++.++.++++|||.+.......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-- 160 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-- 160 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC--
Confidence 9999999999875322 2347899999999999999999999999999999999999999999999999987654321
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......+++.|+|||.. .+..++.++|+||+||++|+|++|+.||.......... .... . .....
T Consensus 161 ~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~-~---------~~~~~ 226 (267)
T cd08224 161 TAAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CKKI-E---------KCDYP 226 (267)
T ss_pred cccceecCCccccCHHHh-ccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH---Hhhh-h---------cCCCC
Confidence 112345578889999988 56678899999999999999999999996433221111 1111 0 01111
Q ss_pred CCCh-hhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 919 NFPA-DEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 919 ~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
+.+. ..+..+.+++.+|++.+|++|||+.+++++|+++.
T Consensus 227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 2222 45667999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=312.19 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=205.0
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+.|+..+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3467788999999999999998788889999886542 345678999999999999999999999877 7789999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++...... ..++.++..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 83 ~~~~L~~~~~~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 160 (260)
T cd05073 83 AKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAR 160 (260)
T ss_pred CCCcHHHHHHhCCcc-ccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccc
Confidence 999999999765432 378899999999999999999999999999999999999999999999999876543211 122
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....++..|+|||++ ....++.++|+||||+++|++++ |+.||...... ........ ....+.
T Consensus 161 ~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~-------------~~~~~~ 224 (260)
T cd05073 161 EGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALER-------------GYRMPR 224 (260)
T ss_pred cCCcccccccCHhHh-ccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhC-------------CCCCCC
Confidence 233456779999998 55678999999999999999999 99999754322 11111111 111122
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
+...+.++.+++.+|++.+|++||++.++.++|+.+
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 344566799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=323.15 Aligned_cols=260 Identities=22% Similarity=0.351 Sum_probs=201.1
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||++..+ ++..+|+|.+...........+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 45788899999999999999966 58889999887654334456799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
+++++|.+++..... +++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---- 157 (333)
T cd06650 85 MDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157 (333)
T ss_pred CCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----
Confidence 999999999976433 78899999999999999999975 7999999999999999999999999998754321
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC------------
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR------------ 907 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 907 (967)
......|+..|+|||.+ .+..++.++|||||||++|||++|+.||....... ....+........
T Consensus 158 ~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 MANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE--LELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ccccCCCCccccCHHHh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH--HHHHhcCcccCCccccccCcccCCc
Confidence 12334688899999998 55678999999999999999999999997433211 1111110000000
Q ss_pred ----------------chhhcchhhc---CCCC-hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 908 ----------------VEDCVDARLR---GNFP-ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 908 ----------------~~~~~~~~~~---~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+.... ...+ ...+.++.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000000000 0011 123467899999999999999999999965
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=314.45 Aligned_cols=259 Identities=22% Similarity=0.390 Sum_probs=207.3
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|++|.||++.. .+++.||||.+..... .....++.+|+++++.++|+||+++++++.+++..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 56778999999999999995 4789999998865432 23346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 761 ISSGSLYKHLHDGSS-RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
+++++|.+++..... ...+++..++.++.|++.|++|||++|++|+||||+||+++.++.++++|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-- 161 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc--
Confidence 999999999874322 23478999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......++..|+|||+. ....++.++|+||||+++|+|++|..||.....+.......+. .......
T Consensus 162 ~~~~~~~~~~~~ape~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------~~~~~~~ 228 (267)
T cd08229 162 AAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------------QCDYPPL 228 (267)
T ss_pred ccccccCCcCccCHHHh-cCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh------------cCCCCCC
Confidence 12234578889999988 5567889999999999999999999999644332221111111 0001111
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
.+...+..+.+++.+|++.||++|||+.+|+++++++-
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 12345678999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.09 Aligned_cols=242 Identities=24% Similarity=0.319 Sum_probs=196.1
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSG 764 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 764 (967)
+.||+|+||.||++..+ +|+.||+|.+..... ......+..|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999854 689999999975432 223456788999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 765 SLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
+|..++..... +++..+..++.||+.||+|||+ +||+||||||+||+++.++.+||+|||++...... ......
T Consensus 81 ~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~ 155 (325)
T cd05594 81 ELFFHLSRERV---FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKT 155 (325)
T ss_pred cHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cccccc
Confidence 99998876443 8899999999999999999997 79999999999999999999999999998753221 112234
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
..|++.|+|||++ ....++.++||||+||++|||++|+.||.....+.. ...+ . .. ...++..
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--~~~i---~-~~----------~~~~p~~ 218 (325)
T cd05594 156 FCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELI---L-ME----------EIRFPRT 218 (325)
T ss_pred ccCCcccCCHHHH-ccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--HHHH---h-cC----------CCCCCCC
Confidence 5689999999998 566789999999999999999999999964432211 1111 0 00 1123445
Q ss_pred hHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 924 EAIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
.+.++.+++.+|++.||++|+ +++++++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 567799999999999999996 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=323.73 Aligned_cols=239 Identities=26% Similarity=0.329 Sum_probs=191.5
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||+|... +++.||+|.++.... ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 578899999975432 22334556677776654 899999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|.+++..... +++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 g~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSGR---FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAST 155 (316)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccccc
Confidence 999999876443 8899999999999999999999999999999999999999999999999987543211 22335
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
..||+.|+|||.+ .+..++.++||||+||++|||++|+.||....... . ...... ....++..
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-~----~~~i~~-----------~~~~~~~~ 218 (316)
T cd05592 156 FCGTPDYIAPEIL-KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-L----FDSILN-----------DRPHFPRW 218 (316)
T ss_pred ccCCccccCHHHH-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-H----HHHHHc-----------CCCCCCCC
Confidence 6689999999998 55678999999999999999999999997544321 1 111110 11234455
Q ss_pred hHHHHHHHHHhhccCCCCCCCCHHH
Q 002094 924 EAIPVIKLGLICASQVPSNRPDMEE 948 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~~e 948 (967)
.+.++.+++.+|++.||++||++.+
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChH
Confidence 6677899999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=314.37 Aligned_cols=256 Identities=25% Similarity=0.318 Sum_probs=194.5
Q ss_pred CccCCCCceEEEEEEeCC---CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCC
Q 002094 688 CELGRGGFGVVYRTILQD---GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSG 764 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 764 (967)
++||+|+||.||+|...+ ...+|+|.+...........+.+|++.++.++|+||+++++++......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 35788888765443344567889999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 765 SLYKHLHDGSSR--NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 765 sL~~~l~~~~~~--~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+|.+++...... ...++..+..++.||+.|++|||+++|+||||||+||+++.++.+||+|||++.............
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 999999765432 225678889999999999999999999999999999999999999999999986543222212223
Q ss_pred cccccccccCcccccC------cccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 843 KIQSALGYMAPEFACR------TVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~------~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
...+++.|+|||+... ...++.++||||+|+++|||++ |..||....... .....+. ... .....
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~----~~~-~~~~~-- 232 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVR----EQD-IKLPK-- 232 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhh----ccC-ccCCC--
Confidence 3445677999998632 2356889999999999999999 888986543321 1111111 110 01111
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
...+...+..+.+++..|+ .||++|||+++|+++|.
T Consensus 233 --~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 233 --PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred --CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1223345566888999998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=313.49 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=204.9
Q ss_pred ccCCCCccCCCCceEEEEEEeC----CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ----DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
.|+..+.||+|+||.||+|... .+..+|+|.+.........+.+..|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 3577889999999999999853 234799999876543445678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++++|.+++..... .+++.++..++.|++.|++|||+++++||||||+||+++.++.++++|||.+.........
T Consensus 85 e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 85 EYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred EcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999999976533 3789999999999999999999999999999999999999999999999999866432221
Q ss_pred cc-cccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 839 IL-SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 839 ~~-~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.. .....++..|+|||.+ ....++.++|+||||+++||+++ |..||....... ....+.. ..
T Consensus 163 ~~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~-------------~~ 226 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIEE-------------GY 226 (267)
T ss_pred eeecCCCccceeecCHhHh-ccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHhC-------------CC
Confidence 11 1122234679999998 55678999999999999999887 999996443211 1111111 11
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
+.+.+...+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1222345567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=319.47 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=213.0
Q ss_pred hhccCCCCccCCCCceEEEEEEeCC-CcEEEEEEeecCCcc--ccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCceeE
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQLL 756 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 756 (967)
...|+..+.||+|.||.||+++.+. |+.+|+|.+...... .+...+.+|+++|+++. |||||.+++++.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4567888999999999999999765 999999999876542 24578999999999998 9999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC----CCeEEeeccccccc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS----GEPKVGDFGLARLL 832 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~----~~~kl~Dfg~a~~~ 832 (967)
|||++.||.|.+.+... . +++..+..++.|++.|++|+|+.||+|||+||+|+|+... +.+|++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999876 2 8999999999999999999999999999999999999633 47999999999987
Q ss_pred CCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc
Q 002094 833 PMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV 912 (967)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (967)
.. ........||+.|+|||+. ....++.++||||+||++|.|++|.+||........ ...+..+.+
T Consensus 190 ~~---~~~~~~~~Gtp~y~APEvl-~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-~~~i~~~~~--------- 255 (382)
T KOG0032|consen 190 KP---GERLHTIVGTPEYVAPEVL-GGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-FLAILRGDF--------- 255 (382)
T ss_pred cC---CceEeeecCCccccCchhh-cCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-HHHHHcCCC---------
Confidence 54 3345578899999999998 557899999999999999999999999975544322 222222211
Q ss_pred chhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 913 DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 913 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
....+........+.+++..|+..||.+|+|+.++++-
T Consensus 256 --~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 --DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred --CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22333455667889999999999999999999999884
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=325.26 Aligned_cols=242 Identities=22% Similarity=0.290 Sum_probs=192.7
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||++..+ +++.||||+++.... ......+..|..++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999965 688999999976432 23345688899999888 799999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..... .......
T Consensus 81 g~L~~~~~~~~~---l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQRK---LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTST 155 (329)
T ss_pred CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCcccc
Confidence 999988865433 89999999999999999999999999999999999999999999999999864321 1112234
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccc---hHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD---VVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
..||+.|+|||++ ....++.++|+||+||++|||++|+.||+..... .....++....+... ....
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~ 224 (329)
T cd05588 156 FCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK----------QIRI 224 (329)
T ss_pred ccCCccccCHHHH-cCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC----------CCCC
Confidence 5689999999998 5667899999999999999999999999632111 111112222111111 1123
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCC
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPD 945 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt 945 (967)
|...+.++.+++.+|++.||.+||+
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~ 249 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLG 249 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCC
Confidence 4556677999999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=310.89 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=201.1
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEE-cCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW-TPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||.||++..+ |..||+|.+.... ..+.+.+|+.++++++|++++++++++. .++..++||||+
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 3577889999999999999875 8889999886443 3467899999999999999999999764 456789999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++...... .+++..++.++.|++.|++|||++|++||||||+||+++.++.+|++|||++...... .
T Consensus 83 ~~~~L~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-----~ 156 (256)
T cd05082 83 AKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----Q 156 (256)
T ss_pred CCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc-----C
Confidence 999999999765432 3789999999999999999999999999999999999999999999999998754321 1
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....++..|+|||+. ....++.++||||||+++|||++ |+.||...... .....+. .......
T Consensus 157 ~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~-------------~~~~~~~ 220 (256)
T cd05082 157 DTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVE-------------KGYKMDA 220 (256)
T ss_pred CCCccceeecCHHHH-ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHh-------------cCCCCCC
Confidence 233345679999988 66678999999999999999997 99998643321 1111111 1112223
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
+...+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 445677899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=324.73 Aligned_cols=242 Identities=21% Similarity=0.341 Sum_probs=194.6
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||+|+.+ +++.||+|++..... ....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 578999999875432 23345677888888766 799999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|..++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..... .......
T Consensus 81 ~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSRK---FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTT 155 (321)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCccccc
Confidence 999998876543 78999999999999999999999999999999999999999999999999875422 1122334
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
..|++.|+|||++ ....++.++||||+||++|||++|+.||...... .....+. .. ...++..
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-~~~~~i~----~~-----------~~~~p~~ 218 (321)
T cd05591 156 FCGTPDYIAPEIL-QELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-DLFESIL----HD-----------DVLYPVW 218 (321)
T ss_pred cccCccccCHHHH-cCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-HHHHHHH----cC-----------CCCCCCC
Confidence 5689999999988 5667899999999999999999999999754432 1111111 10 1123344
Q ss_pred hHHHHHHHHHhhccCCCCCCC-------CHHHHHH
Q 002094 924 EAIPVIKLGLICASQVPSNRP-------DMEEVVN 951 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rp-------t~~evl~ 951 (967)
.+.++.+++.+|++.||++|| +++++++
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 567799999999999999999 7777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=334.61 Aligned_cols=372 Identities=27% Similarity=0.399 Sum_probs=259.2
Q ss_pred CCCCCCeEecCCCccC-ccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccc
Q 002094 91 RLQFLQVLSLSNNNFT-GTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLE 169 (967)
Q Consensus 91 ~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 169 (967)
-|+.++-.|+++|.|+ +..|.....+++++.|-|...++. .+|+++ +.+.+|++|.+++|++. .+...++.|+.|+
T Consensus 5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL-~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEEL-SRLQKLEHLSMAHNQLI-SVHGELSDLPRLR 81 (1255)
T ss_pred ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHH-HHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence 3555666666666666 346666666677777777666665 566664 66777777777777776 3445667777777
Q ss_pred eeeeccccccc-ccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEecccc
Q 002094 170 SVNFSSNRLSG-QLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVN 248 (967)
Q Consensus 170 ~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 248 (967)
.+.+.+|++.. -+|..+..+..|+.||||+|++. ..|..+....++-.|+|++|+|..+....|-+++.|-.||||+|
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~N 160 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNN 160 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccc
Confidence 77777777653 35666667777777777777777 56777777777777777777777444445667777778888888
Q ss_pred ccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccc-cccCCCCCcccccceEEcccCcCCCCCC
Q 002094 249 SLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFS-GRIPSSIGNLVFLKELNISMNQFTGGLP 327 (967)
Q Consensus 249 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 327 (967)
++. .+|+.+.+|..|++|.|++|.+.-.--..+-.+++|++|.+++.+-+ .-+|.++..+.+|..+++|.|.+. .+|
T Consensus 161 rLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vP 238 (1255)
T KOG0444|consen 161 RLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVP 238 (1255)
T ss_pred hhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cch
Confidence 876 67777888888888888888776444445566788888999886543 468889999999999999999998 889
Q ss_pred hhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcc
Q 002094 328 ESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIG 407 (967)
Q Consensus 328 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~ 407 (967)
+.+.++++|+.|+||+|+|+.. ++. .+...+|++|+||+|+++ .+|.+++
T Consensus 239 ecly~l~~LrrLNLS~N~iteL-------------~~~----------------~~~W~~lEtLNlSrNQLt-~LP~avc 288 (1255)
T KOG0444|consen 239 ECLYKLRNLRRLNLSGNKITEL-------------NMT----------------EGEWENLETLNLSRNQLT-VLPDAVC 288 (1255)
T ss_pred HHHhhhhhhheeccCcCceeee-------------ecc----------------HHHHhhhhhhccccchhc-cchHHHh
Confidence 9999999999999999988721 110 011234555555555555 4455555
Q ss_pred cccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCcccee
Q 002094 408 DLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSL 487 (967)
Q Consensus 408 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 487 (967)
.+++|+.|++.+|++.- .-+|..++++.+|+.+..++|.+. .+|+.+..+..|+.|
T Consensus 289 KL~kL~kLy~n~NkL~F-----------------------eGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL 344 (1255)
T KOG0444|consen 289 KLTKLTKLYANNNKLTF-----------------------EGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKL 344 (1255)
T ss_pred hhHHHHHHHhccCcccc-----------------------cCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHh
Confidence 55555555555555431 125666666666666666666665 677777778888888
Q ss_pred eccCCcCcCccchhhhcccCccEEeccCCccccCCc
Q 002094 488 ILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILP 523 (967)
Q Consensus 488 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 523 (967)
.|++|++. .+|+++.-|+.|+.|||..|.-.-..|
T Consensus 345 ~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 345 KLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred ccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 88888877 578888888888888888886442444
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=318.52 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=203.4
Q ss_pred ccCCCCccCCCCceEEEEEEeC-----------------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-----------------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 745 (967)
.|+..+.||+|+||.||++... ++..||+|.+..........++.+|+++++.++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3678889999999999998532 23468999987654344457899999999999999999999
Q ss_pred eEEEcCCceeEEEEecCCCchhhhhhcCCCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC
Q 002094 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSR--------NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS 817 (967)
Q Consensus 746 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~ 817 (967)
+++...+..++||||+++++|.+++...... ..+++.++..++.|++.|++|||++|++|+||||+||+++.
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~ 165 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK 165 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcC
Confidence 9999999999999999999999999764321 13678899999999999999999999999999999999999
Q ss_pred CCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc--CCCCCCCCccchHhH
Q 002094 818 SGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT--GKRPVEYMEDDVVVL 895 (967)
Q Consensus 818 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt--g~~p~~~~~~~~~~~ 895 (967)
++.++|+|||++..+.........+...+++.|+|||.. ..+.++.++|+|||||++|||++ |..||........ .
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~-~ 243 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI-LLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV-I 243 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH-hcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH-H
Confidence 999999999998765432222222233446779999987 45578999999999999999998 7788864433211 1
Q ss_pred HHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 896 CDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
.......... ........+..++..+.+++.+|++.||++||++.|+++.|++
T Consensus 244 -~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 244 -ENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -HHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111000 0001112234456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=323.70 Aligned_cols=260 Identities=27% Similarity=0.391 Sum_probs=207.0
Q ss_pred ccCCCCccCCCCceEEEEEEeC--------CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCc
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ--------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSL 753 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 753 (967)
.|+..+.||+|+||.||++... .+..||+|.+.........+++.+|+++++++ +||||+++++++...+.
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 3678899999999999999742 12368999887554344567899999999999 79999999999999999
Q ss_pred eeEEEEecCCCchhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSS-------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE 820 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~ 820 (967)
.+++|||+++|+|.+++..... ...+++.++..++.|++.||+|||++|++||||||+||+++.++.
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~ 172 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV 172 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc
Confidence 9999999999999999975321 224788999999999999999999999999999999999999999
Q ss_pred eEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHH
Q 002094 821 PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMV 899 (967)
Q Consensus 821 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~ 899 (967)
+||+|||+++...............++..|+|||.+ ....++.++||||||+++|||++ |..||.....+. ....+
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~ 249 (334)
T cd05100 173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LFKLL 249 (334)
T ss_pred EEECCcccceecccccccccccCCCcCceEcCHHHh-ccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH
Confidence 999999999765432222222223345679999988 55678899999999999999998 889986543221 11111
Q ss_pred HhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 900 RGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
. .......+...+.++.+++.+|++.+|++|||+.|+++.|+++..
T Consensus 250 ~-------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 250 K-------------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred H-------------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1 111122344556789999999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=328.27 Aligned_cols=239 Identities=26% Similarity=0.342 Sum_probs=194.4
Q ss_pred CccCCCCceEEEEEEe----CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 688 CELGRGGFGVVYRTIL----QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
+.||+|+||.||++.. .+|+.||+|++..... ......+..|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999874 3588999999976432 2234567889999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+|+|.+++..... +++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++...... .....
T Consensus 82 ~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAY 156 (318)
T ss_pred CCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCcee
Confidence 9999999876433 889999999999999999999999999999999999999999999999998755321 11223
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
...|++.|+|||.+ ....++.++||||||+++|||++|+.||...... .....+. . . ....+.
T Consensus 157 ~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~i~----~---------~--~~~~p~ 219 (318)
T cd05582 157 SFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-ETMTMIL----K---------A--KLGMPQ 219 (318)
T ss_pred cccCChhhcCHHHH-cCCCCCCccceeccceEeeeeccCCCCCCCCCHH-HHHHHHH----c---------C--CCCCCC
Confidence 45689999999988 5567789999999999999999999999754322 1111111 1 0 112344
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHH
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEE 948 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~e 948 (967)
..+..+.+++.+|++.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 55677899999999999999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=338.27 Aligned_cols=260 Identities=25% Similarity=0.322 Sum_probs=194.8
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--------
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP-------- 751 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------- 751 (967)
...|+..+.||+|+||.||+|+.. +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 345788899999999999999964 58899999885432 2346799999999999999999876432
Q ss_pred CceeEEEEecCCCchhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC-CeEEeecccc
Q 002094 752 SLQLLIYEFISSGSLYKHLHDG-SSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG-EPKVGDFGLA 829 (967)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~-~~kl~Dfg~a 829 (967)
...++||||+++ ++.+++... .....+++..+..++.||+.||+|||+++|+||||||+||+++.++ .+||+|||++
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 235689999985 677766532 1223488999999999999999999999999999999999999665 7999999999
Q ss_pred cccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 830 RLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
+...... ......||+.|+|||++.+...++.++||||+||++|||++|++||...... ..+..++.. ...+...
T Consensus 219 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~-~~~p~~~ 293 (440)
T PTZ00036 219 KNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQV-LGTPTED 293 (440)
T ss_pred hhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHH-hCCCCHH
Confidence 8654321 2234567889999998856667899999999999999999999999754332 222222211 1111100
Q ss_pred ---------------hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 910 ---------------DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 910 ---------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
......++..++...+.++.+++.+|++.||.+|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 011111222234455678999999999999999999999873
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=331.31 Aligned_cols=254 Identities=19% Similarity=0.253 Sum_probs=196.5
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||+||+|+.. +++.||||++..... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 3577889999999999999854 688999999976432 2334678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc--
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR-- 837 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~-- 837 (967)
|+++|+|.+++..... +++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEV---FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999999976543 78889999999999999999999999999999999999999999999999753311000
Q ss_pred -------------------------------------------ccccccccccccccCcccccCcccCCcccchhhHHHH
Q 002094 838 -------------------------------------------CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVL 874 (967)
Q Consensus 838 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvl 874 (967)
........||+.|+|||.+ ....++.++||||+||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL-LRKGYTQLCDWWSVGVI 237 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHH-cCCCCCCccceeehhhH
Confidence 0001234689999999998 55678999999999999
Q ss_pred HHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHh--hccCCCCCCCCHHHHHHH
Q 002094 875 VLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLI--CASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 875 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~Rpt~~evl~~ 952 (967)
+|||++|+.||......... ..+. .. ......+.....+.++.+++.+ |...+|.+||+++|+++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~-~~i~----~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQ-LKVI----NW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHH-HHHH----cc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999999754432111 1111 00 0001111112345678889988 445666679999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.41 Aligned_cols=249 Identities=28% Similarity=0.425 Sum_probs=205.4
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.|+..+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4577889999999999999875 89999999976542 46789999999999999999999999998899999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.+++...... .+++..+..++.|++.|++|||+++++|+||||+||+++.++.++|+|||.+....... .
T Consensus 84 ~~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~ 157 (256)
T cd05039 84 KGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----D 157 (256)
T ss_pred CCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-----c
Confidence 99999999765432 38999999999999999999999999999999999999999999999999997653211 1
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....+..|+|||+. ..+.++.++|+||||+++||+++ |+.||...... .....+. ...+...+
T Consensus 158 ~~~~~~~~~ape~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~-------------~~~~~~~~ 221 (256)
T cd05039 158 SGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVE-------------KGYRMEAP 221 (256)
T ss_pred cCCCcccccCchhh-cCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHh-------------cCCCCCCc
Confidence 23345679999988 55678899999999999999997 99999644322 1111111 11122234
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
...+..+.+++.+|++.+|++|||++|++++|+.+
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 45567899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=316.67 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=200.8
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc--ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||++... +++.||+|++...... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 566788999999999999954 6899999998754321 2235578899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++|+|.+++..... ..+++..+..++.|++.|++|||+.+++||||||+||++++++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~ 157 (285)
T cd05605 82 MNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---T 157 (285)
T ss_pred cCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---c
Confidence 999999988865432 238899999999999999999999999999999999999999999999999987654221 1
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....|++.|+|||++ ....++.++||||+||++|||++|+.||...... ....+ +...+. .....+
T Consensus 158 ~~~~~~~~~y~aPE~~-~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~-~~~~~~----------~~~~~~ 224 (285)
T cd05605 158 IRGRVGTVGYMAPEVV-KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREE-VERRVK----------EDQEEY 224 (285)
T ss_pred cccccCCCCccCcHHh-cCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHH-HHHHhh----------hccccc
Confidence 2234678899999998 5567899999999999999999999999754321 11111 111111 011223
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRP-----DMEEVVNI 952 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 952 (967)
+...+..+.+++.+|++.||++|| +++++++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 445667799999999999999999 78887553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=323.50 Aligned_cols=245 Identities=26% Similarity=0.353 Sum_probs=194.3
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHH---cCCCCCceeeeeeEEEcCCceeEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTL---GKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
|+..+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 455678999999999999865 689999999975431 22345566676654 567899999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++++|..+++.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..... .
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--F 154 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--C
Confidence 9999999999888642 389999999999999999999999999999999999999999999999999864322 1
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
........|++.|+|||.+ .+..++.++|||||||++|||++|+.||...... .....+... .
T Consensus 155 ~~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-~~~~~i~~~---------------~ 217 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVL-TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-EVFDSIVND---------------E 217 (324)
T ss_pred CCcccccccCccccCHhHh-cCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhC---------------C
Confidence 1222346689999999998 5567899999999999999999999999754332 111111110 1
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPD-----MEEVVN 951 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~ 951 (967)
..++...+..+.+++.+|++.||.+||+ ++++++
T Consensus 218 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1234556677999999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.21 Aligned_cols=257 Identities=27% Similarity=0.393 Sum_probs=207.3
Q ss_pred ccCCCCccCCCCceEEEEEEeCC-Cc----EEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQD-GR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
.|+..+.||+|+||.||+|..++ |+ .||+|.+..........++.+|+..+++++||||+++++++.. ...++|
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 35778899999999999998643 33 5899988766544456789999999999999999999999987 788999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++|+|.+++...... +++..+..++.|++.|++|||+++++||||||+||+++.++.+||+|||.++.......
T Consensus 87 ~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred EecCCCCcHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 9999999999999765432 88999999999999999999999999999999999999999999999999987654332
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
........++..|+|||.. ....++.++|+||||+++||+++ |+.||....... ..+.+. ...
T Consensus 165 ~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~-------------~~~ 228 (279)
T cd05057 165 EYHAEGGKVPIKWMALESI-LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLLE-------------KGE 228 (279)
T ss_pred ceecCCCcccccccCHHHh-hcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHh-------------CCC
Confidence 2222223345679999988 56678999999999999999998 999997543221 111111 111
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
....+..++..+.+++.+|+..+|.+|||+.++++.|+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 229 RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 122344456779999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=331.82 Aligned_cols=253 Identities=23% Similarity=0.284 Sum_probs=202.9
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||+|+.. +++.||||++..... ......+.+|++++..++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 3677889999999999999965 689999999975432 2345678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc---
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD--- 836 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~--- 836 (967)
|+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999998753 38899999999999999999999999999999999999999999999999997654322
Q ss_pred ------------------------cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccch
Q 002094 837 ------------------------RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDV 892 (967)
Q Consensus 837 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~ 892 (967)
.........||+.|+|||.+ ....++.++|||||||++|||++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~- 236 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ- 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHH-cCCCCCCceeeEecchhhhhhccCCCCCCCCCHH-
Confidence 01122345689999999998 5568899999999999999999999999754422
Q ss_pred HhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCC-HHHHHHH
Q 002094 893 VVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPD-MEEVVNI 952 (967)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~evl~~ 952 (967)
.....+.. .. .....+.....+.++.+++.+|+. ||.+||+ ++|+++.
T Consensus 237 ~~~~~i~~----~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ETYNKIIN----WK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHhc----cC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111111 00 001111111246779999999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=320.18 Aligned_cols=262 Identities=23% Similarity=0.311 Sum_probs=201.1
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|...+.||+|+||.||+|+.+ +++.||+|.+...........+.+|++++++++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 4677889999999999999865 578899999976554444557889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++ +|.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 87 ~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 161 (309)
T cd07872 87 DK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTY 161 (309)
T ss_pred CC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--ccc
Confidence 75 88888765432 27889999999999999999999999999999999999999999999999987543221 122
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch---------hhc
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE---------DCV 912 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 912 (967)
....+++.|+|||.+.....++.++||||+|+++|||++|+.||....... ......+ ....+... +..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFR-LLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH-HhCCCCHHHHhhhcchhhhh
Confidence 334578899999988555678999999999999999999999997543321 1111111 11110000 000
Q ss_pred chhhcC-------CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 913 DARLRG-------NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 913 ~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+..... ......+.++.+++.+|++.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000 011234567889999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=314.13 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=194.2
Q ss_pred cCCCCceEEEEEEeC-CCcEEEEEEeecCCcc--ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCch
Q 002094 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSL 766 (967)
Q Consensus 690 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 766 (967)
||+|+||.||++..+ +|+.||+|.+...... .....+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999854 5899999998653321 1234566799999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccccc
Q 002094 767 YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQS 846 (967)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 846 (967)
.+++...... .+++..+..++.|++.|++|||++||+||||||+||+++.++.++|+|||++....... ......|
T Consensus 81 ~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~ 156 (277)
T cd05607 81 KYHIYNVGER-GLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAG 156 (277)
T ss_pred HHHHHhcccc-CCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCC
Confidence 9888654432 27899999999999999999999999999999999999999999999999987654321 2234568
Q ss_pred cccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHH
Q 002094 847 ALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAI 926 (967)
Q Consensus 847 t~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (967)
++.|+|||++ ....++.++||||+||++|||++|+.||....... ...++....... ... ......+.
T Consensus 157 ~~~y~aPE~~-~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~---------~~~-~~~~~~~~ 224 (277)
T cd05607 157 TNGYMAPEIL-KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLED---------EVK-FEHQNFTE 224 (277)
T ss_pred CCCccCHHHH-ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhcc---------ccc-cccccCCH
Confidence 8899999998 55569999999999999999999999997433211 111222211110 000 01123456
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 927 PVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 927 ~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
++.+++.+|++.||++||+++|+++.
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchhh
Confidence 78999999999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.88 Aligned_cols=253 Identities=28% Similarity=0.387 Sum_probs=195.8
Q ss_pred CccCCCCceEEEEEEeC----CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEE-cCCceeEEEEecC
Q 002094 688 CELGRGGFGVVYRTILQ----DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW-TPSLQLLIYEFIS 762 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 762 (967)
+.||+|+||.||+|... ++..||+|.+.........+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 245799998865433344568889999999999999999999775 4556789999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc--cc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC--IL 840 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~ 840 (967)
+|+|.+++...... .++..+..++.|++.|++|||+.+++||||||+||+++.++.+||+|||+++........ ..
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 81 HGDLRNFIRSETHN--PTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 99999999764332 677888999999999999999999999999999999999999999999998754321110 11
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
.....++..|+|||.. ....++.++||||||+++|||++ |.+||...... .. ....... ....
T Consensus 159 ~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--~~---~~~~~~~----------~~~~ 222 (262)
T cd05058 159 HTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--DI---TVYLLQG----------RRLL 222 (262)
T ss_pred cccCcCCccccChhHh-ccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HH---HHHHhcC----------CCCC
Confidence 1234456789999988 55678999999999999999999 46666543221 11 1111110 0111
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.+...+..+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 233345679999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.75 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=203.3
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|++|.||+|+.+ +++.|++|.+..... ......+.+|++++++++||||+++++++.+++..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 456778999999999999965 689999999875432 345678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.++++.... ..+++..++.++.|++.|++|||+.|++|+||||+||+++.++.++|+|||.+........ ..
T Consensus 82 ~~~~L~~~l~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~ 158 (256)
T cd08529 82 ENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FA 158 (256)
T ss_pred CCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc--hh
Confidence 99999999986532 2388999999999999999999999999999999999999999999999999876643221 22
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....+++.|+|||+. .+..++.++|+||||+++|||++|+.||...... . ....... ......+
T Consensus 159 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~----~~~~~~~----------~~~~~~~ 222 (256)
T cd08529 159 NTIVGTPYYLSPELC-EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-A----LILKIIR----------GVFPPVS 222 (256)
T ss_pred hccccCccccCHHHh-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-H----HHHHHHc----------CCCCCCc
Confidence 344578889999998 5567899999999999999999999999754421 1 1111111 1112233
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+.++.+++.+|++.+|++||++.++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 355677999999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=313.36 Aligned_cols=252 Identities=31% Similarity=0.459 Sum_probs=200.8
Q ss_pred CccCCCCceEEEEEEeCC-------CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 688 CELGRGGFGVVYRTILQD-------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.||+|+||.||+|...+ +..+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2579999886554334567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC-----CeEEeecccccc
Q 002094 761 ISSGSLYKHLHDGSS----RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG-----EPKVGDFGLARL 831 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~----~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~-----~~kl~Dfg~a~~ 831 (967)
+++++|.+++..... ...+++.++..++.|++.|++|||+.+++|+||||+||+++.++ .++++|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 999999999975321 12378899999999999999999999999999999999999877 899999999876
Q ss_pred cCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchh
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVED 910 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (967)
..............++..|+|||.+ ..+.++.++||||||+++|||++ |+.||...... .....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~----------- 226 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESL-LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHV----------- 226 (269)
T ss_pred cccccccccCcccCCCccccCHHHH-ccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHH-----------
Confidence 5432222222233456789999988 56678999999999999999998 99999644321 111111
Q ss_pred hcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 911 CVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 911 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
........+...+..+.+++.+|+..+|.+||+++++++.|++
T Consensus 227 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 --TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111222345567789999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=310.69 Aligned_cols=250 Identities=21% Similarity=0.343 Sum_probs=203.1
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+..+.||+|+||.||++... ++..||+|.++........+.+.+|+.++++++|+||+++++++..++..++||||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 466789999999999999965 6889999998765444456788899999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.+++...... .+++..+..++.|++.|++|||++|++|+||||+||++++++.++++|||.+....... ....
T Consensus 82 ~~~l~~~~~~~~~~-~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 158 (255)
T cd08219 82 GGDLMQKIKLQRGK-LFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AYAC 158 (255)
T ss_pred CCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--cccc
Confidence 99999988754332 37889999999999999999999999999999999999999999999999987654321 1223
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
...+++.|+|||+. ....++.++|+||+|+++|+|++|+.||....... ..... ... .....+.
T Consensus 159 ~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----~~~~~-~~~---------~~~~~~~ 222 (255)
T cd08219 159 TYVGTPYYVPPEIW-ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-----LILKV-CQG---------SYKPLPS 222 (255)
T ss_pred cccCCccccCHHHH-ccCCcCchhhhhhhchhheehhhccCCCCCCCHHH-----HHHHH-hcC---------CCCCCCc
Confidence 45678889999998 56678999999999999999999999996432211 11111 011 0112234
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..+..+.+++.+|++.||++|||+.|++..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 455678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.24 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=205.5
Q ss_pred ccCCCCccCCCCceEEEEEEeCC----CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQD----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
.|+..+.||+|+||.||+|...+ ...||||...........+.+.+|+.++++++||||+++++++.+ ...++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~ 85 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM 85 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence 35777899999999999998643 246899988765534456789999999999999999999998865 5578999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++++|.+++..... .+++..+..++.|++.|++|||+.+++||||||+||+++.++.++++|||++........
T Consensus 86 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY- 162 (270)
T ss_pred EcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccc-
Confidence 99999999999976433 378999999999999999999999999999999999999999999999999876543211
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.......++..|+|||.+ ....++.++||||||+++||+++ |+.||........ . ..+. . ..+
T Consensus 163 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~-~~~~----~---------~~~ 226 (270)
T cd05056 163 YKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-I-GRIE----N---------GER 226 (270)
T ss_pred eecCCCCccccccChhhh-ccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-H-HHHH----c---------CCc
Confidence 112233345679999987 55678999999999999999996 9999965433211 1 1111 0 111
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
...+...+..+.+++.+|+..+|++|||+.++++.|+.+..+
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 227 LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 123455677899999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.66 Aligned_cols=250 Identities=28% Similarity=0.451 Sum_probs=201.0
Q ss_pred CccCCCCceEEEEEEeCC--C--cEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQD--G--RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|++|.||+|.+.+ + ..||+|.+.........+.+.+|++.+++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999999643 2 36999999776543456789999999999999999999999988 888999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc-ccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI-LSS 842 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~ 842 (967)
++|.+++..... ..+++..++.++.|++.||+|||+++++|+||+|+||+++.++.+||+|||.+.......... ...
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 999999987543 348999999999999999999999999999999999999999999999999998764422211 122
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
...++..|+|||.. ....++.++||||||+++|||++ |+.||....... ........ ......+
T Consensus 159 ~~~~~~~y~~pE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~~---------~~~~~~~ 223 (257)
T cd05040 159 HLKVPFAWCAPESL-RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-----ILKKIDKE---------GERLERP 223 (257)
T ss_pred CCCCCceecCHHHh-cccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHhc---------CCcCCCC
Confidence 34567789999988 66678999999999999999998 999996433221 11111100 0111123
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
...+..+.+++.+|++.+|++|||+.++++.|.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 445677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=325.27 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=195.9
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC-----CceeE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP-----SLQLL 756 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 756 (967)
|+..+.||+|+||.||+|+.. +++.||||++..... ......+.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 566789999999999999954 689999999875321 23345788999999999999999999988543 24789
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
||||+. ++|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 82 v~e~~~-~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 82 VFELME-SDLHQVIKANDD---LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEecCC-CCHHHHHHhccc---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 999995 689888875433 8899999999999999999999999999999999999999999999999997543211
Q ss_pred c-ccccccccccccccCcccccC-cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC--------
Q 002094 837 R-CILSSKIQSALGYMAPEFACR-TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG-------- 906 (967)
Q Consensus 837 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 906 (967)
. ........|++.|+|||++.. ...++.++||||+||++|||++|++||........ .+.+.......
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ--LDLITDLLGTPSPETISRV 235 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHh
Confidence 1 112234568899999998733 25788999999999999999999999975432111 11111111100
Q ss_pred ---Cchhhcchh---hcCC---CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 907 ---RVEDCVDAR---LRGN---FPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 907 ---~~~~~~~~~---~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
...+..... .... ..+..+..+.+++.+|++.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000010000 0000 011235568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=320.15 Aligned_cols=241 Identities=23% Similarity=0.342 Sum_probs=192.3
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||+|... +++.||||.++.... ......+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 478999999976431 23345567778887764 899999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 g~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCT 155 (316)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cceee
Confidence 999999976433 7889999999999999999999999999999999999999999999999987432211 12234
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
..||+.|+|||++ .+..++.++||||+||++|||++|+.||...... . ..+.+. .. ...++..
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~-~~~~i~----~~----------~~~~~~~ 218 (316)
T cd05619 156 FCGTPDYIAPEIL-LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-E-LFQSIR----MD----------NPCYPRW 218 (316)
T ss_pred ecCCccccCHHHH-cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-H-HHHHHH----hC----------CCCCCcc
Confidence 5689999999998 5567899999999999999999999999754321 1 111111 00 1123344
Q ss_pred hHHHHHHHHHhhccCCCCCCCCHH-HHH
Q 002094 924 EAIPVIKLGLICASQVPSNRPDME-EVV 950 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~~-evl 950 (967)
.+.++.+++.+|++.||++||++. ++.
T Consensus 219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 219 LTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 556789999999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=322.78 Aligned_cols=241 Identities=23% Similarity=0.321 Sum_probs=194.3
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCC-CceeeeeeEEEcCCceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRH-HNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 759 (967)
|+..+.||+|+||.||+|..+ +++.||||++..... ....+.+..|.+++..+.| ++|+++++++...+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 466789999999999999965 578999999975432 2345678889999999976 568889999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... ...
T Consensus 82 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~ 156 (324)
T cd05587 82 YVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGK 156 (324)
T ss_pred CCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCC
Confidence 9999999999876543 78999999999999999999999999999999999999999999999999864321 111
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......||+.|+|||++ ....++.++||||+||++|||++|+.||....... ....+. . ....
T Consensus 157 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-~~~~i~----~-----------~~~~ 219 (324)
T cd05587 157 TTRTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LFQSIM----E-----------HNVS 219 (324)
T ss_pred ceeeecCCccccChhhh-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHH----c-----------CCCC
Confidence 22345689999999998 55678999999999999999999999997543321 111111 0 1123
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDM 946 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~ 946 (967)
++...+.++.+++.+|++.||.+|++.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 445566789999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=308.73 Aligned_cols=250 Identities=30% Similarity=0.456 Sum_probs=201.5
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
|+..+.||+|+||.||++...+++.+|+|.+.... .....+.+|++++++++||+++++++++......++||||+++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 46678899999999999998778899999886543 3456799999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
++|.+++..... .++++.++.++.|++.|++|||+.+++|+||||+||+++.++.++|+|||.+....... ......
T Consensus 84 ~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~ 160 (256)
T cd05112 84 GCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTG 160 (256)
T ss_pred CcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-ccccCC
Confidence 999999876433 37899999999999999999999999999999999999999999999999987553211 111223
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
..++.+|+|||.. ..+.++.++||||+|+++|||++ |+.||...... .+.... . ...+...+.
T Consensus 161 ~~~~~~~~aPe~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~-~---------~~~~~~~~~ 224 (256)
T cd05112 161 TKFPVKWSSPEVF-SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETI-N---------AGFRLYKPR 224 (256)
T ss_pred CccchhhcCHhHh-ccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHH-h---------CCCCCCCCC
Confidence 3345789999988 55678899999999999999998 99999643321 111111 0 001111233
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
..+..+.+++.+|++.+|++|||+.|+++.|+
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 34577999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.07 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=202.4
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc----cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL----IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
|...+.||+|++|.||++.. .+++.||+|.+..... ......+.+|++++++++||||+++++++..+...++||
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 67789999999999999985 4689999999865432 112357889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++++|.+++..... +++..+.+++.|++.|++|||+.|++||||+|+||++++++.++|+|||.+.........
T Consensus 84 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 84 EYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EECCCCcHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 99999999999876543 788999999999999999999999999999999999999999999999998765432111
Q ss_pred cc-cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 839 IL-SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 839 ~~-~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.. .....++..|+|||.+ .+..++.++||||+|+++|||++|+.||......... .. . ......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~----~---------~~~~~~ 225 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVI-SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-FK----I---------ATQPTN 225 (263)
T ss_pred cccccCCCcCccccCccee-ccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-HH----H---------hccCCC
Confidence 11 1234577889999998 5556899999999999999999999999644322111 11 0 011112
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
...+...+..+.+++.+|+..+|.+|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 33455667789999999999999999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=321.48 Aligned_cols=242 Identities=24% Similarity=0.355 Sum_probs=195.3
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||+|+.+ +++.||||++..... ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 578999999976432 23345677888888877 799999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|..++..... +++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~~---l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSGR---FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTST 155 (318)
T ss_pred CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccccc
Confidence 999998876543 8999999999999999999999999999999999999999999999999986432111 12234
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
..|++.|+|||++ ....++.++|+||+||++|||++|+.||...... . ........ ...++..
T Consensus 156 ~~g~~~y~aPE~~-~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-~----~~~~i~~~-----------~~~~~~~ 218 (318)
T cd05570 156 FCGTPDYIAPEIL-SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-E----LFQSILED-----------EVRYPRW 218 (318)
T ss_pred eecCccccCHHHh-cCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-H----HHHHHHcC-----------CCCCCCc
Confidence 5688999999998 5667899999999999999999999999754322 1 11111110 1123445
Q ss_pred hHHHHHHHHHhhccCCCCCCCCH-----HHHHH
Q 002094 924 EAIPVIKLGLICASQVPSNRPDM-----EEVVN 951 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~-----~evl~ 951 (967)
.+.++.+++.+|++.||++||++ .++++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 56779999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=328.43 Aligned_cols=253 Identities=17% Similarity=0.214 Sum_probs=199.3
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||+++.. +++.||+|.+..... ....+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 4677889999999999999965 588999999965321 2234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++|+|.+++.... ++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 124 y~~gg~L~~~l~~~~----l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~~ 198 (370)
T cd05596 124 YMPGGDLVNLMSNYD----IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MV 198 (370)
T ss_pred CCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-cc
Confidence 999999999986532 6788888999999999999999999999999999999999999999999997654311 11
Q ss_pred ccccccccccccCcccccCc---ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 840 LSSKIQSALGYMAPEFACRT---VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~---~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
......||+.|+|||++... ..++.++||||+||++|||++|+.||...... .....+.. .. ..+
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~----~~-------~~~ 266 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMD----HK-------NSL 266 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHc----CC-------CcC
Confidence 22345689999999987432 34788999999999999999999999754321 11111111 00 001
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCC--CCCHHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSN--RPDMEEVVNI 952 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~~ 952 (967)
..+.....+.++.+++.+|++.+|++ |+|++|+++.
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11111235678999999999999988 9999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=320.41 Aligned_cols=241 Identities=24% Similarity=0.330 Sum_probs=192.6
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||+|+.+ +|+.||+|.++.... ......+..|.+++... +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 588999999976432 22345567788887654 899999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|..++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++..... ......
T Consensus 81 g~L~~~i~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAST 155 (316)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCceec
Confidence 999999876433 788999999999999999999999999999999999999999999999998643211 112334
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
..|++.|+|||++ ....++.++||||+||++|||++|+.||...... ... +.+. . ....++..
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-~~~-~~~~----~----------~~~~~~~~ 218 (316)
T cd05620 156 FCGTPDYIAPEIL-QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-ELF-ESIR----V----------DTPHYPRW 218 (316)
T ss_pred cCCCcCccCHHHH-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHH-HHHH----h----------CCCCCCCC
Confidence 6689999999998 5667899999999999999999999999744322 111 1111 0 01223444
Q ss_pred hHHHHHHHHHhhccCCCCCCCCHH-HHH
Q 002094 924 EAIPVIKLGLICASQVPSNRPDME-EVV 950 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~~-evl 950 (967)
.+.++.+++.+|++.||++||++. ++.
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 567789999999999999999985 544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=327.76 Aligned_cols=262 Identities=22% Similarity=0.286 Sum_probs=199.8
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC-----ceeE
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS-----LQLL 756 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l 756 (967)
|+..+.||+|+||.||++.. .+++.||||++..... ....+++.+|+++++.++|+||+++++++..+. ..++
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 46788999999999999995 4789999999865321 234567889999999999999999999998776 7899
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 82 v~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 82 VTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred Eeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 999997 57888776543 38899999999999999999999999999999999999999999999999997654321
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc----
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV---- 912 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 912 (967)
........+++.|+|||.+.....++.++||||+||++|||++|+.||........ + +.+......+...++.
T Consensus 158 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~-~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 158 -SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-L-DLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred -cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-H-HHHHHHcCCCCHHHHHHhhH
Confidence 12223445788899999985556689999999999999999999999975433211 1 1111111111111000
Q ss_pred -------chhh-------cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 913 -------DARL-------RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 913 -------~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.... ........+.++.+++.+|++.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 001223346678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=327.34 Aligned_cols=257 Identities=19% Similarity=0.252 Sum_probs=194.4
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||++... +++.||+|... ...+.+|++++++++||||+++++++......++|+|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 45788899999999999999954 68899999643 23478899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+. ++|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 165 ~~-~~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~ 239 (391)
T PHA03212 165 YK-TDLYCYLAAKRN---IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANK 239 (391)
T ss_pred CC-CCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccc
Confidence 95 688888865433 7899999999999999999999999999999999999999999999999997542211 112
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCcc------chHhHHHHHHhhhccC--------
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMED------DVVVLCDMVRGALEDG-------- 906 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~------~~~~~~~~~~~~~~~~-------- 906 (967)
.....||+.|+|||++ ....++.++||||+||++|||++|+.||..... ....+..++...-..+
T Consensus 240 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELL-ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 2345789999999998 556789999999999999999999988642211 1111111111110000
Q ss_pred -Cchhhc----c-hhhc-CCCC-----hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 907 -RVEDCV----D-ARLR-GNFP-----ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 907 -~~~~~~----~-~~~~-~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+.. . .... ...+ ...+.++.+++.+|++.||++|||++|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 0 0000 0000 123567899999999999999999999985
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=316.97 Aligned_cols=269 Identities=28% Similarity=0.409 Sum_probs=207.0
Q ss_pred ccCCCCccCCCCceEEEEEEeC-----CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEc--CCcee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-----DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT--PSLQL 755 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~ 755 (967)
.|+..+.||+|+||.||+++.. ++..||||.+.........+.+.+|++.++.++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 3566788999999999999854 3688999999766533346789999999999999999999999877 55789
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+||||+++++|.+++..... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++++|||.+......
T Consensus 85 lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 99999999999999976543 3899999999999999999999999999999999999999999999999999876532
Q ss_pred ccc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc---cCCchhh
Q 002094 836 DRC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE---DGRVEDC 911 (967)
Q Consensus 836 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 911 (967)
... .......++..|+|||.. ....++.++|+||||+++|||++|+.|+......... +...... ...+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~-~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECL-RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLEL 238 (284)
T ss_pred CcceeccCCCCCcccccCcHHH-ccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHHH
Confidence 221 111223345569999988 5557899999999999999999999998643221100 0000000 0000111
Q ss_pred cchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 912 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
+....+...+..++.++.+++.+|++.+|++|||+.|++++|+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1111222234455678999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=342.77 Aligned_cols=263 Identities=20% Similarity=0.241 Sum_probs=204.5
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||+|+.. +|+.||+|++..... ....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 4677889999999999999965 589999999975432 2235679999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 760 FISSGSLYKHLHDGSS--------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~--------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
|++||+|.+++..... ....++..+++++.||++||+|||++||+||||||+||+++.++.++|+|||++..
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCccee
Confidence 9999999999864211 11356778899999999999999999999999999999999999999999999976
Q ss_pred cCCCcc----------------ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhH
Q 002094 832 LPMLDR----------------CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVL 895 (967)
Q Consensus 832 ~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~ 895 (967)
...... ........||+.|+|||.+ .+..++.++||||+||++|||++|+.||..........
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l-~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~ 241 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL-LGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHh-cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence 521110 0111234689999999988 56678999999999999999999999997533221111
Q ss_pred HHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCC-CHHHHHHHHHhhcCC
Q 002094 896 CDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRP-DMEEVVNILELIQSP 959 (967)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~evl~~L~~~~~~ 959 (967)
. ... .++. ......+.+..+.+++.+|++.||++|| +++++.+.|+...+.
T Consensus 242 ~----~~i--------~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 242 R----DVI--------LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred h----hhc--------cChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 000 0000 0001124456789999999999999995 678888888877543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=294.90 Aligned_cols=264 Identities=24% Similarity=0.349 Sum_probs=204.6
Q ss_pred hhccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCC--CCCceeeeeeEEEcC----Cce
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI--RHHNLVALEGYYWTP----SLQ 754 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~----~~~ 754 (967)
.......+.||+|.||.||+|.++ |+.||||++... +.+.+.+|.++.+.+ +|+||+.+++.-... .+.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 334577789999999999999998 999999999753 456788888888775 999999998875432 356
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CcccCCCCCCCEEeCCCCCeEEeec
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT--------NIIHYNLKSTNVLIDSSGEPKVGDF 826 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~--------~ivH~Dik~~Nill~~~~~~kl~Df 826 (967)
|+|.+|.+.|||+++|.+.. ++.+..++++..+|.||+|||.. .|+|||||+.|||+..++...|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 89999999999999998733 88999999999999999999952 5999999999999999999999999
Q ss_pred ccccccCCCccc--cccccccccccccCcccccCcccC-----CcccchhhHHHHHHHHHc----------CCCCCCCCc
Q 002094 827 GLARLLPMLDRC--ILSSKIQSALGYMAPEFACRTVKI-----TEKCDVYGFGVLVLEVVT----------GKRPVEYME 889 (967)
Q Consensus 827 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-----t~~~Dv~slGvll~ellt----------g~~p~~~~~ 889 (967)
|+|..++..... .......||.+|||||++...... -..+||||||.++||++. -++||....
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999887654322 233467799999999998443222 135899999999999986 246776443
Q ss_pred cchHhHHHHHHhhhccCCchhhcchhhcCCCC-----hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 890 DDVVVLCDMVRGALEDGRVEDCVDARLRGNFP-----ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
+....+.++.+- +...++++..| ......+.++|+.||..+|..|.|+-.+.+.|.++.+..|.
T Consensus 441 p~DPs~eeMrkV---------VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ek 509 (513)
T KOG2052|consen 441 PSDPSFEEMRKV---------VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDEK 509 (513)
T ss_pred CCCCCHHHHhcc---------eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChhh
Confidence 332222222111 11133444333 34566789999999999999999999999999998865443
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.72 Aligned_cols=257 Identities=28% Similarity=0.417 Sum_probs=203.4
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCc----EEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
|+..+.||+|+||.||+|... +++ .||+|.+..........++.+|+.+++.++||||+++++++..+ ..++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~ 87 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVT 87 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeee
Confidence 567788999999999999854 343 57888887654334455789999999999999999999998654 467999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++|+|.+++..... .+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++........
T Consensus 88 e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 165 (303)
T cd05110 88 QLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165 (303)
T ss_pred hhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence 99999999999876432 2788999999999999999999999999999999999999999999999999866432222
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.......++..|+|||.+ ....++.++||||||+++||+++ |+.||..... ....+++.. ...
T Consensus 166 ~~~~~~~~~~~y~~PE~~-~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~-------------~~~ 229 (303)
T cd05110 166 YNADGGKMPIKWMALECI-HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEK-------------GER 229 (303)
T ss_pred cccCCCccccccCCHHHh-ccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHC-------------CCC
Confidence 222234456789999988 56678999999999999999997 9999964432 112222211 111
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
...+..++..+.+++.+|+..+|++||+++++++.|+++...
T Consensus 230 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 122334566789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=330.32 Aligned_cols=252 Identities=20% Similarity=0.254 Sum_probs=195.4
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||++... +++.||||++..... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 577889999999999999854 689999999865421 23346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc--
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-- 838 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-- 838 (967)
+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.+......
T Consensus 83 ~~gg~L~~~l~~~~~---~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 83 LPGGDLMTMLIKYDT---FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred CCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 999999999976433 788999999999999999999999999999999999999999999999998643210000
Q ss_pred -------------------------------------------cccccccccccccCcccccCcccCCcccchhhHHHHH
Q 002094 839 -------------------------------------------ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLV 875 (967)
Q Consensus 839 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll 875 (967)
.......||+.|+|||++ ....++.++||||+||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF-LQQGYGQECDWWSLGAIM 238 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH-ccCCCCCceeeEecchhh
Confidence 000124689999999998 556789999999999999
Q ss_pred HHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCC---CCHHHHHHH
Q 002094 876 LEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNR---PDMEEVVNI 952 (967)
Q Consensus 876 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---pt~~evl~~ 952 (967)
|||++|+.||...... ..+..+.. .. ..+..+.....+.++.+++.+|+. +|.+| +|+.|+++.
T Consensus 239 ~elltG~~Pf~~~~~~-~~~~~i~~----~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 239 FECLIGWPPFCSENSH-ETYRKIIN----WR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhcCCCCCCCCCHH-HHHHHHHc----cC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 9999999999754322 11111111 00 000001112345678999999997 66664 699888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=322.51 Aligned_cols=238 Identities=24% Similarity=0.339 Sum_probs=189.7
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHH-HHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMK-TLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||+|+.. +|+.||+|++..... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999965 689999999975432 122344555544 56789999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... .......
T Consensus 81 g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~ 155 (323)
T cd05575 81 GELFFHLQRERS---FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTST 155 (323)
T ss_pred CCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCcccc
Confidence 999999876443 78899999999999999999999999999999999999999999999999864322 1122334
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
..|++.|+|||++ .+..++.++|||||||++|||++|+.||...... +........ ....+..
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~-----------~~~~~~~ 218 (323)
T cd05575 156 FCGTPEYLAPEVL-RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMYDNILNK-----------PLRLKPN 218 (323)
T ss_pred ccCChhhcChhhh-cCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcC-----------CCCCCCC
Confidence 5689999999998 5667899999999999999999999999754321 111111110 1112334
Q ss_pred hHHHHHHHHHhhccCCCCCCCCHH
Q 002094 924 EAIPVIKLGLICASQVPSNRPDME 947 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~~ 947 (967)
.+..+.+++.+|++.||++||++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 567799999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.73 Aligned_cols=241 Identities=23% Similarity=0.320 Sum_probs=194.4
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 759 (967)
|+..+.||+|+||.||+|+.+ +++.||+|.+..... ......+..|..++..+ .|++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 466788999999999999965 578999999976432 22334567788888777 58999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..... ...
T Consensus 82 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~ 156 (323)
T cd05616 82 YVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGV 156 (323)
T ss_pred CCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCC
Confidence 9999999999876543 78999999999999999999999999999999999999999999999999875322 112
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......||+.|+|||++ ....++.++|||||||++|||++|+.||...... .....+... ...
T Consensus 157 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~---------------~~~ 219 (323)
T cd05616 157 TTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEH---------------NVA 219 (323)
T ss_pred ccccCCCChhhcCHHHh-cCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHHHHHHhC---------------CCC
Confidence 23345689999999998 5667899999999999999999999999754332 111111110 122
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDM 946 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~ 946 (967)
++...+.++.+++.+|++.||++|++.
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 345566789999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.95 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=200.4
Q ss_pred hhccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 681 NALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
...|+..+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 34578889999999999999995 468899999987543 2345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++++|.++++.... +++..+..++.|++.|++|||+++|+|||++|+||+++.++.++|+|||++....... .
T Consensus 87 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06646 87 YCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A 161 (267)
T ss_pred CCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence 9999999999875432 7899999999999999999999999999999999999999999999999997653211 1
Q ss_pred ccccccccccccCccccc--CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 840 LSSKIQSALGYMAPEFAC--RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~--~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
......+++.|+|||.+. ....++.++|+||+||++|||++|+.||......... ..+.. . ....+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~-----~---~~~~~~~- 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSK-----S---NFQPPKL- 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeec-----C---CCCCCCC-
Confidence 123456788899999873 2345788999999999999999999998533221110 00000 0 0000000
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
......+..+.+++.+|++.+|++|||++++++.
T Consensus 232 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 232 -KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred -ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 1112345679999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=329.27 Aligned_cols=251 Identities=21% Similarity=0.269 Sum_probs=197.2
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||+|+.. +++.||||++..... ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 577889999999999999965 689999999975432 23345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc-
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI- 839 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 839 (967)
+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~g~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 83 LPGGDMMTLLMKKDT---FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCCcHHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 999999999976443 8899999999999999999999999999999999999999999999999986543211000
Q ss_pred -----------------------------------ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCC
Q 002094 840 -----------------------------------LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884 (967)
Q Consensus 840 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p 884 (967)
......||+.|+|||++ ....++.++||||+||++|||++|+.|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF-LQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHH-cCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 01124589999999998 556789999999999999999999999
Q ss_pred CCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCC---HHHHHH
Q 002094 885 VEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPD---MEEVVN 951 (967)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~evl~ 951 (967)
|....... ...... ... ..+........+..+.+++.+|+. +|.+|++ ++|+++
T Consensus 239 f~~~~~~~-~~~~i~----~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 239 FCSDNPQE-TYRKII----NWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCHHH-HHHHHH----cCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 97543221 111111 100 000001111235678899999996 8999998 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.31 Aligned_cols=244 Identities=21% Similarity=0.289 Sum_probs=193.4
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||+|... +++.||+|++..... ....+.+..|+.++.++ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 578999999976532 23345688999999888 699999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|..++..... +++..+..++.|++.|++|||++||+||||||+||+++.++.+||+|||++...... ......
T Consensus 81 ~~L~~~~~~~~~---l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQRK---LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTST 155 (327)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCceec
Confidence 999998875433 899999999999999999999999999999999999999999999999998743211 112234
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccc-hHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD-VVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
..||+.|+|||++ .+..++.++||||+||++|||++|+.||...... .....+++...+.. .....+.
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~p~ 224 (327)
T cd05617 156 FCGTPNYIAPEIL-RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE----------KPIRIPR 224 (327)
T ss_pred ccCCcccCCHHHH-CCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh----------CCCCCCC
Confidence 5689999999998 5667899999999999999999999999642211 11111111111111 0122445
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHH
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDME 947 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~ 947 (967)
..+..+.+++.+|++.||++|++++
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCC
Confidence 5667789999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=325.41 Aligned_cols=252 Identities=21% Similarity=0.242 Sum_probs=200.6
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||+++.+ +++.||+|++..... ....+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 577789999999999999954 689999999976432 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++|+|.+++..... .+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++........ ..
T Consensus 83 ~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~ 159 (330)
T cd05601 83 QPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VN 159 (330)
T ss_pred CCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-ee
Confidence 999999999976532 388999999999999999999999999999999999999999999999999976643222 12
Q ss_pred cccccccccccCcccccC-----cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 841 SSKIQSALGYMAPEFACR-----TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~-----~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
.....||+.|+|||++.. ...++.++||||+||++|||++|+.||...... .... ........
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~----~i~~~~~~------- 227 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-KTYN----NIMNFQRF------- 227 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-HHHH----HHHcCCCc-------
Confidence 234568899999998742 456788999999999999999999999644322 1111 11111100
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+.....+.++.+++.+|++ +|++|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0111122345678999999997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=326.24 Aligned_cols=253 Identities=22% Similarity=0.255 Sum_probs=194.1
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||+||++... +++.||+|++..... ......+.+|+.++.+++|++|+++++++.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 577889999999999999855 588999999975432 22345788899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc--
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-- 838 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-- 838 (967)
+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 83 LPGGDMMTLLMKKDT---LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred CCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 999999999976543 889999999999999999999999999999999999999999999999998754321100
Q ss_pred -------------------------------cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCC
Q 002094 839 -------------------------------ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEY 887 (967)
Q Consensus 839 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~ 887 (967)
.......||+.|+|||++ .+..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF-MQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHH-cCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001234689999999998 556789999999999999999999999975
Q ss_pred CccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhcc--CCCCCCCCHHHHHHH
Q 002094 888 MEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICAS--QVPSNRPDMEEVVNI 952 (967)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~Rpt~~evl~~ 952 (967)
.... .....+.. .. ..+..+.....+.++.+++.+++. .++..||+++|+++.
T Consensus 239 ~~~~-~~~~~i~~----~~-------~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 239 ETPQ-ETYKKVMN----WK-------ETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCHH-HHHHHHHc----Cc-------CcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 4322 11111111 00 000000011234567788877543 234457899998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.42 Aligned_cols=240 Identities=21% Similarity=0.316 Sum_probs=189.3
Q ss_pred CccCCCCceEEEEEEeCC-------------CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCce
Q 002094 688 CELGRGGFGVVYRTILQD-------------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 754 (967)
+.||+|+||.||+|...+ ...||+|.+.... ......+.+|+.+++.++||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 368999999999998532 2358888876543 23456788999999999999999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC-------eEEeecc
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE-------PKVGDFG 827 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~-------~kl~Dfg 827 (967)
++||||+++|+|..++..... .+++..+++++.||++|++|||+++|+||||||+||+++.++. ++++|||
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998875432 3789999999999999999999999999999999999986654 8999999
Q ss_pred cccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHH-cCCCCCCCCccchHhHHHHHHhhhccC
Q 002094 828 LARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVV-TGKRPVEYMEDDVVVLCDMVRGALEDG 906 (967)
Q Consensus 828 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (967)
.+..... .....++..|+|||.+.....++.++|||||||++|||+ +|+.||........ .. ...
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~----~~~-- 223 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ER----FYE-- 223 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HH----HHh--
Confidence 9865422 123456788999998854667899999999999999998 58888864332111 00 000
Q ss_pred CchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 002094 907 RVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953 (967)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 953 (967)
... ......+.++.+++.+|++.||++||++.++++.+
T Consensus 224 -------~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 -------GQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -------cCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 11122345789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=305.30 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=211.7
Q ss_pred hccCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|+.++.||+|.|++|-.++ .-.|.+||||++.+... ......+.+|++.|+.++|||||++|++...+...|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 467888999999999999888 44799999999987654 2345688999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC-CCCCeEEeecccccccCCCccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID-SSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
.-++|+|++|+.+.... +.+..+.+++.||+.|+.|+|+.++||||+||+||++- .-|-|||.|||++-.+.+ .
T Consensus 98 LGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P---G 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP---G 172 (864)
T ss_pred ecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC---c
Confidence 99999999999876544 88999999999999999999999999999999998775 578999999999977643 2
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
..-....|+..|-|||.+.+...-.+++||||+|||+|.|++|++||+...+.+. +-. ++|-+ .
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-LTm-------------ImDCK--Y 236 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-LTM-------------IMDCK--Y 236 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-hhh-------------hhccc--c
Confidence 3345677899999999997776677899999999999999999999985554322 111 12222 2
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..|...+.+..++|..|+..||++|.+.+||+..
T Consensus 237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 3577888899999999999999999999998753
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=306.69 Aligned_cols=255 Identities=22% Similarity=0.311 Sum_probs=191.9
Q ss_pred ccCCCCceEEEEEEeCCC---cEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCc
Q 002094 689 ELGRGGFGVVYRTILQDG---RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGS 765 (967)
Q Consensus 689 ~lG~G~~g~Vy~~~~~~~---~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 765 (967)
+||+|+||.||+|...++ ..+++|.+.........+.+.+|+..++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999985443 34667766554434456789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccc
Q 002094 766 LYKHLHDGSSR-NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI 844 (967)
Q Consensus 766 L~~~l~~~~~~-~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 844 (967)
|.++++..... ...++..+..++.||+.||+|||+++++||||||+||+++.++.++|+|||++...............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 161 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK 161 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCC
Confidence 99999764322 23667778899999999999999999999999999999999999999999998643221111222345
Q ss_pred cccccccCcccccC------cccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 845 QSALGYMAPEFACR------TVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 845 ~gt~~y~aPE~~~~------~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.++..|+|||+... ...++.++||||||+++|||++ |..||...... ....... ... .....++
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~----~~~-~~~~~~~--- 232 (268)
T cd05086 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVI----KDQ-QVKLFKP--- 232 (268)
T ss_pred cCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH----hhc-ccccCCC---
Confidence 67788999998732 2245789999999999999997 67788644322 1111111 111 1111222
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
..+......+.+++..|+ .+|++||+++|++++|.
T Consensus 233 -~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 -QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222334566888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=321.63 Aligned_cols=242 Identities=22% Similarity=0.282 Sum_probs=190.3
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHH-HHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMK-TLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||+|+.. +++.||+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 578899999875432 122234444444 56788999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|.+++..... +.+..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... .......
T Consensus 81 ~~L~~~~~~~~~---~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~ 155 (325)
T cd05602 81 GELFYHLQRERC---FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTST 155 (325)
T ss_pred CcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCccc
Confidence 999999976443 77888889999999999999999999999999999999999999999999875322 1112334
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
..||+.|+|||++ ....++.++||||+||++|||++|+.||...... . +....... ....+..
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~----~~~~i~~~-----------~~~~~~~ 218 (325)
T cd05602 156 FCGTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-E----MYDNILNK-----------PLQLKPN 218 (325)
T ss_pred ccCCccccCHHHH-cCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-H----HHHHHHhC-----------CcCCCCC
Confidence 5689999999998 5667899999999999999999999999744322 1 11111110 1123345
Q ss_pred hHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 924 EAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+..+.+++.+|++.||.+||++.+.+.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 219 ITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 5677999999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=315.16 Aligned_cols=262 Identities=20% Similarity=0.339 Sum_probs=189.3
Q ss_pred CCCccCCCCceEEEEEEeC---CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEc--CCceeEEEEe
Q 002094 686 KDCELGRGGFGVVYRTILQ---DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT--PSLQLLIYEF 760 (967)
Q Consensus 686 ~~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 760 (967)
..+.||+|+||.||+|+.+ +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred cccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 3568999999999999864 46789999986543 23457889999999999999999998854 4567899999
Q ss_pred cCCCchhhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEe----CCCCCeEEeeccccc
Q 002094 761 ISSGSLYKHLHDGS------SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLI----DSSGEPKVGDFGLAR 830 (967)
Q Consensus 761 ~~~gsL~~~l~~~~------~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill----~~~~~~kl~Dfg~a~ 830 (967)
+.+ +|.+++.... ....+++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 865 7877775321 11248889999999999999999999999999999999999 456789999999998
Q ss_pred ccCCCccc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchH-------hHHHHHHhh
Q 002094 831 LLPMLDRC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVV-------VLCDMVRGA 902 (967)
Q Consensus 831 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~-------~~~~~~~~~ 902 (967)
........ .......+|+.|+|||++.....++.++||||+||++|||++|++||.....+.. ...+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 66432211 1223466889999999885556789999999999999999999999974332110 000111111
Q ss_pred hccCCchh------------hcchhhcC------------CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 903 LEDGRVED------------CVDARLRG------------NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 903 ~~~~~~~~------------~~~~~~~~------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+.... ......+. ........++.+++.+|++.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 00000000 000112345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.87 Aligned_cols=240 Identities=20% Similarity=0.308 Sum_probs=188.2
Q ss_pred ccCCCCceEEEEEEeCC-------------------------CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceee
Q 002094 689 ELGRGGFGVVYRTILQD-------------------------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743 (967)
Q Consensus 689 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 743 (967)
.||+|+||.||+|.... ...||+|.+.... ......+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 59999999999987421 2358899886543 233457888999999999999999
Q ss_pred eeeEEEcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC----
Q 002094 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG---- 819 (967)
Q Consensus 744 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~---- 819 (967)
+++++.+....++||||+++|+|..++..... .+++..+..++.||++||+|||+++|+||||||+||+++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999875433 378999999999999999999999999999999999997543
Q ss_pred ---CeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHH-cCCCCCCCCccchHhH
Q 002094 820 ---EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVV-TGKRPVEYMEDDVVVL 895 (967)
Q Consensus 820 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ell-tg~~p~~~~~~~~~~~ 895 (967)
.++++|||.+..... .....++..|+|||.+.....++.++||||||+++||++ +|+.||........
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-- 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-- 230 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence 379999998754321 122346778999998855567899999999999999995 69999964432211
Q ss_pred HHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 896 CDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
..+... ....+......+.+++.+|++.+|++|||++++++.|.
T Consensus 231 ~~~~~~---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERFYEK---------------KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHh---------------ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111110 01122223456899999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=325.15 Aligned_cols=252 Identities=18% Similarity=0.229 Sum_probs=198.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+.+++.++||||+++++++..++..++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 34688889999999999999965 578999999865321 223456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++....... .
T Consensus 123 Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~ 197 (370)
T cd05621 123 EYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-M 197 (370)
T ss_pred cCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-c
Confidence 999999999998653 27888999999999999999999999999999999999999999999999998654311 1
Q ss_pred cccccccccccccCcccccCc---ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 839 ILSSKIQSALGYMAPEFACRT---VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~---~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
.......||+.|+|||++... ..++.++|+||+||++|||++|+.||...... .....++. ..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~~~i~~-------------~~ 263 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTYSKIMD-------------HK 263 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHHHHHHh-------------CC
Confidence 122355689999999988432 23788999999999999999999999744321 11111111 11
Q ss_pred hcCCCC--hhhHHHHHHHHHhhccCCCCC--CCCHHHHHHH
Q 002094 916 LRGNFP--ADEAIPVIKLGLICASQVPSN--RPDMEEVVNI 952 (967)
Q Consensus 916 ~~~~~~--~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~~ 952 (967)
....++ ...+..+.+++.+|+..++.+ |+|++|+++.
T Consensus 264 ~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 011122 234567889999999865554 8999998775
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=295.07 Aligned_cols=261 Identities=23% Similarity=0.312 Sum_probs=220.8
Q ss_pred ccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEc-CCcee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT-PSLQL 755 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 755 (967)
.++....+.+|.||.||+|.++ +.+.|.||.++....+-+...+..|.-.+..+.|||+..+.+++.+ ....+
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~ 364 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF 364 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence 3566678999999999999765 3456888988877766667789999999999999999999998864 45668
Q ss_pred EEEEecCCCchhhhhh-----cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 756 LIYEFISSGSLYKHLH-----DGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
++|.++.-|+|..++. +....+.++..+...+|.|++.|++|||++||||.||..+|+++|+.-++||+|-.+++
T Consensus 365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhcc
Confidence 8899999999999998 33333357778888999999999999999999999999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 831 LLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
..-+.+.............||+||.+ .+..++.++|||||||++|||+| |+.|+...++. . ++
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal-~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf--E-------------m~ 508 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEAL-QNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--E-------------ME 508 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHH-hhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH--H-------------HH
Confidence 87666666667777778889999998 77899999999999999999999 99998644432 2 22
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
.++..++|-.-|.+|+.+++.++.-||..+|++||++++++.-|.++-.+
T Consensus 509 ~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 509 HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 33445556666889999999999999999999999999999999887544
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=329.84 Aligned_cols=252 Identities=20% Similarity=0.233 Sum_probs=196.2
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||+++.. +++.||||.+..... ......+.+|++++++++|+||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 677889999999999999954 589999999865322 22346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc----
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD---- 836 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~---- 836 (967)
+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 83 IPGGDMMSLLIRLGI---FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 999999999976543 7888899999999999999999999999999999999999999999999975321000
Q ss_pred -------------------------------------cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHH
Q 002094 837 -------------------------------------RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVV 879 (967)
Q Consensus 837 -------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ell 879 (967)
.........||+.|+|||++ ....++.++||||+||++|||+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL-LRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH-cCCCCCcceeeeeccceeeehh
Confidence 00001134689999999998 5667899999999999999999
Q ss_pred cCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCC---CHHHHHHH
Q 002094 880 TGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRP---DMEEVVNI 952 (967)
Q Consensus 880 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---t~~evl~~ 952 (967)
+|+.||........ ... ..... ...........+.++.+++.+|+ .+|.+|+ |+.|+++.
T Consensus 239 ~G~~Pf~~~~~~~~-~~~----i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPAET-QLK----VINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHHHH-HHH----HhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999975443211 111 10000 00111112234566888888876 5999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=328.27 Aligned_cols=251 Identities=20% Similarity=0.246 Sum_probs=194.0
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 567889999999999999954 688999999875432 23346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc---
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR--- 837 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~--- 837 (967)
+++|+|.+++.+... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 83 IPGGDMMSLLIRMGI---FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 999999999976533 78888999999999999999999999999999999999999999999999753210000
Q ss_pred ------------------------------------------ccccccccccccccCcccccCcccCCcccchhhHHHHH
Q 002094 838 ------------------------------------------CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLV 875 (967)
Q Consensus 838 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll 875 (967)
........||+.|+|||++ ....++.++||||+||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL-LRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHh-cCCCCCCeeeEEechHHH
Confidence 0001134689999999998 556789999999999999
Q ss_pred HHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCC---HHHHHH
Q 002094 876 LEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPD---MEEVVN 951 (967)
Q Consensus 876 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~evl~ 951 (967)
|||++|+.||........ ...+.. . ......+.....+.++.+++.+++ .+|++|++ ++|+++
T Consensus 239 ~elltG~~Pf~~~~~~~~-~~~i~~----~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 239 YEMLVGQPPFLAQTPLET-QMKVIN----W-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHhCCCCCCCCCHHHH-HHHHHc----c-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999975433211 111110 0 000111112234566788888875 59999987 777654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=312.84 Aligned_cols=255 Identities=23% Similarity=0.362 Sum_probs=207.6
Q ss_pred HhhccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEE
Q 002094 680 ANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 757 (967)
....|++.+.||+||.+.||++...+.+.||+|++..... ......|..|+..|.++ .|.+||++++|-..++..|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3456788899999999999999988889999988765432 44567899999999999 499999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||- ..+|..+|......- ..| .+..+..|++.|+.++|++||||.|+||.|+++ -.|.+||+|||+|..+.....
T Consensus 439 mE~G-d~DL~kiL~k~~~~~-~~~-~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSID-PDW-FLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eecc-cccHHHHHHhccCCC-chH-HHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcccc
Confidence 9975 459999998765542 334 777899999999999999999999999999999 568999999999998887777
Q ss_pred ccccccccccccccCcccccCc----------ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC
Q 002094 838 CILSSKIQSALGYMAPEFACRT----------VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR 907 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~----------~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (967)
........||+.||+||.+... -..++++||||+|||+|+|+.|+.||...... |. .
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------~a-------K 581 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------IA-------K 581 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------HH-------H
Confidence 7777789999999999987421 12678999999999999999999999632211 11 1
Q ss_pred chhhcchhhcCCCChhhH-HHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 908 VEDCVDARLRGNFPADEA-IPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+..+.++.-..+||..-. .++.++++.|+..||++|||..|+++
T Consensus 582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 233444444445554322 33999999999999999999999875
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=312.19 Aligned_cols=249 Identities=20% Similarity=0.320 Sum_probs=201.2
Q ss_pred ccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|++|.||+|+. .+++.||+|.+..... ...+.+.+|+.+++.+.|+||+++++++..+...++||||+
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 467778899999999999985 4689999999876543 34577899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++... .+++.++..++.|++.|++|||+.||+||||||+||+++.++.++|+|||.+....... ...
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~ 173 (296)
T cd06654 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR 173 (296)
T ss_pred CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--ccc
Confidence 999999998643 27889999999999999999999999999999999999999999999999987543211 112
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....+++.|+|||.. ....++.++|||||||++|+|++|+.||......... ..+.. . .......+
T Consensus 174 ~~~~~~~~y~aPE~~-~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~-~~~~~----~--------~~~~~~~~ 239 (296)
T cd06654 174 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIAT----N--------GTPELQNP 239 (296)
T ss_pred CcccCCccccCHHHH-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH-HHHhc----C--------CCCCCCCc
Confidence 344678899999988 5567889999999999999999999999644322111 11110 0 00011123
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
...+..+.+++.+|+..+|++|||+.|+++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 4455678999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=314.39 Aligned_cols=262 Identities=22% Similarity=0.308 Sum_probs=201.3
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|...+.||+|+||.||+|..+ +++.||+|.+...........+.+|+.++++++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 4677889999999999999865 578999999876544444567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
+ ++|.+++..... .+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++....... ...
T Consensus 87 ~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~ 161 (301)
T cd07873 87 D-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTY 161 (301)
T ss_pred c-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--Ccc
Confidence 7 589888876433 37889999999999999999999999999999999999999999999999987543211 112
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC---Cchhhcc-----
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG---RVEDCVD----- 913 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~----- 913 (967)
....+++.|+|||.+.....++.++||||+|+++|||++|++||........ . ..+....... ......+
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-L-HFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHHcCCCChhhchhhhcccccc
Confidence 2345678899999885556688899999999999999999999975433211 1 1111111100 0001000
Q ss_pred ----hhhcC----CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 914 ----ARLRG----NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 914 ----~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+.... ......+..+.+++.+|++.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 011234567899999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=345.80 Aligned_cols=464 Identities=26% Similarity=0.294 Sum_probs=302.2
Q ss_pred eeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEec
Q 002094 70 RVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSF 149 (967)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L 149 (967)
+++.|+++.|.+-...-+.+.+--+|+.|+|++|++. ..|..+..+.+|+.|+++.|.|. .+|.+. ..+.+|++|.|
T Consensus 22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~-~~~~~l~~lnL 98 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSC-SNMRNLQYLNL 98 (1081)
T ss_pred HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhh-hhhhcchhhee
Confidence 3667777666543322233334445888888888886 56777888888888888888887 567553 77888888888
Q ss_pred cccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCcccccc
Q 002094 150 ANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQ 229 (967)
Q Consensus 150 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 229 (967)
.+|.+. ..|.++..+.+|++|++|+|++. .+|..+..+..+..+..++|..... ++.. .++.++|..|.+.+.
T Consensus 99 ~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~-~ik~~~l~~n~l~~~ 171 (1081)
T KOG0618|consen 99 KNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQT-SIKKLDLRLNVLGGS 171 (1081)
T ss_pred ccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----hccc-cchhhhhhhhhcccc
Confidence 888888 67888888888888888888887 7788888888888888888822211 2222 277788888888877
Q ss_pred CCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcc
Q 002094 230 LPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNL 309 (967)
Q Consensus 230 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 309 (967)
++.++..++. .|+|.+|.+. --.+..+.+|+.|....|++.... -..++|+.|+.++|.+....+ -..-
T Consensus 172 ~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~--~p~p 240 (1081)
T KOG0618|consen 172 FLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDV--HPVP 240 (1081)
T ss_pred hhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecc--cccc
Confidence 7777777766 6888888876 234667777777777777776432 223677777777777762221 1223
Q ss_pred cccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcc-cccEEeccCCCCCCCCCCCcccccccCCCCc
Q 002094 310 VFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM-GLQTVSLSGNRLGESMQYPSFASMKDSYQGL 388 (967)
Q Consensus 310 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L 388 (967)
.+|+++++++|+++ .+|++++.+.+|+.++..+|+++ .+|..++.. +|+.|....|.+...... ...+++|
T Consensus 241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~------le~~~sL 312 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPF------LEGLKSL 312 (1081)
T ss_pred ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCc------cccccee
Confidence 46777777777777 44577777777777777777775 555555544 677777777777654432 2345677
Q ss_pred cEEEccCCcccCCCCCCcccccc-cchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCC
Q 002094 389 QVLDLSSNALSGVIPSNIGDLSS-LMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEK 467 (967)
Q Consensus 389 ~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 467 (967)
++|+|..|+|...++..+.-+.. |..|+.+.|++....-..=..+..|+.|++.+|.|++..-+.+.+...|+.|+|++
T Consensus 313 ~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsy 392 (1081)
T KOG0618|consen 313 RTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSY 392 (1081)
T ss_pred eeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecc
Confidence 77777777777544433333332 56666666666432211222345566666666666655555566666666666666
Q ss_pred CCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccc-cC
Q 002094 468 NFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHG-EL 546 (967)
Q Consensus 468 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~-~~ 546 (967)
|+|.......+.++..|++|+||+|+|+ .+|..+.++..|++|...+|+|. ..| ++..++.|+.+|+|.|+|+- .+
T Consensus 393 NrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l 469 (1081)
T KOG0618|consen 393 NRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTL 469 (1081)
T ss_pred cccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhh
Confidence 6666444445566666666666666666 45666666666666666666666 455 56666666666666666653 33
Q ss_pred CCCCCCCccCCCcccCCCC
Q 002094 547 PVGGFFNTISPSSVSGNPS 565 (967)
Q Consensus 547 p~~~~~~~~~~~~~~~n~~ 565 (967)
|....+.++....++||+|
T Consensus 470 ~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 470 PEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhCCCcccceeeccCCcc
Confidence 4333334455555666665
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=309.27 Aligned_cols=252 Identities=22% Similarity=0.292 Sum_probs=200.1
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
++|+..+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+++++.++|||++++++++..++..++||||
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 45677888999999999999966 47788888886543 33456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|..++..... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.++++|||++...... ...
T Consensus 84 ~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~ 159 (282)
T cd06643 84 CAGGAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR 159 (282)
T ss_pred cCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--ccc
Confidence 999999998865332 3889999999999999999999999999999999999999999999999998754321 112
Q ss_pred cccccccccccCccccc----CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 841 SSKIQSALGYMAPEFAC----RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~----~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.....+++.|+|||++. ....++.++|+||+||++|||++|+.||...... .....+.... ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~------------~~ 226 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSE------------PP 226 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-HHHHHHhhcC------------CC
Confidence 23456788999999873 2345778999999999999999999999644322 1111111110 00
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+...+.++.+++.+|++.||.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 227 TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11123344567999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.60 Aligned_cols=238 Identities=24% Similarity=0.325 Sum_probs=189.3
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHH-HHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMK-TLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||+|+.. +++.||+|++..... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 588999999875432 122344555554 57889999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
++|..++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... .......
T Consensus 81 ~~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~ 155 (321)
T cd05603 81 GELFFHLQRERC---FLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTST 155 (321)
T ss_pred CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCcccc
Confidence 999988865433 78888999999999999999999999999999999999999999999999874321 1122334
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
..|++.|+|||.+ ....++.++||||+||++|||++|+.||...+.. . +....... ....+..
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~----~~~~i~~~-----------~~~~~~~ 218 (321)
T cd05603 156 FCGTPEYLAPEVL-RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-Q----MYDNILHK-----------PLQLPGG 218 (321)
T ss_pred ccCCcccCCHHHh-cCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-H----HHHHHhcC-----------CCCCCCC
Confidence 5689999999998 5667899999999999999999999999654321 1 11111110 1223455
Q ss_pred hHHHHHHHHHhhccCCCCCCCCHH
Q 002094 924 EAIPVIKLGLICASQVPSNRPDME 947 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~~ 947 (967)
.+..+.+++.+|++.||.+||++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 667799999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=311.79 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=200.2
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|++|.||+|+.+ ++..||+|.+..... ......+.+|+.++++++||||+++++++..++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 466788999999999999965 689999999865432 223467889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
+ ++|.+++........+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||++....... ...
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RVY 158 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--ccc
Confidence 7 5888888765443458999999999999999999999999999999999999999999999999987553221 122
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhcc--C---Cchhhcc--h
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALED--G---RVEDCVD--A 914 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~---~~~~~~~--~ 914 (967)
....+++.|+|||.+.....++.++||||+|+++|||++|+.||........ ........... . ......+ .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2345678899999875555678999999999999999999999974432211 11111100000 0 0000000 0
Q ss_pred hh-------cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 915 RL-------RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 915 ~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.. ........+.++.+++.+|++.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 00012234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.92 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=199.7
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc--ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||++... +++.||||.+...... .....+..|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 456678999999999999965 6889999998754322 2234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|.+++...... .+++..+..++.|++.|++|||+.+|+||||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~g~~L~~~l~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---T 157 (285)
T ss_pred cCCCcHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---c
Confidence 9999999998654332 38899999999999999999999999999999999999999999999999987653221 1
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....|+..|+|||.+ ....++.++|+||+|+++|||++|+.||........ . +...... ......+
T Consensus 158 ~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~-~~~~~~~----------~~~~~~~ 224 (285)
T cd05630 158 IKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-R-EEVERLV----------KEVQEEY 224 (285)
T ss_pred ccCCCCCccccChHHH-cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-H-HHHHhhh----------hhhhhhc
Confidence 2234688999999998 566789999999999999999999999975432110 0 0011000 0011123
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPD-----MEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~ 951 (967)
+...+.++.+++.+|++.||++||| ++|+++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 4455667899999999999999999 788776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.15 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=201.2
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||.||+|... +++.||+|.+.........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556678999999999999854 578899998875543445568999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++... .+++..+..++.|++.|++|||+++++|+||+|+||++++++.++++|||++....... ...
T Consensus 85 ~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06642 85 GGGSALDLLKPG----PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhh
Confidence 999999988642 37889999999999999999999999999999999999999999999999987654321 122
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....++..|+|||.+ ....++.++|+||||+++|||++|+.||........ .. . .........+
T Consensus 159 ~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~-~---------~~~~~~~~~~ 222 (277)
T cd06642 159 NTFVGTPFWMAPEVI-KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-----LF-L---------IPKNSPPTLE 222 (277)
T ss_pred hcccCcccccCHHHh-CcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-----Hh-h---------hhcCCCCCCC
Confidence 234578889999998 566788999999999999999999999864332211 00 0 0111112233
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+.++.+++.+|++.+|++||++.++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 455677999999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=317.66 Aligned_cols=241 Identities=23% Similarity=0.324 Sum_probs=193.8
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 759 (967)
|+..+.||+|+||.||+|..+ +|+.||+|++..... ....+.+..|.++++.+. |++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 356788999999999999965 688999999975432 233456788888888885 5778889999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++|+|.+++..... +++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 82 y~~~g~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~--~~ 156 (323)
T cd05615 82 YVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--GV 156 (323)
T ss_pred CCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC--Cc
Confidence 9999999999876443 889999999999999999999999999999999999999999999999998754221 11
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......||+.|+|||++ ....++.++|+||+||++|||++|+.||...... .....+.. ....
T Consensus 157 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~~i~~---------------~~~~ 219 (323)
T cd05615 157 TTRTFCGTPDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-ELFQSIME---------------HNVS 219 (323)
T ss_pred cccCccCCccccCHHHH-cCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHh---------------CCCC
Confidence 22345689999999998 5667899999999999999999999999754332 11111111 0112
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDM 946 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~ 946 (967)
++...+.++.+++.+|++.+|.+|++.
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 345556778999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=320.17 Aligned_cols=241 Identities=24% Similarity=0.319 Sum_probs=190.7
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHH-HHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMK-TLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||+|+.. +|+.||+|++..... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999954 689999999975422 123345555555 46778999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|..++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... .......
T Consensus 81 ~~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~ 155 (325)
T cd05604 81 GELFFHLQRERS---FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTT 155 (325)
T ss_pred CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCccc
Confidence 999988875443 88999999999999999999999999999999999999999999999999864321 1112334
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
..|++.|+|||++ ....++.++||||+||++|||++|+.||...+.. . ........ ....++.
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~----~~~~~~~~-----------~~~~~~~ 218 (325)
T cd05604 156 FCGTPEYLAPEVI-RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-E----MYDNILHK-----------PLVLRPG 218 (325)
T ss_pred ccCChhhCCHHHH-cCCCCCCcCccccccceehhhhcCCCCCCCCCHH-H----HHHHHHcC-----------CccCCCC
Confidence 5689999999998 5667899999999999999999999999754322 1 11111111 0112334
Q ss_pred hHHHHHHHHHhhccCCCCCCCCHHHHH
Q 002094 924 EAIPVIKLGLICASQVPSNRPDMEEVV 950 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~~evl 950 (967)
.+..+.+++.+|++.+|.+||++.+.+
T Consensus 219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 219 ASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 566788999999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=304.53 Aligned_cols=245 Identities=29% Similarity=0.452 Sum_probs=198.4
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
|+..+.||+|+||.||++.. .++.||+|.+.... ....+.+|+.++++++|||++++++++... ..++||||+++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 67788999999999999975 57889999886542 346789999999999999999999998654 57999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
++|.+++...... .+++..+..++.|++.|++|||+.|++||||||+||+++.++.++|+|||.+...... ...
T Consensus 83 ~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~ 156 (254)
T cd05083 83 GNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDN 156 (254)
T ss_pred CCHHHHHHhcCcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-----CCC
Confidence 9999999765432 3789999999999999999999999999999999999999999999999998754321 112
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
...+..|+|||.+ ....++.++|+||+|+++|||++ |+.||....... ....+ ....+...+.
T Consensus 157 ~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~-------------~~~~~~~~~~ 220 (254)
T cd05083 157 SKLPVKWTAPEAL-KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECV-------------EKGYRMEPPE 220 (254)
T ss_pred CCCCceecCHHHh-ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHH-------------hCCCCCCCCC
Confidence 3345679999988 56678999999999999999997 999996443221 11111 1111222334
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
..+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 556779999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=309.35 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=199.1
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc--ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||+||++... +++.||+|.+...... .....+.+|++++++++|++|+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 355678999999999999864 6889999998654321 2234578899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|.+++...... .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---S 157 (285)
T ss_pred ccCccHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC---c
Confidence 9999999888754332 38999999999999999999999999999999999999999999999999987653211 1
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....|+..|+|||.+ ....++.++|+||+|+++|||++|+.||........ ...+.. ..... ...+
T Consensus 158 ~~~~~g~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~-~~~~~----------~~~~ 224 (285)
T cd05632 158 IRGRVGTVGYMAPEVL-NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDR-RVLET----------EEVY 224 (285)
T ss_pred ccCCCCCcCccChHHh-cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-hhhcc----------cccc
Confidence 2345688999999998 556789999999999999999999999975433211 111111 11110 1123
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPD-----MEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~ 951 (967)
+...+.++.+++.+|++.||++||+ +.++++
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 3445567899999999999999999 566655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=309.32 Aligned_cols=248 Identities=21% Similarity=0.326 Sum_probs=196.5
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+..+.||+|+||.||+|+. .+++.||+|.+..........++.+|++++++++||||+++++++..++..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 46678899999999999985 46889999998765434445679999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|..+. .+++..+..++.|++.|++|||+.||+|+||||+||+++.++.++|+|||++...... ...
T Consensus 83 ~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~ 151 (279)
T cd06619 83 GGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAK 151 (279)
T ss_pred CCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----ccc
Confidence 99987552 2678889999999999999999999999999999999999999999999998755321 223
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHh--HHHHHHhhhccCCchhhcchhhcCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVV--LCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
...++..|+|||++ ....++.++|+||+|+++|+|++|+.||......... ...+..... +.......
T Consensus 152 ~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 221 (279)
T cd06619 152 TYVGTNAYMAPERI-SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV---------DEDPPVLP 221 (279)
T ss_pred CCCCChhhcCceee-cCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh---------ccCCCCCC
Confidence 45688899999998 5567899999999999999999999999643221110 001111100 00000001
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
....+.++.+++.+|++.+|++||+++|+++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 12345678999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.35 Aligned_cols=241 Identities=20% Similarity=0.333 Sum_probs=191.3
Q ss_pred CccCCCCceEEEEEEeCC--------CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 688 CELGRGGFGVVYRTILQD--------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+.||+|+||.||+|..+. ...||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 369999999999998542 2348888775433 2345678899999999999999999999999899999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC--------eEEeecccccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE--------PKVGDFGLARL 831 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~--------~kl~Dfg~a~~ 831 (967)
|+++|+|.++++.... .+++..+..++.||+.|++|||++||+||||||+||+++.++. ++++|||.+..
T Consensus 80 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 80 YVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred cCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999986543 3789999999999999999999999999999999999987765 69999998864
Q ss_pred cCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCC-CCCCCCccchHhHHHHHHhhhccCCchh
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK-RPVEYMEDDVVVLCDMVRGALEDGRVED 910 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (967)
... .....++..|+|||++.....++.++||||||+++|||++|. .||........ .....
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--~~~~~---------- 219 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--LQFYE---------- 219 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--HHHHH----------
Confidence 432 223457788999999855456889999999999999999984 66543322111 00000
Q ss_pred hcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 911 CVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 911 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
.+...+.....++.+++.+|++.||++|||++++++.|+
T Consensus 220 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 -----DRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----ccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 012234445567999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=305.40 Aligned_cols=251 Identities=24% Similarity=0.392 Sum_probs=201.7
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-----cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-----IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
|+..+.||+|+||.||+|...+++.+|||.+..... ......+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 567889999999999999988899999999875432 122356889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc-
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR- 837 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 837 (967)
||+++++|.+++.+... +++..+..++.|++.|++|||+.+++|+||+|+||++++++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 82 EFVPGGSISSILNRFGP---LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred ecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999999976433 78899999999999999999999999999999999999999999999999875432111
Q ss_pred ---ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 838 ---CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 838 ---~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
........++..|+|||+. ....++.++|+||+|+++|||++|+.||...+.... ...... . .
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~---~---------~ 224 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVI-NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFYIGA---H---------R 224 (265)
T ss_pred ccccccccccCCCccccChhhh-cCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHHhhh---c---------c
Confidence 1112245578889999998 556788999999999999999999999975432211 111000 0 0
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
......+...+.++.+++.+|++.+|++||++.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1112234456677999999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=307.48 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=197.6
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcC------Cc
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTP------SL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~~ 753 (967)
+.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++++ +|+||+++++++... ..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 44677788999999999999964 58899999987543 3456789999999998 699999999998643 45
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++||||+++++|.+++...... .+++..+..++.|++.|++|||+++|+|+||||+||++++++.++|+|||++....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 78999999999999999864332 38899999999999999999999999999999999999999999999999987653
Q ss_pred CCccccccccccccccccCcccccC----cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACR----TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
.. ........|++.|+|||++.. ...++.++||||+||++|||++|+.||......... .. ...
T Consensus 163 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~----~~-~~~----- 230 (272)
T cd06637 163 RT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----FL-IPR----- 230 (272)
T ss_pred cc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH----HH-Hhc-----
Confidence 21 122334668889999998742 335788999999999999999999999643322111 00 000
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+...+...+..+.+++.+|+..+|.+|||+.|+++
T Consensus 231 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 ----NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00111112334567899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=316.22 Aligned_cols=263 Identities=17% Similarity=0.272 Sum_probs=194.7
Q ss_pred CCccCCC--CceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 687 DCELGRG--GFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 687 ~~~lG~G--~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.++||+| +||+||++.. .+|+.||+|++..... ....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 7889999985 4689999999976542 2334567889999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc---
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI--- 839 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--- 839 (967)
+|+|.+++...... .+++..+..++.|++.||+|||+++|+||||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 83 YGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCcHHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 99999999654332 28899999999999999999999999999999999999999999999998654332111100
Q ss_pred --ccccccccccccCcccccCc-ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC-C-----chh
Q 002094 840 --LSSKIQSALGYMAPEFACRT-VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG-R-----VED 910 (967)
Q Consensus 840 --~~~~~~gt~~y~aPE~~~~~-~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~-----~~~ 910 (967)
......++..|+|||++... ..++.++|||||||++|||++|+.||.......... .......... . ..+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH-HHhcCCccccccccchhhhh
Confidence 11223456779999998443 458899999999999999999999997544322111 1111110000 0 000
Q ss_pred h--------cchh-----------------hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 911 C--------VDAR-----------------LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 911 ~--------~~~~-----------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
. .+.. .........+..+.+++.+|++.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 0000 000112233567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=306.73 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=203.2
Q ss_pred ccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLL 756 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 756 (967)
.|+..+.||+|+||.||+|+.+ +...||+|.+.........+++.+|++++++++|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM 85 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence 3577888999999999999954 3467999988654433345789999999999999999999999998889999
Q ss_pred EEEecCCCchhhhhhcCCCCC------CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 757 IYEFISSGSLYKHLHDGSSRN------CLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~------~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
||||+++|+|.++++...... .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++++|||.+.
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccccc
Confidence 999999999999997655221 48999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 831 LLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
..... .........++..|+|||.+ .....+.++||||+|+++|++++ |..||....... .+... ...
T Consensus 166 ~~~~~-~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-----~~~~~-~~~--- 234 (275)
T cd05046 166 DVYNS-EYYKLRNALIPLRWLAPEAV-QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-----VLNRL-QAG--- 234 (275)
T ss_pred ccCcc-cccccCCceeEEeecChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-----HHHHH-HcC---
Confidence 44221 11222334567789999988 55568899999999999999999 888986433221 11111 101
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
......+...+..+.+++.+|++.+|++|||+.|++++|+
T Consensus 235 -----~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 -----KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -----CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111223445677999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.97 Aligned_cols=248 Identities=26% Similarity=0.404 Sum_probs=204.2
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+++++++.||||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4677788999999999999965 588999999876544445678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++... .+++..+..++.|++.|++|+|+.+++|+||+|+||+++.++.++++|||++....... ...
T Consensus 85 ~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06640 85 GGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--ccc
Confidence 999999998642 27888999999999999999999999999999999999999999999999997654322 122
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....++..|+|||.+ ....++.++|+||||+++|||++|..||......... . ..........+
T Consensus 159 ~~~~~~~~y~apE~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----~----------~~~~~~~~~~~ 222 (277)
T cd06640 159 NTFVGTPFWMAPEVI-QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----F----------LIPKNNPPTLT 222 (277)
T ss_pred ccccCcccccCHhHh-ccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----h----------hhhcCCCCCCc
Confidence 334577889999988 5567899999999999999999999999644322110 0 00111122345
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
...+..+.+++.+|++.+|++||+++++++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 5677889999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.31 Aligned_cols=272 Identities=26% Similarity=0.362 Sum_probs=210.8
Q ss_pred hccCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC------Cce
Q 002094 682 ALLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP------SLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 754 (967)
..|...+.||+||||.||+|+ ..+|+.||||.++........++..+|++++++++|+|||++++.-.+. ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 345667789999999999999 5579999999998877777889999999999999999999999876543 356
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEe--CCCCC--eEEeeccccc
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLI--DSSGE--PKVGDFGLAR 830 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill--~~~~~--~kl~Dfg~a~ 830 (967)
.+|||||.||||+..+.+......+++.+.+.+..+++.||.|||++||+||||||.||++ +++|+ -||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 8999999999999999988777779999999999999999999999999999999999999 34454 5999999999
Q ss_pred ccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhcc-C-Cc
Q 002094 831 LLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALED-G-RV 908 (967)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~-~~ 908 (967)
..++.. .-...+||..|.+||+.-+.+.++..+|.|||||++||++||..||.....+... .+++...+.. + .+
T Consensus 173 el~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~-~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 173 ELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN-KEIMWHIITKKPSGV 248 (732)
T ss_pred cCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc-chhhhhhhccCCCce
Confidence 876533 4567899999999999944578999999999999999999999999754443221 1122211111 1 11
Q ss_pred hhhcchhhcCC--------CC----hhhHHHHHHHHHhhccCCCCCCC--CHHHHHHHHHhhc
Q 002094 909 EDCVDARLRGN--------FP----ADEAIPVIKLGLICASQVPSNRP--DMEEVVNILELIQ 957 (967)
Q Consensus 909 ~~~~~~~~~~~--------~~----~~~~~~l~~li~~cl~~dP~~Rp--t~~evl~~L~~~~ 957 (967)
.-...+..+++ ++ ......+...+..++..+|.+|- .+.+....+.+|.
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 11111111111 12 22233456677778888999987 7766766666654
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=303.07 Aligned_cols=251 Identities=31% Similarity=0.485 Sum_probs=203.2
Q ss_pred CCCCccCCCCceEEEEEEeCC-----CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 685 NKDCELGRGGFGVVYRTILQD-----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+..+.||+|+||.||+++..+ +..||+|.+.........+.+.+|++.++.++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999654 488999999766533356789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++++|.+++....... +++..+..++.|++.|++|||+.+++|+||+|+||+++.++.++++|||.+..........
T Consensus 82 ~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred ccCCCCHHHHHHhhhhcc-CCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 999999999997654322 7899999999999999999999999999999999999999999999999997665432211
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.....+++.|+|||.. ....++.++|+||+|+++++|++ |+.||...... ...+.+. .....
T Consensus 161 -~~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~-------------~~~~~ 223 (258)
T smart00219 161 -KKGGKLPIRWMAPESL-KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEYLK-------------KGYRL 223 (258)
T ss_pred -cccCCCcccccChHHh-ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHh-------------cCCCC
Confidence 1123367889999988 66788999999999999999998 88888643221 1111111 11112
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 953 (967)
..+...+.++.+++.+|++.||++|||+.|+++.|
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 23344667899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=306.01 Aligned_cols=251 Identities=22% Similarity=0.365 Sum_probs=197.5
Q ss_pred CCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 685 NKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
.....||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++..++..++||||+++
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence 44568999999999999954 57889999887554 23456899999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC-CCCeEEeecccccccCCCccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS-SGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
++|.+++.........++..+..++.||+.|++|||++||+||||||+||+++. ++.++|+|||.+....... ....
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~ 167 (268)
T cd06624 90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCTE 167 (268)
T ss_pred CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC--Cccc
Confidence 999999976432211378888999999999999999999999999999999986 6799999999987553211 1222
Q ss_pred cccccccccCcccccCc-ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRT-VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~-~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
...+++.|+|||+.... ..++.++|+||+|+++|+|++|+.||.......... +... ........+
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--~~~~-----------~~~~~~~~~ 234 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--FKVG-----------MFKIHPEIP 234 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--hhhh-----------hhccCCCCC
Confidence 34578899999987332 347889999999999999999999996433221111 0000 001122345
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....++.+++.+|++.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 556677999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.86 Aligned_cols=246 Identities=24% Similarity=0.395 Sum_probs=201.8
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+..+.||.|++|.||+|+.. +++.||+|.+...........+.+|+++++.++|+||+++++++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 567788999999999999965 6889999998765544455678999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.+++... .+++..+..++.|++.|++|||+++++|+||+|+||++++++.++++|||+++...... ....
T Consensus 83 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (274)
T cd06609 83 GGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRN 156 (274)
T ss_pred CCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccc
Confidence 99999998764 38899999999999999999999999999999999999999999999999998765321 1223
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
...+++.|+|||.. .+..++.++||||||+++|||++|+.||........ ... +... .....+.
T Consensus 157 ~~~~~~~y~~PE~~-~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-----~~~-~~~~---------~~~~~~~ 220 (274)
T cd06609 157 TFVGTPFWMAPEVI-KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-----LFL-IPKN---------NPPSLEG 220 (274)
T ss_pred cccCCccccChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-----HHH-hhhc---------CCCCCcc
Confidence 45678889999998 555699999999999999999999999964332111 110 0000 1111122
Q ss_pred h-hHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 923 D-EAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 923 ~-~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
. .+.++.+++.+|+..+|++|||++++++
T Consensus 221 ~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 2 4567999999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=310.87 Aligned_cols=261 Identities=21% Similarity=0.343 Sum_probs=188.8
Q ss_pred CCCccCCCCceEEEEEEeC---CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEc--CCceeEEEEe
Q 002094 686 KDCELGRGGFGVVYRTILQ---DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT--PSLQLLIYEF 760 (967)
Q Consensus 686 ~~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 760 (967)
+++.||+|+||.||+|+.+ ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 3568999999999999965 35789999886543 23467899999999999999999998853 4567899999
Q ss_pred cCCCchhhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEe----CCCCCeEEeeccccc
Q 002094 761 ISSGSLYKHLHDGS------SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLI----DSSGEPKVGDFGLAR 830 (967)
Q Consensus 761 ~~~gsL~~~l~~~~------~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill----~~~~~~kl~Dfg~a~ 830 (967)
+++ +|.+++.... ....+++..+..++.|++.||+|||+++|+||||||+||++ +.++.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 875 7777764321 11247889999999999999999999999999999999999 466789999999998
Q ss_pred ccCCCccc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchH--------hHHHHHHh
Q 002094 831 LLPMLDRC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVV--------VLCDMVRG 901 (967)
Q Consensus 831 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~--------~~~~~~~~ 901 (967)
........ .......+|+.|+|||.+.....++.++||||+||++|||++|++||.....+.. ....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~- 239 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS- 239 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH-
Confidence 66432211 1223456788999999885556689999999999999999999999974332211 1111111
Q ss_pred hhccCCchhhc---------c---hh---------h---cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 902 ALEDGRVEDCV---------D---AR---------L---RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 902 ~~~~~~~~~~~---------~---~~---------~---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.........+. + .. . ...........+.+++.+|++.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000000 0 00 0 00001122345888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.14 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=200.1
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc--------ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCce
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI--------KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 754 (967)
|.....||+|++|.||+|... +++.||+|.+...... +..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 466788999999999999864 5889999988654321 1125688999999999999999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
++||||+++++|.+++..... +++..+..++.|++.|++|||+.|++||||+|+||+++.++.++|+|||.++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGA---FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccC---ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999999976533 78899999999999999999999999999999999999999999999999876642
Q ss_pred Cccc----cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchh
Q 002094 835 LDRC----ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVED 910 (967)
Q Consensus 835 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (967)
.... .......++..|+|||.+ ....++.++|+||+|+++|+|++|+.||........ .. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~------- 225 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-IF----KIG------- 225 (267)
T ss_pred ccccCCccccccccCCCcCccChhHh-ccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-HH----HHh-------
Confidence 1111 111234577889999988 556788999999999999999999999975432211 10 000
Q ss_pred hcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 911 CVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 911 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.......+...+..+.+++.+|++.||++||++.|+++
T Consensus 226 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 ---ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 01122344556678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.49 Aligned_cols=249 Identities=23% Similarity=0.400 Sum_probs=202.4
Q ss_pred hccCCCCccCCCCceEEEEEEeCC-CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|..++ ++.||+|.+.... ..+++.+|++++++++|+||+++++++..+...++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 346788899999999999999765 7899999987543 267899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|.+++..... .+++..+..++.|++.|++|||+.+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 80 ~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 80 CGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 999999999875432 389999999999999999999999999999999999999999999999999876543221 2
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....++..|+|||.. .+..++.++||||||+++|+|++|+.||........... + .. ........
T Consensus 156 ~~~~~~~~~y~~PE~~-~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--~----~~-------~~~~~~~~ 221 (256)
T cd06612 156 RNTVIGTPFWMAPEVI-QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--I----PN-------KPPPTLSD 221 (256)
T ss_pred cccccCCccccCHHHH-hcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--h----cc-------CCCCCCCc
Confidence 2344578889999988 566789999999999999999999999974432211100 0 00 00001112
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+...+..+.+++.+|++.||++|||++|+++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 3344567999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=319.14 Aligned_cols=261 Identities=20% Similarity=0.244 Sum_probs=194.7
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC------
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS------ 752 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 752 (967)
.+.|+..+.||+|+||.||++... +|..||||++..... ......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 345788899999999999999864 589999999865432 234567889999999999999999999986443
Q ss_pred ceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccccccc
Q 002094 753 LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLL 832 (967)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 832 (967)
..++||||+++ ++.+.++. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 46899999976 56666543 2678889999999999999999999999999999999999999999999999754
Q ss_pred CCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHH------------
Q 002094 833 PMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVR------------ 900 (967)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~------------ 900 (967)
.. ........+|+.|+|||.+ .+..++.++||||+||++|||++|+.||...+... .......
T Consensus 174 ~~---~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 174 CT---NFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cc---CccCCCCcccCCCCCchhc-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHHHH
Confidence 32 1222345678899999998 56678999999999999999999999997543211 1111110
Q ss_pred ------hhhcc-CCch-----hhcchhh---cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 901 ------GALED-GRVE-----DCVDARL---RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 901 ------~~~~~-~~~~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..... +... +...... ........+..+.+++.+|++.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0000 0000000 000111234568999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.57 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=205.9
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+..+.||.|+||.||+|... ++..+|+|++...........+.+|++.++.++|+||+++++.+..+...++||||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 577889999999999999954 6789999998765544466789999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc--c
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI--L 840 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~ 840 (967)
+++|.++++.......+++..+..++.|++.|++|||+.|++||||+|+||++++++.++|+|||++.......... .
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 162 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccc
Confidence 99999999765443348899999999999999999999999999999999999999999999999987665432221 2
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC-
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN- 919 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 919 (967)
.....++..|+|||.+.....++.++|+||||+++|||++|+.||...... ......... . .......
T Consensus 163 ~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~----~------~~~~~~~~ 231 (267)
T cd06610 163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQN----D------PPSLETGA 231 (267)
T ss_pred cccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcC----C------CCCcCCcc
Confidence 234567889999998844447899999999999999999999999644332 111111111 0 0011110
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+..+.+++.+|++.||++|||++++++
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11244577899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.69 Aligned_cols=260 Identities=22% Similarity=0.280 Sum_probs=193.0
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-ccHHHHHHHHHHHcCC---CCCceeeeeeEEEc-----CCc
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKI---RHHNLVALEGYYWT-----PSL 753 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~~ 753 (967)
|+..+.||+|+||.||+|..+ +++.||+|.+...... .....+.+|+++++++ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 567788999999999999965 6889999998754321 2234566777776655 79999999998764 245
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++||||+++ +|.+++...... .+++..+..++.|++.||+|+|++||+||||||+||+++.++.+||+|||++....
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPPP-GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 7899999985 888888764432 38899999999999999999999999999999999999999999999999997654
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc-
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV- 912 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 912 (967)
.. .......++..|+|||++ ....++.++||||+||++|||++|++||...... ..+..+... .......++.
T Consensus 160 ~~---~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~-~~~~~~~~~~~ 233 (288)
T cd07863 160 CQ---MALTPVVVTLWYRAPEVL-LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDL-IGLPPEDDWPR 233 (288)
T ss_pred Cc---ccCCCccccccccCchHh-hCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHH-hCCCChhhCcc
Confidence 21 122345678899999988 5567899999999999999999999999644332 122222211 1100000000
Q ss_pred -----chhhc-------CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 913 -----DARLR-------GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 913 -----~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..... ....+..+..+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 0111234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.43 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=201.2
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+..+.||+|+||.||++... ++..||+|.+..........++.+|++++++++||||+++++++..++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 577889999999999999965 5788999988755433345678899999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
+++|.++++.... +++..+..++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++...... ..
T Consensus 83 ~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~ 155 (308)
T cd06615 83 GGSLDQVLKKAGR---IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA 155 (308)
T ss_pred CCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc----cc
Confidence 9999999976532 7899999999999999999997 59999999999999999999999999998754321 12
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC--------------
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR-------------- 907 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------------- 907 (967)
....++..|+|||.. .+..++.++|+||||+++|||++|+.||...... ....+.........
T Consensus 156 ~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 156 NSFVGTRSYMSPERL-QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccCCCCcCccChhHh-cCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCCCCC
Confidence 345678899999987 5567889999999999999999999999643321 11111111100000
Q ss_pred ------chhhcchhh---cCCCC-hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 002094 908 ------VEDCVDARL---RGNFP-ADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953 (967)
Q Consensus 908 ------~~~~~~~~~---~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 953 (967)
..+..+... ....+ ...+.++.+++.+|++.+|++|||++|+++.-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000 01111 12455799999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.72 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=199.6
Q ss_pred cCCCCccCCCCceEEEEEEeC----CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC------
Q 002094 684 LNKDCELGRGGFGVVYRTILQ----DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS------ 752 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 752 (967)
|...+.||+|+||.||+|..+ ++..||||.+..... ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456778999999999999854 368899999876432 234567889999999999999999999886432
Q ss_pred ceeEEEEecCCCchhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccc
Q 002094 753 LQLLIYEFISSGSLYKHLHDGS---SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLA 829 (967)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a 829 (967)
..++++||+++|+|.+++.... ....+++..+.+++.|++.|++|||+++|+||||||+||+++.++.+|++|||.+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 2468899999999998875332 1123788999999999999999999999999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCc
Q 002094 830 RLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRV 908 (967)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 908 (967)
+...............+++.|++||.. ....++.++||||||+++|||++ |++||...... ....++.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~---~~-- 232 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLIK---GN-- 232 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHH-hcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHHc---CC--
Confidence 865432222222233456779999988 56678899999999999999999 89998644321 11111111 00
Q ss_pred hhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
....+...+..+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 233 --------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 --------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1112334556899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.85 Aligned_cols=252 Identities=28% Similarity=0.457 Sum_probs=199.6
Q ss_pred cCCCCccCCCCceEEEEEEeCC-CcEEEEEEeecCCcccc-HHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKS-QEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|+||+||++.... ++.||+|.+........ .....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567889999999999999664 56899999987764222 223456999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++.... .+++..+..++.|+++||++||+++++|+||||+||+++.++.++|+|||.+.... ......
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENF 155 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEB
T ss_pred ccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccc
Confidence 9999999998332 28899999999999999999999999999999999999999999999999987541 222334
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCcc--chHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMED--DVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
....++..|+|||+.......+.++|+||+|+++|+|++|..||..... .............. ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~ 224 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP-----------SSSQ 224 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH-----------HHTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc-----------cccc
Confidence 4667888999999984377899999999999999999999999975521 11111111110000 0001
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
........+.+++.+|++.||++|||+.++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122378999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=294.70 Aligned_cols=248 Identities=22% Similarity=0.377 Sum_probs=205.7
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|++..+||+|+||+||++.++ +|+.||||.+..+. +..++..|+.++++++.|++|++||.+......|+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 3566778999999999999965 69999999987654 5678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
..|+..+.++-+.. ++++.++..+++..++||+|||...-+|||||..|||++.+|.+||+|||.|..+.+ .....
T Consensus 111 GAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKR 186 (502)
T KOG0574|consen 111 GAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKR 186 (502)
T ss_pred CCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhh
Confidence 99999999976544 489999999999999999999999999999999999999999999999999976532 22334
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
..+.|||-|||||++ +.-.|..++||||+|++..||..|++||.....-..+++ +.. .+...-..|
T Consensus 187 NTVIGTPFWMAPEVI-~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM------IPT-------~PPPTF~KP 252 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVI-EEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM------IPT-------KPPPTFKKP 252 (502)
T ss_pred CccccCcccccHHHH-HHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe------ccC-------CCCCCCCCh
Confidence 568899999999999 777899999999999999999999999974332111100 000 010111124
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+.-+.++.+++++|+-+.|++|-|+.++++
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 455678999999999999999999988765
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.60 Aligned_cols=257 Identities=23% Similarity=0.383 Sum_probs=204.7
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||+||++... ++..||+|++.........+.+.+|+++++.++||||+++++++..+...++||||+
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM 85 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence 4577789999999999999965 588999998876544445678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++++|.+++.... .+++..+..++.+++.|+.|||+ ++++||||+|+||+++.++.++|+|||++...... .
T Consensus 86 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~ 158 (284)
T cd06620 86 DCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----I 158 (284)
T ss_pred CCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----c
Confidence 9999999987643 38899999999999999999997 58999999999999999999999999998654221 1
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccch------HhHHHHHHhhhccCCchhhcch
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDV------VVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
.....|+..|+|||++ ....++.++|+|||||++|++++|+.||....... ....++........
T Consensus 159 ~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 229 (284)
T cd06620 159 ADTFVGTSTYMSPERI-QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-------- 229 (284)
T ss_pred cCccccCcccCCHHHH-ccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--------
Confidence 1234678899999988 45588899999999999999999999997443211 11111222111110
Q ss_pred hhcCCCC-hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 915 RLRGNFP-ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 915 ~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
....+ ...+..+.+++.+|++.||++|||++|++++..-+.
T Consensus 230 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 230 --PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred --CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 01111 225567999999999999999999999998754333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=315.13 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=203.9
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCch
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSL 766 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 766 (967)
-+||+|.||+||-|+.. +...+|||-+..... +...-+..|+..-++++|.|||+++|.+.+.+..-+.||-++||||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 47999999999999965 456799998876553 3345588999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC-CCCCeEEeecccccccCCCcccccccccc
Q 002094 767 YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID-SSGEPKVGDFGLARLLPMLDRCILSSKIQ 845 (967)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 845 (967)
.+.++..-..-.-.+.++-.+-+||++||.|||+..|||||||-.||+++ -.|.+||+|||-++...... .....+.
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETFT 737 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETFT 737 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC--ccccccc
Confidence 99998764431136777888999999999999999999999999999997 47899999999998775322 2345677
Q ss_pred ccccccCcccccCc-ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhh
Q 002094 846 SALGYMAPEFACRT-VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADE 924 (967)
Q Consensus 846 gt~~y~aPE~~~~~-~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (967)
||..|||||++.++ ..|+.++|||||||++.||.||++||............ +---+..++.|.+.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-------------VGmyKvHP~iPeel 804 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-------------VGMYKVHPPIPEEL 804 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-------------hcceecCCCCcHHH
Confidence 99999999999443 45899999999999999999999999755443221111 00112356788899
Q ss_pred HHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 925 AIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 925 ~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+.+...+|.+|+.+||..||+++++++
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 999999999999999999999999864
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.55 Aligned_cols=247 Identities=21% Similarity=0.340 Sum_probs=200.7
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+..+.||.|++|.||+|+. .+++.||+|.+.... ....+.+.+|+++++.++|||++++++++...+..++||||++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 67778899999999999985 568999999987654 3345778999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.+++... .+++.++..++.|++.|++|||++|++||||||+||+++.++.++|+|||++........ ...
T Consensus 100 ~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~ 173 (296)
T cd06655 100 GGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRS 173 (296)
T ss_pred CCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCC
Confidence 99999998643 278999999999999999999999999999999999999999999999999875533211 123
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
...++..|+|||.+ ....++.++|+|||||++|+|++|+.||........ ...+... .......+.
T Consensus 174 ~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~~~~------------~~~~~~~~~ 239 (296)
T cd06655 174 TMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATN------------GTPELQNPE 239 (296)
T ss_pred CcCCCccccCcchh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc------------CCcccCCcc
Confidence 44678889999988 566788999999999999999999999975433211 1111000 000111234
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+..+.+++.+|+..||.+|||+.+++.
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 45667899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=320.62 Aligned_cols=254 Identities=18% Similarity=0.200 Sum_probs=197.4
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||++..+ +++.||+|.+..... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 45688899999999999999965 578999999865321 223456789999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++|+|.+++.... ++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 123 Ey~~gg~L~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~ 197 (371)
T cd05622 123 EYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-M 197 (371)
T ss_pred cCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-c
Confidence 9999999999986532 6788889999999999999999999999999999999999999999999997654321 1
Q ss_pred cccccccccccccCcccccCc---ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 839 ILSSKIQSALGYMAPEFACRT---VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~---~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
.......||+.|+|||++... ..++.++||||+||++|||++|+.||...... .....+. .... .
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~----~~~~-------~ 265 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIM----NHKN-------S 265 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHH----cCCC-------c
Confidence 122356689999999988432 23788999999999999999999999744321 1111111 1100 0
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCC--CCCHHHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSN--RPDMEEVVNI 952 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~~ 952 (967)
.........+..+.+++.+|+..++.+ |++++|+++.
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 266 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111112345677899999999844443 7888888774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.52 Aligned_cols=263 Identities=22% Similarity=0.295 Sum_probs=200.7
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|+..+.||+|++|.||+|+.+ +++.||+|++..... ....+.+.+|+.++++++|+|++++++++..+...++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 3677789999999999999976 589999999865432 22345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++++.+..+...... +++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++........ .
T Consensus 82 ~~~~~l~~~~~~~~~---~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~ 156 (286)
T cd07847 82 CDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--D 156 (286)
T ss_pred cCccHHHHHHhCCCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--c
Confidence 999988887654332 88999999999999999999999999999999999999999999999999986643221 1
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhh---hc-------cCC-ch
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGA---LE-------DGR-VE 909 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~---~~-------~~~-~~ 909 (967)
.....++..|+|||.+.....++.++|+||+|+++|||++|+.||........ ...+.... .. ... ..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhcccccccc
Confidence 22345678899999875556688999999999999999999999975443221 11111100 00 000 00
Q ss_pred hhcchhhcCC-----CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 910 DCVDARLRGN-----FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 910 ~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+..... .....+..+.+++.+|++.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000 01133567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=322.11 Aligned_cols=250 Identities=22% Similarity=0.262 Sum_probs=193.6
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||++..+ +++.||+|++..... ......+.+|+.++..++||+|+++++++.+++..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 567789999999999999965 589999999975321 23456788899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc--
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-- 838 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-- 838 (967)
+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 83 LPGGDMMTLLMKKDT---LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred CCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 999999999976443 789999999999999999999999999999999999999999999999998654221100
Q ss_pred -------------------------------cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCC
Q 002094 839 -------------------------------ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEY 887 (967)
Q Consensus 839 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~ 887 (967)
.......||+.|+|||++ .+..++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF-MQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHH-cCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001134689999999998 566789999999999999999999999975
Q ss_pred CccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCC---HHHHH
Q 002094 888 MEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPD---MEEVV 950 (967)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~evl 950 (967)
...... ...+. ... ..+........+.++.+++.+++ .||.+|++ ++|++
T Consensus 239 ~~~~~~-~~~i~----~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 239 ETPQET-YRKVM----NWK-------ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CCHHHH-HHHHH----cCC-------CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 433211 11111 000 00000001124567888888876 49999986 45544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.32 Aligned_cols=249 Identities=21% Similarity=0.331 Sum_probs=201.4
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
..|+..+.||+|+||.||+++. .+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 3467888999999999999995 4799999999976542 3456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|.+++... .+++..+..++.|++.|+.|||+.|++||||||+||+++.++.++|+|||.+........ .
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~ 171 (297)
T cd06656 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 171 (297)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--C
Confidence 9999999998653 278899999999999999999999999999999999999999999999999876533211 1
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....+++.|+|||.. ....++.++|+||+||++|++++|+.||........... +. .........
T Consensus 172 ~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~------------~~~~~~~~~ 237 (297)
T cd06656 172 RSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IA------------TNGTPELQN 237 (297)
T ss_pred cCcccCCccccCHHHH-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-ec------------cCCCCCCCC
Confidence 2345678889999988 556788999999999999999999999964332211000 00 000001112
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+...+..+.+++.+|++.+|++||+++++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 3445567889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.05 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=199.7
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEc-CCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWT-PSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 760 (967)
|+..+.||+|++|.||++..+ +++.||+|.+..... ....+.+.+|++++++++|+|++++++.+.. ....++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 567789999999999999955 578999999875432 2345678999999999999999999998764 4457899999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|.+++...... .+++.++..++.+++.|++++|++|++||||||+||+++.++.++|+|||++....... ..
T Consensus 82 ~~~~~l~~~l~~~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~ 158 (257)
T cd08223 82 CEGGDLYHKLKEQKGK-LLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--DM 158 (257)
T ss_pred cCCCcHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC--Cc
Confidence 9999999999764332 38899999999999999999999999999999999999999999999999987654321 12
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....+++.|+|||+. ....++.++|+||+|++++||++|+.||+..+... +...... + .....
T Consensus 159 ~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-----~~~~~~~-~---------~~~~~ 222 (257)
T cd08223 159 ASTLIGTPYYMSPELF-SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-----LVYRIIE-G---------KLPPM 222 (257)
T ss_pred cccccCCcCccChhHh-cCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHh-c---------CCCCC
Confidence 2345678899999988 56678899999999999999999999997443221 1111111 0 01123
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+...+..+.+++.+|++.+|++|||+.++++
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 223 PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 4455677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.96 Aligned_cols=250 Identities=23% Similarity=0.375 Sum_probs=203.0
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|+||.||.+.. .+++.+++|.+..... .....++.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 56778999999999999884 4688999999875532 344567899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++..... ..+++..+..++.|++.|++|||+.+++|+||+|+||++++++.+||+|||.+........ ..
T Consensus 82 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~ 158 (256)
T cd08221 82 NGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MA 158 (256)
T ss_pred CCCcHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cc
Confidence 99999999986542 2378999999999999999999999999999999999999999999999999876643221 22
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....+++.|+|||.. .+..++.++|+||+|+++|||++|+.||...... .....+..+ .....+
T Consensus 159 ~~~~~~~~y~ape~~-~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-~~~~~~~~~--------------~~~~~~ 222 (256)
T cd08221 159 ETVVGTPYYMSPELC-QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-NLVVKIVQG--------------NYTPVV 222 (256)
T ss_pred cccCCCccccCHhhc-CCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcC--------------CCCCCc
Confidence 345678899999988 4556889999999999999999999999643321 111111110 011122
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
...+.++.+++.+|++.+|++||+++++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 3456679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=308.98 Aligned_cols=262 Identities=23% Similarity=0.280 Sum_probs=198.3
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|+||.||+|+.. +|..||+|++..... ......+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 566788999999999999965 689999999875432 223356788999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++ +|.+++..... .+++..+..++.||++||+|||+++++||||||+||+++.++.++|+|||+++....... ..
T Consensus 82 ~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 156 (284)
T cd07839 82 DQ-DLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--CY 156 (284)
T ss_pred CC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--Cc
Confidence 75 78887765332 389999999999999999999999999999999999999999999999999876543211 12
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc------hhhcchh
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV------EDCVDAR 915 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 915 (967)
....+++.|+|||.+.....++.++||||+||++|||++|..|+....+....+....+ ....... .+..+..
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR-LLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHH-HhCCCChHHhHHhhhccccc
Confidence 33456788999998855556789999999999999999999986543332222222111 1111000 0000100
Q ss_pred hc---------CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 916 LR---------GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 916 ~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.. .+.....+.++.+++.+|++.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 0112234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=305.33 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=199.8
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 44677889999999999999965 48899999987543 34457788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|..++..... .+++..+..++.|++.|++|||+++++||||||+||+++.++.++|+|||.+..... ....
T Consensus 91 ~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~~~~ 166 (292)
T cd06644 91 CPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TLQR 166 (292)
T ss_pred CCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc--cccc
Confidence 999999888765432 378999999999999999999999999999999999999999999999998865422 1112
Q ss_pred cccccccccccCccccc----CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 841 SSKIQSALGYMAPEFAC----RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~----~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.....+++.|+|||++. ....++.++|+|||||++|||++|+.||...... .....+. ... .+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~----~~~------~~-- 233 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIA----KSE------PP-- 233 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHh----cCC------Cc--
Confidence 23455778899999874 2345688999999999999999999999643321 1111111 000 00
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+...+.++.+++.+|++.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11123345567899999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=323.79 Aligned_cols=259 Identities=19% Similarity=0.199 Sum_probs=193.5
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|...+.||+|+||.||++... .++.||||... ...+.+|++++++++|+|||++++++...+..++|||++
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 4677788999999999999965 47889999532 234678999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
. ++|.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...........
T Consensus 243 ~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 243 R-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred C-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 5 688888865432 3899999999999999999999999999999999999999999999999999765432222223
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCc-c-----chHhHHHHHHhhhc-cCCchh----
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYME-D-----DVVVLCDMVRGALE-DGRVED---- 910 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~-~-----~~~~~~~~~~~~~~-~~~~~~---- 910 (967)
....||+.|+|||++ .+..++.++|||||||++|||++|..|+-... . ....+.+++..... ......
T Consensus 320 ~~~~GT~~Y~APE~~-~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 320 YGIAGTVDTNAPEVL-AGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred cccCCCcCCcCHHHH-cCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 345689999999998 55678999999999999999999876543211 1 01112222221110 000000
Q ss_pred -hcc-------hhhcCCCC-------hhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 911 -CVD-------ARLRGNFP-------ADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 911 -~~~-------~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
... ...+.... ......+.+++.+|++.||.+|||+.|+++.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 00000000 0123468899999999999999999999863
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=304.00 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=201.2
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC---CCceeeeeeEEEcCCceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR---HHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e 759 (967)
|+..+.||+|+||.||+|+. .+++.||+|.+.........+++.+|++++++++ |||++++++++......++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 56778899999999999995 4689999999876544455677889999998886 9999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++++|.+++... .+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++++|||.+....... .
T Consensus 83 ~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06917 83 YAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--S 156 (277)
T ss_pred cCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--c
Confidence 99999999998653 38899999999999999999999999999999999999999999999999998765422 2
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......|+..|+|||....+..++.++|+||||+++|+|++|+.||....... ... .+... ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~-~~~~~---------~~~~ 221 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMM-LIPKS---------KPPR 221 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhh-ccccC---------CCCC
Confidence 22345688889999988555567899999999999999999999996443211 110 00000 0111
Q ss_pred CCh-hhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 920 FPA-DEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 920 ~~~-~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.+. ..+.++.+++.+|++.||++||++.|+++.
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 112 245679999999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.23 Aligned_cols=249 Identities=22% Similarity=0.381 Sum_probs=202.4
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|+||.||++... +|+.||+|.+..... .....++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 567789999999999999854 689999999875432 234568999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++...... .+++..+.+++.|++.|++|||+++++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 82 ~~~~l~~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~ 158 (256)
T cd08218 82 EGGDLYKKINAQRGV-LFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--ELA 158 (256)
T ss_pred CCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hhh
Confidence 999999998764332 27889999999999999999999999999999999999999999999999987654321 112
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....+++.|+|||+. .+..++.++|+||||+++++|++|+.||...... +.+...... .....+
T Consensus 159 ~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~~----------~~~~~~ 222 (256)
T cd08218 159 RTCIGTPYYLSPEIC-ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----NLVLKIIRG----------SYPPVS 222 (256)
T ss_pred hhccCCccccCHHHh-CCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----HHHHHHhcC----------CCCCCc
Confidence 234578889999998 5667889999999999999999999999643321 111111110 011234
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+.++.+++.+|++.+|++||++.++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 455677999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.48 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=198.6
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 3566778999999999999854 68899999987654 234456889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++..... +++.++..++.|++.|++|||+.|++|+||||+||+++.++.++|+|||++...... ....
T Consensus 89 ~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~~ 163 (267)
T cd06645 89 GGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKR 163 (267)
T ss_pred CCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cccc
Confidence 99999999876443 889999999999999999999999999999999999999999999999998755321 1222
Q ss_pred ccccccccccCccccc--CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 842 SKIQSALGYMAPEFAC--RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~--~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
....|++.|+|||++. ....++.++|+||+||++|||++|+.||......... ......... .+...
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~~~~~~~~--------~~~~~-- 232 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMTKSNFQ--------PPKLK-- 232 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-HhhhccCCC--------CCccc--
Confidence 3456888999999863 2445788999999999999999999998643322111 111110000 00000
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+..+.+++.+|++.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 01123456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=321.07 Aligned_cols=259 Identities=20% Similarity=0.237 Sum_probs=197.8
Q ss_pred hccCCCCccCCCCceEEEEEEeC---CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ---DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
..|...+.||+|+||.||++... .+..||+|.+... ..+.+|++++++++||||+++++++......++||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 34788899999999999999753 3578999987543 23568999999999999999999999899999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
|++. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.........
T Consensus 166 e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 166 PKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9996 58888884332 3899999999999999999999999999999999999999999999999999766543333
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccc--hHhHHHHHHhhhccCCch-------
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD--VVVLCDMVRGALEDGRVE------- 909 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~------- 909 (967)
.......||+.|+|||++ ....++.++||||+||++|||++|+.||...... ...+..+++.. ......
T Consensus 242 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~-~~~~~~~~~~~~~ 319 (392)
T PHA03207 242 PQCYGWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM-QVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccCccCHhHh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh-ccCccccCCccch
Confidence 333456789999999998 5667899999999999999999999999643321 12222222211 100000
Q ss_pred ---h---hcchhhcCCCC-------hhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 910 ---D---CVDARLRGNFP-------ADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 910 ---~---~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
. ......+..+. ...+.++.+++.+|+..||++|||+.|++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00001111111 1234568899999999999999999998864
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.37 Aligned_cols=255 Identities=24% Similarity=0.376 Sum_probs=198.9
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc---------ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCc
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI---------KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSL 753 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 753 (967)
|...+.||+|+||.||+|... +|+.||+|.++..... ...+.+.+|+.+++.++|||++++++++..++.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 566789999999999999854 6899999988643211 112467889999999999999999999999999
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++||||+++++|.++++... .+++..+..++.|++.|+.|||+++++||||+|+||+++.++.++++|||.+....
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred eEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999997653 38889999999999999999999999999999999999999999999999987654
Q ss_pred CCccccccccccccccccCcccccCcc-cCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTV-KITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV 912 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (967)
............++..|+|||...... .++.++|+||+|+++||+++|..||........ ..+ ......
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~----~~~~~~----- 229 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-MFK----LGNKRS----- 229 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-HHH----hhcccc-----
Confidence 322222233456788899999874432 478999999999999999999999964332111 111 100000
Q ss_pred chhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 913 DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 913 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
............+.++.+++.+|++.+|++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000111122334677999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=314.52 Aligned_cols=256 Identities=18% Similarity=0.201 Sum_probs=195.6
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||+++.. +++.||+|.+..... ....+.+.+|..++..++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 3577889999999999999955 589999999875321 2234568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++|+|.+++..... .+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-V 158 (331)
T ss_pred cCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-c
Confidence 9999999999975332 278899999999999999999999999999999999999999999999999876543211 1
Q ss_pred ccccccccccccCcccccC----cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 840 LSSKIQSALGYMAPEFACR----TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~----~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
......||+.|+|||++.. ...++.++||||+||++|||++|+.||...... . .............
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-~----~~~~i~~~~~~~~----- 228 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-E----TYGKIMNHKEHFQ----- 228 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-H----HHHHHHcCCCccc-----
Confidence 2223568999999998842 245788999999999999999999999643321 1 1111111110000
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCC--CCCCHHHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPS--NRPDMEEVVNI 952 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~--~Rpt~~evl~~ 952 (967)
. .......+..+.+++.+|+..+++ .||+++++++.
T Consensus 229 ~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 F-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 011123456788999987765444 37899888765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=318.25 Aligned_cols=241 Identities=24% Similarity=0.318 Sum_probs=186.8
Q ss_pred cCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC---CCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI---RHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 690 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
||+|+||.||+|+.. +++.||||++..... ......+..|..++... +||+|+++++++.++...++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 589999999865322 12233455566666554 699999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 g~L~~~l~~~~~---~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~ 155 (330)
T cd05586 81 GELFWHLQKEGR---FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNT 155 (330)
T ss_pred ChHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccC
Confidence 999999876443 8899999999999999999999999999999999999999999999999987532211 12234
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC-h
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP-A 922 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 922 (967)
..||+.|+|||.+.....++.++||||+||++|||++|+.||...... .....+. .+. ..++ .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-~~~~~i~-----~~~----------~~~~~~ 219 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-QMYRNIA-----FGK----------VRFPKN 219 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-HHHHHHH-----cCC----------CCCCCc
Confidence 568999999998855556899999999999999999999999644321 1111111 110 0111 1
Q ss_pred hhHHHHHHHHHhhccCCCCCCCC----HHHHHH
Q 002094 923 DEAIPVIKLGLICASQVPSNRPD----MEEVVN 951 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt----~~evl~ 951 (967)
..+.++.+++.+|++.||++||+ +.++++
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 24566889999999999999984 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.46 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=195.7
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc----cccHHHHHHHHHHHcCCCCCceeeeeeEEEc--CCcee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL----IKSQEDFEKEMKTLGKIRHHNLVALEGYYWT--PSLQL 755 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~ 755 (967)
.|+..+.||+|+||.||+|... ++..||+|++..... .+....+.+|+.++++++||||+++++++.+ ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 3678899999999999999864 589999998865421 1234578899999999999999999998865 35678
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
++|||+++++|.+++..... +++..+..++.|++.||+|||+.+++||||+|+||+++.++.++|+|||++......
T Consensus 83 l~~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 99999999999999976443 788999999999999999999999999999999999999999999999998755321
Q ss_pred cc-ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 836 DR-CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 836 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
.. ........++..|+|||.+ ....++.++|+||+|+++|||++|+.||......... ..... .
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~-----~~~~~---------~ 224 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVI-SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI-----FKIAT---------Q 224 (266)
T ss_pred cccCCccccCCccccccCHHHh-CCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH-----HHHhc---------C
Confidence 11 1112234578889999988 5567899999999999999999999999744322111 11110 1
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....++......+.+++ +|+..+|++||+++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 112233444556677777 688899999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.81 Aligned_cols=245 Identities=28% Similarity=0.424 Sum_probs=199.3
Q ss_pred cCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|...+.||.|+||.||-++ .++.+.||||++...+- .+...++..|++.+++++|||++.+.|||-.....|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4556789999999999999 55788999999976653 33457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
|-| |-.+.+.-.+. ++-+.++..|..+.+.||+|||+++.||||||..|||+++.|.|||+|||.|..+.+
T Consensus 108 ClG-SAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------ 178 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ 178 (948)
T ss_pred Hhc-cHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------
Confidence 965 66666654332 377888999999999999999999999999999999999999999999999987643
Q ss_pred cccccccccccCccccc--CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 841 SSKIQSALGYMAPEFAC--RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~--~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
...+.|||-|||||++. ..+.|+-++||||+|++..|+...++|+-.|..- ..+..+..+ -.+.+.
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-SALYHIAQN----------esPtLq- 246 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQN----------ESPTLQ- 246 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-HHHHHHHhc----------CCCCCC-
Confidence 34678999999999874 5789999999999999999999999998655432 122222211 011111
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+-+..+.+++..|+++-|.+|||.+++++
T Consensus 247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2233556889999999999999999998875
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=302.62 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=203.1
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|... +++.||+|.+...........+.+|+..+++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45677889999999999999854 68899999886554344556799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|.+++... .+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++++|||++....... ..
T Consensus 84 ~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06641 84 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK 157 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence 9999999998643 27899999999999999999999999999999999999999999999999987654321 11
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....++..|+|||.. ....++.++|+||+||++|+|++|..||....... +.... . .......
T Consensus 158 ~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~-~---------~~~~~~~ 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-----VLFLI-P---------KNNPPTL 221 (277)
T ss_pred hccccCCccccChhhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-----HHHHH-h---------cCCCCCC
Confidence 2234577889999988 55678899999999999999999999996433211 11110 0 0111223
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
+...+.++.+++.+|++.+|.+||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 44556779999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.85 Aligned_cols=248 Identities=27% Similarity=0.406 Sum_probs=201.3
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc----cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL----IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
|+..+.||+|++|.||+|+.. +++.|++|.+..... .+..+.+.+|+++++.++|+||+++++++......++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566788999999999999976 789999999865432 223467899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++++|.+++..... +++..+..++.|++.|++|||+.|++|+||+|+||+++.++.+||+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 82 ELVPGGSLAKLLKKYGS---FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EecCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 99999999999976532 7899999999999999999999999999999999999999999999999987654322
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
......++..|+|||.......++.++|+||||+++|+|++|+.||...... .....+. ......
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~-------------~~~~~~ 221 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-AAVFKIG-------------RSKELP 221 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-HHHHHHH-------------hcccCC
Confidence 2234567888999998843334889999999999999999999999654321 1111111 001112
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+...+..+.+++.+|++.+|++||++.++++
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 234455677899999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.45 Aligned_cols=262 Identities=24% Similarity=0.341 Sum_probs=200.3
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|+..+.||+|+||.||+|..+ +++.||+|++...... ...+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 3567789999999999999976 5899999988654322 2356788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++++++.++...... +++..+..++.|++.|++|||+.+++|+||+|+||++++++.++|+|||++....... ..
T Consensus 82 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~ 156 (286)
T cd07846 82 VDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EV 156 (286)
T ss_pred CCccHHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cc
Confidence 999999887765332 7899999999999999999999999999999999999999999999999987654322 22
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC--Cchhhcc-----
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG--RVEDCVD----- 913 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----- 913 (967)
.....++..|+|||+......++.++||||||+++|||++|++||...... ........ ..... ......+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIK-CLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHH-HhCCCchhhHHHhccchHh
Confidence 233457888999998855556788999999999999999999999643321 11111110 00000 0000000
Q ss_pred -hhhcC---------CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 914 -ARLRG---------NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 914 -~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..... ...+..+..+.+++.+|++.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000 012234667999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=300.50 Aligned_cols=239 Identities=22% Similarity=0.383 Sum_probs=189.6
Q ss_pred CccCCCCceEEEEEEeCCCc-----------EEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeE
Q 002094 688 CELGRGGFGVVYRTILQDGR-----------SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLL 756 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 756 (967)
+.||+|+||.||+|...+.. .|++|.+..... ....+.+|+.++++++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 36899999999999976433 577887654432 26789999999999999999999999988 77899
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC-------CeEEeecccc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG-------EPKVGDFGLA 829 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~-------~~kl~Dfg~a 829 (967)
||||+++|+|.+++..... .+++..+..++.||+.||+|||+++|+||||||+||+++.++ .++++|||++
T Consensus 78 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999986543 388999999999999999999999999999999999999887 7999999998
Q ss_pred cccCCCccccccccccccccccCcccccCc-ccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCC
Q 002094 830 RLLPMLDRCILSSKIQSALGYMAPEFACRT-VKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGR 907 (967)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (967)
..... .....++..|+|||++... ..++.++||||||+++||+++ |..||........ ..+.. .
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~--~~~~~----~-- 221 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK--ERFYQ----D-- 221 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH--HHHHh----c--
Confidence 75432 2234456779999998433 378899999999999999999 6778764432111 11110 0
Q ss_pred chhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
....+......+.+++.+|+..+|++|||+.++++.|+
T Consensus 222 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 ---------QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---------CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01111222267899999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=314.17 Aligned_cols=255 Identities=18% Similarity=0.195 Sum_probs=195.9
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||+++.+ +++.||+|.+..... ......+.+|+.++..++|++|+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 577789999999999999965 478899999864321 12334588899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++|+|.+++..... .+++..+..++.||+.|++|||+++|+||||||+||+++.++.+||+|||++...... ....
T Consensus 83 ~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~ 159 (332)
T cd05623 83 YVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 159 (332)
T ss_pred cCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence 999999999976432 2788999999999999999999999999999999999999999999999998754321 1122
Q ss_pred cccccccccccCcccccC----cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 841 SSKIQSALGYMAPEFACR----TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~----~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.....||+.|+|||++.. ...++.++|||||||++|||++|+.||...... ..... .........
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-~~~~~----i~~~~~~~~------ 228 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGK----IMNHKERFQ------ 228 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-HHHHH----HhCCCcccc------
Confidence 234568999999998742 345788999999999999999999999644321 11111 111100000
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCC--CCCHHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSN--RPDMEEVVNI 952 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~~ 952 (967)
........+.++.+++.+|+..++.+ |++++|+++.
T Consensus 229 ~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 01112345677899999988655544 7899888755
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=306.79 Aligned_cols=263 Identities=25% Similarity=0.349 Sum_probs=198.4
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|++|.||+|..+ +++.||+|.+...........+.+|++++++++|+||+++++++.+....++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 4677889999999999999965 689999999876543333455778999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++ +|.+++..... .+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||+++....... ..
T Consensus 86 ~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~ 160 (291)
T cd07844 86 DT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TY 160 (291)
T ss_pred CC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--cc
Confidence 85 89998876543 378999999999999999999999999999999999999999999999999875432111 12
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh---c------
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC---V------ 912 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~------ 912 (967)
....++..|+|||.......++.++||||+|+++|||++|+.||.............. ........... .
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIF-RVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHH-HhcCCCChhhhhhhhhccccc
Confidence 2334677899999885555688999999999999999999999965442222111111 11111000000 0
Q ss_pred --------chhhcCCCC-hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 913 --------DARLRGNFP-ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 913 --------~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
........+ .....++.+++.+|++.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000 111266889999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=305.37 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=201.6
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+..+.||+|+||.||++..+ ++..||+|.+...........+.+|+.++++++|+||+++++++..++..++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 577789999999999999975 7899999998765433345678999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
+++|.++++.......+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||.+...... ..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~ 158 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----LA 158 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC----cc
Confidence 99999998765333348999999999999999999996 59999999999999999999999999998755321 12
Q ss_pred ccccccccccCcccccCc-----ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 842 SKIQSALGYMAPEFACRT-----VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~-----~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
....+++.|+|||.+... ..++.++|+||+||++|+|++|+.||....... .. ..+.... ...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~-~~~~~~~----------~~~ 226 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IF-AQLSAIV----------DGD 226 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HH-HHHHHHh----------hcC
Confidence 234577889999987322 235789999999999999999999996432211 11 1111000 011
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
....+...+.++.+++.+|++.+|++||+++++++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 123445567789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=304.20 Aligned_cols=264 Identities=21% Similarity=0.293 Sum_probs=197.8
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
..|...+.||+|+||.||+|... +++.||+|.+...........+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 34677889999999999999854 68999999987654334445678999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+. +++.+++..... .+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||+++....... .
T Consensus 85 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~ 159 (291)
T cd07870 85 MH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--T 159 (291)
T ss_pred cc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--C
Confidence 96 577777654332 267888899999999999999999999999999999999999999999999875432111 1
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC---------Cchhh
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG---------RVEDC 911 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~ 911 (967)
.....+++.|+|||.+.....++.++||||+|+++|||++|+.||+........+.+... .+..+ .....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT-VLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHH-HcCCCChhhhhhhhhcccc
Confidence 233456888999998854456788999999999999999999999755443222222111 00000 00000
Q ss_pred cchhhcCCC---------ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 912 VDARLRGNF---------PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 912 ~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
......... ....+..+.+++.+|++.||++|||++|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000 0122457889999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=301.96 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=203.3
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+..+.||+|++|.||++..+ +++.||+|.+.........+++.+|++++++++||||+++++++..++..++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 466778999999999999965 6899999998776544556788999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
+++|.+++.... ..+++..+.+++.|++.|++|+|+ .+++|+||||+||+++.++.++|+|||.+....... .
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----~ 156 (265)
T cd06605 83 GGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----A 156 (265)
T ss_pred CCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----h
Confidence 999999998653 237889999999999999999999 999999999999999999999999999986553211 1
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....++..|+|||.. ....++.++||||+|+++|+|++|+.||...........+.+....... ....+
T Consensus 157 ~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~ 225 (265)
T cd06605 157 KTFVGTSSYMAPERI-QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP----------PPRLP 225 (265)
T ss_pred hcccCChhccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC----------CCCCC
Confidence 126678889999998 5568899999999999999999999999754322222222222221110 11122
Q ss_pred hh-hHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 922 AD-EAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 922 ~~-~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.. .+.++.++|.+|+..+|++|||+.+++.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 22 5667999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=316.08 Aligned_cols=259 Identities=20% Similarity=0.253 Sum_probs=195.0
Q ss_pred hhccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC------C
Q 002094 681 NALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP------S 752 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~ 752 (967)
.+.|+..+.||+|+||.||+|.. .+++.||||++..... ......+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 34578889999999999999985 4678999999865432 23345678899999999999999999987533 3
Q ss_pred ceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccccccc
Q 002094 753 LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLL 832 (967)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 832 (967)
..++++|++ +++|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 468999987 67898887542 2889999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc
Q 002094 833 PMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV 912 (967)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (967)
.. ......|++.|+|||++.....++.++||||+||++|||++|+.||...... ..+..+... ..... .+..
T Consensus 169 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~-~~~~~-~~~~ 240 (343)
T cd07878 169 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEV-VGTPS-PEVL 240 (343)
T ss_pred CC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHH-hCCCC-HHHH
Confidence 32 1234567889999999855567899999999999999999999999644321 111111110 00000 0000
Q ss_pred c-------hhh---cCCCC--------hhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 913 D-------ARL---RGNFP--------ADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 913 ~-------~~~---~~~~~--------~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
. ... ....+ ......+.+++.+|++.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000 00001 1223457899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=316.63 Aligned_cols=260 Identities=21% Similarity=0.235 Sum_probs=194.8
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC------Cc
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP------SL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 753 (967)
+.|+..+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 45788899999999999999854 588999999875432 23456788899999999999999999988643 34
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++||||+++ ++.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 97 ~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred eEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 6899999976 66666643 27888999999999999999999999999999999999999999999999997653
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHh------------
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRG------------ 901 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~------------ 901 (967)
. ........+|+.|+|||.+ .+..++.++||||+||++|||++|+.||........ ....+..
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred C---ccccCCccccCCccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhh
Confidence 2 1223345688999999998 556789999999999999999999999975432111 1111111
Q ss_pred ------hhcc-CCchhhcchhh--------cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 902 ------ALED-GRVEDCVDARL--------RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 902 ------~~~~-~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.... +.......+.. ....+.....++.+++.+|++.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 00000000000 001112234568999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=314.03 Aligned_cols=255 Identities=19% Similarity=0.206 Sum_probs=195.3
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||+++.+ +++.||+|.+..... ......+.+|..++..++|++|+++++++.+++..++|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 3677889999999999999965 578899999865321 2234568889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++|+|.+++..... .+++..+..++.|++.||+|+|++||+||||||+||+++.++.+||+|||++........ .
T Consensus 82 y~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-V 158 (331)
T ss_pred CCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-e
Confidence 9999999999976432 378899999999999999999999999999999999999999999999999876543211 1
Q ss_pred ccccccccccccCcccccCc----ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 840 LSSKIQSALGYMAPEFACRT----VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~----~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
......|++.|+|||++... +.++.++||||+||++|||++|+.||...... .....+. ...... .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~----~~~~~~-----~ 228 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIM----NHEERF-----Q 228 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-HHHHHHH----cCCCcc-----c
Confidence 22345689999999987321 45788999999999999999999999643321 1111111 100000 0
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCC--CCCHHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSN--RPDMEEVVN 951 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~ 951 (967)
......+.+.++.+++.+|+..++++ |++++++++
T Consensus 229 -~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 -FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 01111234667899999998866554 567877764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=303.12 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=201.2
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||.||++..+ ++..||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 3677888999999999999964 68899999987543 334567899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++..... .+++..+..++.|++.|++|||+++|+|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 85 ~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~ 160 (280)
T cd06611 85 DGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QKR 160 (280)
T ss_pred CCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--ccc
Confidence 99999999876432 38899999999999999999999999999999999999999999999999886543211 122
Q ss_pred ccccccccccCccccc----CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 842 SKIQSALGYMAPEFAC----RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~----~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
....+++.|+|||.+. ....++.++|+||+|+++|||++|+.||...... .....+... . . + .
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~----~-~-----~--~ 227 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKS----E-P-----P--T 227 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhcC----C-C-----C--C
Confidence 3456788899999873 2345678999999999999999999999654322 111111110 0 0 0 0
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
...+...+.++.+++.+|++.+|.+||++.++++.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11233455678999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=300.35 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=199.6
Q ss_pred cCCCCccCCCCceEEEEEEeCC--CcEEEEEEeecCCc---------cccHHHHHHHHHHHcC-CCCCceeeeeeEEEcC
Q 002094 684 LNKDCELGRGGFGVVYRTILQD--GRSVAIKKLTVSGL---------IKSQEDFEKEMKTLGK-IRHHNLVALEGYYWTP 751 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~l~~~~~---------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~ 751 (967)
|+..+.||+|+||.||+|..+. ++.+|+|.+..... .....++.+|+.++.+ ++||||+++++++.+.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5677889999999999999764 68899998864321 1233557788888765 7999999999999999
Q ss_pred CceeEEEEecCCCchhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCCCCeEEeecccc
Q 002094 752 SLQLLIYEFISSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSSGEPKVGDFGLA 829 (967)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~~~~kl~Dfg~a 829 (967)
+..++||||+++++|.+++.... ....+++..+++++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||.+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence 99999999999999999885421 22348899999999999999999996 68999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 830 RLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
....... ......++..|+|||.. ....++.++|+||||+++|||++|+.||...... . ......
T Consensus 162 ~~~~~~~---~~~~~~~~~~~~~Pe~~-~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-~----~~~~~~------ 226 (269)
T cd08528 162 KQKQPES---KLTSVVGTILYSCPEIV-KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-S----LATKIV------ 226 (269)
T ss_pred eeccccc---ccccccCcccCcChhhh-cCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-H----HHHHHh------
Confidence 7654322 23345678889999998 5567899999999999999999999999643221 1 111111
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
+...........+..+.+++.+|++.||++||++.|+.+++++
T Consensus 227 ---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 227 ---EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ---hccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 0111111112345679999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=334.51 Aligned_cols=258 Identities=18% Similarity=0.306 Sum_probs=198.9
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEc--CCceeEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWT--PSLQLLIY 758 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 758 (967)
.|+..+.||+|+||.||++... ++..||+|.+..... ......+..|+.++++++|||||++++++.. ....++||
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM 93 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM 93 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence 4678889999999999999965 577899998875542 2345678999999999999999999998854 45688999
Q ss_pred EecCCCchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcC-------CcccCCCCCCCEEeCCC------------
Q 002094 759 EFISSGSLYKHLHDGSS-RNCLSWRQRFNIILGMAKGLAYLHHT-------NIIHYNLKSTNVLIDSS------------ 818 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~-------~ivH~Dik~~Nill~~~------------ 818 (967)
||+++|+|.+++..... ...+++..++.|+.||+.||+|||+. +||||||||+|||++.+
T Consensus 94 EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~ 173 (1021)
T PTZ00266 94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173 (1021)
T ss_pred eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence 99999999999976322 22489999999999999999999984 49999999999999642
Q ss_pred -----CCeEEeecccccccCCCccccccccccccccccCcccccC-cccCCcccchhhHHHHHHHHHcCCCCCCCCccch
Q 002094 819 -----GEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR-TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDV 892 (967)
Q Consensus 819 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~ 892 (967)
+.+||+|||++...... .......||+.|+|||++.. ...++.++|||||||++|||++|+.||.......
T Consensus 174 n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ 250 (1021)
T PTZ00266 174 NLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250 (1021)
T ss_pred ccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence 34899999999765321 12234568999999998743 3457899999999999999999999997443322
Q ss_pred HhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHH--HHHHhhcC
Q 002094 893 VVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVV--NILELIQS 958 (967)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl--~~L~~~~~ 958 (967)
. ++....... .......+.++.+||..||+.+|.+||++.|++ ..++.+..
T Consensus 251 q----li~~lk~~p-----------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 251 Q----LISELKRGP-----------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred H----HHHHHhcCC-----------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 1 111111100 000123456799999999999999999999998 45554433
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=315.86 Aligned_cols=260 Identities=20% Similarity=0.231 Sum_probs=194.8
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC------Cc
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP------SL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 753 (967)
+.|+..+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 44788899999999999999954 588999999875432 23456788999999999999999999987543 34
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred EEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 6899999976 67776643 26788999999999999999999999999999999999999999999999997653
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhh-----------
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGA----------- 902 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~----------- 902 (967)
. ........+++.|+|||++ .+..++.++||||+||++|||++|+.||...+.. .....++...
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred C---CCcccCCcccCCcCCHHHH-hCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHhh
Confidence 2 1222345688999999998 5667899999999999999999999999754332 1111111100
Q ss_pred -------hc-cCCchh-----hcchhh---cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 903 -------LE-DGRVED-----CVDARL---RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 903 -------~~-~~~~~~-----~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.. .+.... ...... ...........+.+++.+|++.||.+|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 000000 000000 000111234568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=338.53 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=207.2
Q ss_pred ccCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|+.+..||.|.||.||-|+ ..+|+-.|||-++.... .+....+.+|+.++..++|||+|+++|+-.+++..+|-|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 46777899999999999999 55688999998876543 33456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc--
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-- 838 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-- 838 (967)
|++|+|.+.+...+. .++.....+-.|++.|++|||++|||||||||.||+++.+|.+|++|||.|.........
T Consensus 1316 C~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred hccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 999999999987654 455666678899999999999999999999999999999999999999999887543211
Q ss_pred cccccccccccccCcccccCcc--cCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 839 ILSSKIQSALGYMAPEFACRTV--KITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~--~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
..-....||+.|||||++.+.. ....|.||||+||+..||+||+.||...+.+-.+..+.. .+-
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~--------------~gh 1458 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA--------------AGH 1458 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh--------------ccC
Confidence 1223577999999999996533 456799999999999999999999986665433222211 222
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.+++|...+.+-.+++..|+..||++|=++.|+++.
T Consensus 1459 ~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 445677777888899999999999999888776553
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=297.19 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=201.2
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|++++++++||||+++++++......+++|||+
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 4677789999999999999964 578899999976542 35678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++..... .+++..+..++.|++.|++|||+++++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 83 ~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~ 158 (262)
T cd06613 83 GGGSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKR 158 (262)
T ss_pred CCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hcc
Confidence 99999999876522 38899999999999999999999999999999999999999999999999987654211 122
Q ss_pred ccccccccccCcccccCcc---cCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 842 SKIQSALGYMAPEFACRTV---KITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~---~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
....++..|+|||.. ... .++.++|+||+|+++|||++|+.||.......... ....... ... ..
T Consensus 159 ~~~~~~~~y~~Pe~~-~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~~~~~~~--------~~~--~~ 226 (262)
T cd06613 159 KSFIGTPYWMAPEVA-AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LISKSNF--------PPP--KL 226 (262)
T ss_pred ccccCCccccCchhh-cccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccC--------CCc--cc
Confidence 345677889999988 433 78889999999999999999999996443221111 1111000 000 01
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+...+.++.+++.+|++.+|.+|||+++++.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 122334567999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=297.36 Aligned_cols=248 Identities=21% Similarity=0.356 Sum_probs=200.6
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|++|.||++... +++.+|+|.+..... ......+.+|++++++++|||++++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 566788999999999999854 688999999876542 334578999999999999999999999999889999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC-CeEEeecccccccCCCccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG-EPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++++|.+++...... .+++..+.+++.+++.|++|||++|++|+||+|+||+++.++ .++++|||.+....... .
T Consensus 82 ~~~~L~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~ 157 (256)
T cd08220 82 PGGTLAEYIQKRCNS-LLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---K 157 (256)
T ss_pred CCCCHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---c
Confidence 999999999764432 378999999999999999999999999999999999998654 57999999998664321 2
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....++..|+|||.. ....++.++||||||+++|+|++|+.||........ ...... ......
T Consensus 158 ~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~--------------~~~~~~ 221 (256)
T cd08220 158 AYTVVGTPCYISPELC-EGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL-VLKIMS--------------GTFAPI 221 (256)
T ss_pred ccccccCCcccCchhc-cCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH-HHHHHh--------------cCCCCC
Confidence 2235678899999998 556788999999999999999999999965433211 111110 011123
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+...+.++.+++.+|++.+|++|||+.|+++
T Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 3445667999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=303.73 Aligned_cols=262 Identities=22% Similarity=0.287 Sum_probs=198.8
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|++|.||+|+.. ++..||||++..... ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 567788999999999999865 689999998875432 223457899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
. ++|.+++...... .+++..+..++.|++.|++|||+++++|+||+|+||+++.++.++++|||++....... ...
T Consensus 82 ~-~~l~~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (284)
T cd07860 82 H-QDLKKFMDASPLS-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTY 157 (284)
T ss_pred c-cCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--ccc
Confidence 6 5898888764432 38899999999999999999999999999999999999999999999999987553221 112
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC--------------
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR-------------- 907 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------------- 907 (967)
....+++.|+|||...+...++.++||||||+++|||+||+.||....+. ....+.....-....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 23446788999998855555788999999999999999999999754332 222222211100000
Q ss_pred -chhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 908 -VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 908 -~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.......... ...+..+.++.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 237 SFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 001223456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=310.02 Aligned_cols=258 Identities=20% Similarity=0.225 Sum_probs=189.6
Q ss_pred HhhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 680 ANALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
....|+..+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++||||+++++++......++||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 3445788999999999999999965 4678999975432 2356899999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+. ++|.+++..... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.++.... .
T Consensus 137 e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKRSR--PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---A 210 (357)
T ss_pred EccC-CcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---C
Confidence 9995 588888865432 389999999999999999999999999999999999999999999999999874322 1
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCC-CCCCccchH--------hHHHHHHhhhc-cCCc
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP-VEYMEDDVV--------VLCDMVRGALE-DGRV 908 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p-~~~~~~~~~--------~~~~~~~~~~~-~~~~ 908 (967)
.......||+.|+|||++ ....++.++|||||||++|||+++..| |+....... .+.+.+...-. ....
T Consensus 211 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVL-ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred cccccccccccccCCeec-CCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 122345688999999998 556789999999999999999985554 432211100 11111111000 0000
Q ss_pred h---------hhcchh--hcCCC-------ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 909 E---------DCVDAR--LRGNF-------PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 909 ~---------~~~~~~--~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
. .+.+.. .+..+ ....+..+.++|.+|++.||++|||+.|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 0 000000 00000 0122345677999999999999999999875
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=302.19 Aligned_cols=263 Identities=21% Similarity=0.322 Sum_probs=202.3
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+..+.||+|++|.||+|+.. +|..||||.+.........+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 567789999999999999975 6889999999766544445678889999999999999999999999999999999998
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+ +|.+++........+++..+..++.|++.|++|||+++++||||+|+||++++++.++++|||.+....... ....
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~ 158 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--NTFS 158 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--cccc
Confidence 5 888888765544458999999999999999999999999999999999999999999999999987553211 1122
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC---Cchhhcc-hhhc-
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG---RVEDCVD-ARLR- 917 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-~~~~- 917 (967)
...++..|+|||.+.....++.++|+||+|+++|+|++|+.||....... ........ ...+ ....... +...
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRI-MGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHH-hCCCChhhHHHHhcCchhcc
Confidence 34567889999987555567889999999999999999999997543321 11111111 0000 0000000 0000
Q ss_pred ----------CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 918 ----------GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 918 ----------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+..+..+.+++.+|++.||++||+++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.13 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=200.9
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 567789999999999999854 6899999998766432 35678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc-
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL- 840 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~- 840 (967)
++++|.+++..... +++..+..++.|++.|++|||+.|++|+||+|+||++++++.+||+|||.+...........
T Consensus 82 ~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 82 SGGTLEELLEHGRI---LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCcHHHHHhhcCC---CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 99999999976433 78899999999999999999999999999999999999999999999999887654222111
Q ss_pred -cccccccccccCcccccCcc--cCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 841 -SSKIQSALGYMAPEFACRTV--KITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 841 -~~~~~gt~~y~aPE~~~~~~--~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.....+++.|+|||++.... ..+.++||||||+++||+++|+.||............ +. . ...
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~-~~---~----------~~~ 224 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH-VG---A----------GHK 224 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH-Hh---c----------CCC
Confidence 11345778899999984332 3788999999999999999999999754322111111 00 0 011
Q ss_pred CCCChh--hHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 918 GNFPAD--EAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 918 ~~~~~~--~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+.. .+..+.+++.+|++.+|.+|||+.+++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 112222 3667889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=284.28 Aligned_cols=243 Identities=24% Similarity=0.279 Sum_probs=201.7
Q ss_pred HhhccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCcc--ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeE
Q 002094 680 ANALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLL 756 (967)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 756 (967)
+.+.|+..++||+|.||.|-.++. ..++.||+|+++++-.. ...+.-..|-++++..+||.+..+--.|+..+..|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 455567788999999999999984 46899999999877542 233456678899999999999999888999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
||||..||.|.-++.+.+. +++....-+..+|+.||.|||+++||+||+|.+|.|+|.||++||.|||+++.-- .
T Consensus 246 VMeyanGGeLf~HLsrer~---FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~ 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERV---FSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--K 320 (516)
T ss_pred EEEEccCceEeeehhhhhc---ccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc--c
Confidence 9999999999999876544 8888888899999999999999999999999999999999999999999987432 2
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.........|||.|.|||++ ....|..++|+|.+||++|||++|+.||...+. ...+.-+...
T Consensus 321 ~g~t~kTFCGTPEYLAPEVl-eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-~kLFeLIl~e--------------- 383 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVL-EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-EKLFELILME--------------- 383 (516)
T ss_pred ccceeccccCChhhcCchhh-ccccccceeehhhhhHHHHHHHhccCcccccch-hHHHHHHHhh---------------
Confidence 33345578899999999999 777999999999999999999999999964332 2211111111
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCC
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRP 944 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp 944 (967)
.-.+|.....+...++...+.+||++|.
T Consensus 384 d~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 DLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1236777778899999999999999995
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=306.68 Aligned_cols=252 Identities=22% Similarity=0.301 Sum_probs=200.2
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc--ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|++|.||+|... +++.||+|.+...... ...+.+..|+++++.++|+||+++++++......++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 567789999999999999966 4899999999765432 2456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc--
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-- 838 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-- 838 (967)
+.+++|.+++..... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 83 CPGGELFRLLQRQPG-KCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred cCCCCHHHHHHhCCC-CccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 999999999875432 24899999999999999999999999999999999999999999999999998754321110
Q ss_pred -------------------------cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchH
Q 002094 839 -------------------------ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVV 893 (967)
Q Consensus 839 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~ 893 (967)
.......|+..|+|||+. ....++.++||||||+++|+|++|+.||........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI-SGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHH-cCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 011134578889999998 556789999999999999999999999975443211
Q ss_pred hHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCC----HHHHHH
Q 002094 894 VLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPD----MEEVVN 951 (967)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~evl~ 951 (967)
+.... ............+..+.+++.+|++.||++||| ++|+++
T Consensus 241 -~~~~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 241 -FSNIL-------------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred -HHHHh-------------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11111 111111111225678999999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=301.05 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=196.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEc------CCc
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWT------PSL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~ 753 (967)
+.|+..+.||+|+||.||+|... +++.||+|.+.... ....++..|+.++.++ +|+||+++++++.. ...
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 45677889999999999999964 68899999886543 3446788999999998 69999999999853 456
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.+++|||+++|+|.+++...... .+++..+..++.|++.|++|||+++++|+||+|+||+++.++.++|+|||.+....
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGN-ALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 78999999999999998764432 37888899999999999999999999999999999999999999999999987543
Q ss_pred CCccccccccccccccccCcccccC----cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACR----TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
... .......+++.|+|||.+.. ...++.++|+||+||++|||++|+.||.......... .
T Consensus 173 ~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~------------ 237 (282)
T cd06636 173 RTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-L------------ 237 (282)
T ss_pred ccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-h------------
Confidence 211 12234567889999998742 3457889999999999999999999996433211110 0
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..............+.++.+++.+|++.||.+|||+.|+++
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 -IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000111112345667999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=301.26 Aligned_cols=262 Identities=26% Similarity=0.309 Sum_probs=202.8
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|++|.||+|... +|+.||+|++..... ....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 566788999999999999964 689999999876543 234567999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
+++|.+++.... ..+++.+++.++.||+.||+|||+++++|+||||+||+++.++.++++|||.+........ ...
T Consensus 82 -~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (286)
T cd07832 82 -PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157 (286)
T ss_pred -CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence 999999987644 2389999999999999999999999999999999999999999999999999886643221 122
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch---------hh-
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE---------DC- 911 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~- 911 (967)
....++..|+|||.+.....++.++||||+|+++|||++|++||....+. ....... ......... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVF-RTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHH-HHcCCCChHHHhhccCcchhh
Confidence 34567888999998855556789999999999999999998888644322 2121111 111111000 00
Q ss_pred --cchhh----cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 912 --VDARL----RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 912 --~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..... ......+.+..+.+++.+|++.+|.+|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000 00111234578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=307.48 Aligned_cols=198 Identities=25% Similarity=0.362 Sum_probs=168.3
Q ss_pred ccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-C-----CceeeeeeEEEcCCcee
Q 002094 683 LLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-H-----HNLVALEGYYWTPSLQL 755 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~ 755 (967)
.|.+.+.||+|+||.|.+|.. ++++.||||+++... .-..+...|+++|..++ | -|+|+++++|...++.|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 578899999999999999995 469999999998654 33455678899998885 3 48999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC--CCeEEeecccccccC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS--GEPKVGDFGLARLLP 833 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~--~~~kl~Dfg~a~~~~ 833 (967)
+|+|.+.. +|.++++...-.. ++...+..++.||+.||.+||+.+|||+||||+|||+... ..+||+|||.|+...
T Consensus 265 iVfELL~~-NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eeehhhhh-hHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 99999855 9999999877665 8999999999999999999999999999999999999743 479999999998764
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCcc
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMED 890 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~ 890 (967)
..-. ...-+.-|+|||++ -+.+|+.+.||||||||++||++|.+.|.+..+
T Consensus 343 q~vy-----tYiQSRfYRAPEVI-LGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 343 QRVY-----TYIQSRFYRAPEVI-LGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred Ccce-----eeeeccccccchhh-ccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 3211 23334459999999 566999999999999999999999888875443
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=304.56 Aligned_cols=248 Identities=21% Similarity=0.359 Sum_probs=197.4
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|.....||+|+||.||++... ++..||||.+.... ....+.+.+|+..++.++|+||+++++.+..++..++||||++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 344567999999999999854 68899999986543 3345678999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.+++... .+++.++..++.||+.|++|||+++++||||||+||+++.++.++|+|||++....... ....
T Consensus 103 ~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~ 176 (292)
T cd06658 103 GGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRK 176 (292)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCc
Confidence 99999988543 27889999999999999999999999999999999999999999999999987553211 1123
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
...++..|+|||.. ....++.++|+||||+++|||++|+.||....... .... +... ...... ...
T Consensus 177 ~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~-~~~~---------~~~~~~--~~~ 242 (292)
T cd06658 177 SLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRR-IRDN---------LPPRVK--DSH 242 (292)
T ss_pred eeecCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHhc---------CCCccc--ccc
Confidence 35678899999988 55678899999999999999999999996433221 1111 1110 011111 112
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..+..+.+++.+|+..||.+|||++|+++.
T Consensus 243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 345568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=296.88 Aligned_cols=249 Identities=23% Similarity=0.332 Sum_probs=195.1
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc----cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--CceeE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL----IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP--SLQLL 756 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 756 (967)
|+..+.||+|+||.||+|... +++.||+|.+..... ....+.+.+|++++++++||||+++++++.++ ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 577889999999999999964 589999998864321 12345788999999999999999999988764 45779
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
||||+++++|.+++..... +++..+.+++.|++.||+|||+++++|+||||+||+++.++.++|+|||.+.......
T Consensus 84 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 84 FMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEecCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 9999999999999875433 7888899999999999999999999999999999999999999999999987553211
Q ss_pred cc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 837 RC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 837 ~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
.. .......++..|+|||.+ ....++.++|+||||+++|||++|+.||........ ..+ .. ...
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~----~~---------~~~ 225 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVI-SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-IFK----IA---------TQP 225 (265)
T ss_pred ccccccccCCCCccccChhhh-cCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-HHH----Hh---------cCC
Confidence 11 112234578889999988 456788999999999999999999999964322211 111 11 011
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+......+.+++.+|+. +|++||+++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1222345556678899999985 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=300.54 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=194.5
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHH-HcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKT-LGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|+||.||+++.+ +|+.||+|++...........+..|+.. ++..+||||+++++++..++..++||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 567788999999999999965 6899999998765433344566667665 56678999999999999999999999999
Q ss_pred CCCchhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 762 SSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 762 ~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
+ |+|.+++.... ....+++..++.++.||+.|++|||++ +++||||||+||+++.++.+||+|||.+...... .
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---~ 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---V 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc---c
Confidence 7 58888876532 223489999999999999999999997 9999999999999999999999999998765321 1
Q ss_pred ccccccccccccCcccccCc---ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 840 LSSKIQSALGYMAPEFACRT---VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~---~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
......++..|+|||.+... ..++.++|+||+|+++|||++|+.||................ .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------------~ 224 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--------------P 224 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--------------C
Confidence 22334578889999987331 446889999999999999999999996433322222111110 0
Q ss_pred cCCCC-hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 917 RGNFP-ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 917 ~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+ ...+.++.+++.+|+..+|++||+++++++
T Consensus 225 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 224567999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=327.45 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=191.9
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC----------
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS---------- 752 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---------- 752 (967)
|++.+.||+||||.||+++.+ ||+.||||++......+....+.+|++.+++++|||||+++..+.+..
T Consensus 481 FEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~ 560 (1351)
T KOG1035|consen 481 FEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVA 560 (1351)
T ss_pred hHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccc
Confidence 377789999999999999965 899999999987765556678999999999999999999976532110
Q ss_pred --------------------------------------------------------------------------------
Q 002094 753 -------------------------------------------------------------------------------- 752 (967)
Q Consensus 753 -------------------------------------------------------------------------------- 752 (967)
T Consensus 561 ~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~ 640 (1351)
T KOG1035|consen 561 SDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSV 640 (1351)
T ss_pred cchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcc
Confidence
Q ss_pred -----------------------------ceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCc
Q 002094 753 -----------------------------LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803 (967)
Q Consensus 753 -----------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~i 803 (967)
..||=||||+...+.+++++..... .....|+++++|++||+|+|++|+
T Consensus 641 ~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 641 ILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhCce
Confidence 1267789998877777777654321 467889999999999999999999
Q ss_pred ccCCCCCCCEEeCCCCCeEEeecccccccC----------------CCccccccccccccccccCcccccCcc--cCCcc
Q 002094 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLP----------------MLDRCILSSKIQSALGYMAPEFACRTV--KITEK 865 (967)
Q Consensus 804 vH~Dik~~Nill~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~t~~ 865 (967)
|||||||.||++|+++.|||+|||+|.... ........+...||.-|+|||.+.... .|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999998721 011112345677899999999986555 69999
Q ss_pred cchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCC
Q 002094 866 CDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPD 945 (967)
Q Consensus 866 ~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt 945 (967)
+|+||+||+++||+ +||...-+....+. .++.+.+..- ..+.......-.++|.++++.||.+|||
T Consensus 799 iDmYSLGIVlFEM~---yPF~TsMERa~iL~-----~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEML---YPFGTSMERASILT-----NLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred hhhHHHHHHHHHHh---ccCCchHHHHHHHH-----hcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCC
Confidence 99999999999998 46753222211111 1122222111 1223344455678999999999999999
Q ss_pred HHHHHH
Q 002094 946 MEEVVN 951 (967)
Q Consensus 946 ~~evl~ 951 (967)
|.|++.
T Consensus 865 A~eLL~ 870 (1351)
T KOG1035|consen 865 ATELLN 870 (1351)
T ss_pred HHHHhh
Confidence 999874
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=300.44 Aligned_cols=254 Identities=21% Similarity=0.319 Sum_probs=195.9
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEE-----cCCce
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYW-----TPSLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~ 754 (967)
+.|+..+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +||||+++++++. ..+..
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 44688889999999999999864 57899999876432 3346788999999999 6999999999874 34567
Q ss_pred eEEEEecCCCchhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 755 LLIYEFISSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
++||||+++++|.++++... ....+++..+..++.|++.|+.|||+++++||||||+||+++.++.++++|||++....
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 99999999999999886432 22347889999999999999999999999999999999999999999999999987654
Q ss_pred CCccccccccccccccccCcccccC----cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACR----TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
... .......|++.|+|||.+.. ...++.++||||+||++|||++|+.||........ ...+. ...
T Consensus 176 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~~~-----~~~-- 245 (286)
T cd06638 176 STR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFKIP-----RNP-- 245 (286)
T ss_pred cCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhhcc-----ccC--
Confidence 311 12234568889999998732 24478899999999999999999999964432111 11000 000
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.. ....+...+..+.+++.+|++.||++|||+.|+++.
T Consensus 246 ---~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 ---PP--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ---CC--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00 011122344569999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=297.97 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=200.9
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-----cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-----IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
|+..+.||+|++|.||++.. .+++.||+|.+..... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 56778999999999999985 5689999999875432 11346789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC-CeEEeecccccccCCCc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG-EPKVGDFGLARLLPMLD 836 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~~~~~ 836 (967)
|||+++++|.+++.... .+++..+..++.|++.|++|||++|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 82 VEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999997643 378999999999999999999999999999999999998776 59999999987664321
Q ss_pred cc--cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 837 RC--ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 837 ~~--~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
.. .......++..|+|||.+ ....++.++|+||+|+++|+|++|..||........ ...... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~---------~~~~ 226 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVL-RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIFK---------IASA 226 (268)
T ss_pred ccCCccccccccccceeCHhHh-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHHH---------Hhcc
Confidence 11 112234578899999988 556788999999999999999999999963322111 111110 0011
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
......+...+.++.+++.+|++.+|++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1123345556678999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=302.70 Aligned_cols=255 Identities=20% Similarity=0.240 Sum_probs=199.3
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||++..+ .++.||+|.+..... ......+.+|+++++.++||||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 577789999999999999965 578999999876532 22345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc----
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD---- 836 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~---- 836 (967)
+++++|.+++..... +++..+..++.|++.|++|||+++++||||||+||+++.++.++++|||.++......
T Consensus 83 ~~g~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 83 VEGGDCATLLKNIGA---LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 999999999976532 7899999999999999999999999999999999999999999999999886421100
Q ss_pred ---------cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC
Q 002094 837 ---------RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR 907 (967)
Q Consensus 837 ---------~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (967)
.........++..|+|||.+ ....++.++|+||||+++||+++|..||...... ............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-~~~~~~~~~~~~--- 234 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVI-LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQVISDDIE--- 234 (305)
T ss_pred cccccccchhhccccCCccCccccCchhc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccC---
Confidence 00011124567789999988 4567899999999999999999999999643322 111111111000
Q ss_pred chhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
........+.++.+++.+|++.||++||++.++.++|+.
T Consensus 235 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 235 ---------WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ---------CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 001112345678999999999999999998777766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=334.27 Aligned_cols=441 Identities=26% Similarity=0.345 Sum_probs=305.4
Q ss_pred eeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEecc
Q 002094 71 VVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFA 150 (967)
Q Consensus 71 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~ 150 (967)
...|++.++.+ +..|..+..+.+|+.|+++.|.+. ..|...+++++|++|.|.+|.+. ..|.++ ..+++|++|+++
T Consensus 47 L~~l~lsnn~~-~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~-~~lknl~~LdlS 122 (1081)
T KOG0618|consen 47 LKSLDLSNNQI-SSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASI-SELKNLQYLDLS 122 (1081)
T ss_pred eEEeecccccc-ccCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhH-Hhhhcccccccc
Confidence 66777776555 446788999999999999999998 56788999999999999999998 788774 899999999999
Q ss_pred ccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccC
Q 002094 151 NNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQL 230 (967)
Q Consensus 151 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 230 (967)
.|++. .+|..+..+..++.+..++|......+. . .++.++|..|.+.+.++..+..++. .|+|..|.+.
T Consensus 123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~----~-~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~--- 191 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ----T-SIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME--- 191 (1081)
T ss_pred hhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc----c-cchhhhhhhhhcccchhcchhhhhe--eeecccchhh---
Confidence 99998 7888888888888888888822211111 1 1556666666666655555555555 5666666554
Q ss_pred CcCccCCC--------------------CccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccc
Q 002094 231 PEDIGGCS--------------------MLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLES 290 (967)
Q Consensus 231 ~~~~~~l~--------------------~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 290 (967)
-..+..+. +|+.|+.++|.++...+ -..-.+|+++++++|++++ +|+++..+.+|+.
T Consensus 192 ~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~ 268 (1081)
T KOG0618|consen 192 VLDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLSN-LPEWIGACANLEA 268 (1081)
T ss_pred hhhhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeecc--ccccccceeeecchhhhhc-chHHHHhcccceE
Confidence 12233344 44455555555441111 1122467777777777773 4577777777777
Q ss_pred ccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcc---cccEEeccCC
Q 002094 291 LDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM---GLQTVSLSGN 367 (967)
Q Consensus 291 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~---~L~~L~L~~n 367 (967)
|+..+|+++ .+|..+..+.+|+.|.+.+|.+. -+|.....++.|+.|||..|+|. ..|..++.. .+..|+.+.|
T Consensus 269 l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n 345 (1081)
T KOG0618|consen 269 LNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSN 345 (1081)
T ss_pred ecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhc
Confidence 777777775 66777777777777777777777 55666677777778888777776 455444432 4666777777
Q ss_pred CCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCccc
Q 002094 368 RLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLN 447 (967)
Q Consensus 368 ~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 447 (967)
++.....+.. ..++.|+.|++.+|.++...-+.+.+..+|+.|+|++|++.......+.++..|+.|+||+|+|+
T Consensus 346 ~l~~lp~~~e-----~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~ 420 (1081)
T KOG0618|consen 346 KLSTLPSYEE-----NNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT 420 (1081)
T ss_pred cccccccccc-----hhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh
Confidence 7655442221 23456777888888887777677777778888888888876444456677777888888888887
Q ss_pred ccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhh
Q 002094 448 GTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELI 527 (967)
Q Consensus 448 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 527 (967)
.+|+.+..+..|+.|...+|++. ..| .+..+++|+.+|+|.|+|+...-..-..-++|++|||++|.-....-..|.
T Consensus 421 -~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~ 497 (1081)
T KOG0618|consen 421 -TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLK 497 (1081)
T ss_pred -hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhH
Confidence 67777777778888888888877 566 677778888888888877643322222226788888888864335556666
Q ss_pred hccCCceEEecCC
Q 002094 528 NLSHLLSFNISHN 540 (967)
Q Consensus 528 ~l~~L~~L~l~~N 540 (967)
.+.++...++.-|
T Consensus 498 ~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 498 VLKSLSQMDITLN 510 (1081)
T ss_pred HhhhhhheecccC
Confidence 6666666666665
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.25 Aligned_cols=256 Identities=22% Similarity=0.272 Sum_probs=198.3
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEc--CCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT--PSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 760 (967)
|+..+.||.|++|.||++... +++.||+|.+..........++.+|++++++++||||+++++++.. ++..++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 466788999999999999974 5889999998765433456789999999999999999999998864 3467999999
Q ss_pred cCCCchhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 761 ISSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 761 ~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
+++++|.+++.... ....+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--- 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--- 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc---
Confidence 99999998876422 22347889999999999999999999999999999999999999999999999986543211
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCcc---chHhHHHHHHhhhccCCchhhcchhh
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMED---DVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.....++..|+|||.. ....++.++||||+|+++|+|++|+.||+.... .......++.. .......+.
T Consensus 160 -~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-- 231 (287)
T cd06621 160 -AGTFTGTSFYMAPERI-QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKDE-- 231 (287)
T ss_pred -cccccCCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhccC--
Confidence 1234567789999988 566789999999999999999999999975422 11112222111 000010000
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.......+..+.+++.+|++.+|++|||+.|+++
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 -PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0001123567899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=325.03 Aligned_cols=257 Identities=19% Similarity=0.214 Sum_probs=186.5
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCC------CCceeeeeeEEEcC-C
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR------HHNLVALEGYYWTP-S 752 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~-~ 752 (967)
.+.|+..+.||+|+||+||+|... .++.||||+++... ....++..|+++++.++ |.+++++++++... +
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 345788899999999999999864 57889999986432 22344556666665554 45689999988754 5
Q ss_pred ceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCCC------------
Q 002094 753 LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSSG------------ 819 (967)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~~------------ 819 (967)
..++|||++ +++|.+++..... +++..+..++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHGP---FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 678999988 6788888876433 8899999999999999999998 5999999999999998765
Q ss_pred ----CeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhH
Q 002094 820 ----EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVL 895 (967)
Q Consensus 820 ----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~ 895 (967)
.+||+|||.+.... .......||+.|+|||++ .+..++.++|||||||++|||++|+.||+....... +
T Consensus 282 ~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~-~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~ 354 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVV-LGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH-L 354 (467)
T ss_pred CCCceEEECCCCccccCc-----cccccccCCccccCcHHh-hcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-H
Confidence 49999999876322 223456789999999998 556789999999999999999999999975443211 1
Q ss_pred HHHHHhhhccC-----------Cchhhc----------chhh-----cCC--CChhhHHHHHHHHHhhccCCCCCCCCHH
Q 002094 896 CDMVRGALEDG-----------RVEDCV----------DARL-----RGN--FPADEAIPVIKLGLICASQVPSNRPDME 947 (967)
Q Consensus 896 ~~~~~~~~~~~-----------~~~~~~----------~~~~-----~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 947 (967)
.. +...+... ...++. ++.. ... ........+.+||.+|++.||++|||++
T Consensus 355 ~~-i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 355 HL-MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HH-HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 11 11111000 000000 0000 000 0001234578999999999999999999
Q ss_pred HHHH
Q 002094 948 EVVN 951 (967)
Q Consensus 948 evl~ 951 (967)
|+++
T Consensus 434 e~L~ 437 (467)
T PTZ00284 434 QMTT 437 (467)
T ss_pred HHhc
Confidence 9986
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.26 Aligned_cols=244 Identities=21% Similarity=0.287 Sum_probs=190.0
Q ss_pred ccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc--ccHHHHHHHHHHH---cCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 689 ELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI--KSQEDFEKEMKTL---GKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 689 ~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.||+|+||.||++... +++.||+|.+...... .....+.+|..++ ....||+|+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 5899999998765322 1223344454433 33479999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.+++..... +++..+..++.|++.|++|||+++|+||||||+||++++++.++++|||++...... ...
T Consensus 81 ~~~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~ 153 (279)
T cd05633 81 GGDLHYHLSQHGV---FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPH 153 (279)
T ss_pred CCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----Ccc
Confidence 9999999875443 899999999999999999999999999999999999999999999999998754321 122
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
...|++.|+|||.......++.++|+||+||++|||++|+.||......... . ..... .......+.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~-~~~~~----------~~~~~~~~~ 220 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--E-IDRMT----------LTVNVELPD 220 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--H-HHHHh----------hcCCcCCcc
Confidence 3468899999998744556889999999999999999999999743321111 0 11000 011223445
Q ss_pred hhHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 002094 923 DEAIPVIKLGLICASQVPSNRP-----DMEEVVNI 952 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 952 (967)
..+.++.+++.+|++.||++|| |++|+++.
T Consensus 221 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 221 SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 5667899999999999999999 59888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=296.85 Aligned_cols=251 Identities=21% Similarity=0.355 Sum_probs=201.0
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEc--CCceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWT--PSLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 759 (967)
|+..+.||.|+||.||++.. .+++.||+|.+..... ....+.+..|++++++++|+||+++++++.. +...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 56678899999999999985 4688999999875543 3345678899999999999999999998764 345789999
Q ss_pred ecCCCchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHh-----cCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 760 FISSGSLYKHLHDGSS-RNCLSWRQRFNIILGMAKGLAYLH-----HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~~LH-----~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
|+++++|.+++..... ...+++..++.++.|++.|++||| +.+++|+||+|+||+++.++.+|++|||.+....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 9999999999976422 234899999999999999999999 8899999999999999999999999999998765
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcc
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (967)
.... ......+++.|+|||.+ ....++.++|+||||+++|+|++|+.||...... ...+.+ ..
T Consensus 162 ~~~~--~~~~~~~~~~~~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~----~~-------- 224 (265)
T cd08217 162 HDSS--FAKTYVGTPYYMSPEQL-NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QLASKI----KE-------- 224 (265)
T ss_pred CCcc--cccccccCCCccChhhh-cCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HHHHHH----hc--------
Confidence 3221 12345678899999998 5567889999999999999999999999754321 111111 11
Q ss_pred hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 914 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
......+...+..+.+++.+|++.+|++|||++++++.
T Consensus 225 -~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 -GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11122344566789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=294.37 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=205.1
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+..+.||+|++|.||+|+.+ +++.||||++...........+.+|++.+.+++|+|++++++++..+...++||||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 567789999999999999976 4899999998776533456789999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
+++|.+++.... .+++..+..++.|+++|++|+|+ .+++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 83 ~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~~ 157 (264)
T cd06623 83 GGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QC 157 (264)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC--cc
Confidence 999999997653 38899999999999999999999 9999999999999999999999999999876643221 12
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCcc-chHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMED-DVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....++..|+|||.. ....++.++|+||||+++|+|++|+.||..... ... +....... ......
T Consensus 158 ~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~---~~~~~~~~----------~~~~~~ 223 (264)
T cd06623 158 NTFVGTVTYMSPERI-QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF---ELMQAICD----------GPPPSL 223 (264)
T ss_pred cceeecccccCHhhh-CCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHH---HHHHHHhc----------CCCCCC
Confidence 245578889999988 566889999999999999999999999975432 111 11111111 011122
Q ss_pred Chh-hHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 921 PAD-EAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 921 ~~~-~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
+.. .+..+.+++.+|++.+|++|||+.|+++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 333 56789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=278.04 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=198.2
Q ss_pred CccCCCCceEEEEEE-eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEecCCCc
Q 002094 688 CELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEFISSGS 765 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs 765 (967)
+.||+|+|++|--++ ..+|.+||||++.+.. .....++.+|++++.+. .|+||+++++||.++..+|+|||.|.||+
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 459999999999888 7789999999997763 46778999999999999 59999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC---CeEEeecccccccCCCccc-cc-
Q 002094 766 LYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG---EPKVGDFGLARLLPMLDRC-IL- 840 (967)
Q Consensus 766 L~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~---~~kl~Dfg~a~~~~~~~~~-~~- 840 (967)
|.+++++... +++.++.++.++|+.||.|||.+||.|||+||+|||-.... .+|||||.++.-....... ..
T Consensus 163 lLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 163 LLSHIQKRKH---FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred HHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 9999987654 89999999999999999999999999999999999996544 4799999987544321111 11
Q ss_pred ---cccccccccccCcccc----cCcccCCcccchhhHHHHHHHHHcCCCCCCCCcc---------chHhHHHHHHhhhc
Q 002094 841 ---SSKIQSALGYMAPEFA----CRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMED---------DVVVLCDMVRGALE 904 (967)
Q Consensus 841 ---~~~~~gt~~y~aPE~~----~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~---------~~~~~~~~~~~~~~ 904 (967)
-....|+..|||||+. .+...|+.++|.||+||++|-|++|.+||..+-+ ...+..+....-++
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 1134567789999975 2345688899999999999999999999974322 11122222222222
Q ss_pred cCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 905 DGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
++.++ +.| .-+.+.+.+..+++...+..|+.+|.++.+++.
T Consensus 320 EGkYe-FPd-----kdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 320 EGKYE-FPD-----KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCc-CCh-----hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 22111 111 112355677889999999999999999998876
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.62 Aligned_cols=259 Identities=18% Similarity=0.221 Sum_probs=194.4
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcC--CceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTP--SLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 759 (967)
|+..+.||+|+||.||+|+.. +++.||+|+++............+|+.++.++. |+|++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 455678999999999999954 689999999876432233344567888888885 99999999999887 88999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++ ++.+++..... .+++.++..++.|++.||+|||+.|++||||+|+||+++. +.+||+|||.+........
T Consensus 81 ~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 81 LMDM-NLYELIKGRKR--PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred cCCc-cHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 9975 78888765432 3899999999999999999999999999999999999999 9999999999976543211
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc-----------
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV----------- 908 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 908 (967)
.....++..|+|||.......++.++||||+||++|||++|..||...+... ..............
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhccccc
Confidence 1234578889999977555678899999999999999999999997543321 11111111111000
Q ss_pred hhhcchhhcC----CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 909 EDCVDARLRG----NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 909 ~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+.... ......+..+.+++.+|++++|++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000 001234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=299.41 Aligned_cols=263 Identities=23% Similarity=0.263 Sum_probs=200.7
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-ccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--CceeEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVALEGYYWTP--SLQLLIY 758 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 758 (967)
.|+..+.||+|+||.||+|..+ +++.+|+|.++..... .....+.+|+.++++++||||+++++++... ...++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 3577889999999999999976 5889999999755422 2234577899999999999999999998877 8899999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++ +|.+++..... .+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||.+.......
T Consensus 86 e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 160 (293)
T cd07843 86 EYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-- 160 (293)
T ss_pred hhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc--
Confidence 99975 89888876433 38999999999999999999999999999999999999999999999999988664322
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhh---------------
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGAL--------------- 903 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~--------------- 903 (967)
.......+++.|+|||.+.....++.++|+||+|+++|||++|++||...... ...........
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhccch
Confidence 12234456788999998855555789999999999999999999999754332 11111111100
Q ss_pred -ccCCchhhcchhhcCCCChh-hHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 904 -EDGRVEDCVDARLRGNFPAD-EAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 904 -~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
............+...++.. .+..+.+++.+|++.+|++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000011111122223332 4667899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=300.67 Aligned_cols=243 Identities=25% Similarity=0.336 Sum_probs=199.7
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|++|.||++... +++.||+|.+..... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 577789999999999999965 589999999875432 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|.+++..... +++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~~~~---l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----- 154 (290)
T cd05580 83 VPGGELFSHLRKSGR---FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----- 154 (290)
T ss_pred CCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----
Confidence 999999999976543 889999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....+++.|+|||.. .....+.++|+||+|+++|+|++|+.||...... ....... . ....+
T Consensus 155 ~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~-----~----------~~~~~ 217 (290)
T cd05580 155 TYTLCGTPEYLAPEII-LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKIL-----E----------GKVRF 217 (290)
T ss_pred CCCCCCCccccChhhh-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHh-----c----------CCccC
Confidence 2345678899999988 5557889999999999999999999999644321 1111111 0 01223
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
+...+..+.+++.+|+..||.+|+ +++|+++
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 445567899999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=273.52 Aligned_cols=249 Identities=22% Similarity=0.354 Sum_probs=199.7
Q ss_pred CCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEecC
Q 002094 685 NKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
+....||.|..|+|++++.+ .|...|||.++..+..+..+++...++++..- .+|+||+.+|||......++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 44567999999999999976 48899999999888777778888888887766 48999999999999999999999885
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
. ..+..+++... ++++.-+-++...+..||.||-++ ||+|||+||+|||+|+.|.+|+||||++.++ ..+...
T Consensus 175 ~-C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl---vdSkAh 248 (391)
T KOG0983|consen 175 T-CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL---VDSKAH 248 (391)
T ss_pred H-HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee---eccccc
Confidence 3 45555554333 377777778999999999999975 8999999999999999999999999999766 345567
Q ss_pred ccccccccccCcccccC--cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 842 SKIQSALGYMAPEFACR--TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~--~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
+..+|-+.|||||.+.. ...|..++||||||+.++||.||+.||..-+.+-..+..+.. ... +.+++
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln----~eP------P~L~~- 317 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN----EEP------PLLPG- 317 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh----cCC------CCCCc-
Confidence 77889999999998843 245788999999999999999999999875555443332222 110 11111
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+..+.+++..|+.+|+.+||.+.++++
T Consensus 318 -~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 -HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1225667999999999999999999998765
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=293.72 Aligned_cols=243 Identities=24% Similarity=0.328 Sum_probs=197.9
Q ss_pred cCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCch
Q 002094 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSL 766 (967)
Q Consensus 690 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 766 (967)
||+|++|.||+++.. +++.||+|.+..... ....+.+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 489999999976442 23456799999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccccc
Q 002094 767 YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQS 846 (967)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 846 (967)
.+++.+... +++..+..++.|++.||+|+|+++++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus 81 ~~~l~~~~~---l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~ 154 (262)
T cd05572 81 WTILRDRGL---FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCG 154 (262)
T ss_pred HHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccC
Confidence 999976543 7889999999999999999999999999999999999999999999999998664321 2234467
Q ss_pred cccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHH
Q 002094 847 ALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAI 926 (967)
Q Consensus 847 t~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (967)
++.|+|||.. ....++.++|+||+|+++|+|++|..||.....+... ..... .+......++...+.
T Consensus 155 ~~~~~~PE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~---------~~~~~~~~~~~~~~~ 221 (262)
T cd05572 155 TPEYVAPEII-LNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME---IYNDI---------LKGNGKLEFPNYIDK 221 (262)
T ss_pred CcCccChhHh-cCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH---HHHHH---------hccCCCCCCCcccCH
Confidence 8889999987 5567899999999999999999999999755432211 11111 111112334445567
Q ss_pred HHHHHHHhhccCCCCCCCC-----HHHHHH
Q 002094 927 PVIKLGLICASQVPSNRPD-----MEEVVN 951 (967)
Q Consensus 927 ~l~~li~~cl~~dP~~Rpt-----~~evl~ 951 (967)
++.+++.+|++.+|++||+ ++|+++
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 8999999999999999999 666554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=300.54 Aligned_cols=262 Identities=26% Similarity=0.305 Sum_probs=200.9
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc----ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI----KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
|+..+.||+|++|.||+|... +++.||||.+...... .....+..|++++++++|+||+++++++.+....++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 466778999999999999965 6899999999765422 12345778999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+ +++|.+++.... ..+++..+..++.||++||+|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR- 157 (298)
T ss_pred ccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-
Confidence 999 889999997654 2389999999999999999999999999999999999999999999999999976643221
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh-------
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC------- 911 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 911 (967)
......+++.|+|||.+.....++.++|+||||+++|||++|.+||....+. ..+..... ..........
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 158 -KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFE-ALGTPTEENWPGVTSLP 234 (298)
T ss_pred -cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHH-HcCCCchhhhhhccccc
Confidence 2233456778999998855567889999999999999999998888643321 21222211 1111000000
Q ss_pred --cchhhcCC-----CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 912 --VDARLRGN-----FPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 912 --~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
........ .....+.++.+++.+|++.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000 113345678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.42 Aligned_cols=263 Identities=22% Similarity=0.286 Sum_probs=200.2
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||.|++|.||+|..+ +|..||+|++..... ....+.+.+|++++++++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456788999999999999864 799999999876542 223467889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
+ ++|.+++..... ..+++..+..++.|+++||+|||+++++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~ 156 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TY 156 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--cc
Confidence 5 589999876543 2389999999999999999999999999999999999999999999999999875532211 12
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC--------Cchhhcc
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG--------RVEDCVD 913 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 913 (967)
....+++.|+|||++.....++.++|+||+|+++|+|++|+.||....... ...++.+...... ...+...
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 233457889999987555567889999999999999999999997544322 2222222110000 0000000
Q ss_pred hh------hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 914 AR------LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 914 ~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.. ......+..+..+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 000112334567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=294.78 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=206.1
Q ss_pred HHHHHHhhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc--ccHHHHHHHHHHHcCCCCCceeeeeeEEEcC
Q 002094 675 EFAAGANALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALEGYYWTP 751 (967)
Q Consensus 675 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 751 (967)
+....+.+.|..-++||+||||.||-+..+ +|..||.|++.+.... +.......|-.++.+++.+.||.+--.|.++
T Consensus 178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK 257 (591)
T ss_pred HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence 344445566788899999999999999855 6899999998766542 2345677899999999999999999999999
Q ss_pred CceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 752 SLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
+..++|+..|.||+|.-+|....... +++..+.-+|.+|+.||++||+++||+||+||+|||+|+.|+++|+|.|+|..
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~g-F~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPG-FDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCC-CchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEe
Confidence 99999999999999999998766543 99999999999999999999999999999999999999999999999999998
Q ss_pred cCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (967)
++... ......||.+|||||++ ++..|+...|+||+||++|||+.|+.||.....- ..-.+.-+...+
T Consensus 337 i~~g~---~~~~rvGT~GYMAPEvl-~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-vk~eEvdrr~~~------- 404 (591)
T KOG0986|consen 337 IPEGK---PIRGRVGTVGYMAPEVL-QNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-VKREEVDRRTLE------- 404 (591)
T ss_pred cCCCC---ccccccCcccccCHHHH-cCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-hhHHHHHHHHhc-------
Confidence 86532 23445899999999999 5566999999999999999999999999733221 000011111110
Q ss_pred cchhhcCCCChhhHHHHHHHHHhhccCCCCCCC
Q 002094 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRP 944 (967)
Q Consensus 912 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 944 (967)
-..+++...+.+..++.+..+.+||++|.
T Consensus 405 ----~~~ey~~kFS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 405 ----DPEEYSDKFSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred ----chhhcccccCHHHHHHHHHHHccCHHHhc
Confidence 02345666777899999999999999986
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.04 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=199.7
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCC------
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPS------ 752 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------ 752 (967)
.+.|+..+.||+|++|.||+|..+ +++.+++|.+.... ...+.+.+|+.+++++ +|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 355788999999999999999975 57899999887654 3456799999999999 7999999999997644
Q ss_pred ceeEEEEecCCCchhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 753 LQLLIYEFISSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.+..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 4799999999999999987543 123488999999999999999999999999999999999999999999999999876
Q ss_pred cCCCccccccccccccccccCcccccC----cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACR----TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR 907 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (967)
.... ........++..|+|||.+.. ...++.++||||+|+++|+|++|+.||...... ....++....
T Consensus 163 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~----- 234 (275)
T cd06608 163 LDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPRNP----- 234 (275)
T ss_pred cccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhhccC-----
Confidence 5321 122234567888999998732 234678999999999999999999999643221 1111111110
Q ss_pred chhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.. ....+...+..+.+++.+|+..||++|||++++++
T Consensus 235 ~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 PP-------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CC-------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 11112335567999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=299.04 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=196.5
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcC-----Cce
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTP-----SLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~~~ 754 (967)
+.|+..+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.+++++ +|||++++++++... +..
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 4468888999999999999996 468899999886543 3356788899999998 899999999998753 357
Q ss_pred eEEEEecCCCchhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 755 LLIYEFISSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
++||||+++++|.++++... ....+++..++.++.|++.||+|||+++++||||||+||+++.++.++|+|||++....
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 89999999999999886432 12248899999999999999999999999999999999999999999999999987654
Q ss_pred CCccccccccccccccccCcccccCcc----cCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTV----KITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
.... ......++..|+|||.+.... .++.++|+||+||++|||++|+.||...... ....++.+. ...
T Consensus 180 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~~~~-----~~~ 251 (291)
T cd06639 180 STRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKIPRN-----PPP 251 (291)
T ss_pred cccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHhcC-----CCC
Confidence 3211 123345788899999873322 3688999999999999999999999754332 111111111 000
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+......+.+++.+|++.+|++||++.|+++
T Consensus 252 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 252 -------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00112334456999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=307.65 Aligned_cols=246 Identities=27% Similarity=0.404 Sum_probs=195.7
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEE---EEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCc--eeE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVA---IKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSL--QLL 756 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~va---vK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~l 756 (967)
+.....+||+|+|-+||||... +|..|| ||.-.....++..++|..|+.+++.|+||||++++.++.+... .-+
T Consensus 41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 3455678999999999999954 466776 3333333334556899999999999999999999999987655 668
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCCCCEEeC-CCCCeEEeecccccccC
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT--NIIHYNLKSTNVLID-SSGEPKVGDFGLARLLP 833 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~--~ivH~Dik~~Nill~-~~~~~kl~Dfg~a~~~~ 833 (967)
|+|.+..|+|..|+++.+. .....+..|++||++||.|||++ +|+|||||-+||+++ ..|.|||+|.|+|....
T Consensus 121 iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 9999999999999988776 78899999999999999999987 799999999999997 57999999999998764
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcc
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (967)
. .. ...+.|||.|||||++ . ..|.+.+||||||+.++||+|+..||..=....+++...+.+.- ..
T Consensus 198 ~---s~-aksvIGTPEFMAPEmY-E-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK-----P~--- 263 (632)
T KOG0584|consen 198 K---SH-AKSVIGTPEFMAPEMY-E-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK-----PA--- 263 (632)
T ss_pred c---cc-cceeccCccccChHHH-h-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC-----HH---
Confidence 2 22 2348899999999998 3 57999999999999999999999999633333333322222111 11
Q ss_pred hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 914 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+..-...++.++|.+|+.. .++|||+.|++.
T Consensus 264 -----sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 264 -----ALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----HhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 11222345699999999999 999999999875
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=301.67 Aligned_cols=263 Identities=24% Similarity=0.329 Sum_probs=200.6
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|++|.||+|..+ +++.||+|.++.... ....+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 577889999999999999966 578999998865432 234577999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
+++.+..+..... .+++..+..++.||+.|++|||+++++|+|++|+||++++++.++|+|||.+........ ...
T Consensus 83 ~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 83 ERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 9877766654432 278999999999999999999999999999999999999999999999999876654222 122
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc-----------cCCc--
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE-----------DGRV-- 908 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~-- 908 (967)
....++..|+|||++.....++.++|+||+|+++|+|++|++||........ +......... ....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3456778899999985444788999999999999999999999974432211 1111100000 0000
Q ss_pred ---hhhcch-hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 909 ---EDCVDA-RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 909 ---~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+..+. .....++...+.++.+++++|++.+|++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 0011223344778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=301.19 Aligned_cols=247 Identities=20% Similarity=0.310 Sum_probs=197.6
Q ss_pred CCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 685 NKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
.....||+|+||.||++... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 33457999999999999854 68999999986543 23456788999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
++|.+++... .+++..+..++.|++.|++|||+.+++||||+|+||+++.++.++|+|||++....... .....
T Consensus 103 ~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~ 176 (297)
T cd06659 103 GALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKS 176 (297)
T ss_pred CCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccc
Confidence 9999887542 27899999999999999999999999999999999999999999999999987553311 12234
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
..++..|+|||++ ....++.++||||||+++|||++|+.||........ ...+.. ... . .......
T Consensus 177 ~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~----~~~-----~--~~~~~~~ 242 (297)
T cd06659 177 LVGTPYWMAPEVI-SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MKRLRD----SPP-----P--KLKNAHK 242 (297)
T ss_pred eecCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhc----cCC-----C--CccccCC
Confidence 5688899999998 556789999999999999999999999964332211 111111 000 0 0011223
Q ss_pred hHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 924 EAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.+..+.+++.+|++.+|++||+++++++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 45568999999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=301.28 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=194.2
Q ss_pred CCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCceeEEEEecC
Q 002094 685 NKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
+..+.||+|+||.||++... +++.||+|.+...........+.+|+.++.++. |+||+++++++..++..+++|||+.
T Consensus 7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 45678999999999999965 589999999876543445667899999999996 9999999999999999999999986
Q ss_pred CCchhhhh---hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 763 SGSLYKHL---HDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 763 ~gsL~~~l---~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
. ++.++. .... ...+++..+.+++.+++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 87 ~-~l~~l~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--- 161 (288)
T cd06616 87 I-SLDKFYKYVYEVL-KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS--- 161 (288)
T ss_pred C-CHHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC---
Confidence 4 554433 2221 12388999999999999999999975 9999999999999999999999999998755321
Q ss_pred cccccccccccccCcccccCc--ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 839 ILSSKIQSALGYMAPEFACRT--VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~--~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.......++..|+|||.+... ..++.++||||+|+++|||++|+.||....... +.+....... .+.+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~------~~~~ 231 (288)
T cd06616 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF----DQLTQVVKGD------PPIL 231 (288)
T ss_pred CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH----HHHhhhcCCC------CCcC
Confidence 112234578889999998443 368899999999999999999999997443111 1111111100 0111
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
....+...+.++.+++.+|++.+|++|||++++++.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122223456789999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=302.61 Aligned_cols=267 Identities=21% Similarity=0.306 Sum_probs=197.5
Q ss_pred cCCCCccCCCCceEEEEEEeC---CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--CceeE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ---DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP--SLQLL 756 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 756 (967)
|+..+.||+|+||.||+|..+ +++.||+|.+..... ......+.+|+.++++++||||+++++++... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 466778999999999999965 478999999976321 22346678899999999999999999999887 78999
Q ss_pred EEEecCCCchhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC----CCCeEEeeccccc
Q 002094 757 IYEFISSGSLYKHLHDGSS--RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS----SGEPKVGDFGLAR 830 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~----~~~~kl~Dfg~a~ 830 (967)
||||+++ ++.+++..... ...+++..++.++.|++.|++|||+++++||||||+||+++. ++.+|++|||++.
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999975 67676653322 124788999999999999999999999999999999999999 8999999999998
Q ss_pred ccCCCcc-ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccch--------HhHHHHHHh
Q 002094 831 LLPMLDR-CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDV--------VVLCDMVRG 901 (967)
Q Consensus 831 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~--------~~~~~~~~~ 901 (967)
....... ........+++.|+|||.+.....++.++||||||++++||++|++||....... ..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 6643222 1122345678889999987555568899999999999999999999997543322 111111110
Q ss_pred hh-----------ccCCchhhcchhhcCCCC-----------hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 902 AL-----------EDGRVEDCVDARLRGNFP-----------ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 902 ~~-----------~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.- .........+......++ ...+.++.+++.+|++.||++|||+.|+++
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 000000000000011111 134567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=278.02 Aligned_cols=269 Identities=20% Similarity=0.280 Sum_probs=204.2
Q ss_pred ccCCCCccCCCCceEEEEEEeCC-----CcEEEEEEeecCCcc-ccHHHHHHHHHHHcCCCCCceeeeeeEEEc-CCcee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQD-----GRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVALEGYYWT-PSLQL 755 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 755 (967)
.|+..+.||+|.||.||+|+.++ ...+|+|+++.+... .-.....+|+..++.++|||++.+..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 46778899999999999997432 237999999765321 223467899999999999999999998876 78889
Q ss_pred EEEEecCCCchhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC----CCeEEeecccc
Q 002094 756 LIYEFISSGSLYKHLHDGS--SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS----GEPKVGDFGLA 829 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~----~~~kl~Dfg~a 829 (967)
+++||.+. +|...++..+ ....++...+..|++||+.|+.|||+.=|+|||+||.|||+..+ |.|||+|||++
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 99999987 8888886432 22358889999999999999999999999999999999999877 89999999999
Q ss_pred cccCCCcccc-ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccc-------hHhHHHHHHh
Q 002094 830 RLLPMLDRCI-LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD-------VVVLCDMVRG 901 (967)
Q Consensus 830 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~-------~~~~~~~~~~ 901 (967)
+.+...-... ....+.-|..|+|||.+.+...||.+.||||.|||+.||+|-.+.|...+.. ..+-.+-+..
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~ 263 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE 263 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH
Confidence 9886543333 3456778999999999999999999999999999999999988888643221 1111222223
Q ss_pred hhccCCchhhcchhhcCCC-----------C------------hhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 902 ALEDGRVEDCVDARLRGNF-----------P------------ADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~-----------~------------~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.+..+....+.+-+-.+++ . ...+....+++.+++..||.+|.|++++++-
T Consensus 264 vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 264 VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 3333322222222111111 0 1122337899999999999999999998764
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=298.61 Aligned_cols=249 Identities=21% Similarity=0.312 Sum_probs=200.0
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|...+.||+|+||.||++... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 4677889999999999999854 67899999986543 234567899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++.... +++..+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 99 ~~~~L~~~~~~~~----l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~ 172 (293)
T cd06647 99 AGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 172 (293)
T ss_pred CCCcHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--cc
Confidence 9999999986532 67899999999999999999999999999999999999999999999998875543221 22
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....+++.|+|||.. ....++.++|+||||+++|++++|+.||........... ... ........+
T Consensus 173 ~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-----~~~--------~~~~~~~~~ 238 (293)
T cd06647 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IAT--------NGTPELQNP 238 (293)
T ss_pred ccccCChhhcCchhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-----hhc--------CCCCCCCCc
Confidence 334678889999988 556788999999999999999999999975433211000 000 000011112
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
...+..+.+++.+|++.+|++||++.+++..
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3345678999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=298.66 Aligned_cols=246 Identities=28% Similarity=0.391 Sum_probs=195.5
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||+|+.. +++.||+|.+..... .+...++.+|+++++.++||||+++++++...+..++||||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 577788999999999999965 689999999865432 23345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++ ++.+++..... .+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++.....
T Consensus 97 ~~g-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~------ 167 (307)
T cd06607 97 CLG-SASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP------ 167 (307)
T ss_pred hCC-CHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC------
Confidence 974 77777654332 388999999999999999999999999999999999999999999999999875432
Q ss_pred cccccccccccCccccc--CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 841 SSKIQSALGYMAPEFAC--RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~--~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.....+++.|+|||.+. ....++.++||||||+++|||++|+.||........ ..... .. . ...
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-~~~~~----~~-~--------~~~ 233 (307)
T cd06607 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIA----QN-D--------SPT 233 (307)
T ss_pred CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-HHHHh----cC-C--------CCC
Confidence 12345778899999873 245688899999999999999999999965432211 11100 00 0 000
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..+...+..+.+++.+|++.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1122345679999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=296.66 Aligned_cols=262 Identities=23% Similarity=0.311 Sum_probs=200.3
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCC-ccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--CceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSG-LIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP--SLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 759 (967)
|+..+.||+|++|.||+|+.. ++..||+|++.... .......+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456778999999999999966 48899999998664 223456788999999999999999999999887 88999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++ +|.+++..... .+++..++.++.|++.|++|||++|++|+||+|+||++++++.++++|||.+........ .
T Consensus 81 ~~~~-~l~~~~~~~~~--~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEV--KFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-A 156 (287)
T ss_pred cccc-cHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-c
Confidence 9975 88888866432 388999999999999999999999999999999999999999999999999986654321 1
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc-------
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV------- 912 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 912 (967)
......++..|+|||.+.....++.++||||||+++|||++|+.||+..... ..... +...........+.
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEK-IFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHH-HHHHhCCCchhhccccccchh
Confidence 2233456778999998755556889999999999999999999999754432 11111 11111111000000
Q ss_pred ----------chhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 913 ----------DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 913 ----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.......+...++..+.+++.+|++.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000111111223667899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=290.16 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=206.1
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--CceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP--SLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 759 (967)
|+..+.||+|++|.||+|... +++.|++|.+..... ....+.+.+|++++++++|+||+++++++... ...++|||
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 466788999999999999976 689999999876542 23467899999999999999999999999888 88999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++++|.+++.... .+++..++.++.|++.|++|||+.+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 82 YVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred ecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 999999999998654 38999999999999999999999999999999999999999999999999998765432211
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......++..|+|||.. .....+.++||||+|+++++|++|+.||.......... ... ........
T Consensus 159 ~~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~---------~~~~~~~~ 224 (260)
T cd06606 159 GTGSVRGTPYWMAPEVI-RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL----YKI---------GSSGEPPE 224 (260)
T ss_pred cccCCCCCccccCHhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH----Hhc---------cccCCCcC
Confidence 23345678889999988 55568999999999999999999999997554221111 111 11112233
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+...+..+.+++.+|+..+|++||++.++++
T Consensus 225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 45555778999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=299.63 Aligned_cols=264 Identities=20% Similarity=0.228 Sum_probs=197.4
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCc-----e
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSL-----Q 754 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----~ 754 (967)
.|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++++. ||||+++++++..... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 3677889999999999999965 689999998865432 223457888999999995 6999999999876655 7
Q ss_pred eEEEEecCCCchhhhhhcCCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC-CCCeEEeecccccc
Q 002094 755 LLIYEFISSGSLYKHLHDGSSR--NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS-SGEPKVGDFGLARL 831 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~-~~~~kl~Dfg~a~~ 831 (967)
++||||+++ +|.+++...... ..+++..++.++.||+.||+|||+++++||||+|+||+++. ++.++|+|||.+..
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999999986 788888654322 34799999999999999999999999999999999999998 88999999999875
Q ss_pred cCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (967)
..... .......+++.|+|||.+.....++.++|+||||+++|+|++|..||....... ....+.. .+..+....+
T Consensus 161 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFK-LLGTPTEQVW 236 (295)
T ss_pred cCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHH-HhCCCChhhC
Confidence 53211 112234567889999987555568899999999999999999999997543322 2222221 1111100000
Q ss_pred ---cchhh---cC--------CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 912 ---VDARL---RG--------NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 912 ---~~~~~---~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+... .. ...+..+.++.++|.+|++.||.+||+++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 00 011235667899999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=295.28 Aligned_cols=247 Identities=22% Similarity=0.342 Sum_probs=197.1
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|...+.||+|++|.||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 34456899999999999995 468899999886543 2345668899999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.+++... .+++..+..++.|++.|++|||++|++||||+|+||+++.++.++++|||.+....... ....
T Consensus 100 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~ 173 (285)
T cd06648 100 GGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRK 173 (285)
T ss_pred CCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccc
Confidence 99999998762 27889999999999999999999999999999999999999999999999886543211 1223
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
...|++.|+|||.. ....++.++|+||+|+++|||++|+.||...... ........ .. .... ..+.
T Consensus 174 ~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-----~~~~~~~~-~~-----~~~~--~~~~ 239 (285)
T cd06648 174 SLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-----QAMKRIRD-NL-----PPKL--KNLH 239 (285)
T ss_pred cccCCccccCHHHh-cCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHHHHh-cC-----CCCC--cccc
Confidence 35578899999998 5557899999999999999999999998643221 11111110 00 0000 1122
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+..+.+++.+|++.+|++|||+.++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 24567999999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=297.82 Aligned_cols=263 Identities=22% Similarity=0.303 Sum_probs=197.2
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|+..+.||+|++|.||+|..+ +++.||+|.+..... ....+.+.+|++++++++||||+++++++......++||||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 3677889999999999999965 688999999865432 22346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC-CCCeEEeecccccccCCCcccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS-SGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
+++ ++.+++...... ..++..+..++.||+.||+|||+++++|+||+|+||+++. ++.+|++|||++....... .
T Consensus 83 ~~~-~l~~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--~ 158 (294)
T PLN00009 83 LDL-DLKKHMDSSPDF-AKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--R 158 (294)
T ss_pred ccc-cHHHHHHhCCCC-CcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--c
Confidence 964 788887654332 2678888999999999999999999999999999999985 5679999999997553211 1
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc---------hh
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV---------ED 910 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 910 (967)
......+++.|+|||++.....++.++||||+|+++|+|++|+.||....... ...+... ....+.. .+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFR-ILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HhCCCChhhccccccchh
Confidence 12334567889999988555568899999999999999999999997543322 1222111 1000000 00
Q ss_pred hcch--hhcCC----CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 911 CVDA--RLRGN----FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 911 ~~~~--~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.... ..... ..+..+.++.+++.+|++.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00000 11234566899999999999999999999886
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=294.95 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=202.4
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|++|.||+|..+ ++..||+|.+..... ..+.+.+|++.+++++|+|++++++++...+..++|+||
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 34577788999999999999976 689999999976542 467789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 97 ~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 172 (286)
T cd06614 97 MDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--K 172 (286)
T ss_pred cCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--h
Confidence 99999999998754 2389999999999999999999999999999999999999999999999998865543211 1
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....++..|+|||.+ ....++.++|+||||+++|+|++|+.||........ ...+... ... ....
T Consensus 173 ~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-~~~~~~~-----~~~-------~~~~ 238 (286)
T cd06614 173 RNSVVGTPYWMAPEVI-KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-LFLITTK-----GIP-------PLKN 238 (286)
T ss_pred hccccCCcccCCHhHh-cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc-----CCC-------CCcc
Confidence 2234577889999988 556789999999999999999999999964432211 1111110 000 0111
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+...+..+.+++.+|++.+|.+|||+.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 2234567999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=301.67 Aligned_cols=262 Identities=23% Similarity=0.326 Sum_probs=193.8
Q ss_pred CccCCC--CceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRG--GFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
..||+| +||+||++... +|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999964 799999999875432 23346789999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc----
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI---- 839 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~---- 839 (967)
+++.+++...... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 84 GSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999998765433 27889999999999999999999999999999999999999999999998654332111100
Q ss_pred -ccccccccccccCcccccCc-ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc-------------
Q 002094 840 -LSSKIQSALGYMAPEFACRT-VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE------------- 904 (967)
Q Consensus 840 -~~~~~~gt~~y~aPE~~~~~-~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~------------- 904 (967)
......++..|+|||++... ..++.++||||+|+++|||++|+.||........ ..+.......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccchhhh
Confidence 01112345569999998433 3578999999999999999999999975432211 1111110000
Q ss_pred -------------------cCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 905 -------------------DGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 905 -------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
........+...+...+...+..+.+++.+|++.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000011111122223446678999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.78 Aligned_cols=247 Identities=24% Similarity=0.307 Sum_probs=201.8
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||.|+||.||+|... ++..||+|.+..... ....+.+.+|++++++++||||+++++++.++...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 566789999999999999965 589999999976432 23457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+.+++|.+++.... .+++..+..++.|+++|++|||+.+++|+||+|+||++++++.++|+|||.+....... .
T Consensus 82 ~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~ 155 (258)
T cd05578 82 LLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---L 155 (258)
T ss_pred CCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---c
Confidence 99999999997652 38899999999999999999999999999999999999999999999999987654321 2
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....++..|+|||.. ....++.++|+||+|+++|+|++|+.||........ ......... .....
T Consensus 156 ~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~----------~~~~~ 221 (258)
T cd05578 156 TTSTSGTPGYMAPEVL-CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR---DQIRAKQET----------ADVLY 221 (258)
T ss_pred ccccCCChhhcCHHHH-cccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH---HHHHHHhcc----------ccccC
Confidence 2345677889999998 555689999999999999999999999975543211 111111110 12234
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCH--HHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDM--EEVV 950 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~--~evl 950 (967)
+...+..+.+++.+|++.||.+||++ +|++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 55566789999999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=288.21 Aligned_cols=248 Identities=27% Similarity=0.433 Sum_probs=201.4
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+..+.||+|++|.||++... ++..+++|++..... .....+.+|++.+++++|++++++++++......++++||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 566788999999999999975 688999999976542 356789999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.+++.... ..+++..+..++.|++.|++|||++|++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~ 155 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RN 155 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---cc
Confidence 999999987653 2389999999999999999999999999999999999999999999999999876643221 33
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
...++..|+|||.. ....++.++|+||||+++++|++|+.||........... ... ...... ..+.
T Consensus 156 ~~~~~~~~~~PE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~----~~~~~~-------~~~~ 221 (253)
T cd05122 156 TMVGTPYWMAPEVI-NGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK--IAT----NGPPGL-------RNPE 221 (253)
T ss_pred ceecCCcccCHHHH-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH--HHh----cCCCCc-------Cccc
Confidence 55678889999988 555688999999999999999999999975432211110 100 000000 0111
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+..+.+++.+|++.||++|||+.|+++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12567999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=297.16 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=197.4
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||+++.. ++..||+|.+..... .+....+..|++++++++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566788999999999999954 688999999875432 22345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+.+ ++.+.+..... .+++..+..++.|++.|+.|||+++|+||||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~g-~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 107 CLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred CCC-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 975 77777654322 388999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccCccccc--CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 841 SSKIQSALGYMAPEFAC--RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~--~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.....+++.|+|||++. ..+.++.++|||||||++|||++|+.||...... .....+.... ...
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~-------------~~~ 243 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNE-------------SPT 243 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhcc-------------CCC
Confidence 22345778899999873 2456889999999999999999999998643221 1111111110 011
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
......+..+.+++.+|++.+|.+||++.++++....
T Consensus 244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 1123345678999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=294.09 Aligned_cols=245 Identities=25% Similarity=0.336 Sum_probs=194.2
Q ss_pred cCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCch
Q 002094 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSL 766 (967)
Q Consensus 690 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 766 (967)
||+|+||+||++..+ +|+.||+|.+..... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 689999999865432 22345677899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccccc
Q 002094 767 YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQS 846 (967)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 846 (967)
.+++...... .+++..+..++.|++.|+.|||+.|++||||+|+||+++.++.++|+|||.+..... ........+
T Consensus 81 ~~~l~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~ 156 (277)
T cd05577 81 KYHIYNVGEP-GFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAG 156 (277)
T ss_pred HHHHHHcCcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccC
Confidence 9999765532 388999999999999999999999999999999999999999999999999876532 112233457
Q ss_pred cccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHH
Q 002094 847 ALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAI 926 (967)
Q Consensus 847 t~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (967)
+..|+|||.. .+..++.++|+||+|+++|+|++|+.||....... ....+..... ......+...+.
T Consensus 157 ~~~y~~PE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-----------~~~~~~~~~~~~ 223 (277)
T cd05577 157 TPGYMAPEVL-QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRTL-----------EMAVEYPDKFSP 223 (277)
T ss_pred CCCcCCHHHh-cCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhccc-----------cccccCCccCCH
Confidence 7889999998 45568899999999999999999999996443210 0111111100 012223445567
Q ss_pred HHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 927 PVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 927 ~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
.+.+++.+|++.||++|| ++.++++
T Consensus 224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 224 EAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 799999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.88 Aligned_cols=253 Identities=22% Similarity=0.332 Sum_probs=201.7
Q ss_pred hhccCCCCccCCCCceEEEEEEeCCCcE-EEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQDGRS-VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.++|++...||.|+||.||+++.++... .|.|.+.... .+..++|.-|++++..++||+||++++.|...+..|++.|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 3456777889999999999999775444 4556665433 4567889999999999999999999999998999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
||.||-.+..+-.-.. .+++.++.-+.+|++.||.|||++.|||||+|..|||++-+|.++|+|||.+..... ...
T Consensus 110 FC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~q 185 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQ 185 (1187)
T ss_pred ecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHh
Confidence 9999999888766543 389999999999999999999999999999999999999999999999999864321 223
Q ss_pred ccccccccccccCcccccC----cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 840 LSSKIQSALGYMAPEFACR----TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~----~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
....+.|||.|||||+.+. ..+|+.++||||||+++.||..+.+|......- .++..+. ......
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-RVllKia-----KSePPT----- 254 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIA-----KSEPPT----- 254 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-HHHHHHh-----hcCCCc-----
Confidence 3457889999999998743 467899999999999999999999997533321 1111111 111111
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+. -|..-...+.+++.+|+.++|..||++.++++
T Consensus 255 Ll--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 255 LL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11 13444667999999999999999999998874
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=292.17 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=199.6
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|+||.||+|..+ +|..||+|.+..... ....+.+.+|+.+++.++|+||+++++.+......++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 466788999999999999965 588999999876432 234567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC-eEEeecccccccCCCccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE-PKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~-~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++++|.+++...... .+++..+..++.|++.|++|||+.+++|+||||+||++++++. ++++|||.+....... ..
T Consensus 82 ~~~~L~~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~~ 158 (257)
T cd08225 82 DGGDLMKRINRQRGV-LFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--EL 158 (257)
T ss_pred CCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc--cc
Confidence 999999999764432 3789999999999999999999999999999999999998764 6999999987654321 12
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....|++.|+|||+. ....++.++|+||||+++|||++|+.||...... +++...... . ..+.
T Consensus 159 ~~~~~~~~~~~ape~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~-~---------~~~~ 222 (257)
T cd08225 159 AYTCVGTPYYLSPEIC-QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-----QLVLKICQG-Y---------FAPI 222 (257)
T ss_pred ccccCCCccccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhcc-c---------CCCC
Confidence 2234578889999988 5567889999999999999999999999643321 122211111 0 1112
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+..+.+++.+|++.+|++|||+.|+++
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 2344567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=298.61 Aligned_cols=263 Identities=25% Similarity=0.291 Sum_probs=196.9
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-ccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--CceeEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVALEGYYWTP--SLQLLIY 758 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 758 (967)
.|+..+.||+|+||.||+|..+ +|+.||+|.++..... .....+.+|++++++++|+||+++++++... +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 4688889999999999999964 5899999998754322 2234567899999999999999999998754 4679999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++ +|.+++.... ..+++..+..++.|++.|++|||+.|++||||||+||+++.++.++|+|||.+.......
T Consensus 88 e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-- 162 (309)
T cd07845 88 EYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-- 162 (309)
T ss_pred ecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc--
Confidence 99975 7888887543 238999999999999999999999999999999999999999999999999998664322
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchh---hcc--
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVED---CVD-- 913 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-- 913 (967)
.......+++.|+|||.+.+...++.++||||+|+++|||++|++||...... ..+..... ......... ...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQ-LLGTPNESIWPGFSDLP 240 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-hcCCCChhhchhhhccc
Confidence 12223345778999998855566889999999999999999999999754432 21221111 111000000 000
Q ss_pred ----hhhcCC-C------ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 914 ----ARLRGN-F------PADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 914 ----~~~~~~-~------~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
...... + ....+.++.+++.+|++.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 0 01135668899999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=294.69 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=198.5
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|++|.||+|+.. +++.||||++.............+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456788999999999999975 478899999876543233445667999999998 999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
+|+|.+++..... ..+++..+..++.|++.||+|||+++++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---PY 155 (283)
T ss_pred -CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---Cc
Confidence 7899998876542 237999999999999999999999999999999999999999999999999987653311 12
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhH--HH---------HHHhhhccCCchh
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVL--CD---------MVRGALEDGRVED 910 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~--~~---------~~~~~~~~~~~~~ 910 (967)
....++..|+|||.......++.++|+||||++++||++|++||.......... .. |.........+..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 334577889999987566668999999999999999999999996543321110 00 1100000000000
Q ss_pred hcc----hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 911 CVD----ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 911 ~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
... .... ......+..+.+++.+|++.+|++|||++|++.
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 236 RFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000 0000 011122567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=303.71 Aligned_cols=269 Identities=22% Similarity=0.329 Sum_probs=199.6
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC-----Ccee
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP-----SLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~ 755 (967)
+.|+..+.||+|+||.||+|+. .+|+.||+|.+...........+.+|+.++++++|+||+++++++... ...+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 3467888999999999999985 468999999986543334456788999999999999999999987644 3478
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+|+||+++ ++.+.+... .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 85 lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 85 IVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 99999975 787777542 2889999999999999999999999999999999999999999999999998765432
Q ss_pred ccc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh---
Q 002094 836 DRC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC--- 911 (967)
Q Consensus 836 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 911 (967)
... .......+++.|+|||.+.....++.++||||+||++|+|++|+.||...+... ....+......+..+.+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCHHHHHHh
Confidence 111 111234678889999987555678899999999999999999999996433211 11111111111111100
Q ss_pred cchhh---------cCC-----CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH--HHhhc
Q 002094 912 VDARL---------RGN-----FPADEAIPVIKLGLICASQVPSNRPDMEEVVNI--LELIQ 957 (967)
Q Consensus 912 ~~~~~---------~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~~~ 957 (967)
.+... ... ..+..+.++.+++.+|++.||++|||+.|+++. ++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000 000 012235668999999999999999999999886 55444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=280.62 Aligned_cols=254 Identities=25% Similarity=0.356 Sum_probs=200.7
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
..+....||.|+||+|+|-.++ +|+..|||+++......++.++..|.+...+- ++||||+++|.+..++..|+.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3455668999999999998854 79999999999888777888999999976555 799999999999999999999999
Q ss_pred cCCCchhhhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 761 ISSGSLYKHLH---DGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 761 ~~~gsL~~~l~---~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
|+- |++.+-+ ..+.. .+++.-.-+|....+.||.||-+. .|+|||+||+|||++..|.+||||||++... .
T Consensus 145 Md~-SlDklYk~vy~vq~~-~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL---v 219 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKS-RIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL---V 219 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhc-cCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH---H
Confidence 964 6655433 22222 377777778888889999999976 8999999999999999999999999998765 3
Q ss_pred cccccccccccccccCcccccCccc-CCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVK-ITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~-~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
.+...+...|-..|+|||.+..... +..++||||+|+++||+.||..||..+......+.+.+.+.. +.
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdp----------p~ 289 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDP----------PI 289 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCC----------Ce
Confidence 3445556677778999999865544 889999999999999999999999877664443443333211 01
Q ss_pred hcCC-CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 916 LRGN-FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 916 ~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+... ...+...++.++|..|+.+|-..||.+.++.+
T Consensus 290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1111 11345678999999999999999999998765
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=294.72 Aligned_cols=263 Identities=24% Similarity=0.319 Sum_probs=198.1
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC-------
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS------- 752 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 752 (967)
+.|+..+.||+|+||.||+|..+ +|+.||+|.++.... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 34688899999999999999975 588999999976532 233457788999999999999999999987654
Q ss_pred ---ceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccc
Q 002094 753 ---LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLA 829 (967)
Q Consensus 753 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a 829 (967)
..++|+||+++ ++...+..... .+++..+..++.|++.||+|||+.||+|+||||+||++++++.+||+|||.+
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESGLV--HFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999986 67777665422 3899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 830 RLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
........ .......++..|+|||.+......+.++||||+||++|||++|++||..... ...+..+.. ........
T Consensus 164 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~-~~~~~~~~ 240 (302)
T cd07864 164 RLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISR-LCGSPCPA 240 (302)
T ss_pred ccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHH-HhCCCChh
Confidence 76643221 1122334577899999875555678999999999999999999999974432 222222221 11111000
Q ss_pred h---hcc--------------hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 910 D---CVD--------------ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 910 ~---~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
. ... ...+. .....+..+.+++.+|++.||.+|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 000 00000 11234677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=290.00 Aligned_cols=243 Identities=21% Similarity=0.287 Sum_probs=189.5
Q ss_pred ccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc--ccHHHHHHHHH---HHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 689 ELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI--KSQEDFEKEMK---TLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 689 ~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.||+|+||.||++... +++.||+|.+...... .....+..|.. .++...||+|+++++++..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999854 5889999998765322 11223344433 4445579999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
|++|.+++.... .+++..+..++.|++.|++|||+++++||||||+||+++.++.++|+|||.+...... ...
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~ 153 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPH 153 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCc
Confidence 999999886543 3899999999999999999999999999999999999999999999999998755321 112
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
...|+..|+|||.+.....++.++|+||+|+++|||++|+.||......... ..... ........+.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~~~~~-----------~~~~~~~~~~ 220 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRM-----------TLTMAVELPD 220 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--HHHHH-----------hhccCCCCCC
Confidence 3468889999999854556889999999999999999999999744221110 00000 0011223344
Q ss_pred hhHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 923 DEAIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
..+.++.+++.+|+..+|.+|| +++++++
T Consensus 221 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 5567899999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=292.73 Aligned_cols=245 Identities=23% Similarity=0.337 Sum_probs=196.5
Q ss_pred cCCCCceEEEEEEeCC-CcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCch
Q 002094 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSL 766 (967)
Q Consensus 690 lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 766 (967)
||+|+||.||+++..+ |+.||+|.+..... ....+.+.+|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 89999999865432 23456789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc------ccc
Q 002094 767 YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR------CIL 840 (967)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~ 840 (967)
.+++.+.. .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99998654 388999999999999999999999999999999999999999999999999875432211 112
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....++..|+|||.. .....+.++|+||||+++||+++|+.||....... ....... . ....
T Consensus 158 ~~~~~~~~~~~~Pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~-~----------~~~~ 220 (265)
T cd05579 158 DKRIVGTPDYIAPEVI-LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-----IFQNILN-G----------KIEW 220 (265)
T ss_pred ccCcccCccccCHHHh-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHhc-C----------CcCC
Confidence 2345577889999988 44568899999999999999999999996443221 1111110 0 0011
Q ss_pred Chh--hHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 921 PAD--EAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 921 ~~~--~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
+.. .+..+.+++.+|++.+|++|||+.++.+.|+
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 222 2677899999999999999999976666664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=288.34 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=197.2
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCC----ccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--Ccee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSG----LIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP--SLQL 755 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 755 (967)
.|+..+.||+|+||.||+|... ++..||+|.+.... .......+.+|++++++++|+||+++++++.+. +..+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 3678899999999999999954 58999999875432 123346789999999999999999999998764 4578
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+||||+++++|.+++..... +++..+.+++.|++.|++|||+.|++|+||||+||+++.++.++|+|||+++.....
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGA---LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999999875433 788899999999999999999999999999999999999999999999999765321
Q ss_pred cc-ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 836 DR-CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 836 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
.. ........++..|+|||.. ....++.++|+||||+++||+++|+.||........ ..+ . ...
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~----~---------~~~ 224 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVI-SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-IFK----I---------ATQ 224 (264)
T ss_pred cccCccccccCCcccccCHhhh-cCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-HHH----H---------HcC
Confidence 11 1111234578889999988 455688999999999999999999999964322111 111 1 111
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+...+......+.+++.+|++ +|.+||++.+++.
T Consensus 225 ~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 12233456667789999999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=290.03 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=201.9
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|++|.||++... ++..+|+|.+..... ......+.+|++++++++|+||+++++++......++||||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 466788999999999999854 688999999876432 234567888999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 762 SSGSLYKHLHDGSS-RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 762 ~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++++|.+++.+... ...+++..++.++.|++.|++|||+.|++|+||+|+||+++.++.+|++|||.+...... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~ 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----M 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC----C
Confidence 99999999876322 224889999999999999999999999999999999999999999999999999776442 2
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....+++.|+|||.. ....++.++|+||+|+++|||++|+.||...+... ....+ .. ......
T Consensus 158 ~~~~~~~~~~~~Pe~~-~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~~----~~---------~~~~~~ 221 (256)
T cd08530 158 AKTQIGTPHYMAPEVW-KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LRYKV----QR---------GKYPPI 221 (256)
T ss_pred cccccCCccccCHHHH-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH----hc---------CCCCCC
Confidence 2234578889999998 56678899999999999999999999997544321 11111 11 111223
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+...+.++.+++.+|++.+|++|||+.|+++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 3455677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=293.41 Aligned_cols=260 Identities=16% Similarity=0.182 Sum_probs=184.5
Q ss_pred hccCCCCccCCCCceEEEEEEeCCC----cEEEEEEeecCCccccH----------HHHHHHHHHHcCCCCCceeeeeeE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDG----RSVAIKKLTVSGLIKSQ----------EDFEKEMKTLGKIRHHNLVALEGY 747 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~l~~~~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~ 747 (967)
..|...+.||+|+||.||+|...++ ..+|+|........... .....+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4578899999999999999996643 45666654333211100 112234445667789999999997
Q ss_pred EEcCC----ceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEE
Q 002094 748 YWTPS----LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKV 823 (967)
Q Consensus 748 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl 823 (967)
+.... ..++++|++.. ++.+.+..... .++..+..++.|++.|++|||+++|+||||||+||+++.++.++|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKC---KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhcc---CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 65443 33677777643 56666554322 567888999999999999999999999999999999999999999
Q ss_pred eecccccccCCCccc-----cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHH
Q 002094 824 GDFGLARLLPMLDRC-----ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDM 898 (967)
Q Consensus 824 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~ 898 (967)
+|||+++.+...... .......||+.|+|||.. .+..++.++||||+||++|||++|+.||.............
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~-~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH-NGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999999766421111 111234689999999988 56678999999999999999999999997553322211111
Q ss_pred HHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 899 VRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
..+.+ ........ ....++.++.+++..|++.+|++||+++++++.++
T Consensus 247 ~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 247 KCDFI-----KRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHH-----HHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11110 01111111 12345677999999999999999999999998763
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=287.37 Aligned_cols=240 Identities=23% Similarity=0.273 Sum_probs=187.3
Q ss_pred cCCCCc--cCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEE
Q 002094 684 LNKDCE--LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~--lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 759 (967)
|+..+. +|+|+||.||+++.+ +++.+|+|.+....... . |+.....+ +||||+++++++..++..++|||
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 344444 599999999999954 68889999886543211 1 22222212 79999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC-CeEEeecccccccCCCccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG-EPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~ 838 (967)
|+++++|.+++.... .+++..+..++.|+++|++|||+.|++||||||+||+++.++ .++++|||.+.....
T Consensus 90 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~---- 162 (267)
T PHA03390 90 YIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT---- 162 (267)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC----
Confidence 999999999997654 389999999999999999999999999999999999999888 999999999875532
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.....++..|+|||++ ....++.++||||+|+++|||++|+.||.....+......+.... . ...
T Consensus 163 --~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-----------~~~ 227 (267)
T PHA03390 163 --PSCYDGTLDYFSPEKI-KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q-----------KKL 227 (267)
T ss_pred --CccCCCCCcccChhhh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c-----------ccC
Confidence 1234578899999998 556788999999999999999999999975443332222222211 0 011
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCC-HHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPD-MEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~evl~ 951 (967)
..+...+..+.+++.+|++.+|.+||+ ++|+++
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 223356677999999999999999996 588763
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=296.87 Aligned_cols=264 Identities=22% Similarity=0.293 Sum_probs=193.6
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCc-------
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSL------- 753 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 753 (967)
.|+..+.||+|+||.||+|..+ +++.||||.+..... ......+.+|++++++++||||+++++++.....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 3677889999999999999965 689999999865432 2223456789999999999999999999876543
Q ss_pred -eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccccccc
Q 002094 754 -QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLL 832 (967)
Q Consensus 754 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 832 (967)
.++||||+.+ ++.+.+..... .+++.+++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||.+...
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 4899999975 78888765432 3889999999999999999999999999999999999999999999999999766
Q ss_pred CCCccc--cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc---cCC
Q 002094 833 PMLDRC--ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE---DGR 907 (967)
Q Consensus 833 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~ 907 (967)
...... .......++..|+|||.......++.++|+||||+++|||++|+.||........ . ..+..... ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~ 247 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ-L-TLISQLCGSITPEV 247 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHHhCCCChhh
Confidence 432211 1112345677899999875555578899999999999999999999975432211 1 11111110 000
Q ss_pred chh-----hcch-hhcCC--------C-ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 908 VED-----CVDA-RLRGN--------F-PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 908 ~~~-----~~~~-~~~~~--------~-~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
... ..+. ..... . +......+.+++.+|++.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 0000 00000 0 1112345789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=297.17 Aligned_cols=247 Identities=22% Similarity=0.324 Sum_probs=208.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
..|...+.||+|.|+.|..|+.. ++..||+|.+.+... ......+.+|+++|..++|||||+++.+...+...|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 35688889999999999999954 699999999987764 2334558999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+.+|.+++++..... .....+..++.|+.+|++|+|++.|||||+|++||+++.+..+||+|||++..+. ...
T Consensus 136 ya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~~~ 209 (596)
T KOG0586|consen 136 YASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---YGL 209 (596)
T ss_pred eccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---ccc
Confidence 9999999999987765 4457888899999999999999999999999999999999999999999998874 334
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC-
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG- 918 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 918 (967)
......|++.|.|||++.+....++.+|+||+|+++|.|+.|..||+...- .+.-+..+++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------------------k~Lr~rvl~gk 271 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------------------KELRPRVLRGK 271 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc------------------ccccchheeee
Confidence 456788999999999997777788999999999999999999999974322 1111122222
Q ss_pred -CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 919 -NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 919 -~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..+.-...+..+++++++-.+|.+|++++++.+-
T Consensus 272 ~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 2344455678899999999999999999998653
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=286.03 Aligned_cols=247 Identities=25% Similarity=0.411 Sum_probs=202.4
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|++|.||+++.. +++.||+|.+...... .....+.+|++++++++|+|++++++++..+...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 566789999999999999865 5789999999766431 34568999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++.... .+++..+..++.|++.|++|||+.|++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 82 ~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 156 (254)
T cd06627 82 ENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DD 156 (254)
T ss_pred CCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--cc
Confidence 9999999987653 389999999999999999999999999999999999999999999999999987654222 12
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....++..|+|||.. ....++.++|+||+|+++|+|++|+.||........ ..... . ......+
T Consensus 157 ~~~~~~~~y~~pe~~-~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-~~~~~----~----------~~~~~~~ 220 (254)
T cd06627 157 ASVVGTPYWMAPEVI-EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-LFRIV----Q----------DDHPPLP 220 (254)
T ss_pred cccccchhhcCHhhh-cCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHh----c----------cCCCCCC
Confidence 345678889999988 445588999999999999999999999964432111 11110 0 1112234
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+..+.+++.+|++.+|++|||+.+++.
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 455678999999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=300.11 Aligned_cols=265 Identities=22% Similarity=0.284 Sum_probs=198.6
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCC-ccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcC--CceeE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSG-LIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTP--SLQLL 756 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~l 756 (967)
+.|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|+.+++++ +||||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 34677889999999999999965 58899999885432 123345678899999999 999999999998653 35799
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
||||++ ++|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+.......
T Consensus 87 v~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 87 VFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred Eecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 999997 4999888764 37889999999999999999999999999999999999999999999999998664432
Q ss_pred cc---cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhh----------
Q 002094 837 RC---ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGAL---------- 903 (967)
Q Consensus 837 ~~---~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~---------- 903 (967)
.. .......++..|+|||.+......+.++|+||||+++|+|++|+.||........ .........
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHH
Confidence 21 1223456788999999875666788999999999999999999999964332211 111111100
Q ss_pred ccCCchhhcch----hh--cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 904 EDGRVEDCVDA----RL--RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 904 ~~~~~~~~~~~----~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
......+..+. .. ........+.++.+++.+|++.||++|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000001100 00 001112256779999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=296.14 Aligned_cols=263 Identities=16% Similarity=0.251 Sum_probs=193.8
Q ss_pred CCccCCCCceEEEEEEeCCCcEEEEEEeecCC-ccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCc
Q 002094 687 DCELGRGGFGVVYRTILQDGRSVAIKKLTVSG-LIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGS 765 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 765 (967)
.+.+|.|+++.||++.. +++.||||++.... .....+.+.+|++++++++|+||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455556666666555 68999999997652 23456789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc-----cc
Q 002094 766 LYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-----IL 840 (967)
Q Consensus 766 L~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----~~ 840 (967)
|.+++....... +++..+..++.|++.||+|||+++|+||||||+||+++.++.++++|||.+......... ..
T Consensus 86 l~~~l~~~~~~~-~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 86 CEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 999998653332 788999999999999999999999999999999999999999999999988654321111 11
Q ss_pred cccccccccccCcccccCc-ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc----cCC-------c
Q 002094 841 SSKIQSALGYMAPEFACRT-VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE----DGR-------V 908 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~-~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~-------~ 908 (967)
.....++..|+|||++... ..++.++|+||+|+++|||++|+.||.......... +...+... ... .
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL-EKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCccccccCchhhhcCCc
Confidence 2234467789999988433 357889999999999999999999997544322211 11111100 000 0
Q ss_pred hh----hcch----hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 909 ED----CVDA----RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 909 ~~----~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.+ ..+. ............++.+++.+||+.||++|||++++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 0000 00111223345678899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=301.84 Aligned_cols=265 Identities=21% Similarity=0.306 Sum_probs=199.3
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEc----CCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWT----PSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 755 (967)
+.|+..+.||+|++|.||+|... +|+.||+|++..... ......+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 44677889999999999999954 689999999876432 2345677889999999999999999998753 34678
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+||||+. ++|.+++..... +++..+..++.||+.||+|||+++++||||||+||++++++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999996 589888865433 889999999999999999999999999999999999999999999999998765432
Q ss_pred ccc--cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhcc--------
Q 002094 836 DRC--ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALED-------- 905 (967)
Q Consensus 836 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 905 (967)
... .......++..|+|||.+.....++.++||||+|+++|||++|+.||...+.... ...+......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~--~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ--LKLILSVLGSPSEEVLNR 238 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH--HHHHHHHhCCChhHhhhh
Confidence 211 1112346788899999875555689999999999999999999999965432211 1111111110
Q ss_pred ---CCchhhcch-hhcCCC-----ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 906 ---GRVEDCVDA-RLRGNF-----PADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 906 ---~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..+.+..+. ...... .+..+.++.+++.+|++.+|++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 001111110 001111 12346779999999999999999999998763
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=294.16 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=194.6
Q ss_pred ccCCCCccCCCCceEEEEEEeCC-CcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|+..+.||+|++|.||+|..++ ++.||||.+...........+..|+.++.+. .||||+++++++.+....++||||
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 35778899999999999999765 8999999997654333455677788777666 599999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
+.+ ++.+.+..... .+++..+..++.|++.|++|||+ .||+||||+|+||+++.++.++|+|||.+.......
T Consensus 96 ~~~-~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~--- 169 (296)
T cd06618 96 MST-CLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK--- 169 (296)
T ss_pred cCc-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC---
Confidence 854 67776655332 38899999999999999999997 599999999999999999999999999987653211
Q ss_pred ccccccccccccCcccccCc---ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 840 LSSKIQSALGYMAPEFACRT---VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~---~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
......++..|+|||.+... ..++.++|+||||+++|||++|+.||.....+...+..+.... ..
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----~~------- 237 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-----PP------- 237 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-----CC-------
Confidence 12234567789999988332 3478899999999999999999999965333222222211110 00
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..+.....+.++.+++.+|++.||.+||+++++++.
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001112345679999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=318.71 Aligned_cols=258 Identities=27% Similarity=0.372 Sum_probs=214.4
Q ss_pred CCCCccCCCCceEEEEEEeC--------CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCcee
Q 002094 685 NKDCELGRGGFGVVYRTILQ--------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 755 (967)
...+.+|+|+||.|++|... ....||||.++......+.+.+..|+++++.+ +|+||+.++|+|...+..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 44558999999999999833 14579999998877666788999999999999 6999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCC---------C--C--CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeE
Q 002094 756 LIYEFISSGSLYKHLHDGS---------S--R--NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPK 822 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~---------~--~--~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~k 822 (967)
+|+||+..|+|.++++..+ . . ..++....+.++.|||.|++||+++++||||+..+||++.++..+|
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~k 458 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIK 458 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEE
Confidence 9999999999999998766 0 0 1278899999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCccccccccc-cccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHH
Q 002094 823 VGDFGLARLLPMLDRCILSSKI-QSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVR 900 (967)
Q Consensus 823 l~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 900 (967)
|+|||+|+.............. .-...|||||.+ ....++.++|||||||++||+++ |..||........ +.
T Consensus 459 IaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl-~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~-l~---- 532 (609)
T KOG0200|consen 459 IADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESL-FDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE-LL---- 532 (609)
T ss_pred EccccceeccCCCCceEecCCCCccceeecCHHHh-ccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH-HH----
Confidence 9999999966543333222111 123459999999 55789999999999999999999 9999976432211 12
Q ss_pred hhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 901 GALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
+.+..+.+.+.|..+..++.++|+.||+.+|++||++.|+++.++...
T Consensus 533 ---------~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 533 ---------EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred ---------HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 233445566678899999999999999999999999999999999854
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=286.81 Aligned_cols=250 Identities=23% Similarity=0.396 Sum_probs=204.7
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|++|.||++... ++..||+|++..... ......+.+|+++++.++|+|++++++.+...+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 566788999999999999965 689999999976543 245677899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 762 SSGSLYKHLHDGSS-RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 762 ~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++++|.+++..... ...+++..+..++.+++.|++|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 159 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DL 159 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--ce
Confidence 99999999987531 2348999999999999999999999999999999999999999999999999997664322 12
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....+++.|+|||.. ....++.++|+||+|+++++|++|+.||...... +....... ......
T Consensus 160 ~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~----------~~~~~~ 223 (258)
T cd08215 160 AKTVVGTPYYLSPELC-QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELALKILK----------GQYPPI 223 (258)
T ss_pred ecceeeeecccChhHh-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHHHHhc----------CCCCCC
Confidence 2345678889999987 5567889999999999999999999999644321 11111111 111223
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+...+..+.+++.+|++.+|++|||+.|+++
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 4456678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=299.37 Aligned_cols=269 Identities=23% Similarity=0.298 Sum_probs=201.4
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC-----Ccee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP-----SLQL 755 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~ 755 (967)
.|...+.||+|+||+||+++.. +++.||||.+..... ......+.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 4677889999999999999954 689999999875421 23455678899999999999999999988644 3479
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+||||+. ++|.+++..... +++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 86 IVYELMD-TDLHQIIRSSQT---LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEeCCC-CCHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 9999996 688888865432 889999999999999999999999999999999999999999999999999765432
Q ss_pred ccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc-----------
Q 002094 836 DRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE----------- 904 (967)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~----------- 904 (967)
. .......++..|+|||.+.....++.++|+||||+++|+|++|+.||...+.... ... +.....
T Consensus 162 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 162 G--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ-LKL-ITELLGSPSEEDLGFIR 237 (337)
T ss_pred c--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH-HHH-HHHHhCCCChHHhhhcC
Confidence 1 1223445778899999885545688999999999999999999999975432111 111 111000
Q ss_pred cCCchhhcchhh---c---CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH--HHhhcCC
Q 002094 905 DGRVEDCVDARL---R---GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI--LELIQSP 959 (967)
Q Consensus 905 ~~~~~~~~~~~~---~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~~~~~ 959 (967)
............ + ....+..+.++.+++.+|++.+|++|||++|+++. ++.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 000111110000 0 00123456778999999999999999999999876 6555433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-33 Score=272.21 Aligned_cols=246 Identities=22% Similarity=0.278 Sum_probs=191.7
Q ss_pred CCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEE----cCCceeEEEEe
Q 002094 687 DCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYW----TPSLQLLIYEF 760 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~----~~~~~~lv~e~ 760 (967)
.++||-|-.|.|..+..+ +++.+|+|++... ...++|++.--.. .|||||.+++++. ......+|||.
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 357999999999998854 6899999988633 3467788875444 6999999999875 34566799999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC---CCCeEEeecccccccCCCcc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS---SGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~---~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|+||.|.+.+.+.+... +++.++-.|++||+.|++|||+..|.||||||+|+|... +..+||+|||+|+.-..
T Consensus 141 meGGeLfsriq~~g~~a-fTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--- 216 (400)
T KOG0604|consen 141 MEGGELFSRIQDRGDQA-FTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--- 216 (400)
T ss_pred ccchHHHHHHHHccccc-chHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC---
Confidence 99999999998876654 999999999999999999999999999999999999964 45789999999985432
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
...-.....||-|.|||++ +...++..+|+||+||++|-|++|.+||..+.. ..+.-.++..+..+.+. + .
T Consensus 217 ~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~gqy~-F-----P 287 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRTGQYE-F-----P 287 (400)
T ss_pred CccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhccCcc-C-----C
Confidence 1223345568889999999 666799999999999999999999999985543 11222233333322111 0 0
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+-+...++...++|+.+++.+|++|.|+.|+++
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1112334667889999999999999999999875
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=301.83 Aligned_cols=259 Identities=20% Similarity=0.265 Sum_probs=195.2
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC------Cc
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP------SL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 753 (967)
+.|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.++++++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 45788899999999999999954 689999999865321 23445678899999999999999999988643 34
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++||||+.+ +|.+.+... ++...+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.+....
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 96 VYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 6899999965 888877542 6788999999999999999999999999999999999999999999999998654
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC-------
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG------- 906 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 906 (967)
.. .......++..|+|||.+ ....++.++||||+|+++|+|++|+.||...+... .....+. .+..+
T Consensus 170 ~~---~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~ 243 (353)
T cd07850 170 TS---FMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIE-QLGTPSDEFMSR 243 (353)
T ss_pred CC---CCCCCCcccccccCHHHH-hCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHH-hcCCCCHHHHHH
Confidence 31 112334578889999998 56678999999999999999999999997543211 1111110 00000
Q ss_pred ------------------Cchhhcchhh----cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 907 ------------------RVEDCVDARL----RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 907 ------------------~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
...+...... ....+...+..+.+++.+|++.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 000012345678999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=290.85 Aligned_cols=243 Identities=22% Similarity=0.348 Sum_probs=195.0
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCch
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSL 766 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 766 (967)
..||+|+||.||++..+ ++..||||++.... ......+.+|+.+++.++|+|++++++++..++..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 57999999999999864 68999999886433 33456799999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccccc
Q 002094 767 YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQS 846 (967)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 846 (967)
.+++... .+++..+..++.|++.|++|+|+.|++||||+|+||+++.++.++++|||.+....... .......+
T Consensus 105 ~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~ 178 (292)
T cd06657 105 TDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVG 178 (292)
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccccc
Confidence 9987543 27889999999999999999999999999999999999999999999999887553311 12234567
Q ss_pred cccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHH
Q 002094 847 ALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAI 926 (967)
Q Consensus 847 t~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (967)
++.|+|||.. ....++.++|+||+|+++|||++|..||....... ....+.... .... ......+.
T Consensus 179 ~~~y~~pE~~-~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--~~~~~~~~~---------~~~~--~~~~~~~~ 244 (292)
T cd06657 179 TPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRDNL---------PPKL--KNLHKVSP 244 (292)
T ss_pred CccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhhC---------Cccc--CCcccCCH
Confidence 8889999988 55678899999999999999999999996433211 111111110 0000 01123455
Q ss_pred HHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 927 PVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 927 ~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+.+++.+|++.+|.+||++.++++
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhc
Confidence 6889999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=286.32 Aligned_cols=245 Identities=22% Similarity=0.272 Sum_probs=189.6
Q ss_pred CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHH-HcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKT-LGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
+.||+|+||.||+|... +++.||+|.+..... ......+..|..+ ....+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999864 589999999865432 1122334555544 4455899999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
++|.+++..... +++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++..... ...
T Consensus 82 ~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~ 152 (260)
T cd05611 82 GDCASLIKTLGG---LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKK 152 (260)
T ss_pred CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------ccc
Confidence 999999976433 78899999999999999999999999999999999999999999999999875422 234
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
..+++.|+|||.. ....++.++||||+|+++|||++|..||...... .....+..... .........
T Consensus 153 ~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-----------~~~~~~~~~ 219 (260)
T cd05611 153 FVGTPDYLAPETI-LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVFDNILSRRI-----------NWPEEVKEF 219 (260)
T ss_pred CCCCcCccChhhh-cCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhccc-----------CCCCccccc
Confidence 4577889999998 4445899999999999999999999999754332 11111111100 001112234
Q ss_pred hHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 924 EAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
.+..+.+++.+|++.+|++||++.++.+.|.
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 5677999999999999999998876655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=291.34 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=200.1
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|++|.||++... +++.+|+|.+...... .....+.+|++++++++|++|+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999964 6889999998765432 34567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++ ++.+++.... ..+++..+..++.|++.|++|||+++++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPY 155 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccc
Confidence 75 8888887643 238899999999999999999999999999999999999999999999999987664422 122
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC---chhhcc-----
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR---VEDCVD----- 913 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~----- 913 (967)
....++..|+|||.......++.++|+||+|+++|+|++|+.||........ ..... ..+.... .....+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIF-RTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-HHcCCCchHhcccchhhhhhh
Confidence 3355778899999885444789999999999999999999999965443211 11111 1111000 000000
Q ss_pred ----hhhc----CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 914 ----ARLR----GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 914 ----~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+... ....+..+.++.+++.+|+++||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0112335678999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=289.98 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=197.1
Q ss_pred cCCCCccCCCCceEEEEEEe----CCCcEEEEEEeecCCc---cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCcee
Q 002094 684 LNKDCELGRGGFGVVYRTIL----QDGRSVAIKKLTVSGL---IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 755 (967)
|+..+.||+|+||.||++.. .+|..||+|++..... ....+.+.+|+++++++ +|++|+++++++......+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 56678899999999999985 3689999999875432 23346788999999999 5999999999999888999
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+||||+++++|.+++..... +++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLSQRER---FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999999976433 788999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcccccCc-ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 836 DRCILSSKIQSALGYMAPEFACRT-VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
.. .......|+..|+|||..... ...+.++||||||+++|+|++|+.||..... ......+......
T Consensus 159 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~---------- 226 (290)
T cd05613 159 EV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILK---------- 226 (290)
T ss_pred cc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhc----------
Confidence 11 122235578889999988432 3467899999999999999999999963221 1111122211111
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
...+++...+..+.+++.+|++.||++|| ++++++.
T Consensus 227 -~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 -SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01223455667799999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=292.50 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=195.5
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|+..+.||+|+||.||+|+.. ++..+|+|.+..... .....++.+|+++++.++|+|++++++++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 566778999999999999964 578899998864321 23345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+. |++.+.+..... .+++.++..++.|++.|++|||+++++||||+|+||+++.++.++++|||++.....
T Consensus 97 ~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------ 167 (308)
T cd06634 97 CL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167 (308)
T ss_pred cC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC------
Confidence 97 578777754332 378999999999999999999999999999999999999999999999999875432
Q ss_pred cccccccccccCccccc--CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 841 SSKIQSALGYMAPEFAC--RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~--~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.....+++.|+|||.+. ....++.++|||||||++|||++|+.||........ ...+... ....
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~-------------~~~~ 233 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQN-------------ESPA 233 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-HHHHhhc-------------CCCC
Confidence 22345778899999873 235678899999999999999999999864332111 1111110 0001
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
......+..+.+++.+|++.+|++||+++++++.-.
T Consensus 234 ~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 112345667899999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=291.32 Aligned_cols=257 Identities=23% Similarity=0.314 Sum_probs=200.5
Q ss_pred cCCCCccCCCCceEEEEEEe----CCCcEEEEEEeecCCc---cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCcee
Q 002094 684 LNKDCELGRGGFGVVYRTIL----QDGRSVAIKKLTVSGL---IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 755 (967)
|+..+.||+|++|.||+++. .+++.||||.++.... ....+.+.+|++++.++ +||+|+++++++..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 45677899999999999884 3578899999875422 23346788999999999 5999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+||||+++++|.+++.... .+++..+..++.|+++||+|||+.+++||||+|+||+++.++.++++|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999987543 2788999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcccccCcc-cCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 836 DRCILSSKIQSALGYMAPEFACRTV-KITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
.. .......++..|+|||...... ..+.++|+||+|+++|||++|..||...... ....++......
T Consensus 159 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~---------- 226 (288)
T cd05583 159 EE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILK---------- 226 (288)
T ss_pred cc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHHc----------
Confidence 21 1222345788999999873322 3678999999999999999999999632211 111112211111
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
.....+...+..+.+++.+|++.||++|||++++.+.|+..
T Consensus 227 -~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 227 -SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 01223444566789999999999999999999888877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=293.49 Aligned_cols=260 Identities=23% Similarity=0.281 Sum_probs=196.3
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEc-CCceeEE
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWT-PSLQLLI 757 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv 757 (967)
.+.|+..+.||+|+||.||++... +++.||||++..... ....+.+.+|++++++++||||+++++++.. ....++|
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 455788899999999999999854 789999998865432 2345678899999999999999999999865 4578899
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+ +++|.+++... .+++..+..++.|++.||+|||+.+++||||+|+||+++.++.++|+|||.+.....
T Consensus 89 ~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--- 160 (328)
T cd07856 89 TELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--- 160 (328)
T ss_pred eehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---
Confidence 9998 56888887642 267888889999999999999999999999999999999999999999999875422
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC-----------
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG----------- 906 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 906 (967)
......++..|+|||.+.....++.++|+||+|+++|+|++|+.||...... .....+. ......
T Consensus 161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSIIT-DLLGTPPDDVINTICSE 236 (328)
T ss_pred --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-HHhCCCCHHHHHhccch
Confidence 1123456778999998745467899999999999999999999999754321 1111111 111000
Q ss_pred Cchhhc-chhhcCCCC-----hhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 907 RVEDCV-DARLRGNFP-----ADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 907 ~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
...++. ........+ ...+..+.+++.+|++.+|++|||+++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000111111 2345779999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=294.63 Aligned_cols=261 Identities=25% Similarity=0.308 Sum_probs=196.0
Q ss_pred CCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccc-------------cHHHHHHHHHHHcCCCCCceeeeeeEEEc
Q 002094 685 NKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIK-------------SQEDFEKEMKTLGKIRHHNLVALEGYYWT 750 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 750 (967)
...+.||+|+||.||+|..+ +++.||||.+....... ....+.+|++++++++|+||+++++++..
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 34577999999999999954 68999999986543211 01257789999999999999999999999
Q ss_pred CCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 751 PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 751 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
.+..++||||++ |+|.+++..... +++.....++.|++.||+|||++|++|+||+|+||+++.++.++++|||.+.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRKIR---LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcccee
Confidence 999999999997 589998865433 7899999999999999999999999999999999999999999999999987
Q ss_pred ccCCCc------------cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHH
Q 002094 831 LLPMLD------------RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDM 898 (967)
Q Consensus 831 ~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~ 898 (967)
...... .........+++.|+|||.+.....++.++|+||+|+++|||++|+.||....... .+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-~~~~i 246 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID-QLGRI 246 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence 654110 01111233457789999988555567899999999999999999999997554322 11111
Q ss_pred HHhhhccCCchhhcchh-------hc-------CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 899 VRGALEDGRVEDCVDAR-------LR-------GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 899 ~~~~~~~~~~~~~~~~~-------~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
......+....+.... .. .......+.++.+++.+|++.+|++|||++|++.
T Consensus 247 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 247 -FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred -HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111110000000 00 0011234567899999999999999999999986
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=290.85 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=193.6
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+|...+.||+|+||.||+|+.. +++.||+|.+..... ......+.+|+++++.++|||++++++++.+....++|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 3555677999999999999954 688999999875432 2234578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+.+ ++.+++..... .+++.++..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 102 ~~~~-~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 102 YCLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred cCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 9964 77777754332 388999999999999999999999999999999999999999999999998864321
Q ss_pred ccccccccccccCccccc--CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 840 LSSKIQSALGYMAPEFAC--RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~--~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.....++..|+|||++. ....++.++||||||+++|||++|..||......... .... ... ..
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-~~~~----~~~---------~~ 238 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIA----QND---------SP 238 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHH----hcC---------CC
Confidence 22456788899999873 2456888999999999999999999998654322111 1111 000 00
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.......+..+.+++.+|++.+|.+||++.++++.
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122334568999999999999999999998853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=314.23 Aligned_cols=267 Identities=17% Similarity=0.241 Sum_probs=185.9
Q ss_pred hccCCCCccCCCCceEEEEEEeCC--CcEEEEEEe--------------ecC--CccccHHHHHHHHHHHcCCCCCceee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD--GRSVAIKKL--------------TVS--GLIKSQEDFEKEMKTLGKIRHHNLVA 743 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~l--------------~~~--~~~~~~~~~~~E~~~l~~l~h~niv~ 743 (967)
+.|+..+.||+|+||.||++..+. +..+++|.+ ... ........+.+|++++++++|||||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 457888999999999999987542 222222211 000 00123456889999999999999999
Q ss_pred eeeEEEcCCceeEEEEecCCCchhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCe
Q 002094 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSS--RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEP 821 (967)
Q Consensus 744 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~ 821 (967)
+++++..++..++|+|++.+ ++.+++..... ........+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~v 306 (501)
T PHA03210 228 IEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306 (501)
T ss_pred EeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 99999999999999999854 77777654321 1123456778899999999999999999999999999999999999
Q ss_pred EEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCC-CCCCCc-cchHhHHHHH
Q 002094 822 KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKR-PVEYME-DDVVVLCDMV 899 (967)
Q Consensus 822 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~-p~~~~~-~~~~~~~~~~ 899 (967)
||+|||++..+..... .......||..|+|||++ .+..++.++|||||||++|||++|.. ||.... .....+.+.+
T Consensus 307 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 307 VLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEIL-AGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred EEEeCCCceecCcccc-cccccccCCcCCCCchhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 9999999987643221 222346689999999998 55678999999999999999999875 444322 2222222222
Q ss_pred Hhhhc-cCC-------chhhcchhhcC----CC-----ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 900 RGALE-DGR-------VEDCVDARLRG----NF-----PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 900 ~~~~~-~~~-------~~~~~~~~~~~----~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...-. ... +.+.++..... .. ....+..+.+++.+|++.||++|||+.|+++
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 21100 000 00000000000 00 0112345778899999999999999999986
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=298.48 Aligned_cols=269 Identities=22% Similarity=0.275 Sum_probs=197.8
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC------c
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS------L 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~ 753 (967)
+.|...+.||+|+||.||+|+.. +|+.||||++..... ......+.+|+++++.++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 34677889999999999999954 689999999875432 223456889999999999999999999986542 4
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++|+||+.. ++.++... .+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++....
T Consensus 95 ~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEeccccc-CHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 5899999964 67665421 27889999999999999999999999999999999999999999999999987543
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHh----------hh
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRG----------AL 903 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~----------~~ 903 (967)
. ......++..|+|||.+.....++.++|||||||++|||++|+.||....... ........ ..
T Consensus 169 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 169 A-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred C-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHh
Confidence 2 12234567889999988554568899999999999999999999997543221 11111110 00
Q ss_pred ccCCchhhcchhh---cCC---CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH--HHhhcCCCCC
Q 002094 904 EDGRVEDCVDARL---RGN---FPADEAIPVIKLGLICASQVPSNRPDMEEVVNI--LELIQSPLDG 962 (967)
Q Consensus 904 ~~~~~~~~~~~~~---~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~~~~~~~~ 962 (967)
............. +.. ..+..+..+.+++.+|++.||++||+++|++.. ++.+++....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~ 309 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEE 309 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccccc
Confidence 0000000000000 000 011245568899999999999999999999854 7776654333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=292.87 Aligned_cols=265 Identities=24% Similarity=0.281 Sum_probs=194.2
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC-------
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS------- 752 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 752 (967)
+.|+..+.||+|+||.||+|+.+ +++.||||++...... .....+.+|++++++++||||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 34678889999999999999965 6899999998654321 22346788999999999999999999875433
Q ss_pred -ceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 753 -LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 753 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
..++||||+++ ++...+..... .+++..+..++.|+++||+|||++|++|+||||+||++++++.++|+|||++..
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~~~--~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENPSV--KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 45899999975 67777665332 389999999999999999999999999999999999999999999999999976
Q ss_pred cCCCcccc---------ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhh
Q 002094 832 LPMLDRCI---------LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGA 902 (967)
Q Consensus 832 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 902 (967)
........ ......+++.|+|||.+.+...++.++||||+|+++|||++|++||...... .....+.. .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~~-~ 242 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIFK-L 242 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-H
Confidence 54322111 1123456778999998755556889999999999999999999999744332 11111111 1
Q ss_pred hccCCchhhcch---------hhcCCCC-------hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 903 LEDGRVEDCVDA---------RLRGNFP-------ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 903 ~~~~~~~~~~~~---------~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
........+.+. ......+ ......+.+++.+|++.||++|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111000000000 0000000 122356889999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=289.22 Aligned_cols=261 Identities=22% Similarity=0.294 Sum_probs=194.1
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-ccHHHHHHHHHHHcCC---CCCceeeeeeEEEcCCc-----
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKI---RHHNLVALEGYYWTPSL----- 753 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~----- 753 (967)
|+..+.||+|+||.||+|+.+ ++..||+|.++..... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456778999999999999976 4899999999754321 1234566777766555 69999999999987766
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.+++|||+.+ +|.+++...... .+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKP-GLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 8999999975 898888764432 38999999999999999999999999999999999999999999999999987664
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch----
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE---- 909 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 909 (967)
... ......++..|+|||.. ....++.++|+||||+++|||++|++||..... ......+...........
T Consensus 159 ~~~---~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 159 FEM---ALTSVVVTLWYRAPEVL-LQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred CCc---ccccccccccccChHHh-ccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCCC
Confidence 321 12234467889999998 556788999999999999999999999974432 222222222111000000
Q ss_pred -----hhcchhhc---CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 910 -----DCVDARLR---GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 910 -----~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
........ .....+.+..+.+++.+|++.||++||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0011233567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=245.23 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=203.2
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|..-++||+|.||+||+|+. .+++.||+|+++.+.. ..-.....+|+-+++.++|.|||+++++...+...-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 45556899999999999994 4588999999987654 233567899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
+. +|..+....... ++.+.+..++.|+++|+.|.|++.+.|||+||.|.+++.+|+.|++|||+++-++..-. ..
T Consensus 84 dq-dlkkyfdslng~--~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr--cy 158 (292)
T KOG0662|consen 84 DQ-DLKKYFDSLNGD--LDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--CY 158 (292)
T ss_pred hH-HHHHHHHhcCCc--CCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--ee
Confidence 65 888887765443 88899999999999999999999999999999999999999999999999997764332 23
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHH--hhhccCC---chhhcchh
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVR--GALEDGR---VEDCVDAR 915 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~--~~~~~~~---~~~~~~~~ 915 (967)
+...-|..|++|+++.+.+-|++..|+||.||++.|+.. |++.|...+.+.+ +..+.+ +...+.. +....|-+
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq-lkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH-HHHHHHHhCCCccccCCccccCCCCc
Confidence 455668889999999888899999999999999999998 7777765544332 233322 2222211 22222222
Q ss_pred hcCCCCh---------hhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 916 LRGNFPA---------DEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 916 ~~~~~~~---------~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+.++. .....=.+++.+.+.-+|.+|.++++.++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2222222 11222357888899999999999998765
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=252.69 Aligned_cols=212 Identities=24% Similarity=0.333 Sum_probs=176.0
Q ss_pred CCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEecC
Q 002094 685 NKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.....||+|++|.|-+.+ ..+|...|||+++..-..+.+++..+|+.+..+. .+|++|.++|...+.+..++.||.|+
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 556789999999998877 4579999999998876667778899999987665 79999999999999999999999996
Q ss_pred CCchhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 763 SGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 763 ~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
. ||..+-+..- .....++.-.-+||..+.+||.|||++ .++|||+||+|||++.+|++|+||||++.++. ++..
T Consensus 129 t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~---dSiA 204 (282)
T KOG0984|consen 129 T-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV---DSIA 204 (282)
T ss_pred h-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh---hhhH
Confidence 5 7776654322 222478888889999999999999987 89999999999999999999999999998763 3444
Q ss_pred cccccccccccCcccccC---cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHH
Q 002094 841 SSKIQSALGYMAPEFACR---TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVR 900 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~---~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~ 900 (967)
.+...|-..|+|||.+.. ...|+-++||||+|+++.||.+++.||+.+..+-+.+.+.+.
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 445567778999998732 346889999999999999999999999988776665555553
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=289.67 Aligned_cols=248 Identities=21% Similarity=0.301 Sum_probs=201.2
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 759 (967)
|...+.||+|++|.||+++.+ ++..||+|.+..... ....+.+.+|+++++++. ||||+++++++...+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 567788999999999999965 689999999875332 233567889999999998 9999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc-
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC- 838 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 838 (967)
|+++++|.+++.... .+++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++++|||++.........
T Consensus 83 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 83 YAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 999999999997654 3899999999999999999999999999999999999999999999999998766432211
Q ss_pred -----------------cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHh
Q 002094 839 -----------------ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRG 901 (967)
Q Consensus 839 -----------------~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~ 901 (967)
.......++..|+|||.. ....++.++|+||+|++++++++|+.||...... ..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~-- 235 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-LTFQKIL-- 235 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHh-CCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHH--
Confidence 122234567889999987 5556889999999999999999999999744321 1111111
Q ss_pred hhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCH----HHHHH
Q 002094 902 ALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDM----EEVVN 951 (967)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~----~evl~ 951 (967)
.....++...+..+.+++.+|++.+|.+|||+ +++++
T Consensus 236 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 -------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11223444556779999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=295.38 Aligned_cols=258 Identities=23% Similarity=0.280 Sum_probs=194.3
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC------c
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS------L 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~ 753 (967)
+.|+..+.||+|+||.||++.. .++..||||++..... ......+.+|++++++++||||+++++++.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 4578888999999999999984 4689999999864322 223456889999999999999999999886543 3
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++||||+ +++|.+++... .+++..+..++.|++.|++|||+.||+||||||+||+++.++.++++|||.+....
T Consensus 95 ~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 58999998 67998887642 27899999999999999999999999999999999999999999999999987553
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc---------
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE--------- 904 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~--------- 904 (967)
. ......+++.|+|||.+.....++.++|+||+|+++|++++|+.||...... ............
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 170 S-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred c-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHhh
Confidence 2 1223456788999998854456889999999999999999999999744322 111111111000
Q ss_pred -cCCchhhcch--hhc----CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHH
Q 002094 905 -DGRVEDCVDA--RLR----GNFPADEAIPVIKLGLICASQVPSNRPDMEEVV 950 (967)
Q Consensus 905 -~~~~~~~~~~--~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl 950 (967)
.......... ... .......+..+.+++.+|++.||++|||+.+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000000000 000 011234456689999999999999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=293.07 Aligned_cols=270 Identities=24% Similarity=0.308 Sum_probs=205.6
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC-----ceeE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS-----LQLL 756 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l 756 (967)
|+..+.||+|++|.||+|... ++..||+|++..... ....+.+.+|+++++.++|+||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 567789999999999999965 489999999876432 344578999999999999999999999987765 7899
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
||||+++ +|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+.......
T Consensus 82 v~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 82 VTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred Eecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 9999984 8988887654 38999999999999999999999999999999999999999999999999998765422
Q ss_pred cc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC--------
Q 002094 837 RC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR-------- 907 (967)
Q Consensus 837 ~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 907 (967)
.. .......++..|+|||.+.....++.++|+||+|+++|+|++|++||........ ... +........
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~-i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNL-IVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHH-HHHhcCCCChhHhhhcc
Confidence 10 1123445788899999984444789999999999999999999999975443211 111 111111000
Q ss_pred ---chhhcchh-h-----cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH--HHhhcCC
Q 002094 908 ---VEDCVDAR-L-----RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI--LELIQSP 959 (967)
Q Consensus 908 ---~~~~~~~~-~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~~~~~ 959 (967)
..+.+... . ........+..+.+++.+|++.+|.+|||++++++. ++++..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 00111100 0 000122346678999999999999999999999984 6666654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=284.29 Aligned_cols=261 Identities=26% Similarity=0.328 Sum_probs=199.0
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
|+..+.||+|++|.||+|+.. +++.||+|.+..... ....+.+..|++++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 345678999999999999966 489999999976542 233567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
+ ++|.+++..... .+++..+.+++.|++.|++|||++|++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~-~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPG--PLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TY 155 (282)
T ss_pred C-cCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--cc
Confidence 8 489999986532 388999999999999999999999999999999999999999999999999876543221 22
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchh------h--cc
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVED------C--VD 913 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~--~~ 913 (967)
....++..|+|||.+.....++.++||||+|+++||+++|++||...... ..+..+.. ......... . .+
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQ-ILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHH-HhCCCcHHHHHhhccccccc
Confidence 23445677999998855557899999999999999999999999654322 11111111 111000000 0 00
Q ss_pred hhhcC-------CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 914 ARLRG-------NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 914 ~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..... ...+..+..+.+++.+|+..||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 001123567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=283.21 Aligned_cols=249 Identities=22% Similarity=0.303 Sum_probs=193.4
Q ss_pred cCCCCccCCCCceEEEEEEeCC-CcEEEEEEeecCC----ccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQD-GRSVAIKKLTVSG----LIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
|...+.||+|+||.||+++... +..+++|.++... ......++..|+.+++.++||||+++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 5677899999999999998653 4455566554321 1223446778999999999999999999999888999999
Q ss_pred EecCCCchhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 759 EFISSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
||+++++|.+++.... ....+++..+..++.|++.|++|||++|++|+||+|+||+++. +.++++|||.+.......
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~- 159 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC- 159 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc-
Confidence 9999999999887532 2234899999999999999999999999999999999999975 569999999987654321
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.......+++.|+|||.. ....++.++|+||+|+++|+|++|..||...... ........ ...
T Consensus 160 -~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~----------~~~ 222 (260)
T cd08222 160 -DLATTFTGTPYYMSPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-----SVVLRIVE----------GPT 222 (260)
T ss_pred -ccccCCCCCcCccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHc----------CCC
Confidence 223345578889999987 5567888999999999999999999999643221 11111110 111
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+...+.++.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 2234456678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=295.12 Aligned_cols=262 Identities=21% Similarity=0.269 Sum_probs=193.2
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC---------
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP--------- 751 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------- 751 (967)
..|...+.||+|+||.||+|... +|..||+|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 34677889999999999999964 588999999876542 4556788999999999999999999876543
Q ss_pred -----CceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC-CCCeEEee
Q 002094 752 -----SLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS-SGEPKVGD 825 (967)
Q Consensus 752 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~-~~~~kl~D 825 (967)
...++||||++ ++|.+++... .+++..+..++.||+.|++|||+.|++||||||+||+++. ++.++++|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 34689999997 4888887542 2789999999999999999999999999999999999984 56789999
Q ss_pred cccccccCCCccc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc
Q 002094 826 FGLARLLPMLDRC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE 904 (967)
Q Consensus 826 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 904 (967)
||.+......... .......++..|+|||.......++.++||||+||++|||++|+.||........ ........ .
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~-~ 236 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESV-P 236 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhc-C
Confidence 9998765321111 1112345677899999875556788899999999999999999999975433211 11111100 0
Q ss_pred cCCc---h-------hhcc-hhhcC-----CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 905 DGRV---E-------DCVD-ARLRG-----NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 905 ~~~~---~-------~~~~-~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.... . .... ..... ......+.++.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000 0 0000 00000 011234567889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=294.73 Aligned_cols=260 Identities=20% Similarity=0.247 Sum_probs=193.6
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC------Cc
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP------SL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 753 (967)
+.|+..+.||+|+||.||+|.. .+++.||+|++..... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 4568888999999999999985 4689999999875421 23346688899999999999999999987543 34
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.+++++++ +++|.+++... .+++..+..++.|+++|++|||++||+||||||+||+++.++.++|+|||++....
T Consensus 97 ~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred EEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 57788876 77998887643 27899999999999999999999999999999999999999999999999987543
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc---------
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE--------- 904 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~--------- 904 (967)
. ......++..|+|||.......++.++||||+|+++|||++|+.||...... .......+....
T Consensus 172 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 172 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred c-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHhhc
Confidence 2 1223457788999998755456888999999999999999999999644322 112222111100
Q ss_pred -cCCchhhcc---hhhcC---CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 905 -DGRVEDCVD---ARLRG---NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 905 -~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
......+.. ..... ......+.++.+++.+|++.||++||++.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000 00000 0011235568999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=276.38 Aligned_cols=237 Identities=27% Similarity=0.349 Sum_probs=194.6
Q ss_pred cCCCCceEEEEEEeC-CCcEEEEEEeecCCcc--ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCch
Q 002094 690 LGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSL 766 (967)
Q Consensus 690 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 766 (967)
||+|+||.||++... +++.||+|.+...... ...+.+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 5899999998765432 2456889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccccc
Q 002094 767 YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQS 846 (967)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 846 (967)
.+++..... +++..+..++.|++.|+.|+|+.+++|+||+|+||+++.++.++++|||.+....... .......+
T Consensus 81 ~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEGR---FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCG 155 (250)
T ss_pred HHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcC
Confidence 999976543 7899999999999999999999999999999999999999999999999987654321 12334567
Q ss_pred cccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHH
Q 002094 847 ALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAI 926 (967)
Q Consensus 847 t~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (967)
+..|+|||.. .....+.++|+||||+++||+++|+.||...+.. . ....... .....+...+.
T Consensus 156 ~~~~~~Pe~~-~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~----~~~~~~~-----------~~~~~~~~~~~ 218 (250)
T cd05123 156 TPEYLAPEVL-LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK-E----IYEKILK-----------DPLRFPEFLSP 218 (250)
T ss_pred CccccChHHh-CCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-H----HHHHHhc-----------CCCCCCCCCCH
Confidence 8889999988 5556888999999999999999999999644321 1 1111111 11223444567
Q ss_pred HHHHHHHhhccCCCCCCCCHHH
Q 002094 927 PVIKLGLICASQVPSNRPDMEE 948 (967)
Q Consensus 927 ~l~~li~~cl~~dP~~Rpt~~e 948 (967)
.+.+++.+|+..||++||++.+
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCccc
Confidence 7999999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=274.91 Aligned_cols=239 Identities=24% Similarity=0.337 Sum_probs=196.4
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccc--cHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIK--SQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 759 (967)
|+...+||+|+||.|..+..+ +.+.+|||+++++-..+ +.+--..|-++++.- +-|.+++++.+++..+..|+|||
T Consensus 351 FnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVME 430 (683)
T KOG0696|consen 351 FNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVME 430 (683)
T ss_pred cceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEE
Confidence 355789999999999999866 45789999998765432 223345566777666 57899999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+.||+|--+++.... +-+..+.-+|.+||.||-+||++||++||+|..|||+|.+|++||+|||++..-- -...
T Consensus 431 yvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--~~~~ 505 (683)
T KOG0696|consen 431 YVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--FDGV 505 (683)
T ss_pred EecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc--cCCc
Confidence 9999999998887665 6678888999999999999999999999999999999999999999999986432 2223
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......|||.|+|||.+ ...+|+.++|+|||||++|||+.|++||+..+++ ..+..++.. .-.
T Consensus 506 TTkTFCGTPdYiAPEIi-~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-elF~aI~eh---------------nvs 568 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQAIMEH---------------NVS 568 (683)
T ss_pred ceeeecCCCcccccceE-EecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHc---------------cCc
Confidence 44578899999999998 6678999999999999999999999999865543 223222221 234
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCC
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRP 944 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rp 944 (967)
+|...+.+...+.+..+.+.|.+|.
T Consensus 569 yPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 569 YPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred CcccccHHHHHHHHHHhhcCCcccc
Confidence 7888888999999999999999985
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=290.07 Aligned_cols=263 Identities=22% Similarity=0.259 Sum_probs=191.7
Q ss_pred cCCCCccCCCCceEEEEEEeC-C--CcEEEEEEeecCCc-cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcC----Cce
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-D--GRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTP----SLQ 754 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~~ 754 (967)
|+..+.||+|+||.||+++.. . +..||+|++..... ....+.+.+|+++++++ +||||+++++++... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 456778999999999999965 3 67899999865322 22356788899999999 599999999875432 456
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
++++||+. ++|.+++..... +++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.....
T Consensus 82 ~~~~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 82 YLYEELME-ADLHQIIRSGQP---LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEeccc-CCHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 78888886 589888865433 88999999999999999999999999999999999999999999999999976543
Q ss_pred Cccc--cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhh----------
Q 002094 835 LDRC--ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGA---------- 902 (967)
Q Consensus 835 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~---------- 902 (967)
.... .......|+..|+|||.......++.++|+||+|+++|++++|++||...... ..+...+...
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence 2211 11223567889999998745456889999999999999999999999754321 1111111100
Q ss_pred hccCCchhhcch---hhc---CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 903 LEDGRVEDCVDA---RLR---GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 903 ~~~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+........... ... ....+..+..+.+++.+|++.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 000 0011223567999999999999999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=290.93 Aligned_cols=237 Identities=22% Similarity=0.310 Sum_probs=191.7
Q ss_pred ccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|.....+|.|+|+.|-++.. .+++..+||++.... .+-.+|+.++.+. +||||+++++.+.++.+.|+|||+
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 356667799999999998884 468899999997652 3345677666665 799999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEe-CCCCCeEEeecccccccCCCcccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLI-DSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill-~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
+.|+-+.+.+..... .. ..+..|+++|+.|+.|||++||||||+||+|||+ +..++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred ccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 999887777765443 23 6778899999999999999999999999999999 68999999999999866432
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
.....-|..|.|||+. ....+++++|+||+|++||+|++|+.||...+.+.... ..+. .+.
T Consensus 470 -~~tp~~t~~y~APEvl-~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~-----~~i~------------~~~ 530 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVL-AIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH-----TRIQ------------MPK 530 (612)
T ss_pred -hcccchhhcccChhhh-ccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH-----Hhhc------------CCc
Confidence 2233456779999999 57789999999999999999999999998665542211 1111 223
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+....+.+..+|+.+|++.||.+||+|+++..
T Consensus 531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 33556678999999999999999999999865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=264.23 Aligned_cols=266 Identities=24% Similarity=0.352 Sum_probs=199.1
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEc--------CCc
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWT--------PSL 753 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~~ 753 (967)
|....+||+|.||.||+|+.+ .|+.||+|++-.+.. ..-.....+|++++..++|+|++.+++.|.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 455668999999999999955 578899987755432 2234567899999999999999999888753 244
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++||++|+. +|...+.....+ ++..++.++++++..||.|+|+..|+|||+|+.||+++.+|.+||+|||+++.+.
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~vr--~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKVR--FSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCcccc--ccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 7899999987 888888765433 8899999999999999999999999999999999999999999999999997664
Q ss_pred CCcccc--ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHh-HHHHHHhhhccCCchh
Q 002094 834 MLDRCI--LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVV-LCDMVRGALEDGRVED 910 (967)
Q Consensus 834 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 910 (967)
...... ..+...-|..|++||.+.+...++++.|||+.||++.||+|+.+.+....+..+. +..-.-+-+....+.+
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 322221 2234445888999999999999999999999999999999999998765543321 1111111111111111
Q ss_pred hcchhhc----------CCC--------ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 911 CVDARLR----------GNF--------PADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 911 ~~~~~~~----------~~~--------~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
+.+-.+. +++ |-....+..+++.+++..||++|+++++++..
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1111110 010 11112367899999999999999999998754
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=294.69 Aligned_cols=258 Identities=22% Similarity=0.274 Sum_probs=195.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCc------
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSL------ 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 753 (967)
+.|+..+.||+|++|.||+|... ++..||||++..... ......+.+|+.++++++|+|++++++++...+.
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 34677889999999999999965 578999998865421 2334667889999999999999999998765554
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++|+||+ +++|.+++... .+++..+..++.|++.|++|||+.||+||||+|+||+++.++.++|+|||.+....
T Consensus 95 ~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 95 VYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 79999998 56999988752 38999999999999999999999999999999999999999999999999997653
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC-------
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG------- 906 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 906 (967)
.. .....++..|+|||.......++.++||||+|+++||+++|+.||....... .+..+... ....
T Consensus 170 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~-~~~~~~~~~~~ 242 (343)
T cd07851 170 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNL-VGTPDEELLQK 242 (343)
T ss_pred cc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHh-cCCCCHHHHhh
Confidence 21 2334567889999987554578899999999999999999999997543321 11111110 0000
Q ss_pred ----Cchhhcchhh---cCC---CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 907 ----RVEDCVDARL---RGN---FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 907 ----~~~~~~~~~~---~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+.... +.. .....+.++.+++.+|++.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000 000 01123667999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=282.63 Aligned_cols=245 Identities=24% Similarity=0.357 Sum_probs=195.4
Q ss_pred CCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 686 KDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 686 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
.++.||.|.||+||-|+++ +|+.||||++.+..- .+....+++|+.+++.+.||.||.+...|+.++..++|||.+.|
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 4678999999999999954 799999999977654 34567899999999999999999999999999999999999966
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC---CCeEEeecccccccCCCccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS---GEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+..+++-..... .+++.....++.||+.||+|||.++|+|+|+||+|||+.+. .++||||||.|++.+. ...
T Consensus 648 -DMLEMILSsEkg-RL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksF 722 (888)
T KOG4236|consen 648 -DMLEMILSSEKG-RLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSF 722 (888)
T ss_pred -hHHHHHHHhhcc-cchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch---hhh
Confidence 555555433222 38888888899999999999999999999999999999643 3799999999998864 234
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
...+.|||.|.|||++ +.+.|...-|+||.||++|-=++|..||...++- . ..++.. . ..+...-
T Consensus 723 RrsVVGTPAYLaPEVL-rnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI----n----dQIQNA---a---FMyPp~P 787 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVL-RNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI----N----DQIQNA---A---FMYPPNP 787 (888)
T ss_pred hhhhcCCccccCHHHH-hhccccccccceeeeEEEEEEecccccCCCccch----h----HHhhcc---c---cccCCCc
Confidence 5678899999999999 7778999999999999999999999999533221 0 111111 0 0112222
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVV 950 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl 950 (967)
+.+...+..++|...++..-.+|-|.+..+
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 345567789999999999988898876544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=273.44 Aligned_cols=221 Identities=21% Similarity=0.243 Sum_probs=177.2
Q ss_pred CCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCchhhhhh
Q 002094 693 GGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLH 771 (967)
Q Consensus 693 G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 771 (967)
|.+|.||++... +++.||+|++.... .+.+|...+....||||+++++++.+....++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999954 68999999986542 23445555556679999999999999999999999999999999987
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccccccccccc
Q 002094 772 DGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYM 851 (967)
Q Consensus 772 ~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 851 (967)
.... +++..+..++.|++.||+|+|++|++||||||+||+++.++.++++|||.+...... .....++..|+
T Consensus 78 ~~~~---l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~ 149 (237)
T cd05576 78 KFLN---IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC 149 (237)
T ss_pred HhcC---CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence 6433 889999999999999999999999999999999999999999999999987654321 12234566799
Q ss_pred CcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHH
Q 002094 852 APEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKL 931 (967)
Q Consensus 852 aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 931 (967)
|||.. ....++.++|+||+|+++|||++|+.|+....... ........+...+..+.++
T Consensus 150 aPE~~-~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~l 208 (237)
T cd05576 150 APEVG-GISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------------NTHTTLNIPEWVSEEARSL 208 (237)
T ss_pred CCccc-CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------------ccccccCCcccCCHHHHHH
Confidence 99988 55678899999999999999999998875322110 0000112334456678999
Q ss_pred HHhhccCCCCCCCCHHH
Q 002094 932 GLICASQVPSNRPDMEE 948 (967)
Q Consensus 932 i~~cl~~dP~~Rpt~~e 948 (967)
+.+|++.||++||++.+
T Consensus 209 i~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 209 LQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHccCCHHHhcCCCc
Confidence 99999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=306.41 Aligned_cols=145 Identities=26% Similarity=0.340 Sum_probs=129.8
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||+|... +++.||||+++.... ......+..|+.+++.++||||+++++++......++|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 4677889999999999999966 689999999975432 2234678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
|+.+++|.+++..... +++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~~~~---l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHIYGY---FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999976433 7889999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=301.91 Aligned_cols=249 Identities=21% Similarity=0.246 Sum_probs=201.7
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|.+.++||+|+||.|..++.+ .++.||+|++.+... .....-|..|-.+|..-+.+=||.++-.|.++...|+|||
T Consensus 76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd 155 (1317)
T KOG0612|consen 76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD 155 (1317)
T ss_pred hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence 4588899999999999999965 588999999976432 2345678999999999899999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|++||+|-..+..... +++..+..++..|+-||.-+|+.|+|||||||+|||+|..|++||+|||.+-.+.. +...
T Consensus 156 Y~pGGDlltLlSk~~~---~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~-dG~V 231 (1317)
T KOG0612|consen 156 YMPGGDLLTLLSKFDR---LPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA-DGTV 231 (1317)
T ss_pred cccCchHHHHHhhcCC---ChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC-CCcE
Confidence 9999999999987662 88899999999999999999999999999999999999999999999999887764 4445
Q ss_pred ccccccccccccCccccc---Cc-ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 840 LSSKIQSALGYMAPEFAC---RT-VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~---~~-~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
......|||-|++||++. .+ +.|++.+|+||+||++|||+.|.-||....- ...+..++.. +
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl-veTY~KIm~h-------------k 297 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL-VETYGKIMNH-------------K 297 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH-HHHHHHHhch-------------h
Confidence 566788999999999873 12 6789999999999999999999999963221 1222222221 1
Q ss_pred hcCCCC--hhhHHHHHHHHHhhccCCCCCCCC---HHHHH
Q 002094 916 LRGNFP--ADEAIPVIKLGLICASQVPSNRPD---MEEVV 950 (967)
Q Consensus 916 ~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt---~~evl 950 (967)
-.-.+| .+.+.+..+||.+.+. +|+.|.. ++++.
T Consensus 298 ~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 298 ESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred hhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 112234 4467789999998875 4667765 66654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=259.22 Aligned_cols=245 Identities=21% Similarity=0.289 Sum_probs=200.8
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 759 (967)
|+..++||+|+|+.|..++++ ..+.||+|+++++-. .++...++.|-.+..+. +||.+|-++.+|..+...++|.|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 477889999999999999854 578899999876532 33455677787777776 79999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|++||+|--++++++. ++++++.-+..+|+-||.|||++||++||+|..||++|..|++|+.|+|.++.-- ....
T Consensus 332 yv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l--~~gd 406 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--GPGD 406 (593)
T ss_pred EecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC--CCCc
Confidence 9999999777766555 8999999999999999999999999999999999999999999999999986432 2333
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCC--CCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVE--YMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
..+...|||.|+|||.+ ++..|...+|+|++||+++||+.|+.||+ .++.....-.++....+-+. +
T Consensus 407 ~tstfcgtpnyiapeil-rgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek----------q 475 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEIL-RGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK----------Q 475 (593)
T ss_pred ccccccCCCcccchhhh-cccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh----------c
Confidence 45678999999999998 77799999999999999999999999998 44444444444444333221 1
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCC
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRP 944 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rp 944 (967)
...|...+.....+++..+++||++|.
T Consensus 476 iriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 IRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ccccceeehhhHHHHHHhhcCCcHHhc
Confidence 224566666778899999999999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=264.42 Aligned_cols=261 Identities=22% Similarity=0.275 Sum_probs=197.6
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCC--CC----ceeeeeeEEEcCCc
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR--HH----NLVALEGYYWTPSL 753 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~~~~~~~~~~~ 753 (967)
.+.|.+...+|+|.||.|-++..+ .+..||||+++.-. +-.+...-|+++++++. .| -+|.+.+|+.-.++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 345788889999999999999854 47899999987543 33456778899999983 22 37889999999999
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC----------------
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS---------------- 817 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~---------------- 817 (967)
.++|+|.+ |-|+.+++....-.. ++..++..|++|++++++|||+.+++|.|+||+||++.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~-fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIP-FPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccc-cchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 99999988 569999998765443 899999999999999999999999999999999999932
Q ss_pred ----CCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccch-
Q 002094 818 ----SGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDV- 892 (967)
Q Consensus 818 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~- 892 (967)
...++++|||.|++... ..+....|-.|+|||++ -+-.++.++||||+||||+|+++|...|...++-+
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEVi-LgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVI-LGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred ccCCCcceEEEecCCcceecc-----CcceeeeccccCCchhe-eccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 12489999999985432 23567788899999999 56689999999999999999999999998555322
Q ss_pred HhHHHHHHhhhccCCch-----hhcchh-h---------------c--------CCCChhhHHHHHHHHHhhccCCCCCC
Q 002094 893 VVLCDMVRGALEDGRVE-----DCVDAR-L---------------R--------GNFPADEAIPVIKLGLICASQVPSNR 943 (967)
Q Consensus 893 ~~~~~~~~~~~~~~~~~-----~~~~~~-~---------------~--------~~~~~~~~~~l~~li~~cl~~dP~~R 943 (967)
-.+++.+-+.+...-+. ..+..+ + + ......+..++.+|+++|+..||++|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 22222222211100000 000000 0 0 01123456679999999999999999
Q ss_pred CCHHHHHH
Q 002094 944 PDMEEVVN 951 (967)
Q Consensus 944 pt~~evl~ 951 (967)
+|+.|++.
T Consensus 398 iTl~EAL~ 405 (415)
T KOG0671|consen 398 ITLREALS 405 (415)
T ss_pred ccHHHHhc
Confidence 99999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-31 Score=276.82 Aligned_cols=240 Identities=23% Similarity=0.328 Sum_probs=200.9
Q ss_pred CCCCccCCCCceEEEEEEeCCCc-EEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 685 NKDCELGRGGFGVVYRTILQDGR-SVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+....||-||||.|=.+..+... .+|+|.+++... .+..+.+..|-.+|...+.|.||++|.-|.+....|+.||-|
T Consensus 423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC 502 (732)
T KOG0614|consen 423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC 502 (732)
T ss_pred hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence 44557999999999998876443 489998877654 345678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
-||.+...+++... ++..++.-++..+++|++|||++|||+||+||+|.++|.+|.+||.|||+|+....... .
T Consensus 503 lGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---T 576 (732)
T KOG0614|consen 503 LGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---T 576 (732)
T ss_pred cCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc---e
Confidence 99999999988765 78888888999999999999999999999999999999999999999999998864333 3
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
-.+.|||.|.|||.+. ++....++|.||+|+++|||++|.+||...+. ...+..+.++.- ...+|
T Consensus 577 wTFcGTpEYVAPEIIL-nKGHD~avDyWaLGIli~ELL~G~pPFs~~dp-mktYn~ILkGid-------------~i~~P 641 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIIL-NKGHDRAVDYWALGILIYELLTGSPPFSGVDP-MKTYNLILKGID-------------KIEFP 641 (732)
T ss_pred eeecCCcccccchhhh-ccCcchhhHHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHhhhh-------------hhhcc
Confidence 3678999999999994 44678899999999999999999999975443 333333333321 23456
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCC
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPD 945 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt 945 (967)
........++|++.+...|.+|.-
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhc
Confidence 677778999999999999999975
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=283.41 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=202.7
Q ss_pred cCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEE-----cCCceeE
Q 002094 684 LNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYW-----TPSLQLL 756 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~~l 756 (967)
|++.++||.|.+|.||+++ .++++.+|||+..... +..++++.|.++++.. .|||++.++|++. .+++.|+
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 4667889999999999999 5578999999887664 4567889999999888 6999999999985 3578899
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
|||||.+||..++++... ...+.|..+..|++.++.|+.|||...++|||||-.||+++.++.||++|||.+.....
T Consensus 99 VMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds-- 175 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS-- 175 (953)
T ss_pred EeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec--
Confidence 999999999999998876 34599999999999999999999999999999999999999999999999999987653
Q ss_pred cccccccccccccccCcccccCc----ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc
Q 002094 837 RCILSSKIQSALGYMAPEFACRT----VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV 912 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~----~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (967)
.........|||.|||||++... ..++..+|+||+|++..||..|.+|+..+-.-.. .+. +..-.
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra--------LF~---IpRNP 244 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA--------LFL---IPRNP 244 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--------hcc---CCCCC
Confidence 22344567899999999998432 3467789999999999999999999875543211 110 00111
Q ss_pred chhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 913 DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 913 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
-+++ ..|..=..++.++|..|+.+|.++||++.++++
T Consensus 245 PPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 245 PPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred Cccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111 123444677999999999999999999998875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=289.04 Aligned_cols=248 Identities=25% Similarity=0.324 Sum_probs=190.8
Q ss_pred hccCCCCccCCCCceE-EEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGV-VYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.++...+.+|.|+.|+ ||+|... |+.||||++... ......+|+..++.- +|||||++++.-.++...|+..|
T Consensus 509 ~~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 509 LFFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eeeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 3456667899999987 8999986 899999988643 355678999999887 69999999999889999999999
Q ss_pred ecCCCchhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC---C--CCeEEeecccccccC
Q 002094 760 FISSGSLYKHLHDGSSR-NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS---S--GEPKVGDFGLARLLP 833 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~-~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~---~--~~~kl~Dfg~a~~~~ 833 (967)
.|.- +|.+++...... ........+.+..|++.|++|||+.+|||||+||.||||+. + .+++|+|||+++..+
T Consensus 584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 9965 999999874111 11122445778999999999999999999999999999975 3 468999999999887
Q ss_pred CCccccc-cccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhh
Q 002094 834 MLDRCIL-SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911 (967)
Q Consensus 834 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (967)
....+.. .....||.+|+|||++ .....+.++||||+||++|+.++ |.+||+.....+. .++.+......
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L-~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~---NIl~~~~~L~~---- 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQL-REDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA---NILTGNYTLVH---- 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHH-hccccCcccchhhcCceEEEEecCCccCCCchHHhhh---hhhcCccceee----
Confidence 5443332 3467899999999999 55566789999999999999999 5999974332211 12221111100
Q ss_pred cchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 912 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+. ...++ +..+||.+|+++||..||+|.+|+.
T Consensus 735 ----L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 ----LE--PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ----ec--cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 11122 7889999999999999999999873
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=262.92 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=194.6
Q ss_pred cCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCc-cc-----cHHHHHHHHHHHcCCCCCceeeeeeEEE-cCCcee
Q 002094 684 LNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGL-IK-----SQEDFEKEMKTLGKIRHHNLVALEGYYW-TPSLQL 755 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~-~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~ 755 (967)
|-...+||+|||+.||++. ....+.||||+-..... .+ -.+...+|.++-+.+.||.||++++|+. +.+.+|
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 3445679999999999998 45678899997654322 11 1245778999999999999999999997 556778
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCCCCEEeC---CCCCeEEeeccccc
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT--NIIHYNLKSTNVLID---SSGEPKVGDFGLAR 830 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~--~ivH~Dik~~Nill~---~~~~~kl~Dfg~a~ 830 (967)
-|.|||+|.+|+-+++..+. +++.++..|+.||+.||.||.+. +|+|-|+||.|||+- .-|.+||.|||+++
T Consensus 545 TVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 99999999999999987665 78999999999999999999986 799999999999994 45789999999999
Q ss_pred ccCCCccc-----cccccccccccccCcccccCc---ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhh
Q 002094 831 LLPMLDRC-----ILSSKIQSALGYMAPEFACRT---VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGA 902 (967)
Q Consensus 831 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~---~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 902 (967)
+++..... ...+...||++|.+||.+.-+ ...+.|+||||+||++|+.+.|+.||........++.
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq------ 695 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ------ 695 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh------
Confidence 98754333 223457799999999987433 3468899999999999999999999975443322221
Q ss_pred hccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHH
Q 002094 903 LEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVV 950 (967)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl 950 (967)
...+-...+. .-+.-+....+..++|++|+++.-+.|....++.
T Consensus 696 --eNTIlkAtEV--qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 --ENTILKATEV--QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred --hhchhcceec--cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111111111 1111234456788999999999988898877653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=261.09 Aligned_cols=239 Identities=28% Similarity=0.360 Sum_probs=193.2
Q ss_pred CceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCchhhhhhc
Q 002094 694 GFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHD 772 (967)
Q Consensus 694 ~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 772 (967)
+||.||+|+.. +++.+|+|++.........+.+.+|++.+++++|++++++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999997665333267899999999999999999999999998999999999999999999876
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccccccccccC
Q 002094 773 GSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMA 852 (967)
Q Consensus 773 ~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 852 (967)
... +++..++.++.+++.+++|||+.+++|+||+|+||+++.++.++++|||.+....... ......++..|+|
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMA 154 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCC
Confidence 543 7889999999999999999999999999999999999999999999999998664321 2335567788999
Q ss_pred cccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHH
Q 002094 853 PEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLG 932 (967)
Q Consensus 853 PE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 932 (967)
||.. ....++.++|+||+|++++++++|..||........ ..+...... .. ........+.++.+++
T Consensus 155 pE~~-~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-~~~~~~~~~----~~-------~~~~~~~~~~~~~~~i 221 (244)
T smart00220 155 PEVL-LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-LFKKIGKPK----PP-------FPPPEWKISPEAKDLI 221 (244)
T ss_pred HHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHhccC----CC-------CccccccCCHHHHHHH
Confidence 9988 456788899999999999999999999975322211 111111100 00 0000111556799999
Q ss_pred HhhccCCCCCCCCHHHHHH
Q 002094 933 LICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 933 ~~cl~~dP~~Rpt~~evl~ 951 (967)
.+|+..+|++||++.++++
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHccCCchhccCHHHHhh
Confidence 9999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=251.35 Aligned_cols=263 Identities=25% Similarity=0.322 Sum_probs=198.7
Q ss_pred cCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCC-ccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC-----CceeE
Q 002094 684 LNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSG-LIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP-----SLQLL 756 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 756 (967)
.+.++.||-|+||+||.++ -++|+.||.|++..-. ...+.+++-+|++++...+|.|+...++...-+ .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3678899999999999988 4589999999885432 234568899999999999999999998876543 24577
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
+.|.|.. +|+..+-..+. ++.+.+.-+..||++||.|||+.+|.||||||.|.+++++...||||||+++..+. +
T Consensus 135 ~TELmQS-DLHKIIVSPQ~---Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~-d 209 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQA---LTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ-R 209 (449)
T ss_pred HHHHHHh-hhhheeccCCC---CCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch-h
Confidence 8888864 78877765444 88889999999999999999999999999999999999999999999999986544 3
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc----
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV---- 912 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 912 (967)
.....+...-|.-|+|||.+++...|+.+.||||.||++.|++..+..|.....- .-.+++.+.+..+..+.+.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi--qQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI--EQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH--HHHHHHHHHhCCCcHHHHHHHhh
Confidence 3333444556677999999999999999999999999999999988888643321 1122333333322222111
Q ss_pred -------chhhcC---------CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 002094 913 -------DARLRG---------NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953 (967)
Q Consensus 913 -------~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 953 (967)
....+. .-+.+...+...+...++..||++|.+..+.+.-+
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111110 01224445677888899999999999998876543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=277.92 Aligned_cols=265 Identities=19% Similarity=0.200 Sum_probs=179.8
Q ss_pred hhccCCCCccCCCCceEEEEEEe-----------------CCCcEEEEEEeecCCccc-------------cHHHHHHHH
Q 002094 681 NALLNKDCELGRGGFGVVYRTIL-----------------QDGRSVAIKKLTVSGLIK-------------SQEDFEKEM 730 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~l~~~~~~~-------------~~~~~~~E~ 730 (967)
.+.|+..++||+|+||.||+|.. .+++.||||++....... ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 44578899999999999999963 245789999986543110 112334567
Q ss_pred HHHcCCCCCce-----eeeeeEEEc--------CCceeEEEEecCCCchhhhhhcCCC---------------------C
Q 002094 731 KTLGKIRHHNL-----VALEGYYWT--------PSLQLLIYEFISSGSLYKHLHDGSS---------------------R 776 (967)
Q Consensus 731 ~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~ 776 (967)
.++.+++|.++ ++++++|.. .+..++||||+++++|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766544 677777653 3567999999999999999875321 0
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccccccccccCcccc
Q 002094 777 NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFA 856 (967)
Q Consensus 777 ~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 856 (967)
...++..+..++.|++.|++|+|+++|+||||||+||+++.++.+||+|||++........ .......+++.|+|||.+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhh
Confidence 1246788899999999999999999999999999999999999999999999975532111 111123347899999987
Q ss_pred cCcc---------------------cCCcccchhhHHHHHHHHHcCCC-CCCCCccchHhHHHH--HHhhhccCCchhhc
Q 002094 857 CRTV---------------------KITEKCDVYGFGVLVLEVVTGKR-PVEYMEDDVVVLCDM--VRGALEDGRVEDCV 912 (967)
Q Consensus 857 ~~~~---------------------~~t~~~Dv~slGvll~elltg~~-p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 912 (967)
.... ....+.||||+||+++||++|.. ||...........++ ....++ ...
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r-----~~~ 457 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR-----MYK 457 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-----hhc
Confidence 4321 11234799999999999999875 765221111111000 000000 000
Q ss_pred chhhcCCCChhhHHHHHHHHHhhccCCC---CCCCCHHHHHH
Q 002094 913 DARLRGNFPADEAIPVIKLGLICASQVP---SNRPDMEEVVN 951 (967)
Q Consensus 913 ~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rpt~~evl~ 951 (967)
.................+++.+++..+| .+|+|++|+++
T Consensus 458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0111111223446678999999998766 68999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=284.17 Aligned_cols=262 Identities=18% Similarity=0.174 Sum_probs=166.9
Q ss_pred hccCCCCccCCCCceEEEEEEeC-C----CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeE------EEc
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-D----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY------YWT 750 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~~ 750 (967)
+.|+..+.||+|+||.||+|+.. + +..||||++..... .+.+..| + ++...+.+++.+... ...
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e-~-l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE-R-VRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH-H-HHhhchhhHHHHHHhhhccccccc
Confidence 45688899999999999999965 4 68999998764331 1111111 1 111122222222111 245
Q ss_pred CCceeEEEEecCCCchhhhhhcCCCCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCE
Q 002094 751 PSLQLLIYEFISSGSLYKHLHDGSSRN-----------------CLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNV 813 (967)
Q Consensus 751 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Ni 813 (967)
....++||||+.+++|.+++....... ......+..++.|++.||+|||+++|+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 677899999999999999987543110 012334567999999999999999999999999999
Q ss_pred EeCC-CCCeEEeecccccccCCCccccccccccccccccCcccccCcc---------------------cCCcccchhhH
Q 002094 814 LIDS-SGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTV---------------------KITEKCDVYGF 871 (967)
Q Consensus 814 ll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------~~t~~~Dv~sl 871 (967)
|++. ++.+||+|||+++...... ........+++.|+|||.+.... .++.++||||+
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9986 5799999999997654322 22234567889999999652211 23456799999
Q ss_pred HHHHHHHHcCCCCCCCCccchHhHHHHHHhh-hccCCchhhcchhh----cC--CCChhhHHHHHHHHHhhccCCCCCCC
Q 002094 872 GVLVLEVVTGKRPVEYMEDDVVVLCDMVRGA-LEDGRVEDCVDARL----RG--NFPADEAIPVIKLGLICASQVPSNRP 944 (967)
Q Consensus 872 Gvll~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~----~~--~~~~~~~~~l~~li~~cl~~dP~~Rp 944 (967)
||++|||+++..|++.. ...+...+... .....+.....+.. +. +..........+|+.+|++.||++||
T Consensus 366 GviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 99999999977665321 11111111100 00000000000000 00 00111223456899999999999999
Q ss_pred CHHHHHHH
Q 002094 945 DMEEVVNI 952 (967)
Q Consensus 945 t~~evl~~ 952 (967)
|++|+++.
T Consensus 443 ta~e~L~H 450 (566)
T PLN03225 443 SAKAALAH 450 (566)
T ss_pred CHHHHhCC
Confidence 99999873
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=266.12 Aligned_cols=202 Identities=23% Similarity=0.316 Sum_probs=170.0
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
|.+.+.||-|+||.|..+..- ....||+|.+++... ......++.|-++|..-+.+-||+++-.|.+++..|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 566778999999999998844 466799999987654 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccccccc--------
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLL-------- 832 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~-------- 832 (967)
++||++-.+|-+... +.++.+..++.+++.|+++.|..|+|||||||+|||||.+|++||.|||++.-+
T Consensus 711 IPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999999999877665 788888999999999999999999999999999999999999999999997432
Q ss_pred -CCCccc-------------------------------cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc
Q 002094 833 -PMLDRC-------------------------------ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT 880 (967)
Q Consensus 833 -~~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt 880 (967)
...+.. ...-...||+.|+|||++ ....++..+|+||.|||||||+.
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl-~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVL-ARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHh-cccCccccchhhHhhHHHHHHhh
Confidence 110000 000124589999999999 55578999999999999999999
Q ss_pred CCCCCCCCc
Q 002094 881 GKRPVEYME 889 (967)
Q Consensus 881 g~~p~~~~~ 889 (967)
|++||-...
T Consensus 867 g~~pf~~~t 875 (1034)
T KOG0608|consen 867 GQPPFLADT 875 (1034)
T ss_pred CCCCccCCC
Confidence 999996443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=233.40 Aligned_cols=257 Identities=20% Similarity=0.264 Sum_probs=194.6
Q ss_pred hccCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcC--CceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTP--SLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv 757 (967)
+.|+..+.+|+|.++.||.|. ..+.++++||++++- ..+.+.+|+++++.+. ||||+++++...++ ....+|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 446777899999999999999 557889999999753 4678999999999996 99999999998765 455799
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC-CCCeEEeecccccccCCCc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS-SGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~-~~~~kl~Dfg~a~~~~~~~ 836 (967)
+||+.+.+....-.. ++...+...+.++++||.|+|++||.|||+||.||++|. .-..+|+|+|+|.++....
T Consensus 114 FE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 999999877665433 666778889999999999999999999999999999995 5579999999999886533
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHh--------hhcc---
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRG--------ALED--- 905 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~--- 905 (967)
.... ...+--|.-||.+..-..+...-|+|||||+++.|+..+.||-...+....+..+++- .+..
T Consensus 188 eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 188 EYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred eeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 3211 1223337789998777788999999999999999999999997655544444444321 1111
Q ss_pred ---CCchhhcchhhcCC---C-----ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 906 ---GRVEDCVDARLRGN---F-----PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 906 ---~~~~~~~~~~~~~~---~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
++...++....+.. + ..-...+..+++.+.+..|-.+|+|++|+++
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11111111111110 0 0112467899999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=235.04 Aligned_cols=212 Identities=34% Similarity=0.535 Sum_probs=182.4
Q ss_pred cCCCCceEEEEEEeCC-CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCchhh
Q 002094 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYK 768 (967)
Q Consensus 690 lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 768 (967)
||+|++|.||++...+ ++.+++|++.........+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 899999999866532235789999999999999999999999999899999999999999999
Q ss_pred hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC-CCCeEEeecccccccCCCcccccccccccc
Q 002094 769 HLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS-SGEPKVGDFGLARLLPMLDRCILSSKIQSA 847 (967)
Q Consensus 769 ~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 847 (967)
++.... ..+++..++.++.++++++++||+.|++|+||+|.||+++. ++.++++|||.+........ ......+.
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 987653 22789999999999999999999999999999999999998 89999999999986643221 22345567
Q ss_pred ccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHH
Q 002094 848 LGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIP 927 (967)
Q Consensus 848 ~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 927 (967)
..|++||........+.+.|+|++|++++++ ..
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------~~ 189 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------PE 189 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------HH
Confidence 7899999883333788999999999999999 34
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 928 VIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 928 l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
+.+++.+|++.+|++||++.++++.
T Consensus 190 ~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHhhCCcccCcCHHHHhhC
Confidence 7889999999999999999998864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-28 Score=252.51 Aligned_cols=279 Identities=18% Similarity=0.137 Sum_probs=185.0
Q ss_pred CCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCC-CCCCCCCCchhhhcCCCCce
Q 002094 68 TKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSE-NNLSGLIPDEFFRQCGSLRE 146 (967)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~-n~~~~~ip~~~~~~l~~L~~ 146 (967)
+...|+|+|+.|+|+...+.+|..+++|++||||+|+|+.+-|++|.++..|..|-+-+ |+|+ .+|...|++|..|+.
T Consensus 66 P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqr 144 (498)
T KOG4237|consen 66 PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQR 144 (498)
T ss_pred CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHH
Confidence 34678888888888887778888888888888888888888888888888776665554 7887 688888888888888
Q ss_pred EeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCC------------CcccccccCCC
Q 002094 147 VSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLE------------GEIVKGISNLY 214 (967)
Q Consensus 147 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~------------~~~~~~~~~l~ 214 (967)
|.+.-|++.-+..+.|..|++|..|.+..|.+..+.-..|..+.+++.+.+..|.+. ...+-.++...
T Consensus 145 LllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgar 224 (498)
T KOG4237|consen 145 LLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGAR 224 (498)
T ss_pred HhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccce
Confidence 888888888777778888888888888888887444447788888888888877622 12223333333
Q ss_pred CCCeeeccCccccccCCcCccCC-CCcc-EEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccccc
Q 002094 215 DLRAIKLGKNKFSGQLPEDIGGC-SMLK-VLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLD 292 (967)
Q Consensus 215 ~L~~L~L~~n~l~~~~~~~~~~l-~~L~-~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 292 (967)
-..-..+.++++...-+..|... ..+. .+....+.........|.+|++|+.|+|++|+|+++-+.+|.++.+++.|.
T Consensus 225 c~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~ 304 (498)
T KOG4237|consen 225 CVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELY 304 (498)
T ss_pred ecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhh
Confidence 34444444444443333333221 1111 111112222212223466666777777777777666666676677777777
Q ss_pred ccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCc
Q 002094 293 LSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLT 347 (967)
Q Consensus 293 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 347 (967)
|..|+|...-...|.++..|+.|+|.+|+|+...|.+|..+..|..|+|-.|++.
T Consensus 305 L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 305 LTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred cCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 7777666555555666666667777777766666666666666666666666664
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=254.77 Aligned_cols=196 Identities=22% Similarity=0.323 Sum_probs=170.2
Q ss_pred cCCCCccCCCCceEEEEEEeCC-CcEEEEEEeecCCcccc-------HHHHHHHHHHHcCCC---CCceeeeeeEEEcCC
Q 002094 684 LNKDCELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKS-------QEDFEKEMKTLGKIR---HHNLVALEGYYWTPS 752 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~-------~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 752 (967)
|...+.+|+|+||.|+.|+++. ...|+||.+.+++...+ ...+-.|+.+|..++ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 6778899999999999999764 56789998876653211 234678999999997 999999999999999
Q ss_pred ceeEEEEec-CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 753 LQLLIYEFI-SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 753 ~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
.+|++||.. +|.+|.+++..... +++.++..|++||+-|+++||+.||||||||-+||.++.+|-+||+|||.|.+
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999976 56799999987655 88999999999999999999999999999999999999999999999999976
Q ss_pred cCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCC
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVE 886 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~ 886 (967)
... ..-..+.||..|.|||++.+.......-|||++|+++|.++....||.
T Consensus 720 ~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 720 TKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 532 334568899999999999666677888999999999999998888875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=243.20 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=203.6
Q ss_pred HhhccCCCCccCCCCceEEEEEEeC----CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCce
Q 002094 680 ANALLNKDCELGRGGFGVVYRTILQ----DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 754 (967)
..+.|...++||+|.|++||++... ..+.||+|.+.... ...++..|++++..+ .+.||+++.+++...+..
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts---~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS---SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc---CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 3456788899999999999999843 46889999987654 456799999999999 599999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC-CCCCeEEeecccccccC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID-SSGEPKVGDFGLARLLP 833 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~-~~~~~kl~Dfg~a~~~~ 833 (967)
.+|+||++.....++... ++...+..+++.+..||+++|..|||||||||+|++++ ..++-.|+|||+|..++
T Consensus 111 ~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred EEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999888888765 66788999999999999999999999999999999998 46788999999987221
Q ss_pred CCc------------------------------------------cccccccccccccccCcccccCcccCCcccchhhH
Q 002094 834 MLD------------------------------------------RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGF 871 (967)
Q Consensus 834 ~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~sl 871 (967)
... .........||+||+|||++......++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 00011135699999999999888889999999999
Q ss_pred HHHHHHHHcCCCCCCCCccchHhHHHHHHh---------hhccCC--chh------hcchh-----h-------------
Q 002094 872 GVLVLEVVTGKRPVEYMEDDVVVLCDMVRG---------ALEDGR--VED------CVDAR-----L------------- 916 (967)
Q Consensus 872 Gvll~elltg~~p~~~~~~~~~~~~~~~~~---------~~~~~~--~~~------~~~~~-----~------------- 916 (967)
||++..+++++.||-...++...+.+++.. +...+. +.+ ..+.. +
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 999999999999998766666656555421 111111 000 00000 0
Q ss_pred cC-CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 917 RG-NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 917 ~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.. ......+..+.+++.+|+..||.+|.|++++++
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 00 011223446899999999999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=236.91 Aligned_cols=131 Identities=27% Similarity=0.367 Sum_probs=111.6
Q ss_pred hccCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-----C---CceeeeeeEEEc--
Q 002094 682 ALLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-----H---HNLVALEGYYWT-- 750 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~-- 750 (967)
+.|.+.++||.|.|++||.+. ....+.||+|+.+..+ .-.+....|++++++++ | .+||+++++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 568889999999999999998 4568899999998664 33466788999998883 2 479999999964
Q ss_pred --CCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeC
Q 002094 751 --PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLID 816 (967)
Q Consensus 751 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~ 816 (967)
+.+.++|+|++ |..|..+|....-+. ++...+.+|++||+.||.|||++ ||+|.||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 46789999998 668989988765555 89999999999999999999987 999999999999994
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=225.78 Aligned_cols=251 Identities=18% Similarity=0.263 Sum_probs=187.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeE-EEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGY-YWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~ 758 (967)
+.|++.+.+|+|.||.+-.++++ +.+.+++|.+..+. ...++|.+|...--.+ .|.||+.-+++ |+..+..++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 45788899999999999999976 57889999887765 5678899999876666 58999988775 45667778999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC--CCCCeEEeecccccccCCCc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID--SSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~--~~~~~kl~Dfg~a~~~~~~~ 836 (967)
||++.|+|.+-+...+ +.+....+++.|++.|+.|||++.+||||||.+|||+- +..++|+||||..+..+.
T Consensus 102 E~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-- 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-- 175 (378)
T ss_pred ccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc--
Confidence 9999999999887643 66788889999999999999999999999999999993 344899999999875532
Q ss_pred cccccccccccccccCccccc----CcccCCcccchhhHHHHHHHHHcCCCCCCCCcc---chHhHHHHHHhhhccCCch
Q 002094 837 RCILSSKIQSALGYMAPEFAC----RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMED---DVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~----~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~ 909 (967)
.......+..|.|||... +.....+.+|+|.||+++|.++||..||..... .......|..+...
T Consensus 176 ---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~----- 247 (378)
T KOG1345|consen 176 ---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP----- 247 (378)
T ss_pred ---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-----
Confidence 112233455699999752 223456789999999999999999999983322 22223333322211
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
. .... -......+.++.++-+.++|++|-...++.++-+
T Consensus 248 ~-----~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 248 A-----LPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred c-----Cchh-hcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 1 1000 1123455788889999999999966666655543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-27 Score=254.90 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=199.3
Q ss_pred ccCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+....+|.|.||.|||++ .++++..|||.++... ..+.+..++|+-+++..+|||||.++|.+...+..|+.||||
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 45667789999999999999 4578999999998765 345677899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
.||+|.+.-+.... +++.++..+.++..+|++|+|++|-+|||||-.||++++.|.+|++|||.+..+.. .-...
T Consensus 95 gggslQdiy~~Tgp---lselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~Kr 169 (829)
T KOG0576|consen 95 GGGSLQDIYHVTGP---LSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIAKR 169 (829)
T ss_pred CCCcccceeeeccc---chhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--hhhhh
Confidence 99999998776554 88889999999999999999999999999999999999999999999999875532 22334
Q ss_pred ccccccccccCccccc--CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 842 SKIQSALGYMAPEFAC--RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~--~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
..+.||+-|||||+.. +.+.|...+|+|+.|+...|+-.-++|.-.. ...+.+.-+.+....-+... |
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl-hpmr~l~LmTkS~~qpp~lk---D------ 239 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL-HPMRALFLMTKSGFQPPTLK---D------ 239 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc-chHHHHHHhhccCCCCCccc---C------
Confidence 5788999999999863 4567899999999999999998877774211 11122221221111111110 0
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...-...+.++++.|+.++|++|||++.++.
T Consensus 240 -k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 -KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1112345788999999999999999987653
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-28 Score=247.26 Aligned_cols=410 Identities=20% Similarity=0.229 Sum_probs=284.7
Q ss_pred CCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccc-cccCCCCccccccccccceeee
Q 002094 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN-NNLTGPIPESLSFCSSLESVNF 173 (967)
Q Consensus 95 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L 173 (967)
-..+.|..|+|+.+.+.+|+.+++|+.||||+|+|+ .|.+..|.++++|.+|-+.+ |+|+......|++|..|+.|.+
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchh-hcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 567899999999999999999999999999999999 56666789999998888877 9999877788999999999999
Q ss_pred cccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCcc------------ccccCCcCccCCCCcc
Q 002094 174 SSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNK------------FSGQLPEDIGGCSMLK 241 (967)
Q Consensus 174 ~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~------------l~~~~~~~~~~l~~L~ 241 (967)
.-|++.-.....|..+++|..|.+.+|.+..+....|..+..++.+.+..|. +....|..+++.....
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 9999998888899999999999999999986666689999999999999998 3334555666666666
Q ss_pred EEeccccccCCCCChhhhc-CCCCCEEEccCCCCCCcCc-hhhccccccccccccccccccccCCCCCcccccceEEccc
Q 002094 242 VLDFGVNSLSGSLPDSLQR-LNSCSSLSLKGNSFTGEVP-DWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISM 319 (967)
Q Consensus 242 ~L~l~~n~l~~~~~~~l~~-l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 319 (967)
-..+.++++...-+..|.. +..+.+=..+.+...++.| ..|..+++|++|+|++|+|+++-+.+|..+.++++|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 6666666666544444432 2222221222333333444 5699999999999999999999999999999999999999
Q ss_pred CcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcc-cccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcc
Q 002094 320 NQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM-GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNAL 398 (967)
Q Consensus 320 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l 398 (967)
|+|...-...|.++..|+.|+|.+|+|+...|..+... .|.+|+|-+|.+........+..|.. .+..
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr-----------~~~~ 376 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLR-----------KKSV 376 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHh-----------hCCC
Confidence 99998888899999999999999999997767666554 78899998888865544433333322 1221
Q ss_pred cCCCCCCcccccccchhcccccccccc---cCCCcCCcccccEEEecCCcccccCcccccCCCCCCEE-EcCCCCCCCcC
Q 002094 399 SGVIPSNIGDLSSLMLLNMSMNYLFGS---IPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKEL-KLEKNFLSGRI 474 (967)
Q Consensus 399 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L-~L~~N~l~~~~ 474 (967)
.|.+| -..-..++.+.++.+.+... .|++.+... .+.-|+ ..+-+.+. .-|++.+. .+
T Consensus 377 ~~~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~------------s~~cP~---~c~c~~tVvRcSnk~lk-~l 438 (498)
T KOG4237|consen 377 VGNPR--CQSPGFVRQIPISDVAFGDFRCGGPEELGCLT------------SSPCPP---PCTCLDTVVRCSNKLLK-LL 438 (498)
T ss_pred CCCCC--CCCCchhccccchhccccccccCCccccCCCC------------CCCCCC---CcchhhhhHhhcccchh-hc
Confidence 22211 01112344444444433211 111111100 001111 11122221 22222222 34
Q ss_pred CccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCC
Q 002094 475 PSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHN 540 (967)
Q Consensus 475 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N 540 (967)
|..+- ..-++|++.+|.++ .+|.. .+.+| .+|||+|+++......|.+|++|..|-|++|
T Consensus 439 p~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 439 PRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred CCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 43322 13456777777777 55655 56666 7788888877666667778888888877776
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=230.77 Aligned_cols=201 Identities=30% Similarity=0.482 Sum_probs=171.8
Q ss_pred cCCCCccCCCCceEEEEEEeCC-CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+..+.||+|++|.||++...+ ++.+|+|.+.........+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 3556789999999999999765 899999999865432256789999999999999999999999998899999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.+++...... +++..+..++.+++.+++++|+.+++|+|++|+||+++.++.++++|||.+........ ....
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK 157 (225)
T ss_pred CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence 99999999865432 68899999999999999999999999999999999999999999999999987654320 1223
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEY 887 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~ 887 (967)
...++..|++||.......++.++|+|++|++++||++|+.||+.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 455677899999874445677799999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=226.51 Aligned_cols=253 Identities=21% Similarity=0.227 Sum_probs=188.0
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC------Ccee
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP------SLQL 755 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 755 (967)
|...+.+|.|+- .|.-+... .+++||+|++..+.. ....++..+|...+..++|+||++++.++.-. .+.|
T Consensus 19 y~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y 97 (369)
T KOG0665|consen 19 YVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVY 97 (369)
T ss_pred eeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHH
Confidence 455667888888 45544422 488999998865532 45567899999999999999999999998532 4568
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+|||+|.. +|.+.++.. ++-.++..+..|++.|++|+|+.||+|||+||+||++..++.+||.|||+|+....
T Consensus 98 ~v~e~m~~-nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~- 170 (369)
T KOG0665|consen 98 LVMELMDA-NLCQVILME-----LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT- 170 (369)
T ss_pred HHHHhhhh-HHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc-
Confidence 99999965 888888732 56688889999999999999999999999999999999999999999999986533
Q ss_pred ccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch------
Q 002094 836 DRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE------ 909 (967)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 909 (967)
....+....|--|.|||++.+.+ +.+.+||||.||++.||++|+.-|.+.+ .+.+|.+..-..+...
T Consensus 171 --~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d----~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 171 --DFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKD----HIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred --ccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCch----HHHHHHHHHHHhcCCCHHHHHH
Confidence 23455666777799999996655 9999999999999999999999886322 1222222111111000
Q ss_pred ----------------------hhcchhhcCC--CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 910 ----------------------DCVDARLRGN--FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 910 ----------------------~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+.|...+.. .++-....+.+++.+|+..+|++|.+++++++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0011111111 11223445778999999999999999999875
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=271.03 Aligned_cols=312 Identities=22% Similarity=0.259 Sum_probs=149.1
Q ss_pred CCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccC
Q 002094 192 LQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKG 271 (967)
Q Consensus 192 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~ 271 (967)
|+.|++.+|.+. ..|..| ...+|+.|+|.+|++. .++..+..+++|+.|+|+++.....+|. +..+++|+.|+|++
T Consensus 591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSD 666 (1153)
T ss_pred cEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecC
Confidence 444444444443 222223 2344444444444444 2344444445555555544432223332 44445555555555
Q ss_pred CCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCC
Q 002094 272 NSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIP 351 (967)
Q Consensus 272 n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 351 (967)
|.....+|..+..+++|+.|++++|..-+.+|..+ ++++|+.|++++|......|.. .++|+.|++++|.+. .+|
T Consensus 667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP 741 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFP 741 (1153)
T ss_pred CCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-ccc
Confidence 44333444455555555555555443222344333 4455555555555433333321 234555555555544 334
Q ss_pred hhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcC
Q 002094 352 TWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIG 431 (967)
Q Consensus 352 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 431 (967)
..+...+|+.|++.++...... +.+....+..+...++|+.|+|++|...+.+|..++
T Consensus 742 ~~~~l~~L~~L~l~~~~~~~l~----------------------~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~ 799 (1153)
T PLN03210 742 SNLRLENLDELILCEMKSEKLW----------------------ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQ 799 (1153)
T ss_pred ccccccccccccccccchhhcc----------------------ccccccchhhhhccccchheeCCCCCCccccChhhh
Confidence 3332223333333332211100 000001111122234556666666655555566666
Q ss_pred CcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEE
Q 002094 432 KLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYV 511 (967)
Q Consensus 432 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 511 (967)
++++|+.|+|++|...+.+|..+ .+++|+.|+|++|.....+|.. .++|+.|+|++|.++ .+|.++..+++|+.|
T Consensus 800 ~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L 874 (1153)
T PLN03210 800 NLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFL 874 (1153)
T ss_pred CCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEE
Confidence 66666666666654333455444 4566666666665443344432 245666667777666 466666667777777
Q ss_pred eccCCc-cccCCchhhhhccCCceEEecCC
Q 002094 512 DLSFND-LSGILPKELINLSHLLSFNISHN 540 (967)
Q Consensus 512 ~Ls~N~-l~~~~p~~l~~l~~L~~L~l~~N 540 (967)
+|++|+ ++ .+|..+..+++|+.++++++
T Consensus 875 ~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 875 DMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred ECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 776643 44 45555666666667666665
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=271.07 Aligned_cols=348 Identities=23% Similarity=0.280 Sum_probs=257.2
Q ss_pred CCchhhhcCCCCceEeccccc------cCCCCcccccccc-ccceeeecccccccccCccccccccCCeEeecCCcCCCc
Q 002094 133 IPDEFFRQCGSLREVSFANNN------LTGPIPESLSFCS-SLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGE 205 (967)
Q Consensus 133 ip~~~~~~l~~L~~L~L~~n~------l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 205 (967)
+....|.++++|+.|.+.++. +...+|+.|..++ +|+.|.+.+|.++ .+|..| ...+|+.|+|++|.+. .
T Consensus 549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~ 625 (1153)
T PLN03210 549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-K 625 (1153)
T ss_pred ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-c
Confidence 444556777888888776553 3334566666664 5888888888776 566666 4678888888888876 4
Q ss_pred ccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccc
Q 002094 206 IVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKL 285 (967)
Q Consensus 206 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l 285 (967)
.+..+..+++|+.|+|++|.....+| .++.+++|++|++++|.....+|..+.++++|+.|++++|..-+.+|..+ ++
T Consensus 626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l 703 (1153)
T PLN03210 626 LWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL 703 (1153)
T ss_pred cccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence 56677778888888888776544555 47778888888888877666788888888888888888865444566554 67
Q ss_pred cccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEecc
Q 002094 286 ANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLS 365 (967)
Q Consensus 286 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~ 365 (967)
++|+.|++++|.....+|.. ..+|+.|++++|.+. .+|..+ .+++|+.|++.++.... +...+.
T Consensus 704 ~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~-l~~~~~---------- 767 (1153)
T PLN03210 704 KSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEK-LWERVQ---------- 767 (1153)
T ss_pred CCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhh-cccccc----------
Confidence 88888888887655455542 357888888888887 455544 57788888887654321 111000
Q ss_pred CCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCc
Q 002094 366 GNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNW 445 (967)
Q Consensus 366 ~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 445 (967)
.+. .......++|+.|+|++|...+.+|..++++++|+.|+|++|...+.+|..+ ++++|+.|+|++|.
T Consensus 768 --~l~--------~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~ 836 (1153)
T PLN03210 768 --PLT--------PLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCS 836 (1153)
T ss_pred --ccc--------hhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCC
Confidence 000 0011124679999999998888899999999999999999987666788776 78999999999986
Q ss_pred ccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCC-cCcCccchhhhcccCccEEeccCCc
Q 002094 446 LNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQN-NLTGPVPAAIANLSNLKYVDLSFND 517 (967)
Q Consensus 446 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~ 517 (967)
....+|.. ..+|+.|+|++|.++ .+|..+..+++|+.|+|++| ++. .+|..+..+++|+.|++++|.
T Consensus 837 ~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 837 RLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 65555543 368999999999998 78999999999999999995 565 578889999999999999985
|
syringae 6; Provisional |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-25 Score=232.26 Aligned_cols=265 Identities=20% Similarity=0.223 Sum_probs=197.2
Q ss_pred HHhhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCC------CCceeeeeeEEEcC
Q 002094 679 GANALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR------HHNLVALEGYYWTP 751 (967)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~ 751 (967)
.-...|.+....|+|-|++|.+|... .|..||||+++.... -.+.=..|+++|++++ --|+++++..|...
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 34556778888999999999999954 478999999986542 2345578999999994 35899999999999
Q ss_pred CceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC-CCeEEeeccccc
Q 002094 752 SLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS-GEPKVGDFGLAR 830 (967)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~-~~~kl~Dfg~a~ 830 (967)
.+.|+|+|-+.. +|.+.++..+..-.+....+..++.|++-||.+|-..||+|.||||.|||+++. ..+||||||.|.
T Consensus 507 nHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 507 NHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred ceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 999999998754 899999887766558888999999999999999999999999999999999975 467999999998
Q ss_pred ccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchH-hHHHHHHhhh-----c
Q 002094 831 LLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVV-VLCDMVRGAL-----E 904 (967)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~-~~~~~~~~~~-----~ 904 (967)
....... +.+.-+--|.|||.+ -+..|....|+||+||+|||+.||+..|++...... -+..-+.+.+ +
T Consensus 586 ~~~enei----tPYLVSRFYRaPEIi-LG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 586 FASENEI----TPYLVSRFYRAPEII-LGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred ccccccc----cHHHHHHhccCccee-ecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 7653221 122222339999998 566899999999999999999999999986544322 1111111111 1
Q ss_pred cCC---------------------------chhhcch------hh--cCCCChhh---HHHHHHHHHhhccCCCCCCCCH
Q 002094 905 DGR---------------------------VEDCVDA------RL--RGNFPADE---AIPVIKLGLICASQVPSNRPDM 946 (967)
Q Consensus 905 ~~~---------------------------~~~~~~~------~~--~~~~~~~~---~~~l~~li~~cl~~dP~~Rpt~ 946 (967)
.+. +...+.+ .+ .+.++.+. ...+.+|+..|+..||++|.|.
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 110 0000011 01 11133333 3457889999999999999999
Q ss_pred HHHHH
Q 002094 947 EEVVN 951 (967)
Q Consensus 947 ~evl~ 951 (967)
.++++
T Consensus 741 nqAL~ 745 (752)
T KOG0670|consen 741 NQALK 745 (752)
T ss_pred HHHhc
Confidence 98874
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-25 Score=213.57 Aligned_cols=246 Identities=25% Similarity=0.391 Sum_probs=195.5
Q ss_pred CCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCc
Q 002094 687 DCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGS 765 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 765 (967)
..+|.+...|..|+|+++ |..+++|++..... ....++|..|.-.++.+.||||++++|.|..+....++..||+.||
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 446888999999999998 66777788766543 3445789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-Ccc-cCCCCCCCEEeCCCCCeEEe--ecccccccCCCcccccc
Q 002094 766 LYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NII-HYNLKSTNVLIDSSGEPKVG--DFGLARLLPMLDRCILS 841 (967)
Q Consensus 766 L~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-~iv-H~Dik~~Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~ 841 (967)
|+..+++...- ..+..++.++|.+||+|++|||+. .++ .--+.+..|++|++.+++|+ |--++. ..
T Consensus 274 lynvlhe~t~v-vvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf---------qe 343 (448)
T KOG0195|consen 274 LYNVLHEQTSV-VVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---------QE 343 (448)
T ss_pred HHHHHhcCccE-EEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---------ec
Confidence 99999986543 367788999999999999999986 444 44688999999999887775 322221 12
Q ss_pred ccccccccccCcccccCcc--cCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 842 SKIQSALGYMAPEFACRTV--KITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~--~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
.....+|.|++||.+.+.. ..-+++|+|||++++||+-|...||.....-+. . + .+.-++++..
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-g---m----------kialeglrv~ 409 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-G---M----------KIALEGLRVH 409 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-h---h----------hhhhcccccc
Confidence 2334567899999884332 234689999999999999999999975443211 1 1 1223456777
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
.|+..+..+.+++.-|+++||.+||.++.++-+|++++
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 88899999999999999999999999999999999875
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=240.95 Aligned_cols=264 Identities=29% Similarity=0.316 Sum_probs=120.7
Q ss_pred cCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEcc
Q 002094 191 SLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLK 270 (967)
Q Consensus 191 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~ 270 (967)
.-..|+|++|.|+. +|..+. .+|+.|++++|+++. +|.. +++|++|++++|+|+. +|..
T Consensus 202 ~~~~LdLs~~~Lts-LP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lts-LP~l------------- 260 (788)
T PRK15387 202 GNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTS-LPVL------------- 260 (788)
T ss_pred CCcEEEcCCCCCCc-CCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCc-ccCc-------------
Confidence 34566677766663 444443 256666666666652 3321 2445555555555542 2221
Q ss_pred CCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCC
Q 002094 271 GNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNI 350 (967)
Q Consensus 271 ~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 350 (967)
.++|+.|++++|+++ .+|.. ..+|+.|++++|+++. +|.. .++|+.|++++|++++ +
T Consensus 261 --------------p~sL~~L~Ls~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-L 317 (788)
T PRK15387 261 --------------PPGLLELSIFSNPLT-HLPAL---PSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-L 317 (788)
T ss_pred --------------ccccceeeccCCchh-hhhhc---hhhcCEEECcCCcccc-cccc---ccccceeECCCCcccc-C
Confidence 234444455555444 22221 1334455555555542 2221 2445555555555542 2
Q ss_pred ChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCc
Q 002094 351 PTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASI 430 (967)
Q Consensus 351 p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 430 (967)
|.. ...|+.|++++|.+...... ..+|++|+|++|+|++ +|... ++|+.|++++|+|. .+|...
T Consensus 318 p~l--p~~L~~L~Ls~N~L~~LP~l---------p~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~-~LP~l~ 381 (788)
T PRK15387 318 PAL--PSELCKLWAYNNQLTSLPTL---------PSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLT-SLPALP 381 (788)
T ss_pred CCC--cccccccccccCcccccccc---------ccccceEecCCCccCC-CCCCC---cccceehhhccccc-cCcccc
Confidence 221 11234444444444322110 1346666666666663 23221 34555566666655 234321
Q ss_pred CCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccE
Q 002094 431 GKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKY 510 (967)
Q Consensus 431 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 510 (967)
.+|+.|+|++|+|++ +|.. ..+|+.|++++|+|++ +|..+ .+|+.|+|++|+|+ .+|..+.++++|+.
T Consensus 382 ---~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~ 449 (788)
T PRK15387 382 ---SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETT 449 (788)
T ss_pred ---cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCe
Confidence 345555555555552 3322 1345555555555542 33321 23444555555554 34444555555555
Q ss_pred EeccCCccccCCchhh
Q 002094 511 VDLSFNDLSGILPKEL 526 (967)
Q Consensus 511 L~Ls~N~l~~~~p~~l 526 (967)
|+|++|+|++..|..+
T Consensus 450 LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 450 VNLEGNPLSERTLQAL 465 (788)
T ss_pred EECCCCCCCchHHHHH
Confidence 5555555554444444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=206.19 Aligned_cols=168 Identities=21% Similarity=0.252 Sum_probs=127.7
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|+|.++++.... .+++.+++.++.||+.||+|||+++ ||+||+++.++.+++ ||.+...... .
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~ 63 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------Q 63 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------c
Confidence 689999976432 3899999999999999999999998 999999999999999 9998765431 1
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
..|++.|+|||++ .+..++.++|||||||++|||++|+.||............+........ .. ....+..
T Consensus 64 ~~g~~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~-~~~~~~~ 134 (176)
T smart00750 64 SRVDPYFMAPEVI-QGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-------PR-DRSNLES 134 (176)
T ss_pred CCCcccccChHHh-cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC-------cc-ccccHHH
Confidence 2578999999998 6667899999999999999999999999654332233333332221110 00 0011122
Q ss_pred hHH--HHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 924 EAI--PVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 924 ~~~--~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
... ++.+++.+|++.+|++|||+.|+++.+..+.
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 222 6899999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-24 Score=261.50 Aligned_cols=196 Identities=17% Similarity=0.175 Sum_probs=136.7
Q ss_pred CCCC-CceeeeeeEE-------EcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccC
Q 002094 735 KIRH-HNLVALEGYY-------WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806 (967)
Q Consensus 735 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~ 806 (967)
.++| +||+++++++ .+....+.++||+ +++|.+++.... ..+++.++..++.||++||+|||++||+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 4445 5777777776 2334567788987 559999997543 238999999999999999999999999999
Q ss_pred CCCCCCEEeCC-------------------CCCeEEeecccccccCCCcc--------------ccccccccccccccCc
Q 002094 807 NLKSTNVLIDS-------------------SGEPKVGDFGLARLLPMLDR--------------CILSSKIQSALGYMAP 853 (967)
Q Consensus 807 Dik~~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~aP 853 (967)
||||+|||++. ++.+|++|||+++....... ........||+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 34556666666653211000 0001123578889999
Q ss_pred ccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHH
Q 002094 854 EFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGL 933 (967)
Q Consensus 854 E~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 933 (967)
|++ ....++.++|||||||++|||++|.+|+.... .....+.... ..+ ..........+++.
T Consensus 185 E~~-~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~---------~~~-----~~~~~~~~~~~~~~ 246 (793)
T PLN00181 185 EED-NGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRV---------LPP-----QILLNWPKEASFCL 246 (793)
T ss_pred hhh-ccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhh---------cCh-----hhhhcCHHHHHHHH
Confidence 998 55678999999999999999999998864211 1111111100 000 01112234568889
Q ss_pred hhccCCCCCCCCHHHHHH
Q 002094 934 ICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 934 ~cl~~dP~~Rpt~~evl~ 951 (967)
+|++++|.+||++.|+++
T Consensus 247 ~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 247 WLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HhCCCChhhCcChHHHhh
Confidence 999999999999999975
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=238.21 Aligned_cols=262 Identities=31% Similarity=0.368 Sum_probs=204.2
Q ss_pred CccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcc
Q 002094 239 MLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNIS 318 (967)
Q Consensus 239 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 318 (967)
.-..|+++.|.|+ .+|..+. ++|+.|++.+|+|+. +|. .+++|++|+|++|+|+ .+|.. .++|+.|+++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 3456677777776 4565554 367777888887774 443 2578999999999999 45643 4689999999
Q ss_pred cCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcc
Q 002094 319 MNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNAL 398 (967)
Q Consensus 319 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l 398 (967)
+|.++. +|..+ ++|+.|++++|+++ .+|.. ..+|+.|++++|++...... ..+|+.|++++|+|
T Consensus 271 ~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt-~LP~~--p~~L~~LdLS~N~L~~Lp~l---------p~~L~~L~Ls~N~L 334 (788)
T PRK15387 271 SNPLTH-LPALP---SGLCKLWIFGNQLT-SLPVL--PPGLQELSVSDNQLASLPAL---------PSELCKLWAYNNQL 334 (788)
T ss_pred CCchhh-hhhch---hhcCEEECcCCccc-ccccc--ccccceeECCCCccccCCCC---------cccccccccccCcc
Confidence 999984 44433 57889999999998 45653 25799999999999764321 24688999999999
Q ss_pred cCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccc
Q 002094 399 SGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQI 478 (967)
Q Consensus 399 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 478 (967)
++ +|.. ..+|+.|+|++|+|.+ +|.. ..+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++ +|..
T Consensus 335 ~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~-LP~l- 400 (788)
T PRK15387 335 TS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPVL- 400 (788)
T ss_pred cc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCcccC-CCCc-
Confidence 85 4432 2579999999999984 5653 357888999999998 46654 3579999999999994 5654
Q ss_pred cccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCC
Q 002094 479 KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPV 548 (967)
Q Consensus 479 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 548 (967)
.++|+.|++++|+|++ +|..+ .+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+|.+|.
T Consensus 401 --~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 401 --PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred --ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 3679999999999995 67543 46889999999999 7899999999999999999999987764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=239.29 Aligned_cols=339 Identities=22% Similarity=0.297 Sum_probs=190.2
Q ss_pred CCCChhHHHHHHHHHhcCCCCccccCC----CCCCCCCCCccce----------------EEeCCCCCeeeeeeecCCCC
Q 002094 22 DPTFNDDVLGLIVFKAGLEDPKEKLTS----WSEDDDNPCNWVG----------------VKCDPKTKRVVGLTLDGFSL 81 (967)
Q Consensus 22 ~~~~~~d~~all~~k~~~~~~~~~l~s----w~~~~~~~c~w~g----------------v~c~~~~~~v~~l~l~~~~l 81 (967)
..+.++|..+++++.+.+..|. .+.+ |.+.+ ++|.=.. |.|. .+.||.+..-|...
T Consensus 58 ~~~~~~~~~~~~~~~~~l~~p~-~~~~~~~~~~~~~-~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~~~ 133 (754)
T PRK15370 58 ETASPEEIKSKFECLRMLAFPA-YADNIQYSRGGAD-QYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTESEQ 133 (754)
T ss_pred CCCCHHHHHHHHHHHHHhcCCc-hhhccccccCCCC-cccccCCcchhhheeeecCCceEEecC--CCcccccccccccc
Confidence 3446899999999999998884 5666 98765 4885433 6664 45666666655322
Q ss_pred Ccccc--ccccCCCCCCeEecCCCccCcc----------ccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEec
Q 002094 82 SGHIG--RGLLRLQFLQVLSLSNNNFTGT----------INADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSF 149 (967)
Q Consensus 82 ~~~~~--~~l~~l~~L~~L~L~~n~l~~~----------~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L 149 (967)
..... ....+....-.=.. .+.-.+. +.++ -..+.+.|+|++++++ .+|..+ .++|+.|+|
T Consensus 134 ~~~~~~~~~~~~~~~~w~~w~-~~~~~~~~~~r~~a~~r~~~C--l~~~~~~L~L~~~~Lt-sLP~~I---p~~L~~L~L 206 (754)
T PRK15370 134 ASSASGSKDAVNYELIWSEWV-KEAPAKEAANREEAVQRMRDC--LKNNKTELRLKILGLT-TIPACI---PEQITTLIL 206 (754)
T ss_pred cccCCCCCChhhHHHHHHHHH-hcCCCCccccHHHHHHHHHhh--cccCceEEEeCCCCcC-cCCccc---ccCCcEEEe
Confidence 22110 00000000000000 0000000 0011 1134566666666666 455443 245666666
Q ss_pred cccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCcccccc
Q 002094 150 ANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQ 229 (967)
Q Consensus 150 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 229 (967)
++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+ ..+|+.|+|++|.+. .+|..+. .+|+.|+|++|+++ .
T Consensus 207 s~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l--~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~ 276 (754)
T PRK15370 207 DNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATL--PDTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-C 276 (754)
T ss_pred cCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhh--hccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-c
Confidence 666666 3444332 46666666666666 345433 235666777776666 3344333 35677777777766 3
Q ss_pred CCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcc
Q 002094 230 LPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNL 309 (967)
Q Consensus 230 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 309 (967)
+|..+. ++|+.|++++|+|+. +|..+. ++|+.|++++|+++. +|..+ .++|+.|++++|.+++ +|..+.
T Consensus 277 LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~-- 345 (754)
T PRK15370 277 LPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETL--PPGLKTLEAGENALTS-LPASLP-- 345 (754)
T ss_pred cccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCccc--cccceeccccCCcccc-CChhhc--
Confidence 455443 467777777777763 444332 356777777777774 34333 2577778888888774 555443
Q ss_pred cccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCcc
Q 002094 310 VFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQ 389 (967)
Q Consensus 310 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~ 389 (967)
++|+.|++++|+|+ .+|..+. ++|+.|++++|+++ .+|..+. ..|+.|++++|++..... .++.....++++.
T Consensus 346 ~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~-~sL~~LdLs~N~L~~LP~--sl~~~~~~~~~l~ 418 (754)
T PRK15370 346 PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP-AALQIMQASRNNLVRLPE--SLPHFRGEGPQPT 418 (754)
T ss_pred CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH-HHHHHHhhccCCcccCch--hHHHHhhcCCCcc
Confidence 57888888888877 4555543 57888888888887 4555433 246666666666643221 1222333345566
Q ss_pred EEEccCCccc
Q 002094 390 VLDLSSNALS 399 (967)
Q Consensus 390 ~L~L~~N~l~ 399 (967)
.|++.+|.++
T Consensus 419 ~L~L~~Npls 428 (754)
T PRK15370 419 RIIVEYNPFS 428 (754)
T ss_pred EEEeeCCCcc
Confidence 6666666665
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.7e-22 Score=215.80 Aligned_cols=262 Identities=19% Similarity=0.203 Sum_probs=196.1
Q ss_pred ccCCCCccCCCCceEEEEEEeCCC--cEEEEEEeecCCccccHHHHHHHHHHHcCCC----CCceeeeeeEE-EcCCcee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDG--RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR----HHNLVALEGYY-WTPSLQL 755 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~----h~niv~~~~~~-~~~~~~~ 755 (967)
.|...+.||+|+||.||.+...+. ..+|+|........... .+..|..++..+. .+++..+++.. ..+...+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 478899999999999999996553 47888887665322222 6788888888876 36889999888 4777889
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC-----CCeEEeeccccc
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS-----GEPKVGDFGLAR 830 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~-----~~~kl~Dfg~a~ 830 (967)
+||+.+ |.+|.++..... ...++..++.+|+.|++.+|+++|+.|++||||||.|++++.. ..+.+.|||+++
T Consensus 98 iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 999977 779999886655 3349999999999999999999999999999999999999854 358999999998
Q ss_pred ccC--CCcc----cc-c-cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhh
Q 002094 831 LLP--MLDR----CI-L-SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGA 902 (967)
Q Consensus 831 ~~~--~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 902 (967)
.+. .... .. . .....||..|+++... .....+++.|+||+++++.|+..|..||........ ... +...
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H-~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~-~~~~ 252 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVH-LGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSK-FEKD 252 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHh-CCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHH-HHHH
Confidence 332 1111 11 1 2346699999999988 777899999999999999999999999975443211 000 0000
Q ss_pred hccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 903 LEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
. ............+.++.++...+-..+...+|....+...+++....
T Consensus 253 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 253 P---------RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred h---------hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0 00000002334456677777777778999999999999998776543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-22 Score=215.31 Aligned_cols=164 Identities=20% Similarity=0.176 Sum_probs=126.2
Q ss_pred hhccCCCCccCCCCceEEEEEEeC--CCcEEEEEEeecCC----ccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCce
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ--DGRSVAIKKLTVSG----LIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 754 (967)
.+.|+..+.||+|+||+||+|..+ +++.||||++.... .....+.+.+|++++++++|+++++.+.. .+..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence 345788999999999999999864 57788999875331 11235679999999999999999853322 2457
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCC-CCCCEEeCCCCCeEEeecccccccC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL-KSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Di-k~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
++||||++|++|... . . .. ...++.++++||+|+|++||+|||| ||+||+++.++.++|+|||+|+.+.
T Consensus 94 ~LVmE~~~G~~L~~~-~---~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-R---P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred EEEEEccCCCCHHHh-C---c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 999999999999632 1 1 11 1457889999999999999999999 9999999999999999999998775
Q ss_pred CCccccc------cccccccccccCccccc
Q 002094 834 MLDRCIL------SSKIQSALGYMAPEFAC 857 (967)
Q Consensus 834 ~~~~~~~------~~~~~gt~~y~aPE~~~ 857 (967)
....... .....+++.|+|||++.
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 4221111 13456778899999873
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=196.74 Aligned_cols=266 Identities=16% Similarity=0.193 Sum_probs=201.3
Q ss_pred ccCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|.++++||+|.||+++.|+ .-+++.||||.-.... ...++..|.+..+.+ ..+.|..++-+..++..-.+|+|.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 37899999999999999999 5579999999664433 345688888888888 578999998888888888999998
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC-----CeEEeecccccccCCC
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG-----EPKVGDFGLARLLPML 835 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~-----~~kl~Dfg~a~~~~~~ 835 (967)
+ |-||.+.+.-...+ ++..++..+|.|+..-++|+|++.+|+|||||+|+||+..+ .+.++|||+|+.+.+.
T Consensus 106 L-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred h-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 8 66998888755443 89999999999999999999999999999999999997544 4899999999887543
Q ss_pred ccc-----cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccch--HhHHHHHHhhhccCCc
Q 002094 836 DRC-----ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDV--VVLCDMVRGALEDGRV 908 (967)
Q Consensus 836 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~ 908 (967)
... .......||.+||+--.. -+.+-+.+.|+=|+|.++++.+.|..||.....+. ..+.. +...-+...+
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTH-lGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK-IGe~Kr~T~i 260 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK-IGETKRSTPI 260 (449)
T ss_pred cccccCccccccccccceeeeEeecc-ccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH-hccccccCCH
Confidence 221 223356799999998777 45577889999999999999999999998654321 11111 1111011111
Q ss_pred hhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCccc
Q 002094 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEE 965 (967)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~~ 965 (967)
.+ .-...+.++...+.-.-..+-.+-|..+-+...+.++........+
T Consensus 261 ~~---------Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~D 308 (449)
T KOG1165|consen 261 EV---------LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDD 308 (449)
T ss_pred HH---------HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccc
Confidence 11 1233566677877777778888899999988888777765554443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.3e-22 Score=188.91 Aligned_cols=263 Identities=16% Similarity=0.215 Sum_probs=196.2
Q ss_pred hccCCCCccCCCCceEEEEEE-eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCC-CceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRH-HNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|...+.||.|+||.+|.|. ..+|..||||.-.... ....+..|.++.+.+++ ..|..+..|..+...-.+|||
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 346788999999999999999 6789999999765543 23357788899888864 678888888888888999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC---CCCeEEeecccccccCCCc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS---SGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~---~~~~kl~Dfg~a~~~~~~~ 836 (967)
.+ |-||.+.+.-.... ++..+++.+|-|++.-++|+|.++++||||||+|+|++- ...+.++|||+|+.+-+..
T Consensus 92 LL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred cc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 88 66998888765443 889999999999999999999999999999999999974 3468999999998774422
Q ss_pred c-----ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccch--HhHHHHHHhhhccCCch
Q 002094 837 R-----CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDV--VVLCDMVRGALEDGRVE 909 (967)
Q Consensus 837 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 909 (967)
. ........||.+|.+--.. -+...+.+.|+=|+|+++.++-.|..||....... +....+.......
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh-~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~---- 243 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAH-LGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST---- 243 (341)
T ss_pred ccccCccccCCccceeeeehhhhhh-hhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC----
Confidence 2 2234467789999876655 34466788999999999999999999998654321 1111111111110
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 961 (967)
.-.. .-...|.++.-.+.-|-..--++-|...-+-++++.+...+.
T Consensus 244 --~ie~----LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 244 --PIEV----LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred --CHHH----HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 0011 123345667888888888888888998888777766554433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.4e-22 Score=231.23 Aligned_cols=256 Identities=18% Similarity=0.180 Sum_probs=187.1
Q ss_pred CCCCccCCCCceEEEEEEeC-CCcEEEEEEee----cCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 685 NKDCELGRGGFGVVYRTILQ-DGRSVAIKKLT----VSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~----~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
...+.+|.|++|.|+..... .....+.|..+ .... ......+..|+-+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999988877633 33334444332 1111 111223667888888899999988888777666666669
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
|||++ +|...+..... ++..++-.+++|+..|++|+|+.||.|||+|++|+++..+|.+||+|||.+..+......
T Consensus 401 E~~~~-Dlf~~~~~~~~---~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK---LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcccc---cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 99999987633 778889999999999999999999999999999999999999999999999776543333
Q ss_pred --cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 839 --ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 839 --~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.......|+..|+|||+......-.+..||||.|+++..|.+|+.||.........+.+.... .+.-...-
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~-------~~~~~~~~ 549 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS-------DQRNIFEG 549 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc-------cccccccC
Confidence 555678889999999999555445667999999999999999999998543332211000000 00000000
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
........+.+...++.++++.||++|.|+++|++
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 11123455677889999999999999999999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-19 Score=198.45 Aligned_cols=262 Identities=27% Similarity=0.370 Sum_probs=199.3
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccc--cHHHHHHHHHHHcCCCCC-ceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIK--SQEDFEKEMKTLGKIRHH-NLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 760 (967)
|...+.||.|+||.||++... ..+++|.+....... ....+.+|+..++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455678999999999999976 889999997766544 377899999999999988 799999999777778999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC-CeEEeecccccccCCCcccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG-EPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~ 839 (967)
+.++++.+++................++.|++.+++|+|+.+++|||+||+||+++..+ .++++|||.+..........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 99999997776543212378899999999999999999999999999999999999988 79999999998554322221
Q ss_pred ----ccccccccccccCcccccCc--ccCCcccchhhHHHHHHHHHcCCCCCCCCccc--hHhHHHHHHhhhccCCchhh
Q 002094 840 ----LSSKIQSALGYMAPEFACRT--VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD--VVVLCDMVRGALEDGRVEDC 911 (967)
Q Consensus 840 ----~~~~~~gt~~y~aPE~~~~~--~~~t~~~Dv~slGvll~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 911 (967)
......|+..|+|||..... .......|+||+|++++++++|..||...... .....+.+...... .
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----~ 234 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-----S 234 (384)
T ss_pred cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-----c
Confidence 34577889999999988443 57888999999999999999999998654431 11112222111100 0
Q ss_pred cchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 912 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
................+.+++.+|+..+|..|.++.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000002223568899999999999999999887654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-20 Score=218.34 Aligned_cols=141 Identities=24% Similarity=0.414 Sum_probs=77.0
Q ss_pred CccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcC
Q 002094 387 GLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLE 466 (967)
Q Consensus 387 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 466 (967)
+|+.|++++|+|++ +|..+. ++|+.|++++|.+.. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|+
T Consensus 284 sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls 354 (754)
T PRK15370 284 ELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVS 354 (754)
T ss_pred CCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECC
Confidence 34555555555543 222221 345666666666652 333322 456666666666653 454442 466666666
Q ss_pred CCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhh----hccCCceEEecCCcc
Q 002094 467 KNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELI----NLSHLLSFNISHNHL 542 (967)
Q Consensus 467 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~----~l~~L~~L~l~~N~l 542 (967)
+|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|++++|+|+ .+|..+. .++++..|+|.+|++
T Consensus 355 ~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npl 427 (754)
T PRK15370 355 KNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPF 427 (754)
T ss_pred CCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCc
Confidence 66666 3454442 46667777777766 3444443 25666777777766 3444332 335666777777776
Q ss_pred c
Q 002094 543 H 543 (967)
Q Consensus 543 ~ 543 (967)
+
T Consensus 428 s 428 (754)
T PRK15370 428 S 428 (754)
T ss_pred c
Confidence 5
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.6e-20 Score=185.63 Aligned_cols=140 Identities=21% Similarity=0.238 Sum_probs=108.6
Q ss_pred CCccCCCCceEEEEEEeCCCcEEEEEEeecCCcc-cc------------------------HHHHHHHHHHHcCCCCCce
Q 002094 687 DCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLI-KS------------------------QEDFEKEMKTLGKIRHHNL 741 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~------------------------~~~~~~E~~~l~~l~h~ni 741 (967)
.+.||+|+||.||+|...+|+.||||+++..... .. ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999999765321 11 1122459999999987776
Q ss_pred eeeeeEEEcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCcccCCCCCCCEEeCCCCC
Q 002094 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL-HHTNIIHYNLKSTNVLIDSSGE 820 (967)
Q Consensus 742 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~L-H~~~ivH~Dik~~Nill~~~~~ 820 (967)
.....+.. ...++||||++|+++........ .++...+.+++.|++.+|+|+ |+.||+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 44433322 23489999999887765432222 378899999999999999999 689999999999999998 578
Q ss_pred eEEeeccccccc
Q 002094 821 PKVGDFGLARLL 832 (967)
Q Consensus 821 ~kl~Dfg~a~~~ 832 (967)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-20 Score=214.82 Aligned_cols=252 Identities=21% Similarity=0.244 Sum_probs=180.8
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHH--HcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKT--LGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+...+-+|.+.|=+|.+|+.++|. |+||++-.....-+.+.|.++++- ...+++||++++.-+......-|+|-+|.
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 466778999999999999998777 899998776644455555555544 44458999999988877777778888888
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccccccc--CCCcccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLL--PMLDRCI 839 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~--~~~~~~~ 839 (967)
.+ +|++.+..+.- +...+...||.|++.|+..+|..||+|||||.+|||++.=.-+.|.||..-+.. +. ++..
T Consensus 104 kh-nLyDRlSTRPF---L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe-DNPa 178 (1431)
T KOG1240|consen 104 KH-NLYDRLSTRPF---LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE-DNPA 178 (1431)
T ss_pred hh-hhhhhhccchH---HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCC-CCcc
Confidence 66 78888765433 667788889999999999999999999999999999999999999999865322 22 1111
Q ss_pred ccccccc----cccccCcccccCcc----------cCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhc
Q 002094 840 LSSKIQS----ALGYMAPEFACRTV----------KITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALE 904 (967)
Q Consensus 840 ~~~~~~g----t~~y~aPE~~~~~~----------~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 904 (967)
..+.+.. -.+|.|||.+..+. ..+++.||||+||+++|+++ |++||.... +..+-.+
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-----L~aYr~~--- 250 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-----LLAYRSG--- 250 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-----HHhHhcc---
Confidence 1111222 23699999874422 26789999999999999999 899986211 1111110
Q ss_pred cCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 905 DGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
. ......-+ ..-+...+..++..|++.||++|.++++.++.-+.+
T Consensus 251 --~-~~~~e~~L----e~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 251 --N-ADDPEQLL----EKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred --C-ccCHHHHH----HhCcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 0 00000000 011122578899999999999999999998875443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.2e-19 Score=177.79 Aligned_cols=140 Identities=23% Similarity=0.264 Sum_probs=110.9
Q ss_pred CCccCCCCceEEEEEEeCCCcEEEEEEeecCCcc-cc------------------------HHHHHHHHHHHcCCCCCce
Q 002094 687 DCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLI-KS------------------------QEDFEKEMKTLGKIRHHNL 741 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~------------------------~~~~~~E~~~l~~l~h~ni 741 (967)
.+.||+|++|.||+|...+|+.||||+++..... .. ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999999765311 00 1234678999999998887
Q ss_pred eeeeeEEEcCCceeEEEEecCCCchhhh-hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCCC
Q 002094 742 VALEGYYWTPSLQLLIYEFISSGSLYKH-LHDGSSRNCLSWRQRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSSG 819 (967)
Q Consensus 742 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~~ 819 (967)
.....+... ..++||||++|+++... +.. . .++..+..+++.|++.++.++|+ +||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~---~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-V---PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-c---cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 555444333 24899999998855433 322 1 26778899999999999999999 9999999999999998 89
Q ss_pred CeEEeecccccccC
Q 002094 820 EPKVGDFGLARLLP 833 (967)
Q Consensus 820 ~~kl~Dfg~a~~~~ 833 (967)
.++|+|||++...+
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-19 Score=183.40 Aligned_cols=173 Identities=13% Similarity=0.101 Sum_probs=132.5
Q ss_pred HHhhccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCcccc--HH------HHHHHHHHHcCCCCCceeeeeeEEEc
Q 002094 679 GANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKS--QE------DFEKEMKTLGKIRHHNLVALEGYYWT 750 (967)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~--~~------~~~~E~~~l~~l~h~niv~~~~~~~~ 750 (967)
.-.+.|+..+.+|.|+||.||.+.. ++..+|||.++....... .. .+.+|+..+.++.|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3456788999999999999999766 577899999976542111 11 26899999999999999999888653
Q ss_pred C--------CceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeE
Q 002094 751 P--------SLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPK 822 (967)
Q Consensus 751 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~k 822 (967)
. +..++||||++|.+|.++.. .+. ....+++.+++.+|+.|++|||++|+||+++.++ ++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence 3 35789999999999988731 222 2456999999999999999999999999999888 99
Q ss_pred EeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHH
Q 002094 823 VGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVV 879 (967)
Q Consensus 823 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ell 879 (967)
++|||......... |-+.+.....+..++|+|++||++..+.
T Consensus 175 liDfg~~~~~~e~~---------------a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRK---------------AKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchh---------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence 99999876442110 0111223334667999999999887765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.9e-19 Score=184.71 Aligned_cols=233 Identities=18% Similarity=0.254 Sum_probs=149.2
Q ss_pred CCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCC----------CceeeeeeEEEc-
Q 002094 685 NKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRH----------HNLVALEGYYWT- 750 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~~- 750 (967)
...+.||.|+++.||.++.. +++++|||+...... ....+.+.+|.-....+.+ -.++..++....
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 45678999999999999966 489999999866543 3346777777766655422 223333332221
Q ss_pred --------C---C-----ceeEEEEecCCCchhhhhhc---CCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCC
Q 002094 751 --------P---S-----LQLLIYEFISSGSLYKHLHD---GSS-RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKS 810 (967)
Q Consensus 751 --------~---~-----~~~lv~e~~~~gsL~~~l~~---~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~ 810 (967)
. . ..+++|+-+. ++|.+++.. ... ........+..+-.|+++.+++||+.|++|+||+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 1 1 2256777774 488777542 222 11234455566778999999999999999999999
Q ss_pred CCEEeCCCCCeEEeecccccccCCCccccccccccccccccCcccccCc-------ccCCcccchhhHHHHHHHHHcCCC
Q 002094 811 TNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRT-------VKITEKCDVYGFGVLVLEVVTGKR 883 (967)
Q Consensus 811 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~t~~~Dv~slGvll~elltg~~ 883 (967)
+|++++.+|.++|+||+.....+.... ....+..|.|||..... ..+|.+.|.|++|+++|.|++|+.
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999999999999998775543111 13344669999976332 357889999999999999999999
Q ss_pred CCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCC
Q 002094 884 PVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNR 943 (967)
Q Consensus 884 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 943 (967)
||+....... ....-.... +.++.+.++|..+++++|.+|
T Consensus 249 Pf~~~~~~~~-------------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEAD-------------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGST-------------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCcccc-------------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9975433211 000111233 677889999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.4e-19 Score=172.78 Aligned_cols=187 Identities=17% Similarity=0.127 Sum_probs=137.6
Q ss_pred CCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCcc---ccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCceeEEEEe
Q 002094 685 NKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLI---KSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.+...|++|+||+||.+.. .+++++.+.+.....- .....+.+|+++++++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3466899999999997765 6788887776554321 11235889999999995 5789999886 346999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCC-CCCCEEeCCCCCeEEeecccccccCCCccc-
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL-KSTNVLIDSSGEPKVGDFGLARLLPMLDRC- 838 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Di-k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 838 (967)
++|.+|.+.... ....++.|++.+++++|++||+|||| ||+||+++.++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999988654321 11347789999999999999999999 799999999999999999999865432211
Q ss_pred --cc--------cccccccccccCcccccCcccCC-cccchhhHHHHHHHHHcCCCCCC
Q 002094 839 --IL--------SSKIQSALGYMAPEFACRTVKIT-EKCDVYGFGVLVLEVVTGKRPVE 886 (967)
Q Consensus 839 --~~--------~~~~~gt~~y~aPE~~~~~~~~t-~~~Dv~slGvll~elltg~~p~~ 886 (967)
.. ......++.|++|+...--...+ .+.+.++.|.-+|.++|++.+.-
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 00 11222456677777441111222 56799999999999999998853
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-20 Score=206.04 Aligned_cols=254 Identities=26% Similarity=0.312 Sum_probs=131.1
Q ss_pred eeecCCCCC-ccccccccCCCCCCeEecCCCccCcc----ccccccCCCCCcEEEcCCCCCCCCCCc------hhhhcCC
Q 002094 74 LTLDGFSLS-GHIGRGLLRLQFLQVLSLSNNNFTGT----INADLASFGTLQVVDFSENNLSGLIPD------EFFRQCG 142 (967)
Q Consensus 74 l~l~~~~l~-~~~~~~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~n~~~~~ip~------~~~~~l~ 142 (967)
|+|..+.++ +.....+..++.|+.|+++++.++.. ++..+...+.|+.|+++++.+.+ .+. ..+..++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGLQSLLQGLTKGC 81 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHHHHHHHHHHhcC
Confidence 556666665 33344556667788888888777543 45556666777777777777652 111 2245566
Q ss_pred CCceEeccccccCCCCccccccccc---cceeeeccccccc----ccCcccccc-ccCCeEeecCCcCCCcc----cccc
Q 002094 143 SLREVSFANNNLTGPIPESLSFCSS---LESVNFSSNRLSG----QLPYGIWFL-RSLQSLDLSNNLLEGEI----VKGI 210 (967)
Q Consensus 143 ~L~~L~L~~n~l~~~~p~~l~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~n~l~~~~----~~~~ 210 (967)
+|++|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++.. ...+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 7777777777776555555555554 6777777666652 222233344 56666666666665322 2233
Q ss_pred cCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcC----chhhcccc
Q 002094 211 SNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEV----PDWIGKLA 286 (967)
Q Consensus 211 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~----~~~l~~l~ 286 (967)
..+.+|++|++++|.+++.... .++..+..+++|+.|+|++|.+++.. ...+..++
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~--------------------~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~ 221 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIR--------------------ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK 221 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHH--------------------HHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence 4444555555555554421100 11222333344444444444443221 22233444
Q ss_pred ccccccccccccccccCCCCC-----cccccceEEcccCcCCC----CCChhhhcCCCCcEEEccCCcCcC
Q 002094 287 NLESLDLSLNQFSGRIPSSIG-----NLVFLKELNISMNQFTG----GLPESMMNCGNLLAIDVSQNKLTG 348 (967)
Q Consensus 287 ~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~ 348 (967)
+|++|++++|.+++.....+. ..+.|++|++++|.+++ .+...+..+++|+.+++++|.+..
T Consensus 222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~ 292 (319)
T cd00116 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE 292 (319)
T ss_pred CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence 555555555555432111111 12456666666665542 122334445566666666666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.5e-20 Score=204.83 Aligned_cols=135 Identities=23% Similarity=0.266 Sum_probs=80.6
Q ss_pred cccccchhccccccccc----ccCCCcCCcccccEEEecCCccccc----CcccccCCCCCCEEEcCCCCCCCcCCcccc
Q 002094 408 DLSSLMLLNMSMNYLFG----SIPASIGKLKAIQVLDFSDNWLNGT----IPPQIGGAVSLKELKLEKNFLSGRIPSQIK 479 (967)
Q Consensus 408 ~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 479 (967)
.+++|+.|+|++|.+.+ .++..+..+++|+.|++++|.+++. ++..+..+++|++|++++|.+++.....+.
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~ 242 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA 242 (319)
T ss_pred hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHH
Confidence 33445555555555442 1222333445666666666666532 233445566777777777777643222222
Q ss_pred -----ccCccceeeccCCcCcC----ccchhhhcccCccEEeccCCccccC----Cchhhhhc-cCCceEEecCCcc
Q 002094 480 -----NCSSLTSLILSQNNLTG----PVPAAIANLSNLKYVDLSFNDLSGI----LPKELINL-SHLLSFNISHNHL 542 (967)
Q Consensus 480 -----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l-~~L~~L~l~~N~l 542 (967)
..+.|+.|++++|.++. .+...+..+++|+++|+++|.++.. ....+... +.|+.+++.+|+|
T Consensus 243 ~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 243 SALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 23678888888888762 2344556667888888888888744 44445555 6788888887764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-19 Score=197.16 Aligned_cols=226 Identities=25% Similarity=0.313 Sum_probs=182.0
Q ss_pred ccCCCCceEEEEEE----eCCCcEEEEEEeecCCcc-ccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCceeEEEEecC
Q 002094 689 ELGRGGFGVVYRTI----LQDGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 689 ~lG~G~~g~Vy~~~----~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.+|+|+||.|+.+. ...|..+|+|..+..... ........|..++..++ ||.+|+++-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999765 335778999988766542 22225667888888886 9999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
||.+...+..... ++..........++-|++++|+.+|+|||+|++||+++.+|++++.|||+++..-...
T Consensus 81 gg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------ 151 (612)
T ss_pred cchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh------
Confidence 9999888766544 6777777888999999999999999999999999999999999999999997653211
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
...||..|||||.+ . ....++|.||||++++||++|..||.. +.++... +....+|.
T Consensus 152 ~~cgt~eymApEI~-~--gh~~a~D~ws~gvl~felltg~~pf~~---------~~~~~Il-----------~~~~~~p~ 208 (612)
T KOG0603|consen 152 IACGTYEYRAPEII-N--GHLSAADWWSFGVLAFELLTGTLPFGG---------DTMKRIL-----------KAELEMPR 208 (612)
T ss_pred hcccchhhhhhHhh-h--ccCCcccchhhhhhHHHHhhCCCCCch---------HHHHHHh-----------hhccCCch
Confidence 22789999999998 3 467799999999999999999999964 1111111 11234577
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCH
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDM 946 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~ 946 (967)
.....+.+++..+...+|..|.-.
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 777888899999999999999755
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-20 Score=169.36 Aligned_cols=176 Identities=31% Similarity=0.466 Sum_probs=154.1
Q ss_pred CCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEE
Q 002094 385 YQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELK 464 (967)
Q Consensus 385 ~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 464 (967)
+..++.|.||+|+++ .+|..+..+.+|+.|++++|++. .+|..++.+++|+.|+++-|++. ..|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 456788899999998 67778999999999999999996 88999999999999999999997 8899999999999999
Q ss_pred cCCCCCCCc-CCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCccc
Q 002094 465 LEKNFLSGR-IPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLH 543 (967)
Q Consensus 465 L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 543 (967)
|.+|.+... +|..|..++.|+.|+|+.|.+. .+|..++++++|+.|.+.+|.+- .+|.+++.+.+|+.|.+.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 999999754 8999999999999999999999 88999999999999999999988 88999999999999999999999
Q ss_pred ccCCCCCCCCcc---CCCcccCCCC
Q 002094 544 GELPVGGFFNTI---SPSSVSGNPS 565 (967)
Q Consensus 544 ~~~p~~~~~~~~---~~~~~~~n~~ 565 (967)
-..|.-+.+... .....+.|||
T Consensus 187 vlppel~~l~l~~~k~v~r~E~NPw 211 (264)
T KOG0617|consen 187 VLPPELANLDLVGNKQVMRMEENPW 211 (264)
T ss_pred ecChhhhhhhhhhhHHHHhhhhCCC
Confidence 766654433222 2334578887
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-20 Score=170.06 Aligned_cols=141 Identities=30% Similarity=0.491 Sum_probs=95.5
Q ss_pred CCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCccc-ccCcccccCCCCCCEEEcCCCCCCCcCCccccc
Q 002094 402 IPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLN-GTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKN 480 (967)
Q Consensus 402 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 480 (967)
+|..++.+++|+.|+++.|++. ..|..|+.++.|+.|||+.|++. ..+|..|..++.|+.|+|++|.+. .+|..+++
T Consensus 71 lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~ 148 (264)
T KOG0617|consen 71 LPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGK 148 (264)
T ss_pred cChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhh
Confidence 3444555555555565555554 55666666666666666666554 345666777777777777777776 67777788
Q ss_pred cCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCC---ceEEecCCcccccC
Q 002094 481 CSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHL---LSFNISHNHLHGEL 546 (967)
Q Consensus 481 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L---~~L~l~~N~l~~~~ 546 (967)
+++|+.|.+..|.+- ..|..++.+.+|+.|.+.+|+++ .+|.+++++.-+ +.+.+.+|+|...|
T Consensus 149 lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pI 215 (264)
T KOG0617|consen 149 LTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPI 215 (264)
T ss_pred hcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChH
Confidence 888888888888777 67778888888888888888887 666666665433 45667778886544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.8e-18 Score=187.67 Aligned_cols=219 Identities=27% Similarity=0.388 Sum_probs=163.8
Q ss_pred HcCCCCCceeeeeeEEEcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCc-ccCCCCCC
Q 002094 733 LGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI-IHYNLKST 811 (967)
Q Consensus 733 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~i-vH~Dik~~ 811 (967)
++.+.|.|+.+++|.+..+...+.|.+||..|+|.+.+...... ++|.....++++|+.||+|+|...| .|+.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~--~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIK--LDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccC--ccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 45788999999999999999999999999999999999874332 8999999999999999999999866 89999999
Q ss_pred CEEeCCCCCeEEeecccccccCCCccccccccccccccccCcccccCc--c----cCCcccchhhHHHHHHHHHcCCCCC
Q 002094 812 NVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRT--V----KITEKCDVYGFGVLVLEVVTGKRPV 885 (967)
Q Consensus 812 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~----~~t~~~Dv~slGvll~elltg~~p~ 885 (967)
|+++|....+|+.|||+.................-..-|.|||.+... . ..+.+.|+||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998766431111122222234459999988432 1 1577899999999999999999999
Q ss_pred CCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC-h-hhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 886 EYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP-A-DEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
+........ .+.+... .. .. ....++... . +.+.++..+++.||..+|.+||+++.+-..++.+...-
T Consensus 159 ~~~~~~~~~-~eii~~~-~~-~~----~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 159 DLRNLVEDP-DEIILRV-KK-GG----SNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccCCh-HHHHHHH-Hh-cC----CCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 853222111 1222211 11 00 111122211 1 33346899999999999999999999999988877643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=171.67 Aligned_cols=199 Identities=21% Similarity=0.236 Sum_probs=139.6
Q ss_pred CCCceeeeeeEEEc---------------------------CCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHH
Q 002094 737 RHHNLVALEGYYWT---------------------------PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIIL 789 (967)
Q Consensus 737 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~ 789 (967)
+|||||++.++|.+ +...|+||...+. +|.+++..+. .+...+.-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 59999999887642 1245788887755 8999987654 45566777999
Q ss_pred HHHHHHHHHhcCCcccCCCCCCCEEeC--CCC--CeEEeecccccccCCCc----cccccccccccccccCcccccCc-c
Q 002094 790 GMAKGLAYLHHTNIIHYNLKSTNVLID--SSG--EPKVGDFGLARLLPMLD----RCILSSKIQSALGYMAPEFACRT-V 860 (967)
Q Consensus 790 ~i~~aL~~LH~~~ivH~Dik~~Nill~--~~~--~~kl~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~-~ 860 (967)
|+++|+.|||++||.|||+|++||++. +|+ ...++|||++---+... .........|.-..||||+...- +
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999999999999999999999993 343 46889999874221100 01111234455668999987321 1
Q ss_pred c----CCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhc
Q 002094 861 K----ITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICA 936 (967)
Q Consensus 861 ~----~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 936 (967)
. .-.|+|.|+.|-+.||+++...||....+-.-... . ..+...+..+..++..+.+++...+
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r----------~----Yqe~qLPalp~~vpp~~rqlV~~lL 494 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR----------T----YQESQLPALPSRVPPVARQLVFDLL 494 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechh----------h----hhhhhCCCCcccCChHHHHHHHHHh
Confidence 1 13489999999999999999999974221100000 0 0111123456777888999999999
Q ss_pred cCCCCCCCCHHHHHHHHH
Q 002094 937 SQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 937 ~~dP~~Rpt~~evl~~L~ 954 (967)
+.||.+|+++.-....|.
T Consensus 495 ~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 495 KRDPSKRVSPNIAANVLN 512 (598)
T ss_pred cCCccccCCccHHHhHHH
Confidence 999999999877666654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=167.52 Aligned_cols=136 Identities=21% Similarity=0.213 Sum_probs=105.9
Q ss_pred CCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-----CCCceeeeeeEEEcCC---c-ee
Q 002094 685 NKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-----RHHNLVALEGYYWTPS---L-QL 755 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~-~~ 755 (967)
.....||+|+||.||. ...++. .+||++.... ....+.+.+|+++++.+ .||||++++|++.++. . ..
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcC-eEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 5567899999999996 333444 4799887643 23457899999999999 5799999999998763 3 33
Q ss_pred EEEEe--cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCcccCCCCCCCEEeCC----CCCeEEeeccc
Q 002094 756 LIYEF--ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGL-AYLHHTNIIHYNLKSTNVLIDS----SGEPKVGDFGL 828 (967)
Q Consensus 756 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL-~~LH~~~ivH~Dik~~Nill~~----~~~~kl~Dfg~ 828 (967)
+|+|| +.+++|.+++.+.. +++. ..++.+++.++ +|||+++|+||||||+||+++. ++.++|+||+-
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 55799999996532 4444 35678888777 9999999999999999999974 33799999543
Q ss_pred c
Q 002094 829 A 829 (967)
Q Consensus 829 a 829 (967)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.6e-18 Score=197.86 Aligned_cols=248 Identities=17% Similarity=0.173 Sum_probs=179.4
Q ss_pred hhccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC---CCceeeeeeEEEcCCceeEE
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR---HHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv 757 (967)
...|.+.+++|+|+||+||+|...+|+.||+|+=+.... -+|.-=.+++.+|+ -+-|..+..++.-.+..++|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP----WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc----eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 345678889999999999999988899999998766542 22333334444554 23345555555567788999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC-------CCCCeEEeeccccc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID-------SSGEPKVGDFGLAR 830 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~-------~~~~~kl~Dfg~a~ 830 (967)
+||.+.|+|.+++...+ ..+|.-++.++.|+++.+++||..+||||||||+|+++. ....++|+|||.+.
T Consensus 773 ~ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 99999999999998433 389999999999999999999999999999999999994 22358999999997
Q ss_pred ccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchh
Q 002094 831 LLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVED 910 (967)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (967)
.+.-......-...++|-.+-.+|+. .++.++...|.|.++-+++-|+.|++-= .. .....
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~-~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~-----------------~g~~~ 910 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMR-EGRPWTYQIDYFGLAATVHVMLFGKYME-VK-----------------NGSSW 910 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHh-cCCCCchhhhhHHHHHHHHHHHHHHHHH-hc-----------------CCcce
Confidence 77544444445567788889999988 7889999999999999999999887531 00 00011
Q ss_pred hcchhhcCCCChhhH-HHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 911 CVDARLRGNFPADEA-IPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 911 ~~~~~~~~~~~~~~~-~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.++.. ++.--. ..+.+++..+++.|-..=|...++...+++...
T Consensus 911 ~~~~~----~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 911 MVKTN----FPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred ecccc----chhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 11111 111111 124456666777665556777777777766543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-18 Score=186.80 Aligned_cols=173 Identities=24% Similarity=0.354 Sum_probs=127.9
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++.|++|.-.+|.+|+.+.......++.....++.|++.|++| ++.+|+|+||.||+...+..+||.|||+.....
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~ 407 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQD 407 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecc
Confidence 36788888888999999766555557888999999999999999 999999999999999999999999999988765
Q ss_pred CCc----cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCc
Q 002094 834 MLD----RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRV 908 (967)
Q Consensus 834 ~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 908 (967)
... .....+...||..||+||.+ .+..++.++||||+|++++|++. =.-+++ ....+ .-++.+.+
T Consensus 408 ~~~~~~~~~a~~t~~~gt~~YmsPEQi-~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~-----~d~r~g~i 477 (516)
T KOG1033|consen 408 KDETVAPAAASHTQQVGTLLYMSPEQI-RGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATL-----TDIRDGII 477 (516)
T ss_pred cCCcccchhhhhhhcccccccCCHHHH-hhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhh-----hhhhcCCC
Confidence 433 23345567899999999999 77799999999999999999995 222221 00000 01111111
Q ss_pred hhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHH
Q 002094 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEE 948 (967)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e 948 (967)
. +.+..+. +.-..++.+++...|.+||++.+
T Consensus 478 p--------~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 478 P--------PEFLQDY-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred C--------hHHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence 1 1111111 22357899999999999995444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=165.91 Aligned_cols=142 Identities=18% Similarity=0.202 Sum_probs=110.6
Q ss_pred ccCCCCccCCCCceEEEEEE--eCCCcEEEEEEeecCCccc-----------------------cHHHHHHHHHHHcCCC
Q 002094 683 LLNKDCELGRGGFGVVYRTI--LQDGRSVAIKKLTVSGLIK-----------------------SQEDFEKEMKTLGKIR 737 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~l~~~~~~~-----------------------~~~~~~~E~~~l~~l~ 737 (967)
.|...+.||+|++|.||+|+ ..+|+.||+|+++...... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 5689999999987543110 0123678999999996
Q ss_pred CC--ceeeeeeEEEcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-cccCCCCCCCEE
Q 002094 738 HH--NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN-IIHYNLKSTNVL 814 (967)
Q Consensus 738 h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~-ivH~Dik~~Nil 814 (967)
+. .+.+++++ ...++||||++|+++........ .....+...++.|++.+++++|++| ++||||||+||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 53 33444443 23589999999988876543222 2455667889999999999999999 999999999999
Q ss_pred eCCCCCeEEeeccccccc
Q 002094 815 IDSSGEPKVGDFGLARLL 832 (967)
Q Consensus 815 l~~~~~~kl~Dfg~a~~~ 832 (967)
++ ++.++++|||.+...
T Consensus 182 i~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-CCCEEEEEChhhhcc
Confidence 99 889999999998744
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-16 Score=161.95 Aligned_cols=135 Identities=20% Similarity=0.329 Sum_probs=114.4
Q ss_pred CccCCCCceEEEEEEeCCCcEEEEEEeecCCccc-------cHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 688 CELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIK-------SQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.||+|++|.||+|.. .|..|++|+........ ....+.+|++++..+.|++++....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 57889999865433211 124678899999999999988877777777888999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
++|++|.+++... .+ .+..++.+++.+++++|+.+++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998642 22 7888999999999999999999999999999999 78999999998864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.3e-16 Score=186.84 Aligned_cols=153 Identities=33% Similarity=0.518 Sum_probs=106.7
Q ss_pred CCCChhHHHHHHHHHhcCCCCccccCCCCCCCCCC--CccceEEeCCC--C--CeeeeeeecCCCCCccccccccCCCCC
Q 002094 22 DPTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNP--CNWVGVKCDPK--T--KRVVGLTLDGFSLSGHIGRGLLRLQFL 95 (967)
Q Consensus 22 ~~~~~~d~~all~~k~~~~~~~~~l~sw~~~~~~~--c~w~gv~c~~~--~--~~v~~l~l~~~~l~~~~~~~l~~l~~L 95 (967)
..+.+.|..||++||+++.+|.. .+|.++.+.| |.|.||+|+.. . .+|+.|+|.+++++|.+|..++.|++|
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L 444 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL 444 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence 35567899999999999987642 5897531111 27999999532 2 257777887777777777777777777
Q ss_pred CeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccc-cccceeeec
Q 002094 96 QVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFC-SSLESVNFS 174 (967)
Q Consensus 96 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~L~ 174 (967)
+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|.. ++++++|++|+|++|+++|.+|..++.+ .++..++++
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~-l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~ 523 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES-LGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT 523 (623)
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchH-HhcCCCCCEEECcCCcccccCChHHhhccccCceEEec
Confidence 77777777777777777777777777777777777776664 3667777777777777776666666542 344555555
Q ss_pred ccc
Q 002094 175 SNR 177 (967)
Q Consensus 175 ~N~ 177 (967)
+|.
T Consensus 524 ~N~ 526 (623)
T PLN03150 524 DNA 526 (623)
T ss_pred CCc
Confidence 554
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=4e-16 Score=158.80 Aligned_cols=137 Identities=18% Similarity=0.200 Sum_probs=108.5
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCcc---------------------ccHHHHHHHHHHHcCCCCC--
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLI---------------------KSQEDFEKEMKTLGKIRHH-- 739 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---------------------~~~~~~~~E~~~l~~l~h~-- 739 (967)
.|...+.||+|+||.||++..++|+.||||+++..... .....+..|..++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 46778899999999999999888999999987653310 0112367788888888776
Q ss_pred ceeeeeeEEEcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC
Q 002094 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG 819 (967)
Q Consensus 740 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~ 819 (967)
.++..++. ...++||||++|++|.+.... .....++.+++.++.++|+.|++||||||+||++++++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 34444432 345899999999998765321 23457889999999999999999999999999999999
Q ss_pred CeEEeeccccccc
Q 002094 820 EPKVGDFGLARLL 832 (967)
Q Consensus 820 ~~kl~Dfg~a~~~ 832 (967)
.++|+|||.+...
T Consensus 163 ~~~liDfg~~~~~ 175 (198)
T cd05144 163 KIYIIDWPQMVST 175 (198)
T ss_pred cEEEEECCccccC
Confidence 9999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.1e-16 Score=158.57 Aligned_cols=131 Identities=19% Similarity=0.347 Sum_probs=107.3
Q ss_pred ccCCCCceEEEEEEeCCCcEEEEEEeecCCcc-------ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLI-------KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 689 ~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.||+|++|.||+|.+ ++..|++|........ ....++.+|++++..+.|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 5788999986543211 12356788999999998887665555556667779999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
+|++|.+.+.... . .++.+++.+++++|+.|++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~-------~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-------D---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-------H---HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875421 0 7899999999999999999999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.6e-15 Score=178.22 Aligned_cols=135 Identities=20% Similarity=0.272 Sum_probs=110.9
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-c------ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeE
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-I------KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLL 756 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 756 (967)
|...+.||+|+||.||+|.+... .+++|+...... . ...+++.+|+++++.++|++++....++..+...++
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred cCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 35678999999999999987644 444444322111 1 123568899999999999999988888877778899
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
||||++|++|.+++. ....++.+++++++|||+.+++|||+||+||++ .++.++++|||+++.
T Consensus 414 v~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 414 VMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999998875 356789999999999999999999999999999 678999999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.7e-15 Score=173.09 Aligned_cols=207 Identities=23% Similarity=0.276 Sum_probs=142.0
Q ss_pred ccCCCCccCCCCceEEEEEEeCC-CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.|..|+||.||.++++. .+++|+ ++.++.. +.+- ++.....|.+|
T Consensus 84 df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l------ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 84 DFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL------ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred ccceeEeeccCCCCceeeeeccccccchhh-cccccch------hhhc--cccccCCccee-------------------
Confidence 35788999999999999998764 566777 3433221 1110 33333444444
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC------
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML------ 835 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~------ 835 (967)
|+-...++.... ++.. ++.+++|+|+.||+|||+||+|.+++.-|++|+.|||++...-..
T Consensus 136 --gDc~tllk~~g~---lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 --GDCATLLKNIGP---LPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred --chhhhhcccCCC---Ccch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 333333433222 2222 278899999999999999999999999999999999998644211
Q ss_pred -------ccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc
Q 002094 836 -------DRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV 908 (967)
Q Consensus 836 -------~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 908 (967)
........+.||+.|+|||++.. ..|...+|+|++|+++||++-|..||..... +..+...+...+.
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~visd~i~---- 276 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIE---- 276 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhhhhhhhcc----
Confidence 11112234679999999999944 4688899999999999999999999965433 3334433333221
Q ss_pred hhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCC
Q 002094 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRP 944 (967)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 944 (967)
..+-.+..+.++++++.+.++.+|..|-
T Consensus 277 --------wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 277 --------WPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred --------ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1122334456799999999999999995
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.8e-14 Score=145.61 Aligned_cols=136 Identities=21% Similarity=0.262 Sum_probs=97.5
Q ss_pred CCccCCCCceEEEEEEeCCCcEEEEEEeecCCccc-cHHH----------------------HHHHHHHHcCCCCC--ce
Q 002094 687 DCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIK-SQED----------------------FEKEMKTLGKIRHH--NL 741 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~----------------------~~~E~~~l~~l~h~--ni 741 (967)
.+.||+|+||+||+|...+++.||||+++...... .... ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987543211 1111 13455555555333 23
Q ss_pred eeeeeEEEcCCceeEEEEecCCCchhhh-hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCCC
Q 002094 742 VALEGYYWTPSLQLLIYEFISSGSLYKH-LHDGSSRNCLSWRQRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSSG 819 (967)
Q Consensus 742 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~~ 819 (967)
.+++++ ...++||||++++.+... +.... .. ..+.+++.+++.++.++|. .+|+|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 444433 245899999998543221 11111 11 5678899999999999999 9999999999999999 89
Q ss_pred CeEEeeccccccc
Q 002094 820 EPKVGDFGLARLL 832 (967)
Q Consensus 820 ~~kl~Dfg~a~~~ 832 (967)
.++++|||.+...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.5e-14 Score=146.95 Aligned_cols=138 Identities=20% Similarity=0.234 Sum_probs=107.3
Q ss_pred CCCCccC-CCCceEEEEEEeCCCcEEEEEEeecCCc------------cccHHHHHHHHHHHcCCCCCce--eeeeeEEE
Q 002094 685 NKDCELG-RGGFGVVYRTILQDGRSVAIKKLTVSGL------------IKSQEDFEKEMKTLGKIRHHNL--VALEGYYW 749 (967)
Q Consensus 685 ~~~~~lG-~G~~g~Vy~~~~~~~~~vavK~l~~~~~------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~ 749 (967)
.....|| .||.|+||++... +..++||++...+. ......+.+|++++.++.|+++ ++.+++..
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 3356788 9999999999875 78899998854321 1223568889999999988774 66777654
Q ss_pred cC-Cc---eeEEEEecCC-CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEe
Q 002094 750 TP-SL---QLLIYEFISS-GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVG 824 (967)
Q Consensus 750 ~~-~~---~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~ 824 (967)
.. .. .++||||++| .+|.+++.... ++.. .+.+++.++++||++||+||||||.|||++.++.++|+
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~----l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEAP----LSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcCC----CCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEE
Confidence 32 22 2599999997 68988876431 3433 35789999999999999999999999999998999999
Q ss_pred ecccccc
Q 002094 825 DFGLARL 831 (967)
Q Consensus 825 Dfg~a~~ 831 (967)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.7e-15 Score=176.50 Aligned_cols=255 Identities=23% Similarity=0.265 Sum_probs=192.1
Q ss_pred ccCCCCccCCCCceEEEEEEeC--CCcEEEEEEeecCC-ccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCceeEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ--DGRSVAIKKLTVSG-LIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 758 (967)
.|...+.||+|+|+.|-..... ....+|+|.+.... .....+....|..+-..+. |+|++.+++....+...+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 3566677999999999887753 34556777665543 2233455566777777776 999999999999999999999
Q ss_pred EecCCCchhhhh-hcCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCCCEEeCCCC-CeEEeecccccccCC-
Q 002094 759 EFISSGSLYKHL-HDGSSRNCLSWRQRFNIILGMAKGLAYLH-HTNIIHYNLKSTNVLIDSSG-EPKVGDFGLARLLPM- 834 (967)
Q Consensus 759 e~~~~gsL~~~l-~~~~~~~~~~~~~~~~i~~~i~~aL~~LH-~~~ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~~~- 834 (967)
||.+|+++.+-+ +..... .+...+..+..|+..++.|+| ..+++|+|+||+|.+++..+ ..+++|||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~--~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTG--TSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred CcccccccccccccCCccC--CCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999888 443312 455667779999999999999 99999999999999999999 999999999987765
Q ss_pred Cccccccccccc-cccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcc
Q 002094 835 LDRCILSSKIQS-ALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913 (967)
Q Consensus 835 ~~~~~~~~~~~g-t~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (967)
...........| ++.|+|||...+........|+||.|+++..+++|..||+...........|.....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 248 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG---------- 248 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccc----------
Confidence 344444445667 999999999866566778899999999999999999999855443332222222110
Q ss_pred hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHH
Q 002094 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVV 950 (967)
Q Consensus 914 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl 950 (967)
...............++..+++..+|..|.+.+++.
T Consensus 249 -~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 249 -RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -ccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 001112334455677888999999999999988764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.5e-14 Score=135.03 Aligned_cols=132 Identities=21% Similarity=0.145 Sum_probs=112.3
Q ss_pred CCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCC--CceeeeeeEEEcCCceeEEEEecCCC
Q 002094 687 DCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRH--HNLVALEGYYWTPSLQLLIYEFISSG 764 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g 764 (967)
.+.+|+|.++.||++...+ ..+++|....... ...+..|+.+++.++| ..+++++++...++..+++|||++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 4679999999999999864 7899998865432 5678999999999976 58899998888878899999999987
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCCCCEEeCCCCCeEEeeccccccc
Q 002094 765 SLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT---NIIHYNLKSTNVLIDSSGEPKVGDFGLARLL 832 (967)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~---~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 832 (967)
.+..+ +......++.+++++++++|.. +++|+|++|+||+++..+.++++|||.+...
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 76544 4466777899999999999985 7999999999999999899999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.5e-14 Score=169.63 Aligned_cols=116 Identities=30% Similarity=0.534 Sum_probs=87.3
Q ss_pred CCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecC
Q 002094 460 LKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISH 539 (967)
Q Consensus 460 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~ 539 (967)
++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 66777888888877887888888888888888888878887788888888888888888888888888888888888888
Q ss_pred CcccccCCCCC--CCCccCCCcccCCCCCCCccccCCC
Q 002094 540 NHLHGELPVGG--FFNTISPSSVSGNPSLCGSVVNRSC 575 (967)
Q Consensus 540 N~l~~~~p~~~--~~~~~~~~~~~~n~~lc~~~~~~~c 575 (967)
|+++|.+|..- .........+.+|+.+|+.+....|
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence 88888777531 1122334567899999987654455
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.3e-12 Score=148.12 Aligned_cols=143 Identities=22% Similarity=0.256 Sum_probs=101.5
Q ss_pred CCccCCCCceEEEEEEeCCCcEEEEEEeecCCcccc---------------------------------------HHHHH
Q 002094 687 DCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKS---------------------------------------QEDFE 727 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~---------------------------------------~~~~~ 727 (967)
.+.||.|++|+||+|+.++|+.||||+.+......- .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 467999999999999999999999999865321000 01245
Q ss_pred HHHHHHcCC----C-CCceeeeeeEEEcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHhcC
Q 002094 728 KEMKTLGKI----R-HHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAK-GLAYLHHT 801 (967)
Q Consensus 728 ~E~~~l~~l----~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~-aL~~LH~~ 801 (967)
+|++.+.++ + ++++.-..-+....+..++||||++|++|.+........ . .+.+++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhC
Confidence 566555554 2 343332222222245579999999999998876532111 2 23456666666 47889999
Q ss_pred CcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 802 ~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
|++|+|++|.||+++.+++++++|||++..++.
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.1e-14 Score=154.99 Aligned_cols=176 Identities=30% Similarity=0.459 Sum_probs=95.0
Q ss_pred eEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCcc
Q 002094 146 EVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNK 225 (967)
Q Consensus 146 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 225 (967)
..||+.|++. .+|..+..+..|+.|.|.+|.+. .+|..+.++..|++|||+.|+++ ..|..++.| -|+.|-+++|+
T Consensus 79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvli~sNNk 154 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVLIVSNNK 154 (722)
T ss_pred hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cceeEEEecCc
Confidence 3444444444 44444555555555555555554 44555555555555555555554 334444444 25555555555
Q ss_pred ccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCC
Q 002094 226 FSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSS 305 (967)
Q Consensus 226 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 305 (967)
++ .+|+.++.+..|..||.+.|.+. .+|..+.++.+|+.|++..|++. .+|..+.. -.|..||++.|+++ .+|-.
T Consensus 155 l~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNkis-~iPv~ 229 (722)
T KOG0532|consen 155 LT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKIS-YLPVD 229 (722)
T ss_pred cc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCcee-ecchh
Confidence 55 55666666666666666666665 45555555556666666666555 34444442 24555566666665 45555
Q ss_pred CCcccccceEEcccCcCCCCCChhhh
Q 002094 306 IGNLVFLKELNISMNQFTGGLPESMM 331 (967)
Q Consensus 306 ~~~l~~L~~L~L~~N~l~~~~~~~~~ 331 (967)
|.+|..|++|-|.+|.++ ..|..++
T Consensus 230 fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 230 FRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred hhhhhhheeeeeccCCCC-CChHHHH
Confidence 556666666666666555 3344443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2e-12 Score=147.03 Aligned_cols=180 Identities=38% Similarity=0.592 Sum_probs=91.6
Q ss_pred CCCCCEEEccCCCCCCcCchhhcccc-ccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEE
Q 002094 261 LNSCSSLSLKGNSFTGEVPDWIGKLA-NLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAI 339 (967)
Q Consensus 261 l~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 339 (967)
++.++.|++.+|.++ .++.....++ +|+.|++++|++. .+|..+..++.|+.|++++|+++ .+|...+..++|+.|
T Consensus 115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L 191 (394)
T COG4886 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL 191 (394)
T ss_pred ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence 344555555555555 3333344442 5666666666665 34444566666666666666666 334444455666666
Q ss_pred EccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccc
Q 002094 340 DVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSM 419 (967)
Q Consensus 340 ~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 419 (967)
++++|+++ .+|...... ..|++|.+++|.+. ..+..+.++.++..|.+.+
T Consensus 192 ~ls~N~i~-~l~~~~~~~----------------------------~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~ 241 (394)
T COG4886 192 DLSGNKIS-DLPPEIELL----------------------------SALEELDLSNNSII-ELLSSLSNLKNLSGLELSN 241 (394)
T ss_pred eccCCccc-cCchhhhhh----------------------------hhhhhhhhcCCcce-ecchhhhhcccccccccCC
Confidence 66666665 344332111 12333333333221 2333444555555555555
Q ss_pred cccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCc
Q 002094 420 NYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPS 476 (967)
Q Consensus 420 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 476 (967)
|++. ..+..+..+.++++|++++|+++. ++. ++.+.+++.|++++|.+...+|.
T Consensus 242 n~~~-~~~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 242 NKLE-DLPESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred ceee-eccchhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchh
Confidence 5553 224555555556666666666652 222 55555666666666665544443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1e-13 Score=149.71 Aligned_cols=174 Identities=29% Similarity=0.466 Sum_probs=99.3
Q ss_pred ccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEec
Q 002094 285 LANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSL 364 (967)
Q Consensus 285 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L 364 (967)
+.--...||+.|++. .+|..+..+..|+.+.|.+|.+. .+|..++++..|++|||+.|+++ ..|..++...|+.|.+
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~ 150 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIV 150 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEE
Confidence 344455677777776 66777777777777777777776 66777777777777777777776 5666555544444444
Q ss_pred cCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCC
Q 002094 365 SGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDN 444 (967)
Q Consensus 365 ~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 444 (967)
++|+ ++ .+|+.++.+..|..|+.+.|.+. .+|..++++.+|+.|.+..|
T Consensus 151 sNNk-----------------------------l~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn 199 (722)
T KOG0532|consen 151 SNNK-----------------------------LT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRN 199 (722)
T ss_pred ecCc-----------------------------cc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhh
Confidence 4444 43 34555555555666666666654 44555555555555555555
Q ss_pred cccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCc
Q 002094 445 WLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLT 495 (967)
Q Consensus 445 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 495 (967)
++. .+|++++.+ .|..||+|.|+++ .+|-.|.+|+.|++|-|.+|.|+
T Consensus 200 ~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 200 HLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 554 344444422 3444444444444 44444444444444444444444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.3e-12 Score=146.55 Aligned_cols=197 Identities=29% Similarity=0.449 Sum_probs=105.3
Q ss_pred eEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCC-CCceEeccccccCCCCccccccccccceeeecc
Q 002094 97 VLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCG-SLREVSFANNNLTGPIPESLSFCSSLESVNFSS 175 (967)
Q Consensus 97 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 175 (967)
.|+++.|.+... ...+..++.++.|++.+|.++ .+|... ..++ +|++|++++|++. .+|..+..+++|+.|++++
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~-~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLI-GLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCcccc-ccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 355555554322 223344455666666666665 344322 2332 5666666666665 3334455666666666666
Q ss_pred cccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCC
Q 002094 176 NRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLP 255 (967)
Q Consensus 176 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 255 (967)
|+++ .+|...+.+++|+.|++++|++. .+|..+..+..|++|.+++|++. ..+..+..++++..|.+.+|++. ..+
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~ 248 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLP 248 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ecc
Confidence 6665 44444445566666666666655 23333344444666666666432 24455555666666666666655 224
Q ss_pred hhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccC
Q 002094 256 DSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIP 303 (967)
Q Consensus 256 ~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 303 (967)
..+..++++++|++++|.++.... ++.+.+++.|++++|.+....|
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred chhccccccceecccccccccccc--ccccCccCEEeccCccccccch
Confidence 555666666666666666663322 5566666666666666654433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.9e-12 Score=139.01 Aligned_cols=247 Identities=19% Similarity=0.208 Sum_probs=180.2
Q ss_pred CCCCccCC--CCceEEEEEEe---CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEE
Q 002094 685 NKDCELGR--GGFGVVYRTIL---QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 685 ~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 757 (967)
.....+|. |.+|.||.+.. .++..+|+|+-+.... ......-.+|+...+++ .|++.|+.+..+...+..++-
T Consensus 117 ~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiq 196 (524)
T KOG0601|consen 117 PISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQ 196 (524)
T ss_pred ccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceee
Confidence 55677999 99999999885 4688999998543332 23344556677777777 599999988888888999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCcccCCCCCCCEEeCCC-CCeEEeeccccccc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAK----GLAYLHHTNIIHYNLKSTNVLIDSS-GEPKVGDFGLARLL 832 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~----aL~~LH~~~ivH~Dik~~Nill~~~-~~~kl~Dfg~a~~~ 832 (967)
.|++. .++.++-+..... ++....+....+... |+.++|..+++|-|+||.||+...+ ...++.|||+...+
T Consensus 197 tE~~~-~sl~~~~~~~~~~--~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i 273 (524)
T KOG0601|consen 197 TELCG-ESLQSYCHTPCNF--LPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI 273 (524)
T ss_pred ecccc-chhHHhhhccccc--CCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEc
Confidence 99885 6888887764432 556677777777777 9999999999999999999999998 88999999998877
Q ss_pred CCCccccc---cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 833 PMLDRCIL---SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 833 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
....-... .....|...|++||.. .+.++.+.|+|++|.+..+..+|.++....... .|.. ++.
T Consensus 274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~--~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-----~W~~--~r~---- 340 (524)
T KOG0601|consen 274 SDGNFSSVFKVSKRPEGDCIYAAKELL--NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-----SWSQ--LRQ---- 340 (524)
T ss_pred cCCccccceeeeecCCCCceEeChhhh--ccccchHhhhcchhhhhHhhHhhcccccCCCCC-----Cccc--ccc----
Confidence 54331111 1122466679999987 457899999999999999999988776533211 0110 000
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+..++-.....++...+..+++++|..|++++++..
T Consensus 341 ----~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 341 ----GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00122222333445666889999999999999987654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.9e-12 Score=129.06 Aligned_cols=136 Identities=22% Similarity=0.267 Sum_probs=103.8
Q ss_pred cccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccc
Q 002094 406 IGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLT 485 (967)
Q Consensus 406 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 485 (967)
+.....|.+|+||+|.|+ .+.++..-++.++.|++|+|.+... ..+..+.+|+.||||+|.++ .+..+-..+-+++
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK 355 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence 344566778888888876 5666677778888888888888632 23777888888888888887 4555666788889
Q ss_pred eeeccCCcCcCccchhhhcccCccEEeccCCccccCC-chhhhhccCCceEEecCCcccccCC
Q 002094 486 SLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGIL-PKELINLSHLLSFNISHNHLHGELP 547 (967)
Q Consensus 486 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~l~~N~l~~~~p 547 (967)
.|.|++|.|.. -..+..|-+|..||+++|+|.... -..+++||.|+.+.|.+|++.+.+.
T Consensus 356 tL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 356 TLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred eeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 99999998863 345777888999999999987432 2567889999999999999997554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=3e-10 Score=119.19 Aligned_cols=263 Identities=16% Similarity=0.172 Sum_probs=166.2
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeE------EEcCC-cee
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGY------YWTPS-LQL 755 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~------~~~~~-~~~ 755 (967)
+..++.||+|+.+.+|-.-. -+.-+.|++...... .-.+.++.+... .||-+-.-+.| ..+.+ ...
T Consensus 13 i~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa----~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPA----AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred cCCCccccCCccceeeecch--hhchhheeecCCCch----HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 35577899999999996431 122344776654421 112233444444 45543321111 11222 256
Q ss_pred EEEEecCCC-chhhhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 756 LIYEFISSG-SLYKHLH---DGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 756 lv~e~~~~g-sL~~~l~---~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
+.|..+.+. ....+.. +.+.-....|...+++++.+|.+.+.||.+|.+-||+.++|+|+++++.|.|.|-..-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence 788888764 2222222 222222478999999999999999999999999999999999999999999998765443
Q ss_pred cCCCccccccccccccccccCccccc----CcccCCcccchhhHHHHHHHHHcC-CCCCCCCcc---chHhHH-HHHHhh
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFAC----RTVKITEKCDVYGFGVLVLEVVTG-KRPVEYMED---DVVVLC-DMVRGA 902 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~t~~~Dv~slGvll~elltg-~~p~~~~~~---~~~~~~-~~~~~~ 902 (967)
. ..........|...|.+||.-. .+...+...|.|.+||++++++.| ++||..... ....+. ++.
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia--- 240 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA--- 240 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh---
Confidence 3 2333444567888999999652 133457789999999999999995 999984221 111111 122
Q ss_pred hccCCchhhcchh--hc---CCCC-hhhHHHHHHHHHhhccCC--CCCCCCHHHHHHHHHhhcCCC
Q 002094 903 LEDGRVEDCVDAR--LR---GNFP-ADEAIPVIKLGLICASQV--PSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 903 ~~~~~~~~~~~~~--~~---~~~~-~~~~~~l~~li~~cl~~d--P~~Rpt~~evl~~L~~~~~~~ 960 (967)
.+......+.+ ++ .+.| .-.+..+..+..+|+... +.-|||++.++..|..+.+++
T Consensus 241 --~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 241 --HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred --cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 22222222211 11 1112 223556888888898543 668999999999998877654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=3e-11 Score=119.87 Aligned_cols=126 Identities=21% Similarity=0.214 Sum_probs=95.2
Q ss_pred CccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCce-eeeeeEEEcCCceeEEEEecCCCch
Q 002094 688 CELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNL-VALEGYYWTPSLQLLIYEFISSGSL 766 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL 766 (967)
+.++.|.++.||++... ++.|++|....... ....+..|+++++.+.+.++ .+++.+. ....++||||++|.++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 46899999999999875 78899998755431 23456788888888865444 3444443 3345899999999877
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCc-----ccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 767 YKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI-----IHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 767 ~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~i-----vH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
.+. . . ....++.+++++++.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~-----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE-----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc-----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 543 0 0 112356789999999999875 9999999999998 6789999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.7e-10 Score=114.26 Aligned_cols=137 Identities=19% Similarity=0.182 Sum_probs=98.7
Q ss_pred CCccCCCCceEEEEEEeCC-------CcEEEEEEeecCCc---------------------cccHHHH----HHHHHHHc
Q 002094 687 DCELGRGGFGVVYRTILQD-------GRSVAIKKLTVSGL---------------------IKSQEDF----EKEMKTLG 734 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~---------------------~~~~~~~----~~E~~~l~ 734 (967)
...||.|--+.||.|...+ +..+|||+.+.... ......+ ++|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998553 47999998753210 0012223 37999998
Q ss_pred CCCC--CceeeeeeEEEcCCceeEEEEecCCCchhh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCcccCCCCC
Q 002094 735 KIRH--HNLVALEGYYWTPSLQLLIYEFISSGSLYK-HLHDGSSRNCLSWRQRFNIILGMAKGLAYL-HHTNIIHYNLKS 810 (967)
Q Consensus 735 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~i~~~i~~aL~~L-H~~~ivH~Dik~ 810 (967)
++.. -++.+++++ ...++||||+.++.+.. .+++. .++..+...+..+++.++..+ |+.|+||||+++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 8843 455666654 45689999997754322 22221 144456677889999999999 899999999999
Q ss_pred CCEEeCCCCCeEEeeccccccc
Q 002094 811 TNVLIDSSGEPKVGDFGLARLL 832 (967)
Q Consensus 811 ~Nill~~~~~~kl~Dfg~a~~~ 832 (967)
.||+++ ++.+.++|||.+...
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeC
Confidence 999996 578999999988744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.4e-12 Score=135.42 Aligned_cols=179 Identities=21% Similarity=0.195 Sum_probs=101.9
Q ss_pred eEecCCCccCcc----ccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCC--ccccccccccce
Q 002094 97 VLSLSNNNFTGT----INADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPI--PESLSFCSSLES 170 (967)
Q Consensus 97 ~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~--p~~l~~l~~L~~ 170 (967)
.+.+++-++.+. +..-=.++.+|+.+.|.+..+....-.+....+++++.|||++|-++.-. -.-...|++|+.
T Consensus 97 ~~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~ 176 (505)
T KOG3207|consen 97 VLSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLEN 176 (505)
T ss_pred HhhhcCceeEEecHHHHHHHhhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchh
Confidence 455555555443 22223467888888888888763322245577888888888888776422 223456888888
Q ss_pred eeecccccccccCccc-cccccCCeEeecCCcCCC-cccccccCCCCCCeeeccCccccccCCcCccCCCCccEEecccc
Q 002094 171 VNFSSNRLSGQLPYGI-WFLRSLQSLDLSNNLLEG-EIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVN 248 (967)
Q Consensus 171 L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 248 (967)
|+|+.|++........ ..++.|+.|.|+.|.++. .+.......++|..|+|..|..-........-++.|+.|||++|
T Consensus 177 LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N 256 (505)
T KOG3207|consen 177 LNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNN 256 (505)
T ss_pred cccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCC
Confidence 8888888763332222 246677777777777763 22233445566666666666432233333444556666666666
Q ss_pred ccCCCC-ChhhhcCCCCCEEEccCCCCC
Q 002094 249 SLSGSL-PDSLQRLNSCSSLSLKGNSFT 275 (967)
Q Consensus 249 ~l~~~~-~~~l~~l~~L~~L~L~~n~l~ 275 (967)
++.... -.....++.|+.|+++.+.++
T Consensus 257 ~li~~~~~~~~~~l~~L~~Lnls~tgi~ 284 (505)
T KOG3207|consen 257 NLIDFDQGYKVGTLPGLNQLNLSSTGIA 284 (505)
T ss_pred cccccccccccccccchhhhhccccCcc
Confidence 554211 122334444444444444444
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-10 Score=129.94 Aligned_cols=165 Identities=21% Similarity=0.259 Sum_probs=126.9
Q ss_pred eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCchhhhhhcCCCCCCCCHH
Q 002094 703 LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWR 782 (967)
Q Consensus 703 ~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 782 (967)
..++.+|.|...+.... ...+...+.++.++.++||+|+++++.+...+..|+|+|.+. .|..++... +..
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKE 104 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHH
Confidence 44688888888776553 334567788889999999999999999999999999999885 566777653 345
Q ss_pred HHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccccccccccccCcccccCccc
Q 002094 783 QRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVK 861 (967)
Q Consensus 783 ~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 861 (967)
.....++||+.||.|||. .+++|++|.-..|++++.|+.||++|..+...+.... ......--..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s-- 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS-- 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc--
Confidence 666788999999999985 5899999999999999999999999998865543221 11112222347777765211
Q ss_pred CCcccchhhHHHHHHHHHcC
Q 002094 862 ITEKCDVYGFGVLVLEVVTG 881 (967)
Q Consensus 862 ~t~~~Dv~slGvll~elltg 881 (967)
+-..|.|.||++++|++.|
T Consensus 181 -~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 -EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -ccchhhhhHHHHHHHHhCc
Confidence 1457999999999999998
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2e-10 Score=108.85 Aligned_cols=131 Identities=21% Similarity=0.345 Sum_probs=102.6
Q ss_pred ccCCCCceEEEEEEeCCCcEEEEEEeecCCccc-------cHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIK-------SQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 689 ~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.+++|+-+.+|.+.+. |..+++|.-.+..... ..++-.+|++++.+++.-.|....-+..+++...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999875 5556777554333211 1246778999999887666666666677888899999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
+|..|.+.+... ...++..+-.-+.-||..||+|+|+.++||++..++ +.++|||++.+
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999998888654 234667777778899999999999999999997654 99999999863
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.7e-12 Score=130.55 Aligned_cols=245 Identities=22% Similarity=0.255 Sum_probs=153.6
Q ss_pred CCeeeeeeecCCCCCc----cccccccCCCCCCeEecCC---CccCccccc-------cccCCCCCcEEEcCCCCCCCCC
Q 002094 68 TKRVVGLTLDGFSLSG----HIGRGLLRLQFLQVLSLSN---NNFTGTINA-------DLASFGTLQVVDFSENNLSGLI 133 (967)
Q Consensus 68 ~~~v~~l~l~~~~l~~----~~~~~l~~l~~L~~L~L~~---n~l~~~~~~-------~~~~l~~L~~L~Ls~n~~~~~i 133 (967)
...++.|+|+||.+.- .+...+.+.++|+.-++|+ -++...+|+ ++...++|++||||+|.+.-..
T Consensus 29 ~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g 108 (382)
T KOG1909|consen 29 MDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKG 108 (382)
T ss_pred cCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccc
Confidence 3578889999887743 3556677788888888887 233334454 3455678888888888886444
Q ss_pred Cc---hhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCccc---
Q 002094 134 PD---EFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIV--- 207 (967)
Q Consensus 134 p~---~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~--- 207 (967)
+. ++++.+.+|++|+|.+|.+.-.-...++. .|..|. .|+ -..+-++|+.+..++|.+.....
T Consensus 109 ~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~ga~~~ 177 (382)
T KOG1909|consen 109 IRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAASKPKLRVFICGRNRLENGGATAL 177 (382)
T ss_pred hHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCCCcceEEEEeeccccccccHHHH
Confidence 33 33566788888888888776322222221 122222 111 11233456666666666654322
Q ss_pred -ccccCCCCCCeeeccCccccc----cCCcCccCCCCccEEeccccccCCC----CChhhhcCCCCCEEEccCCCCCCcC
Q 002094 208 -KGISNLYDLRAIKLGKNKFSG----QLPEDIGGCSMLKVLDFGVNSLSGS----LPDSLQRLNSCSSLSLKGNSFTGEV 278 (967)
Q Consensus 208 -~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~ 278 (967)
..|...+.|+.+.+..|.|.. .+...|..+++|++|||..|.++.. +.+.+..+++|+.|++++|.++...
T Consensus 178 A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~G 257 (382)
T KOG1909|consen 178 AEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEG 257 (382)
T ss_pred HHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccccccc
Confidence 234455666666666666541 2234566778888888888887643 3455667788888888888887554
Q ss_pred chhh-----ccccccccccccccccccc----cCCCCCcccccceEEcccCcCC
Q 002094 279 PDWI-----GKLANLESLDLSLNQFSGR----IPSSIGNLVFLKELNISMNQFT 323 (967)
Q Consensus 279 ~~~l-----~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 323 (967)
..+| ...++|++|.+.+|.|+.. +...+...+.|..|+|++|.+.
T Consensus 258 a~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 258 AIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 3333 2367888888888888632 2223455788999999999884
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.3e-11 Score=138.94 Aligned_cols=143 Identities=15% Similarity=0.205 Sum_probs=93.9
Q ss_pred cCCCCccCCCCceEEEEEEeCC-CcEEEEEEeecCCcc---------------------------------ccH------
Q 002094 684 LNKDCELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLI---------------------------------KSQ------ 723 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~---------------------------------~~~------ 723 (967)
|+. +.||+|++|+||+|+.++ |+.||||+.++.-.. +-.
T Consensus 122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E 200 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE 200 (537)
T ss_pred cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence 354 789999999999999887 999999999754210 000
Q ss_pred HHHHHHHHHHcCC----CCCceeeeeeEEEc-CCceeEEEEecCCCchhhhh--hcCCCCCCCCHHHHHHHHHHHH-HHH
Q 002094 724 EDFEKEMKTLGKI----RHHNLVALEGYYWT-PSLQLLIYEFISSGSLYKHL--HDGSSRNCLSWRQRFNIILGMA-KGL 795 (967)
Q Consensus 724 ~~~~~E~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~i~~~i~-~aL 795 (967)
-++.+|+..+.++ .+...+.+-.++++ .+..++||||++|+++.+.- .... .+.. .++...+ .-+
T Consensus 201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g----~d~~---~la~~~v~~~~ 273 (537)
T PRK04750 201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG----TDMK---LLAERGVEVFF 273 (537)
T ss_pred hCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC----CCHH---HHHHHHHHHHH
Confidence 1244455444444 23333443333332 45678999999999997642 2211 1111 1222222 223
Q ss_pred HHHhcCCcccCCCCCCCEEeCCCC----CeEEeecccccccCC
Q 002094 796 AYLHHTNIIHYNLKSTNVLIDSSG----EPKVGDFGLARLLPM 834 (967)
Q Consensus 796 ~~LH~~~ivH~Dik~~Nill~~~~----~~kl~Dfg~a~~~~~ 834 (967)
..+...|++|+|++|.||+++.++ +++++|||++...+.
T Consensus 274 ~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 445578999999999999999888 999999999987754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.7e-11 Score=121.88 Aligned_cols=202 Identities=26% Similarity=0.321 Sum_probs=134.2
Q ss_pred HHHcCCCCCceeeeeeEEEcC-----CceeEEEEecCCCchhhhhhcCCCCC-CCCHHHHHHHHHHHHHHHHHHhcC--C
Q 002094 731 KTLGKIRHHNLVALEGYYWTP-----SLQLLIYEFISSGSLYKHLHDGSSRN-CLSWRQRFNIILGMAKGLAYLHHT--N 802 (967)
Q Consensus 731 ~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~i~~~i~~aL~~LH~~--~ 802 (967)
.-+-++.|.|+|+++.|+.+. ....++.|||..|++.++|++.+... .+....-.+|..||..||.|||+- .
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 334556799999999998643 44679999999999999998754332 366667778999999999999985 7
Q ss_pred cccCCCCCCCEEeCCCCCeEEeecccccccCCC--ccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc
Q 002094 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML--DRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT 880 (967)
Q Consensus 803 ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt 880 (967)
|+|+++..+-|++..+|-+|+.--.-....+.. ..........+-++|.+||.- .....+.++|||+||+...||.-
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG-TTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC-cccccccchhhhhhhHHHHHHHH
Confidence 999999999999999998887522111111110 011112233456789999976 45567789999999999999987
Q ss_pred CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 881 GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 881 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+..--.........-..+..-.+. +. ...=..++.+|++..|..||+|.+.+.
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~-----------le-------n~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIG-----------LE-------NGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhhhhheee-----------cc-------CccccCcCcccccCCCCCCcchhhhhc
Confidence 665321111100000000000000 00 001124788899999999999998754
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.15 E-value=6e-12 Score=125.49 Aligned_cols=134 Identities=29% Similarity=0.307 Sum_probs=109.5
Q ss_pred CCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEE
Q 002094 384 SYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKEL 463 (967)
Q Consensus 384 ~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 463 (967)
..+.|++||||+|.|+ .+.+...-.+.++.|++|+|.+.. + ..+..+.+|+.||||+|.++ .+-.+-.++.+.+.|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 3567899999999998 455667778899999999999963 2 33888999999999999997 556666778899999
Q ss_pred EcCCCCCCCcCCccccccCccceeeccCCcCcCcc-chhhhcccCccEEeccCCccccCCc
Q 002094 464 KLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPV-PAAIANLSNLKYVDLSFNDLSGILP 523 (967)
Q Consensus 464 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p 523 (967)
.|+.|.|.. -+.++.+-+|..||+++|+|.... -..+++|+-|+.|.|.+|.|.+...
T Consensus 358 ~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 358 KLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred ehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 999999862 246788899999999999997422 2468999999999999999995543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.9e-12 Score=143.22 Aligned_cols=247 Identities=26% Similarity=0.290 Sum_probs=154.5
Q ss_pred cCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccc
Q 002094 90 LRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLE 169 (967)
Q Consensus 90 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 169 (967)
..+..++.++++.|.+.. +-..+..+++|..|++.+|+|.. +... +..+++|++|+|++|.|+... .+..++.|+
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~-l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~ 143 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENL-LSSLVNLQVLDLSFNKITKLE--GLSTLTLLK 143 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccc-hhhhhcchheecccccccccc--chhhccchh
Confidence 356777777788887774 33457777888888888888873 3321 356788888888888888653 366777788
Q ss_pred eeeecccccccccCccccccccCCeEeecCCcCCCccc-ccccCCCCCCeeeccCccccccCCcCccCCCCccEEecccc
Q 002094 170 SVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIV-KGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVN 248 (967)
Q Consensus 170 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 248 (967)
.|++++|.|+.. ..+..+++|+.+++++|.+....+ . ...+.+++.+++.+|.+.. ...+..+..+..+++..|
T Consensus 144 ~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 144 ELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDN 218 (414)
T ss_pred hheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccc
Confidence 888888888733 345557788888888888775444 2 5667777777777777762 234445555566677777
Q ss_pred ccCCCCChhhhcCC--CCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCC-
Q 002094 249 SLSGSLPDSLQRLN--SCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGG- 325 (967)
Q Consensus 249 ~l~~~~~~~l~~l~--~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~- 325 (967)
.++..-+ +..+. .|+.+++.+|.+. ..+..+..+.++..|++.+|++... ..+...+.+..+.+..|++...
T Consensus 219 ~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 293 (414)
T KOG0531|consen 219 KISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSE 293 (414)
T ss_pred cceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchh
Confidence 7663221 12222 2666777777766 2324456666777777777776633 2345556666666666665521
Q ss_pred --CChh-hhcCCCCcEEEccCCcCcCCCC
Q 002094 326 --LPES-MMNCGNLLAIDVSQNKLTGNIP 351 (967)
Q Consensus 326 --~~~~-~~~l~~L~~L~l~~N~l~~~~p 351 (967)
.... ....++++.+.+..|.+....+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 294 AISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hhhccccccccccccccccccCccccccc
Confidence 1111 3445566666666666654433
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.6e-12 Score=128.78 Aligned_cols=243 Identities=23% Similarity=0.291 Sum_probs=160.8
Q ss_pred ccccCCCCCCeEecCCCccCc----cccccccCCCCCcEEEcCCC---CCCCCCCchhhhcCCCCceEeccccccCCCCc
Q 002094 87 RGLLRLQFLQVLSLSNNNFTG----TINADLASFGTLQVVDFSEN---NLSGLIPDEFFRQCGSLREVSFANNNLTGPIP 159 (967)
Q Consensus 87 ~~l~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~n---~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p 159 (967)
+.+..+..++.|+||+|.|.. .+-..+.+.++|+..++|+= +....+|..+ . .+.
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L-~-----------------~l~ 85 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEAL-K-----------------MLS 85 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHH-H-----------------HHH
Confidence 345566777888888887764 24556666777777777642 1222233321 0 011
Q ss_pred cccccccccceeeecccccccccCccc----cccccCCeEeecCCcCCCcc-------------cccccCCCCCCeeecc
Q 002094 160 ESLSFCSSLESVNFSSNRLSGQLPYGI----WFLRSLQSLDLSNNLLEGEI-------------VKGISNLYDLRAIKLG 222 (967)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~L~L~~n~l~~~~-------------~~~~~~l~~L~~L~L~ 222 (967)
..+..+++|++||||.|-+....+..| .++.+|++|+|.+|.+.-.. .+....-+.|+.+..+
T Consensus 86 ~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~ 165 (382)
T KOG1909|consen 86 KALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICG 165 (382)
T ss_pred HHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEee
Confidence 223334455555555555543222222 33455666666666554211 1223456789999999
Q ss_pred CccccccC----CcCccCCCCccEEeccccccCCC----CChhhhcCCCCCEEEccCCCCCCc----Cchhhcccccccc
Q 002094 223 KNKFSGQL----PEDIGGCSMLKVLDFGVNSLSGS----LPDSLQRLNSCSSLSLKGNSFTGE----VPDWIGKLANLES 290 (967)
Q Consensus 223 ~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~ 290 (967)
+|++.... ...|...+.|+.+.++.|.|... +...|..++.|+.|+|++|-++.. +...+..+++|+.
T Consensus 166 rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~E 245 (382)
T KOG1909|consen 166 RNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRE 245 (382)
T ss_pred ccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchhee
Confidence 99986432 34566778999999999998733 345688999999999999999754 3456778899999
Q ss_pred ccccccccccccCCCC-----CcccccceEEcccCcCCC----CCChhhhcCCCCcEEEccCCcCc
Q 002094 291 LDLSLNQFSGRIPSSI-----GNLVFLKELNISMNQFTG----GLPESMMNCGNLLAIDVSQNKLT 347 (967)
Q Consensus 291 L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~ 347 (967)
|++++|.+......+| ...++|+.|.+.+|.|+. .+...+...+.|..|+|++|.+.
T Consensus 246 l~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 246 LNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 9999999985433333 236899999999999984 23445567899999999999994
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.1e-11 Score=140.91 Aligned_cols=244 Identities=25% Similarity=0.275 Sum_probs=136.9
Q ss_pred cccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEecc
Q 002094 286 ANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLS 365 (967)
Q Consensus 286 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~ 365 (967)
..++.+++..|.+.. +-..+..+.+|..|++.+|+|... ...+..+++|++|++++|.|+. +...-....|+.|+++
T Consensus 72 ~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~-i~~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITK-LEGLSTLTLLKELNLS 148 (414)
T ss_pred HhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccc-ccchhhccchhhheec
Confidence 344444444444442 222344444455555555554422 1114445555555555555542 2222222235555555
Q ss_pred CCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCC-CCcccccccchhcccccccccccCCCcCCcccccEEEecCC
Q 002094 366 GNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIP-SNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDN 444 (967)
Q Consensus 366 ~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 444 (967)
+|.|...... ..+..|+.+++++|++...-+ . ...+.+++.+++++|.+. ....+..+..+..+++.+|
T Consensus 149 ~N~i~~~~~~-------~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 149 GNLISDISGL-------ESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDN 218 (414)
T ss_pred cCcchhccCC-------ccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccc
Confidence 5555443332 226778888888888875544 2 466778888888888874 3344555666666688888
Q ss_pred cccccCcccccCCCC--CCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccC-
Q 002094 445 WLNGTIPPQIGGAVS--LKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGI- 521 (967)
Q Consensus 445 ~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~- 521 (967)
.++..-+ +..+.. |+.+++++|.+. ..+..+..+.++..|++++|++...- .+.....+..+.++.|.+...
T Consensus 219 ~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 293 (414)
T KOG0531|consen 219 KISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALSE 293 (414)
T ss_pred cceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--cccccchHHHhccCcchhcchh
Confidence 7763322 222333 778888888877 44456677777788888888776432 244556666777777775521
Q ss_pred --Cchh-hhhccCCceEEecCCcccccCC
Q 002094 522 --LPKE-LINLSHLLSFNISHNHLHGELP 547 (967)
Q Consensus 522 --~p~~-l~~l~~L~~L~l~~N~l~~~~p 547 (967)
.... ....+.+..+.+..|+.....+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 294 AISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hhhccccccccccccccccccCccccccc
Confidence 1111 4455566666666666665443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.9e-11 Score=116.30 Aligned_cols=108 Identities=22% Similarity=0.309 Sum_probs=25.1
Q ss_pred cCCCCCCeEecCCCccCcccccccc-CCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCcccc-ccccc
Q 002094 90 LRLQFLQVLSLSNNNFTGTINADLA-SFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESL-SFCSS 167 (967)
Q Consensus 90 ~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~ 167 (967)
.+...+++|+|++|+|+.+ +.++ .+.+|+.|||++|.|+ .++. +..+++|++|++++|+|+.. .+.+ ..+++
T Consensus 16 ~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~~--l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~ 89 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLEG--LPGLPRLKTLDLSNNRISSI-SEGLDKNLPN 89 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---TT------TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccc--cchhhhhcCCCEEECCCCCCc-cccC--ccChhhhhhcccCCCCCCcc-ccchHHhCCc
Confidence 3444566666666666643 2343 3556666666666665 2322 34555566666666666532 2222 34555
Q ss_pred cceeeecccccccccC-ccccccccCCeEeecCCcCC
Q 002094 168 LESVNFSSNRLSGQLP-YGIWFLRSLQSLDLSNNLLE 203 (967)
Q Consensus 168 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~n~l~ 203 (967)
|++|+|++|+|...-. ..+..+++|+.|+|.+|.++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 5555555555542211 22334444555555544443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.7e-10 Score=104.37 Aligned_cols=143 Identities=20% Similarity=0.249 Sum_probs=107.9
Q ss_pred CCccCCCCceEEEEEEeCCCcEEEEEEeecCCccc-------cHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 687 DCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIK-------SQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
...+-+|+-+.|+++.+. |+...||.-....... ..++..+|++++.++.--.|....-++.+...-.++||
T Consensus 12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 457889999999999885 8888888654443211 23578889999998865555555555666677789999
Q ss_pred ecCC-CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC---CeEEeecccccc
Q 002094 760 FISS-GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG---EPKVGDFGLARL 831 (967)
Q Consensus 760 ~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~---~~kl~Dfg~a~~ 831 (967)
|++| .++.+++....... ........++..|-+.+.-||..+++|||+..+||++..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 57888887654433 22222367888999999999999999999999999997554 358999999863
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.7e-11 Score=129.01 Aligned_cols=209 Identities=20% Similarity=0.232 Sum_probs=140.3
Q ss_pred cCCCCCCeEecCCCccCcccc-ccccCCCCCcEEEcCCCCCCCCCC-chhhhcCCCCceEeccccccCCCCcccc-cccc
Q 002094 90 LRLQFLQVLSLSNNNFTGTIN-ADLASFGTLQVVDFSENNLSGLIP-DEFFRQCGSLREVSFANNNLTGPIPESL-SFCS 166 (967)
Q Consensus 90 ~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~~~~~ip-~~~~~~l~~L~~L~L~~n~l~~~~p~~l-~~l~ 166 (967)
.++..|+...|.+..+..... .....|++++.||||.|-++.--| ..+...+++|+.|+|+.|++........ ..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 367889999999988763321 466789999999999998874322 3456789999999999999875443322 4678
Q ss_pred ccceeeecccccccc-cCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCC--cCccCCCCccEE
Q 002094 167 SLESVNFSSNRLSGQ-LPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLP--EDIGGCSMLKVL 243 (967)
Q Consensus 167 ~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L 243 (967)
+|+.|.|+.|.++.. +-......|+|+.|+|..|.....-......+..|+.|+|++|++-. .+ ...+.++.|..|
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhh
Confidence 999999999998732 22234468999999999996444445556677889999999998863 33 457788999999
Q ss_pred eccccccCCCC-Chh-----hhcCCCCCEEEccCCCCCCcC-chhhccccccccccccccccc
Q 002094 244 DFGVNSLSGSL-PDS-----LQRLNSCSSLSLKGNSFTGEV-PDWIGKLANLESLDLSLNQFS 299 (967)
Q Consensus 244 ~l~~n~l~~~~-~~~-----l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~N~l~ 299 (967)
+++.+.+.... |+. ...+++|++|++..|+|...- -..+..+++|+.|.+..|.++
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 99999887432 221 233455555555555553210 122333344444444444443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.4e-10 Score=112.38 Aligned_cols=125 Identities=26% Similarity=0.343 Sum_probs=39.8
Q ss_pred cccccchhcccccccccccCCCcC-CcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccc-cccCccc
Q 002094 408 DLSSLMLLNMSMNYLFGSIPASIG-KLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQI-KNCSSLT 485 (967)
Q Consensus 408 ~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~ 485 (967)
+..++++|+|++|.|.. + +.++ .+.+|+.|+|++|.++. + +.+..++.|+.|++++|+|+. ++..+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l-~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-L-EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred ccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-c-cCccChhhhhhcccCCCCCCc-cccchHHhCCcCC
Confidence 33456666666666642 2 2333 45666777777777663 2 235566677777777777763 33333 3567777
Q ss_pred eeeccCCcCcCcc-chhhhcccCccEEeccCCccccCCc---hhhhhccCCceEEe
Q 002094 486 SLILSQNNLTGPV-PAAIANLSNLKYVDLSFNDLSGILP---KELINLSHLLSFNI 537 (967)
Q Consensus 486 ~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~l 537 (967)
.|+|++|+|.... -..+..+++|+.|+|.+|+++...- ..+..+|+|+.||-
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 7777777775422 1345666777777777777663311 23556677776654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1e-10 Score=141.52 Aligned_cols=134 Identities=23% Similarity=0.262 Sum_probs=101.3
Q ss_pred ccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCC-CCCCCchhhhcCCCCceEeccccccCCCCccccccccc
Q 002094 89 LLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNL-SGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSS 167 (967)
Q Consensus 89 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~-~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 167 (967)
..+....++..+-+|++.-. +... ..++|+.|-+..|.- ...++.++|..++.|++|||++|.--+.+|..++.|-+
T Consensus 519 ~~~~~~~rr~s~~~~~~~~~-~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~ 596 (889)
T KOG4658|consen 519 VKSWNSVRRMSLMNNKIEHI-AGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVH 596 (889)
T ss_pred ccchhheeEEEEeccchhhc-cCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhh
Confidence 34446778888888877632 2222 234788888888862 33677788888999999999988777788889999999
Q ss_pred cceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCcc
Q 002094 168 LESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNK 225 (967)
Q Consensus 168 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 225 (967)
|++|+|++..++ .+|..+.+|++|.+|++..+.-...++.....+++|++|.+....
T Consensus 597 LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 597 LRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred hhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 999999999888 888888889999999988887555556666667778877776544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.6e-10 Score=128.39 Aligned_cols=245 Identities=18% Similarity=0.152 Sum_probs=171.9
Q ss_pred cCCCCccCCCCceEEEEEEeC--CCcEEEEEEeecCCccc-cHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ--DGRSVAIKKLTVSGLIK-SQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+.....||.|.|+.||+...+ ++..|++|.+....... +...-..|+-+...+ .|.+++.++..+..-...++=-|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 366778999999999998854 57889999876554322 122223455555555 58888888877777777788899
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC-CCeEEeecccccccCCCccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS-GEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~-~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++++.....-. ..++...++++..|++.++.++|++.++|+|+||+||++..+ +.-++.|||+...+..
T Consensus 347 ~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~---- 419 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF---- 419 (524)
T ss_pred hhcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce----
Confidence 99999887666222 237778899999999999999999999999999999999876 7789999998864321
Q ss_pred ccccccccccccc-CcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 839 ILSSKIQSALGYM-APEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 839 ~~~~~~~gt~~y~-aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
......+.-++. .+|.+.....+..+.|+|+||.-+.|.++|..--..... |.. +.. ..-
T Consensus 420 -~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------~~~--i~~---------~~~ 480 (524)
T KOG0601|consen 420 -SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------SLT--IRS---------GDT 480 (524)
T ss_pred -ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------cee--eec---------ccc
Confidence 112222333455 366665777888999999999999999987754221111 000 000 000
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILEL 955 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 955 (967)
.........+..+.+.+..+++..||.+.+.....+-
T Consensus 481 -p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 481 -PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 1112223667788889999999999999887665443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.3e-09 Score=113.49 Aligned_cols=140 Identities=22% Similarity=0.287 Sum_probs=106.9
Q ss_pred CccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCC--ceeeeeeEEEcC---CceeEEEEecC
Q 002094 688 CELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH--NLVALEGYYWTP---SLQLLIYEFIS 762 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~~ 762 (967)
+.+|.|..+.||+++..+|+.+++|.............+..|+++++.+.+. .+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 5689999999999998777899999876544222456789999999998653 456677776553 25689999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH------------------------------------------ 800 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~------------------------------------------ 800 (967)
|.++.+.+.. ..++..+...++.++++++++||+
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888776532 125666777778888888888773
Q ss_pred --------------CCcccCCCCCCCEEeCC--CCCeEEeecccccc
Q 002094 801 --------------TNIIHYNLKSTNVLIDS--SGEPKVGDFGLARL 831 (967)
Q Consensus 801 --------------~~ivH~Dik~~Nill~~--~~~~kl~Dfg~a~~ 831 (967)
..++|+|+.+.||+++. ++.+.++||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23589999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.3e-10 Score=82.32 Aligned_cols=40 Identities=45% Similarity=1.030 Sum_probs=31.0
Q ss_pred hhHHHHHHHHHhcCC-CCccccCCCCCCC-CCCCccceEEeC
Q 002094 26 NDDVLGLIVFKAGLE-DPKEKLTSWSEDD-DNPCNWVGVKCD 65 (967)
Q Consensus 26 ~~d~~all~~k~~~~-~~~~~l~sw~~~~-~~~c~w~gv~c~ 65 (967)
.+|++||++||+++. ||.+.+.+|+... .+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999998 5778999998863 579999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.5e-08 Score=106.63 Aligned_cols=142 Identities=16% Similarity=0.069 Sum_probs=99.8
Q ss_pred CccCCCCceEEEEEEeCCCcEEEEEEeecCCcc----------ccHHHHHHHHHHHcCCCCCce--eeeeeEEEc-----
Q 002094 688 CELGRGGFGVVYRTILQDGRSVAIKKLTVSGLI----------KSQEDFEKEMKTLGKIRHHNL--VALEGYYWT----- 750 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~----- 750 (967)
+.+-+-....|++..+ +|+.|.||+....... .....+.+|.+.+.++...+| ++++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3344444455777766 4789999977433311 111247889998888743332 344444432
Q ss_pred CCceeEEEEecCCC-chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC-------CCCeE
Q 002094 751 PSLQLLIYEFISSG-SLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS-------SGEPK 822 (967)
Q Consensus 751 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~-------~~~~k 822 (967)
....++|+|++++. +|.+++..... ...+...+..++.+++..++.||+.||+|+|++++|||++. +..+.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEE
Confidence 23468999999986 88888753221 12456677889999999999999999999999999999975 46799
Q ss_pred Eeecccccc
Q 002094 823 VGDFGLARL 831 (967)
Q Consensus 823 l~Dfg~a~~ 831 (967)
++||+.+..
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998753
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.6e-09 Score=131.31 Aligned_cols=125 Identities=22% Similarity=0.258 Sum_probs=53.2
Q ss_pred CCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccc--cCCCCccccccccccceeeecccccccccCccccccccCCe
Q 002094 117 GTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNN--LTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQS 194 (967)
Q Consensus 117 ~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~--l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 194 (967)
...+.+.+-+|.+. .++.. ...++|++|-+..|. +.....+.|..++.|+.|||++|.=-+.+|..++.|-+|++
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~--~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGS--SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hheeEEEEeccchh-hccCC--CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 34444444444443 22222 123345555555543 33222333444555555555544433344444444444444
Q ss_pred EeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEec
Q 002094 195 LDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDF 245 (967)
Q Consensus 195 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 245 (967)
|+|+++.++ ..|..+.+|..|.+|++..+.....+|.....+++|++|.+
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l 649 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRL 649 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEe
Confidence 444444444 33444444444444444443332223333333344444333
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.2e-09 Score=85.53 Aligned_cols=60 Identities=43% Similarity=0.589 Sum_probs=33.2
Q ss_pred ccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcc
Q 002094 483 SLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHL 542 (967)
Q Consensus 483 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l 542 (967)
+|+.|+|++|+|+...+..|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544445555555555555555555555555555555555555555543
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.1e-09 Score=127.59 Aligned_cols=248 Identities=19% Similarity=0.205 Sum_probs=165.2
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.+...+-+-+|.++.++-+.-. .|...++|....... ..+.+...++-.+.-...+|.+++..--+......+++++
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH 884 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH
Confidence 3455567889999999877633 344444443322211 0111222222222323345666665555555677889999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC----
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML---- 835 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~---- 835 (967)
|..+++|..-++.... .+.+........+..+.+|||...+.|+|++|.|.+...+++.++.|||........
T Consensus 885 ~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred HhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999999999987653 444455556677889999999999999999999999999999999999843322110
Q ss_pred -------------------------ccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCcc
Q 002094 836 -------------------------DRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMED 890 (967)
Q Consensus 836 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~ 890 (967)
+.........+|+.|.+||.. .+.....++|+|+.|++++|.++|.+||.....
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~-lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEIL-LGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCccc-ccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 000112245678899999988 566778899999999999999999999965443
Q ss_pred chHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHH
Q 002094 891 DVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDME 947 (967)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 947 (967)
+ ..+..+....+ -....+...+.+..+++.+.+..+|.+|..|.
T Consensus 1041 q-~~f~ni~~~~~------------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 Q-QIFENILNRDI------------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred h-hhhhccccCCC------------CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 2 11111111110 01223455667788999999999999998776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.7e-08 Score=99.85 Aligned_cols=126 Identities=24% Similarity=0.295 Sum_probs=82.9
Q ss_pred EEEEEEeCCCcEEEEEEeecCCc-------------------------cccHHHHHHHHHHHcCCCCC--ceeeeeeEEE
Q 002094 697 VVYRTILQDGRSVAIKKLTVSGL-------------------------IKSQEDFEKEMKTLGKIRHH--NLVALEGYYW 749 (967)
Q Consensus 697 ~Vy~~~~~~~~~vavK~l~~~~~-------------------------~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~ 749 (967)
.||.|...+|..+|||..+.... ........+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999998999999998854210 01124578899999999755 456666552
Q ss_pred cCCceeEEEEecC--CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCcccCCCCCCCEEeCCCCCeEEeec
Q 002094 750 TPSLQLLIYEFIS--SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAY-LHHTNIIHYNLKSTNVLIDSSGEPKVGDF 826 (967)
Q Consensus 750 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~-LH~~~ivH~Dik~~Nill~~~~~~kl~Df 826 (967)
...+||||++ |..+...... . ++......++.+++..+.. +|..|++|||+.+.||+++++ .+.++||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-D----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-G----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhc-c----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 4479999998 6555443322 1 1123445577777775555 579999999999999999877 9999999
Q ss_pred cccccc
Q 002094 827 GLARLL 832 (967)
Q Consensus 827 g~a~~~ 832 (967)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.4e-09 Score=84.40 Aligned_cols=60 Identities=45% Similarity=0.609 Sum_probs=42.1
Q ss_pred CCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCcc
Q 002094 459 SLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDL 518 (967)
Q Consensus 459 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 518 (967)
+|++|++++|+|+...+..|.++++|+.|++++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 566667777766655556677777777777777777766666777777777777777764
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.1e-08 Score=98.95 Aligned_cols=135 Identities=21% Similarity=0.247 Sum_probs=100.5
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc---------------------cccHHHHHHHHHHHcCCCCC--c
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL---------------------IKSQEDFEKEMKTLGKIRHH--N 740 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~---------------------~~~~~~~~~E~~~l~~l~h~--n 740 (967)
...+..||.|--+.||.|..++|.++|||.-+.... ..+....++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345678999999999999999999999996533211 11234578899999999644 6
Q ss_pred eeeeeeEEEcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC
Q 002094 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE 820 (967)
Q Consensus 741 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~ 820 (967)
|.+.+++ +...+||||++|-.|...-- +....-.++..|++-+.-+-..|+||||+++-||+++++|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 7777765 45579999999966654421 22333445556666666666889999999999999999999
Q ss_pred eEEeeccccc
Q 002094 821 PKVGDFGLAR 830 (967)
Q Consensus 821 ~kl~Dfg~a~ 830 (967)
+.++||--+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999996554
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.4e-07 Score=97.96 Aligned_cols=169 Identities=17% Similarity=0.250 Sum_probs=124.7
Q ss_pred ceEEEEEE-eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEE----cCCceeEEEEecCC-Cchhh
Q 002094 695 FGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW----TPSLQLLIYEFISS-GSLYK 768 (967)
Q Consensus 695 ~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-gsL~~ 768 (967)
..+.||+. ..||..|+.|+++-.+. .....-..-+++++++.|+|+|++.+++. .+...++||+|.++ ++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccc-cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 35688988 44899999999944332 11222344578899999999999999886 34556899999876 46666
Q ss_pred hhhcCCCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 769 HLHDGSSR------------NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 769 ~l~~~~~~------------~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
.-...... ...+++..|.++.|++.||.++|+.|..-+-+.+++|+++.+.+++|+..|.........
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 54322111 126778999999999999999999999999999999999998899999888776543211
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCC
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p 884 (967)
+ |.+ .-..+-|.=.+|.+++.|.||..-
T Consensus 448 ---------~-------~~l----e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 448 ---------T-------EPL----ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ---------C-------cch----hHHhhhhHHHHHHHHHHHhhcccc
Confidence 0 112 122357888999999999998653
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.6e-10 Score=124.18 Aligned_cols=129 Identities=31% Similarity=0.366 Sum_probs=98.3
Q ss_pred cccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCc-cccccCccceee
Q 002094 410 SSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPS-QIKNCSSLTSLI 488 (967)
Q Consensus 410 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ 488 (967)
..|...+.++|++. .+..++.-++.|+.|||++|+++.. +.+..++.|++|||++|.++ .+|. .-..+ .|+.|+
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~ 238 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLN 238 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeee
Confidence 35777788888886 6667777788889999999998744 26778888999999999988 4443 22333 389999
Q ss_pred ccCCcCcCccchhhhcccCccEEeccCCccccCCc-hhhhhccCCceEEecCCccccc
Q 002094 489 LSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILP-KELINLSHLLSFNISHNHLHGE 545 (967)
Q Consensus 489 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~ 545 (967)
|++|.++.. ..+.+|.+|+.||||+|-|.+.-. .-+..|..|+.|+|.+|++.+.
T Consensus 239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 999988743 357888999999999998875432 3356778889999999998763
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.8e-07 Score=89.67 Aligned_cols=139 Identities=14% Similarity=0.100 Sum_probs=102.2
Q ss_pred cCCCCceEEEEEEeCCCcEEEEEEeecC--Cc---cccHHHHHHHHHHHcCCCCC--ceeeeeeEEEc--C--CceeEEE
Q 002094 690 LGRGGFGVVYRTILQDGRSVAIKKLTVS--GL---IKSQEDFEKEMKTLGKIRHH--NLVALEGYYWT--P--SLQLLIY 758 (967)
Q Consensus 690 lG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~---~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~--~--~~~~lv~ 758 (967)
-|+||.+-|++.... |..+-+|+-... .. +-....|.+|...+.++... .+.++..+... + ..-++|+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467899999998775 557888876411 11 23567899999999988432 24444422111 1 2246999
Q ss_pred EecCC-CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC--eEEeeccccc
Q 002094 759 EFISS-GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE--PKVGDFGLAR 830 (967)
Q Consensus 759 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~--~kl~Dfg~a~ 830 (967)
|-++| .+|.+++...... +.+...+..++.+++.+++-||+.|+.|+|+.+.||+++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98764 5888887654322 2577788899999999999999999999999999999986666 9999998765
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.8e-09 Score=94.74 Aligned_cols=134 Identities=24% Similarity=0.273 Sum_probs=88.6
Q ss_pred ccchhcccccccccccCC---CcCCcccccEEEecCCcccccCccccc-CCCCCCEEEcCCCCCCCcCCccccccCccce
Q 002094 411 SLMLLNMSMNYLFGSIPA---SIGKLKAIQVLDFSDNWLNGTIPPQIG-GAVSLKELKLEKNFLSGRIPSQIKNCSSLTS 486 (967)
Q Consensus 411 ~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 486 (967)
.+..++|+.|.+. .+++ .+.....|+..+|++|.+. ..|..|. ..+.++.|+|++|+|+ .+|..+..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3556666666653 2333 3344556777788888887 3444443 3447778888888887 67777888888888
Q ss_pred eeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCC
Q 002094 487 LILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVG 549 (967)
Q Consensus 487 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~ 549 (967)
|+++.|.|. ..|..+..|.+|-+||..+|.+. .+|-.+..-+.....++.+++|.+..|.+
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence 888888887 66777777888888888888777 44444433334444556777777766654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.4e-07 Score=94.42 Aligned_cols=106 Identities=23% Similarity=0.279 Sum_probs=82.2
Q ss_pred HHHHHHHHHHHcCCCCC--ceeeeeeEEEcCC----ceeEEEEecCCC-chhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 002094 723 QEDFEKEMKTLGKIRHH--NLVALEGYYWTPS----LQLLIYEFISSG-SLYKHLHDGSSRNCLSWRQRFNIILGMAKGL 795 (967)
Q Consensus 723 ~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL 795 (967)
.....+|.+.+.++... .+++++++..... ..++|+|++++. +|.+++..... .+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 45678888887777432 2445555554422 347999999884 89998876333 45567788999999999
Q ss_pred HHHhcCCcccCCCCCCCEEeCCCC---CeEEeecccccc
Q 002094 796 AYLHHTNIIHYNLKSTNVLIDSSG---EPKVGDFGLARL 831 (967)
Q Consensus 796 ~~LH~~~ivH~Dik~~Nill~~~~---~~kl~Dfg~a~~ 831 (967)
+-||+.||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 132 ~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999998877 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.1e-09 Score=117.53 Aligned_cols=127 Identities=26% Similarity=0.324 Sum_probs=67.7
Q ss_pred ccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEecc
Q 002094 167 SLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFG 246 (967)
Q Consensus 167 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 246 (967)
.|.+.+.++|+++ ....++.-++.|+.|+|++|+++.. ..+..++.|++|||+.|.+....--...++. |+.|.+.
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 3555566666665 4445555666666666666666532 2555566666666666665522111222333 6666666
Q ss_pred ccccCCCCChhhhcCCCCCEEEccCCCCCCcC-chhhccccccccccccccccc
Q 002094 247 VNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEV-PDWIGKLANLESLDLSLNQFS 299 (967)
Q Consensus 247 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~N~l~ 299 (967)
+|.++.. ..+.+|.+|+.||+++|-|.+.- -..+..|..|+.|+|.+|.+.
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 6665521 23455555666666666554321 122445556666666666553
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.6e-08 Score=111.13 Aligned_cols=151 Identities=19% Similarity=0.294 Sum_probs=103.7
Q ss_pred HHHHHHHHHHHhcC-CcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc-------ccccccccccCcccccCc
Q 002094 788 ILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS-------SKIQSALGYMAPEFACRT 859 (967)
Q Consensus 788 ~~~i~~aL~~LH~~-~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~ 859 (967)
+.+++.|+.|+|.. ++||++|.|++|.++..+..|++.|+.+........+... ........|.|||++ ..
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~-~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL-LG 183 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh-cc
Confidence 34555999999986 8999999999999999999999999988655432221111 112223459999999 44
Q ss_pred ccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccC
Q 002094 860 VKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQ 938 (967)
Q Consensus 860 ~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 938 (967)
...+.++|+||+|+++|.+.. |+.-+......... ...+. .+..-...+..+.+.++.+=+.+++..
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--~~~~~----------~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--SFSRN----------LLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh--hhhhc----------ccccccccccccCcHHHHHHHHHHhcC
Confidence 678999999999999999994 66555432211110 00000 111111123456677899999999999
Q ss_pred CCCCCCCHHHHHH
Q 002094 939 VPSNRPDMEEVVN 951 (967)
Q Consensus 939 dP~~Rpt~~evl~ 951 (967)
++.-||++.++..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999998877654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=8.2e-07 Score=101.17 Aligned_cols=143 Identities=18% Similarity=0.239 Sum_probs=96.8
Q ss_pred CCccCCCCceEEEEEEeCCCcEEEEEEeecCCcc-----------------------------c----------cHHHHH
Q 002094 687 DCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLI-----------------------------K----------SQEDFE 727 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------------------------~----------~~~~~~ 727 (967)
.+.|+.++-|+||+|++++|+.||||+.++.-.. . .+-++.
T Consensus 130 ~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 130 PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 3679999999999999999999999988542100 0 001244
Q ss_pred HHHHHHcCC-----CCCceeeeeeEEEcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHH-HHHHhcC
Q 002094 728 KEMKTLGKI-----RHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKG-LAYLHHT 801 (967)
Q Consensus 728 ~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~a-L~~LH~~ 801 (967)
+|+..+.++ ..+.+.-..=|..-.+...++|||++|..+.+...-.... .+ +..++..++++ +..+-..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d---~k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--ID---RKELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHhc
Confidence 555555544 2344332222323346778999999998888774322211 33 23344444433 4555568
Q ss_pred CcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 802 ~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
|+.|+|..|.||+++.+|++.+.|||+....+.
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999987654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 967 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-50 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-49 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-41 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 7e-41 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-33 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-25 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-12 | ||
| 1oec_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-12 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-11 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-08 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 6e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-07 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 3e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-07 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 7e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 3e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-06 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 4e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-06 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 7e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-06 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 967 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-143 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-143 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-29 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 3e-96 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-94 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-80 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-79 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-89 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-89 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-86 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-73 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-14 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-10 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-89 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-87 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-82 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-65 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-61 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 6e-31 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-82 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-67 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-43 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-75 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-73 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-71 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-70 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-41 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 9e-27 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 6e-75 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-73 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-67 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-66 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-65 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-62 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-48 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-63 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-58 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-57 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-56 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-56 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-55 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 6e-55 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 4e-54 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-53 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-51 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-20 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 6e-54 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-52 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-52 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-52 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-50 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-39 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-31 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-19 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-13 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-09 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 9e-52 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-51 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-50 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-43 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-40 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-19 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-50 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-49 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-48 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-43 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-37 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-25 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-19 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-14 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-49 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 7e-49 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 9e-49 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-48 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-48 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-45 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-37 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-33 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-11 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-04 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-47 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-47 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-45 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-39 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-28 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-20 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-14 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-47 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-47 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-46 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-41 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-25 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-41 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-40 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 7e-37 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-36 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-39 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-38 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-33 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-33 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-23 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-20 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 7e-39 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-37 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-10 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-38 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 9e-38 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-35 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 5e-09 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-37 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-36 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-36 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-36 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 5e-36 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 5e-36 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 9e-36 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-35 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-35 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-35 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-35 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 4e-35 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-35 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-34 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-34 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-34 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-34 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-31 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-30 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-29 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-28 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-26 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-34 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-34 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-34 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-34 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 7e-32 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 6e-16 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-16 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 7e-34 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 8e-34 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 8e-34 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 9e-34 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-33 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-33 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-33 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-33 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-33 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-33 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-31 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-31 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 9e-11 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-33 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-33 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-33 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 4e-33 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-33 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-32 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-32 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-32 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-32 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-32 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 5e-32 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-31 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-31 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-27 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 7e-10 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-31 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-31 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-31 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-31 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-31 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 7e-31 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 7e-31 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 8e-31 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-29 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-29 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-29 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-29 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-25 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-23 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-12 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-29 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 6e-29 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-28 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-28 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 9e-28 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 8e-26 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-28 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-28 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-28 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 4e-28 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-28 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-23 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-21 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-18 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-15 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-04 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 5e-28 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-27 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-24 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-24 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-23 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-20 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-13 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-07 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-27 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-27 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-27 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-27 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 7e-27 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 7e-27 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-26 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-26 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 9e-25 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-24 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 8e-22 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 8e-14 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-12 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-06 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-26 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-26 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-26 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-26 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-26 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-26 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-26 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 7e-26 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-25 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-25 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-25 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-25 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-25 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 5e-25 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-24 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-23 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-23 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 9e-22 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 8e-19 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-24 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-22 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-20 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-19 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-24 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-24 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-24 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-24 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-24 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-23 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-23 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-23 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-23 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-23 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-23 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-23 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 8e-23 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-20 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-10 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-09 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 5e-23 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 5e-23 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-23 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 5e-23 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 8e-23 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-22 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-22 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-22 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-22 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-22 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-22 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-22 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-22 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-19 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-15 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 7e-14 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-10 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-09 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 6e-06 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-22 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-22 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-22 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-18 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-15 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-09 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-22 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-22 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-22 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 5e-22 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 5e-22 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-22 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-21 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 8e-20 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-18 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-18 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-16 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-15 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-07 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 6e-22 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 8e-22 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 9e-22 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 9e-22 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-21 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-21 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-21 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-21 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-21 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-21 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-21 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-21 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 3e-21 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 8e-21 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 9e-21 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 9e-21 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-20 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 9e-17 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-04 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-20 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-20 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-20 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 5e-20 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 5e-20 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-19 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-16 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-07 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 5e-20 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 5e-20 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 6e-20 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-19 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-07 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-19 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-19 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-19 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-19 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 4e-19 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-19 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-18 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-06 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 4e-19 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-19 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 8e-19 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 9e-19 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-18 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-18 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-18 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-18 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-18 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 8e-18 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 9e-18 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-11 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-09 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-17 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-17 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-17 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 6e-17 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 6e-17 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 7e-17 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-13 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 9e-13 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 7e-11 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-16 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-16 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-16 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-16 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-16 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 4e-16 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 5e-16 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 5e-16 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 7e-16 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 7e-16 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 7e-16 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-15 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 5e-13 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-12 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 9e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-05 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-15 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-15 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-15 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-15 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-15 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-15 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-12 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-10 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-08 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-07 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 4e-15 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 6e-15 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 6e-05 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 9e-04 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-15 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 6e-15 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 6e-15 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 9e-15 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-14 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-14 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-14 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-14 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-14 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-14 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-14 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 4e-14 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 5e-14 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 5e-14 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 7e-14 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 8e-14 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-08 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-08 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-07 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-13 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 7e-13 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-10 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-10 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-08 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-13 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-13 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-13 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-13 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-13 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-13 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 6e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 6e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 8e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-10 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-10 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-09 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 7e-07 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-12 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 8e-12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-11 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-06 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 8e-05 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-04 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 6e-04 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-12 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-12 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-12 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-12 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-12 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 5e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 7e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-10 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 7e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-07 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 7e-12 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-11 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 2e-11 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 2e-09 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 4e-05 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-11 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-11 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 7e-11 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-09 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-04 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-11 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 7e-11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-04 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 8e-04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 3e-09 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 3e-07 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 1e-05 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-08 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 7e-08 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 6e-05 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 7e-04 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 5e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-06 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-05 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 7e-05 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 9e-05 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 9e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 4e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 3e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 1e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-05 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-06 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-06 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-04 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-04 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-04 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 7e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-06 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-06 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 9e-04 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 7e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-05 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-05 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 8e-05 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-05 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 2e-05 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 4e-05 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-05 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 6e-05 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 6e-05 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-04 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-04 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-04 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 3e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 9e-04 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 7e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 444 bits (1144), Expect = e-143
Identities = 143/503 (28%), Positives = 226/503 (44%), Gaps = 38/503 (7%)
Query: 80 SLSGHIGRGLL-RLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFF 138
+G I L L L LS N+F G + S L+ + S NN SG +P +
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
Query: 139 RQCGSLREVSFANNNLTGPIPESLSFCS-SLESVNFSSNRLSGQLPYGIW--FLRSLQSL 195
+ L+ + + N +G +PESL+ S SL +++ SSN SG + + +LQ L
Sbjct: 340 LKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399
Query: 196 DLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLP 255
L NN G+I +SN +L ++ L N SG +P +G S L+ L +N L G +P
Sbjct: 400 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459
Query: 256 DSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKEL 315
L + + +L L N TGE+P + NL + LS N+ +G IP IG L L L
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL 519
Query: 316 NISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQY 375
+S N F+G +P + +C +L+ +D++ N G IP +FK
Sbjct: 520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK------------------- 560
Query: 376 PSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNY--LFGSIPASIGKL 433
Q +++N ++G I + + + N G + +L
Sbjct: 561 -------------QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607
Query: 434 KAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNN 493
+ + G P S+ L + N LSG IP +I + L L L N+
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 494 LTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFN 553
++G +P + +L L +DLS N L G +P+ + L+ L ++S+N+L G +P G F
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727
Query: 554 TISPSSVSGNPSLCGSVVNRSCP 576
T P+ NP LCG + R P
Sbjct: 728 TFPPAKFLNNPGLCGYPLPRCDP 750
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 444 bits (1144), Expect = e-143
Identities = 164/557 (29%), Positives = 257/557 (46%), Gaps = 47/557 (8%)
Query: 26 NDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHI 85
++ LI FK L D L WS + + PC + GV C +V + L L+
Sbjct: 11 YREIHQLISFKDVLPDK-NLLPDWSSNKN-PCTFDGVTCR--DDKVTSIDLSSKPLNVGF 66
Query: 86 GR--------------------------GLLRLQFLQVLSLSNNNFTGTI--NADLASFG 117
G L L LS N+ +G + L S
Sbjct: 67 SAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCS 126
Query: 118 TLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSF---CSSLESVNFS 174
L+ ++ S N L + SL + + N+++G C L+ + S
Sbjct: 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186
Query: 175 SNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDI 234
N++SG + +L+ LD+S+N I + + L+ + + NK SG I
Sbjct: 187 GNKISGDVDVS--RCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAI 243
Query: 235 GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWI-GKLANLESLDL 293
C+ LK+L+ N G +P L S LSL N FTGE+PD++ G L LDL
Sbjct: 244 STCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDL 301
Query: 294 SLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLP-ESMMNCGNLLAIDVSQNKLTGNIPT 352
S N F G +P G+ L+ L +S N F+G LP ++++ L +D+S N+ +G +P
Sbjct: 302 SGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE 361
Query: 353 WIFKM--GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLS 410
+ + L T+ LS N + P+ + LQ L L +N +G IP + + S
Sbjct: 362 SLTNLSASLLTLDLSSNNFSGPIL-PNLCQNPKNT--LQELYLQNNGFTGKIPPTLSNCS 418
Query: 411 SLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFL 470
L+ L++S NYL G+IP+S+G L ++ L N L G IP ++ +L+ L L+ N L
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
Query: 471 SGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLS 530
+G IPS + NC++L + LS N LTG +P I L NL + LS N SG +P EL +
Sbjct: 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCR 538
Query: 531 HLLSFNISHNHLHGELP 547
L+ +++ N +G +P
Sbjct: 539 SLIWLDLNTNLFNGTIP 555
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-29
Identities = 41/153 (26%), Positives = 73/153 (47%), Gaps = 7/153 (4%)
Query: 407 GDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLE 466
++S+ L + +N F ++ +S+ L ++ L S++ +NG++ + SL L L
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLS 108
Query: 467 KNFLSGRIPS--QIKNCSSLTSLILSQNNLTGPVPA-AIANLSNLKYVDLSFNDLSGILP 523
+N LSG + + + +CS L L +S N L P L++L+ +DLS N +SG
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 524 KELI---NLSHLLSFNISHNHLHGELPVGGFFN 553
+ L IS N + G++ V N
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVDVSRCVN 201
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = 3e-96
Identities = 107/277 (38%), Positives = 169/277 (61%), Gaps = 9/277 (3%)
Query: 685 NKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+ LGRGGFG VY+ L DG VA+K+L + F+ E++ + H NL+ L
Sbjct: 33 SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHD-GSSRNCLSWRQRFNIILGMAKGLAYLHHT-- 801
G+ TP+ +LL+Y ++++GS+ L + S+ L W +R I LG A+GLAYLH
Sbjct: 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 802 -NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTV 860
IIH ++K+ N+L+D E VGDFGLA+L+ D + ++ ++ +G++APE+ T
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYL-STG 210
Query: 861 KITEKCDVYGFGVLVLEVVTGKRPVEY---MEDDVVVLCDMVRGALEDGRVEDCVDARLR 917
K +EK DV+G+GV++LE++TG+R + DD V+L D V+G L++ ++E VD L+
Sbjct: 211 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ 270
Query: 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
GN+ +E +I++ L+C P RP M EVV +LE
Sbjct: 271 GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 310 bits (795), Expect = 5e-94
Identities = 91/569 (15%), Positives = 182/569 (31%), Gaps = 69/569 (12%)
Query: 45 KLTSWSEDDDNPCNWV---GVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLS 101
+W+ + + W GV + RV GL+L+GF SG + + +L L+VL+L
Sbjct: 56 PGANWNFNKE-LDMWGAQPGVSLNSNG-RVTGLSLEGFGASGRVPDAIGQLTELEVLALG 113
Query: 102 NNNFTG----TINADLASFGTLQVVDFSENNLSGLIPDEFFR-QCGSLREVSFANNNLTG 156
++ +++ + + + D R L + ++
Sbjct: 114 SHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQK 173
Query: 157 PIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIV--------- 207
I +S + SN ++ + + L L+ + N+ E +
Sbjct: 174 SIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS 232
Query: 208 ----------KGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSL------- 250
NL DL +++ +LP + +++++ N
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLK 292
Query: 251 -SGSLPDSLQRLNSCSSLSLKGNSF-TGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGN 308
+ + N+ T V + K+ L L+ NQ G + G+
Sbjct: 293 DDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGS 351
Query: 309 LVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMG---LQTVSLS 365
+ L LN++ NQ T + + + NKL IP + + S
Sbjct: 352 EIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFS 410
Query: 366 GNRLGESMQYPSFASMKDSYQG---LQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYL 422
N + S+ +F + + + ++LS+N +S S L +N+ N L
Sbjct: 411 YNEI-GSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469
Query: 423 -------FGSIPASIGKLKAIQVLDFSDNWLNGTIPPQI--GGAVSLKELKLEKNFLSGR 473
+ + +D N L + L + L N S
Sbjct: 470 TEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK- 527
Query: 474 IPSQIKNCSSLTSL------ILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELI 527
P+Q N S+L N P I +L + + ND+ + +++
Sbjct: 528 FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKV-NEKI- 585
Query: 528 NLSHLLSFNISHNHLHGELPVGGFFNTIS 556
++ +I N + + I
Sbjct: 586 -TPNISVLDIKDNPNIS-IDLSYVCPYIE 612
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 3e-80
Identities = 83/552 (15%), Positives = 164/552 (29%), Gaps = 68/552 (12%)
Query: 24 TFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNP-CNWVGVKCDPKTKRVVGLTLDGFSLS 82
T + V + A L + + + G P LD +
Sbjct: 13 TDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWG-- 70
Query: 83 GHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCG 142
G L + LSL +G + + L+V+ +
Sbjct: 71 AQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF------ 124
Query: 143 SLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLR--SLQSLDLSNN 200
P+ +S S E L ++++
Sbjct: 125 ---------------GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSD 169
Query: 201 LLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQR 260
+ I K I N + + + + + L+ G +
Sbjct: 170 PQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWE 228
Query: 261 LNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMN 320
+ + L +L +++ ++P+ + L ++ +N++ N
Sbjct: 229 N-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283
Query: 321 QFTGG--------LPESMMNCGNLLAIDVSQNKL-TGNIPTWIFKMG-LQTVSLSGNRLG 370
+ G + I + N L T + T + KM L + N+L
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343
Query: 371 ESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPA-- 428
+ P+F S L L+L+ N ++ + + G + L+ + N L IP
Sbjct: 344 GKL--PAFGSEI----KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL-KYIPNIF 396
Query: 429 SIGKLKAIQVLDFSDNWLNG-------TIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNC 481
+ + +DFS N + + P +++ + L N +S
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTG 456
Query: 482 SSLTSLILSQNNLTG-------PVPAAIANLSNLKYVDLSFNDLSGILPKELI--NLSHL 532
S L+S+ L N LT N L +DL FN L+ + + L +L
Sbjct: 457 SPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKL-SDDFRATTLPYL 515
Query: 533 LSFNISHNHLHG 544
+ ++S+N
Sbjct: 516 VGIDLSYNSFSK 527
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 2e-79
Identities = 71/495 (14%), Positives = 154/495 (31%), Gaps = 61/495 (12%)
Query: 74 LTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133
++ I + + +NN T ++ + L+ +
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAEN 222
Query: 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQ 193
C + + L V + +LP + L +Q
Sbjct: 223 I------CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQ 276
Query: 194 SLDLSNNLL--------EGEIVKGISNLYDLRAIKLGKNKF-SGQLPEDIGGCSMLKVLD 244
++++ N + + + ++ I +G N + + + L +L+
Sbjct: 277 LINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLE 336
Query: 245 FGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPS 304
N L G + +SL+L N T ++ G +E+L + N+ IP+
Sbjct: 337 CLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPN 394
Query: 305 --SIGNLVFLKELNISMNQFTG-------GLPESMMNCGNLLAIDVSQNKLTGNIPTWIF 355
++ + ++ S N+ L + N+ +I++S N+++
Sbjct: 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454
Query: 356 KM-GLQTVSLSGNRLGE------SMQYPSFASMKDSYQGLQVLDLSSNALSGVIPS-NIG 407
L +++L GN L E + +F + L +DL N L+ +
Sbjct: 455 TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY----LLTSIDLRFNKLTKLSDDFRAT 510
Query: 408 DLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEK 467
L L+ +++S N P ++ + +
Sbjct: 511 TLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQ------------------RDAQG 551
Query: 468 NFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELI 527
N P I C SLT L + N++ V I N+ +D+ N I +
Sbjct: 552 NRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVC 608
Query: 528 NLSHLLSFNISHNHL 542
+ + ++
Sbjct: 609 PYIEAGMYMLFYDKT 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 2e-89
Identities = 101/522 (19%), Positives = 184/522 (35%), Gaps = 42/522 (8%)
Query: 74 LTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133
L + ++S +L L+VL+L +N + + A L + N++ +
Sbjct: 54 LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIK 113
Query: 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFL--RS 191
+ F + +L + ++N L+ + +L+ + S+N++ + S
Sbjct: 114 NNP-FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS 172
Query: 192 LQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIG---GCSMLKVLDFGVN 248
L+ L+LS+N ++ + L + L + L E + + ++ L +
Sbjct: 173 LKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNS 232
Query: 249 SLSGSLPDSLQRLNSCS--SLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSI 306
LS + + L + L L N+ D L LE L N S+
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
Query: 307 GNLVFLKELN---------ISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM 357
L ++ LN IS+ S L +++ N + G +
Sbjct: 293 HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL 352
Query: 358 G-LQTVSLSGNRLGESMQYP-SFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLL 415
L+ +SLS + +F S+ S L +L+L+ N +S + L L +L
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHS--PLHILNLTKNKISKIESDAFSWLGHLEVL 410
Query: 416 NMSMNYLFGSIPAS-IGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSG-- 472
++ +N + + L+ I + S N SL+ L L + L
Sbjct: 411 DLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVD 470
Query: 473 RIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLS--------GILPK 524
PS + +LT L LS NN+ + L L+ +DL N+L+ G
Sbjct: 471 SSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIY 530
Query: 525 ELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSL 566
L LSHL N+ N I L
Sbjct: 531 FLKGLSHLHILNLESNGFDE----------IPVEVFKDLFEL 562
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 9e-89
Identities = 114/538 (21%), Positives = 199/538 (36%), Gaps = 39/538 (7%)
Query: 80 SLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFG--TLQVVDFSENNLSGLIPDEF 137
LS ++L+ LQ L LSNN + +L F +L+ ++ S N + P F
Sbjct: 132 GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
Query: 138 FRQCGSLREVSFANNNLTGPIPESLSF---CSSLESVNFSSNRLSGQLPYGIWFLR--SL 192
G L + N L + E L +S+ +++ S+++LS L+ +L
Sbjct: 192 -HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNL 250
Query: 193 QSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSG 252
LDLS N L + L L L N + G ++ L+ +
Sbjct: 251 TMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310
Query: 253 SL---------PDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIP 303
S+ S Q L L+++ N G + L NL+ L LS + S R
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370
Query: 304 SSIG----NLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM-- 357
++ L LN++ N+ + ++ G+L +D+ N++ + ++
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430
Query: 358 GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGV--IPSNIGDLSSLMLL 415
+ + LS N+ + SFA + LQ L L AL V PS L +L +L
Sbjct: 431 NIFEIYLSYNKY-LQLTRNSFALVPS----LQRLMLRRVALKNVDSSPSPFQPLRNLTIL 485
Query: 416 NMSMNYLFGSIPASIGKLKAIQVLDFSDN--------WLNGTIPPQIGGAVSLKELKLEK 467
++S N + + L+ +++LD N G + G L L LE
Sbjct: 486 DLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLES 545
Query: 468 NFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKEL- 526
N K+ L + L NNL + N +LK ++L N ++ + K
Sbjct: 546 NGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFG 605
Query: 527 INLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIV 584
+L ++ N +F + + P L + + P P+
Sbjct: 606 PAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVR 663
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 5e-86
Identities = 87/491 (17%), Positives = 190/491 (38%), Gaps = 30/491 (6%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+ VL+L++N A+ + L +D N +S L P+ ++ L+ ++ +N L
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL-CQKLPMLKVLNLQHNEL 85
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLY 214
+ ++ +FC++L ++ SN + ++L +LDLS+N L + L
Sbjct: 86 SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145
Query: 215 DLRAIKLGKNKFSGQLPEDIG--GCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGN 272
+L+ + L NK E++ S LK L+ N + P + L L
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 273 SFTGEVPDWIG---KLANLESLDLSLNQFSGRIPSSIGNLVF--LKELNISMNQFTGGLP 327
+ + + ++ +L LS +Q S ++ L + L L++S N
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 328 ESMMNCGNLLAIDVSQNKLTGNIPTWIFKMG-LQTVSLSGNRLGESMQYPSFASMKDSY- 385
+S L + N + + + ++ ++L + +S+ S + D
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
Query: 386 ---QGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYL-FGSIPASIGK---LKAIQV 438
+ L+ L++ N + G+ + L +L L++S ++ ++ + +
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385
Query: 439 LDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQ-IKNCSSLTSLILSQNNLTGP 497
L+ + N ++ L+ L L N + + Q + ++ + LS N
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
Query: 498 VPAAIANLSNLKYVDLSFNDLSGI--LPKELINLSHLLSFNISHNHLHGELPVGGFFNTI 555
+ A + +L+ + L L + P L +L ++S+N++ I
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN----------I 495
Query: 556 SPSSVSGNPSL 566
+ + G L
Sbjct: 496 NDDMLEGLEKL 506
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 4e-73
Identities = 94/483 (19%), Positives = 173/483 (35%), Gaps = 65/483 (13%)
Query: 118 TLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNR 177
+ +V D S L+ +PD+ ++ ++ +N L + + S L S++ N
Sbjct: 5 SHEVADCSHLKLTQ-VPDDLPT---NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 178 LSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGC 237
+S P L L+ L+L +N L + C
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLS------------------------DKTFAFC 96
Query: 238 SMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQ 297
+ L L NS+ + + + +L L N + +L NL+ L LS N+
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 298 FSGRIPS--SIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIF 355
I LK+L +S NQ P G L + ++ +L ++ +
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC 216
Query: 356 KMG----LQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSS 411
++ +SLS ++L + +F +K + L +LDLS N L+ V + L
Sbjct: 217 LELANTSIRNLSLSNSQL-STTSNTTFLGLKWT--NLTMLDLSYNNLNVVGNDSFAWLPQ 273
Query: 412 LMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNW---------LNGTIPPQIGGAVSLKE 462
L + N + S+ L ++ L+ ++ L L+
Sbjct: 274 LEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEH 333
Query: 463 LKLEKNFLSGRIPSQIKNCSSLTSLILSQN--NLTGPVPAAIANL--SNLKYVDLSFNDL 518
L +E N + G + +L L LS + +L +L S L ++L+ N +
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393
Query: 519 SGILPKELINLSHLLSFNISHNHLHGELPVGGF---------------FNTISPSSVSGN 563
S I L HL ++ N + EL + + ++ +S +
Sbjct: 394 SKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALV 453
Query: 564 PSL 566
PSL
Sbjct: 454 PSL 456
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 25/134 (18%), Positives = 45/134 (33%), Gaps = 2/134 (1%)
Query: 75 TLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIP 134
L + G L L L +L+L +N F L+++D NNL+ L
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 135 DEFFRQCGSLREVSFANNNLTGPIPESLS-FCSSLESVNFSSNRLSGQLPYGIWFLRSLQ 193
F SL+ ++ N +T + +L ++ N WF+ +
Sbjct: 578 S-VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWIN 636
Query: 194 SLDLSNNLLEGEIV 207
+ L +
Sbjct: 637 ETHTNIPELSSHYL 650
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 7e-10
Identities = 16/109 (14%), Positives = 36/109 (33%)
Query: 74 LTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133
L L+ L L+++ L NN + + +L+ ++ +N ++ +
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600
Query: 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQL 182
F +L E+ N F + + + + LS
Sbjct: 601 KKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 2e-89
Identities = 85/273 (31%), Positives = 148/273 (54%), Gaps = 9/273 (3%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQ---EDFEKEMKTLGKIRHHNLVALEG 746
+G GGFGVVY+ + + +VA+KKL I ++ + F++E+K + K +H NLV L G
Sbjct: 39 MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ L+Y ++ +GSL L LSW R I G A G+ +LH + IH
Sbjct: 98 FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
++KS N+L+D + K+ DFGLAR + +++S+I YMAPE +IT K
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL--RGEITPKS 215
Query: 867 DVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR-VEDCVDARLRGNFPADEA 925
D+Y FGV++LE++TG V+ + +L D+ ++ + +ED +D ++ + +
Sbjct: 216 DIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSV 273
Query: 926 IPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958
+ + C + + RPD+++V +L+ + +
Sbjct: 274 EAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 282 bits (725), Expect = 1e-87
Identities = 91/276 (32%), Positives = 152/276 (55%), Gaps = 4/276 (1%)
Query: 685 NKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+ +G G FG VY+ +L+DG VA+K+ T +E FE E++TL RH +LV+L
Sbjct: 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE-FETEIETLSFCRHPHLVSL 100
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHD-GSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
G+ + +LIY+++ +G+L +HL+ +SW QR I +G A+GL YLH I
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
IH ++KS N+L+D + PK+ DFG+++ LD+ LS+ ++ LGY+ PE+ ++T
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF-IKGRLT 219
Query: 864 EKCDVYGFGVLVLEVVTGKRPVEY-MEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922
EK DVY FGV++ EV+ + + + ++V L + + +G++E VD L
Sbjct: 220 EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP 279
Query: 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958
+ + C + +RP M +V+ LE
Sbjct: 280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 2e-82
Identities = 96/597 (16%), Positives = 179/597 (29%), Gaps = 79/597 (13%)
Query: 35 FKAGLEDPKEKLTSWSEDD--DNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRL 92
+ +G + +W+ + D + GV D RV GL+L GF G + + +L
Sbjct: 288 YYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNG-RVTGLSLAGFGAKGRVPDAIGQL 346
Query: 93 QFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANN 152
L+VLS ++ T + T + + ++ + F L +
Sbjct: 347 TELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406
Query: 153 ----------------------------NLTGPIPESLSFCSSLESVNFSSNRLSGQLPY 184
N I +++ + L+ + F+++ +
Sbjct: 407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI- 465
Query: 185 GIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLD 244
+ + SNL DL ++L QLP+ + L+ L+
Sbjct: 466 ----AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLN 521
Query: 245 FGVNSLSG---------SLPDSLQRLNSCSSLSLKGNSFTG-EVPDWIGKLANLESLDLS 294
N L D + N+ + K+ L LD
Sbjct: 522 IACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCV 581
Query: 295 LNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMM-NCGNLLAIDVSQNKLTGNIPTW 353
N+ + G V L +L + NQ +PE + + S NKL IP
Sbjct: 582 HNKVR--HLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNI 637
Query: 354 IFKMG---LQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLS 410
+ +V S N++G + S + + LS N + S
Sbjct: 638 FNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGS 697
Query: 411 SLMLLNMSMNYL-------FGSIPASIGKLKAIQVLDFSDNWLNGTIPPQI--GGAVSLK 461
+ + +S N + + + +D N L ++ L
Sbjct: 698 PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLS 756
Query: 462 ELKLEKNFLSGRIPSQIKNCSSLTSL------ILSQNNLTGPVPAAIANLSNLKYVDLSF 515
+ + N S P+Q N S L + N + P I +L + +
Sbjct: 757 NMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGS 815
Query: 516 NDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVS----GNPSLCG 568
ND+ + ++L L +I+ N + V I + G
Sbjct: 816 NDIRKV-DEKL--TPQLYILDIADNPNI-SIDVTSVCPYIEAGMYVLLYDKTQDIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-65
Identities = 78/550 (14%), Positives = 163/550 (29%), Gaps = 78/550 (14%)
Query: 27 DDVLGLIVFKAGLEDPKEKLTSWSEDDD-NPCNWVGVKCDPKTKRVVGLTLDGFSLSGHI 85
D L L+ + S + ++ + NW +
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-------------NFNKELDMWGDQP 315
Query: 86 GRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLR 145
G L + LSL+ G + + L+V+ F ++ + +
Sbjct: 316 GVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDM 375
Query: 146 EVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGE 205
+ L + L + + ++ + ++ + L + +
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP--EMKPIKKDSRISLKDTQIGNL 433
Query: 206 IVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCS 265
N+ + + + I + L+++ F + +
Sbjct: 434 -----------------TNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWE 470
Query: 266 SLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTG- 324
+ L +L ++L ++P + +L L+ LNI+ N+
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 325 --------GLPESMMNCGNLLAIDVSQNKLTG-NIPTWIFKM-GLQTVSLSGNRLGESMQ 374
L + + + N L + KM L + N++
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH--- 587
Query: 375 YPSFASMKDSYQGLQVLDLSSNALSGVIPSNIG-DLSSLMLLNMSMNYLFGSIP--ASIG 431
+F + L L L N + IP + + L S N L IP +
Sbjct: 588 LEAFGTNV----KLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAK 641
Query: 432 KLKAIQVLDFSDN-----WLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTS 486
+ + +DFS N N + ++ + L N + S +++
Sbjct: 642 SVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIST 701
Query: 487 LILSQNNLT-------GPVPAAIANLSNLKYVDLSFNDLSGILPKELI--NLSHLLSFNI 537
+ILS N +T P N L +DL FN L+ + + L +L + ++
Sbjct: 702 IILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSL-SDDFRATTLPYLSNMDV 760
Query: 538 SHNHLHGELP 547
S+N P
Sbjct: 761 SYNCFS-SFP 769
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 2e-61
Identities = 74/472 (15%), Positives = 146/472 (30%), Gaps = 47/472 (9%)
Query: 90 LRLQFLQVLSLSN-NNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVS 148
L+ + N N I+ + LQ++ F+ + + + +
Sbjct: 420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVD------WEDAN 473
Query: 149 FANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEG---- 204
S S L V + QLP ++ L LQSL+++ N
Sbjct: 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL 533
Query: 205 -----EIVKGISNLYDLRAIKLGKNKFSGQLPE--DIGGCSMLKVLDFGVNSLSGSLPDS 257
+ ++ +G N P + L +LD N + ++
Sbjct: 534 KADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVRH--LEA 590
Query: 258 LQRLNSCSSLSLKGNSFTGEVPDWIGKLA-NLESLDLSLNQFSGRIPS--SIGNLVFLKE 314
+ L L N E+P+ +E L S N+ IP+ + ++ +
Sbjct: 591 FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGS 648
Query: 315 LNISMNQFTG-----GLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMG-LQTVSLSGNR 368
++ S N+ N + +S N++ + T+ LS N
Sbjct: 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708
Query: 369 LGE--SMQYPSFASMKDSYQGLQVLDLSSNALSGVIPS-NIGDLSSLMLLNMSMNYLFGS 425
+ + L +DL N L+ + L L +++S N F S
Sbjct: 709 MTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYN-CFSS 767
Query: 426 IPASIGKLKAIQVL------DFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIK 479
P ++ D N + P I SL +L++ N + + ++
Sbjct: 768 FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL- 825
Query: 480 NCSSLTSLILSQNNLT-GPVPAAIANLSNLKYVDLSFNDLSGILPKELINLS 530
L L ++ N V + + Y L ++ I + + +
Sbjct: 826 -TPQLYILDIADNPNISIDVTSVCPYIEAGMY-VLLYDKTQDIRGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-31
Identities = 39/349 (11%), Positives = 98/349 (28%), Gaps = 66/349 (18%)
Query: 224 NKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIG 283
+ + + + ++ + LD ++ + + + + + + + +
Sbjct: 262 KETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLD 320
Query: 284 KLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQ 343
+ L L+ GR+P +IG L LK L+ + T + +
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 344 NKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIP 403
+++ + + + Q L + DL +A++
Sbjct: 381 HRIRMHYK-----------KMFLDYD----------------QRLNLSDLLQDAINRN-- 411
Query: 404 SNIGDLSSLMLLNMSMNYL------FGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGA 457
+ + +++ + I +I +L +Q++ F+++
Sbjct: 412 PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI------ 465
Query: 458 VSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFND 517
+ +NL +L V+L
Sbjct: 466 -----------------------AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502
Query: 518 LSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSL 566
LP L +L L S NI+ N + + + P +
Sbjct: 503 NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL-ADDEDTGPKI 550
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 4e-82
Identities = 102/486 (20%), Positives = 187/486 (38%), Gaps = 37/486 (7%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+ L LS N + SF LQV+D S + + ++ L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA-YQSLSHLSTLILTGNPI 88
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEG-EIVKGISNL 213
+ S SSL+ + L+ + I L++L+ L++++NL++ ++ + SNL
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 214 YDLRAIKLGKNKFSGQLPEDIGGCSMLKV----LDFGVNSLSGSLPDSLQRLNSCSSLSL 269
+L + L NK D+ + + LD +N ++ P + + + L+L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL-HKLTL 207
Query: 270 KGNSFTGEVP-DWIGKLANLESLDLSLNQFSGR------IPSSIGNLVFLKELNISMNQ- 321
+ N + V I LA LE L L +F S++ L L +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 322 --FTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGE-------S 372
+ + + N+ + + + + + + G Q + L + G+ S
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 373 MQYPSFASMKDSYQG-------LQVLDLSSNALS--GVIPSNIGDLSSLMLLNMSMNYLF 423
++ +F S K L+ LDLS N LS G + +SL L++S N +
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 424 GSIPASIGKLKAIQVLDFSDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQIKNCS 482
+ ++ L+ ++ LDF + L + +L L + S
Sbjct: 387 T-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 483 SLTSLILSQNNLTGPV-PAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNH 541
SL L ++ N+ P L NL ++DLS L + P +LS L N+SHN+
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 505
Query: 542 LHGELP 547
Sbjct: 506 FFSLDT 511
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 1e-67
Identities = 89/462 (19%), Positives = 148/462 (32%), Gaps = 37/462 (8%)
Query: 121 VVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSG 180
E N IPD S + + + N L S L+ ++ S +
Sbjct: 11 TYQCMELNFYK-IPDNLPF---STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 181 QLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSML 240
L L +L L+ N ++ + S L L+ + + + IG L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 241 KVLDFGVNSL-SGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLE----SLDLSL 295
K L+ N + S LP+ L + L L N + L + SLDLSL
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 296 NQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMN---CGNLLAIDVSQNKLTGNIPT 352
N + P + + L +L + N + + ++ + + + + + + GN+
Sbjct: 187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
Query: 353 WIFKM--GLQTVSLSGNRLGE-SMQYPSFASMKDSYQGLQVLDLSSNALSGVIP-SNIGD 408
+ GL +++ RL + + + L S + V S
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG 305
Query: 409 LSSLMLLNMS----------------MNYLFGSIPASIGKLKAIQVLDFSDNWLN--GTI 450
L L+N G S L +++ LD S N L+ G
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCC 365
Query: 451 PPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPA-AIANLSNLK 509
G SLK L L N + + S L L +NL +L NL
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424
Query: 510 YVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGF 551
Y+D+S LS L ++ N F
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-43
Identities = 60/299 (20%), Positives = 107/299 (35%), Gaps = 14/299 (4%)
Query: 74 LTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLS--G 131
L L L L+ L S N ++ +L+ +D S N LS G
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD-----LPSLEFLDLSRNGLSFKG 363
Query: 132 LIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIW-FLR 190
F SL+ + + N + + + LE ++F + L + ++ LR
Sbjct: 364 CCSQSDF-GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 191 SLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNS 249
+L LD+S+ + L L +K+ N F DI L LD
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 250 LSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNL 309
L P + L+S L++ N+F L +L+ LD SLN + +
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 541
Query: 310 V-FLKELNISMNQFTGGLPES--MMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLS 365
L LN++ N F + + + V ++ P+ M + +++++
Sbjct: 542 PSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 5e-75
Identities = 94/488 (19%), Positives = 185/488 (37%), Gaps = 31/488 (6%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151
L L L+ N L+ L+ + F + +S + +L + +
Sbjct: 80 QHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFI-PLHNQKTLESLYLGS 138
Query: 152 NNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQ--SLDLSNNLLEGEIVKG 209
N+++ L+ ++F +N + + L+ SL+L+ N + I G
Sbjct: 139 NHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPG 197
Query: 210 ISNLYDLRAIKLGKNKFSGQLPEDIGGCSM--LKVLDFGVNSLSGSLPDSLQRLNSCS-- 265
+ +++ G + + + + ++ L + F P + L S
Sbjct: 198 AFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVE 257
Query: 266 SLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGG 325
S++L+ + F + + L+ LDL+ S +PS + L LK+L +S N+F
Sbjct: 258 SINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENL 316
Query: 326 LPESMMNCGNLLAIDVSQNKLTGNIPTWIFK--MGLQTVSLSGNRLGES-MQYPSFASMK 382
S N +L + + N + T + L+ + LS + + S ++
Sbjct: 317 CQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLS 376
Query: 383 DSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDF 441
LQ L+LS N + + L LL+++ L S L ++VL+
Sbjct: 377 H----LQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432
Query: 442 SDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRI---PSQIKNCSSLTSLILSQNNLTGPV 498
S + L+ + G +L+ L L+ N + ++ L L+LS +L+
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID 492
Query: 499 PAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPS 558
A +L + +VDLS N L+ + L +L + N++ NH+ I PS
Sbjct: 493 QHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK-GIYLNLASNHIS----------IILPS 541
Query: 559 SVSGNPSL 566
+
Sbjct: 542 LLPILSQQ 549
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 253 bits (647), Expect = 2e-73
Identities = 103/467 (22%), Positives = 178/467 (38%), Gaps = 23/467 (4%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151
+ L+ L + L + TL+ + N++S + + F L+ + F N
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGF-PTEKLKVLDFQN 162
Query: 152 NNLTGPIPESLSFCSSLE--SVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKG 209
N + E +S S+N + N ++G + G + QSL+ I KG
Sbjct: 163 NAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKG 221
Query: 210 ISN--LYDLRAIKLGKNKFSGQLPEDIGGCSM--LKVLDFGVNSLSGSLPDSLQRLNSCS 265
+ N + L P G ++ ++ + ++ +
Sbjct: 222 LKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQ 281
Query: 266 SLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGG 325
L L + E+P + L+ L+ L LS N+F S N L L+I N
Sbjct: 282 ELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLE 340
Query: 326 LPESMM-NCGNLLAIDVSQNKLT--GNIPTWIFKMG-LQTVSLSGNRLGESMQYPSFASM 381
L + N NL +D+S + + + + LQ+++LS N S++ +F
Sbjct: 341 LGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP-LSLKTEAFKEC 399
Query: 382 KDSYQGLQVLDLSSNALSGVIP-SNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLD 440
L++LDL+ L S +L L +LN+S + L S L A+Q L+
Sbjct: 400 ----PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455
Query: 441 FSDN---WLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGP 497
N N + L+ L L LS + + + LS N LT
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515
Query: 498 VPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHG 544
A+++L + Y++L+ N +S ILP L LS + N+ N L
Sbjct: 516 SIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 6e-71
Identities = 78/476 (16%), Positives = 154/476 (32%), Gaps = 23/476 (4%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+ L S N N + L +D + + + D F+ L + N L
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT-FQSQHRLDTLVLTANPL 93
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLY 214
+LS +L+ + F +S + ++L+SL L +N + +
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153
Query: 215 DLRAIKLGKNKFSGQLPEDIGGCSMLKV--LDFGVNSLSGSLPDSLQRLNSCSSLSLKGN 272
L+ + N ED+ L+ N ++ + SL+ G
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGT 212
Query: 273 SFTGEVPDWIG--KLANLESLDLSLNQFSGRIPSSIGNLVF--LKELNISMNQFTGGLPE 328
+ + + +L P+ L ++ +N+ + F
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272
Query: 329 SMMNCGNLLAIDVSQNKLTGNIPTWIFKMG-LQTVSLSGNRLGESMQYPSFASMKDSYQG 387
+ L +D++ L+ +P+ + + L+ + LS N+ Q S ++
Sbjct: 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQI-SASNFPS---- 326
Query: 388 LQVLDLSSNALSGVIPSN-IGDLSSLMLLNMSMNYL--FGSIPASIGKLKAIQVLDFSDN 444
L L + N + + + +L +L L++S + + + L +Q L+ S N
Sbjct: 327 LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN 386
Query: 445 WLNGTIPPQIGGAVSLKELKLEKNFLSGRIP-SQIKNCSSLTSLILSQNNLTGPVPAAIA 503
L+ L L L + S +N L L LS + L
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446
Query: 504 NLSNLKYVDLSFNDLSGI---LPKELINLSHLLSFNISHNHLHGELPVGGFFNTIS 556
L L++++L N L L L +S L + F +
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS-SIDQHAFTSLKM 501
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 1e-70
Identities = 87/482 (18%), Positives = 158/482 (32%), Gaps = 29/482 (6%)
Query: 96 QVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLT 155
+ + N I L + + ++FS N L + F + +L + +
Sbjct: 15 KTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTF-SRLINLTFLDLTRCQIY 70
Query: 156 GPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYD 215
++ L+++ ++N L + ++L+ L + + N
Sbjct: 71 WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130
Query: 216 LRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCS--SLSLKGNS 273
L ++ LG N S LKVLDF N++ + + L + SL+L GN
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190
Query: 274 FTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVF--LKELNISMNQFTGGLPESMM 331
+ A +SL+ Q I + N L P
Sbjct: 191 IA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249
Query: 332 NCG--NLLAIDVSQNKLTGNIPTWIFKM-GLQTVSLSGNRLGESMQYPSFASMKDSYQGL 388
++ +I++ ++ GLQ + L+ L S + L
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL--SELPSGLVGLST----L 303
Query: 389 QVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSI-PASIGKLKAIQVLDFSDNWLN 447
+ L LS+N + + + SL L++ N + + L+ ++ LD S + +
Sbjct: 304 KKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
Query: 448 --GTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTG-PVPAAIAN 504
Q+ L+ L L N K C L L L+ L + N
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423
Query: 505 LSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNP 564
L LK ++LS + L + L L N+ NH N +S+
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK-------GNIQKTNSLQTLG 476
Query: 565 SL 566
L
Sbjct: 477 RL 478
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-41
Identities = 61/317 (19%), Positives = 118/317 (37%), Gaps = 12/317 (3%)
Query: 84 HIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGS 143
+ GL+ L L+ L LS N F ++F +L + N + +
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
Query: 144 LREVSFANNNLT--GPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNL 201
LRE+ +++++ L S L+S+N S N L+ LDL+
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411
Query: 202 LEGEIVKGI-SNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSG---SLPDS 257
L+ + + NL+ L+ + L + + G L+ L+ N +S
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
Query: 258 LQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNI 317
LQ L L L + L + +DLS N+ + ++ +L + LN+
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNL 530
Query: 318 SMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPS 377
+ N + LP + I++ QN L F L+ + +L ++
Sbjct: 531 ASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYF---LEWYKENMQKLEDTEDT-L 586
Query: 378 FASMKDSYQGLQVLDLS 394
+ +G+++ D++
Sbjct: 587 CENP-PLLRGVRLSDVT 602
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-27
Identities = 38/201 (18%), Positives = 71/201 (35%), Gaps = 4/201 (1%)
Query: 79 FSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFF 138
S L L LQ L+LS N L+++D + L F
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421
Query: 139 RQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSG---QLPYGIWFLRSLQSL 195
+ L+ ++ +++ L + +L+ +N N Q + L L+ L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481
Query: 196 DLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLP 255
LS L ++L + + L N+ + E + + L+ N +S LP
Sbjct: 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP 540
Query: 256 DSLQRLNSCSSLSLKGNSFTG 276
L L+ +++L+ N
Sbjct: 541 SLLPILSQQRTINLRQNPLDC 561
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 6e-75
Identities = 82/350 (23%), Positives = 124/350 (35%), Gaps = 82/350 (23%)
Query: 224 NKFSGQLPEDIGGCSMLKVLDFGVNSLSGS--LPDSLQRLNSCSSLSL-KGNSFTGEVPD 280
+ G L + + LD +L +P SL L + L + N+ G +P
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 281 WIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAID 340
I KL L L ++ SG IP + + L L+ S N +G LP S+ + N
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN----- 150
Query: 341 VSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSG 400
L + N +SG
Sbjct: 151 -----------------------------------------------LVGITFDGNRISG 163
Query: 401 VIPSNIGDLSSLM-LLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVS 459
IP + G S L + +S N L G IP + L +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-------------------------N 198
Query: 460 LKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLS 519
L + L +N L G + + + L++N+L + + NL +DL N +
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIY 257
Query: 520 GILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGS 569
G LP+ L L L S N+S N+L GE+P GG S+ + N LCGS
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 3e-73
Identities = 85/349 (24%), Positives = 136/349 (38%), Gaps = 57/349 (16%)
Query: 26 NDDVLGLIVFKAGLEDPKEKLTSWSEDDD-NPCNWVGVKCDPKTK--RVVGLTLDGFSLS 82
D L+ K L +P L+SW D W+GV CD T+ RV L L G +L
Sbjct: 5 PQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 83 G--HIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQ 140
I L L +L L + N
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGIN------------------------------------ 87
Query: 141 CGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNN 200
NL GPIP +++ + L + + +SG +P + +++L +LD S N
Sbjct: 88 ------------NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135
Query: 201 LLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSML-KVLDFGVNSLSGSLPDSLQ 259
L G + IS+L +L I N+ SG +P+ G S L + N L+G +P +
Sbjct: 136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA 195
Query: 260 RLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISM 319
LN + + L N G+ G N + + L+ N + + +G L L++
Sbjct: 196 NLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRN 253
Query: 320 NQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNR 368
N+ G LP+ + L +++VS N L G IP + + N+
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 9e-67
Identities = 94/489 (19%), Positives = 167/489 (34%), Gaps = 34/489 (6%)
Query: 74 LTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133
L L G + L L+ L + + TL+ ++ + N +
Sbjct: 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCK 144
Query: 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSF----CSSLESVNFSSNRLSGQLPYGIWFL 189
+F +L V + N + L F S++ S N + + +
Sbjct: 145 LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQG 203
Query: 190 RSLQSLDLSNNLLEGEIVKG-ISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLK------- 241
L L L N I+K + NL L +L +F + +I S+++
Sbjct: 204 IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263
Query: 242 -VLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSG 300
+ L + S++SL G S + D +SL + Q
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHF-KWQSLSIIRCQLKQ 321
Query: 301 RIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMG-- 358
P+ +L FLK L ++MN+ + + + +L +D+S+N L+ +
Sbjct: 322 -FPTL--DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALS-FSGCCSYSDLGT 375
Query: 359 --LQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIP-SNIGDLSSLMLL 415
L+ + LS N + +F +++ LQ LD + L V S L L+ L
Sbjct: 376 NSLRHLDLSFNGA--IIMSANFMGLEE----LQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429
Query: 416 NMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRI 474
++S L ++ L + N + +L L L K L
Sbjct: 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489
Query: 475 PSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLS 534
L L +S NNL + L +L +D SFN + L
Sbjct: 490 WGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAF 549
Query: 535 FNISHNHLH 543
FN+++N +
Sbjct: 550 FNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 6e-66
Identities = 98/491 (19%), Positives = 172/491 (35%), Gaps = 38/491 (7%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151
L L L L+ N + +L+ + E L+ L Q +L++++ A+
Sbjct: 79 LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPI-GQLITLKKLNVAH 137
Query: 152 NNLTG-PIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLR----SLQSLDLSNNLLEGEI 206
N + +P S ++L V+ S N + + FLR SLD+S N ++ I
Sbjct: 138 NFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FI 196
Query: 207 VKGISNLYDLRAIKLGKNKFSGQLPED-IGGCSMLKVLD------FGVNSLSGSLPDSLQ 259
L + L N S + + + + L V +L P ++
Sbjct: 197 QDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIME 256
Query: 260 RLNSCS--SLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNI 317
L + L + + LAN+ ++ L+ + + L+I
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSI 314
Query: 318 SMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPS 377
Q P + L ++ ++ NK + + L + LS N L S S
Sbjct: 315 IRCQLKQ-FPTL--DLPFLKSLTLTMNKGSI-SFKKVALPSLSYLDLSRNALSFSGCC-S 369
Query: 378 FASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPAS-IGKLKAI 436
++ + + L+ LDLS N ++ +N L L L+ + L S L+ +
Sbjct: 370 YSDLGTNS--LRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL 426
Query: 437 QVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQI-KNCSSLTSLILSQNNLT 495
LD S G SL LK+ N S + N ++LT L LS+ L
Sbjct: 427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE 486
Query: 496 GPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTI 555
L L+ +++S N+L + L L + + S N + T
Sbjct: 487 QISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE----------TS 536
Query: 556 SPSSVSGNPSL 566
SL
Sbjct: 537 KGILQHFPKSL 547
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 3e-65
Identities = 95/496 (19%), Positives = 166/496 (33%), Gaps = 42/496 (8%)
Query: 89 LLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVS 148
LQ L LS + L + + N + P F SL +
Sbjct: 52 FSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSP-GSFSGLTSLENLV 110
Query: 149 FANNNLTGPIPESLSFCSSLESVNFSSNRLSG-QLPYGIWFLRSLQSLDLSNNLLEGEIV 207
L + +L+ +N + N + +LP L +L +DLS N ++ V
Sbjct: 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 170
Query: 208 KGISNLYDLRA----IKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLP-DSLQRLN 262
+ L + + + N + + L L N S ++ LQ L
Sbjct: 171 NDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLA 229
Query: 263 SCSSLSLKGNSFTGEV------PDWIGKLANL--ESLDLSLNQFSGRIPSSIGNLVFLKE 314
L F E P + L ++ + L+ L +
Sbjct: 230 GLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSA 289
Query: 315 LNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQ 374
++++ E + ++ + + +L PT L++++L+ N+ S
Sbjct: 290 MSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPTLDLP-FLKSLTLTMNKGSIS-- 343
Query: 375 YPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLML--LNMSMNYLFGSIPASIGK 432
++ L LDLS NALS + DL + L L++S N + A+
Sbjct: 344 -FKKVAL----PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMG 397
Query: 433 LKAIQVLDFSDNWLNGTIPPQ-IGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQ 491
L+ +Q LDF + L L L + +SL +L ++
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAG 457
Query: 492 NNLTG-PVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGG 550
N+ + AN +NL ++DLS L I L L N+SHN+L
Sbjct: 458 NSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL-------- 509
Query: 551 FFNTISPSSVSGNPSL 566
+ S + SL
Sbjct: 510 --LFLDSSHYNQLYSL 523
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-62
Identities = 80/473 (16%), Positives = 147/473 (31%), Gaps = 36/473 (7%)
Query: 97 VLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTG 156
+ + + D+ + + +D S N L L F L+ + + +
Sbjct: 15 TYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSF-SNFSELQWLDLSRCEIET 70
Query: 157 PIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDL 216
++ L ++ + N + P L SL++L L I L L
Sbjct: 71 IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130
Query: 217 RAIKLGKNKFSG-QLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCS----SLSLKG 271
+ + + N +LP + L +D N + + LQ L SL +
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190
Query: 272 NSFTGEVPDWIGKLANLESLDLSLNQFSGRIPS-SIGNLVFLKELNISMNQFTGGLPESM 330
N + D + L L L N S I + NL L + + +F +
Sbjct: 191 NPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249
Query: 331 MNCG--------NLLAIDVSQNKLTGNIPTWIFKMG-LQTVSLSGNRLGESMQYPSFASM 381
+ ++ + + + +SL+G +
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI---KYLEDVPKH 306
Query: 382 KDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDF 441
Q L + L + L L L ++MN SI L ++ LD
Sbjct: 307 ----FKWQSLSIIRCQLKQFPTLD---LPFLKSLTLTMNKG--SISFKKVALPSLSYLDL 357
Query: 442 SDNWLNGTIP--PQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTG-PV 498
S N L+ + G SL+ L L N + + L L + L
Sbjct: 358 SRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTE 416
Query: 499 PAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGF 551
+A +L L Y+D+S+ + + L+ L + ++ N F
Sbjct: 417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-48
Identities = 74/404 (18%), Positives = 140/404 (34%), Gaps = 32/404 (7%)
Query: 156 GPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYD 215
G + + ++ + +LS ++P I S +++DLS N L+ SN +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 216 LRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFT 275
L+ + L + + + G L L N + P S L S +L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 276 GEVPDWIGKLANLESLDLSLNQFSG-RIPSSIGNLVFLKELNISMNQFTGGLPESMMNCG 334
IG+L L+ L+++ N ++P+ NL L +++S N +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 335 NL----LAIDVSQNKLTGNIPTWIFK-MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQ 389
L++D+S N + I F+ + L ++L GN ++ ++ GL
Sbjct: 178 ENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNL----AGLH 232
Query: 390 VLDLSSNALSGVIPSNIGDLSSLM--------LLNMSMNYLFGSIPASIGKLKAIQVLDF 441
V L I + S + ++ F L + +
Sbjct: 233 VHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSL 292
Query: 442 SDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAA 501
+ + + + L + + L P+ + L SL L+ N +
Sbjct: 293 AGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ-FPTL--DLPFLKSLTLTMNKGSISFK-- 345
Query: 502 IANLSNLKYVDLSFNDLSGILPK--ELINLSHLLSFNISHNHLH 543
L +L Y+DLS N LS + + L ++S N
Sbjct: 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-63
Identities = 67/303 (22%), Positives = 114/303 (37%), Gaps = 32/303 (10%)
Query: 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
L RG FG V++ L VA+K + K E E+ +L ++H N++
Sbjct: 26 LQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQ 82
Query: 744 LEGYYWTPSLQ----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
G + LI F GSL L N +SW + +I MA+GLAYLH
Sbjct: 83 FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----ANVVSWNELCHIAETMARGLAYLH 138
Query: 800 HT----------NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG 849
I H ++KS NVL+ ++ + DFGLA +
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 850 YMAPEFACRTVKI----TEKCDVYGFGVLVLEVVTGKRPVEYM-EDDVVVLCDMV--RGA 902
YMAPE + + D+Y G+++ E+ + + ++ ++ + + +
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258
Query: 903 LEDGR---VEDCVDARLRGNFPADEAIPVI-KLGLICASQVPSNRPDMEEVVNILELIQS 958
LED + V LR + + ++ + C R V + +Q
Sbjct: 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318
Query: 959 PLD 961
+
Sbjct: 319 LTN 321
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-58
Identities = 79/284 (27%), Positives = 129/284 (45%), Gaps = 35/284 (12%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+GRG FGVV + + + VAIK++ ++ F E++ L ++ H N+V L G
Sbjct: 15 VVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN---IIH 805
P L+ E+ GSLY LH + + L ++G+AYLH +IH
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 806 YNLKSTNVLIDSSGE-PKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVK 861
+LK N+L+ + G K+ DFG A + + + + G +MAPE
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC--------DIQTHMTNNKGSAAWMAPEV-FEGSN 179
Query: 862 ITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921
+EKCDV+ +G+++ EV+T ++P + + R+ V R
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-------------RIMWAVHNGTRPPLI 226
Query: 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEE 965
+ P+ L C S+ PS RP MEE+V I+ + G +E
Sbjct: 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-57
Identities = 86/277 (31%), Positives = 130/277 (46%), Gaps = 29/277 (10%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALEGY 747
++G G FG V+R G VA+K L + +F +E+ + ++RH N+V G
Sbjct: 44 KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN--IIH 805
P ++ E++S GSLY+ LH +R L R+R ++ +AKG+ YLH+ N I+H
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE-FACRTVK 861
NLKS N+L+D KV DFGL+RL LSSK SA G +MAPE
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSK--SAAGTPEWMAPEVLRDEPS- 216
Query: 862 ITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921
EK DVY FGV++ E+ T ++P + +V R P
Sbjct: 217 -NEKSDVYSFGVILWELATLQQPWGNLNPA-----QVVAAVGFKC---------KRLEIP 261
Query: 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958
+ V + C + P RP ++++L +
Sbjct: 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-56
Identities = 75/291 (25%), Positives = 118/291 (40%), Gaps = 30/291 (10%)
Query: 689 ELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
LG+G FG + + G + +K+L ++Q F KE+K + + H N++ G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDE-ETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+ I E+I G+L + S+ W QR + +A G+AYLH NIIH +
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHSMNIIHRD 133
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLL---PMLDRCILSSKIQSALG---------YMAPEF 855
L S N L+ + V DFGLARL+ + S K +MAPE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE- 192
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915
EK DV+ FG+++ E++ + VRG L+ +C
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC---- 248
Query: 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEEL 966
P + + C P RP ++ + LE ++ L G L
Sbjct: 249 -----PP----SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-56
Identities = 74/286 (25%), Positives = 130/286 (45%), Gaps = 42/286 (14%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGL------IKSQEDFEKEMKTLGKIRHHNL 741
++G+GGFG+V++ +++D VAIK L + I+ ++F++E+ + + H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
V L G P ++ EF+ G LY L D + + W + ++L +A G+ Y+ +
Sbjct: 86 VKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 802 N--IIHYNLKSTNVLIDSSGE-----PKVGDFGLARLLPMLDRCILSSKIQSALG---YM 851
N I+H +L+S N+ + S E KV DFGL++ + LG +M
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--------QSVHSVSGLLGNFQWM 193
Query: 852 APE-FACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVED 910
APE TEK D Y F +++ ++TG+ P + + +M+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI----------- 242
Query: 911 CVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956
+ LR P D + + +C S P RP +V L +
Sbjct: 243 -REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 6e-55
Identities = 73/275 (26%), Positives = 126/275 (45%), Gaps = 24/275 (8%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALEGY 747
+G G FG VY+ VA+K L V+ Q + F+ E+ L K RH N++ GY
Sbjct: 31 RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
P L ++ ++ SLY HLH ++ ++ +I A+G+ YLH +IIH +
Sbjct: 89 STAPQL-AIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKSIIHRD 145
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACR--TVKI 862
LKS N+ + K+GDFGLA R S + + G +MAPE +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATE---KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 863 TEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922
+ + DVY FG+++ E++TG+ P + + ++ + RG+L + +
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL---SPD-------LSKVRS 252
Query: 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957
+ + +L C + RP ++ +E +
Sbjct: 253 NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 4e-54
Identities = 93/472 (19%), Positives = 183/472 (38%), Gaps = 51/472 (10%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
L +++ + I D + + N++ + + + +
Sbjct: 3 LGSATITQDTPINQIFTD-TALAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGI 58
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLY 214
+ + + ++L +NFS+N+L+ P L L + ++NN + + ++NL
Sbjct: 59 K--SIDGVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIAD--ITPLANLT 112
Query: 215 DLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSF 274
+L + L N+ + + + + L L+ N++S +L L S LS GN
Sbjct: 113 NLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQV 167
Query: 275 TGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCG 334
T P + L LE LD+S N+ S S + L L+ L + NQ + +
Sbjct: 168 TDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD--ITPLGILT 221
Query: 335 NLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLS 394
NL + ++ N+L +I T L + L+ N++ + + L L L
Sbjct: 222 NLDELSLNGNQLK-DIGTLASLTNLTDLDLANNQISNL---APLSGLTK----LTELKLG 273
Query: 395 SNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQI 454
+N +S + P + L++L L ++ N L P I LK + L N ++ P +
Sbjct: 274 ANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--V 327
Query: 455 GGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLS 514
L+ L N +S S + N +++ L N ++ P +ANL+ + + L+
Sbjct: 328 SSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 383
Query: 515 FNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSL 566
+ N+S + I+P+++S S
Sbjct: 384 DQAWTNAPVNYKANVSIPNTVKNVTG------------ALIAPATISDGGSY 423
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-53
Identities = 103/472 (21%), Positives = 184/472 (38%), Gaps = 40/472 (8%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151
L L N T T++ + + + + + +L +++F+N
Sbjct: 23 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI---DGVEYLNNLTQINFSN 77
Query: 152 NNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGIS 211
N LT P L + L + ++N+++ P + L +L L L NN + + +
Sbjct: 78 NQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPLK 131
Query: 212 NLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKG 271
NL +L ++L N S + G + L+ L FG N ++ P L L + L +
Sbjct: 132 NLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISS 186
Query: 272 NSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMM 331
N + + KL NLESL + NQ S P +G L L EL+++ NQ ++
Sbjct: 187 NKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLA 240
Query: 332 NCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVL 391
+ NL +D++ N+++ N+ L + L N++ A + L L
Sbjct: 241 SLTNLTDLDLANNQIS-NLAPLSGLTKLTELKLGANQISNI---SPLAGLTA----LTNL 292
Query: 392 DLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIP 451
+L+ N L + P I +L +L L + N + P + L +Q L F +N + +
Sbjct: 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDV 346
Query: 452 PQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYV 511
+ ++ L N +S P + N + +T L L+ T AN+S V
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404
Query: 512 DLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGN 563
L I P + + +I+ N V F+
Sbjct: 405 KNVTGAL--IAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTT 454
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-51
Identities = 90/484 (18%), Positives = 184/484 (38%), Gaps = 43/484 (8%)
Query: 65 DPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDF 124
D + L +++ + L + L + L ++F
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINF 75
Query: 125 SENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPY 184
S N L+ + P + L ++ NN + P L+ ++L + +N+++ P
Sbjct: 76 SNNQLTDITP---LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP- 129
Query: 185 GIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLD 244
+ L +L L+LS+N + + +S L L+ + G + + + L+ LD
Sbjct: 130 -LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLD 183
Query: 245 FGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPS 304
N +S L +L + SL N + P +G L NL+ L L+ NQ
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IG 237
Query: 305 SIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM-GLQTVS 363
++ +L L +L+++ NQ + + L + + N+++ P + + L +
Sbjct: 238 TLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293
Query: 364 LSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLF 423
L+ N+L + +++K+ L L L N +S + P + L+ L L N +
Sbjct: 294 LNENQLEDI---SPISNLKN----LTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV- 343
Query: 424 GSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSS 483
S +S+ L I L N ++ P + + +L L + P K S
Sbjct: 344 -SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVS 399
Query: 484 LTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLH 543
+ + + + PA I++ + D+++N L + S ++
Sbjct: 400 IPNTVKNVTGALIA-PATISDGGSYTEPDITWN-LPSYTNEVSYTFSQPVTIGKGTTTFS 457
Query: 544 GELP 547
G +
Sbjct: 458 GTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-20
Identities = 41/242 (16%), Positives = 78/242 (32%), Gaps = 38/242 (15%)
Query: 88 GLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147
L L L L L+NN + L+ L + N +S + P +L +
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP---LAGLTALTNL 292
Query: 148 SFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIV 207
N L P +S +L + N +S P L LQ L NN + V
Sbjct: 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSD--V 346
Query: 208 KGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSL 267
++NL ++ + G N+ S + + + L + + + + ++ +++
Sbjct: 347 SSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404
Query: 268 SLKGNSFTGEVPDWIGKLANLESLDLSLNQ-----------------------FSGRIPS 304
+ P I + D++ N FSG +
Sbjct: 405 KNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQ 462
Query: 305 SI 306
+
Sbjct: 463 PL 464
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 6e-54
Identities = 65/276 (23%), Positives = 114/276 (41%), Gaps = 30/276 (10%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVALEGY 747
+L G +++ Q G + +K L V + DF +E L H N++ + G
Sbjct: 17 KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 748 YWTPSLQLL--IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN--I 803
+P I ++ GSLY LH+G++ + Q L MA+G+A+LH I
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHTLEPLI 134
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEF--ACRTVK 861
+ L S +V+ID ++ + ++ + ++APE
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYA-PAWVAPEALQKKPEDT 187
Query: 862 ITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921
D++ F VL+ E+VT + P + + ++ +G LR P
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADLSN-----MEIGMKVALEG---------LRPTIP 233
Query: 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957
+ V KL IC ++ P+ RP + +V ILE +Q
Sbjct: 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-52
Identities = 61/283 (21%), Positives = 114/283 (40%), Gaps = 35/283 (12%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALEGY 747
+G+G FG VY VAI+ + + + Q + F++E+ + RH N+V G
Sbjct: 40 LIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+P +I +LY + D L + I + KG+ YLH I+H +
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLHAKGILHKD 155
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE--------FA 856
LKS NV D +G+ + DFGL + +L K++ G ++APE
Sbjct: 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 857 CRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916
+ ++ DV+ G + E+ + P + + ++ + G +
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII------WQMGTG---------M 259
Query: 917 RGNFPADEAIPVIKLGLI--CASQVPSNRPDMEEVVNILELIQ 957
+ N I ++ C + RP +++++LE +
Sbjct: 260 KPNLSQIGMGKEISD-ILLFCWAFEQEERPTFTKLMDMLEKLP 301
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-52
Identities = 94/478 (19%), Positives = 177/478 (37%), Gaps = 34/478 (7%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+ L LS N + SF LQV+D S + I D ++ L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPI 88
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLL-EGEIVKGISNL 213
+ S SSL+ + L+ + I L++L+ L++++NL+ ++ + SNL
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 214 YDLRAIKLGKNKFSGQLPEDIGGCSMLKV----LDFGVNSLSGSLPDSLQRLNSCSSLSL 269
+L + L NK D+ + + LD +N ++ + + L+L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTL 207
Query: 270 KGNSFTGEVPD-WIGKLANLESLDLSL------NQFSGRIPSSIGNLVFLKELNISMNQ- 321
+ N + V I LA LE L L S++ L L +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 322 --FTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFA 379
+ + + N+ + + + + + + G Q + L + Q+P+
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKF---GQFPTL- 322
Query: 380 SMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYL--FGSIPASIGKLKAIQ 437
+ L+ L +SN DL SL L++S N L G S +++
Sbjct: 323 ----KLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 438 VLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIP-SQIKNCSSLTSLILSQNNLTG 496
LD S N + T+ G L+ L + + L S + +L L +S +
Sbjct: 377 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 497 PVPAAIANLSNLKYVDLSFNDLSGILPKELI-NLSHLLSFNISHNHLHGELPVGGFFN 553
LS+L+ + ++ N ++ L +L ++S L +L F +
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNS 492
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 5e-52
Identities = 106/481 (22%), Positives = 175/481 (36%), Gaps = 35/481 (7%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151
L L L L+ N + +LQ + E NL+ L + +L+E++ A+
Sbjct: 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL-ENFPIGHLKTLKELNVAH 133
Query: 152 NNLT-GPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQ----SLDLSNNLLEGEI 206
N + +PE S ++LE ++ SSN++ + L + SLDLS N + I
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192
Query: 207 VKGISNLYDLRAIKLGKNKFSGQLPED-IGGCSMLKVLD------FGVNSLSGSLPDSLQ 259
G L + L N S + + I G + L+V +L +L+
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252
Query: 260 RLNSCSSLSLKGNSFTGEVPDWIG---KLANLESLDLSLNQFSGRIPSSIG--NLVFLKE 314
L + + + + D I L N+ S L R+ L+
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLEL 311
Query: 315 LNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQ 374
+N QF + +L + + NK N + + L+ + LS N L
Sbjct: 312 VNCKFGQFPT------LKLKSLKRLTFTSNKGG-NAFSEVDLPSLEFLDLSRNGLSFK-- 362
Query: 375 YPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASI-GKL 433
+ L+ LDLS N + + SN L L L+ + L S+ L
Sbjct: 363 -GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420
Query: 434 KAIQVLDFSDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQI-KNCSSLTSLILSQ 491
+ + LD S I G SL+ LK+ N I +LT L LSQ
Sbjct: 421 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 492 NNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGF 551
L P A +LS+L+ ++++ N L + L+ L + N P +
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539
Query: 552 F 552
Sbjct: 540 L 540
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-50
Identities = 93/498 (18%), Positives = 166/498 (33%), Gaps = 45/498 (9%)
Query: 89 LLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVS 148
LQVL LS + S L + + N + L F SL+++
Sbjct: 48 FFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL-ALGAFSGLSSLQKLV 106
Query: 149 FANNNLTGPIPESLSFCSSLESVNFSSNRL-SGQLPYGIWFLRSLQSLDLSNNLLEGEIV 207
NL + +L+ +N + N + S +LP L +L+ LDLS+N ++
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
Query: 208 KGISNLYDLRAIK----LGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPD------- 256
+ L+ + + L N + + L L N S ++
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLA 225
Query: 257 SLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQ---FSGRIPSSIGNLVFLK 313
L+ + + L NL + L + I L +
Sbjct: 226 GLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS 285
Query: 314 ELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESM 373
++ S +++ K PT K L+ ++ + N+ G +
Sbjct: 286 SFSLVSVTIERVKDFSYNF--GWQHLELVNCKFG-QFPTLKLK-SLKRLTFTSNKGGNA- 340
Query: 374 QYPSFASMKDSYQGLQVLDLSSNALS--GVIPSNIGDLSSLMLLNMSMNYLFGSIPASIG 431
S + L+ LDLS N LS G + +SL L++S N + ++ ++
Sbjct: 341 --FSEVDLPS----LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFL 393
Query: 432 KLKAIQVLDFSDNWLNGTIPPQI--GGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLIL 489
L+ ++ LDF + L + +L L + SSL L +
Sbjct: 394 GLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 490 SQNNLTGPVPA-AIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPV 548
+ N+ L NL ++DLS L + P +LS L N++ N L
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK----- 507
Query: 549 GGFFNTISPSSVSGNPSL 566
++ SL
Sbjct: 508 -----SVPDGIFDRLTSL 520
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-39
Identities = 85/420 (20%), Positives = 154/420 (36%), Gaps = 36/420 (8%)
Query: 151 NNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGI 210
N IP++L S ++++ S N L Y + LQ LDLS ++
Sbjct: 16 ELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 211 SNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLK 270
+L L + L N G S L+ L +L+ + L + L++
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 271 GNSFT-GEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLK----ELNISMNQFTGG 325
N ++P++ L NLE LDLS N+ + + L + L++S+N
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-F 191
Query: 326 LPESMMNCGNLLAIDVSQNKLTGNIPTWIFK--MGLQTVSLSGNRLGESMQYPSFASMKD 383
+ L + + N + N+ + GL+ L F K
Sbjct: 192 IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF--DKS 249
Query: 384 SYQGLQVLDLSSNALSGV---------IPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLK 434
+ +GL L + L+ + + + + ++SS L+++++ +
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE----RVKDFSYNFG 305
Query: 435 AIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNL 494
Q L+ + P SLK L N + SL L LS+N L
Sbjct: 306 -WQHLELVNCKFGQ-FPT--LKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGL 359
Query: 495 T--GPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFF 552
+ G + ++LKY+DLSFN + + + L L + H++L ++ F
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLK-QMSEFSVF 417
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-31
Identities = 77/414 (18%), Positives = 129/414 (31%), Gaps = 78/414 (18%)
Query: 170 SVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQ 229
+ ++P + S ++LDLS N
Sbjct: 11 TYQCMELNFY-KIPDNL--PFSTKNLDLSFN------------------------PLRHL 43
Query: 230 LPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLE 289
L+VLD + + Q L+ S+L L GN L++L+
Sbjct: 44 GSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQ 103
Query: 290 SLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFT-GGLPESMMNCGNLLAIDVSQNKLTG 348
L + IG+L LKELN++ N LPE N NL +D+S NK+
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 349 ---------------------------NIPTWIFK-MGLQTVSLSGNRLGESMQYPSFAS 380
I FK + L ++L N ++
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 223
Query: 381 MKDSYQGLQVLDL------SSNALSGVIPSNIGDLSSLMLLNMSMNYL---FGSIPASIG 431
+ GL+V L + L S + L +L + + YL I
Sbjct: 224 L----AGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 432 KLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQ 491
L + + + + L+L + P+ SL L +
Sbjct: 280 CLTNVSSFSLVSVTIE-RVKDFSYN-FGWQHLELVNCKFG-QFPTL--KLKSLKRLTFTS 334
Query: 492 NNLTGPVPAAIANLSNLKYVDLSFNDLS--GILPKELINLSHLLSFNISHNHLH 543
N + +L +L+++DLS N LS G + + L ++S N +
Sbjct: 335 NKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-19
Identities = 36/163 (22%), Positives = 57/163 (34%), Gaps = 5/163 (3%)
Query: 390 VLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGT 449
IP N+ S L++S N L S +QVLD S +
Sbjct: 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 450 IPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLK 509
L L L N + SSL L+ + NL I +L LK
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 510 YVDLSFNDLSGI-LPKELINLSHLLSFNISHNHLHGELPVGGF 551
++++ N + LP+ NL++L ++S N + +
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDL 169
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-13
Identities = 29/113 (25%), Positives = 52/113 (46%), Gaps = 2/113 (1%)
Query: 89 LLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVS 148
L L+ L L +S+ + N +L+V+ + N+ + F + +L +
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 149 FANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIW-FLRSLQSLDLSNN 200
+ L P + + SSL+ +N +SN+L +P GI+ L SLQ + L N
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-09
Identities = 22/100 (22%), Positives = 38/100 (38%), Gaps = 2/100 (2%)
Query: 92 LQFLQVLSLSNNNFTGTINAD-LASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFA 150
L L+VL ++ N+F D L +D S+ L + F SL+ ++ A
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMA 502
Query: 151 NNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLR 190
+N L +SL+ + +N P + R
Sbjct: 503 SNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 542
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 9e-52
Identities = 78/285 (27%), Positives = 120/285 (42%), Gaps = 44/285 (15%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSG---LIKSQEDFEKEMKTLGKIRHHNLVALE 745
+G GGFG VYR G VA+K + ++ E+ +E K ++H N++AL
Sbjct: 14 IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN--- 802
G L+ EF G L + L + N + +A+G+ YLH
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 803 IIHYNLKSTNVLIDSSGEP--------KVGDFGLARLLPMLDRCILSSKIQSALG---YM 851
IIH +LKS+N+LI E K+ DFGLAR + SA G +M
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-------WHRTTKMSAAGAYAWM 181
Query: 852 APEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911
APE R ++ DV+ +GVL+ E++TG+ P ++ + G +
Sbjct: 182 APE-VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-----LAVAYGVAMNK----- 230
Query: 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956
L P+ P KL C + P +RP +++ L I
Sbjct: 231 ----LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-51
Identities = 94/494 (19%), Positives = 174/494 (35%), Gaps = 50/494 (10%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151
L + L LS N + LQ+++ I E FR +LR + +
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 152 NNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLEG-EIVK 208
+ + P++ L + LS + +F L++L LDLS N + +
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
Query: 209 GISNLYDLRAIKLGKNKFSGQLPEDIGGCSM--LKVLDFGVNSLSGSLPDSLQRLN---- 262
L L++I N+ ++ L NSL + +
Sbjct: 143 SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR 202
Query: 263 --SCSSLSLKGNSFTGEVPD------------WIGKLANLESLDLSLNQFSGRIPSSIGN 308
L + GN +T ++ + ++ + ++
Sbjct: 203 NMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG 262
Query: 309 LV--FLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFK--MGLQTVSL 364
L ++ L++S +L ++++ NK+ I F LQ ++L
Sbjct: 263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNL 321
Query: 365 SGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFG 424
S N LGE + +F + + +DL N ++ + L L L++ N L
Sbjct: 322 SYNLLGE-LYSSNFYGLPK----VAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-- 374
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSG-RIPSQIKNCSS 483
+I + +I + S N L T+P ++ + L +N L I +
Sbjct: 375 ---TTIHFIPSIPDIFLSGNKLV-TLPK---INLTANLIHLSENRLENLDILYFLLRVPH 427
Query: 484 LTSLILSQNNLTG-PVPAAIANLSNLKYVDLSFNDL-----SGILPKELINLSHLLSFNI 537
L LIL+QN + + +L+ + L N L + + LSHL +
Sbjct: 428 LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487
Query: 538 SHNHLHGELPVGGF 551
+HN+L+ LP G F
Sbjct: 488 NHNYLN-SLPPGVF 500
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-50
Identities = 105/512 (20%), Positives = 188/512 (36%), Gaps = 54/512 (10%)
Query: 89 LLRLQFLQVLSLSNNNFTGTINAD-LASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147
L+ LQ+L L + TI+ + + L+++D + + + + F+ L E+
Sbjct: 44 FPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYF-LHPDAFQGLFHLFEL 102
Query: 148 SFANNNLTGPI--PESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLE 203
L+ + +L ++ S N++ L F L SL+S+D S+N +
Sbjct: 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR-SLYLHPSFGKLNSLKSIDFSSNQIF 161
Query: 204 GEIVKGISNLY--DLRAIKLGKNKFSGQLPEDIGGCSM------LKVLDFGVNSLSGSLP 255
+ L L L N ++ D G C L++LD N + +
Sbjct: 162 LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT 221
Query: 256 D------------SLQRLNSCSSLSLKGNSFTGEVPDWIGKLA--NLESLDLSLNQFSGR 301
SL + ++ + LA ++ LDLS
Sbjct: 222 GNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSL 281
Query: 302 IPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFK--MGL 359
L LK LN++ N+ E+ NL +++S N L + + F +
Sbjct: 282 NSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKV 340
Query: 360 QTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSM 419
+ L N + +Q +F ++ LQ LDL NAL+ I + S+ + +S
Sbjct: 341 AYIDLQKNHI-AIIQDQTFKFLEK----LQTLDLRDNALT-----TIHFIPSIPDIFLSG 390
Query: 420 NYLFGSIPASIGKLKAIQVLDFSDNWLNG-TIPPQIGGAVSLKELKLEKNFLSGRIPSQI 478
N L ++P ++ S+N L I + L+ L L +N S Q
Sbjct: 391 NKL-VTLPKINLTA---NLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQT 446
Query: 479 -KNCSSLTSLILSQNNLTGPVPAAI-----ANLSNLKYVDLSFNDLSGILPKELINLSHL 532
SL L L +N L + LS+L+ + L+ N L+ + P +L+ L
Sbjct: 447 PSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL 506
Query: 533 LSFNISHNHLHGELPVGGFFNTISPSSVSGNP 564
+++ N L L + +S N
Sbjct: 507 RGLSLNSNRLT-VLSHNDLPANLEILDISRNQ 537
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-43
Identities = 90/546 (16%), Positives = 175/546 (32%), Gaps = 51/546 (9%)
Query: 84 HIGRGLLRLQFLQVLSLSNNNFTGTINADLASFG--TLQVVDFSENNLSGLIPDEFFRQC 141
++ +L L+ + S+N +L TL + N+L + ++ +
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198
Query: 142 GSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNL 201
R + ++ S + + + NF SN +S + + + +
Sbjct: 199 NPFRNMVLEILDV------SGNGWTVDITGNF-SNAISKSQAFSLILAHHIMGAGFGFHN 251
Query: 202 LEG---EIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSL 258
++ G++ +R + L LKVL+ N ++ ++
Sbjct: 252 IKDPDQNTFAGLARSS-VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAF 310
Query: 259 QRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNIS 318
L++ L+L N L + +DL N + + L L+ L++
Sbjct: 311 YGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLR 370
Query: 319 MNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSF 378
N T ++ ++ I +S NKL +P + + LS NRL
Sbjct: 371 DNALT-----TIHFIPSIPDIFLSGNKLV-TLPK--INLTANLIHLSENRLENLDILYFL 422
Query: 379 ASMKDSYQGLQVLDLSSNALSGVIPSNI-GDLSSLMLLNMSMNYLFGSIPASIGKLKAIQ 437
+ LQ+L L+ N S + SL L + N L
Sbjct: 423 LRVPH----LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENML--------------- 463
Query: 438 VLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGP 497
W G L+ L L N+L+ P + ++L L L+ N LT
Sbjct: 464 ----QLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVL 519
Query: 498 VPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISP 557
+ +NL+ +D+S N L P ++LS +I+HN E + F N ++
Sbjct: 520 SHNDL--PANLEILDISRNQLLAPNPDVFVSLS---VLDITHNKFICECELSTFINWLNH 574
Query: 558 SSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNHRRKIVLSISALIAIGA 617
++V+ + + + ++ L
Sbjct: 575 TNVT-IAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLM 633
Query: 618 AAFIAI 623
Sbjct: 634 TILTVT 639
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-40
Identities = 83/414 (20%), Positives = 144/414 (34%), Gaps = 33/414 (7%)
Query: 165 CS-SLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGK 223
CS + L+ Q+P L + + L LS N + L L+ ++LG
Sbjct: 2 CSFDGRIAFYRFCNLT-QVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGS 57
Query: 224 NKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEV--PD 280
+ ++ L++LD G + + PD+ Q L L L + V
Sbjct: 58 QYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDG 117
Query: 281 WIGKLANLESLDLSLNQFSG-RIPSSIGNLVFLKELNISMNQFTGGLPESMMNCG--NLL 337
+ L L LDLS NQ + S G L LK ++ S NQ + L
Sbjct: 118 YFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLS 177
Query: 338 AIDVSQNKLTGNIPTWIFK-------MGLQTVSLSGNRLGESMQYPSFASMKDS------ 384
++ N L + K M L+ + +SGN + ++ S
Sbjct: 178 FFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLI 237
Query: 385 -YQGLQVLDLSSNALSGVIPSNIGDL--SSLMLLNMSMNYLFGSIPASIGKLKAIQVLDF 441
+ + + + L SS+ L++S ++F LK ++VL+
Sbjct: 238 LAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNL 297
Query: 442 SDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAA 501
+ N +N G +L+ L L N L S + + L +N++
Sbjct: 298 AYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQT 357
Query: 502 IANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTI 555
L L+ +DL N L+ + + + +S N L LP +
Sbjct: 358 FKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTANL 405
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-19
Identities = 59/257 (22%), Positives = 90/257 (35%), Gaps = 24/257 (9%)
Query: 74 LTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133
L L L L + + L N+ + LQ +D +N L+
Sbjct: 319 LNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT--- 375
Query: 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRS 191
S+ ++ + N L +L + ++ S NRL L + +
Sbjct: 376 ---TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLE-NLDILYFLLRVPH 427
Query: 192 LQSLDLSNNLLEGEIVKGI-SNLYDLRAIKLGKNKFSGQLPEDI-----GGCSMLKVLDF 245
LQ L L+ N S L + LG+N ++ G S L+VL
Sbjct: 428 LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487
Query: 246 GVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSS 305
N L+ P L + LSL N T + ANLE LD+S NQ P
Sbjct: 488 NHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLAPNPDV 545
Query: 306 IGNLVFLKELNISMNQF 322
+ L L+I+ N+F
Sbjct: 546 FVS---LSVLDITHNKF 559
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 4e-50
Identities = 69/317 (21%), Positives = 120/317 (37%), Gaps = 49/317 (15%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDF--EKEMKTLGKIRHHNLVALEGY 747
+GRG +G VY+ L D R VA+K + ++++F EK + + + H N+
Sbjct: 21 IGRGRYGAVYKGSL-DERPVAVKVFS----FANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 748 YWTPSLQ-----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH--- 799
+ LL+ E+ +GSL K+L + W + + +GLAYLH
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSSCRLAHSVTRGLAYLHTEL 131
Query: 800 ------HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA------ 847
I H +L S NVL+ + G + DFGL+ L + +A
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 848 LGYMAPEFACRTV------KITEKCDVYGFGVLVLEVV---TGKRPVEYMEDDVVVLCDM 898
+ YMAPE V ++ D+Y G++ E+ T P E + + +
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTE 251
Query: 899 V--RGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLI------CASQVPSNRPDMEEVV 950
V ED +V + + R FP + + + C Q R +
Sbjct: 252 VGNHPTFEDMQVLVSRE-KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310
Query: 951 NILELIQSPLDGQEELE 967
+ + + + +
Sbjct: 311 ERMAELMMIWERNKSVS 327
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-49
Identities = 85/494 (17%), Positives = 165/494 (33%), Gaps = 56/494 (11%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
++ L LS N T + DL + LQV+ + ++ I + F GSL + ++N+L
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDNHL 86
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLEGEIVKG-IS 211
+ SSL+ +N N L F L +LQ+L + N EI + +
Sbjct: 87 SSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA 145
Query: 212 NLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKG 271
L L +++ + + + L ++ + L L+S L L+
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205
Query: 272 NSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKEL---------------- 315
+ + + + S S L+ L
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265
Query: 316 --NISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMG-LQTVSLSGNRLGES 372
+ + ++ + + + + Q L ++ T + ++ +++ +++
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV-FL 324
Query: 373 MQYPSFASMKDSYQGLQVLDLSSNALSGVIPSN---IGDLSSLMLLNMSMNYL--FGSIP 427
+ +K L+ LDLS N + N G SL L +S N+L
Sbjct: 325 VPCSFSQHLK----SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTG 380
Query: 428 ASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQI--------- 478
+ LK + LD S N + +P ++ L L + + + I
Sbjct: 381 EILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDV 438
Query: 479 ---------KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINL 529
L L +S+N L +P A + L + +S N L + L
Sbjct: 439 SNNNLDSFSLFLPRLQELYISRNKLKT-LPDA-SLFPVLLVMKISRNQLKSVPDGIFDRL 496
Query: 530 SHLLSFNISHNHLH 543
+ L + N
Sbjct: 497 TSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-48
Identities = 94/508 (18%), Positives = 185/508 (36%), Gaps = 51/508 (10%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
V + +FT +I + L ++ +D S N ++ I R C +L+ + ++ +
Sbjct: 7 SGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITY-IGHGDLRACANLQVLILKSSRI 62
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKG-ISNL 213
++ SLE ++ S N LS L SL+ L+L N + V NL
Sbjct: 63 NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 214 YDLRAIKLGKNKFSGQLPE-DIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGN 272
+L+ +++G + ++ D G + L L+ SL SL+ + L+L +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 273 SFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELN-----------ISMNQ 321
+ + L+++ L+L + S + + S N+
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
Query: 322 FTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM----GLQTVSLSGNRLGESMQYPS 377
L ++ + D + N L P+ + ++TV++ + + +
Sbjct: 243 LL-KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYD 301
Query: 378 FASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYL---FGSIPASIGKLK 434
+++ + ++ + + ++ + V S L SL L++S N + + A G
Sbjct: 302 LSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361
Query: 435 AIQVLDFSDNWLNGTIPPQIG---GAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQ 491
++Q L S N L ++ +L L + +N +P + + L LS
Sbjct: 362 SLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSS 419
Query: 492 NNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGF 551
+ V I L+ +D+S N+L L L L IS N L LP
Sbjct: 420 TGIRV-VKTCI--PQTLEVLDVSNNNLDSF-SLFLPRLQEL---YISRNKLK-TLPDASL 471
Query: 552 FN-------------TISPSSVSGNPSL 566
F ++ SL
Sbjct: 472 FPVLLVMKISRNQLKSVPDGIFDRLTSL 499
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-43
Identities = 76/443 (17%), Positives = 150/443 (33%), Gaps = 46/443 (10%)
Query: 92 LQFLQVLSLSNNNFTG-TINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFA 150
L L+ L+L N + + + + LQ + I F SL E+
Sbjct: 97 LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156
Query: 151 NNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGI 210
+L +SL + + + + L L S++ L+L + L +
Sbjct: 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPL 216
Query: 211 SNLYDLRAIKLGKNKFSG----------QLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQR 260
+K + S +L I S ++ D +N L P
Sbjct: 217 PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDV 276
Query: 261 LNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMN 320
++ + + + L + + + L +K + + +
Sbjct: 277 VSELGKV----------------ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 321 QFTGGLPESMMNCGNLLAIDVSQNKLTGN-IPTWIFKMG---LQTVSLSGNRLGE-SMQY 375
+ + +L +D+S+N + + K LQT+ LS N L
Sbjct: 321 KVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTG 380
Query: 376 PSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKA 435
++K+ L LD+S N +P + + LN+S + + I +
Sbjct: 381 EILLTLKN----LTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI-RVVKTCI--PQT 432
Query: 436 IQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLT 495
++VLD S+N L+ + + L+EL + +N L +P L + +S+N L
Sbjct: 433 LEVLDVSNNNLD-SFSLFL---PRLQELYISRNKLK-TLPDAS-LFPVLLVMKISRNQLK 486
Query: 496 GPVPAAIANLSNLKYVDLSFNDL 518
L++L+ + L N
Sbjct: 487 SVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-37
Identities = 68/402 (16%), Positives = 144/402 (35%), Gaps = 36/402 (8%)
Query: 165 CSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKN 224
C + + S + +P G+ +++SLDLS N + + +L+ + L +
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 225 KFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTG-EVPDWI 282
+ + + D L+ LD N LS L+S L+L GN + V
Sbjct: 61 RIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 283 GKLANLESLDLSLNQFSGRIP-SSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDV 341
L NL++L + + I L L EL I +S+ + ++ + +
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 342 SQNKLTGNIPTWIFKM--GLQTVSLSGNRLGESMQYPSFASM------KDSYQGLQVLDL 393
++ + + ++ + L L P K +++G + D
Sbjct: 180 HLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
Query: 394 SSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQ 453
S N L + I +LS + + ++N L P+ + + ++
Sbjct: 239 SFNELL-KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVET------------ 285
Query: 454 IGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDL 513
V+++ L + + +L + + + + + + + + +L +L+++DL
Sbjct: 286 ----VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDL 341
Query: 514 SFNDLSGILPKELI---NLSHLLSFNISHNHLHGELPVGGFF 552
S N + K L + +S NHL G
Sbjct: 342 SENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 65/353 (18%), Positives = 119/353 (33%), Gaps = 28/353 (7%)
Query: 74 LTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133
LTL + + L ++ L L + N + ++
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFRGSVL 235
Query: 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQ 193
DE F + L + + C+ +F+ + G +++
Sbjct: 236 TDESFNELLKLLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289
Query: 194 SLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIG-GCSMLKVLDFGVNSLSG 252
L + L ++ S L ++ I + +K +P L+ LD N +
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVE 348
Query: 253 SLPDSLQRLNSCSSL---SLKGNSFT--GEVPDWIGKLANLESLDLSLNQFSGRIPSSIG 307
+ + SL L N + + + L NL SLD+S N F +P S
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQ 407
Query: 308 NLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGN 367
++ LN+S + + L +DVS N L + ++ + LQ + +S N
Sbjct: 408 WPEKMRFLNLSSTGIR-VVKTCIPQ--TLEVLDVSNNNLD-SFSLFLPR--LQELYISRN 461
Query: 368 RLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMN 420
+L P + L V+ +S N L V L+SL + + N
Sbjct: 462 KL---KTLPDASLFP----VLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-19
Identities = 47/254 (18%), Positives = 87/254 (34%), Gaps = 38/254 (14%)
Query: 73 GLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLS-- 130
L + F L + L+ ++ +++ N+ + +L+ +D SEN +
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEE 349
Query: 131 GLIPDEFFRQCGSLREVSFANNNLT--GPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF 188
L SL+ + + N+L E L +L S++ S N +P +
Sbjct: 350 YLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW 408
Query: 189 LRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVN 248
++ L+LS+ + + I L+VLD N
Sbjct: 409 PEKMRFLNLSSTGIR-------------------------VVKTCI--PQTLEVLDVSNN 441
Query: 249 SLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGN 308
+L S L RL L + N +PD L + +S NQ
Sbjct: 442 NLD-SFSLFLPRL---QELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDR 495
Query: 309 LVFLKELNISMNQF 322
L L+++ + N +
Sbjct: 496 LTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-14
Identities = 36/171 (21%), Positives = 63/171 (36%), Gaps = 28/171 (16%)
Query: 387 GLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWL 446
V D S + + IPS + +++ L++S N + + +QVL + +
Sbjct: 6 ASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 447 NGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLS 506
N TI + SL L LS N+L+ + LS
Sbjct: 63 N-TIEGDA-----------------------FYSLGSLEHLDLSDNHLSSLSSSWFGPLS 98
Query: 507 NLKYVDLSFNDLSGI-LPKELINLSHLLSFNISHNHLHGELPVGGFFNTIS 556
+LKY++L N + + NL++L + I + E+ F S
Sbjct: 99 SLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS 149
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 7e-49
Identities = 70/291 (24%), Positives = 110/291 (37%), Gaps = 34/291 (11%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW 749
+G+G +G V+R Q G +VA+K + + E E+ +RH N++
Sbjct: 16 VGKGRYGEVWRGSWQ-GENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 750 TPSLQ----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH------ 799
T LI + GSLY +L L I+L +A GLA+LH
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 800 --HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA--LGYMAPE- 854
I H +LKS N+L+ +G+ + D GLA + + YMAPE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 855 ----FACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVED 910
++ D++ FG+++ EV +ED D+V +
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248
Query: 911 CV-DARLRGNFPA----DEAIPVIKLGLI--CASQVPSNRPDMEEVVNILE 954
V + R N P D + + L+ C Q PS R + L
Sbjct: 249 VVCVDQQRPNIPNRWFSDPTLTSLA-KLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 9e-49
Identities = 65/300 (21%), Positives = 115/300 (38%), Gaps = 34/300 (11%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW 749
+G+G FG V+R + G VA+K + + E E+ +RH N++
Sbjct: 50 IGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 750 TPSLQ----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH------ 799
+ L+ ++ GSL+ +L+ R ++ + L A GLA+LH
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 800 --HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA--LGYMAPE- 854
I H +LKS N+L+ +G + D GLA I + YMAPE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 855 ----FACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVED 910
+ + ++ D+Y G++ E+ ED + D+V +
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 911 CV-DARLRGNFP----ADEAIPVIKLGLI--CASQVPSNRPDMEEVVNILELIQSPLDGQ 963
V + +LR N P + EA+ V+ ++ C + R + L + +
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMA-KIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 341
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-48
Identities = 66/300 (22%), Positives = 113/300 (37%), Gaps = 36/300 (12%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
++G+G +G V+ + G VA+K + ++ E E+ +RH N++
Sbjct: 44 QIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 749 WTPSLQ----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH----- 799
+ LI ++ +GSLY +L L + + GL +LH
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 800 ---HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA--LGYMAPE 854
I H +LKS N+L+ +G + D GLA + YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 855 -----FACRTVKITEKCDVYGFGVLVL-EVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV 908
+ D+Y FG L+L EV +E+ + D+V +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFG-LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 909 EDCV-DARLRGNFP----ADEAIPVIKLGLI--CASQVPSNRPDMEEVVNILELIQSPLD 961
+ V +LR +FP +DE + + L+ C + P++R V L + D
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMG-KLMTECWAHNPASRLTALRVKKTLAKMSESQD 334
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 2e-48
Identities = 53/344 (15%), Positives = 113/344 (32%), Gaps = 33/344 (9%)
Query: 189 LRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVN 248
++L + +S + + + + ++
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NNPQIETRTGR 66
Query: 249 SLSGSLPDSLQRLNSCS--SLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSI 306
+L + D L+ +L L+ + PD +L++L+ + + +P ++
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
Query: 307 GNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSG 366
L+ L ++ N LP S+ + L + + +P
Sbjct: 124 QQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELP--------------- 167
Query: 367 NRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSI 426
E + + LQ L L + +P++I +L +L L + + L ++
Sbjct: 168 ----EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-AL 221
Query: 427 PASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKL-EKNFLSGRIPSQIKNCSSLT 485
+I L ++ LD PP GG LK L L + + L +P I + L
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLE 280
Query: 486 SLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINL 529
L L +P+ IA L + + + + + +
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 9e-45
Identities = 60/334 (17%), Positives = 115/334 (34%), Gaps = 33/334 (9%)
Query: 165 CSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKN 224
S E++ F + + + + D + +N + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQ----ANSNNPQIETRTGR 66
Query: 225 KFSGQLPEDIGGCSM--LKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWI 282
+ + + L+ L PD RL+ +++ E+PD +
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
Query: 283 GKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVS 342
+ A LE+L L+ N +P+SI +L L+EL+I LPE + +
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182
Query: 343 QNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYP-SFASMKDSYQGLQVLDLSSNALSGV 401
N LQ++ L + P S A+++ L+ L + ++ LS
Sbjct: 183 VN--------------LQSLRLEWTGI---RSLPASIANLQ----NLKSLKIRNSPLSA- 220
Query: 402 IPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLK 461
+ I L L L++ + P G ++ L D T+P I L+
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLE 280
Query: 462 ELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLT 495
+L L R+PS I + +++ +
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 58/384 (15%), Positives = 102/384 (26%), Gaps = 97/384 (25%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151
L Q ++ N + A+ Q+ + L + +
Sbjct: 32 LSQWQRHYNADRNRWHSA-WRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRS 90
Query: 152 NNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGIS 211
L P+ S L+ + + L +LP + L++L L+ N L
Sbjct: 91 VPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-------- 140
Query: 212 NLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKG 271
LP I + L+ L LP+ L ++
Sbjct: 141 -----------------ALPASIASLNRLRELSIRACPELTELPEPLASTDA-------- 175
Query: 272 NSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMM 331
L NL+SL L +P+SI NL LK L I + + L ++
Sbjct: 176 -------SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAI- 225
Query: 332 NCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVL 391
+L L+ L
Sbjct: 226 --HHL-------------------------------------------------PKLEEL 234
Query: 392 DLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIP 451
DL P G + L L + ++P I +L ++ LD +P
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 452 PQIGGAVSLKELKLEKNFLSGRIP 475
I + + + + +
Sbjct: 295 SLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 53/243 (21%), Positives = 85/243 (34%), Gaps = 15/243 (6%)
Query: 88 GLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147
L L + LQ + L L PD Q L +
Sbjct: 76 EDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMEL-PDTMQ-QFAGLETL 132
Query: 148 SFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGI---------WFLRSLQSLDLS 198
+ A N L +P S++ + L ++ + +LP + L +LQSL L
Sbjct: 133 TLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLE 191
Query: 199 NNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSL 258
+ + I+NL +L+++K+ + S L I L+ LD + + P
Sbjct: 192 WTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIF 249
Query: 259 QRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNIS 318
L LK S +P I +L LE LDL R+PS I L + +
Sbjct: 250 GGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309
Query: 319 MNQ 321
+
Sbjct: 310 PHL 312
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 9e-11
Identities = 18/113 (15%), Positives = 40/113 (35%), Gaps = 2/113 (1%)
Query: 91 RLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFA 150
LQ L+ L + N+ + + + L+ +D P F L+ +
Sbjct: 204 NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFG-GRAPLKRLILK 261
Query: 151 NNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLE 203
+ + +P + + LE ++ +LP I L + + + +L
Sbjct: 262 DCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 8/94 (8%), Positives = 26/94 (27%), Gaps = 1/94 (1%)
Query: 91 RLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFA 150
L L+ L L L+ + + + +P + + L ++
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDI-HRLTQLEKLDLR 285
Query: 151 NNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPY 184
+P ++ + + + + +
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 2e-47
Identities = 71/402 (17%), Positives = 155/402 (38%), Gaps = 58/402 (14%)
Query: 119 LQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRL 178
+ ++ + PD + ++T + S+ + + ++
Sbjct: 2 AATLATLPAPINQIFPDADLAE---GIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56
Query: 179 SGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCS 238
+ + GI +L +L+ L+L+ N + + +SNL L + +G NK + + +
Sbjct: 57 A-SIQ-GIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITD--ISALQNLT 110
Query: 239 MLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQF 298
L+ L +++S P + L + SL+L N
Sbjct: 111 NLRELYLNEDNISDISP--------------------------LANLTKMYSLNLGANHN 144
Query: 299 SGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM- 357
S + N+ L L ++ ++ + N +L ++ ++ N++ P + +
Sbjct: 145 LS-DLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLT 199
Query: 358 GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNM 417
L + N++ + A+M L L + +N ++ + P + +LS L L +
Sbjct: 200 SLHYFTAYVNQITDI---TPVANMTR----LNSLKIGNNKITDLSP--LANLSQLTWLEI 250
Query: 418 SMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQ 477
N + S ++ L +++L+ N + + + L L L N L
Sbjct: 251 GTNQI--SDINAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEV 306
Query: 478 IKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLS 519
I ++LT+L LSQN++T P +A+LS + D + +
Sbjct: 307 IGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 3e-47
Identities = 75/354 (21%), Positives = 137/354 (38%), Gaps = 29/354 (8%)
Query: 189 LRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVN 248
L L + V L + + + K + + I + L+ L+ N
Sbjct: 21 LAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGN 76
Query: 249 SLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGN 308
++ P L L ++L + N T + L NL L L+ + S S + N
Sbjct: 77 QITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISD--ISPLAN 130
Query: 309 LVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNR 368
L + LN+ N + N L + V+++K+ P L ++SL+ N+
Sbjct: 131 LTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLTD-LYSLSLNYNQ 188
Query: 369 LGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPA 428
+ + AS+ L N ++ + P + +++ L L + N + P
Sbjct: 189 IEDI---SPLASLTS----LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP- 238
Query: 429 SIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLI 488
+ L + L+ N + + + LK L + N +S S + N S L SL
Sbjct: 239 -LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLF 293
Query: 489 LSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHL 542
L+ N L I L+NL + LS N ++ I P L +LS + S + ++ +
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-45
Identities = 64/363 (17%), Positives = 145/363 (39%), Gaps = 31/363 (8%)
Query: 192 LQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLS 251
+L + + ++L + L K + + L ++
Sbjct: 2 AATLATLPAPINQ--IFPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 252 GSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVF 311
S+ ++ L + L+L GN T P + L L +L + N+ + S++ NL
Sbjct: 58 -SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 312 LKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM-GLQTVSLSGNRLG 370
L+EL ++ + + + N + ++++ N ++ + M GL ++++ +++
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVK 168
Query: 371 ESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASI 430
+ A++ D L L L+ N + + P + L+SL +N + P +
Sbjct: 169 DV---TPIANLTD----LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--V 217
Query: 431 GKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILS 490
+ + L +N + P + L L++ N +S + +K+ + L L +
Sbjct: 218 ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVG 273
Query: 491 QNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGG 550
N ++ + + NLS L + L+ N L + + L++L + +S NH+ P+
Sbjct: 274 SNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLAS 331
Query: 551 FFN 553
Sbjct: 332 LSK 334
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-39
Identities = 62/354 (17%), Positives = 126/354 (35%), Gaps = 52/354 (14%)
Query: 91 RLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFA 150
L+ + L ++ +I + L+ ++ + N ++ + P L +
Sbjct: 42 ELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISP---LSNLVKLTNLYIG 96
Query: 151 NNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGI 210
N +T +L ++L + + + +S + L + SL+L N ++ +
Sbjct: 97 TNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDL-SPL 151
Query: 211 SNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLK 270
SN+ L + + ++K I + L L N + L L S +
Sbjct: 152 SNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAY 207
Query: 271 GNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESM 330
N T P + + L SL + N+ + S + NL L L I NQ + ++
Sbjct: 208 VNQITDITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAV 261
Query: 331 MNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQV 390
+ L ++V N+++ ++ L
Sbjct: 262 KDLTKLKMLNVGSNQISD--------------------------ISVLNNLSQ----LNS 291
Query: 391 LDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDN 444
L L++N L IG L++L L +S N++ P + L + DF++
Sbjct: 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-28
Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 16/229 (6%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+ L+L N+ ++ L++ L + +E+ + + P L +S N +
Sbjct: 134 MYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP---IANLTDLYSLSLNYNQI 189
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLY 214
P L+ +SL N+++ P + + L SL + NN + + ++NL
Sbjct: 190 EDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--LSPLANLS 243
Query: 215 DLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSF 274
L +++G N+ S + + LK+L+ G N +S L L+ +SL L N
Sbjct: 244 QLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQL 299
Query: 275 TGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFT 323
E + IG L NL +L LS N + + +L + + +
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 4e-20
Identities = 37/161 (22%), Positives = 71/161 (44%), Gaps = 12/161 (7%)
Query: 387 GLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWL 446
G L ++ + P DL+ + + + + +L++I L + +
Sbjct: 1 GAATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56
Query: 447 NGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLS 506
I +L+ L L N ++ P + N LT+L + N +T +A+ NL+
Sbjct: 57 --ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLT 110
Query: 507 NLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELP 547
NL+ + L+ +++S I P L NL+ + S N+ NH +L
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS 149
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 26/140 (18%), Positives = 57/140 (40%), Gaps = 9/140 (6%)
Query: 88 GLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147
+ + L L + NN T LA+ L ++ N +S + + L+ +
Sbjct: 216 PVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI---NAVKDLTKLKML 270
Query: 148 SFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIV 207
+ +N ++ L+ S L S+ ++N+L + I L +L +L LS N + +
Sbjct: 271 NVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--I 326
Query: 208 KGISNLYDLRAIKLGKNKFS 227
+ +++L + +
Sbjct: 327 RPLASLSKMDSADFANQVIK 346
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-47
Identities = 93/479 (19%), Positives = 161/479 (33%), Gaps = 88/479 (18%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQ----------- 140
FLQ ++N T + + + + + + P Q
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 141 -CGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSN 199
E+ N L+ +PE LES+ S N L+ +LP L+SL + +
Sbjct: 69 LDRQAHELELNNLGLS-SLPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 200 NLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQ 259
L L + + N+ +LPE + S LK++D NSL LPD
Sbjct: 124 KALSDLPPL-------LEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPP 173
Query: 260 RLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISM 319
L ++ N E+P+ + L L ++ N ++P + L+ +
Sbjct: 174 SL---EFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGN 224
Query: 320 NQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFA 379
N + N L I N L +P L+ +++ N L
Sbjct: 225 NILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPS--LEALNVRDNYL---------T 270
Query: 380 SMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVL 439
+ + Q L LD+S N SG + +L L + + S+ L + L
Sbjct: 271 DLPELPQSLTFLDVSENIFSG-LSELPPNLYYLNASSNEIR----SLCDLPPSL---EEL 322
Query: 440 DFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVP 499
+ S+N L +P L+ L N L+ +P +N L L + N L P
Sbjct: 323 NVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FP 373
Query: 500 AAIANL----------------SNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHL 542
++ NLK + + N L P ++ L ++ +
Sbjct: 374 DIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL---RMNSERV 428
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 5e-47
Identities = 95/454 (20%), Positives = 167/454 (36%), Gaps = 68/454 (14%)
Query: 90 LRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSF 149
+ L L+N + ++ L+ + S N+L+ L P+ SL +
Sbjct: 68 CLDRQAHELELNNLGLS-SLPELP---PHLESLVASCNSLTEL-PELPQ-SLKSLLVDNN 121
Query: 150 ANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKG 209
L+ P LE + S+N+L +LP + L+ +D+ NN L+ ++
Sbjct: 122 NLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDL 171
Query: 210 ISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSL 269
+L + G N+ +LPE + L + NSL LPD L S+
Sbjct: 172 PPSLEFIA---AGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSL---ESIVA 222
Query: 270 KGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPES 329
N E+P+ + L L ++ N +P +L + LN+ N T LPE
Sbjct: 223 GNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPSL---EALNVRDNYLTD-LPEL 275
Query: 330 MMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQ 389
+L +DVS+N + + L ++ S N + P L+
Sbjct: 276 ---PQSLTFLDVSENIFS-GLSELP--PNLYYLNASSNEIRSLCDLPP---------SLE 320
Query: 390 VLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGT 449
L++S+N L +P+ L L+ N+L +P LK L N L
Sbjct: 321 ELNVSNNKLI-ELPALPPRLERLIASF---NHL-AEVPELPQNLK---QLHVEYNPLR-E 371
Query: 450 IPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLK 509
P S+++L++ + +P +N L L + N L P ++ +L
Sbjct: 372 FPDIPE---SVEDLRMNSHLAE--VPELPQN---LKQLHVETNPLRE-FPDIPESVEDL- 421
Query: 510 YVDLSFNDLSGILPKELINLSHLLSFNISHNHLH 543
++ + L H+H H
Sbjct: 422 --RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-46
Identities = 88/418 (21%), Positives = 149/418 (35%), Gaps = 69/418 (16%)
Query: 143 SLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIW-------------FL 189
L+E ++NLT +P S + + P G
Sbjct: 12 FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD 70
Query: 190 RSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNS 249
R L+L+N L + + +L L N + +LPE L V + + +
Sbjct: 71 RQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKA 125
Query: 250 LSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNL 309
LS LP L+ L + N ++P+ + + L+ +D+ N ++P +
Sbjct: 126 LS-DLPPLLEYLG------VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPS- 174
Query: 310 VFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRL 369
L+ + NQ LPE + N L AI N L +P L+++ N L
Sbjct: 175 --LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLS--LESIVAGNNIL 227
Query: 370 GESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPAS 429
E P ++ L + +N L +P L +L + + + +P
Sbjct: 228 EEL---PELQNLP----FLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLT----DLPEL 275
Query: 430 IGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLIL 489
L LD S+N + + +L L N + + + L L +
Sbjct: 276 PQSL---TFLDVSENIFS-GLSELPP---NLYYLNASSNEIR-SLCDLPPS---LEELNV 324
Query: 490 SQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELP 547
S N L +PA L L SFN L+ +P+ NL L ++ +N L E P
Sbjct: 325 SNNKLIE-LPALPPRLERL---IASFNHLAE-VPELPQNLKQL---HVEYNPLR-EFP 373
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-41
Identities = 84/422 (19%), Positives = 153/422 (36%), Gaps = 64/422 (15%)
Query: 74 LTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133
L SL+ + L+ L V + + + L+ + S N L L
Sbjct: 96 LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEKL- 146
Query: 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQ 193
P+ + L+ + NN+L +P+ SLE + +N+L +LP + L L
Sbjct: 147 PE--LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLE-ELP-ELQNLPFLT 198
Query: 194 SLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGS 253
++ NN L+ ++ +L + G N +LPE + L + N L +
Sbjct: 199 AIYADNNSLK-KLPDLPLSLESIV---AGNNILE-ELPE-LQNLPFLTTIYADNNLLK-T 251
Query: 254 LPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLK 313
LPD L +L+++ N T ++P+ L L+ + + + N L
Sbjct: 252 LPDLPPSL---EALNVRDNYLT-DLPELPQSLTFLDVSENIFSG----LSELPPN---LY 300
Query: 314 ELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESM 373
LN S N+ L + +L ++VS NKL +P + L+ + S N L
Sbjct: 301 YLNASSNEIR-SLCDLP---PSLEELNVSNNKLI-ELPALPPR--LERLIASFNHL---- 349
Query: 374 QYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKL 433
A + + Q L+ L + N L P + L + + +P L
Sbjct: 350 -----AEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLRMNS-----HLAEVPELPQNL 398
Query: 434 KAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNN 493
K L N L P S+++L++ + + L + ++
Sbjct: 399 K---QLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHH 451
Query: 494 LT 495
Sbjct: 452 HH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 52/245 (21%), Positives = 94/245 (38%), Gaps = 38/245 (15%)
Query: 303 PSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTV 362
P ++ N FL+E + T +P N + + ++ N P +
Sbjct: 5 PRNVSNT-FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGN----GEQR 58
Query: 363 SLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYL 422
++ +RL + + + L+L++ LS +P L S L S N L
Sbjct: 59 EMAVSRLRDCLD-----------RQAHELELNNLGLS-SLPELPPHLES---LVASCNSL 103
Query: 423 FGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCS 482
+P LK++ V + + L+ P L+ L + N L ++P ++N S
Sbjct: 104 -TELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSS 153
Query: 483 SLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHL 542
L + + N+L +P +L + N L + EL NL L + +N L
Sbjct: 154 FLKIIDVDNNSLKK-LPDLPPSLEFI---AAGNNQLEEL--PELQNLPFLTAIYADNNSL 207
Query: 543 HGELP 547
+LP
Sbjct: 208 K-KLP 211
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-41
Identities = 56/396 (14%), Positives = 126/396 (31%), Gaps = 26/396 (6%)
Query: 158 IPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLR 217
I E + + + + L L +++ LDLS N L ++ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 218 AIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGE 277
+ L N D+ S L+ LD N + L S +L N+ +
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 278 VPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTG-GLPESMMNCGNL 336
V + +++ L+ N+ + G ++ L++ +N+ E + L
Sbjct: 114 VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 337 LAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSN 396
+++ N + ++ + L+T+ LS N+L + P F S + + L +N
Sbjct: 172 EHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKL--AFMGPEFQSAAG----VTWISLRNN 224
Query: 397 ALSGVIPSNIGDLSSLMLLNMSMNYL-FGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIG 455
L +I + +L ++ N G++ K + +Q + +
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNEE 281
Query: 456 GAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILS----QNNLTGPVPAAIANLSNLKYV 511
+L + Q + T + N + + +
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREI 341
Query: 512 DLSFNDLSGILPKELINLSHLLSFNISHNHLHGELP 547
D ++ + + ++ L ++
Sbjct: 342 DALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-40
Identities = 65/430 (15%), Positives = 132/430 (30%), Gaps = 28/430 (6%)
Query: 119 LQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRL 178
++ ++++L + +++E+ + N L+ L+ + LE +N SSN L
Sbjct: 12 YKIEKVTDSSLKQA-LASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 179 SGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCS 238
L + L +L++LDL+NN + + + + + N S ++ G
Sbjct: 71 YETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRG--Q 120
Query: 239 MLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTG-EVPDWIGKLANLESLDLSLNQ 297
K + N ++ + L LK N + LE L+L N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 298 FSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM 357
+ + LK L++S N+ + + + I + NKL I +
Sbjct: 181 IY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236
Query: 358 -GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLN 416
L+ L GN F+ +V ++ + + N + + L +
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKN------QRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 417 MSMNYLFGSIPASIGKLKAIQVLDFSDNWLNG----TIPPQIGGAVSLKELKLEKNFLSG 472
+L A++ + + G + + +E+ K
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350
Query: 473 RIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHL 532
I + +L + L V + L L S L
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPL 409
Query: 533 LSFNISHNHL 542
Sbjct: 410 QLLRAIVKRY 419
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-37
Identities = 58/476 (12%), Positives = 152/476 (31%), Gaps = 53/476 (11%)
Query: 74 LTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133
+ SL + ++ L LS N + ADLA F L++++ S N L +
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL 74
Query: 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQ 193
+LR + NN + L S+E+++ ++N +S ++ + +
Sbjct: 75 D---LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKK 123
Query: 194 SLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSG-QLPEDIGGCSMLKVLDFGVNSLSG 252
++ L+NN + ++ + L N+ E L+ L+ N +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 253 SLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFL 312
+ + A L++LDLS N+ + + + +
Sbjct: 183 DVKGQVV-------------------------FAKLKTLDLSSNKLA-FMGPEFQSAAGV 216
Query: 313 KELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGES 372
+++ N+ + +++ NL D+ N F + +++ + +
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV-KK 274
Query: 373 MQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYL----FGSIPA 428
+ + + + + L +L ++ +
Sbjct: 275 LTGQNEEECT----VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLEC 330
Query: 429 SIGKLKAIQVLDFSDNWLNGTIPPQIGGAV-SLKELKLEKNFLSGRIPSQIKNCSSLTSL 487
+ +D T+ Q+ + L+ +K L ++ + + + L
Sbjct: 331 ERENQARQREIDALKEQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGT 389
Query: 488 ILSQNNLTGPVPAAIANLSNLKYVDLSFNDLS-GILPKELINLSHLLSFNISHNHL 542
+ + A S L+ + + ++ + + + +++ +
Sbjct: 390 LQQAVGQIE-LQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-36
Identities = 50/319 (15%), Positives = 119/319 (37%), Gaps = 21/319 (6%)
Query: 253 SLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFL 312
++ + Q N + +S + N++ LDLS N S + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 313 KELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGES 372
+ LN+S N + + L +D++ N + + ++T+ + N +
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVGPS---IETLHAANNNI-SR 113
Query: 373 MQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFG-SIPASIG 431
+ QG + + L++N ++ + + G S + L++ +N + +
Sbjct: 114 VSCSRG-------QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
Query: 432 KLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQ 491
++ L+ N++ + Q+ LK L L N L+ + + ++ + +T + L
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRN 223
Query: 492 NNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGF 551
N L + A+ NL++ DL N ++ + + + ++ + +L
Sbjct: 224 NKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ-TVAKQTVK-KLTGQNE 280
Query: 552 FNTISPSSVSGNPSLCGSV 570
P+ C +
Sbjct: 281 EECTVPTLGHYGAYCCEDL 299
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 50/316 (15%), Positives = 116/316 (36%), Gaps = 21/316 (6%)
Query: 253 SLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFL 312
++ + Q N + +S + N++ LDLS N S + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 313 KELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGES 372
+ LN+S N + + L +D++ N + + ++T+ + N +
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVGPS---IETLHAANNNI-SR 113
Query: 373 MQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFG-SIPASIG 431
+ QG + + L++N ++ + + G S + L++ +N + +
Sbjct: 114 VSCSRG-------QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
Query: 432 KLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQ 491
++ L+ N++ + Q+ LK L L N L+ + + ++ + +T + L
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRN 223
Query: 492 NNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGF 551
N L + A+ NL++ DL N ++ + ++ + +L
Sbjct: 224 NKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVK-KLTGQNE 280
Query: 552 FNTISPSSVSGNPSLC 567
P+ C
Sbjct: 281 EECTVPTLGHYGAYCC 296
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 52/309 (16%), Positives = 109/309 (35%), Gaps = 20/309 (6%)
Query: 230 LPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLE 289
+ E + K+ +SL +L Q + L L GN + + LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 290 SLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGN 349
L+LS N + +L L+ L+++ N ++ ++ + + N ++
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 350 IPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGV-IPSNIGD 408
+ + G + + L+ N++ ++ +Q LDL N + V
Sbjct: 114 VSCSRGQ-GKKNIYLANNKI-TMLRDLDEGCR----SRVQYLDLKLNEIDTVNFAELAAS 167
Query: 409 LSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKN 468
+L LN+ N+++ + + ++ LD S N L + P+ A + + L N
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNN 224
Query: 469 FLSGRIPSQIKNCSSLTSLILSQNNLT-GPVPAAIANLSNLKYVDLSFNDLSGILPKELI 527
L I ++ +L L N G + + ++ V +E
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283
Query: 528 NLSHLLSFN 536
+ L +
Sbjct: 284 TVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 46/279 (16%), Positives = 112/279 (40%), Gaps = 16/279 (5%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151
++ +++++ + + S ++ +D S N LS I L ++ ++
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ-ISAADLAPFTKLELLNLSS 67
Query: 152 NNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGIS 211
N L + L S+L +++ ++N + + S+++L +NN + + S
Sbjct: 68 NVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RV--SCS 117
Query: 212 NLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSG-SLPDSLQRLNSCSSLSLK 270
+ I L NK + D G S ++ LD +N + + + ++ L+L+
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 271 GNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESM 330
N +V + A L++LDLS N+ + + + + +++ N+ + +++
Sbjct: 178 YNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 331 MNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRL 369
NL D+ N F + +++ +
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 48/385 (12%), Positives = 116/385 (30%), Gaps = 73/385 (18%)
Query: 136 EFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSL 195
E + + +++L + +++ ++ S N LS + L+ L
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 196 DLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLP 255
+LS+N+L D+ S L+ LD N +
Sbjct: 64 NLSSNVLYE--------------------------TLDLESLSTLRTLDLNNNYVQ---- 93
Query: 256 DSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKEL 315
L S +L N+ + V + +++ L+ N+ + G ++ L
Sbjct: 94 -ELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149
Query: 316 NISMNQFTG-GLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQ 374
++ +N+ E + L +++ N + ++ +
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVF------------------ 190
Query: 375 YPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLK 434
L+ LDLSSN L+ + + + +++ N L I ++ +
Sbjct: 191 -----------AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQ 237
Query: 435 AIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNL 494
++ D N + + + + + + K + + C+ T
Sbjct: 238 NLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCC 296
Query: 495 TGPVPAAIANLSNLKYVDLSFNDLS 519
+ + L +
Sbjct: 297 EDL-----PAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 55/327 (16%), Positives = 113/327 (34%), Gaps = 25/327 (7%)
Query: 119 LQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRL 178
++ ++++L + +++E+ + N L+ L+ + LE +N SSN L
Sbjct: 12 YKIEKVTDSSLKQA-LASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 179 SGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCS 238
+ + L +L++LDL+NN ++ + + + N S ++ G
Sbjct: 71 Y-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG--Q 120
Query: 239 MLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTG-EVPDWIGKLANLESLDLSLNQ 297
K + N ++ + L LK N + LE L+L N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 298 FSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM 357
+ + LK L++S N+ + + + I + NKL I +
Sbjct: 181 IY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236
Query: 358 -GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLN 416
L+ L GN F+ +V ++ + + + ++ L
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKN------QRVQTVAKQTVKK-LTGQNEEECTVPTLG 289
Query: 417 MSMNYLFGSIPASIG-KLKAIQVLDFS 442
Y +PA +L A+
Sbjct: 290 HYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 39/231 (16%), Positives = 85/231 (36%), Gaps = 17/231 (7%)
Query: 89 LLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVS 148
L L L+ L L+NN +L +++ + + NN+S + + + +
Sbjct: 76 LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSRGQ---GKKNIY 126
Query: 149 FANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLEGEI 206
ANN +T S ++ ++ N + + + +L+ L+L N +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQYNFI--YD 183
Query: 207 VKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSS 266
VKG L+ + L NK + + + + + + N L + +L+ +
Sbjct: 184 VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEH 241
Query: 267 LSLKGNSFT-GEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELN 316
L+GN F G + D+ K ++++ + + L
Sbjct: 242 FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 33/208 (15%), Positives = 69/208 (33%), Gaps = 10/208 (4%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151
Q + + L+NN T + D +Q +D N + + E +L ++
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 152 NNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGIS 211
N + + + + L++++ SSN+L+ + + + L NN L I K +
Sbjct: 179 NFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234
Query: 212 NLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKG 271
+L L N F +V ++ L + + +L G
Sbjct: 235 FSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYG 292
Query: 272 NSFTGEVPDWIGKLANLESLDLSLNQFS 299
++P + L +
Sbjct: 293 AYCCEDLP----APFADRLIALGHHHHH 316
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-39
Identities = 69/385 (17%), Positives = 135/385 (35%), Gaps = 54/385 (14%)
Query: 89 LLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVS 148
+ + + + + G + L + ++V F + + +P + ++
Sbjct: 20 DCVFYDVHIDMQTQDVYFGFEDITLNN---QKIVTFKNSTMRK-LPAALLDSFRQVELLN 75
Query: 149 FANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGI-WFLRSLQSLDLSNNLLEGEIV 207
+ + + ++ +++ + N + LP + + L L L N L
Sbjct: 76 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS---- 130
Query: 208 KGISNLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSS 266
LP I L L N+L D+ Q S +
Sbjct: 131 ---------------------SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 169
Query: 267 LSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGL 326
L L N T V + +L ++S N S++ + ++EL+ S N +
Sbjct: 170 LQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VV 220
Query: 327 PESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQ 386
+ L + + N LT + + GL V LS N L E + Y F M+
Sbjct: 221 RGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQR--- 273
Query: 387 GLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWL 446
L+ L +S+N L + + +L +L++S N+L + + + ++ L N +
Sbjct: 274 -LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSI 330
Query: 447 NGTIPPQIGGAVSLKELKLEKNFLS 471
T+ +LK L L N
Sbjct: 331 V-TLKL--STHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-37
Identities = 69/414 (16%), Positives = 137/414 (33%), Gaps = 55/414 (13%)
Query: 158 IPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGI-SNLYDL 216
I +L + V+ + L + + + N+ + ++ + + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 217 RAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFT 275
+ L + ++ ++ L G N++ L + F
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR----------------YLPPHVFQ 114
Query: 276 GEVPDWIGKLANLESLDLSLNQFSGRIPSSI-GNLVFLKELNISMNQFTGGLPESMMNCG 334
+ L L L N S +P I N L L++S N ++
Sbjct: 115 N--------VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 165
Query: 335 NLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLS 394
+L + +S N+LT ++ + L ++S N L ++ P ++ LD S
Sbjct: 166 SLQNLQLSSNRLT-HVDLSLIP-SLFHANVSYNLL-STLAIPIA---------VEELDAS 213
Query: 395 SNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQI 454
N+++ V+ + L +L + N L + + +D S N L I
Sbjct: 214 HNSIN-VVRGPV--NVELTILKLQHNNL-TDTAW-LLNYPGLVEVDLSYNELE-KIMYHP 267
Query: 455 -GGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDL 513
L+ L + N L + + +L L LS N+L V L+ + L
Sbjct: 268 FVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYL 325
Query: 514 SFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLC 567
N + + L +L +SHN + F ++ +V C
Sbjct: 326 DHNSIVTLKLSTHHTLKNL---TLSHNDWD-CNSLRALFRNVARPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 19/132 (14%), Positives = 47/132 (35%), Gaps = 3/132 (2%)
Query: 423 FGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQI-KNC 481
+ I +++ + + + + K + + + + ++P+ + +
Sbjct: 10 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSF 68
Query: 482 SSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNH 541
+ L L+ + A A ++ + + FN + + P N+ L + N
Sbjct: 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128
Query: 542 LHGELPVGGFFN 553
L LP G F N
Sbjct: 129 LS-SLPRGIFHN 139
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 66/287 (22%), Positives = 123/287 (42%), Gaps = 34/287 (11%)
Query: 684 LNKDCELGRGGFGVVYRTILQDGR-----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRH 738
K LG G FG VY+ + VAIK+L + K+ ++ E + + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 739 HNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
++ L G T ++QL I + + G L ++ + ++ + + N + +AKG+ YL
Sbjct: 77 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR 858
++H +L + NVL+ + K+ DFGLA+LL ++ + + + +MA E +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE-SIL 192
Query: 859 TVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVD 913
T + DV+ +GV V E++T G +P + + + LE G + C
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------SILEKGERLPQPPIC-- 244
Query: 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSP 959
D V + C +RP E++ + + P
Sbjct: 245 -------TID----VYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-38
Identities = 77/399 (19%), Positives = 134/399 (33%), Gaps = 74/399 (18%)
Query: 150 ANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKG 209
+ + +N + L+ LP + + +L + +N L +
Sbjct: 24 SRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPAL 79
Query: 210 ISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSL 269
L L + N+ + LP G L + + L +LP L +L +
Sbjct: 80 PPELRTLE---VSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLW------I 128
Query: 270 KGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPES 329
GN T +P L+ L +S NQ + +P+ L +L NQ T LP
Sbjct: 129 FGNQLT-SLPVLPP---GLQELSVSDNQLA-SLPALPSEL---CKLWAYNNQLTS-LPML 179
Query: 330 MMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQ 389
L + VS N+L ++PT + L
Sbjct: 180 P---SGLQELSVSDNQLA-SLPTLPSE-------------------------------LY 204
Query: 390 VLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGT 449
L +N L+ +P+ L L++ N L S+P +L + L S N L +
Sbjct: 205 KLWAYNNRLT-SLPALPSGLKELIVSG---NRL-TSLPVLPSEL---KELMVSGNRLT-S 255
Query: 450 IPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLK 509
+P L L + +N L+ R+P + + SS T++ L N L+ A+ +++
Sbjct: 256 LPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAP 311
Query: 510 YVDLSFNDLSGILPKE--LINLSHLLSFNISHNHLHGEL 546
HL + + GE
Sbjct: 312 GYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEP 350
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-35
Identities = 77/377 (20%), Positives = 127/377 (33%), Gaps = 57/377 (15%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
VL++ + T T+ L + + +NNL+ L P LR + + N L
Sbjct: 42 NAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTSL-PALP----PELRTLEVSGNQL 93
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLY 214
T +P L + L L L + N L + L
Sbjct: 94 TS-LPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPVLPPGLQ 144
Query: 215 DLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSF 274
+L + N+ + LP L + N L+ SLP L LS+ N
Sbjct: 145 ELS---VSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPSGLQ---ELSVSDNQL 193
Query: 275 TGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCG 334
+P +L L + + L +P+ LKEL +S N+ T LP
Sbjct: 194 A-SLPTLPSELYKLWAYNNRLTS----LPALPSG---LKELIVSGNRLT-SLPVLP---S 241
Query: 335 NLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLS 394
L + VS N+LT ++P GL ++S+ N+L + S + ++L
Sbjct: 242 ELKELMVSGNRLT-SLPMLP--SGLLSLSVYRNQL--TRLPESLIHLSS----ETTVNLE 292
Query: 395 SNALSGVIPSNIGDLSSLMLLNM---SMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIP 451
N LS + +++S + + S P L + +WL
Sbjct: 293 GNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL-----HLAAADWLVPARE 347
Query: 452 PQIGGAVSLKELKLEKN 468
+ A E N
Sbjct: 348 GEPAPADRWHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 5e-09
Identities = 23/89 (25%), Positives = 39/89 (43%), Gaps = 8/89 (8%)
Query: 459 SLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDL 518
L + ++ L+ +P + + +T+L++ NNLT +PA L L ++S N L
Sbjct: 41 GNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPALPPELRTL---EVSGNQL 93
Query: 519 SGILPKELINLSHLLSFNISHNHLHGELP 547
+ LP L L F+ HL
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLPALPS 121
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-37
Identities = 69/385 (17%), Positives = 135/385 (35%), Gaps = 54/385 (14%)
Query: 89 LLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVS 148
+ + + + + G + L + ++V F + + +P + ++
Sbjct: 26 DCVFYDVHIDMQTQDVYFGFEDITLNN---QKIVTFKNSTMRK-LPAALLDSFRQVELLN 81
Query: 149 FANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGI-WFLRSLQSLDLSNNLLEGEIV 207
+ + + ++ +++ + N + LP + + L L L N L
Sbjct: 82 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS---- 136
Query: 208 KGISNLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSS 266
LP I L L N+L D+ Q S +
Sbjct: 137 ---------------------SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 175
Query: 267 LSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGL 326
L L N T V + +L ++S N S++ + ++EL+ S N +
Sbjct: 176 LQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VV 226
Query: 327 PESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQ 386
+ L + + N LT + + GL V LS N L E + Y F M+
Sbjct: 227 RGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQR--- 279
Query: 387 GLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWL 446
L+ L +S+N L + + +L +L++S N+L + + + ++ L N +
Sbjct: 280 -LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSI 336
Query: 447 NGTIPPQIGGAVSLKELKLEKNFLS 471
T+ +LK L L N
Sbjct: 337 V-TLKL--STHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-36
Identities = 73/427 (17%), Positives = 146/427 (34%), Gaps = 61/427 (14%)
Query: 151 NNNLTGPIPESLSFCSSLESV----NFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLEG 204
N+ PE S+L+ + + + + +G L + + + N+ +
Sbjct: 6 RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR- 64
Query: 205 EIVKGI-SNLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLN 262
++ + + + + L + ++ ++ L G N++
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR----------- 112
Query: 263 SCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSI-GNLVFLKELNISMNQ 321
L + F + L L L N S +P I N L L++S N
Sbjct: 113 -----YLPPHVFQN--------VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN 158
Query: 322 FTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASM 381
++ +L + +S N+LT ++ + L ++S N L ++ P
Sbjct: 159 LERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP-SLFHANVSYNLL-STLAIPIA--- 212
Query: 382 KDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDF 441
++ LD S N+++ V+ + L +L + N L + A + + +D
Sbjct: 213 ------VEELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDL 261
Query: 442 SDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPA 500
S N L I L+ L + N L + + +L L LS N+L V
Sbjct: 262 SYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VER 318
Query: 501 AIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSV 560
L+ + L N + + L +L +SHN + F ++ +V
Sbjct: 319 NQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL---TLSHNDWD-CNSLRALFRNVARPAV 374
Query: 561 SGNPSLC 567
C
Sbjct: 375 DDADQHC 381
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 67/278 (24%), Positives = 124/278 (44%), Gaps = 26/278 (9%)
Query: 689 ELGRGGFGVVYRTILQDGR-----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
LG G FG VY+ + VAIK+L + K+ ++ E + + + ++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
L G T ++QL I + + G L ++ + ++ + + N + +AKG+ YL +
Sbjct: 82 LLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
+H +L + NVL+ + K+ DFGLA+LL ++ + + + +MA E + T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE-SILHRIYT 197
Query: 864 EKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922
+ DV+ +GV V E++T G +P + + + LE G RL P
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------SILEKGE-------RLPQ--PP 242
Query: 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSP 959
I V + + C +RP E++ + + P
Sbjct: 243 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-36
Identities = 79/285 (27%), Positives = 125/285 (43%), Gaps = 30/285 (10%)
Query: 689 ELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+LG G +G VY + + +VA+K L + E+F KE + +I+H NLV L G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+I EF++ G+L +L + +R +S + ++ + YL N IH N
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRN 343
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCD 867
L + N L+ + KV DFGL+RL+ D + + + + APE + K + K D
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSD 401
Query: 868 VYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVDARLRGNFPA 922
V+ FGVL+ E+ T G P ++ V LE R E C +
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQVY------ELLEKDYRMERPEGCPE--------- 446
Query: 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEELE 967
V +L C PS+RP E+ E + +E+E
Sbjct: 447 ----KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 487
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-36
Identities = 76/271 (28%), Positives = 121/271 (44%), Gaps = 30/271 (11%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+LG+G FG V+ VAIK L + S E F +E + + K+RH LV L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL 808
+ ++ E++S GSL L + + L Q ++ +A G+AY+ N +H +L
Sbjct: 249 -SEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVHRDL 306
Query: 809 KSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDV 868
++ N+L+ + KV DFGLARL+ + + + + APE A + T K DV
Sbjct: 307 RAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE-AALYGRFTIKSDV 364
Query: 869 YGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVDARLRGNFPAD 923
+ FG+L+ E+ T G+ P M + V+ +E G +C P
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVL------DQVERGYRMPCPPEC---------PE- 408
Query: 924 EAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
+ L C + P RP E + LE
Sbjct: 409 ---SLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-36
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 31/284 (10%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+LG G FG V+ VA+K + + S E F E + ++H LV L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL 808
T +I EF++ GSL L + + +A+G+A++ N IH +L
Sbjct: 253 -TKEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 809 KSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDV 868
++ N+L+ +S K+ DFGLAR++ + + + + APE A T K DV
Sbjct: 311 RAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPE-AINFGSFTIKSDV 368
Query: 869 YGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVDARLRGNFPAD 923
+ FG+L++E+VT G+ P M + V+ ALE G R E+C P
Sbjct: 369 WSFGILLMEIVTYGRIPYPGMSNPEVI------RALERGYRMPRPENC---------PE- 412
Query: 924 EAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSPLDGQEEL 966
+ + + C P RP E + ++L+ + EE+
Sbjct: 413 ---ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEI 453
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 9e-36
Identities = 62/271 (22%), Positives = 106/271 (39%), Gaps = 20/271 (7%)
Query: 689 ELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
++GRG FG V+ L+ D VA+K + + F +E + L + H N+V L G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
++ E + G L + L + ++ A G+ YL IH +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCD 867
L + N L+ K+ DFG++R Q + + APE A + + + D
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE-ALNYGRYSSESD 297
Query: 868 VYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAI 926
V+ FG+L+ E + G P + + + V + GR+ P
Sbjct: 298 VWSFGILLWETFSLGASPYPNLSNQQTR--EFVE---KGGRLP----------CPELCPD 342
Query: 927 PVIKLGLICASQVPSNRPDMEEVVNILELIQ 957
V +L C + P RP + L+ I+
Sbjct: 343 AVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 81/283 (28%), Positives = 128/283 (45%), Gaps = 26/283 (9%)
Query: 684 LNKDCELGRGGFGVVYRTILQDGR-----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRH 738
L K LG G FG V++ + V IK + +S + M +G + H
Sbjct: 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 739 HNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
++V L G SLQL + +++ GSL H+ R L + N + +AKG+ YL
Sbjct: 75 AHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL 131
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR 858
++H NL + NVL+ S + +V DFG+A LLP D+ +L S+ ++ + +MA E +
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE-SIH 190
Query: 859 TVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917
K T + DV+ +GV V E++T G P + V LE G RL
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP------DLLEKGE-------RLA 237
Query: 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSP 959
P I V + + C + RP +E+ N + + P
Sbjct: 238 Q--PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 73/284 (25%), Positives = 121/284 (42%), Gaps = 43/284 (15%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
E+G G FG+V+ + VAIK + + S+EDF +E + + K+ H LV L G
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL 808
+ L+ EF+ G L +L + R + + L + +G+AYL +IH +L
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 809 KSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG------YMAPEFACRTVKI 862
+ N L+ + KV DFG+ R +L + S+ G + +PE +
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRF-------VLDDQYTSSTGTKFPVKWASPE-VFSFSRY 182
Query: 863 TEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVDARLR 917
+ K DV+ FGVL+ EV + GK P E + VV + G +
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV------EDISTGFRLYKPRLASTH--- 233
Query: 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSPL 960
V ++ C + P +RP ++ L + +S L
Sbjct: 234 ----------VYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 686 KDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVA 743
D E+GRG F VY+ + + VA +L L KS+ + F++E + L ++H N+V
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 744 LEGYYWTPSLQ---LLIY-EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
+ + +++ E ++SG+L +L + + + + KGL +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLH 146
Query: 800 --HTNIIHYNLKSTNVLIDS-SGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAP 853
IIH +LK N+ I +G K+GD GLA L +S ++ +G +MAP
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-------ASFAKAVIGTPEFMAP 199
Query: 854 EFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
E K E DVY FG+ +LE+ T + P
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 69/290 (23%), Positives = 120/290 (41%), Gaps = 36/290 (12%)
Query: 687 DCELGRGGFGVVYRTILQDGR---SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
D ELG G FG V + + + + VAIK L E+ +E + + ++ + +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
L G +L +L+ E G L+K L R + ++ ++ G+ YL N
Sbjct: 75 LIGVCQAEAL-MLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS---KIQSALGYMAPEFACRTV 860
+H +L + NVL+ + K+ DFGL++ L D + K L + APE
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW--PLKWYAPE-CINFR 188
Query: 861 KITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVDAR 915
K + + DV+ +GV + E ++ G++P + M+ V+ +E G +C
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQGKRMECPPEC---- 238
Query: 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEE 965
P + + L C +RPD V + L + E
Sbjct: 239 -----PPE----LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-35
Identities = 77/282 (27%), Positives = 124/282 (43%), Gaps = 30/282 (10%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+LG+G FG V+ VAIK L + S E F +E + + K+RH LV L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL 808
+ ++ E++S GSL L + L Q ++ +A G+AY+ N +H +L
Sbjct: 332 -SEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 389
Query: 809 KSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDV 868
++ N+L+ + KV DFGLARL+ + + + + APE A + T K DV
Sbjct: 390 RAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE-AALYGRFTIKSDV 447
Query: 869 YGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVDARLRGNFPAD 923
+ FG+L+ E+ T G+ P M + V+ +E G +C P
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREVL------DQVERGYRMPCPPEC---------PE- 491
Query: 924 EAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEE 965
+ L C + P RP E + LE + + Q +
Sbjct: 492 ---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 530
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-35
Identities = 80/296 (27%), Positives = 132/296 (44%), Gaps = 34/296 (11%)
Query: 689 ELGRGGFGVVYRTIL-----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
+LG+G FG V G VA+K+L SG Q DF++E++ L + +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILKALHSDFIVK 88
Query: 744 LEGYYWTPSLQ--LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
G + P Q L+ E++ SG L L +R L + + KG+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYSSQICKGMEYLGSR 146
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-ILSSKIQSALGYMAPEFACRTV 860
+H +L + N+L++S K+ DFGLA+LLP+ ++ QS + + APE +
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE-SLSDN 205
Query: 861 KITEKCDVYGFGVLVLEVVT-GKRP----VEYMEDDVVVLCDM----VRGALEDGRVEDC 911
+ + DV+ FGV++ E+ T + E++ + LE+G+
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ---- 261
Query: 912 VDARLRGNFPADEAIP--VIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEE 965
RL PA A P V +L +C + P +RP + L+++ S G E
Sbjct: 262 ---RL----PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 80/278 (28%), Positives = 136/278 (48%), Gaps = 25/278 (8%)
Query: 689 ELGRGGFGVVYRTILQDGR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+G G FG V L+ SVAIK L V K + DF E +G+ H N++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
EG +++ E++ +GSL L ++ + Q ++ G+A G+ YL +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLP-MLDRCILSSKIQSALGYMAPEFACRTVKIT 863
H +L + N+LI+S+ KV DFGL R+L + + + + + +PE A K T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFT 228
Query: 864 EKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922
DV+ +G+++ EV++ G+RP M + V+ A+++G P
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQDVI------KAVDEGYRLPP---------PM 273
Query: 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSP 959
D + +L L C + +NRP E++V+IL+ LI++P
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 71/277 (25%), Positives = 120/277 (43%), Gaps = 42/277 (15%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
ELG G FGVV + VA+K + + S+++F +E +T+ K+ H LV G
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL 808
++ E+IS+G L +L S L Q + + +G+A+L IH +L
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDL 130
Query: 809 KSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG------YMAPEFACRTVKI 862
+ N L+D KV DFG+ R +L + S++G + APE K
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRY-------VLDDQYVSSVGTKFPVKWSAPE-VFHYFKY 182
Query: 863 TEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVDARLR 917
+ K DV+ FG+L+ EV + GK P + + VV + G R
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LKVSQGHRLYRPHLA------ 230
Query: 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
+ ++ C ++P RP +++++ +E
Sbjct: 231 ---SD----TIYQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 34/273 (12%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
ELG G FGVV + VAIK + + S+++F +E K + + H LV L G
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL 808
+I E++++G L +L R+ +Q + + + + YL +H +L
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 146
Query: 809 KSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG------YMAPEFACRTVKI 862
+ N L++ G KV DFGL+R +L + S++G + PE K
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRY-------VLDDEYTSSVGSKFPVRWSPPE-VLMYSKF 198
Query: 863 TEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921
+ K D++ FGVL+ E+ + GK P E + + G P
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHIAQGLRLYR---------P 243
Query: 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
+ V + C + RP + +++ +
Sbjct: 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 33/282 (11%)
Query: 689 ELGRGGFGVVYRTILQDGRS----VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+G G G V L+ VAIK L + + DF E +G+ H N++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
EG L +++ E++ +GSL L + + Q ++ G+ G+ YL +
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYLSDLGYV 173
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPM-LDRCILSSKIQSALGYMAPEFACRTVKIT 863
H +L + NVL+DS+ KV DFGL+R+L D ++ + + + APE A +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE-AIAFRTFS 232
Query: 864 EKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVDARLRG 918
DV+ FGV++ EV+ G+RP M + V+ ++E+G C
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPYWNMTNRDVI------SSVEEGYRLPAPMGCPH----- 281
Query: 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSP 959
+ +L L C + + RP ++V++L+ LI+SP
Sbjct: 282 --------ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 84/285 (29%), Positives = 138/285 (48%), Gaps = 38/285 (13%)
Query: 689 ELGRGGFGVVYRTILQDGR-----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
+G G FG VY+ +L+ VAIK L K + DF E +G+ HHN++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
LEG ++I E++ +G+L K L + S Q ++ G+A G+ YL + N
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYLANMNY 168
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG------YMAPE-FA 856
+H +L + N+L++S+ KV DFGL+R+L ++ G + APE +
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWTAPEAIS 223
Query: 857 CRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915
R K T DV+ FG+++ EV+T G+RP + + V+ A+ DG
Sbjct: 224 YR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM------KAINDGFRLPT---- 271
Query: 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSP 959
P D + +L + C Q + RP ++V+IL+ LI++P
Sbjct: 272 -----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 78/285 (27%), Positives = 125/285 (43%), Gaps = 30/285 (10%)
Query: 689 ELGRGGFGVVYRTILQDGR-SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+LG G +G VY + + +VA+K L + E+F KE + +I+H NLV L G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+I EF++ G+L +L + +R +S + ++ + YL N IH +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCD 867
L + N L+ + KV DFGL+RL+ D + + + + APE + K + K D
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSD 194
Query: 868 VYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVDARLRGNFPA 922
V+ FGVL+ E+ T G P ++ V LE R E C +
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVY------ELLEKDYRMERPEGCPEK-------- 240
Query: 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEELE 967
V +L C PS+RP E+ E + +E+E
Sbjct: 241 -----VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 280
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-34
Identities = 90/475 (18%), Positives = 177/475 (37%), Gaps = 42/475 (8%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+L++S N + +D+ S L+++ S N + L F+ L + ++N L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL-DISVFKFNQELEYLDLSHNKL 81
Query: 155 TGPIPESLSFCS--SLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLEGEIVKGI 210
+S +L+ ++ S N LP F + L+ L LS LE V I
Sbjct: 82 V-----KISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPI 135
Query: 211 SNLYDLR-AIKLGKNKFSGQLPEDIGGCSMLKV-LDFGVNSLSGSLPD-------SLQRL 261
++L + + LG+ + PE + + + + F N + D +L+
Sbjct: 136 AHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195
Query: 262 NSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLV---FLKELNIS 318
N L S+ + + L +L L+ + + I LV + +IS
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255
Query: 319 MNQFTGGLPESMMNCGNL----LAIDVSQNKLTGNIPTWIFKM--GLQTVSLSGNRLGES 372
+ G L + L+I + + G ++I+++ + + + +
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT-RM 314
Query: 373 MQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIG- 431
+ + + LD S+N L+ + N G L+ L L + MN L +
Sbjct: 315 VHMLCPSKISP----FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL-KELSKIAEM 369
Query: 432 --KLKAIQVLDFSDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLI 488
++K++Q LD S N ++ SL L + N L+ I + + L
Sbjct: 370 TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLD 427
Query: 489 LSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLH 543
L N + +P + L L+ ++++ N L + L+ L + N
Sbjct: 428 LHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-32
Identities = 90/475 (18%), Positives = 179/475 (37%), Gaps = 30/475 (6%)
Query: 97 VLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTG 156
++ S N + DL+ +++ S+N +S L + LR + ++N +
Sbjct: 4 LVDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSD-ILSLSKLRILIISHNRIQY 59
Query: 157 PIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGI-SNLYD 215
F LE ++ S N+L + +L+ LDLS N + + N+
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQ 116
Query: 216 LRAIKLGKNKFSGQLPEDIGGCSMLKV-LDFGVNSLSGSLPDSLQRLN--SCSSLSLKGN 272
L+ + L I ++ KV L G P+ LQ N S +
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK 176
Query: 273 SFTGEVPDWIGKLANLESLDLSLNQFSGR------IPSSIGNLVFLKELNISMNQFTGGL 326
F + + +ANLE ++ + I + + L L ++ + T
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236
Query: 327 PESMMNC---GNLLAIDVSQNKLTGNIPTWIFKMGLQTV-SLSGNRLGESMQYPSFASMK 382
++ + +S KL G + F ++ +LS +++ + + +
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296
Query: 383 DSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFS 442
+ + + + + + + V +S + L+ S N L ++ + G L ++ L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 443 DNWLNGTIPPQIG---GAVSLKELKLEKNFLSGRIPSQIKNC-SSLTSLILSQNNLTGPV 498
N L + SL++L + +N +S + SL SL +S N LT +
Sbjct: 357 MNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI 415
Query: 499 PAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFN 553
+ +K +DL N + +PK+++ L L N++ N L +P G F
Sbjct: 416 FRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDR 466
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 6e-16
Identities = 49/231 (21%), Positives = 94/231 (40%), Gaps = 13/231 (5%)
Query: 74 LTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133
+ L G L+ L + + ++ F + F + + +F+ + ++
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR-MV 315
Query: 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRS 191
+ + F+NN LT + E+ + LE++ N+L ++S
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS 375
Query: 192 LQSLDLSNNLLEGEIVKGI-SNLYDLRAIKLGKNKFSGQLPEDIGGC--SMLKVLDFGVN 248
LQ LD+S N + + KG S L ++ + N L + I C +KVLD N
Sbjct: 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN----ILTDTIFRCLPPRIKVLDLHSN 431
Query: 249 SLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPD-WIGKLANLESLDLSLNQF 298
+ S+P + +L + L++ N VPD +L +L+ + L N +
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 8e-16
Identities = 52/280 (18%), Positives = 99/280 (35%), Gaps = 35/280 (12%)
Query: 74 LTLDGFSLSGHIGRGLLRLQ---FLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLS 130
LTL+ + + +L+L + S+SN G ++ + + S + +
Sbjct: 225 LTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVV 284
Query: 131 ----GLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGI 186
G + ++ +F + S S ++FS+N L+ +
Sbjct: 285 SDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENC 344
Query: 187 WFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFG 246
L L++L L N L+ + + + L+ LD
Sbjct: 345 GHLTELETLILQMNQLK--------------ELSKIAEMTTQ-MKS-------LQQLDIS 382
Query: 247 VNSLSGSLPDSL-QRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSS 305
NS+S S SL++ N T + + ++ LDL N+ IP
Sbjct: 383 QNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQ 439
Query: 306 IGNLVFLKELNISMNQFTGGLPESM-MNCGNLLAIDVSQN 344
+ L L+ELN++ NQ +P+ + +L I + N
Sbjct: 440 VVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 76/289 (26%), Positives = 127/289 (43%), Gaps = 55/289 (19%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEG-- 746
LG G FG V+ VA+K L + S + F E + +++H LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 747 ----YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
Y +I E++ +GSL L S L+ + ++ +A+G+A++ N
Sbjct: 78 TQEPIY-------IITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG------YMAPEFA 856
IH +L++ N+L+ + K+ DFGLARL I ++ + G + APE A
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARL-------IEDNEYTAREGAKFPIKWTAPE-A 181
Query: 857 CRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDC 911
T K DV+ FG+L+ E+VT G+ P M + V+ LE G R ++C
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI------QNLERGYRMVRPDNC 235
Query: 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSP 959
P + +L +C + P +RP + + ++LE +
Sbjct: 236 ---------PE----ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 71/284 (25%), Positives = 113/284 (39%), Gaps = 26/284 (9%)
Query: 689 ELGRGGFGVVYRTILQDGRS----VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+GRG FG VY L D A+K L I F E + H N+++L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 745 EGYYWTPSLQLL-IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
G L + ++ G L + + + + + L +AKG+ YL
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLASKKF 149
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD--RCILSSKIQSALGYMAPEFACRTVK 861
+H +L + N ++D KV DFGLAR + + + + + +MA E + +T K
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQTQK 208
Query: 862 ITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920
T K DV+ FGVL+ E++T G P + + L GR
Sbjct: 209 FTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRRLLQ--------- 253
Query: 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQE 964
P P+ ++ L C RP E+V+ + I S G+
Sbjct: 254 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 72/293 (24%), Positives = 125/293 (42%), Gaps = 28/293 (9%)
Query: 684 LNKDCELGRGGFGVVYRTILQDGRS----VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH 739
+ D +G+G FGVVY D AIK L+ ++ E F +E + + H
Sbjct: 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 740 NLVALEG--YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAY 797
N++AL G ++ ++ G L + + S + + + + L +A+G+ Y
Sbjct: 83 NVLALIGIMLPPEGLP-HVLLPYMCHGDLLQFIR--SPQRNPTVKDLISFGLQVARGMEY 139
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSAL--GYMAPEF 855
L +H +L + N ++D S KV DFGLAR + + + + L + A E
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE- 198
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914
+ +T + T K DV+ FGVL+ E++T G P +++ + L GR
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP------FDLTHFLAQGRRLPQ--- 249
Query: 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEELE 967
P + ++ C P+ RP +V +E I S L G ++
Sbjct: 250 ------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQ 296
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-34
Identities = 65/294 (22%), Positives = 125/294 (42%), Gaps = 41/294 (13%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQE--DFEKEMKTLGKIRHHNLVALE 745
++GRG F VYR L DG VA+KK+ + L+ ++ D KE+ L ++ H N++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 746 GYYWTPSLQLLIY-EFISSGSLYKHL-HDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
+ + +L I E +G L + + H + + R + + + L ++H +
Sbjct: 99 ASFIEDN-ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV 157
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTV 860
+H ++K NV I ++G K+GD GL R ++ S +G YM+PE
Sbjct: 158 MHRDIKPANVFITATGVVKLGDLGLGRFFSS-----KTTAAHSLVGTPYYMSPE-RIHEN 211
Query: 861 KITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920
K D++ G L+ E+ + P + ++ LC + + ++
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----------------EQCDY 255
Query: 921 PA-------DEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEELE 967
P +E ++ + C + P RPD+ V ++ + + + E
Sbjct: 256 PPLPSDHYSEELRQLVNM---CINPDPEKRPDVTYVYDVAKRMHACTASSLEHH 306
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 65/283 (22%), Positives = 128/283 (45%), Gaps = 13/283 (4%)
Query: 689 ELGRGGFGVVYRTIL-----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
+LG+G FG V G VA+KKL + DFE+E++ L ++H N+V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 744 LEGYYWTPSLQ--LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
+G ++ + LI E++ GSL +L + + + + KG+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-ILSSKIQSALGYMAPEFACRTV 860
IH +L + N+L+++ K+GDFGL ++LP + +S + + APE +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE-SLTES 192
Query: 861 KITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919
K + DV+ FGV++ E+ T ++ + + ++ + +G + + + + R
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 252
Query: 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962
P + + C + + RP ++ ++ I+ + G
Sbjct: 253 RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 295
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 13/283 (4%)
Query: 689 ELGRGGFGVVYRTILQD-----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
+LG G FG V G VA+K L + + +++E+ L + H +++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 744 LEG--YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
+G + L+ E++ GSL +L R+ + Q + +G+AYLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLP----RHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-ILSSKIQSALGYMAPEFACRTV 860
+ IH +L + NVL+D+ K+GDFGLA+ +P + S + + APE +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE-CLKEY 212
Query: 861 KITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920
K DV+ FGV + E++T + + L + +G + R+ + ++ R
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR 272
Query: 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQ 963
P V L C S RP E ++ IL+ + GQ
Sbjct: 273 PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 63/295 (21%), Positives = 113/295 (38%), Gaps = 41/295 (13%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
LG GGF V L DG A+K++ + +E+ ++E H N++ L Y
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQ-QDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 749 WTPSLQ----LLIYEFISSGSLYKHLHDGSSRN-CLSWRQRFNIILGMAKGLAYLHHTNI 803
L+ F G+L+ + + L+ Q ++LG+ +GL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGY 155
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG-------YMAPE-F 855
H +LK TN+L+ G+P + D G + + Y APE F
Sbjct: 156 AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELF 215
Query: 856 ACRT-VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914
+ ++ I E+ DV+ G ++ ++ G+ P + + + V+ L
Sbjct: 216 SVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS---------- 265
Query: 915 RLRGNFPA-----DEAIPVIKLGLICASQV-PSNRPDMEEVVNILELIQSPLDGQ 963
P ++ + V P RP + +++ LE +Q P GQ
Sbjct: 266 -----IPQSPRHSSALWQLLNSMM----TVDPHQRPHIPLLLSQLEALQPPAPGQ 311
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 65/283 (22%), Positives = 128/283 (45%), Gaps = 13/283 (4%)
Query: 689 ELGRGGFGVVYRTIL-----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
+LG+G FG V G VA+KKL + DFE+E++ L ++H N+V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 744 LEGYYWTPSLQ--LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
+G ++ + LI E++ GSL +L + + + + KG+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-ILSSKIQSALGYMAPEFACRTV 860
IH +L + N+L+++ K+GDFGL ++LP + +S + + APE +
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE-SLTES 223
Query: 861 KITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919
K + DV+ FGV++ E+ T ++ + + ++ + +G + + + + R
Sbjct: 224 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 283
Query: 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962
P + + C + + RP ++ ++ I+ + G
Sbjct: 284 RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG 326
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 74/289 (25%), Positives = 117/289 (40%), Gaps = 38/289 (13%)
Query: 689 ELGRGGFGVVYRTILQDGR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
LG G FG VY + + + +VA+K + ++E F E + + H ++V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
G +I E G L +L ++N L L + K +AYL N +
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYLE--RNKNSLKVLTLVLYSLQICKAMAYLESINCV 135
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG------YMAPEFACR 858
H ++ N+L+ S K+GDFGL+R I A +M+PE +
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRY-------IEDEDYYKASVTRLPIKWMSPE-SIN 187
Query: 859 TVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917
+ T DV+ F V + E+++ GK+P ++E+ V+ G LE G
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI------GVLEKGDRLPK------ 235
Query: 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSPLDGQEE 965
P + L C PS+RP E+V L + Q D E
Sbjct: 236 ---PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME 281
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-33
Identities = 69/348 (19%), Positives = 135/348 (38%), Gaps = 46/348 (13%)
Query: 86 GRGLLRL-----QFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQ 140
+ + + ++L L N + ASF L+ ++ +EN +S + F
Sbjct: 20 RKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNN 78
Query: 141 CGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLS 198
+LR + +N L + S+L ++ S N++ L F L +L+SL++
Sbjct: 79 LFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDY-MFQDLYNLKSLEVG 136
Query: 199 NNLLEGEIVKGI-SNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDS 257
+N L I S L L + L K + E + L VL +++
Sbjct: 137 DNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN------ 189
Query: 258 LQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNI 317
+++ SF L L+ L++S + + + + L L+I
Sbjct: 190 ----------AIRDYSFKR--------LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSI 231
Query: 318 SMNQFTGGLPESM-MNCGNLLAIDVSQNKLTGNIPTWIFKM--GLQTVSLSGNRLGESMQ 374
+ T +P + L +++S N ++ I + LQ + L G +L ++
Sbjct: 232 THCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQL-AVVE 288
Query: 375 YPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYL 422
+F + L+VL++S N L+ + S + +L L + N L
Sbjct: 289 PYAFRGLN----YLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 68/323 (21%), Positives = 115/323 (35%), Gaps = 36/323 (11%)
Query: 263 SCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQF 322
C VP+ I LDL N+ + L+EL ++ N
Sbjct: 17 LCHRKRFV------AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 323 TGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFK--MGLQTVSLSGNRLGESMQYPSFAS 380
+ P + N NL + + N+L IP +F L + +S N++ + F
Sbjct: 69 SAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKI-VILLDYMFQD 126
Query: 381 MKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPA-SIGKLKAIQVL 439
+ + L+ L++ N L + L+SL L + L SIP ++ L + VL
Sbjct: 127 LYN----LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL-TSIPTEALSHLHGLIVL 181
Query: 440 DFSDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPV 498
+N I LK L++ + +LTSL ++ NLT
Sbjct: 182 RLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVP 240
Query: 499 PAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFN----- 553
A+ +L L++++LS+N +S I L L L + L + F
Sbjct: 241 YLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLR 299
Query: 554 ----------TISPSSVSGNPSL 566
T+ S +L
Sbjct: 300 VLNVSGNQLTTLEESVFHSVGNL 322
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-31
Identities = 67/309 (21%), Positives = 117/309 (37%), Gaps = 14/309 (4%)
Query: 240 LKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFS 299
++LD G N + D L L N + P L NL +L L N+
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK 93
Query: 300 GRIPSSI-GNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFK-- 356
IP + L L +L+IS N+ L + NL +++V N L I F
Sbjct: 94 -LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGL 151
Query: 357 MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLN 416
L+ ++L L S+ + + + GL VL L ++ + + L L +L
Sbjct: 152 NSLEQLTLEKCNL-TSIPTEALSHLH----GLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206
Query: 417 MSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQ-IGGAVSLKELKLEKNFLSGRIP 475
+S ++ + + L + L +P + V L+ L L N +S I
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIE 264
Query: 476 SQI-KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLS 534
+ L + L L P A L+ L+ +++S N L+ + ++ +L +
Sbjct: 265 GSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLET 324
Query: 535 FNISHNHLH 543
+ N L
Sbjct: 325 LILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 9e-11
Identities = 28/131 (21%), Positives = 53/131 (40%), Gaps = 5/131 (3%)
Query: 74 LTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133
L + + + L L LS+++ N T + L+ ++ S N +S I
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TI 263
Query: 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRS 191
+ L+E+ L P + + L +N S N+L+ L + F + +
Sbjct: 264 EGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESV-FHSVGN 321
Query: 192 LQSLDLSNNLL 202
L++L L +N L
Sbjct: 322 LETLILDSNPL 332
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 74/287 (25%), Positives = 122/287 (42%), Gaps = 33/287 (11%)
Query: 689 ELGRGGFGVVYRTIL-----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
+LG G FG V G VA+K L D +KE++ L + H N+V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 744 LEGYYWTPSLQ--LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
+G LI EF+ SGSL ++L ++N ++ +Q+ + + KG+ YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLP--KNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-ILSSKIQSALGYMAPEFACRTV 860
+H +L + NVL++S + K+GDFGL + + + S + + APE
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE-CLMQS 204
Query: 861 KITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLC----DM----VRGALEDGRVEDC 911
K DV+ FGV + E++T M + ++ M + L++G+
Sbjct: 205 KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK---- 260
Query: 912 VDARLRGNFPADEAIP--VIKLGLICASQVPSNRPDMEEVVNILELI 956
RL P P V +L C PSNR + ++ E +
Sbjct: 261 ---RL----PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 54/294 (18%), Positives = 107/294 (36%), Gaps = 55/294 (18%)
Query: 689 ELGRGGFGVVYRTILQDGRS--------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHN 740
LG+G F +++ + ++ V +K L E F + + K+ H +
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFFEAASMMSKLSHKH 73
Query: 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
LV G +L+ EF+ GSL +L +NC++ + + +A + +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEE 131
Query: 801 TNIIHYNLKSTNVLIDSSGEP--------KVGDFGLARLLPMLDRCILSSKIQSALGY-- 850
+IH N+ + N+L+ + K+ D G++ +
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDILQE 179
Query: 851 ----MAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALED 905
+ PE + D + FG + E+ + G +P+ ++ + ED
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL------QFYED 233
Query: 906 GRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959
+L PA +A + L C P +RP ++ L + +P
Sbjct: 234 RH-------QL----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-33
Identities = 67/275 (24%), Positives = 110/275 (40%), Gaps = 38/275 (13%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEG-- 746
+G+G FG V + G VA+K + + + F E + ++RH NLV L G
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
L ++ E+++ GSL +L R+ L L + + + YL N +H
Sbjct: 256 VEEKGGL-YIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 313
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
+L + NVL+ KV DFGL + + + + + APE K + K
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREK-KFSTKS 367
Query: 867 DVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVDARLRGNFP 921
DV+ FG+L+ E+ + G+ P + VV +E G + C P
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKDVV------PRVEKGYKMDAPDGC---------P 412
Query: 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956
V + C + RP ++ LE I
Sbjct: 413 P----AVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-33
Identities = 72/297 (24%), Positives = 122/297 (41%), Gaps = 37/297 (12%)
Query: 681 NALLNKDCELGRGGFGVVYRTILQDGR---SVAIKKLTVSGLIKSQEDFEKEMKTLGKIR 737
+ LL D ELG G FG V + + + + VAIK L E+ +E + + ++
Sbjct: 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 394
Query: 738 HHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAY 797
+ +V L G +L +L+ E G L+K L R + ++ ++ G+ Y
Sbjct: 395 NPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKY 451
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS---KIQSALGYMAPE 854
L N +H NL + NVL+ + K+ DFGL++ L D + K L + APE
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW--PLKWYAPE 509
Query: 855 FACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVE 909
K + + DV+ +GV + E ++ G++P + M+ V+ +E G
Sbjct: 510 -CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQGKRMECPP 562
Query: 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSPLDGQEE 965
+C P + + L C +RPD V + S E
Sbjct: 563 EC---------PPE----LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 606
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-33
Identities = 72/287 (25%), Positives = 116/287 (40%), Gaps = 26/287 (9%)
Query: 689 ELGRGGFGVVYRTILQDGRS----VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+GRG FG VY L D A+K L I F E + H N+++L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 745 EGYYWTPSLQLL-IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
G L + ++ G L + + + + + L +AKG+ +L
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLASKKF 213
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSAL--GYMAPEFACRTVK 861
+H +L + N ++D KV DFGLAR + + + +K + L +MA E + +T K
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE-SLQTQK 272
Query: 862 ITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920
T K DV+ FGVL+ E++T G P + + L GR
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRRLLQ--------- 317
Query: 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEELE 967
P P+ ++ L C RP E+V+ + I S G+ +
Sbjct: 318 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 364
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 38/275 (13%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEG-- 746
+G+G FG V + G VA+K + + + F E + ++RH NLV L G
Sbjct: 28 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
L ++ E+++ GSL +L R+ L L + + + YL N +H
Sbjct: 84 VEEKGGL-YIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 141
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
+L + NVL+ KV DFGL + + + + + APE A R K + K
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPE-ALREKKFSTKS 195
Query: 867 DVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVDARLRGNFP 921
DV+ FG+L+ E+ + G+ P + VV +E G + C P
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLKDVV------PRVEKGYKMDAPDGC---------P 240
Query: 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956
V ++ C + RP ++ LE I
Sbjct: 241 PA----VYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 70/287 (24%), Positives = 118/287 (41%), Gaps = 46/287 (16%)
Query: 689 ELGRGGFGVVYRTILQDGR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+G G FG V++ I +VAIK +E F +E T+ + H ++V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
G T + +I E + G L L + L ++ LAYL +
Sbjct: 82 IGVI-TENPVWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESKRFV 138
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG------YMAPEFACR 858
H ++ + NVL+ S+ K+GDFGL+R + S A +MAPE +
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRY-------MEDSTYYKASKGKLPIKWMAPE-SIN 190
Query: 859 TVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVD 913
+ T DV+ FGV + E++ G +P + ++++ V+ G +E+G +C
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI------GRIENGERLPMPPNC-- 242
Query: 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSP 959
P + L C + PS RP E+ L +++
Sbjct: 243 -------PP----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 67/281 (23%), Positives = 115/281 (40%), Gaps = 38/281 (13%)
Query: 686 KDCELGRGGFGVVYRTILQDGRS---VAIKKLTVSGLIKS-QEDFEKEMKTLGKIRHHNL 741
+D ELG G FG V + Q + VA+K L + +++ E + ++ + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
V + G S +L+ E G L K+L + + ++ ++ G+ YL +
Sbjct: 81 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 136
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS---KIQSALGYMAPEFACR 858
N +H +L + NVL+ + K+ DFGL++ L + + K + + APE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW--PVKWYAPE-CIN 193
Query: 859 TVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVD 913
K + K DV+ FGVL+ E + G++P M+ V LE G C
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT------AMLEKGERMGCPAGC-- 245
Query: 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
P + + L +C + NRP V L
Sbjct: 246 -------PRE----MYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 46/208 (22%), Positives = 84/208 (40%), Gaps = 18/208 (8%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNL--VALEG 746
+G GG V++ + + + AIK + + + + E+ L K++ H+ + L
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
Y T ++ E + L L + + +R + M + + +H I+H
Sbjct: 96 YEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 151
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPE----------FA 856
+LK N LI G K+ DFG+A + ++ + YM PE
Sbjct: 152 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 210
Query: 857 CRTVKITEKCDVYGFGVLVLEVVTGKRP 884
KI+ K DV+ G ++ + GK P
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 78/289 (26%), Positives = 125/289 (43%), Gaps = 33/289 (11%)
Query: 689 ELGRGGFGVVYRTILQ--DGRS--VAIK--KLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
+LG G FGVV R G++ VA+K K V ++ +DF +E+ + + H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
L G TP +++ + E GSL L + +A+G+ YL
Sbjct: 85 RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYLESKR 141
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS---KIQSALGYMAPEFACRT 859
IH +L + N+L+ + K+GDFGL R LP D + K+ + APE + +T
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFAWCAPE-SLKT 198
Query: 860 VKITEKCDVYGFGVLVLEVVT-GKRPVEYMED-DVVVLCDMVRGALEDGRVEDCVDARLR 917
+ D + FGV + E+ T G+ P + ++ D L R EDC
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPEDC------ 250
Query: 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEEL 966
P D + + + C + P +RP + + L Q P D + E
Sbjct: 251 ---PQD----IYNVMVQCWAHKPEDRPTFVALRDFLLEAQ-PTDMRAEF 291
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 46/208 (22%), Positives = 84/208 (40%), Gaps = 18/208 (8%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNL--VALEG 746
+G GG V++ + + + AIK + + + + E+ L K++ H+ + L
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
Y T ++ E + L L + + +R + M + + +H I+H
Sbjct: 77 YEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 132
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPE----------FA 856
+LK N LI G K+ DFG+A + ++ + YM PE
Sbjct: 133 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 191
Query: 857 CRTVKITEKCDVYGFGVLVLEVVTGKRP 884
KI+ K DV+ G ++ + GK P
Sbjct: 192 KSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 64/297 (21%), Positives = 120/297 (40%), Gaps = 53/297 (17%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+G GGFG V++ DG++ IK++ + E E+E+K L K+ H N+V G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVK-----YNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 748 Y---------------WTPSLQLLIY-EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGM 791
+ + + L I EF G+L + + L + +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFEQI 131
Query: 792 AKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG-- 849
KG+ Y+H +I+ +LK +N+ + + + K+GDFGL L K + G
Sbjct: 132 TKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN------DGKRTRSKGTL 185
Query: 850 -YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV 908
YM+PE + ++ D+Y G+++ E++ L DG +
Sbjct: 186 RYMSPE-QISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR--------DGII 236
Query: 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEE 965
D D + + +++ S+ P +RP+ E++ L + + + E
Sbjct: 237 SDIFDKKEKT---------LLQK---LLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-31
Identities = 73/479 (15%), Positives = 153/479 (31%), Gaps = 49/479 (10%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+ T TL +D ++++ + + L ++ +NN+
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG---IEKLTGLTKLICTSNNI 76
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLY 214
T LS ++L + SN+L+ L + L L L+ N L +S
Sbjct: 77 TTL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTK---LDVSQNP 127
Query: 215 DLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSF 274
L + +N + ++ D+ + L LD +N L + ++L N
Sbjct: 128 LLTYLNCARNTLT-EI--DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI 182
Query: 275 TGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCG 334
T E+ + + L L+ N + ++ + + L L+ S N+ T + +
Sbjct: 183 T-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE-IDVT--PLT 233
Query: 335 NLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLS 394
L D S N LT + L T+ L E D Q++
Sbjct: 234 QLTYFDCSVNPLT-ELDVSTLS-KLTTLHCIQTDLLEI----------DLTHNTQLIYFQ 281
Query: 395 SNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQI 454
+ + ++ + L LL+ + + + + + L ++ L + +
Sbjct: 282 AEGCRKIKELDVTHNTQLYLLDCQAAGI-TELD--LSQNPKLVYLYLNNTELT-ELD--V 335
Query: 455 GGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLS 514
LK L + S + +L + ++ + N S V
Sbjct: 336 SHNTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPD 393
Query: 515 FNDLSG---ILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGSV 570
D G + + + I+ +L + P + T ++ G +
Sbjct: 394 LLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTVTTPFEA 452
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 68/434 (15%), Positives = 137/434 (31%), Gaps = 95/434 (21%)
Query: 120 QVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLS 179
+ + + PD+ + A + S ++L S++ ++ ++
Sbjct: 2 TLKAGQTQSFNDWFPDD------NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT 55
Query: 180 GQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSM 239
+ GI L L L ++N + + +S +L + NK + D+ +
Sbjct: 56 -DMT-GIEKLTGLTKLICTSNNIT-TL--DLSQNTNLTYLACDSNKLTN---LDVTPLTK 107
Query: 240 LKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFS 299
L L+ N L+ L + L+ N+ T E+ + L LD LN+
Sbjct: 108 LTYLNCDTNKLTKLDVSQNPLL---TYLNCARNTLT-EID--VSHNTQLTELDCHLNKKI 161
Query: 300 GRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGL 359
++ + L L+ S N+ T L S L ++ N +T
Sbjct: 162 TKLD--VTPQTQLTTLDCSFNKITE-LDVS--QNKLLNRLNCDTNNIT------------ 204
Query: 360 QTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSM 419
+ L+ N L LD SSN L+ + ++ L+ L + S+
Sbjct: 205 -KLDLNQN------------------IQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSV 242
Query: 420 NYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIK 479
N L + + L + L L I +
Sbjct: 243 NPL-TELD--VSTLSKLTTLHCIQTDLL-EID--------------------------LT 272
Query: 480 NCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISH 539
+ + L + + + + L +D ++ + +L L+ +++
Sbjct: 273 HNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNN 327
Query: 540 NHLHGELPVGGFFN 553
L EL V
Sbjct: 328 TELT-ELDVSHNTK 340
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 33/238 (13%), Positives = 70/238 (29%), Gaps = 28/238 (11%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151
L L S N T D+++ L + + +L + L
Sbjct: 232 LTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLLEID----LTHNTQLIYFQAEG 284
Query: 152 NNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGIS 211
+ ++ + L ++ + ++ +L + L L L+N L E+ +S
Sbjct: 285 CRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-EL--DVS 336
Query: 212 NLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCS------ 265
+ L+++ +G L ++P NS +
Sbjct: 337 HNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPD 393
Query: 266 SLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFT 323
L GN + G + + + ++ S P+ F E + T
Sbjct: 394 LLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTDNPAVTYT--FTSENGAIVGTVT 447
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 37/297 (12%), Positives = 70/297 (23%), Gaps = 47/297 (15%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQ--EDFEKEMKTLGKIRHHNLVALE 745
L G VV+ ++ A+K T+ E + ++ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 746 GY---------------------------YWTPSLQLLIYEFISS--GSLYKHLHD-GSS 775
Y + LL+ S L+ L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANY-LLLMPAASVDLELLFSTLDFVYVF 187
Query: 776 RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835
R + + + A L ++H + N+ I G +GD +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR 247
Query: 836 DRCILSSKIQSALGYMAPEFA-CRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVV 894
+ Y EF T T + + G+ + V P + +
Sbjct: 248 GPASSVP-----VTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK- 301
Query: 895 LCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951
+ D + P D +I + R E +
Sbjct: 302 --GSWKRPSLRVPGTDSLAFGSCTPLP-DFVKTLIG-RFLNFD--RRRRLLPLEAME 352
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 69/289 (23%), Positives = 113/289 (39%), Gaps = 37/289 (12%)
Query: 689 ELGRGGFGVVYRTILQDGRS------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
LG G FG VY + + VA+K L + + DF E + K H N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHL----HDGSSRNCLSWRQRFNIILGMAKGLAYL 798
G + ++ E ++ G L L S + L+ ++ +A G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 799 HHTNIIHYNLKSTNVLIDSSGEP---KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEF 855
+ IH ++ + N L+ G K+GDFG+AR + + +M PE
Sbjct: 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE- 215
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVE---DC 911
A T K D + FGVL+ E+ + G P + V+ + V GR++ +C
Sbjct: 216 AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL--EFVT---SGGRMDPPKNC 270
Query: 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSP 959
PV ++ C P +RP+ ++ +E Q P
Sbjct: 271 PG-------------PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-31
Identities = 72/326 (22%), Positives = 136/326 (41%), Gaps = 39/326 (11%)
Query: 649 SGGEDYSCSPTKDPNYGKLVMFSGDAEFAAGANALLNKDC-----ELGRGGFGVVYRTIL 703
G ++ S ++ +Y +++ + + + ++ +G G FG V++ I
Sbjct: 352 QGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIY 411
Query: 704 QDGR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759
+VAIK +E F +E T+ + H ++V L G + +I E
Sbjct: 412 MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIME 470
Query: 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG 819
+ G L L + L ++ LAYL +H ++ + NVL+ S+
Sbjct: 471 LCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND 528
Query: 820 EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVV 879
K+GDFGL+R + +SK + + +MAPE + + T DV+ FGV + E++
Sbjct: 529 CVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEIL 586
Query: 880 T-GKRPVEYMEDDVVVLCDMVRGALEDG----RVEDCVDARLRGNFPADEAIPVIKLGLI 934
G +P + ++++ V+ G +E+G +C P + L
Sbjct: 587 MHGVKPFQGVKNNDVI------GRIENGERLPMPPNC---------PPT----LYSLMTK 627
Query: 935 CASQVPSNRPDMEEVVNILE-LIQSP 959
C + PS RP E+ L +++
Sbjct: 628 CWAYDPSRRPRFTELKAQLSTILEEE 653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 52/213 (24%), Positives = 83/213 (38%), Gaps = 23/213 (10%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
LG+G V+R + G AIK ++ + +E + L K+ H N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 748 YWTPSLQL--LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
+ + LI EF GSLY L + S+ L + ++ + G+ +L I+H
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 806 YNLKSTNVLIDSSGEP----KVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE---- 854
N+K N++ + K+ DFG AR L + S G Y+ P+
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELED------DEQFVSLYGTEEYLHPDMYER 189
Query: 855 ---FACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
K D++ GV TG P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 24/211 (11%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
LGRGGFGVV+ D + AIK++ + ++E +E+K L K+ H +V +
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 749 WT---------PSLQLLIY---EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLA 796
S ++ +Y + +L ++ + +I L +A+ +
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 797 YLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLL-------PMLDRCILSSKIQSALG 849
+LH ++H +LK +N+ KVGDFGL + +L ++ +G
Sbjct: 133 FLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVG 192
Query: 850 ---YMAPEFACRTVKITEKCDVYGFGVLVLE 877
YM+PE + K D++ G+++ E
Sbjct: 193 TKLYMSPE-QIHGNSYSHKVDIFSLGLILFE 222
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-31
Identities = 69/289 (23%), Positives = 113/289 (39%), Gaps = 37/289 (12%)
Query: 689 ELGRGGFGVVYRTILQDGRS------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
LG G FG VY + + VA+K L + + DF E + K H N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHL----HDGSSRNCLSWRQRFNIILGMAKGLAYL 798
G + ++ E ++ G L L S + L+ ++ +A G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 799 HHTNIIHYNLKSTNVLIDSSGEP---KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEF 855
+ IH ++ + N L+ G K+GDFG+AR + + +M PE
Sbjct: 198 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE- 256
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVE---DC 911
A T K D + FGVL+ E+ + G P + V+ + V GR++ +C
Sbjct: 257 AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL--EFVT---SGGRMDPPKNC 311
Query: 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSP 959
PV ++ C P +RP+ ++ +E Q P
Sbjct: 312 PG-------------PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-31
Identities = 47/201 (23%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEG 746
++G G FG +DGR IK++ +S + K +E+ +E+ L ++H N+V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ ++ ++ G L+K ++ Q + + + L ++H I+H
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRKILHR 149
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKIT 863
++KS N+ + G ++GDFG+AR+L ++ +G Y++PE C
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIARVLNS-----TVELARACIGTPYYLSPE-ICENKPYN 203
Query: 864 EKCDVYGFGVLVLEVVTGKRP 884
K D++ G ++ E+ T K
Sbjct: 204 NKSDIWALGCVLYELCTLKHA 224
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-31
Identities = 48/209 (22%), Positives = 87/209 (41%), Gaps = 20/209 (9%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNL--VALEG 746
+G GG V++ + + + AIK + + + + E+ L K++ H+ + L
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
Y T ++ E + L L + + +R + M + + +H I+H
Sbjct: 124 YEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 179
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLL-PMLDRCILSSKIQSALGYMAPE----------F 855
+LK N LI G K+ DFG+A + P + S++ + YM PE
Sbjct: 180 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN-YMPPEAIKDMSSSREN 237
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
KI+ K DV+ G ++ + GK P
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 60/272 (22%), Positives = 95/272 (34%), Gaps = 40/272 (14%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKS-QEDFEKEMKTLGKIRHH-NLVALE 745
LG G +G V++ +DGR A+K+ + E+ + K+ H V LE
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
+ + L E SL +H L Q + + LA+LH ++H
Sbjct: 124 QAWEEGGILYLQTEL-CGPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQGLVH 180
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKI 862
++K N+ + G K+GDFGL L + + G YMAPE +
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGT------AGAGEVQEGDPRYMAPE-LLQG-SY 232
Query: 863 TEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922
DV+ G+ +LEV E + +G L F A
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQG-------------YLPPEFTA 275
Query: 923 ---DEAIPVIKLGLICASQVPSNRPDMEEVVN 951
E V+ + P R E ++
Sbjct: 276 GLSSELRSVLVM---MLEPDPKLRATAEALLA 304
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-29
Identities = 53/212 (25%), Positives = 84/212 (39%), Gaps = 23/212 (10%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
LG+G V+R + G AIK ++ + +E + L K+ H N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 749 --WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
T ++LI EF GSLY L + S+ L + ++ + G+ +L I+H
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR 136
Query: 807 NLKSTNVLIDSSGEP----KVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE----- 854
N+K N++ + K+ DFG AR L + S G Y+ P+
Sbjct: 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELED------DEQFVSLYGTEEYLHPDMYERA 190
Query: 855 --FACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
K D++ GV TG P
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 19/209 (9%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVAL-E 745
+G G +G + DG+ + K+L + ++ E+ L +++H N+V +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 746 GYYWTPSLQLLIY-EFISSGSLYKHLHDGSSRN-CLSWRQRFNIILGMAKGLAYLHHTN- 802
+ L I E+ G L + G+ L ++ + L H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 803 ----IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEF 855
++H +LK NV +D K+GDFGLAR+L +S ++ +G YM+PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-----DTSFAKTFVGTPYYMSPE- 186
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
+ EK D++ G L+ E+ P
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-29
Identities = 80/420 (19%), Positives = 149/420 (35%), Gaps = 45/420 (10%)
Query: 145 REVSFANNNLTG--PIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLL 202
N L +P + + V+ S N ++ L+ LQ L +
Sbjct: 13 YNAICINRGLHQVPELP------AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTP 66
Query: 203 EGEIVKGI-SNLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSL--PDSL 258
I L L +KL N+F QL G + L+VL +L G++ +
Sbjct: 67 GLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFF 125
Query: 259 QRLNSCSSLSLKGNSFTGEVPDWI-GKLANLESLDLSLNQFSGRIPSSI----------- 306
+ L S L L+ N+ P + LDL+ N+ I
Sbjct: 126 KPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTL 184
Query: 307 GNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSG 366
L + +++ + ++ +D+S N ++ F +++G
Sbjct: 185 LRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD------AIAG 238
Query: 367 NRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSI 426
++ +S+ + +M S+ D + G+ S + ++S + +F ++
Sbjct: 239 TKI-QSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASG------VKTCDLSKSKIF-AL 290
Query: 427 PASI-GKLKAIQVLDFSDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQI-KNCSS 483
S+ ++ L + N +N I G L +L L +NFL I S++ +N
Sbjct: 291 LKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDK 348
Query: 484 LTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLH 543
L L LS N++ + L NLK + L N L + L+ L + N
Sbjct: 349 LEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 65/363 (17%), Positives = 131/363 (36%), Gaps = 42/363 (11%)
Query: 91 RLQFLQVLSLSNNNFTGTINADL-ASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSF 149
RLQ LQ L + I + +L ++ N L F +L ++
Sbjct: 52 RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQL-ETGAFNGLANLEVLTL 110
Query: 150 ANNNLTGPIPESLSFC--SSLESVNFSSNRLSGQLPYGIWF-LRSLQSLDLSNNLLE--- 203
NL G + F +SLE + N + P + +R LDL+ N ++
Sbjct: 111 TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSIC 170
Query: 204 -------GEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPD 256
+ L + + + + + + + LD N S+
Sbjct: 171 EEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAK 230
Query: 257 SLQRLNSCSSL-------------SLKGNSFTGEVPDWIGKL--ANLESLDLSLNQFSGR 301
+ + + S +F L + +++ DLS ++
Sbjct: 231 RFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-A 289
Query: 302 IPSSI-GNLVFLKELNISMNQFTGGLPESM-MNCGNLLAIDVSQNKLTGNIPTWIFK--M 357
+ S+ + L++L ++ N+ + ++ +LL +++SQN L +I + +F+
Sbjct: 290 LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLD 347
Query: 358 GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNM 417
L+ + LS N + ++ SF + L+ L L +N L V L+SL + +
Sbjct: 348 KLEVLDLSYNHI-RALGDQSFLGL----PNLKELALDTNQLKSVPDGIFDRLTSLQKIWL 402
Query: 418 SMN 420
N
Sbjct: 403 HTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 67/331 (20%), Positives = 126/331 (38%), Gaps = 46/331 (13%)
Query: 253 SLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSI-GNLVF 311
LP + ++ L NS +L +L+ L + I ++ L
Sbjct: 27 ELPAHVNYVD------LSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 312 LKELNISMNQFTGGLPESM-MNCGNLLAIDVSQNKLTG-NIPTWIFK--MGLQTVSLSGN 367
L L + NQF L NL + ++Q L G + FK L+ + L N
Sbjct: 81 LIILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139
Query: 368 RLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGD-----------LSSLMLLN 416
+ + F +M+ VLDL+ N + I LSS+ L +
Sbjct: 140 NIKKIQPASFFLNMR----RFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQD 194
Query: 417 MSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELK-----LEKNFLS 471
M+ +L + K +I LD S N ++ + A++ +++ N S
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS 254
Query: 472 GRIPSQIKNC----------SSLTSLILSQNNLTGPVPAAI-ANLSNLKYVDLSFNDLSG 520
+ K+ S + + LS++ + + ++ ++ ++L+ + L+ N+++
Sbjct: 255 SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEINK 313
Query: 521 ILPKELINLSHLLSFNISHNHLHGELPVGGF 551
I L+HLL N+S N L G + F
Sbjct: 314 IDDNAFWGLTHLLKLNLSQNFL-GSIDSRMF 343
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 45/237 (18%), Positives = 88/237 (37%), Gaps = 18/237 (7%)
Query: 90 LRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSF 149
LRL + + ++ + ++ +D S N + FF + S
Sbjct: 185 LRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL 244
Query: 150 ANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKG 209
+N S + + NF+ L +++ DLS + + ++K
Sbjct: 245 ILSNSYNMG-SSFGHTNFKDPDNFTFKGLEAS---------GVKTCDLSKSKIF-ALLKS 293
Query: 210 I-SNLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPD-SLQRLNSCSS 266
+ S+ DL + L +N+ + ++ ++ G + L L+ N L S+ + L+
Sbjct: 294 VFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEV 351
Query: 267 LSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSI-GNLVFLKELNISMNQF 322
L L N L NL+ L L NQ +P I L L+++ + N +
Sbjct: 352 LDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-29
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 22/212 (10%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL--- 744
LG GGFG V R I G VAIK+ K++E + E++ + K+ H N+V+
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 745 ---EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
L LL E+ G L K+L+ + L ++ ++ L YLH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 802 NIIHYNLKSTNVLIDSSGEP---KVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE- 854
IIH +LK N+++ + K+ D G A+ L +G Y+APE
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ------GELCTEFVGTLQYLAPEL 194
Query: 855 FACRTVKITEKCDVYGFGVLVLEVVTGKRPVE 886
+ K T D + FG L E +TG RP
Sbjct: 195 LEQK--KYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 67/290 (23%), Positives = 113/290 (38%), Gaps = 48/290 (16%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
LG+G FG V + D R AIKK+ + + E+ L + H +V +
Sbjct: 14 LGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 749 WTPSLQLL----------IY---EFISSGSLYKHLHDGSSRN--CLSWRQRFNIILGMAK 793
+ ++ E+ +G+LY +H + WR + + +
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR----LFRQILE 127
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLL---------PMLDRCILSSKI 844
L+Y+H IIH +LK N+ ID S K+GDFGLA+ + + S +
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 845 QSALG---YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRG 901
SA+G Y+A E T EK D+Y G++ E++ P + V +L +
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSV 244
Query: 902 ALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951
++E N +I+L P+ RP ++N
Sbjct: 245 SIE-------FPPDFDDNKM-KVEKKIIRL---LIDHDPNKRPGARTLLN 283
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 50/300 (16%), Positives = 105/300 (35%), Gaps = 45/300 (15%)
Query: 248 NSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIG 307
N+ S S ++ + + K + N+ + +
Sbjct: 9 NNFSLSQNSFYNTISGTYA----------DYFSAWDKWEKQALPGENRNEAVSLLKECL- 57
Query: 308 NLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGN 367
+ EL ++ + LP+++ + ++++QN L ++P L+ + N
Sbjct: 58 -INQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLPELPA--SLEYLDACDN 110
Query: 368 RLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIP 427
RL +++ + L+ LD+ +N L+ ++P L + N N L +P
Sbjct: 111 RL---------STLPELPASLKHLDVDNNQLT-MLPELPALLEYI---NADNNQL-TMLP 156
Query: 428 ASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTS- 486
L +VL +N L +P SL+ L + N L +P+
Sbjct: 157 ELPTSL---EVLSVRNNQLT-FLPELPE---SLEALDVSTNLLE-SLPAVPVRNHHSEET 208
Query: 487 ---LILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLH 543
+N +T +P I +L + L N LS + + L + ++ +
Sbjct: 209 EIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 3e-28
Identities = 66/354 (18%), Positives = 118/354 (33%), Gaps = 43/354 (12%)
Query: 189 LRSLQSLDLSNNL--LEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFG 246
SL N + + +N+ L E + + L
Sbjct: 10 NFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLN 67
Query: 247 VNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSI 306
+LS SLPD+L + L + N+ +P+ +LE LD N+ S +P
Sbjct: 68 RLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELP 119
Query: 307 GNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSG 366
+L K L++ NQ T LPE L I+ N+LT +P L+ +S+
Sbjct: 120 ASL---KHLDVDNNQLTM-LPELP---ALLEYINADNNQLT-MLPELPTS--LEVLSVRN 169
Query: 367 NRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSL----MLLNMSMNYL 422
N+L + + + L+ LD+S+N L +P+ + N +
Sbjct: 170 NQLTF---------LPELPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRI 219
Query: 423 FGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCS 482
IP +I L + DN L+ I + + + + + S Q N
Sbjct: 220 -THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTL 276
Query: 483 SLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFN 536
+ ++ + + + + L LS +S
Sbjct: 277 HRPLADAVTAWFPENKQSDVSQI----WHAFEHEEHANTFSAFLDRLSDTVSAR 326
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-28
Identities = 68/419 (16%), Positives = 114/419 (27%), Gaps = 117/419 (27%)
Query: 127 NNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSS---NRLSGQLP 183
NN L + F N ++G + S E N L
Sbjct: 8 NNNFSLSQNSF-------------YNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK 54
Query: 184 YGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVL 243
+ L L+ L LP+++ + VL
Sbjct: 55 --ECLINQFSELQLNRLNLS-------------------------SLPDNLP--PQITVL 85
Query: 244 DFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIP 303
+ N+L SLP+ L L N + +P+ +L+ LD+ NQ + +P
Sbjct: 86 EITQNALI-SLPELPASL---EYLDACDNRLS-TLPELPA---SLKHLDVDNNQLT-MLP 136
Query: 304 SSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVS 363
L+ +N NQ T LPE +L + V N+LT +P
Sbjct: 137 ELPAL---LEYINADNNQLT-MLPELP---TSLEVLSVRNNQLTF-LPELP--------- 179
Query: 364 LSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLF 423
+ L+ LD+S+N L +P+ +
Sbjct: 180 ----------------------ESLEALDVSTNLLES-LPAVPVRNHHSEETEI------ 210
Query: 424 GSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSS 483
+N + IP I + LE N LS RI + ++
Sbjct: 211 --------------FFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255
Query: 484 LTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHL 542
+ + N + D ++ + H N
Sbjct: 256 QPDYHGPRIYF--SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTF 312
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-26
Identities = 65/350 (18%), Positives = 126/350 (36%), Gaps = 47/350 (13%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151
+ L L+ N + ++ +L + V++ ++N L L P+ SL + +
Sbjct: 58 INQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALISL-PELP----ASLEYLDACD 109
Query: 152 NNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGIS 211
N L+ +PE + L + +N+L+ LP L+ ++ NN L + + +
Sbjct: 110 NRLST-LPELPASLKHL---DVDNNQLT-MLPELP---ALLEYINADNNQLT-MLPELPT 160
Query: 212 NLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSS----L 267
+L L + N+ + LPE L+ LD N L SLP R +
Sbjct: 161 SLEVLS---VRNNQLT-FLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFF 212
Query: 268 SLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLP 327
+ N T +P+ I L ++ L N S RI S+ + + F+
Sbjct: 213 RCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSM--S 269
Query: 328 ESMMNCGNLLAIDVSQNKLTGNIPTWIFKM--------GLQTVSLSGNRLGESMQYPSFA 379
+ N + D N + + ++ T S +RL +++ + +
Sbjct: 270 DGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTS 329
Query: 380 SMK-------DSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYL 422
+ + L S A++ + D +L N+ L
Sbjct: 330 GFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLL 379
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 68/294 (23%), Positives = 110/294 (37%), Gaps = 31/294 (10%)
Query: 689 ELGRGGFGVVYRTILQDGRS----VAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVA 743
LG+G FG V L+ VA+K L + S E+F +E + + H ++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 744 LEG------YYWTPSLQLLIYEFISSGSLYKHL---HDGSSRNCLSWRQRFNIILGMAKG 794
L G + ++I F+ G L+ L G + L + ++ +A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 795 LAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPE 854
+ YL N IH +L + N ++ V DFGL+R + D + + ++A E
Sbjct: 150 MEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE 209
Query: 855 FACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913
+ T DV+ FGV + E++T G+ P Y + + L G
Sbjct: 210 -SLADNLYTVHSDVWAFGVTMWEIMTRGQTP--YAGIEN----AEIYNYLIGGNRLKQ-- 260
Query: 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEELE 967
P + V L C S P RP + LE I L +
Sbjct: 261 -------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 67/291 (23%), Positives = 123/291 (42%), Gaps = 37/291 (12%)
Query: 689 ELGRGGFGVVYRTILQDGRS------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG G FG V+ + VA+K L +++DF++E + L ++H ++V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQHIV 106
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHL------------HDGSSRNCLSWRQRFNIILG 790
G L+++E++ G L + L + + L Q +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGY 850
+A G+ YL + +H +L + N L+ K+GDFG++R + D + + + +
Sbjct: 167 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226
Query: 851 MAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVE 909
M PE + K T + DV+ FGV++ E+ T GK+P + + + + GR
Sbjct: 227 MPPE-SILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI------DCITQGREL 279
Query: 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSP 959
+ P V + C + P R +++V L+ L Q+P
Sbjct: 280 ER---------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKS--QEDFEKEMKTLGKIRHHNLVALEG 746
LG+G FG VY Q +A+K L + L K+ + +E++ +RH N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
Y+ + LI E+ G++Y+ L + ++ I +A L+Y H +IH
Sbjct: 77 YFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVIHR 133
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKIT 863
++K N+L+ S+GE K+ DFG + P SS+ G Y+ PE +
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAP-------SSRRTDLCGTLDYLPPEMIEGRMH-D 185
Query: 864 EKCDVYGFGVLVLEVVTGKRP 884
EK D++ GVL E + GK P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP 206
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 51/202 (25%), Positives = 82/202 (40%), Gaps = 17/202 (8%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+GRG FG V+R Q G A+KK ++ + +E+ + +V L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKK------VRLEVFRVEELVACAGLSSPRIVPLYGA 118
Query: 748 YWTPSLQLLIY-EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ I+ E + GSL + + CL + + +GL YLH I+H
Sbjct: 119 VREGP-WVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 174
Query: 807 NLKSTNVLIDSSGEP-KVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKI 862
++K+ NVL+ S G + DFG A L G +MAPE
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK-PC 233
Query: 863 TEKCDVYGFGVLVLEVVTGKRP 884
K D++ ++L ++ G P
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHP 255
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-28
Identities = 78/471 (16%), Positives = 149/471 (31%), Gaps = 42/471 (8%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+ LSLS N+ + D++ L+V+ S N + L F L + ++N L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSL-DFHVFLFNQDLEYLDVSHNRL 112
Query: 155 TGPIPESLSFC--SSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLEGEIVKGI 210
++S C +SL ++ S N LP F L L L LS + +
Sbjct: 113 Q-----NISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPV 166
Query: 211 SNLYDLRAIKLGKNKFSGQ-LPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSL 269
++L L I L + + + VL + S +N+ L L
Sbjct: 167 AHL-HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQL 225
Query: 270 KGNSFTG-------EVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVF---LKELNISM 319
+ + L ++ L + + + + + ++ LNI
Sbjct: 226 SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285
Query: 320 NQFTGGLPESMMNCGNLLAIDVSQNKLTGN----IPTWIFKM--GLQTVSLSGNRLGESM 373
T + + + ++ + + LS + +
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP-FI 344
Query: 374 QYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKL 433
S L+ + N + + L L L + N L +
Sbjct: 345 HMVCPPSPSS----FTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL-KNFFKVALMT 399
Query: 434 KAIQVLDFSDNWLN----GTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLIL 489
K + L+ D LN A S+ L L N L+G + + + L L
Sbjct: 400 KNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDL 457
Query: 490 SQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHN 540
N + +P + +L L+ ++++ N L + L+ L + N
Sbjct: 458 HNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 75/431 (17%), Positives = 146/431 (33%), Gaps = 48/431 (11%)
Query: 91 RLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFA 150
Q L+ L +S+N I+ +L+ +D S N+ L + F L + +
Sbjct: 98 FNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLS 154
Query: 151 NNNLTGPIPESLSFCS------SLESVNFSSNRLSGQLPYGIWFL--RSLQSLDLSNNLL 202
L S ++ S + G + L + N+L
Sbjct: 155 AAKFR-----QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLF 209
Query: 203 EGEIVKGISNLYDL--RAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQR 260
++ ++ L L IKL + +L+ + + + S++
Sbjct: 210 SVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKL 269
Query: 261 LN----------SCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLV 310
+ +L++ E L +L + F +
Sbjct: 270 FQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFA 329
Query: 311 FLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFK--MGLQTVSLSGNR 368
+ +S++ + + ++ +QN T + LQT+ L N
Sbjct: 330 EMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNG 388
Query: 369 LGESMQYPSFASMKDSYQGLQVLDLSSNAL-SGVIPSNIGDLSSLMLLNMSMNYL----F 423
L ++ A M + L+ LD+S N+L S S+++LN+S N L F
Sbjct: 389 L-KNF--FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVF 445
Query: 424 GSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQI-KNCS 482
+P + +VLD +N + +IP + +L+EL + N L +P + +
Sbjct: 446 RCLPPKV------KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLT 497
Query: 483 SLTSLILSQNN 493
SL + L N
Sbjct: 498 SLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-21
Identities = 76/432 (17%), Positives = 143/432 (33%), Gaps = 49/432 (11%)
Query: 118 TLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESL-SFCSSLESVNFSSN 176
+ + S+N++S L + LR + ++N + + + F LE ++ S N
Sbjct: 53 RTKALSLSQNSISELRMPDI-SFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHN 110
Query: 177 RLSGQLPYGIWFLRSLQSLDLSNNLLEG-EIVKGISNLYDLRAIKLGKNKF-SGQLPEDI 234
RL + + SL+ LDLS N + + K NL L + L KF L
Sbjct: 111 RLQN-ISCCP--MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVA 167
Query: 235 GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLS 294
+LD + G +SLQ N+ + L L + + + L L LS
Sbjct: 168 HLHLSCILLDLVSYHIKGGETESLQIPNT-TVLHLVFHPNSLFSVQVNMSVNALGHLQLS 226
Query: 295 LNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWI 354
+ + + + ++ T L I+ + + +
Sbjct: 227 NIKLNDENCQRLMTFLSELTRGPTLLNVT------------LQHIETTWKCSV-KLFQFF 273
Query: 355 FKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLML 414
+ ++ +++ + E + F + + L SLM+
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETA------------------------LKSLMI 309
Query: 415 LNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRI 474
++ S A + + S + S L +N + +
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369
Query: 475 PSQIKNCSSLTSLILSQNNLT--GPVPAAIANLSNLKYVDLSFNDLSGILPKELINL-SH 531
L +LIL +N L V N+S+L+ +D+S N L+
Sbjct: 370 FQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429
Query: 532 LLSFNISHNHLH 543
+L N+S N L
Sbjct: 430 ILVLNLSSNMLT 441
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 61/395 (15%), Positives = 122/395 (30%), Gaps = 52/395 (13%)
Query: 165 CSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKN 224
V++S+ L+ +P + ++L LS N + +L
Sbjct: 30 NELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSIS----------------ELR-- 68
Query: 225 KFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSL-QRLNSCSSLSLKGNSFTGEVPDWIG 283
DI S L+VL N + SL + L + N +
Sbjct: 69 ------MPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--C 118
Query: 284 KLANLESLDLSLNQF-SGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVS 342
+A+L LDLS N F + GNL L L +S +F + + L +
Sbjct: 119 PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH----LHLSCI 174
Query: 343 QNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVI 402
L LQ + + L + S L L LS+ L+
Sbjct: 175 LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN 234
Query: 403 PSNIGDLS-----SLMLLNMSMNYLFGSIPA-----SIGKLKAIQVLDFSDNWLNGTIPP 452
+ LLN+++ ++ + + ++ L+ + + I
Sbjct: 235 CQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDR 294
Query: 453 QIGGAV-----SLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSN 507
+ SL ++ + + + +LS ++ + S+
Sbjct: 295 EEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSS 354
Query: 508 LKYVDLSFNDLSGILPKELINLSHLLSFNISHNHL 542
+++ + N + + + L L + + N L
Sbjct: 355 FTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 3e-15
Identities = 47/276 (17%), Positives = 89/276 (32%), Gaps = 51/276 (18%)
Query: 70 RVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNL 129
+ LT+ L+ L + + N F + A + F + + S ++
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 130 SGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFL 189
I S ++F N T + + S L+++ N L
Sbjct: 342 P-FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMT 399
Query: 190 RSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNS 249
+++ SL+ + L L+
Sbjct: 400 KNMSSLETLDVSLNS--------------------------------------LNSHAYD 421
Query: 250 LSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNL 309
+ + +S+ LN L N TG V + ++ LDL N+ IP + +L
Sbjct: 422 RTCAWAESILVLN------LSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHL 472
Query: 310 VFLKELNISMNQFTGGLPESM-MNCGNLLAIDVSQN 344
L+ELN++ NQ +P+ + +L I + N
Sbjct: 473 QALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 19/83 (22%), Positives = 36/83 (43%), Gaps = 9/83 (10%)
Query: 474 IPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILP---KELINLS 530
+P + +L LSQN+++ I+ LS L+ + LS N + + +L
Sbjct: 46 VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLE 103
Query: 531 HLLSFNISHNHLHGELPVGGFFN 553
+L ++SHN L + +
Sbjct: 104 YL---DVSHNRLQ-NISCCPMAS 122
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 690 LGRGGFGVVYR---TILQDGRSVAIK--KLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
LG GG VY TIL VAIK + ++ + FE+E+ ++ H N+V++
Sbjct: 19 LGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
L+ E+I +L +++ LS N + G+ + H I+
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMRIV 133
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI---QSALG---YMAPEFACR 858
H ++K N+LIDS+ K+ DFG+A+ L + + LG Y +PE A +
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKAL-------SETSLTQTNHVLGTVQYFSPEQA-K 185
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRP 884
E D+Y G+++ E++ G+ P
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 32/213 (15%)
Query: 690 LGRGGFGVVYR---TILQDGRSVAIKKLTVSGLIKSQ--ED------FEKEMKTLGKIRH 738
LG GG V+ R VA+K L ++ D F +E + + H
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVL------RADLARDPSFYLRFRREAQNAAALNH 71
Query: 739 HNLVAL----EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKG 794
+VA+ E L ++ E++ +L +H ++ ++ +I +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQA 128
Query: 795 LAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YM 851
L + H IIH ++K N++I ++ KV DFG+AR + + + + +G Y+
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT--AAVIGTAQYL 186
Query: 852 APEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
+PE A R + + DVY G ++ EV+TG+ P
Sbjct: 187 SPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
LG+G +G+VY L + +AIK++ + + +E+ ++H N+V G +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 749 WTPSLQLLIY-EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+ I+ E + GSL L + + + +GL YLH I+H +
Sbjct: 89 SENG-FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 808 LKSTNVLIDS-SGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVK-I 862
+K NVLI++ SG K+ DFG ++ L ++ ++ G YMAPE + +
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAG-----INPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 863 TEKCDVYGFGVLVLEVVTGKRP 884
+ D++ G ++E+ TGK P
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP 224
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 59/313 (18%), Positives = 109/313 (34%), Gaps = 38/313 (12%)
Query: 263 SCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQF 322
CS L LK VP I + LDL N S L L L + N+
Sbjct: 39 QCSDLGLK------AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 323 TGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMK 382
+ ++ L + +S+N L IP + L + + NR+ + F+ ++
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS-SLVELRIHDNRI-RKVPKGVFSGLR 147
Query: 383 DSYQGLQVLDLSSNALSGV-IPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDF 441
+ + +++ N L D L L +S L IP + + + L
Sbjct: 148 N----MNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL-TGIPKDL--PETLNELHL 200
Query: 442 SDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQI-KNCSSLTSLILSQNNLTGPVP 499
N + I + L L L N + I + +L L L N L+ VP
Sbjct: 201 DHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR-VP 257
Query: 500 AAIANLSNLKYVDLSFNDLSGILP------KELINLSHLLSFNISHNHLHGELPVGGFFN 553
A + +L L+ V L N+++ + + ++ ++ +N + +
Sbjct: 258 AGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP--------YW 309
Query: 554 TISPSSVSGNPSL 566
+ P++
Sbjct: 310 EVQPATFRCVTDR 322
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 59/330 (17%), Positives = 113/330 (34%), Gaps = 37/330 (11%)
Query: 191 SLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSL 250
L+ + S+ L+ + K IS D + L N S +D G L L N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 251 SGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSI-GNL 309
S + L L + N E+P ++L L + N+ ++P + L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGL 146
Query: 310 VFLKELNISMNQFT-GGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNR 368
+ + + N G + L + +S+ KLT IP + + L + L N+
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPE-TLNELHLDHNK 204
Query: 369 LGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPA 428
+ ++++ L L L N + + ++ L +L L++ N L +PA
Sbjct: 205 I-QAIELEDLLRYS----KLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL-SRVPA 258
Query: 429 SIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLI 488
+ LK +QV+ N + + F + +
Sbjct: 259 GLPDLKLLQVVYLHTNNIT-KVGVND--------------FCPVGFGV---KRAYYNGIS 300
Query: 489 LSQNNLTGPV--PAAIANLSNLKYVDLSFN 516
L N + PA +++ +
Sbjct: 301 LFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 55/286 (19%), Positives = 108/286 (37%), Gaps = 22/286 (7%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+L L NN+ + D L + N +S I ++ F L+++ + N+L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKNHL 114
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF-LRSLQSLDLSNNLL-EGEIVKGISN 212
IP +L SSL + NR+ ++P G++ LR++ +++ N L G +
Sbjct: 115 VE-IPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 213 LYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGN 272
L +++ + K + +P+D+ L L N + + L R + L L N
Sbjct: 171 GLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHN 227
Query: 273 SFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMM- 331
+ L L L L N+ S R+P+ + +L L+ + + N T + +
Sbjct: 228 QIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFC 285
Query: 332 ------NCGNLLAIDVSQNKLT-GNIPTWIFK--MGLQTVSLSGNR 368
I + N + + F+ + +
Sbjct: 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 61/335 (18%), Positives = 115/335 (34%), Gaps = 46/335 (13%)
Query: 94 FLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNN 153
L+V+ S+ + ++ ++D N++S L + F+ L + NN
Sbjct: 34 HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISEL-RKDDFKGLQHLYALVLVNNK 89
Query: 154 LTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNL 213
++ ++ S L+ + S N L ++P + SL L + +N +
Sbjct: 90 ISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR---------- 136
Query: 214 YDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSL--PDSLQRLNSCSSLSLKG 271
K+ K FSG L + ++ G N L S P + L + L +
Sbjct: 137 ------KVPKGVFSG-LRN-------MNCIEMGGNPLENSGFEPGAFDGLKL-NYLRISE 181
Query: 272 NSFTGEVPDWIGKLANLESLDLSLNQFSGRIPS-SIGNLVFLKELNISMNQFTGGLPESM 330
T +P L L L N+ I + L L + NQ S+
Sbjct: 182 AKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSL 237
Query: 331 MNCGNLLAIDVSQNKLTGNIPTWIFKM-GLQTVSLSGNRLGESMQYPSFASMK--DSYQG 387
L + + NKL+ +P + + LQ V L N + + F +
Sbjct: 238 SFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAY 295
Query: 388 LQVLDLSSNALS--GVIPSNIGDLSSLMLLNMSMN 420
+ L +N + V P+ ++ + +
Sbjct: 296 YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 58/268 (21%), Positives = 93/268 (34%), Gaps = 21/268 (7%)
Query: 89 LLRLQFLQVLSLSNNNFTGTINAD-LASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147
LQ L L L NN + I+ + LQ + S+N+L IP SL E+
Sbjct: 74 FKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS---SLVEL 128
Query: 148 SFANNNLTGPIPESLSFCSSLESVNFSSNRL-SGQLPYGIWFLRSLQSLDLSNNLLEGEI 206
+N + S ++ + N L + G + L L +S L I
Sbjct: 129 RIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GI 187
Query: 207 VKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSS 266
K + L + L NK ED+ S L L G N + SL L +
Sbjct: 188 PKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRE 245
Query: 267 LSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSI-------GNLVFLKELNISM 319
L L N + VP + L L+ + L N + ++ + + +++
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFN 303
Query: 320 NQFT-GGLPESMMNC-GNLLAIDVSQNK 345
N + + C + LAI K
Sbjct: 304 NPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 36/190 (18%), Positives = 63/190 (33%), Gaps = 25/190 (13%)
Query: 85 IGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSL 144
G L L +S T I DL TL + N + I E + L
Sbjct: 164 FEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKL 219
Query: 145 REVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEG 204
+ +N + SLSF +L ++ +N+LS ++P G+ L+ LQ + L N +
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT- 277
Query: 205 EIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSL--PDSLQRLN 262
K+G N F + + N + P + + +
Sbjct: 278 ---------------KVGVNDFCPVGFGV--KRAYYNGISLFNNPVPYWEVQPATFRCVT 320
Query: 263 SCSSLSLKGN 272
++
Sbjct: 321 DRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 26/120 (21%), Positives = 41/120 (34%), Gaps = 16/120 (13%)
Query: 459 SLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDL 518
L+ ++ L +P +I T L L N+++ L +L + L N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 519 SGILPKELINLSHLLSFNISHNHLHGELPVGGF------------FNTISPSSVSGNPSL 566
S I K L L IS NHL E+P + SG ++
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNM 149
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 64/297 (21%), Positives = 121/297 (40%), Gaps = 54/297 (18%)
Query: 689 ELGRGGFGVVYRTILQDGRS------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG+G FG+VY + + VAIK + + ++ + +F E + + H++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHL-------HDGSSRNCLSWRQRFNIILGMAKGL 795
L G L+I E ++ G L +L + S + + +A G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGY----- 850
AYL+ +H +L + N ++ K+GDFG+ R I Y
Sbjct: 152 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR------------DIYETDYYRKGGK 199
Query: 851 -------MAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGA 902
M+PE + + T DV+ FGV++ E+ T ++P + + ++ V+
Sbjct: 200 GLLPVRWMSPE-SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------RF 252
Query: 903 LEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959
+ +G + D P + + +L +C P RP E+++ ++ P
Sbjct: 253 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 71/286 (24%), Positives = 120/286 (41%), Gaps = 36/286 (12%)
Query: 689 ELGRGGFGVVYRTILQDGRS------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG FG VY+ L VAIK L +E+F E +++H N+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLH-------------DGSSRNCLSWRQRFNIIL 789
L G +I+ + S G L++ L D + ++ L +++
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 790 GMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG 849
+A G+ YL +++H +L + NVL+ K+ D GL R + D L +
Sbjct: 136 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 195
Query: 850 YMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRV 908
+MAPE A K + D++ +GV++ EV + G +P + VV + + +V
Sbjct: 196 WMAPE-AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV------EMIRNRQV 248
Query: 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
C P D V L + C ++ PS RP +++ + L
Sbjct: 249 LPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 48/212 (22%), Positives = 87/212 (41%), Gaps = 36/212 (16%)
Query: 690 LGRGGFGVVYR---TILQDGRSVAIKKL--TVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+GRGG G VY T+ R VA+K + T+S + ++E +T G+++ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 745 ------EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
+G + + I+ L L + L+ + I+ + L
Sbjct: 100 HDFGEIDGQLY------VDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAA 150
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI---QSALG---YMA 852
H H ++K N+L+ + + DFG+A K+ + +G YMA
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATT-------DEKLTQLGNTVGTLYYMA 203
Query: 853 PEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
PE T + D+Y ++ E +TG P
Sbjct: 204 PERF-SESHATYRADIYALTCVLYECLTGSPP 234
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 72/299 (24%), Positives = 130/299 (43%), Gaps = 52/299 (17%)
Query: 689 ELGRGGFGVVYRTILQDGRS------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG G FG V+ + VA+K L + +++DF++E + L ++H ++V
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHEHIV 80
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHL-------------HDGSSRNCLSWRQRFNIIL 789
G ++++E++ G L K L ++ L Q +I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 790 GMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG 849
+A G+ YL + +H +L + N L+ ++ K+GDFG++R + S+ G
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD-------VYSTDYYRVGG 193
Query: 850 Y-------MAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRG 901
+ M PE + K T + DV+ FGV++ E+ T GK+P + + V+ C
Sbjct: 194 HTMLPIRWMPPE-SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC----- 247
Query: 902 ALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSP 959
+ GRV + P V + L C + P R +++E+ IL L ++
Sbjct: 248 -ITQGRVLER---------PRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 66/302 (21%), Positives = 108/302 (35%), Gaps = 62/302 (20%)
Query: 689 ELGRGGFGVVYRTILQDGRS----VAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVA 743
LG G FG V L+ VA+K + + + E+F E + H N++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 744 LEG-----YYWTPSLQLLIYEFISSGSLYKHL---HDGSSRNCLSWRQRFNIILGMAKGL 795
L G ++I F+ G L+ +L + + + ++ +A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGY----- 850
YL + N +H +L + N ++ V DFGL++ KI S Y
Sbjct: 161 EYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK------------KIYSGDYYRQGRI 208
Query: 851 -------MAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGA 902
+A E + T K DV+ FGV + E+ T G P Y +
Sbjct: 209 AKMPVKWIAIE-SLADRVYTSKSDVWAFGVTMWEIATRGMTP--YPGVQNH----EMYDY 261
Query: 903 LEDGRV----EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958
L G EDC+D + ++ C P +RP + LE +
Sbjct: 262 LLHGHRLKQPEDCLD-------------ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308
Query: 959 PL 960
L
Sbjct: 309 SL 310
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 50/286 (17%), Positives = 104/286 (36%), Gaps = 21/286 (7%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+L L NN T + D + L + N +S I F L + + N L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLSKNQL 112
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF-LRSLQSLDLSNNLL-EGEIVKGI-S 211
+PE + +L+ + N ++ ++ ++ L + ++L N L I G
Sbjct: 113 KE-LPEKM-P-KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 212 NLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKG 271
+ L I++ + +P+ + L L N ++ SL+ LN+ + L L
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225
Query: 272 NSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTG------G 325
NS + + +L L L+ N+ ++P + + +++ + + N +
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284
Query: 326 LPESMMNCGNLLAIDVSQNKLT-GNIPTWIFKM--GLQTVSLSGNR 368
P + + + N + I F+ V L +
Sbjct: 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 63/331 (19%), Positives = 115/331 (34%), Gaps = 38/331 (11%)
Query: 191 SLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSL 250
L+ + S+ LE ++ K + D + L NK + D L L N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 251 SGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSI-GNL 309
S P + L L L N E+P+ L+ L + N+ + ++ S+ L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGL 144
Query: 310 VFLKELNISMNQFT-GGLPESM-MNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGN 367
+ + + N G+ L I ++ +T IP + L + L GN
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP-SLTELHLDGN 202
Query: 368 RLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIP 427
++ + S + L L LS N++S V ++ + L L+++ N L +P
Sbjct: 203 KI-TKVDAASLKGLN----NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVP 256
Query: 428 ASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSL 487
+ K IQV+ +N ++ I P +S + +
Sbjct: 257 GGLADHKYIQVVYLHNNNIS-AIGSN-----------------DFCPPGYNTKKASYSGV 298
Query: 488 ILSQNNLTGPV--PAAIANLSNLKYVDLSFN 516
L N + P+ + V L
Sbjct: 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 66/315 (20%), Positives = 125/315 (39%), Gaps = 29/315 (9%)
Query: 94 FLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNN 153
L+V+ S+ + DL ++D N ++ + D F+ +L + NN
Sbjct: 32 HLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEI-KDGDFKNLKNLHTLILINNK 87
Query: 154 LTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGI-SN 212
++ P + + LE + S N+L +LP + ++LQ L + N + ++ K + +
Sbjct: 88 ISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNG 143
Query: 213 LYDLRAIKLGKNKF-SGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLK 270
L + ++LG N S + G L + +++ ++P L S + L L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLD 200
Query: 271 GNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESM 330
GN T + L NL L LS N S S+ N L+EL+++ N+ +P +
Sbjct: 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 331 MNCGNLLAIDVSQNKLTGNIPTWIFKM--------GLQTVSLSGNRLGESMQYPS-FASM 381
+ + + + N ++ I + F VSL N + PS F +
Sbjct: 260 ADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318
Query: 382 KDSYQGLQVLDLSSN 396
+ L +
Sbjct: 319 YV----RAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 62/310 (20%), Positives = 110/310 (35%), Gaps = 52/310 (16%)
Query: 254 LPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLK 313
LP L+ L+ N T L NL +L L N+ S P + LV L+
Sbjct: 50 LPPDTALLD------LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103
Query: 314 ELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESM 373
L +S NQ +P + K LQ + + N + +
Sbjct: 104 RLYLSKNQLK-------------------------ELPEKMPK-TLQELRVHENEI-TKV 136
Query: 374 QYPSFASMKDSYQGLQVLDLSSNAL-SGVIPSNI-GDLSSLMLLNMSMNYLFGSIPASIG 431
+ F + + V++L +N L S I + + L + ++ + +IP +
Sbjct: 137 RKSVFNGL----NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL- 190
Query: 432 KLKAIQVLDFSDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILS 490
++ L N + + G +L +L L N +S + N L L L+
Sbjct: 191 -PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248
Query: 491 QNNLTGPVPAAIANLSNLKYVDLSFNDLSGI------LPKELINLSHLLSFNISHNHL-H 543
N L VP +A+ ++ V L N++S I P + ++ N + +
Sbjct: 249 NNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307
Query: 544 GELPVGGFFN 553
E+ F
Sbjct: 308 WEIQPSTFRC 317
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 63/314 (20%), Positives = 128/314 (40%), Gaps = 29/314 (9%)
Query: 119 LQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRL 178
L+VV S+ L +P + + NN +T +L ++ +N++
Sbjct: 33 LRVVQCSDLGLEK-VPKDLPP---DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 179 SGQLPYGIWF--LRSLQSLDLSNNLLEGEIVKGI-SNLYDLRAIKLGKNKFSGQLPEDI- 234
S ++ G F L L+ L LS N L+ E+ + + L +LR + +N+ + ++ + +
Sbjct: 89 S-KISPGA-FAPLVKLERLYLSKNQLK-ELPEKMPKTLQELR---VHENEIT-KVRKSVF 141
Query: 235 GGCSMLKVLDFGVNSLSGSL--PDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLD 292
G + + V++ G N L S + Q + S + + + T +P G +L L
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELH 198
Query: 293 LSLNQFSGRIPS-SIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIP 351
L N+ + ++ + S+ L L +L +S N + S+ N +L + ++ NKL +P
Sbjct: 199 LDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256
Query: 352 TWIFKM-GLQTVSLSGNRLGESMQYPSFASMK--DSYQGLQVLDLSSNALSGV-IPSNI- 406
+ +Q V L N + ++ F + L SN + I +
Sbjct: 257 GGLADHKYIQVVYLHNNNI-SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTF 315
Query: 407 GDLSSLMLLNMSMN 420
+ + +
Sbjct: 316 RCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-22
Identities = 59/269 (21%), Positives = 108/269 (40%), Gaps = 41/269 (15%)
Query: 287 NLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKL 346
+L + S ++P + L++ N+ T N NL + + NK+
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 347 TGNIPTWIFK--MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPS 404
+ I F + L+ + LS N+L + + + LQ L + N ++ V S
Sbjct: 89 S-KISPGAFAPLVKLERLYLSKNQL-KELPEKMPKT-------LQELRVHENEITKVRKS 139
Query: 405 NIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELK 464
L+ ++++ + N L K I+ F G L ++
Sbjct: 140 VFNGLNQMIVVELGTNPL---------KSSGIENGAFQ-------------GMKKLSYIR 177
Query: 465 LEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPK 524
+ ++ IP + SLT L L N +T A++ L+NL + LSFN +S +
Sbjct: 178 IADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG 234
Query: 525 ELINLSHLLSFNISHNHLHGELPVGGFFN 553
L N HL ++++N L ++P GG +
Sbjct: 235 SLANTPHLRELHLNNNKLV-KVP-GGLAD 261
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 31/194 (15%), Positives = 74/194 (38%), Gaps = 26/194 (13%)
Query: 82 SGHIGRGLLR-LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQ 140
S I G + ++ L + +++ N T TI L +L + N ++ + +
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK-VDAASLKG 214
Query: 141 CGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNN 200
+L ++ + N+++ SL+ L ++ ++N+L ++P G+ + +Q + L NN
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273
Query: 201 LLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSL--PDSL 258
+ +G N F P + + N + P +
Sbjct: 274 NIS----------------AIGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTF 315
Query: 259 QRLNSCSSLSLKGN 272
+ + +++ L
Sbjct: 316 RCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 36/211 (17%), Positives = 70/211 (33%), Gaps = 31/211 (14%)
Query: 92 LQFLQVLSLSNNNFT-GTINAD-LASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSF 149
L + V+ L N I L + ++ N++ IP SL E+
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLPP---SLTELHL 199
Query: 150 ANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKG 209
N +T SL ++L + S N +S + L+ L L+NN L ++ G
Sbjct: 200 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 258
Query: 210 ISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRL----NSCS 265
+++ ++ + L N S + DF + S + N
Sbjct: 259 LADHKYIQVVYLHNNNI-----------SAIGSNDFCPPGYNTKKA-SYSGVSLFSNPVQ 306
Query: 266 SLSLKGNSFTGEVPDWIGKLANLESLDLSLN 296
++ ++F + ++ L
Sbjct: 307 YWEIQPSTFRC--------VYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 27/133 (20%), Positives = 45/133 (33%), Gaps = 30/133 (22%)
Query: 74 LTLDGFSLSGHIGRGLLR-LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGL 132
L L S+S + G L L+ L L+NN + LA +QVV NN+S +
Sbjct: 221 LGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 278
Query: 133 IPDEF-----FRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIW 187
++F + S VS +N + ++ F
Sbjct: 279 GSNDFCPPGYNTKKASYSGVSLFSNPVQ---------YWEIQPSTFRC------------ 317
Query: 188 FLRSLQSLDLSNN 200
+ ++ L N
Sbjct: 318 -VYVRAAVQLGNY 329
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 40/203 (19%), Positives = 77/203 (37%), Gaps = 23/203 (11%)
Query: 690 LGRGGFGVVYR---TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL-- 744
+ GG G +Y + +GR V +K L SG ++Q E + L ++ H ++V +
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 745 EGYYWTPSLQLLIY---EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
+ + Y E++ SL + L + +L + L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHSI 201
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVK 861
+++ +LK N+++ K+ D G ++ + G+ APE
Sbjct: 202 GLVYNDLKPENIMLTEEQ-LKLIDLGAVS---RINS---FGYLYGTPGFQAPEIV--RTG 252
Query: 862 ITEKCDVYGFGVLVLEVVTGKRP 884
T D+Y G + +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPT 275
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 34/239 (14%), Positives = 68/239 (28%), Gaps = 38/239 (15%)
Query: 683 LLNKDCELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKS--QEDFEKE---MKTLGKI 736
L + LG+ T + G S + + S + ++E ++ L I
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 737 RH-------------------------HNLVALEGYYWTPSLQLLI-YEFISSGSLYKHL 770
++ + E W S L + + + L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 771 HD-GSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLA 829
S+ L R + L + + LA LHH ++H L+ ++++D G + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 830 RLLPMLDRCILSSKIQSALGYMAPEFAC----RTVKITEKCDVYGFGVLVLEVVTGKRP 884
+ A +T D + G+ + + P
Sbjct: 259 VRDGASAVSPIGRGFAPP-ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 39/263 (14%), Positives = 82/263 (31%), Gaps = 25/263 (9%)
Query: 689 ELGRGGFGVVYR------TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
LG G F VY ++ + +K + M+ L H +
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRN--CLSWRQRFNIILGMAKGLAYLHH 800
+ + +L+ E S G+L ++ + + + + M + +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 801 TNIIHYNLKSTNVLIDSSGEP-----------KVGDFGLARLLPMLDR-CILSSKIQSAL 848
IIH ++K N ++ + + D G + + + + I ++K ++
Sbjct: 191 CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET-S 249
Query: 849 GYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV 908
G+ E + D +G V ++ G E + R
Sbjct: 250 GFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMW 308
Query: 909 EDCVDARLRGNFPADEAIPVIKL 931
+ L N P +P + L
Sbjct: 309 NEFFHVML--NIPDCHHLPSLDL 329
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 73/305 (23%), Positives = 118/305 (38%), Gaps = 68/305 (22%)
Query: 689 ELGRGGFGVVYR-TILQDGRS--VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVAL 744
+G G FG V + I +DG AIK++ DF E++ L K+ HH N++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHL-------------HDGSSRNCLSWRQRFNIILGM 791
G L E+ G+L L S+ + LS +Q + +
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 792 AKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR-----------LLPMLDRCIL 840
A+G+ YL IH +L + N+L+ + K+ DFGL+R LP+
Sbjct: 152 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV------ 205
Query: 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDM- 898
+ +MA E + T DV+ +GVL+ E+V+ G P Y C M
Sbjct: 206 --R------WMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--Y--------CGMT 246
Query: 899 ---VRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE- 954
+ L G + P + V L C + P RP +++ L
Sbjct: 247 CAELYEKLPQGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297
Query: 955 LIQSP 959
+++
Sbjct: 298 MLEER 302
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 62/297 (20%), Positives = 107/297 (36%), Gaps = 50/297 (16%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALEGY 747
L GGF VY + GR A+K+L + + +E+ + K+ H N+V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEE-EKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 748 YW-------TPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
T + L+ + G L + L SR LS I + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 801 --TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG--------- 849
IIH +LK N+L+ + G K+ DFG A + S++ ++ +
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 850 -YMAPE-FACRTVK-ITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG 906
Y PE + I EK D++ G ++ + + P E
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE-------------------- 254
Query: 907 RVEDCVDARLRGNF--PADEAIPVIKLGLI--CASQVPSNRPDMEEVVNILELIQSP 959
+ + G + P + + LI P R + EVV+ L+ I +
Sbjct: 255 --DGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 47/207 (22%), Positives = 89/207 (42%), Gaps = 11/207 (5%)
Query: 688 CELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEG 746
+G G VV VAIK++ + S ++ KE++ + + H N+V+
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN------IILGMAKGLAYLHH 800
+ L+ + +S GS+ + + I+ + +GL YLH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVL-DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFAC 857
IH ++K+ N+L+ G ++ DFG++ L + ++ +G +MAPE
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 858 RTVKITEKCDVYGFGVLVLEVVTGKRP 884
+ K D++ FG+ +E+ TG P
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 690 LGRGGFGVVY--RTILQDGRSVAIKKLTVSGLIKS--QEDFEKEMKTLGKIRHHNLVALE 745
LG+G FG VY R Q+ +A+K L S L K + +E++ +RH N++ +
Sbjct: 22 LGKGKFGNVYLAREK-QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
Y+ L+ EF G LYK L ++ + +A L Y H +IH
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCHERKVIH 137
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKI 862
++K N+L+ GE K+ DFG + P S + ++ G Y+ PE
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSVHAP-------SLRRRTMCGTLDYLPPEMIEGK-TH 189
Query: 863 TEKCDVYGFGVLVLEVVTGKRP 884
EK D++ GVL E + G P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-26
Identities = 44/206 (21%), Positives = 80/206 (38%), Gaps = 18/206 (8%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALEGY 747
LG G G + + D R VA+K++ L + ++E++ L + H N++
Sbjct: 31 VLGHGAEGTIVYRGMFDNRDVAVKRI----LPECFSFADREVQLLRESDEHPNVIRYFCT 86
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
Q + E + +L +++ + ++ GLA+LH NI+H +
Sbjct: 87 EKDRQFQYIAIELCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHSLNIVHRD 143
Query: 808 LKSTNVLIDSSGE-----PKVGDFGLARLL--PMLDRCILSSKIQSALGYMAPE--FACR 858
LK N+LI + DFGL + L S + G++APE
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE-GWIAPEMLSEDC 202
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRP 884
T D++ G + V++
Sbjct: 203 KENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 34/238 (14%), Positives = 69/238 (28%), Gaps = 49/238 (20%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIK-----KLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
LG+ T + G S + + S IK ++ ++ L I++
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRN-------------------------- 777
+ + P + + + D +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 778 -CLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836
L R + L + + LA LHH ++H L+ ++++D G + F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV 260
Query: 837 RCILSSKIQSALGYMAPEF----------ACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
+S G+ PE R +T D + G+++ + P
Sbjct: 261 VSSVS------RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 49/224 (21%), Positives = 92/224 (41%), Gaps = 40/224 (17%)
Query: 690 LGRGGFGVVYRTIL--QDGRSVAIKKLTVSGLIKSQ----------------EDFEKEMK 731
L +G F + L +D + A+KK S L K + +DF+ E++
Sbjct: 39 LNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 732 TLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF------ 785
+ I++ + EG +IYE++ + S+ K ++
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY-FFVLDKNYTCFIPIQVIK 154
Query: 786 NIILGMAKGLAYLH-HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI 844
II + +Y+H NI H ++K +N+L+D +G K+ DFG + + KI
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV-------DKKI 207
Query: 845 QSALG---YMAPE-FACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
+ + G +M PE F+ + K D++ G+ + + P
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKS--QEDFEKEMKTLGKIRHHNLVALEG 746
LG+G F VYR + G VAIK + + K+ + + E+K +++H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
Y+ + L+ E +G + ++L + S + + + + G+ YLH I+H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQIITGMLYLHSHGILHR 136
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKIT 863
+L +N+L+ + K+ DFGLA L M K + G Y++PE A R+
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPH-----EKHYTLCGTPNYISPEIATRS-AHG 190
Query: 864 EKCDVYGFGVLVLEVVTGKRP 884
+ DV+ G + ++ G+ P
Sbjct: 191 LESDVWSLGCMFYTLLIGRPP 211
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 43/228 (18%), Positives = 89/228 (39%), Gaps = 41/228 (17%)
Query: 686 KDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHH-NLV 742
+ ++G G FG V++ + DG AIK+ +++ +E+ + H ++V
Sbjct: 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 743 ALEGYY--WTPSLQLLIY-EFISSGSLYKHL-HDGSSRNCLSWRQRFNIILGMAKGLAYL 798
Y+ W +LI E+ + GSL + + + + +++L + +GL Y+
Sbjct: 75 ---RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 799 HHTNIIHYNLKSTNVLIDSSGEP-------------------KVGDFGLARLLPMLDRCI 839
H +++H ++K +N+ I + P K+GD G +
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI------- 184
Query: 840 LSSKIQSALG---YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
S Q G ++A E K D++ + V+ +
Sbjct: 185 --SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 688 CELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEG 746
++G+G FG V++ I + + VAIK + + ED ++E+ L + + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 747 -YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
Y L +++ E++ GS L G L Q I+ + KGL YLH IH
Sbjct: 88 SYLKDTKLWIIM-EYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKKIH 142
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKI 862
++K+ NVL+ GE K+ DFG+A L K + +G +MAPE +
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTD-----TQIKRNTFVGTPFWMAPEVI-KQSAY 196
Query: 863 TEKCDVYGFGVLVLEVVTGKRP 884
K D++ G+ +E+ G+ P
Sbjct: 197 DSKADIWSLGITAIELARGEPP 218
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-25
Identities = 45/223 (20%), Positives = 83/223 (37%), Gaps = 33/223 (14%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALEGY 747
LG G G V GR VA+K++ LI + E+K L + H N++
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRM----LIDFCDIALMEIKLLTESDDHPNVIRYYCS 77
Query: 748 YWTPSLQLLIYEFISSGSLY----KHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
T + E + +L + +++ +A G+A+LH I
Sbjct: 78 ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKI 136
Query: 804 IHYNLKSTNVLIDSSGEP-------------KVGDFGLARLLPMLDRCILSSKIQSALG- 849
IH +LK N+L+ +S + DFGL + L + + + + G
Sbjct: 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS-GQSSFRTNLNNPSGT 195
Query: 850 --YMAPE------FACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
+ APE ++T D++ G + +++ +
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 64/289 (22%), Positives = 109/289 (37%), Gaps = 41/289 (14%)
Query: 263 SCS--SLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMN 320
SCS + T VP I ++ L+L N+ L L +L++S N
Sbjct: 6 SCSGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN 62
Query: 321 QFTGGLPESMMNCG--NLLAIDVSQNKLTGNIPTWIFKMG-LQTVSLSGNRLGESMQYPS 377
+ S + G +L +D+S N + + + + L+ + + L + ++
Sbjct: 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 121
Query: 378 FASMKDSYQGLQVLDLSSNALSGVIPSNI-GDLSSLMLLNMSMNYLFGSIPASI-GKLKA 435
F S++ L LD+S V + I LSSL +L M+ N + I +L+
Sbjct: 122 FLSLR----NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176
Query: 436 IQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLT 495
+ LD S L + P + L SSL L +S NN
Sbjct: 177 LTFLDLSQCQLE-QLSPT-----AFNSL------------------SSLQVLNMSHNNFF 212
Query: 496 GPVPAAIANLSNLKYVDLSFNDLSGILPKELINL-SHLLSFNISHNHLH 543
L++L+ +D S N + +EL + S L N++ N
Sbjct: 213 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 52/259 (20%), Positives = 88/259 (33%), Gaps = 35/259 (13%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGL-IPDEFFRQCGSLREVSFANNN 153
L L +N + L + S N LS + SL+ + + N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 154 LTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLEGEIVKGI- 210
+ + + LE ++F + L Q+ F LR+L LD+S+ GI
Sbjct: 90 VIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIF 146
Query: 211 SNLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSL 269
+ L L +K+ N F DI L LD L L
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE----------------QL 190
Query: 270 KGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPES 329
+F L++L+ L++S N F L L+ L+ S+N +
Sbjct: 191 SPTAFNS--------LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241
Query: 330 MMN--CGNLLAIDVSQNKL 346
+ +L ++++QN
Sbjct: 242 ELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 59/242 (24%), Positives = 92/242 (38%), Gaps = 17/242 (7%)
Query: 335 NLLAIDVSQNKLTGNIPTWIFKM--GLQTVSLSGNRLGE-SMQYPSFASMKDSYQGLQVL 391
+ +++ NKL ++P +F L +SLS N L S L+ L
Sbjct: 29 SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS----LKYL 83
Query: 392 DLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNWLNGTI 450
DLS N + + SN L L L+ + L S+ L+ + LD S
Sbjct: 84 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VA 141
Query: 451 PPQI-GGAVSLKELKLEKNFLSGRIPSQI-KNCSSLTSLILSQNNLTGPVPAAIANLSNL 508
I G SL+ LK+ N I +LT L LSQ L P A +LS+L
Sbjct: 142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 201
Query: 509 KYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSV---SGNPS 565
+ +++S N+ + L+ L + S NH+ + S + + N
Sbjct: 202 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
Query: 566 LC 567
C
Sbjct: 261 AC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 54/258 (20%), Positives = 87/258 (33%), Gaps = 15/258 (5%)
Query: 120 QVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLS 179
+ + L+ +P S + +N L + L ++ SSN LS
Sbjct: 10 TEIRCNSKGLTS-VPTGIPS---SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 180 GQ-LPYGIWF-LRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDI-GG 236
+ F SL+ LDLS N + + L L + + +
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 124
Query: 237 CSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWI-GKLANLESLDLSL 295
L LD + L+S L + GNSF I +L NL LDLS
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 296 NQFSGRIPSSI-GNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWI 354
Q ++ + +L L+ LN+S N F +L +D S N +
Sbjct: 185 CQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQE 242
Query: 355 FK---MGLQTVSLSGNRL 369
+ L ++L+ N
Sbjct: 243 LQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 53/239 (22%), Positives = 84/239 (35%), Gaps = 31/239 (12%)
Query: 89 LLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVS 148
+L L LSLS+N + + SL+ +
Sbjct: 48 FDKLTQLTKLSLSSNGLS-----------------------FKGCCSQSDFGTTSLKYLD 84
Query: 149 FANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLEGEI 206
+ N + + + LE ++F + L Q+ F LR+L LD+S+
Sbjct: 85 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VA 141
Query: 207 VKGI-SNLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLNSC 264
GI + L L +K+ N F DI L LD L P + L+S
Sbjct: 142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 201
Query: 265 SSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLV-FLKELNISMNQF 322
L++ N+F L +L+ LD SLN + + L LN++ N F
Sbjct: 202 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 60/271 (22%), Positives = 92/271 (33%), Gaps = 39/271 (14%)
Query: 67 KTKRVVGLTLDGFSLSGHIGRGLLRL---QFLQVLSLSNNNFTGTINADLASFGTLQVVD 123
K+ + LT+ + I G LR+ LQ L+L N TGT L +
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 124 FSENNLSGLIPDEFFRQCG-----SLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRL 178
+ N+S D + + L+ +S A + E + +L +++ S N
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185
Query: 179 SGQLPYGIWF----LRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDI 234
G+ +LQ L L N + SG
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGM---------------------ETPSGVCSALA 224
Query: 235 GGCSMLKVLDFGVNSLSGSLPDSLQRLNSC-SSLSLKGNSFTGEVPDWIGKLANLESLDL 293
L+ LD NSL + S +SL+L +VP + A L LDL
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDL 281
Query: 294 SLNQFSGRIPSSIGNLVFLKELNISMNQFTG 324
S N+ R P S L + L++ N F
Sbjct: 282 SYNRLD-RNP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 4e-22
Identities = 51/280 (18%), Positives = 93/280 (33%), Gaps = 21/280 (7%)
Query: 280 DWIGKLANLESLDLSLNQFSGRIP-SSIGNLVFLKELNISMNQFTGGLPESM---MNCGN 335
+ G +LE L ++ + + I + LK L + + + +
Sbjct: 37 ELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG 96
Query: 336 LLAIDVSQNKLTGNIPTWIFKM---GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLD 392
L + + ++TG P + + L ++L + + + GL+VL
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLA-ELQQWLKPGLKVLS 155
Query: 393 LSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIP----ASIGKLKAIQVLDFSDNWLN- 447
++ + +L L++S N G K +QVL + +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 448 --GTIPPQIGGAVSLKELKLEKNFLSGRIPSQI-KNCSSLTSLILSQNNLTGPVPAAIAN 504
G V L+ L L N L + S L SL LS L VP +
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL-- 272
Query: 505 LSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHG 544
+ L +DLS+N L L + + ++ N
Sbjct: 273 PAKLSVLDLSYNRLDRNPS--PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 57/303 (18%), Positives = 93/303 (30%), Gaps = 43/303 (14%)
Query: 232 EDIGGCSMLKVLDFGVNSLSGSLPDS-LQRLNSCSSLSLKGNSFTGEVPDWIGKLAN--- 287
E GG L+ L V++ + + + + S L+++ + ++
Sbjct: 37 ELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG 96
Query: 288 LESLDLSLNQFSGRIPSSIGNLVF--LKELNISMNQFTGGLPESMMNCGNLLAIDVSQNK 345
L+ L L + +G P + L LN+ +
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWL---------------- 140
Query: 346 LTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSG----- 400
+ W+ K GL+ +S++ + L LDLS N G
Sbjct: 141 --AELQQWL-KPGLKVLSIAQAHS-LNFSCEQVRVFPA----LSTLDLSDNPELGERGLI 192
Query: 401 --VIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQI-GGA 457
+ P L L L N M G A +Q LD S N L
Sbjct: 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252
Query: 458 VSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFND 517
L L L L ++P + + L+ L LS N L P+ L + + L N
Sbjct: 253 SQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNP 307
Query: 518 LSG 520
Sbjct: 308 FLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 64/356 (17%), Positives = 108/356 (30%), Gaps = 71/356 (19%)
Query: 153 NLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISN 212
N + P P+ S + L + + L Y L + + I
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEY---------LLKRVDTEADLGQFTDIIK 66
Query: 213 LYDLRAIKLGKNKFSGQLPED---IGGCSMLKVLDFGVNSLSGSLPDSLQRL--NSCSSL 267
L+ + + + ++ + G S L+ L ++G+ P L + L
Sbjct: 67 SLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126
Query: 268 SLKGNSFTGEVPDWIGKL-----ANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQF 322
+L+ S+ W+ +L L+ L ++ + L L++S N
Sbjct: 127 NLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185
Query: 323 TGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMK 382
G C LQ ++L + E+ A
Sbjct: 186 LGERGLISALCPLKFP-------------------TLQVLALRNAGM-ETPSGVCSALAA 225
Query: 383 DSYQGLQVLDLSSNALSGVIPSNIGD-LSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDF 441
Q LQ LDLS N+L + D S L LN+S L +P + + VLD
Sbjct: 226 ARVQ-LQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGL--PAKLSVLDL 281
Query: 442 SDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGP 497
S N L+ R PS + + +L L N
Sbjct: 282 SYNRLD-------------------------RNPSPDE-LPQVGNLSLKGNPFLDS 311
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 15/201 (7%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKS--QEDFEKEMKTLGKIRHHNLVALEG 746
LG+GGF + + A K + S L+K +E E+ + H ++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
++ ++ E SL + R L+ + + + G YLH +IH
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 139
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKIT 863
+LK N+ ++ E K+GDFGLA + + + G Y+APE + +
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYDG-----ERKKVLCGTPNYIAPEVLSKK-GHS 193
Query: 864 EKCDVYGFGVLVLEVVTGKRP 884
+ DV+ G ++ ++ GK P
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPP 214
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKS-QEDFEKEMKTLGKIRHHNLVALEG 746
+LG G +G V AIK + + + S +E+ L + H N++ L
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
++ L+ E G L+ + R + II + G+ YLH NI+H
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEI---IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHR 160
Query: 807 NLKSTNVLIDSSGE---PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
+LK N+L++S + K+ DFGL+ + ++ + ++ +A Y+APE + K
Sbjct: 161 DLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERLGTA-YYIAPEVLRK--KYD 215
Query: 864 EKCDVYGFGVLVLEVVTGKRP 884
EKCDV+ GV++ ++ G P
Sbjct: 216 EKCDVWSIGVILFILLAGYPP 236
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 49/202 (24%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKS--QEDFEKEMKTLGKIRHHNLVALEG 746
LG+GGF + + A K + S L+K +E E+ + H ++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLS-WRQRFNIILGMAKGLAYLHHTNIIH 805
++ ++ E SL + R L+ R+ + + G YLH +IH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARY-YLRQIVLGCQYLHRNRVIH 164
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKI 862
+LK N+ ++ E K+GDFGLA + + + G Y+APE +
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-----ERKKVLCGTPNYIAPEVLSKK-GH 218
Query: 863 TEKCDVYGFGVLVLEVVTGKRP 884
+ + DV+ G ++ ++ GK P
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPP 240
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 681 NALLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE---KEMKTLGKI 736
LL+ ++G G G+V GR VA+K + ++ Q+ E E+ +
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD----LRKQQRRELLFNEVVIMRDY 99
Query: 737 RHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLA 796
+H N+V + Y ++ EF+ G+L D S+ L+ Q + + + LA
Sbjct: 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALA 155
Query: 797 YLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGL-ARLLPMLDRCILSSKIQSALG---YMA 852
YLH +IH ++KS ++L+ G K+ DFG A++ + K +S +G +MA
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------PKRKSLVGTPYWMA 209
Query: 853 PEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
PE R+ + D++ G++V+E+V G+ P
Sbjct: 210 PEVISRS-LYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-24
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKS--QEDFEKEMKTLGKIRHHNLVALE 745
LG+G FG V G+ A+K ++ + + +E +E++ L ++ H N++ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
++ L+ E + G L+ + SR S II + G+ Y+H I+H
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGITYMHKNKIVH 149
Query: 806 YNLKSTNVLIDSSGE---PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKI 862
+LK N+L++S + ++ DFGL+ + KI +A Y+APE
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKIGTA-YYIAPEVLHG--TY 204
Query: 863 TEKCDVYGFGVLVLEVVTGKRP 884
EKCDV+ GV++ +++G P
Sbjct: 205 DEKCDVWSTGVILYILLSGCPP 226
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 75/302 (24%), Positives = 125/302 (41%), Gaps = 39/302 (12%)
Query: 689 ELGRGGFGVVYRTILQDGRS--------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH- 739
LG G FG V VA+K L K D EM+ + I H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHL-------------HDGSSRNCLSWRQRFN 786
N++ L G +I E+ S G+L ++L + ++++ +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 787 IILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQS 846
+A+G+ YL IH +L + NVL+ + K+ DFGLAR + +D ++ +
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 847 ALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALED 905
+ +MAPE A T + DV+ FGVL+ E+ T G P + + + L++
Sbjct: 222 PVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLKE 274
Query: 906 GRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEE 965
G D PA+ + + C VPS RP +++V L+ I + +E
Sbjct: 275 GHRMDK---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEY 325
Query: 966 LE 967
L+
Sbjct: 326 LD 327
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 686 KDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE---KEMKTLGKIRHHNL 741
ELG G FG VY+ + G A K + KS+E+ E E++ L H +
Sbjct: 23 IVGELGDGAFGKVYKAKNKETGALAAAKVIE----TKSEEELEDYIVEIEILATCDHPYI 78
Query: 742 VALEG-YYWTPSLQLLIYEFISSGS---LYKHLHDGSSRNCLSWRQRFNIILGMAKGLAY 797
V L G YY L ++I EF G+ + L L+ Q + M + L +
Sbjct: 79 VKLLGAYYHDGKLWIMI-EFCPGGAVDAIMLEL-----DRGLTEPQIQVVCRQMLEALNF 132
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFGL-ARLLPMLDRCILSSKIQSALG---YMAP 853
LH IIH +LK+ NVL+ G+ ++ DFG+ A+ L L K S +G +MAP
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL------QKRDSFIGTPYWMAP 186
Query: 854 E-FACRTVKIT---EKCDVYGFGVLVLEVVTGKRP 884
E C T+K T K D++ G+ ++E+ + P
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 52/212 (24%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 681 NALLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE---KEMKTLGKI 736
+ ++G+G G VY + + G+ VAI+++ + + Q E E+ + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMREN 74
Query: 737 RHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLA 796
++ N+V Y ++ E+++ GSL D + C+ Q + + L
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALE 130
Query: 797 YLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGL-ARLLPMLDRCILSSKIQSALG---YMA 852
+LH +IH ++KS N+L+ G K+ DFG A++ P SK + +G +MA
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------SKRSTMVGTPYWMA 184
Query: 853 PEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
PE R K D++ G++ +E++ G+ P
Sbjct: 185 PEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 686 KDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVA 743
+G G +G VY+ ++ G+ AIK + V+G +E+ ++E+ L K HH N+
Sbjct: 28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIAT 85
Query: 744 LEGYYWTPSLQL------LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAY 797
G + + L+ EF +GS+ L + N L I + +GL++
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE 854
LH +IH ++K NVL+ + E K+ DFG++ L + + +G +MAPE
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-----TVGRRNTFIGTPYWMAPE 199
Query: 855 -FACRTVKIT---EKCDVYGFGVLVLEVVTGKRP 884
AC K D++ G+ +E+ G P
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 17/196 (8%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIK-----KLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG G F +V + G A K + S S+E+ E+E+ L ++ HHN++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
L Y + +LI E +S G L+ L + LS + + I + G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 803 IIHYNLKSTNVLIDSSGEP----KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR 858
I H++LK N+++ P K+ DFGLA + D + + ++APE
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTP-EFVAPEIVNY 192
Query: 859 TVKITEKCDVYGFGVL 874
+ + D++ GV+
Sbjct: 193 E-PLGLEADMWSIGVI 207
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 55/190 (28%), Positives = 90/190 (47%), Gaps = 10/190 (5%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
ELG G FGVV+R G + A K + +E KE++T+ +RH LV L
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+ + ++IYEF+S G L++ + D N +S + + + KGL ++H N +H +
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLD 280
Query: 808 LKSTNVLIDSSGEP--KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
LK N++ + K+ DFGL L + + +A + APE A +
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVKVTTGTA-EFAAPEVAEGKP-VGYY 336
Query: 866 CDVYGFGVLV 875
D++ GVL
Sbjct: 337 TDMWSVGVLS 346
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 58/258 (22%), Positives = 101/258 (39%), Gaps = 16/258 (6%)
Query: 116 FGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSS 175
V + LS +P + R ++ NN+ ++ LE +
Sbjct: 53 SNQFSKVVCTRRGLSE-VPQGIPS---NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGR 108
Query: 176 NRLSGQLPYGI-WFLRSLQSLDLSNNLLEGEIVKGI-SNLYDLRAIKLGKNKFSGQLPED 233
N + Q+ G L SL +L+L +N L I G L LR + L N +P
Sbjct: 109 NSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165
Query: 234 I-GGCSMLKVLDFG-VNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESL 291
L LD G + L + + L + L+L + ++P+ L LE L
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTP-LVGLEEL 223
Query: 292 DLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIP 351
++S N F P S L LK+L + +Q + + +L+ ++++ N L+ ++P
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLP 282
Query: 352 TWIFKM--GLQTVSLSGN 367
+F L + L N
Sbjct: 283 HDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-23
Identities = 49/260 (18%), Positives = 97/260 (37%), Gaps = 14/260 (5%)
Query: 287 NLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKL 346
+ + S +P I + LN+ N ++ + +L + + +N +
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 347 TGNIPTWIFK--MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPS 404
I F L T+ L N L + +F + L+ L L +N + +
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWL-TVIPSGAFEYL----SKLRELWLRNNPIESIPSY 165
Query: 405 NIGDLSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKEL 463
+ SLM L++ I L ++ L+ + P + V L+EL
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI--KDMPNLTPLVGLEEL 223
Query: 464 KLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILP 523
++ N P SSL L + + ++ A L++L ++L+ N+LS +
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPH 283
Query: 524 KELINLSHLLSFNISHNHLH 543
L +L+ ++ HN +
Sbjct: 284 DLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 52/231 (22%), Positives = 90/231 (38%), Gaps = 8/231 (3%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+ L+L NN L+V+ N++ I F SL + +N L
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWL 135
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIW-FLRSLQSLDLS-NNLLEGEIVKGI-S 211
T + + S L + +N + +P + + SL LDL LE I +G
Sbjct: 136 TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFE 193
Query: 212 NLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKG 271
L++L+ + LG +P ++ L+ L+ N P S L+S L +
Sbjct: 194 GLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251
Query: 272 NSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQF 322
+ + + LA+L L+L+ N S L +L EL++ N +
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 20/93 (21%), Positives = 38/93 (40%), Gaps = 1/93 (1%)
Query: 459 SLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDL 518
+ + L L +N + ++ L L L +N++ A L++L ++L N L
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135
Query: 519 SGILPKELINLSHLLSFNISHNHLHGELPVGGF 551
+ I LS L + +N + +P F
Sbjct: 136 TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF 167
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 28/130 (21%), Positives = 48/130 (36%), Gaps = 8/130 (6%)
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQI-KNCS 482
+P I + L+ +N + I L+ L+L +N + +I +
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLA 123
Query: 483 SLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISH-NH 541
SL +L L N LT A LS L+ + L N + I + L+ ++
Sbjct: 124 SLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKK 183
Query: 542 LHGELPVGGF 551
L + G F
Sbjct: 184 LE-YISEGAF 192
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIK-----KLTVSGLI-------KSQEDFEKEMKTLGK 735
+LG G +G V AIK + K E+ E+ L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 736 IRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGL 795
+ H N++ L + L+ EF G L++ + +R+ NI+ + G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQILSGI 159
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGE---PKVGDFGLARLLPMLDRCILSSKIQSALGYMA 852
YLH NI+H ++K N+L+++ K+ DFGL+ + L ++ +A Y+A
Sbjct: 160 CYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--LRDRLGTA-YYIA 216
Query: 853 PEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
PE + K EKCDV+ GV++ ++ G P
Sbjct: 217 PEVLKK--KYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 35/207 (16%), Positives = 82/207 (39%), Gaps = 11/207 (5%)
Query: 688 CELGRG--GFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVA 743
+G+G V G V ++++ + + E+ H N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
+ + ++ F++ GS K L + ++ I+ G+ K L Y+HH
Sbjct: 91 YRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY 149
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLL--PMLDRCILSSKIQSALG---YMAPEFACR 858
+H ++K++++LI G+ + + + ++ + ++ +++PE +
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 859 TVKI-TEKCDVYGFGVLVLEVVTGKRP 884
++ K D+Y G+ E+ G P
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVALEG 746
LG+G FG V + + A+K + + K +E++ L K+ H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
S ++ E + G L+ + R S II + G+ Y+H NI+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMHKHNIVHR 145
Query: 807 NLKSTNVLIDSSGE---PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
+LK N+L++S + K+ DFGL+ + +I +A Y+APE
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTA-YYIAPEVLRG--TYD 200
Query: 864 EKCDVYGFGVLVLEVVTGKRP 884
EKCDV+ GV++ +++G P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 10/189 (5%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
ELG G FGVV+R + GR K + + + E+ + ++ H L+ L
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+ +LI EF+S G L+ + + +S + N + +GL ++H +I+H +
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHEHSIVHLD 174
Query: 808 LKSTNVLIDSSGEP--KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
+K N++ ++ K+ DFGLA L I+ +A + APE R +
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATA-EFAAPEIVDRE-PVGFY 230
Query: 866 CDVYGFGVL 874
D++ GVL
Sbjct: 231 TDMWAIGVL 239
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-23
Identities = 76/312 (24%), Positives = 109/312 (34%), Gaps = 65/312 (20%)
Query: 689 ELGRGGFGVVYRTILQD------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNL 741
LGRG FG V R+VA+K L E+K L I H N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 742 VALEG---YYWTPSLQLLIYEFISSGSL-------------YKHLHDGSSRNCLSWRQRF 785
V L G P ++I EF G+L YK + ++ L+
Sbjct: 94 VNLLGACTKPGGP--LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 786 NIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQ 845
+AKG+ +L IH +L + N+L+ K+ DFGLAR I
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR------------DIY 199
Query: 846 SALGY------------MAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDV 892
Y MAPE T + DV+ FGVL+ E+ + G P ++ D
Sbjct: 200 KDPDYVRKGDARLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 893 VVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952
L++G P + + L C PS RP E+V
Sbjct: 259 EFC-----RRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
Query: 953 LELIQSPLDGQE 964
L + Q+
Sbjct: 305 LGNLLQANAQQD 316
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 17/196 (8%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIK-----KLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG G F +V + G+ A K +L+ S S+E+ E+E+ L +IRH N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
L + + +LI E +S G L+ L + + L+ + + + G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR 128
Query: 803 IIHYNLKSTNVLIDSSGEP----KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR 858
I H++LK N+++ P K+ DFG+A + + + ++APE
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--AGNEFKNIFGTP-EFVAPEIVNY 185
Query: 859 TVKITEKCDVYGFGVL 874
+ + D++ GV+
Sbjct: 186 E-PLGLEADMWSIGVI 200
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 67/289 (23%), Positives = 109/289 (37%), Gaps = 38/289 (13%)
Query: 689 ELGRGGFGVVYRTILQDGR------SVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNL 741
LG G FG V +VA+K L S + +E E+K L + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNI-----------ILG 790
V L G L+I E+ G L L S + +L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 791 M----AKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQS 846
AKG+A+L N IH +L + N+L+ K+ DFGLAR + ++ +
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 847 ALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALED 905
+ +MAPE + T + DV+ +G+ + E+ + G P M D +++
Sbjct: 210 PVKWMAPE-SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY-----KMIKE 263
Query: 906 GRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
G P + + C P RP +++V ++E
Sbjct: 264 GFRMLS---------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 51/228 (22%), Positives = 96/228 (42%), Gaps = 25/228 (10%)
Query: 688 CELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGK-IRHHNLVALE 745
ELGRG +GVV + + G+ +A+K++ + + Q+ ++ + + V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 746 GYYWTPSLQLLIYEF--ISSGSLYKHLHDGSSR---NCLSWRQRFNIILGMAKGLAYLHH 800
G + + E S YK + D + L I + + K L +LH
Sbjct: 73 GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG-----KIAVSIVKALEHLHS 127
Query: 801 T-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE-F 855
++IH ++K +NVLI++ G+ K+ DFG++ L + G YMAPE
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDIDAGCKPYMAPERI 181
Query: 856 ACRTVKI--TEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRG 901
+ + K D++ G+ ++E+ + P + L +V
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE 229
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 681 NALLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH 739
+ + +LG G +G VY+ I + G+ VAIK++ V ++ KE+ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSP 84
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
++V G Y+ + ++ E+ +GS+ + L+ + I+ KGL YLH
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGL-ARLLPMLDRCILSSKIQSALG---YMAPEF 855
IH ++K+ N+L+++ G K+ DFG+ +L + +K + +G +MAPE
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM------AKRNTVIGTPFWMAPEV 196
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
D++ G+ +E+ GK P
Sbjct: 197 IQEI-GYNCVADIWSLGITAIEMAEGKPP 224
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 72/322 (22%), Positives = 126/322 (39%), Gaps = 76/322 (23%)
Query: 689 ELGRGGFGVVYRTILQDGRS------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
++G G FG V++ VA+K L Q DF++E + + + N+V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 743 ALEGYYWTPSLQ----LLIYEFISSGSLYKHL---------------------HDGSSRN 777
L G L++E+++ G L + L
Sbjct: 114 KLLGV----CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 778 CLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837
LS ++ I +A G+AYL +H +L + N L+ + K+ DFGL+R
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR------- 222
Query: 838 CILSSKIQSALGY------------MAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRP 884
I SA Y M PE + + T + DV+ +GV++ E+ + G +P
Sbjct: 223 -----NIYSADYYKADGNDAIPIRWMPPE-SIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
Query: 885 VEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRP 944
M + V+ VR DG + C P + + + L +C S++P++RP
Sbjct: 277 YYGMAHEEVI--YYVR----DGNILAC---------PENCPLELYNLMRLCWSKLPADRP 321
Query: 945 DMEEVVNILELIQSPLDGQEEL 966
+ IL+ + +G +
Sbjct: 322 SFCSIHRILQRMCERAEGTVGV 343
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 51/196 (26%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIK-----KLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG G F VV + G A K + S S+ED E+E+ L +I+H N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
L Y + +LI E ++ G L+ L + + L+ + + + G+ YLH
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 803 IIHYNLKSTNVLIDSSGEP----KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR 858
I H++LK N+++ P K+ DFGLA + + + ++APE
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTP-EFVAPEIVNY 191
Query: 859 TVKITEKCDVYGFGVL 874
+ + D++ GV+
Sbjct: 192 E-PLGLEADMWSIGVI 206
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 54/261 (20%), Positives = 96/261 (36%), Gaps = 16/261 (6%)
Query: 287 NLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKL 346
+ +P I + LN+ NQ S + +L + +S+N +
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 347 TGNIPTWIFK--MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPS 404
I F L T+ L NRL ++ +F + L+ L L +N + +
Sbjct: 101 R-TIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLS----KLKELWLRNNPIESIPSY 154
Query: 405 NIGDLSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKEL 463
+ SL L++ I L ++ L+ + L P + + L EL
Sbjct: 155 AFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL--REIPNLTPLIKLDEL 212
Query: 464 KLEKNFLSGRIPSQI-KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGIL 522
L N LS I + L L + Q+ + A NL +L ++L+ N+L+ +
Sbjct: 213 DLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLP 271
Query: 523 PKELINLSHLLSFNISHNHLH 543
L HL ++ HN +
Sbjct: 272 HDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-22
Identities = 61/258 (23%), Positives = 102/258 (39%), Gaps = 16/258 (6%)
Query: 116 FGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSS 175
V NL +PD + R ++ N + S LE + S
Sbjct: 42 SNQFSKVICVRKNLRE-VPDGIST---NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSR 97
Query: 176 NRLSGQLPYGI-WFLRSLQSLDLSNNLLEGEIVKGI-SNLYDLRAIKLGKNKFSGQLPED 233
N + + G L +L +L+L +N L I G L L+ + L N +P
Sbjct: 98 NHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSY 154
Query: 234 I-GGCSMLKVLD-FGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESL 291
L+ LD + LS + + L++ L+L + E+P+ L L+ L
Sbjct: 155 AFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTP-LIKLDEL 212
Query: 292 DLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIP 351
DLS N S P S L+ L++L + +Q + N +L+ I+++ N LT +P
Sbjct: 213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLP 271
Query: 352 TWIFKM--GLQTVSLSGN 367
+F L+ + L N
Sbjct: 272 HDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-19
Identities = 55/254 (21%), Positives = 102/254 (40%), Gaps = 13/254 (5%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+ N + + ++++ EN + I F+ L + + N++
Sbjct: 45 FSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQI-IKVNSFKHLRHLEILQLSRNHI 100
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLEGEIVKGI-S 211
+ + ++L ++ NRL+ +P G F L L+ L L NN +E I +
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT-TIPNG-AFVYLSKLKELWLRNNPIE-SIPSYAFN 157
Query: 212 NLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLK 270
+ LR + LG+ K + E G S L+ L+ + +L +P+ L L L L
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLS 215
Query: 271 GNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESM 330
GN + P L +L+ L + +Q ++ NL L E+N++ N T +
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLF 275
Query: 331 MNCGNLLAIDVSQN 344
+L I + N
Sbjct: 276 TPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 4e-15
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 10/210 (4%)
Query: 91 RLQFLQVLSLSNNNFTGTINAD-LASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSF 149
L+ L++L LS N+ TI L ++ +N L+ IP+ F L+E+
Sbjct: 86 HLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWL 143
Query: 150 ANNNLTGPIPESLSFCSSLESVNFSS-NRLSGQLPYGIWF--LRSLQSLDLSNNLLEGEI 206
NN + + + SL ++ RLS + G F L +L+ L+L+ L
Sbjct: 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLS-YISEGA-FEGLSNLRYLNLAMCNLRE-- 199
Query: 207 VKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSS 266
+ ++ L L + L N S P G L+ L + + ++ L S
Sbjct: 200 IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVE 259
Query: 267 LSLKGNSFTGEVPDWIGKLANLESLDLSLN 296
++L N+ T D L +LE + L N
Sbjct: 260 INLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 7e-14
Identities = 42/186 (22%), Positives = 68/186 (36%), Gaps = 8/186 (4%)
Query: 92 LQFLQVLSLSNNNFTGTINAD-LASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFA 150
L L L L +N T TI L+ + N + IP F + SLR +
Sbjct: 111 LANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLG 168
Query: 151 NNNLTGPIPE-SLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKG 209
I E + S+L +N + L ++P + L L LDLS N L I G
Sbjct: 169 ELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPG 225
Query: 210 I-SNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLS 268
L L+ + + +++ L ++ N+L+ D L+ +
Sbjct: 226 SFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIH 285
Query: 269 LKGNSF 274
L N +
Sbjct: 286 LHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 25/103 (24%), Positives = 45/103 (43%), Gaps = 3/103 (2%)
Query: 449 TIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNL 508
+P I + + + L L +N + + K+ L L LS+N++ A L+NL
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 509 KYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGF 551
++L N L+ I + LS L + +N + +P F
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF 156
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 28/132 (21%), Positives = 47/132 (35%), Gaps = 8/132 (6%)
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPP-QIGGAVSLKELKLEKNFLSGRIPSQI-KNCS 482
+P I ++L+ +N + I L+ L+L +N + I +
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLA 112
Query: 483 SLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISH-NH 541
+L +L L N LT A LS LK + L N + I + L ++
Sbjct: 113 NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR 172
Query: 542 LHGELPVGGFFN 553
L + G F
Sbjct: 173 LS-YISEGAFEG 183
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 1/88 (1%)
Query: 89 LLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVS 148
L L L L LS N+ + LQ + ++ + I F SL E++
Sbjct: 203 LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEIN 261
Query: 149 FANNNLTGPIPESLSFCSSLESVNFSSN 176
A+NNLT + + LE ++ N
Sbjct: 262 LAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 48/198 (24%), Positives = 94/198 (47%), Gaps = 18/198 (9%)
Query: 684 LNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
++K LG G FG V++ G +A K + G+ K +E+ + E+ + ++ H NL+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLI 149
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNC-LSWRQRFNIILGMAKGLAYLHHT 801
L + + + +L+ E++ G L+ + D + L+ + + +G+ ++H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 802 NIIHYNLKSTNVLIDSSGEP--KVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFA 856
I+H +LK N+L + K+ DFGLAR R K++ G ++APE
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLAR------RYKPREKLKVNFGTPEFLAPEVV 260
Query: 857 CRTVKITEKCDVYGFGVL 874
++ D++ GV+
Sbjct: 261 NYDF-VSFPTDMWSVGVI 277
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQE--DFEKEMKTLGKIRHHNLVALE 745
E+G G FG VY +++ VAIKK++ SG +++ D KE++ L K+RH N +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
G Y L+ E+ GS L + L + + G +GLAYLH N+IH
Sbjct: 121 GCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKI 862
++K+ N+L+ G K+GDFG A ++ + S +G +MAPE +
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIM---------APANSFVGTPYWMAPEVILAMDEG 228
Query: 863 T--EKCDVYGFGVLVLEVVTGKRP 884
K DV+ G+ +E+ K P
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPP 252
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 54/238 (22%), Positives = 96/238 (40%), Gaps = 15/238 (6%)
Query: 335 NLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLS 394
+ Q L +P I Q + L GNR+ + SF + + L +L L
Sbjct: 12 PKVTTSCPQQGLQ-AVPVGIPA-ASQRIFLHGNRI-SHVPAASFRACR----NLTILWLH 64
Query: 395 SNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNWLNGTIPPQ 453
SN L+ + + L+ L L++S N S+ + L + L L + P
Sbjct: 65 SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPG 123
Query: 454 I-GGAVSLKELKLEKNFLSGRIPSQI-KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYV 511
+ G +L+ L L+ N L +P ++ +LT L L N ++ A L +L +
Sbjct: 124 LFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 512 DLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSV--SGNPSLC 567
L N ++ + P +L L++ + N+L LP + + + NP +C
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 48/222 (21%), Positives = 78/222 (35%), Gaps = 11/222 (4%)
Query: 151 NNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGI 210
L +P + ++ + + NR+S R+L L L +N+L I
Sbjct: 20 QQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAA 75
Query: 211 -SNLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLP-DSLQRLNSCSSL 267
+ L L + L N + G L L L L + L + L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134
Query: 268 SLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLP 327
L+ N+ D L NL L L N+ S + L L L + N+ P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 328 ESMMNCGNLLAIDVSQNKLTGNIPTWIFKM--GLQTVSLSGN 367
+ + G L+ + + N L+ +PT LQ + L+ N
Sbjct: 195 HAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 49/233 (21%), Positives = 79/233 (33%), Gaps = 34/233 (14%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNN- 153
Q + L N + A + L ++ N L+ I F L ++ ++N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92
Query: 154 LTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLEGEIVKGIS 211
L P + L +++ L +L G F L +LQ L L +N L+
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPG-LFRGLAALQYLYLQDNALQ-------- 142
Query: 212 NLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLK 270
LP+D L L N +S + + L+S L L
Sbjct: 143 -----------------ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 271 GNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSI-GNLVFLKELNISMNQF 322
N P L L +L L N S +P+ L L+ L ++ N +
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 39/130 (30%), Positives = 55/130 (42%), Gaps = 7/130 (5%)
Query: 74 LTLDGFSLSGHIGRGLLR-LQFLQVLSLSNNNFTGTINAD-LASFGTLQVVDFSENNLSG 131
L LD L +G GL R L LQ L L +N + D G L + N +S
Sbjct: 110 LHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS 167
Query: 132 LIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF-LR 190
+P+ FR SL + N + P + L ++ +N LS LP LR
Sbjct: 168 -VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLR 225
Query: 191 SLQSLDLSNN 200
+LQ L L++N
Sbjct: 226 ALQYLRLNDN 235
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-22
Identities = 77/301 (25%), Positives = 121/301 (40%), Gaps = 43/301 (14%)
Query: 689 ELGRGGFGVVYRTILQDGRS--------VAIKKLTVSGLIKSQEDFEKE---MKTLGKIR 737
LG G FG V VA+K L K D E MK +G +
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG--K 133
Query: 738 HHNLVALEGYYWTPSLQLLIYEFISSGSL-------------YKHLHDGSSRNCLSWRQR 784
H N++ L G +I E+ S G+L Y + + LS +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 785 FNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKI 844
+ +A+G+ YL IH +L + NVL+ K+ DFGLAR + +D ++
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 845 QSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGAL 903
+ + +MAPE A T + DV+ FGVL+ E+ T G P + + + L
Sbjct: 254 RLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL------L 306
Query: 904 EDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQ 963
++G D P++ + + C VPS RP +++V L+ I + Q
Sbjct: 307 KEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357
Query: 964 E 964
E
Sbjct: 358 E 358
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 17/196 (8%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIK-----KLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG G F +V + G A K + S +E+ E+E+ L ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
L Y + +LI E +S G L+ L + LS + + I + G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 803 IIHYNLKSTNVLIDSSGEP----KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR 858
I H++LK N+++ P K+ DFGLA + D + + ++APE
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTP-EFVAPEIVNY 192
Query: 859 TVKITEKCDVYGFGVL 874
+ + D++ GV+
Sbjct: 193 E-PLGLEADMWSIGVI 207
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 49/195 (25%), Positives = 87/195 (44%), Gaps = 12/195 (6%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKS----QEDFEKEMKTLGKIRHHNLVA 743
+G+G F VV R + G+ A+K + V+ S ED ++E ++H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHD-GSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
L Y + + +++EF+ L + + S + + + + L Y H N
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 803 IIHYNLKSTNVLIDSSGEP---KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRT 859
IIH ++K VL+ S K+G FG+A L + ++ + +MAPE R
Sbjct: 151 IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRVGTP-HFMAPEVVKRE 208
Query: 860 VKITEKCDVYGFGVL 874
+ DV+G GV+
Sbjct: 209 P-YGKPVDVWGCGVI 222
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 50/190 (26%), Positives = 80/190 (42%), Gaps = 10/190 (5%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+LG G FG V+ G IK + E E E++ L + H N++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 748 YWTPSLQLLIYEFISSGSLY-KHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ ++ E G L + + + LS ++ M LAY H +++H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148
Query: 807 NLKSTNVLIDSSGE---PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
+LK N+L + K+ DFGLA L ++ +A YMAPE R +T
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAAGTA-LYMAPEVFKR--DVT 203
Query: 864 EKCDVYGFGV 873
KCD++ GV
Sbjct: 204 FKCDIWSAGV 213
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 13/190 (6%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALEG 746
LG+G FG V + + A+K + + +E++ L K+ H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
S ++ E + G L+ + R S II + G+ Y+H NI+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMHKHNIVHR 145
Query: 807 NLKSTNVLIDSSGE---PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
+LK N+L++S + K+ DFGL+ + +I +A Y+APE
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTA-YYIAPEVLRG--TYD 200
Query: 864 EKCDVYGFGV 873
EKCDV+ GV
Sbjct: 201 EKCDVWSAGV 210
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 6e-22
Identities = 56/308 (18%), Positives = 110/308 (35%), Gaps = 24/308 (7%)
Query: 249 SLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGN 308
S S + + S +P + ++SLDLS N+ + S +
Sbjct: 18 SKEESSNQASLSCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQR 74
Query: 309 LVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM--GLQTVSLSG 366
V L+ L ++ N +S + G+L +D+S N L+ N+ + FK L ++L G
Sbjct: 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLG 133
Query: 367 NRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNI-GDLSSLMLLNMSMNYLFGS 425
N + F+ + LQ+L + + I L+ L L + + L S
Sbjct: 134 NPYKTLGETSLFSHLTK----LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL-QS 188
Query: 426 IPA-SIGKLKAIQVLDFSDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQI----- 478
S+ ++ + L + S++ L+L L S++
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET 247
Query: 479 ---KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSF 535
+ ++ ++ +L V + +S L ++ S N L + L+ L
Sbjct: 248 NSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKI 306
Query: 536 NISHNHLH 543
+ N
Sbjct: 307 WLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 3e-21
Identities = 59/287 (20%), Positives = 109/287 (37%), Gaps = 43/287 (14%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
++ L LSNN T N+DL LQ + + N ++ I ++ F GSL + + N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLEGEIVKGI-S 211
+ L WF L SL L+L N + + S
Sbjct: 113 S-------------------------NLSSS-WFKPLSSLTFLNLLGNPYKTLGETSLFS 146
Query: 212 NLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLK 270
+L L+ +++G ++ G + L+ L+ + L P SL+ + + S L L
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 271 GNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVF--------LKELNISMNQF 322
+ ++ +++E L+L S + + + I+
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266
Query: 323 TGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM--GLQTVSLSGN 367
+ + + LL ++ S+N+L ++P IF LQ + L N
Sbjct: 267 F-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 8e-20
Identities = 57/282 (20%), Positives = 96/282 (34%), Gaps = 29/282 (10%)
Query: 240 LKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFS 299
+K LD N ++ LQR + +L L N D L +LE LDLS N S
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113
Query: 300 GRIPSSI-GNLVFLKELNISMNQFTGGLPESM-MNCGNLLAIDVSQNKLTGNIPTWIFK- 356
+ SS L L LN+ N + S+ + L + V I F
Sbjct: 114 -NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG 172
Query: 357 -MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGD-LSSLML 414
L+ + + + L +S + S S+ Q + L L ++ D SS+
Sbjct: 173 LTFLEELEIDASDL-QSYEPKSLKSI----QNVSHLILHMKQHI-LLLEIFVDVTSSVEC 226
Query: 415 LNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRI 474
L + L + + + + + +K+ L ++
Sbjct: 227 LELRDTDL------DTFHFSELSTGETNSLI----------KKFTFRNVKITDESLF-QV 269
Query: 475 PSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFN 516
+ S L L S+N L L++L+ + L N
Sbjct: 270 MKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 54/296 (18%), Positives = 107/296 (36%), Gaps = 28/296 (9%)
Query: 140 QCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF-LRSLQSLDLS 198
C ++ +L IP L+ +++S++ S+NR++ + +LQ+L L+
Sbjct: 29 SCDRNGICKGSSGSLNS-IPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLT 84
Query: 199 NNLLEGEIVKGI-SNLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPD 256
+N + I + S+L L + L N S L S L L+ N +L +
Sbjct: 85 SNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGE 141
Query: 257 S--LQRLNSCSSLSLKGNSFTGEVPD-WIGKLANLESLDLSLNQFSGRIPSSIGNLVFLK 313
+ L L + ++ L LE L++ + P S+ ++ +
Sbjct: 142 TSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVS 201
Query: 314 ELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIF---------KMGLQTVSL 364
L + M Q L + ++ +++ L + + K + V +
Sbjct: 202 HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 365 SGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMN 420
+ L + + GL L+ S N L V L+SL + + N
Sbjct: 262 TDESL------FQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 44/239 (18%), Positives = 91/239 (38%), Gaps = 19/239 (7%)
Query: 322 FTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASM 381
++ ++C S L +IP+ + + ++++ LS NR+ +
Sbjct: 19 KEESSNQASLSCDRNGICKGSSGSLN-SIPSGLTE-AVKSLDLSNNRI-TYISNSDL--- 72
Query: 382 KDSYQGLQVLDLSSNALSGVIPSNI-GDLSSLMLLNMSMNYLFGSIPASI-GKLKAIQVL 439
LQ L L+SN ++ I + L SL L++S NYL ++ +S L ++ L
Sbjct: 73 -QRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFL 129
Query: 440 DFSDNWLNGTIPPQI--GGAVSLKELKLEKNFLSGRIPSQI-KNCSSLTSLILSQNNLTG 496
+ N T+ L+ L++ +I + + L L + ++L
Sbjct: 130 NLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188
Query: 497 PVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHG----ELPVGGF 551
P ++ ++ N+ ++ L +L + S + + L EL G
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET 247
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 54/247 (21%), Positives = 101/247 (40%), Gaps = 26/247 (10%)
Query: 91 RLQFLQVLSLSNNNFTGTINADL-ASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSF 149
R LQ L L++N TI D +S G+L+ +D S N LS + +F+ SL ++
Sbjct: 74 RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131
Query: 150 ANNNLTGPIPESLSF--CSSLESVNFSSNRLSGQLPYGI-WFLRSLQSLDLSNNLL---E 203
N + E+ F + L+ + + ++ L L+ L++ + L E
Sbjct: 132 LGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYE 190
Query: 204 GEIVKGISNLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSG----SLP--- 255
+ +K I N+ L L + L E S ++ L+ L L
Sbjct: 191 PKSLKSIQNVSHLI---LHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGE 246
Query: 256 -DSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSI-GNLVFLK 313
+SL + + ++ + S +V + +++ L L+ S NQ +P I L L+
Sbjct: 247 TNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQ 304
Query: 314 ELNISMN 320
++ + N
Sbjct: 305 KIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 48/271 (17%), Positives = 94/271 (34%), Gaps = 45/271 (16%)
Query: 290 SLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGN 349
S + IPS + +K L++S N+ T + C NL A+ ++ N +
Sbjct: 35 ICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-T 90
Query: 350 IPTWIFK--MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNI- 406
I F L+ + LS N L ++ F + L L+L N + +++
Sbjct: 91 IEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLS----SLTFLNLLGNPYKTLGETSLF 145
Query: 407 GDLSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKL 465
L+ L +L + F I L ++ L+ + L + P+
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKS----------- 193
Query: 466 EKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKE 525
+K+ +++ LIL + + S+++ ++L DL E
Sbjct: 194 ------------LKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSE 241
Query: 526 L--------INLSHLLSFNISHNHLHGELPV 548
L I + I+ L + +
Sbjct: 242 LSTGETNSLIKKFTFRNVKITDESLFQVMKL 272
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 27/121 (22%), Positives = 49/121 (40%), Gaps = 12/121 (9%)
Query: 89 LLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSG-----LIPDEF--FRQC 141
L +Q + L L + + +++ ++ + +L L E +
Sbjct: 194 LKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253
Query: 142 GSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSN 199
+ R V + +L + + L+ S L + FS N+L +P GI F L SLQ + L
Sbjct: 254 FTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGI-FDRLTSLQKIWLHT 310
Query: 200 N 200
N
Sbjct: 311 N 311
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 6e-22
Identities = 75/311 (24%), Positives = 118/311 (37%), Gaps = 63/311 (20%)
Query: 689 ELGRGGFGVVYRTILQDGRS--------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH- 739
LG G FG V VA+K L K D EM+ + I H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHL-------------HDGSSRNCLSWRQRFN 786
N++ L G +I E+ S G+L ++L + ++++ +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 787 IILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQS 846
+A+G+ YL IH +L + NVL+ + K+ DFGLAR I +
Sbjct: 208 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR------------DINN 255
Query: 847 ALGY------------MAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVV 893
Y MAPE A T + DV+ FGVL+ E+ T G P +
Sbjct: 256 IDYYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 310
Query: 894 VLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNIL 953
+ + L++G D PA+ + + C VPS RP +++V L
Sbjct: 311 --VEELFKLLKEGHRMDK---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359
Query: 954 ELIQSPLDGQE 964
+ I + +E
Sbjct: 360 DRILTLTTNEE 370
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 8e-22
Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 45/215 (20%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFE-KEMKTLGKIRHHNLVALEGYY 748
+G G FGVV++ L + VAIKK + + F+ +E++ + ++H N+V L+ ++
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKK------VLQDKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 749 WTPSLQL------LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILG------MAKGLA 796
++ + L+ E++ ++Y+ + Q ++L + + LA
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLK-----QTMPMLLIKLYMYQLLRSLA 155
Query: 797 YLHHTNIIHYNLKSTNVLIDS-SGEPKVGDFGLARLL----PMLDRCILSSKIQSALGYM 851
Y+H I H ++K N+L+D SG K+ DFG A++L P S I S Y
Sbjct: 156 YIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN------VSYICS-RYYR 208
Query: 852 APE--FACR--TVKITEKCDVYGFGVLVLEVVTGK 882
APE F T I D++ G ++ E++ G+
Sbjct: 209 APELIFGATNYTTNI----DIWSTGCVMAELMQGQ 239
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 40/189 (21%), Positives = 79/189 (41%), Gaps = 13/189 (6%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+GRG +G V A KK+ + + + F++E++ + + H N++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+ + L+ E + G L++ + + I+ + +AY H N+ H +
Sbjct: 75 FEDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRD 131
Query: 808 LKSTNVLIDSSGE---PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITE 864
LK N L + K+ DFGLA ++ +K+ + Y++P+
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKVGTP-YYVSPQVLEG--LYGP 186
Query: 865 KCDVYGFGV 873
+CD + GV
Sbjct: 187 ECDEWSAGV 195
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 9e-22
Identities = 47/204 (23%), Positives = 80/204 (39%), Gaps = 28/204 (13%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIK-----KLTVSGLIKS--QEDFEKEMKTLGKIRHHN 740
LG G G V + + VAI+ K + ++ + E E++ L K+ H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
++ ++ ++ ++ E + G L+ + L M + YLH
Sbjct: 202 IIKIKNFFDAEDY-YIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQYLHE 257
Query: 801 TNIIHYNLKSTNVLIDSSGEP---KVGDFGLARLL----PMLDRCILSSKIQSALGYMAP 853
IIH +LK NVL+ S E K+ DFG +++L M C Y+AP
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-------GTPTYLAP 310
Query: 854 E--FACRTVKITEKCDVYGFGVLV 875
E + T D + GV++
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 54/246 (21%), Positives = 104/246 (42%), Gaps = 24/246 (9%)
Query: 668 VMFSGDAEFAAGANALLNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDF 726
+ G + A N L E+G G G V++ + G +A+K++ SG + +
Sbjct: 12 YLTIGGQRYQAEINDL-ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRI 70
Query: 727 EKEMKTLGK-IRHHNLVALEGYYWTPSLQLLIYEFISSGS--LYKHLHDGSSRNCLSWRQ 783
++ + K +V G + T + + E + + + L K + L
Sbjct: 71 LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG--- 127
Query: 784 RFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842
+ + + K L YL +IH ++K +N+L+D G+ K+ DFG++ L +
Sbjct: 128 --KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL------VDDK 179
Query: 843 KIQSALG---YMAPE----FACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVL 895
+ G YMAPE + DV+ G+ ++E+ TG+ P + + D VL
Sbjct: 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL 239
Query: 896 CDMVRG 901
+++
Sbjct: 240 TKVLQE 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 67/306 (21%), Positives = 109/306 (35%), Gaps = 68/306 (22%)
Query: 689 ELGRGGFGVVYRTILQDGRS------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
LG G FG V + + VA+K L + D E L ++ H +++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHL---------------------HDGSSRNCLSW 781
L G LLI E+ GSL L D L+
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 782 RQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841
+ +++G+ YL ++H +L + N+L+ + K+ DFGL+R
Sbjct: 150 GDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR----------- 198
Query: 842 SKIQSALGY------------MAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYM 888
+ Y MA E + T + DV+ FGVL+ E+VT G P +
Sbjct: 199 -DVYEEDSYVKRSQGRIPVKWMAIE-SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 889 EDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEE 948
+ + L+ G + P + + + +L L C Q P RP +
Sbjct: 257 PPERLF------NLLKTGHRMER---------PDNCSEEMYRLMLQCWKQEPDKRPVFAD 301
Query: 949 VVNILE 954
+ LE
Sbjct: 302 ISKDLE 307
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 1e-21
Identities = 52/267 (19%), Positives = 104/267 (38%), Gaps = 26/267 (9%)
Query: 688 CELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEG 746
ELG G GVV++ G +A K + + + +E++ L + +V G
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIH 805
+++ + E + GSL + L + + + + + KGL YL I+H
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHKIMH 155
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKI 862
++K +N+L++S GE K+ DFG++ L + S S +G YM+PE ++
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPE------RL 202
Query: 863 TE-----KCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917
+ D++ G+ ++E+ G+ P+ + + L + + R
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 918 GNFPADEAIPVIKLGLICASQVPSNRP 944
+ + P
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPP 289
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 46/189 (24%), Positives = 88/189 (46%), Gaps = 11/189 (5%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+LGRG FG+V+R ++ K + V G Q +KE+ L RH N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHES 69
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+ + ++I+EFIS +++ ++ + L+ R+ + + + + L +LH NI H++
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHSHNIGHFD 127
Query: 808 LKSTNVLIDSSGEP--KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
++ N++ + K+ +FG AR L + Y APE ++
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAP-EYYAPEVHQHD-VVSTA 183
Query: 866 CDVYGFGVL 874
D++ G L
Sbjct: 184 TDMWSLGTL 192
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 13/189 (6%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
LG G F V+ G+ A+K + S + E E+ L KI+H N+V LE
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR-DSSLENEIAVLKKIKHENIVTLEDI 74
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
Y + + L+ + +S G L+ + R + + +I + + YLH I+H +
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRI---LERGVYTEKDASLVIQQVLSAVKYLHENGIVHRD 131
Query: 808 LKSTNVLIDSSGEP---KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITE 864
LK N+L + E + DFGL++ M I+S+ + GY+APE + ++
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTACGTP-GYVAPEVLAQK-PYSK 186
Query: 865 KCDVYGFGV 873
D + GV
Sbjct: 187 AVDCWSIGV 195
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 69/308 (22%), Positives = 114/308 (37%), Gaps = 58/308 (18%)
Query: 689 ELGRGGFGVVYRTILQDGRS------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NL 741
LG G FG V VA+K L + +E E+K + + H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHD-----------GSSRNCLSWRQRFNIILG 790
V L G L+I E+ G L L + + S R +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGY 850
+A+G+A+L N IH ++ + NVL+ + K+GDFGLAR I + Y
Sbjct: 173 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR------------DIMNDSNY 220
Query: 851 ------------MAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCD 897
MAPE + T + DV+ +G+L+ E+ + G P Y V
Sbjct: 221 IVKGNARLPVKWMAPE-SIFDCVYTVQSDVWSYGILLWEIFSLGLNP--YPGILV---NS 274
Query: 898 MVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957
++DG PA + + C + P++RP +++ + L+
Sbjct: 275 KFYKLVKDGYQMAQ---------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325
Query: 958 SPLDGQEE 965
+ +
Sbjct: 326 QEDRRERD 333
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 51/190 (26%), Positives = 86/190 (45%), Gaps = 12/190 (6%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKS-QEDFEKEMKTLGKIRHHNLVALEG 746
ELG+G F VV R G A K + L + E+E + K++H N+V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
S L+++ ++ G L++ + +R S + I + + +AY H I+H
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAYCHSNGIVHR 129
Query: 807 NLKSTNVLIDSSGEP---KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
NLK N+L+ S + K+ DFGLA + D + GY++PE + +
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTP-GYLSPEVLKKD-PYS 185
Query: 864 EKCDVYGFGV 873
+ D++ GV
Sbjct: 186 KPVDIWACGV 195
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 3e-21
Identities = 51/244 (20%), Positives = 87/244 (35%), Gaps = 49/244 (20%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLI----KSQEDFEKEMKTLGKIRHHNLVA 743
+G+G +GVV Q AIK + + + K E + E++ + K+ H N+
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF------------------ 785
L Y L+ E G L L+ +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 786 -------------------NIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE--PKVG 824
NI+ + L YLH+ I H ++K N L ++ K+
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLV 212
Query: 825 DFGLARLLPML---DRCILSSKIQSALGYMAPE-FACRTVKITEKCDVYGFGVLVLEVVT 880
DFGL++ L + +++K + ++APE KCD + GVL+ ++
Sbjct: 213 DFGLSKEFYKLNNGEYYGMTTKAGTP-YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
Query: 881 GKRP 884
G P
Sbjct: 272 GAVP 275
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-21
Identities = 51/192 (26%), Positives = 85/192 (44%), Gaps = 11/192 (5%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKS-QEDFEKEMKTLGKIRHH-NLVALE 745
ELGRG F VV + I G+ A K L + + + E+ L + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
Y S +LI E+ + G ++ +S +I + +G+ YLH NI+H
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNNIVH 154
Query: 806 YNLKSTNVLIDSSGEP---KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKI 862
+LK N+L+ S K+ DFG++R + C L + + Y+APE I
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--HACELREIMGTP-EYLAPEILNYD-PI 210
Query: 863 TEKCDVYGFGVL 874
T D++ G++
Sbjct: 211 TTATDMWNIGII 222
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 9e-21
Identities = 51/190 (26%), Positives = 86/190 (45%), Gaps = 12/190 (6%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKS-QEDFEKEMKTLGKIRHHNLVALEG 746
ELG+G F VV R G A K + L + E+E + K++H N+V L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
S L+++ ++ G L++ + +R S + I + + +AY H I+H
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAYCHSNGIVHR 152
Query: 807 NLKSTNVLIDSSGEP---KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
NLK N+L+ S + K+ DFGLA + D + GY++PE + +
Sbjct: 153 NLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTP-GYLSPEVLKKD-PYS 208
Query: 864 EKCDVYGFGV 873
+ D++ GV
Sbjct: 209 KPVDIWACGV 218
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-21
Identities = 45/198 (22%), Positives = 81/198 (40%), Gaps = 20/198 (10%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIK-----KLTVSGLIKS--QEDFEKEMKTLGKIRHHN 740
LG G G V + + VAIK K + ++ + E E++ L K+ H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
++ ++ ++ ++ E + G L+ + L M + YLH
Sbjct: 77 IIKIKNFFDAEDY-YIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 801 TNIIHYNLKSTNVLIDSSGEP---KVGDFGLARLLPMLDRCILSSKIQSALGYMAPE--F 855
IIH +LK NVL+ S E K+ DFG +++ + + ++ + + Y+APE
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTP-TYLAPEVLV 189
Query: 856 ACRTVKITEKCDVYGFGV 873
+ T D + GV
Sbjct: 190 SVGTAGYNRAVDCWSLGV 207
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 51/253 (20%), Positives = 104/253 (41%), Gaps = 22/253 (8%)
Query: 284 KLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQ 343
LAN + + + + +L + L+ T E + NL+ +++
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 344 NKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIP 403
N++T ++ + + LSGN L + A ++ ++ LDL+S ++ V
Sbjct: 73 NQIT-DLAPLKNLTKITELELSGNPL---KNVSAIAGLQS----IKTLDLTSTQITDV-- 122
Query: 404 SNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKEL 463
+ + LS+L +L + +N + +I + L +Q L + ++ + P + L L
Sbjct: 123 TPLAGLSNLQVLYLDLNQI-TNISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTL 178
Query: 464 KLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILP 523
K + N +S I + + +L + L N ++ P +AN SNL V L+ ++
Sbjct: 179 KADDNKISD-ISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV 234
Query: 524 KELINLSHLLSFN 536
NL
Sbjct: 235 FYNNNLVVPNVVK 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 46/260 (17%), Positives = 101/260 (38%), Gaps = 19/260 (7%)
Query: 88 GLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147
L + LS T TI + L ++ +N ++ L P + + E+
Sbjct: 36 TQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDLAP---LKNLTKITEL 90
Query: 148 SFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIV 207
+ N L +++ S+++++ +S +++ P + L +LQ L L N + +
Sbjct: 91 ELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN--I 144
Query: 208 KGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSL 267
++ L +L+ + +G + S + S L L N +S + L L + +
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEV 200
Query: 268 SLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLP 327
LK N + P + +NL + L+ + + NLV + P
Sbjct: 201 HLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--AP 256
Query: 328 ESMMNCGNLLAIDVSQNKLT 347
++ + G + +++ N +
Sbjct: 257 ATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 9/65 (13%), Positives = 27/65 (41%), Gaps = 4/65 (6%)
Query: 478 IKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNI 537
++ + ++N+T V A+L + + ++ I + + L++L+ +
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70
Query: 538 SHNHL 542
N +
Sbjct: 71 KDNQI 75
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 27/158 (17%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE-KEMKTLGKIRHHNLVALEGY 747
+G G FGVVY+ L D G VAIKK + + F+ +E++ + K+ H N+V L +
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKK------VLQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 748 YWTPSLQL------LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILG------MAKGL 795
+++ + L+ +++ ++Y+ S Q +I + + L
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKLYMYQLFRSL 169
Query: 796 AYLHHTNIIHYNLKSTNVLIDS-SGEPKVGDFGLARLL 832
AY+H I H ++K N+L+D + K+ DFG A+ L
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 47/199 (23%), Positives = 89/199 (44%), Gaps = 18/199 (9%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALEGY 747
LG G V I L + A+K + + +E++ L + + H N++ L +
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+ L++E + GS+ H+H R + + ++ +A L +LH+ I H +
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 808 LKSTNVLIDSSGEP---KVGDFGLARLLPMLDRC--ILSSKIQSALG---YMAPE----F 855
LK N+L + + K+ DF L + + C I + ++ + G YMAPE F
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 856 ACRTVKITEKCDVYGFGVL 874
+ ++CD++ GV+
Sbjct: 197 SEEASIYDKRCDLWSLGVI 215
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 17/151 (11%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGKIRHHNL 741
+G G +GVV++ G+ VAIKK ED +E++ L +++H NL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKK------FLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
V L + L++E+ ++ L + + +I + + + H
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH-TVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLL 832
N IH ++K N+LI K+ DFG ARLL
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLL 152
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-20
Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 60/226 (26%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEK----EMKTLGKIRHHNLVAL 744
G+G FG V + G SVAIKK + F M+ L + H N+V L
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKK------VIQDPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 745 EGYYWTPSLQ-------LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILG------M 791
+ Y++T + ++ E++ +L++ RN + IL +
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC-----RNYYRRQVAPPPILIKVFLFQL 138
Query: 792 AKGLAYLHHT--NIIHYNLKSTNVLID-SSGEPKVGDFGLARLL----PMLD----RCIL 840
+ + LH N+ H ++K NVL++ + G K+ DFG A+ L P + R
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-- 196
Query: 841 SSKIQSALGYMAPE--FACR--TVKITEKCDVYGFGVLVLEVVTGK 882
Y APE F + T + D++ G + E++ G+
Sbjct: 197 ---------YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGE 229
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-20
Identities = 74/477 (15%), Positives = 147/477 (30%), Gaps = 93/477 (19%)
Query: 95 LQVLSLSNNNFTGTINADLAS-FGTLQVVDFSENNLS--GLIP-DEFFRQCGSLREVSFA 150
+Q L + + A+L QVV + L+ R +L E++
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 151 NNNLTGP----IPESLSFCS-SLESVNFSSNRLSGQLPYGIWFL-------RSLQSLDLS 198
+N L + + L S ++ ++ + L+G G L +LQ L LS
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA---GCGVLSSTLRTLPTLQELHLS 121
Query: 199 NNLLEGEIVKGIS-----NLYDLRAIKLGKNKFSGQLPEDIG----GCSMLKVLDFGVNS 249
+NLL ++ + L ++L S E + K L N
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 250 LSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGR----IPSS 305
++ ++ L LK + LE+L L + +
Sbjct: 182 IN---EAGVRVL----CQGLKDSP------------CQLEALKLESCGVTSDNCRDLCGI 222
Query: 306 IGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLS 365
+ + L+EL + N+ G++ ++ L + L+T+ +
Sbjct: 223 VASKASLRELALGSNKL-----------GDVGMAELCPGLLHPSS-------RLRTLWIW 264
Query: 366 GNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDL-----SSLMLLNMSMN 420
+ + + + L+ L L+ N L + + L L +
Sbjct: 265 ECGITAK-GCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 323
Query: 421 YL----FGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAV-----SLKELKLEKNFLS 471
+ + + + + L S+N L ++ + L+ L L +S
Sbjct: 324 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383
Query: 472 ----GRIPSQIKNCSSLTSLILSQNNLTGPVPAAIA-----NLSNLKYVDLSFNDLS 519
+ + + SL L LS N L + L+ + L S
Sbjct: 384 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-19
Identities = 69/410 (16%), Positives = 132/410 (32%), Gaps = 59/410 (14%)
Query: 190 RSLQSLDLSNNLLEGEIVKGI-SNLYDLRAIKLGKNKFSGQLPEDIG----GCSMLKVLD 244
+QSLD+ L + L + ++L + +DI L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 245 FGVNSLSGS----LPDSLQRLNSC-SSLSLKGNSFTGE----VPDWIGKLANLESLDLSL 295
N L + LQ + LSL+ TG + + L L+ L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 296 NQFSGRIPSSIGNLV-----FLKELNISMNQFT----GGLPESMMNCGNLLAIDVSQNKL 346
N + + L++L + + L + + + VS N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 347 TGNIPTWIFKM------GLQTVSLSGNRLG-ESMQYPSFASMKDSYQGLQVLDLSSNAL- 398
+ + L+ + L + ++ + + S L+ L L SN L
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRD--LCGIVASKASLRELALGSNKLG 240
Query: 399 -SGVI---PSNIGDLSSLMLLNMSMNYL----FGSIPASIGKLKAIQVLDFSDNWLNGTI 450
G+ P + S L L + + G + + ++++ L + N L
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 300
Query: 451 PPQIGGAV-----SLKELKLEKNFLSGR----IPSQIKNCSSLTSLILSQNNLTGPVPAA 501
+ + L+ L ++ + S + L L +S N L
Sbjct: 301 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRE 360
Query: 502 IA-----NLSNLKYVDLSFNDLSGI----LPKELINLSHLLSFNISHNHL 542
+ S L+ + L+ D+S L L+ L ++S+N L
Sbjct: 361 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-16
Identities = 70/397 (17%), Positives = 131/397 (32%), Gaps = 63/397 (15%)
Query: 84 HIGRGLLRLQFLQVLSLSNNNFTG----TINADLASFG-TLQVVDFSENNLSG-----LI 133
I L L L+L +N + L + +Q + L+G L
Sbjct: 47 DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 106
Query: 134 PDEFFRQCGSLREVSFANNNLTGPIPESLS-----FCSSLESVNFSSNRLSGQ----LPY 184
R +L+E+ ++N L + L LE + LS L
Sbjct: 107 --STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS 164
Query: 185 GIWFLRSLQSLDLSNNLLEGEIVKGIS-----NLYDLRAIKLGKNKFSGQ----LPEDIG 235
+ + L +SNN + V+ + + L A+KL + L +
Sbjct: 165 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 224
Query: 236 GCSMLKVLDFGVNSLSGS----LPDSLQRLNSC-SSLSLKGNSFTGEVPDWIGKL----A 286
+ L+ L G N L L L +S +L + T + + ++
Sbjct: 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE 284
Query: 287 NLESLDLSLNQFSGRIPSSIGNLVF-----LKELNISMNQFTG----GLPESMMNCGNLL 337
+L+ L L+ N+ + + L+ L + FT + LL
Sbjct: 285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLL 344
Query: 338 AIDVSQNKLTGNIPTWIFKM------GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVL 391
+ +S N+L + + L+ + L+ + +S S A+ + L+ L
Sbjct: 345 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS-SCSSLAATLLANHSLREL 403
Query: 392 DLSSN--------ALSGVIPSNIGDLSSLMLLNMSMN 420
DLS+N L + L L+L ++ +
Sbjct: 404 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 46/227 (20%), Positives = 75/227 (33%), Gaps = 35/227 (15%)
Query: 84 HIGRGLLRLQFLQVLSLSNNNFTGT-----INADLASFGTLQVVDFSENNLS-----GLI 133
+ + L+ L+L +N L L+ + E ++ L
Sbjct: 218 DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC 277
Query: 134 PDEFFRQCGSLREVSFANNNLTGP----IPESLSFC-SSLESVNFSSNRLSGQ----LPY 184
R SL+E+S A N L + E+L LES+ S +
Sbjct: 278 --RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335
Query: 185 GIWFLRSLQSLDLSNNLLEGEIVKGIS-----NLYDLRAIKLGKNKFSGQ----LPEDIG 235
+ R L L +SNN LE V+ + LR + L S L +
Sbjct: 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLL 395
Query: 236 GCSMLKVLDFGVNSLSGS----LPDSLQRLNSC-SSLSLKGNSFTGE 277
L+ LD N L + L +S+++ L L ++ E
Sbjct: 396 ANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 54/229 (23%), Positives = 95/229 (41%), Gaps = 18/229 (7%)
Query: 684 LNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGK-IRHHNL 741
L E+GRG +G V + + G+ +A+K++ + K Q+ ++ + + +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 742 VALEGYYWTPSLQLLIYEF--ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
V G + + E S YK+++ + I L K L +L
Sbjct: 84 VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDD-VIPEEILGKITLATVKALNHLK 142
Query: 800 HT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE- 854
IIH ++K +N+L+D SG K+ DFG++ L + S G YMAPE
Sbjct: 143 ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL------VDSIAKTRDAGCRPYMAPER 196
Query: 855 FACRTVKI--TEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRG 901
+ + DV+ G+ + E+ TG+ P L +V+G
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 66/320 (20%), Positives = 106/320 (33%), Gaps = 76/320 (23%)
Query: 689 ELGRGGFGVVYRTILQDGRS------VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NL 741
LG G FG V VA+K L +E E+K + ++ H N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 742 VALEGYYWTPSLQ----LLIYEFISSGSLYKHL--------------------HDGSSRN 777
V L G LI+E+ G L +L + N
Sbjct: 112 VNLLGA----CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 778 CLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837
L++ +AKG+ +L + +H +L + NVL+ K+ DFGLAR
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR------- 220
Query: 838 CILSSKIQSALGY------------MAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRP 884
I S Y MAPE + T K DV+ +G+L+ E+ + G P
Sbjct: 221 -----DIMSDSNYVVRGNARLPVKWMAPE-SLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
Query: 885 VEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRP 944
+ D +++G D P + + C + RP
Sbjct: 275 YPGIPVDANFY-----KLIQNGFKMDQ---------PFYATEEIYIIMQSCWAFDSRKRP 320
Query: 945 DMEEVVNILE-LIQSPLDGQ 963
+ + L + +
Sbjct: 321 SFPNLTSFLGCQLADAEEAM 340
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 24/207 (11%), Positives = 52/207 (25%), Gaps = 54/207 (26%)
Query: 689 ELGRGGFGVVYR---TILQDGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVA 743
G ++ T L R VA+ + G++ ++ L +I +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 744 L------EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAY 797
+ ++ E+I GSL + S + +A
Sbjct: 96 VLDVVHTRAGGL------VVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADA 144
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFAC 857
H + + V + G+ + M
Sbjct: 145 AHRAGVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA--- 179
Query: 858 RTVKITEKCDVYGFGVLVLEVVTGKRP 884
+ D+ G G + ++ + P
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWP 201
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 1e-19
Identities = 41/219 (18%), Positives = 81/219 (36%), Gaps = 48/219 (21%)
Query: 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS 818
+ +L ++ S +I + +A+ + +LH ++H +LK +N+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 200
Query: 819 GEPKVGDFGLARLL-----------PMLDRCILSSKIQSALGYMAPEFACRTVKITEKCD 867
KVGDFGL + PM + ++ + L YM+PE + K D
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL-YMSPE-QIHGNNYSHKVD 258
Query: 868 VYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD---- 923
++ G+++ E++ ME RV D R FP
Sbjct: 259 IFSLGLILFELLYSFST--QME-----------------RVRIITDVR-NLKFPLLFTQK 298
Query: 924 --EAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960
+ +++ S P+ RP+ ++I++ +
Sbjct: 299 YPQEHMMVQD---MLSPSPTERPEAT------DIIENAI 328
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 22/99 (22%), Positives = 37/99 (37%), Gaps = 1/99 (1%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+GRGGFGVV+ D + AIK++ + ++E +E+K L K+ H +V +
Sbjct: 14 MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 73
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNI 787
+ E + S I
Sbjct: 74 LETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKI 112
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 17/151 (11%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGKIRHHNL 741
+G G +G+V + GR VAIKK +D + +E+K L ++RH NL
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKK------FLESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
V L L++EF+ ++ L N L ++ + + G+ + H
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLL 832
NIIH ++K N+L+ SG K+ DFG AR L
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 46/190 (24%), Positives = 83/190 (43%), Gaps = 11/190 (5%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIK-SQEDFEKEMKTLGKIRHHNLVALEG 746
ELG+G F VV R + + G+ A + L + E+E + ++H N+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
LI++ ++ G L D +R S + I + + + + H ++H
Sbjct: 78 SISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHR 134
Query: 807 NLKSTNVLIDSSGEP---KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
NLK N+L+ S + K+ DFGLA + ++ + GY++PE +
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGTP-GYLSPEVLRKD-PYG 191
Query: 864 EKCDVYGFGV 873
+ D++ GV
Sbjct: 192 KPVDLWACGV 201
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 45/193 (23%), Positives = 86/193 (44%), Gaps = 19/193 (9%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHH-NLVAL 744
LG G F + + + + ++ A+K +I + + + +KE+ L H N+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVK------IISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
+ L+ E ++ G L++ + + S + I+ + ++++H ++
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIK---KKKHFSETEASYIMRKLVSAVSHMHDVGVV 128
Query: 805 HYNLKSTNVLIDSSGEP---KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVK 861
H +LK N+L + K+ DFG ARL P D L + + Y APE +
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCFTL-HYAAPELLNQN-G 185
Query: 862 ITEKCDVYGFGVL 874
E CD++ GV+
Sbjct: 186 YDESCDLWSLGVI 198
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 29/204 (14%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIK--------KLTVSGLIKSQEDFEKEMKTLGKIRHH 739
LGRG VV R I + A+K + + + +E KE+ L K+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 740 -NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
N++ L+ Y T + L+++ + G L+ +L + + LS ++ I+ + + + L
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICAL 140
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLL----PMLDRCILSSKIQSALGYMAPE 854
H NI+H +LK N+L+D K+ DFG + L + + C + Y+APE
Sbjct: 141 HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC------GTP-SYLAPE 193
Query: 855 -----FACRTVKITEKCDVYGFGV 873
++ D++ GV
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 4e-19
Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE---KEMKTLGKIRHHNLVALE 745
LGRGGFG V+ ++ G+ A KKL +K ++ ++ E K L K+ +V+L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLN-KKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCL--SWRQRF---NIILGMAKGLAYLHH 800
+ T + L+ ++ G + H+++ N R F I+ G L +LH
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQ 307
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFAC 857
NII+ +LK NVL+D G ++ D GLA L +K + G +MAPE
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-----TKTKGYAGTPGFMAPELLL 362
Query: 858 RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALED 905
+ D + GV + E++ + P + V ++ + LE
Sbjct: 363 GE-EYDFSVDYFALGVTLYEMIAARGPF-RARGEKVENKELKQRVLEQ 408
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 91.3 bits (226), Expect = 4e-19
Identities = 52/364 (14%), Positives = 119/364 (32%), Gaps = 28/364 (7%)
Query: 88 GLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147
+L + T + ++ + + +++ + + + ++ ++
Sbjct: 16 PDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV---QGIQYLPNVTKL 70
Query: 148 SFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIV 207
N LT I + L+ +L + N++ L + L+ L+SL L +N + +
Sbjct: 71 FLNGNKLTD-I-KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS--DI 124
Query: 208 KGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSL 267
G+ +L L ++ LG NK + + + L L N +S + L L +L
Sbjct: 125 NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNL 180
Query: 268 SLKGNSFTGEVPDW--IGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGG 325
L N + D + L NL+ L+L + + + NLV + +
Sbjct: 181 YLSKN----HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT- 235
Query: 326 LPESMMNCGNLLAIDVSQNKLTGN-----IPTWIFKMGLQTVSLSGNRLGESMQYPSFAS 380
PE + + G+ +V + I +G G + + +
Sbjct: 236 -PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSY 294
Query: 381 MKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLD 440
D ++ + + P+ G + + + + +
Sbjct: 295 DVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDFTLYAV 354
Query: 441 FSDN 444
F
Sbjct: 355 FKAE 358
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 89.8 bits (222), Expect = 1e-18
Identities = 49/287 (17%), Positives = 97/287 (33%), Gaps = 44/287 (15%)
Query: 284 KLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQ 343
A +L + + L + ++ + + ++ I
Sbjct: 19 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-----------SVQGIQYLP 65
Query: 344 NKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIP 403
N + + L+GN+L + ++K+ L L L N + +
Sbjct: 66 N--------------VTKLFLNGNKLTD---IKPLTNLKN----LGWLFLDENKIKDL-- 102
Query: 404 SNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKEL 463
S++ DL L L++ N + I + L ++ L +N + I + L L
Sbjct: 103 SSLKDLKKLKSLSLEHNGI-SDING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTL 158
Query: 464 KLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILP 523
LE N +S I + + L +L LS+N+++ A+A L NL ++L +
Sbjct: 159 SLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPI 214
Query: 524 KELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGSV 570
NL + + L + + P+ P V
Sbjct: 215 NHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 261
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 10/83 (12%), Positives = 30/83 (36%), Gaps = 6/83 (7%)
Query: 460 LKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLS 519
+ E + P + L + ++T V L+++ + + +D+
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 520 GILPKELINLSHLLSFNISHNHL 542
+ + + L ++ ++ N L
Sbjct: 57 SV--QGIQYLPNVTKLFLNGNKL 77
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 4e-19
Identities = 59/227 (25%), Positives = 92/227 (40%), Gaps = 25/227 (11%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE---KEMKTLGKIRHHNLVALE 745
LG+GGFG V ++ G+ A KKL IK ++ E + L K+ +V+L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLE-KKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHHTN 802
Y T L+ ++ G L H++ R F I G L LH
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG----LEDLHRER 306
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR----CILSSKIQSALGYMAPEFACR 858
I++ +LK N+L+D G ++ D GLA +P +GYMAPE
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-------GTVGYMAPEVVKN 359
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALED 905
+ T D + G L+ E++ G+ P + ++ R E
Sbjct: 360 E-RYTFSPDWWALGCLLYEMIAGQSPF-QQRKKKIKREEVERLVKEV 404
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 46/189 (24%), Positives = 89/189 (47%), Gaps = 14/189 (7%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
ELGRG +VYR + A+K L + ++ E+ L ++ H N++ L+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+ TP+ L+ E ++ G L+ + + S R + + + + +AYLH I+H +
Sbjct: 117 FETPTEISLVLELVTGGELFDRI---VEKGYYSERDAADAVKQILEAVAYLHENGIVHRD 173
Query: 808 LKSTNVLIDSSGEP---KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITE 864
LK N+L + K+ DFGL++++ + ++ + + GY APE
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTP-GYCAPEILRGC-AYGP 229
Query: 865 KCDVYGFGV 873
+ D++ G+
Sbjct: 230 EVDMWSVGI 238
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 8e-19
Identities = 48/203 (23%), Positives = 96/203 (47%), Gaps = 28/203 (13%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIK-------KLTVSGLIKSQEDFEKEMKTLGKIRHH- 739
+GRG VV R + G A+K +L+ L + +E +E L ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
+++ L Y + S L+++ + G L+ +L + + LS ++ +I+ + + +++LH
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSIMRSLLEAVSFLH 217
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLL----PMLDRCILSSKIQSALGYMAPE- 854
NI+H +LK N+L+D + + ++ DFG + L + + C + GY+APE
Sbjct: 218 ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC------GTP-GYLAPEI 270
Query: 855 ----FACRTVKITEKCDVYGFGV 873
++ D++ GV
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGV 293
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 9e-19
Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 16/148 (10%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGKIRHHNLV 742
+G G +GVVY+ GR VA+K+ I+ + E +E+ L ++ H N+V
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKR------IRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
+L + L++EF+ L K L + + L Q + + +G+A+ H
Sbjct: 83 SLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG--LQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
I+H +LK N+LI+S G K+ DFGLAR
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 1e-18
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDF----EKEM-KTLGKIRHHNLVA 743
+GRGGFG VY D G+ A+K L + Q + E+ M + +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHH 800
+ + TP I + ++ G L+ HL RF IILG L ++H+
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILG----LEHMHN 310
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFAC 857
+++ +LK N+L+D G ++ D GLA K +++G YMAPE
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFS-------KKKPHASVGTHGYMAPEVLQ 363
Query: 858 RTVKITEKCDVYGFGVLVLEVVTGKRP 884
+ V D + G ++ +++ G P
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 45/197 (22%), Positives = 82/197 (41%), Gaps = 27/197 (13%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALEG 746
++G G + V R I A+K + KS+ D +E++ L + H N++ L+
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIID-----KSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
Y ++ E + G L + + S R+ ++ + K + YLH ++H
Sbjct: 84 VYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQGVVHR 140
Query: 807 NLKSTNVLIDSSGEP----KVGDFGLARLL-----PMLDRCILSSKIQSALGYMAPEFAC 857
+LK +N+L ++ DFG A+ L ++ C ++APE
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-------YTANFVAPEVLE 193
Query: 858 RTVKITEKCDVYGFGVL 874
R CD++ GVL
Sbjct: 194 RQ-GYDAACDIWSLGVL 209
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 2e-18
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 20/155 (12%)
Query: 684 LNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGK 735
L K +G G +G V++ + VA+K+ ++ +D E +E+ L +
Sbjct: 7 LEK---IGEGTYGTVFKAKNRETHEIVALKR------VRLDDDDEGVPSSALREICLLKE 57
Query: 736 IRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGL 795
++H N+V L + L++EF L K+ + L + + + KGL
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD--LDPEIVKSFLFQLLKGL 114
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
+ H N++H +LK N+LI+ +GE K+ +FGLAR
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 3e-18
Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 16/148 (10%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGKIRHHNLV 742
+G G +GVVY+ G + A+KK I+ +++ E +E+ L +++H N+V
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKK------IRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
L T +L++E + L K L + F +L + G+AY H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF--LLQLLNGIAYCHDRR 120
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
++H +LK N+LI+ GE K+ DFGLAR
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 16/149 (10%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGKIRHHNL 741
+G G +GVVY+ G VA+KK I+ + E +E+ L ++ H N+
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKK------IRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
V L T + L++EF+ L K + + + + + + +GLA+ H
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSH 122
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
++H +LK N+LI++ G K+ DFGLAR
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 43/194 (22%), Positives = 79/194 (40%), Gaps = 21/194 (10%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALEGY 747
LG G G V + G+ A+K L+ +E+ + ++V +
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALK------LLYDSPKARQEVDHHWQASGGPHIVCILDV 90
Query: 748 YWTPSLQ----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
Y L+I E + G L+ + + + + R+ I+ + + +LH NI
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQ-AFTEREAAEIMRDIGTAIQFLHSHNI 149
Query: 804 IHYNLKSTNVLIDSSGEP---KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTV 860
H ++K N+L S + K+ DFG A+ + L + + Y+APE
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTP-YYVAPEVLGPE- 204
Query: 861 KITEKCDVYGFGVL 874
K + CD++ GV+
Sbjct: 205 KYDKSCDMWSLGVI 218
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 9e-18
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 11/152 (7%)
Query: 684 LNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE----KEMKTLGKIRH 738
L+ LG G F VY+ + VAIKK+ + ++++ +E+K L ++ H
Sbjct: 15 LDF---LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 739 HNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
N++ L + S L+++F+ + L + D S L+ +L +GL YL
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYL 128
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
H I+H +LK N+L+D +G K+ DFGLA+
Sbjct: 129 HQHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 35/212 (16%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQE----DFEKEMKTLGKIRHHNLVAL 744
LG G F V L R AIK L +IK + E+++ + ++ H V L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV--MSRLDHPFFVKL 95
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLS-WRQRF---NIILGMAKGLAYLHH 800
+ + +G L K++ RF I+ L YLH
Sbjct: 96 YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSA----LEYLHG 148
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFAC 857
IIH +LK N+L++ ++ DFG A++L + ++ S +G Y++PE
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK---QARANSFVGTAQYVSPEL-- 203
Query: 858 RTVKITEK-----CDVYGFGVLVLEVVTGKRP 884
+TEK D++ G ++ ++V G P
Sbjct: 204 ----LTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 23/155 (14%), Positives = 55/155 (35%), Gaps = 7/155 (4%)
Query: 388 LQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLN 447
L + L++ ++ + + I ++ L ++ + + I L ++ L +
Sbjct: 46 LTYITLANINVTDL--TGIEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVT 101
Query: 448 GTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSN 507
P + G SL L + + I ++I + S+ LS N + L
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPE 160
Query: 508 LKYVDLSFNDLSGILPKELINLSHLLSFNISHNHL 542
LK +++ F+ + + + L +
Sbjct: 161 LKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 17/114 (14%), Positives = 50/114 (43%), Gaps = 4/114 (3%)
Query: 429 SIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLI 488
+ ++ ++ + ++ + I A ++K+L + + + I S+L L
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATN--YNPISGLSNLERLR 94
Query: 489 LSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHL 542
+ ++T ++ L++L +D+S + + ++ L + S ++S+N
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 31/237 (13%), Positives = 68/237 (28%), Gaps = 62/237 (26%)
Query: 285 LANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQN 344
+ L + + + + L + ++ T +L I+
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-----------DLTGIE---- 63
Query: 345 KLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPS 404
++ ++++ Y + + + L+ L + ++
Sbjct: 64 YAHN----------IKDLTINNIHATN---YNPISGLSN----LERLRIMGKDVTSDKIP 106
Query: 405 NIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELK 464
N+ L+SL LL++S + SI I L + +D S N I P
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP------------ 154
Query: 465 LEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGI 521
+K L SL + + + I + L + + G
Sbjct: 155 -------------LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 29/186 (15%), Positives = 68/186 (36%), Gaps = 11/186 (5%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151
+ L ++ A + S L + + N++ L ++++++ N
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNS---LTYITLANINVTDL---TGIEYAHNIKDLTINN 75
Query: 152 NNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGIS 211
+ T +S S+LE + ++ + L SL LD+S++ + I+ I+
Sbjct: 76 IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 212 NLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKG 271
L + +I L N + + LK L+ + + ++ + L
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 272 NSFTGE 277
+ G+
Sbjct: 191 QTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 31/192 (16%), Positives = 70/192 (36%), Gaps = 16/192 (8%)
Query: 211 SNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLK 270
S LG++ + + + + + + V L+G ++ ++ L++
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTIN 74
Query: 271 GNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESM 330
T P I L+NLE L + + ++ L L L+IS + + +
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 331 MNCGNLLAIDVSQNKLTGNIPTWIFKM-GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQ 389
+ +ID+S N +I + + L+++++ + + + Y L
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD---YRGIEDFPK----LN 184
Query: 390 VLDLSSNALSGV 401
L S + G
Sbjct: 185 QLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 19/141 (13%), Positives = 52/141 (36%), Gaps = 6/141 (4%)
Query: 88 GLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147
G+ ++ L+++N + T ++ L+ + +++ SL +
Sbjct: 61 GIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKI-PNLSGLTSLTLL 117
Query: 148 SFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIV 207
+++ I ++ + S++ S N + + L L+SL++ + +
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD--Y 174
Query: 208 KGISNLYDLRAIKLGKNKFSG 228
+GI + L + G
Sbjct: 175 RGIEDFPKLNQLYAFSQTIGG 195
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 35/161 (21%), Positives = 78/161 (48%), Gaps = 19/161 (11%)
Query: 686 KDCELGRGGFGVVYRTILQD---GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
+ C++GRG +G VY+ +D + A+K++ +G+ S +E+ L +++H N++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC---REIALLRELKHPNVI 81
Query: 743 ALEGYYWTPSLQL--LIYEFISSGSLYKHLHDGSSRNCLSWRQRFN------IILGMAKG 794
+L+ + + + + L++++ L+ + + + ++ + G
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 795 LAYLHHTNIIHYNLKSTNVLIDSS----GEPKVGDFGLARL 831
+ YLH ++H +LK N+L+ G K+ D G ARL
Sbjct: 141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 12/146 (8%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFE----KEMKTLGKIRHHNLVAL 744
LG G + VY+ VA+K++ ++ +E +E+ L ++H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
T L++E++ L ++L D + ++ + + +GLAY H ++
Sbjct: 66 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI--INMHNVKLFLFQLLRGLAYCHRQKVL 122
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLAR 830
H +LK N+LI+ GE K+ DFGLAR
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLAR 148
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 22/158 (13%)
Query: 684 LNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGK 735
L K LG G + VY+ + G VA+K+ +K + E +E+ + +
Sbjct: 10 LEK---LGNGTYATVYKGLNKTTGVYVALKE------VKLDSE-EGTPSTAIREISLMKE 59
Query: 736 IRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNC---LSWRQRFNIILGMA 792
++H N+V L T + L++EF+ + L K++ + N L +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
+GLA+ H I+H +LK N+LI+ G+ K+GDFGLAR
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-17
Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 28/163 (17%)
Query: 684 LNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGK 735
L K +G+G FG V++ + G+ VA+KK + + + E +E+K L
Sbjct: 22 LAK---IGQGTFGEVFKARHRKTGQKVALKK------VLMENEKEGFPITALREIKILQL 72
Query: 736 IRHHNLVALEGYYWTPSLQL--------LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNI 787
++H N+V L T + L+++F L L + + + + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK--FTLSEIKRV 129
Query: 788 ILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
+ + GL Y+H I+H ++K+ NVLI G K+ DFGLAR
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-17
Identities = 42/199 (21%), Positives = 79/199 (39%), Gaps = 28/199 (14%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALEG 746
LG G G V + + A+K +++ +E++ + ++V +
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALK------MLQDCPKARREVELHWRASQCPHIVRIVD 122
Query: 747 YYWTPSLQ----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
Y L++ E + G L+ + D + + R+ I+ + + + YLH N
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSIN 181
Query: 803 IIHYNLKSTNVLIDSSGEP---KVGDFGLARLL----PMLDRCILSSKIQSALGYMAPEF 855
I H ++K N+L S K+ DFG A+ + C + Y+APE
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY------TP-YYVAPEV 234
Query: 856 ACRTVKITEKCDVYGFGVL 874
K + CD++ GV+
Sbjct: 235 LGPE-KYDKSCDMWSLGVI 252
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-17
Identities = 51/361 (14%), Positives = 111/361 (30%), Gaps = 79/361 (21%)
Query: 190 RSLQSLDLSNNLLEGE----IVKGISNLYDLRAIKLGKNKFSGQ----LPEDIGGCSMLK 241
S++ L + + E + + ++ I L N + L E+I L+
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 242 VLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGR 301
+ +F + + L +L L ++ LS N F
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQ-ALLKCP-------------KLHTVRLSDNAFGPT 109
Query: 302 ----IPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM 357
+ + L+ L + N P++ L K
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLG---PQAGAKIARALQELAVNKKAKNAP------- 159
Query: 358 GLQTVSLSGNRLG-ESMQYPSFASMKDSYQGLQVLDLSSNAL-----SGVIPSNIGDLSS 411
L+++ NRL SM+ +A S++ L + + N + ++ +
Sbjct: 160 PLRSIICGRNRLENGSMKE--WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQE 217
Query: 412 LMLLNMSMNYLFG-----SIPASIGKLKAIQVLDFSDNWLNGTIPPQIG--GAVSL-KEL 463
L +L++ N F ++ ++ ++ L +D + GA ++
Sbjct: 218 LKVLDLQDNT-FTHLGSSALAIALKSWPNLRELGLNDC--------LLSARGAAAVVDAF 268
Query: 464 KLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIA-----NLSNLKYVDLSFNDL 518
+N L +L L N + + + +L +++L+ N
Sbjct: 269 SKLEN-------------IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
Query: 519 S 519
S
Sbjct: 316 S 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 53/335 (15%), Positives = 105/335 (31%), Gaps = 81/335 (24%)
Query: 95 LQVLSLSNNNFTG----TINADLASFGTLQVVDFSENNLSGLIPD------EFFRQCGSL 144
++ SL + T ++ A L +++ + S N + + E L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG---TEAARWLSENIASKKDL 62
Query: 145 REVSFANNNLTGP----------IPESLSFCSSLESVNFSSNRLSGQLPYGIWFL----- 189
F++ + ++L C L +V S N P L
Sbjct: 63 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG---PTAQEPLIDFLS 119
Query: 190 --RSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGV 247
L+ L L NN L + I+ L+ + + K L+ + G
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARA--LQELAVNKKA---------KNAPPLRSIICGR 168
Query: 248 NSLSG----SLPDSLQRLNSCSSLSLKGNSFTGE-VPDWIGKL----ANLESLDLSLNQF 298
N L + Q ++ + N E + + + L+ LDL N F
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
Query: 299 SGR----IPSSIGNLVFLKELNISMNQFTG----GLPESMMNCGN--LLAIDVSQNKLT- 347
+ + ++ + L+EL ++ + + ++ N L + + N++
Sbjct: 229 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288
Query: 348 -----------GNIPTWIFKMGLQTVSLSGNRLGE 371
+P L + L+GNR E
Sbjct: 289 DAVRTLKTVIDEKMPD------LLFLELNGNRFSE 317
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 47/250 (18%), Positives = 84/250 (33%), Gaps = 52/250 (20%)
Query: 84 HIGRGLLRLQFLQVLSLSNNNFTGTINADLASF----GTLQVVDFSENN----------- 128
+ + LL+ L + LS+N F T L F L+ + N
Sbjct: 85 LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR 144
Query: 129 -LSGLIPDEFFRQCGSLREVSFANNNLTGP----IPESLSFCSSLESVNFSSNRLSGQ-- 181
L L ++ + LR + N L ++ L +V N + +
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204
Query: 182 ---LPYGIWFLRSLQSLDLSNNLL--EG--EIVKGISNLYDLRAIKLGKNKFSGQLPEDI 234
L G+ + + L+ LDL +N G + + + +LR + L S
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS-----AR 259
Query: 235 GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIG-----KLANLE 289
G +++ N LQ L L+ N + + K+ +L
Sbjct: 260 GAAAVVDAFSKLENI-------GLQTLR------LQYNEIELDAVRTLKTVIDEKMPDLL 306
Query: 290 SLDLSLNQFS 299
L+L+ N+FS
Sbjct: 307 FLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 51/317 (16%), Positives = 100/317 (31%), Gaps = 72/317 (22%)
Query: 266 SLSLKGNSFTGE----VPDWIGKLANLESLDLSLNQFSGR----IPSSIGNLVFLKELNI 317
SLK ++ T E V + + +++ + LS N + +I + L+
Sbjct: 8 GKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 67
Query: 318 SMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLG-ESMQYP 376
S FTG + + + LL + + L TV LS N G + +
Sbjct: 68 SDI-FTGRVKDEIPEALRLLLQALLKCP------------KLHTVRLSDNAFGPTAQEP- 113
Query: 377 SFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKL-KA 435
+ L+ L L +N +G + + L K
Sbjct: 114 -LIDFLSKHTPLEHLYLHNN--------GLGPQAGAKIARA----LQELAVNKKAKNAPP 160
Query: 436 IQVLDFSDNWLNGTIPPQIG--GAV----------SLKELKLEKNFL-----SGRIPSQI 478
++ + N ++ L +K+ +N + + +
Sbjct: 161 LRSIICGRN--------RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGL 212
Query: 479 KNCSSLTSLILSQNNLTGPVPAAIA----NLSNLKYVDLSFNDLSG----ILPKELINLS 530
C L L L N T +A+A + NL+ + L+ LS + L
Sbjct: 213 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE 272
Query: 531 H--LLSFNISHNHLHGE 545
+ L + + +N + +
Sbjct: 273 NIGLQTLRLQYNEIELD 289
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 22/222 (9%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
LG G +G V + +VA+K + + + E+ +KE+ + H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 749 WTPSLQLLIYEFISSGSLYKH------LHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
++Q L E+ S G L+ + + ++ Q ++ G + YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQ---LMAG----VVYLHGIG 125
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRT 859
I H ++K N+L+D K+ DFGLA + +R L + G Y+APE R
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL---LNKMCGTLPYVAPELLKRR 182
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRG 901
E DV+ G+++ ++ G+ P + D D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 58/222 (26%), Positives = 89/222 (40%), Gaps = 60/222 (27%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQE----DFEKEMKTLGKIRHHNLVAL 744
LG G FG V ++ G A+K L ++K ++ EK + L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI--LQAVNFPFLVKL 106
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN----------IILGMAKG 794
E + S ++ E+++ G ++ HL RF+ I+L
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIVLT---- 153
Query: 795 LAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR----CILSSKIQSALG- 849
YLH ++I+ +LK N+LID G +V DFG A+ + R C G
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWTLC----------GT 201
Query: 850 --YMAPEFACRTVKITEK-----CDVYGFGVLVLEVVTGKRP 884
+APE I K D + GVL+ E+ G P
Sbjct: 202 PEALAPEI------ILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 32/157 (20%), Positives = 62/157 (39%), Gaps = 18/157 (11%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLT-VSGLIKSQEDFEK---------EMKTLGKIRH 738
+ G +G V + +G VAIK++ ++ E++ L H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 739 HNLVALEGYYWTPSLQL-----LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAK 793
N++ L + L+ E + + L + +H R +S + + +
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH--DQRIVISPQHIQYFMYHILL 145
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
GL LH ++H +L N+L+ + + + DF LAR
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR 182
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 37/157 (23%), Positives = 62/157 (39%), Gaps = 27/157 (17%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK---------EMKTLGKIRH 738
+G G +G V + R VAIKK+ FE E+ L ++ H
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKIL--------RVFEDLIDCKRILREIAILNRLNH 111
Query: 739 HNLVALEGYYWTPSLQL-----LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAK 793
++V + ++ ++ E S K + L+ ++ +
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR---TPVYLTELHIKTLLYNLLV 167
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
G+ Y+H I+H +LK N L++ KV DFGLAR
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIK-----KLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
+G+G F V + GR VAIK +L + L K +E++ + + H N+V
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK----LFREVRIMKILNHPNIVK 78
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLS---WRQRFNIILGMAKGLAYLHH 800
L T LI E+ S G ++ +L + + R +F I+ + Y H
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYL---VAHGRMKEKEARSKFRQIV---SAVQYCHQ 132
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTV 860
I+H +LK+ N+L+D+ K+ DFG + L + + Y APE
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFCGA-PPYAAPELFQGKK 189
Query: 861 KITEKCDVYGFGVLVLEVVTGKRP 884
+ DV+ GV++ +V+G P
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLP 213
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 4e-16
Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 22/208 (10%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQE--DFEKEMKTLGKIRHHNLVALEG 746
+GRG FG V L++ + A+K L ++K E F +E L + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHHTNI 803
+ + L+ ++ G L L R RF +++ + +H +
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE-MARFYLAEMVIA----IDSVHQLHY 196
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE----FA 856
+H ++K N+L+D +G ++ DFG L M D + SS A+G Y++PE
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSS---VAVGTPDYISPEILQAME 252
Query: 857 CRTVKITEKCDVYGFGVLVLEVVTGKRP 884
+ +CD + GV + E++ G+ P
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 39/168 (23%), Positives = 66/168 (39%), Gaps = 34/168 (20%)
Query: 684 LNKDCELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKE------------- 729
+ + +G G +G VY+ G VA+K + V
Sbjct: 14 VAE---IGVGAYGTVYKARDPHSGHFVALKSVRV--------PNGGGGGGGLPISTVREV 62
Query: 730 --MKTLGKIRHHNLVALE----GYYWTPSLQL-LIYEFISSGSLYKHLHDGSSRNCLSWR 782
++ L H N+V L +++ L++E + L +L L
Sbjct: 63 ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG-LPAE 120
Query: 783 QRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
+++ +GL +LH I+H +LK N+L+ S G K+ DFGLAR
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-16
Identities = 46/215 (21%), Positives = 80/215 (37%), Gaps = 39/215 (18%)
Query: 690 LGRGGFGVVY--RTILQDGRSVAIKKLTVSGLIKSQED--FEKEMKTLGKIRHHNLVALE 745
+GRG FG V R + A+K L+ +IK + F +E + +V L
Sbjct: 77 IGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN----------IILGMAKGL 795
+ ++ E++ G L + ++L L
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMS----------NYDVPEKWARFYTAEVVLA----L 181
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMA 852
+H IH ++K N+L+D SG K+ DFG + + +A+G Y++
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG----MVRCDTAVGTPDYIS 237
Query: 853 PE---FACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
PE +CD + GV + E++ G P
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-16
Identities = 48/212 (22%), Positives = 85/212 (40%), Gaps = 35/212 (16%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQE----DFEKEMKTLGKIRHHNLVAL 744
+G+G FG V D + A+K + ++ E E ++ + + H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQI--MQGLEHPFLVNL 80
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN----------IILGMAKG 794
+ ++ + + G L HL +N F +++
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHL----QQN-----VHFKEETVKLFICELVMA---- 127
Query: 795 LAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPE 854
L YL + IIH ++K N+L+D G + DF +A +LP +++ + YMAPE
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITTMAGT-KPYMAPE 184
Query: 855 FACRTVKI--TEKCDVYGFGVLVLEVVTGKRP 884
+ D + GV E++ G+RP
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 32/166 (19%)
Query: 684 LNKDCELGRGGFGVVY--RTILQDGRSVAIKKLTVSGLIKSQEDFEKE------------ 729
+ + +G G +G V+ R + GR VA+K++ V +E
Sbjct: 16 VAE---IGEGAYGKVFKARDLKNGGRFVALKRVRV--------QTGEEGMPLSTIREVAV 64
Query: 730 MKTLGKIRHHNLVALE----GYYWTPSLQL-LIYEFISSGSLYKHLHDGSSRNCLSWRQR 784
++ L H N+V L +L L++E + L +L D +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETI 122
Query: 785 FNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
+++ + +GL +LH ++H +LK N+L+ SSG+ K+ DFGLAR
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 45/176 (25%), Positives = 77/176 (43%), Gaps = 24/176 (13%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
LG G +G V + +VA+K + + + E+ +KE+ + H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLS-------WRQRFNIILGMAKGLAYLHHT 801
++Q L E+ S G L+ + + + Q ++ G + YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQ---LMAG----VVYLHGI 124
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPE 854
I H ++K N+L+D K+ DFGLA + +R L + G Y+APE
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL---LNKMCGTLPYVAPE 177
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 44/262 (16%), Positives = 99/262 (37%), Gaps = 19/262 (7%)
Query: 88 GLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147
+L + T + ++ + + +++ + + + ++ ++
Sbjct: 19 SDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV---QGIQYLPNVTKL 73
Query: 148 SFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIV 207
N LT I + L+ +L + N++ L + L+ L+SL L +N + +
Sbjct: 74 FLNGNKLTD-I-KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS--DI 127
Query: 208 KGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSL 267
G+ +L L ++ LG NK + + + L L N +S + L L +L
Sbjct: 128 NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNL 183
Query: 268 SLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLP 327
L N + ++ + L NL+ L+L + + + NLV + + P
Sbjct: 184 YLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--P 239
Query: 328 ESMMNCGNLLAIDVSQNKLTGN 349
E + + G+ +V +
Sbjct: 240 EIISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 49/283 (17%), Positives = 98/283 (34%), Gaps = 56/283 (19%)
Query: 284 KLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQ 343
A +L + + L + ++ + + ++ I
Sbjct: 22 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-----------SVQGIQYLP 68
Query: 344 NKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIP 403
N + + L+GN+L + A++K+ L L L N + +
Sbjct: 69 N--------------VTKLFLNGNKLTD---IKPLANLKN----LGWLFLDENKVKDL-- 105
Query: 404 SNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKEL 463
S++ DL L L++ N + S + L ++ L +N + I + L L
Sbjct: 106 SSLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTL 161
Query: 464 KLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILP 523
LE N +S I + + L +L LS+N+++ A+A L NL ++L +
Sbjct: 162 SLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPI 217
Query: 524 KELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSL 566
NL + + L ++P +S +
Sbjct: 218 NHQSNLVVPNTVKNTDGSL------------VTPEIISDDGDY 248
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 80.2 bits (197), Expect = 1e-15
Identities = 62/376 (16%), Positives = 118/376 (31%), Gaps = 27/376 (7%)
Query: 145 REVSFANNNL-TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLE 203
+E+ N T P +S F + + + + S+ S L
Sbjct: 210 KELELVQNAFFTDPNDQSAWF--YHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTV 267
Query: 204 GEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNS 263
G + + + D + + G+ L + +S
Sbjct: 268 GSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDS 327
Query: 264 CSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFT 323
L + D L +LS+ + S + S + + L+EL
Sbjct: 328 QKECVLLKDRPECWCRD-SATDEQLFRCELSVEK-STVLQSELESCKELQELEPENKWCL 385
Query: 324 GGLPESMMNCGNLLAIDVSQ---NKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFAS 380
+ M LL + + L P + S +
Sbjct: 386 LTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL----------RSKFLLENSV 435
Query: 381 MKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLD 440
+K Y ++VL L+ L+ + ++ L + L++S N L ++P ++ L+ ++VL
Sbjct: 436 LKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQ 492
Query: 441 FSDNWLNGTIPPQIGGAVSLKELKLEKNFLSG-RIPSQIKNCSSLTSLILSQNNLTGPVP 499
SDN L + + L+EL L N L + +C L L L N+L
Sbjct: 493 ASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550
Query: 500 ---AAIANLSNLKYVD 512
L ++ +
Sbjct: 551 IQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 5e-13
Identities = 42/291 (14%), Positives = 79/291 (27%), Gaps = 37/291 (12%)
Query: 117 GTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFS-- 174
GTL ++ + + + +L +P+ S +
Sbjct: 272 GTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKEC 331
Query: 175 --SNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIK------------ 220
L +LS + + + +L+ ++
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL 390
Query: 221 -LGKNKFSGQLPEDIGGCSMLKVLDF--------GVNSLSGSLPDSLQRLNSCSSLSLKG 271
+ E + S LK +D + L L
Sbjct: 391 LMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAH 450
Query: 272 NSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFT--GGLPES 329
T V + +L + LDLS N+ +P ++ L L+ L S N G+
Sbjct: 451 KDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDGVA-- 505
Query: 330 MMNCGNLLAIDVSQNKLTG--NIPTWIFKMGLQTVSLSGNRLGESMQYPSF 378
N L + + N+L I + L ++L GN L +
Sbjct: 506 --NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 2e-12
Identities = 45/195 (23%), Positives = 70/195 (35%), Gaps = 29/195 (14%)
Query: 89 LLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI--------------- 133
L + LQ L N TI + + L + S L
Sbjct: 368 LESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRS 427
Query: 134 -----PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF 188
+ +R + A+ +LT + L + ++ S NRL LP +
Sbjct: 428 KFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAA 484
Query: 189 LRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPE--DIGGCSMLKVLDFG 246
LR L+ L S+N L E V G++NL L+ + L N+ Q + C L +L+
Sbjct: 485 LRCLEVLQASDNAL--ENVDGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQ 541
Query: 247 VNSLSGSLPDSLQRL 261
NSL +RL
Sbjct: 542 GNSLC-QEEGIQERL 555
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 1e-09
Identities = 35/203 (17%), Positives = 67/203 (33%), Gaps = 7/203 (3%)
Query: 340 DVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALS 399
D+ L +P F++ + + + + + L +LS +
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST 362
Query: 400 GVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVS 459
V+ S + L L + +I I ++A+ L + L + +
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQYFSTLKAVDPMR 418
Query: 460 LKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLS 519
L ++ + + L L+ +LT V + L + ++DLS N L
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR 476
Query: 520 GILPKELINLSHLLSFNISHNHL 542
+ P L L L S N L
Sbjct: 477 AL-PPALAALRCLEVLQASDNAL 498
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 9e-09
Identities = 27/113 (23%), Positives = 43/113 (38%), Gaps = 8/113 (7%)
Query: 88 GLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147
L +L + L LS+N + LA+ L+V+ S+N L + L+E+
Sbjct: 458 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG---VANLPRLQEL 513
Query: 148 SFANNNLTG-PIPESLSFCSSLESVNFSSNRLSGQLPYG---IWFLRSLQSLD 196
NN L + L C L +N N L + L S+ S+
Sbjct: 514 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 4e-05
Identities = 16/72 (22%), Positives = 29/72 (40%), Gaps = 2/72 (2%)
Query: 84 HIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGS 143
+ L L+ L+VL S+N ++ +A+ LQ + N L + C
Sbjct: 477 ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534
Query: 144 LREVSFANNNLT 155
L ++ N+L
Sbjct: 535 LVLLNLQGNSLC 546
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 23/154 (14%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-------KEMKTLGKIRHHNL 741
LG G +G VY+ I +VAIK+ I+ + + E +E+ L +++H N+
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKR------IRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
+ L+ LI+E+ + L K++ +S R + + + G+ + H
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHSR 151
Query: 802 NIIHYNLKSTNVLIDSS-----GEPKVGDFGLAR 830
+H +LK N+L+ S K+GDFGLAR
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE---KEMKTLGKIRHHNLVALE 745
LG+G FG V + GR A+K L +I ++++ E + L RH L AL+
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILK-KEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHHT- 801
+ T + E+ + G L+ HL R R RF I+ L YLH
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSA----LDYLHSEK 268
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACR 858
N+++ +LK N+++D G K+ DFGL + + D + +++ G Y+APE
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKD----GATMKTFCGTPEYLAPEVLED 323
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRP 884
D +G GV++ E++ G+ P
Sbjct: 324 N-DYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 60/222 (27%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQE----DFEKEMKTLGKIRHHNLVAL 744
LG G FG V+ + GR A+K L +++ ++ + E+ M L + H ++ +
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM--LSIVTHPFIIRM 71
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN----------IILGMAKG 794
G + +I ++I G L+ L R QRF + L
Sbjct: 72 WGTFQDAQQIFMIMDYIEGGELFSLL-----RKS----QRFPNPVAKFYAAEVCLA---- 118
Query: 795 LAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR----CILSSKIQSALG- 849
L YLH +II+ +LK N+L+D +G K+ DFG A+ +P D C G
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTYTLC----------GT 166
Query: 850 --YMAPEFACRTVKITEK-----CDVYGFGVLVLEVVTGKRP 884
Y+APE ++ K D + FG+L+ E++ G P
Sbjct: 167 PDYIAPEV------VSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 55/252 (21%), Positives = 103/252 (40%), Gaps = 54/252 (21%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDF--------------------- 726
E+G+G +GVV D A+K L+ LI+
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 727 ----EKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY---EFISSGSLYKHLHDG--SSRN 777
+E+ L K+ H N+V L P+ + +Y E ++ G + + S
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPN-EDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 778 CLSW-RQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836
+ + +I G + YLH+ IIH ++K +N+L+ G K+ DFG++ D
Sbjct: 139 ARFYFQD---LIKG----IEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 837 RCILSSKIQSALG---YMAPEFACRTVKIT---EKCDVYGFGVLVLEVVTGKRPVEYMED 890
+ + + +G +MAPE + + + DV+ GV + V G+ P +M++
Sbjct: 192 -----ALLSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQCP--FMDE 243
Query: 891 DVVVLCDMVRGA 902
++ L ++
Sbjct: 244 RIMCLHSKIKSQ 255
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 46/217 (21%), Positives = 81/217 (37%), Gaps = 38/217 (17%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQE--DFEKEMKTLGKIRHHNLVALEG 746
+GRG F V ++ G+ A+K + ++K E F +E L + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILG--MAK--------GLA 796
+ + L+ E+ G L L +F + MA+ +
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLL------------SKFGERIPAEMARFYLAEIVMAID 176
Query: 797 YLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAP 853
+H +H ++K N+L+D G ++ DFG L + + A+G Y++P
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG----TVRSLVAVGTPDYLSP 232
Query: 854 E------FACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
E T +CD + GV E+ G+ P
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 45/258 (17%), Positives = 91/258 (35%), Gaps = 40/258 (15%)
Query: 263 SCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQF 322
C L+ ++PD + + ++LDLS N S + L+ L++S +
Sbjct: 13 QCMELNFY------KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI 64
Query: 323 TGGLPESM-MNCGNLLAIDVSQNKLTGNIPTWIFK--MGLQTVSLSGNRLGESMQYPSFA 379
+ + + +L + ++ N + ++ F LQ + L S++
Sbjct: 65 QT-IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNL-ASLENFPIG 121
Query: 380 SMKDSYQGLQVLDLSSNALSGVIPSNI-GDLSSLMLLNMSMNYLFGSIPASIGKLKAIQV 438
+K L+ L+++ N + +L++L L++S N K+++I
Sbjct: 122 HLKT----LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN-----------KIQSIYC 166
Query: 439 LDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPV 498
D + L L N ++ I L L L N L
Sbjct: 167 TDL-RVLHQMP--------LLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVP 216
Query: 499 PAAIANLSNLKYVDLSFN 516
L++L+ + L N
Sbjct: 217 DGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 39/172 (22%), Positives = 77/172 (44%), Gaps = 12/172 (6%)
Query: 388 LQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNWL 446
+ LDLS N L + + L +L++S + +I L + L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPI 88
Query: 447 NGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQI-KNCSSLTSLILSQNNLTG-PVPAAIA 503
++ G SL++L + L+ + + + +L L ++ N + +P +
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 504 NLSNLKYVDLSFNDLSGILPKELINLSHL----LSFNISHNHLHGELPVGGF 551
NL+NL+++DLS N + I +L L + LS ++S N ++ + G F
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 50/231 (21%), Positives = 86/231 (37%), Gaps = 31/231 (13%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+ L LS N + SF LQV+D S + I D ++ L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPI 88
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLEGEIVKGI-S 211
+ S SSL+ + L+ L L++L+ L++++NL++ + S
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLA-SLENFP-IGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 212 NLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCS-SLSLK 270
NL +L + L NK S+ + L ++ + SL L
Sbjct: 147 NLTNLEHLDLSSNKIQ---------------------SIYCTDLRVLHQMPLLNLSLDLS 185
Query: 271 GNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSI-GNLVFLKELNISMN 320
N + K L+ L L NQ +P I L L+++ + N
Sbjct: 186 LNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 48/262 (18%), Positives = 91/262 (34%), Gaps = 64/262 (24%)
Query: 143 SLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF-LRSLQSLDLSNNL 201
S + + + N L S L+ ++ S + + G + L L +L L+ N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 202 LEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQR 260
++ L G S L+ L
Sbjct: 88 IQ-------------------------SLALGAFSGLSSLQKLV---------------- 106
Query: 261 LNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQF-SGRIPSSIGNLVFLKELNISM 319
+ SL+ G L L+ L+++ N S ++P NL L+ L++S
Sbjct: 107 AVETNLASLENFPI--------GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 320 NQFTGGLPESMMNCGNL----LAIDVSQNKLTGNIPTWIF-KMGLQTVSLSGNRLGESMQ 374
N+ + + L++D+S N + I F ++ L+ ++L N+L +S+
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQL-KSVP 216
Query: 375 YPSFASMKDSYQGLQVLDLSSN 396
F + LQ + L +N
Sbjct: 217 DGIFDRLT----SLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 28/130 (21%), Positives = 56/130 (43%), Gaps = 7/130 (5%)
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPP-QIGGAVSLKELKLEKNFLSGRIPSQI-KNCS 482
IP ++ + + LD S N L + L+ L L + + I ++ S
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76
Query: 483 SLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHL 542
L++LIL+ N + A + LS+L+ + +L+ + + +L L N++HN +
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 543 HGELPVGGFF 552
+ +F
Sbjct: 137 Q-SFKLPEYF 145
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 29/140 (20%), Positives = 52/140 (37%), Gaps = 9/140 (6%)
Query: 91 RLQFLQVLSLSNNNFTGTINADLAS-FGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSF 149
L LQ L N ++ TL+ ++ + N + E+F +L +
Sbjct: 98 GLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156
Query: 150 ANNNLTGPIPESLSFCSSLESVNF----SSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGE 205
++N + L + +N S N ++ + G + L+ L L N L+
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-S 214
Query: 206 IVKGI-SNLYDLRAIKLGKN 224
+ GI L L+ I L N
Sbjct: 215 VPDGIFDRLTSLQKIWLHTN 234
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 42/231 (18%), Positives = 82/231 (35%), Gaps = 15/231 (6%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN-NN 153
L + FG L+ ++ S+N++ +I + F L E+ NN
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 154 LTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNL----LEGEIVKG 209
L PE+ +L+ + S+ + LD+ +N+ +E G
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151
Query: 210 ISNLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLS 268
+S + L KN ++ G + ++ N+L D + L
Sbjct: 152 LSFE--SVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILD 208
Query: 269 LKGNSFTGEVPDWIGKLANLESLD-LSLNQFSGRIPSSIGNLVFLKELNIS 318
+ +P + L NL+ L S ++P ++ LV L E +++
Sbjct: 209 ISRTRIH-SLPSYG--LENLKKLRARSTYNLK-KLP-TLEKLVALMEASLT 254
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 51/264 (19%), Positives = 90/264 (34%), Gaps = 25/264 (9%)
Query: 263 SCS--SLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMN 320
CS + + T E+P + N L L + + L+++ IS N
Sbjct: 8 HCSNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN 64
Query: 321 QFTGGLPESM-MNCGNLLAIDVSQ-NKLTGNIPTWIFKM--GLQTVSLSGNRLGESMQYP 376
+ + N L I + + N L I F+ LQ + +S + + +
Sbjct: 65 DVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI-KHLPDV 122
Query: 377 SFASMKDSYQGLQVLDLSSNALSGVIPSNI--GDLSSLMLLNMSMNYLFGSIPASIGKLK 434
+LD+ N I N G ++L ++ N + I S
Sbjct: 123 HKIHSLQ----KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI-QEIHNSAFNGT 177
Query: 435 AIQVLDFSDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSL-ILSQN 492
+ L+ SDN +P + GA L + + + +PS +L L S
Sbjct: 178 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG--LENLKKLRARSTY 234
Query: 493 NLTGPVPAAIANLSNLKYVDLSFN 516
NL +P + L L L++
Sbjct: 235 NLKK-LP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 46/288 (15%), Positives = 96/288 (33%), Gaps = 44/288 (15%)
Query: 165 CS-SLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGI-SNLYDLRAIKLG 222
C S ++++ ++P + R+ L L I KG S DL I++
Sbjct: 7 CHCSNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEIS 62
Query: 223 KNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDW 281
+N + D+ L + +++ N+ ++ +F
Sbjct: 63 QNDVLEVIEADVFSNLPKLHEIR-------------IEKANNLLYIN--PEAFQN----- 102
Query: 282 IGKLANLESLDLSLNQFSGRIPSSI-GNLVFLKELNISMNQFTGGLPESMMN--CGNLLA 338
L NL+ L +S +P + + L+I N + + +
Sbjct: 103 ---LPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVI 158
Query: 339 IDVSQNKLTGNIPTWIFK-MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNA 397
+ +++N + I F L ++LS N E + F +LD+S
Sbjct: 159 LWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASG----PVILDISRTR 213
Query: 398 LSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNW 445
+ + + +L L + Y +P ++ KL A+ +
Sbjct: 214 IHSLPSYGLENLKKLRARS---TYNLKKLP-TLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 38/220 (17%), Positives = 78/220 (35%), Gaps = 14/220 (6%)
Query: 339 IDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNAL 398
++K+T IP+ + + + +L +Q +F+ D L+ +++S N +
Sbjct: 14 FLCQESKVT-EIPSDLPR-NAIELRFVLTKL-RVIQKGAFSGFGD----LEKIEISQNDV 66
Query: 399 SGVIPSNI-GDLSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNWLNGTIPPQI-G 455
VI +++ +L L + + I L +Q L S+ + +P
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKI 125
Query: 456 GAVSLKELKLEKNFLSGRIPSQI--KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDL 513
++ L ++ N I L L++N + +A +
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185
Query: 514 SFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFN 553
N+L + S + +IS +H LP G N
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLEN 224
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 26/137 (18%), Positives = 41/137 (29%), Gaps = 5/137 (3%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGT-LQVVDFSENNLSGLIPDEFFRQCGS-LREVSF 149
L LQ L +SN + ++D +N I F +
Sbjct: 103 LPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161
Query: 150 ANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGI-WFLRSLQSLDLSNNLLEGEIVK 208
N + + + E +N L +LP + LD+S +
Sbjct: 162 NKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSY 220
Query: 209 GISNLYDLRAIKLGKNK 225
G+ NL LRA K
Sbjct: 221 GLENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 9e-04
Identities = 17/106 (16%), Positives = 38/106 (35%), Gaps = 5/106 (4%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+L L+ N I+ + L ++ S+NN +P++ F + + +
Sbjct: 156 SVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 214
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNN 200
L L + + + + +LP + L +L L+
Sbjct: 215 HSLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTYP 256
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 37/217 (17%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK---------EMKTLGKIRH 738
LG G +GVV G VAIKK+ F+K E+K L +H
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEP---------FDKPLFALRTLREIKILKHFKH 68
Query: 739 HNLVALEGYYWTPSLQL-----LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAK 793
N++ + S + +I E + + LH S LS I +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT-----DLHRVISTQMLSDDHIQYFIYQTLR 123
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---- 849
+ LH +N+IH +LK +N+LI+S+ + KV DFGLAR++ Q +
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 850 ----YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
Y APE + K + DV+ G ++ E+ +
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK---EMKTLGKIRHHNLVALE 745
LG G FG V G VA+K L I+S + K E++ L RH +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQ-KIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLS---WRQRFNIILGMAKGLAYLHHTN 802
TP+ ++ E++S G L+ ++ + R+ F IL + Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILS---AVDYCHRHM 131
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRT 859
++H +LK NVL+D+ K+ DFGL+ + M D L +++ G Y APE
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFL----RTSCGSPNYAAPEVISGR 185
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRP 884
+ + D++ GV++ ++ G P
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLP 210
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 39/217 (17%)
Query: 690 LGRGGFGVVY----RTILQDGRSVAIKKLTVSGLIKSQEDFE---KEMKTLGKIRHHN-L 741
LG G +G V+ + G+ A+K L + +++ + E E + L IR L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN----------IILGM 791
V L + T + LI ++I+ G L+ HL S+ R+RF I+L
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHL----SQ-----RERFTEHEVQIYVGEIVLA- 171
Query: 792 AKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG-- 849
L +LH II+ ++K N+L+DS+G + DFGL++ + D + + G
Sbjct: 172 ---LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADE---TERAYDFCGTI 224
Query: 850 -YMAPEFACRTVKITEK-CDVYGFGVLVLEVVTGKRP 884
YMAP+ +K D + GVL+ E++TG P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-15
Identities = 48/251 (19%), Positives = 91/251 (36%), Gaps = 82/251 (32%)
Query: 689 ELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEK---EMKTLGKIRHHNLVAL 744
LG G FG+V + G+ A+KK+ +D E+ + + H N++ L
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVL--------QDPRYKNRELDIMKVLDHVNIIKL 65
Query: 745 EGYYWTPSLQL--------------------------------------LIYEFISSGSL 766
Y++T + +I E++ +L
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TL 124
Query: 767 YKHLHDGSSRNCLSWRQRFNIILG------MAKGLAYLHHTNIIHYNLKSTNVLIDS-SG 819
+K L ++ + + + L + + + ++H I H ++K N+L++S
Sbjct: 125 HKVL-----KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 820 EPKVGDFGLARLL----PMLD----RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGF 871
K+ DFG A+ L P + R Y APE + T D++
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRF-----------YRAPELMLGATEYTPSIDLWSI 228
Query: 872 GVLVLEVVTGK 882
G + E++ GK
Sbjct: 229 GCVFGELILGK 239
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 39/215 (18%)
Query: 690 LGRGGFGVVY----RTILQDGRSVAIKKLTVSGLIKSQEDFE---KEMKTLGKIRHHNLV 742
LG+GG+G V+ T G+ A+K L + ++++ +D E L +++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN----------IILGMA 792
L + T LI E++S G L+ L F I +
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGELFMQLER---------EGIFMEDTACFYLAEISMA-- 133
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG--- 849
L +LH II+ +LK N++++ G K+ DFGL + + D + + G
Sbjct: 134 --LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHD----GTVTHTFCGTIE 186
Query: 850 YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
YMAPE R+ D + G L+ +++TG P
Sbjct: 187 YMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIK-----KLTVSGLIKSQEDFEKEMKTLGKIRHH--N 740
LG GGFG VY I + D VAIK +++ G + + E+ L K+
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 741 LVALEGYYWTPSLQLLIYEFIS-SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
++ L ++ P +LI E L+ + + R L + + + + + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCH 166
Query: 800 HTNIIHYNLKSTNVLIDS-SGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEF 855
+ ++H ++K N+LID GE K+ DFG LL + G Y PE+
Sbjct: 167 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-------DTVYTDFDGTRVYSPPEW 219
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
V+ G+L+ ++V G P
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 39/180 (21%), Positives = 69/180 (38%), Gaps = 27/180 (15%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIK-----KLTVSGLIKSQED--FEKEMKTLGKIRHHNL 741
LG G FG V+ + + + V +K K+ I+ + E+ L ++ H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 742 VALEGYYWTPSLQLLIYEFISSGS-LYKHLHDGSSRNCLS---WRQRFNIILGMAKGLAY 797
+ + + L+ E SG L+ + L F ++ + Y
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFI---DRHPRLDEPLASYIFRQLVS---AVGY 145
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLL---PMLDRCILSSKIQSALGYMAPE 854
L +IIH ++K N++I K+ DFG A L + + + Y APE
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGT------IEYCAPE 199
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 37/213 (17%)
Query: 690 LGRGGFGVVY----RTILQDGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVAL 744
LG+G FG V+ + + A+K L + L + + + E L ++ H +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN----------IILGMAKG 794
+ T LI +F+ G L+ L F + L
Sbjct: 92 HYAFQTEGKLYLILDFLRGGDLFTRLSK---------EVMFTEEDVKFYLAELALA---- 138
Query: 795 LAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YM 851
L +LH II+ +LK N+L+D G K+ DFGL++ + K S G YM
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDH----EKKAYSFCGTVEYM 193
Query: 852 APEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
APE R T+ D + FGVL+ E++TG P
Sbjct: 194 APEVVNRR-GHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 40/157 (25%), Positives = 63/157 (40%), Gaps = 27/157 (17%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK---------EMKTLGKIRH 738
+GRG +G VY ++VAIKK+ FE E+ L +++
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVN--------RMFEDLIDCKRILREITILNRLKS 84
Query: 739 HNLVALEGYYWTPSLQL-----LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAK 793
++ L L ++ E S L K + L+ I+ +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFK---TPIFLTEEHIKTILYNLLL 140
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
G ++H + IIH +LK N L++ KV DFGLAR
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 25/175 (14%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+G G FGV VA+K + I ++E+ +RH N+V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN--VQREIINHRSLRHPNIVRFKEVI 85
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLS-------WRQRFNIILGMAKGLAYLHHT 801
TP+ +I E+ S G LY+ + + S ++Q ++ G ++Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERI---CNAGRFSEDEARFFFQQ---LLSG----VSYCHSM 135
Query: 802 NIIHYNLKSTNVLIDSSGEP--KVGDFGLARLLPMLDRCILSSKIQSALGYMAPE 854
I H +LK N L+D S P K+ DFG ++ + S + + Y+APE
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTVGT-PAYIAPE 187
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 14/149 (9%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK---EMKTLGKIRHHNLVALE 745
LG G FG V G VA+K L I+S + K E++ L RH +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQ-KIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLS---WRQRFNIILGMAKGLAYLHHTN 802
TPS ++ E++S G L+ ++ L R+ F IL G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILS---GVDYCHRHM 136
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARL 831
++H +LK NVL+D+ K+ DFGL+ +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNM 165
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 37/212 (17%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE---KEMKTLGKIRHHNLVALE 745
LG+G FG V + GR A+K L +I ++++ E + L RH L AL+
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFN----------IILGMAKGL 795
+ T + E+ + G L+ HL S + F I+ L
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHL---------SRERVFTEERARFYGAEIVSA----L 118
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMA 852
YLH ++++ ++K N+++D G K+ DFGL + + D + +++ G Y+A
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISD----GATMKTFCGTPEYLA 173
Query: 853 PEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
PE D +G GV++ E++ G+ P
Sbjct: 174 PEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 48/218 (22%), Positives = 82/218 (37%), Gaps = 39/218 (17%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIK-----KLTVSGLIKSQEDFEKE---MKTLGKIRHH 739
LG+GGFG V+ L D VAIK ++ + E + +G H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 740 -NLVALEGYYWTPSLQLLIYEFISSGS-LYKHLHDGSSRNCLS-------WRQRFNIILG 790
++ L ++ T +L+ E L+ ++ + + L + Q
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGPSRCFFGQ------- 147
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDS-SGEPKVGDFGLARLLPMLDRCILSSKIQSALG 849
+ + + H ++H ++K N+LID G K+ DFG LL G
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-------DEPYTDFDG 200
Query: 850 ---YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884
Y PE+ R V+ G+L+ ++V G P
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 39/178 (21%), Positives = 66/178 (37%), Gaps = 22/178 (12%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK---EMKTLGKIRHHNLVAL- 744
LG G +G V + + A+K L L + E++ L ++RH N++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 745 EGYYW-TPSLQLLIYEFISSGSL-------YKHLHDGSSRNCLSWRQRFNIILGMAKGLA 796
+ Y ++ E+ G K + Q +I G L
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF--CQ---LIDG----LE 123
Query: 797 YLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPE 854
YLH I+H ++K N+L+ + G K+ G+A L Q + + PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 7e-14
Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 24/206 (11%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE---KEMKTLGKIRHHN-LVAL 744
LG+G FG V + + A+K L ++ +D E E + L L L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILK-KDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHHT 801
+ T + E+++ G L H+ F I +G L +L
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIG----LFFLQSK 461
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACR 858
II+ +LK NV++DS G K+ DFG+ + + D ++ G Y+APE
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWD----GVTTKTFCGTPDYIAPEIIAY 516
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRP 884
+ D + FGVL+ E++ G+ P
Sbjct: 517 Q-PYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 38/148 (25%), Positives = 70/148 (47%), Gaps = 19/148 (12%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALEGY 747
LGRG + V+ I + + V +K L +K ++ ++E+K L +R N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK---PVKKKK-IKREIKILENLRGGPNIITLADI 99
Query: 748 YWTPSLQ--LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNI--ILGMAKGLAYLHHTNI 803
P + L++E +++ + + + RF + IL K L Y H I
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI-----RFYMYEIL---KALDYCHSMGI 151
Query: 804 IHYNLKSTNVLIDSS-GEPKVGDFGLAR 830
+H ++K NV+ID + ++ D+GLA
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 39/164 (23%), Positives = 67/164 (40%), Gaps = 7/164 (4%)
Query: 388 LQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLN 447
++ L+ +P ++ +L++S N L+ A++ + L+ L
Sbjct: 12 HLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL- 67
Query: 448 GTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSN 507
T G L L L N L +P + +LT L +S N LT A+ L
Sbjct: 68 -TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125
Query: 508 LKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGF 551
L+ + L N+L + P L L ++++N+L ELP G
Sbjct: 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLL 168
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 44/184 (23%), Positives = 67/184 (36%), Gaps = 14/184 (7%)
Query: 240 LKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFS 299
+L N L +L + L+L T G L L +LDLS NQ
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVLGTLDLSHNQLQ 90
Query: 300 GRIPSSIGNLVFLKELNISMNQFTGGLPESMM-NCGNLLAIDVSQNKLTGNIPTWIFKM- 357
+P L L L++S N+ T LP + G L + + N+L +P +
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 358 -GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLN 416
L+ +SL+ N L + + + L L L N+L IP L
Sbjct: 148 PKLEKLSLANNNL-TELPAGLLNGL----ENLDTLLLQENSLYT-IPKGFFGSHLLPFAF 201
Query: 417 MSMN 420
+ N
Sbjct: 202 LHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 47/212 (22%), Positives = 84/212 (39%), Gaps = 19/212 (8%)
Query: 262 NSCS--SLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISM 319
S ++ + T +P + + L LS N +++ L +LN+
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 320 NQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMG-LQTVSLSGNRLGESMQYPSF 378
+ T + + L +D+S N+L ++P + L + +S NRL S+ +
Sbjct: 65 AELTKLQVDGTL--PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL-TSLPLGAL 120
Query: 379 ASMKDSYQGLQVLDLSSNALSGVIPSNIGD-LSSLMLLNMSMNYLFGSIPASI-GKLKAI 436
+ + LQ L L N L +P + L L+++ N L +PA + L+ +
Sbjct: 121 RGLGE----LQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNL-TELPAGLLNGLENL 174
Query: 437 QVLDFSDNWLNGTIPPQIGGAVSLKELKLEKN 468
L +N L TIP G+ L L N
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 54/250 (21%), Positives = 83/250 (33%), Gaps = 35/250 (14%)
Query: 359 LQTVSLSGNRLGESMQYPS--FASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLN 416
V+ L P +L LS N L + + + L LN
Sbjct: 12 HLEVNCDKRNLTA---LPPDLPKD-------TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 417 MSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPS 476
+ L + G L + LD S N L ++P +L L + N L+ +P
Sbjct: 62 LDRAEL-TKLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL 117
Query: 477 QI-KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSF 535
+ L L L N L P + L+ + L+ N+L+ + L L +L +
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 536 NISHNHLHGELPVGGFFNTISPSSV--SGNPSLC--------------GSVVNRSCPAVQ 579
+ N L+ +P GFF + GNP LC V V
Sbjct: 178 LLQENSLYT-IP-KGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGVD 235
Query: 580 NKPIVLNPNS 589
K + N S
Sbjct: 236 VKAMTSNVAS 245
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 49/205 (23%), Positives = 78/205 (38%), Gaps = 14/205 (6%)
Query: 119 LQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRL 178
V+ + NL+ +P + + + + N L +L + L +N L
Sbjct: 12 HLEVNCDKRNLTA-LPPDLPK---DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 179 SGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDI-GGC 237
+ +L L L +LDLS+N L+ + L L + + N+ + LP G
Sbjct: 68 T-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGL 123
Query: 238 SMLKVLDFGVNSLSGSLPDSL-QRLNSCSSLSLKGNSFTGEVPDWI-GKLANLESLDLSL 295
L+ L N L +LP L LSL N+ T E+P + L NL++L L
Sbjct: 124 GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQE 181
Query: 296 NQFSGRIPSSIGNLVFLKELNISMN 320
N IP L + N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 44/182 (24%), Positives = 69/182 (37%), Gaps = 13/182 (7%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+L LS N A L + L ++ L+ L + L + ++N L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL---QVDGTLPVLGTLDLSHNQL 89
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLEGEIVKGI-S 211
+P +L ++ S NRL+ LP G L LQ L L N L+ + G+ +
Sbjct: 90 QS-LPLLGQTLPALTVLDVSFNRLT-SLPLGA-LRGLGELQELYLKGNELK-TLPPGLLT 145
Query: 212 NLYDLRAIKLGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLK 270
L + L N + +LP + G L L NSL ++P + L
Sbjct: 146 PTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLH 203
Query: 271 GN 272
GN
Sbjct: 204 GN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 41/136 (30%), Positives = 60/136 (44%), Gaps = 7/136 (5%)
Query: 91 RLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFA 150
L L L LS+N ++ + L V+D S N L+ L P R G L+E+
Sbjct: 75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSL-PLGALRGLGELQELYLK 132
Query: 151 NNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLEGEIVK 208
N L P L+ LE ++ ++N L+ +LP G+ L +L +L L N L I K
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGL-LNGLENLDTLLLQENSLYT-IPK 189
Query: 209 GISNLYDLRAIKLGKN 224
G + L L N
Sbjct: 190 GFFGSHLLPFAFLHGN 205
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 44/260 (16%), Positives = 89/260 (34%), Gaps = 42/260 (16%)
Query: 165 CSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGI-SNLYDLRAIKLGK 223
C E + + ++P S Q+L L L I SNL ++ I +
Sbjct: 10 CHQEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSI 64
Query: 224 NKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWI 282
+ QL S + ++ ++ + + + PD +
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIE-------------IRNTRNLTYID----------PDAL 101
Query: 283 GKLANLESLDLSLNQFSGRIP--SSIGNLVFLKELNISMNQFTGGLPESM-MNCGNLLA- 338
+L L+ L + P + + + L I+ N + +P + N
Sbjct: 102 KELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160
Query: 339 IDVSQNKLTGNIPTWIFK-MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNA 397
+ + N T ++ + F L V L+ N+ + +F + G +LD+S +
Sbjct: 161 LKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY---SGPSLLDVSQTS 216
Query: 398 LSGVIPSNI-GDLSSLMLLN 416
++ +PS L L+ N
Sbjct: 217 VT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 38/211 (18%), Positives = 81/211 (38%), Gaps = 16/211 (7%)
Query: 335 NLLAIDVSQNKLTGNIPTWIFK--MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLD 392
+ + + + L IP+ F + + +S + + ++ SF ++ + ++
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK----VTHIE 86
Query: 393 LSSNALSGVIPSNI-GDLSSLMLLNMSMNYLFGSIPA--SIGKLKAIQVLDFSDNWLNGT 449
+ + I + +L L L + L P + +L+ +DN +
Sbjct: 87 IRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTS 145
Query: 450 IPPQI--GGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNN-LTGPVPAAIANL- 505
IP G LKL N + + N + L ++ L++N LT A +
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204
Query: 506 SNLKYVDLSFNDLSGILPKELINLSHLLSFN 536
S +D+S ++ + K L +L L++ N
Sbjct: 205 SGPSLLDVSQTSVTALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 27/176 (15%), Positives = 57/176 (32%), Gaps = 8/176 (4%)
Query: 387 GLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNW 445
Q L L L + +L ++ + +S++ + + L + ++ +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 446 LNGTIPPQI-GGAVSLKELKLEKNFLSGRIP--SQIKNCSSLTSLILSQNNLTGPVPA-A 501
I P LK L + L P +++ + L ++ N +P A
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 502 IANLSN-LKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTIS 556
L N + L N + + N + L + ++ N + F S
Sbjct: 151 FQGLCNETLTLKLYNNGFTSV-QGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 35/229 (15%), Positives = 70/229 (30%), Gaps = 33/229 (14%)
Query: 95 LQVLSLSNNNFTGTINAD-LASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNN 153
Q L L + TI + ++ + + S + + F + + N
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 154 -LTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLLEGEIVKGI 210
LT P++L L+ + + L P L++++N +
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPY-------M 143
Query: 211 SNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLK 270
+++ N F G C+ L N + S+ ++ L
Sbjct: 144 TSIPV--------NAFQGL-------CNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187
Query: 271 GNSFTGEVPDWI--GKLANLESLDLSLNQFSGRIPSSI-GNLVFLKELN 316
N + + G + LD+S + +PS +L L N
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 33/190 (17%), Positives = 68/190 (35%), Gaps = 16/190 (8%)
Query: 92 LQFLQVLSLSNNNFTGTINADL-ASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFA 150
L + + +S + + + + + ++ I + ++ L+ +
Sbjct: 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113
Query: 151 NNNLTGPIPESLSFCS--SLESVNFSSNRLSGQLPYGIWFL---RSLQSLDLSNNLLEGE 205
N L P+ S + + N +P F +L L NN
Sbjct: 114 NTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNA-FQGLCNETLTLKLYNNGFT-S 170
Query: 206 IVKGISNLYDLRAIKLGKNKFSGQLPEDI--GGCSMLKVLDFGVNSLSGSLP----DSLQ 259
+ N L A+ L KNK+ + +D G S +LD S++ +LP + L+
Sbjct: 171 VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLK 229
Query: 260 RLNSCSSLSL 269
L + ++ +L
Sbjct: 230 ELIARNTWTL 239
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 46/218 (21%), Positives = 95/218 (43%), Gaps = 48/218 (22%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK---------EMKTLGKIRHH 739
+G G +G+V + VAIKK++ FE E+K L + RH
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISP---------FEHQTYCQRTLREIKILLRFRHE 85
Query: 740 NLVALEGYYWTPSLQL-----LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKG 794
N++ + P+++ ++ + + + L+ LS + + +G
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMET-----DLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 795 LAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYM--- 851
L Y+H N++H +LK +N+L++++ + K+ DFGLAR ++ G++
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTGFLTEY 191
Query: 852 -------APEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
APE + T+ D++ G ++ E+++ +
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 50/217 (23%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK---------EMKTLGKIRHH 739
+G G +G V + + G VAIKKL F+ E++ L +RH
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLY--------RPFQSELFAKRAYRELRLLKHMRHE 84
Query: 740 NLVALEGYYWTPSLQL-------LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMA 792
N++ L + TP L L+ F+ + L L + ++ M
Sbjct: 85 NVIGLLDVF-TPDETLDDFTDFYLVMPFMGT-----DLGKLMKHEKLGEDRIQFLVYQML 138
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG--- 849
KGL Y+H IIH +LK N+ ++ E K+ DFGLAR + S +
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR------------QADSEMTGYV 186
Query: 850 ----YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
Y APE ++ T+ D++ G ++ E++TGK
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 32/150 (21%), Positives = 60/150 (40%), Gaps = 16/150 (10%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALEG 746
LG G G V + + A+K ++ +E++ + ++V +
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKM------LQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 747 YYWTPSLQ----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
Y L++ E + G L+ + D + + R+ I+ + + + YLH N
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSIN 137
Query: 803 IIHYNLKSTNVLIDSSGEP---KVGDFGLA 829
I H ++K N+L S K+ DFG A
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 49/219 (22%), Positives = 94/219 (42%), Gaps = 41/219 (18%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL---- 744
LG GG G+V+ + + VAIKK+ ++ + +E+K + ++ H N+V +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVFEIL 77
Query: 745 -----EGYYWTPSLQL-----LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKG 794
+ SL ++ E++ + L + + L + + +G
Sbjct: 78 GPSGSQLTDDVGSLTELNSVYIVQEYMET-----DLANVLEQGPLLEEHARLFMYQLLRG 132
Query: 795 LAYLHHTNIIHYNLKSTNVLIDSSG-EPKVGDFGLARLLPMLDRCILSSKIQSALGYM-- 851
L Y+H N++H +LK N+ I++ K+GDFGLAR++ S G++
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM---------DPHYSHKGHLSE 183
Query: 852 --------APEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
+P T+ D++ G + E++TGK
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 18/219 (8%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKS--QEDFEKEMKTLGKIRHHNLVALEG 746
LG G FG V + + VA+K ++ L KS E+E+ L +RH +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLS---WRQRFNIILGMAKGLAYLHHTNI 803
TP+ +++ E+ G L+ ++ + ++ R+ F I+ + Y H I
Sbjct: 77 VITTPTDIVMVIEYAG-GELFDYI---VEKKRMTEDEGRRFFQQIIC---AIEYCHRHKI 129
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
+H +LK N+L+D + K+ DFGL+ + M D L + S Y APE +
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKTSCGS-PNYAAPEVINGKLYAG 186
Query: 864 EKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGA 902
+ DV+ G+++ ++ G+ P + ++ + L V
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFD--DEFIPNLFKKVNSC 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 51/217 (23%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK---------EMKTLGKIRHH 739
+G G +G V I + G VAIKKL+ F+ E+ L ++H
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLS--------RPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 740 NLVALEGYYWTPSLQL-------LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMA 792
N++ L + TP+ L L+ F+ + L + ++ ++ M
Sbjct: 84 NVIGLLDVF-TPASSLRNFYDFYLVMPFMQT-----DLQKIMGLKFSEEKIQY-LVYQML 136
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG--- 849
KGL Y+H ++H +LK N+ ++ E K+ DFGLAR + +
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR------------HADAEMTGYV 184
Query: 850 ----YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
Y APE + + D++ G ++ E++TGK
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 48/194 (24%), Positives = 78/194 (40%), Gaps = 16/194 (8%)
Query: 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEP 821
S + + ++ L+ +AKG+ +L IH +L + N+L+
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232
Query: 822 KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT- 880
K+ DFGLAR + + + L +MAPE T + DV+ FGVL+ E+ +
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIFSL 291
Query: 881 GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVP 940
G P ++ D L++G R+R P + + L C P
Sbjct: 292 GASPYPGVKIDEEFC-----RRLKEGT-------RMR--APDYTTPEMYQTMLDCWHGEP 337
Query: 941 SNRPDMEEVVNILE 954
S RP E+V L
Sbjct: 338 SQRPTFSELVEHLG 351
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 6e-13
Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 34/211 (16%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE---KEMKTLGKIRHHN-LVAL 744
+GRG + V L+ R A+K + L+ ED + E + +H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHHT 801
+ T S + E+++ G L H+ R RF I L L YLH
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLA----LNYLHER 129
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFAC- 857
II+ +LK NVL+DS G K+ D+G+ + + + G Y+APE
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRP----GDTTSTFCGTPNYIAPEILRG 184
Query: 858 ----RTVKITEKCDVYGFGVLVLEVVTGKRP 884
+V D + GVL+ E++ G+ P
Sbjct: 185 EDYGFSV------DWWALGVLMFEMMAGRSP 209
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 6e-13
Identities = 44/192 (22%), Positives = 76/192 (39%), Gaps = 18/192 (9%)
Query: 387 GLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASI--GKLKAIQVLDFSDN 444
+L S L +P ++ S LL++S N L + A +L + L S N
Sbjct: 19 ASNILSCSKQQLP-NVPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHN 74
Query: 445 WLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQI-KNCSSLTSLILSQNNLTGPVPAAI 502
LN I + +L+ L L N L + + + +L L+L N++ A
Sbjct: 75 HLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAF 132
Query: 503 ANLSNLKYVDLSFNDLSGILP---KELINLSHLLSFNISHNHLHGELPVGGFFNTISPSS 559
+++ L+ + LS N +S K+ L L+ ++S N L +LP+ +
Sbjct: 133 EDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVK 191
Query: 560 VS----GNPSLC 567
NP C
Sbjct: 192 NGLYLHNNPLEC 203
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 39/172 (22%), Positives = 70/172 (40%), Gaps = 16/172 (9%)
Query: 254 LPDSLQRLNSCSSLSLKGNSFTGEVPDWI-GKLANLESLDLSLNQFSGRIPSSI-GNLVF 311
LP L+ L N+ + +W +L NL SL LS N + I S +
Sbjct: 37 LPSYTALLD------LSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN 89
Query: 312 LKELNISMNQFTGGLPESM-MNCGNLLAIDVSQNKLTGNIPTWIFK--MGLQTVSLSGNR 368
L+ L++S N L E + + L + + N + + F+ LQ + LS N+
Sbjct: 90 LRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQ 147
Query: 369 LGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMN 420
+ + L +LDLSSN L + +++ L + + + ++
Sbjct: 148 I-SRFPVELIKDG-NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 40/167 (23%), Positives = 73/167 (43%), Gaps = 13/167 (7%)
Query: 118 TLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNR 177
++D S NNLS L + + +L + ++N+L E+ +L ++ SSN
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99
Query: 178 LSGQLPYGIWF--LRSLQSLDLSNNLLEGEIVKGI-SNLYDLRAIKLGKNKFSGQLPEDI 234
L L + F L++L+ L L NN + + + ++ L+ + L +N+ S + P ++
Sbjct: 100 LH-TLDEFL-FSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155
Query: 235 ----GGCSMLKVLDFGVNSLSGSLPDSLQRLNS--CSSLSLKGNSFT 275
L +LD N L LQ+L + + L L N
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 34/160 (21%), Positives = 61/160 (38%), Gaps = 7/160 (4%)
Query: 95 LQVLSLSNNNFTG-TINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNN 153
+L LS+NN + L + S N+L+ I E F +LR + ++N+
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNH 99
Query: 154 LTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIW-FLRSLQSLDLSNNLL---EGEIVKG 209
L S +LE + +N + + + + LQ L LS N + E++K
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKD 158
Query: 210 ISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNS 249
+ L L + L NK D+ +++
Sbjct: 159 GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 33/136 (24%), Positives = 58/136 (42%), Gaps = 8/136 (5%)
Query: 91 RLQFLQVLSLSNNNFTGTINAD-LASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSF 149
RL L L LS+N+ I+++ L+ +D S N+L L + F +L +
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTL-DEFLFSDLQALEVLLL 119
Query: 150 ANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWF----LRSLQSLDLSNNLLEGE 205
NN++ + + L+ + S N++S + P + L L LDLS+N L+
Sbjct: 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKL 178
Query: 206 IVKGISNLYDLRAIKL 221
+ + L L
Sbjct: 179 PLTDLQKLPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 48/198 (24%), Positives = 72/198 (36%), Gaps = 47/198 (23%)
Query: 263 SCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQF 322
SCS L VP + + LDLS N S +
Sbjct: 24 SCSKQQLP------NVPQSL--PSYTALLDLSHNNLS----------------RLRAEWT 59
Query: 323 TGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFK--MGLQTVSLSGNRLGESMQYPSFAS 380
L NL ++ +S N L I + F L+ + LS N L ++ F+
Sbjct: 60 PTRLT-------NLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSD 110
Query: 381 MKDSYQGLQVLDLSSNALSGVIPSNI-GDLSSLMLLNMSMNYLFGSIPA----SIGKLKA 435
+ Q L+VL L +N + V+ N D++ L L +S N + P KL
Sbjct: 111 L----QALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPK 164
Query: 436 IQVLDFSDNWLNGTIPPQ 453
+ +LD S N L +P
Sbjct: 165 LMLLDLSSNKLK-KLPLT 181
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 55/206 (26%), Positives = 86/206 (41%), Gaps = 24/206 (11%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE---KEMKTLGKIRHHN-LVAL 744
+GRG + V L+ R A++ + L+ ED + E + +H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHHT 801
+ T S + E+++ G L H+ R RF I L L YLH
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLA----LNYLHER 172
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACR 858
II+ +LK NVL+DS G K+ D+G+ + + + G Y+APE
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRP----GDTTSTFCGTPNYIAPEILRG 227
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRP 884
D + GVL+ E++ G+ P
Sbjct: 228 E-DYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 9/182 (4%)
Query: 388 LQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNWL 446
+ LDL SN LS + L+ L LL ++ N L ++PA I +LK ++ L +DN L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKL 97
Query: 447 NGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQI-KNCSSLTSLILSQNNLTGPVPAAIAN 504
+P + V+L EL+L++N L +P ++ + + LT L L N L
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDK 155
Query: 505 LSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSV--SG 562
L++LK + L N L + L+ L + + +N L +P G F + +
Sbjct: 156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQE 214
Query: 563 NP 564
NP
Sbjct: 215 NP 216
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 59/262 (22%), Positives = 90/262 (34%), Gaps = 67/262 (25%)
Query: 263 SCS----SLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNIS 318
SC+ S+ T +P I A+ + LDL N+ S + L L+ L ++
Sbjct: 13 SCNNNKNSVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLN 69
Query: 319 MNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSF 378
N+ +P IF L
Sbjct: 70 DNKLQ-------------------------TLPAGIF-----------KELKN------- 86
Query: 379 ASMKDSYQGLQVLDLSSNALSGVIPSNIGD-LSSLMLLNMSMNYLFGSIPASI-GKLKAI 436
L+ L ++ N L +P + D L +L L + N L S+P + L +
Sbjct: 87 ---------LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKL 135
Query: 437 QVLDFSDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQI-KNCSSLTSLILSQNNL 494
L N L ++P + SLKEL+L N L R+P + L +L L N L
Sbjct: 136 TYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQL 193
Query: 495 TGPVPAAIANLSNLKYVDLSFN 516
A +L LK + L N
Sbjct: 194 KRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 21/214 (9%)
Query: 334 GNLLAIDVSQNKLT---GNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQV 390
N ++D S KLT NIP + + L N+L S+ +F L++
Sbjct: 16 NNKNSVDCSSKKLTAIPSNIPA-----DTKKLDLQSNKL-SSLPSKAF----HRLTKLRL 65
Query: 391 LDLSSNALSGVIPSNI-GDLSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNWLNG 448
L L+ N L +P+ I +L +L L ++ N L ++P + +L + L N L
Sbjct: 66 LYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLK- 122
Query: 449 TIPPQI-GGAVSLKELKLEKNFLSGRIPSQI-KNCSSLTSLILSQNNLTGPVPAAIANLS 506
++PP++ L L L N L +P + +SL L L N L A L+
Sbjct: 123 SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLT 181
Query: 507 NLKYVDLSFNDLSGILPKELINLSHLLSFNISHN 540
LK + L N L + +L L + N
Sbjct: 182 ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 5e-06
Identities = 49/187 (26%), Positives = 76/187 (40%), Gaps = 17/187 (9%)
Query: 118 TLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFC-SSLESVNFSSN 176
+ +D N LS L P + F + LR + +N L +P + +LE++ + N
Sbjct: 38 DTKKLDLQSNKLSSL-PSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDN 95
Query: 177 RLSGQLPYGI-WFLRSLQSLDLSNNLLEGEIVKGI-SNLYDLRAIKLGKNKFSGQLPEDI 234
+L LP G+ L +L L L N L+ + + +L L + LG N+ LP+ +
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152
Query: 235 -GGCSMLKVLDFGVNSLSGSLP----DSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLE 289
+ LK L N L +P D L L +L L N L L+
Sbjct: 153 FDKLTSLKELRLYNNQLK-RVPEGAFDKLTELK---TLKLDNNQLKRVPEGAFDSLEKLK 208
Query: 290 SLDLSLN 296
L L N
Sbjct: 209 MLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 29/104 (27%), Positives = 41/104 (39%), Gaps = 5/104 (4%)
Query: 449 TIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAI-ANLSN 507
IP I K+L L+ N LS + L L L+ N L +PA I L N
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKN 86
Query: 508 LKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGF 551
L+ + ++ N L + L +L + N L LP F
Sbjct: 87 LETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVF 129
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 36/130 (27%), Positives = 61/130 (46%), Gaps = 9/130 (6%)
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQI-KNCS 482
+IP++I + LD N L+ ++P + L+ L L N L +P+ I K
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELK 85
Query: 483 SLTSLILSQNNLTGPVPAAI-ANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNH 541
+L +L ++ N L +P + L NL + L N L + P+ +L+ L ++ +N
Sbjct: 86 NLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE 144
Query: 542 LHGELPVGGF 551
L LP G F
Sbjct: 145 LQ-SLPKGVF 153
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 15/119 (12%)
Query: 91 RLQFLQVLSLSNNNFTGTINADL-ASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSF 149
RL L++L L++N T+ A + L+ + ++N L L P F Q +L E+
Sbjct: 59 RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQAL-PIGVFDQLVNLAELRL 116
Query: 150 ANNNLTGPIPE----SLSFCSSLESVNFSSNRLSGQLPYGIWF--LRSLQSLDLSNNLL 202
N L +P SL+ L ++ N L LP G+ F L SL+ L L NN L
Sbjct: 117 DRNQLKS-LPPRVFDSLT---KLTYLSLGYNELQ-SLPKGV-FDKLTSLKELRLYNNQL 169
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 24/206 (11%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE---KEMKTLGKIRHHN-LVAL 744
LG+G FG V + + A+K L ++ +D E E + L L L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILK-KDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHHT 801
+ T + E+++ G L H+ F I +G L +L
Sbjct: 87 HSCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIG----LFFLQSK 140
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACR 858
II+ +LK NV++DS G K+ DFG+ + + D ++ G Y+APE
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWD----GVTTKTFCGTPDYIAPEIIAY 195
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRP 884
+ D + FGVL+ E++ G+ P
Sbjct: 196 Q-PYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 50/225 (22%), Positives = 99/225 (44%), Gaps = 45/225 (20%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK---------EMKTLGKIRHH 739
LG+G +G+V+++I + G VA+KK+ + F+ E+ L ++ H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIF--------DAFQNSTDAQRTFREIMILTELSGH 68
Query: 740 -NLVALEGYYWTPSLQ--LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLA 796
N+V L + + L+++++ + LH N L + ++ + K +
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMET-----DLHAVIRANILEPVHKQYVVYQLIKVIK 123
Query: 797 YLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG------- 849
YLH ++H ++K +N+L+++ KV DFGL+R + R + +
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 850 ------------YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
Y APE + K T+ D++ G ++ E++ GK
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 50/217 (23%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK---------EMKTLGKIRHH 739
+G G G+V R+VAIKKL+ F+ E+ + + H
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLS--------RPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 740 NLVALEGYYWTPSLQL-------LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMA 792
N++ L + TP L ++ E + + +L + + R + ++ M
Sbjct: 85 NIIGLLNVF-TPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHE----RMSY-LLYQML 137
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG--- 849
G+ +LH IIH +LK +N+++ S K+ DFGLAR ++ +
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGTSFMMTPYV 187
Query: 850 ----YMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
Y APE + E D++ G ++ E++ G
Sbjct: 188 VTRYYRAPEV-ILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 4e-12
Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 32/161 (19%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK---------EMKTLGKIRHH 739
+G G G+V R+VAIKKL+ F+ E+ + + H
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLS--------RPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 740 NLVALEGYYWTPSLQL-------LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMA 792
N+++L + TP L L+ E + + +L + + R + ++ M
Sbjct: 122 NIISLLNVF-TPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHE----RMSY-LLYQML 174
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833
G+ +LH IIH +LK +N+++ S K+ DFGLAR
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 31/158 (19%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEK---------EMKTLGKIRHH 739
+G G +G V + G VA+KKL+ F+ E++ L ++H
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLS--------RPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 740 NLVALEGYYWTPSLQL-------LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMA 792
N++ L + TP+ L L+ + + L++ L+ +I +
Sbjct: 89 NVIGLLDVF-TPARSLEEFNDVYLVTHLMGA-----DLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 793 KGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
+GL Y+H +IIH +LK +N+ ++ E K+ DFGLAR
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-12
Identities = 46/214 (21%), Positives = 86/214 (40%), Gaps = 43/214 (20%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDF----EKEMKTLGKIRH------ 738
+G+G FG V + + + VA+K ++++++ F +E++ L +R
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALK------MVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 739 HNLVALEGY-YW-------TPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILG 790
N++ + + L + +YE I ++ R
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNK-FQGFSLPLVRK---------FAHS 208
Query: 791 MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEP--KVGDFGLARLLPMLDRCILSSKIQSAL 848
+ + L LH IIH +LK N+L+ G KV DFG + + + + IQS
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQS-R 263
Query: 849 GYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK 882
Y APE + D++ G ++ E++TG
Sbjct: 264 FYRAPEVILG-ARYGMPIDMWSLGCILAELLTGY 296
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 30/184 (16%), Positives = 69/184 (37%), Gaps = 20/184 (10%)
Query: 359 LQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMS 418
+L + + S + +Q + ++ + + + + ++L L++S
Sbjct: 21 AVKQNLGKQSVTD---LVSQKELSG----VQNFNGDNSNIQSL--AGMQFFTNLKELHLS 71
Query: 419 MNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQI 478
N + S + + L ++ L + N L + + L L L+ N L +
Sbjct: 72 HNQI--SDLSPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELRD--TDSL 124
Query: 479 KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNIS 538
+ +L L + N L V + LS L+ +DL N+++ L L + +++
Sbjct: 125 IHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLT 180
Query: 539 HNHL 542
Sbjct: 181 GQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 44/235 (18%), Positives = 82/235 (34%), Gaps = 20/235 (8%)
Query: 88 GLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147
L +L + T ++ +Q + +N+ L + +L+E+
Sbjct: 14 PDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSL---AGMQFFTNLKEL 68
Query: 148 SFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIV 207
++N ++ L + LE ++ + NRL L L L NN L
Sbjct: 69 HLSHNQISD--LSPLKDLTKLEELSVNRNRLKNLNGIP---SACLSRLFLDNNELRD--T 121
Query: 208 KGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSL 267
+ +L +L + + NK +G S L+VLD N ++ + L RL + +
Sbjct: 122 DSLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWI 177
Query: 268 SLKGNSFTGEVPDWIGKLANLESL-DLSLNQFSGRIPSSIGNLVFLKELNISMNQ 321
L G E + +L ++ D S P I N + +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWEL 229
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 37/251 (14%), Positives = 68/251 (27%), Gaps = 67/251 (26%)
Query: 282 IGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDV 341
LAN +L + S L ++ N + M NL + +
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHL 70
Query: 342 SQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGV 401
S N+++ LS + L+ L ++ N
Sbjct: 71 SHNQIS---------------DLSP-----------LKDLTK----LEELSVNRN----- 95
Query: 402 IPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLK 461
+ +L+ + + L +N L + +L+
Sbjct: 96 ---RLKNLNGIPSAC-------------------LSRLFLDNNELR-DTDS-LIHLKNLE 131
Query: 462 ELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGI 521
L + N L I + S L L L N +T + L + ++DL+
Sbjct: 132 ILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNE 187
Query: 522 LPKELINLSHL 532
K L
Sbjct: 188 PVKYQPELYIT 198
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 41/234 (17%), Positives = 71/234 (30%), Gaps = 18/234 (7%)
Query: 189 LRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVN 248
L + +L + + L ++ + + + LK L N
Sbjct: 18 LANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHLSHN 73
Query: 249 SLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGN 308
+S L L+ L LS+ N A L L L N+ S+ +
Sbjct: 74 QIS-DL-SPLKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFLDNNELRD--TDSLIH 126
Query: 309 LVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNR 368
L L+ L+I N+ + L +D+ N++T N + + L+G +
Sbjct: 127 LKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEIT-NTGGLTRLKKVNWIDLTGQK 183
Query: 369 LGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYL 422
+ Y V D +S SN G +L Y
Sbjct: 184 CVNEPVK----YQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 16/113 (14%), Positives = 41/113 (36%), Gaps = 9/113 (7%)
Query: 430 IGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLIL 489
L + + + ++ + + + + ++ ++L L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70
Query: 490 SQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHL 542
S N ++ P + +L+ L+ + ++ N L + LS L + +N L
Sbjct: 71 SHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNEL 118
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE---KEMKTLGK-IRHHNLVAL 744
LG+G FG V+ + + AIK L ++ +D E E + L H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHHT 801
+ T + E+++ G L H+ R F IILG L +LH
Sbjct: 84 FCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILG----LQFLHSK 137
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACR 858
I++ +LK N+L+D G K+ DFG+ + + + +K + G Y+APE
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTNTFCGTPDYIAPEILLG 192
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRP 884
K D + FGVL+ E++ G+ P
Sbjct: 193 Q-KYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE---KEMKTLGKIRHHN-LVAL 744
LG+G FG V +++ G A+K L +I +D E E + L R+H L L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLK-KDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHHT 801
+ TP + EF++ G L H+ SR R RF II L +LH
Sbjct: 90 FCCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISA----LMFLHDK 143
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACR 858
II+ +LK NVL+D G K+ DFG+ + + + + G Y+APE
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICN----GVTTATFCGTPDYIAPEI--- 195
Query: 859 TVKITEK-----CDVYGFGVLVLEVVTGKRP 884
+ E D + GVL+ E++ G P
Sbjct: 196 ---LQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 58/459 (12%), Positives = 146/459 (31%), Gaps = 39/459 (8%)
Query: 87 RGLLRLQFLQVLSLSNNNFTG-TINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLR 145
+G ++ + I A +S+ L+ + ++ + + + +
Sbjct: 74 KGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFK 133
Query: 146 EVSFAN-NNLTGP-IPESLSFCSSLESVNFSSNRLSGQLPYGIWFL----RSLQSLDLSN 199
+ ++ + + + C +L+ ++ + + + + SL SL++S
Sbjct: 134 VLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC 193
Query: 200 --NLLEGEIVKGI-SNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSG---- 252
+ + ++ + + +L+++KL + +L + L+ L G +
Sbjct: 194 LASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDV 253
Query: 253 --SLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGR-IPSSIGNL 309
L +L LS ++ +P + L +L+LS + +
Sbjct: 254 YSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQC 313
Query: 310 VFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQ-NKLTGNIPTWIFKMGLQTVSLSGNR 368
L+ L + GL C +L + V + + GL +VS+ +
Sbjct: 314 PKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPK 373
Query: 369 L------GESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYL 422
L M + ++ + + L + +++ L
Sbjct: 374 LESVLYFCRQMTNAALITIARNRPNMTRFRLCI-------------IEPKAPDYLTLEPL 420
Query: 423 FGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQI-KNC 481
A + K ++ L S + A ++ L + S + C
Sbjct: 421 DIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGC 480
Query: 482 SSLTSLILSQNNLTGP-VPAAIANLSNLKYVDLSFNDLS 519
SL L + + A + L ++ + +S +S
Sbjct: 481 DSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 62/491 (12%), Positives = 147/491 (29%), Gaps = 48/491 (9%)
Query: 87 RGLLRLQFLQVLSLSNNNFTGTINADLAS-FGTLQVVDFSE--------------NNLSG 131
+ ++ + N A + F ++ V+
Sbjct: 35 KSWYEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVY 94
Query: 132 LIPDEFFRQCGSLREVSFANNNLTGPIPESLS-FCSSLESVNFSS-NRLSGQ-LPYGIWF 188
+ L E+ +T E ++ + + + SS S L
Sbjct: 95 PWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAAT 154
Query: 189 LRSLQSLDLSNNLLEGEIVKGISNLYD----LRAIKLG--KNKFSGQLPEDIG-GCSMLK 241
R+L+ LDL + ++ +S+ D L ++ + ++ S E + C LK
Sbjct: 155 CRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLK 214
Query: 242 VLDF-------GVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLS 294
L + +L P L+ L + + + + L L
Sbjct: 215 SLKLNRAVPLEKLATLLQRAP-QLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGF 273
Query: 295 LNQFSGRIPSSIGNLVFLKELNISMNQFTG-GLPESMMNCGNLLAIDVSQNKLTGNIPTW 353
+ +P+ L LN+S L + + C L + V + +
Sbjct: 274 WDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL-DYIEDA---G 329
Query: 354 IFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIP--SNIGDLSS 411
+ + L R+ S + ++ + QGL + + L V+ + + ++
Sbjct: 330 LEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTN-AA 388
Query: 412 LMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLS 471
L+ + + + + ++ + L+ + L+ L L L+
Sbjct: 389 LITIARNRPNM---TRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLS-GLLT 444
Query: 472 GRIPSQI-KNCSSLTSLILSQNNLTGPVPAAIA-NLSNLKYVDLSFNDLSG-ILPKELIN 528
++ I + L ++ + + +L+ +++ L
Sbjct: 445 DKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASK 504
Query: 529 LSHLLSFNISH 539
L + S +S
Sbjct: 505 LETMRSLWMSS 515
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 37/270 (13%), Positives = 81/270 (30%), Gaps = 28/270 (10%)
Query: 287 NLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKL 346
+ S++L + + L I + + +
Sbjct: 67 KVRSVELKGKPHFADFNLVPDGW---------GGYVYPWIEAMSSSYTWLEEIRLKRMVV 117
Query: 347 TGNIPTWIFKM--GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGV--- 401
T + I K + + LS A++ + + L+ LDL + + V
Sbjct: 118 TDDCLELIAKSFKNFKVLVLSSCE---GFSTDGLAAIAATCRNLKELDLRESDVDDVSGH 174
Query: 402 ----IPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGA 457
P L SL + ++ F ++ + + ++ L + + + A
Sbjct: 175 WLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRA 234
Query: 458 VSLKELKLEKNFLSGR------IPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYV 511
L+EL R + + C L L + + +PA + S L +
Sbjct: 235 PQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTL 294
Query: 512 DLSFNDLSGILPKELI-NLSHLLSFNISHN 540
+LS+ + +L+ L +
Sbjct: 295 NLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 24/206 (11%)
Query: 690 LGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFE---KEMKTLGK-IRHHNLVAL 744
+G+G FG V + A+K L I +++ + E L K ++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQ-KKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRF---NIILGMAKGLAYLHHT 801
+ T + ++I+ G L+ HL R L R RF I L YLH
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASA----LGYLHSL 158
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACR 858
NI++ +LK N+L+DS G + DFGL + + +S + G Y+APE +
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEH----NSTTSTFCGTPEYLAPEVLHK 213
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRP 884
D + G ++ E++ G P
Sbjct: 214 Q-PYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 60/392 (15%), Positives = 109/392 (27%), Gaps = 98/392 (25%)
Query: 190 RSLQSLDLSNNLLEGEIVKGI-----SNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLD 244
+ SLDLS N L + + + ++ L N
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG----------------F 65
Query: 245 FGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKL-----ANLESLDLSLNQFS 299
+ L L + +SL+L GN + + D + K + LDL N FS
Sbjct: 66 KNSDELVQILAAIPANV---TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122
Query: 300 GRIPSSIGNLVF-----LKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWI 354
+ S + LN+ N + L ++
Sbjct: 123 SKSSSEFKQAFSNLPASITSLNLRGNDLGI-------KSSDELIQILAAIPAN------- 168
Query: 355 FKMGLQTVSLSGNRLG-ESMQYPSFASM-KDSYQGLQVLDLSSN--------ALSGVIPS 404
+ +++L GN L ++ A + LDLS+N L+ + S
Sbjct: 169 ----VNSLNLRGNNLASKNCAE--LAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS 222
Query: 405 NIGDLSSLMLLNMSMNYLFGS----IPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSL 460
+ ++ LN+ +N L G + LK +Q + + +
Sbjct: 223 I---PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNM------SKEQC 273
Query: 461 KELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANL-----SNLKYVDLSF 515
K L + N + + + + I+NL L
Sbjct: 274 KALG-----------AAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLN 322
Query: 516 NDLSGI-----LPKELINLSHLLSFNISHNHL 542
L ++L L + L
Sbjct: 323 QCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 50/301 (16%), Positives = 94/301 (31%), Gaps = 42/301 (13%)
Query: 287 NLESLDLSLNQFSGRIPSSIG-----NLVFLKELNISMNQFT----GGLPESMM-NCGNL 336
+ SLDLSLN + + LN+S N L + + N+
Sbjct: 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82
Query: 337 LAIDVSQNKLTGNIPTWIFKM------GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQV 390
++++S N L+ + K + + L N + + +
Sbjct: 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITS 142
Query: 391 LDLSSNALSGVIPSNIGDL-----SSLMLLNMSMNYLFGSIPASIGKL-----KAIQVLD 440
L+L N L + + +++ LN+ N L A + K ++ LD
Sbjct: 143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLD 202
Query: 441 FSDNWLNGTIPPQIGGAV-----SLKELKLEKNFLSG----RIPSQIKNCSSLTSLILSQ 491
S N L ++ + L L N L G + + L ++ L
Sbjct: 203 LSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDY 262
Query: 492 NNLTGPVPA-------AIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHG 544
+ + A N+ + VD + ++ + NL LS L
Sbjct: 263 DIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLN 322
Query: 545 E 545
+
Sbjct: 323 Q 323
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 45/364 (12%), Positives = 110/364 (30%), Gaps = 71/364 (19%)
Query: 84 HIGRGLLRLQFLQVLSLSNNNFTGTINADLAS-----FGTLQVVDFSENNLS----GLIP 134
+ + L LS NN +L ++ ++ S N+L +
Sbjct: 13 PVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELV 72
Query: 135 DEFFRQCGSLREVSFANNNLTGP----IPESLSFC-SSLESVNFSSNRLSGQLPYGIWFL 189
++ ++ + N L+ + ++L+ ++ ++ N S +
Sbjct: 73 QILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSK---SSSEF 129
Query: 190 --------RSLQSLDLSNNLLEGEIVKGISNL-----YDLRAIKLGKNKFSGQLPEDIGG 236
S+ SL+L N L + + + ++ ++ L N +
Sbjct: 130 KQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA--------- 180
Query: 237 CSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKL-----ANLESL 291
L+ L + +SL L N + + + ++ SL
Sbjct: 181 -------SKNCAELAKFLASIPASV---TSLDLSANLLGLKSYAELAYIFSSIPNHVVSL 230
Query: 292 DLSLNQFSG----RIPSSIGNLVFLKELNISMNQFTG-------GLPESMMNCGNLLAID 340
+L LN G + +L L+ + + + L + N ++ +D
Sbjct: 231 NLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVD 290
Query: 341 VSQNKLTGNIPTWIFKM------GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLS 394
+ ++ + I + SL L + ++ + + L+ +
Sbjct: 291 KNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQT 350
Query: 395 SNAL 398
L
Sbjct: 351 CKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 40/194 (20%), Positives = 76/194 (39%), Gaps = 30/194 (15%)
Query: 379 ASMKDSYQGLQVLDLSSNALSGVIPSNIGDL-----SSLMLLNMSMNYLFGSIPASIGKL 433
G+ LDLS N L + + +S+ LN+S N L + ++
Sbjct: 15 EEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQI 74
Query: 434 -----KAIQVLDFSDNWLNGTIPPQIGGAV-----SLKELKLEKNFLSGR----IPSQIK 479
+ L+ S N+L+ ++ + ++ L L N S +
Sbjct: 75 LAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFS 134
Query: 480 NC-SSLTSLILSQNNLTGPVPAAIANL-----SNLKYVDLSFNDLS----GILPKELINL 529
N +S+TSL L N+L + + +N+ ++L N+L+ L K L ++
Sbjct: 135 NLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASI 194
Query: 530 -SHLLSFNISHNHL 542
+ + S ++S N L
Sbjct: 195 PASVTSLDLSANLL 208
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 48/223 (21%), Positives = 86/223 (38%), Gaps = 47/223 (21%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDF----EKEMKTLGKIRHHNLVAL 744
LG G F V+ + + VA+K +++ + + E E+K L ++ +
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMK------IVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHL---HDGSSRNCLSWRQRFN-----------IILG 790
+ L+LL + F G H+ + N L+ +++ I
Sbjct: 81 DSMGANHILKLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 791 MAKGLAYLH-HTNIIHYNLKSTNVLIDSSGEP------KVGDFGLARLLPMLDRCILSSK 843
+ GL Y+H IIH ++K NVL++ P K+ D G A ++
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNS 195
Query: 844 IQSALGYMAPEFACRTV----KITEKCDVYGFGVLVLEVVTGK 882
IQ+ Y +PE V D++ L+ E++TG
Sbjct: 196 IQTRE-YRSPE-----VLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 7e-11
Identities = 32/184 (17%), Positives = 53/184 (28%), Gaps = 44/184 (23%)
Query: 690 LGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGK----IRHHNLVALE 745
+G G FG V++TI D VAIK + + G +K + + + +L++ E
Sbjct: 28 IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHL---------------------------------HD 772
T L GS L
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 773 GSS-----RNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDF 826
G S +I+ + LA + H +L NVL+ + K+
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYT 206
Query: 827 GLAR 830
+
Sbjct: 207 LNGK 210
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 2e-09
Identities = 25/96 (26%), Positives = 41/96 (42%), Gaps = 2/96 (2%)
Query: 449 TIPPQIGGAVSLKELKLEKNFLSGRIPSQ-IKNCSSLTSLILSQNNLTGPVPAAIANLSN 507
+ GA +L EL +E + + ++ L +L + ++ L P A
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 508 LKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLH 543
L ++LSFN L + K + LS L +S N LH
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 22/93 (23%), Positives = 31/93 (33%), Gaps = 1/93 (1%)
Query: 108 TINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSS 167
L L + + R G LR ++ + L P++ F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 168 LESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNN 200
L +N S N L L + SLQ L LS N
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 20/94 (21%), Positives = 35/94 (37%), Gaps = 1/94 (1%)
Query: 277 EVPDWIGKLANLESLDLSLNQFSGRIPS-SIGNLVFLKELNISMNQFTGGLPESMMNCGN 335
+ + NL L + Q + + L L+ L I + P++
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 336 LLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRL 369
L +++S N L + + LQ + LSGN L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 12/87 (13%), Positives = 24/87 (27%), Gaps = 12/87 (13%)
Query: 481 CSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKE-LINLSHLLSFNISH 539
+ L +++ + NL + + L L L L + I
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 540 NHLHGELPVGGFFNTISPSSVSGNPSL 566
+ L ++P + P L
Sbjct: 66 SGL----------RFVAPDAFHFTPRL 82
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 8e-04
Identities = 18/112 (16%), Positives = 37/112 (33%), Gaps = 3/112 (2%)
Query: 165 CSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKG-ISNLYDLRAIKLGK 223
+ + + + + +L L + N + + L +LR + + K
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 224 NKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFT 275
+ P+ L L+ N+L ++Q L+ L L GN
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSL-QELVLSGNPLH 116
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 64/457 (14%), Positives = 138/457 (30%), Gaps = 70/457 (15%)
Query: 92 LQFLQVLSLSNNNFTGTINADLAS--FGTLQVVDFSE-NNLSGLIPDEFFRQCGSLREVS 148
L+ L+ + + LA L+ + + + + C ++ +
Sbjct: 111 LRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLL 170
Query: 149 FANNNLTGPIPESLSF----CSSLESVNFSSNRLSGQLPYGIWFL----RSLQSLDLSNN 200
++ + + L +SLE +NF + P + + RSL S+ + +
Sbjct: 171 MEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDF 230
Query: 201 LLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQR 260
L + K + L+ G + +P+
Sbjct: 231 ----------EILELVGFFKA---------------AANLEEFCGGSLNEDIGMPEKYMN 265
Query: 261 LNSCSSLSLKGNSFTG--EVPDWIGKLANLESLDLS-LNQFSGRIPSSIGNLVFLKELNI 317
L L G S+ G E+P A + LDL + + I L+ L
Sbjct: 266 LVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLET 325
Query: 318 SMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPS 377
GL C L + + + Q + + +
Sbjct: 326 RNVIGDRGLEVLAQYCKQLKRLRIERGA------------DEQGMEDEEGLVSQR----G 369
Query: 378 FASMKDSYQGLQVLDLSSNALSGV----IPSNIGDLSSLMLLNMSMNYLFGSIPASIG-- 431
++ Q L+ + + + ++ I + + +L L+ + +P G
Sbjct: 370 LIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVR 429
Query: 432 ----KLKAIQVLDFSDN--WLNGTIPPQIG-GAVSLKELKLEKNFLSGR-IPSQIKNCSS 483
K ++ F L IG + +++ + L S + + C +
Sbjct: 430 SLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPN 489
Query: 484 LTSLILSQNNLTGP-VPAAIANLSNLKYVDLSFNDLS 519
L L + + + AA+ L +L+Y+ + S
Sbjct: 490 LQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 58/341 (17%), Positives = 113/341 (33%), Gaps = 50/341 (14%)
Query: 237 CSMLKVLDFGVNSLSGSLPDSLQRLN--SCSSLSLKGNSFTGEVPDWIGKLA----NLES 290
+ V D ++ L+ + D L+ L CS + G + + +++
Sbjct: 119 FRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDG----------LLSIVTHCRKIKT 168
Query: 291 LDLSLNQFSGRIPSSIGNLV----FLKELNISMNQFTG----GLPESMMNCGNLLAIDVS 342
L + + FS + + L L+ LN M +F L NC +L+++ V
Sbjct: 169 LLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVG 228
Query: 343 QNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVI 402
++ + FK G L E + P + L L LS + +
Sbjct: 229 DFEILELV--GFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-M 285
Query: 403 PSNIGDLSSLMLLNMSMNYLFG-SIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLK 461
P + + L++ L I K ++VL+ + + + LK
Sbjct: 286 PILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLK 345
Query: 462 ELKLEKNFLSGRIPSQI------------KNCSSLTSLILSQNNLTGPVPAAIA----NL 505
L++E+ + + + C L + + +++T +I NL
Sbjct: 346 RLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNL 405
Query: 506 SNLKYVDLSFNDLSGILPKE------LINLSHLLSFNISHN 540
+ + V L + LP + LI L F
Sbjct: 406 CDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLR 446
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 37/334 (11%), Positives = 97/334 (29%), Gaps = 33/334 (9%)
Query: 91 RLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFA 150
+ L + + + + + L+ N +P+++ +
Sbjct: 218 NCRSLVSVKVGDFEIL-ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLG 276
Query: 151 NNNLT-GPIPESLSFCSSLESVNFSSNRLSG-QLPYGIWFLRSLQSLDLSNNLLEGEIVK 208
+ + +P F + + ++ L I +L+ L+ N + + +
Sbjct: 277 LSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEV 336
Query: 209 GISNLYDLRAIKLGKNKFSGQLPEDIG------------GCSMLKVL--------DFGVN 248
L+ +++ + + ++ G GC L+ + + +
Sbjct: 337 LAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLE 396
Query: 249 SLSGSLPD--SLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLN--QFSGRIPS 304
S+ L + + + + V + L L + S
Sbjct: 397 SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLS 456
Query: 305 SIG-NLVFLKELNISMNQFT-GGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM--GLQ 360
IG ++ + + + GL E C NL +++ + L+
Sbjct: 457 YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLR 516
Query: 361 TVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLS 394
+ + G R SM M Y ++++
Sbjct: 517 YLWVQGYRA--SMTGQDLMQMARPYWNIELIPSR 548
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 46/220 (20%), Positives = 90/220 (40%), Gaps = 53/220 (24%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDF----EKEMKTLGKIRH------ 738
+G+G FG V + + VAIK +IK+++ F + E++ L +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIK------IIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 739 HNLVALEGYYW--------TPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILG 790
+ +V L+ ++ L +Y+ + + + ++ + +R +Q
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTN-FRGVSLNLTRKFA--QQ------- 165
Query: 791 MAKGLAYLHHT--NIIHYNLKSTNVLIDSSGEP--KVGDFGLARLLPMLDRCILSSKIQS 846
M L +L +IIH +LK N+L+ + K+ DFG + + IQS
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQS 221
Query: 847 ALGYMAPEFACRTV----KITEKCDVYGFGVLVLEVVTGK 882
Y +PE V D++ G +++E+ TG+
Sbjct: 222 RF-YRSPE-----VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 50/373 (13%), Positives = 101/373 (27%), Gaps = 90/373 (24%)
Query: 189 LRSLQSLDLSNNLLEGEIVKGI-----SNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVL 243
L SL+ L+L+ + + S + L + L + G ++L V
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLD-----PAGLRTLLPV- 124
Query: 244 DFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKL-----ANLESLDLSLNQF 298
L L+ NS E + L + +L LS N
Sbjct: 125 -----------------FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPL 167
Query: 299 SGR----IPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWI 354
+ + + + L++ LLA + +N+
Sbjct: 168 TAAGVAVLMEGLAGNTSVTHLSLLHTGLGDE-------GLELLAAQLDRNR--------- 211
Query: 355 FKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLML 414
LQ ++++ N G++ + A + L++L L N + +L
Sbjct: 212 ---QLQELNVAYNGAGDT-AALALARAAREHPSLELLHLYFN--------ELSSEGRQVL 259
Query: 415 LNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRI 474
++ G + + S +V L E++ N
Sbjct: 260 RDL------------GGAAEGGARVVVSLTEGTAV---SEYWSVILSEVQRNLNSWD--- 301
Query: 475 PSQIKNCSSLTSLILSQNNLTGPVPAAIANL----SNLKYVDLSFNDLSGILPKELINLS 530
++++ L L + P A L ++ +
Sbjct: 302 RARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLG---SSGSPSGSWSH 358
Query: 531 HLLSFNISHNHLH 543
H+H H
Sbjct: 359 PQFEKGAGHHHHH 371
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 42/259 (16%), Positives = 68/259 (26%), Gaps = 47/259 (18%)
Query: 74 LTLDGFSLSGHIGRGLLR-LQFLQVLSLSNNNFTGTINADLASF-----GTLQVVDFSEN 127
+ L L R LL + L L N+ DL + + S N
Sbjct: 106 VNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNN 165
Query: 128 NL---------SGLIPDEFFRQCGSLREVSFANNNLTGP----IPESLSFCSSLESVNFS 174
L GL S+ +S + L + L L+ +N +
Sbjct: 166 PLTAAGVAVLMEGL------AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVA 219
Query: 175 SNRLSGQLPYGIWFL-------RSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFS 227
N L SL+ L L N L E + + +L A + G
Sbjct: 220 YNGAG---DTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDL--GGAAEGGARVVV 274
Query: 228 GQL---PEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGK 284
+L + +NS + L L+ + P +
Sbjct: 275 SLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLEL---LLRDLEDSRGATLNPWRKAQ 331
Query: 285 L----ANLESLDLSLNQFS 299
L + +L L
Sbjct: 332 LLRVEGEVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 44/285 (15%), Positives = 81/285 (28%), Gaps = 58/285 (20%)
Query: 92 LQFLQVLSLSNNNFTGTINADLA-----SFGTLQVVDFSENNLS--GLIPDEFFRQCGSL 144
L L+ L+L+ T +A L V+ + L GL
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLR--TLLPVFLRA 128
Query: 145 REVSFANNNLTGP----IPESLSF-CSSLESVNFSSNRLSGQLPYGIWFL-------RSL 192
R++ N+L + + L + ++ S+N L+ G+ L S+
Sbjct: 129 RKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAA---GVAVLMEGLAGNTSV 185
Query: 193 QSLDLSNNLLEGE----IVKGISNLYDLRAIKLGKNKFSGQ----LPEDIGGCSMLKVLD 244
L L + L E + + L+ + + N L L++L
Sbjct: 186 THLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLH 245
Query: 245 FGVNSLSGS----LPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLA-------------- 286
N LS L D + + + T W L+
Sbjct: 246 LYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARV 305
Query: 287 ----NLESLDLSLNQFSGRIPSSIGNLV----FLKELNISMNQFT 323
L DL ++ + P L+ ++ L +
Sbjct: 306 QRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 8/148 (5%)
Query: 389 QVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNWLN 447
+ LDL S L+ + + L+ L LN+ N L ++ A + L + L ++N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 448 GTIPPQI-GGAVSLKELKLEKNFLSGRIPSQI-KNCSSLTSLILSQNNLTGPVPA-AIAN 504
++P + L +L L N L +PS + + L L L+ N L +PA A
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDK 153
Query: 505 LSNLKYVDLSFNDLSGILPKELINLSHL 532
L+NL+ + LS N L + L L
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKL 181
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 23/188 (12%)
Query: 264 CSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFT 323
C SL VP I A+ E LDL + ++ L L LN+ NQ
Sbjct: 21 CQGKSLDS------VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ 72
Query: 324 GGLPESMMNC-GNLLAIDVSQNKLTGNIPTWIFKM--GLQTVSLSGNRLGESMQYPSFAS 380
L + + L + ++ N+L ++P +F L + L GN+L +S+ F
Sbjct: 73 -TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVF-- 127
Query: 381 MKDSYQGLQVLDLSSNALSGVIPSNIGD-LSSLMLLNMSMNYLFGSIPASI-GKLKAIQV 438
D L+ L L++N L IP+ D L++L L++S N L S+P +L +Q
Sbjct: 128 --DRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQL-QSVPHGAFDRLGKLQT 183
Query: 439 LDFSDN-W 445
+ N +
Sbjct: 184 ITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 43/172 (25%), Positives = 69/172 (40%), Gaps = 18/172 (10%)
Query: 349 NIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGD 408
IP + + L L ++ +F + L L+L N L + + + D
Sbjct: 32 GIPA-----DTEKLDLQSTGL-ATLSDATFRGLTK----LTWLNLDYNQLQ-TLSAGVFD 80
Query: 409 -LSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNWLNGTIPPQI-GGAVSLKELKL 465
L+ L L ++ N L S+P + L + L N L ++P + LKEL+L
Sbjct: 81 DLTELGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRL 138
Query: 466 EKNFLSGRIPSQI-KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFN 516
N L IP+ ++L +L LS N L A L L+ + L N
Sbjct: 139 NTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 42/159 (26%), Positives = 65/159 (40%), Gaps = 11/159 (6%)
Query: 215 DLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSL-QRLNSCSSLSLKGNS 273
D + L + G + L L+ N L +L + L +L L N
Sbjct: 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQ 94
Query: 274 FTGEVPDWI-GKLANLESLDLSLNQFSGRIPSSI-GNLVFLKELNISMNQFTGGLPESMM 331
+P + L L+ L L NQ +PS + L LKEL ++ NQ +P
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151
Query: 332 NC-GNLLAIDVSQNKLTGNIPTWIFK--MGLQTVSLSGN 367
+ NL + +S N+L ++P F LQT++L GN
Sbjct: 152 DKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 29/128 (22%), Positives = 53/128 (41%), Gaps = 8/128 (6%)
Query: 74 LTLDGFSLS-GHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGL 132
L LD + G + + L+ LS N T +I A+L L+ ++ S+N +SG
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSG- 78
Query: 133 IPDEFFRQCGSLREVSFANNNLTGP-IPESLSFCSSLESVNFSSN---RLSGQLPYGIWF 188
+ +C +L ++ + N + E L +L+S++ + L+
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKL 138
Query: 189 LRSLQSLD 196
L L LD
Sbjct: 139 LPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 25/88 (28%), Positives = 37/88 (42%), Gaps = 9/88 (10%)
Query: 459 SLKELKLEKN-FLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLS---NLKYVDLS 514
+KEL L+ + G++ L L LT +IANL LK ++LS
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKLELS 72
Query: 515 FNDLSGILPKELINLSHLLSFNISHNHL 542
N +SG L +L N+S N +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKI 100
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 21/86 (24%), Positives = 39/86 (45%), Gaps = 3/86 (3%)
Query: 140 QCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSN 199
+ L +S N LT +L + L+ + S NR+SG L +L L+LS
Sbjct: 40 EFEELEFLSTINVGLT--SIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG 97
Query: 200 NLLEG-EIVKGISNLYDLRAIKLGKN 224
N ++ ++ + L +L+++ L
Sbjct: 98 NKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 29/157 (18%), Positives = 55/157 (35%), Gaps = 32/157 (20%)
Query: 359 LQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMS 418
++ + L +R E + D ++ L+ L + L+ + +N+ L+ L L +S
Sbjct: 19 VKELVLDNSRSNE----GKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 419 MNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQI 478
N + G + K + L+ S N + L ++ +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK-----------DLSTIE------------PL 109
Query: 479 KNCSSLTSLILSQNNLTGPV---PAAIANLSNLKYVD 512
K +L SL L +T L L Y+D
Sbjct: 110 KKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 30/159 (18%), Positives = 54/159 (33%), Gaps = 31/159 (19%)
Query: 139 RQCGSLREVSFANNNLT-GPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDL 197
R ++E+ N+ G + LE ++ + L+ + + L L+ L+L
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLEL 71
Query: 198 SNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDS 257
S+N + G + +L + L NK I +
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTI---------------------EP 108
Query: 258 LQRLNSCSSLSLKGNSFTGEVPDW----IGKLANLESLD 292
L++L + SL L T + D+ L L LD
Sbjct: 109 LKKLENLKSLDLFNCEVT-NLNDYRENVFKLLPQLTYLD 146
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 35/142 (24%), Positives = 61/142 (42%), Gaps = 7/142 (4%)
Query: 402 IPSNI-GDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQI-GGAVS 459
IP +I + L L N L KL ++ ++FS+N + I GA
Sbjct: 26 IPEHIPQYTAELRLNNNEFTVL--EATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82
Query: 460 LKELKLEKNFLSGRIPSQI-KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDL 518
+ E+ L N L + ++ K SL +L+L N +T + LS+++ + L N +
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141
Query: 519 SGILPKELINLSHLLSFNISHN 540
+ + P L L + N+ N
Sbjct: 142 TTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 23/130 (17%), Positives = 47/130 (36%), Gaps = 8/130 (6%)
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPPQIG--GAVSLKELKLEKNFLSGRIPSQI-KNC 481
IP I + L ++N + L+++ N ++ I +
Sbjct: 25 KIPEHIPQ--YTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGA 80
Query: 482 SSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNH 541
S + ++L+ N L L +LK + L N ++ + I LS + ++ N
Sbjct: 81 SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQ 140
Query: 542 LHGELPVGGF 551
+ + G F
Sbjct: 141 IT-TVAPGAF 149
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 26/136 (19%), Positives = 55/136 (40%), Gaps = 11/136 (8%)
Query: 267 LSLKGNSFTGEVPDWI-GKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGG 325
L L N FT I KL L ++ S N+ + + + E+ ++ N+
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95
Query: 326 LPESMM-NCGNLLAIDVSQNKLTGNIPTWIFK--MGLQTVSLSGNRLGESMQYPSFASMK 382
+ M +L + + N++T + F ++ +SL N++ ++ +F ++
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI-TTVAPGAFDTLH 153
Query: 383 DSYQGLQVLDLSSNAL 398
L L+L +N
Sbjct: 154 S----LSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 41/165 (24%), Positives = 66/165 (40%), Gaps = 11/165 (6%)
Query: 163 SFCS-SLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGI-SNLYDLRAIK 220
C +V+ S+ +L+ ++P I + L L+NN GI L LR I
Sbjct: 7 EKCRCEGTTVDCSNQKLN-KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKIN 63
Query: 221 LGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSL-QRLNSCSSLSLKGNSFTGEV 278
NK + + E G S + + N L ++ + + L S +L L+ N T
Sbjct: 64 FSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVG 121
Query: 279 PDWIGKLANLESLDLSLNQFSGRIPSSI-GNLVFLKELNISMNQF 322
D L+++ L L NQ + + L L LN+ N F
Sbjct: 122 NDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 25/120 (20%), Positives = 52/120 (43%), Gaps = 7/120 (5%)
Query: 118 TLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNR 177
+ + N + L F++ LR+++F+NN +T + S + + +SNR
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92
Query: 178 LSGQLPYGIWF--LRSLQSLDLSNNLLEGEIVKGI-SNLYDLRAIKLGKNKFSGQLPEDI 234
L + + + F L SL++L L +N + + L +R + L N+ + +
Sbjct: 93 LEN-VQHKM-FKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 33/138 (23%), Positives = 60/138 (43%), Gaps = 19/138 (13%)
Query: 339 IDVSQNKLTGNIPTWIFKM--GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSN 396
+ ++ N+ T T IFK L+ ++ S N++ ++ +F + G+ + L+SN
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAF----EGASGVNEILLTSN 91
Query: 397 ALSGVIPSNIGD-LSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNWLNGTIPPQI 454
L + + L SL L + N + + L ++++L DN + T+ P
Sbjct: 92 RLEN-VQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAP-- 146
Query: 455 GGA----VSLKELKLEKN 468
GA SL L L N
Sbjct: 147 -GAFDTLHSLSTLNLLAN 163
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.1 bits (121), Expect = 9e-07
Identities = 34/215 (15%), Positives = 67/215 (31%), Gaps = 32/215 (14%)
Query: 326 LPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPS--FASMKD 383
+ E+ + + +WI ++ L V + L + + K
Sbjct: 131 IVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKK 190
Query: 384 SYQGLQVLDLSSNALSGVIPSNIGD-----LSSLMLLNMSMNYLFGSIPASIGKLKAIQV 438
L+ L++ S L + +I L L+L +Y F L
Sbjct: 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL----- 245
Query: 439 LDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQI---KNCSSLTSLILSQNNLT 495
+ P +LK L + + L ++ +S LT
Sbjct: 246 -------FSKDRFP------NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292
Query: 496 GPVPAAIA----NLSNLKYVDLSFNDLSGILPKEL 526
+ + +LK++++ +N LS + KEL
Sbjct: 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.2 bits (116), Expect = 4e-06
Identities = 30/165 (18%), Positives = 62/165 (37%), Gaps = 22/165 (13%)
Query: 403 PSNIGDLSSLM--LLNMSMNYLFGSIPASIGKLK--AIQVLDFSDNWLNGTIPPQIGGAV 458
DLS ++ + ++ + G+ SIGK ++ L+ L ++ I G+
Sbjct: 158 WIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217
Query: 459 --SLKELKL---EKNFLSGRIPSQI------KNCSSLTSLILSQNNLTGPVPAAIAN--- 504
+L++L L +++ + +L L + V
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 505 LSNLKYVDLSFNDLSG----ILPKELINLSHLLSFNISHNHLHGE 545
L L+ +D+S L+ +L + + HL N+ +N+L E
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.5 bits (109), Expect = 3e-05
Identities = 19/161 (11%), Positives = 55/161 (34%), Gaps = 17/161 (10%)
Query: 69 KRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLAS--FGTLQVVDFS- 125
+ L + ++ G L+ L + + ++ D+ L+ +
Sbjct: 169 DAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYV 228
Query: 126 -------ENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLS---FCSSLESVNFSS 175
+ +++ P + +L+ + + + E LE+++ S+
Sbjct: 229 GVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA 288
Query: 176 NRLSG----QLPYGIWFLRSLQSLDLSNNLLEGEIVKGISN 212
L+ L + ++ L+ +++ N L E+ K +
Sbjct: 289 GVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 1e-04
Identities = 31/177 (17%), Positives = 62/177 (35%), Gaps = 27/177 (15%)
Query: 156 GPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGI--SNL 213
+ L L ++ + + L G +L+SL++ + L +V+ I S+L
Sbjct: 162 VDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 214 YDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNS 273
+L + L ED G + V S +L+ L +
Sbjct: 219 PNLEKLVLYVGV------EDYGFDGDMNVFR---PLFSKDRFPNLKWLG------IVDAE 263
Query: 274 FTGEVPDWIGK---LANLESLDLSLNQFSGR----IPSSIGNLVFLKELNISMNQFT 323
V + + L LE++D+S + + + + LK +N+ N +
Sbjct: 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 9e-07
Identities = 30/132 (22%), Positives = 48/132 (36%), Gaps = 8/132 (6%)
Query: 74 LTLDGFSLS-GHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGL 132
L LD + G I L+ LSL N N L L+ ++ SEN + G
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN--LPKLPKLKKLELSENRIFG- 85
Query: 133 IPDEFFRQCGSLREVSFANNNLTGP-IPESLSFCSSLESVNFSSNRLSGQLPYG---IWF 188
D + +L ++ + N L E L L+S++ + ++ Y
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKL 145
Query: 189 LRSLQSLDLSNN 200
L L LD +
Sbjct: 146 LPQLTYLDGYDR 157
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 23/85 (27%), Positives = 37/85 (43%), Gaps = 3/85 (3%)
Query: 459 SLKELKLEKNFLS-GRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFND 517
+++EL L+ + G+I +L L L L + + L LK ++LS N
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENR 82
Query: 518 LSGILPKELINLSHLLSFNISHNHL 542
+ G L L +L N+S N L
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKL 107
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 21/91 (23%), Positives = 38/91 (41%), Gaps = 3/91 (3%)
Query: 135 DEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQS 194
+ + +L +S N L +L L+ + S NR+ G L L +L
Sbjct: 42 EGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99
Query: 195 LDLSNNLLEG-EIVKGISNLYDLRAIKLGKN 224
L+LS N L+ ++ + L L+++ L
Sbjct: 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 33/158 (20%), Positives = 53/158 (33%), Gaps = 32/158 (20%)
Query: 358 GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNM 417
++ + L + + + + L+ L L + L V SN+ L L L +
Sbjct: 25 AVRELVLDNCKSND----GKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLEL 78
Query: 418 SMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQ 477
S N +FG + KL + L+ S N L + L+
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLK-----------DISTLE------------P 115
Query: 478 IKNCSSLTSLILSQN---NLTGPVPAAIANLSNLKYVD 512
+K L SL L NL + L L Y+D
Sbjct: 116 LKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 31/147 (21%), Positives = 61/147 (41%), Gaps = 9/147 (6%)
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQI-KNCS 482
IP ++ + I + N + IPP L+ + L N +S + +
Sbjct: 25 EIPTNL--PETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 483 SLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHL 542
SL SL+L N +T + L +L+ + L+ N ++ + +L +L ++ N L
Sbjct: 81 SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
Query: 543 HGELPVGGFFNTISPSSV--SGNPSLC 567
+ G F + ++ + NP +C
Sbjct: 141 Q-TIAKGTFSPLRAIQTMHLAQNPFIC 166
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 30/160 (18%), Positives = 63/160 (39%), Gaps = 18/160 (11%)
Query: 264 CSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFT 323
C L E+P + + + L N P + L+ +++S NQ +
Sbjct: 18 CRGKGLT------EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS 69
Query: 324 GGLPESM-MNCGNLLAIDVSQNKLTGNIPTWIFK--MGLQTVSLSGNRLGESMQYPSFAS 380
L +L ++ + NK+T +P +F+ LQ + L+ N++ ++ +F
Sbjct: 70 -ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAF-- 124
Query: 381 MKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMN 420
L +L L N L + L ++ ++++ N
Sbjct: 125 --QDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 31/135 (22%), Positives = 57/135 (42%), Gaps = 14/135 (10%)
Query: 339 IDVSQNKLTGNIPTWIFK--MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSN 396
I + QN + IP F L+ + LS N++ + +F + L L L N
Sbjct: 37 IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQI-SELAPDAF----QGLRSLNSLVLYGN 90
Query: 397 ALSGVIPSNIGD-LSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNWLNGTIPPQI 454
++ +P ++ + L SL LL ++ N + + L + +L DN L TI
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGT 147
Query: 455 -GGAVSLKELKLEKN 468
+++ + L +N
Sbjct: 148 FSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 23/112 (20%), Positives = 48/112 (42%), Gaps = 5/112 (4%)
Query: 91 RLQFLQVLSLSNNNFTGTINADL-ASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSF 149
+ L+ + LSNN + + D +L + N ++ L P F SL+ +
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITEL-PKSLFEGLFSLQLLLL 111
Query: 150 ANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIW-FLRSLQSLDLSNN 200
N + ++ +L ++ N+L + G + LR++Q++ L+ N
Sbjct: 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 40/165 (24%), Positives = 66/165 (40%), Gaps = 12/165 (7%)
Query: 163 SFCS-SLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGI-SNLYDLRAIK 220
+ C+ S V+ L+ ++P + ++ + L N ++ I G S LR I
Sbjct: 7 AACTCSNNIVDCRGKGLT-EIPTNL--PETITEIRLEQNTIK-VIPPGAFSPYKKLRRID 62
Query: 221 LGKNKFSGQLPEDI-GGCSMLKVLDFGVNSLSGSLPDSL-QRLNSCSSLSLKGNSFTGEV 278
L N+ S +L D G L L N ++ LP SL + L S L L N +
Sbjct: 63 LSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CL 119
Query: 279 PDWI-GKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQF 322
L NL L L N+ + L ++ ++++ N F
Sbjct: 120 RVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 41/130 (31%), Positives = 60/130 (46%), Gaps = 5/130 (3%)
Query: 389 QVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNWLN 447
Q+L L N ++ + P L +L L + N L G++P + L + VLD N L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 448 GTIPPQI-GGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLS 506
+P + V LKEL + N L+ +P I+ + LT L L QN L A LS
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 507 NLKYVDLSFN 516
+L + L N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 39/133 (29%), Positives = 56/133 (42%), Gaps = 12/133 (9%)
Query: 241 KVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFT---GEVPDWIGKLANLESLDLSLNQ 297
++L N ++ P L + L L N V D L L LDL NQ
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD---SLTQLTVLDLGTNQ 99
Query: 298 FSGRIPSSI-GNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFK 356
+ +PS++ LV LKEL + N+ T LP + +L + + QN+L +IP F
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFD 156
Query: 357 --MGLQTVSLSGN 367
L L GN
Sbjct: 157 RLSSLTHAYLFGN 169
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 2e-06
Identities = 117/679 (17%), Positives = 196/679 (28%), Gaps = 206/679 (30%)
Query: 242 VLDFGVNSLSGS-------LPDSLQRLNSC-SSLSLKGNS----FTGEV--PD--WIGKL 285
V D + LS D++ +L K F EV + ++
Sbjct: 38 VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSP 97
Query: 286 ANLESLDLSLNQ---FSGRIPSSIGNLVFLKELNIS----MNQFTGGL----PES----- 329
E S+ R N VF K N+S + L P
Sbjct: 98 IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK-YNVSRLQPYLKLRQALLELRPAKNVLID 156
Query: 330 -MMNCG-NLLAIDVSQN-----KLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMK 382
++ G +A+DV + K+ I W+ + S + E +Q +
Sbjct: 157 GVLGSGKTWVALDVCLSYKVQCKMDFKI-FWL-NLKNCN---SPETVLEMLQKLLYQIDP 211
Query: 383 DSYQGLQVLDLSSNALSGVIPSNIGD----LSSLMLLNMSMNYLFGSIPASIGKLKAIQV 438
+ D SSN I I L L+ N L V
Sbjct: 212 N---WTSRSDHSSN-----IKLRIHSIQAELRRLLKSKPYENCLL--------------V 249
Query: 439 LDFSDNWLNGTIPPQIGGAVSL--KEL-----KLEKNFLSGRIPSQIKNCSSLTSLILSQ 491
L + + A +L K L K +FLS + I SL
Sbjct: 250 LL--NVQ-----NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI-------SLDHHS 295
Query: 492 NNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGF 551
LT P + +L LKY+D D LP+E++
Sbjct: 296 MTLT---PDEVKSLL-LKYLDCRPQD----LPREVL------------------------ 323
Query: 552 FNTISPSSVSGNPSLCGSVVNRSCPAVQNKPIVLNPNSSNPYTGNSSPNHRRKIVLSISA 611
T +P + S+ + + + + + I S++
Sbjct: 324 --TTNPRRL----SIIAESIRD------------GLATWDNWKHVNCDKLTTIIESSLNV 365
Query: 612 L-IAIGAAAFIAIGV------IAVTVLNIRVRSSMSRAAAALSFSGGEDYSCSPTKDPNY 664
L A F + V I +L++ + + ++ + + YS K P
Sbjct: 366 LEPAEYRKMFDRLSVFPPSAHIPTILLSL-IWFDVIKSDVMVVVNKLHKYSLV-EKQPKE 423
Query: 665 GKLVMFSGDAEFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQE 724
+ + S E L + L +R+I+ K LI
Sbjct: 424 STISIPSIYLEL----KVKLENEYAL--------HRSIVD--HYNIPKTFDSDDLIPPYL 469
Query: 725 D---FEKEMKTLGKIRHH--NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCL 779
D + +G HH N+ E + L + F+ K HD ++ N
Sbjct: 470 DQYFYSH----IG---HHLKNIEHPERMTLFRMV-FLDFRFLEQ----KIRHDSTAWNAS 517
Query: 780 SWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839
N + + Y + I N D E V + LP ++ +
Sbjct: 518 G--SILNTLQQLKF---YKPY---ICDN--------DPKYERLVNA--ILDFLPKIEENL 559
Query: 840 LSSK----IQSALGYMAPE 854
+ SK ++ AL MA +
Sbjct: 560 ICSKYTDLLRIAL--MAED 576
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 8e-06
Identities = 56/338 (16%), Positives = 100/338 (29%), Gaps = 86/338 (25%)
Query: 661 DPNYGKLVMFSGDAEFAAGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLI 720
NY F + + + + R L + V K VS
Sbjct: 88 RINYK----------FLMSPIKTEQRQPSMMTRMY-IEQRDRLYNDNQV-FAKYNVS--- 132
Query: 721 KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSL-----QLLIYEFISSGSLYKHLHDG-- 773
+ + K + L ++R V ++G + + + S + +
Sbjct: 133 -RLQPYLKLRQALLELRPAKNVLIDG------VLGSGKTWVALDVCLSYKVQCKMDFKIF 185
Query: 774 --SSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKV----GDFG 827
+ +NC +L M + L Y I N S D S K+
Sbjct: 186 WLNLKNC----NSPETVLEMLQKLLY-----QIDPNWTS---RSDHSSNIKLRIHSIQAE 233
Query: 828 LARLL--PMLDRCIL------SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVV 879
L RLL + C+L ++K +A +C+ + T V + +
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQNAKAWNAF-----NLSCKILLTTRFKQ-------VTDFL 281
Query: 880 TGKRPVEYMEDDVVVLCDMVRGALEDGRVED----CVDARLRGNFP--ADEAIPVIKLGL 933
+ D L V+ +D R + P P +L +
Sbjct: 282 SAATTTHISLDH-------HSMTLTPDEVKSLLLKYLDCRP-QDLPREVLTTNP-RRLSI 332
Query: 934 ICAS-QVPSNRPDMEEVVN---ILELIQSPLDGQEELE 967
I S + D + VN + +I+S L+ E E
Sbjct: 333 IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE 370
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 313 KELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGES 372
+ N+ T + ++ +N + + + S K I ++ ++L GN+L
Sbjct: 22 IKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLP---NVRYLALGGNKL-HD 77
Query: 373 MQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGD-LSSLMLLNMSMNYLFGSIPASI- 430
+ + + + L L L+ N L + P+ + D L++L L + N L S+P +
Sbjct: 78 I--SALKELTN----LTYLILTGNQLQSL-PNGVFDKLTNLKELVLVENQL-QSLPDGVF 129
Query: 431 GKLKAIQVLDFSDNWLNGTIPPQI-GGAVSLKELKLEKNFLSGRIPSQI-KNCSSLTSLI 488
KL + L+ + N L ++P + +L EL L N L +P + + L L
Sbjct: 130 DKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLR 187
Query: 489 LSQNNLTGPVP-AAIANLSNLKYVDLSFN 516
L QN L VP L++L+Y+ L N
Sbjct: 188 LYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 9e-04
Identities = 51/233 (21%), Positives = 84/233 (36%), Gaps = 51/233 (21%)
Query: 215 DLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSF 274
+ L K + S + + + + S+ +Q L + L+L GN
Sbjct: 20 ETIKANLKKKSVT-DAVTQNELNS-IDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKL 75
Query: 275 TG-EVPDWIGKLANLESLDLSLNQFSGRIPSSI-GNLVFLKELNISMNQFT---GGLPES 329
+L NL L L+ NQ +P+ + L LKEL + NQ G+ +
Sbjct: 76 HDISALK---ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDK 131
Query: 330 MMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQ 389
+ N L +++ N+L ++P +F D L
Sbjct: 132 LTNLTYL---NLAHNQLQ-SLPKGVF---------------------------DKLTNLT 160
Query: 390 VLDLSSNALSGVIPSNIGD-LSSLMLLNMSMNYLFGSIP----ASIGKLKAIQ 437
LDLS N L +P + D L+ L L + N L S+P + L+ I
Sbjct: 161 ELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIW 211
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 39/234 (16%), Positives = 76/234 (32%), Gaps = 65/234 (27%)
Query: 690 LGRGGFGVVYRTI--LQDGRSVAIKKLTVSGLIKSQEDF----EKEMKTLGKIRH----- 738
LG G FG V + + VA+K +I++ + E+ L KI+
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALK------IIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 739 -HNLVALEGYYW--------TPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIIL 789
V + ++ L +EF+ + ++ L + L
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENN-FQPYP-------LPHVRHMAYQL 132
Query: 790 GMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL--------- 840
A L +LH + H +LK N+L +S + + + + +
Sbjct: 133 CHA--LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 841 ------SSKIQSALGYMAPEFACRTVKI------TEKCDVYGFGVLVLEVVTGK 882
++ + + Y PE + + CDV+ G ++ E G
Sbjct: 191 FDHEHHTTIVATRH-YRPPE-------VILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 38/172 (22%), Positives = 64/172 (37%), Gaps = 41/172 (23%)
Query: 84 HIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGS 143
+ L L+ + L+LS NN I ++LSG+ +
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-KI-----------------SSLSGME---------N 71
Query: 144 LREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLE 203
LR +S N + I + +LE + S N+++ L GI L +L+ L +SNN +
Sbjct: 72 LRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKIT 128
Query: 204 G-EIVKGISNLYDLRAIKLGKNKFSGQLPED----------IGGCSMLKVLD 244
+ ++ L L + L N E+ + LK LD
Sbjct: 129 NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 32/163 (19%), Positives = 58/163 (35%), Gaps = 39/163 (23%)
Query: 172 NFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLP 231
+ + + + L++ + L LS N + E + +S + +LR + LG+N
Sbjct: 31 HGMIPPIEK-MDATLSTLKACKHLALSTNNI--EKISSLSGMENLRILSLGRNLIK---- 83
Query: 232 EDIGG----CSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLAN 287
I L+ L N ++ SL G I KL N
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA----------------SLSG----------IEKLVN 116
Query: 288 LESLDLSLNQFSG-RIPSSIGNLVFLKELNISMNQFTGGLPES 329
L L +S N+ + + L L++L ++ N E+
Sbjct: 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 27/141 (19%), Positives = 57/141 (40%), Gaps = 16/141 (11%)
Query: 383 DSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFS 442
+ + + L LS+N + + S++ + +L +L++ N + I ++ L S
Sbjct: 45 STLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLI-KKIENLDAVADTLEELWIS 101
Query: 443 DNWLNGTIPPQIGGAVSLKELKLEKNFLSG-RIPSQIKNCSSLTSLILSQNNLTGPVPAA 501
N + ++ I V+L+ L + N ++ ++ L L+L+ N L
Sbjct: 102 YNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159
Query: 502 ----------IANLSNLKYVD 512
+ L NLK +D
Sbjct: 160 NATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 29/118 (24%), Positives = 52/118 (44%), Gaps = 10/118 (8%)
Query: 426 IPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLT 485
+ A++ LKA + L S N + I + G +L+ L L +N + +I + +L
Sbjct: 40 MDATLSTLKACKHLALSTNNI-EKISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 486 SLILSQNNLTGPVPAAIANLSNLKYVDLSFN---DLSGILPKELINLSHLLSFNISHN 540
L +S N + + I L NL+ + +S N + I +L L L ++ N
Sbjct: 97 ELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEI--DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 20/91 (21%), Positives = 40/91 (43%), Gaps = 12/91 (13%)
Query: 457 AVSLKELKLEKNFLS-GRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLS---NLKYVD 512
A ++++L ++ + + + L LS NN+ I++LS NL+ +
Sbjct: 22 ATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILS 76
Query: 513 LSFNDLSGILPKELINLSHLL-SFNISHNHL 542
L N + I + L ++ L IS+N +
Sbjct: 77 LGRNLIKKI--ENLDAVADTLEELWISYNQI 105
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 15/88 (17%), Positives = 29/88 (32%), Gaps = 9/88 (10%)
Query: 458 VSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLS---NLKYVDLS 514
V +EL L + I + ++ S N + + LK + ++
Sbjct: 19 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-----KLDGFPLLRRLKTLLVN 72
Query: 515 FNDLSGILPKELINLSHLLSFNISHNHL 542
N + I L L +++N L
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSL 100
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 19/109 (17%), Positives = 36/109 (33%), Gaps = 7/109 (6%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151
L + S+N L+ + + N + I + + L E+ N
Sbjct: 41 LDQFDAIDFSDNEIRKLDG--FPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTN 97
Query: 152 NNLTGP-IPESLSFCSSLESVNFSSN---RLSGQLPYGIWFLRSLQSLD 196
N+L + L+ SL + N Y I+ + ++ LD
Sbjct: 98 NSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 17/129 (13%), Positives = 46/129 (35%), Gaps = 7/129 (5%)
Query: 97 VLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTG 156
++ L+ + + +D + + + + F++N +
Sbjct: 1 MVKLTAELIEQAAQ--YTNAVRDRELDLRGYKIPVI--ENLGATLDQFDAIDFSDNEIR- 55
Query: 157 PIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEG-EIVKGISNLYD 215
+ + L+++ ++NR+ L L L L+NN L + +++L
Sbjct: 56 KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS 114
Query: 216 LRAIKLGKN 224
L + + +N
Sbjct: 115 LTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 25/161 (15%), Positives = 50/161 (31%), Gaps = 42/161 (26%)
Query: 359 LQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMS 418
+ + L G ++ P ++ + +D S N + + L L L ++
Sbjct: 21 DRELDLRGYKI------PVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVN 72
Query: 419 MNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQI 478
N + L + L ++N L L +L +
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLV-----------ELGDLD------------PL 109
Query: 479 KNCSSLTSLILSQNNLTGPV-------PAAIANLSNLKYVD 512
+ SLT L + +N PV I + ++ +D
Sbjct: 110 ASLKSLTYLCILRN----PVTNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 28/131 (21%), Positives = 45/131 (34%), Gaps = 8/131 (6%)
Query: 195 LDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIG-GCSMLKVLDFGVNSLSGS 253
+ L+ L+E + +N R + L K + E++G +DF N +
Sbjct: 2 VKLTAELIE-QA-AQYTNAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIR-K 56
Query: 254 LPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSG-RIPSSIGNLVFL 312
L D L +L + N L +L L L+ N + +L L
Sbjct: 57 L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 115
Query: 313 KELNISMNQFT 323
L I N T
Sbjct: 116 TYLCILRNPVT 126
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 46/242 (19%), Positives = 85/242 (35%), Gaps = 77/242 (31%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDF----EKEMKTLGKIRH-----H 739
+G G FG V + + + A+K ++++ + + + E L KI++ +
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVK------VVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 740 NLVALEGY-YW-------TPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGM 791
N+V G + L +YE I+ ++ ++G + + +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGPSLYEIIT-----RNNYNGFHIEDIK-----LYCIEI 146
Query: 792 AKGLAYLHHTNIIHYNLKSTNVLIDSSGEP-------------------------KVGDF 826
K L YL ++ H +LK N+L+D K+ DF
Sbjct: 147 LKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 827 GLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKI------TEKCDVYGFGVLVLEVVT 880
G A S I + Y APE + D++ FG ++ E+ T
Sbjct: 207 GCA----TFKSDYHGSIINTRQ-YRAPE-------VILNLGWDVSSDMWSFGCVLAELYT 254
Query: 881 GK 882
G
Sbjct: 255 GS 256
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 48/253 (18%), Positives = 88/253 (34%), Gaps = 23/253 (9%)
Query: 89 LLRLQFLQVLSLS-NNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147
RL V++ +F A+ S +Q +D S + + QC L+ +
Sbjct: 64 TGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123
Query: 148 SFANNNLTGPIPESLSFCSSLESVNFSSNRL--SGQLPYGIWFLRSLQSLDLSNNLLEGE 205
S L+ PI +L+ S+L +N S L + L L+LS
Sbjct: 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC----- 178
Query: 206 IVKGISNLYDLRAIKLGKNKFSGQLPE-DIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSC 264
+ + +++ S + + ++ G + +++L P +L L+
Sbjct: 179 --FDFTE----KHVQVAVAHVSETITQLNLSGYRK-NLQKSDLSTLVRRCP-NLVHLDLS 230
Query: 265 SSLSLKGNSFTGEVPDWIGKLANLESLDLS-LNQFSGRIPSSIGNLVFLKELNISMNQFT 323
S+ LK + F +L L+ L LS +G + LK L +
Sbjct: 231 DSVMLKNDCFQ-----EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 285
Query: 324 GGLPESMMNCGNL 336
G L +L
Sbjct: 286 GTLQLLKEALPHL 298
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 39/215 (18%), Positives = 79/215 (36%), Gaps = 14/215 (6%)
Query: 335 NLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLS 394
++A ++ + + +Q + LS + + S + + LQ L L
Sbjct: 71 GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS----TLHGILSQCSKLQNLSLE 126
Query: 395 SNALSGVIPSNIGDLSSLMLLNMSMNYLF--GSIPASIGKLKAIQVLDFSDNWLNGTIPP 452
LS I + + S+L+ LN+S F ++ + + L+ S +
Sbjct: 127 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV 186
Query: 453 QIGGAV---SLKELKLEK--NFLSGR-IPSQIKNCSSLTSLILSQ-NNLTGPVPAAIANL 505
Q+ A ++ +L L L + + ++ C +L L LS L L
Sbjct: 187 QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL 246
Query: 506 SNLKYVDLSF-NDLSGILPKELINLSHLLSFNISH 539
+ L+++ LS D+ EL + L + +
Sbjct: 247 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 46/240 (19%), Positives = 79/240 (32%), Gaps = 77/240 (32%)
Query: 690 LGRGGFGVVYRTI--LQDGRSVAIKKLTVSGLIKSQEDF----EKEMKTLGKIRH----- 738
LG G FG V I GR VA+K ++K+ + + E++ L +
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVK------IVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 739 -HNLVALEGYYW--------TPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNI-- 787
V + ++ L L Y+FI F +
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENG----------------FLPFRLDH 119
Query: 788 ILGMAK----GLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL--- 840
I MA + +LH + H +LK N+L S + + + R L +
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 841 ------------SSKIQSALGYMAPEFACRTVKI------TEKCDVYGFGVLVLEVVTGK 882
S+ + + Y APE + ++ CDV+ G +++E G
Sbjct: 180 DFGSATYDDEHHSTLVSTRH-YRAPE-------VILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 33/164 (20%), Positives = 51/164 (31%), Gaps = 30/164 (18%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-KEMKTLGKIRHHNLVALEGY 747
+G GGFG++Y A + V E K + + K +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK----KWI 100
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCL-------------SWRQRFNI----ILG 790
L I F SG G S + F LG
Sbjct: 101 ERKQLDYLGIPLFYGSGL---TEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157
Query: 791 --MAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKV--GDFGLAR 830
M L Y+H +H ++K+ N+L+ +V D+GL+
Sbjct: 158 IRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 26/174 (14%), Positives = 51/174 (29%), Gaps = 47/174 (27%)
Query: 690 LGRGGFGVVY---------RTILQDGRSVAIK------KLTVSGLIKSQEDFEKEMKTLG 734
R G++Y + ++K +L + ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 735 KIRHHNLVALEGYYWT----------------PSLQLLIYEFISSGSLYKHLHDGSSRNC 778
K+ L+A+ SLQ D S ++
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQ--------------SALDVSPKHV 155
Query: 779 LSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKV--GDFGLAR 830
LS R + + L +LH +H N+ + N+ +D + +V +G A
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 39/160 (24%), Positives = 55/160 (34%), Gaps = 37/160 (23%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-KEMKTL------------GK 735
+G G FG + L VAIK L Q E + K L G
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGP 75
Query: 736 IRHHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGL 795
+N + LE PSL+ L D R S + I + + +
Sbjct: 76 CGKYNAMVLE--LLGPSLE--------------DLFDLCDRT-FSLKTVLMIAIQLISRM 118
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVG-----DFGLAR 830
Y+H N+I+ ++K N LI G DF LA+
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 30/112 (26%), Positives = 47/112 (41%), Gaps = 8/112 (7%)
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSL 484
+P I + + L N +P ++ L + L N +S N + L
Sbjct: 24 VLPKGIPR--DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 485 TSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPK----ELINLSHL 532
+LILS N L P L +L+ + L ND+S + P+ +L LSHL
Sbjct: 81 LTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVV-PEGAFNDLSALSHL 131
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 40/160 (25%), Positives = 60/160 (37%), Gaps = 39/160 (24%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-KEMKTL------------GK 735
+G G FG +Y + G VAIK V Q E K K + G
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 736 IRHHNLVALE--GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAK 793
+N++ +E G PSL+ L + SR S + + M
Sbjct: 76 EGDYNVMVMELLG----PSLE--------------DLFNFCSRK-FSLKTVLLLADQMIS 116
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEPK---VGDFGLAR 830
+ Y+H N IH ++K N L+ + + DFGLA+
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 35/162 (21%), Positives = 58/162 (35%), Gaps = 41/162 (25%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-KEMKTL------------GK 735
+G G FGV++ L + + VAIK Q E + K L G+
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76
Query: 736 IRHHNLVALE--GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAK 793
HN++ ++ G PSL+ L D R S + M
Sbjct: 77 EGLHNVLVIDLLG----PSLE--------------DLLDLCGRK-FSVKTVAMAAKQMLA 117
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEPK-----VGDFGLAR 830
+ +H ++++ ++K N LI V DFG+ +
Sbjct: 118 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 57/359 (15%), Positives = 104/359 (28%), Gaps = 109/359 (30%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
LG G F V+ + +Q + VA+K + + E E++ L +R+ +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSD-PNDPNRE 101
Query: 749 WTPSLQLLIYEFISSGSLYKHL---HDGSSRNCLSWRQRFN-----------IILGMAKG 794
L + +F SG H+ + + L W + N II + +G
Sbjct: 102 MVVQL---LDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 795 LAYLH-HTNIIHYNLKSTNVLIDSS----------------------------------- 818
L YLH IIH ++K N+L+ +
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 819 --------------GEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITE 864
+ K+ D G A + + IQ+ Y + E
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQT-RQYRSLE-VLIGSGYNT 272
Query: 865 KCDVYGFGVLVLEVVTGK-----RPVEYMEDDVVVLCDMVR--GAL-------------- 903
D++ + E+ TG E D + ++ G +
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332
Query: 904 --EDGRVEDCVDARLRG---------NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951
+ G ++ + G + +EA L +P R E +
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 40/132 (30%), Positives = 61/132 (46%), Gaps = 9/132 (6%)
Query: 241 KVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWI-GKLANLESLDLSLNQFS 299
LD NSL L S + L L GN +P+ + KL +L L+LS NQ
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 300 GRIPSSI-GNLVFLKELNISMNQFTGGLPESMMN-CGNLLAIDVSQNKLTGNIPTWIFK- 356
+P+ + L LKEL ++ NQ LP+ + + L + + QN+L ++P +F
Sbjct: 90 -SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDR 146
Query: 357 -MGLQTVSLSGN 367
LQ + L N
Sbjct: 147 LTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 6/131 (4%)
Query: 389 QVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASI-GKLKAIQVLDFSDNWLN 447
LDL +N+L + +L+SL L + N L S+P + KL ++ L+ S N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 448 GTIPPQI-GGAVSLKELKLEKNFLSGRIPSQI-KNCSSLTSLILSQNNLTGPVPAAIANL 505
++P + LKEL L N L +P + + L L L QN L L
Sbjct: 90 -SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL 147
Query: 506 SNLKYVDLSFN 516
++L+Y+ L N
Sbjct: 148 TSLQYIWLHDN 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 37/160 (23%), Positives = 61/160 (38%), Gaps = 39/160 (24%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFE-KEMKTL------------GK 735
+G G FG +Y +Q VAIK V Q +E K + L G
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 736 IRHHNLVALE--GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAK 793
+N++ ++ G PSL+ L + SR LS + + M
Sbjct: 74 EGDYNVLVMDLLG----PSLE--------------DLFNFCSRK-LSLKTVLMLADQMIN 114
Query: 794 GLAYLHHTNIIHYNLKSTNVLIDSSGEPK---VGDFGLAR 830
+ ++H + +H ++K N L+ + DFGLA+
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 967 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.59 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.53 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.42 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.41 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.41 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.36 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.34 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.34 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.31 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.23 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.97 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.96 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.95 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.94 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.92 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.77 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.57 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.53 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.45 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.44 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.24 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.19 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.98 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.92 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.88 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.83 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.81 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.72 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.42 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.42 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.36 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.33 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.18 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.98 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.97 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.93 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.92 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.65 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.6 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.55 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.49 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.45 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.17 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.92 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.57 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.09 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.62 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.4 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 87.11 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-76 Score=727.29 Aligned_cols=546 Identities=33% Similarity=0.534 Sum_probs=441.4
Q ss_pred CCCChhHHHHHHHHHhcCCCCccccCCCCCCCCCCCccceEEeCCCCCeeeeeeecCCCCCcc---cc------------
Q 002094 22 DPTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSGH---IG------------ 86 (967)
Q Consensus 22 ~~~~~~d~~all~~k~~~~~~~~~l~sw~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~---~~------------ 86 (967)
+...++|++|||+||+++.||. .++||+.+ .+||.|.||+|+ +++|+.|+|.+++++|. ++
T Consensus 7 ~~~~~~~~~all~~k~~~~~~~-~l~~W~~~-~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLPDKN-LLPDWSSN-KNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCSCTT-SSTTCCTT-SCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred ccCCHHHHHHHHHHHhhCCCcc-cccCCCCC-CCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 3335789999999999999998 89999855 458999999998 68999999999999887 44
Q ss_pred -----------ccccCCCCCCeEecCCCccCccccc--cccCCCCCcEEEcCCCCCCCCCCchhh---------------
Q 002094 87 -----------RGLLRLQFLQVLSLSNNNFTGTINA--DLASFGTLQVVDFSENNLSGLIPDEFF--------------- 138 (967)
Q Consensus 87 -----------~~l~~l~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~Ls~n~~~~~ip~~~~--------------- 138 (967)
..++++++|++|+|++|+++|.+|. .++.+++|++|+|++|.+++.+|..++
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 4678889999999999999988888 888888888888888877766665431
Q ss_pred ----------------------------------hcCCCCceEeccccccCCCCccccccccccceeeecccccccccCc
Q 002094 139 ----------------------------------RQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPY 184 (967)
Q Consensus 139 ----------------------------------~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 184 (967)
..+++|++|+|++|++++.+|. ++.+++|++|+|++|++++.+|.
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~ 241 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSR 241 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHH
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccH
Confidence 2344455555555555555554 77777777777777777777776
Q ss_pred cccccccCCeEeecCCcCC----------------------CcccccccCC-CCCCeeeccCccccccCCcCccCCCCcc
Q 002094 185 GIWFLRSLQSLDLSNNLLE----------------------GEIVKGISNL-YDLRAIKLGKNKFSGQLPEDIGGCSMLK 241 (967)
Q Consensus 185 ~~~~l~~L~~L~L~~n~l~----------------------~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 241 (967)
.+..+++|++|+|++|.++ +.+|..+..+ ++|++|+|++|++++.+|..|+++++|+
T Consensus 242 ~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 321 (768)
T 3rgz_A 242 AISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE 321 (768)
T ss_dssp HTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCC
T ss_pred HHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCcc
Confidence 6666666666666665554 3555566554 8889999999988888888888888888
Q ss_pred EEeccccccCCCCChh-hhcCCCCCEEEccCCCCCCcCchhhcccc-ccccccccccc----------------------
Q 002094 242 VLDFGVNSLSGSLPDS-LQRLNSCSSLSLKGNSFTGEVPDWIGKLA-NLESLDLSLNQ---------------------- 297 (967)
Q Consensus 242 ~L~l~~n~l~~~~~~~-l~~l~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~L~~N~---------------------- 297 (967)
+|++++|++++.+|.. +.++++|++|+|++|++++.+|..+..++ +|++|++++|+
T Consensus 322 ~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L 401 (768)
T 3rgz_A 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401 (768)
T ss_dssp EEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEEC
T ss_pred EEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEEC
Confidence 8888888888777765 88888888888888888877777776655 55555555554
Q ss_pred ----cccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcc-cccEEeccCCCCCCC
Q 002094 298 ----FSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM-GLQTVSLSGNRLGES 372 (967)
Q Consensus 298 ----l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~ 372 (967)
+++.+|..+.++++|++|++++|++++.+|..+.++++|+.|++++|++++.+|..+... +|++|++++|++...
T Consensus 402 ~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 481 (768)
T 3rgz_A 402 QNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGE 481 (768)
T ss_dssp CSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSC
T ss_pred CCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCc
Confidence 444555556666667777777777766667777777777777777777776666665543 677777777777543
Q ss_pred CCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcc
Q 002094 373 MQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPP 452 (967)
Q Consensus 373 ~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 452 (967)
. +..+..+++|++|+|++|++++.+|.+++.+++|++|+|++|++.+.+|..++.+++|+.|++++|+++|.+|.
T Consensus 482 ~-----p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~ 556 (768)
T 3rgz_A 482 I-----PSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556 (768)
T ss_dssp C-----CGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCG
T ss_pred C-----CHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCCh
Confidence 2 34456788999999999999999999999999999999999999999999999999999999999999877775
Q ss_pred cc----------------------------------------------------------------------cCCCCCCE
Q 002094 453 QI----------------------------------------------------------------------GGAVSLKE 462 (967)
Q Consensus 453 ~~----------------------------------------------------------------------~~l~~L~~ 462 (967)
.+ ..+++|+.
T Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~ 636 (768)
T 3rgz_A 557 AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636 (768)
T ss_dssp GGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCE
T ss_pred HHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccE
Confidence 44 33567899
Q ss_pred EEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcc
Q 002094 463 LKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHL 542 (967)
Q Consensus 463 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l 542 (967)
|+|++|+++|.+|..|+++++|+.|+|++|+++|.+|..|+++++|++||||+|+++|.+|..+..+++|+.|||++|++
T Consensus 637 LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l 716 (768)
T 3rgz_A 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL 716 (768)
T ss_dssp EECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEE
T ss_pred EECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCccCCCcccCCCCCCCccccCCCCCC
Q 002094 543 HGELPVGGFFNTISPSSVSGNPSLCGSVVNRSCPAV 578 (967)
Q Consensus 543 ~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~c~~~ 578 (967)
+|.||.++.++++...+|.|||++||.++. .|+..
T Consensus 717 ~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~ 751 (768)
T 3rgz_A 717 SGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS 751 (768)
T ss_dssp EEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred cccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence 999999999999999999999999999985 77643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=567.54 Aligned_cols=467 Identities=34% Similarity=0.499 Sum_probs=404.2
Q ss_pred CCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceE
Q 002094 68 TKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147 (967)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L 147 (967)
-..++.|++.++.+++.++. ++++++|++|+|++|++++.+|..|+.+++|++|+|++|.+++.+|.. .+++|++|
T Consensus 199 l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~---~l~~L~~L 274 (768)
T 3rgz_A 199 CVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PLKSLQYL 274 (768)
T ss_dssp CTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC---CCTTCCEE
T ss_pred CCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc---ccCCCCEE
Confidence 35677888888888887776 888999999999999999888888999999999999999988877763 78888889
Q ss_pred eccccccCCCCccccccc-cccceeeecccccccccCccccccccCCeEeecCCcCCCccccc-ccCCCCCCeeeccCcc
Q 002094 148 SFANNNLTGPIPESLSFC-SSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKG-ISNLYDLRAIKLGKNK 225 (967)
Q Consensus 148 ~L~~n~l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~ 225 (967)
+|++|++++.+|..+..+ ++|++|+|++|++++.+|..|+.+++|++|+|++|.+++.+|.. +.++++|++|+|++|+
T Consensus 275 ~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~ 354 (768)
T 3rgz_A 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354 (768)
T ss_dssp ECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSE
T ss_pred ECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCc
Confidence 999888888888888765 88999999999998888888889999999999999888777665 8888999999999999
Q ss_pred ccccCCcCccCCC-CccEEeccccccCCCCChhhhc--CCCCCEEEccCCCCCCcCchhhcccccccccccccccccccc
Q 002094 226 FSGQLPEDIGGCS-MLKVLDFGVNSLSGSLPDSLQR--LNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRI 302 (967)
Q Consensus 226 l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~l~~--l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 302 (967)
+++.+|..+..++ +|++|++++|++++.+|..+.. +++|++|++++|.+++.+|..+.++++|++|+|++|++++.+
T Consensus 355 l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 434 (768)
T 3rgz_A 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434 (768)
T ss_dssp EEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCC
T ss_pred cCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcc
Confidence 9888888888887 8888888888888888887776 788889999999888888888888999999999999998888
Q ss_pred CCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcc-cccEEeccCCCCCCCCCCCccccc
Q 002094 303 PSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM-GLQTVSLSGNRLGESMQYPSFASM 381 (967)
Q Consensus 303 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~L~~L~L~~n~l~~~~~~~~~~~~ 381 (967)
|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++++.+|..+... +|++|++++|++.... +..
T Consensus 435 p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-----p~~ 509 (768)
T 3rgz_A 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI-----PKW 509 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCC-----CGG
T ss_pred cHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcC-----ChH
Confidence 8888889999999999999988888889899999999999999988888877664 7899999999886432 344
Q ss_pred ccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCC--------------------------------
Q 002094 382 KDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPAS-------------------------------- 429 (967)
Q Consensus 382 ~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-------------------------------- 429 (967)
+..+++|++|+|++|++++.+|..+..+++|+.|++++|.+.|.+|..
T Consensus 510 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (768)
T 3rgz_A 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHG 589 (768)
T ss_dssp GGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCS
T ss_pred HhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccc
Confidence 566788899999999998888888888888999998888887766643
Q ss_pred --------------------------------------cCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCC
Q 002094 430 --------------------------------------IGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLS 471 (967)
Q Consensus 430 --------------------------------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 471 (967)
+..+++|+.|||++|+++|.+|..++.+++|+.|+|++|+++
T Consensus 590 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~ 669 (768)
T 3rgz_A 590 AGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669 (768)
T ss_dssp SEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCC
T ss_pred cccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccC
Confidence 444678999999999999999999999999999999999999
Q ss_pred CcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCc-ccc
Q 002094 472 GRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNH-LHG 544 (967)
Q Consensus 472 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~-l~~ 544 (967)
|.+|..|+++++|+.|||++|+++|.+|..++++++|++||||+|+++|.+|.. ..+..+....+.+|+ ++|
T Consensus 670 g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCG 742 (768)
T ss_dssp SCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEES
T ss_pred CCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcC
Confidence 999999999999999999999999999999999999999999999999999975 334455566677886 555
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-59 Score=561.08 Aligned_cols=483 Identities=20% Similarity=0.266 Sum_probs=342.8
Q ss_pred ChhHHHHHHHHHhcCCCCcc--------ccCCCCCCCCCCCcc---ceEEeCCCCCeeeeeeecCCCCCccccccccCCC
Q 002094 25 FNDDVLGLIVFKAGLEDPKE--------KLTSWSEDDDNPCNW---VGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQ 93 (967)
Q Consensus 25 ~~~d~~all~~k~~~~~~~~--------~l~sw~~~~~~~c~w---~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~ 93 (967)
...|+.||.+||+++.+|.. ...+|+.+ .+||.| .||+|+.. +||++|+|.+++++|.+|+++++|+
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~ 105 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCc
Confidence 35799999999999875532 34589876 458999 99999864 8999999999999999999999999
Q ss_pred CCCeEecCCCcc------Cc------cccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEecc-----------
Q 002094 94 FLQVLSLSNNNF------TG------TINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFA----------- 150 (967)
Q Consensus 94 ~L~~L~L~~n~l------~~------~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~----------- 150 (967)
+|++|+|++|++ .+ .+|... +..|+ +++++|.+.+.+|..+...+..+..+++.
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~ 182 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred cceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence 999999999987 33 333333 55667 77888877777766553333333333333
Q ss_pred ---------ccccCCCCccccccccccceeeecccccccc-----------------cCcccc--ccccCCeEeecCCcC
Q 002094 151 ---------NNNLTGPIPESLSFCSSLESVNFSSNRLSGQ-----------------LPYGIW--FLRSLQSLDLSNNLL 202 (967)
Q Consensus 151 ---------~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~L~~n~l 202 (967)
+|++++ +|..|+++++|++|+|++|++++. +|..++ ++++|++|+|++|.+
T Consensus 183 l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l 261 (636)
T 4eco_A 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261 (636)
T ss_dssp CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTT
T ss_pred hhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcC
Confidence 456666 666666666666666666666664 666666 666666666666666
Q ss_pred CCcccccccCCCCCCeeeccCcc-ccc-cCCcCccCC------CCccEEeccccccCCCCCh--hhhcCCCCCEEEccCC
Q 002094 203 EGEIVKGISNLYDLRAIKLGKNK-FSG-QLPEDIGGC------SMLKVLDFGVNSLSGSLPD--SLQRLNSCSSLSLKGN 272 (967)
Q Consensus 203 ~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l------~~L~~L~l~~n~l~~~~~~--~l~~l~~L~~L~L~~n 272 (967)
.+.+|..|+++++|++|+|++|+ +++ .+|..++.+ ++|++|++++|+++ .+|. .+.++++|+.|+|++|
T Consensus 262 ~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N 340 (636)
T 4eco_A 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYN 340 (636)
T ss_dssp CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSC
T ss_pred CccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCC
Confidence 66666666666666666666666 665 566666554 66666666666666 5565 6666666666666666
Q ss_pred CCCCcCchhhccccccccccccccccccccCCCCCcccc-cceEEcccCcCCCCCChhhhcCC--CCcEEEccCCcCcCC
Q 002094 273 SFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVF-LKELNISMNQFTGGLPESMMNCG--NLLAIDVSQNKLTGN 349 (967)
Q Consensus 273 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~ 349 (967)
+++|.+| .+..+++|++|+|++|+++ .+|..+..+++ |++|++++|+++ .+|..+..++ +|+.|++++|++++.
T Consensus 341 ~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~ 417 (636)
T 4eco_A 341 QLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSV 417 (636)
T ss_dssp CCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTT
T ss_pred cCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCc
Confidence 6666666 6666666666666666666 55666666666 666666666666 5555555443 666666666666655
Q ss_pred CChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCC
Q 002094 350 IPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPAS 429 (967)
Q Consensus 350 ~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 429 (967)
+|..+.... ...-.+++|++|+|++|++++..+..+..+++|++|+|++|++. .+|..
T Consensus 418 ~p~~l~~~~---------------------~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~ 475 (636)
T 4eco_A 418 DGKNFDPLD---------------------PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKN 475 (636)
T ss_dssp TTCSSCTTC---------------------SSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSS
T ss_pred chhhhcccc---------------------cccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHH
Confidence 554332100 00012457888888888888554444556788888888888887 55544
Q ss_pred cCC-c-------ccccEEEecCCcccccCccccc--CCCCCCEEEcCCCCCCCcCCccccccCccceeec------cCCc
Q 002094 430 IGK-L-------KAIQVLDFSDNWLNGTIPPQIG--GAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLIL------SQNN 493 (967)
Q Consensus 430 ~~~-l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L------s~N~ 493 (967)
+.. . ++|+.|+|++|+++ .+|..+. .+++|++|+|++|++++ +|..+..+++|+.|+| ++|+
T Consensus 476 ~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~ 553 (636)
T 4eco_A 476 SLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNR 553 (636)
T ss_dssp SSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCB
T ss_pred HhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCc
Confidence 332 2 38889999999888 6777776 88899999999999986 8888888999999988 5678
Q ss_pred CcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccc
Q 002094 494 LTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHG 544 (967)
Q Consensus 494 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 544 (967)
+.+.+|..+.++++|++|+|++|++ +.+|..+. ++|+.|+|++|++..
T Consensus 554 l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 554 TLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp CCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred ccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence 8889999999999999999999999 57777765 789999999998874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=555.39 Aligned_cols=473 Identities=21% Similarity=0.286 Sum_probs=375.4
Q ss_pred ChhHHHHHHHHHhcCCCCccccCCCCCCC----CCC--Ccc------------ceEEeCCCCCeeeeeeecCCCCCcccc
Q 002094 25 FNDDVLGLIVFKAGLEDPKEKLTSWSEDD----DNP--CNW------------VGVKCDPKTKRVVGLTLDGFSLSGHIG 86 (967)
Q Consensus 25 ~~~d~~all~~k~~~~~~~~~l~sw~~~~----~~~--c~w------------~gv~c~~~~~~v~~l~l~~~~l~~~~~ 86 (967)
..+|++||++||+++.|| +|+.++ .+| |.| .||+|+. .+||++|+|.+++++|.+|
T Consensus 267 ~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip 340 (876)
T 4ecn_A 267 YIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVP 340 (876)
T ss_dssp HHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEEC
T ss_pred chHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCc
Confidence 468999999999999888 786554 234 999 9999986 6899999999999999999
Q ss_pred ccccCCCCCCeEec-CCCccCccccccc---------------------------------------------------c
Q 002094 87 RGLLRLQFLQVLSL-SNNNFTGTINADL---------------------------------------------------A 114 (967)
Q Consensus 87 ~~l~~l~~L~~L~L-~~n~l~~~~~~~~---------------------------------------------------~ 114 (967)
++|++|++|++|+| ++|.++|..|-.. .
T Consensus 341 ~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~ 420 (876)
T 4ecn_A 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420 (876)
T ss_dssp GGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred hHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence 99999999999999 8898887733221 1
Q ss_pred CCCCCcEEEcCC--CCCCCCCCchhhhcCCCCceEeccccccCC-----------------CCccccc--cccccceeee
Q 002094 115 SFGTLQVVDFSE--NNLSGLIPDEFFRQCGSLREVSFANNNLTG-----------------PIPESLS--FCSSLESVNF 173 (967)
Q Consensus 115 ~l~~L~~L~Ls~--n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~-----------------~~p~~l~--~l~~L~~L~L 173 (967)
....++.+.+.. |++++ ||.. |+++++|++|+|++|++++ .+|..++ ++++|++|+|
T Consensus 421 ~~l~l~~l~l~~~~N~L~~-IP~~-l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~L 498 (876)
T 4ecn_A 421 SRISLKDTQIGNLTNRITF-ISKA-IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498 (876)
T ss_dssp CCCCCCTTTTTCCSCEEEE-ECGG-GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred cccchhhceeccccCcccc-hhHH-HhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEEC
Confidence 112333344443 78887 8876 6899999999999999998 3888887 9999999999
Q ss_pred cccccccccCccccccccCCeEeecCCc-CCC-cccccccCCC-------CCCeeeccCccccccCCc--CccCCCCccE
Q 002094 174 SSNRLSGQLPYGIWFLRSLQSLDLSNNL-LEG-EIVKGISNLY-------DLRAIKLGKNKFSGQLPE--DIGGCSMLKV 242 (967)
Q Consensus 174 ~~N~l~~~~p~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l~-------~L~~L~L~~n~l~~~~~~--~~~~l~~L~~ 242 (967)
++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+++++ +|++|+|++|+++ .+|. .|+++++|++
T Consensus 499 s~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~ 577 (876)
T 4ecn_A 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGL 577 (876)
T ss_dssp ESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCE
T ss_pred cCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCE
Confidence 9999999999999999999999999998 988 7888777665 9999999999999 7888 8999999999
Q ss_pred EeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccc-cccccccccccccccCCCCCcccc--cceEEccc
Q 002094 243 LDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLAN-LESLDLSLNQFSGRIPSSIGNLVF--LKELNISM 319 (967)
Q Consensus 243 L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~L~~ 319 (967)
|++++|+++ .+| .|..+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|+++ .+|..+..+.. |+.|+|++
T Consensus 578 L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~ 653 (876)
T 4ecn_A 578 LDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSY 653 (876)
T ss_dssp EECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCS
T ss_pred EECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcC
Confidence 999999999 778 8999999999999999999 78888999999 999999999998 78888877654 99999999
Q ss_pred CcCCCCCChhh---h--cCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEcc
Q 002094 320 NQFTGGLPESM---M--NCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLS 394 (967)
Q Consensus 320 N~l~~~~~~~~---~--~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~ 394 (967)
|++++.+|... . .+++|+.|++++|+++ .+|..++. .+++|+.|+|+
T Consensus 654 N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~---------------------------~l~~L~~L~Ls 705 (876)
T 4ecn_A 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFA---------------------------TGSPISTIILS 705 (876)
T ss_dssp SCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHH---------------------------TTCCCSEEECC
T ss_pred CcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHc---------------------------cCCCCCEEECC
Confidence 99998766432 2 3458999999999998 66766542 12345555555
Q ss_pred CCcccCCCCCCcc-------cccccchhcccccccccccCCCcC--CcccccEEEecCCcccccCcccccCCCCCCEEEc
Q 002094 395 SNALSGVIPSNIG-------DLSSLMLLNMSMNYLFGSIPASIG--KLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKL 465 (967)
Q Consensus 395 ~N~l~~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 465 (967)
+|+|+...+..+. ++++|+.|+|++|++. .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|
T Consensus 706 ~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~L 783 (876)
T 4ecn_A 706 NNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGI 783 (876)
T ss_dssp SCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEEC
T ss_pred CCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEEC
Confidence 5555522222222 2336777777777766 5666665 67777777777777765 5666777777777777
Q ss_pred CC------CCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecC
Q 002094 466 EK------NFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISH 539 (967)
Q Consensus 466 ~~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~ 539 (967)
++ |++.+.+|..|.++++|+.|+|++|+| +.+|..+. ++|+.|||++|++....+..+.....+..+.|.+
T Consensus 784 s~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~ 860 (876)
T 4ecn_A 784 RHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLY 860 (876)
T ss_dssp CCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEEC
T ss_pred CCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecC
Confidence 55 777778888888888888888888888 56777655 5788888888888777777777776777777777
Q ss_pred Cccc
Q 002094 540 NHLH 543 (967)
Q Consensus 540 N~l~ 543 (967)
|++.
T Consensus 861 n~~~ 864 (876)
T 4ecn_A 861 DKTQ 864 (876)
T ss_dssp CTTS
T ss_pred CCcc
Confidence 7665
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-56 Score=543.46 Aligned_cols=510 Identities=22% Similarity=0.219 Sum_probs=370.2
Q ss_pred CCccceEEeCCC---------CCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCC
Q 002094 56 PCNWVGVKCDPK---------TKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSE 126 (967)
Q Consensus 56 ~c~w~gv~c~~~---------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 126 (967)
.|.++-|.|... ..+++.|+|.++.+++..+..+.++++|++|+|++|++++..|..|+.+++|++|+|++
T Consensus 3 ~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 82 (680)
T 1ziw_A 3 TVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82 (680)
T ss_dssp -CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred eeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence 466666777532 35799999999999998888899999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcc
Q 002094 127 NNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEI 206 (967)
Q Consensus 127 n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 206 (967)
|+++ .+|...|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|++|+|++|.+++..
T Consensus 83 n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 161 (680)
T 1ziw_A 83 NELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161 (680)
T ss_dssp SCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred CccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence 9998 577777899999999999999999888889999999999999999999988999999999999999999999887
Q ss_pred ccccc--CCCCCCeeeccCccccccCCcCccCC---------------------------CCccEEeccccccCCCCChh
Q 002094 207 VKGIS--NLYDLRAIKLGKNKFSGQLPEDIGGC---------------------------SMLKVLDFGVNSLSGSLPDS 257 (967)
Q Consensus 207 ~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l---------------------------~~L~~L~l~~n~l~~~~~~~ 257 (967)
+..+. .+++|++|++++|++++..|..|..+ ++|+.|++++|.+++..|..
T Consensus 162 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~ 241 (680)
T 1ziw_A 162 SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241 (680)
T ss_dssp HHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTT
T ss_pred HHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhH
Confidence 77654 45788888888888887777665543 34555666666666666666
Q ss_pred hhcCCC--CCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCC----------------------------
Q 002094 258 LQRLNS--CSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIG---------------------------- 307 (967)
Q Consensus 258 l~~l~~--L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~---------------------------- 307 (967)
|.+++. |+.|+|++|++++..+..|+.+++|++|++++|++.+..|..|.
T Consensus 242 ~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~ 321 (680)
T 1ziw_A 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321 (680)
T ss_dssp TGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEEC
T ss_pred hhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccC
Confidence 666543 66666666666666666666666666666666666655554444
Q ss_pred -----cccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCC-CChhhh----cccccEEeccCCCCCCCCCCCc
Q 002094 308 -----NLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGN-IPTWIF----KMGLQTVSLSGNRLGESMQYPS 377 (967)
Q Consensus 308 -----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~p~~~~----~~~L~~L~L~~n~l~~~~~~~~ 377 (967)
.+++|++|++++|++++..+..|.++++|+.|++++|.+... ++...+ ..+|+.|++++|++....
T Consensus 322 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~---- 397 (680)
T 1ziw_A 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE---- 397 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEEC----
T ss_pred hhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEC----
Confidence 445555555556666655555566666666665555543211 111100 013444444444443221
Q ss_pred ccccccCCCCccEEE-------------------------ccCCcccCCCCCCcccccccchhcccccccc--cccCCCc
Q 002094 378 FASMKDSYQGLQVLD-------------------------LSSNALSGVIPSNIGDLSSLMLLNMSMNYLF--GSIPASI 430 (967)
Q Consensus 378 ~~~~~~~~~~L~~L~-------------------------L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~ 430 (967)
+..+..+++|++|+ +++|++.+..+..|..+++|+.|++++|.+. +.+|..|
T Consensus 398 -~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~ 476 (680)
T 1ziw_A 398 -SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476 (680)
T ss_dssp -TTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTT
T ss_pred -hhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCccc
Confidence 11223344444444 4444444444445555555555555555554 4567777
Q ss_pred CCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCC--------ccccccCccceeeccCCcCcCccchhh
Q 002094 431 GKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIP--------SQIKNCSSLTSLILSQNNLTGPVPAAI 502 (967)
Q Consensus 431 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 502 (967)
..+++|+.|+|++|++++..+..|.++++|++|+|++|++++..+ ..|+++++|+.|+|++|+++...+..|
T Consensus 477 ~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~ 556 (680)
T 1ziw_A 477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVF 556 (680)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred ccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHc
Confidence 888888888888888887777778888888888888888875422 237788888888888888886555678
Q ss_pred hcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCC-C-CCCccCCCcccCCCCCCCccc
Q 002094 503 ANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVG-G-FFNTISPSSVSGNPSLCGSVV 571 (967)
Q Consensus 503 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~-~~~~~~~~~~~~n~~lc~~~~ 571 (967)
.++++|+.|||++|++++..+..|..+++|+.|+|++|++++..|.. . .+..+....+.+|||.|+|..
T Consensus 557 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 557 KDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred ccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 89999999999999999877778888999999999999998755531 1 245566777899999999874
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-55 Score=530.23 Aligned_cols=506 Identities=21% Similarity=0.224 Sum_probs=431.5
Q ss_pred cceEEeCCC---------CCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCC
Q 002094 59 WVGVKCDPK---------TKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNL 129 (967)
Q Consensus 59 w~gv~c~~~---------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~ 129 (967)
+.-|.|... ...++.|++.++.+++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 556888642 34789999999999998889999999999999999999999999999999999999999999
Q ss_pred CCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCccccc
Q 002094 130 SGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKG 209 (967)
Q Consensus 130 ~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~ 209 (967)
++..|. .|+++++|++|+|++|++++..|..++++++|++|+|++|++++..+..+..+++|++|+|++|.+++..+..
T Consensus 94 ~~~~~~-~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 94 IFMAET-ALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp SEECTT-TTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred cccChh-hhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 966565 4699999999999999999877888999999999999999999755455556999999999999999988999
Q ss_pred ccCCCCCC--eeeccCccccccCCcCccCCCCccEEeccccccC--------------------------CCCChhhhcC
Q 002094 210 ISNLYDLR--AIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLS--------------------------GSLPDSLQRL 261 (967)
Q Consensus 210 ~~~l~~L~--~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--------------------------~~~~~~l~~l 261 (967)
|+.+++|+ .|++++|++++..|..|.. .+|++|++++|... ...+..+..+
T Consensus 173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l 251 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251 (606)
T ss_dssp HHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGG
T ss_pred hhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchh
Confidence 99999999 8999999999887777655 68888888877510 1112233333
Q ss_pred C--CCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEE
Q 002094 262 N--SCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAI 339 (967)
Q Consensus 262 ~--~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 339 (967)
. +|+.|++++|.+++..+..|..+++|++|++++|+++ .+|..+..+++|++|++++|++++..|..+.++++|+.|
T Consensus 252 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 330 (606)
T 3t6q_A 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330 (606)
T ss_dssp GGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEE
T ss_pred hcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEE
Confidence 2 7889999999999888888999999999999999998 778889999999999999999998888899999999999
Q ss_pred EccCCcCcCCCChh-hhc-ccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcc
Q 002094 340 DVSQNKLTGNIPTW-IFK-MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNM 417 (967)
Q Consensus 340 ~l~~N~l~~~~p~~-~~~-~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 417 (967)
++++|.+.+.+|.. +.. .+|++|++++|.+..... ....+..+++|++|++++|++.+..|..|..+++|++|++
T Consensus 331 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~---~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 407 (606)
T 3t6q_A 331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDC---CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407 (606)
T ss_dssp ECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEE---STTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEEC
T ss_pred ECCCCCcccccchhhhhccCcCCEEECCCCccccccC---cchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEEC
Confidence 99999998777654 333 489999999999865321 1234566789999999999999888999999999999999
Q ss_pred cccccccccCC-CcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCc---CCccccccCccceeeccCCc
Q 002094 418 SMNYLFGSIPA-SIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGR---IPSQIKNCSSLTSLILSQNN 493 (967)
Q Consensus 418 s~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L~Ls~N~ 493 (967)
++|++.+..+. .+..+++|+.|++++|.+++..|..+..+++|++|+|++|++++. .+..+..+++|+.|+|++|+
T Consensus 408 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~ 487 (606)
T 3t6q_A 408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487 (606)
T ss_dssp TTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSC
T ss_pred CCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCc
Confidence 99999877654 488999999999999999988888999999999999999999863 33678899999999999999
Q ss_pred CcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCC-CCCCccCCCcccCCCCCCCccc
Q 002094 494 LTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVG-GFFNTISPSSVSGNPSLCGSVV 571 (967)
Q Consensus 494 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~~ 571 (967)
+++..|..|.++++|++|||++|++++..|..+..++.| .|++++|++++.+|.. ..+..+....+.+|||.|.|..
T Consensus 488 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred cCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 998889999999999999999999999999999999999 9999999999766642 2234566677899999998876
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=548.84 Aligned_cols=495 Identities=21% Similarity=0.217 Sum_probs=430.8
Q ss_pred CccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccc-cccccCCCCCcEEEcCCCCCCCCCCc
Q 002094 57 CNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTI-NADLASFGTLQVVDFSENNLSGLIPD 135 (967)
Q Consensus 57 c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~n~~~~~ip~ 135 (967)
|.|..|-+ ...+++.|+|++|.+++..+..|.++++|++|+|++|++.+.+ |..|+++++|++|+|++|.+++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 56777766 4578999999999999999999999999999999999777666 78999999999999999999976665
Q ss_pred hhhhcCCCCceEeccccccCCCCccc--cccccccceeeecccccccccC-ccccccccCCeEeecCCcCCCcccccccC
Q 002094 136 EFFRQCGSLREVSFANNNLTGPIPES--LSFCSSLESVNFSSNRLSGQLP-YGIWFLRSLQSLDLSNNLLEGEIVKGISN 212 (967)
Q Consensus 136 ~~~~~l~~L~~L~L~~n~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 212 (967)
. |+++++|++|+|++|++++.+|.. |+++++|++|+|++|++++..+ ..|+++++|++|+|++|.+++..+..+..
T Consensus 92 ~-~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~ 170 (844)
T 3j0a_A 92 A-FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170 (844)
T ss_dssp S-SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred H-ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence 4 699999999999999999877665 9999999999999999997765 57999999999999999999999999988
Q ss_pred C--CCCCeeeccCccccccCCcCccCCCC------ccEEeccccccCCCCChhhhc------------------------
Q 002094 213 L--YDLRAIKLGKNKFSGQLPEDIGGCSM------LKVLDFGVNSLSGSLPDSLQR------------------------ 260 (967)
Q Consensus 213 l--~~L~~L~L~~n~l~~~~~~~~~~l~~------L~~L~l~~n~l~~~~~~~l~~------------------------ 260 (967)
+ ++|+.|+|++|.+.+..|..++.+++ |++|++++|.+++..+..+..
T Consensus 171 l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~ 250 (844)
T 3j0a_A 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH 250 (844)
T ss_dssp HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCS
T ss_pred ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccc
Confidence 8 89999999999999988888887766 999999999888766655432
Q ss_pred --------------CCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCC
Q 002094 261 --------------LNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGL 326 (967)
Q Consensus 261 --------------l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 326 (967)
.++|+.|+|++|.+.+..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..
T Consensus 251 ~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 330 (844)
T 3j0a_A 251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330 (844)
T ss_dssp SSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCC
T ss_pred ccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccC
Confidence 268999999999999888999999999999999999999888889999999999999999999888
Q ss_pred ChhhhcCCCCcEEEccCCcCcCCCChhhhc-ccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCC
Q 002094 327 PESMMNCGNLLAIDVSQNKLTGNIPTWIFK-MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSN 405 (967)
Q Consensus 327 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~ 405 (967)
|..|..+++|+.|++++|++.+..+..+.. .+|++|+|++|.+.... .+++|+.|++++|+++. +|..
T Consensus 331 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~----------~~~~L~~L~l~~N~l~~-l~~~ 399 (844)
T 3j0a_A 331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIH----------FIPSIPDIFLSGNKLVT-LPKI 399 (844)
T ss_dssp SCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCS----------SCCSCSEEEEESCCCCC-CCCC
T ss_pred HHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCccc----------CCCCcchhccCCCCccc-cccc
Confidence 999999999999999999998666655543 48999999999987533 26789999999999984 4443
Q ss_pred cccccccchhccccccccccc-CCCcCCcccccEEEecCCcccccCcc-cccCCCCCCEEEcCCCCCC-----CcCCccc
Q 002094 406 IGDLSSLMLLNMSMNYLFGSI-PASIGKLKAIQVLDFSDNWLNGTIPP-QIGGAVSLKELKLEKNFLS-----GRIPSQI 478 (967)
Q Consensus 406 ~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~ 478 (967)
..+++.|++++|++.+.. +..+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..|
T Consensus 400 ---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~ 476 (844)
T 3j0a_A 400 ---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVF 476 (844)
T ss_dssp ---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCS
T ss_pred ---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhh
Confidence 467899999999997542 22356899999999999999865443 4566889999999999997 4456778
Q ss_pred cccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCCCCCCccCCC
Q 002094 479 KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPS 558 (967)
Q Consensus 479 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~ 558 (967)
.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+. ++|+.|+|++|++++.+|.. +..+...
T Consensus 477 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l 552 (844)
T 3j0a_A 477 EGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVL 552 (844)
T ss_dssp SCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEE
T ss_pred cCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEE
Confidence 9999999999999999999999999999999999999999988887776 89999999999999988853 5567777
Q ss_pred cccCCCCCCCcccc
Q 002094 559 SVSGNPSLCGSVVN 572 (967)
Q Consensus 559 ~~~~n~~lc~~~~~ 572 (967)
.+.+|||.|+|.+.
T Consensus 553 ~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 553 DITHNKFICECELS 566 (844)
T ss_dssp EEEEECCCCSSSCC
T ss_pred EecCCCcccccccH
Confidence 88999999988763
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-55 Score=530.32 Aligned_cols=482 Identities=20% Similarity=0.217 Sum_probs=415.7
Q ss_pred eeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEecccc
Q 002094 73 GLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANN 152 (967)
Q Consensus 73 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n 152 (967)
.++..+.+++. +|..+.. ++++|+|++|++++..|..|+++++|++|+|++|++++..|. .|+++++|++|+|++|
T Consensus 16 ~~~c~~~~l~~-iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~Ls~n 91 (606)
T 3t6q_A 16 TYNCENLGLNE-IPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED-TFQSQHRLDTLVLTAN 91 (606)
T ss_dssp EEECTTSCCSS-CCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTT-TTTTCTTCCEEECTTC
T ss_pred eEECCCCCccc-CcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChh-hccCccccCeeeCCCC
Confidence 45666666653 4555543 789999999999999999999999999999999999965555 4799999999999999
Q ss_pred ccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCc
Q 002094 153 NLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPE 232 (967)
Q Consensus 153 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 232 (967)
++++..|..|+++++|++|+|++|++++..|..+..+++|++|+|++|.+++.....+..+++|++|++++|++++..+.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 171 (606)
T 3t6q_A 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171 (606)
T ss_dssp CCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHH
T ss_pred cccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChh
Confidence 99999999999999999999999999988788899999999999999999987666666799999999999999988899
Q ss_pred CccCCCCcc--EEeccccccCCCCChhhhcCCCCCEEEccCCCC--------------------------CCcCchhhcc
Q 002094 233 DIGGCSMLK--VLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSF--------------------------TGEVPDWIGK 284 (967)
Q Consensus 233 ~~~~l~~L~--~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l--------------------------~~~~~~~l~~ 284 (967)
.|+.+++|+ .|++++|.+++..|..+.. .+|+.|++++|.. ....+..+..
T Consensus 172 ~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~ 250 (606)
T 3t6q_A 172 DMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250 (606)
T ss_dssp HHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGG
T ss_pred hhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhch
Confidence 999999999 8999999999877777654 6888999888751 1122333444
Q ss_pred cc--ccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcc-cccE
Q 002094 285 LA--NLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM-GLQT 361 (967)
Q Consensus 285 l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~L~~ 361 (967)
+. +|+.|++++|.+++..+..|..+++|++|++++|+++ .+|..+..+++|+.|++++|++++..|..+... +|++
T Consensus 251 l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 329 (606)
T 3t6q_A 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329 (606)
T ss_dssp GGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSE
T ss_pred hhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCE
Confidence 43 7999999999999888888999999999999999999 778899999999999999999997777666554 8999
Q ss_pred EeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCC--CCCcccccccchhcccccccccccCCCcCCcccccEE
Q 002094 362 VSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVI--PSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVL 439 (967)
Q Consensus 362 L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 439 (967)
|++++|.+..... ...+..+++|++|++++|++++.. +..+..+++|++|++++|.+.+..|..+..+++|+.|
T Consensus 330 L~l~~n~~~~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 405 (606)
T 3t6q_A 330 LSIKGNTKRLELG----TGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405 (606)
T ss_dssp EECCSCSSCCBCC----SSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEE
T ss_pred EECCCCCcccccc----hhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeE
Confidence 9999998864322 223456899999999999999876 8889999999999999999999999999999999999
Q ss_pred EecCCcccccCccc-ccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCc---cchhhhcccCccEEeccC
Q 002094 440 DFSDNWLNGTIPPQ-IGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGP---VPAAIANLSNLKYVDLSF 515 (967)
Q Consensus 440 ~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~ 515 (967)
++++|++++..|.. +..+++|++|++++|.+++..|..++.+++|+.|+|++|++++. .+..+..+++|++|+|++
T Consensus 406 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~ 485 (606)
T 3t6q_A 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485 (606)
T ss_dssp ECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTT
T ss_pred ECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCC
Confidence 99999999776654 89999999999999999999999999999999999999999873 336799999999999999
Q ss_pred CccccCCchhhhhccCCceEEecCCcccccCCCC-CCCCccCCCcccCCCC
Q 002094 516 NDLSGILPKELINLSHLLSFNISHNHLHGELPVG-GFFNTISPSSVSGNPS 565 (967)
Q Consensus 516 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~ 565 (967)
|++++..|..|..+++|+.|+|++|++++.+|.. .....+ ...+.+|.-
T Consensus 486 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l 535 (606)
T 3t6q_A 486 CDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535 (606)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCC
T ss_pred CccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcc
Confidence 9999999999999999999999999999877742 112233 344556643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-55 Score=527.67 Aligned_cols=505 Identities=20% Similarity=0.184 Sum_probs=430.6
Q ss_pred CCCcc----ceEEeCCC---------CCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcE
Q 002094 55 NPCNW----VGVKCDPK---------TKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQV 121 (967)
Q Consensus 55 ~~c~w----~gv~c~~~---------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (967)
+||.| ..|.|... ..+++.|+|.++.+++..+..|.++++|++|+|++|++++..|..|+++++|++
T Consensus 5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~ 84 (606)
T 3vq2_A 5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN 84 (606)
T ss_dssp -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCE
Confidence 45665 35778532 357999999999999988889999999999999999999999999999999999
Q ss_pred EEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeeccccccc-ccCccccccccCCeEeecCC
Q 002094 122 VDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSG-QLPYGIWFLRSLQSLDLSNN 200 (967)
Q Consensus 122 L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~n 200 (967)
|+|++|.+++..|.. |+++++|++|+|++|++++..+..++++++|++|+|++|++++ .+|..|+++++|++|+|++|
T Consensus 85 L~Ls~n~l~~~~p~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 85 LILTGNPIQSFSPGS-FSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp EECTTCCCCCCCTTS-STTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred eECCCCcccccChhh-cCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 999999999765654 6999999999999999998888899999999999999999986 56999999999999999999
Q ss_pred cCCCcccccccCCCCCC----eeeccCccccccCCcCccCCCCccEEeccccccC-CCCChhhhcCCCCCEEEc------
Q 002094 201 LLEGEIVKGISNLYDLR----AIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLS-GSLPDSLQRLNSCSSLSL------ 269 (967)
Q Consensus 201 ~l~~~~~~~~~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~l~~l~~L~~L~L------ 269 (967)
.+++..+..|+.+.+|+ +|++++|++++..+..+... +|++|++++|.++ +..|..+.++++|+.+++
T Consensus 164 ~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~ 242 (606)
T 3vq2_A 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK 242 (606)
T ss_dssp CCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCT
T ss_pred cceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccc
Confidence 99999899888887776 79999999997776666665 8999999999987 356677788888777666
Q ss_pred ---------------------------cCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcC
Q 002094 270 ---------------------------KGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQF 322 (967)
Q Consensus 270 ---------------------------~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 322 (967)
..|.+.+.+|. +..+++|+.|++++|.+. .+| .+..+++|+.|++++|++
T Consensus 243 ~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l 319 (606)
T 3vq2_A 243 DERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL 319 (606)
T ss_dssp TSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC
T ss_pred cCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC
Confidence 66777777776 888999999999999997 455 788899999999999999
Q ss_pred CCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCC
Q 002094 323 TGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVI 402 (967)
Q Consensus 323 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~ 402 (967)
+.+| .+ .+++|+.|++++|+..+.++ .....+|++|++++|.+..... ....+..+++|++|++++|.+++ +
T Consensus 320 -~~lp-~~-~l~~L~~L~l~~n~~~~~~~-~~~l~~L~~L~ls~n~l~~~~~---~~~~~~~~~~L~~L~L~~n~l~~-~ 391 (606)
T 3vq2_A 320 -KQFP-TL-DLPFLKSLTLTMNKGSISFK-KVALPSLSYLDLSRNALSFSGC---CSYSDLGTNSLRHLDLSFNGAII-M 391 (606)
T ss_dssp -SSCC-CC-CCSSCCEEEEESCSSCEECC-CCCCTTCCEEECCSSCEEEEEE---CCHHHHCCSCCCEEECCSCSEEE-E
T ss_pred -cccc-cC-CCCccceeeccCCcCccchh-hccCCCCCEEECcCCccCCCcc---hhhhhccCCcccEeECCCCcccc-c
Confidence 5677 45 89999999999996654442 2233489999999998864321 12334567899999999999985 5
Q ss_pred CCCcccccccchhcccccccccccC-CCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCC-cCCccccc
Q 002094 403 PSNIGDLSSLMLLNMSMNYLFGSIP-ASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSG-RIPSQIKN 480 (967)
Q Consensus 403 ~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~ 480 (967)
|..+..+++|+.|++++|++.+..| ..+..+++|++|++++|++++..|..+..+++|++|+|++|.+++ .+|..|+.
T Consensus 392 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 471 (606)
T 3vq2_A 392 SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471 (606)
T ss_dssp CCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred hhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhcc
Confidence 5889999999999999999988877 688999999999999999998899999999999999999999987 47889999
Q ss_pred cCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCC-CCCC-ccCCC
Q 002094 481 CSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVG-GFFN-TISPS 558 (967)
Q Consensus 481 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~~~~-~~~~~ 558 (967)
+++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|+.|+|++|+++ .+|.. ..+. .+...
T Consensus 472 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l 550 (606)
T 3vq2_A 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFF 550 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEE
T ss_pred CCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEE
Confidence 999999999999999988999999999999999999999999999999999999999999998 56654 1122 35566
Q ss_pred cccCCCCCCCccccC
Q 002094 559 SVSGNPSLCGSVVNR 573 (967)
Q Consensus 559 ~~~~n~~lc~~~~~~ 573 (967)
.+.+|||.|+|++..
T Consensus 551 ~l~~N~~~c~c~~~~ 565 (606)
T 3vq2_A 551 NLTNNSVACICEHQK 565 (606)
T ss_dssp ECCSCCCCCSSTTHH
T ss_pred EccCCCcccCCccHH
Confidence 789999999888643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=512.13 Aligned_cols=481 Identities=20% Similarity=0.183 Sum_probs=351.6
Q ss_pred CeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEe
Q 002094 69 KRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVS 148 (967)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~ 148 (967)
.+++.|++.++.+++..+..++++++|++|+|++|++++..+..|+.+++|++|+|++|++++ +|...|+++++|++|+
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~ 127 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITLD 127 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCSCTTTTCTTCCEEE
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCc-cChhHccccCCCCEEE
Confidence 356677777777777666677777777777777777776555567777777777777777763 4434456777777777
Q ss_pred ccccccCCCCccccccccccceeeecccccccccCcccc--ccccCCeEeecCCcCCCcccc------------------
Q 002094 149 FANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIW--FLRSLQSLDLSNNLLEGEIVK------------------ 208 (967)
Q Consensus 149 L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~n~l~~~~~~------------------ 208 (967)
|++|++++..|..++++++|++|+|++|++++..+..+. .+++|++|+|++|.+++..+.
T Consensus 128 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l 207 (680)
T 1ziw_A 128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL 207 (680)
T ss_dssp CCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCC
T ss_pred CCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhcccccc
Confidence 777777766666677777777777777776655554433 235566666666665555444
Q ss_pred ---------------------------------cccCCCC--CCeeeccCccccccCCcCccCCCCccEEeccccccCCC
Q 002094 209 ---------------------------------GISNLYD--LRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGS 253 (967)
Q Consensus 209 ---------------------------------~~~~l~~--L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 253 (967)
.|.+++. |+.|+|++|++++..+..|+.+++|++|++++|++++.
T Consensus 208 ~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 287 (680)
T 1ziw_A 208 GPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL 287 (680)
T ss_dssp HHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEE
T ss_pred ChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCcc
Confidence 4444432 66666666666666566666666666666666666655
Q ss_pred CChhhhcCCCCCEEEccCCCCCC-----cCc----hhhccccccccccccccccccccCCCCCcccccceEEc-------
Q 002094 254 LPDSLQRLNSCSSLSLKGNSFTG-----EVP----DWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNI------- 317 (967)
Q Consensus 254 ~~~~l~~l~~L~~L~L~~n~l~~-----~~~----~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L------- 317 (967)
.|..|.++++|+.|++++|...+ .+| ..|..+++|++|++++|++.+..+..|..+++|++|++
T Consensus 288 ~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~ 367 (680)
T 1ziw_A 288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL 367 (680)
T ss_dssp CTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCC
T ss_pred ChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhh
Confidence 55555555555444444433221 111 14555666777777777777666666666655555555
Q ss_pred ---------------------ccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCCh-hhhc-ccccEEeccCCCCCCCCC
Q 002094 318 ---------------------SMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPT-WIFK-MGLQTVSLSGNRLGESMQ 374 (967)
Q Consensus 318 ---------------------~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~-~~L~~L~L~~n~l~~~~~ 374 (967)
++|++++..|..|..+++|+.|++++|++.+.+|. .+.. .+|++|++++|++....
T Consensus 368 ~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~- 446 (680)
T 1ziw_A 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLT- 446 (680)
T ss_dssp CEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECC-
T ss_pred hhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeC-
Confidence 55566666777888888999999999988876663 3332 37889999999875433
Q ss_pred CCcccccccCCCCccEEEccCCccc--CCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCc-
Q 002094 375 YPSFASMKDSYQGLQVLDLSSNALS--GVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIP- 451 (967)
Q Consensus 375 ~~~~~~~~~~~~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p- 451 (967)
...+..+++|+.|++++|.++ +.+|..|..+++|+.|+|++|++.+..+..|.++++|++|+|++|++++..+
T Consensus 447 ----~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 522 (680)
T 1ziw_A 447 ----RNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKH 522 (680)
T ss_dssp ----TTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGST
T ss_pred ----hhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchh
Confidence 233456789999999999997 5789999999999999999999998888899999999999999999986422
Q ss_pred -------ccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCch
Q 002094 452 -------PQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPK 524 (967)
Q Consensus 452 -------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 524 (967)
..+.++++|++|+|++|+++...+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|.
T Consensus 523 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~ 602 (680)
T 1ziw_A 523 ANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602 (680)
T ss_dssp TSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHH
T ss_pred hccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChh
Confidence 2378899999999999999966666899999999999999999988888899999999999999999999998
Q ss_pred hhh-hccCCceEEecCCcccccCCC-CCCCCcc
Q 002094 525 ELI-NLSHLLSFNISHNHLHGELPV-GGFFNTI 555 (967)
Q Consensus 525 ~l~-~l~~L~~L~l~~N~l~~~~p~-~~~~~~~ 555 (967)
.+. .+++|+.|++++|+|.+.++. .++..++
T Consensus 603 ~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~~ 635 (680)
T 1ziw_A 603 VFGPAFRNLTELDMRFNPFDCTCESIAWFVNWI 635 (680)
T ss_dssp HHHHHHTTCSEEECTTCCCCBCCCCCSSEECCS
T ss_pred HhcccccccCEEEccCCCcccCCccHHHHHHHH
Confidence 888 899999999999999999885 5554444
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-53 Score=523.52 Aligned_cols=488 Identities=20% Similarity=0.209 Sum_probs=427.2
Q ss_pred CCeeeeeeecCCCCCccc-cccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCc-hhhhcCCCCc
Q 002094 68 TKRVVGLTLDGFSLSGHI-GRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPD-EFFRQCGSLR 145 (967)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~-~~~~~l~~L~ 145 (967)
-.+++.|+|+++...+.+ +..|.++++|++|+|++|++++..|..|+++++|++|+|++|.+++.+|. ..|+++++|+
T Consensus 47 l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~ 126 (844)
T 3j0a_A 47 LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126 (844)
T ss_dssp CCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCC
T ss_pred cccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCC
Confidence 357889999999888888 66899999999999999999999999999999999999999999987665 3579999999
Q ss_pred eEeccccccCCCCc-cccccccccceeeecccccccccCcccccc--ccCCeEeecCCcCCCcccccccCCCC------C
Q 002094 146 EVSFANNNLTGPIP-ESLSFCSSLESVNFSSNRLSGQLPYGIWFL--RSLQSLDLSNNLLEGEIVKGISNLYD------L 216 (967)
Q Consensus 146 ~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~------L 216 (967)
+|+|++|.+++..+ ..|+++++|++|+|++|++++..+..+..+ ++|+.|+|++|.+.+..+..+..+.+ |
T Consensus 127 ~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L 206 (844)
T 3j0a_A 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206 (844)
T ss_dssp EEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCB
T ss_pred EEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCce
Confidence 99999999998765 579999999999999999999999999888 89999999999999988888877766 9
Q ss_pred CeeeccCccccccCCcCccC--------------------------------------CCCccEEeccccccCCCCChhh
Q 002094 217 RAIKLGKNKFSGQLPEDIGG--------------------------------------CSMLKVLDFGVNSLSGSLPDSL 258 (967)
Q Consensus 217 ~~L~L~~n~l~~~~~~~~~~--------------------------------------l~~L~~L~l~~n~l~~~~~~~l 258 (967)
+.|++++|++++..+..+.. .++|++|++++|.+.+..+..|
T Consensus 207 ~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~ 286 (844)
T 3j0a_A 207 EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF 286 (844)
T ss_dssp SEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCS
T ss_pred eEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhh
Confidence 99999999887666554432 2689999999999998889999
Q ss_pred hcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcE
Q 002094 259 QRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLA 338 (967)
Q Consensus 259 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 338 (967)
..+++|+.|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|+.|++++|++++..+..|..+++|+.
T Consensus 287 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 366 (844)
T 3j0a_A 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366 (844)
T ss_dssp SSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCE
T ss_pred hcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCE
Confidence 99999999999999999999999999999999999999999888999999999999999999999988899999999999
Q ss_pred EEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCC-CCcccccccchhcc
Q 002094 339 IDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIP-SNIGDLSSLMLLNM 417 (967)
Q Consensus 339 L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L 417 (967)
|++++|.+++ ++. ..+|+.|++++|++..... ...+++.|++++|++++... ..+..+++|+.|+|
T Consensus 367 L~Ls~N~l~~-i~~---~~~L~~L~l~~N~l~~l~~---------~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~L 433 (844)
T 3j0a_A 367 LDLRDNALTT-IHF---IPSIPDIFLSGNKLVTLPK---------INLTANLIHLSENRLENLDILYFLLRVPHLQILIL 433 (844)
T ss_dssp EEEETCCSCC-CSS---CCSCSEEEEESCCCCCCCC---------CCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEE
T ss_pred EECCCCCCCc-ccC---CCCcchhccCCCCcccccc---------cccccceeecccCccccCchhhhhhcCCccceeeC
Confidence 9999999984 333 4579999999999975432 24679999999999997532 23568899999999
Q ss_pred cccccccccCC-CcCCcccccEEEecCCccc-----ccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccC
Q 002094 418 SMNYLFGSIPA-SIGKLKAIQVLDFSDNWLN-----GTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQ 491 (967)
Q Consensus 418 s~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 491 (967)
++|++.+..+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus 434 s~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 513 (844)
T 3j0a_A 434 NQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNS 513 (844)
T ss_dssp ESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEES
T ss_pred CCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCC
Confidence 99999865443 4667899999999999997 44556788999999999999999999999999999999999999
Q ss_pred CcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCCCCCCccCCCcccCCCCCCCccc
Q 002094 492 NNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGSVV 571 (967)
Q Consensus 492 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~ 571 (967)
|+|++..|..+. ++|+.|||++|+|++..|..| .+|+.|++++|++.|.++...+..++ ..+|...|+.+.
T Consensus 514 N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~~~f~~~~----~~~~~~~~~~~~ 584 (844)
T 3j0a_A 514 NRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELSTFINWL----NHTNVTIAGPPA 584 (844)
T ss_dssp CCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSCCSHHHHH----HHTTTTTCCCGG
T ss_pred CCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccccHHHHHHH----HhcCcccccccc
Confidence 999988777776 899999999999999999876 47899999999999998866554433 245666777776
Q ss_pred cCCCCC
Q 002094 572 NRSCPA 577 (967)
Q Consensus 572 ~~~c~~ 577 (967)
...|..
T Consensus 585 ~~~C~~ 590 (844)
T 3j0a_A 585 DIYCVY 590 (844)
T ss_dssp GCCCSS
T ss_pred cCccCC
Confidence 667754
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=496.88 Aligned_cols=471 Identities=22% Similarity=0.201 Sum_probs=418.2
Q ss_pred CCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceE
Q 002094 68 TKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147 (967)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L 147 (967)
-.+++.|++.++.+++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|.+++..+. .|+++++|++|
T Consensus 55 l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L 133 (606)
T 3vq2_A 55 FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESF-PIGQLITLKKL 133 (606)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSS-CCTTCTTCCEE
T ss_pred CccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCcccccccc-ccCCCCCCCEE
Confidence 35789999999999998888999999999999999999999999999999999999999999854444 47999999999
Q ss_pred eccccccCC-CCccccccccccceeeecccccccccCccccccccCC----eEeecCCcCCCcccccccCCCCCCeeecc
Q 002094 148 SFANNNLTG-PIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQ----SLDLSNNLLEGEIVKGISNLYDLRAIKLG 222 (967)
Q Consensus 148 ~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 222 (967)
+|++|++++ .+|..|+++++|++|+|++|++++..|..+..+++|+ +|++++|.+++..+..+... +|+.|+++
T Consensus 134 ~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~ 212 (606)
T 3vq2_A 134 NVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLR 212 (606)
T ss_dssp ECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEE
T ss_pred eCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeecc
Confidence 999999987 5699999999999999999999999899999888876 79999999998777777666 99999999
Q ss_pred Ccccc-ccCCcCccCCCCccEEec---------------------------------cccccCCCCChhhhcCCCCCEEE
Q 002094 223 KNKFS-GQLPEDIGGCSMLKVLDF---------------------------------GVNSLSGSLPDSLQRLNSCSSLS 268 (967)
Q Consensus 223 ~n~l~-~~~~~~~~~l~~L~~L~l---------------------------------~~n~l~~~~~~~l~~l~~L~~L~ 268 (967)
+|.++ +..|..+++++.|+.+++ ..|.+.+.+|. +..+++|+.|+
T Consensus 213 ~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~ 291 (606)
T 3vq2_A 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMS 291 (606)
T ss_dssp SCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEE
T ss_pred CCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEE
Confidence 99986 455666777777777666 56677777776 89999999999
Q ss_pred ccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcC
Q 002094 269 LKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTG 348 (967)
Q Consensus 269 L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 348 (967)
+++|.++. +| .+..+++|++|++++|++ +.+| .+ .+++|+.|++++|+..+.. .+..+++|+.|++++|++++
T Consensus 292 l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~ 364 (606)
T 3vq2_A 292 LAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSF 364 (606)
T ss_dssp EESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEE
T ss_pred ecCccchh-hh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCC
Confidence 99999974 55 789999999999999999 5778 45 9999999999999665443 67799999999999999986
Q ss_pred C--CChhhhc-ccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCC-CCcccccccchhccccccccc
Q 002094 349 N--IPTWIFK-MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIP-SNIGDLSSLMLLNMSMNYLFG 424 (967)
Q Consensus 349 ~--~p~~~~~-~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~ 424 (967)
. +|..+.. .+|++|++++|.+.... ..+..+++|++|++++|++.+..| ..+..+++|++|++++|.+.+
T Consensus 365 ~~~~~~~~~~~~~L~~L~L~~n~l~~~~------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~ 438 (606)
T 3vq2_A 365 SGCCSYSDLGTNSLRHLDLSFNGAIIMS------ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438 (606)
T ss_dssp EEECCHHHHCCSCCCEEECCSCSEEEEC------CCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEE
T ss_pred CcchhhhhccCCcccEeECCCCccccch------hhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCc
Confidence 5 3665555 48999999999986532 345668999999999999999888 789999999999999999999
Q ss_pred ccCCCcCCcccccEEEecCCcccc-cCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhh
Q 002094 425 SIPASIGKLKAIQVLDFSDNWLNG-TIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIA 503 (967)
Q Consensus 425 ~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 503 (967)
..|..+..+++|++|++++|++++ .+|..+..+++|++|+|++|++++..|..|+.+++|+.|+|++|++++..|..|.
T Consensus 439 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 518 (606)
T 3vq2_A 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518 (606)
T ss_dssp CCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTT
T ss_pred cchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHcc
Confidence 999999999999999999999997 4788999999999999999999999999999999999999999999999999999
Q ss_pred cccCccEEeccCCccccCCchhhhhcc-CCceEEecCCcccccCCCCCCCCcc
Q 002094 504 NLSNLKYVDLSFNDLSGILPKELINLS-HLLSFNISHNHLHGELPVGGFFNTI 555 (967)
Q Consensus 504 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~l~~N~l~~~~p~~~~~~~~ 555 (967)
++++|++|||++|+++ .+|..+..++ +|+.|++++|+|.+.++..++.+++
T Consensus 519 ~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~~~~l 570 (606)
T 3vq2_A 519 QLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWV 570 (606)
T ss_dssp TCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTHHHHTTT
T ss_pred CCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccHHHHHHH
Confidence 9999999999999999 6777799997 5999999999999988876555554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=489.43 Aligned_cols=473 Identities=21% Similarity=0.199 Sum_probs=395.6
Q ss_pred CCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceE
Q 002094 68 TKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147 (967)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L 147 (967)
..+++.|++.++.+++..+..|.++++|++|+|++|++++..+..|+.+++|++|+|++|++++ +|...|+++++|++|
T Consensus 27 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L 105 (570)
T 2z63_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKL 105 (570)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE-ECTTTTTTCTTCCEE
T ss_pred cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCc-cCHhhhcCccccccc
Confidence 3578899999999999888899999999999999999999888999999999999999999985 555567999999999
Q ss_pred eccccccCCCCccccccccccceeeeccccccc-ccCccccccccCCeEeecCCcCCCcccccccCCCCC----Ceeecc
Q 002094 148 SFANNNLTGPIPESLSFCSSLESVNFSSNRLSG-QLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDL----RAIKLG 222 (967)
Q Consensus 148 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L~ 222 (967)
+|++|++++..+..++++++|++|+|++|++++ .+|..|+++++|++|++++|.+++..+..++.+++| +.|+++
T Consensus 106 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~ 185 (570)
T 2z63_A 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185 (570)
T ss_dssp ECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECT
T ss_pred cccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccC
Confidence 999999998777679999999999999999987 468999999999999999999999888999999888 899999
Q ss_pred CccccccCCcCccCCCCccEEeccccccCC-CCChhhhcCCC--------------------------------CCEEEc
Q 002094 223 KNKFSGQLPEDIGGCSMLKVLDFGVNSLSG-SLPDSLQRLNS--------------------------------CSSLSL 269 (967)
Q Consensus 223 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~l~~l~~--------------------------------L~~L~L 269 (967)
+|.+++..+..|..+ +|++|++++|.... .++..+..+++ ++.+++
T Consensus 186 ~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l 264 (570)
T 2z63_A 186 LNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264 (570)
T ss_dssp TCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEE
T ss_pred CCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhh
Confidence 999998888888776 89999999885332 12223333333 344555
Q ss_pred cCC-CCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcC
Q 002094 270 KGN-SFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTG 348 (967)
Q Consensus 270 ~~n-~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 348 (967)
++| .+.+..+..+..+++|++|++++|.+. .+|..+..+ +|++|++++|.+. .+|. ..+++|+.|++++|.+.+
T Consensus 265 ~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~ 339 (570)
T 2z63_A 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGN 339 (570)
T ss_dssp EETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCC
T ss_pred hcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccc
Confidence 555 566677888888899999999999888 577778888 8999999999888 4454 477889999999998886
Q ss_pred CCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccC-
Q 002094 349 NIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIP- 427 (967)
Q Consensus 349 ~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p- 427 (967)
..+. ....+|++|++++|.+.... .....+..+++|++|++++|.+.+..+. +..+++|++|++++|.+.+..+
T Consensus 340 ~~~~-~~~~~L~~L~l~~n~l~~~~---~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~ 414 (570)
T 2z63_A 340 AFSE-VDLPSLEFLDLSRNGLSFKG---CCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEF 414 (570)
T ss_dssp BCCC-CBCTTCCEEECCSSCCBEEE---EEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTS
T ss_pred cccc-ccCCCCCEEeCcCCccCccc---cccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccch
Confidence 6655 33347899999999886432 1123345678899999999999866555 8889999999999999887666
Q ss_pred CCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCC-CcCCccccccCccceeeccCCcCcCccchhhhccc
Q 002094 428 ASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLS-GRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLS 506 (967)
Q Consensus 428 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 506 (967)
..+..+++|++|++++|++.+..|..+.++++|++|+|++|.++ +.+|..+..+++|+.|+|++|++++..|..|.+++
T Consensus 415 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 494 (570)
T 2z63_A 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494 (570)
T ss_dssp CTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred hhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhccc
Confidence 57888999999999999998888888999999999999999987 57888899999999999999999988888999999
Q ss_pred CccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCCCCC
Q 002094 507 NLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFF 552 (967)
Q Consensus 507 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~ 552 (967)
+|++|+|++|++++..|..|..+++|+.|++++|+++|.+|...++
T Consensus 495 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~ 540 (570)
T 2z63_A 495 SLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 540 (570)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHH
T ss_pred CCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHH
Confidence 9999999999999888888899999999999999999988876554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=444.13 Aligned_cols=257 Identities=26% Similarity=0.368 Sum_probs=216.6
Q ss_pred CCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 685 NKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+..++||+|+||+||+|++. +++.||||+++........++|.+|+.++++++|||||+++|+|.+++..++||
T Consensus 29 ~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~ 108 (308)
T 4gt4_A 29 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIF 108 (308)
T ss_dssp EEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEE
Confidence 44678999999999999863 468899999976655556788999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEee
Q 002094 759 EFISSGSLYKHLHDGSS-------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGD 825 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~D 825 (967)
|||++|+|.++++.... ...++|.++.+|+.|||.||+|||+++||||||||+|||+++++.+||+|
T Consensus 109 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~D 188 (308)
T 4gt4_A 109 SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISD 188 (308)
T ss_dssp ECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECC
Confidence 99999999999975432 12489999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhc
Q 002094 826 FGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALE 904 (967)
Q Consensus 826 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 904 (967)
||+|+.....+.....+...||+.|+|||++ ..+.++.++|||||||++|||+| |+.||....... ..+.+
T Consensus 189 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l-~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~~~~i----- 260 (308)
T 4gt4_A 189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAI-MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VVEMI----- 260 (308)
T ss_dssp SCCBCGGGGGGCBCSSSSSCBCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--HHHHH-----
T ss_pred cccceeccCCCceeEecccccCCcccCHHHH-hCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--HHHHH-----
Confidence 9999876544444445567899999999998 66789999999999999999998 899997654321 11111
Q ss_pred cCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 905 DGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
....+.+.|.+++.++.+++.+||+.||++||||+||++.|+.+.
T Consensus 261 --------~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 261 --------RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp --------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --------HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 112233457788889999999999999999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=442.45 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=217.2
Q ss_pred ccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLL 756 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 756 (967)
.|...+.||+|+||+||+|++. ++..||||+++... ....++|.+|++++++++|||||+++|+|.+++..++
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3566788999999999999864 47889999997654 3456789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeec
Q 002094 757 IYEFISSGSLYKHLHDGS----------SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDF 826 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Df 826 (967)
|||||++|+|.++++... ....++|.++.+++.|||.||+|||+++|+||||||+|||+++++.+||+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCc
Confidence 999999999999997642 2235999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhcc
Q 002094 827 GLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALED 905 (967)
Q Consensus 827 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 905 (967)
|+|+...............||+.|+|||++ ....++.++|||||||++|||+| |+.||....... ....+
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~-~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-~~~~i------- 243 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIECI------- 243 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHH-------
T ss_pred ccceecCCCCceeecCceecChhhcCHHHH-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH-------
Confidence 999876554444444556799999999998 66789999999999999999999 999997654321 11111
Q ss_pred CCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 906 GRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
....+.+.|..++.++.+++.+||+.||++||||+|+.+.|+++.+.
T Consensus 244 -------~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 244 -------TQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11123345677888999999999999999999999999999988653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=436.57 Aligned_cols=262 Identities=27% Similarity=0.432 Sum_probs=209.0
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
++..+.||+|+||+||+|+++ ..||||+++.... .+..++|.+|++++++++|||||+++|++.+ +..++|||||+
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred eEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 466778999999999999875 3699999875442 3445789999999999999999999998864 56899999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+|+|.++++.... .++|.++.+|+.|||.||+|||+++||||||||+|||+++++.+||+|||+|+............
T Consensus 115 gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~ 192 (307)
T 3omv_A 115 GSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE 192 (307)
T ss_dssp SCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----------
T ss_pred CCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeec
Confidence 9999999986543 38999999999999999999999999999999999999999999999999998765433333445
Q ss_pred cccccccccCcccccC--cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 843 KIQSALGYMAPEFACR--TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~--~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
...||+.|+|||++.. .+.++.++|||||||++|||+||+.||......... ...+......+. ....
T Consensus 193 ~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~-~~~~~~~~~~p~---------~~~~ 262 (307)
T 3omv_A 193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI-IFMVGRGYASPD---------LSKL 262 (307)
T ss_dssp -CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HHHHHTTCCCCC---------STTS
T ss_pred ccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH-HHHHhcCCCCCC---------cccc
Confidence 6789999999998842 346899999999999999999999999765443222 222221111110 1234
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
+.+++.++.+++.+||+.||++||||+||++.|+.++..+
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 5667888999999999999999999999999999988765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=444.50 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=209.8
Q ss_pred cCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
+...++||+|+||+||+|+++ +++.||||+++... ....++|.+|++++++++|||||+++|+|.+++..++|
T Consensus 43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 455678999999999999864 47899999997554 44567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEee
Q 002094 758 YEFISSGSLYKHLHDGSS------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGD 825 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~D 825 (967)
||||++|+|.++++.... ..+++|.++.+|+.|||.||+|||+++|+||||||+|||+++++.+||+|
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcc
Confidence 999999999999976432 23589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhc
Q 002094 826 FGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALE 904 (967)
Q Consensus 826 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 904 (967)
||+|+...........+...||+.|+|||++ ....++.++|||||||++|||+| |+.||....... .. ..+
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~-~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-~~-~~i----- 273 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-AI-DCI----- 273 (329)
T ss_dssp CC----------------CCCCGGGCCHHHH-TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-HH-HHH-----
T ss_pred cccceeccCCCcceecCcccccccccChhhh-cCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-HH-HHH-----
Confidence 9999876544444444567799999999998 66789999999999999999999 999997654321 11 111
Q ss_pred cCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 905 DGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
....+.+.|..++.++.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 274 --------~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 --------TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --------HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11223445677888999999999999999999999999999998764
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-50 Score=474.54 Aligned_cols=478 Identities=19% Similarity=0.216 Sum_probs=334.3
Q ss_pred CCccceEEeCCC-----------CCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEc
Q 002094 56 PCNWVGVKCDPK-----------TKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDF 124 (967)
Q Consensus 56 ~c~w~gv~c~~~-----------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (967)
.|.|.|| |+.. ..+++.|++.++.+++..+..+.++++|++|+|++|++++..|..|+.+++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4999999 8643 235777777777777776777777777777777777777777777777777777777
Q ss_pred CCCCCCCCCCchhhhcCCCCceEeccccccCC-CCccccccccccceeeecccccccccC-ccccccccCCeEeecCCcC
Q 002094 125 SENNLSGLIPDEFFRQCGSLREVSFANNNLTG-PIPESLSFCSSLESVNFSSNRLSGQLP-YGIWFLRSLQSLDLSNNLL 202 (967)
Q Consensus 125 s~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~n~l 202 (967)
++|++++ ++...|+++++|++|+|++|++++ ..|..++++++|++|+|++|++.+.+| ..|..+++|++|+|++|.+
T Consensus 82 s~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 82 SDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp TTSCCCS-CCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCccCc-cCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 7777774 444445777777777777777775 345667777777777777777433443 5677777777777777777
Q ss_pred CCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCC--C-hhhhcCCCCCEEEccCCCCCCcCc
Q 002094 203 EGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSL--P-DSLQRLNSCSSLSLKGNSFTGEVP 279 (967)
Q Consensus 203 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~-~~l~~l~~L~~L~L~~n~l~~~~~ 279 (967)
++..|..+..+++|++|+++.|.+.......++.+++|++|++++|++++.. | .....+++|+.|++++|.+++..+
T Consensus 161 ~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 240 (549)
T 2z81_A 161 RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240 (549)
T ss_dssp CEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHH
T ss_pred cccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHH
Confidence 7777777777777777777777765332223455777777777777777532 1 123446677777777777765443
Q ss_pred hh----hcccccccccccccccccccc------CCCCCcccccceEEcccCcCCCC-----CChhhhcCCCCcEEEccCC
Q 002094 280 DW----IGKLANLESLDLSLNQFSGRI------PSSIGNLVFLKELNISMNQFTGG-----LPESMMNCGNLLAIDVSQN 344 (967)
Q Consensus 280 ~~----l~~l~~L~~L~L~~N~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~l~~N 344 (967)
.. +..+++|+.|++++|.+.+.. ...+..+.+|+.|.+.++.+... .+..+...++|+.|++++|
T Consensus 241 ~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n 320 (549)
T 2z81_A 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320 (549)
T ss_dssp HHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESS
T ss_pred HHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccC
Confidence 33 345667777777777776531 12345667777777777766531 2333455677888888888
Q ss_pred cCcCCCChhhh--cccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCC--CCcccccccchhccccc
Q 002094 345 KLTGNIPTWIF--KMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIP--SNIGDLSSLMLLNMSMN 420 (967)
Q Consensus 345 ~l~~~~p~~~~--~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~Ls~N 420 (967)
++. .+|..++ ..+|++|++++|++..... ........+++|++|+|++|++++..+ ..+..+++|++|++++|
T Consensus 321 ~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N 397 (549)
T 2z81_A 321 KVF-LVPCSFSQHLKSLEFLDLSENLMVEEYL--KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRN 397 (549)
T ss_dssp CCC-CCCHHHHHHCTTCCEEECCSSCCCHHHH--HHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTC
T ss_pred ccc-cCCHHHHhcCccccEEEccCCccccccc--cchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCC
Confidence 876 6776654 3478888888888754210 001123456788888888888876543 45777888888888888
Q ss_pred ccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccch
Q 002094 421 YLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPA 500 (967)
Q Consensus 421 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 500 (967)
++. .+|..+..+++|++|++++|+++ .+|..+ .++|++|+|++|+|++.+ ..+++|+.|+|++|+|+ .+|.
T Consensus 398 ~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~ 468 (549)
T 2z81_A 398 TFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD 468 (549)
T ss_dssp CCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC
T ss_pred CCc-cCChhhcccccccEEECCCCCcc-cccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC
Confidence 887 67777888888888888888886 344433 257888888888887542 56788888888888887 4565
Q ss_pred hhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCC
Q 002094 501 AIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPV 548 (967)
Q Consensus 501 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 548 (967)
...+++|++|||++|++++.+|..+..+++|+.|++++|++.|.+|.
T Consensus 469 -~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 469 -ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp -GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred -cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 46788888888888888888888888888888888888888877774
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=482.95 Aligned_cols=437 Identities=20% Similarity=0.260 Sum_probs=372.4
Q ss_pred CCCCeEecCCCccCccccccccCCCCCcEEEcCCCCC------CC------CCCchhhhcCCCCceEeccccccCCCCcc
Q 002094 93 QFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNL------SG------LIPDEFFRQCGSLREVSFANNNLTGPIPE 160 (967)
Q Consensus 93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~------~~------~ip~~~~~~l~~L~~L~L~~n~l~~~~p~ 160 (967)
.+++.|+|++|+++|.+|++|+.+++|++|+|++|.+ .| .+|... +..|+ +++++|.+.+.+|.
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~---~~~l~-l~l~~~~l~~~~~~ 156 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ---KQKMR-MHYQKTFVDYDPRE 156 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH---HHHHH-THHHHHHTCCCGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH---HHHHH-hhHHHhhhccCchh
Confidence 4789999999999999999999999999999999976 33 566654 56677 99999999998888
Q ss_pred cccc-ccccceeeec--------------------ccccccccCccccccccCCeEeecCCcCCCc--------------
Q 002094 161 SLSF-CSSLESVNFS--------------------SNRLSGQLPYGIWFLRSLQSLDLSNNLLEGE-------------- 205 (967)
Q Consensus 161 ~l~~-l~~L~~L~L~--------------------~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-------------- 205 (967)
.+.. +..+..+++. +|+++| +|..++++++|++|+|++|.+++.
T Consensus 157 ~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~ 235 (636)
T 4eco_A 157 DFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA 235 (636)
T ss_dssp GSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHH
T ss_pred hHHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchh
Confidence 7763 2333333333 688988 898999999999999999999985
Q ss_pred ---cccccc--CCCCCCeeeccCccccccCCcCccCCCCccEEeccccc-cCC-CCChhhhcC------CCCCEEEccCC
Q 002094 206 ---IVKGIS--NLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNS-LSG-SLPDSLQRL------NSCSSLSLKGN 272 (967)
Q Consensus 206 ---~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~-~~~~~l~~l------~~L~~L~L~~n 272 (967)
+|..++ ++++|++|+|++|++.+.+|..|+++++|++|++++|+ +++ .+|..+..+ ++|++|+|++|
T Consensus 236 ~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n 315 (636)
T 4eco_A 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315 (636)
T ss_dssp HHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSS
T ss_pred cccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCC
Confidence 888888 99999999999999998999999999999999999998 887 788888776 89999999999
Q ss_pred CCCCcCch--hhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCC-CcEEEccCCcCcCC
Q 002094 273 SFTGEVPD--WIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGN-LLAIDVSQNKLTGN 349 (967)
Q Consensus 273 ~l~~~~~~--~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~ 349 (967)
+++ .+|. .++.+++|++|++++|+++|.+| .+..+++|++|++++|+++ .+|..+..+++ |+.|++++|+++ .
T Consensus 316 ~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~ 391 (636)
T 4eco_A 316 NLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-Y 391 (636)
T ss_dssp CCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-S
T ss_pred cCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-c
Confidence 998 7777 88999999999999999988888 8888999999999999988 77888888888 999999999888 5
Q ss_pred CChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcc-------cccccchhccccccc
Q 002094 350 IPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIG-------DLSSLMLLNMSMNYL 422 (967)
Q Consensus 350 ~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~Ls~N~l 422 (967)
+|..+.. ..+++|++|++++|++++.+|..+. .+++|++|+|++|++
T Consensus 392 lp~~~~~--------------------------~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l 445 (636)
T 4eco_A 392 IPNIFDA--------------------------KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQI 445 (636)
T ss_dssp CCSCCCT--------------------------TCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCC
T ss_pred cchhhhh--------------------------cccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCcc
Confidence 6643321 1235799999999999999999998 888999999999999
Q ss_pred ccccCCCcCCcccccEEEecCCcccccCcccccC-C-------CCCCEEEcCCCCCCCcCCcccc--ccCccceeeccCC
Q 002094 423 FGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGG-A-------VSLKELKLEKNFLSGRIPSQIK--NCSSLTSLILSQN 492 (967)
Q Consensus 423 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l-------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N 492 (967)
.+..+..+..+++|++|+|++|+++ .+|..+.. . ++|++|+|++|+++ .+|..+. .+++|+.|+|++|
T Consensus 446 ~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N 523 (636)
T 4eco_A 446 SKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYN 523 (636)
T ss_dssp CSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSS
T ss_pred CcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCC
Confidence 8444444566999999999999999 66655443 2 29999999999999 7888887 9999999999999
Q ss_pred cCcCccchhhhcccCccEEec------cCCccccCCchhhhhccCCceEEecCCcccccCCCCCCCCccCCCcccCCCCC
Q 002094 493 NLTGPVPAAIANLSNLKYVDL------SFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSL 566 (967)
Q Consensus 493 ~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~l 566 (967)
+|++ +|..+.++++|++|+| ++|++.+.+|..+..+++|+.|+|++|++ +.+|.. +...+....+.+|++.
T Consensus 524 ~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 524 SFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNI 600 (636)
T ss_dssp CCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTC
T ss_pred CCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCc
Confidence 9997 8999999999999999 56889999999999999999999999999 789875 3466777788999988
Q ss_pred CCc
Q 002094 567 CGS 569 (967)
Q Consensus 567 c~~ 569 (967)
|-.
T Consensus 601 ~~~ 603 (636)
T 4eco_A 601 SID 603 (636)
T ss_dssp EEE
T ss_pred ccc
Confidence 744
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=470.66 Aligned_cols=465 Identities=21% Similarity=0.239 Sum_probs=404.3
Q ss_pred CCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceee
Q 002094 93 QFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVN 172 (967)
Q Consensus 93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 172 (967)
+++++|+|++|++++..+..|+.+++|++|+|++|++++ ++...|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~-i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCc-cCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 579999999999999989999999999999999999985 5556689999999999999999998889999999999999
Q ss_pred ecccccccccCccccccccCCeEeecCCcCCC-cccccccCCCCCCeeeccCccccccCCcCccCCCCc----cEEeccc
Q 002094 173 FSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEG-EIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSML----KVLDFGV 247 (967)
Q Consensus 173 L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~l~~ 247 (967)
|++|++++..+..++.+++|++|+|++|.+++ .+|..|+++++|++|++++|++++..+..++.+++| +.|++++
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 99999997766689999999999999999997 468999999999999999999998888899999988 8999999
Q ss_pred cccCCCCChhhhcCCCCCEEEccCCCCCC-cCchh------------------------------hcccc--cccccccc
Q 002094 248 NSLSGSLPDSLQRLNSCSSLSLKGNSFTG-EVPDW------------------------------IGKLA--NLESLDLS 294 (967)
Q Consensus 248 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~~~------------------------------l~~l~--~L~~L~L~ 294 (967)
|.+++..|..+..+ +|+.|++++|.... ..+.. +..+. .++.++++
T Consensus 187 n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 265 (570)
T 2z63_A 187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265 (570)
T ss_dssp CCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred CCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence 99998888888776 89999999985331 11222 22222 24455666
Q ss_pred cc-ccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCC
Q 002094 295 LN-QFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESM 373 (967)
Q Consensus 295 ~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~ 373 (967)
+| .+.+..|..+..+++|+.|++++|.++ .+|..+..+ +|+.|++++|.+. .+|.. ...+|+.|++++|.+....
T Consensus 266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~~-~l~~L~~L~l~~n~~~~~~ 341 (570)
T 2z63_A 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPTL-KLKSLKRLTFTSNKGGNAF 341 (570)
T ss_dssp ETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCBC-BCSSCCEEEEESCBSCCBC
T ss_pred cchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCcc-cccccCEEeCcCCcccccc
Confidence 66 677788889999999999999999998 578888888 9999999999998 66653 3358999999999986543
Q ss_pred CCCcccccccCCCCccEEEccCCcccCCC--CCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCc
Q 002094 374 QYPSFASMKDSYQGLQVLDLSSNALSGVI--PSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIP 451 (967)
Q Consensus 374 ~~~~~~~~~~~~~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 451 (967)
.. ..+++|++|++++|++++.. +..+..+++|++|++++|.+.+..+. +..+++|+.|++++|++.+..|
T Consensus 342 ~~-------~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~ 413 (570)
T 2z63_A 342 SE-------VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSE 413 (570)
T ss_dssp CC-------CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTT
T ss_pred cc-------ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccc
Confidence 21 46789999999999998664 67788999999999999999866555 9999999999999999997766
Q ss_pred -ccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCc-CccchhhhcccCccEEeccCCccccCCchhhhhc
Q 002094 452 -PQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLT-GPVPAAIANLSNLKYVDLSFNDLSGILPKELINL 529 (967)
Q Consensus 452 -~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 529 (967)
..+..+++|++|++++|.+.+..|..|..+++|+.|+|++|.++ +.+|..|..+++|++|+|++|++++..|..|..+
T Consensus 414 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 493 (570)
T 2z63_A 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493 (570)
T ss_dssp SCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred hhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcc
Confidence 57899999999999999999999999999999999999999998 6799999999999999999999999999999999
Q ss_pred cCCceEEecCCcccccCCCC-CCCCccCCCcccCCCCCCCccc
Q 002094 530 SHLLSFNISHNHLHGELPVG-GFFNTISPSSVSGNPSLCGSVV 571 (967)
Q Consensus 530 ~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~~ 571 (967)
++|+.|++++|++++.+|.. ..+..+....+.+||+.|.++.
T Consensus 494 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 494 SSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred cCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 99999999999999866542 2345566777899999998754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=480.85 Aligned_cols=460 Identities=20% Similarity=0.210 Sum_probs=309.1
Q ss_pred CCCCeEecCCCccCccccccccCCCCCcEEEc-CCCCCCCCCCchhhhcCCC--------CceEec-------cccccCC
Q 002094 93 QFLQVLSLSNNNFTGTINADLASFGTLQVVDF-SENNLSGLIPDEFFRQCGS--------LREVSF-------ANNNLTG 156 (967)
Q Consensus 93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L-s~n~~~~~ip~~~~~~l~~--------L~~L~L-------~~n~l~~ 156 (967)
.+++.|+|++|+++|.+|+.|+.|++|++|+| ++|.++|..|......... ++..++ ...++.+
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57999999999999999999999999999999 9998887755321100000 000000 0000000
Q ss_pred -----------CCccccccccccceeeecc--cccccccCccccccccCCeEeecCCcCCC-----------------cc
Q 002094 157 -----------PIPESLSFCSSLESVNFSS--NRLSGQLPYGIWFLRSLQSLDLSNNLLEG-----------------EI 206 (967)
Q Consensus 157 -----------~~p~~l~~l~~L~~L~L~~--N~l~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~~ 206 (967)
..+........++.+.+.. |++++ +|..|+++++|++|+|++|.+++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 0011111222333333333 55655 55556666666666666666665 25
Q ss_pred ccccc--CCCCCCeeeccCccccccCCcCccCCCCccEEeccccc-cCC-CCChhhhcCC-------CCCEEEccCCCCC
Q 002094 207 VKGIS--NLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNS-LSG-SLPDSLQRLN-------SCSSLSLKGNSFT 275 (967)
Q Consensus 207 ~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~-~~~~~l~~l~-------~L~~L~L~~n~l~ 275 (967)
|..++ ++++|++|+|++|++.+.+|..|+++++|++|++++|+ +++ .+|..+..++ +|+.|+|++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 55555 66666666666666666666666666666666666665 655 5555555444 6666666666666
Q ss_pred CcCch--hhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCC-CcEEEccCCcCcCCCCh
Q 002094 276 GEVPD--WIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGN-LLAIDVSQNKLTGNIPT 352 (967)
Q Consensus 276 ~~~~~--~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~p~ 352 (967)
.+|. .++++++|+.|+|++|+++ .+| .++.+++|+.|+|++|+++ .+|..+.++++ |+.|++++|+++ .+|.
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~ 636 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence 5555 5666666666666666666 555 5666666666666666666 55666666666 666666666666 4554
Q ss_pred hhhcc---cccEEeccCCCCCCCCCCCccccccc--CCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccC
Q 002094 353 WIFKM---GLQTVSLSGNRLGESMQYPSFASMKD--SYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIP 427 (967)
Q Consensus 353 ~~~~~---~L~~L~L~~n~l~~~~~~~~~~~~~~--~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 427 (967)
.+... +|+.|+|++|++.... +.+..... ..++|+.|+|++|+++...+..+..+++|+.|+|++|++. .+|
T Consensus 637 ~~~~~~~~~L~~L~Ls~N~l~g~i--p~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip 713 (876)
T 4ecn_A 637 IFNAKSVYVMGSVDFSYNKIGSEG--RNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIP 713 (876)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTS--SSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCC
T ss_pred hhhccccCCCCEEECcCCcCCCcc--ccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccC
Confidence 44332 2666666666664422 11111111 2358999999999999554444568999999999999998 666
Q ss_pred CCcCC--------cccccEEEecCCcccccCccccc--CCCCCCEEEcCCCCCCCcCCccccccCccceeeccC------
Q 002094 428 ASIGK--------LKAIQVLDFSDNWLNGTIPPQIG--GAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQ------ 491 (967)
Q Consensus 428 ~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~------ 491 (967)
..+.. +++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..++.+++|+.|+|++
T Consensus 714 ~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~ 791 (876)
T 4ecn_A 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEG 791 (876)
T ss_dssp TTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTC
T ss_pred hHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCccc
Confidence 65443 339999999999999 7888887 99999999999999997 799999999999999977
Q ss_pred CcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCCCCCC--ccCCCcccCCCCCC
Q 002094 492 NNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFN--TISPSSVSGNPSLC 567 (967)
Q Consensus 492 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~--~~~~~~~~~n~~lc 567 (967)
|++.+.+|..|.++++|+.|+|++|++ +.+|..+. ++|+.|+|++|++...-+ ..+.. ......+.+|++.|
T Consensus 792 N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~-~~~~~~~~~~~~~L~~n~~~~ 865 (876)
T 4ecn_A 792 NRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDV-TSVCPYIEAGMYVLLYDKTQD 865 (876)
T ss_dssp CBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEEC-GGGHHHHHTTCCEEECCTTSE
T ss_pred ccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccCh-HHccccccchheeecCCCccc
Confidence 889999999999999999999999999 68888765 699999999999974332 22211 12344566777655
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=434.35 Aligned_cols=267 Identities=27% Similarity=0.348 Sum_probs=221.7
Q ss_pred hhccCCCCccCCCCceEEEEEEeCC------CcEEEEEEeecCCccccHHHHHHHHHHHcCCCC-CceeeeeeEEEcC-C
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQD------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRH-HNLVALEGYYWTP-S 752 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~-~ 752 (967)
.+.|+..+.||+|+||+||+|.+.. ++.||||++.........++|.+|++++++++| ||||+++|+|.++ +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 3457888899999999999998542 368999999876655556789999999999965 8999999999765 5
Q ss_pred ceeEEEEecCCCchhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC
Q 002094 753 LQLLIYEFISSGSLYKHLHDGSS-------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG 819 (967)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~ 819 (967)
..++|||||++|+|.++++.... ...+++.++..++.|||.||+|||+++||||||||+|||+++++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence 68999999999999999975422 23489999999999999999999999999999999999999999
Q ss_pred CeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHH
Q 002094 820 EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDM 898 (967)
Q Consensus 820 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~ 898 (967)
.+||+|||+|+...........+...||+.|+|||++ ....++.++|||||||++|||+| |+.||.......... ..
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l-~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~-~~ 300 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-RR 300 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-HH
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHH-hcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH-HH
Confidence 9999999999877554444455567899999999998 66789999999999999999998 999998655432211 11
Q ss_pred HHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 899 VRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
+....+...|..++.++.+++.+||+.||++||||+|+++.|+.+.+.-.+
T Consensus 301 -------------i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~ 351 (353)
T 4ase_A 301 -------------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 351 (353)
T ss_dssp -------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC-
T ss_pred -------------HHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhC
Confidence 122234456677888999999999999999999999999999998765443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=463.20 Aligned_cols=457 Identities=20% Similarity=0.210 Sum_probs=379.0
Q ss_pred eeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccc
Q 002094 72 VGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151 (967)
Q Consensus 72 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~ 151 (967)
..|++++++++. +|..+. ++|++|+|++|++++..|..|..+++|++|+|++|++++..|. .|+++++|++|+|++
T Consensus 3 ~~l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~ 78 (520)
T 2z7x_B 3 FLVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS-VFKFNQELEYLDLSH 78 (520)
T ss_dssp CEEECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGG-GGTTCTTCCEEECCS
T ss_pred ceEecCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChH-HhhcccCCCEEecCC
Confidence 357888888884 677666 8999999999999988888999999999999999999865454 468999999999999
Q ss_pred cccCCCCccccccccccceeeeccccccc-ccCccccccccCCeEeecCCcCCCcccccccCCCCC--CeeeccCccc--
Q 002094 152 NNLTGPIPESLSFCSSLESVNFSSNRLSG-QLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDL--RAIKLGKNKF-- 226 (967)
Q Consensus 152 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l-- 226 (967)
|+++ .+|.. .+++|++|+|++|++++ .+|..|+.+++|++|+|++|.+++ ..+..+++| ++|++++|++
T Consensus 79 N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~ 152 (520)
T 2z7x_B 79 NKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG 152 (520)
T ss_dssp SCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred Ccee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc
Confidence 9998 45655 88999999999999987 468889999999999999999886 456667777 9999999999
Q ss_pred cccCCcCccCCC-CccEEeccccccCCCCCh-hhhcCCCCCEEEccCCC-------CCCcCchhhccccccccccccccc
Q 002094 227 SGQLPEDIGGCS-MLKVLDFGVNSLSGSLPD-SLQRLNSCSSLSLKGNS-------FTGEVPDWIGKLANLESLDLSLNQ 297 (967)
Q Consensus 227 ~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~-~l~~l~~L~~L~L~~n~-------l~~~~~~~l~~l~~L~~L~L~~N~ 297 (967)
.+..|..+..++ +...+++++|++.+.++. .+.++++|+.|++++|. +.+.++ .+..+++|+.|++++|.
T Consensus 153 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~ 231 (520)
T 2z7x_B 153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIE 231 (520)
T ss_dssp SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEE
T ss_pred cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccc
Confidence 778888888776 455678888888765544 57788999999999987 665555 68889999999999988
Q ss_pred cccccCCCCC---cccccceEEcccCcCCCCCChhh-----hcCCCCcEEEccCCcCcCCCC-hhhhc----ccccEEec
Q 002094 298 FSGRIPSSIG---NLVFLKELNISMNQFTGGLPESM-----MNCGNLLAIDVSQNKLTGNIP-TWIFK----MGLQTVSL 364 (967)
Q Consensus 298 l~~~~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~~~p-~~~~~----~~L~~L~L 364 (967)
+++..+..+. ..++|++|++++|++++.+|..+ .++++|+.+++++|.+ .+| ..+.. .+++.|++
T Consensus 232 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l 309 (520)
T 2z7x_B 232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTV 309 (520)
T ss_dssp EEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEE
T ss_pred cCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEc
Confidence 8754322221 13589999999999998888888 8899999999999998 566 33332 36999999
Q ss_pred cCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhccccccccc--ccCCCcCCcccccEEEec
Q 002094 365 SGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFG--SIPASIGKLKAIQVLDFS 442 (967)
Q Consensus 365 ~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls 442 (967)
++|.+..... ...+++|++|++++|++++.+|..+..+++|++|++++|++.+ .+|..+..+++|++|+++
T Consensus 310 ~~n~l~~~~~-------~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls 382 (520)
T 2z7x_B 310 SGTRMVHMLC-------PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDIS 382 (520)
T ss_dssp ESSCCCCCCC-------CSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECC
T ss_pred CCCccccccc-------hhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECC
Confidence 9998865321 1467899999999999999899999999999999999999986 567889999999999999
Q ss_pred CCcccccCcc-cccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccC
Q 002094 443 DNWLNGTIPP-QIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGI 521 (967)
Q Consensus 443 ~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 521 (967)
+|++++.+|. .+..+++|++|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|++++.
T Consensus 383 ~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l 459 (520)
T 2z7x_B 383 QNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSV 459 (520)
T ss_dssp SSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred CCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCcc
Confidence 9999975665 488899999999999999988877665 79999999999999 7888888999999999999999954
Q ss_pred CchhhhhccCCceEEecCCcccccCCCCCC
Q 002094 522 LPKELINLSHLLSFNISHNHLHGELPVGGF 551 (967)
Q Consensus 522 ~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~ 551 (967)
.+..+..+++|+.|++++|+++|.++...+
T Consensus 460 ~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~ 489 (520)
T 2z7x_B 460 PDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 489 (520)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCCHHHHHH
T ss_pred CHHHhccCCcccEEECcCCCCcccCCchHH
Confidence 444589999999999999999988775443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=461.72 Aligned_cols=478 Identities=19% Similarity=0.174 Sum_probs=397.1
Q ss_pred eeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccc
Q 002094 74 LTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNN 153 (967)
Q Consensus 74 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~ 153 (967)
.+.++++++. +|..+. ++|++|+|++|++++..|..|+.+++|++|+|++|++++..| ..|+.+++|++|+|++|+
T Consensus 10 c~~~~~~l~~-ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~ 85 (549)
T 2z81_A 10 CDGRSRSFTS-IPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG-DAFYSLGSLEHLDLSDNH 85 (549)
T ss_dssp EECTTSCCSS-CCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTSC
T ss_pred EECCCCcccc-ccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccCh-hhccccccCCEEECCCCc
Confidence 5777777764 565554 799999999999999999999999999999999999996544 457999999999999999
Q ss_pred cCCCCccccccccccceeeeccccccc-ccCccccccccCCeEeecCCc-CCCcccccccCCCCCCeeeccCccccccCC
Q 002094 154 LTGPIPESLSFCSSLESVNFSSNRLSG-QLPYGIWFLRSLQSLDLSNNL-LEGEIVKGISNLYDLRAIKLGKNKFSGQLP 231 (967)
Q Consensus 154 l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 231 (967)
+++..|..|+++++|++|+|++|++++ ..|..+.++++|++|+|++|. +....+..|.++++|++|++++|++++..|
T Consensus 86 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 165 (549)
T 2z81_A 86 LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165 (549)
T ss_dssp CCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred cCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccCh
Confidence 999888889999999999999999997 357789999999999999998 454555789999999999999999999999
Q ss_pred cCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcC--c-hhhccccccccccccccccccccC----C
Q 002094 232 EDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEV--P-DWIGKLANLESLDLSLNQFSGRIP----S 304 (967)
Q Consensus 232 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~--~-~~l~~l~~L~~L~L~~N~l~~~~~----~ 304 (967)
..++.+++|++|+++.|.+.......+..+++|++|++++|++++.. + .....+++|+.|++++|.+++..+ .
T Consensus 166 ~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 245 (549)
T 2z81_A 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245 (549)
T ss_dssp TTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHG
T ss_pred hhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHH
Confidence 99999999999999999987433333467999999999999999752 2 233567899999999999986543 3
Q ss_pred CCCcccccceEEcccCcCCCCC------ChhhhcCCCCcEEEccCCcCcCC-----CChhhh-cccccEEeccCCCCCCC
Q 002094 305 SIGNLVFLKELNISMNQFTGGL------PESMMNCGNLLAIDVSQNKLTGN-----IPTWIF-KMGLQTVSLSGNRLGES 372 (967)
Q Consensus 305 ~~~~l~~L~~L~L~~N~l~~~~------~~~~~~l~~L~~L~l~~N~l~~~-----~p~~~~-~~~L~~L~L~~n~l~~~ 372 (967)
.+..+++|+.|++++|.+.+.. ...+..+++|+.|+++++.+... ++.... ..+++.|++++|.+...
T Consensus 246 ~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~i 325 (549)
T 2z81_A 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325 (549)
T ss_dssp GGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCC
T ss_pred HhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccC
Confidence 4566789999999999987632 23456788999999999987632 222111 24799999999998643
Q ss_pred CCCCcccccccCCCCccEEEccCCcccCCCC---CCcccccccchhcccccccccccC--CCcCCcccccEEEecCCccc
Q 002094 373 MQYPSFASMKDSYQGLQVLDLSSNALSGVIP---SNIGDLSSLMLLNMSMNYLFGSIP--ASIGKLKAIQVLDFSDNWLN 447 (967)
Q Consensus 373 ~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~ 447 (967)
. ...+..+++|++|++++|++++.+| ..++.+++|++|+|++|++.+..+ ..+..+++|++|++++|+++
T Consensus 326 p-----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 400 (549)
T 2z81_A 326 P-----CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400 (549)
T ss_dssp C-----HHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred C-----HHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc
Confidence 2 1223457899999999999998663 457889999999999999986543 56889999999999999998
Q ss_pred ccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhh
Q 002094 448 GTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELI 527 (967)
Q Consensus 448 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 527 (967)
.+|..+..+++|++|+|++|++++ +|..+ .++|+.|+|++|+|++.+ ..+++|++|||++|+|+ .+|. ..
T Consensus 401 -~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~ 470 (549)
T 2z81_A 401 -PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-AS 470 (549)
T ss_dssp -CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GG
T ss_pred -cCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cc
Confidence 689899999999999999999984 44443 268999999999999753 57899999999999999 5665 56
Q ss_pred hccCCceEEecCCcccccCCC-CCCCCccCCCcccCCCCCCCcc
Q 002094 528 NLSHLLSFNISHNHLHGELPV-GGFFNTISPSSVSGNPSLCGSV 570 (967)
Q Consensus 528 ~l~~L~~L~l~~N~l~~~~p~-~~~~~~~~~~~~~~n~~lc~~~ 570 (967)
.+++|+.|+|++|++++.+|. ...+..+....+.+|||.|+|+
T Consensus 471 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 471 LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp GCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred cCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 899999999999999987764 2335566777889999999886
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=428.56 Aligned_cols=251 Identities=21% Similarity=0.379 Sum_probs=204.1
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|+..+.||+|+||+||+|+.+ +|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35788899999999999999964 699999999976543 3346789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
||+||+|.+++...... .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... ...
T Consensus 104 y~~gg~L~~~i~~~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~ 180 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGV-LFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVE 180 (350)
T ss_dssp CCTTCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--HHH
T ss_pred CCCCCcHHHHHHHcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC--Ccc
Confidence 99999999999765432 378999999999999999999999999999999999999999999999999987643 112
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......||+.|+|||++ .+..++.++||||+||++|||++|+.||...... ..+..+..+. ...
T Consensus 181 ~~~~~~GT~~YmAPE~l-~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i~~~~--------------~~~ 244 (350)
T 4b9d_A 181 LARACIGTPYYLSPEIC-ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-NLVLKIISGS--------------FPP 244 (350)
T ss_dssp HHHHHHSCCTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTC--------------CCC
T ss_pred cccccCCCccccCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHcCC--------------CCC
Confidence 23456799999999998 6668999999999999999999999999754322 2222222111 112
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+...+.++.++|.+|++.||++|||++|+++
T Consensus 245 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 34556778999999999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=418.92 Aligned_cols=248 Identities=19% Similarity=0.254 Sum_probs=210.8
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||+||+|+.+ +|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4788899999999999999964 689999999975432 2346789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
||+||+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.......
T Consensus 113 y~~gG~L~~~i~~~~~---l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred cCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999986543 8999999999999999999999999999999999999999999999999999875434434
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......||+.|+|||++ .+..++.++||||+||++|||++|++||..... ...+..+... ...
T Consensus 190 ~~~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~---------------~~~ 252 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-GLIFAKIIKL---------------EYD 252 (311)
T ss_dssp CBCCCCSCGGGCCHHHH-HHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHT---------------CCC
T ss_pred cccCcccCcccCCHHHH-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcC---------------CCC
Confidence 45567899999999998 666789999999999999999999999975432 2222222211 123
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVV 950 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl 950 (967)
+|...+.++.+++.+|++.||++|||++|++
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 4555677899999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=421.58 Aligned_cols=248 Identities=21% Similarity=0.332 Sum_probs=207.1
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4677789999999999999965 69999999997654 234567899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
+||+|.+++... .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ...
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~ 227 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR 227 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCB
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Ccc
Confidence 999999999753 28999999999999999999999999999999999999999999999999998764322 223
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....||+.|+|||++ ....++.++||||+||++|||++|++||...... ..+. .+.... ......+
T Consensus 228 ~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~-~i~~~~-----------~~~~~~~ 293 (346)
T 4fih_A 228 KSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMK-MIRDNL-----------PPRLKNL 293 (346)
T ss_dssp CCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHH-HHHHSS-----------CCCCSCG
T ss_pred cccccCcCcCCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHH-HHHcCC-----------CCCCCcc
Confidence 467899999999998 6668999999999999999999999999754322 1111 111100 0011223
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+.++.+++.+|++.||++|||++|+++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 456678999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=421.62 Aligned_cols=255 Identities=21% Similarity=0.244 Sum_probs=207.7
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..++||+|+||.||+|+.+ +|+.||||+++.... ..+|++++++++|||||++++++.+++..|+|||||
T Consensus 59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4566778999999999999965 689999999976542 246999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC-CeEEeecccccccCCCccc--
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG-EPKVGDFGLARLLPMLDRC-- 838 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~-- 838 (967)
+||+|.++++.... +++..+..++.||+.||+|||+++|+||||||+|||++.+| ++||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 133 EGGSLGQLIKQMGC---LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred CCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 99999999986543 89999999999999999999999999999999999999987 6999999999876532211
Q ss_pred -cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 839 -ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 839 -~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.......||+.|+|||++ .+..++.++||||+||++|||++|++||....... ....+.... ...
T Consensus 210 ~~~~~~~~GT~~YmAPE~~-~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~------------~~~ 275 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVV-MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEP------------PPI 275 (336)
T ss_dssp ----CCCCCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSC------------CGG
T ss_pred eecCCccccCccccCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCC------------CCc
Confidence 122346799999999998 56689999999999999999999999997543321 122222110 001
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
...++..+..+.+++.+|+++||++|||++|+++.|....++.
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 1245667788999999999999999999999999887765443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=412.12 Aligned_cols=246 Identities=28% Similarity=0.417 Sum_probs=198.8
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEc----CCceeEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWT----PSLQLLI 757 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv 757 (967)
|+..++||+|+||+||+|... +++.||||++..... ....+.|.+|++++++++|||||++++++.+ +...++|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 455678999999999999965 589999999976543 3345779999999999999999999999864 3457899
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCEEeC-CCCCeEEeecccccccCC
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN--IIHYNLKSTNVLID-SSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~--ivH~Dik~~Nill~-~~~~~kl~Dfg~a~~~~~ 834 (967)
||||+||+|.+++++... +++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999986543 899999999999999999999998 99999999999998 479999999999986432
Q ss_pred CccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 835 LDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
.......||+.|+|||++ .+ .++.++|||||||++|||+||+.||.......... ..+ ..+..
T Consensus 185 ----~~~~~~~GTp~YmAPE~~-~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~-~~i----~~~~~------ 247 (290)
T 3fpq_A 185 ----SFAKAVIGTPEFMAPEMY-EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-RRV----TSGVK------ 247 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGG-GT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-HHH----TTTCC------
T ss_pred ----CccCCcccCccccCHHHc-CC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHH-HHH----HcCCC------
Confidence 223456799999999988 33 69999999999999999999999997544332211 111 11100
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...++...+.++.+++.+|++.||++|||++|+++
T Consensus 248 --~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 --PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01122334567999999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=405.56 Aligned_cols=247 Identities=21% Similarity=0.301 Sum_probs=193.2
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||+||+|+.+ +|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 34788899999999999999954 699999999976542 234568999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+ +|+|.+++..... +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--- 165 (275)
T ss_dssp ECC-CEEHHHHHHHSCS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC---
Confidence 999 6799999976543 899999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......||+.|+|||++.+....+.++||||+||++|||++|+.||...... .....+... ..
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-~~~~~i~~~---------------~~ 229 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-VLFKNISNG---------------VY 229 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHT---------------CC
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcC---------------CC
Confidence 22345679999999999854444578999999999999999999999753321 111111111 12
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.++...+.++.+++.+|++.||++|||++|+++
T Consensus 230 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 345556778999999999999999999999876
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=449.97 Aligned_cols=456 Identities=20% Similarity=0.221 Sum_probs=386.3
Q ss_pred CeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecc
Q 002094 96 QVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSS 175 (967)
Q Consensus 96 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 175 (967)
++|++++|+++ .+|..+. ++|++|+|++|.+++ ++...|.++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 78 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISE-LWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSH 78 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCC-CCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccc-cChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCC
Confidence 57999999999 4677666 899999999999995 4545579999999999999999998899999999999999999
Q ss_pred cccccccCccccccccCCeEeecCCcCCC-cccccccCCCCCCeeeccCccccccCCcCccCCCCc--cEEecccccc--
Q 002094 176 NRLSGQLPYGIWFLRSLQSLDLSNNLLEG-EIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSML--KVLDFGVNSL-- 250 (967)
Q Consensus 176 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~l~~n~l-- 250 (967)
|+|+ .+|.. .+++|++|+|++|.+++ ..|..|+++++|++|+|++|++++ ..+..+++| ++|++++|.+
T Consensus 79 N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~ 152 (520)
T 2z7x_B 79 NKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG 152 (520)
T ss_dssp SCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred Ccee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc
Confidence 9999 56665 89999999999999998 468999999999999999999986 467778888 9999999999
Q ss_pred CCCCChhhhcCC-CCCEEEccCCCCCCcCc-hhhccccccccccccccc-------cccccCCCCCcccccceEEcccCc
Q 002094 251 SGSLPDSLQRLN-SCSSLSLKGNSFTGEVP-DWIGKLANLESLDLSLNQ-------FSGRIPSSIGNLVFLKELNISMNQ 321 (967)
Q Consensus 251 ~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~-------l~~~~~~~~~~l~~L~~L~L~~N~ 321 (967)
.+..|..+..+. +...+++++|.+.+.++ ..+..+++|+.|++++|. +.+.+| .++.+++|+.|++++|.
T Consensus 153 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~ 231 (520)
T 2z7x_B 153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIE 231 (520)
T ss_dssp SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEE
T ss_pred cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccc
Confidence 888888888776 34467889999877654 467889999999999998 777776 78999999999999999
Q ss_pred CCCCCChhhh---cCCCCcEEEccCCcCcCCCChhh-----hc-ccccEEeccCCCCCCCCCCCcccccccCCCCccEEE
Q 002094 322 FTGGLPESMM---NCGNLLAIDVSQNKLTGNIPTWI-----FK-MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLD 392 (967)
Q Consensus 322 l~~~~~~~~~---~l~~L~~L~l~~N~l~~~~p~~~-----~~-~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~ 392 (967)
+++..+..+. ..++|+.|++++|++++.+|..+ .. ..|+.+++++|.+ .... ..+...+ ...+|+.|+
T Consensus 232 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~-~~~~~~~-~~~~L~~L~ 308 (520)
T 2z7x_B 232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQ-SYIYEIF-SNMNIKNFT 308 (520)
T ss_dssp EEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCT-HHHHHHH-HTCCCSEEE
T ss_pred cCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecch-hhhhccc-ccCceeEEE
Confidence 8864433322 25699999999999999999877 33 3799999999998 2211 1111111 115699999
Q ss_pred ccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccc--cCcccccCCCCCCEEEcCCCCC
Q 002094 393 LSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNG--TIPPQIGGAVSLKELKLEKNFL 470 (967)
Q Consensus 393 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l 470 (967)
+++|.+.... .+..+++|++|++++|++.+.+|..+..+++|++|+|++|++++ .+|..+..+++|++|+|++|++
T Consensus 309 l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l 386 (520)
T 2z7x_B 309 VSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSV 386 (520)
T ss_dssp EESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCC
T ss_pred cCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcC
Confidence 9999987543 23688999999999999999899999999999999999999986 5678899999999999999999
Q ss_pred CCcCCc-cccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCC
Q 002094 471 SGRIPS-QIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVG 549 (967)
Q Consensus 471 ~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~ 549 (967)
++.+|. .+..+++|+.|+|++|++++..|..+. ++|++|||++|+++ .+|..+..+++|+.|++++|+++ .+|..
T Consensus 387 ~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~ 462 (520)
T 2z7x_B 387 SYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDG 462 (520)
T ss_dssp BCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTT
T ss_pred CcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHH
Confidence 985665 588999999999999999988887765 79999999999999 78888889999999999999999 57754
Q ss_pred C--CCCccCCCcccCCCCCCCccc
Q 002094 550 G--FFNTISPSSVSGNPSLCGSVV 571 (967)
Q Consensus 550 ~--~~~~~~~~~~~~n~~lc~~~~ 571 (967)
. .+..+....+.+||+.|.|++
T Consensus 463 ~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 463 IFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp TTTTCTTCCEEECCSSCBCCCHHH
T ss_pred HhccCCcccEEECcCCCCcccCCc
Confidence 2 244566667899999998876
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=422.84 Aligned_cols=249 Identities=21% Similarity=0.343 Sum_probs=207.9
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
..|+..++||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 45788889999999999999965 69999999997654 33456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
|+||+|.++++... +++.++..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.... ..
T Consensus 230 ~~gG~L~~~i~~~~----l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~ 303 (423)
T 4fie_A 230 LEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR 303 (423)
T ss_dssp CTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CC
T ss_pred CCCCcHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--cc
Confidence 99999999997532 8999999999999999999999999999999999999999999999999998764322 23
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....||+.|||||++ ....++.++||||+||++|||++|++||...... ..+ ..+.... .. ....
T Consensus 304 ~~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~-~~i~~~~---------~~--~~~~ 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAM-KMIRDNL---------PP--RLKN 369 (423)
T ss_dssp BCCCEECTTTCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHH-HHHHHSC---------CC--CCSC
T ss_pred ccccccCcCcCCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHH-HHHHcCC---------CC--CCcc
Confidence 3467899999999998 6668999999999999999999999999754322 111 1111100 00 1122
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+...+.++.+|+.+|++.||++|||++|+++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3455677999999999999999999999876
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=411.43 Aligned_cols=260 Identities=23% Similarity=0.313 Sum_probs=200.1
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC----ceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS----LQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e 759 (967)
|...+.||+|+||+||+|+++ |+.||||++.... .....++.|+..+.+++|||||++++++.+++ ..++|||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 456788999999999999984 8999999997543 22233455666677899999999999998654 5689999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT--------NIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~--------~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
||++|+|.++++... ++|..+.+++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 82 y~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999998642 89999999999999999999987 899999999999999999999999999987
Q ss_pred cCCCcccc--ccccccccccccCcccccCc-----ccCCcccchhhHHHHHHHHHcCCCCCCCCccchH----------h
Q 002094 832 LPMLDRCI--LSSKIQSALGYMAPEFACRT-----VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVV----------V 894 (967)
Q Consensus 832 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~----------~ 894 (967)
........ ......||+.|+|||++... ..++.++|||||||++|||+||++||........ .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 65432221 22346799999999988432 2477899999999999999999887753322111 1
Q ss_pred HHHHHHhhhccCCchhhcchhhcCCCC-----hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 895 LCDMVRGALEDGRVEDCVDARLRGNFP-----ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
..++... ..+..+++..| .+.+..+.+++.+||+.||++||||+||+++|+++.++
T Consensus 238 ~~~~~~~---------~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 VEEMRKV---------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHH---------HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHH---------HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1111111 11222233333 24556799999999999999999999999999998754
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=446.72 Aligned_cols=491 Identities=20% Similarity=0.156 Sum_probs=342.1
Q ss_pred CeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEe
Q 002094 69 KRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVS 148 (967)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~ 148 (967)
..++.|+|++|.+++..+.+|.++++|++|+|++|+|+++.+.+|.++++|++|+|++|+++ .+|...|+++++|++|+
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLV 130 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECGGGGTTCTTCCEEE
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC-CCCHHHhcCCCCCCEEE
Confidence 46788888888888877778888999999999999888888888888899999999999887 56767788889999999
Q ss_pred ccccccCCCCccccccccccceeeecccccccc-cCccccccccCCeEeecCCcCCCcccccccCCCCCC----eeeccC
Q 002094 149 FANNNLTGPIPESLSFCSSLESVNFSSNRLSGQ-LPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLR----AIKLGK 223 (967)
Q Consensus 149 L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~~ 223 (967)
|++|++++..+..|+++++|++|+|++|++++. .|..+..+++|++|+|++|++++..+..|..+.+++ .++++.
T Consensus 131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~ 210 (635)
T 4g8a_A 131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 210 (635)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhccc
Confidence 999988887777888888999999999888753 577788888899999999988888888777665544 577888
Q ss_pred ccccccCCcCccCCCCccEEeccccccCCC-CChhhhcCCCCCEEEccCCC------CCCc-------------------
Q 002094 224 NKFSGQLPEDIGGCSMLKVLDFGVNSLSGS-LPDSLQRLNSCSSLSLKGNS------FTGE------------------- 277 (967)
Q Consensus 224 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~l~~l~~L~~L~L~~n~------l~~~------------------- 277 (967)
|.++...+..+. ...++.+++.+|..... .+..+..+..++...+..+. +...
T Consensus 211 n~l~~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~ 289 (635)
T 4g8a_A 211 NPMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 289 (635)
T ss_dssp CCCCEECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEE
T ss_pred CcccccCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 888765544443 34566677776654421 23334455555544432221 1111
Q ss_pred --------CchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCC
Q 002094 278 --------VPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGN 349 (967)
Q Consensus 278 --------~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 349 (967)
....+..+.+++.+++.+|.+.... .+.....|+.|++.+|.+....+. .++.|+.++++.|.+..
T Consensus 290 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~- 363 (635)
T 4g8a_A 290 YLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGN- 363 (635)
T ss_dssp CCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCC-
T ss_pred hhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCC-
Confidence 1122334445555555555554321 244455666677776666644332 34556666666666552
Q ss_pred CChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccC-C
Q 002094 350 IPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIP-A 428 (967)
Q Consensus 350 ~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~ 428 (967)
.+......+|+.|++++|.+...... ........+|+.|+++.|.+.. .+..+..+++|+.+++++|......+ .
T Consensus 364 ~~~~~~l~~L~~L~ls~n~l~~~~~~---~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~ 439 (635)
T 4g8a_A 364 AFSEVDLPSLEFLDLSRNGLSFKGCC---SQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS 439 (635)
T ss_dssp BCCCCBCTTCCEEECCSSCCBEEEEC---CHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSC
T ss_pred Ccccccccccccchhhcccccccccc---ccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccccccc
Confidence 22333334677777777776432211 1122345667777777777764 34556777888888887777665443 4
Q ss_pred CcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCC-CCcCCccccccCccceeeccCCcCcCccchhhhcccC
Q 002094 429 SIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFL-SGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSN 507 (967)
Q Consensus 429 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 507 (967)
.+..+.+++.++++.|.+.+..+..+..+++|+.|+|++|.+ .+..|..|..+++|+.|+|++|+|++..|..|.++++
T Consensus 440 ~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~ 519 (635)
T 4g8a_A 440 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 519 (635)
T ss_dssp TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCC
Confidence 567788888888888888877777788888888888888864 3456777888888888888888888877888888888
Q ss_pred ccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCCC--CCCccCCCcccCCCCCCCccc
Q 002094 508 LKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGG--FFNTISPSSVSGNPSLCGSVV 571 (967)
Q Consensus 508 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~--~~~~~~~~~~~~n~~lc~~~~ 571 (967)
|++|+|++|+|++..|..|..+++|+.|+|++|++++.+|..- ....+....+.+|||.|+|.+
T Consensus 520 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 520 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp CCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 8888888888888888888888888888888888887666421 113455556788888888765
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=409.44 Aligned_cols=242 Identities=24% Similarity=0.318 Sum_probs=196.1
Q ss_pred ccCCCCccCCCCceEEEEEEeC----CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ----DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
.|+..+.||+|+||+||+|+.. .++.||||++..... ......+.+|++++++++|||||++++++.+++..|+|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4788899999999999999852 478999999976532 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
||||+||+|.+++.+... +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 105 mEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 179 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-- 179 (304)
T ss_dssp ECCCTTCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEcCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC--
Confidence 999999999999987543 899999999999999999999999999999999999999999999999999865331
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
........||+.|+|||++ ....++.++||||+||++|||++|+.||...... ..+..+... .
T Consensus 180 ~~~~~~~~GT~~YmAPE~~-~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i~~~---------------~ 242 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-ETMTMILKA---------------K 242 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHH-HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHC---------------C
T ss_pred CccccccccCcccCCHHHh-ccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-HHHHHHHcC---------------C
Confidence 2233457799999999998 6668999999999999999999999999754332 222222111 1
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDM 946 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 946 (967)
..+|...+.++.+++.+|++.||++|||+
T Consensus 243 ~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 LGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 23455667789999999999999999985
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=445.26 Aligned_cols=458 Identities=19% Similarity=0.167 Sum_probs=378.1
Q ss_pred eeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccc
Q 002094 72 VGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151 (967)
Q Consensus 72 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~ 151 (967)
..+++.++++++ +|..+. ++|++|+|++|++++..+..|+.+++|++|+|++|++++..| ..|.++++|++|+|++
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDF-HVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECT-TTTTTCTTCCEEECTT
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCH-HHhCCCCCCCEEECCC
Confidence 677888888886 676664 899999999999999988999999999999999999996545 4579999999999999
Q ss_pred cccCCCCccccccccccceeeecccccccc-cCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccc--cc
Q 002094 152 NNLTGPIPESLSFCSSLESVNFSSNRLSGQ-LPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKF--SG 228 (967)
Q Consensus 152 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l--~~ 228 (967)
|+++ .+|.. .+++|++|+|++|++++. +|..|+++++|++|+|++|.+++.....+.++ +|++|++++|++ ++
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L-~L~~L~L~~n~l~~~~ 185 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL-HLSCILLDLVSYHIKG 185 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTS-CEEEEEEEESSCCCCS
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhc-eeeEEEeecccccccc
Confidence 9999 56655 899999999999999973 46899999999999999999986443334444 449999999999 88
Q ss_pred cCCcCccCCC-CccEEeccccccCCCCCh-hhhcCCCCCEEEccCCCC-----CCcCchhhccccccccccccccccccc
Q 002094 229 QLPEDIGGCS-MLKVLDFGVNSLSGSLPD-SLQRLNSCSSLSLKGNSF-----TGEVPDWIGKLANLESLDLSLNQFSGR 301 (967)
Q Consensus 229 ~~~~~~~~l~-~L~~L~l~~n~l~~~~~~-~l~~l~~L~~L~L~~n~l-----~~~~~~~l~~l~~L~~L~L~~N~l~~~ 301 (967)
..|..|..++ ..-.++++.|.+.+.++. .+..+++|+.|++++|+. .+ ....+..+++|+.|+++++.+.+.
T Consensus 186 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~~ 264 (562)
T 3a79_B 186 GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTWK 264 (562)
T ss_dssp SSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECHH
T ss_pred cCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcHH
Confidence 8888888765 222568899998876554 467789999999999862 22 234577888888888888777642
Q ss_pred c----CCCCCcccccceEEcccCcCCCCCChhh-----hcCCCCcEEEccCCcCcCCCCh-hhh----cccccEEeccCC
Q 002094 302 I----PSSIGNLVFLKELNISMNQFTGGLPESM-----MNCGNLLAIDVSQNKLTGNIPT-WIF----KMGLQTVSLSGN 367 (967)
Q Consensus 302 ~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~~~p~-~~~----~~~L~~L~L~~n 367 (967)
. +..+ ..++|++|++++|++++.+|..+ .+++.|+.++++.|.+ .+|. .++ ..+++.|++++|
T Consensus 265 ~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n 341 (562)
T 3a79_B 265 CSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDT 341 (562)
T ss_dssp HHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESS
T ss_pred HHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCC
Confidence 1 1111 23489999999999998888887 7888888888888887 4563 322 246999999999
Q ss_pred CCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhccccccccc--ccCCCcCCcccccEEEecCCc
Q 002094 368 RLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFG--SIPASIGKLKAIQVLDFSDNW 445 (967)
Q Consensus 368 ~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~ 445 (967)
.+..... ...+++|++|++++|++++.+|..+..+++|++|+|++|++.+ .+|..+..+++|++|++++|+
T Consensus 342 ~~~~~~~-------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~ 414 (562)
T 3a79_B 342 PFIHMVC-------PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNS 414 (562)
T ss_dssp CCCCCCC-------CSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSC
T ss_pred CcccccC-------ccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCc
Confidence 9864321 1467899999999999999999999999999999999999986 446789999999999999999
Q ss_pred ccccCcc-cccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCch
Q 002094 446 LNGTIPP-QIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPK 524 (967)
Q Consensus 446 l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 524 (967)
+++.+|. .+..+++|++|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+.++++|++|+|++|+|++..+.
T Consensus 415 l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~ 491 (562)
T 3a79_B 415 LNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDG 491 (562)
T ss_dssp CBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTT
T ss_pred CCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHH
Confidence 9985555 588899999999999999988777665 79999999999999 6777777999999999999999954444
Q ss_pred hhhhccCCceEEecCCcccccCCCCCC
Q 002094 525 ELINLSHLLSFNISHNHLHGELPVGGF 551 (967)
Q Consensus 525 ~l~~l~~L~~L~l~~N~l~~~~p~~~~ 551 (967)
.+..+++|+.|++++|+|+|.+|...+
T Consensus 492 ~~~~l~~L~~L~l~~N~~~c~c~~~~~ 518 (562)
T 3a79_B 492 VFDRLTSLQYIWLHDNPWDCTCPGIRY 518 (562)
T ss_dssp STTTCTTCCCEECCSCCBCCCHHHHHH
T ss_pred HHhcCCCCCEEEecCCCcCCCcchHHH
Confidence 499999999999999999998886544
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=401.54 Aligned_cols=247 Identities=21% Similarity=0.351 Sum_probs=190.0
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC----------
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS---------- 752 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---------- 752 (967)
|+..+.||+|+||+||+|+.+ +|+.||||++.........+.+.+|++++++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 677889999999999999965 689999999987664455678999999999999999999999987544
Q ss_pred --ceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 753 --LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 753 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
..|+|||||++|+|.+++.........++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~ 166 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 166 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccce
Confidence 368999999999999999876554446778889999999999999999999999999999999999999999999998
Q ss_pred ccCCCccc----------cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHH
Q 002094 831 LLPMLDRC----------ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVR 900 (967)
Q Consensus 831 ~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~ 900 (967)
........ ...+...||+.|+|||++ .+..++.++||||+||++|||++ ||....+... .+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~-~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~----~~~ 238 (299)
T 4g31_A 167 AMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI-HGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR----TLT 238 (299)
T ss_dssp -------------------------CCCTTSCHHHH-TTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH----HHH
T ss_pred ecCCCccccccccccccccccCCcccCccccCHHHH-cCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH----HHH
Confidence 76432211 112345799999999998 56689999999999999999996 7753211111 111
Q ss_pred hhhccCCchhhcchhhcCCCC---hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 901 GALEDGRVEDCVDARLRGNFP---ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.. . ...+| ......+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~-~------------~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 239 DV-R------------NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-H------------TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-h------------cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 1 11122 223345778999999999999999999876
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=429.04 Aligned_cols=457 Identities=22% Similarity=0.241 Sum_probs=369.8
Q ss_pred CCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeee
Q 002094 94 FLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNF 173 (967)
Q Consensus 94 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 173 (967)
..+++++++|++++ +|..+. ++|++|+|++|.+++ ++...|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 32 ~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 107 (562)
T 3a79_B 32 LESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISE-LRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDV 107 (562)
T ss_dssp -CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCC-CCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccc-cChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEEC
Confidence 34899999999996 676554 899999999999995 55556799999999999999999999999999999999999
Q ss_pred cccccccccCccccccccCCeEeecCCcCCCc-ccccccCCCCCCeeeccCccccccCCcCccCCCCc--cEEecccccc
Q 002094 174 SSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGE-IVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSML--KVLDFGVNSL 250 (967)
Q Consensus 174 ~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~l~~n~l 250 (967)
++|+|+ .+|.. .+++|++|+|++|.+++. .|..|+++++|++|+|++|++++ ..+..+++| ++|++++|.+
T Consensus 108 s~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 108 SHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp TTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSC
T ss_pred CCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEEeecccc
Confidence 999999 56766 899999999999999974 46899999999999999999986 355666666 9999999999
Q ss_pred --CCCCChhhhcCC--CCCEEEccCCCCCCcCch-hhccccccccccccccc-----cccccCCCCCcccccceEEcccC
Q 002094 251 --SGSLPDSLQRLN--SCSSLSLKGNSFTGEVPD-WIGKLANLESLDLSLNQ-----FSGRIPSSIGNLVFLKELNISMN 320 (967)
Q Consensus 251 --~~~~~~~l~~l~--~L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~L~~N~-----l~~~~~~~~~~l~~L~~L~L~~N 320 (967)
++..|..+..+. .+ .+++++|.+.+.++. .+..+++|+.|++++|+ +.+.+ ..+..+++|+.|+++++
T Consensus 182 ~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~-~~l~~l~~L~~L~L~~~ 259 (562)
T 3a79_B 182 HIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL-SELTRGPTLLNVTLQHI 259 (562)
T ss_dssp CCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHH-HHHHSCSSCEEEEEEEE
T ss_pred cccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHHH-HHHhccCcceEEEecCC
Confidence 888898888765 33 568899998876553 56789999999999985 33222 34677888999999888
Q ss_pred cCCCCCChh---hhcCCCCcEEEccCCcCcCCCChhhhc---cc---ccEEeccCCCCCCCCCCCcccccccCCCCccEE
Q 002094 321 QFTGGLPES---MMNCGNLLAIDVSQNKLTGNIPTWIFK---MG---LQTVSLSGNRLGESMQYPSFASMKDSYQGLQVL 391 (967)
Q Consensus 321 ~l~~~~~~~---~~~l~~L~~L~l~~N~l~~~~p~~~~~---~~---L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L 391 (967)
.+.+..... ....++|+.|++++|++++.+|..++. .+ |+.+++..|.+ .... ..+...+ ...+|++|
T Consensus 260 ~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~~p~-~~~~~~~-~~~~L~~L 336 (562)
T 3a79_B 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-LFSK-EALYSVF-AEMNIKML 336 (562)
T ss_dssp EECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-SSCH-HHHHHHH-HTCCCSEE
T ss_pred cCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee-ecCh-hhhhhhh-ccCcceEE
Confidence 877432111 123459999999999999999987642 23 44445555544 1110 0011111 12579999
Q ss_pred EccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccc--cCcccccCCCCCCEEEcCCCC
Q 002094 392 DLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNG--TIPPQIGGAVSLKELKLEKNF 469 (967)
Q Consensus 392 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~ 469 (967)
++++|.+.... ....+++|++|++++|++.+.+|..+.++++|++|+|++|++++ .+|..+..+++|++|+|++|+
T Consensus 337 ~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~ 414 (562)
T 3a79_B 337 SISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNS 414 (562)
T ss_dssp EEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSC
T ss_pred EccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCc
Confidence 99999987433 12688999999999999999999999999999999999999996 345779999999999999999
Q ss_pred CCCcCCc-cccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCC
Q 002094 470 LSGRIPS-QIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPV 548 (967)
Q Consensus 470 l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 548 (967)
+++.+|. .+..+++|+.|+|++|++++.+|..+. ++|++|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|.
T Consensus 415 l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~ 490 (562)
T 3a79_B 415 LNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPD 490 (562)
T ss_dssp CBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCT
T ss_pred CCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCH
Confidence 9985554 688999999999999999988777654 79999999999999 67777779999999999999999 5665
Q ss_pred C--CCCCccCCCcccCCCCCCCccc
Q 002094 549 G--GFFNTISPSSVSGNPSLCGSVV 571 (967)
Q Consensus 549 ~--~~~~~~~~~~~~~n~~lc~~~~ 571 (967)
. ..+..+....+.+|||.|+|++
T Consensus 491 ~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 491 GVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp TSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCcCCCcch
Confidence 4 3345566777899999998875
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=391.32 Aligned_cols=296 Identities=31% Similarity=0.497 Sum_probs=265.7
Q ss_pred CCChhHHHHHHHHHhcCCCCccccCCCCCCCCCCCc--cceEEeCCCC--CeeeeeeecCCCCCc--cccccccCCCCCC
Q 002094 23 PTFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCN--WVGVKCDPKT--KRVVGLTLDGFSLSG--HIGRGLLRLQFLQ 96 (967)
Q Consensus 23 ~~~~~d~~all~~k~~~~~~~~~l~sw~~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~~--~~~~~l~~l~~L~ 96 (967)
.|.++|++||++||+++.||. .+++|..++ +||. |.||+|+..+ ++|+.|+|.+++++| .+|..+.++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~-~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTT-DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTS-CTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCCC-CCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 467899999999999999987 799997754 5788 9999998655 899999999999999 8999999999999
Q ss_pred eEecCC-CccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecc
Q 002094 97 VLSLSN-NNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSS 175 (967)
Q Consensus 97 ~L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 175 (967)
+|+|++ |++++.+|..|+.+++|++|+|++|++++.+|.. |..+++|++|+|++|++++.+|..++.+++|++|+|++
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF-LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGG-GGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHH-HhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence 999995 9999999999999999999999999999888875 58899999999999999999999999999999999999
Q ss_pred cccccccCccccccc-cCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCC
Q 002094 176 NRLSGQLPYGIWFLR-SLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSL 254 (967)
Q Consensus 176 N~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 254 (967)
|++++.+|..+..++ +|++|+|++|.+++.+|..+..+. |++|+|++|++++..|..|+.+++|++|++++|++++.+
T Consensus 159 N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 237 (313)
T 1ogq_A 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred CcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeec
Confidence 999999999999988 899999999999988999998887 999999999999888889999999999999999998666
Q ss_pred ChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCc-CCC
Q 002094 255 PDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQ-FTG 324 (967)
Q Consensus 255 ~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~ 324 (967)
|. +..+++|++|+|++|++++.+|..+..+++|++|+|++|++++.+|.. ..+++|+.|++++|. +.+
T Consensus 238 ~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 238 GK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp GG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred Cc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence 55 788889999999999998888888888999999999999998888875 788888888888887 443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=407.75 Aligned_cols=366 Identities=17% Similarity=0.154 Sum_probs=246.7
Q ss_pred CCCceEeccccccCCCCccccccccccceeeeccccccccc-CccccccccCCeEeecCCcCCCcccccccCCCCCCeee
Q 002094 142 GSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQL-PYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIK 220 (967)
Q Consensus 142 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 220 (967)
++|++|+|++|++++..|..|+++++|++|+|++|++.+.+ +..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 45555555555555555555555555556666555554333 34455556666666666665555555566666666666
Q ss_pred ccCccccccCCcC--ccCCCCccEEeccccccCCCCChh-hhcCCCCCEEEccCCCCCCcCchhhccc--cccccccccc
Q 002094 221 LGKNKFSGQLPED--IGGCSMLKVLDFGVNSLSGSLPDS-LQRLNSCSSLSLKGNSFTGEVPDWIGKL--ANLESLDLSL 295 (967)
Q Consensus 221 L~~n~l~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~-l~~l~~L~~L~L~~n~l~~~~~~~l~~l--~~L~~L~L~~ 295 (967)
|++|++++..+.. |+.+++|++|++++|++++..|.. +.++++|++|+|++|.+++..+..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 6666665533333 666666666666666666555554 5666666666666666666666666555 5666677777
Q ss_pred cccccccCCC--------CCcccccceEEcccCcCCCCCChhhhcC---CCCcEEEccCCcCcCCCChhhhcccccEEec
Q 002094 296 NQFSGRIPSS--------IGNLVFLKELNISMNQFTGGLPESMMNC---GNLLAIDVSQNKLTGNIPTWIFKMGLQTVSL 364 (967)
Q Consensus 296 N~l~~~~~~~--------~~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L 364 (967)
|.+.+..+.. +..+++|++|++++|++++..|..+... ++|+.|++++|.+.+...
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~------------- 256 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF------------- 256 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT-------------
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc-------------
Confidence 7666443332 2345667777777777776666655543 566666666665543210
Q ss_pred cCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccc--cccchhcccccccccccCCCcCCcccccEEEec
Q 002094 365 SGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDL--SSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFS 442 (967)
Q Consensus 365 ~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 442 (967)
..+.+.+..+..+..+ ++|+.|++++|.+.+..|..+..+++|++|+|+
T Consensus 257 -----------------------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls 307 (455)
T 3v47_A 257 -----------------------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLA 307 (455)
T ss_dssp -----------------------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECT
T ss_pred -----------------------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECC
Confidence 1112222222233332 567777788887777777788888888888888
Q ss_pred CCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCC
Q 002094 443 DNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGIL 522 (967)
Q Consensus 443 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 522 (967)
+|++++..|..|.++++|++|+|++|++++..|..|+.+++|+.|+|++|++++..|..|.++++|++|+|++|++++..
T Consensus 308 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 387 (455)
T 3v47_A 308 QNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVP 387 (455)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCC
Confidence 88888777888888888888888888888777888888899999999999998888888999999999999999999877
Q ss_pred chhhhhccCCceEEecCCcccccCCCC
Q 002094 523 PKELINLSHLLSFNISHNHLHGELPVG 549 (967)
Q Consensus 523 p~~l~~l~~L~~L~l~~N~l~~~~p~~ 549 (967)
+..+..+++|+.|++++|+++|.+|..
T Consensus 388 ~~~~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 388 DGIFDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred HhHhccCCcccEEEccCCCcccCCCcc
Confidence 778888999999999999999988854
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=407.52 Aligned_cols=375 Identities=18% Similarity=0.162 Sum_probs=297.4
Q ss_pred CCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceee
Q 002094 93 QFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVN 172 (967)
Q Consensus 93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 172 (967)
++|++|+|++|++++..|..|+.+++|++|+|++|.+.+.++...|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 78999999999999999999999999999999999998888888889999999999999999988899999999999999
Q ss_pred ecccccccccCcc--ccccccCCeEeecCCcCCCccccc-ccCCCCCCeeeccCccccccCCcCccCC--CCccEEeccc
Q 002094 173 FSSNRLSGQLPYG--IWFLRSLQSLDLSNNLLEGEIVKG-ISNLYDLRAIKLGKNKFSGQLPEDIGGC--SMLKVLDFGV 247 (967)
Q Consensus 173 L~~N~l~~~~p~~--~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~l~~ 247 (967)
|++|++++..|.. |..+++|++|+|++|.+++..|.. +.++++|++|+|++|++++..+..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 9999998755544 888999999999999998877766 7888888888888888888878777766 6778888888
Q ss_pred cccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcc---cccceEEcccCcCCC
Q 002094 248 NSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNL---VFLKELNISMNQFTG 324 (967)
Q Consensus 248 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~ 324 (967)
|.+.+..+..+.. .....+..+++|++|++++|++.+..|..+..+ ++|+.|++++|.+.+
T Consensus 190 n~l~~~~~~~~~~----------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~ 253 (455)
T 3v47_A 190 ITLQDMNEYWLGW----------------EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253 (455)
T ss_dssp CBCTTCSTTCTTH----------------HHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTS
T ss_pred Ccccccchhhccc----------------cccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccc
Confidence 8777544332210 000112233445555555555544444333332 556666666665443
Q ss_pred CCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCC
Q 002094 325 GLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPS 404 (967)
Q Consensus 325 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~ 404 (967)
.. +..+.+.+..+..+.. -..++|++|++++|++++.+|.
T Consensus 254 ~~--------------~~~~~~~~~~~~~~~~--------------------------~~~~~L~~L~l~~n~l~~~~~~ 293 (455)
T 3v47_A 254 SS--------------FGHTNFKDPDNFTFKG--------------------------LEASGVKTCDLSKSKIFALLKS 293 (455)
T ss_dssp CC--------------TTCCSSCCCCTTTTGG--------------------------GTTSCCCEEECCSSCCCEECTT
T ss_pred cc--------------cchhhhccCccccccc--------------------------ccccCceEEEecCccccccchh
Confidence 21 1112222111111100 0135788999999999988999
Q ss_pred CcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCcc
Q 002094 405 NIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSL 484 (967)
Q Consensus 405 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 484 (967)
.+..+++|++|+|++|++.+..|..|.++++|++|+|++|++++..|..+..+++|++|+|++|++++..|..|..+++|
T Consensus 294 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 373 (455)
T 3v47_A 294 VFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNL 373 (455)
T ss_dssp TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred hcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccc
Confidence 99999999999999999998889999999999999999999998889999999999999999999998889999999999
Q ss_pred ceeeccCCcCcCccchhhhcccCccEEeccCCccccCCc
Q 002094 485 TSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILP 523 (967)
Q Consensus 485 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 523 (967)
+.|+|++|+|++..+..|..+++|++|+|++|++++..|
T Consensus 374 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 374 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred cEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999999998877888999999999999999998887
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=391.09 Aligned_cols=262 Identities=19% Similarity=0.255 Sum_probs=202.8
Q ss_pred hhccCCCCccCCCCceEEEEEEeC----CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCcee
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ----DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 755 (967)
.+.|+..+.||+|+||+||+|+.+ .++.||||++.... ...++.+|+++++.+ +|||||++++++.+++..+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 456899999999999999999853 46889999986543 356788999999988 6999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC-CCeEEeecccccccCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS-GEPKVGDFGLARLLPM 834 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~-~~~kl~Dfg~a~~~~~ 834 (967)
+||||+++|+|.+++.. +++.++..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 97 lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999999842 8899999999999999999999999999999999999876 7999999999976543
Q ss_pred Cccc--------------------------cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCC
Q 002094 835 LDRC--------------------------ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYM 888 (967)
Q Consensus 835 ~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~ 888 (967)
.... .......||+.|+|||++.+...++.++||||+||++|||++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 2110 11223569999999999866667899999999999999999999999765
Q ss_pred ccchHhHHHHHHhhhc---------------------cCCchhhcc---------h---------hhcCCCChhhHHHHH
Q 002094 889 EDDVVVLCDMVRGALE---------------------DGRVEDCVD---------A---------RLRGNFPADEAIPVI 929 (967)
Q Consensus 889 ~~~~~~~~~~~~~~~~---------------------~~~~~~~~~---------~---------~~~~~~~~~~~~~l~ 929 (967)
.++...+..+....-. ........+ + ....+.....+.++.
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 5554444333321000 000000000 0 000011233456789
Q ss_pred HHHHhhccCCCCCCCCHHHHHH
Q 002094 930 KLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 930 ~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+|+.+|++.||++|||++|+++
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHCcCChhHCcCHHHHhc
Confidence 9999999999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=396.09 Aligned_cols=264 Identities=21% Similarity=0.277 Sum_probs=203.7
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEc------CCc
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWT------PSL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~ 753 (967)
+.|+..+.||+|+||+||+|+.+ +|+.||||++..... ....+.+.+|++++++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 34788899999999999999964 699999999976543 3345678899999999999999999998764 356
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.|+|||||+ |+|.+++..... +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~---l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQP---LTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 799999996 689999976543 8999999999999999999999999999999999999999999999999998664
Q ss_pred CCc--cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh
Q 002094 834 MLD--RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911 (967)
Q Consensus 834 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (967)
... .........||+.|+|||++.+...++.++||||+||++|||++|++||...... ..+..++.. ...+.....
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~-~g~p~~~~~ 287 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMV-LGTPSPAVI 287 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHH-HCCCCGGGT
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHh-cCCCChHHh
Confidence 321 1223346789999999999866667899999999999999999999999754332 222222221 111111000
Q ss_pred cc----------hhh--cCCC-----ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 912 VD----------ARL--RGNF-----PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 912 ~~----------~~~--~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.. ..+ .... .+..+.++.+|+.+|+..||++|||++|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 000 0000 1234567899999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=378.46 Aligned_cols=278 Identities=33% Similarity=0.566 Sum_probs=236.4
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+.|+..+.||+|+||.||+|+.++++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 117 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred hccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence 4578899999999999999998889999999887654 345678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 762 SSGSLYKHLHDGSSR-NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~-~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
++|+|.+++...... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++...........
T Consensus 118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 999999999765432 2489999999999999999999999999999999999999999999999999986554333333
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCcc-chHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMED-DVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
.....||+.|+|||.+ ....++.++||||||+++|||++|+.||..... +......|.........+.+.+++.....
T Consensus 198 ~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYF-IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK 276 (321)
T ss_dssp BCCCEEETTTCCHHHH-HHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred ccccCCCccccCHHHh-cCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccc
Confidence 4456689999999988 556789999999999999999999999974322 22334455555555566666777777777
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 961 (967)
.+.+.+..+.+++.+|++.||++|||++|+++.|+.+.+..+
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 788899999999999999999999999999999998876544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=394.72 Aligned_cols=384 Identities=25% Similarity=0.307 Sum_probs=157.6
Q ss_pred CeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCC-------------cEEEcCCCCCCCCCCc
Q 002094 69 KRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTL-------------QVVDFSENNLSGLIPD 135 (967)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-------------~~L~Ls~n~~~~~ip~ 135 (967)
.++..+++.++.+ |.+|.++++|++|++|++++|+++|.+|..++.+++| ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 3555666666666 6666666666666666666666666666666666554 555555555542 332
Q ss_pred hhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCC
Q 002094 136 EFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYD 215 (967)
Q Consensus 136 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 215 (967)
..++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|+|++|.+++ +| .|+++++
T Consensus 89 ----~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~ 154 (454)
T 1jl5_A 89 ----LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSF 154 (454)
T ss_dssp ----CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTT
T ss_pred ----CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCC
Confidence 12445555555555554 3322 2445555555555542 1111 1345555555555543 22 3455555
Q ss_pred CCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccc
Q 002094 216 LRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSL 295 (967)
Q Consensus 216 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 295 (967)
|++|++++|++++ +|..+ .+|++|++++|++++ +| .+.++++|+.|++++|++++ +|.. .++|++|++++
T Consensus 155 L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~ 224 (454)
T 1jl5_A 155 LKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL---PLSLESIVAGN 224 (454)
T ss_dssp CCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCS
T ss_pred CCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC---cCcccEEECcC
Confidence 5555555555443 23222 244445555554443 23 34444444444444444443 2211 12444444444
Q ss_pred cccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCC
Q 002094 296 NQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQY 375 (967)
Q Consensus 296 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~ 375 (967)
|+++ .+| .++.+++|++|++++|++++ +|.. .++|+.|++++|++++ +|..
T Consensus 225 n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---------------------- 275 (454)
T 1jl5_A 225 NILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---------------------- 275 (454)
T ss_dssp SCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC----------------------
T ss_pred CcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc----------------------
Confidence 4444 333 24444444444444444442 2211 2344444444444442 2221
Q ss_pred CcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCc-ccccEEEecCCcccccCcccc
Q 002094 376 PSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKL-KAIQVLDFSDNWLNGTIPPQI 454 (967)
Q Consensus 376 ~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~ 454 (967)
.++|++|++++|++++. |.. .++|+.|++++|++.+ ++ .+ ++|+.|++++|++++ +|..
T Consensus 276 ---------~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~- 335 (454)
T 1jl5_A 276 ---------PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL- 335 (454)
T ss_dssp ---------CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC-
T ss_pred ---------cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc-
Confidence 24455555555555542 110 1345555555555543 11 12 355666666666653 3432
Q ss_pred cCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcC--ccchhhhcccCccEEeccCCccccCCchhhhhccCC
Q 002094 455 GGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTG--PVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHL 532 (967)
Q Consensus 455 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 532 (967)
+++|++|++++|+++ .+|. .+++|+.|+|++|++++ .+|.++..+ +.|.+.+.+|.. +++|
T Consensus 336 --~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~---~~~L 398 (454)
T 1jl5_A 336 --PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL---PQNL 398 (454)
T ss_dssp --CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC---------------
T ss_pred --CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc---cCcC
Confidence 345666666666665 3443 34556666666666665 444444332 223444444432 2455
Q ss_pred ceEEecCCcccc
Q 002094 533 LSFNISHNHLHG 544 (967)
Q Consensus 533 ~~L~l~~N~l~~ 544 (967)
+.|++++|++++
T Consensus 399 ~~L~ls~N~l~~ 410 (454)
T 1jl5_A 399 KQLHVETNPLRE 410 (454)
T ss_dssp ------------
T ss_pred CEEECCCCcCCc
Confidence 566666666655
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=399.60 Aligned_cols=250 Identities=21% Similarity=0.281 Sum_probs=202.6
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHH---HHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDF---EKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
+.|+..+.||+|+||.||+|+.+ +|+.||||++..... ......+ ..++.+++.++|||||++++++.+++..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 34688899999999999999965 689999999975432 1222333 34467788899999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+|||||+||+|.+++..... +++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 269 lVmEy~~GGdL~~~l~~~~~---l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 99999999999999986543 899999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 836 DRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
......||+.|+|||++..+..++.++|+||+||++|||++|++||........ .++.+....
T Consensus 346 ----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~~i~~----------- 408 (689)
T 3v5w_A 346 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT----------- 408 (689)
T ss_dssp ----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHHHHHH-----------
T ss_pred ----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhhcC-----------
Confidence 223567999999999985556799999999999999999999999974322111 111111111
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPD-----MEEVVN 951 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~ 951 (967)
....+|...+.++.++|.+|++.||++|++ ++|+++
T Consensus 409 ~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 409 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 122356667788999999999999999998 577653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=377.51 Aligned_cols=275 Identities=39% Similarity=0.695 Sum_probs=236.4
Q ss_pred HhhccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 680 ANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
..+.|+..+.||+|+||.||+|..++++.||||++...........+.+|++++++++||||+++++++..++..++|||
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 107 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 107 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred HhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence 34567999999999999999999888999999999766543344479999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 760 FISSGSLYKHLHDGSSR-NCLSWRQRFNIILGMAKGLAYLHHT---NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~-~~~~~~~~~~i~~~i~~aL~~LH~~---~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
|+++|+|.+++...... ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++......
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 187 (326)
T 3uim_A 108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187 (326)
T ss_dssp CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSS
T ss_pred eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcc
Confidence 99999999999875432 3589999999999999999999999 9999999999999999999999999999876532
Q ss_pred ccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCC---CccchHhHHHHHHhhhccCCchhhc
Q 002094 836 DRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEY---MEDDVVVLCDMVRGALEDGRVEDCV 912 (967)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (967)
. ........||+.|+|||.+ ....++.++||||+|+++|||++|+.||+. .........+|+.............
T Consensus 188 ~-~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (326)
T 3uim_A 188 D-THVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALV 265 (326)
T ss_dssp S-SCEECCCCSCGGGCCHHHH-HHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSS
T ss_pred c-ccccccccCCcCccCHHHh-ccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhc
Confidence 2 2233456689999999988 556789999999999999999999999962 2333445677888888888888888
Q ss_pred chhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 913 DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 913 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
+......++...+..+.+++.+|++.||++|||++|+++.|++.
T Consensus 266 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 266 DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 88888888899999999999999999999999999999999863
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=403.98 Aligned_cols=471 Identities=22% Similarity=0.208 Sum_probs=385.5
Q ss_pred eeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEec
Q 002094 70 RVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSF 149 (967)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L 149 (967)
+.+.|+|.+|.+++..+.+|.+|++|++|+|++|+|++..+..|.++++|++|+|++|++++ +|...|+++++|++|+|
T Consensus 77 ~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~-l~~~~~~~L~~L~~L~L 155 (635)
T 4g8a_A 77 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNV 155 (635)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCC-STTCCCTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCC-CChhhhhcCcccCeecc
Confidence 67889999999999888889999999999999999999888899999999999999999994 66666899999999999
Q ss_pred cccccCC-CCccccccccccceeeecccccccccCccccccccCC----eEeecCCcCCCcccccccCCCCCCeeeccCc
Q 002094 150 ANNNLTG-PIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQ----SLDLSNNLLEGEIVKGISNLYDLRAIKLGKN 224 (967)
Q Consensus 150 ~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 224 (967)
++|++++ ..|..++.+++|++|+|++|+|++..+..+..+.+++ .++++.|.++...+..+.. ..+..+++.+|
T Consensus 156 s~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~-~~~~~l~l~~n 234 (635)
T 4g8a_A 156 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNN 234 (635)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESC
T ss_pred ccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccc-hhhhhhhhhcc
Confidence 9999986 4678899999999999999999998888888877655 6889999998665555544 35677777777
Q ss_pred ccccc-CCcCccCCCCccEEec------------------------------cccccCC---CCChhhhcCCCCCEEEcc
Q 002094 225 KFSGQ-LPEDIGGCSMLKVLDF------------------------------GVNSLSG---SLPDSLQRLNSCSSLSLK 270 (967)
Q Consensus 225 ~l~~~-~~~~~~~l~~L~~L~l------------------------------~~n~l~~---~~~~~l~~l~~L~~L~L~ 270 (967)
..+.. .+..+.+++.++...+ ..+.... ..+..+..+.+++.+.+.
T Consensus 235 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 314 (635)
T 4g8a_A 235 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLV 314 (635)
T ss_dssp CSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEE
T ss_pred cccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccc
Confidence 54421 1223334444443333 2222211 123445667889999999
Q ss_pred CCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcC--
Q 002094 271 GNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTG-- 348 (967)
Q Consensus 271 ~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-- 348 (967)
+|.+.... .+....+|+.|++.+|.+.+..+ ..+..|+.+++.+|.+... .....+++|+.|++++|.+..
T Consensus 315 ~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~ 387 (635)
T 4g8a_A 315 SVTIERVK--DFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKG 387 (635)
T ss_dssp SCEEEECG--GGGSCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEE
T ss_pred cccccccc--ccccchhhhhhhcccccccCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhcccccccc
Confidence 99887543 35667899999999999985533 3567899999999988743 345678999999999999863
Q ss_pred CCChhhhc-ccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCC-CCcccccccchhccccccccccc
Q 002094 349 NIPTWIFK-MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIP-SNIGDLSSLMLLNMSMNYLFGSI 426 (967)
Q Consensus 349 ~~p~~~~~-~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~ 426 (967)
..+..... .+++.+++..|.+... ...+..+++|+.++++.|+.....+ ..+..+++++.+++++|.+.+..
T Consensus 388 ~~~~~~~~~~~L~~L~~~~~~~~~~------~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~ 461 (635)
T 4g8a_A 388 CCSQSDFGTISLKYLDLSFNGVITM------SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 461 (635)
T ss_dssp ECCHHHHSCSCCCEEECCSCSEEEE------CSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECC
T ss_pred ccccchhhhhhhhhhhccccccccc------cccccccccccchhhhhcccccccccccccccccccccccccccccccc
Confidence 33444433 4899999999887442 2234567899999999988876554 56889999999999999999999
Q ss_pred CCCcCCcccccEEEecCCcc-cccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcc
Q 002094 427 PASIGKLKAIQVLDFSDNWL-NGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANL 505 (967)
Q Consensus 427 p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 505 (967)
+..+..++.|+.|+|++|++ .+..|..|..+++|++|+|++|+|++..|..|+++++|+.|+|++|+|++..|..|.++
T Consensus 462 ~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l 541 (635)
T 4g8a_A 462 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 541 (635)
T ss_dssp TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTC
T ss_pred ccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCC
Confidence 99999999999999999985 45678899999999999999999999999999999999999999999999999999999
Q ss_pred cCccEEeccCCccccCCchhhhhc-cCCceEEecCCcccccCCCCCCCCcc
Q 002094 506 SNLKYVDLSFNDLSGILPKELINL-SHLLSFNISHNHLHGELPVGGFFNTI 555 (967)
Q Consensus 506 ~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~l~~N~l~~~~p~~~~~~~~ 555 (967)
++|++|||++|+|++..|..|..+ ++|+.|+|++|+|+|.+...++.+++
T Consensus 542 ~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~wl 592 (635)
T 4g8a_A 542 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWI 592 (635)
T ss_dssp TTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHHHHH
T ss_pred CCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHHHHH
Confidence 999999999999999999999998 68999999999999988765554444
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=387.79 Aligned_cols=384 Identities=27% Similarity=0.298 Sum_probs=263.6
Q ss_pred CCeeeeeeecCCCCCccccccccCCCCC-------------CeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCC
Q 002094 68 TKRVVGLTLDGFSLSGHIGRGLLRLQFL-------------QVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIP 134 (967)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L-------------~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip 134 (967)
-.+.+.|++.++.++|.+|.+++++++| ++|++++|++++. |. -.++|++|++++|.+++ +|
T Consensus 33 L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l-p~---~~~~L~~L~l~~n~l~~-lp 107 (454)
T 1jl5_A 33 VKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-PE---LPPHLESLVASCNSLTE-LP 107 (454)
T ss_dssp -CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-CS---CCTTCSEEECCSSCCSS-CC
T ss_pred ccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-CC---CcCCCCEEEccCCcCCc-cc
Confidence 3567788999999999999999999875 9999999999974 33 24799999999999997 77
Q ss_pred chhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCC
Q 002094 135 DEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLY 214 (967)
Q Consensus 135 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 214 (967)
.. +++|++|++++|++++. |.. .++|++|+|++|++++ +| .|+.+++|++|++++|++++ +|..+ .
T Consensus 108 ~~----~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~ 173 (454)
T 1jl5_A 108 EL----PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---P 173 (454)
T ss_dssp CC----CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---T
T ss_pred cc----cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---c
Confidence 53 48999999999999963 321 2799999999999996 77 59999999999999999996 44433 5
Q ss_pred CCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccccccc
Q 002094 215 DLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLS 294 (967)
Q Consensus 215 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 294 (967)
+|++|++++|++++ +| .++++++|++|++++|++++ +|... ++|++|++++|.++ .+|. ++.+++|++|+++
T Consensus 174 ~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~ 245 (454)
T 1jl5_A 174 SLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYAD 245 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECC
T ss_pred cccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-cccc-cCCCCCCCEEECC
Confidence 89999999999997 55 69999999999999999996 44432 58999999999999 5664 8999999999999
Q ss_pred ccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCC
Q 002094 295 LNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQ 374 (967)
Q Consensus 295 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~ 374 (967)
+|++++ +|.. +++|+.|++++|++++ +|.. .++|+.|++++|++++ +|..
T Consensus 246 ~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~--------------------- 295 (454)
T 1jl5_A 246 NNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSEL--------------------- 295 (454)
T ss_dssp SSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESCC---------------------
T ss_pred CCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccCc---------------------
Confidence 999985 5543 4789999999999996 4543 4789999999999985 2210
Q ss_pred CCcccccccCCCCccEEEccCCcccCCCCCCcccc-cccchhcccccccccccCCCcCCcccccEEEecCCcccccCccc
Q 002094 375 YPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDL-SSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQ 453 (967)
Q Consensus 375 ~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 453 (967)
.++|++|++++|++++. + .+ ++|++|++++|++.+ +|.. +++|+.|++++|+++ .+|.
T Consensus 296 ----------~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~- 354 (454)
T 1jl5_A 296 ----------PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE- 354 (454)
T ss_dssp ----------CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC-
T ss_pred ----------CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc-
Confidence 13455555555555531 1 12 356666666666664 4443 467788888888887 4555
Q ss_pred ccCCCCCCEEEcCCCCCCC--cCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCcccc--CCchhhhhc
Q 002094 454 IGGAVSLKELKLEKNFLSG--RIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSG--ILPKELINL 529 (967)
Q Consensus 454 ~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l 529 (967)
.+++|++|+|++|++++ .+|..++. |+.|++.+.+|.. +++|++||+++|++++ .+|.+
T Consensus 355 --~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s---- 417 (454)
T 1jl5_A 355 --LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPES---- 417 (454)
T ss_dssp --CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC--------------------------------------
T ss_pred --hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccchhh----
Confidence 36788888888888887 56665553 3457777777764 5788999999999987 56644
Q ss_pred cCCceEEecCCcccccCCC
Q 002094 530 SHLLSFNISHNHLHGELPV 548 (967)
Q Consensus 530 ~~L~~L~l~~N~l~~~~p~ 548 (967)
++.|.+.+|.+.+.+|.
T Consensus 418 --l~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 418 --VEDLRMNSERVVDPYEF 434 (454)
T ss_dssp -------------------
T ss_pred --HhheeCcCcccCCcccc
Confidence 55667888888887664
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=378.16 Aligned_cols=262 Identities=27% Similarity=0.389 Sum_probs=217.7
Q ss_pred hccCCCCccCCCCceEEEEEEeC--------CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCC
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ--------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPS 752 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 752 (967)
+.|+..+.||+|+||.||+|+.. ++..||||++.........+.+.+|+++++++ +||||+++++++.+++
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 44678889999999999999852 45679999998765455567899999999999 8999999999999999
Q ss_pred ceeEEEEecCCCchhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC
Q 002094 753 LQLLIYEFISSGSLYKHLHDGSS-------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG 819 (967)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~ 819 (967)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 240 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence 99999999999999999986542 12478999999999999999999999999999999999999999
Q ss_pred CeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHH
Q 002094 820 EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDM 898 (967)
Q Consensus 820 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~ 898 (967)
.+||+|||+++...............+++.|+|||++ ....++.++|||||||++|||++ |+.||........ ...
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~--~~~ 317 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--FKL 317 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHH-HTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHH
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHh-cCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHH
Confidence 9999999999876543333333455678899999988 55679999999999999999999 9999975443211 111
Q ss_pred HHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 899 VRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
+ ....+...+..++.++.+++.+|++.||++|||+.|+++.|+++...
T Consensus 318 ~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 318 L-------------KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp H-------------HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-------------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1 11223345566778899999999999999999999999999998643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=397.54 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=206.8
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|+++++.++|||||++++++.+++..++||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 45788899999999999999965 69999999997654 34467799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC--CCeEEeecccccccCCCccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS--GEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~--~~~kl~Dfg~a~~~~~~~~~ 838 (967)
|+||+|.+++..... .+++.++..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-- 311 (573)
T 3uto_A 236 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 311 (573)
T ss_dssp CCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--
T ss_pred cCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--
Confidence 999999999975432 38999999999999999999999999999999999999854 899999999998775422
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
......||+.|+|||++ .+..++.++||||+||++|||++|++||...... ..+..+..... ....
T Consensus 312 -~~~~~~GT~~y~APEv~-~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-~~~~~i~~~~~-----------~~~~ 377 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVA-EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDW-----------NMDD 377 (573)
T ss_dssp -EEEEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTTCC-----------CCCS
T ss_pred -ceeeeEECccccCHHHh-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHhCCC-----------CCCc
Confidence 23346799999999998 6668999999999999999999999999754432 22221111100 0111
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+...+.++.+||.+|++.||++|||++|+++
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112345667899999999999999999999876
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=367.54 Aligned_cols=265 Identities=32% Similarity=0.480 Sum_probs=207.6
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|+. +|+.||||++..... ....+++.+|++++++++||||+++++++...+..++||||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 4567888999999999999987 489999999976543 23456799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN--IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~--ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
+++|+|.+++........+++..++.++.|++.||+|||++| |+||||||+||+++.++.+||+|||+++.... ..
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~ 193 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TF 193 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc--cc
Confidence 999999999987543334889999999999999999999999 99999999999999999999999999975432 12
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......||+.|+|||.+ ....++.++||||+|+++|||++|+.||......... ..+. ....+.
T Consensus 194 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~--~~~~------------~~~~~~ 258 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVL-RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV--AAVG------------FKCKRL 258 (309)
T ss_dssp --------CCTTSCHHHH-TTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH--HHHH------------HSCCCC
T ss_pred cccccCCCCccccChhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH------------hcCCCC
Confidence 223456789999999998 5667899999999999999999999999755432111 1110 011123
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCcc
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQE 964 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~ 964 (967)
..+...+.++.+++.+|++.||++|||++|+++.|+.+.+...+..
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 4456677789999999999999999999999999999987765543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=379.19 Aligned_cols=364 Identities=19% Similarity=0.178 Sum_probs=263.2
Q ss_pred CCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCcc
Q 002094 81 LSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPE 160 (967)
Q Consensus 81 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~ 160 (967)
..+..+..++++++|++|+|++|++++. | .++.+++|++|+|++|++++ +| ++.+++|++|+|++|++++. +
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~---~~~l~~L~~L~Ls~N~l~~~-~- 101 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD---LSQNTNLTYLACDSNKLTNL-D- 101 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC---CTTCTTCSEEECCSSCCSCC-C-
T ss_pred cCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec---cccCCCCCEEECcCCCCcee-e-
Confidence 3344455677888888888888888875 4 68888888888888888885 44 57788888888888888864 3
Q ss_pred ccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCc
Q 002094 161 SLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSML 240 (967)
Q Consensus 161 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 240 (967)
++.+++|++|+|++|++++. | ++.+++|++|++++|.+++. .++++++|++|++++|+..+.+ .++.+++|
T Consensus 102 -~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L 172 (457)
T 3bz5_A 102 -VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQL 172 (457)
T ss_dssp -CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTC
T ss_pred -cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcC
Confidence 77888888888888888753 3 77788888888888888764 2677777777777777554444 46677777
Q ss_pred cEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccC
Q 002094 241 KVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMN 320 (967)
Q Consensus 241 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 320 (967)
++|++++|++++ +| +..+++|+.|++++|++++. .++.+++|++|++++|++++ +| +..+++|+.|++++|
T Consensus 173 ~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N 243 (457)
T 3bz5_A 173 TTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVN 243 (457)
T ss_dssp CEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSS
T ss_pred CEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCC
Confidence 777777777775 33 66667777777777777654 25666666677777776665 34 566666666666666
Q ss_pred cCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccC
Q 002094 321 QFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSG 400 (967)
Q Consensus 321 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~ 400 (967)
++++.. +..+++|+.|++++|+ |+.|++++|.+.+
T Consensus 244 ~l~~~~---~~~l~~L~~L~l~~n~------------------------------------------L~~L~l~~n~~~~ 278 (457)
T 3bz5_A 244 PLTELD---VSTLSKLTTLHCIQTD------------------------------------------LLEIDLTHNTQLI 278 (457)
T ss_dssp CCSCCC---CTTCTTCCEEECTTCC------------------------------------------CSCCCCTTCTTCC
T ss_pred cCCCcC---HHHCCCCCEEeccCCC------------------------------------------CCEEECCCCccCC
Confidence 666543 3345555666555443 3445666666666
Q ss_pred CCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccc
Q 002094 401 VIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKN 480 (967)
Q Consensus 401 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 480 (967)
.+| ++.+++|+.|++++|.+.+.+|. ...+|+.|++++| ++|++|+|++|++++. + +++
T Consensus 279 ~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~ 337 (457)
T 3bz5_A 279 YFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSH 337 (457)
T ss_dssp EEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTT
T ss_pred ccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--ccc
Confidence 665 45678888888888887777764 3345566666555 5789999999999874 3 888
Q ss_pred cCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCC
Q 002094 481 CSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVG 549 (967)
Q Consensus 481 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~ 549 (967)
+++|+.|++++|+|++ ++.|..|++++|.++|. ..+..|..+++++|+++|.||..
T Consensus 338 l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 338 NTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp CTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred CCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence 9999999999999986 35677788999999876 35677888999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=367.58 Aligned_cols=263 Identities=27% Similarity=0.408 Sum_probs=214.9
Q ss_pred hccCCCCccCCCCceEEEEEEeC----CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ----DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|+..+.||+|+||.||+|... .+..||||++.........+.+.+|++++++++||||+++++++.+++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 34677889999999999999974 35569999998765455667899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++|+|.++++.... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 129 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp EECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred eeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 999999999999976433 389999999999999999999999999999999999999999999999999987654221
Q ss_pred -ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 838 -CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 838 -~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
........+|+.|+|||.+ ....++.++||||+|+++|||++ |+.||........ ... +...
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-----~~~----------~~~~ 270 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAI-AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-----ISS----------VEEG 270 (325)
T ss_dssp CCEECC---CCGGGSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-----HHH----------HHTT
T ss_pred ceeeccCCCCcccccCHhHh-cCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-----HHH----------HHcC
Confidence 1122334467789999998 55678999999999999999999 9999975543211 111 1111
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
.+...+...+..+.+++.+|++.||++|||++|++++|+.+.+..++
T Consensus 271 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 23334566778899999999999999999999999999999866554
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=380.12 Aligned_cols=259 Identities=24% Similarity=0.341 Sum_probs=214.8
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|...+.||+|+||.||+|..+ +++.||||.+.........+++.+|++++++++||||+++++++..++..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 34677889999999999999976 78999999997654334456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++|+|.++++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..........
T Consensus 194 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~ 271 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271 (377)
T ss_dssp CTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred CCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence 999999999975432 388999999999999999999999999999999999999999999999999986543222222
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
.....+++.|+|||.+ ....++.++||||||+++|||++ |+.||........ .+. +....+..
T Consensus 272 ~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--~~~-------------~~~~~~~~ 335 (377)
T 3cbl_A 272 GGLRQVPVKWTAPEAL-NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--REF-------------VEKGGRLP 335 (377)
T ss_dssp SSCCEEEGGGSCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH--HHH-------------HHTTCCCC
T ss_pred CCCCCCCcCcCCHhHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH-------------HHcCCCCC
Confidence 2234467789999988 55678999999999999999998 9999976543211 111 11222334
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.+..++.++.+++.+||+.||++|||++++++.|+++.+
T Consensus 336 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 566677889999999999999999999999999999865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=355.43 Aligned_cols=256 Identities=28% Similarity=0.413 Sum_probs=214.6
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+.|+..+.||+|+||.||+|...+++.||+|++.... ...+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 3467788999999999999999889999999998654 34578999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... .....
T Consensus 88 ~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 164 (269)
T 4hcu_A 88 EHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSS 164 (269)
T ss_dssp TTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHST
T ss_pred CCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc-ccccc
Confidence 99999999976443 3899999999999999999999999999999999999999999999999999866432 22233
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....+++.|+|||.+ ....++.++||||+|+++|||++ |+.||........ .... ........
T Consensus 165 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-----~~~~----------~~~~~~~~ 228 (269)
T 4hcu_A 165 TGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDI----------STGFRLYK 228 (269)
T ss_dssp TSTTCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----HHHH----------HTTCCCCC
T ss_pred cCcccccccCCHHHh-cCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-----HHHH----------hcCccCCC
Confidence 455667889999998 56678999999999999999999 9999975443211 1111 11112233
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
+...+..+.+++.+|++.||++|||++|+++.|+++.+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 45566779999999999999999999999999998864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=361.46 Aligned_cols=263 Identities=26% Similarity=0.385 Sum_probs=213.4
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 34677889999999999999965 58999999886543 45567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc-
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI- 839 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 839 (967)
+++|+|.+++..... .+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 89 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp CTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred cCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999999999987433 38999999999999999999999999999999999999999999999999998764322111
Q ss_pred -----------ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc
Q 002094 840 -----------LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV 908 (967)
Q Consensus 840 -----------~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 908 (967)
......||+.|+|||.+ ....++.++||||||+++|||++|..||..........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------------- 232 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMI-NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------------- 232 (310)
T ss_dssp -------------CCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-------------
T ss_pred ccccccccccccccccCCCcceeCHHHh-cCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-------------
Confidence 11145689999999998 66788999999999999999999999987433221100
Q ss_pred hhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 002094 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961 (967)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 961 (967)
............+..++..+.+++.+|++.||++|||++|+++.|++++..+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00011111222345566679999999999999999999999999999876543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.35 Aligned_cols=281 Identities=31% Similarity=0.545 Sum_probs=224.3
Q ss_pred CcHHHHHHHhhccCCC------CccCCCCceEEEEEEeCCCcEEEEEEeecCCc---cccHHHHHHHHHHHcCCCCCcee
Q 002094 672 GDAEFAAGANALLNKD------CELGRGGFGVVYRTILQDGRSVAIKKLTVSGL---IKSQEDFEKEMKTLGKIRHHNLV 742 (967)
Q Consensus 672 ~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l~h~niv 742 (967)
...++...+.++ ... +.||+|+||.||+|.. +++.||||++..... ....+.+.+|++++++++||||+
T Consensus 16 ~~~~l~~~~~~f-~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 93 (307)
T 2nru_A 16 SFYELKNVTNNF-DERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93 (307)
T ss_dssp CHHHHHHHTTTT-CCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBC
T ss_pred cHHHHHHHHccc-ccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeE
Confidence 345566655543 444 8899999999999987 589999999875432 23467899999999999999999
Q ss_pred eeeeEEEcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeE
Q 002094 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPK 822 (967)
Q Consensus 743 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~k 822 (967)
++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||+|||++||+||||||+||+++.++.+|
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~k 173 (307)
T 2nru_A 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAK 173 (307)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEE
T ss_pred EEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEE
Confidence 99999999999999999999999999997654444589999999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhh
Q 002094 823 VGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGA 902 (967)
Q Consensus 823 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 902 (967)
|+|||++................|++.|+|||.+ . +.++.++||||+|+++|+|++|+.||....... ....+....
T Consensus 174 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~ 250 (307)
T 2nru_A 174 ISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-R-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDIKEEI 250 (307)
T ss_dssp ECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHH-T-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTTHHHHHH
T ss_pred EeecccccccccccccccccccCCCcCcCChHHh-c-CCCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHHHHHHHh
Confidence 9999999876543333334456789999999987 3 358899999999999999999999997543321 112222221
Q ss_pred hc-cCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 903 LE-DGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 903 ~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.. ...+.+.++..+ ...+...+..+.+++.+|++.||++|||++++++.|+++..
T Consensus 251 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 251 EDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11 122333333333 23466778889999999999999999999999999998864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=371.78 Aligned_cols=260 Identities=30% Similarity=0.438 Sum_probs=204.1
Q ss_pred hccCCCCccCCCCceEEEEEEeC----CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ----DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|+..+.||+|+||.||+|+.+ ++..||||+++........+++.+|++++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 35788999999999999999864 57789999998765445567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++|+|.++++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 125 ~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp EECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 999999999999986533 389999999999999999999999999999999999999999999999999987643221
Q ss_pred c-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 838 C-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 838 ~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
. .......+++.|+|||.+ ....++.++||||||+++|||++ |+.||....... .... +...
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~~-------------i~~~ 266 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIKA-------------VDEG 266 (373)
T ss_dssp -----------CTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHHH-------------HHTT
T ss_pred cceeccCCCcCCCccChhhh-ccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH-------------HHcC
Confidence 1 111223356789999998 56678999999999999999998 999997544321 1111 1222
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
.+...+..++..+.+++.+|++.||++|||+.|++++|+++.+.
T Consensus 267 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 23344556778899999999999999999999999999998654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=381.31 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=217.7
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+.|+..+.||+|+||.||+|..+++..||||+++... ...+.+.+|++++++++|||||++++++. .+..++||||+
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 3467788999999999999999889999999997654 45788999999999999999999999986 56789999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++|+|.++++..... .+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 265 ~~g~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~ 342 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-EYTAR 342 (454)
T ss_dssp TTCBHHHHHHSHHHH-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH-HHHTT
T ss_pred CCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC-ceecc
Confidence 999999999754321 2788999999999999999999999999999999999999999999999999876432 12223
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....+++.|+|||.+ ....++.++||||||+++|||++ |+.||........ . ..+ ....+...
T Consensus 343 ~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~-~-~~i-------------~~~~~~~~ 406 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-I-RAL-------------ERGYRMPR 406 (454)
T ss_dssp CSSSSCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-H-HHH-------------HHTCCCCC
T ss_pred CCCcccccccCHHHh-ccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH-H-HHH-------------HcCCCCCC
Confidence 344567889999998 55679999999999999999999 9999976543211 1 111 11223344
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCcc
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQE 964 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~ 964 (967)
+..++.++.+++.+||+.||++|||+++++++|+++....+++-
T Consensus 407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~~ 450 (454)
T 1qcf_A 407 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQY 450 (454)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCSS
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccccc
Confidence 56677889999999999999999999999999999987766553
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=353.08 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=214.2
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+.|+..+.||+|+||.||+|..+++..||||++.... ...+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 4467888999999999999999988899999997654 34577999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||.+....... ....
T Consensus 86 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~ 162 (268)
T 3sxs_A 86 SNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSS 162 (268)
T ss_dssp TTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEEC
T ss_pred CCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhcc
Confidence 99999999976432 38899999999999999999999999999999999999999999999999998765422 2233
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....+++.|+|||.+ ....++.++||||+|+++|||++ |+.||........ .... ........
T Consensus 163 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~~~----------~~~~~~~~ 226 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVF-HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-----VLKV----------SQGHRLYR 226 (268)
T ss_dssp CSCCCCGGGCCHHHH-HHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----HHHH----------HTTCCCCC
T ss_pred cCCCcCcccCCHHHH-hccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-----HHHH----------HcCCCCCC
Confidence 445567789999988 56678999999999999999999 9999975443211 1111 11112223
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
+...+..+.+++.+|++.||++|||++|+++.|+.+++..
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 4445677999999999999999999999999999998653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=354.93 Aligned_cols=249 Identities=20% Similarity=0.322 Sum_probs=207.9
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 4578899999999999999995 568999999997654 34467799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK 172 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--cc
Confidence 9999999999764 27899999999999999999999999999999999999999999999999998664322 22
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....||+.|+|||.+ ....++.++||||+|+++|||++|+.||........ ........ ......
T Consensus 173 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~------------~~~~~~ 238 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNG------------TPELQN 238 (297)
T ss_dssp BCCCCSCGGGCCHHHH-HCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHC------------SCCCSC
T ss_pred cCCccCCcCccChhhh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCC------------CCCCCC
Confidence 3456789999999998 556789999999999999999999999975443221 11111110 011223
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+...+..+.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 4556677999999999999999999999876
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=366.74 Aligned_cols=266 Identities=25% Similarity=0.395 Sum_probs=215.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
+.|+..+.||+|+||.||+|+.. +++.||||++.........+.+.+|++++++++||||+++++++.+.+..+
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 45688889999999999999964 348899999987654455678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEE
Q 002094 756 LIYEFISSGSLYKHLHDGSS---------------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVL 814 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nil 814 (967)
+||||+++|+|.+++..... ...+++.+++.++.||+.||+|||++||+||||||+||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 206 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 206 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence 99999999999999976431 134899999999999999999999999999999999999
Q ss_pred eCCCCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchH
Q 002094 815 IDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVV 893 (967)
Q Consensus 815 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~ 893 (967)
++.++.+||+|||++................+++.|+|||.+ ....++.++||||||+++|||++ |+.||........
T Consensus 207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 285 (343)
T 1luf_A 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285 (343)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh-ccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHH
Confidence 999999999999999866443332334456678899999988 55678999999999999999999 9999975443211
Q ss_pred hHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCc
Q 002094 894 VLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQ 963 (967)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~ 963 (967)
.. .+..+ .....+...+.++.+++.+|++.||++|||+.++++.|+++.+...+.
T Consensus 286 -----~~-~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~ 340 (343)
T 1luf_A 286 -----IY-YVRDG---------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGT 340 (343)
T ss_dssp -----HH-HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-----
T ss_pred -----HH-HHhCC---------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhh
Confidence 11 11111 112345566778999999999999999999999999999998877654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=370.85 Aligned_cols=265 Identities=28% Similarity=0.368 Sum_probs=219.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC--------CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCC
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ--------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPS 752 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 752 (967)
+.|...+.||+|+||.||+|+.. .+..||||++..........++.+|+++++++ +||||+++++++..++
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 45678889999999999999852 34679999998765555667899999999999 8999999999999999
Q ss_pred ceeEEEEecCCCchhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC
Q 002094 753 LQLLIYEFISSGSLYKHLHDGSS-------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG 819 (967)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~ 819 (967)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 228 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 228 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC
Confidence 99999999999999999986542 12489999999999999999999999999999999999999999
Q ss_pred CeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHH
Q 002094 820 EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDM 898 (967)
Q Consensus 820 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~ 898 (967)
.+||+|||+++...............+|+.|+|||.+ ....++.++||||||+++|||++ |+.||....... ..+.
T Consensus 229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--~~~~ 305 (382)
T 3tt0_A 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LFKL 305 (382)
T ss_dssp CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHH
T ss_pred cEEEcccCcccccccccccccccCCCCCcceeCHHHh-cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH
Confidence 9999999999876543333344456678899999988 56678999999999999999999 999997544321 1111
Q ss_pred HHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 899 VRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
+ ....+...+...+.++.+++.+|++.||++|||++|+++.|+++......
T Consensus 306 ~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 306 L-------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp H-------------HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred H-------------HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 1 11122334556677899999999999999999999999999998754433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=371.39 Aligned_cols=264 Identities=28% Similarity=0.359 Sum_probs=216.7
Q ss_pred hhccCCCCccCCCCceEEEEEEe------CCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCc
Q 002094 681 NALLNKDCELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSL 753 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 753 (967)
.+.|+..+.||+|+||.||+|++ .+++.||||++.........+.+.+|+++++++ +||||+++++++.+++.
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 45578889999999999999973 246899999998765445567899999999999 79999999999987654
Q ss_pred -eeEEEEecCCCchhhhhhcCCC---------------------------------------------------------
Q 002094 754 -QLLIYEFISSGSLYKHLHDGSS--------------------------------------------------------- 775 (967)
Q Consensus 754 -~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 775 (967)
.++||||+++|+|.++++....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 8999999999999999986543
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccccccccc
Q 002094 776 ------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG 849 (967)
Q Consensus 776 ------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 849 (967)
...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++................||+.
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~ 260 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence 11288999999999999999999999999999999999999999999999999987654444444556778899
Q ss_pred ccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHH
Q 002094 850 YMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPV 928 (967)
Q Consensus 850 y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 928 (967)
|+|||++ ....++.++||||||+++|||++ |+.||............ + ........+...+.++
T Consensus 261 y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-~-------------~~~~~~~~~~~~~~~l 325 (359)
T 3vhe_A 261 WMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-L-------------KEGTRMRAPDYTTPEM 325 (359)
T ss_dssp GCCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH-H-------------HHTCCCCCCTTCCHHH
T ss_pred eEChhhh-cCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH-H-------------HcCCCCCCCCCCCHHH
Confidence 9999988 56678999999999999999998 99999765443222111 1 1112233455567789
Q ss_pred HHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 929 IKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 929 ~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
.+++.+|++.||++|||++|+++.|+++.++
T Consensus 326 ~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 326 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999988753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=360.92 Aligned_cols=267 Identities=24% Similarity=0.280 Sum_probs=208.6
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCc----eeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSL----QLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~lv 757 (967)
+.|+..+.||+|+||.||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++..... .++|
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 34688889999999999999886 8999999997543 344566779999999999999999999987543 6999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------CcccCCCCCCCEEeCCCCCeEEeecc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT----------NIIHYNLKSTNVLIDSSGEPKVGDFG 827 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~----------~ivH~Dik~~Nill~~~~~~kl~Dfg 827 (967)
|||+++|+|.++++... +++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 99999999999997642 89999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCc----ccCCcccchhhHHHHHHHHHcCCCCCCCCccchH-hHHHHHHhh
Q 002094 828 LARLLPMLDRCILSSKIQSALGYMAPEFACRT----VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVV-VLCDMVRGA 902 (967)
Q Consensus 828 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~-~~~~~~~~~ 902 (967)
+++...............||+.|+|||.+... ..++.++||||||+++|||++|+.||....+... ..... .
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~---~ 253 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE---I 253 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH---H
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh---h
Confidence 99876543333334456789999999988432 4567789999999999999999999975332111 00000 0
Q ss_pred hccCCchhhcc----hhhcCCC-----ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 903 LEDGRVEDCVD----ARLRGNF-----PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 903 ~~~~~~~~~~~----~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.......+..+ ...+... ....+.++.+++.+|++.||++|||++|+++.|+++.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00111111111 1111111 22456679999999999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=359.84 Aligned_cols=248 Identities=23% Similarity=0.290 Sum_probs=206.6
Q ss_pred ccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|+..+.||+|+||.||+|.. .+|+.||||++..... ....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 468889999999999999996 5799999999976542 33456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 96 ~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~---~~ 169 (328)
T 3fe3_A 96 ASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GK 169 (328)
T ss_dssp CTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS---CG
T ss_pred CCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC---Cc
Confidence 999999999976543 889999999999999999999999999999999999999999999999999766432 22
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....||+.|+|||.+......+.++||||+||++|||++|+.||+...... ....+..+ ....
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~---------------~~~~ 233 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-LRERVLRG---------------KYRI 233 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC---------------CCCC
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhC---------------CCCC
Confidence 3456799999999998544444689999999999999999999997543221 11111110 1123
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
|...+.++.+++.+|++.||.+|||++|+++.
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 45566779999999999999999999998763
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.49 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=211.0
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+.|+..+.||+|+||.||++..+++..||||++.... ...+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 3467788999999999999999988999999998654 34577999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... .....
T Consensus 102 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~ 178 (283)
T 3gen_A 102 ANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSS 178 (283)
T ss_dssp TTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH-HHHST
T ss_pred CCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc-ccccc
Confidence 99999999976432 2899999999999999999999999999999999999999999999999999866432 22223
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....+++.|+|||.+ ....++.++||||+|+++|||++ |+.||........ ... + ....+...
T Consensus 179 ~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-~~~-~-------------~~~~~~~~ 242 (283)
T 3gen_A 179 VGSKFPVRWSPPEVL-MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AEH-I-------------AQGLRLYR 242 (283)
T ss_dssp TSTTSCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHH-H-------------HTTCCCCC
T ss_pred cCCccCcccCCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-HHH-H-------------hcccCCCC
Confidence 345567889999998 55678999999999999999998 9999975543211 111 1 11122233
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
+...+..+.+++.+|++.||++|||++|+++.|+++.+
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 45556789999999999999999999999999998864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=360.89 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=207.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|+.. +++.||||++.........+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 34678889999999999999966 78999999997665444557789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...........
T Consensus 87 ~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 87 CSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp CTTEEGGGGSBTTTB---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 999999999976543 89999999999999999999999999999999999999999999999999986644333333
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....||+.|+|||++......+.++||||+|+++|||++|+.||............+..... ....
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------------~~~~ 230 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------------YLNP 230 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT-------------TSTT
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc-------------cCCc
Confidence 446779999999999855444588999999999999999999999865544333333322111 1111
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
....+..+.+++.+|++.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 23456678999999999999999999998763
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=370.32 Aligned_cols=262 Identities=24% Similarity=0.371 Sum_probs=214.3
Q ss_pred hccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
+.|+..+.||+|+||.||+|.+. +++.||||++..........++.+|+.++++++||||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 44678889999999999999943 467899999976554556678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC---CeEEeeccc
Q 002094 756 LIYEFISSGSLYKHLHDGSS----RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG---EPKVGDFGL 828 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~---~~kl~Dfg~ 828 (967)
+||||+++|+|.+++..... ...+++.+++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 99999999999999976432 12489999999999999999999999999999999999999555 599999999
Q ss_pred ccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCC
Q 002094 829 ARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGR 907 (967)
Q Consensus 829 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (967)
++...............+|+.|+|||.+ ....++.++|||||||++|||++ |+.||....... ....+
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~~~~i-------- 299 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAF-MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFV-------- 299 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHH--------
T ss_pred ccccccccccccCCCcCCcccEECHHHh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH--------
Confidence 9765332333334456678899999988 56679999999999999999998 999997544321 11111
Q ss_pred chhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
....+...+...+..+.+++.+|++.||++|||++|+++.|+.+.+.
T Consensus 300 -----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 300 -----TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp -----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----HcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 11112334556677899999999999999999999999999887643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=360.24 Aligned_cols=261 Identities=26% Similarity=0.376 Sum_probs=217.2
Q ss_pred hccCCCCccCCCCceEEEEEEe------CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
+.|...+.||+|+||.||+|.. .+++.||||++.........+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 3467788999999999999985 2458899999986654555678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEE
Q 002094 756 LIYEFISSGSLYKHLHDGSS---------------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVL 814 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nil 814 (967)
+||||+++++|.+++..... ...+++..++.++.||+.||+|||++||+||||||+||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl 182 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence 99999999999999986543 123789999999999999999999999999999999999
Q ss_pred eCCCCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchH
Q 002094 815 IDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVV 893 (967)
Q Consensus 815 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~ 893 (967)
++.++.+||+|||++................+++.|+|||.+ ....++.++||||+|+++|||++ |+.||........
T Consensus 183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcccccChhhh-cCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999876543333334455678889999988 55678999999999999999999 9999975543211
Q ss_pred hHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 894 VLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.+.+ ........+...+..+.+++.+|++.||++|||++|+++.|+++..
T Consensus 262 --~~~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 262 --FNLL-------------KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp --HHHH-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHh-------------hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111 1112233455667789999999999999999999999999998864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=362.05 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=205.4
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCc----EEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLL 756 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 756 (967)
+.|+..+.||+|+||.||+|+.. +++ +||+|.+.........+++.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 34688889999999999999954 344 468888866554556788999999999999999999999998754 789
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
|+||+++|+|.+++..... .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 94 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 9999999999999987543 38999999999999999999999999999999999999999999999999998775544
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
.........+|+.|+|||.+ .+..++.++||||||+++|||++ |+.||....... ... .+...
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~-------------~~~~~ 235 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS-------------ILEKG 235 (327)
T ss_dssp C-------CCCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH-------------HHHTT
T ss_pred ccccccCCCccccccChHHh-ccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHH-------------HHHcC
Confidence 43344455678899999998 56688999999999999999999 999997554322 111 11222
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.+...+..++..+.+++.+|++.||++|||+.|+++.|+.+..
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 2334456677889999999999999999999999999988765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=355.48 Aligned_cols=268 Identities=22% Similarity=0.325 Sum_probs=212.4
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||+|+.. +++.||+|.+..... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 45788899999999999999954 689999999865432 233568999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 91 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 166 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SL 166 (294)
T ss_dssp ECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc-cc
Confidence 99999999999976543 899999999999999999999999999999999999999999999999999866432 22
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......||+.|+|||.+ ....++.++||||+|+++|||++|+.||......... ....... .. ....
T Consensus 167 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-----~~~~~~~-~~-----~~~~ 234 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQA-KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-----IKHIQDS-VP-----NVTT 234 (294)
T ss_dssp --------CCSSCCHHHH-HTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-----HHHHSSC-CC-----CHHH
T ss_pred cccCccccCccccCHhHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhhcc-CC-----Ccch
Confidence 223356689999999998 5567899999999999999999999999755432211 1111111 00 0111
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCC-CHHHHHHHHHhhcCCCCCccc
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRP-DMEEVVNILELIQSPLDGQEE 965 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~evl~~L~~~~~~~~~~~~ 965 (967)
..+.+.+..+.+++.+|++.||++|| +++++.+.|+.+..+-...++
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~ 282 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED 282 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence 12344567799999999999999998 999999999998876655544
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=382.99 Aligned_cols=259 Identities=28% Similarity=0.395 Sum_probs=218.0
Q ss_pred ccCCCCccCCCCceEEEEEEeCC-CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||.||+|+++. +..||||.+.... ...++|.+|++++++++|||||++++++...+..++||||+
T Consensus 221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 35778899999999999999764 8899999997654 35678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++|+|.+++...... .+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 299 ~~g~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~ 376 (495)
T 1opk_A 299 TYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 376 (495)
T ss_dssp TTCBHHHHHHHSCTT-TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC-CEECC
T ss_pred CCCCHHHHHHhcCcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC-ceeec
Confidence 999999999865433 3899999999999999999999999999999999999999999999999999876432 22223
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....+++.|+|||.+ ....++.++||||||+++|||++ |+.||........ .+ .+....+...
T Consensus 377 ~~~~~~~~y~aPE~~-~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~--~~-------------~~~~~~~~~~ 440 (495)
T 1opk_A 377 AGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YE-------------LLEKDYRMER 440 (495)
T ss_dssp TTCCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HH-------------HHHTTCCCCC
T ss_pred CCCcCCcceeCHhHH-hcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH--HH-------------HHHcCCCCCC
Confidence 345567889999998 55678999999999999999999 9999976543311 11 1222334445
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 961 (967)
+..++.++.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~ 481 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSC
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccc
Confidence 66778889999999999999999999999999999876544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=364.72 Aligned_cols=266 Identities=23% Similarity=0.347 Sum_probs=213.8
Q ss_pred hccCCCCccCCCCceEEEEEEe------CCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCce
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 754 (967)
+.|+..+.||+|+||.||+|.. .++..||||++.........+.+.+|+++++++ +||||+++++++...+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 4568888999999999999995 245689999997654444557899999999999 899999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEE
Q 002094 755 LLIYEFISSGSLYKHLHDGSSR--------------------NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVL 814 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~--------------------~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nil 814 (967)
++||||+++|+|.+++...... ..+++..++.++.||+.||+|||++||+||||||+||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 204 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence 9999999999999999865431 23789999999999999999999999999999999999
Q ss_pred eCCCCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchH
Q 002094 815 IDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVV 893 (967)
Q Consensus 815 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~ 893 (967)
++.++.+||+|||++................+|+.|+|||.+ ....++.++||||||+++|||++ |+.||........
T Consensus 205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 283 (344)
T 1rjb_A 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283 (344)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh-ccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence 999999999999999876543333344456678899999988 55678999999999999999998 9999976543322
Q ss_pred hHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 894 VLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
....+. .......+...+.++.+++.+|++.||++|||+.|+++.|+.+.....+
T Consensus 284 -~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 284 -FYKLIQ-------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp -HHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred -HHHHHh-------------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 111121 1122334556677899999999999999999999999999998876544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=363.56 Aligned_cols=276 Identities=26% Similarity=0.388 Sum_probs=218.2
Q ss_pred ccCCCCccCCCCceEEEEEEeC-----CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--Ccee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-----DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP--SLQL 755 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 755 (967)
.|+..+.||+|+||.||++.++ +++.||||++.........+.+.+|++++++++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3578889999999999998743 68899999998765455567899999999999999999999999874 5678
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+||||+++|+|.+++.... +++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 112 lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 9999999999999997643 789999999999999999999999999999999999999999999999999877543
Q ss_pred ccc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 836 DRC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 836 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
... .......+++.|+|||.+ ....++.++||||+|+++|||++|+.||............+...........+..+.
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECL-KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred ccccccccCCCCCceeeChHHh-cCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 221 223345678889999998 566788999999999999999999999964322211111110011111112233333
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCc
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQ 963 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~ 963 (967)
......+...+.++.+++.+|++.||++|||++|+++.|+.+.+.+.++
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 3444556777888999999999999999999999999999987665543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=361.58 Aligned_cols=273 Identities=24% Similarity=0.365 Sum_probs=210.4
Q ss_pred hccCCCCccCCCCceEEEEEEe-----CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--Cce
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP--SLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 754 (967)
+.|+..+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 4568888999999999999984 368899999997554 34457899999999999999999999998643 558
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 999999999999999987543 388999999999999999999999999999999999999999999999999987643
Q ss_pred Cccc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc----cCCch
Q 002094 835 LDRC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE----DGRVE 909 (967)
Q Consensus 835 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~ 909 (967)
.... .......++..|+|||.+ ....++.++||||+|+++|||++|..||.....+ .......... .....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp ---------CTTCGGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHh-cCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHHH
Confidence 2221 222344567789999998 5567899999999999999999999998643211 1111100000 00011
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 961 (967)
+......+...+..++.++.+++.+|++.||++|||++|+++.|+++++.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 1222223444566778889999999999999999999999999999987654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=357.26 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=218.6
Q ss_pred hccCCCCccCCCCceEEEEEEe------CCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCce
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 754 (967)
+.|+..+.||+|+||.||+|+. .+++.||||++.........+.+.+|+++++++ +||||+++++++..++..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 4567888999999999999984 346899999998765445567899999999999 999999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSR---------------NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG 819 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~---------------~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~ 819 (967)
++||||+++|+|.+++...... ..+++..++.++.|++.||+|||++||+||||||+||+++.++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 182 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence 9999999999999999865431 1389999999999999999999999999999999999999999
Q ss_pred CeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHH
Q 002094 820 EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDM 898 (967)
Q Consensus 820 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~ 898 (967)
.+||+|||++................+++.|+|||.+ ....++.++||||+|+++|||++ |+.||......... ...
T Consensus 183 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~ 260 (313)
T 1t46_A 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-YKM 260 (313)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-HHH
T ss_pred CEEEccccccccccccccceeccCCCCcceeeChHHh-cCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-HHH
Confidence 9999999999877554433344456678899999988 55678999999999999999999 99999765443221 111
Q ss_pred HHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 899 VRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
+. ...+...+...+..+.+++.+|++.||++|||++|+++.|+++.+.
T Consensus 261 ~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 261 IK-------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp HH-------------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hc-------------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11 1122233455677899999999999999999999999999987643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=376.41 Aligned_cols=262 Identities=29% Similarity=0.418 Sum_probs=211.5
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+.|+..+.||+|+||.||+|..+++..||||++.... ...++|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 3467788999999999999999888899999997654 346789999999999999999999999866 6789999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++|+|.+++...... .+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 261 ~~gsL~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~ 338 (452)
T 1fmk_A 261 SKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTAR 338 (452)
T ss_dssp TTCBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred cCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC-ceecc
Confidence 999999999753222 2889999999999999999999999999999999999999999999999999866432 12222
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....+++.|+|||.+ ....++.++||||||+++|||++ |+.||........ ... +....+...
T Consensus 339 ~~~~~~~~y~aPE~~-~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-----~~~----------i~~~~~~~~ 402 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQ----------VERGYRMPC 402 (452)
T ss_dssp ----CCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----HHH----------HHTTCCCCC
T ss_pred cCCcccccccCHhHH-hcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH-----HHH----------HHcCCCCCC
Confidence 345567889999988 55678999999999999999999 9999975543211 111 111223345
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCcc
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQE 964 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~ 964 (967)
+..++..+.+++.+||+.||++|||++++++.|+++....+++.
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 66778889999999999999999999999999999987665543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=367.38 Aligned_cols=346 Identities=25% Similarity=0.411 Sum_probs=157.6
Q ss_pred CCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccce
Q 002094 91 RLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLES 170 (967)
Q Consensus 91 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 170 (967)
.+++|+.|++++++++. +| .+..+++|++|+|++|.+++. |. +..+++|++|+|++|++++..+ ++.+++|++
T Consensus 44 ~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~-~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDI-TP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred HhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCc-hh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 34555666666665553 22 245555555555555555532 22 3455555555555555553322 445555555
Q ss_pred eeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEecccccc
Q 002094 171 VNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSL 250 (967)
Q Consensus 171 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 250 (967)
|+|++|++++..+ +..+++|++|+|++|.+++. + .++.+++|++|+++ |.+
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-------------------------~-~~~~l~~L~~L~l~-~~~ 167 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-------------------------S-ALSGLTSLQQLSFG-NQV 167 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-------------------------G-GGTTCTTCSEEEEE-ESC
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-------------------------h-hhccCCcccEeecC-Ccc
Confidence 5555555443321 44444444444444444432 1 24444444444443 223
Q ss_pred CCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhh
Q 002094 251 SGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESM 330 (967)
Q Consensus 251 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 330 (967)
.+.. .+.++++|+.|++++|.+++. ..+..+++|++|++++|++.+..| ++.+++|+.|++++|++++. ..+
T Consensus 168 ~~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l 239 (466)
T 1o6v_A 168 TDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTL 239 (466)
T ss_dssp CCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGG
T ss_pred cCch--hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhh
Confidence 2211 144445555555555554432 124444555555555555443322 34444555555555554432 234
Q ss_pred hcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCccccc
Q 002094 331 MNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLS 410 (967)
Q Consensus 331 ~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 410 (967)
..+++|+.|++++|++++..+ +..+++|+.|++++|++++..+ +.
T Consensus 240 ~~l~~L~~L~l~~n~l~~~~~------------------------------~~~l~~L~~L~l~~n~l~~~~~--~~--- 284 (466)
T 1o6v_A 240 ASLTNLTDLDLANNQISNLAP------------------------------LSGLTKLTELKLGANQISNISP--LA--- 284 (466)
T ss_dssp GGCTTCSEEECCSSCCCCCGG------------------------------GTTCTTCSEEECCSSCCCCCGG--GT---
T ss_pred hcCCCCCEEECCCCccccchh------------------------------hhcCCCCCEEECCCCccCcccc--cc---
Confidence 444445555554444442111 0122344444444444443322 33
Q ss_pred ccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeecc
Q 002094 411 SLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILS 490 (967)
Q Consensus 411 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 490 (967)
.+++|+.|++++|++++..+ +..+++|+.|+|++|++++..| +..+++|+.|+++
T Consensus 285 ---------------------~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~ 339 (466)
T 1o6v_A 285 ---------------------GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339 (466)
T ss_dssp ---------------------TCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECC
T ss_pred ---------------------CCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECC
Confidence 33444444444444443222 3444444555555554444333 4445555555555
Q ss_pred CCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccc
Q 002094 491 QNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHG 544 (967)
Q Consensus 491 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 544 (967)
+|++++. ..+.++++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 340 ~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 340 NNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp SSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred CCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 5555433 234555555555555555554444 4455555555555555554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=358.79 Aligned_cols=271 Identities=26% Similarity=0.354 Sum_probs=211.5
Q ss_pred hccCCCCccCCCCceEEEEEEe-----CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--Cce
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP--SLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 754 (967)
..|+..+.||+|+||.||+|++ .+++.||||++.........+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4467888999999999999983 368999999998665555668899999999999999999999999876 667
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
++||||+++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 999999999999999965433 289999999999999999999999999999999999999999999999999987654
Q ss_pred Cccc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc---cCCchh
Q 002094 835 LDRC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE---DGRVED 910 (967)
Q Consensus 835 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 910 (967)
.... .......+|..|+|||.+ ....++.++||||+|+++|||++|+.|+...... .......... ......
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECL-MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---FLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSCCGGGHHHHHHH
T ss_pred CCcceeccCCCCCCccccCCeee-cCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---HhhccCCcccccCHHHHHH
Confidence 3221 233456678889999988 5567889999999999999999999987422110 0000000000 000111
Q ss_pred hcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 911 CVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 911 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
......+...+...+..+.+++.+|++.||++|||++|++++|+++.+
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 122222344566777889999999999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=360.43 Aligned_cols=263 Identities=27% Similarity=0.394 Sum_probs=216.1
Q ss_pred hccCCCCccCCCCceEEEEEEeC--------CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCC
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ--------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPS 752 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 752 (967)
+.|+..+.||+|+||.||+|... ++..||||++.........+.+.+|+++++++ +||||+++++++...+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 45688899999999999999863 46789999998765455567899999999999 8999999999999999
Q ss_pred ceeEEEEecCCCchhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC
Q 002094 753 LQLLIYEFISSGSLYKHLHDGSS-------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG 819 (967)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~ 819 (967)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 194 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 194 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence 99999999999999999986542 12388999999999999999999999999999999999999999
Q ss_pred CeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHH
Q 002094 820 EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDM 898 (967)
Q Consensus 820 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~ 898 (967)
.+||+|||++................+++.|+|||.+ ....++.++||||+|+++|||++ |+.||....... ....
T Consensus 195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~ 271 (334)
T 2pvf_A 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--LFKL 271 (334)
T ss_dssp CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHH
T ss_pred CEEEccccccccccccccccccCCCCcccceeChHHh-cCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--HHHH
Confidence 9999999999876543333334455677889999988 55678999999999999999999 999997543321 1111
Q ss_pred HHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 899 VRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
+. ...+...+...+.++.+++.+|++.||++|||+.|+++.|+++....
T Consensus 272 ~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 272 LK-------------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HH-------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred Hh-------------cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11 11122345566778999999999999999999999999999987543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=373.82 Aligned_cols=330 Identities=17% Similarity=0.147 Sum_probs=224.1
Q ss_pred cCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEcc
Q 002094 191 SLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLK 270 (967)
Q Consensus 191 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~ 270 (967)
+++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 112 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDIS 112 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECT
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECC
Confidence 44455555555544444445555555555555555554445555555555555555555554444445555555555555
Q ss_pred CCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCC
Q 002094 271 GNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNI 350 (967)
Q Consensus 271 ~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 350 (967)
+|++++..+..|..+++|++|+|++|++.+..+..|..+++|+.|+|++|++++..+..|.++++|+.|++++|.+
T Consensus 113 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i---- 188 (477)
T 2id5_A 113 ENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI---- 188 (477)
T ss_dssp TSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCC----
T ss_pred CCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcC----
Confidence 5555555555556666666666666666655555566666666666666666654444555555555555554444
Q ss_pred ChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCc
Q 002094 351 PTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASI 430 (967)
Q Consensus 351 p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 430 (967)
.+..+..|..+++|+.|++++|.+.+.+|..+
T Consensus 189 ------------------------------------------------~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~ 220 (477)
T 2id5_A 189 ------------------------------------------------NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNC 220 (477)
T ss_dssp ------------------------------------------------CEECTTCSCSCTTCCEEEEECCTTCCEECTTT
T ss_pred ------------------------------------------------cEeChhhcccCcccceeeCCCCccccccCccc
Confidence 44444455566666666666666666666666
Q ss_pred CCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccE
Q 002094 431 GKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKY 510 (967)
Q Consensus 431 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 510 (967)
....+|+.|+|++|++++..+..+..+++|++|+|++|.+++..+..|..+++|+.|+|++|++++..|..|.++++|++
T Consensus 221 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 300 (477)
T 2id5_A 221 LYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRV 300 (477)
T ss_dssp TTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCE
T ss_pred ccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCE
Confidence 66668888888888888555567888889999999999998878888899999999999999999888899999999999
Q ss_pred EeccCCccccCCchhhhhccCCceEEecCCcccccCCCCCCCCccCCCcccCCCCCCCcccc
Q 002094 511 VDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGSVVN 572 (967)
Q Consensus 511 L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~ 572 (967)
|+|++|+|++..+..|..+++|+.|+|++|+|.+.++..+++.+.....+.++...|..+..
T Consensus 301 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~ 362 (477)
T 2id5_A 301 LNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEF 362 (477)
T ss_dssp EECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESGG
T ss_pred EECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCchH
Confidence 99999999988888888999999999999999987775555555555667888888877653
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=366.56 Aligned_cols=345 Identities=24% Similarity=0.360 Sum_probs=223.5
Q ss_pred CCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeee
Q 002094 141 CGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIK 220 (967)
Q Consensus 141 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 220 (967)
+++|++|++++|.++. +| .+..+++|++|+|++|++++..+ +..+++|++|+|++|.+++..+ +.++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 4455555555555553 33 25555566666666665554332 5556666666666666554443 55566666666
Q ss_pred ccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccccccccccccc
Q 002094 221 LGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSG 300 (967)
Q Consensus 221 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 300 (967)
+++|++++..+ +..+++|++|++++|.+++. + .+..+++|+.|+++ |.+.+..+ +.++++|++|++++|.+.+
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~ 191 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD 191 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCC
Confidence 66666554322 56666666666666666642 2 35566666666664 33332221 4555555555555555442
Q ss_pred ccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccc
Q 002094 301 RIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFAS 380 (967)
Q Consensus 301 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 380 (967)
. ..+..+++|+.|++++|.+.+..| .
T Consensus 192 ~--------------------------~~l~~l~~L~~L~l~~n~l~~~~~-~--------------------------- 217 (466)
T 1o6v_A 192 I--------------------------SVLAKLTNLESLIATNNQISDITP-L--------------------------- 217 (466)
T ss_dssp C--------------------------GGGGGCTTCSEEECCSSCCCCCGG-G---------------------------
T ss_pred C--------------------------hhhccCCCCCEEEecCCccccccc-c---------------------------
Confidence 2 224445555555555555543222 0
Q ss_pred cccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCC
Q 002094 381 MKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSL 460 (967)
Q Consensus 381 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 460 (967)
..+++|+.|++++|++++. ..+..+++|+.|++++|.+.+..+ +..+++|+.|++++|++++..+ +..+++|
T Consensus 218 --~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L 289 (466)
T 1o6v_A 218 --GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTAL 289 (466)
T ss_dssp --GGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTC
T ss_pred --cccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCcc
Confidence 1123444444545444432 235556666666666666665444 7778889999999999986544 8899999
Q ss_pred CEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCC
Q 002094 461 KELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHN 540 (967)
Q Consensus 461 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N 540 (967)
+.|+|++|++++..+ ++.+++|+.|+|++|++++..| +..+++|++|++++|++++. ..+..+++|+.|++++|
T Consensus 290 ~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n 363 (466)
T 1o6v_A 290 TNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHN 363 (466)
T ss_dssp SEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSS
T ss_pred CeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCC
Confidence 999999999997655 8999999999999999998776 88999999999999999976 57899999999999999
Q ss_pred cccccCCCCCCCCccCCCcccCCCCCC
Q 002094 541 HLHGELPVGGFFNTISPSSVSGNPSLC 567 (967)
Q Consensus 541 ~l~~~~p~~~~~~~~~~~~~~~n~~lc 567 (967)
++++.+| ...+..+....+.+|++..
T Consensus 364 ~l~~~~~-~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 364 QISDLTP-LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CCCBCGG-GTTCTTCCEEECCCEEEEC
T ss_pred ccCccch-hhcCCCCCEEeccCCcccC
Confidence 9999888 3334556666677887654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=352.26 Aligned_cols=272 Identities=22% Similarity=0.280 Sum_probs=216.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC--ceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS--LQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 758 (967)
+.|...+.||+|+||.||+|+.. +++.||||++.........+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 45788899999999999999976 489999999986655556778899999999999999999999998655 678999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEe----CCCCCeEEeecccccccCC
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLI----DSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill----~~~~~~kl~Dfg~a~~~~~ 834 (967)
||+++++|.+++........+++..++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||+++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 999999999999876554458999999999999999999999999999999999999 7788899999999987643
Q ss_pred CccccccccccccccccCcccccC-------cccCCcccchhhHHHHHHHHHcCCCCCCCCccch---HhHHHHHHhhhc
Q 002094 835 LDRCILSSKIQSALGYMAPEFACR-------TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDV---VVLCDMVRGALE 904 (967)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~---~~~~~~~~~~~~ 904 (967)
.. ......||+.|+|||++.. ...++.++||||+|+++|||++|+.||....... .....+..+..
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p- 244 (319)
T 4euu_A 169 DE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP- 244 (319)
T ss_dssp TC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC-
T ss_pred CC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC-
Confidence 22 2334568999999998732 4678999999999999999999999997433322 22222222111
Q ss_pred cCCchhhc-----------chhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 905 DGRVEDCV-----------DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 905 ~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
...+.... +.......+...+..+.+++.+|++.||++|||++|+++...+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 00000000 001112345677888999999999999999999999999887654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=345.87 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=213.2
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+.|+..+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 3467788999999999999999889999999998654 34578999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||.+...... .....
T Consensus 86 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~ 162 (267)
T 3t9t_A 86 EHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSS 162 (267)
T ss_dssp TTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHST
T ss_pred CCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc-ccccc
Confidence 99999999986533 3789999999999999999999999999999999999999999999999999866431 22223
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....+++.|+|||.+ ....++.++||||+|+++|||++ |+.||....... ...... ...+...
T Consensus 163 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~i~----------~~~~~~~ 226 (267)
T 3t9t_A 163 TGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDIS----------TGFRLYK 226 (267)
T ss_dssp TSTTCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHH----------TTCCCCC
T ss_pred ccccccccccChhhh-cCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-----HHHHHh----------cCCcCCC
Confidence 345567889999998 55678999999999999999999 999997543321 111111 1112223
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
+...+..+.+++.+|++.||++|||++|+++.|+++.+
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 44556789999999999999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=349.19 Aligned_cols=257 Identities=26% Similarity=0.350 Sum_probs=200.3
Q ss_pred hccCCCCccCCCCceEEEEEEeCC----CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|+..+.||+|+||.||+|.... +..||+|++.........+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 456788899999999999999643 45799999876554455678999999999999999999999984 5678999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST- 170 (281)
T ss_dssp EECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc-
Confidence 999999999999986532 38999999999999999999999999999999999999999999999999998764322
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
........+++.|+|||.+ ....++.++||||+|+++|||++ |+.||........ ...+. ...
T Consensus 171 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~~i~-------------~~~ 234 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRIE-------------NGE 234 (281)
T ss_dssp --------CCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHH-------------TTC
T ss_pred ccccccCCCcccccChhhc-ccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HHHHH-------------cCC
Confidence 1222344567889999988 56678999999999999999997 9999975543321 11111 111
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
+...+...+..+.+++.+|++.||++|||+.|+++.|+++.+
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 235 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 223456677889999999999999999999999999998864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=359.75 Aligned_cols=257 Identities=29% Similarity=0.397 Sum_probs=206.9
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCc----EEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
.|+..+.||+|+||.||+|... +++ +||+|.+...........+.+|+.++++++||||+++++++. .+..++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 4677889999999999999964 344 388888765543344456889999999999999999999885 5668899
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++|+|.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp EECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999999999976532 388899999999999999999999999999999999999999999999999988765444
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
........+++.|+|||.+ ....++.++||||+|+++|||++ |+.||........ .+.+ ....
T Consensus 171 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~-------------~~~~ 234 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESI-HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--PDLL-------------EKGE 234 (325)
T ss_dssp CCC-----CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH--HHHH-------------HTTC
T ss_pred cccccCCCCcccccChHHh-ccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH--HHHH-------------HcCC
Confidence 4444566788899999998 56679999999999999999999 9999975443211 1111 1112
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
+...+..++.++.+++.+|++.||++|||++|+++.|+++..
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 233344556678899999999999999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=352.85 Aligned_cols=248 Identities=23% Similarity=0.294 Sum_probs=206.3
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||+|+.+ +|+.||+|++..... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 34678889999999999999965 689999999976431 234677899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.... ..
T Consensus 85 E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 159 (337)
T 1o6l_A 85 EYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred eCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CC
Confidence 99999999999976443 88999999999999999999999999999999999999999999999999975432 11
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......||+.|+|||++ ....++.++||||+||++|||++|+.||...... .....+... ..
T Consensus 160 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~~---------------~~ 222 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILME---------------EI 222 (337)
T ss_dssp CCBCCCEECGGGCCGGGG-SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHC---------------CC
T ss_pred CcccccccChhhCChhhh-cCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-HHHHHHHcC---------------CC
Confidence 223456799999999998 5667899999999999999999999999754322 111111110 12
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
.++...+.++.+++.+|++.||++|| +++|+++
T Consensus 223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 24556677899999999999999999 8998865
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=348.70 Aligned_cols=263 Identities=25% Similarity=0.448 Sum_probs=199.8
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|+.. ..||||++..... ....+.+.+|++++++++||||+++++++ .....++||||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 100 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 100 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred cceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence 45788889999999999999864 4699999976543 33457899999999999999999999965 55678999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++...........
T Consensus 101 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 101 CEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp CCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred cCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 999999999975433 389999999999999999999999999999999999999999999999999976644333333
Q ss_pred cccccccccccCccccc--CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 841 SSKIQSALGYMAPEFAC--RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~--~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.....||+.|+|||.+. ....++.++||||+|+++|||++|+.||.......... +.+........ ..
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~---------~~ 248 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-EMVGRGSLSPD---------LS 248 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH-HHHHHTSCCCC---------TT
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH-HHhcccccCcc---------hh
Confidence 44567899999999873 24567889999999999999999999997654433222 22211110000 11
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
.....++..+.+++.+|++.||++|||++|+++.|+++.++
T Consensus 249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e 289 (289)
T 3og7_A 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289 (289)
T ss_dssp SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence 12345667899999999999999999999999999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=356.91 Aligned_cols=263 Identities=25% Similarity=0.334 Sum_probs=198.0
Q ss_pred hccCCCCccCCCCceEEEEEEeCCC----cEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCce--
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDG----RSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQ-- 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-- 754 (967)
+.|+..+.||+|+||.||+|..... ..||||++..... ....+.+.+|++++++++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 3467888999999999999996543 2799999976532 34467899999999999999999999999877655
Q ss_pred ----eEEEEecCCCchhhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecc
Q 002094 755 ----LLIYEFISSGSLYKHLHDGSS---RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFG 827 (967)
Q Consensus 755 ----~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg 827 (967)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecc
Confidence 899999999999999964321 1148999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccC
Q 002094 828 LARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG 906 (967)
Q Consensus 828 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (967)
+++...............+++.|+|||.+ ....++.++||||+|+++|||++ |+.||........ ...+.
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~~~~------- 253 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESL-ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-YNYLI------- 253 (323)
T ss_dssp C-----------------CCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHH-------
T ss_pred ccccccccccccccccccCcccccCchhh-cCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-HHHHh-------
Confidence 99876543333334455677889999998 56678999999999999999999 9999975543321 11111
Q ss_pred CchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 907 RVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
.......+...+.++.+++.+|++.||++|||+.++++.|+++....
T Consensus 254 -------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 254 -------GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -------cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11122345566778999999999999999999999999999987543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=352.24 Aligned_cols=263 Identities=25% Similarity=0.329 Sum_probs=204.1
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||+||+|+..+|+.||||++..... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 45788899999999999999998899999999976543 23356789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++ +|.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...... ..
T Consensus 101 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~ 175 (311)
T 3niz_A 101 MEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--RS 175 (311)
T ss_dssp CSE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--C-
T ss_pred CCC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc--cc
Confidence 985 88888876443 38999999999999999999999999999999999999999999999999998764321 22
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcc---h---
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD---A--- 914 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--- 914 (967)
.....+|+.|+|||.+.....++.++||||+|+++|||++|+.||........ ...+.. ........++.. .
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~-~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFS-ILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHH-HHCCCCTTTSGGGTTSHHH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHH-HHCCCChHHhhhhhccchh
Confidence 33456899999999985556789999999999999999999999975544322 222221 111111111000 0
Q ss_pred ---hh-------cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 915 ---RL-------RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 915 ---~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.. .....+..+.++.+++.+|++.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 00012234567899999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=354.80 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=205.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCc----EEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLL 756 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 756 (967)
+.|+..+.||+|+||.||+|... +++ +||+|.+.........+.+.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 34678889999999999999954 344 368887766555566788999999999999999999999998754 789
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
|+||+++|+|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 94 v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 9999999999999987543 28999999999999999999999999999999999999999999999999998765433
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
.........+|+.|+|||.+ ....++.++||||+|+++|||++ |+.||........ ... +...
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~~-------------~~~~ 235 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSI-------------LEKG 235 (327)
T ss_dssp --------CCCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHH-------------HHTT
T ss_pred ccccccCCCccccccCHHHH-cCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HHH-------------HHcC
Confidence 33334455677889999998 56678999999999999999999 9999975543321 111 1222
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
.....+...+.++.+++.+|++.||++|||++|+++.|+++...
T Consensus 236 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 236 ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 23334566777899999999999999999999999999988753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=357.28 Aligned_cols=252 Identities=22% Similarity=0.340 Sum_probs=205.8
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-----ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCce
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-----KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 754 (967)
.+.|+..+.||+|+||.||+|+.+ +|+.||||.+...... ...+.+.+|+.++++++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 345788899999999999999965 6899999999765432 2357899999999999999999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC----CeEEeeccccc
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG----EPKVGDFGLAR 830 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~----~~kl~Dfg~a~ 830 (967)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999997643 389999999999999999999999999999999999998776 79999999998
Q ss_pred ccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchh
Q 002094 831 LLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVED 910 (967)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (967)
..... .......||+.|+|||++ ....++.++||||+||++|+|++|..||...... ..+..+......
T Consensus 168 ~~~~~---~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~------ 236 (361)
T 2yab_A 168 EIEDG---VEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANITAVSYD------ 236 (361)
T ss_dssp ECCTT---CCCCCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTTCCC------
T ss_pred EcCCC---CccccCCCCccEECchHH-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCC------
Confidence 76432 223456799999999998 5667899999999999999999999999754332 222221111000
Q ss_pred hcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 911 CVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 911 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+.. ++...+..+.+++.+|+..||++|||++|+++
T Consensus 237 -~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 -FDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0001 11234567899999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=370.98 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=209.9
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC-ceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS-LQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|..+ ++.||||+++... ..+.|.+|++++++++||||+++++++.+.. ..++||||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 34577789999999999999986 7899999997653 4567999999999999999999999987665 78999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++|+|.++++..... .+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred cCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----
Confidence 9999999999865432 2789999999999999999999999999999999999999999999999999854321
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
.....+++.|+|||.+ ....++.++||||||+++|||++ |+.||........ . ..+....+..
T Consensus 343 ~~~~~~~~~y~aPE~~-~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~-------------~~i~~~~~~~ 406 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--V-------------PRVEKGYKMD 406 (450)
T ss_dssp ----CCCTTTSCHHHH-HSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--H-------------HHHHTTCCCC
T ss_pred ccCCCCCcceeCHHHh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H-------------HHHHcCCCCC
Confidence 1223567889999998 56679999999999999999998 9999975543221 1 1111223344
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
.+..++..+.++|.+||+.||++|||+.++++.|+++...
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 5677888999999999999999999999999999998743
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.22 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=216.6
Q ss_pred hccCCCCccCCCCceEEEEEEeCC-CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|.... +..||+|.+.... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 346778899999999999999764 8899999997544 4567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|.+++...... .+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||.+...... ....
T Consensus 91 ~~~~~L~~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~ 168 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTA 168 (288)
T ss_dssp CTTEEHHHHHHHCCTT-TSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS-SSEE
T ss_pred CCCCcHHHHHHhcccC-CccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC-cccc
Confidence 9999999999875443 3899999999999999999999999999999999999999999999999999876532 2233
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
.....+++.|+|||.+ ....++.++||||+|+++|+|++ |..||........ .+. .....+..
T Consensus 169 ~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--~~~-------------~~~~~~~~ 232 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YEL-------------LEKDYRME 232 (288)
T ss_dssp ETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHH-------------HHTTCCCC
T ss_pred ccCCccccCcCChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH-------------HhccCCCC
Confidence 3455677889999988 55678999999999999999999 9999975443211 111 11222334
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
.+...+..+.+++.+|++.||++|||++|+++.|+.+.++.
T Consensus 233 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 45667788999999999999999999999999999876543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.46 Aligned_cols=254 Identities=29% Similarity=0.542 Sum_probs=207.8
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccH------HHHHHHHHHHcCCCCCceeeeeeEEEcCCce
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQ------EDFEKEMKTLGKIRHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 754 (967)
+.|+..+.||+|+||.||+|+.. +++.||||++......... +.+.+|++++++++||||+++++++.++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 34677889999999999999964 7899999998665432221 67999999999999999999999986554
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCEEeCCCCC-----eEEeecc
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN--IIHYNLKSTNVLIDSSGE-----PKVGDFG 827 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~--ivH~Dik~~Nill~~~~~-----~kl~Dfg 827 (967)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||++| |+||||||+||+++.++. +||+|||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 799999999999998876543 3899999999999999999999999 999999999999988776 9999999
Q ss_pred cccccCCCccccccccccccccccCccccc-CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC
Q 002094 828 LARLLPMLDRCILSSKIQSALGYMAPEFAC-RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG 906 (967)
Q Consensus 828 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (967)
+++.... ......||+.|+|||.+. ....++.++||||+|+++|||++|+.||.............+.
T Consensus 175 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------ 243 (287)
T 4f0f_A 175 LSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR------ 243 (287)
T ss_dssp TCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH------
T ss_pred ccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh------
Confidence 9974432 233467899999999873 3445788999999999999999999999765544332222221
Q ss_pred CchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 907 RVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
........+...+..+.+++.+|++.||++|||++|+++.|+++
T Consensus 244 ------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 ------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 12223345667778899999999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=343.09 Aligned_cols=253 Identities=27% Similarity=0.397 Sum_probs=208.8
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--CceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP--SLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 759 (967)
.|+..+.||+|+||.||+|+.+ ++.||||++..... ....+.+.+|++++++++||||+++++++.++ +..++|||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 4677889999999999999986 89999999976543 34456799999999999999999999999877 77899999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN--IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~--ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|+++|+|.++++..... .+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++++|||++....
T Consensus 90 ~~~~~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~---- 164 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---- 164 (271)
T ss_dssp CCTTCBHHHHHHSCSSC-CCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS----
T ss_pred ccCCCcHHHHHhhcccC-CCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec----
Confidence 99999999999875432 3899999999999999999999999 9999999999999999999999998875432
Q ss_pred ccccccccccccccCcccccCc--ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 838 CILSSKIQSALGYMAPEFACRT--VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~--~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
.....||+.|+|||.+... ..++.++||||+|+++|||++|+.||........ ... .....
T Consensus 165 ---~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~-------------~~~~~ 227 (271)
T 3kmu_A 165 ---SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMK-------------VALEG 227 (271)
T ss_dssp ---CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHH-------------HHHSC
T ss_pred ---ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHH-------------HHhcC
Confidence 2345678999999988432 2233489999999999999999999975543221 111 11112
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.+...+...+..+.+++.+|++.||++|||++|+++.|+++.+
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 2334556677889999999999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=360.92 Aligned_cols=262 Identities=26% Similarity=0.357 Sum_probs=202.0
Q ss_pred cCCCCccCCCCceEEEEEEeC--CC--cEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEc-CCceeEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ--DG--RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT-PSLQLLIY 758 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 758 (967)
|+..+.||+|+||.||+|... ++ ..||||.+.........+++.+|+.++++++||||+++++++.+ ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 456678999999999999854 22 46899998765544566889999999999999999999998754 46789999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++|+|.+++..... .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 171 e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp ECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred ECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999976443 2789999999999999999999999999999999999999999999999999865432211
Q ss_pred --cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 839 --ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 839 --~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
.......+++.|+|||.+ ....++.++||||||+++|||++ |.+||........ ...+. ..
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~~~~-------------~~ 312 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL-------------QG 312 (373)
T ss_dssp ---------CCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HHHHH-------------TT
T ss_pred cccccCCCCCcccccChHHh-cCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HHHHH-------------cC
Confidence 122345577889999998 56688999999999999999999 7888864433211 11111 11
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCc
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQ 963 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~ 963 (967)
.+...+..++..+.+++.+||+.||++|||++|+++.|+++...+.+.
T Consensus 313 ~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 122335566778999999999999999999999999999998776654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=347.64 Aligned_cols=248 Identities=21% Similarity=0.316 Sum_probs=204.4
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 455678999999999999976 79999999997654 3456789999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+++|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 126 ~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 199 (321)
T 2c30_A 126 GGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK 199 (321)
T ss_dssp SCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBC
T ss_pred CCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccc
Confidence 99999998653 28999999999999999999999999999999999999999999999999998664321 2234
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
...||+.|+|||.+ ....++.++||||+|+++|||++|+.||...... ... ..+... . .+ ....+.
T Consensus 200 ~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-~~~-~~~~~~---~------~~--~~~~~~ 265 (321)
T 2c30_A 200 SLVGTPYWMAPEVI-SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAM-KRLRDS---P------PP--KLKNSH 265 (321)
T ss_dssp CCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHH-HHHHHS---S------CC--CCTTGG
T ss_pred cccCCccccCHhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH-HHHhcC---C------CC--CcCccc
Confidence 56789999999998 5667899999999999999999999999754322 111 111110 0 00 011123
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..+..+.+++.+|++.||++|||++|+++.
T Consensus 266 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 266 KVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 456679999999999999999999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=348.48 Aligned_cols=264 Identities=26% Similarity=0.364 Sum_probs=210.2
Q ss_pred hccCCCCccCCCCceEEEEEEeCC----CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEE-cCCceeE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW-TPSLQLL 756 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~l 756 (967)
..|+..+.||+|+||.||+|+..+ ...||+|.+.........+.+.+|++++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 346777899999999999998543 23689999876554555678999999999999999999999864 4567899
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
||||+++|+|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 105 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EEECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EEeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 9999999999999976433 37899999999999999999999999999999999999999999999999998664322
Q ss_pred c--ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcc
Q 002094 837 R--CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913 (967)
Q Consensus 837 ~--~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (967)
. ........+|+.|+|||.+ ....++.++||||+|+++|||++ |.+||........ ...+.
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-~~~~~-------------- 246 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TVYLL-------------- 246 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-HHHHH--------------
T ss_pred hhccccccCCCCCccccChHHh-cCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-HHHHh--------------
Confidence 1 1223345677889999988 56678999999999999999999 6666654332211 11111
Q ss_pred hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCc
Q 002094 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQ 963 (967)
Q Consensus 914 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~ 963 (967)
.......+...+..+.+++.+|++.||++|||++|+++.|+++...+.+.
T Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 247 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 11122234556678999999999999999999999999999999877664
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.78 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=203.1
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||.||+|...+|+.||||++..... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 3677889999999999999998899999999976543 223467889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++ +|.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus 83 ~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 157 (288)
T 1ob3_A 83 DQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKY 157 (288)
T ss_dssp SE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred CC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--cccc
Confidence 86 99998876433 3889999999999999999999999999999999999999999999999999765421 1122
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc--------c
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV--------D 913 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 913 (967)
....+|+.|+|||.+.....++.++||||+|+++|||++|+.||...... .....+.+. ........+. +
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRI-LGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHH-HCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH-HCCCChhhchhhhcccccc
Confidence 34568999999999855567899999999999999999999999755432 222222221 1111100000 0
Q ss_pred hhhc-------CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 914 ARLR-------GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 914 ~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+... ..+....+.++.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 0112345677999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=354.59 Aligned_cols=267 Identities=27% Similarity=0.348 Sum_probs=217.5
Q ss_pred hhccCCCCccCCCCceEEEEEEe------CCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCC-
Q 002094 681 NALLNKDCELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPS- 752 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~- 752 (967)
.+.|+..+.||+|+||.||+|.. .+++.||||++.........+.+.+|+++++++ +||||+++++++..++
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 35578889999999999999984 356899999998765445567899999999999 7999999999987654
Q ss_pred ceeEEEEecCCCchhhhhhcCCCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC
Q 002094 753 LQLLIYEFISSGSLYKHLHDGSSR-------------NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG 819 (967)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~ 819 (967)
..++||||+++++|.+++...... ..+++..++.++.|++.||+|||++||+||||||+||+++.++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC
Confidence 489999999999999999875431 2278999999999999999999999999999999999999999
Q ss_pred CeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHH
Q 002094 820 EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDM 898 (967)
Q Consensus 820 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~ 898 (967)
.+||+|||+++...............+|+.|+|||.+ ....++.++||||+|+++|||++ |+.||............+
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 264 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhh-ccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHh
Confidence 9999999999876543333344556678899999988 56678999999999999999998 999997554432221111
Q ss_pred HHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 899 VRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
.. ......+...+..+.+++.+|++.||++|||+.|+++.|+.+.++-.+
T Consensus 265 ~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 314 (316)
T 2xir_A 265 KE--------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314 (316)
T ss_dssp HH--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred cc--------------CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcc
Confidence 11 112233455667899999999999999999999999999998765443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=359.89 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=215.2
Q ss_pred hccCCCCccCCCCceEEEEEEeCC------CcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCce
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 754 (967)
+.|+..+.||+|+||.||+|.... ...||+|.+.........+.+.+|+++++++ +||||+++++++..++..
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 446778899999999999999642 2479999998765445567899999999999 899999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEE
Q 002094 755 LLIYEFISSGSLYKHLHDGSS-----------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKV 823 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl 823 (967)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEB
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEE
Confidence 999999999999999975321 123789999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhh
Q 002094 824 GDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGA 902 (967)
Q Consensus 824 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 902 (967)
+|||++................+++.|+|||.+ ....++.++||||||+++|||++ |..||........ ....+.
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~-- 281 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKLVK-- 281 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HHHHHH--
T ss_pred CccccccccccccceeecCCCCCCccccCHHHh-ccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HHHHHh--
Confidence 999999866443333334456678899999988 55678999999999999999999 9999975443322 111111
Q ss_pred hccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 903 LEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
.......+...+..+.+++.+|++.||++|||++|+++.|+++.++
T Consensus 282 -----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 282 -----------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp -----------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1122233455667899999999999999999999999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=349.36 Aligned_cols=255 Identities=29% Similarity=0.500 Sum_probs=203.8
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.|+..+.||+|+||.||+|... ++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred HeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 4677889999999999999986 789999998643 34678999999999999999999999876 45799999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCCCCEEeCCCCC-eEEeecccccccCCCccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH---TNIIHYNLKSTNVLIDSSGE-PKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~---~~ivH~Dik~~Nill~~~~~-~kl~Dfg~a~~~~~~~~~ 838 (967)
+|+|.+++........+++..++.++.|+++||+|||+ +||+||||||+||+++.++. +||+|||++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~---- 158 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---- 158 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc----
Confidence 99999999876544347899999999999999999999 89999999999999998887 79999999975532
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
......||+.|+|||.+ ....++.++||||||+++|||++|+.||.............+. ...+.
T Consensus 159 -~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------------~~~~~ 223 (307)
T 2eva_A 159 -HMTNNKGSAAWMAPEVF-EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-------------NGTRP 223 (307)
T ss_dssp -------CCTTSSCHHHH-TCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-------------TTCCC
T ss_pred -ccccCCCCCceEChhhh-CCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-------------cCCCC
Confidence 12244689999999998 5667899999999999999999999999754433221111111 11122
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
..+...+..+.+++.+|++.||++|||++|+++.|+.+.+.+.+
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 33445667799999999999999999999999999998866544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=353.39 Aligned_cols=263 Identities=30% Similarity=0.465 Sum_probs=207.2
Q ss_pred ccCCCCccCCCCceEEEEEEeCC-----CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQD-----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
.|+..+.||+|+||.||+|.... +..||||.+...........+.+|++++++++||||+++++++...+..++|
T Consensus 45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 124 (333)
T 1mqb_A 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 124 (333)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence 34566889999999999998643 2469999998665445567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++|+|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 125 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 125 TEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp EECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 999999999999976433 389999999999999999999999999999999999999999999999999987643221
Q ss_pred c-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 838 C-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 838 ~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
. .......+++.|+|||.+ ....++.++||||+|+++|||++ |+.||....... ....+. ..
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~-------------~~ 266 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAIN-------------DG 266 (333)
T ss_dssp --------CCCGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH-------------TT
T ss_pred cccccCCCCccccccCchhc-ccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHH-------------CC
Confidence 1 112234457789999988 55678999999999999999999 999996543321 111111 11
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCc
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQ 963 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~ 963 (967)
.+...+...+..+.+++.+|++.||++||++.++++.|+++....+..
T Consensus 267 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 122335566778999999999999999999999999999987655443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=347.45 Aligned_cols=262 Identities=27% Similarity=0.413 Sum_probs=212.6
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+.|+..+.||+|+||.||+|..++++.||||.+.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 3467788999999999999999888899999997654 34678999999999999999999999986 45689999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++++|.+++...... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.+....... ....
T Consensus 90 ~~~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 167 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAR 167 (279)
T ss_dssp TTCBHHHHTTSHHHH-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECC
T ss_pred CCCCHHHHHhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cccc
Confidence 999999999753211 38899999999999999999999999999999999999999999999999998765422 2223
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....+++.|+|||.+ ....++.++||||+|+++|||++ |+.||....... ..... ....+...
T Consensus 168 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~~~----------~~~~~~~~ 231 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VIQNL----------ERGYRMVR 231 (279)
T ss_dssp TTCCCCTTTSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHH----------HTTCCCCC
T ss_pred cCCCCccCccChhhh-ccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-----HHHHH----------hcccCCCC
Confidence 345567889999988 55678999999999999999999 999997544321 11111 11112233
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCcc
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQE 964 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~ 964 (967)
+...+..+.+++.+|++.||++|||++++++.|+++.....++.
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 45667789999999999999999999999999999886655543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=348.15 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=211.7
Q ss_pred CCccCCCCceEEEEEEeC---CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 687 DCELGRGGFGVVYRTILQ---DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
.+.||+|+||.||+|+.. ++..||||++.........+.+.+|++++++++||||+++++++ ..+..++||||+++
T Consensus 15 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~ 93 (287)
T 1u59_A 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGG 93 (287)
T ss_dssp EEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred hccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence 348999999999999854 57889999998765455667899999999999999999999999 45668999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc-cccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-ILSS 842 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~ 842 (967)
++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++......... ....
T Consensus 94 ~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 171 (287)
T 1u59_A 94 GPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171 (287)
T ss_dssp EEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred CCHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence 999999975432 3899999999999999999999999999999999999999999999999999876432221 2223
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
...+++.|+|||.+ ....++.++||||+|+++|||++ |+.||....... ....+ ....+...+
T Consensus 172 ~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i-------------~~~~~~~~~ 235 (287)
T 1u59_A 172 AGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFI-------------EQGKRMECP 235 (287)
T ss_dssp SSCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHH-------------HTTCCCCCC
T ss_pred cccccccccCHHHh-ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHH-------------hcCCcCCCC
Confidence 44568899999988 55678999999999999999998 999997554321 11111 111223455
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCc
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQ 963 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~ 963 (967)
...+.++.+++.+|++.||++|||+.++++.|+++..+...+
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 667788999999999999999999999999999987654443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=355.24 Aligned_cols=263 Identities=24% Similarity=0.369 Sum_probs=214.7
Q ss_pred hhccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCce
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 754 (967)
.+.|+..+.||+|+||.||+|+.. +++.||||.+...........+.+|++++++++||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 345788899999999999999854 36889999998665445566799999999999999999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecc
Q 002094 755 LLIYEFISSGSLYKHLHDGS-------SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFG 827 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg 827 (967)
++||||+++|+|.+++.... ....+++..+++++.|++.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCc
Confidence 99999999999999997532 11237899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccC
Q 002094 828 LARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG 906 (967)
Q Consensus 828 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (967)
++................+++.|+|||.+ ....++.++||||+|+++|||++ |+.||....... .......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~~~~~-- 255 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-----VLRFVME-- 255 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-----HHHHHHT--
T ss_pred cccccccccccccccCCCCCCCccChhhh-ccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-----HHHHHHc--
Confidence 99866443322333445678889999988 55678999999999999999999 899997544321 1111111
Q ss_pred CchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 907 RVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
......+...+..+.+++.+|++.||++|||+.|+++.|+++...
T Consensus 256 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 256 --------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred --------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 111223456677899999999999999999999999999987653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=378.84 Aligned_cols=262 Identities=29% Similarity=0.418 Sum_probs=216.9
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+.|+..+.||+|+||.||+|.++++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 3467788999999999999999888899999998654 346789999999999999999999999866 6789999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++|+|.++++..... .+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 344 ~~gsL~~~l~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~ 421 (535)
T 2h8h_A 344 SKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTAR 421 (535)
T ss_dssp TTEEHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-HHHTT
T ss_pred cCCcHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC-ceecc
Confidence 999999999753222 2889999999999999999999999999999999999999999999999999866431 11222
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....++..|+|||.+ ....++.++||||||+++|||++ |+.||........ ... +....+...
T Consensus 422 ~~~~~~~~y~aPE~~-~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~-----~~~----------i~~~~~~~~ 485 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQ----------VERGYRMPC 485 (535)
T ss_dssp CSTTSCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH-----HHH----------HHTTCCCCC
T ss_pred cCCcCcccccCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHH----------HHcCCCCCC
Confidence 344567889999988 55678999999999999999999 9999975543211 111 111223344
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCcc
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQE 964 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~ 964 (967)
+..++..+.++|.+||+.||++|||+++++++|+++....+++.
T Consensus 486 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~ 529 (535)
T 2h8h_A 486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529 (535)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSS
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCccc
Confidence 56777889999999999999999999999999999987766653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=346.26 Aligned_cols=264 Identities=27% Similarity=0.359 Sum_probs=211.2
Q ss_pred cCCCCccCCCCceEEEEEEeCC----CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCce-eEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQD----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQ-LLIY 758 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv~ 758 (967)
|+..+.||+|+||.||+|...+ +..||+|.+.........+.+.+|++++++++||||+++++++.+++.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 4556889999999999998532 2379999997655445567899999999999999999999999766555 8999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc--
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD-- 836 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~-- 836 (967)
||+.+|+|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 103 e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp CCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred ecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 99999999999987433 37899999999999999999999999999999999999999999999999997654322
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.........+++.|+|||.. ....++.++||||+|+++|||++|..|+....... .....+. ...
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~-------------~~~ 245 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESL-QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DLTHFLA-------------QGR 245 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHH-TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GHHHHHH-------------TTC
T ss_pred ccccCcCCCCCccccChhhh-ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HHHHHhh-------------cCC
Confidence 11223355678899999998 66678999999999999999999555543222221 1111111 111
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCcc
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQE 964 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~ 964 (967)
....+...+..+.+++.+|++.||.+|||++++++.|+++.+++.+.+
T Consensus 246 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 223345566789999999999999999999999999999988776554
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=343.91 Aligned_cols=263 Identities=22% Similarity=0.263 Sum_probs=204.9
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|+..+.||+|+||+||+|... +++.||||++..... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 3677889999999999999965 689999999976543 23457789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++ ++.+.+..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus 83 ~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 157 (292)
T 3o0g_A 83 CDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRC 157 (292)
T ss_dssp CSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--CSC
T ss_pred CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--ccc
Confidence 986 55555554322 2899999999999999999999999999999999999999999999999999876432 223
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch------
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA------ 914 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 914 (967)
.....||+.|+|||.+.....++.++||||+|+++|||++|..||............+.... .......+...
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL-GTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH-CCCCTTTCTTGGGSTTC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh-CCCChhhhhhhcccccc
Confidence 34567899999999985555589999999999999999998888654444333333333221 11111110000
Q ss_pred ---------hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 915 ---------RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 915 ---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..........+..+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0011122345678999999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.04 Aligned_cols=262 Identities=26% Similarity=0.349 Sum_probs=199.9
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcC--CCCCceeeeeeEEEc----CCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGK--IRHHNLVALEGYYWT----PSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~----~~~~~ 755 (967)
+.|+..+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++.. ....+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 4578889999999999999988 5899999998653 34455566666554 799999999998654 34578
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCcccCCCCCCCEEeCCCCCeEEeecc
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH--------HTNIIHYNLKSTNVLIDSSGEPKVGDFG 827 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH--------~~~ivH~Dik~~Nill~~~~~~kl~Dfg 827 (967)
+||||+++|+|.++++.. .+++..+++++.|++.||+||| +++|+||||||+||+++.++.+||+|||
T Consensus 83 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 999999999999999643 3899999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCcccc--ccccccccccccCcccccCcc-----cCCcccchhhHHHHHHHHHcC----------CCCCCCCcc
Q 002094 828 LARLLPMLDRCI--LSSKIQSALGYMAPEFACRTV-----KITEKCDVYGFGVLVLEVVTG----------KRPVEYMED 890 (967)
Q Consensus 828 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-----~~t~~~Dv~slGvll~elltg----------~~p~~~~~~ 890 (967)
+++......... ......||+.|+|||.+.... .++.++||||||+++|||++| +.||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 997654322211 123457899999999884332 455799999999999999999 888864333
Q ss_pred chHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 891 DVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
.......+.............. ....+...+..+.+++.+|++.||++|||++|+++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcchhhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2222222222111111000000 0012234678899999999999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.12 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=204.6
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 34678889999999999999965 58899999987543 4456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC--CCCeEEeecccccccCCCccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS--SGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
+++|+|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-- 158 (321)
T 1tki_A 83 ISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence 999999999976432 3899999999999999999999999999999999999987 7899999999998764322
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
......||+.|+|||.+ ....++.++||||+|+++|+|++|+.||...... .....+...... .....
T Consensus 159 -~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~-------~~~~~-- 226 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVH-QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYT-------FDEEA-- 226 (321)
T ss_dssp -EEEEEESCGGGSCHHHH-TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCC-------CCHHH--
T ss_pred -ccccccCChhhcCcHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHcCCCC-------CChhh--
Confidence 23356789999999998 5557899999999999999999999999754332 222222211110 00000
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+.++.+++.+|++.||++|||+.|+++
T Consensus 227 --~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 --FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1234567999999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=358.42 Aligned_cols=277 Identities=26% Similarity=0.381 Sum_probs=213.7
Q ss_pred hccCCCCccCCCCceEEEEEEe-----CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEE--cCCce
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW--TPSLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~ 754 (967)
+.|+..+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++. .....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 3467788999999999999984 368899999997654 344567999999999999999999999887 45568
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
++||||+++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 899999999999999976432 289999999999999999999999999999999999999999999999999987654
Q ss_pred Cccc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcc
Q 002094 835 LDRC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913 (967)
Q Consensus 835 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (967)
.... .......+++.|+|||.+ ....++.++||||+|+++|+|++|+.||.....+..................+...
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESL-SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHh-ccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 2222 223345678889999988 55678999999999999999999999986432211100000000000001112223
Q ss_pred hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 914 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
...+...+...+..+.+++.+|++.||++|||++|+++.|+.+.....+
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 3334455677788899999999999999999999999999998765443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=360.78 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=205.2
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
.+.|+..+.||+|+||.||+|... +|+.||+|++..... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 345788899999999999999854 689999999976653 234567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC---CCCCeEEeecccccccCCC
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID---SSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~---~~~~~kl~Dfg~a~~~~~~ 835 (967)
||+++|+|.+.+..... +++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|||++......
T Consensus 90 E~~~gg~L~~~i~~~~~---~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 90 DLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCCBCCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999999999987543 89999999999999999999999999999999999998 4678999999999766432
Q ss_pred ccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 836 DRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
. .......||+.|+|||++ ....++.++||||+||++|+|++|++||...... .....+..+...
T Consensus 167 ~--~~~~~~~gt~~Y~APE~l-~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~----------- 231 (444)
T 3soa_A 167 Q--QAWFGFAGTPGYLSPEVL-RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-RLYQQIKAGAYD----------- 231 (444)
T ss_dssp C--CBCCCSCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCCC-----------
T ss_pred C--ceeecccCCcccCCHHHh-cCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCCC-----------
Confidence 2 223456799999999998 5667899999999999999999999999654322 222222211110
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.........+.++.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 011112345677999999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=352.39 Aligned_cols=247 Identities=20% Similarity=0.269 Sum_probs=202.9
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|...+.||+|+||.||+|.. .+++.||||++..... ......+.+|+++++.++||||+++++++..++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3468888999999999999996 5789999999975421 123457899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+ +|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--- 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--- 161 (336)
T ss_dssp CCC-CEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS---
T ss_pred ECC-CCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC---
Confidence 999 6789998876443 899999999999999999999999999999999999999999999999999866432
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......||+.|+|||.+......+.++||||+|+++|+|++|+.||+...... ....+. ....
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---------------~~~~i~-~~~~ 225 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---------------LFKKVN-SCVY 225 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---------------CBCCCC-SSCC
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---------------HHHHHH-cCCC
Confidence 223455689999999998544445789999999999999999999997432210 000000 0112
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+...+..+.+++.+|++.||.+|||++|+++
T Consensus 226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 345566778999999999999999999999976
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.81 Aligned_cols=265 Identities=22% Similarity=0.301 Sum_probs=195.1
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|..+ +|+.||||++.........+.+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 34688899999999999999964 68999999997665444557789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 761 ISSGSLYKHLHDGS---SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 761 ~~~gsL~~~l~~~~---~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
++ |+|.+++.... ....+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 162 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV- 162 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC-
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc-
Confidence 98 59999886532 11238899999999999999999999999999999999999999999999999998664321
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC---chhhc--
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR---VEDCV-- 912 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-- 912 (967)
.......+|+.|+|||.+.....++.++||||+||++|||++|+.||...... .....+... ..... .....
T Consensus 163 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~-~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 163 -NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDI-MGTPNESLWPSVTKL 239 (317)
T ss_dssp -CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHH-HCSCCTTTCGGGGGC
T ss_pred -ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHH-hCCCChhHhhhhhhh
Confidence 12334568999999999855567899999999999999999999999755432 222222221 11110 00000
Q ss_pred ---------------chhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 913 ---------------DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 913 ---------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+....+...+.++.+++.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000011112234567999999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=350.74 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=205.1
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-----ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-----KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
+.|+..+.||+|+||.||+|... +|+.||||.+...... ...+.+.+|++++++++||||+++++++..+...+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45788899999999999999965 5899999999765421 24678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC----CeEEeecccccc
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG----EPKVGDFGLARL 831 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~----~~kl~Dfg~a~~ 831 (967)
+||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999997643 389999999999999999999999999999999999998877 899999999987
Q ss_pred cCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (967)
..... ......||+.|+|||++ ....++.++||||+|+++|+|++|+.||...... .....+...... .
T Consensus 168 ~~~~~---~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~---~--- 236 (326)
T 2y0a_A 168 IDFGN---EFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVSAVNYE---F--- 236 (326)
T ss_dssp CCTTS---CCCCCCSCTTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHTCCC---C---
T ss_pred CCCCC---ccccccCCcCcCCceee-cCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHHhcCCC---c---
Confidence 64322 23356789999999998 6667899999999999999999999999654322 111111111000 0
Q ss_pred cchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 912 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.. ......+..+.+++.+|++.||++|||++|+++
T Consensus 237 -~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 237 -ED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -CH----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -Cc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 011234567899999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.23 Aligned_cols=250 Identities=30% Similarity=0.452 Sum_probs=196.5
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc---cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL---IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||+|... ++.||||++..... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 4677889999999999999985 89999999875432 2335789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCCCCEEeCC--------CCCeEEeeccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN---IIHYNLKSTNVLIDS--------SGEPKVGDFGL 828 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~---ivH~Dik~~Nill~~--------~~~~kl~Dfg~ 828 (967)
|+++++|.+++... .+++..++.++.|++.||+|||++| |+||||||+||+++. ++.+||+|||.
T Consensus 87 ~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 87 FARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp CCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred cCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999998643 3889999999999999999999998 899999999999986 67899999999
Q ss_pred ccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc
Q 002094 829 ARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV 908 (967)
Q Consensus 829 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 908 (967)
+...... ......|++.|+|||.+ ....++.++||||+|+++|||++|+.||......... ..
T Consensus 163 ~~~~~~~----~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~----------- 225 (271)
T 3dtc_A 163 AREWHRT----TKMSAAGAYAWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA-YG----------- 225 (271)
T ss_dssp -----------------CCGGGSCHHHH-HHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-HH-----------
T ss_pred ccccccc----cccCCCCccceeCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-Hh-----------
Confidence 9765432 12245689999999988 5667899999999999999999999999755432211 11
Q ss_pred hhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
..........+...+..+.+++.+|++.||++|||++|+++.|+++
T Consensus 226 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 226 --VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111222334566677899999999999999999999999999864
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=354.72 Aligned_cols=335 Identities=17% Similarity=0.179 Sum_probs=191.8
Q ss_pred CCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEe
Q 002094 117 GTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLD 196 (967)
Q Consensus 117 ~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 196 (967)
++|+.|++++|.++ .+|..+|..+++|++|+|++|++++..+..|+.+++|++|+|++|++++..|..|..+++|++|+
T Consensus 45 ~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp CCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 34444444444444 45555566666666666666666655555666666666666666666655555566666666666
Q ss_pred ecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCC
Q 002094 197 LSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTG 276 (967)
Q Consensus 197 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 276 (967)
|++|.++..++..|.++++|++|++++|++++..+..|+.+++|++|++++|+++ +
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~------------------------~ 179 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT------------------------H 179 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS------------------------B
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC------------------------c
Confidence 6666665444444455555555555555555444444444444554444444444 2
Q ss_pred cCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhc
Q 002094 277 EVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFK 356 (967)
Q Consensus 277 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 356 (967)
. .+..+++|+.|++++|.+++. ...++|++|++++|+++.. |.
T Consensus 180 ~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-------------------------~~---- 222 (390)
T 3o6n_A 180 V---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-------------------------RG---- 222 (390)
T ss_dssp C---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-------------------------EC----
T ss_pred c---ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-------------------------cc----
Confidence 2 123334444444444444321 1112333333333333211 00
Q ss_pred ccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccc
Q 002094 357 MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAI 436 (967)
Q Consensus 357 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 436 (967)
...++|+.|++++|++++. .. +..+++|
T Consensus 223 --------------------------~~~~~L~~L~l~~n~l~~~--~~------------------------l~~l~~L 250 (390)
T 3o6n_A 223 --------------------------PVNVELTILKLQHNNLTDT--AW------------------------LLNYPGL 250 (390)
T ss_dssp --------------------------CCCSSCCEEECCSSCCCCC--GG------------------------GGGCTTC
T ss_pred --------------------------cccccccEEECCCCCCccc--HH------------------------HcCCCCc
Confidence 0113455555555555532 22 3344455
Q ss_pred cEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCC
Q 002094 437 QVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFN 516 (967)
Q Consensus 437 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 516 (967)
++|+|++|++++..|..+..+++|++|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|
T Consensus 251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N 328 (390)
T 3o6n_A 251 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 328 (390)
T ss_dssp SEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSS
T ss_pred cEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCC
Confidence 555555555555555666666666666666666663 4555567778888888888887 46666778888888888888
Q ss_pred ccccCCchhhhhccCCceEEecCCcccccCCCCCCCCccCCCcccCCCCCCCccc
Q 002094 517 DLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGSVV 571 (967)
Q Consensus 517 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~ 571 (967)
++++. | +..+++|+.|++++|++++.... ..+..+....+.+++..|.++.
T Consensus 329 ~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~~ 379 (390)
T 3o6n_A 329 SIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDY 379 (390)
T ss_dssp CCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTTC
T ss_pred cccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceecccc
Confidence 88754 2 56778888888888888875432 2344555666778888887543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=339.57 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=209.6
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|... +++.||||++.........+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 44688899999999999999975 68999999997665445567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||.+...........
T Consensus 87 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 87 CSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 99999999987543 389999999999999999999999999999999999999999999999999986643333233
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
.....|++.|+|||.+......+.++||||+|+++|||++|+.||............+..... ....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~ 230 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------------YLNP 230 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-------------TSTT
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-------------ccCc
Confidence 445678999999999844444578999999999999999999999865544333333322110 0111
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+..+.+++.+|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 2345667899999999999999999999876
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=354.14 Aligned_cols=253 Identities=21% Similarity=0.339 Sum_probs=201.8
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCC--CceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRH--HNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||++...+++.||||++..... ....+.+.+|++++++++| |||+++++++..+...++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 45788899999999999999988899999999976543 2345779999999999976 99999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
| +.+++|.+++..... +++.++..++.||+.||+|||++||+||||||+||+++ ++.+||+|||+++........
T Consensus 89 e-~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp C-CCSEEHHHHHHHSCC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred e-CCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 9 567899999987543 88999999999999999999999999999999999996 678999999999876543333
Q ss_pred cccccccccccccCcccccC----------cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc
Q 002094 839 ILSSKIQSALGYMAPEFACR----------TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV 908 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~----------~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 908 (967)
.......||+.|+|||++.. ...++.++||||+||++|||++|+.||...........
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------------ 231 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH------------ 231 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH------------
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHH------------
Confidence 33446679999999998732 25688999999999999999999999975443322221
Q ss_pred hhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
...+......++...+..+.+++.+|++.||++|||+.|+++.
T Consensus 232 -~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 232 -AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1222333344555566789999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=360.67 Aligned_cols=274 Identities=20% Similarity=0.236 Sum_probs=217.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC--ceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS--LQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 758 (967)
+.|...+.||+|+||.||+|+.. +|+.||||++.........+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 45788899999999999999976 489999999986655556778899999999999999999999998655 679999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEe----CCCCCeEEeecccccccCC
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLI----DSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill----~~~~~~kl~Dfg~a~~~~~ 834 (967)
||+++|+|.+++........+++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+|||+++....
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 999999999999875544458999999999999999999999999999999999999 7777899999999987643
Q ss_pred CccccccccccccccccCcccccC-------cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC
Q 002094 835 LDRCILSSKIQSALGYMAPEFACR-------TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR 907 (967)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (967)
. .......||+.|+|||++.. ...++.++||||||+++|||++|+.||......... .+.+........
T Consensus 169 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~-~~~~~~~~~~~p 244 (396)
T 4eut_A 169 D---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYKIITGKP 244 (396)
T ss_dssp G---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC-HHHHHHHHHSCC
T ss_pred C---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch-HHHHHHHhcCCC
Confidence 2 22335668999999998732 156788999999999999999999999743322111 112222221111
Q ss_pred c---hhhc-----------chhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 908 V---EDCV-----------DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 908 ~---~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
. .... +.......+...+..+.+++.+|++.||++|||++|+++.++++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0 0000 00111233467788899999999999999999999999999988754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=353.92 Aligned_cols=251 Identities=20% Similarity=0.316 Sum_probs=200.1
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC---------
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS--------- 752 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------- 752 (967)
.|+..+.||+|+||.||+|+.+ +|+.||||++.........+.+.+|++++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 4678899999999999999976 799999999987665556788999999999999999999999986543
Q ss_pred ------------------------------------------------ceeEEEEecCCCchhhhhhcCCCCCCCCHHHH
Q 002094 753 ------------------------------------------------LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQR 784 (967)
Q Consensus 753 ------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~ 784 (967)
..++||||+++++|.+++.........++..+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 166 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence 27899999999999999988766555778889
Q ss_pred HHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc----------cccccccccccccCcc
Q 002094 785 FNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC----------ILSSKIQSALGYMAPE 854 (967)
Q Consensus 785 ~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE 854 (967)
+.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++........ .......||+.|+|||
T Consensus 167 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 246 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246 (332)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred HHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence 999999999999999999999999999999999999999999999876543211 1233456899999999
Q ss_pred cccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHh
Q 002094 855 FACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLI 934 (967)
Q Consensus 855 ~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 934 (967)
.+ ....++.++||||+|+++|||++|..|+.. .. ...... ...... ......+..+.+++.+
T Consensus 247 ~~-~~~~~~~~~Di~slG~il~el~~~~~~~~~----~~---~~~~~~-~~~~~~---------~~~~~~~~~~~~li~~ 308 (332)
T 3qd2_B 247 QI-HGNNYSHKVDIFSLGLILFELLYSFSTQME----RV---RIITDV-RNLKFP---------LLFTQKYPQEHMMVQD 308 (332)
T ss_dssp HH-HCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----HH---HHHHHH-HTTCCC---------HHHHHHCHHHHHHHHH
T ss_pred Hh-cCCCCcchhhHHHHHHHHHHHHHcCCChhH----HH---HHHHHh-hccCCC---------cccccCChhHHHHHHH
Confidence 98 556789999999999999999998877521 01 111111 000000 0112334567899999
Q ss_pred hccCCCCCCCCHHHHHH
Q 002094 935 CASQVPSNRPDMEEVVN 951 (967)
Q Consensus 935 cl~~dP~~Rpt~~evl~ 951 (967)
|++.||++|||++|+++
T Consensus 309 ~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 309 MLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHCSSGGGSCCHHHHHH
T ss_pred HccCCCCcCCCHHHHhh
Confidence 99999999999999876
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=378.76 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=205.9
Q ss_pred ccCCCCceEEEEEEeC---CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCc
Q 002094 689 ELGRGGFGVVYRTILQ---DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGS 765 (967)
Q Consensus 689 ~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 765 (967)
.||+|+||.||+|.++ ++..||||+++........+++.+|++++++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 4678999999876545567889999999999999999999999976 56899999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc-cccccc
Q 002094 766 LYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-ILSSKI 844 (967)
Q Consensus 766 L~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~ 844 (967)
|.+++..... .+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++........ ......
T Consensus 422 L~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 499 (613)
T 2ozo_A 422 LHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499 (613)
T ss_dssp HHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------------
T ss_pred HHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCC
Confidence 9999976432 3899999999999999999999999999999999999999999999999999876432221 112233
Q ss_pred cccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 845 QSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 845 ~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
.+++.|+|||++ ....++.++|||||||++|||++ |+.||........ .+ .+....+...+..
T Consensus 500 ~~~~~y~APE~~-~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--~~-------------~i~~~~~~~~p~~ 563 (613)
T 2ozo_A 500 KWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MA-------------FIEQGKRMECPPE 563 (613)
T ss_dssp --CCTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH--HH-------------HHHTTCCCCCCTT
T ss_pred CCccceeCHhhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HH-------------HHHcCCCCCCCCc
Confidence 456789999998 56689999999999999999998 9999986554321 11 1112223445677
Q ss_pred hHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 924 EAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
++.++.++|.+||+.||++|||+.++++.|+.+....
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 8889999999999999999999999999999875433
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=343.16 Aligned_cols=265 Identities=14% Similarity=0.144 Sum_probs=212.4
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|+..+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++++ +|++++++++++......++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 4478888999999999999995 578999999987544 234588899999999 79999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC-----eEEeecccccccCC
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE-----PKVGDFGLARLLPM 834 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~-----~kl~Dfg~a~~~~~ 834 (967)
|+ +++|.+++..... .+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 87 ~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred ec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 99 9999999986533 3899999999999999999999999999999999999987776 99999999987654
Q ss_pred Cccc-----cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccc--hHhHHHHHHhhhccCC
Q 002094 835 LDRC-----ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD--VVVLCDMVRGALEDGR 907 (967)
Q Consensus 835 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~ 907 (967)
.... .......||+.|+|||.+ ....++.++||||+|+++|||++|+.||...... ......+...... ..
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 241 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-TP 241 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-SC
T ss_pred ccccccccccCccCCCCCcccCCchhh-cCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC-cc
Confidence 2221 123456789999999998 6667899999999999999999999999854321 1111211111111 00
Q ss_pred chhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCc
Q 002094 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQ 963 (967)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~ 963 (967)
. .. .....+.++.+++.+|++.||++|||++++++.|+++.+.....
T Consensus 242 ~-----~~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 242 L-----RE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp H-----HH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred H-----HH----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 0 01 12245567999999999999999999999999999988665443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=352.82 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=205.8
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+++++.++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 34688899999999999999965 588999999975432 234578899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+.||+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVH---FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--- 168 (384)
T ss_dssp CCCTTEEHHHHHHTTCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT---
T ss_pred ecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC---
Confidence 99999999999986543 899999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccccCcccccC--cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 839 ILSSKIQSALGYMAPEFACR--TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~--~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.......||+.|+|||++.. ...++.++||||+||++|||++|+.||........ .+...... ..
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~~-----------~~ 235 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEIVHTFE-----------TT 235 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHHHHHHH-----------HC
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HHHHHHHh-----------hc
Confidence 23345679999999999843 34588999999999999999999999974322111 11111110 01
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCC-HHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPD-MEEVVN 951 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~evl~ 951 (967)
...++...+..+.+++.+|++.||++||+ ++++.+
T Consensus 236 ~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 22345666778999999999999999998 666543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=345.46 Aligned_cols=250 Identities=26% Similarity=0.311 Sum_probs=195.1
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-------------------------ccHHHHHHHHHHHcC
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-------------------------KSQEDFEKEMKTLGK 735 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-------------------------~~~~~~~~E~~~l~~ 735 (967)
+.|+..+.||+|+||.||+|+.. +++.||||++...... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 34688889999999999999964 6889999999754321 113568999999999
Q ss_pred CCCCceeeeeeEEEc--CCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCE
Q 002094 736 IRHHNLVALEGYYWT--PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNV 813 (967)
Q Consensus 736 l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Ni 813 (967)
++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999986 5678999999999999887543 2389999999999999999999999999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCccccccccccccccccCcccccCccc--CCcccchhhHHHHHHHHHcCCCCCCCCccc
Q 002094 814 LIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVK--ITEKCDVYGFGVLVLEVVTGKRPVEYMEDD 891 (967)
Q Consensus 814 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~t~~~Dv~slGvll~elltg~~p~~~~~~~ 891 (967)
+++.++.+||+|||++....... .......||+.|+|||.+..... .+.++||||+|+++|||++|+.||......
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 99999999999999998764322 22345678999999999843322 478899999999999999999999644321
Q ss_pred hHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 892 VVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
. ....+. . ...........+..+.+++.+|++.||++|||++|+++
T Consensus 247 -~-~~~~~~---~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 247 -C-LHSKIK---S---------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -H-HHHHHH---H---------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -H-HHHHHh---c---------ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 111111 0 01111112345677999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=355.12 Aligned_cols=243 Identities=23% Similarity=0.307 Sum_probs=198.6
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|+..+.||+|+||.||+|+.+ +++.||||++..... ....+.+.+|.++++.+ +||||+++++++.+++..++|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 45688899999999999999965 589999999976431 23456788999999988 799999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.... .
T Consensus 103 ~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~--~ 177 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--N 177 (353)
T ss_dssp EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--C
Confidence 999999999999976543 89999999999999999999999999999999999999999999999999975432 2
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
........||+.|+|||++ ....++.++||||+||++|||++|+.||...... .....+... .
T Consensus 178 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~---------------~ 240 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-DLFEAILND---------------E 240 (353)
T ss_dssp --------CCGGGCCHHHH-HHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHC---------------C
T ss_pred CccccccCCCcCeEChhhc-CCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-HHHHHHHcC---------------C
Confidence 2233456799999999988 5667899999999999999999999999754432 112211111 1
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDM 946 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 946 (967)
..++...+..+.+++.+|++.||++||++
T Consensus 241 ~~~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 241 VVYPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 23455566779999999999999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=348.76 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=200.6
Q ss_pred hccCCCCccCCCCceEEEEEEeC----CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCc---
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ----DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSL--- 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 753 (967)
+.|...+.||+|+||.||+|... .+..||||++..... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 45678889999999999999854 345899999976543 3345679999999999999999999999987553
Q ss_pred --eeEEEEecCCCchhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccc
Q 002094 754 --QLLIYEFISSGSLYKHLHDGS---SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGL 828 (967)
Q Consensus 754 --~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~ 828 (967)
.++||||+++++|.+++.... ....+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence 489999999999999985432 223489999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCC
Q 002094 829 ARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGR 907 (967)
Q Consensus 829 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (967)
+................+++.|+|||.+ ....++.++||||||+++|||++ |+.||........ ...+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~~------- 263 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--YDYLL------- 263 (313)
T ss_dssp C----------------CCGGGSCHHHH-HSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHHH-------
T ss_pred ceecccccccCcccccCCCccccCchhh-cCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHHH-------
Confidence 9876543333334455678899999998 56678999999999999999999 9999975443211 11111
Q ss_pred chhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
...+...+...+..+.+++.+|++.||++|||+.++++.|+++.+.+
T Consensus 264 ------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 264 ------HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ------TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ------cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11122345566778999999999999999999999999999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=345.84 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=205.1
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||+|+.+ +|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 4678889999999999999965 689999999976432 2345778899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 87 ~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----- 158 (318)
T 1fot_A 87 YIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 158 (318)
T ss_dssp CCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred CCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-----
Confidence 9999999999986543 88999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......||+.|+|||.+ ....++.++|+||+|+++|||++|+.||...... .....+... ...
T Consensus 159 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~---------------~~~ 221 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNA---------------ELR 221 (318)
T ss_dssp CBCCCCSCTTTCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHC---------------CCC
T ss_pred ccccccCCccccCHhHh-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhC---------------CCC
Confidence 12345789999999998 5667899999999999999999999999654322 111111111 112
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
++...+.++.+++.+|++.||++|| +++|+++
T Consensus 222 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 4555667899999999999999999 8888874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=353.28 Aligned_cols=252 Identities=22% Similarity=0.345 Sum_probs=205.1
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|+..+.||+|+||.||+|..+ +|+.||+|++..... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45788899999999999999965 689999999976543 2345678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC---CCeEEeecccccccCCCc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS---GEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~---~~~kl~Dfg~a~~~~~~~ 836 (967)
|+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 109 ~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 109 LVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp CCCSCBHHHHHTTCSC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred cCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 9999999999876543 8999999999999999999999999999999999999865 45999999999866432
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.......||+.|+|||++ ....++.++||||+||++|+|++|+.||...... .....+..+... .
T Consensus 185 --~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~-----------~ 249 (362)
T 2bdw_A 185 --EAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYD-----------Y 249 (362)
T ss_dssp --CSCCCSCSCTTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCC-----------C
T ss_pred --cccccCCCCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCC-----------C
Confidence 223356789999999998 5667899999999999999999999999654322 111111111110 0
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
........+.++.+++.+|++.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011123456779999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=343.90 Aligned_cols=257 Identities=26% Similarity=0.351 Sum_probs=207.0
Q ss_pred hccCCCCccCCCCceEEEEEEeCC----CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|...+.||+|+||.||+|+..+ +..||||.+.........+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence 346788899999999999998542 346999999876545567889999999999999999999999864 457899
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.+.......
T Consensus 91 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 167 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED- 167 (281)
T ss_dssp EECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred EecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc-
Confidence 999999999999976432 38899999999999999999999999999999999999999999999999998664322
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
........+++.|+|||.+ ....++.++||||+|+++|||++ |+.||........ ...+. ...
T Consensus 168 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--~~~~~-------------~~~ 231 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--IGVLE-------------KGD 231 (281)
T ss_dssp -----CCCCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--HHHHH-------------HTC
T ss_pred ccccccCCCCcceeCchhh-ccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--HHHHh-------------cCC
Confidence 2223345577889999988 56678999999999999999998 9999975443221 11111 111
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
....+...+..+.+++.+|++.||++|||+.|+++.|+++.+
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 232 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 223345566789999999999999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=352.24 Aligned_cols=249 Identities=22% Similarity=0.378 Sum_probs=190.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++..++..++||||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 45788899999999999999976 57899999997643 346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC---CCCeEEeecccccccCCCcc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS---SGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~---~~~~kl~Dfg~a~~~~~~~~ 837 (967)
+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++. ++.+||+|||+++....
T Consensus 130 ~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~--- 203 (349)
T 2w4o_A 130 VTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--- 203 (349)
T ss_dssp CCSCBHHHHHTTCSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc---
Confidence 999999999976443 899999999999999999999999999999999999975 88999999999986542
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
........||+.|+|||++ .+..++.++|||||||++|||++|+.||............+..... ...
T Consensus 204 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~-----------~~~ 271 (349)
T 2w4o_A 204 QVLMKTVCGTPGYCAPEIL-RGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY-----------YFI 271 (349)
T ss_dssp ---------CGGGSCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC-----------CCC
T ss_pred ccccccccCCCCccCHHHh-cCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC-----------ccC
Confidence 1223356789999999998 5667899999999999999999999999755443322222221110 011
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+.....+.++.+++.+|++.||++|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1223455677999999999999999999999886
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=355.53 Aligned_cols=249 Identities=21% Similarity=0.284 Sum_probs=200.2
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|+..+.||+|+||.||+|+.+ +++.||||+++.... ....+.+.+|..++.++ +|||||++++++.+++..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 34688899999999999999966 578999999976532 22234688899998877 899999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++|+|..++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.... .
T Consensus 132 ~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~ 206 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--P 206 (396)
T ss_dssp EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--T
T ss_pred EEcCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc--C
Confidence 999999999999986543 89999999999999999999999999999999999999999999999999975322 1
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccch---HhHHHHHHhhhccCCchhhcch
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDV---VVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
........||+.|+|||++ ....++.++||||+||++|||++|+.||....... ....+.+...+..
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l-~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--------- 276 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------- 276 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH---------
T ss_pred CCccccccCCcccCCchhh-cCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc---------
Confidence 2234456799999999998 56678999999999999999999999996432111 0001111111111
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCH
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDM 946 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 946 (967)
....+|...+.++.+++.+|++.||++||++
T Consensus 277 -~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 277 -KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -cccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1223566677889999999999999999996
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=358.33 Aligned_cols=356 Identities=19% Similarity=0.229 Sum_probs=302.6
Q ss_pred CCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceE
Q 002094 68 TKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147 (967)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L 147 (967)
-.+++.|++.++.+++. | .+..+++|++|+|++|++++. | ++.+++|++|+|++|++++ +| ++.+++|++|
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~---~~~l~~L~~L 111 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD---VTPLTKLTYL 111 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC---CTTCTTCCEE
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee---cCCCCcCCEE
Confidence 35789999999999985 4 799999999999999999985 3 9999999999999999996 44 6899999999
Q ss_pred eccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCcccc
Q 002094 148 SFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFS 227 (967)
Q Consensus 148 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 227 (967)
+|++|++++. | ++.+++|++|++++|++++. + ++.+++|++|++++|...+.+ .+..+++|++|++++|+++
T Consensus 112 ~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~ 183 (457)
T 3bz5_A 112 NCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT 183 (457)
T ss_dssp ECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccc
Confidence 9999999974 4 89999999999999999974 3 889999999999999655555 5889999999999999999
Q ss_pred ccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCC
Q 002094 228 GQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIG 307 (967)
Q Consensus 228 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 307 (967)
+ +| ++.+++|++|++++|++++. .+..+++|+.|++++|++++ +| +..+++|++|++++|++++.. ++
T Consensus 184 ~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~ 251 (457)
T 3bz5_A 184 E-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VS 251 (457)
T ss_dssp C-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CT
T ss_pred e-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HH
Confidence 7 44 88999999999999999975 48899999999999999997 45 889999999999999999753 56
Q ss_pred cccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCC
Q 002094 308 NLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQG 387 (967)
Q Consensus 308 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~ 387 (967)
.+++|+.|++++|+ |+.|++++|++.+.+|. ..+++
T Consensus 252 ~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~~------------------------------~~l~~ 287 (457)
T 3bz5_A 252 TLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQA------------------------------EGCRK 287 (457)
T ss_dssp TCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEEC------------------------------TTCTT
T ss_pred HCCCCCEEeccCCC--------------CCEEECCCCccCCcccc------------------------------ccccc
Confidence 78889999988764 56788899987765541 13467
Q ss_pred ccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCC
Q 002094 388 LQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEK 467 (967)
Q Consensus 388 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 467 (967)
|+.|++++|...+.+|. ..++|+.|++++| ++|++|++++|++++. .++.+++|+.|++++
T Consensus 288 L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~ 348 (457)
T 3bz5_A 288 IKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL---DVSHNTKLKSLSCVN 348 (457)
T ss_dssp CCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC---CCTTCTTCSEEECCS
T ss_pred CCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc---ccccCCcCcEEECCC
Confidence 88888888887777764 3456677776665 5789999999999974 388999999999999
Q ss_pred CCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhh
Q 002094 468 NFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELIN 528 (967)
Q Consensus 468 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 528 (967)
|+|++ ++.|..|++++|.++|. +.+..|..+++++|+++|.+|..+..
T Consensus 349 N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~ 396 (457)
T 3bz5_A 349 AHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLD 396 (457)
T ss_dssp SCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBC
T ss_pred CCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHhc
Confidence 99985 35678889999999975 46778899999999999999976543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=355.93 Aligned_cols=253 Identities=22% Similarity=0.339 Sum_probs=202.1
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCC--CCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIR--HHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 758 (967)
..|+..+.||+|+||.||++...+++.||||++..... ....+.+.+|++++++++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 34788899999999999999988899999999976543 334578999999999996 599999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
| +.+++|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||+++........
T Consensus 136 E-~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHHHCSS---CCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9 567899999987543 88999999999999999999999999999999999995 589999999999876543333
Q ss_pred cccccccccccccCcccccC----------cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc
Q 002094 839 ILSSKIQSALGYMAPEFACR----------TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV 908 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~----------~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 908 (967)
.......||+.|+|||++.. ...++.++|||||||++|||++|+.||.........+..
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~----------- 279 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA----------- 279 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH-----------
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHH-----------
Confidence 33445679999999998743 236889999999999999999999999754332222211
Q ss_pred hhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..+......++...+.++.+++.+|++.||++|||++|+++.
T Consensus 280 --~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 --IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 122222333444556779999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=355.48 Aligned_cols=272 Identities=15% Similarity=0.171 Sum_probs=208.0
Q ss_pred hccCCCCccCCCCceEEEEEEeCC------CcEEEEEEeecCCccc----------cHHHHHHHHHHHcCCCCCceeeee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD------GRSVAIKKLTVSGLIK----------SQEDFEKEMKTLGKIRHHNLVALE 745 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~ 745 (967)
+.|+..+.||+|+||.||+|..+. ++.||||++....... ....+..|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 457888999999999999999764 4789999987654210 012344566678888999999999
Q ss_pred eEEEcC----CceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC--CCC
Q 002094 746 GYYWTP----SLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID--SSG 819 (967)
Q Consensus 746 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~--~~~ 819 (967)
+++... ...++||||+ +++|.+++..... .+++..++.++.||+.||+|||++||+||||||+||+++ .++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 998764 4479999999 9999999987432 389999999999999999999999999999999999998 889
Q ss_pred CeEEeecccccccCCCcccc-----ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHh
Q 002094 820 EPKVGDFGLARLLPMLDRCI-----LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVV 894 (967)
Q Consensus 820 ~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~ 894 (967)
.+||+|||+++.+....... ......||+.|+|||.+ ....++.++|||||||++|||++|+.||.....+...
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH-NGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh-CCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 99999999998764322111 11344599999999998 5667899999999999999999999999853332221
Q ss_pred HHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 895 LCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
......... ..+.+..+..+. ....+.++.+++..|++.||++||++++++++|+++.+....
T Consensus 271 -~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 271 -VRDSKIRYR-ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp -HHHHHHHHH-HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -HHHHHHHhh-hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 111111111 122333333221 234566799999999999999999999999999988765443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=349.46 Aligned_cols=244 Identities=23% Similarity=0.305 Sum_probs=205.3
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||+|+.+ +|+.||||++..... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 4678889999999999999965 689999999975432 2345788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 122 ~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---- 194 (350)
T 1rdq_E 122 YVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred CCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC----
Confidence 9999999999986543 899999999999999999999999999999999999999999999999999866431
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
.....||+.|+|||.+ ....++.++||||+||++|||++|+.||...... .....+..+ ...
T Consensus 195 -~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~~---------------~~~ 256 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEII-LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSG---------------KVR 256 (350)
T ss_dssp -BCCCEECGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHC---------------CCC
T ss_pred -cccccCCccccCHHHh-cCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HHHHHHHcC---------------CCC
Confidence 2345789999999998 5567899999999999999999999999754322 212222211 122
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPD-----MEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~ 951 (967)
++...+.++.+++.+|++.||++||+ ++|+++
T Consensus 257 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 45566778999999999999999998 777764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=350.47 Aligned_cols=262 Identities=24% Similarity=0.369 Sum_probs=209.1
Q ss_pred hhccCCCCccCCCCceEEEEEEe------CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCce
Q 002094 681 NALLNKDCELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 754 (967)
.+.|+..+.||+|+||.||+|.. .+++.||||.+..........++.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 44578889999999999999983 357789999997655455667899999999999999999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCCC----CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC---CCCeEEeecc
Q 002094 755 LLIYEFISSGSLYKHLHDGSSR----NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS---SGEPKVGDFG 827 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~---~~~~kl~Dfg 827 (967)
++||||+++++|.+++...... ..+++..++.++.|++.||+|||++||+||||||+||+++. +..+||+|||
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence 9999999999999999865422 24889999999999999999999999999999999999984 4469999999
Q ss_pred cccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccC
Q 002094 828 LARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDG 906 (967)
Q Consensus 828 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (967)
++................+++.|+|||.+ ....++.++||||||+++|||++ |+.||....... ..+.+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~------ 259 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAF-MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFVT------ 259 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHH------
T ss_pred cccccccccccccCCCcCCCcceeCHhHh-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HHHHHh------
Confidence 99765433333334456678899999988 55678999999999999999998 999997543321 111111
Q ss_pred CchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 907 RVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.......+...+..+.+++.+|++.||++|||+.++++.|+.+..
T Consensus 260 -------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 260 -------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp -------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 111223345667789999999999999999999999999988764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=353.09 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=193.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 45788899999999999999966 78999999997654 2346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC--eEEeecccccccCCCccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE--PKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~--~kl~Dfg~a~~~~~~~~~ 838 (967)
+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++. +||+|||+++.... .
T Consensus 98 ~~~~~L~~~l~~~~~---~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~---~ 171 (361)
T 3uc3_A 98 ASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---H 171 (361)
T ss_dssp CCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc---c
Confidence 999999999976443 899999999999999999999999999999999999987665 99999999874322 1
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......||+.|+|||.+......+.++||||+||++|||++|+.||....... .....+..... .....
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~---------~~~~~ 241 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILS---------VKYSI 241 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHT---------TCCCC
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhc---------CCCCC
Confidence 223355689999999998444334455999999999999999999997543321 11122221111 11111
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
......+..+.+++.+|++.||++|||++|+++.
T Consensus 242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1122346779999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=348.19 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=208.2
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcE--EEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRS--VAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|+..+.||+|+||.||+|+.. ++.. ||||.+.........+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 44688889999999999999954 4554 4999987654445567799999999999 899999999999999999999
Q ss_pred EEecCCCchhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEe
Q 002094 758 YEFISSGSLYKHLHDGS-------------SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVG 824 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~ 824 (967)
|||+++++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEc
Confidence 99999999999998653 12348999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhh
Q 002094 825 DFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGAL 903 (967)
Q Consensus 825 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 903 (967)
|||+++.... ........+++.|+|||.+ ....++.++||||+|+++|||++ |+.||....... .....
T Consensus 185 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-----~~~~~- 254 (327)
T 1fvr_A 185 DFGLSRGQEV---YVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEKL- 254 (327)
T ss_dssp CTTCEESSCE---ECCC----CCTTTCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHG-
T ss_pred ccCcCccccc---cccccCCCCCccccChhhh-ccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-----HHHHh-
Confidence 9999874322 2223344567889999988 55678999999999999999998 999997544321 11111
Q ss_pred ccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 904 EDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
....+...+...+..+.+++.+|++.||++|||++|+++.|+++....
T Consensus 255 ---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 255 ---------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp ---------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---------hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 111223345566788999999999999999999999999999887544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.48 Aligned_cols=255 Identities=21% Similarity=0.361 Sum_probs=204.1
Q ss_pred hccCCCCccCCCCceEEEEEEeCC-C-------cEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCc
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD-G-------RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 753 (967)
+.|...+.||+|+||.||+|+... + ..||+|++.... ....+.+.+|++++++++||||+++++++.+++.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 456778899999999999998553 3 579999986544 3456789999999999999999999999999999
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC--------eEEee
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE--------PKVGD 825 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~--------~kl~D 825 (967)
.++||||+++|+|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999999999986533 3889999999999999999999999999999999999988876 99999
Q ss_pred cccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCC-CCCCCCccchHhHHHHHHhhhc
Q 002094 826 FGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK-RPVEYMEDDVVVLCDMVRGALE 904 (967)
Q Consensus 826 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 904 (967)
||.+..... .....+++.|+|||.+.....++.++||||+|+++|||++|. +||...... . .......
T Consensus 165 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-~-~~~~~~~--- 233 (289)
T 4fvq_A 165 PGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-R-KLQFYED--- 233 (289)
T ss_dssp CCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-H-HHHHHHT---
T ss_pred CcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-H-HHHHhhc---
Confidence 999875432 223457888999999855477899999999999999999955 454433221 1 1111110
Q ss_pred cCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 905 DGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
....+...+.++.+++.+|++.||++|||++|+++.|+++..+-..
T Consensus 234 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 234 ------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp ------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred ------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 1122333455688999999999999999999999999999876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=346.52 Aligned_cols=260 Identities=14% Similarity=0.137 Sum_probs=207.8
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|+..+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 3467888999999999999995 5789999999876542 23588999999999 99999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC-----eEEeecccccccCC
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE-----PKVGDFGLARLLPM 834 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~-----~kl~Dfg~a~~~~~ 834 (967)
|+ +++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred eC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 99 9999999986522 3899999999999999999999999999999999999998887 99999999987643
Q ss_pred Ccccc-----ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccch--HhHHHHHHhhhccCC
Q 002094 835 LDRCI-----LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDV--VVLCDMVRGALEDGR 907 (967)
Q Consensus 835 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~ 907 (967)
..... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||....... .....+........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 240 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTH-LGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP- 240 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-
T ss_pred CCCCccccccccCCcCCCccccChHHH-cCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-
Confidence 22211 12456799999999998 56678999999999999999999999998543221 11111111111000
Q ss_pred chhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
... .....+ ++.+++.+|++.||.+||+++++.+.|+++.+.
T Consensus 241 -----~~~----~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 241 -----IEV----LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp -----HHH----HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----HHH----HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 000 012234 799999999999999999999999999987644
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=351.20 Aligned_cols=254 Identities=23% Similarity=0.338 Sum_probs=203.2
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc----cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL----IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLL 756 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 756 (967)
+.|+..+.||+|+||.||+|..+ +++.||||++..... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 45788899999999999999965 689999999864321 2246789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC---eEEeeccccccc
Q 002094 757 IYEFISSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE---PKVGDFGLARLL 832 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~---~kl~Dfg~a~~~ 832 (967)
||||+++++|.+++.... ....+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 999999999988876432 2223789999999999999999999999999999999999986654 999999999876
Q ss_pred CCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc
Q 002094 833 PMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV 912 (967)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (967)
... ........||+.|+|||++ ....++.++||||+||++|||++|+.||..... .....+...... .
T Consensus 184 ~~~--~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~~~~-------~ 251 (351)
T 3c0i_A 184 GES--GLVAGGRVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYK-------M 251 (351)
T ss_dssp CTT--SCBCCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHTCCC-------C
T ss_pred cCC--CeeecCCcCCcCccCHHHH-cCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcCCCC-------C
Confidence 532 1223456799999999998 556789999999999999999999999975321 112222211100 0
Q ss_pred chhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 913 DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 913 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.... ....+.++.+++.+|++.||++|||+.|+++
T Consensus 252 ~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 NPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 1234567999999999999999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=351.30 Aligned_cols=251 Identities=21% Similarity=0.317 Sum_probs=205.3
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++.+....++||||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 45788899999999999999965 68999999997654 23456799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC--CCCeEEeecccccccCCCccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS--SGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
+++|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||++.......
T Consensus 130 ~~gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-- 205 (387)
T 1kob_A 130 LSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 205 (387)
T ss_dssp CCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred CCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc--
Confidence 999999999976432 3899999999999999999999999999999999999974 5789999999998764322
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
......||+.|+|||++ ....++.++||||+||++|||++|+.||...... .....+..... ....
T Consensus 206 -~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~-----------~~~~ 271 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDW-----------EFDE 271 (387)
T ss_dssp -CEEEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCC-----------CCCS
T ss_pred -ceeeeccCCCccCchhc-cCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC-----------CCCc
Confidence 22345689999999998 5667899999999999999999999999754332 11211111100 0111
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
......+.++.+++.+|++.||++|||++|+++
T Consensus 272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 223345677999999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=347.01 Aligned_cols=248 Identities=22% Similarity=0.283 Sum_probs=200.5
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 758 (967)
.|+..+.||+|+||.||+|+.+ +++.||+|++..... ....+.+.+|..+++++ +||||+++++++.+++..++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 3677889999999999999965 588999999976542 23356788999999887 8999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..... .
T Consensus 90 e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~--~ 164 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--G 164 (345)
T ss_dssp CCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT--T
T ss_pred eCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC--C
Confidence 99999999999976443 899999999999999999999999999999999999999999999999999754321 1
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchH---hHHHHHHhhhccCCchhhcchh
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVV---VLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
.......||+.|+|||.+ ....++.++||||+||++|||++|+.||........ .....+...+..
T Consensus 165 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~---------- 233 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------- 233 (345)
T ss_dssp CCBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH----------
T ss_pred CcccccCCCccccCcccc-CCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc----------
Confidence 223456799999999998 556789999999999999999999999964221100 000111111111
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDM 946 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 946 (967)
....++...+.++.+++.+|++.||++||++
T Consensus 234 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 234 KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1223456667789999999999999999996
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=355.30 Aligned_cols=269 Identities=16% Similarity=0.254 Sum_probs=204.9
Q ss_pred hccCCCCccCCC--CceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRG--GFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|+..+.||+| +||.||+|+.. +|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 457888999999 99999999976 699999999976543 23456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++|+|.+++....... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+........
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDG-MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTC-CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred EEccCCCCHHHHHhhhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 99999999999998754333 89999999999999999999999999999999999999999999999998865422111
Q ss_pred -----ccccccccccccccCcccccCc-ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhcc----C-
Q 002094 838 -----CILSSKIQSALGYMAPEFACRT-VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALED----G- 906 (967)
Q Consensus 838 -----~~~~~~~~gt~~y~aPE~~~~~-~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~- 906 (967)
........||+.|+|||.+... ..++.++||||+||++|||++|+.||........... ...+.... .
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-KLNGTVPCLLDTST 262 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH-C-------------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HhcCCCCccccccc
Confidence 1112234688899999998443 5789999999999999999999999975443322211 11110000 0
Q ss_pred -----------------Cchhhcc---------hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 907 -----------------RVEDCVD---------ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 907 -----------------~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
...+... ......++...+..+.+++.+|++.||++|||++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000000 000111234456679999999999999999999999853
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=340.89 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=205.0
Q ss_pred ccCCCC-ccCCCCceEEEEEEe---CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 683 LLNKDC-ELGRGGFGVVYRTIL---QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 683 ~~~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
.|+..+ .||+|+||.||+|.. .+++.||||++..... ....+++.+|++++++++||||+++++++ ..+..++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 345555 899999999999964 3468899999976543 23357899999999999999999999999 56678999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EECCTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEeCCCCCHHHHHHhCcC---CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 999999999999987543 88999999999999999999999999999999999999999999999999987644222
Q ss_pred c-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 838 C-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 838 ~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
. .......+++.|+|||.+ ....++.++||||+|+++|||++ |+.||....... ....+ ...
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~-------------~~~ 236 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAML-------------EKG 236 (291)
T ss_dssp EEEC----CCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH-------------HTT
T ss_pred cccccccCCCCceeeChHHh-ccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH-------------HcC
Confidence 1 112234467889999988 55678899999999999999999 999997554321 11111 111
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.+...+...+..+.+++.+|++.||++|||+.++++.|+++..
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 237 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1233456677889999999999999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=360.38 Aligned_cols=253 Identities=19% Similarity=0.229 Sum_probs=204.6
Q ss_pred hccCCCCccCCCCceEEEEEEeCC-CcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD-GRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||+||+|+.+. ++.||||++..... ......+.+|..++..++||||+++++++.+++..++||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 456888999999999999999764 78999999975321 112334889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 154 Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~~ 230 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GT 230 (437)
T ss_dssp CCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-SC
T ss_pred ecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-CC
Confidence 99999999999987432 3899999999999999999999999999999999999999999999999999766432 22
Q ss_pred cccccccccccccCccccc----CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 839 ILSSKIQSALGYMAPEFAC----RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~----~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
.......||+.|+|||++. ....++.++||||+||++|||++|+.||...... .....++...
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~------------ 297 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHK------------ 297 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHH------------
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhhcc------------
Confidence 2334567999999999984 1456899999999999999999999999754332 2222222111
Q ss_pred hhcCCCC---hhhHHHHHHHHHhhccCCCCC--CCCHHHHHH
Q 002094 915 RLRGNFP---ADEAIPVIKLGLICASQVPSN--RPDMEEVVN 951 (967)
Q Consensus 915 ~~~~~~~---~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~ 951 (967)
.+..+| ...+.++.+++.+|+..+|++ ||+++|+++
T Consensus 298 -~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 298 -ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp -HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred -ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 111122 335677999999999888888 999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=347.18 Aligned_cols=248 Identities=22% Similarity=0.311 Sum_probs=204.2
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|+..+.||+|+||.||+|+.+ +++.||||++..... ....+.+..|.+++..+ +||+|+++++++.+.+..++|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 44688889999999999999976 478999999976432 23456788999999988 899999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||++||+|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.... .
T Consensus 100 ~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~ 174 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--D 174 (353)
T ss_dssp EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--T
T ss_pred EeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc--C
Confidence 999999999999986443 89999999999999999999999999999999999999999999999999975422 1
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
........||+.|+|||++ ....++.++||||+||++|||++|+.||...... .....+... .
T Consensus 175 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~---------------~ 237 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEH---------------N 237 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHH-TTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHC---------------C
T ss_pred CcccccccCCccccChhhh-cCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-HHHHHHHhC---------------C
Confidence 2223456799999999998 5667899999999999999999999999754322 212111111 1
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPD-----MEEVVN 951 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~ 951 (967)
..++...+.++.+++.+|++.||++||+ ++|+++
T Consensus 238 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 2345566778999999999999999996 456543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=350.14 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=203.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|+..+.||+|+||.||+|+.+ +|+.||||++..... ....+.+..|.+++..+ +||||+++++++.+++..++|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 45688899999999999999975 589999999976432 23456788899998876 899999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||++||+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 171 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-- 171 (345)
T ss_dssp EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred EeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC--
Confidence 999999999999976443 899999999999999999999999999999999999999999999999999754321
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
........||+.|+|||.+ .+..++.++|+||+||++|||++|+.||...... .....+.. . .
T Consensus 172 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~-----~----------~ 234 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFHSIRM-----D----------N 234 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH-----C----------C
T ss_pred CCcccCCCCCcccCChhhh-cCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHHh-----C----------C
Confidence 1223456799999999998 5567899999999999999999999999754332 11111111 0 1
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHH-HHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDME-EVV 950 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-evl 950 (967)
..++...+.++.+++.+|++.||++||++. |++
T Consensus 235 ~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 234455667899999999999999999997 553
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=358.76 Aligned_cols=247 Identities=22% Similarity=0.342 Sum_probs=205.3
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|...+.||+|+||.||+|+.. +|+.||||++..... ......+.+|+++++.++||||+++++++..++..++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4677889999999999999965 799999999975432 2345679999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 97 ~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~---~ 170 (476)
T 2y94_A 97 YVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---E 170 (476)
T ss_dssp CCSSEEHHHHTTSSSS---CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT---C
T ss_pred CCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc---c
Confidence 9999999999976433 899999999999999999999999999999999999999999999999999876432 2
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......||+.|+|||.+......+.++||||+||++|||++|+.||+..... .....+..+ ...
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~---------------~~~ 234 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-TLFKKICDG---------------IFY 234 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-HHHHHHHTT---------------CCC
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-HHHHHHhcC---------------CcC
Confidence 2335578999999999854444578999999999999999999999754322 111111111 112
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+...+.++.+++.+|++.||++|||++|+++
T Consensus 235 ~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 34445677999999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=351.60 Aligned_cols=246 Identities=22% Similarity=0.309 Sum_probs=197.1
Q ss_pred CCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCc
Q 002094 687 DCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGS 765 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 765 (967)
.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 567999999999999964 68999999998654 2456789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEe--CCCCCeEEeecccccccCCCcccccccc
Q 002094 766 LYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLI--DSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 766 L~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
|.+++..... .+++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||+++...... ....
T Consensus 173 L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~ 247 (373)
T 2x4f_A 173 LFDRIIDESY--NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKV 247 (373)
T ss_dssp EHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCC
T ss_pred HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cccc
Confidence 9999875432 38899999999999999999999999999999999999 667899999999998764322 2334
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
..||+.|+|||++ ....++.++|||||||++|||++|+.||...... ..+..+....+. ........
T Consensus 248 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~-----------~~~~~~~~ 314 (373)
T 2x4f_A 248 NFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWD-----------LEDEEFQD 314 (373)
T ss_dssp CCSSCTTCCHHHH-TTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCC-----------SCSGGGTT
T ss_pred ccCCCcEeChhhc-cCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCC-----------CChhhhcc
Confidence 5689999999988 6667899999999999999999999999754432 222222221111 00011123
Q ss_pred hHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 924 EAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+.++.+++.+|++.||.+|||++|+++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 4567999999999999999999999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=344.47 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=195.0
Q ss_pred hccCCCCccCCCCceEEEEEEe----CCCcEEEEEEeecCCc---cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCce
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL----QDGRSVAIKKLTVSGL---IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 754 (967)
+.|+..+.||+|+||.||+++. .+++.||+|++..... ......+.+|++++++++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4478889999999999999996 4789999999976532 23345688999999999999999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
++||||+++++|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGI---FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 999999999999999976443 78999999999999999999999999999999999999999999999999875432
Q ss_pred CccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 835 LDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
. ........||+.|+|||.+ ....++.++||||+|+++|||++|+.||...... .....+...
T Consensus 174 ~--~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~------------- 236 (327)
T 3a62_A 174 D--GTVTHTFCGTIEYMAPEIL-MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-KTIDKILKC------------- 236 (327)
T ss_dssp -------CTTSSCCTTSCHHHH-TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHT-------------
T ss_pred C--CccccccCCCcCccCHhhC-cCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhC-------------
Confidence 1 1223356789999999998 5567899999999999999999999999754332 111111111
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
...++...+.++.+++.+|++.||++|| ++.|+++
T Consensus 237 --~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 --KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1224455677899999999999999999 6777764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=357.76 Aligned_cols=254 Identities=18% Similarity=0.193 Sum_probs=204.1
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||+|+.+ +++.||+|++..... ....+.+.+|+.+++.++|||||++++++.+++..++||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 45688899999999999999976 588999999975321 122345889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||++||+|.+++.... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...... .
T Consensus 149 E~~~gg~L~~~l~~~~----~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~ 223 (410)
T 3v8s_A 149 EYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-M 223 (410)
T ss_dssp CCCTTEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-E
T ss_pred eCCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-c
Confidence 9999999999997642 7899999999999999999999999999999999999999999999999998764322 2
Q ss_pred cccccccccccccCcccccCcc---cCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 839 ILSSKIQSALGYMAPEFACRTV---KITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~---~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
.......||+.|+|||++.... .++.++||||+||++|||++|+.||...... .....++.... .
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~-----------~ 291 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHKN-----------S 291 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHH-----------H
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-hHHHHHHhccc-----------c
Confidence 2234567999999999884332 2788999999999999999999999744322 22222221110 0
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCC--CCCHHHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSN--RPDMEEVVNI 952 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~~ 952 (967)
...+.....+.++.+++.+|++.+|.+ ||+++|+++.
T Consensus 292 ~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 292 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111112345677999999999999988 9999998863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.90 Aligned_cols=265 Identities=18% Similarity=0.222 Sum_probs=202.3
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc--ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI--KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||+|... +++.||+|++...... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 45788899999999999999965 6889999999765322 23477999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 114 e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~ 189 (309)
T 2h34_A 114 RLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK-L 189 (309)
T ss_dssp ECCCCEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc-c
Confidence 99999999999986533 8999999999999999999999999999999999999999999999999987654321 1
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......|++.|+|||.+ ....++.++||||+|+++|||++|+.||...... .....+.... . . ..
T Consensus 190 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~----~----~---~~ 255 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERF-SESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAI----P----R---PS 255 (309)
T ss_dssp -------CCGGGCCGGGT-CC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCC----C----C---GG
T ss_pred ccccccCCCcCccCHHHH-cCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCC----C----C---cc
Confidence 223355689999999998 5667899999999999999999999999754322 1111111100 0 0 11
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCC-CHHHHHHHHHhhcCCCCCcc
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRP-DMEEVVNILELIQSPLDGQE 964 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~evl~~L~~~~~~~~~~~ 964 (967)
..+...+..+.+++.+|++.||++|| |++++++.|+++....++.+
T Consensus 256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------
T ss_pred ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 12344566799999999999999999 99999999999887665543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=369.18 Aligned_cols=334 Identities=17% Similarity=0.188 Sum_probs=199.8
Q ss_pred CCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEe
Q 002094 117 GTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLD 196 (967)
Q Consensus 117 ~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 196 (967)
.+++.|++++|.+. .+|..+|..+++|++|+|++|++++..|..|+.+++|++|+|++|+|++..|..|+.+++|++|+
T Consensus 51 ~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp CCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 34455555555554 45555566666666666666666666666666666666666666666665555566666666666
Q ss_pred ecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCC
Q 002094 197 LSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTG 276 (967)
Q Consensus 197 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 276 (967)
|++|.+++.++..|+++++|++|+|++|.+++..|..|+++++|++|++++|.++ +
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~------------------------~ 185 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT------------------------H 185 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCS------------------------B
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCC------------------------C
Confidence 6666666544444555555555555555555444444444445554444444444 2
Q ss_pred cCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhc
Q 002094 277 EVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFK 356 (967)
Q Consensus 277 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 356 (967)
.. +..+++|+.|++++|.+++. ...++ |+.|++++|.+.. ++.
T Consensus 186 ~~---~~~l~~L~~L~l~~n~l~~l-----~~~~~------------------------L~~L~ls~n~l~~-~~~---- 228 (597)
T 3oja_B 186 VD---LSLIPSLFHANVSYNLLSTL-----AIPIA------------------------VEELDASHNSINV-VRG---- 228 (597)
T ss_dssp CC---GGGCTTCSEEECCSSCCSEE-----ECCTT------------------------CSEEECCSSCCCE-EEC----
T ss_pred cC---hhhhhhhhhhhcccCccccc-----cCCch------------------------hheeeccCCcccc-ccc----
Confidence 21 23334444444444444321 11122 3333333333321 000
Q ss_pred ccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccc
Q 002094 357 MGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAI 436 (967)
Q Consensus 357 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 436 (967)
...++|+.|+|++|.+++. ..+..+++|
T Consensus 229 --------------------------~~~~~L~~L~L~~n~l~~~--------------------------~~l~~l~~L 256 (597)
T 3oja_B 229 --------------------------PVNVELTILKLQHNNLTDT--------------------------AWLLNYPGL 256 (597)
T ss_dssp --------------------------SCCSCCCEEECCSSCCCCC--------------------------GGGGGCTTC
T ss_pred --------------------------ccCCCCCEEECCCCCCCCC--------------------------hhhccCCCC
Confidence 0012455555555555431 234445556
Q ss_pred cEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCC
Q 002094 437 QVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFN 516 (967)
Q Consensus 437 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 516 (967)
+.|+|++|.+++..|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|++|+|++|
T Consensus 257 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N 334 (597)
T 3oja_B 257 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 334 (597)
T ss_dssp SEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSS
T ss_pred CEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCC
Confidence 666666666666666666666677777777777764 4556677788888888888888 57777888888888899888
Q ss_pred ccccCCchhhhhccCCceEEecCCcccccCCCCCCCCccCCCcccCCCCCCCcc
Q 002094 517 DLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGSV 570 (967)
Q Consensus 517 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~ 570 (967)
++++.. +..+++|+.|++++|+|+|..+. .++..+....+.+++..|+.+
T Consensus 335 ~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 335 SIVTLK---LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp CCCCCC---CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred CCCCcC---hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence 888653 56678899999999999886543 345566667788999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=339.74 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=200.7
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC-CceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP-SLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||++..+ |+.||||.+.... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 34688889999999999999875 8999999987543 456799999999999999999999997654 478999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|.+++...... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHH-HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCCCHHHHHHhcccc-cCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-----
Confidence 9999999999754321 2688999999999999999999999999999999999999999999999998755321
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
.....+++.|+|||.+ ....++.++||||+|+++|||++ |+.||........ ... +.......
T Consensus 171 ~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~~-------------~~~~~~~~ 234 (278)
T 1byg_A 171 QDTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPR-------------VEKGYKMD 234 (278)
T ss_dssp -----CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHH-------------HTTTCCCC
T ss_pred ccCCCccccccCHHHh-CCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH-------------HhcCCCCC
Confidence 2234567889999988 56678999999999999999998 9999975433211 111 11112233
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.+...+..+.+++.+|++.||++|||+.|+++.|++++.
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 456677889999999999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=374.15 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=204.4
Q ss_pred CCccCCCCceEEEEEEeC---CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 687 DCELGRGGFGVVYRTILQ---DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.+.||+|+||.||+|.+. .++.||||+++.... ....+++.+|++++++++|||||++++++.. +..++||||++
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 357999999999999753 467899999976543 3346789999999999999999999999964 55889999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc-cccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR-CILS 841 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 841 (967)
+|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus 453 ~g~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 453 LGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp TEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCCHHHHHhhCCC---CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999976543 89999999999999999999999999999999999999999999999999987654222 1223
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (967)
....+|+.|+|||++ ....++.++|||||||++|||++ |+.||........ . +.+....+...
T Consensus 530 ~~~~~t~~y~APE~~-~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--~-------------~~i~~~~~~~~ 593 (635)
T 4fl3_A 530 THGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--T-------------AMLEKGERMGC 593 (635)
T ss_dssp -----CGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--H-------------HHHHTTCCCCC
T ss_pred cCCCCceeeeChhhh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H-------------HHHHcCCCCCC
Confidence 344567889999998 66689999999999999999998 9999976544311 1 11122223445
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 921 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
+..++.++.++|.+||+.||++|||++++++.|+++..
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 66778889999999999999999999999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=342.59 Aligned_cols=262 Identities=23% Similarity=0.279 Sum_probs=200.3
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|+..+.||+|+||.||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 4677889999999999999975 589999999866543 22356788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++++|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+....... ..
T Consensus 84 ~~~~~l~~~~~~~~~---~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 158 (311)
T 4agu_A 84 CDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--DY 158 (311)
T ss_dssp CSEEHHHHHHHTSSC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCchHHHHHhhhcC---CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--cc
Confidence 999999998876543 8999999999999999999999999999999999999999999999999998764322 22
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc--h------hhc
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV--E------DCV 912 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~------~~~ 912 (967)
.....||+.|+|||.+.....++.++||||+|+++|||++|+.||........ ... +......... . ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYL-IRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHH-HHHHHCSCCHHHHHHHHTCGGG
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHHHhccccccccccccccccc
Confidence 33557899999999986557789999999999999999999999975543322 111 1111110000 0 000
Q ss_pred c-hhhcC--C------CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 913 D-ARLRG--N------FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 913 ~-~~~~~--~------~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
. ..... . .....+.++.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00000 0 01245667999999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=345.33 Aligned_cols=245 Identities=24% Similarity=0.305 Sum_probs=192.6
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||+||+|+.. +|+.||||++..... ......+..|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 44788899999999999999976 799999999865432 23334555666655555 8999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+ +++|.+++..... .+++..++.++.|++.||+|||+++|+||||||+||+++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--- 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--- 210 (311)
T ss_dssp ECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC---
Confidence 999 6699988876533 3899999999999999999999999999999999999999999999999999866432
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......||+.|+|||++. + .++.++|||||||++|||++|..|+..... ... +.... ...
T Consensus 211 ~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~-----~~~~~--------~~~ 271 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQ-G-SYGTAADVFSLGLTILEVACNMELPHGGEG----WQQ-----LRQGY--------LPP 271 (311)
T ss_dssp ----CCCCCGGGCCGGGGG-T-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHH-----HTTTC--------CCH
T ss_pred CCCcccCCCccccCHhHhc-C-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHH-----HhccC--------CCc
Confidence 2234556899999999883 3 689999999999999999999776542211 111 11110 011
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.++...+.++.+++.+|++.||++|||++|+++
T Consensus 272 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 112334567999999999999999999999886
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=359.09 Aligned_cols=319 Identities=22% Similarity=0.199 Sum_probs=178.3
Q ss_pred EEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCC
Q 002094 121 VVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNN 200 (967)
Q Consensus 121 ~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n 200 (967)
.++.++++++ .+|..+ .++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 15 ~v~c~~~~l~-~ip~~~---~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 15 AVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp EEECCSCCCS-SCCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-cCCCCC---CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 3444444444 344433 245666666666666665666666666666666666666666666666666666666666
Q ss_pred cCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCch
Q 002094 201 LLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPD 280 (967)
Q Consensus 201 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 280 (967)
.+++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|.+++..+..|.++++|+.|+|++|.+++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 66665555666666666666666666666666666666777777777666666666666666677777777766665556
Q ss_pred hhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhccccc
Q 002094 281 WIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQ 360 (967)
Q Consensus 281 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~ 360 (967)
.+..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|.......
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~-------------------------- 224 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL-------------------------- 224 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTC--------------------------
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCc--------------------------
Confidence 666666666666666666655555555566666666655554433333222222
Q ss_pred EEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEE
Q 002094 361 TVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLD 440 (967)
Q Consensus 361 ~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 440 (967)
+|+.|+|++|++++..+..+..+++|+.|+|++|.+.+..+..|..+++|+.|+
T Consensus 225 --------------------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 278 (477)
T 2id5_A 225 --------------------------NLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQ 278 (477)
T ss_dssp --------------------------CCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEE
T ss_pred --------------------------cccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEE
Confidence 344444444444433223344444444444444444433344444444444444
Q ss_pred ecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCc
Q 002094 441 FSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLT 495 (967)
Q Consensus 441 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 495 (967)
|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus 279 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 279 LVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp CCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred CCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 4444444444444444444444444444444333334444444444444444443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=350.09 Aligned_cols=271 Identities=17% Similarity=0.202 Sum_probs=204.3
Q ss_pred hccCCCCccCCCCceEEEEEEeC----CCcEEEEEEeecCCccc----------cHHHHHHHHHHHcCCCCCceeeeeeE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ----DGRSVAIKKLTVSGLIK----------SQEDFEKEMKTLGKIRHHNLVALEGY 747 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~ 747 (967)
+.|+..+.||+|+||.||+|... ++..||||++....... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 45788899999999999999975 57889999987654210 11346778899999999999999999
Q ss_pred EEc----CCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC--Ce
Q 002094 748 YWT----PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG--EP 821 (967)
Q Consensus 748 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~--~~ 821 (967)
+.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++ .+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 987 67889999999 999999998654 389999999999999999999999999999999999998877 99
Q ss_pred EEeecccccccCCCccc-----cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHH
Q 002094 822 KVGDFGLARLLPMLDRC-----ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLC 896 (967)
Q Consensus 822 kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~ 896 (967)
||+|||+++.+...... .......||+.|+|||.+ ....++.++||||||+++|||++|+.||...........
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH-KGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 99999999876432211 112355789999999998 556789999999999999999999999964323222222
Q ss_pred HHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 897 DMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
......... ......... .....+.++.+++.+|++.||++|||++++++.|+++...+.+
T Consensus 272 ~~~~~~~~~--~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 332 (345)
T 2v62_A 272 TAKTNLLDE--LPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGP 332 (345)
T ss_dssp HHHHHHHHT--TTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCC
T ss_pred HHHHhhccc--ccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccC
Confidence 222211110 011010000 1124566799999999999999999999999999987765543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.31 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=199.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|...+.||+|+||.||++... ++..||+|++.........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 45788899999999999999964 68999999998766556678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEe---CCCCCeEEeecccccccCCCc
Q 002094 761 ISSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLI---DSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 761 ~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill---~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
+++|+|.+++.... ....+++..++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~- 180 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD- 180 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc-
Confidence 99999999986432 11238999999999999999999999999999999999999 45678999999999765432
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.......|++.|+|||.+ . ..++.++||||+|+++|||++|+.||......... ..... .. ...
T Consensus 181 --~~~~~~~~t~~y~aPE~~-~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~--~~~~~--~~--------~~~ 244 (285)
T 3is5_A 181 --EHSTNAAGTALYMAPEVF-K-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ--QKATY--KE--------PNY 244 (285)
T ss_dssp --------CTTGGGCCHHHH-T-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH--CC--------CCC
T ss_pred --ccCcCcccccCcCChHHh-c-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH--hhhcc--CC--------ccc
Confidence 223456689999999987 3 46889999999999999999999999754432111 11100 00 000
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
. ......+.++.+++.+|++.||++|||++|+++
T Consensus 245 ~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 A-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011124567899999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=349.94 Aligned_cols=248 Identities=21% Similarity=0.260 Sum_probs=195.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHH-HcCCCCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKT-LGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|+..+.||+|+||.||+|+.+ +++.||||++..... ......+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 34688899999999999999976 588999999976543 2234456677776 5778999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||++||+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.... .
T Consensus 118 ~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~--~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERC---FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--H 192 (373)
T ss_dssp EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--C
T ss_pred EeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--C
Confidence 999999999999976443 88999999999999999999999999999999999999999999999999975432 1
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
........||+.|+|||++ ....++.++|+||+||++|||++|+.||...... .....+... .
T Consensus 193 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~---------------~ 255 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNILNK---------------P 255 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-HHHHHHHHS---------------C
T ss_pred CCccccccCCccccCHHHh-CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhc---------------c
Confidence 2233456799999999998 5667899999999999999999999999754322 212222111 1
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..++...+..+.+++.+|++.||++||++.+.++
T Consensus 256 ~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 256 LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 1234556677999999999999999999864333
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.08 Aligned_cols=270 Identities=23% Similarity=0.334 Sum_probs=208.7
Q ss_pred hhccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEE----cCCcee
Q 002094 681 NALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW----TPSLQL 755 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~ 755 (967)
.+.|+..+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++. .....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 34578899999999999999996 578999999987643 345678999999999999999999999986 345778
Q ss_pred EEEEecCCCchhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 756 LIYEFISSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
+||||+++|+|.+++.... ....+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.+.....
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 9999999999999997632 122489999999999999999999999999999999999999999999999999876532
Q ss_pred Ccccc-------ccccccccccccCcccccCc--ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhcc
Q 002094 835 LDRCI-------LSSKIQSALGYMAPEFACRT--VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALED 905 (967)
Q Consensus 835 ~~~~~-------~~~~~~gt~~y~aPE~~~~~--~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 905 (967)
..... ......||+.|+|||.+... ..++.++||||||+++|||++|+.||.............+
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------ 260 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV------ 260 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH------
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh------
Confidence 11100 11234568899999988432 2368899999999999999999999953111100111111
Q ss_pred CCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCcc
Q 002094 906 GRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQE 964 (967)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~ 964 (967)
........+...+.++.+++.+|++.||++|||++|+++.|+.+....-+++
T Consensus 261 -------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 312 (317)
T 2buj_A 261 -------QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312 (317)
T ss_dssp -------HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC--
T ss_pred -------hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCC
Confidence 1111222234556789999999999999999999999999999987765543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=344.44 Aligned_cols=250 Identities=22% Similarity=0.372 Sum_probs=181.2
Q ss_pred CCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCceeEEEEecC
Q 002094 685 NKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
...+.||+|+||.||+|..+ +++.||||++... ....+.+|+++++.+. ||||+++++++.++...++||||++
T Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp TTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 34578999999999999965 6899999999643 4567889999999996 9999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC---CeEEeecccccccCCCcccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG---EPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~ 839 (967)
+|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus 90 ~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~ 164 (325)
T 3kn6_A 90 GGELFERIKKKKH---FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQ 164 (325)
T ss_dssp SCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred CCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CC
Confidence 9999999987543 89999999999999999999999999999999999997665 7999999999865432 22
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccch--HhHHHHHHhhhccCCchhhcchhhc
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDV--VVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
......||+.|+|||.+ ....++.++||||+|+++|||++|+.||....... ....+..... ..+... ..
T Consensus 165 ~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-~~~~~~------~~ 236 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELL-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKGDFS------FE 236 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH-TTTCCC------CC
T ss_pred cccccCCCcCccCHHHh-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH-HcCCCC------CC
Confidence 23345679999999998 66678999999999999999999999997433210 0011111111 111000 00
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.......+.++.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0011235677999999999999999999998864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=343.16 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=202.4
Q ss_pred HhhccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCC--CCCceeeeeeEEEcC----Cc
Q 002094 680 ANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI--RHHNLVALEGYYWTP----SL 753 (967)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~----~~ 753 (967)
..+.|+..+.||+|+||.||+|+.. ++.||||++... ....+..|.+++... +||||+++++++... ..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 3456789999999999999999986 899999998643 234455566666554 899999999999876 67
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CcccCCCCCCCEEeCCCCCeEEee
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT--------NIIHYNLKSTNVLIDSSGEPKVGD 825 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~--------~ivH~Dik~~Nill~~~~~~kl~D 825 (967)
.++||||+++|+|.++++.. .+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 89999999999999999764 289999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCcccc--ccccccccccccCcccccCcccCCc------ccchhhHHHHHHHHHcC----------CCCCCC
Q 002094 826 FGLARLLPMLDRCI--LSSKIQSALGYMAPEFACRTVKITE------KCDVYGFGVLVLEVVTG----------KRPVEY 887 (967)
Q Consensus 826 fg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~t~------~~Dv~slGvll~elltg----------~~p~~~ 887 (967)
||++.......... ......||+.|+|||.+ .....+. ++|||||||++|||++| +.||..
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL-DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHH-TTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhc-ccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 99997664322211 12345789999999988 3333333 49999999999999999 666653
Q ss_pred CccchHhHHHHHHhhhccCCchhhcchhhcCCCC-----hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 002094 888 MEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP-----ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961 (967)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 961 (967)
..........+.... . ....+...+ ..++.++.+++.+|++.||++|||++|+++.|+++.+..+
T Consensus 265 ~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 265 LVPSDPSYEDMREIV-C--------IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TSCSSCCHHHHHHHH-T--------TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hcCCCCchhhhHHHH-h--------hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 322221111111111 1 011122222 3677889999999999999999999999999999886654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=342.25 Aligned_cols=266 Identities=22% Similarity=0.373 Sum_probs=201.3
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||+|.. .+|+.||||++..... ......+.+|++++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 3478889999999999999996 4789999999975432 334567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 759 EFISSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
||+++++|.+++.... ....+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~- 190 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 190 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC-
Confidence 9999999999987521 12238899999999999999999999999999999999999999999999999987654321
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.......|++.|+|||.+ ....++.++||||||+++|||++|+.||.............+. .. ...
T Consensus 191 -~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~--------~~~ 256 (310)
T 2wqm_A 191 -TAAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE----QC--------DYP 256 (310)
T ss_dssp ---------CCSSCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH----TT--------CSC
T ss_pred -ccccccCCCeeEeChHHh-CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh----cc--------cCC
Confidence 222345688999999988 5667899999999999999999999999754333222221111 11 011
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
.......+.++.+++.+|++.||++|||++++++.|+++.....+
T Consensus 257 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 111234567799999999999999999999999999998754433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=350.62 Aligned_cols=272 Identities=24% Similarity=0.368 Sum_probs=212.6
Q ss_pred hccCCCCccCCCCceEEEEEEe-----CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC--ce
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS--LQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 754 (967)
+.|+..+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 4467788999999999999984 368999999997643 345678999999999999999999999987644 67
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
++||||+++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999999999987543 389999999999999999999999999999999999999999999999999987654
Q ss_pred Cccc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc----cCCch
Q 002094 835 LDRC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE----DGRVE 909 (967)
Q Consensus 835 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~ 909 (967)
.... .......++..|+|||.+ ....++.++||||+|+++|||++|..||...... ..+....... ...+.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhh-cCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHHH
Confidence 3221 122344567789999988 5557889999999999999999999998532111 1111000000 00011
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
+.+....+...+...+.++.+++.+|++.||++|||+.|+++.|++++.++
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 122222233445667788999999999999999999999999999987643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=346.06 Aligned_cols=245 Identities=21% Similarity=0.301 Sum_probs=203.3
Q ss_pred HhhccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCcc-------ccHHHHHHHHHHHcCCCCCceeeeeeEEEcC
Q 002094 680 ANALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLI-------KSQEDFEKEMKTLGKIRHHNLVALEGYYWTP 751 (967)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 751 (967)
..+.|+..+.||+|+||.||+|+. .+++.||||++...... .....+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 445678899999999999999995 46899999999765421 1234678899999999999999999999999
Q ss_pred CceeEEEEecCCC-chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 752 SLQLLIYEFISSG-SLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 752 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
+..++||||+.+| +|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999999776 99999986544 8999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchh
Q 002094 831 LLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVED 910 (967)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (967)
...... ......||+.|+|||.+......+.++||||+|+++|||++|+.||......
T Consensus 179 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------- 236 (335)
T 3dls_A 179 YLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------- 236 (335)
T ss_dssp ECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------------
T ss_pred ECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------------
Confidence 764322 2334668999999999844444488999999999999999999999642210
Q ss_pred hcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 911 CVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 911 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
... ....+...+.++.+++.+|++.||++|||++|+++.
T Consensus 237 -~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -VEA--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TTT--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -Hhh--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 112233456779999999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=345.29 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=197.5
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCce----
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQ---- 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---- 754 (967)
+.|+..+.||+|+||.||+|+. .+++.||||++..... ......+.+|++++++++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 4578889999999999999995 5789999999976542 22346789999999999999999999998765443
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
++||||+++++|.++++.... +++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 999999999999999976543 89999999999999999999999999999999999999999999999999986643
Q ss_pred Cccc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcc
Q 002094 835 LDRC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913 (967)
Q Consensus 835 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (967)
.... .......||+.|+|||.+ ....++.++||||+|+++|||++|+.||........ ..... ...... .
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~----~~~~~~---~ 239 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHV----REDPIP---P 239 (311)
T ss_dssp -------------CCTTCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHH----HCCCCC---H
T ss_pred cccccccccccCcCcccCCHHHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHh----cCCCCC---c
Confidence 2221 223345689999999998 556789999999999999999999999975443221 11111 111000 0
Q ss_pred hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHH-HHHHHHhhcC
Q 002094 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEE-VVNILELIQS 958 (967)
Q Consensus 914 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e-vl~~L~~~~~ 958 (967)
.. .....+.++.+++.+|++.||++||++.+ +.+.+.++..
T Consensus 240 ~~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 240 SA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HH----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred cc----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 00 12235567999999999999999996555 5566665543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.49 Aligned_cols=247 Identities=28% Similarity=0.427 Sum_probs=202.2
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||+|... ++..||||++..... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 34678889999999999999865 577999999865432 223567999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++++|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 89 e~~~~~~l~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~---- 161 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 161 (279)
T ss_dssp CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred ecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc----
Confidence 99999999999976543 88999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......|++.|+|||.+ ....++.++||||+|+++|+|++|+.||........ ...+. ....
T Consensus 162 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~---------------~~~~ 224 (279)
T 3fdn_A 162 SRRTDLCGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKRIS---------------RVEF 224 (279)
T ss_dssp ------CCCCTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHH---------------HTCC
T ss_pred ccccccCCCCCccCHhHh-ccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-HHHHH---------------hCCC
Confidence 122355789999999988 566788999999999999999999999975432211 11111 1122
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.++...+..+.+++.+|++.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 3455566779999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=346.49 Aligned_cols=247 Identities=28% Similarity=0.415 Sum_probs=200.9
Q ss_pred ccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||+|+. .+++.||||++..... ....+++.+|++++++++||||+++++++..++..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 367788999999999999995 5789999999976542 2234678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+. |++.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 135 ~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 135 YCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp CCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred cCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 997 588888764332 389999999999999999999999999999999999999999999999999976542
Q ss_pred ccccccccccccCccccc--CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 840 LSSKIQSALGYMAPEFAC--RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~--~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.....||+.|+|||.+. ....++.++||||||+++|||++|+.||........ ...+.. .. ..
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~~~~----~~---------~~ 271 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQ----NE---------SP 271 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHH----SC---------CC
T ss_pred -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHh----cC---------CC
Confidence 23456899999999874 356789999999999999999999999975433211 111111 10 01
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
...+...+..+.+++.+|++.||++|||++++++.
T Consensus 272 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11233456679999999999999999999998764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=361.35 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=207.1
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||+|..+ +|+.||||++..... ......+.+|++++++++|||||++++++.+.+..++||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 34677889999999999999975 689999999976432 234567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||++||+|.+++...... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 264 Ey~~gg~L~~~l~~~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-- 340 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQA-GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 340 (576)
T ss_dssp CCCCSCBHHHHHHSSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred EcCCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc--
Confidence 999999999999865433 38999999999999999999999999999999999999999999999999998764322
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccc--hHhHHHHHHhhhccCCchhhcchhh
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD--VVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
......||+.|+|||++ ....++.++||||+||++|||++|+.||...... .......+. ..
T Consensus 341 -~~~~~~GT~~Y~APEvl-~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--------------~~ 404 (576)
T 2acx_A 341 -TIKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--------------EV 404 (576)
T ss_dssp -CEECCCSCGGGCCHHHH-TTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--------------HC
T ss_pred -cccccCCCccccCHHHH-cCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--------------cc
Confidence 22345799999999998 5567899999999999999999999999754321 111111111 01
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
...++...+.++.+++.+|++.||++|| +++|+++
T Consensus 405 ~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 2234556677899999999999999999 7788764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=342.04 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=205.2
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-----ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-----KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
+.|+..+.||+|+||.||+|... +|+.||||.+...... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45788899999999999999965 6899999999765432 24678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC----CeEEeecccccc
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG----EPKVGDFGLARL 831 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~----~~kl~Dfg~a~~ 831 (967)
+||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSC---EEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 99999999999999976433 88999999999999999999999999999999999999887 799999999987
Q ss_pred cCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (967)
.... .......||+.|+|||.+ ....++.++||||+|+++|+|++|+.||...... .....+..... .
T Consensus 169 ~~~~---~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~---~---- 236 (321)
T 2a2a_A 169 IEDG---VEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANITSVSY---D---- 236 (321)
T ss_dssp CCTT---CCCCCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTTCC---C----
T ss_pred cCcc---ccccccCCCCCccCcccc-cCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhccc---c----
Confidence 6432 223455689999999998 5667899999999999999999999999754332 11111111000 0
Q ss_pred cchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 912 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.... .+...+..+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 237 FDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 11234567999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=349.34 Aligned_cols=273 Identities=23% Similarity=0.275 Sum_probs=198.9
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHH--HcCCCCCceeeeeeEEEc-----CCce
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKT--LGKIRHHNLVALEGYYWT-----PSLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~-----~~~~ 754 (967)
+.|+..+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. ....
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 3467788999999999999987 58999999997543 3344445444 455899999999986532 2356
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------CcccCCCCCCCEEeCCCCCeEEee
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT---------NIIHYNLKSTNVLIDSSGEPKVGD 825 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~---------~ivH~Dik~~Nill~~~~~~kl~D 825 (967)
++||||+++|+|.+++.... .++..+++++.||+.||+|||++ ||+||||||+||+++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 89999999999999997643 58899999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCcc------ccccccccccccccCcccccCc------ccCCcccchhhHHHHHHHHHcCCCCCCCCccchH
Q 002094 826 FGLARLLPMLDR------CILSSKIQSALGYMAPEFACRT------VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVV 893 (967)
Q Consensus 826 fg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~------~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~ 893 (967)
||++........ ........||+.|+|||++... ..++.++||||||+++|||++|..||........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987643211 1122345689999999988431 4567899999999999999999777643221110
Q ss_pred hHHHHHHhhhccCCchh----hcchhhcCCC------ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCc
Q 002094 894 VLCDMVRGALEDGRVED----CVDARLRGNF------PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQ 963 (967)
Q Consensus 894 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~ 963 (967)
....+...........+ ......+..+ ....+..+.+++.+|++.||++|||++|+++.|+++....+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 00000000000000000 0001111222 2345678999999999999999999999999999998776654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=338.07 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=209.0
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.+.|+..+.||+|+||.||+|... +++.||||++.........+.+.+|+.++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 345788899999999999999854 6899999999876655567889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++++|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+....... .
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 174 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--C
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc--c
Confidence 99999999998652 38999999999999999999999999999999999999999999999999997664321 2
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......|++.|+|||.+ ....++.++||||||+++|||++|+.||........ ...+. ......
T Consensus 175 ~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~-------------~~~~~~ 238 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--LFLIP-------------KNNPPT 238 (303)
T ss_dssp CBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHH-------------HSCCCC
T ss_pred ccCccCCCcCccCHHHH-hcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH--HHHhh-------------cCCCCC
Confidence 23456789999999998 566789999999999999999999999975433211 11110 011222
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.+...+..+.+++.+|++.||++|||+.|+++.
T Consensus 239 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 344566779999999999999999999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=333.84 Aligned_cols=251 Identities=22% Similarity=0.344 Sum_probs=204.6
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|+..+.||+|+||.||+|..+ +++.||+|++..... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 45788889999999999999965 589999999976543 3345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC---eEEeecccccccCCCc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE---PKVGDFGLARLLPMLD 836 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~---~kl~Dfg~a~~~~~~~ 836 (967)
|+++++|.+.+..... +++..+..++.|++.||+|||++||+||||||+||+++.++. +||+|||.+......
T Consensus 86 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~- 161 (284)
T 3kk8_A 86 LVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 161 (284)
T ss_dssp CCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-
T ss_pred cCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-
Confidence 9999999998876543 899999999999999999999999999999999999986655 999999999766432
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.......|++.|+|||.+ ....++.++||||+|+++|+|++|+.||...... .....+...... .
T Consensus 162 --~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~-----------~ 226 (284)
T 3kk8_A 162 --EAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYD-----------Y 226 (284)
T ss_dssp --CBCCCSCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCC-----------C
T ss_pred --ccccCCCCCcCCcCchhh-cCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-HHHHHHHhcccc-----------C
Confidence 223356789999999998 5667899999999999999999999999654332 111111111110 0
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
........+.++.+++.+|++.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11112345667999999999999999999999977
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=354.60 Aligned_cols=255 Identities=17% Similarity=0.182 Sum_probs=202.2
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||+++.+ +|+.||||++..... ....+.+.+|..++..++||||+++++++.+++..++||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 45688899999999999999975 689999999975321 122345889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||++||+|.+++..... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...... .
T Consensus 141 E~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~-~ 217 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-T 217 (412)
T ss_dssp CCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-C
T ss_pred cCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC-c
Confidence 99999999999976432 38999999999999999999999999999999999999999999999999998764322 1
Q ss_pred cccccccccccccCcccccC------cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc
Q 002094 839 ILSSKIQSALGYMAPEFACR------TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV 912 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~------~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (967)
.......||+.|+|||++.. ...++.++||||+||++|||++|+.||...... .....++......
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~------- 289 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-ETYGKIVHYKEHL------- 289 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHHHC-------
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccCc-------
Confidence 22334679999999998842 356899999999999999999999999754332 2222222111000
Q ss_pred chhhcCCCChhhHHHHHHHHHhhccCCCCCC---CCHHHHHH
Q 002094 913 DARLRGNFPADEAIPVIKLGLICASQVPSNR---PDMEEVVN 951 (967)
Q Consensus 913 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---pt~~evl~ 951 (967)
.....+...+.++.++|.+|+. +|++| |+++|+++
T Consensus 290 ---~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 290 ---SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ---CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ---CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0011223456779999999999 99988 58888864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=331.30 Aligned_cols=246 Identities=20% Similarity=0.310 Sum_probs=203.9
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.+.|+..+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 345788899999999999999965 47799999997654 3456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEe---CCCCCeEEeecccccccCCCc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLI---DSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill---~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
|+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||++ +.++.++|+|||.+......
T Consensus 87 ~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 87 LCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp CCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred ccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 9999999999876543 8899999999999999999999999999999999999 78899999999999866432
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.......||+.|+|||.+ .+ .++.++||||+|+++|||++|+.||...... .....+....
T Consensus 163 --~~~~~~~~t~~y~aPE~~-~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~-------------- 223 (277)
T 3f3z_A 163 --KMMRTKVGTPYYVSPQVL-EG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS-EVMLKIREGT-------------- 223 (277)
T ss_dssp --SCBCCCCSCTTTCCHHHH-TT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCC--------------
T ss_pred --cchhccCCCCCccChHHh-cc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCC--------------
Confidence 223456689999999988 33 4899999999999999999999999754432 1111111111
Q ss_pred cCCCCh----hhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 917 RGNFPA----DEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 917 ~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+. ..+..+.+++.+|++.||++|||+.|+++
T Consensus 224 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 224 -FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111 34567999999999999999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=333.02 Aligned_cols=249 Identities=22% Similarity=0.354 Sum_probs=185.8
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||+|+. .+|+.||||.+..... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 3468888999999999999996 4789999999965432 223477999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||.+.......
T Consensus 91 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-- 166 (278)
T ss_dssp ECCTTEEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred ecCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--
Confidence 99999999999986432 38999999999999999999999999999999999999999999999999998664321
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......|++.|+|||.+ ....++.++||||+|+++|||++|+.||........ .. ..... ..
T Consensus 167 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~---------~~~~~--~~ 229 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIA-TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LN---------KVVLA--DY 229 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSS--CC
T ss_pred CcceeccCCCCcCCcchh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HH---------HHhhc--cc
Confidence 122345688999999988 556788999999999999999999999975432211 00 00000 11
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+...+.++.+++.+|++.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 234456678999999999999999999999876
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=358.94 Aligned_cols=248 Identities=23% Similarity=0.287 Sum_probs=196.3
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCC--ccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSG--LIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||+|... +|+.||||++.... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 45788899999999999999954 68999999997542 1234467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
||+++|+|.+++..... +++..+..++.||+.||+|||+ +||+||||||+||+++.++.+||+|||+++.... .
T Consensus 228 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~ 302 (446)
T 4ejn_A 228 EYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--D 302 (446)
T ss_dssp CCCSSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred eeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--C
Confidence 99999999999976543 8999999999999999999998 9999999999999999999999999999975432 1
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
........||+.|+|||++ ....++.++||||+||++|||++|+.||...... .....+... .
T Consensus 303 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~~---------------~ 365 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILME---------------E 365 (446)
T ss_dssp ----CCSSSCGGGCCHHHH-HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHC---------------C
T ss_pred CcccccccCCccccCHhhc-CCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-HHHHHHHhC---------------C
Confidence 2233456799999999998 6668899999999999999999999999754332 111111110 1
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
..++...+.++.+++.+|++.||++|| |++|+++
T Consensus 366 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 224555677899999999999999999 9999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=345.80 Aligned_cols=262 Identities=22% Similarity=0.297 Sum_probs=196.7
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|...+.||+|+||.||+|... +++.||||++...........+.+|++++++++||||+++++++..++..++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 3677889999999999999975 689999999975543222234567999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++ +|.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus 83 ~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~ 157 (324)
T 3mtl_A 83 DK-DLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKTY 157 (324)
T ss_dssp SE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred cc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--cccc
Confidence 85 89998876543 3889999999999999999999999999999999999999999999999999765421 2223
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc---hhhcchh---
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV---EDCVDAR--- 915 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--- 915 (967)
....||+.|+|||.+.....++.++||||+|+++|||++|+.||....... .... +......+.. .......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~-i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHF-IFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH-HHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHHhCCCChHhchhhhcchhhc
Confidence 345679999999998555678999999999999999999999997554322 2222 2222211111 1111000
Q ss_pred ------hcC----CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 916 ------LRG----NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 916 ------~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
... ......+.++.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000 011234567899999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=339.92 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=204.6
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEc----------
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT---------- 750 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------- 750 (967)
..|+..+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 44688899999999999999976 79999999997543 357889999999999999999998854
Q ss_pred ------CCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEe
Q 002094 751 ------PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVG 824 (967)
Q Consensus 751 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~ 824 (967)
....++||||+++++|.+++...... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 34578999999999999999764322 38999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc
Q 002094 825 DFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE 904 (967)
Q Consensus 825 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 904 (967)
|||++....... ......|++.|+|||.+ ....++.++||||+|+++|||++|..|+... . ..... +.
T Consensus 165 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~---~~~~~-~~ 232 (284)
T 2a19_B 165 DFGLVTSLKNDG---KRTRSKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELLHVCDTAFET----S---KFFTD-LR 232 (284)
T ss_dssp CCTTCEESSCCS---CCCCCCSCCTTSCHHHH-HCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----H---HHHHH-HH
T ss_pred cchhheeccccc---cccccCCcccccChhhh-ccCCCcchhhhHHHHHHHHHHHhcCCcchhH----H---HHHHH-hh
Confidence 999998764322 23345689999999998 5567899999999999999999999987311 0 11111 11
Q ss_pred cCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCcc
Q 002094 905 DGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQE 964 (967)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~ 964 (967)
....+...+..+.+++.+|++.||++|||+.|+++.|+.+.+..+..+
T Consensus 233 ------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 233 ------------DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp ------------TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred ------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 112234455678999999999999999999999999999987766543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=337.41 Aligned_cols=263 Identities=22% Similarity=0.278 Sum_probs=200.7
Q ss_pred hhccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc----cccHHHHHHHHHHHcCC---CCCceeeeeeEEEcCC
Q 002094 681 NALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL----IKSQEDFEKEMKTLGKI---RHHNLVALEGYYWTPS 752 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~ 752 (967)
.+.|+..+.||+|+||.||+|+. .+++.||||++..... ......+.+|+++++++ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 44678899999999999999995 4689999999875431 12234677788777766 4999999999997655
Q ss_pred -----ceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecc
Q 002094 753 -----LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFG 827 (967)
Q Consensus 753 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg 827 (967)
..++||||+. ++|.+++....... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~-~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPG-LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTC-SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 4789999997 59999998765433 8999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC
Q 002094 828 LARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR 907 (967)
Q Consensus 828 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (967)
+++.... ........||+.|+|||.+ ....++.++||||+||++|||++|++||...... .....+... .....
T Consensus 166 ~a~~~~~---~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~-~~~~~ 239 (308)
T 3g33_A 166 LARIYSY---QMALTPVVVTLWYRAPEVL-LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDL-IGLPP 239 (308)
T ss_dssp CTTTSTT---CCCSGGGGCCCSSCCHHHH-HTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHHHHHH-HCCCC
T ss_pred cccccCC---CcccCCccccccccCchHH-cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH-hCCCC
Confidence 9986643 2223456789999999998 5567899999999999999999999999754432 222222221 11111
Q ss_pred chhhcc------hhhcC-------CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 908 VEDCVD------ARLRG-------NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 908 ~~~~~~------~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+.. ..... ...++.+..+.+++.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111000 00000 011245567899999999999999999999876
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=333.66 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=201.6
Q ss_pred CCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 685 NKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
.....||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp SSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 4455899999999999995 468899999997654 34457899999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC-CCCeEEeecccccccCCCccccccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS-SGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
++|.+++.........++..+..++.|++.||+|||++||+||||||+||+++. ++.+||+|||.+....... ....
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 181 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTE 181 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------C
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--Cccc
Confidence 999999987654444778999999999999999999999999999999999987 8999999999998664321 1233
Q ss_pred cccccccccCcccccCc-ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRT-VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~-~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
...|++.|+|||.+... ..++.++||||||+++|||++|+.||.............. ........+
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------------~~~~~~~~~ 248 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-------------MFKVHPEIP 248 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH-------------HHCCCCCCC
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc-------------ccccccccc
Confidence 55689999999988432 2478999999999999999999999964333221111100 011223445
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+.++.+++.+|++.||++|||++|+++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 666778999999999999999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=344.25 Aligned_cols=264 Identities=25% Similarity=0.307 Sum_probs=201.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|+..+.||+|+||.||+|+.. +|+.||||++...... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 34677889999999999999975 4899999998765432 234668899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++++|.++...... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 105 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 179 (331)
T 4aaa_A 105 FVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GE 179 (331)
T ss_dssp CCSEEHHHHHHHSTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cCCcchHHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--cc
Confidence 9999999888765443 899999999999999999999999999999999999999999999999999765432 12
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc-----------cCCc
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE-----------DGRV 908 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~ 908 (967)
......|++.|+|||.+.....++.++||||+|+++|||++|+.||........ ...++...-. ....
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhhcccc
Confidence 233456899999999985555789999999999999999999999975543322 2222211100 0000
Q ss_pred hhhcchhhcCC-----CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 909 EDCVDARLRGN-----FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 909 ~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+..... ..+..+..+.+++.+|++.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000000 11245677999999999999999999998875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=350.53 Aligned_cols=265 Identities=22% Similarity=0.310 Sum_probs=194.5
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCC--cee
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPS--LQL 755 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~~ 755 (967)
.+.|+..+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++++. ||||+++++++..++ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 345788899999999999999954 689999999865422 344567889999999997 999999999997544 679
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+||||++ ++|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 88 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 9999998 5899998763 2889999999999999999999999999999999999999999999999999865321
Q ss_pred c-------------------cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHH
Q 002094 836 D-------------------RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLC 896 (967)
Q Consensus 836 ~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~ 896 (967)
. .........||+.|+|||++.....++.++||||+||++|||++|++||...... ..+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~ 241 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM-NQLE 241 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence 1 1112234578999999999865578999999999999999999999999754432 2222
Q ss_pred HHHHhhhccCCchhh-----------cc----------------------hhhcCCCChhhHHHHHHHHHhhccCCCCCC
Q 002094 897 DMVRGALEDGRVEDC-----------VD----------------------ARLRGNFPADEAIPVIKLGLICASQVPSNR 943 (967)
Q Consensus 897 ~~~~~~~~~~~~~~~-----------~~----------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 943 (967)
.++ ..+..+....+ .+ .......+...+.++.+++.+|++.||++|
T Consensus 242 ~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 242 RII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 222 22211111100 00 000000112446679999999999999999
Q ss_pred CCHHHHHHH
Q 002094 944 PDMEEVVNI 952 (967)
Q Consensus 944 pt~~evl~~ 952 (967)
||++|+++.
T Consensus 321 ~t~~e~l~H 329 (388)
T 3oz6_A 321 ISANDALKH 329 (388)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhCC
Confidence 999998864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=341.71 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=209.2
Q ss_pred HHHhhccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcC--CCCCceeeeeeEEEcCC---
Q 002094 678 AGANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGK--IRHHNLVALEGYYWTPS--- 752 (967)
Q Consensus 678 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~--- 752 (967)
....+.|+..+.||+|+||.||+|+.. ++.||||++... ....+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 344556789999999999999999984 899999998643 35667888888776 78999999999998775
Q ss_pred -ceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCcccCCCCCCCEEeCCCCCeEE
Q 002094 753 -LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH--------HTNIIHYNLKSTNVLIDSSGEPKV 823 (967)
Q Consensus 753 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH--------~~~ivH~Dik~~Nill~~~~~~kl 823 (967)
..++||||+++|+|.+++... .+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred ceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 789999999999999999764 2899999999999999999999 899999999999999999999999
Q ss_pred eecccccccCCCcccc--ccccccccccccCcccccCcc-----cCCcccchhhHHHHHHHHHcC----------CCCCC
Q 002094 824 GDFGLARLLPMLDRCI--LSSKIQSALGYMAPEFACRTV-----KITEKCDVYGFGVLVLEVVTG----------KRPVE 886 (967)
Q Consensus 824 ~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-----~~t~~~Dv~slGvll~elltg----------~~p~~ 886 (967)
+|||++.......... ......||+.|+|||.+.... .++.++||||||+++|||++| +.||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9999997664322211 234557899999999884332 234789999999999999999 77886
Q ss_pred CCccchHhHHHHHHhhhccCCchhhcchhhcCCC-----ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 887 YMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF-----PADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
...........+...... ...+... ..+.+..+.+++.+|++.||++|||++|+++.|+++.++
T Consensus 269 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCE---------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTSCSSCCHHHHHHHHTT---------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccCcCcccHHHHHHHHHH---------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 443322222222222111 1112222 235667899999999999999999999999999998765
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=349.82 Aligned_cols=266 Identities=14% Similarity=0.160 Sum_probs=207.3
Q ss_pred hccCCCCccCCCCceEEEEEEeCC---------CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceee---------
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD---------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA--------- 743 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 743 (967)
+.|+..+.||+|+||.||+|+... ++.||||.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 457888999999999999999763 789999998754 35889999999999999987
Q ss_pred ------eeeEEEc-CCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC
Q 002094 744 ------LEGYYWT-PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID 816 (967)
Q Consensus 744 ------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~ 816 (967)
+++++.. ....++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 5677765 67889999999 9999999986522 2389999999999999999999999999999999999999
Q ss_pred CCC--CeEEeecccccccCCCccc-----cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCc
Q 002094 817 SSG--EPKVGDFGLARLLPMLDRC-----ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYME 889 (967)
Q Consensus 817 ~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~ 889 (967)
.++ .+||+|||+++........ .......||+.|+|||.+ .+..++.++||||||+++|||++|+.||....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH-KGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 988 8999999999876432211 112345789999999988 56678999999999999999999999998554
Q ss_pred cchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 002094 890 DDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961 (967)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 961 (967)
................. ....+. .......+.++.+++.+|++.||++|||+++++++|+++.+...
T Consensus 273 ~~~~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKP--GPFVGP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TCHHHHHHHHHHHHHSC--CCEECT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCHHHHHHHHHhccCCh--hhhhhh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 33333333222221110 000000 00112345779999999999999999999999999999875543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=344.60 Aligned_cols=258 Identities=22% Similarity=0.267 Sum_probs=200.8
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-----CCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-----HHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~ 755 (967)
+.|+..+.||+|+||.||+|+. .+++.||||++.... .....+..|+++++.+. ||||+++++++...+..+
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~ 112 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence 4578889999999999999996 468999999997432 34567788999998886 999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC------------------
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS------------------ 817 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~------------------ 817 (967)
+||||+ +++|.+++....... +++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 113 lv~e~~-~~~L~~~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRNNYNG-FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp EEECCC-CCBHHHHHHHTTTCC-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred EEEcCC-CCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 999999 889999998765433 889999999999999999999999999999999999975
Q ss_pred -------CCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCcc
Q 002094 818 -------SGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMED 890 (967)
Q Consensus 818 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~ 890 (967)
++.+||+|||++..... ......||+.|+|||++ .+..++.++||||+||++|||++|+.||.....
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVI-LNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHH-cCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 78999999999986533 22356789999999998 566799999999999999999999999975443
Q ss_pred chHhHHHHHHhhhccCC-----------chhhcc-hhhcCCCC--------------------hhhHHHHHHHHHhhccC
Q 002094 891 DVVVLCDMVRGALEDGR-----------VEDCVD-ARLRGNFP--------------------ADEAIPVIKLGLICASQ 938 (967)
Q Consensus 891 ~~~~~~~~~~~~~~~~~-----------~~~~~~-~~~~~~~~--------------------~~~~~~l~~li~~cl~~ 938 (967)
. ..... +........ .....+ ......++ ......+.+++.+|++.
T Consensus 265 ~-~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 265 M-EHLAM-MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp H-HHHHH-HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred H-HHHHH-HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 2 11111 111111000 000000 00000011 11125688999999999
Q ss_pred CCCCCCCHHHHHH
Q 002094 939 VPSNRPDMEEVVN 951 (967)
Q Consensus 939 dP~~Rpt~~evl~ 951 (967)
||++|||++|+++
T Consensus 343 dP~~Rpta~elL~ 355 (360)
T 3llt_A 343 DPTLRPSPAELLK 355 (360)
T ss_dssp SGGGSCCHHHHTT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=335.23 Aligned_cols=265 Identities=15% Similarity=0.164 Sum_probs=208.0
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEE-EcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY-WTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e 759 (967)
+.|+..+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+++++.++|++++..+.++ ...+..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 4578889999999999999996 5789999999876542 24589999999999988766666655 56677799999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC---CCCCeEEeecccccccCCCc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID---SSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~---~~~~~kl~Dfg~a~~~~~~~ 836 (967)
|+ +++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++ .++.+||+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred ec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99 8999999975433 389999999999999999999999999999999999994 78899999999998765422
Q ss_pred cc-----cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCcc--chHhHHHHHHhhhccCCch
Q 002094 837 RC-----ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMED--DVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 837 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 909 (967)
.. .......||+.|+|||.+ .+..++.++||||||+++|||++|+.||..... .......+........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTH-LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred cccccccccccccccccccCChhhh-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 21 123456789999999998 566789999999999999999999999975332 1112222222111110
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCc
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQ 963 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~ 963 (967)
... .....+.++.+++.+|++.||++|||++++++.|+++.+.....
T Consensus 239 ---~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 239 ---IEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp ---HHH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ---hHH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 000 12334567999999999999999999999999999987655443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=333.19 Aligned_cols=259 Identities=22% Similarity=0.357 Sum_probs=205.9
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-----ccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-----KSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
+.|+..+.||+|+||.||+|... +++.||+|.+...... ...+.+.+|++++++++||||+++++++..+...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 34688899999999999999976 6899999999765421 24678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC----CeEEeecccccc
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG----EPKVGDFGLARL 831 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~----~~kl~Dfg~a~~ 831 (967)
+||||+++++|.+++..... +++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||.+..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999999976433 89999999999999999999999999999999999998877 899999999986
Q ss_pred cCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (967)
..... ......+++.|+|||.+ ....++.++||||+|+++|+|++|+.||...... .....+... ...
T Consensus 162 ~~~~~---~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-----~~~-- 229 (283)
T 3bhy_A 162 IEAGN---EFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-ETLTNISAV-----NYD-- 229 (283)
T ss_dssp CC-----------CCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTT-----CCC--
T ss_pred ccCCC---cccccCCCcCccCccee-cCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-HHHHHhHhc-----ccC--
Confidence 64321 22345689999999988 6667899999999999999999999999754332 111111110 000
Q ss_pred cchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH--HHHhhcCC
Q 002094 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN--ILELIQSP 959 (967)
Q Consensus 912 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~--~L~~~~~~ 959 (967)
.... .....+..+.+++.+|++.||++|||+.|+++ .++.++..
T Consensus 230 ~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 230 FDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp CCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred Ccch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 0000 11234567899999999999999999999987 45665543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=341.75 Aligned_cols=263 Identities=19% Similarity=0.247 Sum_probs=196.2
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
.+.|+..+.||+|+||.||+|+.. +++.||||++..... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 345788999999999999999854 689999999976543 223456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC-----CCCCeEEeecccccccC
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID-----SSGEPKVGDFGLARLLP 833 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~-----~~~~~kl~Dfg~a~~~~ 833 (967)
||+++ +|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|||++....
T Consensus 113 e~~~~-~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp ECCSE-EHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred ecCCC-CHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99985 99999987554 88999999999999999999999999999999999994 45569999999998664
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh--
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC-- 911 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 911 (967)
.. ........+|+.|+|||.+.....++.++||||+||++|||++|+.||...... .....+... ........+
T Consensus 189 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~-~~~~~~~~~~~ 264 (329)
T 3gbz_A 189 IP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEV-LGLPDDTTWPG 264 (329)
T ss_dssp -------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH-HCCCCTTTSTT
T ss_pred Cc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHHHHH-hCCCchhhhhh
Confidence 32 122334567999999999855566899999999999999999999999754432 222222221 111100000
Q ss_pred -cc-hhhcCC------------CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 912 -VD-ARLRGN------------FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 912 -~~-~~~~~~------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.. ...... .+...+.++.+++.+|++.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 000000 11224567899999999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.91 Aligned_cols=264 Identities=20% Similarity=0.314 Sum_probs=187.3
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|... +++.||||++.........+++.+|++++++++||||+++++++..++..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 45788889999999999999854 68999999987654444567789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 761 ISSGSLYKHLHDG-----SSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 761 ~~~gsL~~~l~~~-----~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+++++|.+++... .....+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 9999999998641 12234899999999999999999999999999999999999999999999999998766432
Q ss_pred cc---ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc
Q 002094 836 DR---CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV 912 (967)
Q Consensus 836 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (967)
.. ........||+.|+|||.+.....++.++||||+|+++|||++|+.||......... ...... . .....
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~----~-~~~~~ 248 (303)
T 2vwi_A 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-MLTLQN----D-PPSLE 248 (303)
T ss_dssp -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-HHHHTS----S-CCCTT
T ss_pred CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH-HHHhcc----C-CCccc
Confidence 11 112234568999999998844456899999999999999999999999755443221 111111 0 00111
Q ss_pred chhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 913 DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 913 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
............+.++.+++.+|++.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111112223445667999999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=336.20 Aligned_cols=255 Identities=20% Similarity=0.311 Sum_probs=195.3
Q ss_pred ccCC-CCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNK-DCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~-~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+. .+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 3555 46899999999999995 478999999997654 34567899999999885 79999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC---eEEeecccccccCCCc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE---PKVGDFGLARLLPMLD 836 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~---~kl~Dfg~a~~~~~~~ 836 (967)
|+++++|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 92 KMRGGSILSHIHKRRH---FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp CCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred cCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 9999999999976543 889999999999999999999999999999999999988775 9999999987653211
Q ss_pred cc-----cccccccccccccCcccccC----cccCCcccchhhHHHHHHHHHcCCCCCCCCccchH---------hHHHH
Q 002094 837 RC-----ILSSKIQSALGYMAPEFACR----TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVV---------VLCDM 898 (967)
Q Consensus 837 ~~-----~~~~~~~gt~~y~aPE~~~~----~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~---------~~~~~ 898 (967)
.. .......||+.|+|||.+.. ...++.++||||+|+++|||++|+.||........ .....
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 11 11223458999999998832 24588999999999999999999999975432110 00000
Q ss_pred HHhhhccCCchhhcchhhcCCCC----hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 899 VRGALEDGRVEDCVDARLRGNFP----ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+...+... ...++ ...+..+.+++.+|++.||++|||++|+++
T Consensus 249 ~~~~i~~~----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 249 LFESIQEG----------KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHC----------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhcc----------CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11111111 01112 134567999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=346.07 Aligned_cols=253 Identities=14% Similarity=0.172 Sum_probs=204.5
Q ss_pred hccCCCCccCCCCceEEEEEE------eCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC---CCceeeeeeEEEcCC
Q 002094 682 ALLNKDCELGRGGFGVVYRTI------LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR---HHNLVALEGYYWTPS 752 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 752 (967)
+.|...+.||+|+||.||+|+ ..+++.||||++... ...++..|++++++++ |+||+++++++..++
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 456888899999999999994 456899999999754 3557888888888876 999999999999999
Q ss_pred ceeEEEEecCCCchhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC-----------CC
Q 002094 753 LQLLIYEFISSGSLYKHLHDGS--SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS-----------SG 819 (967)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~-----------~~ 819 (967)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 9999999999999999997522 2234899999999999999999999999999999999999998 89
Q ss_pred CeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHH
Q 002094 820 EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMV 899 (967)
Q Consensus 820 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~ 899 (967)
.+||+|||+++...............||+.|+|||++ .+..++.++|||||||++|||++|+.||........
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------ 293 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML-SNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------ 293 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH-TTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh-cCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------
Confidence 9999999999765433333444567799999999998 556799999999999999999999999853322100
Q ss_pred HhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCC-CCHHHHHHHHHhhcCC
Q 002094 900 RGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNR-PDMEEVVNILELIQSP 959 (967)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-pt~~evl~~L~~~~~~ 959 (967)
......+ .+ .....+.+++..|++.+|.+| |+++++.+.|+++...
T Consensus 294 -----------~~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 -----------KPEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -----------EECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----------eechhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0011111 11 235668899999999999988 6888888888887654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=333.60 Aligned_cols=263 Identities=16% Similarity=0.172 Sum_probs=203.6
Q ss_pred hhccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEE-EcCCceeEEE
Q 002094 681 NALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY-WTPSLQLLIY 758 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 758 (967)
.+.|+..+.||+|+||.||+|+. .+++.||||++..... ...+.+|+++++.++|++++..++++ ...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 45678899999999999999995 5789999998765442 23588899999999888777666655 5677789999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEe---CCCCCeEEeecccccccCCC
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLI---DSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill---~~~~~~kl~Dfg~a~~~~~~ 835 (967)
||+ +++|.+++..... .+++..+..++.|++.||+|||++||+||||||+||++ +.++.+||+|||+++.....
T Consensus 85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred Ecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 999 8999999985433 28999999999999999999999999999999999999 78899999999999876542
Q ss_pred ccc-----cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccc--hHhHHHHHHhhhccCCc
Q 002094 836 DRC-----ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD--VVVLCDMVRGALEDGRV 908 (967)
Q Consensus 836 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 908 (967)
... .......||+.|+|||.+ ....++.++||||+|+++|||++|+.||...... ...............
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 238 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTH-LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 238 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred ccCccCCCCcccccCCCccccchHHh-cCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch--
Confidence 221 123356789999999998 5667899999999999999999999999754321 111111111111100
Q ss_pred hhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
... .....+.++.+++.+|++.||++|||++++++.|+++.+..
T Consensus 239 ----~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 239 ----IEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ----HHH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----hhh----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 000 11234567999999999999999999999999999887543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=344.02 Aligned_cols=267 Identities=21% Similarity=0.240 Sum_probs=203.8
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCC----ccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSG----LIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 345788999999999999999964 68899999986542 1345678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCC-------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 002094 756 LIYEFISSGSLYKHLHDGSS-------------------------------------RNCLSWRQRFNIILGMAKGLAYL 798 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~-------------------------------------~~~~~~~~~~~i~~~i~~aL~~L 798 (967)
+||||+++|+|.+++..... ...+++..++.++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999999852110 11135677889999999999999
Q ss_pred hcCCcccCCCCCCCEEeCCCC--CeEEeecccccccCCCcc--ccccccccccccccCcccccC-cccCCcccchhhHHH
Q 002094 799 HHTNIIHYNLKSTNVLIDSSG--EPKVGDFGLARLLPMLDR--CILSSKIQSALGYMAPEFACR-TVKITEKCDVYGFGV 873 (967)
Q Consensus 799 H~~~ivH~Dik~~Nill~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~t~~~Dv~slGv 873 (967)
|+++|+||||||+||+++.++ .+||+|||++........ ........||+.|+|||.+.. ...++.++||||+|+
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998776 899999999986533211 112345678999999998843 367889999999999
Q ss_pred HHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH--
Q 002094 874 LVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN-- 951 (967)
Q Consensus 874 ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~-- 951 (967)
++|||++|+.||........ .......... .........+..+.+++.+|++.||++|||+.|+++
T Consensus 265 il~el~~g~~pf~~~~~~~~-~~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADT-ISQVLNKKLC-----------FENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHH-HHHHHHCCCC-----------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred HHHHHHHCCCCCCCCChHHH-HHHHHhcccc-----------cCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 99999999999975543321 1111111100 001111234667999999999999999999999987
Q ss_pred HHHhhcCC
Q 002094 952 ILELIQSP 959 (967)
Q Consensus 952 ~L~~~~~~ 959 (967)
.++++...
T Consensus 333 ~~~~~~~~ 340 (345)
T 3hko_A 333 WISQFSDK 340 (345)
T ss_dssp HHHTTSSC
T ss_pred hhccChHh
Confidence 34554443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.63 Aligned_cols=261 Identities=27% Similarity=0.412 Sum_probs=198.8
Q ss_pred hccCCCCccCCCCceEEEEEEeC--CCc--EEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ--DGR--SVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
+.|+..+.||+|+||.||+|++. +++ .||||++..... ....+.+.+|++++++++||||+++++++..+. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 34688889999999999999853 233 689999875532 234578999999999999999999999997654 88
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+||||+++++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 99999999999999976432 3889999999999999999999999999999999999999999999999999876542
Q ss_pred ccc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcc
Q 002094 836 DRC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913 (967)
Q Consensus 836 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (967)
... .......+++.|+|||.+ ....++.++||||+|+++|||++ |+.||....... .......
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~--------- 239 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESL-KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----ILHKIDK--------- 239 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHT---------
T ss_pred ccchhhhccCCCCceeeCchhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-----HHHHHHc---------
Confidence 221 123345677889999988 55678899999999999999999 999997554321 1111111
Q ss_pred hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 914 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
.......+...+.++.+++.+|++.||++|||+.++++.|+++....
T Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 11122334566778999999999999999999999999999887543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=343.32 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=198.3
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|+..+.||+|+||.||+|..+ +++.||||++..... ...+|++++.++ +||||+++++++.+++..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 45788899999999999999965 688999999976542 245688888777 79999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC-C---CeEEeecccccccCCC
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS-G---EPKVGDFGLARLLPML 835 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~-~---~~kl~Dfg~a~~~~~~ 835 (967)
|+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||++..+ + .+||+|||++......
T Consensus 97 ~~~gg~L~~~i~~~~~---~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 97 LMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCCSCBHHHHHHTCTT---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 9999999999976543 8999999999999999999999999999999999998533 3 4999999999866432
Q ss_pred ccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 836 DRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
. .......||+.|+|||++ ....++.++||||+||++|||++|+.||.....+.. .++.... ..+.. .
T Consensus 174 ~--~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~i-~~~~~------~ 241 (342)
T 2qr7_A 174 N--GLLMTPCYTANFVAPEVL-ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP--EEILARI-GSGKF------S 241 (342)
T ss_dssp T--CCBCCSSCCSSCCCHHHH-HHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH--HHHHHHH-HHCCC------C
T ss_pred C--CceeccCCCccccCHHHh-cCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH--HHHHHHH-ccCCc------c
Confidence 2 223345689999999998 555688999999999999999999999975322111 1111111 11110 1
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+...+.++.+++.+|++.||++|||+.|+++
T Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 112233456778999999999999999999999876
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=338.65 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=202.0
Q ss_pred hccCCC-CccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKD-CELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 757 (967)
++|... +.||+|+||.||+|... +++.||||++..... ......+.+|+.+++++ .||||+++++++..++..++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 344555 78999999999999965 689999999976543 34467899999999999 569999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC---CCCeEEeecccccccCC
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS---SGEPKVGDFGLARLLPM 834 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~---~~~~kl~Dfg~a~~~~~ 834 (967)
|||+++|+|.+++...... .+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~~~~~~~~-~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAE-MVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EECCTTEEGGGGGSSCC-C-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEecCCCcHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 9999999999998654333 3899999999999999999999999999999999999987 78999999999987643
Q ss_pred CccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 835 LDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
. .......||+.|+|||.+ ....++.++||||+|+++|||++|+.||........ ...+... ..
T Consensus 187 ~---~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~-----------~~ 250 (327)
T 3lm5_A 187 A---CELREIMGTPEYLAPEIL-NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLNISQV-----------NV 250 (327)
T ss_dssp ----------CCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHT-----------CC
T ss_pred c---cccccccCCcCccCCeee-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHhc-----------cc
Confidence 2 223346789999999998 666889999999999999999999999975443211 1111111 01
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..........+..+.+++.+|++.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 251 DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11122234556779999999999999999999998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=329.54 Aligned_cols=248 Identities=22% Similarity=0.343 Sum_probs=196.8
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||+|... +|+.||||.+..... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4677889999999999999976 789999999975431 2345689999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++++|.+++..... +++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+...... .
T Consensus 92 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~---~ 165 (276)
T 2h6d_A 92 YVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---E 165 (276)
T ss_dssp CCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred ccCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC---c
Confidence 9999999999976543 889999999999999999999999999999999999999999999999999866432 1
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......+++.|+|||.+......+.++||||+|+++|+|++|+.||...... . ..+.+.. . ...
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~-~~~~~~~----~----------~~~ 229 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-T-LFKKIRG----G----------VFY 229 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-H-HHHHHHH----C----------CCC
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-H-HHHHhhc----C----------ccc
Confidence 2234568899999999844434478999999999999999999999754322 1 1111110 0 112
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.+...+..+.+++.+|++.||++|||++|+++.
T Consensus 230 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 344556779999999999999999999999873
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=345.41 Aligned_cols=256 Identities=24% Similarity=0.331 Sum_probs=204.7
Q ss_pred hccCCCCccCCCCceEEEEEEe----CCCcEEEEEEeecCCc---cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCc
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL----QDGRSVAIKKLTVSGL---IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 753 (967)
+.|+..+.||+|+||.||+++. .+++.||||++..... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 3468889999999999999997 3689999999865431 22345678899999999 69999999999999999
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++||||+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999999976543 8899999999999999999999999999999999999999999999999998654
Q ss_pred CCccccccccccccccccCcccccC-cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACR-TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV 912 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (967)
.. .........||+.|+|||++.. ...++.++|||||||++|||++|+.||....... ....+......
T Consensus 211 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~-------- 280 (355)
T 1vzo_A 211 AD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILK-------- 280 (355)
T ss_dssp GG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHH--------
T ss_pred cC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhc--------
Confidence 32 2222335678999999999843 2457899999999999999999999997432211 11122221111
Q ss_pred chhhcCCCChhhHHHHHHHHHhhccCCCCCCC-----CHHHHHHHH
Q 002094 913 DARLRGNFPADEAIPVIKLGLICASQVPSNRP-----DMEEVVNIL 953 (967)
Q Consensus 913 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~~L 953 (967)
....++...+..+.+++.+|++.||++|| |++|+++..
T Consensus 281 ---~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 281 ---SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ---cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 12334566677899999999999999999 999987643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=332.33 Aligned_cols=247 Identities=27% Similarity=0.403 Sum_probs=198.9
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEc----CCceeE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWT----PSLQLL 756 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l 756 (967)
.|...+.||+|+||.||+|... ++..||+|.+..... ....+.+.+|++++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4667778999999999999964 578999999976543 3345779999999999999999999998864 355789
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCEEeC-CCCCeEEeecccccccC
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN--IIHYNLKSTNVLID-SSGEPKVGDFGLARLLP 833 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~--ivH~Dik~~Nill~-~~~~~kl~Dfg~a~~~~ 833 (967)
||||+++++|.+++..... +++..++.++.|++.||+|||+++ |+||||||+||+++ .++.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHccC---CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999976433 889999999999999999999998 99999999999997 78999999999997543
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcc
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (967)
.. ......|++.|+|||.+ . +.++.++||||+|+++|+|++|+.||............ ......
T Consensus 184 ~~----~~~~~~~t~~y~aPE~~-~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~~~~------ 247 (290)
T 1t4h_A 184 AS----FAKAVIGTPEFMAPEMY-E-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR----VTSGVK------ 247 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGG-G-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH----HTTTCC------
T ss_pred cc----ccccccCCcCcCCHHHH-h-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH----HhccCC------
Confidence 21 22345689999999987 3 45899999999999999999999999754443222111 111000
Q ss_pred hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 914 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+...+.++.+++.+|++.||++|||++|+++
T Consensus 248 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 ---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 01122333457999999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=352.52 Aligned_cols=254 Identities=21% Similarity=0.304 Sum_probs=192.2
Q ss_pred HhhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-------cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC
Q 002094 680 ANALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-------IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP 751 (967)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 751 (967)
..+.|...+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3456788999999999999999965 589999999975431 1122358899999999999999999999854
Q ss_pred CceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC---CeEEeeccc
Q 002094 752 SLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG---EPKVGDFGL 828 (967)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~---~~kl~Dfg~ 828 (967)
+..++||||+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 557999999999999999876543 89999999999999999999999999999999999997544 599999999
Q ss_pred ccccCCCccccccccccccccccCcccccC--cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC
Q 002094 829 ARLLPMLDRCILSSKIQSALGYMAPEFACR--TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG 906 (967)
Q Consensus 829 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (967)
++.... ........||+.|+|||++.. ...++.++||||+|+++|||++|+.||............+.. +
T Consensus 289 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~-----~ 360 (419)
T 3i6u_A 289 SKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-----G 360 (419)
T ss_dssp TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT-----T
T ss_pred ceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc-----C
Confidence 987643 222345678999999998742 456788999999999999999999999754332221111111 1
Q ss_pred CchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 907 RVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.... .+. .....+..+.+++.+|++.||++|||++|+++
T Consensus 361 ~~~~--~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 361 KYNF--IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCCC--CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC--Cch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000 000 01234567999999999999999999999876
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=344.20 Aligned_cols=260 Identities=21% Similarity=0.335 Sum_probs=205.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|... +++.||+|++.........+.+.+|++++++++||||+++++++..++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 34678889999999999999966 68999999998765445567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
+++++|.+++..... +++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++..... .
T Consensus 113 ~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~ 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 185 (360)
T ss_dssp CTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----H
T ss_pred CCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc----c
Confidence 999999999976543 88999999999999999999996 999999999999999999999999999875422 1
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhh-----------------
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGA----------------- 902 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~----------------- 902 (967)
......||+.|+|||.+ ....++.++||||+|+++|||++|+.||.......... .....
T Consensus 186 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL--MFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp C----CCCCTTCCHHHH-TTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHH--HHC-------------------
T ss_pred cccCCCCCCCeECHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HhcccccccCCCCCCCcccCCC
Confidence 22345789999999998 56678999999999999999999999997544322111 00000
Q ss_pred ---------hccCCchhhcchhhc---CC-CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 903 ---------LEDGRVEDCVDARLR---GN-FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 903 ---------~~~~~~~~~~~~~~~---~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.......+..+.... .. .....+.++.+++.+|++.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000001111111111 11 12235667999999999999999999999976
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=332.78 Aligned_cols=246 Identities=17% Similarity=0.271 Sum_probs=200.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||+|... +++.||||++..... .....++.+|+..+.++ +||||+++++++.+++..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 44688899999999999999976 799999999976532 33456788999999998 9999999999999999999999
Q ss_pred EecCCCchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC-------------------
Q 002094 759 EFISSGSLYKHLHDGSS-RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS------------------- 818 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~------------------- 818 (967)
||+++++|.+++..... ...+++..++.++.||+.||+|||++||+||||||+||+++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 99999999999976421 1238999999999999999999999999999999999999844
Q ss_pred CCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHH
Q 002094 819 GEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDM 898 (967)
Q Consensus 819 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~ 898 (967)
..+||+|||.+...... ....||+.|+|||.+.....++.++||||+|+++|||++|.+|+..... ...+
T Consensus 171 ~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----~~~~ 240 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEI 240 (289)
T ss_dssp CCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----HHHH
T ss_pred eEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----HHHH
Confidence 47999999999866431 2345899999999985555677899999999999999999987643211 1111
Q ss_pred HHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 899 VRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
. . ......+...+.++.+++.+|++.||++|||+.|+++
T Consensus 241 ~-----~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 241 R-----Q---------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp H-----T---------TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-----c---------CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 1 1122345556778999999999999999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=333.61 Aligned_cols=249 Identities=21% Similarity=0.299 Sum_probs=206.6
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|...+.||+|+||.||++... +++.||+|.+..... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 45788899999999999999976 578999999876532 234567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.+.......
T Consensus 95 e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-- 169 (294)
T ss_dssp ECCTTCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred ecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc--
Confidence 99999999999876433 8899999999999999999999999999999999999999999999999998664321
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......|++.|+|||.+ ....++.++||||+|+++|||++|+.||........ ...+. .. ..
T Consensus 170 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~-----~~----------~~ 232 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIK-----KN----------EY 232 (294)
T ss_dssp CCBCCCCSCCSSCCHHHH-TTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHH-----TT----------CC
T ss_pred cccccccCCCCcCCcchh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHh-----hc----------cC
Confidence 223446689999999998 566789999999999999999999999975443211 11111 00 11
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..+...+..+.+++.+|++.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 2344556779999999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=355.23 Aligned_cols=250 Identities=24% Similarity=0.321 Sum_probs=204.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|...+.||+|+||.||+|+.+ +|+.||+|++..... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 34567788999999999999975 689999999975432 234567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 759 EFISSGSLYKHLHDGSS-RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
||++||+|.+++..... ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~- 343 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ- 343 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC-
Confidence 99999999999976542 2348999999999999999999999999999999999999999999999999998764322
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.......||+.|+|||++ .+..++.++||||+||++|||++|+.||....... ...++...... ..
T Consensus 344 -~~~~~~~GT~~Y~APE~l-~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~~-----------~~ 409 (543)
T 3c4z_A 344 -TKTKGYAGTPGFMAPELL-LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVLE-----------QA 409 (543)
T ss_dssp -CCBCCCCSCTTTSCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHHH-----------CC
T ss_pred -cccccccCCccccChhhh-cCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHhh-----------cc
Confidence 123345799999999998 55678999999999999999999999997543211 11111111111 01
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDM 946 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 946 (967)
..++...+..+.+++.+|++.||++||++
T Consensus 410 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 VTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 23456667789999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=331.19 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=208.4
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 34688889999999999999965 578899999865432 223567999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.+......
T Consensus 94 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred EeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence 99999999999976543 889999999999999999999999999999999999999999999999998765431
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
......|++.|+|||.+ ....++.++||||+|+++|||++|+.||........ ...+. . ...
T Consensus 168 -~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~----~-----------~~~ 229 (284)
T 2vgo_A 168 -RRRTMCGTLDYLPPEMI-EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-HRRIV----N-----------VDL 229 (284)
T ss_dssp -CBCCCCSCGGGCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHH----T-----------TCC
T ss_pred -ccccccCCCCcCCHHHh-ccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-HHHHh----c-----------ccc
Confidence 22345689999999998 566789999999999999999999999975433211 11111 0 112
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH--HHHhhcCC
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN--ILELIQSP 959 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~--~L~~~~~~ 959 (967)
.++...+..+.+++.+|++.||++|||++|+++ .++...+.
T Consensus 230 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~ 272 (284)
T 2vgo_A 230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272 (284)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCC
T ss_pred CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccc
Confidence 344556678999999999999999999999986 44444433
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.62 Aligned_cols=265 Identities=22% Similarity=0.268 Sum_probs=201.4
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEc--------C
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWT--------P 751 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~ 751 (967)
+.|+..+.||+|+||.||+|+. .+|+.||||++..... ......+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 3478889999999999999997 4789999999866543 2334678899999999999999999999876 3
Q ss_pred CceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 752 SLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
+..++||||+++ +|.+.+..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 467899999986 77777765433 289999999999999999999999999999999999999999999999999987
Q ss_pred cCCCc--cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC---
Q 002094 832 LPMLD--RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG--- 906 (967)
Q Consensus 832 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 906 (967)
..... .........||+.|+|||.+.....++.++||||+|+++|||++|+.||....... ....+. ......
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~-~~~~~~~~~ 251 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALIS-QLCGSITPE 251 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH-HHHCCCCTT
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH-HHhCCCChh
Confidence 64322 12223456789999999988555678999999999999999999999997544322 122221 111111
Q ss_pred CchhhcchhhcC-------CC-C-h------hhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 907 RVEDCVDARLRG-------NF-P-A------DEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 907 ~~~~~~~~~~~~-------~~-~-~------~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
............ .. . . ..+..+.+++.+|++.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 011100000000 00 0 0 11355889999999999999999999886
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.70 Aligned_cols=253 Identities=21% Similarity=0.273 Sum_probs=189.5
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCcccc-HHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKS-QEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|+..+.||+|+||.||+|.. .+|+.||||++........ .+.+.++...++.++||||+++++++.+++..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 4468888999999999999996 4789999999976543333 3344555556888899999999999999999999999
Q ss_pred ecCCCchhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 760 FISSGSLYKHLHDG-SSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 760 ~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|+++ +|.+++... .....+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++......
T Consensus 87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 163 (290)
T 3fme_A 87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-- 163 (290)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc--
Confidence 9975 887777542 1122389999999999999999999998 9999999999999999999999999999766432
Q ss_pred ccccccccccccccCcccc---cCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 838 CILSSKIQSALGYMAPEFA---CRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~---~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
.......||+.|+|||.+ .....++.++||||+|+++|||++|+.||+............+...
T Consensus 164 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 230 (290)
T 3fme_A 164 -VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP------------ 230 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC------------
T ss_pred -ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC------------
Confidence 223345689999999986 2456789999999999999999999999976544433332222211
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+...+.++.+++.+|++.||++|||++|+++
T Consensus 231 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 -SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111122345667999999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.79 Aligned_cols=264 Identities=22% Similarity=0.250 Sum_probs=201.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccc----cHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIK----SQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLL 756 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 756 (967)
+.|+..+.||+|+||.||+|+.. +|+.||||++....... ....+.+|++++++++||||+++++++.+.+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 45788899999999999999965 58999999997543211 12468899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
||||+++ +|.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 90 v~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEECCSE-EHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEcCCC-CHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 9999986 88888876432 37889999999999999999999999999999999999999999999999998664322
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch--
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA-- 914 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 914 (967)
.......+|+.|+|||.+.....++.++||||+|+++|||++|.+||...... ..+..+.... .......+.+.
T Consensus 167 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~-~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 167 --RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETL-GTPTEEQWPDMCS 242 (346)
T ss_dssp --CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH-CCCCTTTSSSTTS
T ss_pred --ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHc-CCCChhhhhhhcc
Confidence 22345678999999999855556899999999999999999999999754432 2223332221 11111111110
Q ss_pred -------hhcCCC-----ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 915 -------RLRGNF-----PADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 915 -------~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
...... ....+.++.+++.+|++.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000001 13445779999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=335.75 Aligned_cols=256 Identities=18% Similarity=0.221 Sum_probs=203.2
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEc--CCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWT--PSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv 757 (967)
+.|+..+.||+|+||.||+|+. .+++.||||++... ..+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 4578889999999999999985 57899999998743 3577999999999997 9999999999987 5678999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC-CeEEeecccccccCCCc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG-EPKVGDFGLARLLPMLD 836 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~~~~~ 836 (967)
|||+++++|.+++.. +++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 112 ~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 999999999999854 78899999999999999999999999999999999999776 89999999998664322
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcc---
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD--- 913 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 913 (967)
......+++.|+|||.+.....++.++||||+|+++|||++|+.||.........+..+....- .....+..+
T Consensus 186 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~-~~~~~~~~~~~~ 261 (330)
T 3nsz_A 186 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG-TEDLYDYIDKYN 261 (330)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC-HHHHHHHHHHTT
T ss_pred ---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC-CchhhhHHHHhc
Confidence 2344568889999999855577899999999999999999999999655444333333222110 000000000
Q ss_pred --------------------hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 914 --------------------ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 914 --------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.......+...+.++.+++.+|++.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00111122335678999999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=347.58 Aligned_cols=244 Identities=21% Similarity=0.279 Sum_probs=187.4
Q ss_pred CCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHc-CCCCCceeeeeeEEEc----CCceeEEEEe
Q 002094 687 DCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLG-KIRHHNLVALEGYYWT----PSLQLLIYEF 760 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~----~~~~~lv~e~ 760 (967)
.+.||+|+||.||++..+ +++.||||++... ..+.+|++++. ..+||||+++++++.. ....++||||
T Consensus 67 ~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~ 140 (400)
T 1nxk_A 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140 (400)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred cceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence 368999999999999965 6899999998632 35778888864 4589999999998865 5668999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC---CCCeEEeecccccccCCCcc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS---SGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~---~~~~kl~Dfg~a~~~~~~~~ 837 (967)
+++|+|.+++...... .+++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||+++.....
T Consensus 141 ~~gg~L~~~l~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~-- 217 (400)
T 1nxk_A 141 LDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-- 217 (400)
T ss_dssp CCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred CCCCcHHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC--
Confidence 9999999999875432 3899999999999999999999999999999999999987 789999999999865421
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchH---hHHHHHHhhhccCCchhhcch
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVV---VLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 914 (967)
.......||+.|+|||++ ....++.++|||||||++|||++|+.||........ ....+..+..
T Consensus 218 -~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~----------- 284 (400)
T 1nxk_A 218 -NSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY----------- 284 (400)
T ss_dssp ----------CTTCCGGGS-CCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC-----------
T ss_pred -CccccCCCCCCccCHhhc-CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc-----------
Confidence 223456689999999998 667899999999999999999999999974432110 1111111100
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..........+.++.+++.+|++.||++|||++|+++.
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00111123456779999999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=352.01 Aligned_cols=266 Identities=20% Similarity=0.216 Sum_probs=188.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC-----Cce
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP-----SLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 754 (967)
+.|+..+.||+|+||.||+|+.. +++.||||++..... ....+++.+|++++++++|||||++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 45788999999999999999855 689999999965432 33457899999999999999999999998533 568
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
++||||+. ++|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~lv~e~~~-~~L~~~~~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRTPVY---LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCCS-EEHHHHHHSSCC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEeccc-cchhhhcccCCC---CCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 99999985 699999876543 89999999999999999999999999999999999999999999999999987643
Q ss_pred Cccc-------------------------cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc---------
Q 002094 835 LDRC-------------------------ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT--------- 880 (967)
Q Consensus 835 ~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt--------- 880 (967)
.... .......||+.|+|||++.....++.++||||+||++|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 2111 122345679999999987566779999999999999999999
Q ss_pred --CCCCCCCCccc------------------hHhHHHHHHhhhccCCchhh-----------cch---hh---cCCCChh
Q 002094 881 --GKRPVEYMEDD------------------VVVLCDMVRGALEDGRVEDC-----------VDA---RL---RGNFPAD 923 (967)
Q Consensus 881 --g~~p~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~-----------~~~---~~---~~~~~~~ 923 (967)
|+++|...... .......+...+.......+ ... .. .....+.
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 66666432210 00111111111111110000 000 00 0001133
Q ss_pred hHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 924 EAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+.++.+|+.+|+..||++|||++|+++
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 4677999999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=338.81 Aligned_cols=249 Identities=21% Similarity=0.308 Sum_probs=206.5
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
.+.|...+.||+|+||.||++... +++.||+|++..... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 345788899999999999999965 478999999876532 23457789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 195 (335)
T ss_dssp ECCCTTCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EecCCCCCHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence 999999999999876433 8999999999999999999999999999999999999999999999999998764322
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.......|++.|+|||.+ ....++.++||||||+++|||++|+.||........ ...+... .
T Consensus 196 -~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~---------------~ 257 (335)
T 2owb_A 196 -ERKKVLCGTPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKN---------------E 257 (335)
T ss_dssp -CCBCCCCSCCSSCCHHHH-HTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHT---------------C
T ss_pred -ccccccCCCccccCHHHh-ccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHhcC---------------C
Confidence 223456689999999998 556789999999999999999999999975433211 1111110 1
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+...+..+.+++.+|++.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1234455677999999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.79 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=202.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|...+.||+|+||.||+++.. +|+.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 44688899999999999999965 68999999998654 23446789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEe---CCCCCeEEeecccccccCCCcc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLI---DSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill---~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
+++++|.+++..... +++..+..++.|++.||+|||++||+||||||+||++ +.++.++|+|||++.....
T Consensus 88 ~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--- 161 (304)
T 2jam_A 88 VSGGELFDRILERGV---YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--- 161 (304)
T ss_dssp CCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC---
T ss_pred CCCccHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC---
Confidence 999999999876443 8899999999999999999999999999999999999 7888999999999875432
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.......|++.|+|||.+ ....++.++||||+|+++|||++|+.||...... .....+..+.. ...
T Consensus 162 -~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~-----------~~~ 227 (304)
T 2jam_A 162 -GIMSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-KLFEKIKEGYY-----------EFE 227 (304)
T ss_dssp -BTTHHHHSCCCBCCTTTB-SSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHCCC-----------CCC
T ss_pred -CccccccCCCCccChHHh-ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCC-----------CCC
Confidence 122345688999999998 5667899999999999999999999999754322 11111111110 011
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.......+..+.+++.+|++.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1233456678999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=339.68 Aligned_cols=260 Identities=23% Similarity=0.375 Sum_probs=200.3
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|..+. .||+|++..... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 110 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred HHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence 346888999999999999998753 499999876532 23345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc---c
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD---R 837 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~---~ 837 (967)
+++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++ ++.+||+|||++....... .
T Consensus 111 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 111 CKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp CCSEEHHHHTTSSCC--CCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred ccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 999999999976542 388999999999999999999999999999999999998 6899999999987553211 1
Q ss_pred ccccccccccccccCcccccC--------cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 838 CILSSKIQSALGYMAPEFACR--------TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~--------~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
........|++.|+|||.+.. ...++.++||||||+++|||++|+.||........ ..... . ..
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~----~-~~-- 259 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-IWQMG----T-GM-- 259 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-HHHHH----T-TC--
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhc----c-CC--
Confidence 122234558899999998843 24578899999999999999999999975543211 11111 0 00
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
. ....+...+.++.+++.+|++.||++|||+++++++|+++.+..
T Consensus 260 ---~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 260 ---K---PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp ---C---CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred ---C---CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 00111234456999999999999999999999999999988654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=342.81 Aligned_cols=257 Identities=24% Similarity=0.291 Sum_probs=189.0
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEE--------cCC
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYW--------TPS 752 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--------~~~ 752 (967)
.|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++++. ||||+++++++. ...
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 5788899999999999999964 68999999986554 344567899999999996 999999999984 334
Q ss_pred ceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 753 LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN--IIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~--ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
..++||||+. |+|.+++........+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence 4789999996 699998876433345899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCcccc----------ccccccccccccCccccc--CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHH
Q 002094 831 LLPMLDRCI----------LSSKIQSALGYMAPEFAC--RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDM 898 (967)
Q Consensus 831 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~--~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~ 898 (967)
......... ......||+.|+|||.+. ....++.++||||||+++|||++|+.||...... .+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~ 261 (337)
T 3ll6_A 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-----RI 261 (337)
T ss_dssp CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----Hh
Confidence 764322211 111345889999999873 3456889999999999999999999999643221 11
Q ss_pred HHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 899 VRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
.........+...+..+.+++.+|++.||++|||++|+++.|+++...
T Consensus 262 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 262 -------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111122233345588999999999999999999999999988643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.90 Aligned_cols=255 Identities=21% Similarity=0.338 Sum_probs=203.7
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEE--cCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYW--TPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv 757 (967)
+.|+..+.||+|+||.||++... +++.||+|.+..... ....+.+.+|++++++++||||+++++++. .....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 34678889999999999999965 689999999976543 334567999999999999999999999875 35678999
Q ss_pred EEecCCCchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 758 YEFISSGSLYKHLHDGSS-RNCLSWRQRFNIILGMAKGLAYLHHTN-----IIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~-----ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
|||+++++|.+++..... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+..
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 999999999999975322 224899999999999999999999998 99999999999999999999999999976
Q ss_pred cCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (967)
..... .......|++.|+|||.+ ....++.++||||+|+++|||++|+.||...... . ....+ ..+
T Consensus 166 ~~~~~--~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~-~~~~i----~~~----- 231 (279)
T 2w5a_A 166 LNHDT--SFAKTFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-E-LAGKI----REG----- 231 (279)
T ss_dssp C---C--HHHHHHHSCCTTCCHHHH-HCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-H-HHHHH----HHT-----
T ss_pred ecccc--ccccccCCCccccChHHh-ccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-H-HHHHH----hhc-----
Confidence 54321 112345688999999998 5557899999999999999999999999754322 1 11111 111
Q ss_pred cchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 912 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
.....+...+.++.+++.+|++.||++|||++|+++.+.
T Consensus 232 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 232 ----KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ----ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 112334556778999999999999999999999987654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=346.97 Aligned_cols=261 Identities=21% Similarity=0.286 Sum_probs=197.6
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCc------ee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSL------QL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~ 755 (967)
..|+..+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+. .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 35788899999999999999988788899999865432 22479999999999999999999865433 67
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC-CCCCeEEeecccccccCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID-SSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~-~~~~~kl~Dfg~a~~~~~ 834 (967)
+||||++++.+....+.......+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|||+++....
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 9999998754444333222223489999999999999999999999999999999999998 799999999999987643
Q ss_pred CccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh---
Q 002094 835 LDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC--- 911 (967)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 911 (967)
.. ......+|+.|+|||.+.....++.++||||+||++|||++|+.||...... ..+..++... ..+....+
T Consensus 195 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~-g~p~~~~~~~~ 269 (394)
T 4e7w_A 195 GE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVL-GTPSREQIKTM 269 (394)
T ss_dssp TC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH-CCCCHHHHHHH
T ss_pred CC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh-CCCCHHHHHhh
Confidence 22 2335668999999998856667999999999999999999999999754432 2222332211 11110000
Q ss_pred ------------cchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 912 ------------VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 912 ------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
........++...+.++.+++.+|++.||++|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000111233456789999999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=366.24 Aligned_cols=257 Identities=26% Similarity=0.355 Sum_probs=207.2
Q ss_pred hccCCCCccCCCCceEEEEEEeCC----CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|+..+.||+|+||.||+|.... +..||||++.........+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 446778899999999999999642 46799999876554445578999999999999999999999985 4668999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++|+|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 469 ~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~- 545 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST- 545 (656)
T ss_dssp EECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred EEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc-
Confidence 999999999999986532 38899999999999999999999999999999999999999999999999998764322
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
........+++.|+|||.+ ....++.++||||||+++|||++ |..||........ . ..+. ...
T Consensus 546 ~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-~-~~i~-------------~~~ 609 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-I-GRIE-------------NGE 609 (656)
T ss_dssp --------CCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-H-HHHH-------------HTC
T ss_pred ceeccCCCCCcceeCHHHh-cCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH-H-HHHH-------------cCC
Confidence 1222344567889999998 56688999999999999999997 9999975443211 1 1111 111
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
+...+..++..+.+++.+|++.||++|||+.|+++.|+++.+
T Consensus 610 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 610 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 233456677889999999999999999999999999998863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=353.39 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=203.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|+..+.||+|+||+||+|+.+ +++.||||++..... ......+.+|++++++++||||+++++++.++...++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 45788999999999999999965 689999999965432 3456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC---CCCCeEEeecccccccCCCc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID---SSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~---~~~~~kl~Dfg~a~~~~~~~ 836 (967)
|+++|+|.+.+..... +++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|||+++.....
T Consensus 102 ~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp CCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 9999999999876543 89999999999999999999999999999999999995 4567999999999866432
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.......||+.|+|||++. +.++.++||||+||++|+|++|++||...... .....+..+... .
T Consensus 178 --~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~-----------~ 241 (486)
T 3mwu_A 178 --TKMKDRIGTAYYIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGKYA-----------F 241 (486)
T ss_dssp ------CCTTGGGGCCGGGGG--SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCC-----------S
T ss_pred --CccCCCcCCCCCCCHHHhC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC-----------C
Confidence 2233557899999999983 35899999999999999999999999754332 112211111110 0
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..+.....+.++.+++.+|++.||++|||+.|+++.
T Consensus 242 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001123456679999999999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=348.90 Aligned_cols=258 Identities=21% Similarity=0.225 Sum_probs=193.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC------c
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS------L 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~ 753 (967)
+.|+..+.||+|+||.||+|... +++.||||++..... ....+++.+|+++++.++||||+++++++.... .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 44788899999999999999854 689999999976532 334577899999999999999999999996553 4
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++||||+++ ++.+.+... +++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 142 ~~lv~E~~~~-~l~~~~~~~-----l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 142 VYLVMELMDA-NLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEEEECCSE-EHHHHHTSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEEEEeCCCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 6999999987 466666432 7899999999999999999999999999999999999999999999999998654
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc-----
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV----- 908 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 908 (967)
. ........||+.|+|||++ .+..++.++||||+||++|||++|+.||...... ..+..++... ..+..
T Consensus 216 ~---~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~l-g~p~~~~~~~ 289 (464)
T 3ttj_A 216 T---SFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQL-GTPCPEFMKK 289 (464)
T ss_dssp ----CCCC----CCCTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH-CSCCHHHHTT
T ss_pred C---CcccCCCcccccccCHHHH-cCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc-CCCCHHHHHH
Confidence 3 2223456789999999998 5568999999999999999999999999754432 2222222211 10000
Q ss_pred -----hhhcch---------------hhcCCC---ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 909 -----EDCVDA---------------RLRGNF---PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 909 -----~~~~~~---------------~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...++. ...... ....+.++.+++.+|++.||++|||++|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 000000 0112567999999999999999999999876
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=337.24 Aligned_cols=256 Identities=22% Similarity=0.354 Sum_probs=204.3
Q ss_pred HHHhhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-------ccHHHHHHHHHHHcCC-CCCceeeeeeEE
Q 002094 678 AGANALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-------KSQEDFEKEMKTLGKI-RHHNLVALEGYY 748 (967)
Q Consensus 678 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 748 (967)
....+.|+..+.||+|+||.||+|+.. +|+.||||++...... ...+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 334455788899999999999999975 7999999999765421 1145688999999999 799999999999
Q ss_pred EcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccc
Q 002094 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGL 828 (967)
Q Consensus 749 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~ 828 (967)
...+..++||||+++++|.+++..... +++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVA---LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCc
Confidence 999999999999999999999976433 89999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccC-----cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhh
Q 002094 829 ARLLPMLDRCILSSKIQSALGYMAPEFACR-----TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGAL 903 (967)
Q Consensus 829 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 903 (967)
+....... ......||+.|+|||++.. ...++.++||||||+++|||++|+.||...... .....+.....
T Consensus 247 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~ 322 (365)
T 2y7j_A 247 SCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-LMLRMIMEGQY 322 (365)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC
T ss_pred ccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCC
Confidence 98764322 2345678999999998732 235788999999999999999999999654321 11111111100
Q ss_pred ccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 904 EDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
. ...+ .....+..+.+++.+|++.||++|||++|+++
T Consensus 323 ~------~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 323 Q------FSSP-----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp C------CCHH-----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C------CCCc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0000 01234566999999999999999999999976
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=331.83 Aligned_cols=253 Identities=22% Similarity=0.359 Sum_probs=200.0
Q ss_pred HHHhhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeE
Q 002094 678 AGANALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLL 756 (967)
Q Consensus 678 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 756 (967)
....+.|+..+.||+|+||.||+|... +|+.||||.+.... ....+.+|++++++++||||+++++++...+..++
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 334556788899999999999999975 58999999997653 34678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
||||+++++|.+++..... .+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||.+......
T Consensus 102 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT- 178 (314)
T ss_dssp EEECCTTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT-
T ss_pred EeecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh-
Confidence 9999999999999874322 3899999999999999999999999999999999999999999999999999765432
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
........|++.|+|||.+ ....++.++||||+|+++|+|++|+.||......... .. ..... ..
T Consensus 179 -~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~----~~~~~--------~~ 243 (314)
T 3com_A 179 -MAKRNTVIGTPFWMAPEVI-QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI-FM----IPTNP--------PP 243 (314)
T ss_dssp -BSCBCCCCSCGGGCCHHHH-SSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HH----HHHSC--------CC
T ss_pred -ccccCccCCCCCccChhhc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH-HH----HhcCC--------Cc
Confidence 1223455789999999998 5567899999999999999999999999754332111 10 00000 00
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+...+..+.+++.+|++.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11123445677999999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=353.58 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=198.7
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|+..+.||+|+||.||+|+.+ ++..||||++..... ......+.+|+++++.++|||||++++++.++...++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 35788899999999999999965 688999999976542 2345779999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC---CCCeEEeecccccccCCCc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS---SGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~---~~~~kl~Dfg~a~~~~~~~ 836 (967)
|+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||++......
T Consensus 117 ~~~~g~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 117 CYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp CCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred cCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 9999999998876543 889999999999999999999999999999999999976 445999999999876432
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.......||+.|+|||++ . ..++.++||||+||++|+|++|++||...... .....+.......
T Consensus 193 --~~~~~~~gt~~y~aPE~l-~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~----------- 256 (494)
T 3lij_A 193 --KKMKERLGTAYYIAPEVL-R-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-EILRKVEKGKYTF----------- 256 (494)
T ss_dssp --BCBCCCCSCTTTCCHHHH-T-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCC-----------
T ss_pred --ccccccCCCcCeeCHHHH-c-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCC-----------
Confidence 223456799999999988 3 46899999999999999999999999754432 2122211111100
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+.....+..+.+++.+|++.||.+|||+.|+++
T Consensus 257 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00111234567999999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=340.96 Aligned_cols=258 Identities=22% Similarity=0.279 Sum_probs=196.5
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC------c
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS------L 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~ 753 (967)
+.|+..+.||+|+||.||+|.. .+|+.||||++..... ....+++.+|+++++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 4478888999999999999996 4689999999965432 234567899999999999999999999997653 4
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++||||+ +++|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 59999999 78999999763 28899999999999999999999999999999999999999999999999998654
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc-----
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV----- 908 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 908 (967)
. ......+|+.|+|||.+.....++.++||||+||++|||++|+.||...... ..+..++... .....
T Consensus 180 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~-g~~~~~~~~~ 252 (367)
T 1cm8_A 180 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVT-GTPPAEFVQR 252 (367)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH-CCCCHHHHHT
T ss_pred c-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc-CCCCHHHHHH
Confidence 2 1234568999999999855578999999999999999999999999754432 2222222111 10000
Q ss_pred ------hhhcch------hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 909 ------EDCVDA------RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 909 ------~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...... .-........+..+.+++.+|++.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000000 0001122345677999999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=355.06 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=205.3
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||+|+.. +|+.||||++..... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 45788899999999999999965 789999999976543 345678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEe---CCCCCeEEeecccccccCCC
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLI---DSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill---~~~~~~kl~Dfg~a~~~~~~ 835 (967)
||+.+|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 106 e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 106 EVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp CCCCSCBHHHHHHTCSC---CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred ecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 99999999999976543 8999999999999999999999999999999999999 46789999999999866432
Q ss_pred ccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 836 DRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
. ......||+.|+|||.+. +.++.++||||+||++|+|++|++||...... .....+..+...
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~----------- 245 (484)
T 3nyv_A 183 K---KMKDKIGTAYYIAPEVLH--GTYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKYT----------- 245 (484)
T ss_dssp C---SHHHHTTGGGTCCHHHHH--TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCC-----------
T ss_pred c---ccccCCCCccccCceeec--CCCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCC-----------
Confidence 2 233456899999999883 36899999999999999999999999754432 112111111100
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+.....+.++.+++.+|++.||++|||+.|+++
T Consensus 246 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 001112345677999999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=347.46 Aligned_cols=266 Identities=19% Similarity=0.212 Sum_probs=197.4
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC-----Cce
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP-----SLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 754 (967)
+.|+..+.||+|+||.||+|+.. +++.||||++..... ....+++.+|++++++++||||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 45788899999999999999965 588999999975432 33457899999999999999999999998765 568
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
++||||++ ++|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 106 ~lv~e~~~-~~L~~~~~~~~~---l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTPIF---LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEecCC-cCHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99999987 499999976543 89999999999999999999999999999999999999999999999999987643
Q ss_pred Cccc--------------------cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCC--------
Q 002094 835 LDRC--------------------ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVE-------- 886 (967)
Q Consensus 835 ~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~-------- 886 (967)
.... .......||+.|+|||++.....++.++||||+||++|||++|..||.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 2211 122456789999999987567779999999999999999998554443
Q ss_pred ---CCcc---------------chHhHHHHHHhhhccCCchh-----------hcchh-hcCCC-----ChhhHHHHHHH
Q 002094 887 ---YMED---------------DVVVLCDMVRGALEDGRVED-----------CVDAR-LRGNF-----PADEAIPVIKL 931 (967)
Q Consensus 887 ---~~~~---------------~~~~~~~~~~~~~~~~~~~~-----------~~~~~-~~~~~-----~~~~~~~l~~l 931 (967)
.... ........+...+..+.... .+... ..... .+..+.++.++
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 1110 00011111111111111100 00000 00000 12356679999
Q ss_pred HHhhccCCCCCCCCHHHHHH
Q 002094 932 GLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 932 i~~cl~~dP~~Rpt~~evl~ 951 (967)
+.+|++.||++|||++|+++
T Consensus 342 l~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhcCCcccCCCHHHHhc
Confidence 99999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.23 Aligned_cols=253 Identities=21% Similarity=0.337 Sum_probs=199.8
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCC--CCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIR--HHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||++..++++.||||++..... ....+.+.+|++++++++ ||||+++++++..++..++||
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 45788899999999999999988899999999976543 334578999999999997 599999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
| +.+++|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++.........
T Consensus 108 e-~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 108 E-CGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp C-CCSEEHHHHHHHCSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-------
T ss_pred e-cCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcccc
Confidence 9 567899999987543 88999999999999999999999999999999999996 489999999999876543333
Q ss_pred cccccccccccccCcccccC----------cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc
Q 002094 839 ILSSKIQSALGYMAPEFACR----------TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV 908 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~----------~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 908 (967)
.......|++.|+|||.+.. ...++.++||||+|+++|||++|+.||............
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~----------- 251 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA----------- 251 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH-----------
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH-----------
Confidence 33345668999999998733 146888999999999999999999999754433222211
Q ss_pred hhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
..+......++...+.++.+++.+|++.||++|||++|+++.
T Consensus 252 --~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 252 --IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp --HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 122222334455556789999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.88 Aligned_cols=264 Identities=20% Similarity=0.268 Sum_probs=204.1
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccc----------------cHHHHHHHHHHHcCCCCCceeeee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIK----------------SQEDFEKEMKTLGKIRHHNLVALE 745 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~~~ 745 (967)
+.|+..+.||+|+||.||+|.. +++.||||++....... ..+.+.+|++++++++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3478888999999999999999 89999999997543211 117899999999999999999999
Q ss_pred eEEEcCCceeEEEEecCCCchhhh------hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCC
Q 002094 746 GYYWTPSLQLLIYEFISSGSLYKH------LHDGSSRNCLSWRQRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSS 818 (967)
Q Consensus 746 ~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~ 818 (967)
+++.+.+..++||||+++++|.++ +.... ...+++..++.++.|++.||+|||+ +||+||||||+||+++.+
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence 999999999999999999999999 54422 2348999999999999999999999 999999999999999999
Q ss_pred CCeEEeecccccccCCCccccccccccccccccCcccccCcccCCc-ccchhhHHHHHHHHHcCCCCCCCCccchHhHHH
Q 002094 819 GEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITE-KCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCD 897 (967)
Q Consensus 819 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~-~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~ 897 (967)
+.+||+|||.+...... ......|++.|+|||.+.....++. ++||||+|+++|||++|+.||............
T Consensus 189 ~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp SCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred CcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 99999999999865432 2345678999999999844435655 999999999999999999999755442222222
Q ss_pred HHHhhhccCCchh-hcch---hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 898 MVRGALEDGRVED-CVDA---RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 898 ~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+.......+.... .... ..........+.++.+++.+|++.||++|||++|+++
T Consensus 265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2111111000000 0000 0000011445678999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=353.84 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=200.4
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc------------ccHHHHHHHHHHHcCCCCCceeeeeeE
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI------------KSQEDFEKEMKTLGKIRHHNLVALEGY 747 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~~~~ 747 (967)
.+.|...+.||+|+||.||+|..+ +++.||||++...... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 345788899999999999999965 5789999999764321 335679999999999999999999999
Q ss_pred EEcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC---CeEEe
Q 002094 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG---EPKVG 824 (967)
Q Consensus 748 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~---~~kl~ 824 (967)
+.++...++||||+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999999999876543 89999999999999999999999999999999999998765 69999
Q ss_pred ecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc
Q 002094 825 DFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE 904 (967)
Q Consensus 825 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 904 (967)
|||++...... .......||+.|+|||.+ . +.++.++||||+||++|+|++|++||...... .....+..+...
T Consensus 192 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~ 265 (504)
T 3q5i_A 192 DFGLSSFFSKD---YKLRDRLGTAYYIAPEVL-K-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-DIIKKVEKGKYY 265 (504)
T ss_dssp CCTTCEECCTT---SCBCCCCSCTTTCCHHHH-T-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCC
T ss_pred ECCCCEEcCCC---CccccccCCcCCCCHHHh-c-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCC
Confidence 99999876432 223456789999999988 3 46899999999999999999999999754432 111111111000
Q ss_pred cCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 905 DGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.... .....+.++.+++.+|++.||.+|||++|+++
T Consensus 266 -------~~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 266 -------FDFN----DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -------CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------CCcc----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 01234567999999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=328.75 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=201.4
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc---cccHHHHHHHHHHHcCCCCCceeeeeeEEE--cCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL---IKSQEDFEKEMKTLGKIRHHNLVALEGYYW--TPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~ 755 (967)
+.|+..+.||+|+||.||++... +++.||+|++..... ....+.+.+|++++++++||||+++++++. +....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 45789999999999999999964 688999999975431 234578999999999999999999999984 456789
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+||||++++ +.+++...... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+......
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEK-RFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEehhccCC-HHHHHHhCccc-ccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 999999886 77777654333 3899999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccccccccCcccccCc-ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 836 DRCILSSKIQSALGYMAPEFACRT-VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
..........|++.|+|||..... ...+.++||||+|+++|||++|+.||...... .....+. ..
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~i~-----~~-------- 228 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-KLFENIG-----KG-------- 228 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHH-----HC--------
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHHHHh-----cC--------
Confidence 333333456689999999988432 23478999999999999999999999754321 1111111 00
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
....+...+..+.+++.+|++.||++|||++|+++.
T Consensus 229 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 --SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 122445667789999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=336.27 Aligned_cols=262 Identities=21% Similarity=0.317 Sum_probs=203.8
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC-----CceeE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP-----SLQLL 756 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 756 (967)
.|+..+.||+|+||.||+|... +++.||||++...........+.+|++++++++||||+++++++..+ ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 4788899999999999999965 68899999997655444557899999999999999999999998754 36799
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
||||+++ +|.+++.... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 108 v~e~~~~-~L~~~l~~~~----~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 108 VQDLMET-DLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEECCSE-EHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEcccCc-CHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 9999975 9999987632 8899999999999999999999999999999999999999999999999998765322
Q ss_pred cc-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh----
Q 002094 837 RC-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC---- 911 (967)
Q Consensus 837 ~~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 911 (967)
.. .......||+.|+|||.+.....++.++||||+|+++|||++|+.||........ +..++ ..........+
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~-~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHIL-GILGSPSQEDLNCII 260 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHH-HHHCSCCHHHHHTCC
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHH-HHhCCCCHHHHHHhh
Confidence 21 1124567899999999875666789999999999999999999999975443221 22222 11111111000
Q ss_pred -------cchhh-cCC-----CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 912 -------VDARL-RGN-----FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 912 -------~~~~~-~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..... ... .....+.++.+++.+|++.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 000 11334567999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=345.00 Aligned_cols=260 Identities=15% Similarity=0.204 Sum_probs=206.0
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCC-CceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRH-HNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|+..+.||+|+||.||+|+. .+++.||||++..... ..++.+|+++++.++| ++++.+..++...+..++|||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4578899999999999999995 5689999998876542 2347899999999976 566666667777888899999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEe---CCCCCeEEeecccccccCCCc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLI---DSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill---~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
|+ +++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 84 ~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99 8999999985433 38999999999999999999999999999999999999 578999999999998765422
Q ss_pred cc-----cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccc--hHhHHHHHHhhhccCCch
Q 002094 837 RC-----ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD--VVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 837 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~ 909 (967)
.. .......||+.|+|||.+ ....++.++|||||||++|||++|+.||...... ...+..+...... ..+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~ 238 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTH-LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-TSIE 238 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-SCHH
T ss_pred cccccccccccccCCCccccCHHHh-cCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-ccHH
Confidence 21 122356789999999998 6667899999999999999999999999864432 1222222221111 0010
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
. .....+.++.+++.+|++.||++||++++++++|+++..
T Consensus 239 -----~----l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 239 -----A----LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp -----H----HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred -----H----HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1 112345679999999999999999999999999998864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=349.49 Aligned_cols=243 Identities=16% Similarity=0.163 Sum_probs=188.6
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc--cccHHHHHHHH---HHHcCCCCCceeeee-------eEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL--IKSQEDFEKEM---KTLGKIRHHNLVALE-------GYY 748 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~~ 748 (967)
+.|+..+.||+|+||.||+|+. .+|+.||||++..... ....+.+.+|+ +.+++++|||||+++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 4567788999999999999995 5699999999975432 33467899999 556666899999998 666
Q ss_pred EcCCc-----------------eeEEEEecCCCchhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCC
Q 002094 749 WTPSL-----------------QLLIYEFISSGSLYKHLHDGSS----RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807 (967)
Q Consensus 749 ~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~D 807 (967)
..++. .++||||+ +|+|.+++..... ...+++..++.++.||+.||+|||++||+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 55532 78999999 5799999975321 11244688889999999999999999999999
Q ss_pred CCCCCEEeCCCCCeEEeecccccccCCCccccccccccccccccCcccccCc----------ccCCcccchhhHHHHHHH
Q 002094 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRT----------VKITEKCDVYGFGVLVLE 877 (967)
Q Consensus 808 ik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~t~~~Dv~slGvll~e 877 (967)
|||+||+++.++.+||+|||+++.... ......| +.|+|||++... ..++.++|||||||++||
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 999999999999999999999985432 2234556 899999998333 278999999999999999
Q ss_pred HHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 878 VVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 878 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
|++|+.||....... ..... . ......+.++.+++.+|++.||++|||+.|+++
T Consensus 306 lltg~~Pf~~~~~~~--------------~~~~~----~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 306 IWCADLPITKDAALG--------------GSEWI----F--RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHSSCCC------C--------------CSGGG----G--SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHCCCCCccccccc--------------chhhh----h--hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999996432210 00111 0 112344567999999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.91 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=199.5
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.+.|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 345788899999999999999976 58999999987554 3456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++++|.+++..... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..... ...
T Consensus 97 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 172 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TLQ 172 (302)
T ss_dssp CCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--HHH
T ss_pred eCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc--ccc
Confidence 9999999999875332 289999999999999999999999999999999999999999999999998754321 111
Q ss_pred ccccccccccccCccccc----CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 840 LSSKIQSALGYMAPEFAC----RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~----~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
......|++.|+|||.+. ....++.++||||+|+++|||++|+.||....... ....+... . .
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~----~--------~ 239 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKS----D--------P 239 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHS----C--------C
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhcc----C--------C
Confidence 223456889999999873 35568899999999999999999999997544321 11111111 0 0
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+...+..+.+++.+|++.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011123445677999999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=345.84 Aligned_cols=252 Identities=15% Similarity=0.042 Sum_probs=181.5
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHH---HHHcCCCCCceeeee-------eEEEc
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEM---KTLGKIRHHNLVALE-------GYYWT 750 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~~~~ 750 (967)
|...+.||+|+||.||+|+.. +|+.||||++..... ....+.+.+|+ +.++. +||||++++ +++..
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEE
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheec
Confidence 677889999999999999965 789999999987653 23455677884 55555 799988754 44443
Q ss_pred CC-----------------ceeEEEEecCCCchhhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCcccCC
Q 002094 751 PS-----------------LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQR------FNIILGMAKGLAYLHHTNIIHYN 807 (967)
Q Consensus 751 ~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~------~~i~~~i~~aL~~LH~~~ivH~D 807 (967)
++ ..++||||++ |+|.+++...... +.+..+ ..++.||+.||+|||++||+|||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--YVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--cchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 32 3799999999 7999999864221 344455 67889999999999999999999
Q ss_pred CCCCCEEeCCCCCeEEeecccccccCCCccccccccccccccccCcccccC-cccCCcccchhhHHHHHHHHHcCCCCCC
Q 002094 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR-TVKITEKCDVYGFGVLVLEVVTGKRPVE 886 (967)
Q Consensus 808 ik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~t~~~Dv~slGvll~elltg~~p~~ 886 (967)
|||+||+++.++.+||+|||+++..... .....+|+.|+|||.+.. ...++.++||||+||++|||++|+.||.
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999865421 114456689999999832 2578999999999999999999999997
Q ss_pred CCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 887 YMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....... ........................+..+.+++.+|++.||++|||+.|+++
T Consensus 295 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 295 LVTPGIK-------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp BCCTTCT-------TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CcCcccc-------cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 5432210 000000001111111222223466788999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=335.99 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=196.5
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-------cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-------IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS 752 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 752 (967)
.+.|...+.||+|+||.||+|... +++.||||.+..... ......+.+|++++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 345788999999999999999965 578999999865431 122345889999999999999999999987654
Q ss_pred ceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC---eEEeecccc
Q 002094 753 LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE---PKVGDFGLA 829 (967)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~---~kl~Dfg~a 829 (967)
.++||||+++++|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||++
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred -eEEEEecCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 8999999999999999876443 899999999999999999999999999999999999987654 999999999
Q ss_pred cccCCCccccccccccccccccCccccc--CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC
Q 002094 830 RLLPMLDRCILSSKIQSALGYMAPEFAC--RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR 907 (967)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (967)
...... .......||+.|+|||.+. ....++.++||||+|+++|||++|+.||............+.....
T Consensus 165 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---- 237 (322)
T 2ycf_A 165 KILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY---- 237 (322)
T ss_dssp EECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC----
T ss_pred eecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc----
Confidence 866431 1223456899999999863 3557889999999999999999999999754332221111111100
Q ss_pred chhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.. .+. .....+..+.+++.+|++.||++|||++|+++
T Consensus 238 -~~--~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 238 -NF--IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -CC--CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -cc--Cch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00 000 01234567999999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=341.96 Aligned_cols=260 Identities=21% Similarity=0.283 Sum_probs=197.9
Q ss_pred hhccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC--------
Q 002094 681 NALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP-------- 751 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------- 751 (967)
.+.|+..+.||+|+||.||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 34578889999999999999985 5789999999875432 234799999999999999999998543
Q ss_pred ------------------------------CceeEEEEecCCCchhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 002094 752 ------------------------------SLQLLIYEFISSGSLYKHLHDG-SSRNCLSWRQRFNIILGMAKGLAYLHH 800 (967)
Q Consensus 752 ------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~~LH~ 800 (967)
...++||||+++ +|.+.+... .....+++..+..++.||+.||+|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 337899999985 877777542 112238999999999999999999999
Q ss_pred CCcccCCCCCCCEEeC-CCCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHH
Q 002094 801 TNIIHYNLKSTNVLID-SSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVV 879 (967)
Q Consensus 801 ~~ivH~Dik~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ell 879 (967)
+||+||||||+||+++ .++.+||+|||+++...... ......+|+.|+|||.+.....++.++||||+||++|||+
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 9999999999999997 68899999999998664322 2345567899999998855567899999999999999999
Q ss_pred cCCCCCCCCccchHhHHHHHHhhhccCCchhhc---------------chhhcCCCChhhHHHHHHHHHhhccCCCCCCC
Q 002094 880 TGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV---------------DARLRGNFPADEAIPVIKLGLICASQVPSNRP 944 (967)
Q Consensus 880 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 944 (967)
+|+.||...... ..+..++.. ...+...++. ....+..++...+..+.+++.+|++.||++||
T Consensus 237 ~g~~pf~~~~~~-~~~~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 237 LGKPLFSGETSI-DQLVRIIQI-MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp HSSCSSCCSSHH-HHHHHHHHH-HCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred hCCCCCCCCChH-HHHHHHHHH-hCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 999999754432 222233221 1111111100 01111113445677799999999999999999
Q ss_pred CHHHHHH
Q 002094 945 DMEEVVN 951 (967)
Q Consensus 945 t~~evl~ 951 (967)
|+.|+++
T Consensus 315 t~~e~l~ 321 (383)
T 3eb0_A 315 NPYEAMA 321 (383)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=334.54 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=195.6
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEc------CCc
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWT------PSL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~ 753 (967)
+.|+..+.||+|+||.||+|+.. +++.||||++.... .....+.+|+.+++++ +||||+++++++.. .+.
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 44688899999999999999964 68999999997654 3456799999999998 79999999999976 467
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 8999999999999999986532 238899999999999999999999999999999999999999999999999987654
Q ss_pred CCccccccccccccccccCcccccC----cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACR----TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
.. ........|++.|+|||.+.. ...++.++||||+|+++|+|++|+.||........ ...+.. ..
T Consensus 181 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~--- 250 (326)
T 2x7f_A 181 RT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-LFLIPR----NP--- 250 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHH----SC---
T ss_pred cC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHhhc----Cc---
Confidence 21 112334568999999998842 45688999999999999999999999975443211 111111 00
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+...+..+.+++.+|++.||++|||++|+++
T Consensus 251 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 251 ------APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ------CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ------cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 011112344567999999999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=362.67 Aligned_cols=243 Identities=23% Similarity=0.310 Sum_probs=202.9
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|+..+.||+|+||.||+|+.+ +++.||||++..... ....+.+..|.+++..+ +||+|+++++++.+.+..++|
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 34678889999999999999965 578999999975421 23456788999999988 799999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 421 ~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-- 495 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-- 495 (674)
T ss_dssp EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT--
T ss_pred EeCcCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC--
Confidence 999999999999986543 899999999999999999999999999999999999999999999999999854321
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
........||+.|+|||++ ....++.++|||||||++|||++|+.||...... .....+. . ..
T Consensus 496 ~~~~~~~~GT~~Y~APE~l-~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-~~~~~i~----~-----------~~ 558 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIM----E-----------HN 558 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHH-TCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH----S-----------SC
T ss_pred CcccccccCCCcccCHhhh-cCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-HHHHHHH----h-----------CC
Confidence 2234457799999999998 6668999999999999999999999999754332 1111111 1 01
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDM 946 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 946 (967)
..++...+.++.+++.+|++.||++||++
T Consensus 559 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 559 VAYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 23556677889999999999999999997
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=346.25 Aligned_cols=258 Identities=20% Similarity=0.254 Sum_probs=199.4
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCC------CCCceeeeeeEEEcCCce
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI------RHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~ 754 (967)
..|+..+.||+|+||.||+|... +++.||||++.... .....+.+|+++++.+ .|+||+++++++......
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 34788899999999999999865 58999999997542 3345677788877665 578999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC--eEEeeccccccc
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE--PKVGDFGLARLL 832 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~--~kl~Dfg~a~~~ 832 (967)
++||||+. ++|.+++....... +++..+..++.||+.||+|||+++|+||||||+||+++.++. +||+|||++...
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCC-CCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEEeccC-CCHHHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 99999996 59999988755433 899999999999999999999999999999999999999887 999999999754
Q ss_pred CCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC------
Q 002094 833 PMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG------ 906 (967)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 906 (967)
.. ......||+.|+|||++ ....++.++|||||||++|||++|++||...... ..+..++.. ....
T Consensus 253 ~~-----~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~-~~l~~i~~~-~~~p~~~~~~ 324 (429)
T 3kvw_A 253 HQ-----RVYTYIQSRFYRAPEVI-LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG-DQLACMIEL-LGMPSQKLLD 324 (429)
T ss_dssp TC-----CCCSSCSCGGGCCHHHH-HTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH-HCCCCHHHHH
T ss_pred CC-----cccccCCCCCccChHHH-hCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH-cCCCCHHHHH
Confidence 32 22345789999999998 5567899999999999999999999999755433 222222221 1100
Q ss_pred ---Cchhhcchhh---------------------------cC---------CCChhhHHHHHHHHHhhccCCCCCCCCHH
Q 002094 907 ---RVEDCVDARL---------------------------RG---------NFPADEAIPVIKLGLICASQVPSNRPDME 947 (967)
Q Consensus 907 ---~~~~~~~~~~---------------------------~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 947 (967)
+...+++... +. ..+...+..+.+++.+|++.||++|||++
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 0001110000 00 01112356789999999999999999999
Q ss_pred HHHH
Q 002094 948 EVVN 951 (967)
Q Consensus 948 evl~ 951 (967)
|+++
T Consensus 405 e~L~ 408 (429)
T 3kvw_A 405 QALR 408 (429)
T ss_dssp HHHT
T ss_pred HHhC
Confidence 9986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=327.82 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=194.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEc----------
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT---------- 750 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------- 750 (967)
+.|+..+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 34688899999999999999964 78999999996532 445779999999999999999999998864
Q ss_pred ---CCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecc
Q 002094 751 ---PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFG 827 (967)
Q Consensus 751 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg 827 (967)
.+..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 3567899999999999999986432 37889999999999999999999999999999999999999999999999
Q ss_pred cccccCCCcc------------ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhH
Q 002094 828 LARLLPMLDR------------CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVL 895 (967)
Q Consensus 828 ~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~ 895 (967)
.+........ ........|++.|+|||.+.....++.++||||+|+++|||++ ||.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~--- 235 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV--- 235 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH---
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH---
Confidence 9976542110 1122345688999999998555578999999999999999998 554222111
Q ss_pred HHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 896 CDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+..... ... .......++...+..+.+++.+|++.||++|||++|+++
T Consensus 236 -~~~~~~-~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 -NILKKL-RSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHHH-HST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHhc-ccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111 110 111223345566677999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=344.91 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=196.6
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC------Ccee
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP------SLQL 755 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 755 (967)
.|+..+.||+|+||.||+|+.. +|+.||||++.... ....+|++++++++|||||++++++... ...+
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4677889999999999999975 58999999986543 2235799999999999999999988532 1256
Q ss_pred EEEEecCCCchhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC-CCeEEeecccccccC
Q 002094 756 LIYEFISSGSLYKHLHDG-SSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS-GEPKVGDFGLARLLP 833 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~-~~~kl~Dfg~a~~~~ 833 (967)
+||||+++ ++.+.+... .....+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 89999986 566655431 112248999999999999999999999999999999999999965 568999999998664
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc-
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV- 912 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 912 (967)
... ......+|+.|+|||++.....++.++||||+||++|||++|+.||...... ..+.+++... ..+....+.
T Consensus 209 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~l-g~p~~~~~~~ 283 (420)
T 1j1b_A 209 RGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVL-GTPTREQIRE 283 (420)
T ss_dssp TTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH-CSCCHHHHHH
T ss_pred cCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh-CCCCHHHHHh
Confidence 322 2334678999999999855557899999999999999999999999754432 2233333211 111111100
Q ss_pred ---------chhh-----cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH--HHHhhc
Q 002094 913 ---------DARL-----RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN--ILELIQ 957 (967)
Q Consensus 913 ---------~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~--~L~~~~ 957 (967)
.+.+ ...++...+.++.+++.+|++.||++|||+.|+++ .++++.
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0000 00123345678999999999999999999999985 344443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=337.51 Aligned_cols=264 Identities=19% Similarity=0.233 Sum_probs=196.2
Q ss_pred HhhccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCcc----------ccHHHHHHHHHHHcCCCCCceeeeeeEEE
Q 002094 680 ANALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLI----------KSQEDFEKEMKTLGKIRHHNLVALEGYYW 749 (967)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 749 (967)
..+.|+..+.||+|+||.||+|...+|+.||||++...... ...+.+.+|++++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 34567889999999999999999888999999998654321 11378999999999999999999999985
Q ss_pred c-----CCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEe
Q 002094 750 T-----PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVG 824 (967)
Q Consensus 750 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~ 824 (967)
. ....++||||++ |+|.+++..... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 3 335799999998 588888875432 38999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc
Q 002094 825 DFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE 904 (967)
Q Consensus 825 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 904 (967)
|||++..... ........+|+.|+|||.+.....++.++||||+|+++|+|++|+.||...... .....++. ...
T Consensus 177 Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~-~~~ 251 (362)
T 3pg1_A 177 DFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQLNKIVE-VVG 251 (362)
T ss_dssp CTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH-HHC
T ss_pred ecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-HcC
Confidence 9999975432 222345678899999998855577899999999999999999999999754332 12222221 111
Q ss_pred cCCchhh-----------cchhhc-------CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 905 DGRVEDC-----------VDARLR-------GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 905 ~~~~~~~-----------~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+..... ...... .......+..+.+++.+|++.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1111110 000000 0012334567999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=326.50 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=203.9
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--------cccHHHHHHHHHHHcCCC-CCceeeeeeEEEc
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--------IKSQEDFEKEMKTLGKIR-HHNLVALEGYYWT 750 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 750 (967)
.+.|+..+.||+|+||.||+|..+ +|+.||||++..... ....+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 345788899999999999999975 689999999976531 122456889999999995 9999999999999
Q ss_pred CCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 751 PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 751 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
++..++||||+++++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||.+.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 9999999999999999999976433 8999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCccccc-----CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhcc
Q 002094 831 LLPMLDRCILSSKIQSALGYMAPEFAC-----RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALED 905 (967)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 905 (967)
...... ......+++.|+|||.+. ....++.++||||+|+++|||++|+.||...... .....+.....
T Consensus 173 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~-- 246 (298)
T 1phk_A 173 QLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMSGNY-- 246 (298)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC--
T ss_pred hcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-HHHHHHhcCCc--
Confidence 664321 233456899999999873 2446788999999999999999999999654322 11111111110
Q ss_pred CCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 906 GRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..........+..+.+++.+|++.||++|||+.|+++
T Consensus 247 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 247 ---------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ---------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0011112345677999999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=340.42 Aligned_cols=263 Identities=20% Similarity=0.347 Sum_probs=183.6
Q ss_pred cCC-CCccCCCCceEEEEEEeC---CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEE--cCCceeEE
Q 002094 684 LNK-DCELGRGGFGVVYRTILQ---DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW--TPSLQLLI 757 (967)
Q Consensus 684 ~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv 757 (967)
|+. +++||+|+||.||+|+.+ +++.||||++.... ....+.+|++++++++||||+++++++. .....++|
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 444 568999999999999965 57899999997543 2346889999999999999999999995 46778999
Q ss_pred EEecCCCchhhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEe----CCCCCeEEeecc
Q 002094 758 YEFISSGSLYKHLHDGS------SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLI----DSSGEPKVGDFG 827 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~------~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill----~~~~~~kl~Dfg 827 (967)
|||+++ +|.+++.... ....+++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+|||
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 999975 7877775321 11238999999999999999999999999999999999999 677899999999
Q ss_pred cccccCCCcc-ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccc--------hHhHHHH
Q 002094 828 LARLLPMLDR-CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD--------VVVLCDM 898 (967)
Q Consensus 828 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~--------~~~~~~~ 898 (967)
+++....... ........||+.|+|||++.....++.++||||+||++|||++|++||.....+ ...+..+
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 9987643211 122345678999999999855567899999999999999999999999744332 1112222
Q ss_pred HHhhhccCCchhhcchh-----------h-cC------------CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 899 VRGALEDGRVEDCVDAR-----------L-RG------------NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 899 ~~~~~~~~~~~~~~~~~-----------~-~~------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+. .+..+....+.+.. . +. ......+..+.+|+.+|++.||++|||++|+++
T Consensus 258 ~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 258 FN-VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HH-HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HH-hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11 11111100000000 0 00 001112456889999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.99 Aligned_cols=258 Identities=20% Similarity=0.265 Sum_probs=183.8
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC------Cc
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP------SL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 753 (967)
+.|+..+.||+|+||.||+|.. .+|+.||||++..... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 4578889999999999999985 4689999999965432 33457788999999999999999999998654 56
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++||||+ +++|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 79999999 67999888652 38999999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch----
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE---- 909 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 909 (967)
. ......||+.|+|||.+.....++.++||||+||++|||++|+.||...... ..+..+.. ....+...
T Consensus 184 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~-~~g~p~~~~~~~ 256 (367)
T 2fst_X 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILR-LVGTPGAELLKK 256 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH-HHCSCCHHHHTT
T ss_pred c-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-HhCCCCHHHHHH
Confidence 2 1334678999999999855578899999999999999999999999754432 22222221 11111000
Q ss_pred -------hhcchhhc-CC-----CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 910 -------DCVDARLR-GN-----FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 910 -------~~~~~~~~-~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
........ .. .....+..+.+++.+|++.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000000 00 01234567899999999999999999999976
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=334.37 Aligned_cols=258 Identities=21% Similarity=0.233 Sum_probs=190.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC------c
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS------L 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~ 753 (967)
+.|+..+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 34788889999999999999854 689999999976432 334567889999999999999999999997654 6
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++||||+++ +|.+.+.. .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred eEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 7999999975 78888753 27899999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC-------
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG------- 906 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 906 (967)
. ........||+.|+|||.+ ....++.++||||+||++|||++|+.||...... .....++.. ...+
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~-~~~~~~~~~~~ 252 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQ-LGTPCPEFMKK 252 (371)
T ss_dssp --------------CTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHC--CCCCCHHHHTT
T ss_pred c---ccccCCceecCCccCHHHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH-hCCCCHHHHHH
Confidence 2 1223456789999999998 5567899999999999999999999999754432 111111111 0000
Q ss_pred -------------C-----chhhcchhhcCC---CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 907 -------------R-----VEDCVDARLRGN---FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 907 -------------~-----~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
. ............ .+...+..+.+++.+|++.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 000000000000 01123667999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=328.74 Aligned_cols=262 Identities=23% Similarity=0.306 Sum_probs=201.2
Q ss_pred hccCCCCccCCCCceEEEEEEe--CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCC---CCCceeeeeeEEE-----c
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL--QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKI---RHHNLVALEGYYW-----T 750 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~ 750 (967)
+.|+..+.||+|+||.||+|.. .+|+.||||++..... ......+.+|+++++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 4578889999999999999997 4688999999875432 12223566777776665 8999999999987 5
Q ss_pred CCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 751 PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 751 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
....++||||++ |+|.+++....... +++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.+.
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~-~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPG-VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTC-SCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 567899999998 59999998754433 8999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchh
Q 002094 831 LLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVED 910 (967)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (967)
.... ........|++.|+|||.+ ....++.++||||+|+++|||++|+.||...... .....++.. ........
T Consensus 169 ~~~~---~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~-~~~~~~~~ 242 (326)
T 1blx_A 169 IYSF---QMALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDV-IGLPGEED 242 (326)
T ss_dssp CCCG---GGGGCCCCCCCTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHH-HCCCCGGG
T ss_pred cccC---CCCccccccccceeCHHHH-hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHH-cCCCCccc
Confidence 6542 1223456789999999998 5567899999999999999999999999755432 222222221 11111111
Q ss_pred hcc------hh-------hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 911 CVD------AR-------LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 911 ~~~------~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+.. .. ....+....+..+.+++.+|++.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 100 00 011123456678999999999999999999999984
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=335.10 Aligned_cols=271 Identities=21% Similarity=0.252 Sum_probs=192.3
Q ss_pred HHhhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCc----
Q 002094 679 GANALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSL---- 753 (967)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 753 (967)
...+.|+..+.||+|+||.||+|+.. +|+.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 34456799999999999999999975 68999999986543 223456778888888999999999999865433
Q ss_pred ---eeEEEEecCCCchhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCCCCEEeCC-CCCeEEeec
Q 002094 754 ---QLLIYEFISSGSLYKHLHD-GSSRNCLSWRQRFNIILGMAKGLAYLH--HTNIIHYNLKSTNVLIDS-SGEPKVGDF 826 (967)
Q Consensus 754 ---~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~i~~~i~~aL~~LH--~~~ivH~Dik~~Nill~~-~~~~kl~Df 826 (967)
.++||||+++ +|.+.+.. ......+++..+..++.|++.|++||| ++||+||||||+||+++. ++.+||+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 7899999987 44444332 122234889999999999999999999 999999999999999996 899999999
Q ss_pred ccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC
Q 002094 827 GLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG 906 (967)
Q Consensus 827 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (967)
|++....... ......||+.|+|||.+.....++.++||||+|+++|||++|+.||...... ..+..+++... ..
T Consensus 177 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~-~~ 251 (360)
T 3e3p_A 177 GSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRVLG-CP 251 (360)
T ss_dssp TTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC-CC
T ss_pred CCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHHcC-CC
Confidence 9998764322 2335568999999998855666899999999999999999999999754432 22333332111 00
Q ss_pred Cch------------hhc------chhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH--HHhhc
Q 002094 907 RVE------------DCV------DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI--LELIQ 957 (967)
Q Consensus 907 ~~~------------~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~~~ 957 (967)
... ... ............+.++.+++.+|++.||++|||+.|+++. ++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 000 000 0011112233467789999999999999999999999863 44443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.86 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=203.0
Q ss_pred HhhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 680 ANALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
..+.|+..+.||+|+||.||+|+.. +++.||||++..... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3456788999999999999999975 689999999976543 34567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC---CCeEEeecccccccCC
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS---GEPKVGDFGLARLLPM 834 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~---~~~kl~Dfg~a~~~~~ 834 (967)
|||+++++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 100 ~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp ECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 999999999998876443 8999999999999999999999999999999999999754 4799999999986543
Q ss_pred CccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 835 LDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
.. ......+++.|+|||.+ .+ .++.++||||+|+++|+|++|+.||...... .....+..+.. .
T Consensus 177 ~~---~~~~~~~~~~y~aPE~~-~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~-----~----- 240 (287)
T 2wei_A 177 NT---KMKDRIGTAYYIAPEVL-RG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGKY-----A----- 240 (287)
T ss_dssp CS---SCSCHHHHHTTCCHHHH-TT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC-----C-----
T ss_pred CC---ccccccCcccccChHHh-cC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCC-----C-----
Confidence 21 22345588899999988 33 4889999999999999999999999754332 11111111100 0
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.........+.++.+++.+|++.||++|||++|+++
T Consensus 241 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 -FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000011234567999999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=336.69 Aligned_cols=258 Identities=21% Similarity=0.254 Sum_probs=197.3
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCce-----
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQ----- 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----- 754 (967)
+.|...+.||+|+||.||+|... +|+.||||++..... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 34677889999999999999965 689999999976542 23357789999999999999999999999877655
Q ss_pred -eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 755 -LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 755 -~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
++||||+. ++|.+++... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 122 ~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGME-----FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTTSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEEcccc-ccHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 5888887432 8899999999999999999999999999999999999999999999999998553
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc-----
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV----- 908 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 908 (967)
. ......||+.|+|||.+.....++.++||||+|+++|||++|+.||...... ..+..+.... .....
T Consensus 196 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~-~~~~~~~~~~ 268 (371)
T 4exu_A 196 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVT-GVPGTEFVQK 268 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHH-CCCCHHHHTT
T ss_pred c-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHh-CCCcHHHHHH
Confidence 2 2234568999999999855578999999999999999999999999754432 2222222111 00000
Q ss_pred ------hhhcchhhcC------CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 909 ------EDCVDARLRG------NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 909 ------~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.......... ......+..+.+++.+|++.||++|||++|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000000 0123446779999999999999999999999763
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.58 Aligned_cols=263 Identities=22% Similarity=0.236 Sum_probs=201.6
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC-----Ccee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP-----SLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~ 755 (967)
+.|+..+.||+|+||.||+|... +|+.||||++...........+.+|++++++++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 34678889999999999999965 68999999997654444566788999999999999999999988654 6789
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+||||++ ++|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 91 lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 9999997 5899998763 2889999999999999999999999999999999999999999999999999876432
Q ss_pred cccc--------ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC
Q 002094 836 DRCI--------LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR 907 (967)
Q Consensus 836 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (967)
.... ......||+.|+|||.+.....++.++||||+|+++|||++|+.||........ ...+ ........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~-~~~~~~~~ 243 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLI-FGIIGTPH 243 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH-HHHHCCCC
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHH-HHHhCCCc
Confidence 1111 122356899999999875667889999999999999999999999975543221 1111 11111110
Q ss_pred c------------hhhcchhhcC------CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 908 V------------EDCVDARLRG------NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 908 ~------------~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
. .+........ ......+.++.+++.+|++.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 0000000000 011345667899999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=339.90 Aligned_cols=260 Identities=19% Similarity=0.227 Sum_probs=198.4
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCC--------CCceeeeeeEEE---
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR--------HHNLVALEGYYW--- 749 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~--- 749 (967)
+.|+..+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++++++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 45788899999999999999854 68899999997542 34567899999998885 788999999987
Q ss_pred -cCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeCCCC--------
Q 002094 750 -TPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSG-------- 819 (967)
Q Consensus 750 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~~~~-------- 819 (967)
.....++||||+ ++++.+++...... .+++..++.++.||+.||+|||++ ||+||||||+||+++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQ-GLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 556789999999 55666666544322 389999999999999999999998 999999999999999775
Q ss_pred -----------------------------------------CeEEeecccccccCCCccccccccccccccccCcccccC
Q 002094 820 -----------------------------------------EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR 858 (967)
Q Consensus 820 -----------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 858 (967)
.+||+|||.+..... ......||+.|+|||++ .
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~-~ 266 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVL-I 266 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHH-H
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChhh-c
Confidence 899999999986543 13345689999999998 5
Q ss_pred cccCCcccchhhHHHHHHHHHcCCCCCCCCccch----HhHHHHHHhhhccCCc---------hhhcch-----------
Q 002094 859 TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDV----VVLCDMVRGALEDGRV---------EDCVDA----------- 914 (967)
Q Consensus 859 ~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~---------~~~~~~----------- 914 (967)
...++.++|||||||++|||++|+.||....... ......+......... .++...
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 5578999999999999999999999997543211 1111111111111000 000000
Q ss_pred --------hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 915 --------RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 915 --------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
......+...+..+.+++.+|++.||++|||++|+++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0011245667788999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.29 Aligned_cols=256 Identities=22% Similarity=0.314 Sum_probs=180.7
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHH-HHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMK-TLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|+..+.||+|+||.||+|... +|+.||||++..........++..|+. +++.++||||+++++++..++..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 34678889999999999999975 689999999987654444455666666 7788899999999999999999999999
Q ss_pred ecCCCchhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 760 FISSGSLYKHLHDG--SSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 760 ~~~~gsL~~~l~~~--~~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
|+++ +|.+++... .....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 179 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS- 179 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc-
Confidence 9986 787777531 1122388999999999999999999999 9999999999999999999999999999765432
Q ss_pred cccccccccccccccCccccc---CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcc
Q 002094 837 RCILSSKIQSALGYMAPEFAC---RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~---~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (967)
.......|++.|+|||.+. ....++.++||||||+++|||++|+.||........ .+.... ....
T Consensus 180 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~------~~~~ 247 (327)
T 3aln_A 180 --IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----QLTQVV------KGDP 247 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCC------CSCC
T ss_pred --cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----HHHHHh------cCCC
Confidence 1223446899999999873 345688999999999999999999999975332111 010000 0000
Q ss_pred hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 914 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+........+..+.+++.+|++.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111222346678999999999999999999999976
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=324.97 Aligned_cols=262 Identities=21% Similarity=0.269 Sum_probs=194.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEE-----------
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYW----------- 749 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----------- 749 (967)
+.|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 34678889999999999999976 48999999987654 345678999999999999999999999874
Q ss_pred ---cCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC-CCCCeEEee
Q 002094 750 ---TPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID-SSGEPKVGD 825 (967)
Q Consensus 750 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~-~~~~~kl~D 825 (967)
+....++||||++ |+|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++ .++.+||+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3467789999998 5999998642 378999999999999999999999999999999999997 567999999
Q ss_pred cccccccCCCcc-ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc
Q 002094 826 FGLARLLPMLDR-CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE 904 (967)
Q Consensus 826 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 904 (967)
||++........ ........++..|+|||.+.....++.++||||+|+++|||++|+.||...... .....+.... .
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~~~-~ 242 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-EQMQLILESI-P 242 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHS-C
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc-C
Confidence 999986643211 112234556888999998856577899999999999999999999999755432 2222222111 0
Q ss_pred cCC----------chhhcchhhc-C-----CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 905 DGR----------VEDCVDARLR-G-----NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 905 ~~~----------~~~~~~~~~~-~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
... +......... . ......+.++.+++.+|++.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 0000001010 0 012345677999999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=327.45 Aligned_cols=264 Identities=21% Similarity=0.271 Sum_probs=203.3
Q ss_pred hccCCCCccCCCCceEEEEEEe--CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCC------ceeeeeeEEEcCCc
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL--QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH------NLVALEGYYWTPSL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~ 753 (967)
+.|+..+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+++++.++|+ +++++++++...+.
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 3578889999999999999986 368899999986532 3456788999998887654 59999999999999
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC----------------
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS---------------- 817 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~---------------- 817 (967)
.++||||+ +++|.+++...... .+++..+..++.|++.||+|||++||+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFL-PFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCC-CCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 99999999 88999999875432 3889999999999999999999999999999999999987
Q ss_pred ---CCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHh
Q 002094 818 ---SGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVV 894 (967)
Q Consensus 818 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~ 894 (967)
++.+||+|||++..... ......||+.|+|||.+ ....++.++||||+|+++|||++|+.||........
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 242 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVI-LALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH- 242 (339)
T ss_dssp EESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHH-TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH-
T ss_pred cccCCCceEeeCcccccCcc-----ccccccCCccccChHHh-hCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH-
Confidence 66899999999986432 22345789999999998 566789999999999999999999999975443221
Q ss_pred HHHHHHhhhccCCc--------hhhc---------------------ch-hhcCCCChhhHHHHHHHHHhhccCCCCCCC
Q 002094 895 LCDMVRGALEDGRV--------EDCV---------------------DA-RLRGNFPADEAIPVIKLGLICASQVPSNRP 944 (967)
Q Consensus 895 ~~~~~~~~~~~~~~--------~~~~---------------------~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 944 (967)
.. .+......... .... .. ......+...+.++.+++.+|++.||++||
T Consensus 243 ~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 243 LA-MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HH-HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HH-HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 11 11111110000 0000 00 000112345577899999999999999999
Q ss_pred CHHHHHHH--HHhhc
Q 002094 945 DMEEVVNI--LELIQ 957 (967)
Q Consensus 945 t~~evl~~--L~~~~ 957 (967)
|++|+++. ++.++
T Consensus 322 t~~ell~hp~f~~~~ 336 (339)
T 1z57_A 322 TLREALKHPFFDLLK 336 (339)
T ss_dssp CHHHHTTSGGGGGGG
T ss_pred CHHHHhcCHHHHHHh
Confidence 99999853 44443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=329.73 Aligned_cols=256 Identities=21% Similarity=0.259 Sum_probs=196.8
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCc------e
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSL------Q 754 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~ 754 (967)
.|...+.||+|+||.||+|+.. +|+.||||++..... ....+.+.+|+.++++++||||+++++++...+. .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 4677889999999999999965 689999999976532 2335678999999999999999999999987654 4
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
++||||++ ++|.+++.. .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 105 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp EEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred EEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 99999997 588887743 288999999999999999999999999999999999999999999999999976432
Q ss_pred CccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc------
Q 002094 835 LDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV------ 908 (967)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 908 (967)
......+|+.|+|||.+.....++.++||||+|+++|||++|+.||...... ..+..+.... .....
T Consensus 179 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~-~~~~~~~~~~~ 251 (353)
T 3coi_A 179 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVT-GVPGTEFVQKL 251 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHH-CBCCHHHHTTC
T ss_pred -----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh-CCCCHHHHHHH
Confidence 1234568899999998855567899999999999999999999999754432 1222222111 00000
Q ss_pred -----hhhcc---hhhc---CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 909 -----EDCVD---ARLR---GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 909 -----~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..... ...+ .......+..+.+++.+|++.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0000 1123456778999999999999999999999975
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=324.90 Aligned_cols=269 Identities=21% Similarity=0.263 Sum_probs=187.5
Q ss_pred CChhHHHHHHHHHhcC-CCCccccCCCC---CCCCCCCccceEEeCC--------CCCeeeeeeecCCCCCccccccccC
Q 002094 24 TFNDDVLGLIVFKAGL-EDPKEKLTSWS---EDDDNPCNWVGVKCDP--------KTKRVVGLTLDGFSLSGHIGRGLLR 91 (967)
Q Consensus 24 ~~~~d~~all~~k~~~-~~~~~~l~sw~---~~~~~~c~w~gv~c~~--------~~~~v~~l~l~~~~l~~~~~~~l~~ 91 (967)
...+|++||++||+++ .||.+.+++|. ....++|.|.|++|+. ...+|+.|+|.++.++ .+|+.+++
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 3568999999999999 68877889994 3345689999999952 3467888888888887 67777888
Q ss_pred CCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCcccccc-------
Q 002094 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSF------- 164 (967)
Q Consensus 92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~------- 164 (967)
+++|++|+|++|+++ .+|..++.+++|++|+|++|.++ .+|.. ++.+++|++|+|++|++.+.+|..++.
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~-l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~ 179 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPAS-IASLNRLRELSIRACPELTELPEPLASTDASGEH 179 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGG-GGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCE
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHH-HhcCcCCCEEECCCCCCccccChhHhhccchhhh
Confidence 888888888888888 77777888888888888888887 67765 577888888888888777777776654
Q ss_pred --ccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccE
Q 002094 165 --CSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKV 242 (967)
Q Consensus 165 --l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 242 (967)
+++|++|+|++|+++ .+|..+..+++|++|+|++|.+++ +|..+..+++|++|+|++|++.+.+|..|+++++|++
T Consensus 180 ~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~ 257 (328)
T 4fcg_A 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257 (328)
T ss_dssp EESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCE
T ss_pred ccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCE
Confidence 666666666666666 556666666666666666666664 3334666666666666666666566666666666666
Q ss_pred EeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccccccccccc
Q 002094 243 LDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQF 298 (967)
Q Consensus 243 L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l 298 (967)
|++++|++.+.+|..+.++++|+.|+|++|.+.+.+|..++.+++|+.+++..|.+
T Consensus 258 L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp EECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred EECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 66666555555555555555555555555555555555555555555555554444
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=349.12 Aligned_cols=269 Identities=26% Similarity=0.287 Sum_probs=206.8
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEc------CCce
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT------PSLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~ 754 (967)
+.|+..+.||+|+||.||+|... +|+.||||++.........+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 45899999999999999999964 6899999998766545556789999999999999999999998755 6777
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC---eEEeecccccc
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE---PKVGDFGLARL 831 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~---~kl~Dfg~a~~ 831 (967)
++||||+++|+|.+++........+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||.+..
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 999999999999999987655445889999999999999999999999999999999999987665 89999999987
Q ss_pred cCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (967)
.... .......||+.|+|||.+ .+..++.++||||+|+++|||++|+.||...... ..|.............
T Consensus 174 ~~~~---~~~~~~~gt~~Y~APE~l-~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 174 LDQG---ELCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVREKSNEHIV 245 (676)
T ss_dssp TTSC---CCCCCCCSCCTTCSSCSS-CCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC------CC
T ss_pred cccc---cccccccCCcccCChHHh-ccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhhcccchhhh
Confidence 6432 223456789999999998 6678999999999999999999999999643221 1111111000000000
Q ss_pred cch------------hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHH-----HHHHHHhhcC
Q 002094 912 VDA------------RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEE-----VVNILELIQS 958 (967)
Q Consensus 912 ~~~------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e-----vl~~L~~~~~ 958 (967)
... ..........+..+.+++.+|++.||++|||++| +.+.++++.+
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000 0112234567889999999999999999999987 5666666553
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=322.80 Aligned_cols=251 Identities=21% Similarity=0.266 Sum_probs=181.2
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccH-HHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|+..+.||+|+||.||+|... +|+.||||++......... +.+.++..+++.++||||+++++++..++..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 3577889999999999999975 6899999999876543333 3444555678888999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
+ ++.+..+..... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++...... .
T Consensus 106 ~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~---~ 179 (318)
T 2dyl_A 106 M-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---K 179 (318)
T ss_dssp C-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred c-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC---c
Confidence 9 445555544322 2388999999999999999999995 9999999999999999999999999999765431 2
Q ss_pred ccccccccccccCccccc----CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 840 LSSKIQSALGYMAPEFAC----RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~----~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
......+++.|+|||.+. ....++.++||||||+++|||++|+.||..................
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 247 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP------------ 247 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC------------
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC------------
Confidence 233456899999999884 2456788999999999999999999999764443332222221110
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.........+.++.+++.+|++.||.+|||++|+++
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000111235667999999999999999999999876
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=326.77 Aligned_cols=250 Identities=20% Similarity=0.269 Sum_probs=171.8
Q ss_pred ccCC-CCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEc----CCceeE
Q 002094 683 LLNK-DCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT----PSLQLL 756 (967)
Q Consensus 683 ~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l 756 (967)
.|.. .+.||+|+||.||+|..+ +++.||||++.... ....+....++.++||||+++++++.. ....++
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 3566 456999999999999976 68999999986432 222233334566799999999999875 445789
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC---CCCeEEeecccccccC
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS---SGEPKVGDFGLARLLP 833 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~---~~~~kl~Dfg~a~~~~ 833 (967)
||||+++|+|.+++...... .+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||++....
T Consensus 104 v~e~~~gg~L~~~l~~~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQ-AFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CC-CCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred EEeccCCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 99999999999999875432 3899999999999999999999999999999999999976 4559999999997654
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcc
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (967)
.. ......+|+.|+|||.+ ....++.++||||+|+++|+|++|+.||.......... . ....+... .
T Consensus 183 ~~----~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~-~~~~~~~~------~ 249 (336)
T 3fhr_A 183 QN----ALQTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-G-MKRRIRLG------Q 249 (336)
T ss_dssp --------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred cc----ccccCCCCcCccChhhh-CCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-h-HHHhhhcc------c
Confidence 21 22345678999999998 66678999999999999999999999996443321100 0 00000000 0
Q ss_pred hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 914 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...........+.++.+++.+|++.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111122456678999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=338.56 Aligned_cols=254 Identities=21% Similarity=0.275 Sum_probs=190.1
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +|||||++++++.+++..++||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 445667789999999998777778999999998753 345678999999876 899999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCC----CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC-------------CCeEE
Q 002094 761 ISSGSLYKHLHDGSSRN----CLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS-------------GEPKV 823 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~----~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~-------------~~~kl 823 (967)
+. |+|.+++....... ..++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 96 59999998654321 11333567899999999999999999999999999999654 47999
Q ss_pred eecccccccCCCcccc--ccccccccccccCcccccC------cccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHh
Q 002094 824 GDFGLARLLPMLDRCI--LSSKIQSALGYMAPEFACR------TVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVV 894 (967)
Q Consensus 824 ~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~ 894 (967)
+|||++.......... ......||+.|+|||++.. ...++.++||||+||++|||++ |+.||.......
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-- 247 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-- 247 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence 9999998765422211 1234578999999998843 2568999999999999999999 999997443322
Q ss_pred HHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 895 LCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..+......... .....+...+.++.+++.+|++.||++|||+.|+++
T Consensus 248 -~~i~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -SNIIRGIFSLDE--------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HHHHHTCCCCCC--------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHhcCCCCccc--------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 122222211111 111123456788999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=328.75 Aligned_cols=242 Identities=26% Similarity=0.398 Sum_probs=198.6
Q ss_pred hhccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccc-----cHHHHHHHHHHHcCCC--CCceeeeeeEEEcCC
Q 002094 681 NALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIK-----SQEDFEKEMKTLGKIR--HHNLVALEGYYWTPS 752 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~-----~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 752 (967)
.+.|+..+.||+|+||.||+|+. .+++.||||++....... ....+.+|+.++++++ |+||+++++++..++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 34578889999999999999985 468999999997654211 2245778999999986 599999999999999
Q ss_pred ceeEEEEecCC-CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC-CCCCeEEeeccccc
Q 002094 753 LQLLIYEFISS-GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID-SSGEPKVGDFGLAR 830 (967)
Q Consensus 753 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~-~~~~~kl~Dfg~a~ 830 (967)
..++||||+.+ ++|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+|||++.
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cEEEEEEcCCCCccHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999986 899999976433 88999999999999999999999999999999999998 78899999999998
Q ss_pred ccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchh
Q 002094 831 LLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVED 910 (967)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (967)
..... ......||+.|+|||++......+.++||||||+++|||++|+.||..... ....
T Consensus 199 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~~~--------- 258 (320)
T 3a99_A 199 LLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRG--------- 258 (320)
T ss_dssp ECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHC---------
T ss_pred ccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------hhcc---------
Confidence 76432 223456899999999884444457889999999999999999999963211 1110
Q ss_pred hcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 911 CVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 911 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...++...+.++.+++.+|++.||++|||++|+++
T Consensus 259 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 259 ------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11133445667999999999999999999999976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=326.82 Aligned_cols=198 Identities=23% Similarity=0.317 Sum_probs=167.2
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CC-----ceeeeeeEEEcCCce
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HH-----NLVALEGYYWTPSLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~ 754 (967)
+.|+..+.||+|+||.||+|... +++.||||++.... ....++..|+++++.++ |+ +|+++++++...+..
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 45788899999999999999965 68899999997432 33566788888887774 44 599999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCCCCEEeC--CCCCeEEeeccccc
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH--TNIIHYNLKSTNVLID--SSGEPKVGDFGLAR 830 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~--~~ivH~Dik~~Nill~--~~~~~kl~Dfg~a~ 830 (967)
++||||+++ +|.+++....... +++..+..++.|++.||+|||+ .||+||||||+||+++ .++.+||+|||+++
T Consensus 132 ~lv~e~~~~-~L~~~l~~~~~~~-~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNTNFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCCC-BHHHHHHHTTTSC-CCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCCC-CHHHHHhhcCcCC-CCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 999999965 9999998754333 8999999999999999999994 6999999999999995 57889999999998
Q ss_pred ccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCc
Q 002094 831 LLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYME 889 (967)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~ 889 (967)
.... ......||+.|+|||++ .+..++.++||||+||++|||++|+.||....
T Consensus 210 ~~~~-----~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 210 QLGQ-----RIYQYIQSRFYRSPEVL-LGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ETTC-----CCCSSCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccc-----ccccccCCccccChHHH-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 6643 12346789999999998 55678999999999999999999999997544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=317.07 Aligned_cols=86 Identities=31% Similarity=0.377 Sum_probs=50.5
Q ss_pred ccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCc
Q 002094 454 IGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLL 533 (967)
Q Consensus 454 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 533 (967)
+..+++|++|++++|++++. ..+..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..| +..+++|+
T Consensus 261 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 336 (347)
T 4fmz_A 261 VKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMD 336 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCS
T ss_pred HhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccc
Confidence 44445555555555555532 235566666666666666666666666666666666666666665554 56666666
Q ss_pred eEEecCCccc
Q 002094 534 SFNISHNHLH 543 (967)
Q Consensus 534 ~L~l~~N~l~ 543 (967)
.|++++|+++
T Consensus 337 ~L~l~~N~i~ 346 (347)
T 4fmz_A 337 SADFANQVIK 346 (347)
T ss_dssp EESSSCC---
T ss_pred eeehhhhccc
Confidence 6666666654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.61 Aligned_cols=242 Identities=24% Similarity=0.367 Sum_probs=192.3
Q ss_pred hhccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCcc-----ccHHHHHHHHHHHcCC----CCCceeeeeeEEEc
Q 002094 681 NALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLI-----KSQEDFEKEMKTLGKI----RHHNLVALEGYYWT 750 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~~E~~~l~~l----~h~niv~~~~~~~~ 750 (967)
.+.|+..+.||+|+||.||+|+. .+++.||||++...... .....+.+|++++.++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 34578899999999999999985 46889999999765421 1223456788888887 89999999999999
Q ss_pred CCceeEEEEe-cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC-CCCCeEEeeccc
Q 002094 751 PSLQLLIYEF-ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID-SSGEPKVGDFGL 828 (967)
Q Consensus 751 ~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~-~~~~~kl~Dfg~ 828 (967)
.+..++|||| +.+++|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+|||+
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999 789999999986443 89999999999999999999999999999999999999 789999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCc
Q 002094 829 ARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRV 908 (967)
Q Consensus 829 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 908 (967)
+...... ......|++.|+|||.+......+.++||||+|+++|||++|+.||..... ...
T Consensus 187 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~-------- 247 (312)
T 2iwi_A 187 GALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------ILE-------- 247 (312)
T ss_dssp CEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHH--------
T ss_pred hhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------Hhh--------
Confidence 9876432 223456899999999884444445689999999999999999999963211 110
Q ss_pred hhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 909 EDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....++...+..+.+++.+|++.||++|||++|+++
T Consensus 248 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 -------AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -------TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 012234556677999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=329.47 Aligned_cols=260 Identities=21% Similarity=0.238 Sum_probs=198.7
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-----------CCceeeeeeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-----------HHNLVALEGYYW 749 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~ 749 (967)
+.|+..+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++++++ ||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 3478889999999999999996 468999999997532 34567889999988875 899999999987
Q ss_pred cCC----ceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeC------CC
Q 002094 750 TPS----LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLID------SS 818 (967)
Q Consensus 750 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~------~~ 818 (967)
..+ ..++||||+ +++|.+++....... +++..+..++.||+.||+|||++ ||+||||||+||+++ ..
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~-~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRG-IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSC-CCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccC-CcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 644 678999999 889999998754333 88999999999999999999998 999999999999994 44
Q ss_pred CCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccc-----hH
Q 002094 819 GEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD-----VV 893 (967)
Q Consensus 819 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~-----~~ 893 (967)
+.+||+|||++..... ......||+.|+|||.+ .+..++.++||||+|+++|||++|+.||...... ..
T Consensus 175 ~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 175 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVL-LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHH-HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ceEEEcccccccccCC-----CCCCCCCCccccCcHHH-hCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4799999999986643 12345689999999998 5567899999999999999999999999744321 11
Q ss_pred hHHHHHHhhhccC-------C-chhhcc-------------------hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCH
Q 002094 894 VLCDMVRGALEDG-------R-VEDCVD-------------------ARLRGNFPADEAIPVIKLGLICASQVPSNRPDM 946 (967)
Q Consensus 894 ~~~~~~~~~~~~~-------~-~~~~~~-------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 946 (967)
....++...-..+ . ...+.+ ......++...+.++.+++.+|++.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 1222221110000 0 000000 001223567778899999999999999999999
Q ss_pred HHHHH
Q 002094 947 EEVVN 951 (967)
Q Consensus 947 ~evl~ 951 (967)
+|+++
T Consensus 329 ~ell~ 333 (373)
T 1q8y_A 329 GGLVN 333 (373)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99986
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=313.54 Aligned_cols=308 Identities=23% Similarity=0.335 Sum_probs=244.2
Q ss_pred ccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCc
Q 002094 161 SLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSML 240 (967)
Q Consensus 161 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 240 (967)
.+..+++|++|++++|+++. ++ .+..+++|++|+|++|.+++..+ +..+++|++|++++|+++.. ..+..+++|
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L 112 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNL 112 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcC
Confidence 46678889999999988874 34 37788888889998888886554 88888888888888888753 357888888
Q ss_pred cEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccC
Q 002094 241 KVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMN 320 (967)
Q Consensus 241 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 320 (967)
++|++++|.+++. +. +..+++|+.|++++|......+ .+..+++|++|++++|.+.+..+ +..+++|++|++++|
T Consensus 113 ~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 113 RELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp SEEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred CEEECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 8888888888754 33 7778888888888886554433 37777888888888887775433 677777777777777
Q ss_pred cCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccC
Q 002094 321 QFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSG 400 (967)
Q Consensus 321 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~ 400 (967)
.+++..+ +..+++|+.|++++|.+.+..+ +..+++|++|++++|++++
T Consensus 188 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~------------------------------~~~~~~L~~L~l~~n~l~~ 235 (347)
T 4fmz_A 188 QIEDISP--LASLTSLHYFTAYVNQITDITP------------------------------VANMTRLNSLKIGNNKITD 235 (347)
T ss_dssp CCCCCGG--GGGCTTCCEEECCSSCCCCCGG------------------------------GGGCTTCCEEECCSSCCCC
T ss_pred ccccccc--ccCCCccceeecccCCCCCCch------------------------------hhcCCcCCEEEccCCccCC
Confidence 7774433 6777777777777777663221 2346789999999999997
Q ss_pred CCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccc
Q 002094 401 VIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKN 480 (967)
Q Consensus 401 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 480 (967)
..+ +..+++|++|++++|.+.+. ..+..+++|+.|++++|++++. +.+..+++|++|++++|++++..|..|+.
T Consensus 236 ~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 309 (347)
T 4fmz_A 236 LSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGG 309 (347)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHT
T ss_pred Ccc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhc
Confidence 665 88999999999999999753 4688999999999999999864 46888999999999999999888999999
Q ss_pred cCccceeeccCCcCcCccchhhhcccCccEEeccCCccc
Q 002094 481 CSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLS 519 (967)
Q Consensus 481 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 519 (967)
+++|+.|+|++|++++..| +..+++|++||+++|+|+
T Consensus 310 l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 310 LTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred cccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 9999999999999997766 889999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=323.63 Aligned_cols=257 Identities=20% Similarity=0.282 Sum_probs=197.2
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CC-cEEEEEEeecCCccccHHHHHHHHHHHcCCCCCc------eeeeeeEEEcCCc
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DG-RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHN------LVALEGYYWTPSL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 753 (967)
+.|+..+.||+|+||.||+|... ++ +.||||++.... ...+.+.+|++++++++|++ ++.+++++...+.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 45788899999999999999964 34 689999997532 34567888999998886655 8999999999999
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEe------------------
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLI------------------ 815 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill------------------ 815 (967)
.++||||+ ++++.+++...... .+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQ-PYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred EEEEEecc-CCChHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 99999999 56777777654322 38999999999999999999999999999999999999
Q ss_pred -CCCCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHh
Q 002094 816 -DSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVV 894 (967)
Q Consensus 816 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~ 894 (967)
+.++.+||+|||++..... ......||+.|+|||.+ .+..++.++||||+|+++|||++|+.||........
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 247 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVI-LELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH- 247 (355)
T ss_dssp EESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred ccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeee-ecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 5678999999999986432 22345789999999998 566789999999999999999999999975443221
Q ss_pred HHHHHHhhhccCCchhhc----------c---------------------hhhcCCCChhhHHHHHHHHHhhccCCCCCC
Q 002094 895 LCDMVRGALEDGRVEDCV----------D---------------------ARLRGNFPADEAIPVIKLGLICASQVPSNR 943 (967)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~----------~---------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 943 (967)
... +....... ...+. . ...........+.++.+++.+|++.||++|
T Consensus 248 ~~~-~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 248 LVM-MEKILGPI-PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHH-HHHHHCCC-CHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHH-HHHHcCCC-cHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 111 11111100 00000 0 000011223446689999999999999999
Q ss_pred CCHHHHHH
Q 002094 944 PDMEEVVN 951 (967)
Q Consensus 944 pt~~evl~ 951 (967)
||++|+++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=330.35 Aligned_cols=249 Identities=21% Similarity=0.281 Sum_probs=187.0
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +|||||++++++.+....++||||+
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 3677889999999997665566799999999975442 2357899999998 7999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC-----CCCeEEeecccccccCCCc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS-----SGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~-----~~~~kl~Dfg~a~~~~~~~ 836 (967)
. |+|.+++...... ..+..++.++.||+.||+|||++||+||||||+||+++. ...+||+|||+++......
T Consensus 101 ~-g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 101 A-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp S-EEHHHHHHSSSCC--CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred C-CCHHHHHHhcCCC--ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 7 5999999865432 344566789999999999999999999999999999953 2368899999998764322
Q ss_pred cc-cccccccccccccCcccccC--cccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhc
Q 002094 837 RC-ILSSKIQSALGYMAPEFACR--TVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV 912 (967)
Q Consensus 837 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (967)
.. .......||+.|+|||++.. ...++.++||||+||++|||++ |..||........ ... .......
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~---~~~---~~~~~~~--- 248 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA---NIL---LGACSLD--- 248 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH---HHH---TTCCCCT---
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH---HHH---hccCCcc---
Confidence 11 22345679999999999843 4567889999999999999999 9999964332211 111 1110000
Q ss_pred chhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 913 DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 913 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+...+..+.+++.+|++.||++|||++|+++
T Consensus 249 ----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 ----CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ----TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 01112344566889999999999999999999983
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=321.69 Aligned_cols=314 Identities=19% Similarity=0.191 Sum_probs=205.7
Q ss_pred ccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEe
Q 002094 165 CSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLD 244 (967)
Q Consensus 165 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 244 (967)
+++|++|++++|.++...+..+..+++|++|+|++|.+++..+..|..+++|++|+|++|++++
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~---------------- 107 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY---------------- 107 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC----------------
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCc----------------
Confidence 4566666666666654333334555566666666555554444444444444444444444444
Q ss_pred ccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCC
Q 002094 245 FGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTG 324 (967)
Q Consensus 245 l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 324 (967)
..|..|.++++|++|+|++|+++...+..|..+++|++|++++|++.+..+..+..+++|++|++++|++++
T Consensus 108 --------~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 108 --------LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp --------CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred --------CCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence 444444444444444444444443333334555555555555555554444555555556666666655553
Q ss_pred CCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCC
Q 002094 325 GLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPS 404 (967)
Q Consensus 325 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~ 404 (967)
. .+..+++|+.|++++|.+++. ...++|+.|++++|.+..
T Consensus 180 ~---~~~~l~~L~~L~l~~n~l~~~---------------------------------~~~~~L~~L~l~~n~l~~---- 219 (390)
T 3o6n_A 180 V---DLSLIPSLFHANVSYNLLSTL---------------------------------AIPIAVEELDASHNSINV---- 219 (390)
T ss_dssp C---CGGGCTTCSEEECCSSCCSEE---------------------------------ECCSSCSEEECCSSCCCE----
T ss_pred c---ccccccccceeeccccccccc---------------------------------CCCCcceEEECCCCeeee----
Confidence 3 234445555666655554410 011245555555555442
Q ss_pred CcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCcc
Q 002094 405 NIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSL 484 (967)
Q Consensus 405 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 484 (967)
. |.. ..++|+.|++++|++++. ..+..+++|++|+|++|.+++..|..|..+++|
T Consensus 220 --------------------~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 274 (390)
T 3o6n_A 220 --------------------V-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 274 (390)
T ss_dssp --------------------E-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSC
T ss_pred --------------------c-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccC
Confidence 2 111 135788899999998753 578899999999999999999899999999999
Q ss_pred ceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCCCCCCccCCCcccCCC
Q 002094 485 TSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNP 564 (967)
Q Consensus 485 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 564 (967)
+.|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|++++|+++. +|. ..+..+....+.+||
T Consensus 275 ~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~-~~~-~~~~~L~~L~l~~N~ 350 (390)
T 3o6n_A 275 ERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LKL-STHHTLKNLTLSHND 350 (390)
T ss_dssp CEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CCC-CTTCCCSEEECCSSC
T ss_pred CEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce-eCc-hhhccCCEEEcCCCC
Confidence 999999999995 6777889999999999999999 567789999999999999999985 453 345667778899999
Q ss_pred CCCCccc
Q 002094 565 SLCGSVV 571 (967)
Q Consensus 565 ~lc~~~~ 571 (967)
+.|.+..
T Consensus 351 ~~~~~~~ 357 (390)
T 3o6n_A 351 WDCNSLR 357 (390)
T ss_dssp EEHHHHH
T ss_pred ccchhHH
Confidence 9997654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=317.83 Aligned_cols=258 Identities=31% Similarity=0.498 Sum_probs=190.6
Q ss_pred CCCEEEccCCCCCC--cCchhhccccccccccccc-cccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEE
Q 002094 263 SCSSLSLKGNSFTG--EVPDWIGKLANLESLDLSL-NQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAI 339 (967)
Q Consensus 263 ~L~~L~L~~n~l~~--~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 339 (967)
+++.|+|++|.+++ .+|..+..+++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|.++++
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~---- 126 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT---- 126 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTT----
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCC----
Confidence 45566666666665 5555566666666666653 5555555555555555555555555555555555555444
Q ss_pred EccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccc
Q 002094 340 DVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSM 419 (967)
Q Consensus 340 ~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 419 (967)
|++|+|++|++++.+|..+..+++|++|+|++
T Consensus 127 ------------------------------------------------L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (313)
T 1ogq_A 127 ------------------------------------------------LVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp ------------------------------------------------CCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred ------------------------------------------------CCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence 45555555555555566666667777777777
Q ss_pred cccccccCCCcCCcc-cccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCcc
Q 002094 420 NYLFGSIPASIGKLK-AIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPV 498 (967)
Q Consensus 420 N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 498 (967)
|++.+.+|..+..++ +|+.|++++|++++.+|..+..+. |++|+|++|.+++.+|..|..+++|+.|+|++|++++.+
T Consensus 159 N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 237 (313)
T 1ogq_A 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred CcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeec
Confidence 777767777777776 788888888888878888888776 888888888888888888888888999999999888766
Q ss_pred chhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCCCCCCccCCCcccCCCCCCCccccCCC
Q 002094 499 PAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGSVVNRSC 575 (967)
Q Consensus 499 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~c 575 (967)
|. +..+++|++|+|++|++++.+|..+..+++|+.|+|++|+++|.+|....+..+....+.+||++||.++. .|
T Consensus 238 ~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 238 GK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp GG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred Cc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 65 78889999999999999989999999999999999999999999998777777888889999999998774 45
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.04 Aligned_cols=235 Identities=12% Similarity=0.074 Sum_probs=185.4
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||.||+|+.. +++.||||++..... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 34788899999999999999975 489999999986643 223478999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||++|++|.+++... ....++.+++.|++.||+|||++||+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999542 3556788999999999999999999999999999999999999998443
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
|++ .++.++||||||+++|||++|+.||......... ..... ....... ...
T Consensus 175 -----------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-----~~~~~--~~~~~~~--~~~ 226 (286)
T 3uqc_A 175 -----------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-----APAER--DTAGQPI--EPA 226 (286)
T ss_dssp -----------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-----EECCB--CTTSCBC--CHH
T ss_pred -----------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-----HHHHH--HhccCCC--Chh
Confidence 333 3678999999999999999999999754332100 00000 0000000 000
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 961 (967)
......+.++.+++.+|++.||++| |+.|+++.|+++....+
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 1123456679999999999999999 99999999999876544
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=337.09 Aligned_cols=314 Identities=19% Similarity=0.180 Sum_probs=219.6
Q ss_pred ccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEe
Q 002094 165 CSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLD 244 (967)
Q Consensus 165 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 244 (967)
+++++.|++++|.++...+..|..+++|++|+|++|.+++..+..|+.+++|++|+|++|.+++..|..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 56788888888888765555567778888888887777766666666666666666666666655555555555555555
Q ss_pred ccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCC
Q 002094 245 FGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTG 324 (967)
Q Consensus 245 l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 324 (967)
|++|.+++ ..+..|+++++|++|+|++|.+++..|..|..+++|++|+|++|.+++
T Consensus 130 L~~n~l~~------------------------l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 130 LERNDLSS------------------------LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp CCSSCCCC------------------------CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred eeCCCCCC------------------------CCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 55555553 333334444455555555555544444445555555555555555553
Q ss_pred CCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCC
Q 002094 325 GLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPS 404 (967)
Q Consensus 325 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~ 404 (967)
.. +..+++|+.|++++|.+++. ....+|+.|++++|.++.
T Consensus 186 ~~---~~~l~~L~~L~l~~n~l~~l---------------------------------~~~~~L~~L~ls~n~l~~---- 225 (597)
T 3oja_B 186 VD---LSLIPSLFHANVSYNLLSTL---------------------------------AIPIAVEELDASHNSINV---- 225 (597)
T ss_dssp CC---GGGCTTCSEEECCSSCCSEE---------------------------------ECCTTCSEEECCSSCCCE----
T ss_pred cC---hhhhhhhhhhhcccCccccc---------------------------------cCCchhheeeccCCcccc----
Confidence 31 33445566666666655420 011345555555555542
Q ss_pred CcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCcc
Q 002094 405 NIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSL 484 (967)
Q Consensus 405 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 484 (967)
..+. + .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|..|+.+++|
T Consensus 226 --------------------~~~~-~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 280 (597)
T 3oja_B 226 --------------------VRGP-V--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 280 (597)
T ss_dssp --------------------EECS-C--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSC
T ss_pred --------------------cccc-c--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCC
Confidence 2111 1 1478999999999986 4789999999999999999999999999999999
Q ss_pred ceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCCCCCCccCCCcccCCC
Q 002094 485 TSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNP 564 (967)
Q Consensus 485 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 564 (967)
+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++. |. ..+..+....+.+||
T Consensus 281 ~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~~~L~~L~l~~N~ 356 (597)
T 3oja_B 281 ERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-KL-STHHTLKNLTLSHND 356 (597)
T ss_dssp CEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-CC-CTTCCCSEEECCSSC
T ss_pred CEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-Ch-hhcCCCCEEEeeCCC
Confidence 999999999996 6778888999999999999999 6788899999999999999999864 43 335667777899999
Q ss_pred CCCCccc
Q 002094 565 SLCGSVV 571 (967)
Q Consensus 565 ~lc~~~~ 571 (967)
|.|.+..
T Consensus 357 ~~~~~~~ 363 (597)
T 3oja_B 357 WDCNSLR 363 (597)
T ss_dssp EEHHHHH
T ss_pred CCChhHH
Confidence 9998644
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=346.39 Aligned_cols=239 Identities=20% Similarity=0.258 Sum_probs=192.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC--CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCc-----e
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ--DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSL-----Q 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~ 754 (967)
+.|+..+.||+|+||.||+|... +|+.||||++...........+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 45788899999999999999975 5899999998765544556788999999999999999999999987655 6
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
++||||++|++|.+++.. .+++.+++.++.||+.||+|||++||+||||||+||+++.+ .+||+|||+++....
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 999999999999987754 38999999999999999999999999999999999999875 899999999986543
Q ss_pred CccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 835 LDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
. ....||+.|+|||++ .. .++.++|||||||++|+|++|.+||...... ...
T Consensus 234 ~------~~~~gt~~y~aPE~~-~~-~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------~~~-- 285 (681)
T 2pzi_A 234 F------GYLYGTPGFQAPEIV-RT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVD------------------GLP-- 285 (681)
T ss_dssp C------SCCCCCTTTSCTTHH-HH-CSCHHHHHHHHHHHHHHHHSCCCEETTEECS------------------SCC--
T ss_pred C------CccCCCccccCHHHH-cC-CCCCceehhhhHHHHHHHHhCCCCCcccccc------------------ccc--
Confidence 1 456689999999988 33 3488999999999999999999988532110 000
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCC-HHHHHHHHHhh
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPD-MEEVVNILELI 956 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~evl~~L~~~ 956 (967)
........+..+.+++.+|++.||++||+ ++++.+.|..+
T Consensus 286 --~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 --EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp --TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00001122356889999999999999995 66677666654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=349.61 Aligned_cols=385 Identities=18% Similarity=0.126 Sum_probs=213.4
Q ss_pred CCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCC----CCccccccccccceeeecccccccccCcccc-ccc-
Q 002094 117 GTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTG----PIPESLSFCSSLESVNFSSNRLSGQLPYGIW-FLR- 190 (967)
Q Consensus 117 ~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~- 190 (967)
++|++|||++|+++......++..+++|++|+|++|++++ .++..+..+++|++|+|++|++++..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 4678888888888755445556778888888888888774 2355666677888888888877754443332 244
Q ss_pred ---cCCeEeecCCcCCC----cccccccCCCCCCeeeccCccccccCCcCcc-----CCCCccEEeccccccCCCCChhh
Q 002094 191 ---SLQSLDLSNNLLEG----EIVKGISNLYDLRAIKLGKNKFSGQLPEDIG-----GCSMLKVLDFGVNSLSGSLPDSL 258 (967)
Q Consensus 191 ---~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~l~~n~l~~~~~~~l 258 (967)
+|++|+|++|.++. .++..+..+++|++|+|++|++++..+..+. ..++|++|++++|++++....
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-- 160 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE-- 160 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH--
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH--
Confidence 57777777777663 3355566666666666666666543332222 133455555555555432210
Q ss_pred hcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCC-----cccccceEEcccCcCCCC----CChh
Q 002094 259 QRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIG-----NLVFLKELNISMNQFTGG----LPES 329 (967)
Q Consensus 259 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~~~~ 329 (967)
.++..+..+++|++|++++|.+.+..+..+. ..++|++|++++|.+++. ++..
T Consensus 161 ------------------~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 222 (461)
T 1z7x_W 161 ------------------PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222 (461)
T ss_dssp ------------------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred ------------------HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHH
Confidence 1123333444555555555544432222222 133566666666666543 3555
Q ss_pred hhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCC----CCCC
Q 002094 330 MMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGV----IPSN 405 (967)
Q Consensus 330 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~----~~~~ 405 (967)
+..+++|+.|++++|++.+.....+. ..+...+++|++|++++|++++. ++..
T Consensus 223 l~~~~~L~~L~Ls~n~l~~~~~~~l~-----------------------~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 279 (461)
T 1z7x_W 223 VASKASLRELALGSNKLGDVGMAELC-----------------------PGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHH-----------------------HHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred HHhCCCccEEeccCCcCChHHHHHHH-----------------------HHHhcCCCCceEEECcCCCCCHHHHHHHHHH
Confidence 55666666666666665532111110 00111234455555555555432 3344
Q ss_pred cccccccchhcccccccccccCCCcCC-----cccccEEEecCCccccc----CcccccCCCCCCEEEcCCCCCCCcCCc
Q 002094 406 IGDLSSLMLLNMSMNYLFGSIPASIGK-----LKAIQVLDFSDNWLNGT----IPPQIGGAVSLKELKLEKNFLSGRIPS 476 (967)
Q Consensus 406 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~ 476 (967)
+..+++|++|++++|.+.+..+..+.. .++|++|+|++|.+++. ++..+..+++|++|+|++|.+++..+.
T Consensus 280 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 359 (461)
T 1z7x_W 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359 (461)
T ss_dssp HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred HhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHH
Confidence 444555555555555554332222222 24666777777766643 344555566777777777776654444
Q ss_pred cccc-----cCccceeeccCCcCcC----ccchhhhcccCccEEeccCCccccCCchhhhh-----ccCCceEEecCCcc
Q 002094 477 QIKN-----CSSLTSLILSQNNLTG----PVPAAIANLSNLKYVDLSFNDLSGILPKELIN-----LSHLLSFNISHNHL 542 (967)
Q Consensus 477 ~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~-----l~~L~~L~l~~N~l 542 (967)
.+.. .++|+.|+|++|++++ .+|..+..+++|++|||++|++++.-...+.. ...|+.|++.++.+
T Consensus 360 ~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~ 439 (461)
T 1z7x_W 360 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCC
T ss_pred HHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeeccccc
Confidence 3332 5577777777777765 56666777777777777777776443322221 23466666666655
Q ss_pred cc
Q 002094 543 HG 544 (967)
Q Consensus 543 ~~ 544 (967)
..
T Consensus 440 ~~ 441 (461)
T 1z7x_W 440 SE 441 (461)
T ss_dssp CH
T ss_pred CH
Confidence 53
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=351.56 Aligned_cols=392 Identities=19% Similarity=0.151 Sum_probs=284.3
Q ss_pred CCCCCeEecCCCccCcccccc-ccCCCCCcEEEcCCCCCCCC----CCchhhhcCCCCceEeccccccCCCCccccc-cc
Q 002094 92 LQFLQVLSLSNNNFTGTINAD-LASFGTLQVVDFSENNLSGL----IPDEFFRQCGSLREVSFANNNLTGPIPESLS-FC 165 (967)
Q Consensus 92 l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~n~~~~~----ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l 165 (967)
+++|++|+|++|+++...... +..+++|++|+|++|++++. ++ ..+..+++|++|+|++|++++..+..+. .+
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~-~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l 80 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDIS-SALRVNPALAELNLRSNELGDVGVHCVLQGL 80 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHH-HHHHTCTTCCEEECTTCCCHHHHHHHHHHTT
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHH-HHHHhCCCcCEEeCCCCcCChHHHHHHHHHH
Confidence 357899999999998765444 78899999999999999743 23 3467889999999999999875554443 45
Q ss_pred c----ccceeeeccccccc----ccCccccccccCCeEeecCCcCCCccccccc-----CCCCCCeeeccCccccccC--
Q 002094 166 S----SLESVNFSSNRLSG----QLPYGIWFLRSLQSLDLSNNLLEGEIVKGIS-----NLYDLRAIKLGKNKFSGQL-- 230 (967)
Q Consensus 166 ~----~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~n~l~~~~-- 230 (967)
+ +|++|+|++|+++. .++..+..+++|++|+|++|.+++..+..+. ..++|++|+|++|++++..
T Consensus 81 ~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~ 160 (461)
T 1z7x_W 81 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE 160 (461)
T ss_dssp CSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred hhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH
Confidence 5 79999999999994 5688899999999999999999876555443 3568999999999998744
Q ss_pred --CcCccCCCCccEEeccccccCCCCChhhhc-----CCCCCEEEccCCCCCCc----Cchhhccccccccccccccccc
Q 002094 231 --PEDIGGCSMLKVLDFGVNSLSGSLPDSLQR-----LNSCSSLSLKGNSFTGE----VPDWIGKLANLESLDLSLNQFS 299 (967)
Q Consensus 231 --~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~-----l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~N~l~ 299 (967)
+..+..+++|++|++++|.++...+..+.. .++|++|+|++|.+++. ++..+..+++|++|++++|++.
T Consensus 161 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~ 240 (461)
T 1z7x_W 161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240 (461)
T ss_dssp HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCC
Confidence 556777899999999999988655555543 67999999999999864 4777888899999999999887
Q ss_pred ccc-----CCCCCcccccceEEcccCcCCCC----CChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCC
Q 002094 300 GRI-----PSSIGNLVFLKELNISMNQFTGG----LPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLG 370 (967)
Q Consensus 300 ~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~ 370 (967)
+.. +..+..+++|++|++++|++++. ++..+..+++|+.|++++|.+.+..+..+..
T Consensus 241 ~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~-------------- 306 (461)
T 1z7x_W 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE-------------- 306 (461)
T ss_dssp HHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH--------------
T ss_pred hHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH--------------
Confidence 542 22233578889999999888854 5667777888888888888876432222211
Q ss_pred CCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccC
Q 002094 371 ESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTI 450 (967)
Q Consensus 371 ~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 450 (967)
......++|++|++++|.+++.... .++..+..+++|++|+|++|++++..
T Consensus 307 ---------~l~~~~~~L~~L~L~~n~l~~~~~~--------------------~l~~~l~~~~~L~~L~Ls~n~i~~~~ 357 (461)
T 1z7x_W 307 ---------TLLEPGCQLESLWVKSCSFTAACCS--------------------HFSSVLAQNRFLLELQISNNRLEDAG 357 (461)
T ss_dssp ---------HHTSTTCCCCEEECTTSCCBGGGHH--------------------HHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred ---------HhccCCccceeeEcCCCCCchHHHH--------------------HHHHHHhhCCCccEEEccCCcccccc
Confidence 0111224677777777766532100 13344555566777777777766544
Q ss_pred cccccC-----CCCCCEEEcCCCCCCC----cCCccccccCccceeeccCCcCcCccchhhhc-----ccCccEEeccCC
Q 002094 451 PPQIGG-----AVSLKELKLEKNFLSG----RIPSQIKNCSSLTSLILSQNNLTGPVPAAIAN-----LSNLKYVDLSFN 516 (967)
Q Consensus 451 p~~~~~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N 516 (967)
+..+.. .++|++|+|++|.+++ .+|..+..+++|++|+|++|++++.....+.. ..+|+.|++.+|
T Consensus 358 ~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~ 437 (461)
T 1z7x_W 358 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDI 437 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTC
T ss_pred HHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeeccc
Confidence 444432 5678888888888875 67777888888888888888887653333331 335777777777
Q ss_pred ccccCCchhhh
Q 002094 517 DLSGILPKELI 527 (967)
Q Consensus 517 ~l~~~~p~~l~ 527 (967)
.+....++.+.
T Consensus 438 ~~~~~~~~~l~ 448 (461)
T 1z7x_W 438 YWSEEMEDRLQ 448 (461)
T ss_dssp CCCHHHHHHHH
T ss_pred ccCHHHHHHHH
Confidence 77655554443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-32 Score=300.19 Aligned_cols=289 Identities=21% Similarity=0.227 Sum_probs=142.4
Q ss_pred ccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEecc
Q 002094 167 SLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFG 246 (967)
Q Consensus 167 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 246 (967)
+|+.+++++|.++ .+|..+ .++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|+++++|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCC--CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCC--CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 3444444444444 333332 1344444454444444444444444444444444444444444444445555555555
Q ss_pred ccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCC
Q 002094 247 VNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGL 326 (967)
Q Consensus 247 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 326 (967)
+|+++ .+|..+. ++|++|++++|++++..+..|..+++|++|++++|.++. .+..
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------~~~~ 165 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN----------------------SGFE 165 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBG----------------------GGSC
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcccc----------------------CCCC
Confidence 55444 2222222 344455555555444444444444555555555544431 0122
Q ss_pred ChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCc
Q 002094 327 PESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNI 406 (967)
Q Consensus 327 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~ 406 (967)
+..+..+ +|+.|++++|++++ +|..+ .++|++|++++|++++..+..+
T Consensus 166 ~~~~~~l-~L~~L~l~~n~l~~-l~~~~------------------------------~~~L~~L~l~~n~i~~~~~~~l 213 (332)
T 2ft3_A 166 PGAFDGL-KLNYLRISEAKLTG-IPKDL------------------------------PETLNELHLDHNKIQAIELEDL 213 (332)
T ss_dssp TTSSCSC-CCSCCBCCSSBCSS-CCSSS------------------------------CSSCSCCBCCSSCCCCCCTTSS
T ss_pred cccccCC-ccCEEECcCCCCCc-cCccc------------------------------cCCCCEEECCCCcCCccCHHHh
Confidence 3333333 34444444444331 12110 1345556666666666666666
Q ss_pred ccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCcccccc-----
Q 002094 407 GDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNC----- 481 (967)
Q Consensus 407 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l----- 481 (967)
..+++|+.|+|++|++.+..+..+..+++|+.|+|++|+++ .+|..+..+++|++|++++|+|++..+..|...
T Consensus 214 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 292 (332)
T 2ft3_A 214 LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVK 292 (332)
T ss_dssp TTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSS
T ss_pred cCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccc
Confidence 66677777777777766655556666666666666666665 555556666666666666666665444444432
Q ss_pred -CccceeeccCCcCc--CccchhhhcccCccEEeccCC
Q 002094 482 -SSLTSLILSQNNLT--GPVPAAIANLSNLKYVDLSFN 516 (967)
Q Consensus 482 -~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N 516 (967)
++|+.|++++|++. +..|..|..+++|+.|++++|
T Consensus 293 ~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 293 RAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp SCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred cccccceEeecCcccccccCcccccccchhhhhhcccc
Confidence 34555555555554 344444555555555555544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=303.05 Aligned_cols=221 Identities=22% Similarity=0.340 Sum_probs=175.0
Q ss_pred CCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHH-cCCCCCceeeeeeEEEc----CCceeEEEEe
Q 002094 687 DCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTL-GKIRHHNLVALEGYYWT----PSLQLLIYEF 760 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~~lv~e~ 760 (967)
.+.||+|+||.||+|.. .+++.||||++.. ...+.+|++++ +..+||||+++++++.. ....++||||
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 96 (299)
T 3m2w_A 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96 (299)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred CcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEee
Confidence 37799999999999996 4689999999863 24577888887 55699999999999876 6678999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC---CCCeEEeecccccccCCCcc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS---SGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~---~~~~kl~Dfg~a~~~~~~~~ 837 (967)
+++|+|.+++...... .+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||++....
T Consensus 97 ~~~~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---- 171 (299)
T 3m2w_A 97 LDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---- 171 (299)
T ss_dssp CCSCBHHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred cCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence 9999999999875432 3899999999999999999999999999999999999997 7889999999986431
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
...++.++||||+|+++|||++|+.||........ .. . ....... ..
T Consensus 172 ---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----~~-----~-~~~~~~~-~~ 218 (299)
T 3m2w_A 172 ---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SP-----G-MKTRIRM-GQ 218 (299)
T ss_dssp ---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------C-----C-SCCSSCT-TC
T ss_pred ---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----hH-----H-HHHHHhh-cc
Confidence 23467799999999999999999999964332110 00 0 0000000 00
Q ss_pred CCCC----hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 918 GNFP----ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 918 ~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+ ...+.++.+++.+|++.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1112 345677999999999999999999999987
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-32 Score=298.67 Aligned_cols=289 Identities=20% Similarity=0.279 Sum_probs=160.9
Q ss_pred CCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCc
Q 002094 56 PCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPD 135 (967)
Q Consensus 56 ~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~ 135 (967)
.|.|+.+.|... +++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|++++..|.
T Consensus 32 ~c~l~~l~~~~~------------~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 96 (332)
T 2ft3_A 32 HCHLRVVQCSDL------------GLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK 96 (332)
T ss_dssp EEETTEEECCSS------------CCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGG
T ss_pred cccCCEEECCCC------------Ccc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHh
Confidence 478888888632 111 2233221 4566666666666655555566666666666666666533332
Q ss_pred hhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCC--cccccccCC
Q 002094 136 EFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEG--EIVKGISNL 213 (967)
Q Consensus 136 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l 213 (967)
.|+.+++|++|+|++|+++ .+|..+. ++|++|++++|++++..+..|..+++|++|++++|.++. ..+..+..+
T Consensus 97 -~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l 172 (332)
T 2ft3_A 97 -AFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL 172 (332)
T ss_dssp -GSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC
T ss_pred -HhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC
Confidence 3455666666666666665 3343333 566666666666664444455566666666666666542 445555555
Q ss_pred CCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccc
Q 002094 214 YDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDL 293 (967)
Q Consensus 214 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 293 (967)
+|++|++++|++++ +|..+. ++|++|++++|.+++..+..|..+++|+.|+|++|++++..+..+..+++|++|+|
T Consensus 173 -~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 248 (332)
T 2ft3_A 173 -KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL 248 (332)
T ss_dssp -CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEEC
T ss_pred -ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEEC
Confidence 66666666666653 333332 45666666666666555556666666666666666666555555666666666666
Q ss_pred cccccccccCCCCCcccccceEEcccCcCCCCCChhhhcC------CCCcEEEccCCcCc--CCCChhhhc-ccccEEec
Q 002094 294 SLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNC------GNLLAIDVSQNKLT--GNIPTWIFK-MGLQTVSL 364 (967)
Q Consensus 294 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~l~~N~l~--~~~p~~~~~-~~L~~L~L 364 (967)
++|+++ .+|..+..+++|++|++++|++++..+..|... .+|+.|++++|++. +..|..+.. .+|+.+++
T Consensus 249 ~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l 327 (332)
T 2ft3_A 249 DNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQF 327 (332)
T ss_dssp CSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC
T ss_pred CCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhc
Confidence 666665 455556666666666666666665555555432 45566666666655 233333322 25666666
Q ss_pred cCCC
Q 002094 365 SGNR 368 (967)
Q Consensus 365 ~~n~ 368 (967)
++|+
T Consensus 328 ~~n~ 331 (332)
T 2ft3_A 328 GNYK 331 (332)
T ss_dssp ----
T ss_pred cccc
Confidence 6553
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-32 Score=297.60 Aligned_cols=291 Identities=18% Similarity=0.261 Sum_probs=212.5
Q ss_pred CCCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCC
Q 002094 55 NPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIP 134 (967)
Q Consensus 55 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip 134 (967)
|.|.|+.+.|... +++ .+|..+. +.|++|+|++|++++..+..|+.+++|++|+|++|++++..|
T Consensus 29 c~c~l~~l~~~~~------------~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 93 (330)
T 1xku_A 29 CQCHLRVVQCSDL------------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP 93 (330)
T ss_dssp CEEETTEEECTTS------------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCT
T ss_pred CcCCCeEEEecCC------------Ccc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCH
Confidence 3477888888642 221 1233232 567888888888887777778888888888888888875545
Q ss_pred chhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCC--cccccccC
Q 002094 135 DEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEG--EIVKGISN 212 (967)
Q Consensus 135 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~ 212 (967)
.. |+.+++|++|+|++|+++ .+|..+. ++|++|++++|++++..+..|..+++|++|+|++|.++. ..+..+.+
T Consensus 94 ~~-~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 169 (330)
T 1xku_A 94 GA-FAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169 (330)
T ss_dssp TT-TTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGG
T ss_pred HH-hcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccC
Confidence 43 578888888888888887 4555443 678888888888887766677788888888888888764 56677888
Q ss_pred CCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccccc
Q 002094 213 LYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLD 292 (967)
Q Consensus 213 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 292 (967)
+++|++|++++|+++. +|..+. ++|++|++++|++++..|..|.++++|+.|+|++|.+++..+..+..+++|++|+
T Consensus 170 l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 246 (330)
T 1xku_A 170 MKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246 (330)
T ss_dssp CTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred CCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEE
Confidence 8888888888888874 454443 7788888888888877778888888888888888888877777788888888888
Q ss_pred ccccccccccCCCCCcccccceEEcccCcCCCCCChhhhc------CCCCcEEEccCCcCcC--CCChhhhc-ccccEEe
Q 002094 293 LSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMN------CGNLLAIDVSQNKLTG--NIPTWIFK-MGLQTVS 363 (967)
Q Consensus 293 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------l~~L~~L~l~~N~l~~--~~p~~~~~-~~L~~L~ 363 (967)
|++|+++ .+|..+..+++|++|++++|++++..+..|.. .+.|+.|++++|++.. ..|..+.. ..++.++
T Consensus 247 L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~ 325 (330)
T 1xku_A 247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 325 (330)
T ss_dssp CCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEE
T ss_pred CCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEE
Confidence 8888887 67777888888888888888888777766653 3677888888888753 23333332 3688888
Q ss_pred ccCCC
Q 002094 364 LSGNR 368 (967)
Q Consensus 364 L~~n~ 368 (967)
|++|+
T Consensus 326 L~~N~ 330 (330)
T 1xku_A 326 LGNYK 330 (330)
T ss_dssp C----
T ss_pred ecccC
Confidence 88774
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-33 Score=316.57 Aligned_cols=240 Identities=15% Similarity=0.127 Sum_probs=177.1
Q ss_pred cCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCC-Cce---------eeeeeE---
Q 002094 684 LNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRH-HNL---------VALEGY--- 747 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h-~ni---------v~~~~~--- 747 (967)
|...+.||+|+||.||+|+. .+|+.||||++..... ....+.+.+|+.+++.++| ++. +...+.
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 46677899999999999994 4799999999874432 2235779999999999976 211 111111
Q ss_pred ---------EEc-----CCceeEEEEecCCCchhhhhhc----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Q 002094 748 ---------YWT-----PSLQLLIYEFISSGSLYKHLHD----GSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLK 809 (967)
Q Consensus 748 ---------~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik 809 (967)
+.. ....+++|+++ +++|.+++.. ......+++..++.++.||+.||+|||++||+|||||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiK 238 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 238 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence 111 12346667755 6799988852 1122247788999999999999999999999999999
Q ss_pred CCCEEeCCCCCeEEeecccccccCCCccccccccccccccccCccccc---------CcccCCcccchhhHHHHHHHHHc
Q 002094 810 STNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFAC---------RTVKITEKCDVYGFGVLVLEVVT 880 (967)
Q Consensus 810 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~t~~~Dv~slGvll~ellt 880 (967)
|+|||++.++.+||+|||+++..... .....| +.|+|||++. ....++.++|||||||++|||++
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999998865431 334556 8999999883 44457889999999999999999
Q ss_pred CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHH
Q 002094 881 GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVV 950 (967)
Q Consensus 881 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl 950 (967)
|+.||....... ..+.... .....+.++.+++.+|++.||++|||+.|++
T Consensus 313 g~~Pf~~~~~~~------------------~~~~~~~--~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 313 ADLPNTDDAALG------------------GSEWIFR--SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp SSCCCCTTGGGS------------------CSGGGGS--SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCCCCcchhh------------------hHHHHHh--hcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999997443211 0111111 1123456799999999999999999976664
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-31 Score=293.67 Aligned_cols=290 Identities=19% Similarity=0.222 Sum_probs=158.6
Q ss_pred ccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEc
Q 002094 190 RSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSL 269 (967)
Q Consensus 190 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 269 (967)
.+|+.++++++.++. +|..+. ++++.|+|++|++++..+..|+++++|++|++++|++++..|..|.++++|++|+|
T Consensus 31 c~l~~l~~~~~~l~~-lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCccc-cCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 356677777766663 233222 34555555555555444445555555555555555555444444444455555555
Q ss_pred cCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcC-
Q 002094 270 KGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTG- 348 (967)
Q Consensus 270 ~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~- 348 (967)
++|+++ .+|..+. ++|++|++++|++++..+..|.++++|+.|++++|++..
T Consensus 108 s~n~l~-------------------------~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 160 (330)
T 1xku_A 108 SKNQLK-------------------------ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 160 (330)
T ss_dssp CSSCCS-------------------------BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG
T ss_pred CCCcCC-------------------------ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCcc
Confidence 444444 2333222 455555555555555555555555555555555555531
Q ss_pred -CCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccC
Q 002094 349 -NIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIP 427 (967)
Q Consensus 349 -~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 427 (967)
..+. .+..+++|++|++++|+++. +|..+. ++|++|++++|++.+..|
T Consensus 161 ~~~~~----------------------------~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~ 209 (330)
T 1xku_A 161 GIENG----------------------------AFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDA 209 (330)
T ss_dssp GBCTT----------------------------GGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECT
T ss_pred CcChh----------------------------hccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCH
Confidence 1111 11223445555555555543 222222 455566666666655555
Q ss_pred CCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhc---
Q 002094 428 ASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIAN--- 504 (967)
Q Consensus 428 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--- 504 (967)
..+..+++|+.|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..|..
T Consensus 210 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~ 288 (330)
T 1xku_A 210 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 288 (330)
T ss_dssp GGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSC
T ss_pred HHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCccc
Confidence 56666666666666666666555556666666666666666666 55666666666666666666666555555543
Q ss_pred ---ccCccEEeccCCcccc--CCchhhhhccCCceEEecCCc
Q 002094 505 ---LSNLKYVDLSFNDLSG--ILPKELINLSHLLSFNISHNH 541 (967)
Q Consensus 505 ---l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~l~~N~ 541 (967)
...|+.|++++|++.. ..|..|..+..++.++|++|+
T Consensus 289 ~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 289 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 2566777777777652 556677777777777777764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-33 Score=309.20 Aligned_cols=242 Identities=17% Similarity=0.176 Sum_probs=180.9
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-------cccHHHHHHHHHHHcCCC---------CCceeeee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-------IKSQEDFEKEMKTLGKIR---------HHNLVALE 745 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~E~~~l~~l~---------h~niv~~~ 745 (967)
+.|+..+.||+|+||.||+|+. +|+.||||++..... ....+.+.+|+++++.++ |||||++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4468889999999999999998 689999999986532 233477889999988875 66666665
Q ss_pred eEE-----------------Ec-------------CCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 002094 746 GYY-----------------WT-------------PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGL 795 (967)
Q Consensus 746 ~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL 795 (967)
+++ .+ .+..++||||+++|++.+.+.+ ..+++..+..++.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 543 32 6788999999999977777643 2378999999999999999
Q ss_pred HHHh-cCCcccCCCCCCCEEeCCCC--------------------CeEEeecccccccCCCccccccccccccccccCcc
Q 002094 796 AYLH-HTNIIHYNLKSTNVLIDSSG--------------------EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPE 854 (967)
Q Consensus 796 ~~LH-~~~ivH~Dik~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 854 (967)
+||| ++||+||||||+|||++.++ .+||+|||+|+.... ....||+.|+|||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 9999 89999999999999999887 899999999986542 2347899999999
Q ss_pred cccCcccCCcccchhhHHHH-HHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHH
Q 002094 855 FACRTVKITEKCDVYGFGVL-VLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGL 933 (967)
Q Consensus 855 ~~~~~~~~t~~~Dv~slGvl-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 933 (967)
++.+. . +.++||||++++ .+++++|..||... ................. .......+...+.++.+++.
T Consensus 248 ~~~g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~dli~ 317 (336)
T 2vuw_A 248 LFTGD-G-DYQFDIYRLMKKENNNRWGEYHPYSNV----LWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRKIQEFHR 317 (336)
T ss_dssp GGCCC-S-SHHHHHHHHHHHHHTTCTTSCCTHHHH----HHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHHHHHHHH
T ss_pred hhcCC-C-ccceehhhhhCCCCcccccccCCCcch----hhhhHHHHhhhhhhccC----cccchhhhhhcCHHHHHHHH
Confidence 98433 3 889999998766 78888899998421 00001111111100000 00011123456788999999
Q ss_pred hhccCCCCCCCCHHHHH
Q 002094 934 ICASQVPSNRPDMEEVV 950 (967)
Q Consensus 934 ~cl~~dP~~Rpt~~evl 950 (967)
+|++.| |++|++
T Consensus 318 ~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 318 TMLNFS-----SATDLL 329 (336)
T ss_dssp HGGGSS-----SHHHHH
T ss_pred HHhccC-----CHHHHH
Confidence 999976 998887
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-34 Score=341.73 Aligned_cols=477 Identities=16% Similarity=0.122 Sum_probs=272.8
Q ss_pred CChhHHHHHHHHHhcCCCCccccCCCCCCCCCCCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCC
Q 002094 24 TFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNN 103 (967)
Q Consensus 24 ~~~~d~~all~~k~~~~~~~~~l~sw~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n 103 (967)
..|+|. |..+-+-+.++. .+.++. --|+.|+++.+.. .+ .+.+.. .....++..+.++++|++|+|+++
T Consensus 15 ~LPdei--l~~I~~~L~~~~-d~~~~s---~vck~W~~~~~~~--~~--~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~ 83 (592)
T 3ogk_B 15 ATVDDV--IEQVMTYITDPK-DRDSAS---LVCRRWFKIDSET--RE--HVTMAL-CYTATPDRLSRRFPNLRSLKLKGK 83 (592)
T ss_dssp CCGGGT--HHHHHTTCCCHH-HHHHHT---TSCHHHHHHHHHH--CC--EEEESC-GGGSCHHHHHHHCTTCSEEEEECS
T ss_pred CCCHHH--HHHHHHhcCCHH-HHHHHH---HHhHHHHHhhhcc--cc--EEEEee-ccccChHHHHHhCCCCeEEEecCC
Confidence 356664 677777774432 223332 2135899996532 22 222222 223334455678899999999875
Q ss_pred cc---Ccccccccc------------CCCCCcEEEcCCCCCCCCCCchhhhcCCC-CceEeccccc-cCC-CCccccccc
Q 002094 104 NF---TGTINADLA------------SFGTLQVVDFSENNLSGLIPDEFFRQCGS-LREVSFANNN-LTG-PIPESLSFC 165 (967)
Q Consensus 104 ~l---~~~~~~~~~------------~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~-L~~L~L~~n~-l~~-~~p~~l~~l 165 (967)
.. .+.+|..++ .+++|++|+|++|.+++..+..+...+++ |++|+|++|. ++. .++.....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~ 163 (592)
T 3ogk_B 84 PRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHC 163 (592)
T ss_dssp CGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHC
T ss_pred cchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhC
Confidence 32 133443333 56777777777776665444333222333 7777777665 211 111222366
Q ss_pred cccceeeecccccccc----cCccccccccCCeEeecCCcCCC----cccccccCCCCCCeeeccCccccccCCcCccCC
Q 002094 166 SSLESVNFSSNRLSGQ----LPYGIWFLRSLQSLDLSNNLLEG----EIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGC 237 (967)
Q Consensus 166 ~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 237 (967)
++|++|+|++|.+++. ++..+..+++|++|+|++|.+++ ..+..+.++++|++|+|++|.+.+ ++..+.++
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhh
Confidence 7777777777776544 22334456777777777777652 233344556667777777766664 45566666
Q ss_pred CCccEEeccccccC---CCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccC-CCCCcccccc
Q 002094 238 SMLKVLDFGVNSLS---GSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIP-SSIGNLVFLK 313 (967)
Q Consensus 238 ~~L~~L~l~~n~l~---~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~ 313 (967)
++|++|+++.+... +..+..+..+++|+.|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|+
T Consensus 243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~ 321 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLE 321 (592)
T ss_dssp TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCC
T ss_pred hHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCC
Confidence 66666666643322 223344555666666666654332 445555566666666666666543322 2234556666
Q ss_pred eEEcccCcCCCCCChhhhcCCCCcEEEccC-----------CcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccc
Q 002094 314 ELNISMNQFTGGLPESMMNCGNLLAIDVSQ-----------NKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMK 382 (967)
Q Consensus 314 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~-----------N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 382 (967)
.|+++++...+.++..+..+++|+.|++++ |.+++. .+....
T Consensus 322 ~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~---------------------------~~~~l~ 374 (592)
T 3ogk_B 322 VLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQR---------------------------GLIALA 374 (592)
T ss_dssp EEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHH---------------------------HHHHHH
T ss_pred EEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHH---------------------------HHHHHH
Confidence 666662222222233334556666666652 233211 111222
Q ss_pred cCCCCccEEEccCCcccCCCCCCccc-ccccchhccc----ccccccc-----cCCCcCCcccccEEEecCC--cccccC
Q 002094 383 DSYQGLQVLDLSSNALSGVIPSNIGD-LSSLMLLNMS----MNYLFGS-----IPASIGKLKAIQVLDFSDN--WLNGTI 450 (967)
Q Consensus 383 ~~~~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~ 450 (967)
..+++|++|+++.|++++..+..+.. +++|+.|+++ .|.+++. ++..+.++++|+.|++++| .+++..
T Consensus 375 ~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~ 454 (592)
T 3ogk_B 375 QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG 454 (592)
T ss_dssp HHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHH
T ss_pred hhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHH
Confidence 34567777777777777655555554 6777777775 5566542 3334566788888888743 355554
Q ss_pred cccccC-CCCCCEEEcCCCCCCCc-CCccccccCccceeeccCCcCcCc-cchhhhcccCccEEeccCCccccCCchhhh
Q 002094 451 PPQIGG-AVSLKELKLEKNFLSGR-IPSQIKNCSSLTSLILSQNNLTGP-VPAAIANLSNLKYVDLSFNDLSGILPKELI 527 (967)
Q Consensus 451 p~~~~~-l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 527 (967)
+..+.. +++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++..+..+++|++|+|++|++++.-...+.
T Consensus 455 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~ 534 (592)
T 3ogk_B 455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQ 534 (592)
T ss_dssp HHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGG
T ss_pred HHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHH
Confidence 444443 67788888888888753 445567788888888888887654 344456788888888888888765333333
Q ss_pred -hccCCceEEecCC
Q 002094 528 -NLSHLLSFNISHN 540 (967)
Q Consensus 528 -~l~~L~~L~l~~N 540 (967)
.++.+....+..+
T Consensus 535 ~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 535 MARPYWNIELIPSR 548 (592)
T ss_dssp GCCTTEEEEEECCC
T ss_pred HhCCCcEEEEecCc
Confidence 4566655555543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=297.14 Aligned_cols=283 Identities=19% Similarity=0.182 Sum_probs=227.9
Q ss_pred CCCCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCC
Q 002094 54 DNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133 (967)
Q Consensus 54 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~i 133 (967)
.++|.|.|+ |+.. +++++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|++++..
T Consensus 27 ~~~C~~~~~-c~~~----------~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 92 (353)
T 2z80_A 27 SLSCDRNGI-CKGS----------SGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIE 92 (353)
T ss_dssp CCEECTTSE-EECC----------STTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEEC
T ss_pred CCCCCCCeE-eeCC----------CCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccC
Confidence 357999998 8643 23333 2454444 48999999999999887779999999999999999998644
Q ss_pred CchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccC-ccccccccCCeEeecCC-cCCCccccccc
Q 002094 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLP-YGIWFLRSLQSLDLSNN-LLEGEIVKGIS 211 (967)
Q Consensus 134 p~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~n-~l~~~~~~~~~ 211 (967)
| ..|+++++|++|+|++|++++..+..|+++++|++|+|++|++++..+ ..+..+++|++|++++| .+++..+..|.
T Consensus 93 ~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~ 171 (353)
T 2z80_A 93 E-DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171 (353)
T ss_dssp T-TTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTT
T ss_pred H-hhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHcc
Confidence 4 457899999999999999997766668999999999999999995444 47889999999999999 57777788899
Q ss_pred CCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhc---ccccc
Q 002094 212 NLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIG---KLANL 288 (967)
Q Consensus 212 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~---~l~~L 288 (967)
++++|++|++++|++++..|..|+.+++|++|++++|+++...+..+..+++|+.|++++|.+++..+..+. ....+
T Consensus 172 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l 251 (353)
T 2z80_A 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLI 251 (353)
T ss_dssp TCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCC
T ss_pred CCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchh
Confidence 999999999999999988899999999999999999999754444456689999999999999876554433 34556
Q ss_pred cccccccccccc----ccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCC
Q 002094 289 ESLDLSLNQFSG----RIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIP 351 (967)
Q Consensus 289 ~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 351 (967)
+.++|+++.+++ .+|..+..+++|++|++++|+++...+..|..+++|+.|++++|++.+..|
T Consensus 252 ~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 252 KKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 666676666654 356678888999999999999985544456889999999999999987766
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=286.78 Aligned_cols=254 Identities=21% Similarity=0.245 Sum_probs=183.1
Q ss_pred CCCCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCC-
Q 002094 54 DNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGL- 132 (967)
Q Consensus 54 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~- 132 (967)
.|.|.|.+|.|+.. .++ .+|..+. ++|++|+|++|+++...+..|+.+++|++|+|++|.++..
T Consensus 4 ~C~C~~~~l~c~~~--~l~-----------~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 68 (306)
T 2z66_A 4 RCSCSGTEIRCNSK--GLT-----------SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68 (306)
T ss_dssp TCEEETTEEECCSS--CCS-----------SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEE
T ss_pred CCeeCCCEEEcCCC--Ccc-----------cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCccc
Confidence 35689999999743 121 1233222 5788999999988866556678888888888888888732
Q ss_pred -CCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccC-ccccccccCCeEeecCCcCCCcccccc
Q 002094 133 -IPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLP-YGIWFLRSLQSLDLSNNLLEGEIVKGI 210 (967)
Q Consensus 133 -ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~~ 210 (967)
+|.. +..+++|++|+|++|+++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+++..+..|
T Consensus 69 ~~~~~-~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 146 (306)
T 2z66_A 69 CCSQS-DFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146 (306)
T ss_dssp EEEHH-HHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTT
T ss_pred Ccccc-cccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhc
Confidence 2333 456788888888888887 456668888888888888888876554 567778888888888888777777777
Q ss_pred cCCCCCCeeeccCccccc-cCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccc
Q 002094 211 SNLYDLRAIKLGKNKFSG-QLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLE 289 (967)
Q Consensus 211 ~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 289 (967)
.++++|++|+|++|++++ ..|..+..+++|++|++++|++++..|..|..+++|++|+|++|++++..+..+..+++|+
T Consensus 147 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 226 (306)
T 2z66_A 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 226 (306)
T ss_dssp TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCC
T ss_pred ccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCC
Confidence 777778888888777775 5667777777777777777777766677777777777777777777766666666677777
Q ss_pred cccccccccccccCCCCCccc-ccceEEcccCcCCC
Q 002094 290 SLDLSLNQFSGRIPSSIGNLV-FLKELNISMNQFTG 324 (967)
Q Consensus 290 ~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~ 324 (967)
+|+|++|++++..|..+..++ +|++|+|++|.+++
T Consensus 227 ~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 227 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp EEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred EeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 777777777666666666663 66666666666654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=295.42 Aligned_cols=289 Identities=19% Similarity=0.215 Sum_probs=183.5
Q ss_pred HHhcCCCCccccCCCCCCC-CCCCccceEEeCCCC--CeeeeeeecCCCCCccccccc--cCCCCCCeEecCCCccCccc
Q 002094 35 FKAGLEDPKEKLTSWSEDD-DNPCNWVGVKCDPKT--KRVVGLTLDGFSLSGHIGRGL--LRLQFLQVLSLSNNNFTGTI 109 (967)
Q Consensus 35 ~k~~~~~~~~~l~sw~~~~-~~~c~w~gv~c~~~~--~~v~~l~l~~~~l~~~~~~~l--~~l~~L~~L~L~~n~l~~~~ 109 (967)
.|+++.|+..+|.+|...- .++|.|.++-|.... ..+.. ..+... ..++..+ ...++++.|+|++|+++ .+
T Consensus 21 ~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~--~~g~~~-~~~~~~l~~~~~~~l~~L~L~~n~l~-~l 96 (328)
T 4fcg_A 21 GSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIET--RTGRAL-KATADLLEDATQPGRVALELRSVPLP-QF 96 (328)
T ss_dssp --CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCC--SHHHHH-HHHHHHHHHHTSTTCCEEEEESSCCS-SC
T ss_pred ccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccc--cCCcch-hhhHHHHhcccccceeEEEccCCCch-hc
Confidence 4566778878899997532 357999988883221 11111 111000 0111111 23577888888888887 66
Q ss_pred cccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCcccccc
Q 002094 110 NADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFL 189 (967)
Q Consensus 110 ~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 189 (967)
|..+..+++|++|+|++|.++ .+|.. ++.+++|++|+|++|+++ .+|..++.+++|++|+|++|++.+.+|..+...
T Consensus 97 p~~l~~l~~L~~L~L~~n~l~-~lp~~-~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~ 173 (328)
T 4fcg_A 97 PDQAFRLSHLQHMTIDAAGLM-ELPDT-MQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173 (328)
T ss_dssp CSCGGGGTTCSEEEEESSCCC-CCCSC-GGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE
T ss_pred ChhhhhCCCCCEEECCCCCcc-chhHH-HhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc
Confidence 777888888888888888887 67765 477888888888888888 667778888888888888877777777765440
Q ss_pred ccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEc
Q 002094 190 RSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSL 269 (967)
Q Consensus 190 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 269 (967)
.....|.++++|++|+|++|+++ .+|..++.+++|++|++++|++++ +|..+..+++|++|+|
T Consensus 174 ---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~L 236 (328)
T 4fcg_A 174 ---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL 236 (328)
T ss_dssp ---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEEC
T ss_pred ---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEEC
Confidence 01112334555555555555555 455555566666666666666653 4445666666666666
Q ss_pred cCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCc
Q 002094 270 KGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLT 347 (967)
Q Consensus 270 ~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 347 (967)
++|.+.+.+|..+..+++|++|+|++|++.+.+|..+..+++|++|+|++|++.+.+|..+.++++|+.+++..|.+.
T Consensus 237 s~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred cCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 666666666666666666666666666666666666666666666666666666666666666666666666665554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=283.11 Aligned_cols=281 Identities=19% Similarity=0.181 Sum_probs=219.6
Q ss_pred CCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEE
Q 002094 237 CSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELN 316 (967)
Q Consensus 237 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 316 (967)
++.....++++|.++ .+|..+. ++|++|++++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 30 C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 30 CDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp ECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 344455677777776 4555443 4778888888888766666788888888888888888877777788888888888
Q ss_pred cccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCC
Q 002094 317 ISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSN 396 (967)
Q Consensus 317 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N 396 (967)
+++|++++..+..|.++++|++|++++|++++ +|. ...+..+++|++|++++|
T Consensus 107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~--------------------------~~~~~~l~~L~~L~l~~n 159 (353)
T 2z80_A 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGE--------------------------TSLFSHLTKLQILRVGNM 159 (353)
T ss_dssp CCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCS--------------------------SCSCTTCTTCCEEEEEES
T ss_pred CCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCc--------------------------hhhhccCCCCcEEECCCC
Confidence 88888886666668888888888888888773 322 012234678888888888
Q ss_pred -cccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCC
Q 002094 397 -ALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIP 475 (967)
Q Consensus 397 -~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 475 (967)
.+++..+..|.++++|++|++++|.+.+..|..+..+++|++|++++|+++...+..+..+++|++|+|++|.+++..+
T Consensus 160 ~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~ 239 (353)
T 2z80_A 160 DTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF 239 (353)
T ss_dssp SSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCC
T ss_pred ccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccc
Confidence 4776777889999999999999999998889999999999999999999874444445568899999999999987665
Q ss_pred cccc---ccCccceeeccCCcCcC----ccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCC
Q 002094 476 SQIK---NCSSLTSLILSQNNLTG----PVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELP 547 (967)
Q Consensus 476 ~~~~---~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 547 (967)
..+. ..+.++.++|++|.+++ .+|..+..+++|++|||++|+++...+..|..+++|+.|++++|++.|.+|
T Consensus 240 ~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 240 SELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp C------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 5443 46678888999888876 478889999999999999999995544446899999999999999999887
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-30 Score=279.31 Aligned_cols=249 Identities=20% Similarity=0.247 Sum_probs=186.6
Q ss_pred CeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCC--Cccccccccccceeee
Q 002094 96 QVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGP--IPESLSFCSSLESVNF 173 (967)
Q Consensus 96 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~--~p~~l~~l~~L~~L~L 173 (967)
+.+++++++++. +|..+. ++|++|+|++|+++ .+|..+|+.+++|++|+|++|+++.. .|..+..+++|++|+|
T Consensus 10 ~~l~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred CEEEcCCCCccc-CCCCCC--CCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 467777888774 444333 68888999998888 67777778888888888888888743 3566777888888888
Q ss_pred cccccccccCccccccccCCeEeecCCcCCCccc-ccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCC
Q 002094 174 SSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIV-KGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSG 252 (967)
Q Consensus 174 ~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 252 (967)
++|+++ .+|..+..+++|++|+|++|.+++..+ ..+..+++|++|++++|++++..+..|.++++|++|++++|.+++
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence 888887 456667788888888888888876655 567778888888888888877777777777888888888887775
Q ss_pred -CCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhh
Q 002094 253 -SLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMM 331 (967)
Q Consensus 253 -~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 331 (967)
..|..+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..+..+..+++|++|++++|++++..|..+.
T Consensus 165 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 244 (306)
T 2z66_A 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 244 (306)
T ss_dssp GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCC
T ss_pred ccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHH
Confidence 4667777777777777777777766677777777777777777777765555666777777777777777777777776
Q ss_pred cCC-CCcEEEccCCcCcCC
Q 002094 332 NCG-NLLAIDVSQNKLTGN 349 (967)
Q Consensus 332 ~l~-~L~~L~l~~N~l~~~ 349 (967)
.++ +|+.|++++|++++.
T Consensus 245 ~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 245 HFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp CCCTTCCEEECTTCCEECS
T ss_pred hhhccCCEEEccCCCeecc
Confidence 663 677777777777654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-31 Score=286.74 Aligned_cols=250 Identities=16% Similarity=0.179 Sum_probs=194.4
Q ss_pred ccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCC-CCCCCchhh------hcCCCCceEeccccccCCCCccc
Q 002094 89 LLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNL-SGLIPDEFF------RQCGSLREVSFANNNLTGPIPES 161 (967)
Q Consensus 89 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~-~~~ip~~~~------~~l~~L~~L~L~~n~l~~~~p~~ 161 (967)
++..++|+.|++++|++ .+|..+... |+.|+|++|.+ .+.+|..++ .++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 45667788888888888 667666655 88888888888 445665432 15888888888888888888877
Q ss_pred c--ccccccceeeecccccccccCcccccc-----ccCCeEeecCCcCCCcccccccCCCCCCeeeccCcccccc--CCc
Q 002094 162 L--SFCSSLESVNFSSNRLSGQLPYGIWFL-----RSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQ--LPE 232 (967)
Q Consensus 162 l--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~~~ 232 (967)
+ +.+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..+..|+++++|++|+|++|++.+. .+.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 6 8888888888888888876 7777777 8888888888888888888888888888888888887664 233
Q ss_pred Cc--cCCCCccEEeccccccCCC--C-ChhhhcCCCCCEEEccCCCCCCcCc-hhhccccccccccccccccccccCCCC
Q 002094 233 DI--GGCSMLKVLDFGVNSLSGS--L-PDSLQRLNSCSSLSLKGNSFTGEVP-DWIGKLANLESLDLSLNQFSGRIPSSI 306 (967)
Q Consensus 233 ~~--~~l~~L~~L~l~~n~l~~~--~-~~~l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~ 306 (967)
.+ +.+++|++|++++|++++. + ...+..+++|++|+|++|++++..| ..+..+++|++|+|++|+++ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 33 7888888888888888732 2 2344677888888888888887664 45667788888888888888 667766
Q ss_pred CcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcC
Q 002094 307 GNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTG 348 (967)
Q Consensus 307 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 348 (967)
. ++|++|+|++|+|++. |. +..+++|+.|++++|++++
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 6 7888888888888866 55 8888888888888888874
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-32 Score=324.99 Aligned_cols=406 Identities=13% Similarity=0.110 Sum_probs=234.7
Q ss_pred ccccccCCCCCcEEEcCCCCC---CCCCCc-----------hhhhcCCCCceEeccccccCCCCccccccc-c-ccceee
Q 002094 109 INADLASFGTLQVVDFSENNL---SGLIPD-----------EFFRQCGSLREVSFANNNLTGPIPESLSFC-S-SLESVN 172 (967)
Q Consensus 109 ~~~~~~~l~~L~~L~Ls~n~~---~~~ip~-----------~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l-~-~L~~L~ 172 (967)
++..+..+++|++|+|+++.. .+.+|. .++..+++|++|+|++|.+++..+..++.+ + +|++|+
T Consensus 65 ~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~ 144 (592)
T 3ogk_B 65 PDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK 144 (592)
T ss_dssp HHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEE
T ss_pred hHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEE
Confidence 344455666777777765432 122221 112245566666666665554444444442 2 366666
Q ss_pred ecccc-ccc-ccCccccccccCCeEeecCCcCCCc----ccccccCCCCCCeeeccCcccc----ccCCcCccCCCCccE
Q 002094 173 FSSNR-LSG-QLPYGIWFLRSLQSLDLSNNLLEGE----IVKGISNLYDLRAIKLGKNKFS----GQLPEDIGGCSMLKV 242 (967)
Q Consensus 173 L~~N~-l~~-~~p~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~ 242 (967)
|++|. ++. .++.....+++|++|+|++|.+++. ++..+.++++|++|++++|.++ +.++..+.++++|++
T Consensus 145 L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~ 224 (592)
T 3ogk_B 145 LDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS 224 (592)
T ss_dssp EESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCE
T ss_pred CcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcE
Confidence 65554 111 1111223455555555555555433 2223344455555555555554 222233344455555
Q ss_pred EeccccccCCCCChhhhcCCCCCEEEccCCCCC---CcCchhhccccccccccccccccccccCCCCCcccccceEEccc
Q 002094 243 LDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFT---GEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISM 319 (967)
Q Consensus 243 L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~---~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 319 (967)
|++++|.+.+ ++..+.++++|+.|+++.+... +..+..+..+++|+.|+++++... .+|..+..+++|++|+|++
T Consensus 225 L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~ 302 (592)
T 3ogk_B 225 VKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLY 302 (592)
T ss_dssp EECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETT
T ss_pred EeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCC
Confidence 5555555543 3444555555555555432211 112233444445555555443222 3334444445555555555
Q ss_pred CcCCCCCC-hhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccC---
Q 002094 320 NQFTGGLP-ESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSS--- 395 (967)
Q Consensus 320 N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~--- 395 (967)
|.+++... ..+..+++|+.|+++ |.+. . ..+......+++|++|++++
T Consensus 303 ~~l~~~~~~~~~~~~~~L~~L~L~-~~~~-----------------------~----~~l~~~~~~~~~L~~L~L~~g~~ 354 (592)
T 3ogk_B 303 ALLETEDHCTLIQKCPNLEVLETR-NVIG-----------------------D----RGLEVLAQYCKQLKRLRIERGAD 354 (592)
T ss_dssp CCCCHHHHHHHHTTCTTCCEEEEE-GGGH-----------------------H----HHHHHHHHHCTTCCEEEEECCCC
T ss_pred CcCCHHHHHHHHHhCcCCCEEecc-CccC-----------------------H----HHHHHHHHhCCCCCEEEeecCcc
Confidence 54433222 223444555555554 2221 1 11222334567899999993
Q ss_pred --------CcccCCC-CCCcccccccchhcccccccccccCCCcCC-cccccEEEec----CCccccc-----CcccccC
Q 002094 396 --------NALSGVI-PSNIGDLSSLMLLNMSMNYLFGSIPASIGK-LKAIQVLDFS----DNWLNGT-----IPPQIGG 456 (967)
Q Consensus 396 --------N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~p~~~~~ 456 (967)
|.+++.. +.....+++|++|+++.|.+++..+..+.. +++|+.|+++ .|.+++. ++..+.+
T Consensus 355 ~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~ 434 (592)
T 3ogk_B 355 EQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIG 434 (592)
T ss_dssp SSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHH
T ss_pred ccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHh
Confidence 5665432 222445889999999999998877777766 8999999996 7778753 3444677
Q ss_pred CCCCCEEEcCCCC--CCCcCCccccc-cCccceeeccCCcCcC-ccchhhhcccCccEEeccCCccccC-CchhhhhccC
Q 002094 457 AVSLKELKLEKNF--LSGRIPSQIKN-CSSLTSLILSQNNLTG-PVPAAIANLSNLKYVDLSFNDLSGI-LPKELINLSH 531 (967)
Q Consensus 457 l~~L~~L~L~~N~--l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~ 531 (967)
+++|++|+|++|. +++..+..+.. +++|+.|+|++|++++ .++..+.++++|++|+|++|++++. ++..+..+++
T Consensus 435 ~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~ 514 (592)
T 3ogk_B 435 CKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPS 514 (592)
T ss_dssp CTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSS
T ss_pred CCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCc
Confidence 8999999998544 66665555544 8999999999999986 3456678899999999999998765 4455568999
Q ss_pred CceEEecCCcccc
Q 002094 532 LLSFNISHNHLHG 544 (967)
Q Consensus 532 L~~L~l~~N~l~~ 544 (967)
|+.|+|++|+++.
T Consensus 515 L~~L~ls~n~it~ 527 (592)
T 3ogk_B 515 LRYLWVQGYRASM 527 (592)
T ss_dssp CCEEEEESCBCCT
T ss_pred cCeeECcCCcCCH
Confidence 9999999999875
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-29 Score=268.09 Aligned_cols=228 Identities=20% Similarity=0.199 Sum_probs=174.7
Q ss_pred cEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecC
Q 002094 120 QVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSN 199 (967)
Q Consensus 120 ~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 199 (967)
+.++++++.++ .+|..+ .++|++|+|++|++++..+..|+.+++|++|+|++|++++..|..|..+++|++|+|++
T Consensus 14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 34455555554 345432 35666677777776666666677777777777777777766667777777777777777
Q ss_pred Cc-CCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcC
Q 002094 200 NL-LEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEV 278 (967)
Q Consensus 200 n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 278 (967)
|. ++...+..|..+++|++|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|+|++|++++..
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence 75 66666777777777777777777777777777888888888888888888666667888888888888888888777
Q ss_pred chhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCC
Q 002094 279 PDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIP 351 (967)
Q Consensus 279 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 351 (967)
+..+..+++|++|++++|++++..|..+..+++|+.|++++|++++..+..+..+++|+.|++++|++....+
T Consensus 170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 7778888999999999999988888889999999999999999998777889999999999999999886544
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=284.48 Aligned_cols=269 Identities=19% Similarity=0.188 Sum_probs=229.5
Q ss_pred cCCCCCCCCCCCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccC-cccccccc-------CCC
Q 002094 46 LTSWSEDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFT-GTINADLA-------SFG 117 (967)
Q Consensus 46 l~sw~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~-~~~~~~~~-------~l~ 117 (967)
..+|.... .|+.|..+.......+++.+++.++.+ .+|..+... |++|+|++|+++ +.+|..+. .++
T Consensus 21 ~~~~~~~~-~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~ 95 (312)
T 1wwl_A 21 KPDWSSAF-NCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGIS 95 (312)
T ss_dssp SCCGGGGG-GSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTS
T ss_pred ccchHHHh-hhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcC
Confidence 45686543 356677665544456788999999999 778777665 999999999994 56777766 799
Q ss_pred CCcEEEcCCCCCCCCCCchhh-hcCCCCceEeccccccCCCCccccccc-----cccceeeecccccccccCcccccccc
Q 002094 118 TLQVVDFSENNLSGLIPDEFF-RQCGSLREVSFANNNLTGPIPESLSFC-----SSLESVNFSSNRLSGQLPYGIWFLRS 191 (967)
Q Consensus 118 ~L~~L~Ls~n~~~~~ip~~~~-~~l~~L~~L~L~~n~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~ 191 (967)
+|++|+|++|++++.+|..+| +.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|+.+++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 999999999999999998865 8999999999999999987 8888888 99999999999999888899999999
Q ss_pred CCeEeecCCcCCCc--ccccc--cCCCCCCeeeccCccccc---cCCcCccCCCCccEEeccccccCCCCC-hhhhcCCC
Q 002094 192 LQSLDLSNNLLEGE--IVKGI--SNLYDLRAIKLGKNKFSG---QLPEDIGGCSMLKVLDFGVNSLSGSLP-DSLQRLNS 263 (967)
Q Consensus 192 L~~L~L~~n~l~~~--~~~~~--~~l~~L~~L~L~~n~l~~---~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~ 263 (967)
|++|+|++|++.+. .+..+ .++++|++|+|++|++++ .....+.++++|++|++++|++++..| ..+..+++
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 254 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTT
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCC
Confidence 99999999998865 33444 899999999999999983 222445688999999999999998775 56777899
Q ss_pred CCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCC
Q 002094 264 CSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGG 325 (967)
Q Consensus 264 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 325 (967)
|++|+|++|+|+ .+|..+. ++|++|+|++|++++. |. +..+++|++|++++|++++.
T Consensus 255 L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 255 LNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp CCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred CCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 999999999999 6677666 8999999999999966 65 99999999999999999853
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-28 Score=280.23 Aligned_cols=231 Identities=22% Similarity=0.238 Sum_probs=164.3
Q ss_pred CCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceee
Q 002094 93 QFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVN 172 (967)
Q Consensus 93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 172 (967)
++|++|+|++|++++..+..|..+++|++|+|++|++++ ++...|.++++|++|+|++|++++..+..|..+++|++|+
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 153 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW 153 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEE
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCC-cChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEE
Confidence 578888888888888778888888888888888888774 3334457777777777777777766666677777777777
Q ss_pred ecccccccccCccccccccCCeEeecCC-cCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccC
Q 002094 173 FSSNRLSGQLPYGIWFLRSLQSLDLSNN-LLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLS 251 (967)
Q Consensus 173 L~~N~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 251 (967)
|++|+|++..+..|..+++|++|+|++| .+....+ ..|.++++|++|++++|+++
T Consensus 154 L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~------------------------~~~~~l~~L~~L~L~~n~l~ 209 (452)
T 3zyi_A 154 LRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE------------------------GAFEGLFNLKYLNLGMCNIK 209 (452)
T ss_dssp CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT------------------------TTTTTCTTCCEEECTTSCCS
T ss_pred CCCCCcceeCHhHHhcCCcccEEeCCCCCCccccCh------------------------hhccCCCCCCEEECCCCccc
Confidence 7777776555556666666666666653 3332222 34555555555555555555
Q ss_pred CCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhh
Q 002094 252 GSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMM 331 (967)
Q Consensus 252 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 331 (967)
+. | .+..+++|+.|+|++|.+++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|.
T Consensus 210 ~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 287 (452)
T 3zyi_A 210 DM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT 287 (452)
T ss_dssp SC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSST
T ss_pred cc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhc
Confidence 32 2 356667777777777777777777777778888888888888777777788888888888888888877777788
Q ss_pred cCCCCcEEEccCCcCcCCC
Q 002094 332 NCGNLLAIDVSQNKLTGNI 350 (967)
Q Consensus 332 ~l~~L~~L~l~~N~l~~~~ 350 (967)
.+++|+.|+|++|++....
T Consensus 288 ~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 288 PLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp TCTTCCEEECCSSCEECST
T ss_pred cccCCCEEEccCCCcCCCC
Confidence 8888888888888887543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-28 Score=278.80 Aligned_cols=229 Identities=21% Similarity=0.241 Sum_probs=163.2
Q ss_pred CCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceee
Q 002094 93 QFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVN 172 (967)
Q Consensus 93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 172 (967)
++++.|+|++|++++..+..|..+++|++|+|++|++++ ++...|.++++|++|+|++|++++..+..|..+++|++|+
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~-i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 142 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELW 142 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCE-ECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEE
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCc-cChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceee
Confidence 578888888888888777788888888888888888773 4545567777777777777777766666677777777777
Q ss_pred ecccccccccCccccccccCCeEeecCC-cCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccC
Q 002094 173 FSSNRLSGQLPYGIWFLRSLQSLDLSNN-LLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLS 251 (967)
Q Consensus 173 L~~N~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 251 (967)
|++|+|++..+..|..+++|++|+|++| .+....+ ..|.++++|++|++++|+++
T Consensus 143 L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~------------------------~~~~~l~~L~~L~L~~n~l~ 198 (440)
T 3zyj_A 143 LRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISE------------------------GAFEGLSNLRYLNLAMCNLR 198 (440)
T ss_dssp CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT------------------------TTTTTCSSCCEEECTTSCCS
T ss_pred CCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCc------------------------chhhcccccCeecCCCCcCc
Confidence 7777777555556666666666666663 3332223 34445555555555555555
Q ss_pred CCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhh
Q 002094 252 GSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMM 331 (967)
Q Consensus 252 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 331 (967)
.+| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|++++..+..|.
T Consensus 199 -~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 276 (440)
T 3zyj_A 199 -EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFT 276 (440)
T ss_dssp -SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTS
T ss_pred -ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhc
Confidence 223 356666777777777777766677777777888888888888777777788888888888888888877777788
Q ss_pred cCCCCcEEEccCCcCcC
Q 002094 332 NCGNLLAIDVSQNKLTG 348 (967)
Q Consensus 332 ~l~~L~~L~l~~N~l~~ 348 (967)
.+++|+.|+|++|++..
T Consensus 277 ~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 277 PLHHLERIHLHHNPWNC 293 (440)
T ss_dssp SCTTCCEEECCSSCEEC
T ss_pred cccCCCEEEcCCCCccC
Confidence 88888888888888864
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-28 Score=279.68 Aligned_cols=230 Identities=20% Similarity=0.176 Sum_probs=189.1
Q ss_pred CCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeec
Q 002094 142 GSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKL 221 (967)
Q Consensus 142 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 221 (967)
++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|++|+|++|.+++..+..|.++++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 45666666666666666667777777777777777777666677777777777777777777777777777888888888
Q ss_pred cCccccccCCcCccCCCCccEEeccc-cccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccccccccccccc
Q 002094 222 GKNKFSGQLPEDIGGCSMLKVLDFGV-NSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSG 300 (967)
Q Consensus 222 ~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 300 (967)
++|+++...+..|.++++|++|++++ |.+....+..|.++++|++|+|++|++++. | .+..+++|++|+|++|++++
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~ 232 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPE 232 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSE
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcc
Confidence 88888777677888888899999988 445544455799999999999999999965 4 48899999999999999999
Q ss_pred ccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhc-ccccEEeccCCCCCCCC
Q 002094 301 RIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFK-MGLQTVSLSGNRLGESM 373 (967)
Q Consensus 301 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~L~~n~l~~~~ 373 (967)
..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+.. .+|+.|+|++|++....
T Consensus 233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence 88999999999999999999999999999999999999999999999655555443 48999999999987654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=277.92 Aligned_cols=238 Identities=21% Similarity=0.234 Sum_probs=185.3
Q ss_pred cceEEeCCC---------CCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCC
Q 002094 59 WVGVKCDPK---------TKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNL 129 (967)
Q Consensus 59 w~gv~c~~~---------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~ 129 (967)
|..|.|... ...++.|+|.++.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 678999643 34678899999999999889999999999999999999999999999999999999999999
Q ss_pred CCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecc-cccccccCccccccccCCeEeecCCcCCCcccc
Q 002094 130 SGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSS-NRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVK 208 (967)
Q Consensus 130 ~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~ 208 (967)
+ .+|...|..+++|++|+|++|+++...+..|..+++|++|+|++ |.+....+..|.++++|++|+|++|.++...
T Consensus 125 ~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~-- 201 (440)
T 3zyj_A 125 T-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP-- 201 (440)
T ss_dssp S-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC--
T ss_pred C-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc--
Confidence 9 57777789999999999999999988888999999999999999 4555455557899999999999999988542
Q ss_pred cccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccc
Q 002094 209 GISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANL 288 (967)
Q Consensus 209 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 288 (967)
.+..+++|++|+|++|++++..|..|.++++|++|++++|++++..+..|.++++|+.|+|++|+|++..+..|..+++|
T Consensus 202 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 281 (440)
T 3zyj_A 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL 281 (440)
T ss_dssp CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTC
T ss_pred ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCC
Confidence 46666777777777777766666666666666666666666665555555555555555555555555444445555555
Q ss_pred ccccccccccc
Q 002094 289 ESLDLSLNQFS 299 (967)
Q Consensus 289 ~~L~L~~N~l~ 299 (967)
+.|+|++|.+.
T Consensus 282 ~~L~L~~Np~~ 292 (440)
T 3zyj_A 282 ERIHLHHNPWN 292 (440)
T ss_dssp CEEECCSSCEE
T ss_pred CEEEcCCCCcc
Confidence 55555555443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-29 Score=273.52 Aligned_cols=266 Identities=20% Similarity=0.197 Sum_probs=194.0
Q ss_pred cEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccC
Q 002094 241 KVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMN 320 (967)
Q Consensus 241 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 320 (967)
+.++++.+.+.......+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+ +..+++|++|++++|
T Consensus 13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 344444555443333344445556666666666665555566666666666666666654433 556666666666666
Q ss_pred cCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccC
Q 002094 321 QFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSG 400 (967)
Q Consensus 321 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~ 400 (967)
++++.. ..++|+.|++++|++++..+ ..+++|++|++++|++++
T Consensus 91 ~l~~l~-----~~~~L~~L~l~~n~l~~~~~-------------------------------~~~~~L~~L~l~~N~l~~ 134 (317)
T 3o53_A 91 YVQELL-----VGPSIETLHAANNNISRVSC-------------------------------SRGQGKKNIYLANNKITM 134 (317)
T ss_dssp EEEEEE-----ECTTCCEEECCSSCCSEEEE-------------------------------CCCSSCEEEECCSSCCCS
T ss_pred cccccc-----CCCCcCEEECCCCccCCcCc-------------------------------cccCCCCEEECCCCCCCC
Confidence 665322 23566666666666653211 124668888888888888
Q ss_pred CCCCCcccccccchhcccccccccccCCCcC-CcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCcccc
Q 002094 401 VIPSNIGDLSSLMLLNMSMNYLFGSIPASIG-KLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIK 479 (967)
Q Consensus 401 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 479 (967)
..+..+..+++|++|+|++|.+.+..+..+. .+++|++|+|++|++++. +. ...+++|++|+|++|++++ +|..+.
T Consensus 135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~ 211 (317)
T 3o53_A 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQ 211 (317)
T ss_dssp GGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGG
T ss_pred ccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhc
Confidence 8888888899999999999999887777764 789999999999999865 33 3458899999999999995 555699
Q ss_pred ccCccceeeccCCcCcCccchhhhcccCccEEeccCCccc-cCCchhhhhccCCceEEec-CCcccccCCC
Q 002094 480 NCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLS-GILPKELINLSHLLSFNIS-HNHLHGELPV 548 (967)
Q Consensus 480 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~l~-~N~l~~~~p~ 548 (967)
.+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.++++ .+.++|..|.
T Consensus 212 ~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 212 SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp GGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred ccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 9999999999999999 57888999999999999999998 8888999999999999999 5567765553
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.6e-28 Score=259.47 Aligned_cols=267 Identities=19% Similarity=0.179 Sum_probs=213.4
Q ss_pred eeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEecccc
Q 002094 73 GLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANN 152 (967)
Q Consensus 73 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n 152 (967)
.++..+++++. +|..+ .++|++|+|++|++++..+..|..+++|++|+|++|.+++..|. .|..+++|++|+|++|
T Consensus 15 ~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 15 TTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA-AFTGLALLEQLDLSDN 90 (285)
T ss_dssp EEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSC
T ss_pred EEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHh-hcCCccCCCEEeCCCC
Confidence 34444555543 33332 46889999999999988888899999999999999999854444 4688999999999999
Q ss_pred c-cCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCC
Q 002094 153 N-LTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLP 231 (967)
Q Consensus 153 ~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 231 (967)
+ ++...|..|..+++|++|+|++|++++..|..+..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 7 887778889999999999999999998888888899999999999999998888888999999999999999987777
Q ss_pred cCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccc
Q 002094 232 EDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVF 311 (967)
Q Consensus 232 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 311 (967)
..|..+++|++|++++|.+++..|..|..+++|+.|+|++|.+++..+..+..+++|++|++++|++....+. ..-...
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~ 249 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAW 249 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHH
T ss_pred HHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHH
Confidence 7889999999999999999988888999999999999999999987778889999999999999998754321 122345
Q ss_pred cceEEcccCcCCCCCChhhhc--CCCCcEEEccCC
Q 002094 312 LKELNISMNQFTGGLPESMMN--CGNLLAIDVSQN 344 (967)
Q Consensus 312 L~~L~L~~N~l~~~~~~~~~~--l~~L~~L~l~~N 344 (967)
++.+..+.+.+....|+.+.+ +..+...++++|
T Consensus 250 l~~~~~~~~~~~c~~p~~l~g~~l~~l~~~~l~~C 284 (285)
T 1ozn_A 250 LQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQGC 284 (285)
T ss_dssp HHHCCSEECCCBEEESGGGTTCBGGGSCGGGSCCC
T ss_pred HHhcccccCccccCCchHhCCcChhhcCHHHhccC
Confidence 667777788888777777654 334444444443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=287.73 Aligned_cols=301 Identities=25% Similarity=0.257 Sum_probs=169.4
Q ss_pred CccccCCCCCCCCCCCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcE
Q 002094 42 PKEKLTSWSEDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQV 121 (967)
Q Consensus 42 ~~~~l~sw~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (967)
.....++|.... +||.|+|..|..... ..+....++.|++++|+++ .+|..+. ++|++
T Consensus 8 ~~~~w~~W~~~~-~~~~~~~r~~~~~~~------------------~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~ 65 (622)
T 3g06_A 8 YDAVWSAWRRAA-PAEESRGRAAVVQKM------------------RACLNNGNAVLNVGESGLT-TLPDCLP--AHITT 65 (622)
T ss_dssp --CHHHHHHHTC-CGGGHHHHHHHHHHH------------------HHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSE
T ss_pred HHHHHHHHHhcC-CcchhccccccCccc------------------ccccCCCCcEEEecCCCcC-ccChhhC--CCCcE
Confidence 344567897654 479997754421000 0000112444444444444 3333333 44555
Q ss_pred EEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCc
Q 002094 122 VDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNL 201 (967)
Q Consensus 122 L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~ 201 (967)
|+|++|+++ .+|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+
T Consensus 66 L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~ 132 (622)
T 3g06_A 66 LVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQ 132 (622)
T ss_dssp EEECSCCCS-CCCC----CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSC
T ss_pred EEecCCCCC-CCCC----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCC
Confidence 555555554 3333 24455555555555552 332 44555555555555553 222 34555555555555
Q ss_pred CCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchh
Q 002094 202 LEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDW 281 (967)
Q Consensus 202 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 281 (967)
+++. |.. +++|++|+|++|++++ +|. .+++|+.|++++|+|++ +| ..+++|+.|+|++|.|++ +|.
T Consensus 133 l~~l-p~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~- 198 (622)
T 3g06_A 133 LTSL-PVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPT- 198 (622)
T ss_dssp CSCC-CCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-
T ss_pred CCcC-CCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCC-
Confidence 5542 221 2555666666665553 222 23456666666666663 33 345666777777777764 332
Q ss_pred hccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccE
Q 002094 282 IGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQT 361 (967)
Q Consensus 282 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~ 361 (967)
.+++|+.|++++|.++ .+|.. +++|+.|+|++|+|++ +| ..+++|+.|++++|+|+ .+|.
T Consensus 199 --~~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~--------- 258 (622)
T 3g06_A 199 --LPSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM--------- 258 (622)
T ss_dssp --CCTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---------
T ss_pred --ccchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---------
Confidence 2366777777777776 34432 3677888888888775 44 44577888888888776 3332
Q ss_pred EeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcc
Q 002094 362 VSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLK 434 (967)
Q Consensus 362 L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 434 (967)
.+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|.+.+..|..+..++
T Consensus 259 ----------------------~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 259 ----------------------LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp ----------------------CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred ----------------------ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 1356777777777777 5567778888888888888888877776665554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-31 Score=316.51 Aligned_cols=461 Identities=14% Similarity=0.104 Sum_probs=265.8
Q ss_pred CCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCcc---cc------------ccccCCCCCc
Q 002094 56 PCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGT---IN------------ADLASFGTLQ 120 (967)
Q Consensus 56 ~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~---~~------------~~~~~l~~L~ 120 (967)
|+.|+++.. .....+++..+... .....+.++++|++|+|+++..... .| ..+..+++|+
T Consensus 34 ck~W~~~~~----~~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~ 108 (594)
T 2p1m_B 34 CKSWYEIER----WCRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE 108 (594)
T ss_dssp CHHHHHHHH----HHCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred HHHHHHhhh----hhceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCC
Confidence 457998822 22334555443211 1123466788999999998753211 11 1124567888
Q ss_pred EEEcCCCCCCCCCCchhhhcCCCCceEecccc-ccCCC-CccccccccccceeeecccccccccCcccc----ccccCCe
Q 002094 121 VVDFSENNLSGLIPDEFFRQCGSLREVSFANN-NLTGP-IPESLSFCSSLESVNFSSNRLSGQLPYGIW----FLRSLQS 194 (967)
Q Consensus 121 ~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n-~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~----~l~~L~~ 194 (967)
+|+|++|.+++..+..+...+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++|++
T Consensus 109 ~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~ 188 (594)
T 2p1m_B 109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS 188 (594)
T ss_dssp EEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCE
T ss_pred eEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcE
Confidence 88888887776555554446778888888877 44432 333345778888888888877655444333 4567888
Q ss_pred EeecCCc--CCCc-ccccccCCCCCCeeeccCccccccCCcCccCCCCccEEecccc-------ccCCCCChhhhcCCCC
Q 002094 195 LDLSNNL--LEGE-IVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVN-------SLSGSLPDSLQRLNSC 264 (967)
Q Consensus 195 L~L~~n~--l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n-------~l~~~~~~~l~~l~~L 264 (967)
|+|++|. ++.. ....+.++++|++|+|++|...+.++..+..+++|++|+++.+ .+.+ ++..+.++++|
T Consensus 189 L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L 267 (594)
T 2p1m_B 189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKEL 267 (594)
T ss_dssp EECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTC
T ss_pred EEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCc
Confidence 8887775 2211 1112234577777777777322235666667777777774433 2332 33456666777
Q ss_pred CEE-EccCCCCCCcCchhhccccccccccccccccccccCC-CCCcccccceEEcccCcCCCC-CChhhhcCCCCcEEEc
Q 002094 265 SSL-SLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPS-SIGNLVFLKELNISMNQFTGG-LPESMMNCGNLLAIDV 341 (967)
Q Consensus 265 ~~L-~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l 341 (967)
+.| .+.+... +.++..+..+++|++|+|++|.+++.... .+..+++|++|++++| +++. ++.....+++|+.|++
T Consensus 268 ~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L 345 (594)
T 2p1m_B 268 RCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRV 345 (594)
T ss_dssp CEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEE
T ss_pred ccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEE
Confidence 766 3332222 23344444566677777766665533211 2345566666666666 3321 1122234666666666
Q ss_pred cCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcc-cccccchhccc--
Q 002094 342 SQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIG-DLSSLMLLNMS-- 418 (967)
Q Consensus 342 ~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls-- 418 (967)
+++.-.| ....+.+++ ..+..+...+++|+.|+++.|.+++..+..+. .+++|+.|+++
T Consensus 346 ~~~~~~g--------------~~~~~~l~~----~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~ 407 (594)
T 2p1m_B 346 FPSEPFV--------------MEPNVALTE----QGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCII 407 (594)
T ss_dssp ECSCTTC--------------SSCSSCCCH----HHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEES
T ss_pred ecCcccc--------------cccCCCCCH----HHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecc
Confidence 3321000 001111111 00111222356677777777776654444443 36677777777
Q ss_pred c----ccccc-----ccCCCcCCcccccEEEecCCcccccCcccccC-CCCCCEEEcCCCCCCCcCCccc-cccCcccee
Q 002094 419 M----NYLFG-----SIPASIGKLKAIQVLDFSDNWLNGTIPPQIGG-AVSLKELKLEKNFLSGRIPSQI-KNCSSLTSL 487 (967)
Q Consensus 419 ~----N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L 487 (967)
+ |.+++ .++..+..+++|+.|+|++ .+++..+..+.. +++|++|+|++|.+++..+..+ ..+++|+.|
T Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L 486 (594)
T 2p1m_B 408 EPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKL 486 (594)
T ss_dssp STTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEE
T ss_pred cCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEE
Confidence 3 34431 1222355677888888877 666555555555 7788889998888876555444 668889999
Q ss_pred eccCCcCcCccch-hhhcccCccEEeccCCccccCCchhh-hhccCCceEEecCCccc
Q 002094 488 ILSQNNLTGPVPA-AIANLSNLKYVDLSFNDLSGILPKEL-INLSHLLSFNISHNHLH 543 (967)
Q Consensus 488 ~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~l~~N~l~ 543 (967)
+|++|.+++.... ....+++|++|++++|+++..-...+ ..+++|+...+..+.-.
T Consensus 487 ~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~ 544 (594)
T 2p1m_B 487 EIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAP 544 (594)
T ss_dssp EEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCG
T ss_pred ECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCcc
Confidence 9999988655444 34458889999999998864444445 45677777666665443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-29 Score=272.48 Aligned_cols=253 Identities=17% Similarity=0.149 Sum_probs=130.9
Q ss_pred eecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEecccccc
Q 002094 75 TLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154 (967)
Q Consensus 75 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l 154 (967)
++..+.+...+...+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+ |..+++|++|+|++|++
T Consensus 16 ~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~Ls~n~l 92 (317)
T 3o53_A 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYV 92 (317)
T ss_dssp SCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE---ETTCTTCCEEECCSSEE
T ss_pred eccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh---hhhcCCCCEEECcCCcc
Confidence 333333333333333445556666666666665555555666666666666665554322 45555566666665555
Q ss_pred CCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCc
Q 002094 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDI 234 (967)
Q Consensus 155 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 234 (967)
++. ...++|++|++++|++++..+.. +++|++|+|++|.+++..+..+..+++|++|+|++|++++..+..+
T Consensus 93 ~~l-----~~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 164 (317)
T 3o53_A 93 QEL-----LVGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164 (317)
T ss_dssp EEE-----EECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGG
T ss_pred ccc-----cCCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHH
Confidence 532 12355555555555555443332 3455555555555555555555555555555555555555444444
Q ss_pred c-CCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccc
Q 002094 235 G-GCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLK 313 (967)
Q Consensus 235 ~-~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 313 (967)
. .+++|++|++++|.+++. + ....+++|++|+|++|++++.. ..+..+++|++|+|++|+++ .+|..+..+++|+
T Consensus 165 ~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~-~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~ 240 (317)
T 3o53_A 165 AASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240 (317)
T ss_dssp GGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCC
T ss_pred hhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcch-hhhcccCcccEEECcCCccc-chhhHhhcCCCCC
Confidence 2 455555555555555533 1 1223555555555555555332 23555555555555555555 3444455555555
Q ss_pred eEEcccCcCC-CCCChhhhcCCCCcEEEcc
Q 002094 314 ELNISMNQFT-GGLPESMMNCGNLLAIDVS 342 (967)
Q Consensus 314 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~ 342 (967)
.|++++|.+. +..|..+..+++|+.|+++
T Consensus 241 ~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp EEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred EEEccCCCccCcCHHHHHhccccceEEECC
Confidence 5555555555 4444555555555555554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-27 Score=249.27 Aligned_cols=217 Identities=18% Similarity=0.224 Sum_probs=171.9
Q ss_pred CCCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCC
Q 002094 55 NPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIP 134 (967)
Q Consensus 55 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip 134 (967)
++|.|.|+.|... ..++.+++.+++++. +|..+. ++|++|+|++|++++..+..|..+++|++|+|++|+++ .+|
T Consensus 3 ~~C~~~~~~C~c~-~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~ 77 (270)
T 2o6q_A 3 ALCKKDGGVCSCN-NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLP 77 (270)
T ss_dssp CCBGGGTCSBEEE-TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCC
T ss_pred ccCCCCCCCCEeC-CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeC
Confidence 4799999998653 346678888888875 555444 67899999999998877778888999999999999888 577
Q ss_pred chhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCC
Q 002094 135 DEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLY 214 (967)
Q Consensus 135 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 214 (967)
..+|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|..++
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 157 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCc
Confidence 77778888888888888888877777788888888888888888877777778888888888888888877777777788
Q ss_pred CCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCC
Q 002094 215 DLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTG 276 (967)
Q Consensus 215 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 276 (967)
+|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|+|++|.+..
T Consensus 158 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 88888888888776666667777777777777777776655567777777777777777653
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-26 Score=271.53 Aligned_cols=88 Identities=32% Similarity=0.345 Sum_probs=67.9
Q ss_pred ccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEec
Q 002094 434 KAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDL 513 (967)
Q Consensus 434 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 513 (967)
++|+.|+|++|++++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..|.++++|+.|+|
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 566777777777764 44 34567888888888887 4554 5678888888888888 67888888899999999
Q ss_pred cCCccccCCchhhhhcc
Q 002094 514 SFNDLSGILPKELINLS 530 (967)
Q Consensus 514 s~N~l~~~~p~~l~~l~ 530 (967)
++|++++..|..+..++
T Consensus 292 ~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 292 EGNPLSERTLQALREIT 308 (622)
T ss_dssp CSCCCCHHHHHHHHHHH
T ss_pred cCCCCCCcCHHHHHhcc
Confidence 99999888888887776
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-28 Score=283.32 Aligned_cols=186 Identities=15% Similarity=0.097 Sum_probs=132.0
Q ss_pred ccCCCCceEEEEEE-eCCCcEEEEEEeecCCc---------cccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEE
Q 002094 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGL---------IKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 689 ~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 757 (967)
..+.|+.|.++.++ ...|+.||||.+..... ....++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777666655 33589999999976532 12346799999999999 799999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||++|++|.+.+..... ++.. +|+.||+.||+|+|++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-- 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-- 392 (569)
T ss_dssp EECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--
Confidence 999999999999987543 5543 58999999999999999999999999999999999999999999866432
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCC
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p 884 (967)
........||++|+|||++. +.+..++|+||+|++++++.++..+
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~--g~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFA--ENKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred CccccCceechhhccHHHhC--CCCCCcccccccccchhhhccccch
Confidence 22334567999999999983 3567789999999998887765544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-28 Score=278.99 Aligned_cols=234 Identities=19% Similarity=0.199 Sum_probs=166.6
Q ss_pred CCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEcc
Q 002094 263 SCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVS 342 (967)
Q Consensus 263 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 342 (967)
+|+.|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|++|+|++|.|++.. ..++|+.|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEECc
Confidence 55556666665555555556666666666666666654443 555666666666666655322 12566666666
Q ss_pred CCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhccccccc
Q 002094 343 QNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYL 422 (967)
Q Consensus 343 ~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 422 (967)
+|.+++..+ ..+++|+.|+|++|.+++..|..++.+++|+.|+|++|.+
T Consensus 108 ~N~l~~~~~-------------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 156 (487)
T 3oja_A 108 NNNISRVSC-------------------------------SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156 (487)
T ss_dssp SSCCCCEEE-------------------------------CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCC
T ss_pred CCcCCCCCc-------------------------------cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCC
Confidence 666653211 1245688888888888888788888888888888888888
Q ss_pred ccccCCCcC-CcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchh
Q 002094 423 FGSIPASIG-KLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAA 501 (967)
Q Consensus 423 ~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 501 (967)
.+..|..+. .+++|+.|+|++|.+++. | .+..+++|++|+|++|.|++. |..|..+++|+.|+|++|+|++ +|..
T Consensus 157 ~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~ 232 (487)
T 3oja_A 157 DTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKA 232 (487)
T ss_dssp CEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTT
T ss_pred CCcChHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchh
Confidence 887777776 688888888888888865 3 234578888888888888854 4458888888888888888885 6777
Q ss_pred hhcccCccEEeccCCccc-cCCchhhhhccCCceEEec
Q 002094 502 IANLSNLKYVDLSFNDLS-GILPKELINLSHLLSFNIS 538 (967)
Q Consensus 502 ~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~l~ 538 (967)
+..+++|+.|++++|+++ +.+|..+..++.|+.++++
T Consensus 233 l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred hccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 888888888888888887 6777778888888777775
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=278.18 Aligned_cols=234 Identities=18% Similarity=0.175 Sum_probs=129.6
Q ss_pred CCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceee
Q 002094 93 QFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVN 172 (967)
Q Consensus 93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 172 (967)
++|++|+|++|++++..|..|+.+++|++|+|++|.+++.+| |+.+++|++|+|++|++++.. ..++|++|+
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~ 105 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELL-----VGPSIETLH 105 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEE
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCCC-----CCCCcCEEE
Confidence 366777777777666666666666666666666666664433 456666666666666665322 225666666
Q ss_pred ecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCcc-CCCCccEEeccccccC
Q 002094 173 FSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIG-GCSMLKVLDFGVNSLS 251 (967)
Q Consensus 173 L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~ 251 (967)
|++|+|++..+. .+++|++|+|++|.+++..+..|+++++|++|+|++|++++..|..+. .+++|++|+|++|.|+
T Consensus 106 L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~ 182 (487)
T 3oja_A 106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (487)
T ss_dssp CCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred CcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence 666666654443 235566666666666655555555556666666666666555555544 4555555555555555
Q ss_pred CCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCC-CCCChhh
Q 002094 252 GSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFT-GGLPESM 330 (967)
Q Consensus 252 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~ 330 (967)
+.. .+..+++|+.|+|++|.|++..| .+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|.+. +.+|..+
T Consensus 183 ~~~--~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~ 258 (487)
T 3oja_A 183 DVK--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258 (487)
T ss_dssp EEE--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHH
T ss_pred ccc--ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHH
Confidence 431 12235555555555555554333 25555555555555555553 4444555555555555555554 3344444
Q ss_pred hcCCCCcEEEc
Q 002094 331 MNCGNLLAIDV 341 (967)
Q Consensus 331 ~~l~~L~~L~l 341 (967)
..++.|+.+++
T Consensus 259 ~~l~~L~~l~~ 269 (487)
T 3oja_A 259 SKNQRVQTVAK 269 (487)
T ss_dssp TTCHHHHHHHH
T ss_pred HhCCCCcEEec
Confidence 44444444444
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.8e-29 Score=297.46 Aligned_cols=415 Identities=15% Similarity=0.145 Sum_probs=239.2
Q ss_pred CeEecCCCccCccccccccCCCCCcEEEcCCCCCCC---CCC-----------chhhhcCCCCceEeccccccCCCCccc
Q 002094 96 QVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSG---LIP-----------DEFFRQCGSLREVSFANNNLTGPIPES 161 (967)
Q Consensus 96 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~---~ip-----------~~~~~~l~~L~~L~L~~n~l~~~~p~~ 161 (967)
+.++++++... .....+..+++|+.|+|+++.... ..| ..++..+++|++|+|++|.+++..+..
T Consensus 46 ~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~ 124 (594)
T 2p1m_B 46 RKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLEL 124 (594)
T ss_dssp CEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHH
T ss_pred eEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHH
Confidence 34555443222 122345667778888887765321 111 122345667777777777666555555
Q ss_pred cc-cccccceeeeccc-ccccc-cCccccccccCCeEeecCCcCCCccccccc----CCCCCCeeeccCcc--cccc-CC
Q 002094 162 LS-FCSSLESVNFSSN-RLSGQ-LPYGIWFLRSLQSLDLSNNLLEGEIVKGIS----NLYDLRAIKLGKNK--FSGQ-LP 231 (967)
Q Consensus 162 l~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~----~l~~L~~L~L~~n~--l~~~-~~ 231 (967)
+. .+++|++|+|++| .++.. ++..+..+++|++|+|++|.+++..+..+. .+++|++|++++|. ++.. ++
T Consensus 125 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~ 204 (594)
T 2p1m_B 125 IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALE 204 (594)
T ss_dssp HHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHH
T ss_pred HHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHH
Confidence 54 5667777777666 44432 233334566677777766666554433332 44466666666654 2110 11
Q ss_pred cCccCCCCccEEecccc-ccCCCCChhhhcCCCCCEEEccCCC-------CCCcCchhhccccccccc-ccccccccccc
Q 002094 232 EDIGGCSMLKVLDFGVN-SLSGSLPDSLQRLNSCSSLSLKGNS-------FTGEVPDWIGKLANLESL-DLSLNQFSGRI 302 (967)
Q Consensus 232 ~~~~~l~~L~~L~l~~n-~l~~~~~~~l~~l~~L~~L~L~~n~-------l~~~~~~~l~~l~~L~~L-~L~~N~l~~~~ 302 (967)
..+..+++|++|++++| .+.+ ++..+..+++|+.|++..+. +.+ ++..+.++++|+.| .+.+... +.+
T Consensus 205 ~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l 281 (594)
T 2p1m_B 205 RLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYL 281 (594)
T ss_dssp HHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGG
T ss_pred HHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch-hhH
Confidence 11233456666666655 2332 45555555666666544332 221 22234444555544 2222221 122
Q ss_pred CCCCCcccccceEEcccCcCCCCCC-hhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCccccc
Q 002094 303 PSSIGNLVFLKELNISMNQFTGGLP-ESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASM 381 (967)
Q Consensus 303 ~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 381 (967)
+..+..+++|++|+|++|.+++... ..+..+++|+.|++++| +. . ..+...
T Consensus 282 ~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~-----------------------~----~~l~~l 333 (594)
T 2p1m_B 282 PAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IE-----------------------D----AGLEVL 333 (594)
T ss_dssp GGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GH-----------------------H----HHHHHH
T ss_pred HHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cC-----------------------H----HHHHHH
Confidence 2223344455555555555432211 11334455555555444 21 1 111222
Q ss_pred ccCCCCccEEEccC---------CcccCCCCCCcc-cccccchhcccccccccccCCCcC-CcccccEEEec--C----C
Q 002094 382 KDSYQGLQVLDLSS---------NALSGVIPSNIG-DLSSLMLLNMSMNYLFGSIPASIG-KLKAIQVLDFS--D----N 444 (967)
Q Consensus 382 ~~~~~~L~~L~L~~---------N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N 444 (967)
...+++|++|++++ +.+++.....+. .+++|+.|.++.|.+++..+..+. .+++|+.|+++ + |
T Consensus 334 ~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~ 413 (594)
T 2p1m_B 334 ASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPD 413 (594)
T ss_dssp HHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCC
T ss_pred HHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcc
Confidence 33467788888843 445433222232 478899999999999876665565 58899999999 4 5
Q ss_pred cccc-----cCcccccCCCCCCEEEcCCCCCCCcCCccccc-cCccceeeccCCcCcCccchhh-hcccCccEEeccCCc
Q 002094 445 WLNG-----TIPPQIGGAVSLKELKLEKNFLSGRIPSQIKN-CSSLTSLILSQNNLTGPVPAAI-ANLSNLKYVDLSFND 517 (967)
Q Consensus 445 ~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~ 517 (967)
.+++ .++..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ .++++|++|+|++|+
T Consensus 414 ~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~ 492 (594)
T 2p1m_B 414 YLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCP 492 (594)
T ss_dssp TTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCS
T ss_pred cccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCC
Confidence 5652 1222356788999999987 777665566665 8999999999999987766666 779999999999999
Q ss_pred cccCCch-hhhhccCCceEEecCCccc
Q 002094 518 LSGILPK-ELINLSHLLSFNISHNHLH 543 (967)
Q Consensus 518 l~~~~p~-~l~~l~~L~~L~l~~N~l~ 543 (967)
+++..+. ....+++|+.|++++|+++
T Consensus 493 ~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 493 FGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp CCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred CcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 9765544 3455899999999999885
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=239.99 Aligned_cols=225 Identities=22% Similarity=0.196 Sum_probs=172.0
Q ss_pred EEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCc
Q 002094 122 VDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNL 201 (967)
Q Consensus 122 L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~ 201 (967)
++.++..++ .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.
T Consensus 12 ~~c~~~~l~-~ip~~l---~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 12 YQCMELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EECTTSCCS-SCCSSS---CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEecCCCcc-ccCCCC---CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 344444444 455433 2456777777777776666667777777777777777776666667777777777777777
Q ss_pred CCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCC-CChhhhcCCCCCEEEccCCCCCCcCch
Q 002094 202 LEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGS-LPDSLQRLNSCSSLSLKGNSFTGEVPD 280 (967)
Q Consensus 202 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~ 280 (967)
+++..+..|.++++|++|++++|++++..+..++.+++|++|++++|++++. +|..|.++++|++|+|++|++++..+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~ 167 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence 7777777777777777777777777766666788888888888888888764 588888889999999999999887778
Q ss_pred hhccccccc----cccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCC
Q 002094 281 WIGKLANLE----SLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIP 351 (967)
Q Consensus 281 ~l~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 351 (967)
.+..+++|+ .|++++|++++..+..+ ...+|++|++++|++++..+..|..+++|+.|++++|++++..+
T Consensus 168 ~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp GGHHHHTCTTCCEEEECCSSCCCEECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred HhhhhhhccccceeeecCCCcccccCcccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 888888887 78999999986555444 44589999999999998877788999999999999999997765
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-25 Score=235.80 Aligned_cols=207 Identities=23% Similarity=0.258 Sum_probs=127.1
Q ss_pred CCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceee
Q 002094 93 QFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVN 172 (967)
Q Consensus 93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 172 (967)
++|++|+|++|++++..+..|..+++|++|+|++|++++ ++...|..+++|++|+|++|++++..+..|.++++|++|+
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCc-cCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence 467788888888777666677777777777777777763 3433456666666666666666655555666666666666
Q ss_pred ecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCC
Q 002094 173 FSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSG 252 (967)
Q Consensus 173 L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 252 (967)
+++|++++..+..+..+++|++|+|++|.+++.. +|..|+.+++|++|++++|++++
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-----------------------l~~~~~~l~~L~~L~Ls~N~l~~ 163 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFK-----------------------LPEYFSNLTNLEHLDLSSNKIQS 163 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCC-----------------------CCGGGGGCTTCCEEECCSSCCCE
T ss_pred CCCCCccccCchhcccCCCCCEEECcCCccceec-----------------------CchhhccCCCCCEEECCCCCCCc
Confidence 6666666544445555555555555555555421 24444455555555555555554
Q ss_pred CCChhhhcCCCCC----EEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCC
Q 002094 253 SLPDSLQRLNSCS----SLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTG 324 (967)
Q Consensus 253 ~~~~~l~~l~~L~----~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 324 (967)
..+..+..+++|+ .|++++|.+++..+..+.. .+|+.|+|++|++++..+..+..+++|+.|++++|.+..
T Consensus 164 ~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp ECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred CCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 4444444444444 6667777776554444433 467777777777776555556777777777777777764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=9e-25 Score=233.70 Aligned_cols=211 Identities=18% Similarity=0.187 Sum_probs=144.9
Q ss_pred ccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCcccccccccc
Q 002094 89 LLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSL 168 (967)
Q Consensus 89 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 168 (967)
+..+++|+.|++++|.++.. ..++.+++|++|+|++|.+++ ++ .+..+++|++|+|++|++++..+..|+.+++|
T Consensus 37 ~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 111 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-IS--ALKELTNLTYLILTGNQLQSLPNGVFDKLTNL 111 (272)
T ss_dssp HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-CG--GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred cccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-ch--hhcCCCCCCEEECCCCccCccChhHhcCCcCC
Confidence 45667777777777777642 346677777777777777764 32 35677777777777777776666667777777
Q ss_pred ceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEecccc
Q 002094 169 ESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVN 248 (967)
Q Consensus 169 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 248 (967)
++|+|++|++++..+..|..+++|++|+|++|.+++..+..|.++++|++|++++|++++..+..|+.+++|++|++++|
T Consensus 112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (272)
T 3rfs_A 112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191 (272)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence 77777777777666666677777777777777777666666677777777777777777666666677777777777777
Q ss_pred ccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccc
Q 002094 249 SLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVF 311 (967)
Q Consensus 249 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 311 (967)
++++..+..+..+++|+.|+|++|.+.+. +++|+.|++..|.++|.+|..++.+..
T Consensus 192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 192 QLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred cCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence 77766666667777777777777766533 345666677777777766666665543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-25 Score=237.56 Aligned_cols=229 Identities=16% Similarity=0.150 Sum_probs=153.1
Q ss_pred CCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCcccccccccccee
Q 002094 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESV 171 (967)
Q Consensus 92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 171 (967)
+..+..+++.++.+... ..+..+++|+.|++++|.++ .++. +..+++|++|+|++|++++. ..++.+++|++|
T Consensus 18 ~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 90 (272)
T 3rfs_A 18 FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQG--IQYLPNVRYLALGGNKLHDI--SALKELTNLTYL 90 (272)
T ss_dssp HHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCTT--GGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEE
T ss_pred HHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-cccc--cccCCCCcEEECCCCCCCCc--hhhcCCCCCCEE
Confidence 33455566666666644 34566777777777777776 3332 46777777777777777753 367777777777
Q ss_pred eecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccC
Q 002094 172 NFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLS 251 (967)
Q Consensus 172 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 251 (967)
+|++|++++..+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|+.+++|++|++++|+++
T Consensus 91 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 170 (272)
T 3rfs_A 91 ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ 170 (272)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcC
Confidence 77777777666666677777777777777777666666777777777777777777666666667777777777777776
Q ss_pred CCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhh
Q 002094 252 GSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMM 331 (967)
Q Consensus 252 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 331 (967)
+..+..|..+++|++|+|++|++++..+..+..+++|++|++++|.+.+. +++|+.|+++.|+++|.+|..++
T Consensus 171 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~ 243 (272)
T 3rfs_A 171 SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAG 243 (272)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTS
T ss_pred ccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccc
Confidence 66555666667777777777777666666666666666666666665533 33566666666666666666555
Q ss_pred cCC
Q 002094 332 NCG 334 (967)
Q Consensus 332 ~l~ 334 (967)
.+.
T Consensus 244 ~~~ 246 (272)
T 3rfs_A 244 SVA 246 (272)
T ss_dssp CBC
T ss_pred ccC
Confidence 443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.9e-24 Score=227.17 Aligned_cols=205 Identities=20% Similarity=0.203 Sum_probs=122.5
Q ss_pred CCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEee
Q 002094 118 TLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDL 197 (967)
Q Consensus 118 ~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (967)
.++.+++++++++ .+|..+ .++|++|+|++|++++..+..|+++++|++|+|++|+++...+..|..+++|++|+|
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l 92 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNI---PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCC---CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred CCCEEEccCCCCC-ccCCCC---CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence 4566666666666 455433 245666666666666555555666666666666666655444444455555555555
Q ss_pred cCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCc
Q 002094 198 SNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGE 277 (967)
Q Consensus 198 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 277 (967)
++|.+++..+.. |.++++|++|++++|++++..+..|..+++|++|+|++|.+++.
T Consensus 93 ~~n~l~~~~~~~------------------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 148 (270)
T 2o6q_A 93 TDNKLQALPIGV------------------------FDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSL 148 (270)
T ss_dssp CSSCCCCCCTTT------------------------TTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCcCCcCCHhH------------------------cccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCcc
Confidence 555555444444 44455555555555555544445555555555566666665555
Q ss_pred CchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCC
Q 002094 278 VPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNI 350 (967)
Q Consensus 278 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 350 (967)
.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|++....
T Consensus 149 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred CHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 5555666666666666666666555555666777777777777777666666777777777777777776544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.9e-24 Score=228.12 Aligned_cols=204 Identities=23% Similarity=0.224 Sum_probs=103.1
Q ss_pred ccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccC
Q 002094 113 LASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSL 192 (967)
Q Consensus 113 ~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 192 (967)
++.+++|+.+++++|.++ .+|..++ ++|++|+|++|++++..+..|..+++|++|+|++|+|++..+. ..+++|
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 344455555555555554 3444331 4555555555555555555555555555555555555533221 344455
Q ss_pred CeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCC
Q 002094 193 QSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGN 272 (967)
Q Consensus 193 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n 272 (967)
++|+|++|.++ .+|..+..+++|++|++++|+|++..+..|.++++|++|+|++|
T Consensus 80 ~~L~Ls~N~l~-------------------------~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N 134 (290)
T 1p9a_G 80 GTLDLSHNQLQ-------------------------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134 (290)
T ss_dssp CEEECCSSCCS-------------------------SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-------------------------cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence 55555555444 23333444444444444444444433444444445555555555
Q ss_pred CCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcC
Q 002094 273 SFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTG 348 (967)
Q Consensus 273 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 348 (967)
+|++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++..
T Consensus 135 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 554444444455555555555555555433334455555555555555555 444555555566666666666653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.1e-26 Score=251.42 Aligned_cols=264 Identities=20% Similarity=0.202 Sum_probs=163.7
Q ss_pred CCccceEEeCCCCCeeeeeeecCCCCCccccccccCC--CCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCC-
Q 002094 56 PCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRL--QFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGL- 132 (967)
Q Consensus 56 ~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~- 132 (967)
|+.|+++.|++ ..++.+++.++.+. +..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|.+++.
T Consensus 36 c~~W~~~~~~~--~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~ 109 (336)
T 2ast_B 36 CKRWYRLASDE--SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST 109 (336)
T ss_dssp CHHHHHHHTCS--TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH
T ss_pred HHHHHHHhcCc--hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH
Confidence 45799999874 34667788777665 3456666 7888888888888876555 55678888888888877654
Q ss_pred CCchhhhcCCCCceEeccccccCCCCccccccccccceeeeccc-ccccc-cCccccccccCCeEeecCC-cCCCc-ccc
Q 002094 133 IPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSN-RLSGQ-LPYGIWFLRSLQSLDLSNN-LLEGE-IVK 208 (967)
Q Consensus 133 ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~n-~l~~~-~~~ 208 (967)
+| ..+..+++|++|+|++|++++..+..++.+++|++|+|++| .+++. ++..+..+++|++|+|++| .+++. ++.
T Consensus 110 ~~-~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~ 188 (336)
T 2ast_B 110 LH-GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV 188 (336)
T ss_dssp HH-HHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHH
T ss_pred HH-HHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHH
Confidence 33 34577778888888888777777777777777777777777 56653 5555667777777777777 77654 455
Q ss_pred cccCCC-CCCeeeccCc--ccc-ccCCcCccCCCCccEEeccccc-cCCCCChhhhcCCCCCEEEccCCC-CCCcCchhh
Q 002094 209 GISNLY-DLRAIKLGKN--KFS-GQLPEDIGGCSMLKVLDFGVNS-LSGSLPDSLQRLNSCSSLSLKGNS-FTGEVPDWI 282 (967)
Q Consensus 209 ~~~~l~-~L~~L~L~~n--~l~-~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~l 282 (967)
.+..++ +|++|+|++| .++ +.++..+..+++|++|++++|. +++..+..+..+++|++|+|++|. +.......+
T Consensus 189 ~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l 268 (336)
T 2ast_B 189 AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLEL 268 (336)
T ss_dssp HHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGG
T ss_pred HHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHH
Confidence 566666 6777777776 333 3344455556666666666666 454555555556666666666653 221111234
Q ss_pred ccccccccccccccccccccCCCCCccc-ccceEEcccCcCCCCCChhh
Q 002094 283 GKLANLESLDLSLNQFSGRIPSSIGNLV-FLKELNISMNQFTGGLPESM 330 (967)
Q Consensus 283 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~ 330 (967)
..+++|++|++++| ++ ...+..+. .++.|++++|++++..|..+
T Consensus 269 ~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~ 313 (336)
T 2ast_B 269 GEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTI 313 (336)
T ss_dssp GGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred hcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcc
Confidence 45555555555555 21 11223332 24444455555554444433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=226.98 Aligned_cols=206 Identities=24% Similarity=0.219 Sum_probs=165.3
Q ss_pred cccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCcc
Q 002094 162 LSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLK 241 (967)
Q Consensus 162 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 241 (967)
++.+++|+++++++|+++ .+|..+. ++++.|+|++|.+++..+..|.++++|++|+|++|++++..+. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 444555555555555555 3343332 4566666666666666666666677777777777777654332 6789999
Q ss_pred EEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCc
Q 002094 242 VLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQ 321 (967)
Q Consensus 242 ~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 321 (967)
+|++++|+++ .+|..+..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 9999999998 678889999999999999999998888999999999999999999998877788999999999999999
Q ss_pred CCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhc-ccccEEeccCCCCCCCCC
Q 002094 322 FTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFK-MGLQTVSLSGNRLGESMQ 374 (967)
Q Consensus 322 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~L~~n~l~~~~~ 374 (967)
+++..+..|..+++|+.|+|++|+++ .+|..++. ..|+.|+|++|++.....
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence 99887888899999999999999999 56666555 489999999999976443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.5e-24 Score=232.38 Aligned_cols=224 Identities=15% Similarity=0.190 Sum_probs=163.7
Q ss_pred CCcEEEcCCCCCCCCCCchh--hhcCCCCceEeccccccCCCCcccc--ccccccceeeecccccccccC----cccccc
Q 002094 118 TLQVVDFSENNLSGLIPDEF--FRQCGSLREVSFANNNLTGPIPESL--SFCSSLESVNFSSNRLSGQLP----YGIWFL 189 (967)
Q Consensus 118 ~L~~L~Ls~n~~~~~ip~~~--~~~l~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p----~~~~~l 189 (967)
.++.|.++++.++...-..+ +..+++|++|+|++|++++..|..+ +.+++|++|+|++|++++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 45666666666542111111 2245678888888888888888777 788888888888888886554 334568
Q ss_pred ccCCeEeecCCcCCCcccccccCCCCCCeeeccCcccccc--C--CcCccCCCCccEEeccccccCCCCCh----hhhcC
Q 002094 190 RSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQ--L--PEDIGGCSMLKVLDFGVNSLSGSLPD----SLQRL 261 (967)
Q Consensus 190 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~--~~~~~~l~~L~~L~l~~n~l~~~~~~----~l~~l 261 (967)
++|++|+|++|.+++..+..|+++++|++|+|++|++.+. + +..++.+++|++|++++|+++. ++. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 8888888888888888888888888888888888887642 2 2334678888888888888863 233 25677
Q ss_pred CCCCEEEccCCCCCCcCchhhccc---cccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcE
Q 002094 262 NSCSSLSLKGNSFTGEVPDWIGKL---ANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLA 338 (967)
Q Consensus 262 ~~L~~L~L~~n~l~~~~~~~l~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 338 (967)
++|++|+|++|++++..|..+..+ ++|++|+|++|+++ .+|..+. ++|+.|+|++|++++. |. +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 888888888888887777666666 58888888888888 5666664 6888888888888854 33 577788888
Q ss_pred EEccCCcCc
Q 002094 339 IDVSQNKLT 347 (967)
Q Consensus 339 L~l~~N~l~ 347 (967)
|++++|+++
T Consensus 299 L~L~~N~l~ 307 (310)
T 4glp_A 299 LTLDGNPFL 307 (310)
T ss_dssp EECSSTTTS
T ss_pred EECcCCCCC
Confidence 888888876
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.1e-25 Score=246.95 Aligned_cols=253 Identities=17% Similarity=0.160 Sum_probs=136.9
Q ss_pred EecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCc---hhhhcCC-CCceEeccccccCCCCccccccc-----ccc
Q 002094 98 LSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPD---EFFRQCG-SLREVSFANNNLTGPIPESLSFC-----SSL 168 (967)
Q Consensus 98 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~---~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l-----~~L 168 (967)
+.|++|++++.+|..+...++|++|||++|.+++..+. ..|..++ +|++|+|++|++++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 44555555555555555555555666665555532221 2344555 56666666666665555555554 566
Q ss_pred ceeeecccccccccCcccccc-----ccCCeEeecCCcCCCccccccc----C-CCCCCeeeccCccccccCC----cCc
Q 002094 169 ESVNFSSNRLSGQLPYGIWFL-----RSLQSLDLSNNLLEGEIVKGIS----N-LYDLRAIKLGKNKFSGQLP----EDI 234 (967)
Q Consensus 169 ~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~----~-l~~L~~L~L~~n~l~~~~~----~~~ 234 (967)
++|+|++|++++..+..+... ++|++|+|++|.+++..+..+. . .++|++|+|++|++++... ..+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 666666666655444433332 5566666666666555444332 2 1456666666666653222 223
Q ss_pred cCCC-CccEEeccccccCCCCChhhh----cC-CCCCEEEccCCCCCCc----Cchhhcc-ccccccccccccccccccC
Q 002094 235 GGCS-MLKVLDFGVNSLSGSLPDSLQ----RL-NSCSSLSLKGNSFTGE----VPDWIGK-LANLESLDLSLNQFSGRIP 303 (967)
Q Consensus 235 ~~l~-~L~~L~l~~n~l~~~~~~~l~----~l-~~L~~L~L~~n~l~~~----~~~~l~~-l~~L~~L~L~~N~l~~~~~ 303 (967)
..++ +|++|++++|++++..+..+. .+ ++|++|+|++|.|++. ++..+.. .++|++|+|++|++++..+
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 242 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL 242 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCH
T ss_pred hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHH
Confidence 3333 666666666666655544333 23 4666666666666642 2333433 2366666666666654322
Q ss_pred ----CCCCcccccceEEcccCcCCCCCC-------hhhhcCCCCcEEEccCCcCcCCC
Q 002094 304 ----SSIGNLVFLKELNISMNQFTGGLP-------ESMMNCGNLLAIDVSQNKLTGNI 350 (967)
Q Consensus 304 ----~~~~~l~~L~~L~L~~N~l~~~~~-------~~~~~l~~L~~L~l~~N~l~~~~ 350 (967)
..+..+++|+.|+|++|.+.+..+ ..+..+++|+.||+++|++....
T Consensus 243 ~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~ 300 (362)
T 3goz_A 243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSH 300 (362)
T ss_dssp HHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGG
T ss_pred HHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcc
Confidence 234555667777777776443332 24556666777777777776443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=221.67 Aligned_cols=191 Identities=18% Similarity=0.256 Sum_probs=107.2
Q ss_pred CCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCc
Q 002094 56 PCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPD 135 (967)
Q Consensus 56 ~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~ 135 (967)
||.|.|++|.. ....+++.+++++. +|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|.+++ ++.
T Consensus 4 Cp~~~gC~C~~---~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~ 76 (251)
T 3m19_A 4 CETVTGCTCNE---GKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSA 76 (251)
T ss_dssp CHHHHSSEEEG---GGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC-CCT
T ss_pred CCCCCceEcCC---CCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCc-cCH
Confidence 68999999953 23345666666553 343333 456666666666666655566666666666666666653 333
Q ss_pred hhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCC
Q 002094 136 EFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYD 215 (967)
Q Consensus 136 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 215 (967)
..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~---------------------- 134 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLK---------------------- 134 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC----------------------
T ss_pred hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCccc----------------------
Confidence 3345555555555555555554444555555555555555555544444444444444
Q ss_pred CCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCc
Q 002094 216 LRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGE 277 (967)
Q Consensus 216 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 277 (967)
+|+|++|++++..+..|+.+++|++|++++|++++..+..|..+++|+.|+|++|.++..
T Consensus 135 --~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 135 --ELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp --EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred --EEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 445555554444444455555555555555555555555555666666666666666543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-24 Score=253.44 Aligned_cols=186 Identities=16% Similarity=0.198 Sum_probs=146.0
Q ss_pred CCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccc-------cHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 686 KDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIK-------SQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 686 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
..+.||+|+||.||+|.. .++.+++|+........ ..+++.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999954 48899999875433211 1345899999999999999997777777778889999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++++|.+++.. +..++.|+++||+|||+++|+||||||+||+++. .+||+|||+++........
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 99999999999875 4579999999999999999999999999999998 9999999999877542221
Q ss_pred c-----ccccccccccccCcccccC-cccCCcccchhhHHHHHHHHHcCCCCC
Q 002094 839 I-----LSSKIQSALGYMAPEFACR-TVKITEKCDVYGFGVLVLEVVTGKRPV 885 (967)
Q Consensus 839 ~-----~~~~~~gt~~y~aPE~~~~-~~~~t~~~Dv~slGvll~elltg~~p~ 885 (967)
. ......||+.|+|||++.. ...|+..+|+|+..+-..+-+.++.+|
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1 1235679999999999832 145778899999998888888777766
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-25 Score=250.82 Aligned_cols=247 Identities=22% Similarity=0.281 Sum_probs=156.4
Q ss_pred ccccccCCCCCCeEecCCCccCcccc----ccccCCCCCcEEEcCCC---CCCCCCCchh------hhcCCCCceEeccc
Q 002094 85 IGRGLLRLQFLQVLSLSNNNFTGTIN----ADLASFGTLQVVDFSEN---NLSGLIPDEF------FRQCGSLREVSFAN 151 (967)
Q Consensus 85 ~~~~l~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~Ls~n---~~~~~ip~~~------~~~l~~L~~L~L~~ 151 (967)
+...+..+++|++|+|++|++++..+ ..+..+++|++|+|++| ++++.+|..+ +..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 45667788999999999999987643 45778999999999986 4455566554 46778888888888
Q ss_pred cccCC----CCccccccccccceeeecccccccccCcccc----cc---------ccCCeEeecCCcCCC-ccc---ccc
Q 002094 152 NNLTG----PIPESLSFCSSLESVNFSSNRLSGQLPYGIW----FL---------RSLQSLDLSNNLLEG-EIV---KGI 210 (967)
Q Consensus 152 n~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~L~~n~l~~-~~~---~~~ 210 (967)
|++++ .+|..+..+++|++|+|++|++++..+..+. .+ ++|++|+|++|.++. ..+ ..+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 88887 4666778888888888888888754444333 33 777777777777762 233 345
Q ss_pred cCCCCCCeeeccCccccc-----cCCcCccCCCCccEEeccccccC----CCCChhhhcCCCCCEEEccCCCCCCcCchh
Q 002094 211 SNLYDLRAIKLGKNKFSG-----QLPEDIGGCSMLKVLDFGVNSLS----GSLPDSLQRLNSCSSLSLKGNSFTGEVPDW 281 (967)
Q Consensus 211 ~~l~~L~~L~L~~n~l~~-----~~~~~~~~l~~L~~L~l~~n~l~----~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 281 (967)
..+++|++|+|++|+++. ..+..+..+++|++|+|++|.++ ..+|..+..+++|+.|+|++|.+++.....
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~ 263 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence 566666666666666652 22335555555666665555553 334444555555555555555544331100
Q ss_pred hccccccccccccccccccccCCCC--CcccccceEEcccCcCCC----CCChhh-hcCCCCcEEEccCCcCcCCCC
Q 002094 282 IGKLANLESLDLSLNQFSGRIPSSI--GNLVFLKELNISMNQFTG----GLPESM-MNCGNLLAIDVSQNKLTGNIP 351 (967)
Q Consensus 282 l~~l~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~l~~N~l~~~~p 351 (967)
++..+ +.+++|++|+|++|.+++ .+|..+ .++++|+.|++++|++++..+
T Consensus 264 --------------------l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 264 --------------------VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp --------------------HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred --------------------HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 22233 225556666666666664 345555 456677777777777765553
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=218.48 Aligned_cols=196 Identities=18% Similarity=0.188 Sum_probs=134.9
Q ss_pred CCCeEecCCCccCccccccccCCCCCcEEEcCCCC-CCCCCCchhhhcCCCCceEeccc-cccCCCCcccccccccccee
Q 002094 94 FLQVLSLSNNNFTGTINADLASFGTLQVVDFSENN-LSGLIPDEFFRQCGSLREVSFAN-NNLTGPIPESLSFCSSLESV 171 (967)
Q Consensus 94 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~-~~~~ip~~~~~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L 171 (967)
+|++|+|++|++++..+..|+.+++|++|+|++|+ ++ .++...|.++++|++|+|++ |++++..+..|.++++|++|
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 78899999999988777788888888888888886 66 56665678888888888887 88887766778888888888
Q ss_pred eecccccccccCccccccccCC---eEeecCC-cCCCcccccccCCCCCC-eeeccCccccccCCcCccCCCCccEEecc
Q 002094 172 NFSSNRLSGQLPYGIWFLRSLQ---SLDLSNN-LLEGEIVKGISNLYDLR-AIKLGKNKFSGQLPEDIGGCSMLKVLDFG 246 (967)
Q Consensus 172 ~L~~N~l~~~~p~~~~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 246 (967)
+|++|++++ +|. |..+++|+ +|++++| .+++..+..|.++++|+ +|++++|+++...+..|.. ++|++|+++
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~ 187 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN 187 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence 888888875 555 66777777 7777777 77766666677777777 7777777776333333433 566666666
Q ss_pred ccc-cCCCCChhhhcC-CCCCEEEccCCCCCCcCchhhcccccccccccccc
Q 002094 247 VNS-LSGSLPDSLQRL-NSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLN 296 (967)
Q Consensus 247 ~n~-l~~~~~~~l~~l-~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N 296 (967)
+|+ +++..+..|.++ ++|+.|++++|++++..+. .+++|+.|+++++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 663 654445555555 5555565555555533222 3444555554443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=231.26 Aligned_cols=246 Identities=16% Similarity=0.158 Sum_probs=174.9
Q ss_pred CCCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCC
Q 002094 55 NPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIP 134 (967)
Q Consensus 55 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip 134 (967)
|-|.|+.|.|+.. +++ .+|..+ .+++++|+|++|+|+...+.+|+++++|++|+|++|++.+.+|
T Consensus 7 C~C~~~~v~C~~~------------~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~ 71 (350)
T 4ay9_X 7 CHCSNRVFLCQES------------KVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 71 (350)
T ss_dssp SEEETTEEEEEST------------TCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEEC
T ss_pred cEeeCCEEEecCC------------CCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccC
Confidence 3478999999642 222 245444 3579999999999997777789999999999999999988888
Q ss_pred chhhhcCCCCce-EeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecC-CcCCCcccccccC
Q 002094 135 DEFFRQCGSLRE-VSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSN-NLLEGEIVKGISN 212 (967)
Q Consensus 135 ~~~~~~l~~L~~-L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~ 212 (967)
...|.++++|++ +.+++|+++...|..|..+++|++|++++|+|++..+..+....++..|++.+ |.+....+..|..
T Consensus 72 ~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~ 151 (350)
T 4ay9_X 72 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151 (350)
T ss_dssp TTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTT
T ss_pred hhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhh
Confidence 888899988775 66677899988888899999999999999999877666777777888888865 5677666667776
Q ss_pred CC-CCCeeeccCccccccCCcCccCCCCccEEeccc-cccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccc
Q 002094 213 LY-DLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGV-NSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLES 290 (967)
Q Consensus 213 l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 290 (967)
+. .++.|+|++|+|+.. +.......+|++|++++ |.++...+..|.++++|+.|+|++|+|+...+..+.++++|+.
T Consensus 152 ~~~~l~~L~L~~N~i~~i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~ 230 (350)
T 4ay9_X 152 LSFESVILWLNKNGIQEI-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA 230 (350)
T ss_dssp SBSSCEEEECCSSCCCEE-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEEC
T ss_pred cchhhhhhccccccccCC-ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhh
Confidence 64 577788888888744 33333456777777764 5555444455677777777777777777555555555555555
Q ss_pred ccccccccccccCCCCCcccccceEEcccC
Q 002094 291 LDLSLNQFSGRIPSSIGNLVFLKELNISMN 320 (967)
Q Consensus 291 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 320 (967)
+++. .+. .+| .+.++++|+.+++.++
T Consensus 231 l~~~--~l~-~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 231 RSTY--NLK-KLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp TTCT--TCC-CCC-CTTTCCSCCEEECSCH
T ss_pred ccCC--CcC-cCC-CchhCcChhhCcCCCC
Confidence 4432 233 334 3555566666665443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-24 Score=241.51 Aligned_cols=257 Identities=16% Similarity=0.140 Sum_probs=209.7
Q ss_pred eeecCCCCCccccccccCCCCCCeEecCCCccCcccc----ccccCCC-CCcEEEcCCCCCCCCCCchhhhcC-----CC
Q 002094 74 LTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTIN----ADLASFG-TLQVVDFSENNLSGLIPDEFFRQC-----GS 143 (967)
Q Consensus 74 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~Ls~n~~~~~ip~~~~~~l-----~~ 143 (967)
.++..++++|.++..+...++|++|+|++|++++..+ ..|..++ +|++|+|++|.+++..+.. +..+ ++
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~-l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDE-LVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHH-HHHHHHTSCTT
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHH-HHHHHhccCCC
Confidence 4677889999988888888889999999999998877 7888998 9999999999999766654 3554 99
Q ss_pred CceEeccccccCCCCccccccc-----cccceeeecccccccccCccccc-----cccCCeEeecCCcCCCcccc----c
Q 002094 144 LREVSFANNNLTGPIPESLSFC-----SSLESVNFSSNRLSGQLPYGIWF-----LRSLQSLDLSNNLLEGEIVK----G 209 (967)
Q Consensus 144 L~~L~L~~n~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~n~l~~~~~~----~ 209 (967)
|++|+|++|++++..+..++.. ++|++|+|++|+|++..+..+.. .++|++|+|++|.+++.... .
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999998888766554 89999999999999776655543 36999999999999965544 4
Q ss_pred ccCCC-CCCeeeccCccccccCCcCcc----CC-CCccEEeccccccCCC----CChhhhcC-CCCCEEEccCCCCCCcC
Q 002094 210 ISNLY-DLRAIKLGKNKFSGQLPEDIG----GC-SMLKVLDFGVNSLSGS----LPDSLQRL-NSCSSLSLKGNSFTGEV 278 (967)
Q Consensus 210 ~~~l~-~L~~L~L~~n~l~~~~~~~~~----~l-~~L~~L~l~~n~l~~~----~~~~l~~l-~~L~~L~L~~n~l~~~~ 278 (967)
+..++ +|++|+|++|++++..+..+. .+ ++|++|+|++|.|++. ++..+..+ ++|++|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45565 999999999999977765444 44 6999999999999864 45566664 59999999999999765
Q ss_pred c----hhhcccccccccccccccccc-------ccCCCCCcccccceEEcccCcCCCCCChhhh
Q 002094 279 P----DWIGKLANLESLDLSLNQFSG-------RIPSSIGNLVFLKELNISMNQFTGGLPESMM 331 (967)
Q Consensus 279 ~----~~l~~l~~L~~L~L~~N~l~~-------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 331 (967)
+ ..+..+++|++|+|++|.+.+ .++..+..+++|+.|++++|++.+..+..+.
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~~ 305 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPIS 305 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHHH
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHHH
Confidence 5 345677999999999999543 2445788899999999999999876555443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-25 Score=250.06 Aligned_cols=268 Identities=21% Similarity=0.224 Sum_probs=153.2
Q ss_pred ChhhhcCCCCCEEEccCCCCCCcCc----hhhcccccccccccccc---ccccccCCC-------CCcccccceEEcccC
Q 002094 255 PDSLQRLNSCSSLSLKGNSFTGEVP----DWIGKLANLESLDLSLN---QFSGRIPSS-------IGNLVFLKELNISMN 320 (967)
Q Consensus 255 ~~~l~~l~~L~~L~L~~n~l~~~~~----~~l~~l~~L~~L~L~~N---~l~~~~~~~-------~~~l~~L~~L~L~~N 320 (967)
+..+..+++|+.|+|++|.++...+ ..+..+++|++|+|++| ++.+.+|.. +..+++|++|+|++|
T Consensus 25 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n 104 (386)
T 2ca6_A 25 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 104 (386)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCC
Confidence 3444444444555555554443322 22334555555555543 222233322 356677777788777
Q ss_pred cCCC----CCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCC
Q 002094 321 QFTG----GLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSN 396 (967)
Q Consensus 321 ~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N 396 (967)
++++ .+|..+..+++|+.|+|++|.++...+..+... +..+ ..|++ ....++|++|+|++|
T Consensus 105 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~-l~~l--~~~~~------------~~~~~~L~~L~L~~n 169 (386)
T 2ca6_A 105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA-LQEL--AVNKK------------AKNAPPLRSIICGRN 169 (386)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH-HHHH--HHHHH------------HHTCCCCCEEECCSS
T ss_pred cCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH-HHHH--hhhhh------------cccCCCCcEEECCCC
Confidence 7776 356677778888888888887753333222210 0000 00000 000156667777777
Q ss_pred ccc-CCCC---CCcccccccchhcccccccc--c---ccCCCcCCcccccEEEecCCccc----ccCcccccCCCCCCEE
Q 002094 397 ALS-GVIP---SNIGDLSSLMLLNMSMNYLF--G---SIPASIGKLKAIQVLDFSDNWLN----GTIPPQIGGAVSLKEL 463 (967)
Q Consensus 397 ~l~-~~~~---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L 463 (967)
+++ +.++ ..+..+++|++|+|++|++. + ..+..+..+++|+.|+|++|.++ +.+|..+..+++|++|
T Consensus 170 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L 249 (386)
T 2ca6_A 170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 249 (386)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred CCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEE
Confidence 665 2223 34455666777777777665 2 34446677777777777777775 4566667777777777
Q ss_pred EcCCCCCCCc----CCcccc--ccCccceeeccCCcCcC----ccchhh-hcccCccEEeccCCccccCCc--hhhh-hc
Q 002094 464 KLEKNFLSGR----IPSQIK--NCSSLTSLILSQNNLTG----PVPAAI-ANLSNLKYVDLSFNDLSGILP--KELI-NL 529 (967)
Q Consensus 464 ~L~~N~l~~~----~p~~~~--~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~p--~~l~-~l 529 (967)
+|++|.|++. +|..+. .+++|+.|+|++|.+++ .+|..+ .++++|++|+|++|++++..+ ..+. .+
T Consensus 250 ~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~l 329 (386)
T 2ca6_A 250 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVF 329 (386)
T ss_dssp ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHHHHHHHH
T ss_pred ECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHHHHHHHHh
Confidence 7777777654 455553 37777777777777776 366665 557777777777777776653 3332 34
Q ss_pred cCCceEEe
Q 002094 530 SHLLSFNI 537 (967)
Q Consensus 530 ~~L~~L~l 537 (967)
++++.+++
T Consensus 330 ~~~~~~~l 337 (386)
T 2ca6_A 330 STRGRGEL 337 (386)
T ss_dssp HHHTCCEE
T ss_pred hhcCcchh
Confidence 44444444
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=229.41 Aligned_cols=228 Identities=18% Similarity=0.201 Sum_probs=189.0
Q ss_pred CCCCCCeEecCCCccCccccc---cccCCCCCcEEEcCCCCCCCCCCchhh-hcCCCCceEeccccccCCCCc----ccc
Q 002094 91 RLQFLQVLSLSNNNFTGTINA---DLASFGTLQVVDFSENNLSGLIPDEFF-RQCGSLREVSFANNNLTGPIP----ESL 162 (967)
Q Consensus 91 ~l~~L~~L~L~~n~l~~~~~~---~~~~l~~L~~L~Ls~n~~~~~ip~~~~-~~l~~L~~L~L~~n~l~~~~p----~~l 162 (967)
+-..++.|.++++.++...-. .+..+++|++|+|++|.+++.+|..++ ..+++|++|+|++|++++..+ ..+
T Consensus 62 ~~~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~ 141 (310)
T 4glp_A 62 KALRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQ 141 (310)
T ss_dssp SSCCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHT
T ss_pred hhcceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHh
Confidence 344578899999888643111 223457799999999999998888766 889999999999999998665 345
Q ss_pred ccccccceeeecccccccccCccccccccCCeEeecCCcCCCc--c--cccccCCCCCCeeeccCccccccCCc----Cc
Q 002094 163 SFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGE--I--VKGISNLYDLRAIKLGKNKFSGQLPE----DI 234 (967)
Q Consensus 163 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~--~--~~~~~~l~~L~~L~L~~n~l~~~~~~----~~ 234 (967)
..+++|++|+|++|++++..|..|..+++|++|+|++|++.+. . +..+..+++|++|+|++|+++.. +. .+
T Consensus 142 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~ 220 (310)
T 4glp_A 142 WLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETP-TGVCAALA 220 (310)
T ss_dssp TBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCH-HHHHHHHH
T ss_pred hhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCch-HHHHHHHH
Confidence 6799999999999999988889999999999999999998753 2 23347899999999999999732 22 35
Q ss_pred cCCCCccEEeccccccCCCCChhhhcC---CCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccc
Q 002094 235 GGCSMLKVLDFGVNSLSGSLPDSLQRL---NSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVF 311 (967)
Q Consensus 235 ~~l~~L~~L~l~~n~l~~~~~~~l~~l---~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 311 (967)
+.+++|++|++++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|++|+|++|++++. |. +..+++
T Consensus 221 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~ 295 (310)
T 4glp_A 221 AAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPE 295 (310)
T ss_dssp HHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCC
T ss_pred hcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCC
Confidence 788999999999999998888888777 69999999999999 5676664 8999999999999964 43 788999
Q ss_pred cceEEcccCcCCC
Q 002094 312 LKELNISMNQFTG 324 (967)
Q Consensus 312 L~~L~L~~N~l~~ 324 (967)
|+.|+|++|++++
T Consensus 296 L~~L~L~~N~l~~ 308 (310)
T 4glp_A 296 VDNLTLDGNPFLV 308 (310)
T ss_dssp CSCEECSSTTTSC
T ss_pred ccEEECcCCCCCC
Confidence 9999999999974
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-24 Score=240.07 Aligned_cols=253 Identities=16% Similarity=0.166 Sum_probs=156.2
Q ss_pred CCCeEecCCCccCccccccccCC--CCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCC-Cccccccccccce
Q 002094 94 FLQVLSLSNNNFTGTINADLASF--GTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGP-IPESLSFCSSLES 170 (967)
Q Consensus 94 ~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~ 170 (967)
.++.|++++|++. +..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|++++. +|..+..+++|++
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~ 122 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN 122 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCE
Confidence 3677777777766 3455555 6777777777777765554 23567777777777777654 5666677777777
Q ss_pred eeecccccccccCccccccccCCeEeecCC-cCCCc-ccccccCCCCCCeeeccCc-ccccc-CCcCccCCC-CccEEec
Q 002094 171 VNFSSNRLSGQLPYGIWFLRSLQSLDLSNN-LLEGE-IVKGISNLYDLRAIKLGKN-KFSGQ-LPEDIGGCS-MLKVLDF 245 (967)
Q Consensus 171 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~-~L~~L~l 245 (967)
|+|++|++++..+..+..+++|++|+|++| .+++. .+..+.++++|++|++++| .+++. ++..+..++ +|++|++
T Consensus 123 L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l 202 (336)
T 2ast_B 123 LSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 202 (336)
T ss_dssp EECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEEC
T ss_pred EeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEe
Confidence 777777777666666667777777777777 56542 4555666677777777777 66643 455566666 7777777
Q ss_pred ccc--ccC-CCCChhhhcCCCCCEEEccCCC-CCCcCchhhccccccccccccccc-cccccCCCCCcccccceEEcccC
Q 002094 246 GVN--SLS-GSLPDSLQRLNSCSSLSLKGNS-FTGEVPDWIGKLANLESLDLSLNQ-FSGRIPSSIGNLVFLKELNISMN 320 (967)
Q Consensus 246 ~~n--~l~-~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N 320 (967)
++| .++ +.++..+..+++|+.|+|++|. +++..+..+..+++|++|++++|. +.......+.++++|+.|++++|
T Consensus 203 ~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 203 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 776 343 3345556666677777777666 555555566666666666666663 22221124556666666666666
Q ss_pred cCCCCCChhhhcCCCCcEEEccCCcCcCCCChhh
Q 002094 321 QFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWI 354 (967)
Q Consensus 321 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~ 354 (967)
++......+. .++..|++++|++++..|..+
T Consensus 283 -i~~~~~~~l~--~~l~~L~l~~n~l~~~~~~~~ 313 (336)
T 2ast_B 283 -VPDGTLQLLK--EALPHLQINCSHFTTIARPTI 313 (336)
T ss_dssp -SCTTCHHHHH--HHSTTSEESCCCSCCTTCSSC
T ss_pred -cCHHHHHHHH--hhCcceEEecccCccccCCcc
Confidence 3322222221 124444566666666555443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.7e-23 Score=215.30 Aligned_cols=211 Identities=18% Similarity=0.199 Sum_probs=182.0
Q ss_pred CCcc-ce--EEeCC------CCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCc-cCccccccccCCCCCcEEEcC
Q 002094 56 PCNW-VG--VKCDP------KTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNN-FTGTINADLASFGTLQVVDFS 125 (967)
Q Consensus 56 ~c~w-~g--v~c~~------~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls 125 (967)
.|.+ .+ |.|.. -...++.|++.++.+++..+..+.++++|++|+|++|+ +++..+..|..+++|++|+|+
T Consensus 9 ~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~ 88 (239)
T 2xwt_C 9 ECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88 (239)
T ss_dssp SEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEE
T ss_pred eeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECC
Confidence 4543 44 55964 23478999999999998877789999999999999997 888877899999999999999
Q ss_pred C-CCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccc---eeeeccc-ccccccCccccccccCC-eEeecC
Q 002094 126 E-NNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLE---SVNFSSN-RLSGQLPYGIWFLRSLQ-SLDLSN 199 (967)
Q Consensus 126 ~-n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~L~~ 199 (967)
+ |+++ .+|...|.++++|++|+|++|++++ +|. |+.+++|+ +|++++| ++++..+..|..+++|+ +|+|++
T Consensus 89 ~~n~l~-~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~ 165 (239)
T 2xwt_C 89 NTRNLT-YIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN 165 (239)
T ss_dssp EETTCC-EECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCS
T ss_pred CCCCee-EcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCC
Confidence 9 9998 5666678999999999999999997 665 88899998 9999999 99988778899999999 999999
Q ss_pred CcCCCcccccccCCCCCCeeeccCcc-ccccCCcCccCC-CCccEEeccccccCCCCChhhhcCCCCCEEEccCCC
Q 002094 200 NLLEGEIVKGISNLYDLRAIKLGKNK-FSGQLPEDIGGC-SMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNS 273 (967)
Q Consensus 200 n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 273 (967)
|.++...+..|.. ++|+.|+|++|+ +++..+..|.++ ++|++|++++|++++. |.. .+++|+.|+++++.
T Consensus 166 n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 166 NGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNTW 237 (239)
T ss_dssp CCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC-
T ss_pred CCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCcc
Confidence 9999665556666 899999999995 998778889999 9999999999999954 443 67899999998763
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.2e-22 Score=211.20 Aligned_cols=179 Identities=21% Similarity=0.238 Sum_probs=108.5
Q ss_pred cceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccc
Q 002094 168 LESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGV 247 (967)
Q Consensus 168 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 247 (967)
.++++++++.++ .+|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|++++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 334444444444 2333222 3445555555555544444555555555555555555555555555556666666666
Q ss_pred cccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCC
Q 002094 248 NSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLP 327 (967)
Q Consensus 248 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 327 (967)
|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 66665555556666666666666666665555556667777777777777765555567777777777777777776666
Q ss_pred hhhhcCCCCcEEEccCCcCcCC
Q 002094 328 ESMMNCGNLLAIDVSQNKLTGN 349 (967)
Q Consensus 328 ~~~~~l~~L~~L~l~~N~l~~~ 349 (967)
..|..+++|+.|++++|++.+.
T Consensus 173 ~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 173 GAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHhCCCCCCEEEeeCCceeCC
Confidence 6777777777777777777765
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-23 Score=243.18 Aligned_cols=212 Identities=23% Similarity=0.382 Sum_probs=169.5
Q ss_pred cccCCCCCCCCCCC-----ccceE-EeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCC
Q 002094 44 EKLTSWSEDDDNPC-----NWVGV-KCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFG 117 (967)
Q Consensus 44 ~~l~sw~~~~~~~c-----~w~gv-~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 117 (967)
..+.+|..+. .+| .|.|+ .|.. .+++.|++.++++++ +|..+. ++|++|+|++|+|+ .+| ..++
T Consensus 31 ~~l~~W~~~~-~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~ 100 (571)
T 3cvr_A 31 SAWDKWEKQA-LPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPA 100 (571)
T ss_dssp HHHHHHHTTC-CTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCT
T ss_pred HHHHHHhccC-Cccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccC
Confidence 3567786543 468 79999 8863 478999999999988 777664 88999999999998 556 5678
Q ss_pred CCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEee
Q 002094 118 TLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDL 197 (967)
Q Consensus 118 ~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (967)
+|++|+|++|++++ +|. + .. +|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|
T Consensus 101 ~L~~L~Ls~N~l~~-ip~-l-~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 167 (571)
T 3cvr_A 101 SLEYLDACDNRLST-LPE-L-PA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSV 167 (571)
T ss_dssp TCCEEECCSSCCSC-CCC-C-CT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCEEEccCCCCCC-cch-h-hc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEEC
Confidence 99999999999996 777 3 43 89999999999997 565 68899999999999986 565 5789999999
Q ss_pred cCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCc-------cEEeccccccCCCCChhhhcCCCCCEEEcc
Q 002094 198 SNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSML-------KVLDFGVNSLSGSLPDSLQRLNSCSSLSLK 270 (967)
Q Consensus 198 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-------~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~ 270 (967)
++|.|++ +|. |. ++|+.|+|++|+|+ .+|. |.. +| ++|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus 168 s~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~ 238 (571)
T 3cvr_A 168 RNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILE 238 (571)
T ss_dssp CSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECC
T ss_pred CCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEee
Confidence 9999987 444 65 88999999999998 5565 554 66 88888888888 577777778888888888
Q ss_pred CCCCCCcCchhhccccc
Q 002094 271 GNSFTGEVPDWIGKLAN 287 (967)
Q Consensus 271 ~n~l~~~~~~~l~~l~~ 287 (967)
+|.+++.+|..+..++.
T Consensus 239 ~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 239 DNPLSSRIRESLSQQTA 255 (571)
T ss_dssp SSSCCHHHHHHHHHHHH
T ss_pred CCcCCCcCHHHHHHhhc
Confidence 88888888877776554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-22 Score=205.99 Aligned_cols=187 Identities=20% Similarity=0.241 Sum_probs=144.1
Q ss_pred CCCCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCC
Q 002094 54 DNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133 (967)
Q Consensus 54 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~i 133 (967)
.|.|.|++|.|+... ++ .+|..+ .++|++|+|++|++++..+..|+.+++|++|+|++|+++ .+
T Consensus 4 ~C~C~~~~v~c~~~~--l~-----------~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~ 67 (208)
T 2o6s_A 4 RCSCSGTTVECYSQG--RT-----------SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SL 67 (208)
T ss_dssp TCEEETTEEECCSSC--CS-----------SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CC
T ss_pred CCEECCCEEEecCCC--cc-----------CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-cc
Confidence 356899999997431 11 123222 357899999999999877777888999999999999988 56
Q ss_pred CchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCC
Q 002094 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNL 213 (967)
Q Consensus 134 p~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 213 (967)
|...|..+++|++|+|++|++++..+..|+.+++|++|+|++|+|++..+..|..+++|++|+|++|.+++..+..|..+
T Consensus 68 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 147 (208)
T 2o6s_A 68 PNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL 147 (208)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred ChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccC
Confidence 66667888899999999998887777778888888888888888887766677888888888888888887777777888
Q ss_pred CCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCC
Q 002094 214 YDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNS 263 (967)
Q Consensus 214 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~ 263 (967)
++|++|+|++|.+.+ .+++|++|+++.|+++|.+|..++.++.
T Consensus 148 ~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 148 TSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp TTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred CCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 888888888887653 3456777777777777777776665543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-22 Score=218.37 Aligned_cols=207 Identities=22% Similarity=0.344 Sum_probs=108.5
Q ss_pred EecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccc
Q 002094 98 LSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNR 177 (967)
Q Consensus 98 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~ 177 (967)
+.+..+.+++.+ .+..+++|++|++++|.++. +|. +..+++|++|+|++|++++..+ +..+++|++|+|++|+
T Consensus 24 ~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~~--~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~ 96 (308)
T 1h6u_A 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IEG--VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (308)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CTT--GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-chh--hhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCc
Confidence 344455554432 23445556666666665552 332 3555555555555555554322 5555555555555555
Q ss_pred cccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChh
Q 002094 178 LSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDS 257 (967)
Q Consensus 178 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 257 (967)
+++. + .+..+++|++|+|++|.+++.. .+..+++|++|++++|.+++..+
T Consensus 97 l~~~-~-~~~~l~~L~~L~l~~n~l~~~~--------------------------~l~~l~~L~~L~l~~n~l~~~~~-- 146 (308)
T 1h6u_A 97 LKNV-S-AIAGLQSIKTLDLTSTQITDVT--------------------------PLAGLSNLQVLYLDLNQITNISP-- 146 (308)
T ss_dssp CSCC-G-GGTTCTTCCEEECTTSCCCCCG--------------------------GGTTCTTCCEEECCSSCCCCCGG--
T ss_pred CCCc-h-hhcCCCCCCEEECCCCCCCCch--------------------------hhcCCCCCCEEECCCCccCcCcc--
Confidence 5532 1 3444555555555555544322 14444555555555555543222
Q ss_pred hhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCc
Q 002094 258 LQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLL 337 (967)
Q Consensus 258 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 337 (967)
+..+++|+.|+|++|++++..+ +..+++|+.|++++|++++..+ +..+++|++|++++|++++.. .+..+++|+
T Consensus 147 l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~ 220 (308)
T 1h6u_A 147 LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLF 220 (308)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCC
T ss_pred ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCC
Confidence 5555555555555555554322 5555666666666666654322 555666666666666666443 256666666
Q ss_pred EEEccCCcCc
Q 002094 338 AIDVSQNKLT 347 (967)
Q Consensus 338 ~L~l~~N~l~ 347 (967)
.|++++|+++
T Consensus 221 ~L~l~~N~i~ 230 (308)
T 1h6u_A 221 IVTLTNQTIT 230 (308)
T ss_dssp EEEEEEEEEE
T ss_pred EEEccCCeee
Confidence 6666666665
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=4.2e-22 Score=216.84 Aligned_cols=207 Identities=18% Similarity=0.268 Sum_probs=159.1
Q ss_pred eecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEecccccc
Q 002094 75 TLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154 (967)
Q Consensus 75 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l 154 (967)
.+....+++.+ .+.++++|++|++++|+++.. + .+..+++|++|+|++|.+++ ++. +..+++|++|+|++|++
T Consensus 25 ~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~-~~~--~~~l~~L~~L~L~~n~l 97 (308)
T 1h6u_A 25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITD-LAP--LKNLTKITELELSGNPL 97 (308)
T ss_dssp HTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG--GTTCCSCCEEECCSCCC
T ss_pred HhCCCCcCcee--cHHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCC-Chh--HccCCCCCEEEccCCcC
Confidence 34444444432 345788999999999999864 4 68999999999999999985 444 78999999999999999
Q ss_pred CCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCc
Q 002094 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDI 234 (967)
Q Consensus 155 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 234 (967)
++. ..+..+++|++|+|++|++++. + .+..+++|++|+|++|.+++..+ +..+++|++|+|++|++++..+ +
T Consensus 98 ~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l 169 (308)
T 1h6u_A 98 KNV--SAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--L 169 (308)
T ss_dssp SCC--GGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--G
T ss_pred CCc--hhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--h
Confidence 864 3689999999999999999864 3 38899999999999999987654 7788888888888888875433 7
Q ss_pred cCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccccccccccccc
Q 002094 235 GGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSG 300 (967)
Q Consensus 235 ~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 300 (967)
..+++|++|++++|++++..+ +..+++|++|+|++|++++..+ +..+++|+.|+|++|++++
T Consensus 170 ~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 170 ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp TTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred cCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 777778888887777775433 6677777777777777765442 6666777777777777663
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-22 Score=221.85 Aligned_cols=240 Identities=18% Similarity=0.126 Sum_probs=166.8
Q ss_pred CeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCc-cccccccccce-eee
Q 002094 96 QVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIP-ESLSFCSSLES-VNF 173 (967)
Q Consensus 96 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~-L~L 173 (967)
++++.++++++ .+|..+ .+++++|+|++|+|+ .||...|+++++|++|+|++|++.+.+| ..|.++++|+. +.+
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 45677788887 456555 367888888888887 6777778888888888888888866554 46778887765 566
Q ss_pred cccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccC-ccccccCCcCccCCC-CccEEeccccccC
Q 002094 174 SSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGK-NKFSGQLPEDIGGCS-MLKVLDFGVNSLS 251 (967)
Q Consensus 174 ~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~-~L~~L~l~~n~l~ 251 (967)
++|+|+...|..|..+++|++|++++|.+++..+..+....++..|++.+ |++....+..|..+. .+++|++++|+|+
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 67888877778888888888888888888877777777777777888755 566655556676664 5777888888887
Q ss_pred CCCChhhhcCCCCCEEEccC-CCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhh
Q 002094 252 GSLPDSLQRLNSCSSLSLKG-NSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESM 330 (967)
Q Consensus 252 ~~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 330 (967)
.. |.......+|+.|++.+ |.++.+.++.|.++++|++|+|++|+|+...+..+.++++|+.+++ +.++ .+| .+
T Consensus 168 ~i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l 242 (350)
T 4ay9_X 168 EI-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TL 242 (350)
T ss_dssp EE-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CT
T ss_pred CC-ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-Cc
Confidence 43 33333456677777764 5666555566777888888888888887544444444444444333 2233 444 36
Q ss_pred hcCCCCcEEEccCC
Q 002094 331 MNCGNLLAIDVSQN 344 (967)
Q Consensus 331 ~~l~~L~~L~l~~N 344 (967)
.++++|+.++++++
T Consensus 243 ~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 243 EKLVALMEASLTYP 256 (350)
T ss_dssp TTCCSCCEEECSCH
T ss_pred hhCcChhhCcCCCC
Confidence 67777777777644
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=6.9e-21 Score=194.73 Aligned_cols=163 Identities=21% Similarity=0.190 Sum_probs=100.4
Q ss_pred CCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeec
Q 002094 142 GSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKL 221 (967)
Q Consensus 142 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 221 (967)
++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|.++++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence 34555555555555444444555555555555555555444444555555666666666555555555556666666666
Q ss_pred cCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccc
Q 002094 222 GKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGR 301 (967)
Q Consensus 222 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 301 (967)
++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|+|++|.+.+ .+++|++|+++.|+++|.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ 180 (208)
T 2o6s_A 108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGV 180 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTT
T ss_pred CCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCce
Confidence 6666665555556666667777777777665555556677777777777776653 345677888888888888
Q ss_pred cCCCCCcccc
Q 002094 302 IPSSIGNLVF 311 (967)
Q Consensus 302 ~~~~~~~l~~ 311 (967)
+|..++.++.
T Consensus 181 ip~~~~~l~~ 190 (208)
T 2o6s_A 181 VRNSAGSVAP 190 (208)
T ss_dssp BBCTTSSBCT
T ss_pred eeccCccccC
Confidence 8877776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-21 Score=209.92 Aligned_cols=145 Identities=17% Similarity=0.155 Sum_probs=117.0
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCcc-----------------ccHHHHHHHHHHHcCCCCCceeee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLI-----------------KSQEDFEKEMKTLGKIRHHNLVAL 744 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~~ 744 (967)
..|...+.||+|+||.||+|...+|+.||||.++..... .....+.+|++++++++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 345566899999999999999977999999999643311 13467899999999998 4 666
Q ss_pred eeEEEcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEe
Q 002094 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVG 824 (967)
Q Consensus 745 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~ 824 (967)
.+++.. +..++||||++|++|.+ +.. .....++.|++.||+|||++||+||||||+||+++ ++.+||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 665543 56699999999999998 421 12446999999999999999999999999999999 9999999
Q ss_pred ecccccccCCCccccccccccccccccCcccc
Q 002094 825 DFGLARLLPMLDRCILSSKIQSALGYMAPEFA 856 (967)
Q Consensus 825 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 856 (967)
|||+++.. ..+.|||++
T Consensus 235 DFG~a~~~---------------~~~~a~e~l 251 (282)
T 1zar_A 235 DFPQSVEV---------------GEEGWREIL 251 (282)
T ss_dssp CCTTCEET---------------TSTTHHHHH
T ss_pred ECCCCeEC---------------CCCCHHHHH
Confidence 99998733 236788876
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=220.53 Aligned_cols=188 Identities=26% Similarity=0.336 Sum_probs=107.6
Q ss_pred CCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeee
Q 002094 94 FLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNF 173 (967)
Q Consensus 94 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 173 (967)
+|+.|+|++|++++ +|..+ +++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.. +|++|+|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip----~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP----ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc----cccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence 66666666666665 44444 256666666666666 455 234566666666666664 444 433 5666666
Q ss_pred cccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCC
Q 002094 174 SSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGS 253 (967)
Q Consensus 174 ~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 253 (967)
++|+|++ +|. .+++|++|+|++|.|++ +|. .+++|++|+|++|+|++
T Consensus 128 s~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-------------------------lp~---~l~~L~~L~Ls~N~L~~- 174 (571)
T 3cvr_A 128 DNNQLTM-LPE---LPALLEYINADNNQLTM-------------------------LPE---LPTSLEVLSVRNNQLTF- 174 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC-------------------------CCC---CCTTCCEEECCSSCCSC-
T ss_pred CCCcCCC-CCC---cCccccEEeCCCCccCc-------------------------CCC---cCCCcCEEECCCCCCCC-
Confidence 6666654 333 34555555555555554 222 23444455555555443
Q ss_pred CChhhhcCCCCCEEEccCCCCCCcCchhhcccccc-------ccccccccccccccCCCCCcccccceEEcccCcCCCCC
Q 002094 254 LPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANL-------ESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGL 326 (967)
Q Consensus 254 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 326 (967)
+|. |. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|.+++.+
T Consensus 175 lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~ 246 (571)
T 3cvr_A 175 LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRI 246 (571)
T ss_dssp CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHH
T ss_pred cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcC
Confidence 333 33 45555555555555 3333 332 44 77777777777 46666777778888888888887777
Q ss_pred ChhhhcCC
Q 002094 327 PESMMNCG 334 (967)
Q Consensus 327 ~~~~~~l~ 334 (967)
|..+..++
T Consensus 247 p~~l~~l~ 254 (571)
T 3cvr_A 247 RESLSQQT 254 (571)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhh
Confidence 77776654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=6.9e-21 Score=196.15 Aligned_cols=178 Identities=22% Similarity=0.280 Sum_probs=145.7
Q ss_pred cEEEccCCcccCCCCCCcccccccchhcccccccccccC-CCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCC
Q 002094 389 QVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIP-ASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEK 467 (967)
Q Consensus 389 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 467 (967)
+.+++++|.++. +|..+. ..+++|+|++|++.+..+ ..|..+++|+.|+|++|++++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 478888888875 455443 346789999999887754 4588999999999999999988888899999999999999
Q ss_pred CCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCC
Q 002094 468 NFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELP 547 (967)
Q Consensus 468 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 547 (967)
|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.++
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99998888889999999999999999998889999999999999999999999989999999999999999999998887
Q ss_pred CCCCCCccCCCc-ccCCCCCCCcc
Q 002094 548 VGGFFNTISPSS-VSGNPSLCGSV 570 (967)
Q Consensus 548 ~~~~~~~~~~~~-~~~n~~lc~~~ 570 (967)
...+..++.... +.+|+ .|..|
T Consensus 171 l~~l~~~~~~~~~~~~~~-~C~~P 193 (220)
T 2v70_A 171 LAWLGEWLRKKRIVTGNP-RCQKP 193 (220)
T ss_dssp GHHHHHHHHHSCCBCCCC-EEEES
T ss_pred hHHHHHHHHhcCccccCC-ccCCC
Confidence 544433332222 23443 46544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-20 Score=193.91 Aligned_cols=158 Identities=22% Similarity=0.290 Sum_probs=136.4
Q ss_pred cEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCC
Q 002094 389 QVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKN 468 (967)
Q Consensus 389 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 468 (967)
+.+++++|.++. +|..+. ++|+.|+|++|++.+..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 567788888774 444443 67888999999988777778899999999999999999888889999999999999999
Q ss_pred CCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCC
Q 002094 469 FLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPV 548 (967)
Q Consensus 469 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 548 (967)
+|+...+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|.+....
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l 170 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL 170 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCcc
Confidence 99977777788999999999999999988899999999999999999999988888899999999999999999876654
Q ss_pred C
Q 002094 549 G 549 (967)
Q Consensus 549 ~ 549 (967)
.
T Consensus 171 ~ 171 (220)
T 2v9t_B 171 K 171 (220)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.3e-20 Score=190.30 Aligned_cols=158 Identities=24% Similarity=0.284 Sum_probs=128.3
Q ss_pred CCCCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCC
Q 002094 54 DNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133 (967)
Q Consensus 54 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~i 133 (967)
.+.|.|.+|.|+.. ++ +.+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+++ .+
T Consensus 16 ~~~Cs~~~v~c~~~--~l-----------~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i 79 (229)
T 3e6j_A 16 QCSCSGTTVDCRSK--RH-----------ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-AL 79 (229)
T ss_dssp TCEEETTEEECTTS--CC-----------SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred CCEEeCCEeEccCC--Cc-----------CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-Cc
Confidence 45799999999743 11 12344333 78999999999999988999999999999999999996 67
Q ss_pred CchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCC
Q 002094 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNL 213 (967)
Q Consensus 134 p~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 213 (967)
|...|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|++++..+..|..+
T Consensus 80 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 158 (229)
T 3e6j_A 80 PVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL 158 (229)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTC
T ss_pred ChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCC
Confidence 7777888999999999999999877777888999999999999988 678888888888888888888887766677777
Q ss_pred CCCCeeeccCccccc
Q 002094 214 YDLRAIKLGKNKFSG 228 (967)
Q Consensus 214 ~~L~~L~L~~n~l~~ 228 (967)
++|+.|+|++|.+..
T Consensus 159 ~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 159 SSLTHAYLFGNPWDC 173 (229)
T ss_dssp TTCCEEECTTSCBCT
T ss_pred CCCCEEEeeCCCccC
Confidence 777777777777664
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.5e-21 Score=236.53 Aligned_cols=218 Identities=18% Similarity=0.167 Sum_probs=99.1
Q ss_pred hhHHHHHHHHHhcCCC-CccccCCCCCCCCCCCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCc
Q 002094 26 NDDVLGLIVFKAGLED-PKEKLTSWSEDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNN 104 (967)
Q Consensus 26 ~~d~~all~~k~~~~~-~~~~l~sw~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~ 104 (967)
..|+++|+++..+... .+..-.+|.......+.|.+++++ +.+++.|+|.++++... +..+ |+.++|++|.
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~~~l~L~~n~~~~~-~~~~-----l~~l~Ls~~~ 202 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVS--TPLTPKIELFANGKDEA-NQAL-----LQHKKLSQYS 202 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceec--CCccceEEeeCCCCCcc-hhhH-----hhcCccCccc
Confidence 4688999999988742 233445686555556789999986 47899999988887763 3332 3444455554
Q ss_pred cCc---------cccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecc
Q 002094 105 FTG---------TINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSS 175 (967)
Q Consensus 105 l~~---------~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 175 (967)
|.+ ..+..+..++.|+.|+|++|.+. .+|..+| .+++|++|+|++|+|+ .+|..|+.|++|++|+|++
T Consensus 203 i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~-~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~ 279 (727)
T 4b8c_D 203 IDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIF-KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSH 279 (727)
T ss_dssp -------------------CCCCCCEEECTTSCCS-CCCGGGG-GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTT
T ss_pred ccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhc-CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcC
Confidence 443 34566666667777777777666 5665554 5666677777766666 5666666666666666666
Q ss_pred cccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCC-ccEEeccccccCCCC
Q 002094 176 NRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSM-LKVLDFGVNSLSGSL 254 (967)
Q Consensus 176 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~ 254 (967)
|+|+ .+|..|+.+++|++|+|++|.|+ .+|..|+++++|++|+|++|++++.+|..+..+.. +..|+|++|.+++.+
T Consensus 280 N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~ 357 (727)
T 4b8c_D 280 NRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPL 357 (727)
T ss_dssp SCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_pred CcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcC
Confidence 6666 55666666666666666666665 34555666666666666666666666555544321 223555666665555
Q ss_pred Ch
Q 002094 255 PD 256 (967)
Q Consensus 255 ~~ 256 (967)
|.
T Consensus 358 p~ 359 (727)
T 4b8c_D 358 PH 359 (727)
T ss_dssp CC
T ss_pred cc
Confidence 44
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=5.4e-20 Score=198.27 Aligned_cols=171 Identities=21% Similarity=0.309 Sum_probs=98.7
Q ss_pred CCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCe
Q 002094 115 SFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQS 194 (967)
Q Consensus 115 ~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 194 (967)
.+++|+.|++++|.+++ ++. +..+++|++|+|++|++++..+ ++.+++|++|+|++|++++ +| .+..+++|++
T Consensus 44 ~l~~L~~L~l~~~~i~~-~~~--~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~ 116 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKS-VQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS 116 (291)
T ss_dssp HHHTCCEEECTTSCCCC-CTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred hcCcccEEEccCCCccc-Chh--HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence 34444445555444442 222 3445555555555555554322 5555555555555555543 22 2555555555
Q ss_pred EeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCC
Q 002094 195 LDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSF 274 (967)
Q Consensus 195 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 274 (967)
|+|++|.+++. ..+..+++|+.|++++|++++. ..++.+++|++|++++|++++..+ +..+++|+.|+|++|.+
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 55555555543 3455566666666666666543 456666677777777777765433 66777777777777777
Q ss_pred CCcCchhhcccccccccccccccccc
Q 002094 275 TGEVPDWIGKLANLESLDLSLNQFSG 300 (967)
Q Consensus 275 ~~~~~~~l~~l~~L~~L~L~~N~l~~ 300 (967)
++. + .+..+++|+.|++++|++..
T Consensus 191 ~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 191 SDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred CCC-h-hhccCCCCCEEECcCCcccC
Confidence 743 3 36777778888888877764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=9.7e-20 Score=203.04 Aligned_cols=162 Identities=25% Similarity=0.205 Sum_probs=139.0
Q ss_pred CCccEEEccCCcccCCCCCCcc-cccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEE
Q 002094 386 QGLQVLDLSSNALSGVIPSNIG-DLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELK 464 (967)
Q Consensus 386 ~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 464 (967)
..++.|+|++|+|++..+..+. ++++|+.|+|++|+|.+..+..|..+++|++|+|++|+|++..+..|..+++|++|+
T Consensus 39 ~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 118 (361)
T 2xot_A 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL 118 (361)
T ss_dssp TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEE
Confidence 4578899999999888888887 899999999999999888888899999999999999999887777889999999999
Q ss_pred cCCCCCCCcCCccccccCccceeeccCCcCcCccchhh---hcccCccEEeccCCccccCCchhhhhccCC--ceEEecC
Q 002094 465 LEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAI---ANLSNLKYVDLSFNDLSGILPKELINLSHL--LSFNISH 539 (967)
Q Consensus 465 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L--~~L~l~~ 539 (967)
|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|||++|+|++..+..+..++.+ +.|+|++
T Consensus 119 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~ 198 (361)
T 2xot_A 119 LYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198 (361)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCS
T ss_pred CCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecC
Confidence 99999998888899999999999999999997655556 678999999999999998777888888874 7888888
Q ss_pred CcccccCC
Q 002094 540 NHLHGELP 547 (967)
Q Consensus 540 N~l~~~~p 547 (967)
|+|.+...
T Consensus 199 N~~~C~C~ 206 (361)
T 2xot_A 199 NPLECDCK 206 (361)
T ss_dssp SCEECCHH
T ss_pred CCccCCcC
Confidence 88886543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=7.6e-20 Score=197.11 Aligned_cols=172 Identities=22% Similarity=0.329 Sum_probs=97.0
Q ss_pred hcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCe
Q 002094 139 RQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRA 218 (967)
Q Consensus 139 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 218 (967)
..+++|++|++++|.++.. + .+..+++|++|+|++|++++..+ +..+++|++|+|++|.+++. ..+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCE
Confidence 4455566666666665533 2 35556666666666666654333 55566666666666665542 23555666666
Q ss_pred eeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccccccccccc
Q 002094 219 IKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQF 298 (967)
Q Consensus 219 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l 298 (967)
|+|++|++++. ..+..+++|++|++++|++++. ..+..+++|+.|+|++|++++..+ +..+++|++|++++|++
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 66666665542 3455556666666666666543 455556666666666666654433 55566666666666666
Q ss_pred ccccCCCCCcccccceEEcccCcCCC
Q 002094 299 SGRIPSSIGNLVFLKELNISMNQFTG 324 (967)
Q Consensus 299 ~~~~~~~~~~l~~L~~L~L~~N~l~~ 324 (967)
++. + .+..+++|+.|++++|+++.
T Consensus 191 ~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 191 SDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred CCC-h-hhccCCCCCEEECcCCcccC
Confidence 532 2 25556666666666666553
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=4.2e-20 Score=218.12 Aligned_cols=106 Identities=25% Similarity=0.333 Sum_probs=53.1
Q ss_pred ccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccc
Q 002094 234 IGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLK 313 (967)
Q Consensus 234 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 313 (967)
+..+++|++|+|++|++.+. ..+..+++|+.|+|++|.|++. ..+..+++|+.|+|++|++.+..| +..+++|+
T Consensus 105 l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~ 178 (605)
T 1m9s_A 105 LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 178 (605)
T ss_dssp STTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCC
T ss_pred hccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCC
Confidence 44444444444444444421 2344445555555555555433 344555555555555555554433 55555555
Q ss_pred eEEcccCcCCCCCChhhhcCCCCcEEEccCCcCc
Q 002094 314 ELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLT 347 (967)
Q Consensus 314 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 347 (967)
.|+|++|+|++. ..+..+++|+.|+|++|++.
T Consensus 179 ~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 179 NLYLSKNHISDL--RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp EEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred EEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence 555555555542 23555555566666655555
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=8.6e-20 Score=215.48 Aligned_cols=171 Identities=21% Similarity=0.308 Sum_probs=80.2
Q ss_pred CCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCe
Q 002094 115 SFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQS 194 (967)
Q Consensus 115 ~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 194 (967)
.+++|+.|+|++|.++ .+|. +..+++|++|+|++|++++..| +..+++|++|+|++|+|++ +| .+..+++|+.
T Consensus 41 ~L~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~ 113 (605)
T 1m9s_A 41 ELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKS 113 (605)
T ss_dssp HHTTCCCCBCTTCCCC-CCTT--GGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCE
T ss_pred cCCCCCEEECcCCCCC-CChH--HccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCE
Confidence 3444444444444443 2221 3444444444444444443322 4444444444444444442 11 3444444444
Q ss_pred EeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCC
Q 002094 195 LDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSF 274 (967)
Q Consensus 195 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 274 (967)
|+|++|.+++. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.|++..| +..+++|+.|+|++|.|
T Consensus 114 L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 114 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp EECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCC
Confidence 55544444432 2344444455555555544432 344455555555555555554333 55555555555555555
Q ss_pred CCcCchhhcccccccccccccccccc
Q 002094 275 TGEVPDWIGKLANLESLDLSLNQFSG 300 (967)
Q Consensus 275 ~~~~~~~l~~l~~L~~L~L~~N~l~~ 300 (967)
++. ..+..+++|+.|+|++|++.+
T Consensus 188 ~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 188 SDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred CCC--hHHccCCCCCEEEccCCcCcC
Confidence 532 235555555555555555553
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=2e-19 Score=200.49 Aligned_cols=156 Identities=22% Similarity=0.124 Sum_probs=76.0
Q ss_pred CceEeccccccCCCCccccc-cccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeecc
Q 002094 144 LREVSFANNNLTGPIPESLS-FCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLG 222 (967)
Q Consensus 144 L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 222 (967)
+++|+|++|+|++..+..|. .+++|++|+|++|+|++..+..|..+++|++|+|++|.|++..+..|.++++|++|+|+
T Consensus 41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 120 (361)
T 2xot_A 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120 (361)
T ss_dssp CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence 34444444444433333343 44444444444444444444444444444444444444444444444445555555555
Q ss_pred CccccccCCcCccCCCCccEEeccccccCCCCChhh---hcCCCCCEEEccCCCCCCcCchhhccccc--cccccccccc
Q 002094 223 KNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSL---QRLNSCSSLSLKGNSFTGEVPDWIGKLAN--LESLDLSLNQ 297 (967)
Q Consensus 223 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l---~~l~~L~~L~L~~n~l~~~~~~~l~~l~~--L~~L~L~~N~ 297 (967)
+|+|++..+..|.++++|++|+|++|+|++..+..| ..+++|+.|+|++|+|++..+..+..++. |+.|+|++|.
T Consensus 121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~ 200 (361)
T 2xot_A 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP 200 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence 555554445555555555555555555554333333 34556666666666666554455555554 2555555555
Q ss_pred cc
Q 002094 298 FS 299 (967)
Q Consensus 298 l~ 299 (967)
+.
T Consensus 201 ~~ 202 (361)
T 2xot_A 201 LE 202 (361)
T ss_dssp EE
T ss_pred cc
Confidence 54
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.3e-19 Score=184.77 Aligned_cols=113 Identities=23% Similarity=0.265 Sum_probs=44.7
Q ss_pred hhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCC
Q 002094 138 FRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLR 217 (967)
Q Consensus 138 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 217 (967)
|..+++|++|+|++|+|++..+..|+++++|++|+|++|+|++..+..|..+++|++|+|++|.+++..+..|.++++|+
T Consensus 53 ~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 132 (220)
T 2v70_A 53 FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR 132 (220)
T ss_dssp GGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCS
T ss_pred hccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCC
Confidence 33444444444444444433333344444444444444444433333333444444444444444433333333333333
Q ss_pred eeeccCccccccCCcCccCCCCccEEecccccc
Q 002094 218 AIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSL 250 (967)
Q Consensus 218 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 250 (967)
+|+|++|++++..|..|..+++|++|++++|.+
T Consensus 133 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 165 (220)
T 2v70_A 133 LLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165 (220)
T ss_dssp EEECTTSCCCCBCTTTTTTCTTCCEEECCSCCE
T ss_pred EEECCCCcCCEECHHHhcCCCCCCEEEecCcCC
Confidence 333333333333333333333333333333333
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-21 Score=229.39 Aligned_cols=217 Identities=20% Similarity=0.142 Sum_probs=127.4
Q ss_pred cCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccc
Q 002094 90 LRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLE 169 (967)
Q Consensus 90 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 169 (967)
..+++|+.|+|++|+++ .+|..++.+++|+.|++++|.....+|. .+..+++.+.+|..++.+++|+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~------------ll~~~~~~~~~~~~l~~l~~L~ 412 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL------------LMRALDPLLYEKETLQYFSTLK 412 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH------------HHHHHCTGGGHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH------------HHHhcccccCCHHHHHHHHhcc
Confidence 45666666666666665 5566666666666666654431100000 0111224556677777777777
Q ss_pred eee-ecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEecccc
Q 002094 170 SVN-FSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVN 248 (967)
Q Consensus 170 ~L~-L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 248 (967)
.|+ ++.|++. +|+.+.+++|.++...+. .|+.|+|++|++++ +|. |+.+++|++|+|++|
T Consensus 413 ~L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N 473 (567)
T 1dce_A 413 AVDPMRAAYLD-----------DLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHN 473 (567)
T ss_dssp HHCGGGHHHHH-----------HHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSS
T ss_pred cCcchhhcccc-----------hhhhhhhhcccccccCcc------CceEEEecCCCCCC-CcC-ccccccCcEeecCcc
Confidence 777 6665443 344445555554432221 35666666666664 344 666666666666666
Q ss_pred ccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccccccccccccccc-CCCCCcccccceEEcccCcCCCCCC
Q 002094 249 SLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRI-PSSIGNLVFLKELNISMNQFTGGLP 327 (967)
Q Consensus 249 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~ 327 (967)
+|+ .+|..|.++++|+.|+|++|+|++ +| .++.+++|++|+|++|+|++.. |..++.+++|+.|+|++|++++.+|
T Consensus 474 ~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 474 RLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred ccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 666 556666666666666666666664 34 5666666666666666666554 6666666667777777776665543
Q ss_pred h---hhhcCCCCcEEEc
Q 002094 328 E---SMMNCGNLLAIDV 341 (967)
Q Consensus 328 ~---~~~~l~~L~~L~l 341 (967)
. .+..+++|+.|++
T Consensus 551 ~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 551 IQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTHHHHHCTTCSEEEC
T ss_pred HHHHHHHHCcccCccCC
Confidence 2 2344677777754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=7.1e-19 Score=182.36 Aligned_cols=156 Identities=22% Similarity=0.213 Sum_probs=125.6
Q ss_pred ccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCC
Q 002094 388 LQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEK 467 (967)
Q Consensus 388 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 467 (967)
-+.+++++++++. +|..+. ++|++|+|++|.+.+..|..|..+++|+.|+|++|++++..+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcCc-cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 4567777777763 344333 6788888888888877788888888888888888888765556678888888888888
Q ss_pred CCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCC
Q 002094 468 NFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELP 547 (967)
Q Consensus 468 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 547 (967)
|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|++.+.++
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 8888777777888888888888888888 678888888888889999888887777788888888888888888887665
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-21 Score=230.00 Aligned_cols=90 Identities=24% Similarity=0.358 Sum_probs=43.7
Q ss_pred cCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCcc-chhhhcccCc
Q 002094 430 IGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPV-PAAIANLSNL 508 (967)
Q Consensus 430 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L 508 (967)
++.+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|++ +| .|+.+++|+.|+|++|+|++.. |..|+.+++|
T Consensus 459 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L 535 (567)
T 1dce_A 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535 (567)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCC
Confidence 444444444444444444 344444444445555555555443 33 4455555555555555555443 4555555555
Q ss_pred cEEeccCCccccCC
Q 002094 509 KYVDLSFNDLSGIL 522 (967)
Q Consensus 509 ~~L~Ls~N~l~~~~ 522 (967)
+.|+|++|++++.+
T Consensus 536 ~~L~L~~N~l~~~~ 549 (567)
T 1dce_A 536 VLLNLQGNSLCQEE 549 (567)
T ss_dssp CEEECTTSGGGGSS
T ss_pred CEEEecCCcCCCCc
Confidence 55555555555443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.3e-19 Score=181.45 Aligned_cols=134 Identities=22% Similarity=0.268 Sum_probs=81.5
Q ss_pred CCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeec
Q 002094 142 GSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKL 221 (967)
Q Consensus 142 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 221 (967)
++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|.|++..+..|.++++|++|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 45555666666665555555666666666666666666555666666666666666666666555555566666666666
Q ss_pred cCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCC
Q 002094 222 GKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFT 275 (967)
Q Consensus 222 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 275 (967)
++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 666666555566666666666666666666555555666666666666666654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=4.3e-19 Score=188.07 Aligned_cols=168 Identities=22% Similarity=0.268 Sum_probs=86.6
Q ss_pred CCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCcccccccccccee
Q 002094 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESV 171 (967)
Q Consensus 92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 171 (967)
+..+..+++++|.+++.. .+..+++|++|++++|.++ .+| .+..+++|++|+|++|++++..+ ++.+++|++|
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 444555666666666432 4556666666666666665 344 24566666666666666664433 6666666666
Q ss_pred eecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccC
Q 002094 172 NFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLS 251 (967)
Q Consensus 172 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 251 (967)
+|++|++++. |.. .. ++|++|+|++|.+++. ..+..+++|+.|+|++|++++. + .++.+++|++|++++|+++
T Consensus 91 ~L~~N~l~~l-~~~-~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNL-NGI-PS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCC-TTC-CC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCc-Ccc-cc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 6666666532 221 12 5555555555555542 2344555555555555554432 1 3444444444444444444
Q ss_pred CCCChhhhcCCCCCEEEccCCCCC
Q 002094 252 GSLPDSLQRLNSCSSLSLKGNSFT 275 (967)
Q Consensus 252 ~~~~~~l~~l~~L~~L~L~~n~l~ 275 (967)
+. ..+..+++|+.|++++|.++
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEE
T ss_pred ch--HHhccCCCCCEEeCCCCccc
Confidence 32 33444444444444444443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.8e-19 Score=213.91 Aligned_cols=222 Identities=20% Similarity=0.218 Sum_probs=109.5
Q ss_pred CCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceee
Q 002094 93 QFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVN 172 (967)
Q Consensus 93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 172 (967)
++++.|+|++|.+... +. ..|+.++|+.|.|++ +++..|++. ..|..+..+++|+.|+
T Consensus 173 ~~~~~l~L~~n~~~~~-~~-----~~l~~l~Ls~~~i~~---------------~~~~~n~~~-~~~~~~~~l~~L~~L~ 230 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-NQ-----ALLQHKKLSQYSIDE---------------DDDIENRMV-MPKDSKYDDQLWHALD 230 (727)
T ss_dssp -----------------------------------------------------------------------CCCCCCEEE
T ss_pred CccceEEeeCCCCCcc-hh-----hHhhcCccCcccccC---------------cccccccee-cChhhhccCCCCcEEE
Confidence 5688889998888753 22 345666677766653 234455555 5566777777777777
Q ss_pred ecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCC
Q 002094 173 FSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSG 252 (967)
Q Consensus 173 L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 252 (967)
|++|++. .+|..+..+++|++|+|++|.|+ .+|..|+++++|++|+|++|+|+ .+|..|+++++|++|+|++|.|+
T Consensus 231 Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~- 306 (727)
T 4b8c_D 231 LSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT- 306 (727)
T ss_dssp CTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-
T ss_pred CCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-
Confidence 7777777 56666667777888888888777 56677778888888888888887 66888888888888888888887
Q ss_pred CCChhhhcCCCCCEEEccCCCCCCcCchhhccccc-cccccccccccccccCCCCCcccccceEEcccC--------cCC
Q 002094 253 SLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLAN-LESLDLSLNQFSGRIPSSIGNLVFLKELNISMN--------QFT 323 (967)
Q Consensus 253 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N--------~l~ 323 (967)
.+|..|.++++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.. |+.|++++| .+.
T Consensus 307 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~ 380 (727)
T 4b8c_D 307 TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQ 380 (727)
T ss_dssp CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--------------------------
T ss_pred ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCcc
Confidence 66777888888888999999988888888766533 335789999998887754 456666666 233
Q ss_pred CCCChhhhcCCCCcEEEccCCcC
Q 002094 324 GGLPESMMNCGNLLAIDVSQNKL 346 (967)
Q Consensus 324 ~~~~~~~~~l~~L~~L~l~~N~l 346 (967)
+..+..+.++..+....+++|-+
T Consensus 381 ~~~~~~~~~l~~~~~~~ls~Nil 403 (727)
T 4b8c_D 381 QSTEHLATDLAKRTFTVLSYNTL 403 (727)
T ss_dssp ---------------------CC
T ss_pred ccccchhhcccccceeeeecccc
Confidence 33333344444444555555544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=8.9e-19 Score=176.21 Aligned_cols=113 Identities=25% Similarity=0.327 Sum_probs=55.3
Q ss_pred cccEEEecCCcccccCcc-cccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEec
Q 002094 435 AIQVLDFSDNWLNGTIPP-QIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDL 513 (967)
Q Consensus 435 ~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 513 (967)
+|++|+|++|++++..+. .|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|++|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 344444444444433322 2444444555555555554444444555555555555555555444444555555555555
Q ss_pred cCCccccCCchhhhhccCCceEEecCCcccccCC
Q 002094 514 SFNDLSGILPKELINLSHLLSFNISHNHLHGELP 547 (967)
Q Consensus 514 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 547 (967)
++|+|++..|..|..+++|+.|+|++|+|+|.++
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 5555555555555555555555555555555444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.3e-18 Score=171.47 Aligned_cols=153 Identities=16% Similarity=0.224 Sum_probs=129.7
Q ss_pred CCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEE
Q 002094 384 SYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKEL 463 (967)
Q Consensus 384 ~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 463 (967)
.+++|+.|++++|.++ .+| .+..+++|++|++++|.+. .+..+..+++|++|++++|++++..+..+..+++|++|
T Consensus 42 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 117 (197)
T 4ezg_A 42 QMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117 (197)
T ss_dssp HHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred hcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence 4567899999999998 444 6888999999999999764 34578889999999999999998788899999999999
Q ss_pred EcCCCCCCCcCCccccccCccceeeccCCc-CcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcc
Q 002094 464 KLEKNFLSGRIPSQIKNCSSLTSLILSQNN-LTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHL 542 (967)
Q Consensus 464 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l 542 (967)
+|++|++++..|..++.+++|+.|+|++|+ ++ .+| .+..+++|++|++++|++++. + .+..+++|+.|++++|++
T Consensus 118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC--
T ss_pred EecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCccc
Confidence 999999998888899999999999999998 65 455 689999999999999999864 3 788999999999999998
Q ss_pred cc
Q 002094 543 HG 544 (967)
Q Consensus 543 ~~ 544 (967)
.+
T Consensus 194 ~~ 195 (197)
T 4ezg_A 194 GG 195 (197)
T ss_dssp --
T ss_pred CC
Confidence 64
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.2e-18 Score=182.57 Aligned_cols=168 Identities=21% Similarity=0.315 Sum_probs=87.6
Q ss_pred CCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeee
Q 002094 141 CGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIK 220 (967)
Q Consensus 141 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 220 (967)
+.++..+++++|.+++.. .+..+++|++|++++|+++ .+| .+..+++|++|+|++|.+++..+ +.++++|++|+
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 344555555555555322 3555555555666555555 233 45555556666666665554433 55555555555
Q ss_pred ccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccccccccccccc
Q 002094 221 LGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSG 300 (967)
Q Consensus 221 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 300 (967)
|++|++++. +. +.. ++|++|++++|++++. ..+..+++|+.|+|++|++++. + .+..+++|++|+|++|++++
T Consensus 92 L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 92 VNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred CCCCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence 555555532 22 112 5555666666655532 2355555555555555555543 2 35555555555555555554
Q ss_pred ccCCCCCcccccceEEcccCcCC
Q 002094 301 RIPSSIGNLVFLKELNISMNQFT 323 (967)
Q Consensus 301 ~~~~~~~~l~~L~~L~L~~N~l~ 323 (967)
. ..+..+++|+.|++++|.++
T Consensus 165 ~--~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEEEEE
T ss_pred h--HHhccCCCCCEEeCCCCccc
Confidence 3 34445555555555555544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=7.9e-18 Score=170.18 Aligned_cols=154 Identities=18% Similarity=0.285 Sum_probs=94.9
Q ss_pred cccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCcc
Q 002094 162 LSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLK 241 (967)
Q Consensus 162 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 241 (967)
.+.+++|++|++++|+++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|++++..+..|+.+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 356677777777777776 444 56667777777777775542 23566666677777777776665666666666677
Q ss_pred EEeccccccCCCCChhhhcCCCCCEEEccCCC-CCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccC
Q 002094 242 VLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNS-FTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMN 320 (967)
Q Consensus 242 ~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 320 (967)
+|++++|++++..|..+..+++|++|+|++|. ++ .++ .+..+++|++|++++|++++ ++ .+..+++|+.|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 76666666665556666666666666666665 44 233 45566666666666666653 22 4555555666666555
Q ss_pred cCC
Q 002094 321 QFT 323 (967)
Q Consensus 321 ~l~ 323 (967)
++.
T Consensus 192 ~i~ 194 (197)
T 4ezg_A 192 TIG 194 (197)
T ss_dssp ---
T ss_pred ccC
Confidence 554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-17 Score=166.54 Aligned_cols=132 Identities=23% Similarity=0.278 Sum_probs=110.3
Q ss_pred cEEEccCCcccCCCCCCcccccccchhcccccccccccCC-CcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCC
Q 002094 389 QVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPA-SIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEK 467 (967)
Q Consensus 389 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 467 (967)
+.+++++|+++ .+|..+.. +|++|++++|++.+..+. .|..+++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 57778888776 44544433 788888888888766654 488888999999999999888888899999999999999
Q ss_pred CCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCc
Q 002094 468 NFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILP 523 (967)
Q Consensus 468 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 523 (967)
|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99998888889999999999999999998889999999999999999999987665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=5.6e-18 Score=178.92 Aligned_cols=138 Identities=20% Similarity=0.197 Sum_probs=106.5
Q ss_pred ccCCCCccCCCCceEEEEEEe-CCCcE--EEEEEeecCCcc-----------------------ccHHHHHHHHHHHcCC
Q 002094 683 LLNKDCELGRGGFGVVYRTIL-QDGRS--VAIKKLTVSGLI-----------------------KSQEDFEKEMKTLGKI 736 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~l~~~~~~-----------------------~~~~~~~~E~~~l~~l 736 (967)
.|...+.||+|+||.||+|.. .+|+. ||||+++..... .....+.+|++.+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356678899999999999997 67989 999987543211 0123688999999999
Q ss_pred CCCce--eeeeeEEEcCCceeEEEEecCC-C----chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCcccCCC
Q 002094 737 RHHNL--VALEGYYWTPSLQLLIYEFISS-G----SLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH-HTNIIHYNL 808 (967)
Q Consensus 737 ~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH-~~~ivH~Di 808 (967)
.|+++ +.++++ +..++||||+.+ | +|.+.... .++..+..++.|++.|++||| +.||+||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 87754 333332 356899999942 4 66665432 224457789999999999999 999999999
Q ss_pred CCCCEEeCCCCCeEEeeccccccc
Q 002094 809 KSTNVLIDSSGEPKVGDFGLARLL 832 (967)
Q Consensus 809 k~~Nill~~~~~~kl~Dfg~a~~~ 832 (967)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999988 9999999999754
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=7.9e-18 Score=185.11 Aligned_cols=291 Identities=12% Similarity=0.070 Sum_probs=143.6
Q ss_pred ccccceeeecccccccccCccccc-cccCCeEeecCCcCC--CcccccccCCCCCCeeeccCccccccCCcCccC-----
Q 002094 165 CSSLESVNFSSNRLSGQLPYGIWF-LRSLQSLDLSNNLLE--GEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGG----- 236 (967)
Q Consensus 165 l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~----- 236 (967)
+.+++.|.++++ +....-..+.. +++|+.|||++|++. ..... .++.++.+.+..|.+ .+.+|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I---~~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFV---PAYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEE---CTTTTEEEETTE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccc---ccccccccccccccc---CHHHhccccccc
Confidence 667888888764 22121123333 667777777777776 22211 122234444444422 2334444
Q ss_pred ---CCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccc
Q 002094 237 ---CSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLK 313 (967)
Q Consensus 237 ---l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 313 (967)
+++|+.|++.. +++...+.+|.++++|+.|++.+|.+..+.+.+|.++.++..+.+..+...
T Consensus 97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~-------------- 161 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAY-------------- 161 (329)
T ss_dssp EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHH--------------
T ss_pred ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhh--------------
Confidence 55555555555 555444445555555555555555555444444544444444433332110
Q ss_pred eEEcccCcCCCCCChhhhcCCCCc-EEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEE
Q 002094 314 ELNISMNQFTGGLPESMMNCGNLL-AIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLD 392 (967)
Q Consensus 314 ~L~L~~N~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~ 392 (967)
.........+|.++.+|+ .+++... +.++..++... -...+++.+.
T Consensus 162 ------~~~~~i~~~~f~~~~~L~~~i~~~~~---~~l~~~~~~~~------------------------~~~~~~~~l~ 208 (329)
T 3sb4_A 162 ------RFKNRWEHFAFIEGEPLETTIQVGAM---GKLEDEIMKAG------------------------LQPRDINFLT 208 (329)
T ss_dssp ------HTSTTTTTSCEEESCCCEEEEEECTT---CCHHHHHHHTT------------------------CCGGGCSEEE
T ss_pred ------hccccccccccccccccceeEEecCC---CcHHHHHhhcc------------------------cCccccceEE
Confidence 011112233444555555 3444322 12233222110 0012223333
Q ss_pred ccCCcccCCCCCCc-ccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCC-EEEcCCCCC
Q 002094 393 LSSNALSGVIPSNI-GDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLK-ELKLEKNFL 470 (967)
Q Consensus 393 L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~L~~N~l 470 (967)
+.++-.. .....+ ..+++|+.|+|++|.+....+..|.++.+|+.|+|++| ++...+..|.++.+|+ .+++.+ .+
T Consensus 209 ~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l 285 (329)
T 3sb4_A 209 IEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SV 285 (329)
T ss_dssp EEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TC
T ss_pred EeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cc
Confidence 3322110 000001 11345555555555555444455666666666666665 5545555666666666 666666 55
Q ss_pred CCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEec
Q 002094 471 SGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDL 513 (967)
Q Consensus 471 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 513 (967)
+...+.+|.++++|+.|+|++|+++.+.+.+|.++++|+.|+.
T Consensus 286 ~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 286 TAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred eEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 5455667777777777777777777666667777777777653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.1e-17 Score=181.73 Aligned_cols=85 Identities=19% Similarity=0.124 Sum_probs=46.8
Q ss_pred CCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccc-eEEcccCcCCCCCChhhhcCCCCcEE
Q 002094 261 LNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLK-ELNISMNQFTGGLPESMMNCGNLLAI 339 (967)
Q Consensus 261 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L 339 (967)
+++|+.|+|++|+++.+.+.+|.++++|+.|+|.+| +..+.+.+|.++.+|+ .+++.+ .++.+.+.+|.+|++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 455555555555555444555555555555555555 4444444555555555 555555 4444455555555555555
Q ss_pred EccCCcCc
Q 002094 340 DVSQNKLT 347 (967)
Q Consensus 340 ~l~~N~l~ 347 (967)
++++|+++
T Consensus 303 ~l~~n~i~ 310 (329)
T 3sb4_A 303 LATGDKIT 310 (329)
T ss_dssp EECSSCCC
T ss_pred EeCCCccC
Confidence 55555555
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.7e-17 Score=165.19 Aligned_cols=134 Identities=24% Similarity=0.282 Sum_probs=104.0
Q ss_pred hhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCc
Q 002094 414 LLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNN 493 (967)
Q Consensus 414 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 493 (967)
.+++++|.+. .+|..+. ++|+.|+|++|+++ .+|..|..+++|++|+|++|.|++..+..|.++++|+.|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 3444444443 3343332 46777888888876 567778888888888888888887777888888889999999999
Q ss_pred CcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCCCC
Q 002094 494 LTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGF 551 (967)
Q Consensus 494 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~ 551 (967)
|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|.+......+
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l 147 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWL 147 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHH
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHH
Confidence 9888888888899999999999999877777888899999999999999876654433
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.3e-16 Score=155.01 Aligned_cols=130 Identities=19% Similarity=0.166 Sum_probs=69.9
Q ss_pred cchhcccccccc-cccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeecc
Q 002094 412 LMLLNMSMNYLF-GSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILS 490 (967)
Q Consensus 412 L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 490 (967)
|+.|++++|.+. +.+|..+..+++|+.|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+|+
T Consensus 26 L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 103 (168)
T 2ell_A 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103 (168)
T ss_dssp CSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECB
T ss_pred CCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEecc
Confidence 444444444443 33444444445555555555555433 445555555555555555554455555556666666666
Q ss_pred CCcCcCcc-chhhhcccCccEEeccCCccccCCc---hhhhhccCCceEEecCCccc
Q 002094 491 QNNLTGPV-PAAIANLSNLKYVDLSFNDLSGILP---KELINLSHLLSFNISHNHLH 543 (967)
Q Consensus 491 ~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~l~~N~l~ 543 (967)
+|++++.. +..+..+++|++|++++|++++..+ ..+..+++|+.|++++|.+.
T Consensus 104 ~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 104 GNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp SSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred CCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 66665432 1455666666666666666664444 35556666666666666554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.9e-16 Score=154.27 Aligned_cols=135 Identities=21% Similarity=0.191 Sum_probs=122.1
Q ss_pred CCCccEEEccCCccc-CCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEE
Q 002094 385 YQGLQVLDLSSNALS-GVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKEL 463 (967)
Q Consensus 385 ~~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 463 (967)
.++|++|++++|+++ +.+|..+..+++|++|++++|.+.+. ..+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 478999999999998 77888899999999999999999865 889999999999999999998788888889999999
Q ss_pred EcCCCCCCCcC-CccccccCccceeeccCCcCcCccc---hhhhcccCccEEeccCCccccC
Q 002094 464 KLEKNFLSGRI-PSQIKNCSSLTSLILSQNNLTGPVP---AAIANLSNLKYVDLSFNDLSGI 521 (967)
Q Consensus 464 ~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~ 521 (967)
+|++|.+++.. +..+..+++|+.|+|++|++++..+ ..|..+++|++||+++|.+...
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 99999999643 3789999999999999999997665 5899999999999999998843
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=6.7e-16 Score=153.06 Aligned_cols=136 Identities=18% Similarity=0.255 Sum_probs=95.2
Q ss_pred CCCCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCC
Q 002094 54 DNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLI 133 (967)
Q Consensus 54 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~i 133 (967)
.|.|.|++|.|+.. +++ . +|..+ .++|++|++++|++++..+..|..+++|++|+|++|+++ .+
T Consensus 4 ~C~C~~~~l~~~~~--~l~----------~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~ 67 (177)
T 2o6r_A 4 RCSCSGTEIRCNSK--GLT----------S-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SL 67 (177)
T ss_dssp TCEEETTEEECCSS--CCS----------S-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CC
T ss_pred CCEeCCCEEEecCC--CCc----------c-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcce-Ee
Confidence 34589999999743 111 1 23222 257888888888888776677778888888888888887 45
Q ss_pred CchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCc
Q 002094 134 PDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGE 205 (967)
Q Consensus 134 p~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 205 (967)
|...|..+++|++|+|++|++++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|.+.+.
T Consensus 68 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 68 PDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 555567777777777777777766666677777777777777777755555556677777777777766643
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.9e-16 Score=150.84 Aligned_cols=128 Identities=21% Similarity=0.248 Sum_probs=86.2
Q ss_pred cccchhcccccccc-cccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceee
Q 002094 410 SSLMLLNMSMNYLF-GSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLI 488 (967)
Q Consensus 410 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 488 (967)
++|+.|++++|.+. +.+|..+..+++|+.|++++|++++. ..+..+++|++|+|++|.+++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 44555555555554 45555556666666666666666644 5566677777777777777766666666777777777
Q ss_pred ccCCcCcCc-cchhhhcccCccEEeccCCccccCCc---hhhhhccCCceEEecC
Q 002094 489 LSQNNLTGP-VPAAIANLSNLKYVDLSFNDLSGILP---KELINLSHLLSFNISH 539 (967)
Q Consensus 489 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~l~~ 539 (967)
|++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 777777753 34677777777777777777776655 5677777777777653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.63 E-value=3.8e-15 Score=167.07 Aligned_cols=265 Identities=13% Similarity=0.155 Sum_probs=209.0
Q ss_pred CCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCcccccccccccee
Q 002094 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESV 171 (967)
Q Consensus 92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 171 (967)
...++.+.+.+ +++.+-..+|.+. +|+.++|..| ++ .|+...|.++ +|+.+.|.+ +++.+.+.+|.+|++|+.+
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~-~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l 185 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LK-SIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKA 185 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CC-EECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-cc-EECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCee
Confidence 46777777765 4666667788875 7999998877 55 5777778874 699999986 7777777889999999999
Q ss_pred eecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccC
Q 002094 172 NFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLS 251 (967)
Q Consensus 172 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 251 (967)
+|++|+++......|. ..+|+.+.|.++ ++.+....|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .++++
T Consensus 186 ~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~ 260 (401)
T 4fdw_A 186 DLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVT 260 (401)
T ss_dssp ECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCC
T ss_pred ecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCcc
Confidence 9999999866556665 689999999854 77788888999999999999875 56566777877 78999999 55677
Q ss_pred CCCChhhhcCCCCCEEEccCCCCC-----CcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCC
Q 002094 252 GSLPDSLQRLNSCSSLSLKGNSFT-----GEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGL 326 (967)
Q Consensus 252 ~~~~~~l~~l~~L~~L~L~~n~l~-----~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 326 (967)
.....+|.++++|+.+.+.+|.+. .+.+.+|.++++|+.++|.+ .++.+...+|.++.+|+.+.|..| ++...
T Consensus 261 ~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~ 338 (401)
T 4fdw_A 261 NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQIN 338 (401)
T ss_dssp EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEEC
T ss_pred EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEc
Confidence 667888999999999999888775 46677899999999999984 577677778999999999999655 77677
Q ss_pred ChhhhcCCCCcEEEccCCcCcCCCChhhhc--ccccEEeccCCCCC
Q 002094 327 PESMMNCGNLLAIDVSQNKLTGNIPTWIFK--MGLQTVSLSGNRLG 370 (967)
Q Consensus 327 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~--~~L~~L~L~~n~l~ 370 (967)
..+|.++ +|+.+++++|.+....+..+.. ..++.|++..+.+.
T Consensus 339 ~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 339 FSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp TTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred HHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 8899999 9999999999887544443333 25778888777653
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=151.44 Aligned_cols=113 Identities=20% Similarity=0.214 Sum_probs=64.6
Q ss_pred cccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEecc
Q 002094 435 AIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLS 514 (967)
Q Consensus 435 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 514 (967)
+|+.|++++|++++..+..+..+++|++|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 108 (177)
T 2o6r_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD 108 (177)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence 44555555555554444445555555555555555554444455566666666666666665555555666666666666
Q ss_pred CCccccCCchhhhhccCCceEEecCCcccccCC
Q 002094 515 FNDLSGILPKELINLSHLLSFNISHNHLHGELP 547 (967)
Q Consensus 515 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 547 (967)
+|++++..+..+..+++|+.|++++|+++|.+|
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 666665555455556666666666666665544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=4.2e-16 Score=149.70 Aligned_cols=129 Identities=22% Similarity=0.215 Sum_probs=117.5
Q ss_pred CCCccEEEccCCccc-CCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEE
Q 002094 385 YQGLQVLDLSSNALS-GVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKEL 463 (967)
Q Consensus 385 ~~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 463 (967)
.++|+.|++++|.++ +.+|..+..+++|++|++++|.+.+. ..+..+++|++|++++|++++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 467999999999998 78888999999999999999999866 789999999999999999998789888889999999
Q ss_pred EcCCCCCCCc-CCccccccCccceeeccCCcCcCccc---hhhhcccCccEEeccC
Q 002094 464 KLEKNFLSGR-IPSQIKNCSSLTSLILSQNNLTGPVP---AAIANLSNLKYVDLSF 515 (967)
Q Consensus 464 ~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~ 515 (967)
++++|++++. .+..++.+++|+.|++++|++++..+ ..+..+++|++||+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999974 45889999999999999999997766 5899999999999974
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-15 Score=152.46 Aligned_cols=84 Identities=27% Similarity=0.304 Sum_probs=33.2
Q ss_pred CCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeecc
Q 002094 143 SLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLG 222 (967)
Q Consensus 143 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 222 (967)
+|++|+|++|+|+ .+|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 3344444444443 233334444444444444444443333334444444444444444443333333333333333333
Q ss_pred Ccccc
Q 002094 223 KNKFS 227 (967)
Q Consensus 223 ~n~l~ 227 (967)
+|+++
T Consensus 111 ~N~l~ 115 (193)
T 2wfh_A 111 GNDIS 115 (193)
T ss_dssp SSCCC
T ss_pred CCCCC
Confidence 33333
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.61 E-value=5.2e-15 Score=165.98 Aligned_cols=267 Identities=12% Similarity=0.133 Sum_probs=175.1
Q ss_pred CCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCe
Q 002094 115 SFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQS 194 (967)
Q Consensus 115 ~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 194 (967)
.+..++.+.+.++ ++ .|+...|.++ +|+.+.|.+| ++.+...+|.++ +|+.+.|.. .++...+.+|.++++|+.
T Consensus 111 ~~~~l~~i~ip~~-i~-~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~ 184 (401)
T 4fdw_A 111 ILKGYNEIILPNS-VK-SIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKK 184 (401)
T ss_dssp ECSSCSEEECCTT-CC-EECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCE
T ss_pred ecCCccEEEECCc-cC-EehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCe
Confidence 3466677776643 33 4666667764 6777777665 665666667664 577777764 566566677777777888
Q ss_pred EeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCC
Q 002094 195 LDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSF 274 (967)
Q Consensus 195 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 274 (967)
++|++|.++.+....|. ..+|+.+.|..+ +..+...+|.++++|+.+++..| ++.....+|.+ .+|+.+.| .+.+
T Consensus 185 l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i 259 (401)
T 4fdw_A 185 ADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGV 259 (401)
T ss_dssp EECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTC
T ss_pred eecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCc
Confidence 88877777766666666 467777777744 66566677777777877777764 55455566666 67777777 4456
Q ss_pred CCcCchhhccccccccccccccccc-----cccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCC
Q 002094 275 TGEVPDWIGKLANLESLDLSLNQFS-----GRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGN 349 (967)
Q Consensus 275 ~~~~~~~l~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 349 (967)
+.+...+|.++++|+.+++.+|.+. .+.+..|.++++|+.+.|. +.++.....+|.+|++|+.+++..| ++..
T Consensus 260 ~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I 337 (401)
T 4fdw_A 260 TNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQI 337 (401)
T ss_dssp CEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEE
T ss_pred cEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEE
Confidence 6566677777777887777776654 3455667777778887777 4466666777777777887777554 4422
Q ss_pred CChhhhcccccEEeccCCCCCCCCCCCcccccccCC-CCccEEEccCCccc
Q 002094 350 IPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSY-QGLQVLDLSSNALS 399 (967)
Q Consensus 350 ~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~-~~L~~L~L~~N~l~ 399 (967)
-+..+...+|+.+++.+|.+..... ..+..+ .+++.|++..+.+.
T Consensus 338 ~~~aF~~~~L~~l~l~~n~~~~l~~-----~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 338 NFSAFNNTGIKEVKVEGTTPPQVFE-----KVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CTTSSSSSCCCEEEECCSSCCBCCC-----SSCCCSCTTCCEEEECGGGHH
T ss_pred cHHhCCCCCCCEEEEcCCCCccccc-----ccccCCCCCccEEEeCHHHHH
Confidence 2333333477777777776654332 122233 35677777666554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-16 Score=174.02 Aligned_cols=138 Identities=12% Similarity=0.137 Sum_probs=100.0
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCcc-------------ccHHH--------HHHHHHHHcCCCCCc
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLI-------------KSQED--------FEKEMKTLGKIRHHN 740 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-------------~~~~~--------~~~E~~~l~~l~h~n 740 (967)
..|...+.||+|++|.||+|...+|+.||||+++..... ..... ...|...+.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 357888999999999999999989999999987542110 01111 234566666664433
Q ss_pred ee--eeeeEEEcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC
Q 002094 741 LV--ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS 818 (967)
Q Consensus 741 iv--~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~ 818 (967)
+. ..+++ ...++||||++|++|.+.... .....++.|++.++.|||+.|||||||||.|||++++
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 32 22222 123799999999888765421 1234688999999999999999999999999999876
Q ss_pred C----------CeEEeeccccccc
Q 002094 819 G----------EPKVGDFGLARLL 832 (967)
Q Consensus 819 ~----------~~kl~Dfg~a~~~ 832 (967)
+ .+.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 6 3899999987643
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.4e-14 Score=161.39 Aligned_cols=123 Identities=15% Similarity=0.092 Sum_probs=64.9
Q ss_pred CCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCc
Q 002094 404 SNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSS 483 (967)
Q Consensus 404 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 483 (967)
..|..+..++.+....+.+ ....|..+.+|+.+.+.++ ++......|.++.+|+.++|.++ ++..-..+|.++.+
T Consensus 270 ~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~ 344 (394)
T 4fs7_A 270 SLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTS 344 (394)
T ss_dssp CTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTT
T ss_pred cccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCC
Confidence 3444444444444433322 1234555556666666543 44344455666666666666533 44344456666666
Q ss_pred cceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCce
Q 002094 484 LTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLS 534 (967)
Q Consensus 484 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 534 (967)
|+.++|..| ++.+...+|.++.+|+.+++..+ ++ .+..+|.+.++|+.
T Consensus 345 L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 345 LSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp CCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred CCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 666666655 55455566666666666666544 22 22345555555544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.59 E-value=4.5e-17 Score=164.76 Aligned_cols=138 Identities=22% Similarity=0.248 Sum_probs=95.3
Q ss_pred ccCCCCCCeEecCCCccCccccc------cccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCcccc
Q 002094 89 LLRLQFLQVLSLSNNNFTGTINA------DLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESL 162 (967)
Q Consensus 89 l~~l~~L~~L~L~~n~l~~~~~~------~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l 162 (967)
+.....++.++++.++++|.+|. .|..+++|++|+|++|.+++ +| .+..+++|++|+|++|+++ .+|..+
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~--~~~~l~~L~~L~l~~n~l~-~l~~~~ 89 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS--SLSGMENLRILSLGRNLIK-KIENLD 89 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC--CHHHHTTCCEEEEEEEEEC-SCSSHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc--ccccCCCCCEEECCCCCcc-cccchh
Confidence 44556777777777777777665 67777777777777777774 55 3577777777777777777 456666
Q ss_pred ccccccceeeecccccccccCccccccccCCeEeecCCcCCCccc-ccccCCCCCCeeeccCccccccCCc
Q 002094 163 SFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIV-KGISNLYDLRAIKLGKNKFSGQLPE 232 (967)
Q Consensus 163 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~ 232 (967)
..+++|++|+|++|++++ +| .+..+++|++|+|++|.+++... ..+..+++|++|++++|++++..|.
T Consensus 90 ~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 90 AVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp HHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred hcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 677777777777777775 34 56677777777777777775433 4566666677777777766655443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.3e-14 Score=161.54 Aligned_cols=102 Identities=13% Similarity=0.144 Sum_probs=60.6
Q ss_pred CcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCcc
Q 002094 405 NIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSL 484 (967)
Q Consensus 405 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 484 (967)
.|..+.+|+.+.+..+ +.......|.++.+|+.++|.++ ++......|.++.+|+.+.+..| ++..-..+|.++++|
T Consensus 292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 368 (394)
T 4fs7_A 292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINL 368 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTC
T ss_pred cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCC
Confidence 4445555555555433 33334455666666666666543 54444566667777777777655 554555677777777
Q ss_pred ceeeccCCcCcCccchhhhcccCccEE
Q 002094 485 TSLILSQNNLTGPVPAAIANLSNLKYV 511 (967)
Q Consensus 485 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L 511 (967)
+.+++..+ ++ .+..+|.++++|+.+
T Consensus 369 ~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 369 KKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp CEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred CEEEECCC-CE-EhhheecCCCCCcEE
Confidence 77777654 33 234567777777654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.7e-16 Score=160.55 Aligned_cols=136 Identities=20% Similarity=0.261 Sum_probs=92.4
Q ss_pred ccCCCCCcEEEcCCCCCCCCCCc-----hhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCcccc
Q 002094 113 LASFGTLQVVDFSENNLSGLIPD-----EFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIW 187 (967)
Q Consensus 113 ~~~l~~L~~L~Ls~n~~~~~ip~-----~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 187 (967)
+.....++.++++.+.++|.+|. ..|..+++|++|+|++|++++ +| .+..+++|++|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 45566777777777777777665 235777888888888888876 55 7777888888888888877 5666667
Q ss_pred ccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCC-cCccCCCCccEEeccccccCCC
Q 002094 188 FLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLP-EDIGGCSMLKVLDFGVNSLSGS 253 (967)
Q Consensus 188 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~ 253 (967)
.+++|++|+|++|.+++. + .+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+.+.
T Consensus 91 ~~~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 91 VADTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHHHCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred cCCcCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 777788888887777753 2 46666667777777776664322 3455556666666666655543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=7.7e-15 Score=145.15 Aligned_cols=131 Identities=19% Similarity=0.201 Sum_probs=79.9
Q ss_pred cccccchhcccccccccccCCCcCCcc-cccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccce
Q 002094 408 DLSSLMLLNMSMNYLFGSIPASIGKLK-AIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTS 486 (967)
Q Consensus 408 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 486 (967)
++.+|+.|++++|.+.. +|. +..+. +|+.|++++|++++. ..+..+++|++|+|++|+|++..+..|..+++|+.
T Consensus 17 ~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 92 (176)
T 1a9n_A 17 NAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92 (176)
T ss_dssp CTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred CcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence 34445555555555542 232 33332 666666666666643 45666667777777777776544444567777777
Q ss_pred eeccCCcCcCccch--hhhcccCccEEeccCCccccCCch----hhhhccCCceEEecCCcccc
Q 002094 487 LILSQNNLTGPVPA--AIANLSNLKYVDLSFNDLSGILPK----ELINLSHLLSFNISHNHLHG 544 (967)
Q Consensus 487 L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~----~l~~l~~L~~L~l~~N~l~~ 544 (967)
|+|++|+|+ .+|. .+..+++|+.|++++|+++. +|. .+..+++|+.||+++|....
T Consensus 93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred EECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 777777775 3444 66777777777777777763 344 36777777777777776653
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.53 E-value=9.7e-15 Score=143.29 Aligned_cols=109 Identities=24% Similarity=0.231 Sum_probs=81.4
Q ss_pred ccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccC
Q 002094 436 IQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSF 515 (967)
Q Consensus 436 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 515 (967)
.+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 356777777776 4565553 6777777777777777777777788888888888888776666777788888888888
Q ss_pred CccccCCchhhhhccCCceEEecCCcccccCC
Q 002094 516 NDLSGILPKELINLSHLLSFNISHNHLHGELP 547 (967)
Q Consensus 516 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 547 (967)
|+|++..+..|..+++|+.|+|++|+|++.++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 88877766677778888888888888877665
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=1.9e-14 Score=142.24 Aligned_cols=105 Identities=23% Similarity=0.236 Sum_probs=49.8
Q ss_pred cCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCCh--hhhcCCCCCEEE
Q 002094 191 SLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPD--SLQRLNSCSSLS 268 (967)
Q Consensus 191 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~--~l~~l~~L~~L~ 268 (967)
+|++|+|++|.+++. ..|..+++|++|+|++|++++..+..|..+++|++|++++|+++ .+|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence 444444444444432 33444444444444444444332233344555555555555553 2333 445555555555
Q ss_pred ccCCCCCCcCch----hhccccccccccccccccc
Q 002094 269 LKGNSFTGEVPD----WIGKLANLESLDLSLNQFS 299 (967)
Q Consensus 269 L~~n~l~~~~~~----~l~~l~~L~~L~L~~N~l~ 299 (967)
+++|.++. .|. .+..+++|++||+++|.+.
T Consensus 120 l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 120 ILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 55555542 233 2555555555555555543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.48 E-value=9.4e-14 Score=136.65 Aligned_cols=108 Identities=22% Similarity=0.279 Sum_probs=69.9
Q ss_pred cEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCC
Q 002094 437 QVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFN 516 (967)
Q Consensus 437 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 516 (967)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45666666664 4555443 56666666666666666666666777777777777776655555666777777777777
Q ss_pred ccccCCchhhhhccCCceEEecCCcccccCC
Q 002094 517 DLSGILPKELINLSHLLSFNISHNHLHGELP 547 (967)
Q Consensus 517 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 547 (967)
+|++..+..|..+++|+.|+|++|+|.+..+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 7775555556667777777777776665443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.42 E-value=4.2e-13 Score=131.51 Aligned_cols=107 Identities=26% Similarity=0.241 Sum_probs=80.0
Q ss_pred chhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCC
Q 002094 413 MLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQN 492 (967)
Q Consensus 413 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 492 (967)
+.+++++|.+. .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 44555555554 3444332 56777778888877777777888888888888888888777777788888888888888
Q ss_pred cCcCccchhhhcccCccEEeccCCccccCC
Q 002094 493 NLTGPVPAAIANLSNLKYVDLSFNDLSGIL 522 (967)
Q Consensus 493 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 522 (967)
+|++..+..|.++++|++|+|++|+++...
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 888777777888888888888888887553
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=3e-15 Score=166.32 Aligned_cols=171 Identities=19% Similarity=0.157 Sum_probs=87.3
Q ss_pred CCCCCeEecCCCccCccccccccCC-----CCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccc---
Q 002094 92 LQFLQVLSLSNNNFTGTINADLASF-----GTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLS--- 163 (967)
Q Consensus 92 l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~--- 163 (967)
+++|+.|+|++|+++......++.. ++|++|+|++|.+++.....+...+++|++|+|++|+++......++
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 3567777777777775444333332 56777777777765433334444556666666666666543333332
Q ss_pred --cccccceeeecccccccc----cCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCC
Q 002094 164 --FCSSLESVNFSSNRLSGQ----LPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGC 237 (967)
Q Consensus 164 --~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 237 (967)
..++|++|+|++|+|+.. ++..+..+++|++|+|++|.|++.... .++..+...
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~--------------------~L~~~L~~~ 210 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE--------------------LLAAQLDRN 210 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHH--------------------HHHHHGGGC
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHH--------------------HHHHHHhcC
Confidence 235566666666665532 222334455555555555555432211 112233344
Q ss_pred CCccEEeccccccCCC----CChhhhcCCCCCEEEccCCCCCCcCchhh
Q 002094 238 SMLKVLDFGVNSLSGS----LPDSLQRLNSCSSLSLKGNSFTGEVPDWI 282 (967)
Q Consensus 238 ~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~l 282 (967)
++|++|+|++|.|+.. ++..+...++|++|+|++|.|+......+
T Consensus 211 ~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp SCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred CCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 4555555555555432 22333444555666666665554433333
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=5.8e-13 Score=130.97 Aligned_cols=106 Identities=26% Similarity=0.234 Sum_probs=76.6
Q ss_pred chhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCC
Q 002094 413 MLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQN 492 (967)
Q Consensus 413 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 492 (967)
+.+++++|.+. .+|..+. ++|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 34455555553 4444443 56777777777777666777777778888888888887666666788888888888888
Q ss_pred cCcCccchhhhcccCccEEeccCCccccC
Q 002094 493 NLTGPVPAAIANLSNLKYVDLSFNDLSGI 521 (967)
Q Consensus 493 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 521 (967)
+|++..+..|..+++|++|+|++|++...
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 88866666688888888888888888743
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.36 E-value=3.1e-11 Score=135.89 Aligned_cols=135 Identities=14% Similarity=0.217 Sum_probs=82.3
Q ss_pred CCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccc
Q 002094 401 VIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKN 480 (967)
Q Consensus 401 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 480 (967)
+-..+|.++..|+.+.+..+.. ......|.++..|+.+.+. +.++......|.++.+|+.+.|..+ ++..-..+|.+
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 332 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAG 332 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred cccceeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence 4455666777777777655443 2445567777777777775 3455455566777777777777654 55445567777
Q ss_pred cCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcc
Q 002094 481 CSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHL 542 (967)
Q Consensus 481 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l 542 (967)
+.+|+.+.|..+ ++.+...+|.++.+|+.+++.+|.... ..+.....|+.+.+..|.+
T Consensus 333 C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 333 CEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp CTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred CCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 888888887644 665666778888888888887775431 3455566677776665544
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.5e-14 Score=158.88 Aligned_cols=158 Identities=22% Similarity=0.247 Sum_probs=75.9
Q ss_pred CCCceEeccccccCCCCccccccc-----cccceeeecccccccccCccc-cccccCCeEeecCCcCCCccccccc----
Q 002094 142 GSLREVSFANNNLTGPIPESLSFC-----SSLESVNFSSNRLSGQLPYGI-WFLRSLQSLDLSNNLLEGEIVKGIS---- 211 (967)
Q Consensus 142 ~~L~~L~L~~n~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~n~l~~~~~~~~~---- 211 (967)
++|++|+|++|+++......+... ++|++|+|++|+|+......+ ..+++|++|+|++|.+++.....++
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 344455555555443322222222 455566666665543322222 2345566666666666544433332
Q ss_pred -CCCCCCeeeccCcccccc----CCcCccCCCCccEEeccccccCCC----CChhhhcCCCCCEEEccCCCCCCcC----
Q 002094 212 -NLYDLRAIKLGKNKFSGQ----LPEDIGGCSMLKVLDFGVNSLSGS----LPDSLQRLNSCSSLSLKGNSFTGEV---- 278 (967)
Q Consensus 212 -~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~---- 278 (967)
..++|++|+|++|.++.. ++..+..+++|++|+|++|.|+.. ++..+...++|+.|+|++|.|+...
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 334566666666665432 222334555666666666665532 2334445555666666666655322
Q ss_pred chhhccccccccccccccccc
Q 002094 279 PDWIGKLANLESLDLSLNQFS 299 (967)
Q Consensus 279 ~~~l~~l~~L~~L~L~~N~l~ 299 (967)
...+...++|++|+|++|.|+
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCC
T ss_pred HHHHHhCCCCCEEeccCCCCC
Confidence 222233344555555555444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.5e-11 Score=136.72 Aligned_cols=336 Identities=12% Similarity=0.188 Sum_probs=161.1
Q ss_pred cCccccccccCCC-CCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccc---cCCCCccccccccccceeeeccccccc
Q 002094 105 FTGTINADLASFG-TLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNN---LTGPIPESLSFCSSLESVNFSSNRLSG 180 (967)
Q Consensus 105 l~~~~~~~~~~l~-~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~---l~~~~p~~l~~l~~L~~L~L~~N~l~~ 180 (967)
++.+-..+|.++. .|+.+.|..+ ++ .|....|.++++|+.+.+..|. ++.+...+|.++.+|+.+.+..+ ++.
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt-~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~ 127 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VT-EIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE 127 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CC-EECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-ee-EEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce
Confidence 3444455666664 4777777654 44 4666667777777777776653 44444556666666666665443 333
Q ss_pred ccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhc
Q 002094 181 QLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQR 260 (967)
Q Consensus 181 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~ 260 (967)
....+|..+.+|+.+.+..+ +.......|..+..|+.+.+..+ ++.....+|.+ ..|+.+.+..+-.. ....+|.+
T Consensus 128 I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~ 203 (394)
T 4gt6_A 128 IDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSE 203 (394)
T ss_dssp ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTT
T ss_pred ehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhh
Confidence 44455566666666666432 33344455555555555555443 22233333432 34555544433221 22334444
Q ss_pred CCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEE
Q 002094 261 LNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAID 340 (967)
Q Consensus 261 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 340 (967)
+.+++......+..... ...+.......... + ..+.....+..+.+. +.++.....+|.++.+
T Consensus 204 c~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~-----~-----~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~----- 266 (394)
T 4gt6_A 204 CFALSTITSDSESYPAI-DNVLYEKSANGDYA-----L-----IRYPSQREDPAFKIP-NGVARIETHAFDSCAY----- 266 (394)
T ss_dssp CTTCCEEEECCSSSCBS-SSCEEEECTTSCEE-----E-----EECCTTCCCSEEECC-TTEEEECTTTTTTCSS-----
T ss_pred ccccceecccccccccc-cceeeccccccccc-----c-----cccccccccceEEcC-CcceEcccceeeeccc-----
Confidence 44444444333332211 10000000000000 0 000011112222221 1112222333444444
Q ss_pred ccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhccccc
Q 002094 341 VSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMN 420 (967)
Q Consensus 341 l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 420 (967)
|+.+.+.++..+ +...+|.++++|+.+.+. +
T Consensus 267 -----------------------------------------------L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~ 297 (394)
T 4gt6_A 267 -----------------------------------------------LASVKMPDSVVS-IGTGAFMNCPALQDIEFS-S 297 (394)
T ss_dssp -----------------------------------------------CCEEECCTTCCE-ECTTTTTTCTTCCEEECC-T
T ss_pred -----------------------------------------------ccEEecccccce-ecCcccccccccccccCC-C
Confidence 444444332221 334455555556655554 3
Q ss_pred ccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccch
Q 002094 421 YLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPA 500 (967)
Q Consensus 421 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 500 (967)
.+.......|.++.+|+.++|.++ ++......|.++.+|+.+.+..+ ++..-..+|.++++|+.+++.+|.... .
T Consensus 298 ~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~ 372 (394)
T 4gt6_A 298 RITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---N 372 (394)
T ss_dssp TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---H
T ss_pred cccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---h
Confidence 344344556666677777777654 44445566777777777777644 554555678888888888888775431 3
Q ss_pred hhhcccCccEEeccCCcc
Q 002094 501 AIANLSNLKYVDLSFNDL 518 (967)
Q Consensus 501 ~~~~l~~L~~L~Ls~N~l 518 (967)
.|....+|+.+.+..|.+
T Consensus 373 ~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 373 AISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TCBCCCCC----------
T ss_pred hhhccCCCCEEEeCCCCE
Confidence 566677788877776654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=1.8e-12 Score=143.42 Aligned_cols=106 Identities=26% Similarity=0.326 Sum_probs=61.9
Q ss_pred EEecCC-cccccCcccccCCCCCCEEEcCC-CCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCC
Q 002094 439 LDFSDN-WLNGTIPPQIGGAVSLKELKLEK-NFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFN 516 (967)
Q Consensus 439 L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 516 (967)
++++++ .|+ .+|. +..+++|++|+|++ |.|++..+..|+++++|+.|+|++|+|++..|..|.+|++|++|||++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455555 555 3455 55555666666654 6666555555666666666666666666655556666666666666666
Q ss_pred ccccCCchhhhhccCCceEEecCCcccccCC
Q 002094 517 DLSGILPKELINLSHLLSFNISHNHLHGELP 547 (967)
Q Consensus 517 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 547 (967)
+|++..+..|..++ |+.|+|.+|+|.+...
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCA 120 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCCCGG
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccCCCc
Confidence 66655555554444 6666666666665443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.2e-11 Score=136.80 Aligned_cols=130 Identities=20% Similarity=0.105 Sum_probs=81.2
Q ss_pred hccccc-ccccccCCCcCCcccccEEEecC-CcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCC
Q 002094 415 LNMSMN-YLFGSIPASIGKLKAIQVLDFSD-NWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQN 492 (967)
Q Consensus 415 L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 492 (967)
++++++ .|. .+|. +..+++|+.|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 345554 554 3555 66666677777774 7777666667777777777777777777777777777777777777777
Q ss_pred cCcCccchhhhcccCccEEeccCCccccCCc-hhhhhccCCceEEecCCcccccCC
Q 002094 493 NLTGPVPAAIANLSNLKYVDLSFNDLSGILP-KELINLSHLLSFNISHNHLHGELP 547 (967)
Q Consensus 493 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p 547 (967)
+|++..+..|..++ |+.|+|++|++...-. .+|..+.......+..+.+++.-|
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~ 145 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ 145 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCC
Confidence 77766555666555 7777777777764322 233333333333344455554444
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=7.2e-11 Score=124.91 Aligned_cols=137 Identities=12% Similarity=0.056 Sum_probs=107.7
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
|+....++.|+.+.||++... ++.+++|+...... .....+.+|+++++.+. +..+.++++++...+..++||||++
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 455667888888999999754 78999999875321 22345889999988884 6678889999988888999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH------------------------------------------ 800 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~------------------------------------------ 800 (967)
|.++.+.+.. ......++.+++++++.||+
T Consensus 94 G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 94 GVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp SEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred CeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 9999876421 12234688899999999998
Q ss_pred -----------------CCcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 801 -----------------TNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 801 -----------------~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
..++|+|+++.||+++.+..+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348899999999999876556799999775
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.04 E-value=5.4e-11 Score=130.70 Aligned_cols=210 Identities=15% Similarity=0.131 Sum_probs=108.7
Q ss_pred CCeeeeeeecCCCCCc-c-------ccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhh
Q 002094 68 TKRVVGLTLDGFSLSG-H-------IGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFR 139 (967)
Q Consensus 68 ~~~v~~l~l~~~~l~~-~-------~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~ 139 (967)
..+|+.|.+...+..| . +..++.++++|+.|.+.++..... ++++... +.+ ..++.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~--------------~is~~~~-~~L-~~ll~ 169 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQ--------------EISWIEQ-VDL-SPVLD 169 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTC--------------CGGGCBC-CBC-HHHHH
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhc--------------ccccccc-cCH-HHHHh
Confidence 4567788877665543 2 133455677888887765432110 0000000 011 12334
Q ss_pred cCCCCceEeccccccCCCCccccccccccceeeecccccccccCcccc--ccccCCeEeecC--CcCCCc-----ccccc
Q 002094 140 QCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIW--FLRSLQSLDLSN--NLLEGE-----IVKGI 210 (967)
Q Consensus 140 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~--n~l~~~-----~~~~~ 210 (967)
.+++|+.|+|++|.-. .++. +. +++|++|+|..+.+.......+. .+++|++|+|+. |...+. +...+
T Consensus 170 ~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l 246 (362)
T 2ra8_A 170 AMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246 (362)
T ss_dssp TCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred cCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence 5555555555554211 1122 22 55666666665555433222332 456666666542 111110 01112
Q ss_pred --cCCCCCCeeeccCccccccCCcCcc---CCCCccEEeccccccCCC----CChhhhcCCCCCEEEccCCCCCCcCchh
Q 002094 211 --SNLYDLRAIKLGKNKFSGQLPEDIG---GCSMLKVLDFGVNSLSGS----LPDSLQRLNSCSSLSLKGNSFTGEVPDW 281 (967)
Q Consensus 211 --~~l~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 281 (967)
..+++|++|+|.+|.+.+..+..+. .+++|++|+|+.|.+.+. ++..+..+++|+.|+|++|.|+...-..
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~ 326 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKE 326 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHH
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHH
Confidence 2356777777777777643333222 467888888888887753 2334456788888888888877543333
Q ss_pred hccccccccccccccc
Q 002094 282 IGKLANLESLDLSLNQ 297 (967)
Q Consensus 282 l~~l~~L~~L~L~~N~ 297 (967)
+...- ...++++.++
T Consensus 327 l~~al-g~~~~~~~~~ 341 (362)
T 2ra8_A 327 LQKSL-PMKIDVSDSQ 341 (362)
T ss_dssp HHHHC-CSEEECCSBC
T ss_pred HHHHc-CCEEEecCCc
Confidence 33311 2457777776
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.97 E-value=2.5e-10 Score=125.41 Aligned_cols=63 Identities=17% Similarity=0.251 Sum_probs=28.3
Q ss_pred CCCCCEEEccCCCCCCcCchhhc---cccccccccccccccccc----cCCCCCcccccceEEcccCcCC
Q 002094 261 LNSCSSLSLKGNSFTGEVPDWIG---KLANLESLDLSLNQFSGR----IPSSIGNLVFLKELNISMNQFT 323 (967)
Q Consensus 261 l~~L~~L~L~~n~l~~~~~~~l~---~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 323 (967)
+++|+.|+|.+|.+.+..+..+. .+++|++|+|+.|.+.+. ++..+..+++|+.|+|++|.|+
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 45555555555555432222222 244555555555555432 2222233445555555555444
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.96 E-value=7.6e-10 Score=116.88 Aligned_cols=127 Identities=14% Similarity=0.117 Sum_probs=96.2
Q ss_pred ccC-CCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCc--eeeeeeEEEcCCceeEEEEecCCCc
Q 002094 689 ELG-RGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHN--LVALEGYYWTPSLQLLIYEFISSGS 765 (967)
Q Consensus 689 ~lG-~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs 765 (967)
.++ .|..+.||++...+|+.+++|..... ....+.+|+++++.+.+.+ +.+++++...++..++||||++|.+
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~ 101 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 101 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence 344 55569999998777888999987643 1245788888888885434 5568888887788899999999988
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------
Q 002094 766 LYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN------------------------------------------- 802 (967)
Q Consensus 766 L~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~------------------------------------------- 802 (967)
+. ... .+ ...++.++++.++.||+..
T Consensus 102 l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 102 LL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp TT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 84 211 11 2256778888888888643
Q ss_pred ---------------cccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 803 ---------------IIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 803 ---------------ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
++|+|++|.||+++.++.+.++|||.+.
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 8999999999999876666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.3e-09 Score=120.96 Aligned_cols=140 Identities=19% Similarity=0.260 Sum_probs=104.4
Q ss_pred CCccCCCCceEEEEEEeCCCcEEEEEEee--cCCccccHHHHHHHHHHHcCCC--CCceeeeeeEEEcC---CceeEEEE
Q 002094 687 DCELGRGGFGVVYRTILQDGRSVAIKKLT--VSGLIKSQEDFEKEMKTLGKIR--HHNLVALEGYYWTP---SLQLLIYE 759 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e 759 (967)
.+.++.|.++.||+.... +..+++|+.. ..........+.+|+++++.+. +..+++++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 456899999999999876 4688888776 3332233457889999998886 45578888888766 45799999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH--------------------------------------- 800 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~--------------------------------------- 800 (967)
|++|..+.+... ..++..++..++.+++++|+.||+
T Consensus 122 ~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999977743211 126778888999999999999996
Q ss_pred -------------------CCcccCCCCCCCEEeCCCCC--eEEeeccccccc
Q 002094 801 -------------------TNIIHYNLKSTNVLIDSSGE--PKVGDFGLARLL 832 (967)
Q Consensus 801 -------------------~~ivH~Dik~~Nill~~~~~--~kl~Dfg~a~~~ 832 (967)
.+++|||+++.||+++.++. +.++||+.+..-
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999997753 589999988643
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.95 E-value=3.5e-08 Score=110.29 Aligned_cols=123 Identities=14% Similarity=0.150 Sum_probs=66.0
Q ss_pred CCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccC
Q 002094 403 PSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCS 482 (967)
Q Consensus 403 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 482 (967)
..+|.++..|+.+.+..+ +...-...|.++.+|+.+.+..+ ++......|.++.+|+.+.+.++.++.....+|.++.
T Consensus 233 ~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~ 310 (379)
T 4h09_A 233 DGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCV 310 (379)
T ss_dssp TTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCT
T ss_pred cccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCC
Confidence 344555555555555443 33333445555566666666433 3333344555666666666666655544455666666
Q ss_pred ccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhc
Q 002094 483 SLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINL 529 (967)
Q Consensus 483 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 529 (967)
+|+.+.|..+ ++.+...+|.++.+|+.+.+..+ ++.+-..+|.+.
T Consensus 311 ~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 311 KLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp TCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred CCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 6666666543 54444556666666666666543 443444445443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.7e-08 Score=111.17 Aligned_cols=303 Identities=12% Similarity=0.054 Sum_probs=180.6
Q ss_pred cccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCC
Q 002094 185 GIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSC 264 (967)
Q Consensus 185 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 264 (967)
++....+|+.+.+.. .++.+...+|.++.+|+.+.|..+ ++.+...+|.++ +|+.+.+..+
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~---------------- 101 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER---------------- 101 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT----------------
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce----------------
Confidence 345566677776653 355455556666666666666543 444444455554 3444443321
Q ss_pred CEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCC
Q 002094 265 SSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQN 344 (967)
Q Consensus 265 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 344 (967)
++.+...+|.. .+|+.+.+..+- .......|.+. +|+.+.+..+ ++......|..+.+++.+.+..+
T Consensus 102 ---------l~~I~~~aF~~-~~L~~i~lp~~~-~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~ 168 (379)
T 4h09_A 102 ---------VKKFGDYVFQG-TDLDDFEFPGAT-TEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSN 168 (379)
T ss_dssp ---------CCEECTTTTTT-CCCSEEECCTTC-CEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTT
T ss_pred ---------eeEeccceecc-CCcccccCCCcc-ccccccccccc-eeeeeeccce-eeccccchhcccccccccccccc
Confidence 22222233332 245555554332 21222233332 3444444332 33344556666777777666554
Q ss_pred cCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhccccccccc
Q 002094 345 KLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFG 424 (967)
Q Consensus 345 ~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 424 (967)
.................. .........+..+.+..+. .......+....+|+.+.+..+ +..
T Consensus 169 ~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~ 230 (379)
T 4h09_A 169 NKNYVAENYVLYNKNKTI----------------LESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTT 230 (379)
T ss_dssp CSSEEEETTEEEETTSSE----------------EEECCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCE
T ss_pred cceeecccceecccccce----------------eccccccccccccccccce-eEEeecccccccccceeeeccc-eeE
Confidence 432111111000000000 0011122334444443322 2244556677778888877654 444
Q ss_pred ccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhc
Q 002094 425 SIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIAN 504 (967)
Q Consensus 425 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 504 (967)
.....|.++..|+.+.+..+ ++......|.++.+|+.+.+..+ +.......|.++++|+.+.+.++.++.+...+|.+
T Consensus 231 i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~ 308 (379)
T 4h09_A 231 LGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMD 308 (379)
T ss_dssp ECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTT
T ss_pred EccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcC
Confidence 56678889999999999876 66566778888999999999754 55456678999999999999999998777889999
Q ss_pred ccCccEEeccCCccccCCchhhhhccCCceEEecCC
Q 002094 505 LSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHN 540 (967)
Q Consensus 505 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N 540 (967)
+.+|+.++|..+ ++.+-..+|.++.+|+.+.+..+
T Consensus 309 c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 309 CVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred CCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 999999999865 77677789999999999888654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.92 E-value=1.1e-11 Score=128.88 Aligned_cols=23 Identities=9% Similarity=-0.126 Sum_probs=17.3
Q ss_pred CCccceEEeCCCCCeeeeeeecC
Q 002094 56 PCNWVGVKCDPKTKRVVGLTLDG 78 (967)
Q Consensus 56 ~c~w~gv~c~~~~~~v~~l~l~~ 78 (967)
.|.|.|+.|++...+|+.+...+
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~ 99 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSS 99 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEEC
T ss_pred HHhcCcEEECCCCCEEEEEEecC
Confidence 58999999997766776665544
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.77 E-value=2.9e-09 Score=115.03 Aligned_cols=184 Identities=17% Similarity=0.129 Sum_probs=119.9
Q ss_pred CCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCc--eeeeeeEEEcCC---ceeEEEEe
Q 002094 687 DCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHN--LVALEGYYWTPS---LQLLIYEF 760 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~~~~~~~~~~---~~~lv~e~ 760 (967)
.+.++.|....||+.. +.+++|+.... .....+.+|+++++.+ .+.. +.+++.+..... ..|+||||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4468999999999873 56888876432 3456789999998877 3322 344444433332 34799999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH---------------------------------------- 800 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~---------------------------------------- 800 (967)
++|.++.+.... .++..++..++.++++.++.||+
T Consensus 98 i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 98 IKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred cCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999888653321 15677777888888888888885
Q ss_pred ------------------CCcccCCCCCCCEEeCC--CCCeEEeecccccccCCCccccccccc---c---------ccc
Q 002094 801 ------------------TNIIHYNLKSTNVLIDS--SGEPKVGDFGLARLLPMLDRCILSSKI---Q---------SAL 848 (967)
Q Consensus 801 ------------------~~ivH~Dik~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~---~---------gt~ 848 (967)
..++|+|+++.||++++ ...+.++||+.+..-+...+-...... . ..+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 13699999999999987 456789999998654321110000000 0 001
Q ss_pred cccC-cccccCcccCCcccchhhHHHHHHHHHcCCCCC
Q 002094 849 GYMA-PEFACRTVKITEKCDVYGFGVLVLEVVTGKRPV 885 (967)
Q Consensus 849 ~y~a-PE~~~~~~~~t~~~Dv~slGvll~elltg~~p~ 885 (967)
+... |+.. . ......+.|+++.++|++.+|+.+|
T Consensus 253 ~~~~~~~~~-~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVL-E--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHH-H--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHH-H--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1112 2222 0 1122368999999999999999876
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.57 E-value=5.7e-09 Score=103.37 Aligned_cols=72 Identities=13% Similarity=0.103 Sum_probs=42.2
Q ss_pred cccccccCCCCCCeEecCCC-ccCcc----ccccccCCCCCcEEEcCCCCCCCCCCc---hhhhcCCCCceEeccccccC
Q 002094 84 HIGRGLLRLQFLQVLSLSNN-NFTGT----INADLASFGTLQVVDFSENNLSGLIPD---EFFRQCGSLREVSFANNNLT 155 (967)
Q Consensus 84 ~~~~~l~~l~~L~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~Ls~n~~~~~ip~---~~~~~l~~L~~L~L~~n~l~ 155 (967)
.+...+...+.|++|+|++| ++... +...+...+.|++|+|++|.|...... ..+...++|++|+|++|+|+
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34556677788888888888 77643 334455566777777777776532111 11233345555555555554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.53 E-value=2.3e-08 Score=103.84 Aligned_cols=105 Identities=20% Similarity=0.189 Sum_probs=62.6
Q ss_pred cCCcccccE--EEecCCccc---ccCcccccCCCCCCEEEcCCCCCCC--cCCccccccCccceeeccCCcCcCccchhh
Q 002094 430 IGKLKAIQV--LDFSDNWLN---GTIPPQIGGAVSLKELKLEKNFLSG--RIPSQIKNCSSLTSLILSQNNLTGPVPAAI 502 (967)
Q Consensus 430 ~~~l~~L~~--L~Ls~N~l~---~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 502 (967)
+...+.|+. ++++.|+.. +.++.....+++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 444444444 555555332 1112222345667777777777776 3455666777777777777777754 234
Q ss_pred hccc--CccEEeccCCccccCCc-------hhhhhccCCceEE
Q 002094 503 ANLS--NLKYVDLSFNDLSGILP-------KELINLSHLLSFN 536 (967)
Q Consensus 503 ~~l~--~L~~L~Ls~N~l~~~~p-------~~l~~l~~L~~L~ 536 (967)
..+. +|++|+|++|.+.+.+| ..+..+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 4444 77777777777776555 2356677777665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.44 E-value=6.7e-08 Score=95.59 Aligned_cols=112 Identities=13% Similarity=0.157 Sum_probs=54.2
Q ss_pred CcccccEEEecCC-ccccc----CcccccCCCCCCEEEcCCCCCCCc----CCccccccCccceeeccCCcCcCc----c
Q 002094 432 KLKAIQVLDFSDN-WLNGT----IPPQIGGAVSLKELKLEKNFLSGR----IPSQIKNCSSLTSLILSQNNLTGP----V 498 (967)
Q Consensus 432 ~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~ 498 (967)
..+.|++|+|++| .+... +...+...++|++|+|++|.|... +...+...++|+.|+|++|.|+.. +
T Consensus 34 ~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l 113 (185)
T 1io0_A 34 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 113 (185)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHH
Confidence 3344444444444 44321 122233344555555555555422 223334445566666666666532 2
Q ss_pred chhhhcccCccEEec--cCCccccC----CchhhhhccCCceEEecCCccc
Q 002094 499 PAAIANLSNLKYVDL--SFNDLSGI----LPKELINLSHLLSFNISHNHLH 543 (967)
Q Consensus 499 p~~~~~l~~L~~L~L--s~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~ 543 (967)
...+...++|++|+| ++|.|... +...+...+.|+.|+|++|.+.
T Consensus 114 ~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 114 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 334444556666666 55665533 2233444456666666666554
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=2.9e-06 Score=89.64 Aligned_cols=131 Identities=20% Similarity=0.213 Sum_probs=92.9
Q ss_pred ccCCCCce-EEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCceeEEEEecCCCc
Q 002094 689 ELGRGGFG-VVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQLLIYEFISSGS 765 (967)
Q Consensus 689 ~lG~G~~g-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gs 765 (967)
.+..|..| .||+.... ++..+++|+-.. ....++.+|.+.++.+. +--+.++++++.+++..++|||+++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 35556665 69998754 467889997653 24567888999887773 3346788888888889999999999988
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 002094 766 LYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-------------------------------------------- 801 (967)
Q Consensus 766 L~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-------------------------------------------- 801 (967)
+.+...... .....++.+++..++.||+.
T Consensus 107 ~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 776543211 12233455555555555531
Q ss_pred --------------CcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 802 --------------NIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 802 --------------~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 15899999999999887767799999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=4.1e-06 Score=90.12 Aligned_cols=132 Identities=16% Similarity=0.095 Sum_probs=91.4
Q ss_pred CccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCC---ceeeeeeEEE-cCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH---NLVALEGYYW-TPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~ 763 (967)
+.++.|....||+. |+.+++|+... ......+.+|+++++.+.+. .+.+++.++. ..+..++||||++|
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 45788888899998 67788887432 23456799999999988642 3556666664 45567899999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT------------------------------------------ 801 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~------------------------------------------ 801 (967)
.++.+..... ++......++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~~-----l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMAV-----LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHTT-----SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhhh-----CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8886632111 23444444555555555555431
Q ss_pred ------------------CcccCCCCCCCEEeCC---CCCe-EEeecccccc
Q 002094 802 ------------------NIIHYNLKSTNVLIDS---SGEP-KVGDFGLARL 831 (967)
Q Consensus 802 ------------------~ivH~Dik~~Nill~~---~~~~-kl~Dfg~a~~ 831 (967)
.++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999987 4665 8999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=1.2e-05 Score=88.73 Aligned_cols=81 Identities=2% Similarity=-0.026 Sum_probs=54.5
Q ss_pred Ccc-CCCCceEEEEEEeC-------CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCC-C--CceeeeeeEEEcC---
Q 002094 688 CEL-GRGGFGVVYRTILQ-------DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIR-H--HNLVALEGYYWTP--- 751 (967)
Q Consensus 688 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~--- 751 (967)
+.| +.|....+|+.... +++.+++|+...... ......+.+|+++++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88889999998754 267888887654320 101245778888887773 2 3466777776554
Q ss_pred CceeEEEEecCCCchhh
Q 002094 752 SLQLLIYEFISSGSLYK 768 (967)
Q Consensus 752 ~~~~lv~e~~~~gsL~~ 768 (967)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999876543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.88 E-value=3.5e-06 Score=80.88 Aligned_cols=63 Identities=8% Similarity=0.106 Sum_probs=27.9
Q ss_pred cccccccceeeecccc-cccccCcccccc----ccCCeEeecCCc-CCCcccccccCCCCCCeeeccCc
Q 002094 162 LSFCSSLESVNFSSNR-LSGQLPYGIWFL----RSLQSLDLSNNL-LEGEIVKGISNLYDLRAIKLGKN 224 (967)
Q Consensus 162 l~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n 224 (967)
+.++++|++|+|++|. |++..-..+..+ ++|++|+|++|. +++..-..+.++++|++|+|+++
T Consensus 81 L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c 149 (176)
T 3e4g_A 81 MEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDL 149 (176)
T ss_dssp GTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESC
T ss_pred hcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCC
Confidence 3444445555555442 333222222221 245555555552 55444444444455555555444
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.83 E-value=4.5e-05 Score=85.40 Aligned_cols=76 Identities=16% Similarity=0.092 Sum_probs=49.3
Q ss_pred CCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc------cccHHHHHHHHHHHcCCCC--C-ceeeeeeEEEcCCceeE
Q 002094 687 DCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL------IKSQEDFEKEMKTLGKIRH--H-NLVALEGYYWTPSLQLL 756 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~l 756 (967)
.+.+|.|.++.||++... +++.|+||....... .....++..|.++++.+.. + .+.+++.+ ++...++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 347999999999999754 468899998653221 1123456778888876632 3 34455543 3455689
Q ss_pred EEEecCCC
Q 002094 757 IYEFISSG 764 (967)
Q Consensus 757 v~e~~~~g 764 (967)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.81 E-value=8.7e-06 Score=78.14 Aligned_cols=86 Identities=19% Similarity=0.199 Sum_probs=56.0
Q ss_pred ccccEEEecCCcccccCcccccCCCCCCEEEcCCCC-CCCcCCcccccc----CccceeeccCCc-CcCccchhhhcccC
Q 002094 434 KAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNF-LSGRIPSQIKNC----SSLTSLILSQNN-LTGPVPAAIANLSN 507 (967)
Q Consensus 434 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 507 (967)
..|+.||++++.++..--..+.++++|++|+|++|. |+..--..+..+ ++|+.|+|++|. |+...-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 357777777777665545556667777777777764 554333334443 367788888774 77665666777778
Q ss_pred ccEEeccCCc-cc
Q 002094 508 LKYVDLSFND-LS 519 (967)
Q Consensus 508 L~~L~Ls~N~-l~ 519 (967)
|++|+|+++. ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 8888888775 44
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.72 E-value=5.7e-05 Score=82.69 Aligned_cols=136 Identities=15% Similarity=0.253 Sum_probs=77.5
Q ss_pred ccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-----CCCceeeee-e--EEEcCCceeEEEEe
Q 002094 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-----RHHNLVALE-G--YYWTPSLQLLIYEF 760 (967)
Q Consensus 689 ~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~-~--~~~~~~~~~lv~e~ 760 (967)
.++.|..+.||+....+| .+++|+.... ..++..|+++++.+ ..|.++... | +....+..++||||
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 466677899999987654 5899988642 23344455554443 234443311 1 12245667899999
Q ss_pred cCCCchh--------------hhhhcCC-----CC------CCCCHHHHH------------------------------
Q 002094 761 ISSGSLY--------------KHLHDGS-----SR------NCLSWRQRF------------------------------ 785 (967)
Q Consensus 761 ~~~gsL~--------------~~l~~~~-----~~------~~~~~~~~~------------------------------ 785 (967)
++|..+. ..+|... .. ....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 1122110 00 011232211
Q ss_pred -HHHHHHHHHHHHHh-------------cCCcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 786 -NIILGMAKGLAYLH-------------HTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 786 -~i~~~i~~aL~~LH-------------~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
.+...+..++++|+ ..+++|+|+++.||+++.++.+.++||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11112334566665 3579999999999999888899999999775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00057 Score=72.95 Aligned_cols=135 Identities=19% Similarity=0.142 Sum_probs=91.4
Q ss_pred CCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC---CCceeeeeeEEEcCCceeEEEEecCC
Q 002094 687 DCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR---HHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
.+.++.|....+|+... +++.+++|+.... ....+..|++.++.+. ...+++++.++...+..++||||++|
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 35689999999999886 4778899987642 3567889988888773 35688888888888889999999998
Q ss_pred Cchhh-----------hhhcCCC-CC------------------CCCHHHHH---HHHH----------------HHHHH
Q 002094 764 GSLYK-----------HLHDGSS-RN------------------CLSWRQRF---NIIL----------------GMAKG 794 (967)
Q Consensus 764 gsL~~-----------~l~~~~~-~~------------------~~~~~~~~---~i~~----------------~i~~a 794 (967)
..+.. .+|.... .. .-+|.... ++.. .++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 75421 2333221 00 12454332 1111 11111
Q ss_pred -HHHHh----cCCcccCCCCCCCEEeCCCCCeEEeecc
Q 002094 795 -LAYLH----HTNIIHYNLKSTNVLIDSSGEPKVGDFG 827 (967)
Q Consensus 795 -L~~LH----~~~ivH~Dik~~Nill~~~~~~kl~Dfg 827 (967)
...|. ...++|+|+.+.|++++.++ +.++||+
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 22343 23689999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00027 Score=75.07 Aligned_cols=77 Identities=19% Similarity=0.220 Sum_probs=55.6
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCC---CceeeeeeEEEcCCceeEEEEe
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRH---HNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~ 760 (967)
....+.+|.|..+.||+.+..||+.|+||+..... ......|..|++.|+.+.. -.+++++++. ..++||||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 34456789999999999999999999999865443 2334568889988877632 2344555542 34799999
Q ss_pred cCCCc
Q 002094 761 ISSGS 765 (967)
Q Consensus 761 ~~~gs 765 (967)
++++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.36 E-value=2.2e-05 Score=76.84 Aligned_cols=71 Identities=17% Similarity=0.137 Sum_probs=37.8
Q ss_pred ccccccCCCCCCeEecCCC-ccCcc----ccccccCCCCCcEEEcCCCCCCCCCC---chhhhcCCCCceEeccccccC
Q 002094 85 IGRGLLRLQFLQVLSLSNN-NFTGT----INADLASFGTLQVVDFSENNLSGLIP---DEFFRQCGSLREVSFANNNLT 155 (967)
Q Consensus 85 ~~~~l~~l~~L~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~Ls~n~~~~~ip---~~~~~~l~~L~~L~L~~n~l~ 155 (967)
+...+.+-+.|++|+|++| +|... +-+.+..-+.|+.|+|++|+|.+..- .+.+..-+.|++|+|++|.|+
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 3344555677888888774 66532 33445555666666666666652211 111233344555555555554
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00061 Score=76.69 Aligned_cols=79 Identities=14% Similarity=0.057 Sum_probs=47.8
Q ss_pred hcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccccc--ccccccCcccccCc--ccCCcccchhhHHHH
Q 002094 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQ--SALGYMAPEFACRT--VKITEKCDVYGFGVL 874 (967)
Q Consensus 799 H~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~--~~~t~~~Dv~slGvl 874 (967)
+...++|||+++.||+++.++ ++++||+.+..-+...+ -.... -...|++|+..... .......++......
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQ 305 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHH
Confidence 456899999999999998776 99999998875432111 00111 11346666654211 111223455577777
Q ss_pred HHHHHcC
Q 002094 875 VLEVVTG 881 (967)
Q Consensus 875 l~elltg 881 (967)
+|+.+++
T Consensus 306 ~~~~y~~ 312 (420)
T 2pyw_A 306 TWNLFNK 312 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7777764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00011 Score=71.99 Aligned_cols=65 Identities=18% Similarity=0.265 Sum_probs=29.6
Q ss_pred ccccccceeeeccc-ccccc----cCccccccccCCeEeecCCcCCCccccccc----CCCCCCeeeccCcccc
Q 002094 163 SFCSSLESVNFSSN-RLSGQ----LPYGIWFLRSLQSLDLSNNLLEGEIVKGIS----NLYDLRAIKLGKNKFS 227 (967)
Q Consensus 163 ~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~----~l~~L~~L~L~~n~l~ 227 (967)
.+-+.|++|+|++| +|... +...+..-+.|+.|+|++|.|.+.....|+ .-+.|++|+|++|+|.
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 33455666666654 55421 222333445555555555555533322222 2334444444444443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0035 Score=67.79 Aligned_cols=139 Identities=12% Similarity=0.110 Sum_probs=80.8
Q ss_pred CccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCC--ceeeeeeE-----EEcCCceeEEEEe
Q 002094 688 CELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH--NLVALEGY-----YWTPSLQLLIYEF 760 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~ 760 (967)
..++ |....||+....+|+.+++|...... .....+..|..+++.+... .+++++.. ....+..+++|||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 3466 88889999887778789999886432 2345677787777666311 23444432 1224556789999
Q ss_pred cCCCchhh-----------h---hhc----CC--CCCCCCHHHH----------------------HHHHHHHHHHHHHH
Q 002094 761 ISSGSLYK-----------H---LHD----GS--SRNCLSWRQR----------------------FNIILGMAKGLAYL 798 (967)
Q Consensus 761 ~~~gsL~~-----------~---l~~----~~--~~~~~~~~~~----------------------~~i~~~i~~aL~~L 798 (967)
++|..+.. . +|. .. .....++... ...+..++..++..
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98854321 0 111 00 0111222211 01111222222222
Q ss_pred ----hcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 799 ----HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 799 ----H~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
+...++|||+++.||+++ + .+.++||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234589999999999998 4 899999988754
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.00087 Score=61.23 Aligned_cols=59 Identities=20% Similarity=0.232 Sum_probs=39.5
Q ss_pred eeeccCCcCc-CccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccC
Q 002094 486 SLILSQNNLT-GPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGEL 546 (967)
Q Consensus 486 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 546 (967)
.++.+++.|+ ..+|..+. ++|++|||++|+|+.+.+..|..+++|+.|+|++|+|.+..
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC 71 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDC 71 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSG
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccC
Confidence 5667777765 23443322 35788888888888777777788888888877766665433
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00063 Score=72.69 Aligned_cols=136 Identities=11% Similarity=0.098 Sum_probs=73.6
Q ss_pred CCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCce-eeeeeEEEcCCceeEEEEec-CCC
Q 002094 687 DCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNL-VALEGYYWTPSLQLLIYEFI-SSG 764 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~g 764 (967)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+....+ .+++++ .++..++|+||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 457888999999998 55888877643211 1123457776666532222 344443 344457899999 665
Q ss_pred chhh------------------hhhcCCCCC--CCC-HHHHHHHHHH--------------HHHHHH----HHhc----C
Q 002094 765 SLYK------------------HLHDGSSRN--CLS-WRQRFNIILG--------------MAKGLA----YLHH----T 801 (967)
Q Consensus 765 sL~~------------------~l~~~~~~~--~~~-~~~~~~i~~~--------------i~~aL~----~LH~----~ 801 (967)
++.. .+|...... ... +.....+... +...+. .+.. .
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4421 112211100 011 1111111110 111111 1111 2
Q ss_pred CcccCCCCCCCEEeCCCCCeEEeeccccccc
Q 002094 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLL 832 (967)
Q Consensus 802 ~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 832 (967)
.++|+|+.+.||+ ..++.+.++||..+..-
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 4799999999999 56678899999987643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0015 Score=71.00 Aligned_cols=32 Identities=25% Similarity=0.253 Sum_probs=27.5
Q ss_pred CCcccCCCCCCCEEeCCC----CCeEEeeccccccc
Q 002094 801 TNIIHYNLKSTNVLIDSS----GEPKVGDFGLARLL 832 (967)
Q Consensus 801 ~~ivH~Dik~~Nill~~~----~~~kl~Dfg~a~~~ 832 (967)
..++|||+.+.||+++.+ +.+.++||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999874 67899999988654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0031 Score=69.20 Aligned_cols=138 Identities=14% Similarity=0.166 Sum_probs=81.9
Q ss_pred CccCCCCceEEEEEEeC--------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCceeEEE
Q 002094 688 CELGRGGFGVVYRTILQ--------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.+..|....+|++... +++.|++|+.... ......+.+|.++++.+. +.-..++++++.. .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 45666888889998864 2578999876332 234566778999888774 3223566665533 3999
Q ss_pred EecCCCchhhh-----------------hhcCCC--CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 002094 759 EFISSGSLYKH-----------------LHDGSS--RNCLS--WRQRFNIILGMAK-------------------GLAYL 798 (967)
Q Consensus 759 e~~~~gsL~~~-----------------l~~~~~--~~~~~--~~~~~~i~~~i~~-------------------aL~~L 798 (967)
||++|..+... +|.... ..... |.++.++..++.. .++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998655311 122211 11122 4555555544321 22333
Q ss_pred h----c----CCcccCCCCCCCEEeCCC----CCeEEeecccccc
Q 002094 799 H----H----TNIIHYNLKSTNVLIDSS----GEPKVGDFGLARL 831 (967)
Q Consensus 799 H----~----~~ivH~Dik~~Nill~~~----~~~kl~Dfg~a~~ 831 (967)
. . ..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 2 258999999999999876 7899999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.60 E-value=0.01 Score=58.14 Aligned_cols=101 Identities=10% Similarity=0.041 Sum_probs=66.3
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccccc
Q 002094 765 SLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH-HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSK 843 (967)
Q Consensus 765 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH-~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 843 (967)
+|.+.|..... +++++++|.++.|.+.+|.-.- ++.-..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence 78888876544 4999999999999999988762 22111233456889999999888763 1110
Q ss_pred ccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCC
Q 002094 844 IQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRP 884 (967)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p 884 (967)
.....+.|||.. . ...+.+.=|||+|+++|.-+--..|
T Consensus 98 -~~~~~~~~pe~~-~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLG-Y-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCS-S-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhc-c-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 112236788876 2 3567888999999999999974444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0036 Score=70.24 Aligned_cols=72 Identities=14% Similarity=0.153 Sum_probs=48.2
Q ss_pred CccCCCCceEEEEEEeCC--------CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCc-eeeeeeEEEcCCceeEEE
Q 002094 688 CELGRGGFGVVYRTILQD--------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHN-LVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 758 (967)
+.|+.|....||++...+ ++.+++|+..... ..+.+.+|..+++.+...+ .+++++.+.. .+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC---cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 457888889999998753 5789999874321 1245567888888774323 3566665432 3899
Q ss_pred EecCCCch
Q 002094 759 EFISSGSL 766 (967)
Q Consensus 759 e~~~~gsL 766 (967)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987544
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.003 Score=57.63 Aligned_cols=54 Identities=15% Similarity=0.285 Sum_probs=22.2
Q ss_pred eEecCCCccC-ccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccc
Q 002094 97 VLSLSNNNFT-GTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNN 153 (967)
Q Consensus 97 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~ 153 (967)
.++.++++++ ..+|..+. .+|++|+|++|+|+ .+|..+|..+++|++|+|++|.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP 66 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANP 66 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCC
Confidence 4555555554 22332211 13444444444444 3344444444444444444443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.45 E-value=0.008 Score=64.69 Aligned_cols=139 Identities=12% Similarity=0.100 Sum_probs=76.1
Q ss_pred CccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCc--eeeeeeE------EEcCCceeEEEE
Q 002094 688 CELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHN--LVALEGY------YWTPSLQLLIYE 759 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e 759 (967)
+.|+.|....+|+....+| .+++|...... ...++..|+++++.+.... +.+++.. ....+..+++|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 3577788899999987655 67889876521 1234556666665552111 2333321 122356689999
Q ss_pred ecCCCchhh--------------hhhcC----CCCC--C---CCHHHHHH------------HHHHHHHHHHHHhc----
Q 002094 760 FISSGSLYK--------------HLHDG----SSRN--C---LSWRQRFN------------IILGMAKGLAYLHH---- 800 (967)
Q Consensus 760 ~~~~gsL~~--------------~l~~~----~~~~--~---~~~~~~~~------------i~~~i~~aL~~LH~---- 800 (967)
|++|..+.. .+|.. .... . ..|...+. +...+...++++++
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 999865321 12211 0000 0 11322111 01123444555542
Q ss_pred ---CCcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 801 ---TNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 801 ---~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
.+++|+|+.+.||+++.++.+.++||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 368999999999999877656899999775
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.17 E-value=0.0042 Score=68.42 Aligned_cols=73 Identities=11% Similarity=0.033 Sum_probs=42.5
Q ss_pred CccCCCCceEEEEEEeCC---------CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCc-eeeeeeEEEcCCceeEE
Q 002094 688 CELGRGGFGVVYRTILQD---------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHN-LVALEGYYWTPSLQLLI 757 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv 757 (967)
+.++.|..-.+|+....+ ++.+++|+...... ...+...|.++++.+.... +.++++.. + -++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 357778888999998654 26888887654321 1112356777777663222 34555543 2 3789
Q ss_pred EEecCCCch
Q 002094 758 YEFISSGSL 766 (967)
Q Consensus 758 ~e~~~~gsL 766 (967)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999988543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.92 E-value=0.025 Score=61.18 Aligned_cols=31 Identities=19% Similarity=0.270 Sum_probs=27.5
Q ss_pred CcccCCCCCCCEEeCCCCCeEEeeccccccc
Q 002094 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLL 832 (967)
Q Consensus 802 ~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 832 (967)
.++|+|+.+.||+++.++.+.++||+.+..-
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 6899999999999998889999999887643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.57 E-value=0.023 Score=63.97 Aligned_cols=73 Identities=14% Similarity=0.076 Sum_probs=45.7
Q ss_pred CccCCCCceEEEEEEeCC-CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCce-eeeeeEEEcCCceeEEEEecCCCc
Q 002094 688 CELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNL-VALEGYYWTPSLQLLIYEFISSGS 765 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gs 765 (967)
+.|+.|-...+|++...+ ++.+++|+..... ...-+..+|..+++.+...++ .++++.+. + ..||||++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 457888889999998765 4788888774322 111112578888877754333 56666652 2 35999999855
Q ss_pred h
Q 002094 766 L 766 (967)
Q Consensus 766 L 766 (967)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.62 E-value=0.03 Score=62.25 Aligned_cols=73 Identities=12% Similarity=0.089 Sum_probs=46.0
Q ss_pred CccCCCCceEEEEEEeCC--------CcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCceeEEE
Q 002094 688 CELGRGGFGVVYRTILQD--------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.+..|....+|+....+ ++.|++|+..... ....+..+|.++++.+. +.-..++++.+ + -+.||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 356778888999998763 5788998864432 11122456777776663 22234555433 2 37899
Q ss_pred EecCCCch
Q 002094 759 EFISSGSL 766 (967)
Q Consensus 759 e~~~~gsL 766 (967)
||++|..+
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.40 E-value=0.25 Score=54.60 Aligned_cols=29 Identities=17% Similarity=0.299 Sum_probs=24.8
Q ss_pred cccCCCCCCCEEe------CCCCCeEEeecccccc
Q 002094 803 IIHYNLKSTNVLI------DSSGEPKVGDFGLARL 831 (967)
Q Consensus 803 ivH~Dik~~Nill------~~~~~~kl~Dfg~a~~ 831 (967)
++|+|+.+.||++ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999998763
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.11 E-value=0.48 Score=32.94 Aligned_cols=10 Identities=20% Similarity=0.265 Sum_probs=3.7
Q ss_pred HHHHHHHHHH
Q 002094 612 LIAIGAAAFI 621 (967)
Q Consensus 612 ii~i~~~~~~ 621 (967)
..|++.++++
T Consensus 13 A~gVVgGv~~ 22 (44)
T 2l2t_A 13 AAGVIGGLFI 22 (44)
T ss_dssp HHHHHHHHHH
T ss_pred EEeehHHHHH
Confidence 3333333333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 967 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-50 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-31 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-30 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-12 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-21 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-09 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-08 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 8e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 6e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 5e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 8e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 6e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 7e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-64
Identities = 72/275 (26%), Positives = 126/275 (45%), Gaps = 18/275 (6%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALEGY 747
+G G FG VY+ VA+K L V+ Q + F+ E+ L K RH N++ GY
Sbjct: 15 RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
P L ++ ++ SLY HLH ++ + +I A+G+ YLH +IIH +
Sbjct: 73 STAPQL-AIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKSIIHRD 129
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFAC--RTVKITEK 865
LKS N+ + K+GDFGLA + ++ ++ +MAPE + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 866 CDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEA 925
DVY FG+++ E++TG+ P + + ++ + RG L + ++
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK----------VRSNCP 239
Query: 926 IPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960
+ +L C + RP +++ +EL+ L
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-59
Identities = 68/266 (25%), Positives = 120/266 (45%), Gaps = 20/266 (7%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
LG G FG V+ VA+K L + S + F E + +++H LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL 808
+ +I E++ +GSL L S L+ + ++ +A+G+A++ N IH +L
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 809 KSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDV 868
++ N+L+ + K+ DFGLARL+ + + + + APE T K DV
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEA-INYGTFTIKSDV 193
Query: 869 YGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPV 928
+ FG+L+ E+VT R + V+ ++ RG R P + +
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG--------------YRMVRPDNCPEEL 239
Query: 929 IKLGLICASQVPSNRPDMEEVVNILE 954
+L +C + P +RP + + ++LE
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 8e-57
Identities = 79/277 (28%), Positives = 133/277 (48%), Gaps = 24/277 (8%)
Query: 690 LGRGGFGVVYRTILQDG-----RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+G G FG VY+ +L+ VAIK L K + DF E +G+ HHN++ L
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
EG ++I E++ +G+L K L + S Q ++ G+A G+ YL + N +
Sbjct: 75 EGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMNYV 132
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLP-MLDRCILSSKIQSALGYMAPEFACRTVKIT 863
H +L + N+L++S+ KV DFGL+R+L + +S + + + APE K T
Sbjct: 133 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA-ISYRKFT 191
Query: 864 EKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923
DV+ FG+++ EV+T + L + V ++ R P D
Sbjct: 192 SASDVWSFGIVMWEVMTYGERPYWE--------------LSNHEVMKAINDGFRLPTPMD 237
Query: 924 EAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSP 959
+ +L + C Q + RP ++V+IL+ LI++P
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-56
Identities = 73/266 (27%), Positives = 116/266 (43%), Gaps = 20/266 (7%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+LG+G FG V+ VAIK L + S E F +E + + K+RH LV L
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL 808
+ ++ E++S GSL L + + Q ++ +A G+AY+ N +H +L
Sbjct: 82 SEEPI-YIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMNYVHRDL 139
Query: 809 KSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDV 868
++ N+L+ + KV DFGLARL+ + + + + APE + T K DV
Sbjct: 140 RAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDV 197
Query: 869 YGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPV 928
+ FG+L+ E+ T R + VL D V+ R P + +
Sbjct: 198 WSFGILLTELTTKGRVPYPGMVNREVL--------------DQVERGYRMPCPPECPESL 243
Query: 929 IKLGLICASQVPSNRPDMEEVVNILE 954
L C + P RP E + LE
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (494), Expect = 2e-56
Identities = 63/295 (21%), Positives = 117/295 (39%), Gaps = 42/295 (14%)
Query: 689 ELGRGGFGVVYR------TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
++G G FG V++ + VA+K L Q DF++E + + + N+V
Sbjct: 20 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNC---------------------LSW 781
L G L++E+++ G L + L S LS
Sbjct: 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139
Query: 782 RQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841
++ I +A G+AYL +H +L + N L+ + K+ DFGL+R + D
Sbjct: 140 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD 199
Query: 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRG 901
+ +M PE + T + DV+ +GV++ E+ + Y V+ + G
Sbjct: 200 GNDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG 258
Query: 902 ALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956
+ P + + + L +C S++P++RP + IL+ +
Sbjct: 259 NILA--------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 4e-56
Identities = 69/269 (25%), Positives = 120/269 (44%), Gaps = 20/269 (7%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
E+G G FG+V+ + VAIK + + S+EDF +E + + K+ H LV L G
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL 808
+ L++EF+ G L +L + R + + L + +G+AYL +IH +L
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 809 KSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDV 868
+ N L+ + KV DFG+ R + D+ S+ + + + +PE + + K DV
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEV-FSFSRYSSKSDV 185
Query: 869 YGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPV 928
+ FGVL+ EV + + + V+ D+ G R P + V
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG--------------FRLYKPRLASTHV 231
Query: 929 IKLGLICASQVPSNRPDMEEVVNILELIQ 957
++ C + P +RP ++ L I
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 192 bits (488), Expect = 1e-55
Identities = 74/280 (26%), Positives = 120/280 (42%), Gaps = 20/280 (7%)
Query: 689 ELGRGGFGVVYRTILQD-GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+LG G +G VY + + +VA+K L E+F KE + +I+H NLV L G
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+I EF++ G+L +L + +R +S + ++ + YL N IH +
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 140
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCD 867
L + N L+ + KV DFGL+RL+ D + + + + APE K + K D
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 198
Query: 868 VYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIP 927
V+ FGVL+ E+ T D +V + ++ R P
Sbjct: 199 VWAFGVLLWEIATYGMSPYPGID--------------LSQVYELLEKDYRMERPEGCPEK 244
Query: 928 VIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEELE 967
V +L C PS+RP E+ E + +E+E
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 284
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 192 bits (488), Expect = 2e-55
Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 27/279 (9%)
Query: 690 LGRGGFGVVYRTIL----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALE 745
+G G FG V L + VAIK L K + DF E +G+ H N++ LE
Sbjct: 34 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 93
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
G + ++I EF+ +GSL L + + Q ++ G+A G+ YL N +H
Sbjct: 94 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--TVIQLVGMLRGIAAGMKYLADMNYVH 151
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALG---YMAPEFACRTVKI 862
+L + N+L++S+ KV DFGL+R L + + AP A + K
Sbjct: 152 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP-EAIQYRKF 210
Query: 863 TEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921
T DV+ +G+++ EV++ G+RP M + V+ + ++ R P
Sbjct: 211 TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI---------------NAIEQDYRLPPP 255
Query: 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSP 959
D + +L L C + ++RP ++VN L+ +I++P
Sbjct: 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-55
Identities = 65/267 (24%), Positives = 114/267 (42%), Gaps = 22/267 (8%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
ELG G FGVV + VAIK + + S+++F +E K + + H LV L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 749 WTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNL 808
+I E++++G L +L + R+ +Q + + + + YL +H +L
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 126
Query: 809 KSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDV 868
+ N L++ G KV DFGL+R + D S + + + PE K + K D+
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEV-LMYSKFSSKSDI 184
Query: 869 YGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIP 927
+ FGVL+ E+ + GK P E + + + LR P +
Sbjct: 185 WAFGVLMWEIYSLGKMPYERFTNS---------------ETAEHIAQGLRLYRPHLASEK 229
Query: 928 VIKLGLICASQVPSNRPDMEEVVNILE 954
V + C + RP + +++ +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-55
Identities = 69/290 (23%), Positives = 121/290 (41%), Gaps = 28/290 (9%)
Query: 683 LLNKDCELGRGGFGVVYRTILQ---DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH 739
LL D ELG G FG V + + + VAIK L E+ +E + + ++ +
Sbjct: 10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 69
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
+V L G +L +L+ E G L+K L R + ++ ++ G+ YL
Sbjct: 70 YIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE 126
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD-RCILSSKIQSALGYMAPEFACR 858
N +H +L + NVL+ + K+ DFGL++ L D S + L + APE
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC-IN 185
Query: 859 TVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917
K + + DV+ +GV + E ++ G++P + M+ V+ ++ R
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---------------AFIEQGKR 230
Query: 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE----LIQSPLDGQ 963
P + + L C +RPD V + + S ++G
Sbjct: 231 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-54
Identities = 64/271 (23%), Positives = 109/271 (40%), Gaps = 26/271 (9%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+G+G FG V G VA+K + + + F E + ++RH NLV L G
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 749 WTPSLQL-LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
L ++ E+++ GSL +L R+ L L + + + YL N +H +
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 128
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCD 867
L + NVL+ KV DFGL + + + + APE R K + K D
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEA-LREKKFSTKSD 182
Query: 868 VYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIP 927
V+ FG+L+ E+ + R V+ + +G + + P
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------YKMDAPDGCPPA 228
Query: 928 VIKLGLICASQVPSNRPDMEEVVNILELIQS 958
V ++ C + RP ++ LE I++
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (475), Expect = 2e-53
Identities = 72/296 (24%), Positives = 128/296 (43%), Gaps = 40/296 (13%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQ--EDFEKEMKTLGKIRHHNLVALE 745
E+G G FG VY +++ VAIKK++ SG ++ +D KE++ L K+RH N +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
G Y L+ E+ + + L + + G +GLAYLH N+IH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 138
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPE--FACRTVKIT 863
++K+ N+L+ G K+GDFG A ++ + + + +MAPE A +
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT------PYWMAPEVILAMDEGQYD 192
Query: 864 EKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923
K DV+ G+ +E+ K P+ + + + L + + + ++
Sbjct: 193 GKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIAQNESPALQSGHW----------SE 241
Query: 924 EAIPVIKLGLICASQVPSNRPDMEEVVN------------ILELIQSPLDGQEELE 967
+ C ++P +RP E ++ I++LIQ D EL+
Sbjct: 242 YFRNFVDS---CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELD 294
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 2e-53
Identities = 61/294 (20%), Positives = 109/294 (37%), Gaps = 32/294 (10%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+G+G FG V+R G VA+K + + E E+ +RH N++
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 749 WTPSLQL----LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH---- 800
+ L+ ++ GSL+ +L+ R ++ + L A GLA+LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 801 ----TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC--ILSSKIQSALGYMAPE 854
I H +LKS N+L+ +G + D GLA I + YMAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 855 FA-----CRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRG-----ALE 904
+ + ++ D+Y G++ E+ ED + D+V +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 905 DGRVEDCVDARLRGNFPADEAIP-VIKLGLICASQVPSNRPDMEEVVNILELIQ 957
E + + + + EA+ + K+ C + R + L +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-53
Identities = 64/275 (23%), Positives = 115/275 (41%), Gaps = 26/275 (9%)
Query: 686 KDCELGRGGFGVVYRTILQD---GRSVAIKKLTVSGLIKS-QEDFEKEMKTLGKIRHHNL 741
+D ELG G FG V + Q ++VA+K L + +++ E + ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
V + G S +L+ E G L K+L + + ++ ++ G+ YL +
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLL-PMLDRCILSSKIQSALGYMAPEFACRTV 860
N +H +L + NVL+ + K+ DFGL++ L + + + + + APE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC-INYY 185
Query: 861 KITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919
K + K DV+ FGVL+ E + G++P M+ V ++ R
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------------EVTAMLEKGERMG 230
Query: 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
PA + L +C + NRP V L
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-53
Identities = 57/264 (21%), Positives = 104/264 (39%), Gaps = 17/264 (6%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
LG G +G V + +VA+K + + + E+ +KE+ + H N+V G+
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
++Q L E+ S G L+ + + + G+ YLH I H +
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 128
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCD 867
+K N+L+D K+ DFGLA + +R L +K+ L Y+APE R E D
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 188
Query: 868 VYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIP 927
V+ G+++ ++ G+ P + D D + +
Sbjct: 189 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------DSAPLA 238
Query: 928 VIKLGLICASQVPSNRPDMEEVVN 951
++ + PS R + ++
Sbjct: 239 LLHK---ILVENPSARITIPDIKK 259
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 7e-53
Identities = 63/288 (21%), Positives = 104/288 (36%), Gaps = 36/288 (12%)
Query: 689 ELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NL 741
LG G FG V +VA+K L S + +E E+K L + +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHD---------------GSSRNCLSWRQRFN 786
V L G L+I E+ G L L L +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 787 IILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQS 846
+AKG+A+L N IH +L + N+L+ K+ DFGLAR + ++ +
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 847 ALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG 906
+ +MAPE T + DV+ +G+ + E+ + M++
Sbjct: 210 PVKWMAPES-IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE----- 263
Query: 907 RVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
R P + + C P RP +++V ++E
Sbjct: 264 --------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 9e-52
Identities = 69/292 (23%), Positives = 122/292 (41%), Gaps = 24/292 (8%)
Query: 683 LLNKDCELGRGGFGVVYRTILQDGRS----VAIKKLTVSGLIKSQEDFEKEMKTLGKIRH 738
+++ + +GRG FG VY L D A+K L I F E + H
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 739 HNLVALEGYYW-TPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAY 797
N+++L G + L++ ++ G L + + + + + L +AKG+ +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKF 145
Query: 798 LHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA--LGYMAPEF 855
L +H +L + N ++D KV DFGLAR + + + +K + + +MA E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915
+T K T K DV+ FGVL+ E++T P + + +++G
Sbjct: 206 -LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------------- 251
Query: 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEELE 967
R P P+ ++ L C RP E+V+ + I S G+ +
Sbjct: 252 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 302
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 69/266 (25%), Positives = 110/266 (41%), Gaps = 27/266 (10%)
Query: 689 ELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQ--EDFEKEMKTLGKIRHHNLVALE 745
LG+G FG VY Q +A+K L + L K+ +E++ +RH N++ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
GY+ + LI E+ G++Y+ L + ++ I +A L+Y H +IH
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKRVIH 129
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
++K N+L+ S+GE K+ DFG + P R + L Y+ PE EK
Sbjct: 130 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMI-EGRMHDEK 184
Query: 866 CDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEA 925
D++ GVL E + GK P + + + R+ FP
Sbjct: 185 VDLWSLGVLCYEFLVGKPP--FEANTYQETYKRIS--------------RVEFTFPDFVT 228
Query: 926 IPVIKLGLICASQVPSNRPDMEEVVN 951
L PS RP + EV+
Sbjct: 229 EGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 68/276 (24%), Positives = 113/276 (40%), Gaps = 24/276 (8%)
Query: 689 ELGRGGFGVVYRTIL----QDGRSVAIKKLTVSGLIKSQ--EDFEKEMKTLGKIRHHNLV 742
+LG G FGVV R SVA+K L L + + +DF +E+ + + H NL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
L G TP + ++ E GSL L + +A+G+ YL
Sbjct: 75 RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYLESKR 131
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM-LDRCILSSKIQSALGYMAPEFACRTVK 861
IH +L + N+L+ + K+GDFGL R LP D ++ + + AP + +T
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP-ESLKTRT 190
Query: 862 ITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921
+ D + FGV + E+ T + + +L + + R EDC
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD------- 243
Query: 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957
+ + + C + P +RP + + L Q
Sbjct: 244 ------IYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-50
Identities = 58/293 (19%), Positives = 102/293 (34%), Gaps = 41/293 (13%)
Query: 689 ELGRGGFGVVYRTILQD------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NL 741
LG G FG V VA+K L +E E+K + ++ H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 742 VALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSR--------------------NCLSW 781
V L G LI+E+ G L +L + N L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 782 RQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841
+AKG+ +L + +H +L + NVL+ K+ DFGLAR + ++
Sbjct: 164 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR 223
Query: 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRG 901
+ + +MAPE T K DV+ +G+L+ E+ + +++
Sbjct: 224 GNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN 282
Query: 902 ALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
+ + P + + C + RP + + L
Sbjct: 283 -------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 2e-50
Identities = 65/284 (22%), Positives = 117/284 (41%), Gaps = 28/284 (9%)
Query: 689 ELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLV 742
ELG+G FG+VY + + VAIK + + ++ + +F E + + H++V
Sbjct: 27 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLH-------DGSSRNCLSWRQRFNIILGMAKGL 795
L G L+I E ++ G L +L + S + + +A G+
Sbjct: 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146
Query: 796 AYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEF 855
AYL+ +H +L + N ++ K+GDFG+ R + D K + +M+PE
Sbjct: 147 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 206
Query: 856 ACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915
+ T DV+ FGV++ E+ T + VL ++ G L D
Sbjct: 207 L-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---------- 255
Query: 916 LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959
P + + +L +C P RP E+++ ++ P
Sbjct: 256 ----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 4e-50
Identities = 55/279 (19%), Positives = 118/279 (42%), Gaps = 14/279 (5%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
ELG G GVV++ + G +A K + + + +E++ L + +V G
Sbjct: 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN-IIHY 806
+++ + E + GSL + L + + + + + KGL YL + I+H
Sbjct: 73 FYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
++K +N+L++S GE K+ DFG++ L +++ YM+PE + + +
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPE-RLQGTHYSVQS 184
Query: 867 DVYGFGVLVLEVVTGKRPV--EYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADE 924
D++ G+ ++E+ G+ P+ ++ ++ V G + R ++ D
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 925 AIP--VIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961
P + +L ++ P P + + + L
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 5e-50
Identities = 63/278 (22%), Positives = 122/278 (43%), Gaps = 26/278 (9%)
Query: 689 ELGRGGFGVVYR-TILQDGRS----VAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVA 743
LG G FG VY+ + +G VAIK+L + K+ ++ E + + + ++
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 744 LEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
L G T ++ LI + + G L ++ + ++ + + N + +AKG+ YL +
Sbjct: 76 LLGICLTSTV-QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRRL 132
Query: 804 IHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
+H +L + NVL+ + K+ DFGLA+LL ++ + + + +MA E T
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI-LHRIYT 191
Query: 864 EKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922
+ DV+ +GV V E++T G +P + + + ++ R P
Sbjct: 192 HQSDVWSYGVTVWELMTFGSKPYDGIPAS---------------EISSILEKGERLPQPP 236
Query: 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQSP 959
I V + + C +RP E++ + + P
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-49
Identities = 56/273 (20%), Positives = 106/273 (38%), Gaps = 28/273 (10%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALEG 746
+G G +G + DG+ + K+L + +++ + E+ L +++H N+V
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 747 YYW--TPSLQLLIYEFISSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLH---- 799
T + ++ E+ G L + G+ R L ++ + L H
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 800 -HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR 858
++H +LK NV +D K+GDFGLAR+L + YM+PE
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYMSPEQ-MN 187
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918
+ EK D++ G L+ E+ P + G++ + R+
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-----------GKIREGKFRRIPY 236
Query: 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951
+ DE +I + +RP +EE++
Sbjct: 237 RYS-DELNEIITR---MLNLKDYHRPSVEEILE 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-48
Identities = 54/268 (20%), Positives = 98/268 (36%), Gaps = 23/268 (8%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
ELG G FG VY+ + A K + + ED+ E+ L H N+V L
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
++ + ++ EF + G++ + + L+ Q + L YLH IIH +
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNKIIHRD 135
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFA----CRTVKIT 863
LK+ N+L G+ K+ DFG++ +MAPE +
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193
Query: 864 EKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923
K DV+ G+ ++E+ + P + + + VL + +
Sbjct: 194 YKADVWSLGITLIEMAEIEPPH-HELNPMRVLLKIAKSEPPTLAQPSRWS---------S 243
Query: 924 EAIPVIKLGLICASQVPSNRPDMEEVVN 951
+K C + R +++
Sbjct: 244 NFKDFLKK---CLEKNVDARWTTSQLLQ 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-48
Identities = 68/274 (24%), Positives = 117/274 (42%), Gaps = 31/274 (11%)
Query: 687 DCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVAL 744
D E+GRG F VY+ + + VA +L L KS+ + F++E + L ++H N+V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 745 EGYYWTPSLQ----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH- 799
+ + +L+ E ++SG+L +L + + + + KGL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 800 -HTNIIHYNLKSTNVLIDS-SGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFAC 857
IIH +LK N+ I +G K+GD GLA L + + +MAPE
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYE 186
Query: 858 RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917
K E DVY FG+ +LE+ T + P ++ + + G
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-------------VKP 231
Query: 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951
+F V ++ C Q R +++++N
Sbjct: 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 6e-48
Identities = 63/285 (22%), Positives = 110/285 (38%), Gaps = 35/285 (12%)
Query: 689 ELGRGGFGVVYRTILQDG---RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVAL 744
+G G FG V + ++ AIK++ DF E++ L K+ HH N++ L
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLH-------------DGSSRNCLSWRQRFNIILGM 791
G L E+ G+L L S+ + LS +Q + +
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 792 AKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYM 851
A+G+ YL IH +L + N+L+ + K+ DFGL+R + + + + + +M
Sbjct: 137 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWM 193
Query: 852 APEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911
A E T DV+ +GVL+ E+V+ + + +G
Sbjct: 194 AIES-LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---------- 242
Query: 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956
R P + V L C + P RP +++ L +
Sbjct: 243 ----YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-47
Identities = 51/264 (19%), Positives = 106/264 (40%), Gaps = 22/264 (8%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
++G+G G VY + + G+ VAI+++ + K +E E+ + + ++ N+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 85
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
Y ++ E+++ GSL + C+ Q + + L +LH +IH +
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCD 867
+KS N+L+ G K+ DFG + S + +MAPE K D
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEV-VTRKAYGPKVD 198
Query: 868 VYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAIP 927
++ G++ +E++ G+ P E+ + L + + + + +
Sbjct: 199 IWSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGTPELQNPEKLS---------AIFRD 248
Query: 928 VIKLGLICASQVPSNRPDMEEVVN 951
+ C R +E++
Sbjct: 249 FLNR---CLDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 4e-47
Identities = 69/292 (23%), Positives = 112/292 (38%), Gaps = 37/292 (12%)
Query: 689 ELGRGGFGVVYRTIL--------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH- 739
LG G FG V VA+K L K D EM+ + I H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHLH-------------DGSSRNCLSWRQRFN 786
N++ L G +I E+ S G+L ++L + LS + +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 787 IILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQS 846
+A+G+ YL IH +L + NVL+ K+ DFGLAR + +D ++ +
Sbjct: 140 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199
Query: 847 ALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG 906
+ +MAPE T + DV+ FGVL+ E+ T +
Sbjct: 200 PVKWMAPEA-LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF----------- 247
Query: 907 RVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958
+ R + P++ + + C VPS RP +++V L+ I +
Sbjct: 248 ---KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 4e-47
Identities = 68/272 (25%), Positives = 109/272 (40%), Gaps = 23/272 (8%)
Query: 689 ELGRGGFGVVYRTIL----QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVAL 744
+G G FG V++ I +VAIK +E F +E T+ + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
G + +I E + G L L L ++ LAYL +
Sbjct: 74 IGVITENPV-WIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESKRFV 130
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITE 864
H ++ + NVL+ S+ K+GDFGL+R + +SK + + +MAPE + T
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPES-INFRRFTS 188
Query: 865 KCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADE 924
DV+ FGV + E++ + V+ GR+E+ + N P
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----------GRIENGERLPMPPNCPPT- 237
Query: 925 AIPVIKLGLICASQVPSNRPDMEEVVNILELI 956
+ L C + PS RP E+ L I
Sbjct: 238 ---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-46
Identities = 73/292 (25%), Positives = 109/292 (37%), Gaps = 36/292 (12%)
Query: 689 ELGRGGFGVVYRTI------LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NL 741
LGRG FG V R+VA+K L E+K L I HH N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 742 VALEGYYWTPSLQLLI-YEFISSGSLYKHLH-------------DGSSRNCLSWRQRFNI 787
V L G P L++ EF G+L +L + ++ L+
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 788 ILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSA 847
+AKG+ +L IH +L + N+L+ K+ DFGLAR + + +
Sbjct: 140 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 199
Query: 848 LGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR 907
L +MAPE T + DV+ FGVL+ E+ + C ++
Sbjct: 200 LKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK------- 251
Query: 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE-LIQS 958
R P + + L C PS RP E+V L L+Q+
Sbjct: 252 ------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 2e-46
Identities = 53/277 (19%), Positives = 97/277 (35%), Gaps = 29/277 (10%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQ--EDFEKEMKTLGKIRHHNLVALE 745
LG G F V L R AIK L +IK +E + ++ H V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
+ + +G L K++ + L YLH IIH
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKGIIH 131
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
+LK N+L++ ++ DFG A++L + ++ Y++PE +
Sbjct: 132 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL-LTEKSACKS 190
Query: 866 CDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD-- 923
D++ G ++ ++V G P + + ++ + +L +FP
Sbjct: 191 SDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKII--------------KLEYDFPEKFF 234
Query: 924 -EAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959
+A +++ + R EE+ L P
Sbjct: 235 PKARDLVEK---LLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (421), Expect = 8e-46
Identities = 64/266 (24%), Positives = 112/266 (42%), Gaps = 22/266 (8%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
ELG G FGVV+R T G + A K + +E KE++T+ +RH LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+ + ++IYEF+S G L++ + D N +S + + + KGL ++H N +H +
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLD 149
Query: 808 LKSTNVLIDS--SGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
LK N++ + S E K+ DFGL LD + APE +
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYY 205
Query: 866 CDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEA 925
D++ GVL +++G P + ++ V+ + +D ++
Sbjct: 206 TDMWSVGVLSYILLSGLSP--FGGENDDETLRNVK------SCDWNMDDSAFSGIS-EDG 256
Query: 926 IPVIKLGLICASQVPSNRPDMEEVVN 951
I+ P+ R + + +
Sbjct: 257 KDFIRK---LLLADPNTRMTIHQALE 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 6e-44
Identities = 57/282 (20%), Positives = 120/282 (42%), Gaps = 21/282 (7%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+G G +G+V + VAIKK++ + +E+K L + RH N++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
P+++ + ++ + + L+ LS + + +GL Y+H N++H +
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 134
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLL-PMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
LK +N+L++++ + K+ DFGLAR+ P D ++ + Y APE + T+
Sbjct: 135 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 194
Query: 867 DVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG------NF 920
D++ G ++ E+++ + + + + + G L ED +
Sbjct: 195 DIWSVGCILAEMLSNRPI--FPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 252
Query: 921 PADEAIPVIKLGLICASQV-----------PSNRPDMEEVVN 951
P +P +L S+ P R ++E+ +
Sbjct: 253 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 7e-43
Identities = 57/266 (21%), Positives = 116/266 (43%), Gaps = 23/266 (8%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+LGRG FG+V+R + ++ K + V G Q +KE+ L RH N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHES 69
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+ + ++I+EFIS +++ ++ + L+ R+ + + + + L +LH NI H++
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHSHNIGHFD 127
Query: 808 LKSTNVLIDSSGEP--KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
++ N++ + K+ +FG AR L D + +A Y APE + ++
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPE-VHQHDVVSTA 183
Query: 866 CDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEA 925
D++ G LV +++G P ++ + + + + E D EA
Sbjct: 184 TDMWSLGTLVYVLLSGINP--FLAETNQQIIENIM------NAEYTFDEEAFKEIS-IEA 234
Query: 926 IPVIKLGLICASQVPSNRPDMEEVVN 951
+ + + +R E +
Sbjct: 235 MDFVDR---LLVKERKSRMTASEALQ 257
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (391), Expect = 1e-42
Identities = 59/279 (21%), Positives = 109/279 (39%), Gaps = 23/279 (8%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALEGY 747
++G G +GVVY+ G + A+KK+ + + +E+ L +++H N+V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
T +L++E + L + +L + G+AY H ++H +
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRD 125
Query: 808 LKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCD 867
LK N+LI+ GE K+ DFGLAR + R + L Y AP+ + K + D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--LWYRAPDVLMGSKKYSTTID 183
Query: 868 VYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD----ARLRGNFPAD 923
++ G + E+V G + + L ++ + + NF
Sbjct: 184 IWSVGCIFAEMVNGTPL--FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 924 EAIPVIKLG---------LI--CASQVPSNRPDMEEVVN 951
E +P L+ P+ R ++ +
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 3e-42
Identities = 62/267 (23%), Positives = 110/267 (41%), Gaps = 23/267 (8%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
LG G F V + + VAIK + L + E E+ L KI+H N+VAL+
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
Y + LI + +S G L+ + + + + R +I + + YLH I+H +
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLGIVHRD 132
Query: 808 LKSTNVLI---DSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITE 864
LK N+L D + + DFGL+++ D + S GY+AP ++
Sbjct: 133 LKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAP-EVLAQKPYSK 188
Query: 865 KCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADE 924
D + GV+ ++ G P + +++ L + + + E D+ + D
Sbjct: 189 AVDCWSIGVIAYILLCGYPP--FYDENDAKLFEQIL------KAEYEFDSPYWDDIS-DS 239
Query: 925 AIPVIKLGLICASQVPSNRPDMEEVVN 951
A I+ + P R E+ +
Sbjct: 240 AKDFIRH---LMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (389), Expect = 2e-41
Identities = 62/266 (23%), Positives = 111/266 (41%), Gaps = 22/266 (8%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
ELG G FGVV+R + GR K + + + E+ + ++ H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+ +LI EF+S G L+ + + +S + N + +GL ++H +I+H +
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHEHSIVHLD 152
Query: 808 LKSTNVLIDS--SGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
+K N++ ++ + K+ DFGLA L + + + APE R +
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDRE-PVGFY 208
Query: 866 CDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEA 925
D++ GVL +++G P EDD+ L ++ R E D + EA
Sbjct: 209 TDMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKRCDWE-------FDEDAFSSVS-PEA 259
Query: 926 IPVIKLGLICASQVPSNRPDMEEVVN 951
IK + P R + + +
Sbjct: 260 KDFIKN---LLQKEPRKRLTVHDALE 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (379), Expect = 5e-41
Identities = 60/280 (21%), Positives = 114/280 (40%), Gaps = 37/280 (13%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKS--------QEDFEKEMKTLGKIR-H 738
LGRG VV R I + A+K + V+G +E KE+ L K+ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 739 HNLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
N++ L+ Y T + L+++ + G L+ +L + + LS ++ I+ + + + L
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICAL 126
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFAC- 857
H NI+H +LK N+L+D K+ DFG + L ++ ++ Y+APE
Sbjct: 127 HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIEC 183
Query: 858 ----RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913
++ D++ GV++ ++ G P + +++ M+ +
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQMLMLRMI------------MS 229
Query: 914 ARLRGNFPADEAIPVIKLGLI--CASQVPSNRPDMEEVVN 951
+ P + L+ P R EE +
Sbjct: 230 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 9e-40
Identities = 60/283 (21%), Positives = 110/283 (38%), Gaps = 29/283 (10%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYY 748
+G G FGVVY+ + G VAIKK+ ++ + +E++ + K+ H N+V L ++
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 749 WTPSLQ------LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
++ + L+ +++ H ++ L + + + LAY+H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 803 IIHYNLKSTNVLIDSSGE-PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVK 861
I H ++K N+L+D K+ DFG A+ L + + + Y APE
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPELIFGATD 199
Query: 862 ITEKCDVYGFGVLVLEVVTGKRP-VEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920
T DV+ G ++ E++ G+ D +V V G ++ + F
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 259
Query: 921 PADEAIPVIKLGLICASQV------------PSNRPDMEEVVN 951
P +A P K+ P+ R E
Sbjct: 260 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 60/279 (21%), Positives = 109/279 (39%), Gaps = 21/279 (7%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALEG 746
++G G +GVVY+ G VA+KK+ + + +E+ L ++ H N+V L
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
T + L++EF+ D S+ + + + + +GLA+ H ++H
Sbjct: 69 VIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
+LK N+LI++ G K+ DFGLAR + R + L Y APE +
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT--LWYRAPEILLGCKYYSTAV 184
Query: 867 DVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGAL---EDGRVEDCVDARLRGNFPAD 923
D++ G + E+VT + + ++ L + R E + +FP
Sbjct: 185 DIWSLGCIFAEMVTRRALFPG-DSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 924 EAIPVIKLGLICASQV-----------PSNRPDMEEVVN 951
K+ P+ R + +
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-39
Identities = 51/271 (18%), Positives = 103/271 (38%), Gaps = 28/271 (10%)
Query: 690 LGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALEGY 747
LG G G V + + A+K ++ +E++ + ++V +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKM------LQDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 748 YWTPSLQ----LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNI 803
Y L++ E + G L+ + D + + R+ I+ + + + YLH NI
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSINI 132
Query: 804 IHYNLKSTNVLIDSSGEP---KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTV 860
H ++K N+L S K+ DFG A+ + Y+APE
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPE- 188
Query: 861 KITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920
K + CD++ GV++ ++ G P + + + + ++ + G+ E
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQYE--FPNPEWSEV 244
Query: 921 PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951
+E +I+ P+ R + E +N
Sbjct: 245 S-EEVKMLIRN---LLKTEPTQRMTITEFMN 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-38
Identities = 59/279 (21%), Positives = 106/279 (37%), Gaps = 22/279 (7%)
Query: 690 LGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQED----FEKEMKTLGKIRHHNLVAL 744
LG G F VY+ + VAIKK+ + ++++ +E+K L ++ H N++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
+ S L+++F+ + + L+ +L +GL YLH I+
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITE 864
H +LK N+L+D +G K+ DFGLA+ + Y APE
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 865 KCDVYGFGVLVLEVVTGKRPVEYMED-DVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923
D++ G ++ E++ + D D + G + + D F +
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240
Query: 924 EAIPVIKLG---------LI--CASQVPSNRPDMEEVVN 951
IP+ + LI P R + +
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-38
Identities = 57/279 (20%), Positives = 102/279 (36%), Gaps = 21/279 (7%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALEG 746
++G G +G V++ + VA+K++ + + +E+ L +++H N+V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ L++EF L + + + KGL + H N++H
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
+LK N+LI+ +GE K+ +FGLAR + RC S L Y P+ +
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 867 DVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEAI 926
D++ G + E+ RP+ D L + R + +L P
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 927 PVIKLGLI--------------CASQVPSNRPDMEEVVN 951
L + P R EE +
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 142 bits (360), Expect = 2e-38
Identities = 59/279 (21%), Positives = 111/279 (39%), Gaps = 25/279 (8%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQ--EDFEKEMKTLGKIRHHNLVALE 745
LG GG V+ L+ R VA+K L F +E + + H +VA+
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 746 GYYWTPS----LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT 801
+ L ++ E++ +L +H ++ ++ +I + L + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQN 130
Query: 802 NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM-LDRCILSSKIQSALGYMAPEFACRTV 860
IIH ++K N++I ++ KV DFG+AR + + ++ + Y++PE A R
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA-RGD 189
Query: 861 KITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNF 920
+ + DVY G ++ EV+TG+ P V + + + + A L
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD--- 246
Query: 921 PADEAIPVIKLGLICASQVPSNRP-DMEEVVNILELIQS 958
+ L ++ P NR E+ L + +
Sbjct: 247 ---------AVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 145 bits (367), Expect = 2e-38
Identities = 46/202 (22%), Positives = 79/202 (39%), Gaps = 13/202 (6%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQED-----FEKEMKTLGKIRHHNLV 742
+GRGGFG VY G+ A+K L + Q + + + +V
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
+ + TP I + ++ G L+ HL S + GL ++H+
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF 127
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKI 862
+++ +LK N+L+D G ++ D GLA GYMAPE + V
Sbjct: 128 VVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQKGVAY 183
Query: 863 TEKCDVYGFGVLVLEVVTGKRP 884
D + G ++ +++ G P
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSP 205
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 68/288 (23%), Positives = 113/288 (39%), Gaps = 38/288 (13%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGL-----IKSQEDFEKEMKTLGKIR--HHN 740
LG GGFG VY I + D VAIK + + + + E+ L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
++ L ++ P +LI E + R L + + + + + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 801 TNIIHYNLKSTNVLIDSS-GEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRT 859
++H ++K N+LID + GE K+ DFG LL + + Y PE+
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYH 184
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919
V+ G+L+ ++V G P E+ E +++RG + R
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQVF-----------FRQR 226
Query: 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQEELE 967
E +I+ C + PS+RP EE+ N +Q L QE E
Sbjct: 227 VS-SECQHLIRW---CLALRPSDRPTFEEIQN-HPWMQDVLLPQETAE 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (356), Expect = 8e-38
Identities = 43/275 (15%), Positives = 88/275 (32%), Gaps = 23/275 (8%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
++G G FG +Y + G VAIK V E K ++ + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVK---TKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
++ + SL + S + S + + M + Y+H N IH +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSKNFIHRD 128
Query: 808 LKSTNVLIDSSGEPKV---GDFGLARLLP-----MLDRCILSSKIQSALGYMAPEFACRT 859
+K N L+ + + DFGLA+ + + Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN-THLG 187
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919
++ + + D+ G +++ G P + ++ + + L
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK----RQKYERISEKKMSTPIEVLCKG 243
Query: 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
+P E + C S ++PD + +
Sbjct: 244 YP-SEFATYLNF---CRSLRFDDKPDYSYLRQLFR 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 6e-37
Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 12/216 (5%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQ--EDFEKEMKTLGK-IRHHNLVAL 744
LG+G FG V+ + + AIK L ++ E E + L H L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 745 EGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
+ T + E+++ G L H+ S + + + GL +LH I+
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKGIV 125
Query: 805 HYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITE 864
+ +LK N+L+D G K+ DFG+ + + D ++ Y+APE K
Sbjct: 126 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEI-LLGQKYNH 182
Query: 865 KCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVR 900
D + FGVL+ E++ G+ P + D L +R
Sbjct: 183 SVDWWSFGVLLYEMLIGQSP--FHGQDEEELFHSIR 216
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 63/284 (22%), Positives = 108/284 (38%), Gaps = 26/284 (9%)
Query: 689 ELGRGGFGVVY--RTILQDGRSVAIKKLTVS----GLIKSQEDFEKEMKTLGKIRHHNLV 742
E+G G +G V+ R + GR VA+K++ V G+ S ++ L H N+V
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYK---HLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
L + + + D + +++ + +GL +LH
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRT 859
++H +LK N+L+ SSG+ K+ DFGLAR+ + + L Y APE
Sbjct: 134 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRAPEV-LLQ 189
Query: 860 VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL-RG 918
D++ G + E+ K DV L ++ G + D L R
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248
Query: 919 NFPADEAIPVIKLG---------LI--CASQVPSNRPDMEEVVN 951
F + A P+ K L+ C + P+ R ++
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 137 bits (347), Expect = 2e-36
Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 14/215 (6%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQ--EDFEKEMKTLGKIRHHNLVALE 745
LG G FG V+ +GR A+K L +++ + E E L + H ++ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
G + +I ++I G L+ L + L YLH +II+
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKDIIY 127
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
+LK N+L+D +G K+ DFG A+ +P + + Y+APE T +
Sbjct: 128 RDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV-VSTKPYNKS 181
Query: 866 CDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVR 900
D + FG+L+ E++ G P + + + + + +
Sbjct: 182 IDWWSFGILIYEMLAGYTP--FYDSNTMKTYEKIL 214
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 9e-36
Identities = 58/273 (21%), Positives = 109/273 (39%), Gaps = 29/273 (10%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQ-----EDFEKEMKTLGKIRHHNLV 742
ELG G F VV + G A K + S+ ED E+E+ L +I+H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 743 ALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
L Y + +LI E ++ G L+ L + + L+ + + + G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ 133
Query: 803 IIHYNLKSTNVLIDSSGEP----KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACR 858
I H++LK N+++ P K+ DFGLA + + I ++APE
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEI-VN 189
Query: 859 TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918
+ + D++ GV+ +++G P ++ D V V+
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSA----------VNYEFED 237
Query: 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951
+ ++ + + P R +++ +
Sbjct: 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (334), Expect = 7e-35
Identities = 44/278 (15%), Positives = 92/278 (33%), Gaps = 27/278 (9%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGY 747
+G G FGV++ T L + + VAIK E +T + + Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR---SDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYN 807
+ L ++ + SL L S + M + +H ++++ +
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD 126
Query: 808 LKSTNVLIDS-----SGEPKVGDFGLARLL--PMLDRCILSSKIQSALG---YMAPEFAC 857
+K N LI + V DFG+ + P+ + I + ++ G YM+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN-TH 185
Query: 858 RTVKITEKCDVYGFGVLVLEVVTGKRPVEYM-EDDVVVLCDMVRGALEDGRVEDCVDARL 916
+ + + D+ G + + + G P + + + + + + + L
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE-----L 240
Query: 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954
FP K + PD + + +
Sbjct: 241 CAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 9e-35
Identities = 56/283 (19%), Positives = 100/283 (35%), Gaps = 27/283 (9%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALEG 746
+G G +G V + + G VAIKKL + + +E++ L +RH N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDG-SSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
+ +F L + ++ M KGL Y+H IIH
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIH 144
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
+LK N+ ++ E K+ DFGLAR + Y APE ++ T+
Sbjct: 145 RDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQT 199
Query: 866 CDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPADEA 925
D++ G ++ E++TGK + D + + E + +
Sbjct: 200 VDIWSVGCIMAEMITGKTL--FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
Query: 926 IPVIK---------------LGLI--CASQVPSNRPDMEEVVN 951
+P ++ + L+ R E +
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-34
Identities = 48/208 (23%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 689 ELGRGGFGVVYR-TILQDGRSVAIKKLTVSGLIKS-QEDFEKEMKTLGKIRHHNLVALEG 746
++G+G FG V++ + G+ VA+KK+ + + +E+K L ++H N+V L
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 747 YYWTPSLQ--------LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYL 798
T + L+++F + + + ++ + GL Y+
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYI 133
Query: 799 HHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML--DRCILSSKIQSALGYMAPEFA 856
H I+H ++K+ NVLI G K+ DFGLAR + + + L Y PE
Sbjct: 134 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 857 CRTVKITEKCDVYGFGVLVLEVVTGKRP 884
D++G G ++ E+ T
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (331), Expect = 6e-34
Identities = 50/199 (25%), Positives = 81/199 (40%), Gaps = 12/199 (6%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQ--EDFEKEMKTLGKIRHHNLVALE 745
LG G FG V + G A+K L ++K + E E + L + LV LE
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
+ S ++ E+++ G ++ HL S + YLH ++I+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
+LK N+LID G +V DFG A+ + + +APE + +
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI-ILSKGYNKA 218
Query: 866 CDVYGFGVLVLEVVTGKRP 884
D + GVL+ E+ G P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 49/199 (24%), Positives = 80/199 (40%), Gaps = 9/199 (4%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQE--DFEKEMKTLGKIRHHNLVALE 745
LG+G FG V GR A+K L +I E E + L RH L AL+
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 746 GYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIH 805
+ T + E+ + G L+ HL + + + L YLH ++++
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRDVVY 128
Query: 806 YNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEK 865
++K N+++D G K+ DFGL + Y+AP
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAP-EVLEDNDYGRA 185
Query: 866 CDVYGFGVLVLEVVTGKRP 884
D +G GV++ E++ G+ P
Sbjct: 186 VDWWGLGVVMYEMMCGRLP 204
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 11/204 (5%)
Query: 689 ELGRGGFGVVYR----TILQDGRSVAIKKLTVSGLI---KSQEDFEKEMKTLGKIRHH-N 740
LG G +G V+ + G+ A+K L + ++ K+ E E + L IR
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 741 LVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH 800
LV L + T + LI ++I+ G L+ HL R + + + + L +LH
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK 147
Query: 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTV 860
II+ ++K N+L+DS+G + DFGL++ + +
Sbjct: 148 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 207
Query: 861 KITEKCDVYGFGVLVLEVVTGKRP 884
+ D + GVL+ E++TG P
Sbjct: 208 GHDKAVDWWSLGVLMYELLTGASP 231
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (309), Expect = 3e-31
Identities = 42/217 (19%), Positives = 88/217 (40%), Gaps = 18/217 (8%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHH-NLVALEG 746
+LGRG + V+ I + + V +K L ++ ++E+K L +R N++ L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLAD 97
Query: 747 YYWTPSLQL--LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNII 804
P + L++E +++ + L+ + + K L Y H I+
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMGIM 151
Query: 805 HYNLKSTNVLIDSSG-EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKIT 863
H ++K NV+ID + ++ D+GLA + ++ + PE
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYD 208
Query: 864 EKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVR 900
D++ G ++ ++ K P + D+ L + +
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 120 bits (300), Expect = 3e-30
Identities = 76/310 (24%), Positives = 112/310 (36%), Gaps = 16/310 (5%)
Query: 27 DDVLGLIVFKAGLEDPKEKLTSWSEDDDNPCN--WVGVKCDPKTK--RVVGLTLDGFSLS 82
D L+ K L +P L+SW D CN W+GV CD T+ RV L L G +L
Sbjct: 6 QDKQALLQIKKDLGNPT-TLSSWLPTTD-CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 83 G--HIGRGLLRLQFLQVLSLSNN-NFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFR 139
I L L +L L + N G I +A L + + N +F
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN-VSGAIPDFLS 122
Query: 140 QCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQ--SLDL 197
Q +L + F+ N L+G +P S+S +L + F NR+SG +P L
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 198 SNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDS 257
N L + A + G +
Sbjct: 183 RNRL---TGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 258 LQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNI 317
+ + + L L+ N G +P + +L L SL++S N G IP GNL
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAY 298
Query: 318 SMNQFTGGLP 327
+ N+ G P
Sbjct: 299 ANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 91.0 bits (224), Expect = 2e-20
Identities = 54/280 (19%), Positives = 94/280 (33%), Gaps = 9/280 (3%)
Query: 271 GNSFTGEVPDWIGKLANLESLDLSLNQFSGR--IPSSIGNLVFLKELNISMN-QFTGGLP 327
++ G + D + + +LDLS IPSS+ NL +L L I G +P
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 328 ESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQG 387
++ L + ++ N+ I Q +L + + S
Sbjct: 95 PAIAKLTQLHYLYITHT----NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 388 LQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLN 447
L + N +SG IP + G S L + +D S N
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM-L 209
Query: 448 GTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSN 507
+ G+ + ++ +L L L N + G +P + L
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269
Query: 508 LKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELP 547
L +++SFN+L G +P + NL ++N P
Sbjct: 270 LHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-30
Identities = 46/202 (22%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEG 746
+G G +G V + G VA+KKL+ I + +E++ L ++H N++ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 747 YYWTPS----LQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN 802
+ + G+ ++ L+ +I + +GL Y+H +
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 803 IIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKI 862
IIH +LK +N+ ++ E K+ DFGLAR + Y APE +
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-----YVATRWYRAPEIMLNWMHY 196
Query: 863 TEKCDVYGFGVLVLEVVTGKRP 884
+ D++ G ++ E++TG+
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 5e-28
Identities = 46/215 (21%), Positives = 85/215 (39%), Gaps = 7/215 (3%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQ-EDFEKEMKTLGKIRHHNLVALEG 746
+G G G+V R+VAIKKL+ ++ + +E+ + + H N+++L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 747 YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHY 806
+ + L + L + ++ M G+ +LH IIH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 143
Query: 807 NLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKC 866
+LK +N+++ S K+ DFGLAR + + Y APE + E
Sbjct: 144 DLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEV-ILGMGYKENV 199
Query: 867 DVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRG 901
D++ G ++ E+V K D + ++
Sbjct: 200 DIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQ 233
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 113 bits (284), Expect = 1e-27
Identities = 82/409 (20%), Positives = 159/409 (38%), Gaps = 40/409 (9%)
Query: 132 LIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRS 191
+ D + ++ V N+T + S + + ++ + + G+ +L +
Sbjct: 15 IFTDTALAEK--MKTV-LGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SID-GVEYLNN 67
Query: 192 LQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLS 251
L ++ SNN L + NL L I + N+ + P L +
Sbjct: 68 LTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDI 125
Query: 252 GSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVF 311
L + N+ I L+ L SL + NL
Sbjct: 126 DPLKNLTNLNRLEL----SSNTI-----SDISALSGLTSLQQLSFGNQVTDLKPLANLTT 176
Query: 312 LKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGE 371
L+ L+IS N+ + + + L + N+++ P I L +SL+GN+L +
Sbjct: 177 LERLDISSNKVSDISVLAKLTNLESL--IATNNQISDITPLGILTN-LDELSLNGNQLKD 233
Query: 372 SMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIG 431
+ AS+ + L LDL++N +S + P + L+ L L + N + P +
Sbjct: 234 ---IGTLASLTN----LTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LA 282
Query: 432 KLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQ 491
L A+ L+ ++N L P +L L L N +S P + + + L L +
Sbjct: 283 GLTALTNLELNENQLEDISPISN--LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFAN 338
Query: 492 NNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHN 540
N ++ +++ANL+N+ ++ N +S + P L NL+ + ++
Sbjct: 339 NKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 99.3 bits (246), Expect = 8e-23
Identities = 71/371 (19%), Positives = 138/371 (37%), Gaps = 47/371 (12%)
Query: 211 SNLYDLRAIKLGKNKFSGQLP-EDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSL 269
+ L + LGK + + D+ + L+ G+ S+ G ++ LN+ + ++
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 73
Query: 270 KGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIP-----SSIGNLVFLKELNISMNQFTG 324
N T P + L L + ++ NQ + P + G +F ++
Sbjct: 74 SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131
Query: 325 GLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDS 384
+ N ++ + + LT L+ E + S S
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191
Query: 385 YQGL----QVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLD 440
+ L ++N +S + P I ++L L+++ N L ++ L + LD
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 441 FSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIP--------------------SQIKN 480
++N ++ P + G L ELKL N +S P S I N
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 481 CSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHN 540
+LT L L NN++ P +++L+ L+ + + N +S L NL+++ + HN
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 541 HLHGELPVGGF 551
+ P+
Sbjct: 362 QISDLTPLANL 372
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.8 bits (237), Expect = 1e-21
Identities = 68/404 (16%), Positives = 136/404 (33%), Gaps = 38/404 (9%)
Query: 65 DPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDF 124
D + L +++ + L + L +I+ + L ++F
Sbjct: 18 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINF 73
Query: 125 SENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPY 184
S N L+ + P + L ++ NN + P + + ++ + +
Sbjct: 74 SNNQLTDITP---LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT---DIDP 127
Query: 185 GIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLD 244
+ SN + IS L L +++ + + + L+ LD
Sbjct: 128 LKNLTNLNRLELSSNTI------SDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLD 181
Query: 245 FGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPS 304
N +S + +L + SL N + P I NL+ L L+ NQ
Sbjct: 182 ISSNKVSDISVLA--KLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IG 235
Query: 305 SIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSL 364
++ +L L +L+++ NQ + P S L + + N+++ P
Sbjct: 236 TLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNISPLAGLTALTNL--- 290
Query: 365 SGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFG 424
+ S + + L L L N +S + P + L+ L L + N +
Sbjct: 291 -----ELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV-- 341
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKN 468
S +S+ L I L N ++ P + + +L L
Sbjct: 342 SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 84.3 bits (207), Expect = 1e-17
Identities = 52/235 (22%), Positives = 92/235 (39%), Gaps = 44/235 (18%)
Query: 163 SFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLG 222
+ ++LES+ ++N++S P L +L L L+ N L+ + +++L +L + L
Sbjct: 194 AKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 223 KNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWI 282
N+ S P + G + L L G N +S P L L + ++L L N I
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE--DISPI 303
Query: 283 GKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVS 342
L NL L L N S P + +L L+ L + N+ + S+ N N+ +
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 343 QNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNA 397
N+++ P A++ + L L+ A
Sbjct: 360 HNQISDLTP--------------------------LANLT----RITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 1e-07
Identities = 21/111 (18%), Positives = 40/111 (36%), Gaps = 7/111 (6%)
Query: 42 PKEKLTSWSEDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLS 101
P LT+ + + N + K + LTL ++S + L LQ L +
Sbjct: 280 PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFA 337
Query: 102 NNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANN 152
NN + + LA+ + + N +S L P + ++ +
Sbjct: 338 NNKVSDV--SSLANLTNINWLSAGHNQISDLTP---LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 2e-04
Identities = 13/75 (17%), Positives = 26/75 (34%), Gaps = 4/75 (5%)
Query: 479 KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNIS 538
+ +L + N+T V +L + + + I + L++L N S
Sbjct: 19 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFS 74
Query: 539 HNHLHGELPVGGFFN 553
+N L P+
Sbjct: 75 NNQLTDITPLKNLTK 89
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (264), Expect = 3e-25
Identities = 40/214 (18%), Positives = 72/214 (33%), Gaps = 19/214 (8%)
Query: 689 ELGRGGFGVVYRTI-LQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEG- 746
+LG G F V+ + + VA+K + + E E E+K L ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT--EAAEDEIKLLQRVNDADNTKEDSM 77
Query: 747 ------------YYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKG 794
+ P+ ++ F G L + I + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 795 LAYL-HHTNIIHYNLKSTNVLIDSSGEP-KVGDFGLARLLPMLDRCILSSKIQSALGYMA 852
L Y+ IIH ++K NVL++ P + +A L + Y +
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 853 PEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVE 886
PE D++ L+ E++TG E
Sbjct: 198 PEV-LLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (249), Expect = 1e-23
Identities = 58/303 (19%), Positives = 109/303 (35%), Gaps = 13/303 (4%)
Query: 119 LQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRL 178
L+VV S+ L +P + + NN +T +L ++ +N++
Sbjct: 12 LRVVQCSDLGLEK-VPKDLPP---DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 179 SGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCS 238
S P L L+ L LS N L+ K L +LR + K + +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 239 MLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQF 298
+++ L SG + Q + S + + + T +P + +L L L N+
Sbjct: 128 VVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKI 183
Query: 299 SGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMG 358
+ +S+ L L +L +S N + S+ N +L + ++ NKL
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243
Query: 359 LQTVSLSGNRLGESMQYPSFASM--KDSYQGLQVLDLSSNALS--GVIPSNIGDLSSLML 414
+Q V L N + ++ F + L SN + + PS +
Sbjct: 244 IQVVYLHNNNI-SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 302
Query: 415 LNM 417
+ +
Sbjct: 303 VQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 99.3 bits (246), Expect = 3e-23
Identities = 55/306 (17%), Positives = 109/306 (35%), Gaps = 24/306 (7%)
Query: 263 SCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQF 322
CS L L+ +VP + + LDL N+ + NL L L + N+
Sbjct: 16 QCSDLGLE------KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 323 TGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMK 382
+ P + L + +S+N+L + Q + + N + + +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTL--QELRVHENEITKVRKS---VFNG 122
Query: 383 DSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFS 442
+ + L + SG+ + L + ++ + +IP + ++ L
Sbjct: 123 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLD 179
Query: 443 DNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAI 502
N + + G +L +L L N +S + N L L L+ N L VP +
Sbjct: 180 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 238
Query: 503 ANLSNLKYVDLSFNDLSGI------LPKELINLSHLLSFNISHNHL-HGELPVGGFFNTI 555
A+ ++ V L N++S I P + ++ N + + E+ F
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 298
Query: 556 SPSSVS 561
++V
Sbjct: 299 VRAAVQ 304
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.0 bits (131), Expect = 1e-08
Identities = 21/139 (15%), Positives = 38/139 (27%), Gaps = 2/139 (1%)
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSL 484
+P + +LD +N + +L L L N +S P L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 485 TSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHG 544
L LS+N L L L+ + + + L + +
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 545 ELPVGGFFNTISPSSVSGN 563
E +S ++
Sbjct: 142 ENGAFQGMKKLSYIRIADT 160
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (231), Expect = 2e-21
Identities = 56/282 (19%), Positives = 89/282 (31%), Gaps = 15/282 (5%)
Query: 263 SCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQF 322
SC L+ VP I A + + L N+ S +S L L + N
Sbjct: 17 SCPQQGLQ------AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL 68
Query: 323 TGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMK 382
+ L +D+S N ++ F + +L L +
Sbjct: 69 ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH---LDRCGLQELGPGLF 125
Query: 383 DSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFS 442
LQ L L NAL + DL +L L + N + + L ++ L
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 443 DNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAI 502
N + P L L L N LS + +L L L+ N A
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRAR 244
Query: 503 ANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHG 544
+ L+ S +++ LP+ L ++ N L G
Sbjct: 245 PLWAWLQKFRGSSSEVPCSLPQRLAGRDLK---RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (225), Expect = 9e-21
Identities = 53/281 (18%), Positives = 95/281 (33%), Gaps = 13/281 (4%)
Query: 121 VVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSG 180
+ L +P + + + N ++ S C +L + SN L+
Sbjct: 15 TTSCPQQGLQA-VPVGIPA---ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70
Query: 181 QLPYGIWFLRSLQSLDLSNNLLEGEIV-KGISNLYDLRAIKLGKNKFSGQLPEDIGGCSM 239
L L+ LDLS+N + L L + L + P G +
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130
Query: 240 LKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFS 299
L+ L N+L D+ + L + + L L GN + L +L+ L L N+ +
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 300 GRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGL 359
P + +L L L + N + E++ L + ++ N + L
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWL 250
Query: 360 QTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSG 400
Q S + + P G + L++N L G
Sbjct: 251 QKFRGSSSEV--PCSLPQ------RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (224), Expect = 1e-20
Identities = 47/254 (18%), Positives = 88/254 (34%), Gaps = 4/254 (1%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
Q + L N + A + L ++ N L+ + F + N L
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLY 214
P + L +++ L P L +LQ L L +N L+ +L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 215 DLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSF 274
+L + L N+ S G L L N ++ P + + L +L L N+
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 275 TGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCG 334
+ + + L L+ L L+ N + + +L++ S ++ LP+ +
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQRL---A 269
Query: 335 NLLAIDVSQNKLTG 348
++ N L G
Sbjct: 270 GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.6 bits (197), Expect = 4e-17
Identities = 50/286 (17%), Positives = 89/286 (31%), Gaps = 12/286 (4%)
Query: 164 FCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGK 223
+ + + L +P GI + Q + L N + +L + L
Sbjct: 9 YNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 224 NKFSGQLPEDIGGCSMLKVLDFGVNSLSGSL-PDSLQRLNSCSSLSLKGNSFTGEVPDWI 282
N + G ++L+ LD N+ S+ P + L +L L P
Sbjct: 66 NVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF 125
Query: 283 GKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVS 342
LA L+ L L N + +L L L + N+ + + +L + +
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 343 QNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVI 402
QN++ P +G L + + LQ L L+ N
Sbjct: 186 QNRVAHVHPHAFRDLGRLMT----LYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-D 240
Query: 403 PSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNG 448
+ L S + + S+P L + + N L G
Sbjct: 241 CRARPLWAWLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.1 bits (162), Expect = 1e-12
Identities = 40/232 (17%), Positives = 65/232 (28%), Gaps = 5/232 (2%)
Query: 45 KLTSWSEDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNN 104
LT + D L L L L L
Sbjct: 57 NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116
Query: 105 FTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSF 164
LQ + +N L L D F +L + N ++ +
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG-NLTHLFLHGNRISSVPERAFRG 175
Query: 165 CSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKN 224
SL+ + NR++ P+ L L +L L N L + ++ L L+ ++L N
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
Query: 225 KFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTG 276
+ + L+ + + SLP L L N G
Sbjct: 236 PWVCD-CRARPLWAWLQKFRGSSSEVPCSLPQRLAGR---DLKRLAANDLQG 283
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.1 bits (220), Expect = 7e-21
Identities = 22/151 (14%), Positives = 44/151 (29%), Gaps = 16/151 (10%)
Query: 689 ELGRGGFGVVYRTILQDGRSVAIKKLTVSGL---------IKSQEDFEKEMKTLGKIRHH 739
+G G V+ + +K V F +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 740 NLVALEGYYWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLH 799
L L+G +Y + + L + + ++ + + +A +
Sbjct: 67 ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKFY 120
Query: 800 HTNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830
H I+H +L NVL+ G + DF +
Sbjct: 121 HRGIVHGDLSQYNVLVSEEG-IWIIDFPQSV 150
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.9 bits (159), Expect = 2e-12
Identities = 41/206 (19%), Positives = 70/206 (33%), Gaps = 16/206 (7%)
Query: 263 SCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQF 322
+C +L +P + K + L LS N +++ L +LN+ +
Sbjct: 16 NCDKRNLT------ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 323 TGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMK 382
T + L +D+S N+L L + +S NRL +
Sbjct: 68 TK--LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125
Query: 383 DSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFS 442
L+ N L + P + L L+++ N L + L+ + L
Sbjct: 126 LQELYLKG-----NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 443 DNWLNGTIPPQIGGAVSLKELKLEKN 468
+N L TIP G+ L L N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.0 bits (154), Expect = 1e-11
Identities = 44/209 (21%), Positives = 68/209 (32%), Gaps = 7/209 (3%)
Query: 138 FRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDL 197
+ S EV+ NLT +P L ++ S N L + L L+L
Sbjct: 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 198 SNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDS 257
E ++ L L + L N+ ++ VLD N L+ +
Sbjct: 63 DRA--ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLGA 119
Query: 258 LQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNI 317
L+ L L LKGN P + LE L L+ N + + L L L +
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 318 SMNQFTGGLPESMMNCGNLLAIDVSQNKL 346
N +P+ L + N
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.8 bits (151), Expect = 3e-11
Identities = 37/210 (17%), Positives = 64/210 (30%), Gaps = 12/210 (5%)
Query: 115 SFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFS 174
+ V+ + NL+ +P + + + + N L +L + L +N
Sbjct: 8 KVASHLEVNCDKRNLTA-LPPDLPK---DTTILHLSENLLYTFSLATLMPYTRLTQLN-- 61
Query: 175 SNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVK--GISNLYDLRAIKLGKNKFSGQLPE 232
L + +L L + L L + + N+ +
Sbjct: 62 ---LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 233 DIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLD 292
+ G L+ L N L P L LSL N+ T + L NL++L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 293 LSLNQFSGRIPSSIGNLVFLKELNISMNQF 322
L N IP L + N +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 7e-07
Identities = 36/237 (15%), Positives = 73/237 (30%), Gaps = 35/237 (14%)
Query: 282 IGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDV 341
+ K+A+ ++ + +P + L++S N ++M L +++
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 342 SQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGV 401
+ +LT + LG +
Sbjct: 63 DRAELTKLQVDGTLPV-----------LGTLDLSHNQLQSLPLLGQTLPAL--------- 102
Query: 402 IPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLK 461
+L++S N L ++ L +Q L N L P + L+
Sbjct: 103 -----------TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE 151
Query: 462 ELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDL 518
+L L N L+ + +L +L+L +N+L +P L + L N
Sbjct: 152 KLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 1e-05
Identities = 38/180 (21%), Positives = 60/180 (33%), Gaps = 5/180 (2%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
+L LS N A L + L ++ L+ L D G+L +L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSL 92
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLY 214
+L ++ S NRL+ + L LQ L L N L+ ++
Sbjct: 93 PLLGQ----TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148
Query: 215 DLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSF 274
L + L N + + G L L NSL ++P + L GN +
Sbjct: 149 KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 13/67 (19%), Positives = 25/67 (37%), Gaps = 3/67 (4%)
Query: 477 QIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFN 536
++ +S + + NLT +P + + + LS N L L+ + L N
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 537 ISHNHLH 543
+ L
Sbjct: 62 LDRAELT 68
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 0.001
Identities = 14/62 (22%), Positives = 26/62 (41%), Gaps = 3/62 (4%)
Query: 453 QIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVD 512
++ S E+ +K L+ +P + T L LS+N L A + + L ++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 513 LS 514
L
Sbjct: 62 LD 63
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (152), Expect = 3e-11
Identities = 41/267 (15%), Positives = 79/267 (29%), Gaps = 17/267 (6%)
Query: 96 QVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLT 155
Q L L+ N + L S G + + + + + F ++ + +N+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHF--SPFRVQHMDLSNSVIE 59
Query: 156 G-PIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLY 214
+ LS CS L++++ RLS + + +L L+LS E
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 215 DLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSG---------SLPDSLQRLNSCS 265
R +L + + + +LSG + N
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179
Query: 266 SLSLKGNSFTGEVPDWIGKLANLESLDLS-LNQFSGRIPSSIGNLVFLKELNISMNQFTG 324
+ +L L+ L LS +G + LK L + G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 325 GLPESMMNCGNLLAIDVSQNKLTGNIP 351
L +L ++ + T
Sbjct: 240 TLQLLKEALPHL---QINCSHFTTIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.7 bits (148), Expect = 1e-10
Identities = 34/281 (12%), Positives = 81/281 (28%), Gaps = 27/281 (9%)
Query: 243 LDFGVNSLSGSLPDSLQRLNSCSSLSLK-GNSFTGEVPDWIGKLANLESLDLSLNQFSGR 301
LD +L PD RL S ++ + SF + ++ +DLS +
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 302 -IPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQ 360
+ + L+ L++ + + + ++ NL+ +++S
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 361 TVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMN 420
+ + ++ L L N
Sbjct: 122 RLDELNLSWCFDFTEKHVQVA--------------------VAHVSETITQLNLSGYRKN 161
Query: 421 YLFGSIPASIGKLKAIQVLDFSDNWL-NGTIPPQIGGAVSLKELKLEK-NFLSGRIPSQI 478
+ + + + LD SD+ + + L+ L L + + ++
Sbjct: 162 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLEL 221
Query: 479 KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLS 519
+L +L + G + L +L+ F ++
Sbjct: 222 GEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIA 262
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 4e-08
Identities = 42/310 (13%), Positives = 92/310 (29%), Gaps = 47/310 (15%)
Query: 120 QVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLS 179
Q +D + NL + Q + + + P+ E S
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLAEHFS---------------- 44
Query: 180 GQLPYGIWFLRSLQSLDLSNNLLEGEIVKGI-SNLYDLRAIKLGKNKFSGQLPEDIGGCS 238
+Q +DLSN+++E + GI S L+ + L + S + + S
Sbjct: 45 ---------PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS 95
Query: 239 MLKVLDFGVNSLSGSLP--------DSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLES 290
L L+ S L LN V + L
Sbjct: 96 NLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 155
Query: 291 LDLSLNQFSGRIPSSIGNLVFLKELNISMN-QFTGGLPESMMNCGNLLAIDVSQ-NKLTG 348
N + + + L L++S + + L + +S+ +
Sbjct: 156 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP 215
Query: 349 NIPTWIFKM-GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIG 407
+ ++ L+T+ + G +++ + L L ++ + + + IG
Sbjct: 216 ETLLELGEIPTLKTLQVFGIV--------PDGTLQLLKEALPHLQINCSHFTTIARPTIG 267
Query: 408 DLSSLMLLNM 417
+ + + +
Sbjct: 268 NKKNQEIWGI 277
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 4e-07
Identities = 39/254 (15%), Positives = 86/254 (33%), Gaps = 19/254 (7%)
Query: 70 RVVGLTLDGFSLSGHIGRGLLRLQF----LQVLSLSNNNFTG-TINADLASFGTLQVVDF 124
R++ + F L F +Q + LSN+ T++ L+ LQ +
Sbjct: 19 RLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78
Query: 125 SENNLSGLIPDEFFRQCGSLREVSFA--NNNLTGPIPESLSFCSSLESVNF------SSN 176
LS I + + +L ++ + + + LS CS L+ +N +
Sbjct: 79 EGLRLSDPIVNTLA-KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK 137
Query: 177 RLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKN-KFSGQLPEDIG 235
+ + + + L NL + ++ + +L + L + ++
Sbjct: 138 HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFF 197
Query: 236 GCSMLKVLDF-GVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLS 294
+ L+ L + L + + +L + G G + L L ++
Sbjct: 198 QLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLK---EALPHLQIN 254
Query: 295 LNQFSGRIPSSIGN 308
+ F+ +IGN
Sbjct: 255 CSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 20/124 (16%), Positives = 43/124 (34%), Gaps = 25/124 (20%)
Query: 389 QVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNG 448
Q LDL+ L + + ++ +++ + + +Q +D S++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 449 TIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNL 508
+ I + CS L +L L L+ P+ +A SNL
Sbjct: 61 STLHGI-----------------------LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNL 97
Query: 509 KYVD 512
++
Sbjct: 98 VRLN 101
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.3 bits (130), Expect = 2e-09
Identities = 25/123 (20%), Positives = 46/123 (37%), Gaps = 9/123 (7%)
Query: 291 LDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNI 350
L L+ + + + L+ + L++S N+ P ++ L + S N N+
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNA-LENV 58
Query: 351 PTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLS 410
LQ + L NRL +S S L +L+L N+L L+
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPR----LVLLNLQGNSLCQ-EEGIQERLA 113
Query: 411 SLM 413
++
Sbjct: 114 EML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.6 bits (123), Expect = 1e-08
Identities = 30/127 (23%), Positives = 52/127 (40%), Gaps = 9/127 (7%)
Query: 389 QVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNG 448
+VL L+ L+ + ++ L + L++S N L P ++ L+ ++VL SDN L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE- 56
Query: 449 TIPPQIGGAVSLKELKLEKNFL-SGRIPSQIKNCSSLTSLILSQNNLTGP---VPAAIAN 504
+ L+EL L N L + +C L L L N+L
Sbjct: 57 -NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 505 LSNLKYV 511
L ++ +
Sbjct: 116 LPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 3e-07
Identities = 26/109 (23%), Positives = 39/109 (35%), Gaps = 5/109 (4%)
Query: 88 GLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREV 147
L +L + L LS+N A LA+ L+V+ S+N L + + L
Sbjct: 15 HLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQEL--- 70
Query: 148 SFANNNLTG-PIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSL 195
NN L + L C L +N N L + L S+
Sbjct: 71 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 5e-07
Identities = 22/121 (18%), Positives = 38/121 (31%), Gaps = 7/121 (5%)
Query: 193 QSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSG 252
+ L L++ L ++ + L + + L N+ P + L+VL N+L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 253 SLPDSLQRLNSCSSLSLKGNSFTG-EVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVF 311
D + L L L N + L L+L N L
Sbjct: 58 --VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114
Query: 312 L 312
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 2e-06
Identities = 23/111 (20%), Positives = 41/111 (36%), Gaps = 7/111 (6%)
Query: 96 QVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLT 155
+VL L++ + T + L + +D S N L L P L + ++N
Sbjct: 1 RVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLRALPPA--LAALRCLEVLQASDNA-- 54
Query: 156 GPIPESLSFCSSLESVNFSSNRL-SGQLPYGIWFLRSLQSLDLSNNLLEGE 205
+ ++ L+ + +NRL + L L+L N L E
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 58.0 bits (138), Expect = 2e-09
Identities = 46/339 (13%), Positives = 99/339 (29%), Gaps = 61/339 (17%)
Query: 263 SCSSLSLKGNSFTGE----VPDWIGKLANLESLDLSLNQFSGR----IPSSIGNLVFLKE 314
S SLK ++ T E V + + +++ + LS N + +I + L+
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 315 LNISMNQ----------FTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSL 364
S L ++++ C L + +S N + + L
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 365 SGNRLGESMQYPSFASMK-------------DSYQGLQVLDLSSNALSGVIPSNIGDLSS 411
L + P + + L+ + N L
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 412 LMLLNMSMNYLFGSIPASIGKLKAIQVL-------------DFSDNWLNGTIPPQIGGAV 458
L ++ + I + ++ L + + + + +
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 459 SLKELKLEKNFLSGRIPSQIKNC------SSLTSLILSQNNLTGPVPAAIA-----NLSN 507
+L+EL L LS R + + + L +L L N + + + +
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 508 LKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGEL 546
L +++L+ N S + + + S GEL
Sbjct: 304 LLFLELNGNRFSE-EDDVVDEIREVFS-----TRGRGEL 336
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 40/325 (12%), Positives = 88/325 (27%), Gaps = 32/325 (9%)
Query: 143 SLREVSFANNNLTG----PIPESLSFCSSLESVNFSSNRLSGQ----LPYGIWFLRSLQS 194
S+ S + +T + L S++ + S N + + L I + L+
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 195 LDLSNN---LLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLS 251
+ S+ ++ EI + + L + + ++
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 252 GSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFS----GRIPSSIG 307
L L + + V L S+ N+ +
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 308 NLVFLKELNISMNQFTGGLPESMMNCG----------NLLAIDVSQNKLTGNIPTWIFKM 357
+ L + + N E ++ G +L + +
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 358 GLQTVSLSGNRLG-ESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGD-----LSS 411
L+ + L+ L A K GLQ L L N + + +
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 412 LMLLNMSMNYLFGSIPASIGKLKAI 436
L+ L ++ N F + +++ +
Sbjct: 304 LLFLELNGNR-FSEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.3 bits (113), Expect = 2e-06
Identities = 35/322 (10%), Positives = 86/322 (26%), Gaps = 30/322 (9%)
Query: 119 LQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGP----IPESLSFCSSLESVNFS 174
L++ + + + + S++E+ + N + + E+++ LE FS
Sbjct: 10 LKLDAITTEDEKSVF--AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 175 SN---RLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLP 231
R+ ++P + L + + + L K+ L
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 232 EDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGE----VPDWIGKLAN 287
G ++ + S+ N
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 288 LESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFT---------GGLPESMMNCGNLLA 338
L ++ + N + + + L ++ + NL
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 339 IDVSQNKLTGNIPTWIFKM-------GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVL 391
+ ++ L+ + GLQT+ L N + + + L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 392 DLSSNALSGVIPSNIGDLSSLM 413
+L+ N S + ++ +
Sbjct: 308 ELNGNRFSE-EDDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.0 bits (112), Expect = 3e-06
Identities = 41/340 (12%), Positives = 96/340 (28%), Gaps = 36/340 (10%)
Query: 191 SLQSLDLSNNLLEGE----IVKGISNLYDLRAIKLGKNKFSGQ----LPEDIGGCSMLKV 242
S++ L + + E + + ++ I L N + L E+I L++
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 243 LDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRI 302
+F + + + + K L ++ LS N F
Sbjct: 64 AEF--------------SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 109
Query: 303 PSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTW--IFKMGLQ 360
+ + + + GL +++ NK N P I +
Sbjct: 110 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 169
Query: 361 TVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMN 420
+ S ++ Q Q + + L + + N +
Sbjct: 170 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 229
Query: 421 YLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAV------SLKELKLEKNFLSGRI 474
++ ++ ++ L +D L+ + A L+ L+L+ N +
Sbjct: 230 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA 289
Query: 475 PSQI-----KNCSSLTSLILSQNNLTGPVPAAIANLSNLK 509
+ + L L L+ N + + + +
Sbjct: 290 VRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREVF 328
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.0 bits (133), Expect = 8e-09
Identities = 56/315 (17%), Positives = 84/315 (26%), Gaps = 21/315 (6%)
Query: 240 LKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFS 299
L+ LS SLP+ L SL NS T E+P+ L +L + +L S
Sbjct: 40 AHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94
Query: 300 GRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGN-------IPT 352
P V +L + + N L +
Sbjct: 95 DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 154
Query: 353 WIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSL 412
L ++ + P +S + L + +
Sbjct: 155 LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNN 214
Query: 413 MLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSG 472
+L + G L N S
Sbjct: 215 LLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSN 274
Query: 473 RIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHL 532
I S SL L +S N L +PA L L SFN L+ + P+ NL L
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLAEV-PELPQNLKQL 329
Query: 533 LSFNISHNHLHGELP 547
++ +N L E P
Sbjct: 330 ---HVEYNPLR-EFP 340
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 1e-07
Identities = 19/94 (20%), Positives = 36/94 (38%), Gaps = 9/94 (9%)
Query: 416 NMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIP 475
+N I + +++ L+ S+N L +P L+ L N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP 320
Query: 476 SQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLK 509
+N L L + N L P ++ +L+
Sbjct: 321 ELPQN---LKQLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 1e-07
Identities = 23/91 (25%), Positives = 37/91 (40%), Gaps = 9/91 (9%)
Query: 127 NNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGI 186
N S SL E++ +NN L +P LE + S N L+ ++P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLA-EVPE-- 321
Query: 187 WFLRSLQSLDLSNNLLEGEIVKGISNLYDLR 217
++L+ L + N L E ++ DLR
Sbjct: 322 -LPQNLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 2e-07
Identities = 20/87 (22%), Positives = 33/87 (37%), Gaps = 9/87 (10%)
Query: 272 NSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMM 331
N+ + E+ +LE L++S N+ +P+ L+ L S N +PE
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELP- 323
Query: 332 NCGNLLAIDVSQNKLTGNIPTWIFKMG 358
NL + V N L P +
Sbjct: 324 --QNLKQLHVEYNPLRE-FPDIPESVE 347
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 65/328 (19%), Positives = 99/328 (30%), Gaps = 21/328 (6%)
Query: 164 FCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGK 223
+ ++ LS LP L+SL S N L E+ + +L L
Sbjct: 36 LDRQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 90
Query: 224 NKFSG---QLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPD 280
S L + L+ L NS + D F +
Sbjct: 91 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
Query: 281 WIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAID 340
+ +L L++L ++ + L +I + N L I
Sbjct: 151 QLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 210
Query: 341 VSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDS----YQGLQVLDLSSN 396
N L L L E Q +F + ++ L N
Sbjct: 211 ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLN 270
Query: 397 ALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGG 456
A S I S SL LN+S N L +PA +L + L S N L +P
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRL---ERLIASFNHLA-EVPELPQ- 324
Query: 457 AVSLKELKLEKNFLSGRIPSQIKNCSSL 484
+LK+L +E N L P ++ L
Sbjct: 325 --NLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 1e-06
Identities = 25/96 (26%), Positives = 40/96 (41%), Gaps = 12/96 (12%)
Query: 172 NFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLP 231
+ N S ++ SL+ L++SNN L E+ L L N + ++P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVP 320
Query: 232 EDIGGCSMLKVLDFGVNSLSG--SLPDSLQ--RLNS 263
E LK L N L +P+S++ R+NS
Sbjct: 321 ELPQN---LKQLHVEYNPLREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 44/302 (14%), Positives = 85/302 (28%), Gaps = 22/302 (7%)
Query: 258 LQRLNSC-----SSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNL--V 310
+ RL C L L + +P+ +LESL S N + +P +L +
Sbjct: 29 VSRLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSL 83
Query: 311 FLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLG 370
+ N+ L E + N L + + L+ + L
Sbjct: 84 LVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLE 143
Query: 371 ESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASI 430
+ Q L L + + LS ++ + ++
Sbjct: 144 FIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNL 203
Query: 431 GKLKA-----IQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLT 485
L + D + ++ + + S L
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263
Query: 486 SLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGE 545
+ N + + + +L+ +++S N L + P L L S NHL E
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIEL-PALPPRLERL---IASFNHL-AE 318
Query: 546 LP 547
+P
Sbjct: 319 VP 320
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 4e-05
Identities = 21/127 (16%), Positives = 41/127 (32%), Gaps = 13/127 (10%)
Query: 49 WSEDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGT 108
V + + S I L+ L++SNN
Sbjct: 240 PELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-E 298
Query: 109 INADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSL 168
+ A L+ + S N+L+ +P+ +L+++ N L P+ S+
Sbjct: 299 LP---ALPPRLERLIASFNHLAE-VPEL----PQNLKQLHVEYNPLRE-FPDIP---ESV 346
Query: 169 ESVNFSS 175
E + +S
Sbjct: 347 EDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 23/94 (24%), Positives = 37/94 (39%), Gaps = 9/94 (9%)
Query: 149 FANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVK 208
+ N + I SLE +N S+N+L +LP L+ L S N L E+ +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPE 321
Query: 209 GISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKV 242
NL L + N + P+ L++
Sbjct: 322 LPQNLKQLH---VEYNPLR-EFPDIPESVEDLRM 351
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 2e-08
Identities = 32/239 (13%), Positives = 70/239 (29%), Gaps = 7/239 (2%)
Query: 259 QRLNSCSSLSL--KGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELN 316
R+ CS+ + + T E+P + N L L + + L+++
Sbjct: 3 HRICHCSNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIE 59
Query: 317 ISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYP 376
IS N + + + L + L + P
Sbjct: 60 ISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLP 119
Query: 377 SFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAI 436
+ + L + + N + S +G ++L ++ N + + +
Sbjct: 120 DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLD 179
Query: 437 QVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLT 495
++ +N L GA L + + + ++N L + S NL
Sbjct: 180 ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 12/69 (17%), Positives = 24/69 (34%), Gaps = 4/69 (5%)
Query: 475 PSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLS 534
+I +CS+ + ++ +T +P+ + N + L I L
Sbjct: 2 HHRICHCSN-RVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 535 FNISHNHLH 543
IS N +
Sbjct: 58 IEISQNDVL 66
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 5e-04
Identities = 32/232 (13%), Positives = 58/232 (25%), Gaps = 8/232 (3%)
Query: 118 TLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNR 177
+ +V E+ ++ IP + R + E+ F L + S LE + S N
Sbjct: 9 SNRVFLCQESKVTE-IPSDLPR---NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 64
Query: 178 LSGQL----PYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPED 233
+ + + L ++ +N L I K + +
Sbjct: 65 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 124
Query: 234 IGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDL 293
+L + +N + + L L N E
Sbjct: 125 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLS 184
Query: 294 SLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNK 345
N L+IS + + N L A K
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 5e-04
Identities = 7/66 (10%), Positives = 19/66 (28%), Gaps = 13/66 (19%)
Query: 131 GLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLR 190
+P++ F + + + L L + + + L+
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN-------------LK 236
Query: 191 SLQSLD 196
L +L+
Sbjct: 237 KLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 9/47 (19%), Positives = 17/47 (36%), Gaps = 3/47 (6%)
Query: 501 AIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELP 547
S +D+S + + L NL L + + + +LP
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 24/269 (8%), Positives = 63/269 (23%), Gaps = 31/269 (11%)
Query: 159 PESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRA 218
+ CS+ ++++ ++P + R+ L
Sbjct: 2 HHRICHCSN-RVFLCQESKVT-EIPSDL--PRNAIELRFVLT------------------ 39
Query: 219 IKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEV 278
K G L+ ++ N + + + +
Sbjct: 40 ------KLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY 93
Query: 279 PDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLA 338
+ L ++ + + + L+++ + + + L
Sbjct: 94 INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSF 153
Query: 339 IDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNAL 398
V I T N + + G +LD+S +
Sbjct: 154 ESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 213
Query: 399 SGVIPSNIGDLSSLMLLNMSMNYLFGSIP 427
+ + +L L + Y +P
Sbjct: 214 HSLPSYGLENLKKLRARS---TYNLKKLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 17/224 (7%), Positives = 53/224 (23%), Gaps = 5/224 (2%)
Query: 229 QLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANL 288
++P D+ L F + L + + + N + +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 289 ESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTG 348
+ + + ++ + +L + +
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 349 NIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGD 408
+ L ++ + Q ++ +N L +
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 409 LSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPP 452
S ++L++S + + LK ++ + +P
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRAR---STYNLKKLPT 240
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (130), Expect = 2e-08
Identities = 15/92 (16%), Positives = 31/92 (33%), Gaps = 5/92 (5%)
Query: 458 VSLKELKLEKNFLS-GRIPSQIKNCSSLTSLILSQNNLTG----PVPAAIANLSNLKYVD 512
+ ++ L ++ LS R + + L LT + +A+ L ++
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 513 LSFNDLSGILPKELINLSHLLSFNISHNHLHG 544
L N+L + ++ S I L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 5e-08
Identities = 19/91 (20%), Positives = 29/91 (31%), Gaps = 9/91 (9%)
Query: 119 LQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTG----PIPESLSFCSSLESVNFS 174
+Q +D LS E + V + LT I +L +L +N
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 175 SNRLSGQLPYGI-----WFLRSLQSLDLSNN 200
SN L + + +Q L L N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 8e-08
Identities = 17/128 (13%), Positives = 39/128 (30%), Gaps = 10/128 (7%)
Query: 240 LKVLDFGVNSLSGS-LPDSLQRLNSCSSLSLKGNSFTGE----VPDWIGKLANLESLDLS 294
++ LD LS + + L L C + L T + + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 295 LNQFSGRIPSSIGNLVF-----LKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGN 349
N+ + + +++L++ TG + + L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 123
Query: 350 IPTWIFKM 357
+ ++
Sbjct: 124 LGDAGLQL 131
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 9e-08
Identities = 16/80 (20%), Positives = 25/80 (31%), Gaps = 9/80 (11%)
Query: 459 SLKELKLEKNFLSGR----IPSQIKNCSSLTSLILSQNNLTGPVPAAIA-----NLSNLK 509
L+ L L +S + + + SL L LS N L + L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 510 YVDLSFNDLSGILPKELINL 529
+ L S + L L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 3e-07
Identities = 15/89 (16%), Positives = 31/89 (34%), Gaps = 10/89 (11%)
Query: 436 IQVLDFSDNWLNGTIPPQIGGAV-SLKELKLEKNFLSGR----IPSQIKNCSSLTSLILS 490
IQ LD L+ ++ + + ++L+ L+ I S ++ +L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 491 QNNLTGPVPAAIA-----NLSNLKYVDLS 514
N L + ++ + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 14/82 (17%), Positives = 30/82 (36%), Gaps = 9/82 (10%)
Query: 475 PSQIKNCSSLTSLILSQNNLTGPVPAAIA----NLSNLKYVDLSFNDLSGILPKELI--- 527
+ S L L L+ +++ +++A +L+ +DLS N L +L+
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 528 --NLSHLLSFNISHNHLHGELP 547
L + + E+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 15/90 (16%), Positives = 30/90 (33%), Gaps = 5/90 (5%)
Query: 388 LQVLDLSSNALSGV-IPSNIGDLSSLMLLNMSMNYL----FGSIPASIGKLKAIQVLDFS 442
+Q LD+ LS + L ++ + L I +++ A+ L+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 443 DNWLNGTIPPQIGGAVSLKELKLEKNFLSG 472
N L + + K++K L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 13/92 (14%), Positives = 27/92 (29%), Gaps = 5/92 (5%)
Query: 143 SLREVSFANNNLT-GPIPESLSFCSSLESVNFSSNRLSGQ----LPYGIWFLRSLQSLDL 197
++ + L+ E L + V L+ + + +L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 198 SNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQ 229
+N L V + + K+ K
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 12/85 (14%), Positives = 28/85 (32%), Gaps = 5/85 (5%)
Query: 191 SLQSLDLS-NNLLEGEIVKGISNLYDLRAIKLGKNKFSGQ----LPEDIGGCSMLKVLDF 245
+QSLD+ L + + + L + ++L + + + L L+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 246 GVNSLSGSLPDSLQRLNSCSSLSLK 270
N L + + S ++
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQ 87
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 16/82 (19%), Positives = 29/82 (35%), Gaps = 9/82 (10%)
Query: 162 LSFCSSLESVNFSSNRLSGQ----LPYGIWFLRSLQSLDLSNNLLEGEIVKGIS-----N 212
S L + + +S L + SL+ LDLSNN L + +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 213 LYDLRAIKLGKNKFSGQLPEDI 234
L + L +S ++ + +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 16/94 (17%), Positives = 33/94 (35%), Gaps = 8/94 (8%)
Query: 335 NLLAIDVSQNKLTGNIPTWIFKM--GLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLD 392
++ ++D+ +L+ + + Q V L L E+ + +S L L+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA-RCKDISSALRVNPALAELN 61
Query: 393 LSSNALSGVIPSNIGDL-----SSLMLLNMSMNY 421
L SN L V + + L++
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 15/115 (13%), Positives = 35/115 (30%), Gaps = 28/115 (24%)
Query: 287 NLESLDLSLNQFS-GRIPSSIGNLVFLKELNISMNQFTG----GLPESMMNCGNLLAIDV 341
+++SLD+ + S R + L + + + T + ++ L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL----- 57
Query: 342 SQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSN 396
++L N LG+ + ++ +Q L L +
Sbjct: 58 ------------------AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 6e-06
Identities = 14/88 (15%), Positives = 30/88 (34%), Gaps = 9/88 (10%)
Query: 135 DEFFRQCGSLREVSFANNNLTG----PIPESLSFCSSLESVNFSSNRLSGQLPYGI---- 186
+ LR + A+ +++ + +L SL ++ S+N L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 187 -WFLRSLQSLDLSNNLLEGEIVKGISNL 213
L+ L L + E+ + L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 8e-06
Identities = 19/87 (21%), Positives = 29/87 (33%), Gaps = 9/87 (10%)
Query: 236 GCSMLKVLDFGVNSLSG----SLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGK-----LA 286
S+L+VL +S SL +L +S L L N + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 287 NLESLDLSLNQFSGRIPSSIGNLVFLK 313
LE L L +S + + L K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 16/89 (17%), Positives = 31/89 (34%), Gaps = 6/89 (6%)
Query: 95 LQVLSLSNNNFTGTINADLAS-FGTLQVVDFSENNLSGLIPD---EFFRQCGSLREVSFA 150
+Q L + + A+L QVV + L+ R +L E++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 151 NNNLTGPIPESLSFCSSLESVNFSSNRLS 179
+N L + L++ + +LS
Sbjct: 64 SNELGDVGVHCV--LQGLQTPSCKIQKLS 90
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 12/68 (17%), Positives = 20/68 (29%), Gaps = 5/68 (7%)
Query: 483 SLTSLILSQNNLT-GPVPAAIANLSNLKYVDLSFNDLSGI----LPKELINLSHLLSFNI 537
+ SL + L+ + L + V L L+ + L L N+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 538 SHNHLHGE 545
N L
Sbjct: 63 RSNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 9e-05
Identities = 11/83 (13%), Positives = 25/83 (30%), Gaps = 9/83 (10%)
Query: 258 LQRLNSCSSLSLKGNSFTGE----VPDWIGKLANLESLDLSLNQFSGRIPSSIG-----N 308
Q + L L + + + +L LDLS N +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 309 LVFLKELNISMNQFTGGLPESMM 331
L++L + ++ + + +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQ 447
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 20/94 (21%), Positives = 42/94 (44%), Gaps = 15/94 (15%)
Query: 410 SSLMLLNMSMNYL----FGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAV-----SL 460
S L +L ++ + S+ A++ +++ LD S+N L Q+ +V L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 461 KELKLEKNFLSGRIPSQI----KNCSSLTSLILS 490
++L L + S + ++ K+ SL ++S
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLR--VIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 2e-04
Identities = 14/90 (15%), Positives = 34/90 (37%), Gaps = 11/90 (12%)
Query: 312 LKELNISMNQFTG----GLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKM------GLQT 361
L+ L ++ + L +++ +L +D+S N L + + L+
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 362 VSLSGNRLGESMQYPSFASMKDSYQGLQVL 391
+ L E M+ +++ L+V+
Sbjct: 431 LVLYDIYWSEEME-DRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 22/114 (19%), Positives = 33/114 (28%), Gaps = 14/114 (12%)
Query: 49 WSEDDDNPCNWVGVKCDPKTKRVVGLTLDGFSLSG--HIGRGLLRLQFLQVLSLSNNNFT 106
ED G+ RV+ L S S + LL L+ L LSNN
Sbjct: 351 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410
Query: 107 GTINADLASF-----GTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLT 155
L L+ + + S + D L+ + +L
Sbjct: 411 DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR-------LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 17/84 (20%), Positives = 29/84 (34%), Gaps = 9/84 (10%)
Query: 211 SNLYDLRAIKLGKNKFSGQ----LPEDIGGCSMLKVLDFGVNSLSGS----LPDSLQRLN 262
LR + L S L + L+ LD N L + L +S+++
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425
Query: 263 SC-SSLSLKGNSFTGEVPDWIGKL 285
L L ++ E+ D + L
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 16/81 (19%), Positives = 31/81 (38%), Gaps = 6/81 (7%)
Query: 359 LQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGD-----LSSLM 413
L+ + L+ + +S S A+ + L+ LDLS+N L + + L
Sbjct: 371 LRVLWLADCDVSDS-SCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 414 LLNMSMNYLFGSIPASIGKLK 434
L + Y + + L+
Sbjct: 430 QLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 18/89 (20%), Positives = 30/89 (33%), Gaps = 9/89 (10%)
Query: 74 LTLDGFSLSGHIGRGLL-RLQFLQVLSLSNNNFTGTINADLASF----GTLQVVDFSENN 128
L + LS LL LQ QV+ L + T D++S L ++ N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 129 LSG----LIPDEFFRQCGSLREVSFANNN 153
L + ++++S N
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.0 bits (123), Expect = 7e-08
Identities = 31/230 (13%), Positives = 67/230 (29%), Gaps = 20/230 (8%)
Query: 92 LQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151
L ++ +N T T+ A + + ++ + E + +L + +
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI---EGVQYLNNLIGLELKD 72
Query: 152 NNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGIS 211
N +T P + ++ + + + + ++ + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 212 NLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKG 271
LY + +G +V D + L N S +S
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS--- 189
Query: 272 NSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQ 321
+ L NL + L NQ S P + N L + ++ NQ
Sbjct: 190 ---------PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 9e-07
Identities = 36/230 (15%), Positives = 68/230 (29%), Gaps = 22/230 (9%)
Query: 261 LNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMN 320
L + ++ ++ T V L + +L + + L L L + N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDN 73
Query: 321 QFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFAS 380
Q T P + L + + K I L S + +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 381 MKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLD 440
+ I + L +S+ S + L + L
Sbjct: 134 LYLDLN--------------QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLK 179
Query: 441 FSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILS 490
DN ++ P + +L E+ L+ N +S P + N S+L + L+
Sbjct: 180 ADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 3e-06
Identities = 40/212 (18%), Positives = 74/212 (34%), Gaps = 12/212 (5%)
Query: 335 NLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLG--ESMQY-PSFASMKDSYQGLQVL 391
N + I ++ +T + G+ T+S G + E +QY + ++ + L
Sbjct: 20 NAIKIAAGKSNVTDTVTQADLD-GITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITDL 78
Query: 392 DLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIP 451
N G+ + + + S + S+ +
Sbjct: 79 APLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138
Query: 452 PQIGGAVSLKELKLEKNFLSGRIP----SQIKNCSSLTSLILSQNNLTGPVPAAIANLSN 507
QI L L + G + + N S LT+L N ++ P +A+L N
Sbjct: 139 NQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPN 196
Query: 508 LKYVDLSFNDLSGILPKELINLSHLLSFNISH 539
L V L N +S + P L N S+L +++
Sbjct: 197 LIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 5e-06
Identities = 30/225 (13%), Positives = 75/225 (33%), Gaps = 25/225 (11%)
Query: 132 LIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRS 191
+ PD +++ +N+T + + + + +++ ++ + G+ +L +
Sbjct: 12 IFPDPALAN---AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNN 64
Query: 192 LQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLS 251
L L+L +N + + K + ++ +
Sbjct: 65 LIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 252 GSLPDSLQRLNSCSSLSLKGNSFTG--------------EVPDWIGKLANLESLDLSLNQ 297
+ +LQ L + + G + L+ L +L N+
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 298 FSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVS 342
S P + +L L E+++ NQ + P + N NL + ++
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 6e-05
Identities = 10/75 (13%), Positives = 29/75 (38%), Gaps = 4/75 (5%)
Query: 479 KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNIS 538
++ + ++N+T V A+L + + ++ I + + L++L+ +
Sbjct: 16 PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 539 HNHLHGELPVGGFFN 553
N + P+
Sbjct: 72 DNQITDLAPLKNLTK 86
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 34/233 (14%), Positives = 72/233 (30%), Gaps = 20/233 (8%)
Query: 65 DPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDF 124
DP + + +++ + L + LS T + L ++
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70
Query: 125 SENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPY 184
+N ++ L P + + + E+S I S + + ++
Sbjct: 71 KDNQITDLAPLKNLTKI-TELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 185 GIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLD 244
+ L + + + L G ++ + + + S L L
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD----------LTPLANLSKLTTLK 179
Query: 245 FGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQ 297
N +S P L L + + LK N + P + +NL + L+ NQ
Sbjct: 180 ADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 26/230 (11%), Positives = 71/230 (30%), Gaps = 22/230 (9%)
Query: 189 LRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVN 248
L + + + + + + ++L + + + E + + L L+ N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 249 SLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGN 308
++ P + LS + + + S++
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 309 LVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNR 368
L +++ G ++ N ++ L T+ N+
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSI---------GNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 369 LGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMS 418
+ + AS+ + L + L +N +S V P + + S+L ++ ++
Sbjct: 185 ISDI---SPLASLPN----LIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 32/206 (15%), Positives = 69/206 (33%), Gaps = 28/206 (13%)
Query: 132 LIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRS 191
+ D+ F + + ++T + + + +S++ + +++ + GI +L +
Sbjct: 17 IFSDDAFAETIKD---NLKKKSVTDAV--TQNELNSIDQIIANNSDIKS--VQGIQYLPN 69
Query: 192 LQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLS 251
+ L L+ N L ++NL +L + L +NK L+ S
Sbjct: 70 VTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDI 127
Query: 252 GSLPDSLQRLNSCSSLSLKGNSFTGEVPDW----------------IGKLANLESLDLSL 295
L Q + + + + L L++L LS
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSK 187
Query: 296 NQFSGRIPSSIGNLVFLKELNISMNQ 321
N S ++ L L L + +Q
Sbjct: 188 NHISD--LRALAGLKNLDVLELF-SQ 210
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 8e-05
Identities = 32/205 (15%), Positives = 71/205 (34%), Gaps = 20/205 (9%)
Query: 261 LNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMN 320
+LK S T V +L +++ + + + I L + +L ++ N
Sbjct: 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 321 QFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFAS 380
+ T P + + L +D ++ K ++ L + + + P S
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138
Query: 381 MKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLD 440
+ + + + L+ L L++ N + +P + L +Q L
Sbjct: 139 LYLGNNKIT------------DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184
Query: 441 FSDNWLNGTIPPQIGGAVSLKELKL 465
S N + + + G +L L+L
Sbjct: 185 LSKNHI--SDLRALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 27/186 (14%), Positives = 62/186 (33%), Gaps = 16/186 (8%)
Query: 243 LDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRI 302
+ S++ ++ + LNS + + I L N+ L L+ N+ +
Sbjct: 29 DNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIK 84
Query: 303 PSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTV 362
P + + L+ + + L + L + + + + L
Sbjct: 85 PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNN 144
Query: 363 SLSGNRLGESMQYPSFASMKDSY----------QGLQVLDLSSNALSGVIPSNIGDLSSL 412
++ + + S++D+ LQ L LS N +S + + L +L
Sbjct: 145 KITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNL 202
Query: 413 MLLNMS 418
+L +
Sbjct: 203 DVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.001
Identities = 34/243 (13%), Positives = 74/243 (30%), Gaps = 50/243 (20%)
Query: 278 VPDWIGK------LANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMM 331
VP I + A +L + + + L + ++ + + + +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQ 65
Query: 332 NCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVL 391
N+ + ++ NKLT P K S S + +
Sbjct: 66 YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125
Query: 392 DLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIP 451
D+ G + L ++ + + + +L + L DN ++ +P
Sbjct: 126 DI------------NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP 173
Query: 452 PQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYV 511
+ + L +L LS+N+++ A+A L NL +
Sbjct: 174 --------------------------LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVL 205
Query: 512 DLS 514
+L
Sbjct: 206 ELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 17/96 (17%), Positives = 38/96 (39%), Gaps = 22/96 (22%)
Query: 425 SIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSL 484
++P I ++ FSD+ TI + L+K ++ + +S+
Sbjct: 9 TVPTPIKQI-------FSDDAFAETI-----------KDNLKKKSVTDAVT--QNELNSI 48
Query: 485 TSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSG 520
+I + +++ I L N+ + L+ N L+
Sbjct: 49 DQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD 82
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 29/198 (14%), Positives = 60/198 (30%), Gaps = 23/198 (11%)
Query: 132 LIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRS 191
+ D + + N+T + S + + ++ + + G+ +L +
Sbjct: 11 IFTDTALAE---KMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SID-GVEYLNN 63
Query: 192 LQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLS 251
L ++ SNN L + + L + + +
Sbjct: 64 LTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 123
Query: 252 GSLPDSLQRLNSCSSLSLKGNSFTGEVPDW--------------IGKLANLESLDLSLNQ 297
+L RL S+ ++ +G + L LE LD+S N+
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNK 183
Query: 298 FSGRIPSSIGNLVFLKEL 315
S S + L L+ L
Sbjct: 184 VSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 37/191 (19%), Positives = 63/191 (32%), Gaps = 20/191 (10%)
Query: 261 LNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMN 320
L L + T V L + +L + L L ++N S N
Sbjct: 17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 72
Query: 321 QFTGGLPES------------MMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNR 368
Q T P +++ I + + NR
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 369 LGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPA 428
L S S S LQ L+ SSN ++ + P + +L++L L++S N + S +
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKV--SDIS 188
Query: 429 SIGKLKAIQVL 439
+ KL ++ L
Sbjct: 189 VLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 6e-04
Identities = 13/73 (17%), Positives = 26/73 (35%), Gaps = 4/73 (5%)
Query: 479 KNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNIS 538
+ +L + N+T V +L + + + I + L++L N S
Sbjct: 15 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFS 70
Query: 539 HNHLHGELPVGGF 551
+N L P+
Sbjct: 71 NNQLTDITPLKNL 83
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 33/162 (20%), Positives = 57/162 (35%), Gaps = 21/162 (12%)
Query: 388 LQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSD---- 443
+ L + + + L++L +N S N L P +++ +
Sbjct: 42 VTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADI 99
Query: 444 ------------NWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQ 491
N I +LE + + S + +SL L S
Sbjct: 100 TPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSS 159
Query: 492 NNLTGPVPAAIANLSNLKYVDLSFNDLSGILP-KELINLSHL 532
N +T P +ANL+ L+ +D+S N +S I +L NL L
Sbjct: 160 NQVTDLKP--LANLTTLERLDISSNKVSDISVLAKLTNLESL 199
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.4 bits (103), Expect = 2e-05
Identities = 31/180 (17%), Positives = 59/180 (32%), Gaps = 10/180 (5%)
Query: 339 IDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNAL 398
+D + L IP I + L+ N + S + L L+L N L
Sbjct: 13 VDCTGRGLK-EIPRDIPL-HTTELLLNDNE----LGRISSDGLFGRLPHLVKLELKRNQL 66
Query: 399 SGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAV 458
+G+ P+ S + L + N + L ++ L+ DN ++ +P
Sbjct: 67 TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
Query: 459 SLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDL 518
SL L + L L+ P+ + +++ DL ++
Sbjct: 127 SLTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.3 bits (100), Expect = 4e-05
Identities = 34/208 (16%), Positives = 60/208 (28%), Gaps = 30/208 (14%)
Query: 163 SFCS-SLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKL 221
+ C +V+ + L ++P I L L++N L
Sbjct: 4 AMCHCEGTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISS-------------- 46
Query: 222 GKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDW 281
G L L+ N L+G P++ + + L L N
Sbjct: 47 ---------DGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKM 97
Query: 282 IGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDV 341
L L++L+L NQ S +P S +L L + L +
Sbjct: 98 FLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS-LNLASNPFNCNCHLAWFAEWLRKKSL 156
Query: 342 SQNKLTGNIPTWIFKMGLQTVSLSGNRL 369
+ P+ + +Q L +
Sbjct: 157 NGGAARCGAPSKV--RDVQIKDLPHSEF 182
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (100), Expect = 4e-05
Identities = 18/143 (12%), Positives = 40/143 (27%), Gaps = 9/143 (6%)
Query: 158 IPESLSF--CSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYD 215
I ++ + ++ ++ + L ++D S+N + + G L
Sbjct: 8 IEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRR 64
Query: 216 LRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFT 275
L+ + + N+ L L NSL + +
Sbjct: 65 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124
Query: 276 GEVPDW----IGKLANLESLDLS 294
+ I K+ + LD
Sbjct: 125 TNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 7e-05
Identities = 12/72 (16%), Positives = 24/72 (33%), Gaps = 3/72 (4%)
Query: 476 SQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSF 535
+Q N L L + + A L +D S N++ + L L +
Sbjct: 12 AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68
Query: 536 NISHNHLHGELP 547
+++N +
Sbjct: 69 LVNNNRICRIGE 80
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 5e-04
Identities = 28/157 (17%), Positives = 52/157 (33%), Gaps = 14/157 (8%)
Query: 362 VSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNY 421
V L+ + ++ QY + + LDL + VI + L ++ S N
Sbjct: 1 VKLTAELIEQAAQYTNAVR-------DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE 52
Query: 422 LFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSG-RIPSQIKN 480
+ L+ ++ L ++N + L EL L N L + +
Sbjct: 53 IRKLDGFP--LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLAS 110
Query: 481 CSSLTSLILS---QNNLTGPVPAAIANLSNLKYVDLS 514
SLT L + N I + ++ +D
Sbjct: 111 LKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.002
Identities = 22/142 (15%), Positives = 47/142 (33%), Gaps = 7/142 (4%)
Query: 256 DSLQRLNSCS--SLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLK 313
+ Q N+ L L+G + + L +++D S N+ R L LK
Sbjct: 10 QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLK 66
Query: 314 ELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESM 373
L ++ N+ +L + ++ N L + L++++
Sbjct: 67 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 125
Query: 374 QYPSF-ASMKDSYQGLQVLDLS 394
+ + ++VLD
Sbjct: 126 NKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (99), Expect = 5e-05
Identities = 26/135 (19%), Positives = 54/135 (40%), Gaps = 6/135 (4%)
Query: 196 DLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLP 255
+L +E ++ +S YD L + D+ ++ VL+ +S++ +L
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLR 58
Query: 256 DSLQRLNSCSSLSLKGNSFTG--EVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLK 313
+ + SL+L N ++ + K NL+ L+LS N+ + L+
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 314 ELNISMNQFTGGLPE 328
EL + N + +
Sbjct: 119 ELWLDGNSLSDTFRD 133
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 9e-05
Identities = 25/122 (20%), Positives = 41/122 (33%), Gaps = 9/122 (7%)
Query: 425 SIPASIGKLK--AIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCS 482
+ + K + Q LD P + L + + + +N
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL----RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIP 65
Query: 483 SLTSLILSQNNLTG--PVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHN 540
L SL LS N L + + + NLK ++LS N+L + I L + N
Sbjct: 66 ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN 125
Query: 541 HL 542
L
Sbjct: 126 SL 127
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.002
Identities = 19/116 (16%), Positives = 38/116 (32%), Gaps = 6/116 (5%)
Query: 89 LLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVS 148
+ + +L + DL + V++ + + L L ++
Sbjct: 16 MSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAATL--RIIEENIPELLSLN 71
Query: 149 FANNNLTG--PIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLL 202
+NN L + + +L+ +N S N L + L+ L L N L
Sbjct: 72 LSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 43.1 bits (100), Expect = 5e-05
Identities = 29/200 (14%), Positives = 67/200 (33%), Gaps = 31/200 (15%)
Query: 253 SLPDSLQRL---NSCSSLSLKGNSFTGEVP------DWIGKLANLESLDLSLNQFSGRIP 303
++ D+++ S + + G +P + L + L LS N +I
Sbjct: 6 TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS 64
Query: 304 SSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVS 363
S+ + L+ L++ N E++ + L ++ + L+ +
Sbjct: 65 -SLSGMENLRILSLGRNLIKK--IENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLY 121
Query: 364 LSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLF 423
+S N++ + A++ L+ L L+ N L N + +
Sbjct: 122 MSNNKITNWGEIDKLAALDK----LEDLLLAGNPLYNDYKENNATSEYRIEV-------- 169
Query: 424 GSIPASIGKLKAIQVLDFSD 443
+ +L ++ LD
Sbjct: 170 ------VKRLPNLKKLDGMP 183
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 8e-05
Identities = 19/110 (17%), Positives = 35/110 (31%), Gaps = 2/110 (1%)
Query: 459 SLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNN-LTGPVPAAIANLSNLKYVDLSFND 517
L+ ++ + +LT L + L + L L+ + + +
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 518 LSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLC 567
L + P L N+S N L ++ +SGNP C
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 1e-04
Identities = 22/108 (20%), Positives = 37/108 (34%), Gaps = 2/108 (1%)
Query: 263 SCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSI-GNLVFLKELNISMNQ 321
S L + + + NL L + Q + L L+ L I +
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 322 FTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRL 369
P++ L +++S N L + + LQ + LSGN L
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 6e-04
Identities = 22/151 (14%), Positives = 37/151 (24%), Gaps = 7/151 (4%)
Query: 140 QCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIW-FLRSLQSLDLS 198
+ + L +L + + + L L L++L +
Sbjct: 6 CPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 199 NNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSL-PDS 257
+ L L + L N L L+ L N L S
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRW 123
Query: 258 LQRLNSCSSLSLKGNSFTGEVPDWIGKLANL 288
LQR + G LA++
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQ---GPLAHM 151
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 7e-04
Identities = 9/65 (13%), Positives = 21/65 (32%), Gaps = 2/65 (3%)
Query: 481 CSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLS-FNDLSGILPKELINLSHLLSFNISH 539
+ L +++ + NL + + L + ++L L L + I
Sbjct: 7 PHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 540 NHLHG 544
+ L
Sbjct: 66 SGLRF 70
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.002
Identities = 19/142 (13%), Positives = 39/142 (27%), Gaps = 1/142 (0%)
Query: 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNL 154
L + + L L + + R G LR ++ + L
Sbjct: 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 155 TGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLY 214
P++ F L +N S N L + L + + N L ++ +
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128
Query: 215 DLRAIKLGKNKFSGQLPEDIGG 236
+ + + K +
Sbjct: 129 EEGLGGVPEQKLQCHGQGPLAH 150
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 967 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.8 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.59 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.55 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.51 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.38 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.32 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.29 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.52 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.45 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.09 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.87 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.61 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.59 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.53 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.11 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.93 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.54 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.61 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-49 Score=416.50 Aligned_cols=264 Identities=26% Similarity=0.424 Sum_probs=209.3
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||+||+|+++ ..||||+++.... ....+.|.+|++++++++|||||++++++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 34688899999999999999864 3699999976543 4456789999999999999999999998754 568999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++|+|.++++.... .+++..+..++.|||+||+|||+++||||||||+|||++.++.+||+|||+|+..........
T Consensus 85 ~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 85 CEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp CCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 999999999976543 389999999999999999999999999999999999999999999999999987654444444
Q ss_pred cccccccccccCcccccC--cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 841 SSKIQSALGYMAPEFACR--TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~--~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.....||+.|+|||++.. ...++.++|||||||++|||+||+.||.......... ..+......+. ..
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~-~~~~~~~~~p~---------~~ 232 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-FMVGRGYLSPD---------LS 232 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH-HHHHHTSCCCC---------GG
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH-HHHhcCCCCCc---------ch
Confidence 456779999999998743 2457999999999999999999999997654433222 22221111111 11
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
..+.+++.++.+++.+||+.||++||||+|+++.|+.+.+.+
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 234566778999999999999999999999999999987643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=412.51 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=203.8
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.|+..+.||+|+||.||+|++.+++.||||++.... ...++|.+|++++++++|||||+++|++..++..++||||++
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 356678899999999999999989999999997644 456789999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+|+|.+++..... .+++..+..++.|||.||+|+|+++|+||||||+||++++++.+||+|||+++...... .....
T Consensus 84 ~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSST 160 (263)
T ss_dssp TCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred CCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC-ceeec
Confidence 9999999876543 38899999999999999999999999999999999999999999999999998765422 22233
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcC-CCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTG-KRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
...||+.|+|||.+ ....++.++|||||||++|||+|+ ++||..... ...... + ....+...|
T Consensus 161 ~~~gt~~y~aPE~l-~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~-i-------------~~~~~~~~p 224 (263)
T d1sm2a_ 161 GTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVED-I-------------STGFRLYKP 224 (263)
T ss_dssp ----CTTSCCHHHH-TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHH-H-------------HHTCCCCCC
T ss_pred ceecCcccCChHHh-cCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHH-H-------------HhcCCCCCc
Confidence 46789999999998 666899999999999999999995 555543322 121111 1 112233445
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
..++.++.+++.+||+.||++||||+|+++.|+++.+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 6677889999999999999999999999999998863
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-49 Score=413.38 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=206.8
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||+||+|+.+ +|+.||||++......+..+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 4677889999999999999965 689999999987654445567999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++|+|.+++.... .+++.++..++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+...........
T Consensus 86 ~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 86 SGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp TTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 9999999997543 3899999999999999999999999999999999999999999999999999877544444445
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....||+.|+|||++.....++.++||||+||++|||++|+.||............+.... ......
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~-------------~~~~~~ 229 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-------------TYLNPW 229 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC-------------TTSTTG
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------CCCCcc
Confidence 5678999999999984444457889999999999999999999975544333222221110 111122
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+.++.+++.+|++.||++|||++|+++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 345677899999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-48 Score=417.55 Aligned_cols=260 Identities=27% Similarity=0.365 Sum_probs=218.1
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||+||+|+++ +++.||||+++... ...++|.+|++++++++|||||++++++.+++..++||||+
T Consensus 18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 4577889999999999999976 58899999987654 45678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++|+|.+++...... .+++..+..++.|||.||+|||++||+||||||+|||+++++.+||+|||+|+.... ......
T Consensus 96 ~~g~l~~~l~~~~~~-~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~-~~~~~~ 173 (287)
T d1opja_ 96 TYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAH 173 (287)
T ss_dssp TTCBHHHHHHHSCTT-TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS-SSSEEE
T ss_pred cCcchHHHhhhcccc-chHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC-CCceee
Confidence 999999999765443 389999999999999999999999999999999999999999999999999987654 222334
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....|++.|+|||++ ....++.++|||||||++|||++|..||........ ..+. +....+.+.+
T Consensus 174 ~~~~g~~~y~aPE~~-~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~-------------i~~~~~~~~~ 238 (287)
T d1opja_ 174 AGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYEL-------------LEKDYRMERP 238 (287)
T ss_dssp TTEEECGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHH-------------HHTTCCCCCC
T ss_pred ccccccccccChHHH-cCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHH-------------HhcCCCCCCC
Confidence 456688899999988 566899999999999999999997776643332211 1111 2223344566
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLD 961 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 961 (967)
...+.++.+++.+||+.||++|||++|+++.|+.+.++-.
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~ 278 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSC
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCC
Confidence 7778889999999999999999999999999999876544
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-48 Score=416.04 Aligned_cols=258 Identities=29% Similarity=0.421 Sum_probs=204.4
Q ss_pred ccCCCCccCCCCceEEEEEEeCC-C---cEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQD-G---RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
.|+..+.||+|+||+||+|+.+. + ..||||++.........++|.+|++++++++|||||+++|++.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 35566789999999999999753 2 3689999877655556678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++|+|.+++..... .+++.++..++.|||+||+|||+++|+||||||+|||++.++.+||+|||+++........
T Consensus 107 Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp ECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 99999999998876543 3899999999999999999999999999999999999999999999999999876542221
Q ss_pred c---ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 839 I---LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 839 ~---~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
. ......||+.|+|||.+ ..+.++.++|||||||++|||+| |+.||....... ....+ ..
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--~~~~i-------------~~ 248 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAI-QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--VINAI-------------EQ 248 (299)
T ss_dssp -----------CGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH-------------HT
T ss_pred ceeeecccccCCccccCHHHH-hcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--HHHHH-------------Hc
Confidence 1 12234578999999998 66789999999999999999998 899997554321 11111 12
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
..+.+.+.+++.++.+++.+||+.||++||||+|+++.|+++.+
T Consensus 249 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 249 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 22344566778889999999999999999999999999998765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=402.07 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=215.6
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|++.+++..++||||++
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 457889999999999999999989999999998654 356789999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+|+|.+++..... .+++..+++++.||++||+|||++||+||||||+||+++.++.+||+|||+++..... ......
T Consensus 83 ~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCCCC
T ss_pred CCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC-Cceeec
Confidence 9999999776543 2789999999999999999999999999999999999999999999999999876543 223344
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
...||+.|+|||.+ ....++.++||||||+++|||+| |+.||+....... ... +....+...|
T Consensus 160 ~~~~t~~y~aPE~~-~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-----~~~----------i~~~~~~~~p 223 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVL-MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----AEH----------IAQGLRLYRP 223 (258)
T ss_dssp CSCCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-----HHH----------HHTTCCCCCC
T ss_pred ccCCCCCcCCcHHh-cCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-----HHH----------HHhCCCCCCc
Confidence 56789999999998 56678999999999999999998 8999976543321 111 1112233456
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
...+.++.+++.+||+.||++|||++|+++.|.+|
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 67778899999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=410.14 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=211.0
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecC
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFIS 762 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 762 (967)
.|+..+.||+|+||.||+|++++++.||||++.... ...+.|.+|++++++++|||||+++|++.+ +..++||||++
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 467788999999999999999988999999997654 456789999999999999999999998754 56799999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+|+|.+++...... .+++..+.+++.||++||+|||+++|+||||||+||++++++.+||+|||+|+..... ......
T Consensus 91 ~g~L~~~~~~~~~~-~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~~~~ 168 (272)
T d1qpca_ 91 NGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTARE 168 (272)
T ss_dssp TCBHHHHTTSHHHH-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEECCT
T ss_pred CCcHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC-cccccc
Confidence 99999987654332 3899999999999999999999999999999999999999999999999999877542 223344
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCCh
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPA 922 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (967)
...||+.|+|||++ ....++.++|||||||++|||+||..|+........... .+ ....+...+.
T Consensus 169 ~~~gt~~y~APE~~-~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~-~i-------------~~~~~~~~p~ 233 (272)
T d1qpca_ 169 GAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ-NL-------------ERGYRMVRPD 233 (272)
T ss_dssp TCCCCTTTSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HH-------------HTTCCCCCCT
T ss_pred ccCCcccccChHHH-hCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH-HH-------------HhcCCCCCcc
Confidence 56789999999998 566789999999999999999996555433322222111 11 1122334566
Q ss_pred hhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 923 DEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 923 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
..+.++.+++.+||+.||++||||+|++++|+.+..
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 677889999999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=408.46 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=209.7
Q ss_pred ccCCCCceEEEEEEeC---CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCCCc
Q 002094 689 ELGRGGFGVVYRTILQ---DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISSGS 765 (967)
Q Consensus 689 ~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 765 (967)
+||+|+||+||+|.++ ++..||||+++........++|.+|++++++++|||||+++|++.. +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 5999999999999864 3557999999876555567889999999999999999999999865 46789999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc-cccccc
Q 002094 766 LYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-ILSSKI 844 (967)
Q Consensus 766 L~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~ 844 (967)
|.+++..... .+++..+.+++.|||.||+|||+++|+||||||+||+++.++.+||+|||+++........ ......
T Consensus 95 L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~ 172 (285)
T d1u59a_ 95 LHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172 (285)
T ss_dssp HHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSS
T ss_pred HHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccccccccc
Confidence 9999865433 3899999999999999999999999999999999999999999999999999877543322 223355
Q ss_pred cccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCChh
Q 002094 845 QSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFPAD 923 (967)
Q Consensus 845 ~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (967)
.||+.|+|||++ ....++.++|||||||++|||+| |+.||........ ...+ ....+.+.|..
T Consensus 173 ~gt~~y~aPE~~-~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~--~~~i-------------~~~~~~~~p~~ 236 (285)
T d1u59a_ 173 KWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAFI-------------EQGKRMECPPE 236 (285)
T ss_dssp CCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HHHH-------------HTTCCCCCCTT
T ss_pred ccCccccChHHH-hCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH--HHHH-------------HcCCCCCCCCc
Confidence 688999999998 66689999999999999999998 9999976543211 1111 12223456677
Q ss_pred hHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 924 EAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 924 ~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
++.++.+++.+||+.||++||||.+|++.|+.+..
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 88899999999999999999999999999987653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=407.18 Aligned_cols=262 Identities=29% Similarity=0.447 Sum_probs=208.7
Q ss_pred cCCCCccCCCCceEEEEEEeCCC-----cEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQDG-----RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
|+..+.||+|+||.||+|.++.. ..||||++..........+|.+|++++++++|||||+++|++.+.+..++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 56778999999999999996642 4799999976655555678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc-
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR- 837 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 837 (967)
||+.++++.+++..... .+++.++.+++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 89 e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 89 EYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp ECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 99999999998876543 389999999999999999999999999999999999999999999999999987643222
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
........||+.|+|||++ ....++.++|||||||++|||++|..|+.......... + .+....+
T Consensus 167 ~~~~~~~~gt~~Y~APE~l-~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~-~-------------~i~~~~~ 231 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-K-------------AINDGFR 231 (283)
T ss_dssp -------CCCGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-H-------------HHHTTCC
T ss_pred ceEeccCCCCccccCHHHH-ccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHH-H-------------HHhccCC
Confidence 2223345689999999988 66789999999999999999999666654332222211 1 1222334
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
.+.+.+++.++.+++.+||+.||++||||+|++++|+++.+.-+.
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~ 276 (283)
T d1mqba_ 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276 (283)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccc
Confidence 456677888899999999999999999999999999988765433
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=401.89 Aligned_cols=248 Identities=20% Similarity=0.324 Sum_probs=208.1
Q ss_pred ccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 478889999999999999995 469999999997654 344678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
+||+|.+++... .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ...
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR 173 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCB
T ss_pred CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--ccc
Confidence 999999988653 28999999999999999999999999999999999999999999999999998764322 233
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....||+.|+|||++ .+..++.++||||+||++|||++|+.||...... .....+.... ......+
T Consensus 174 ~~~~gt~~Y~aPE~~-~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~~~~~~------------~~~~~~~ 239 (293)
T d1yhwa1 174 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIATNG------------TPELQNP 239 (293)
T ss_dssp CCCCSCGGGCCHHHH-SSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHHC------------SCCCSSG
T ss_pred cccccCCCccChhhh-cCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-HHHHHHHhCC------------CCCCCCc
Confidence 456799999999998 5667899999999999999999999999654332 1111111110 1112234
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+.++.+++.+|++.||++|||++|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 556778999999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=399.41 Aligned_cols=245 Identities=28% Similarity=0.432 Sum_probs=207.4
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||+||+|+.+ +++.||||++..... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 3678889999999999999975 689999999875432 2346789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 87 y~~~g~L~~~l~~~~~---l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---- 159 (263)
T d2j4za1 87 YAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---- 159 (263)
T ss_dssp CCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC----
T ss_pred ecCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC----
Confidence 9999999999986543 899999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......||+.|+|||++ .+..++.++||||+||++|||++|+.||...... .....+.+ ....
T Consensus 160 ~~~~~~Gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~---------------~~~~ 222 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ETYKRISR---------------VEFT 222 (263)
T ss_dssp CCEETTEEGGGCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHT---------------TCCC
T ss_pred cccccCCCCcccCHHHH-cCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-HHHHHHHc---------------CCCC
Confidence 22356799999999998 5667899999999999999999999999754322 11111111 1223
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
+|...+.++.+++.+|++.||++|||++|+++
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 45567788999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=402.88 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=204.1
Q ss_pred CccCCCCceEEEEEEeCC---CcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEecCC
Q 002094 688 CELGRGGFGVVYRTILQD---GRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFISS 763 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 763 (967)
++||+|+||+||+|.+++ ++.||||+++.... ....++|.+|++++++++|||||+++|++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 46899999975432 3345789999999999999999999999865 457899999999
Q ss_pred CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc-cccc
Q 002094 764 GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC-ILSS 842 (967)
Q Consensus 764 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~ 842 (967)
|+|.++++.... +++..+..++.||+.||+|||+++|+||||||+||+++.++.+|++|||+++........ ....
T Consensus 92 g~L~~~l~~~~~---l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccC---CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 999999987544 899999999999999999999999999999999999999999999999999876543222 2233
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
...||+.|+|||.+ ....++.++|||||||++|||+| |+.||....... ....+ ....+.+.|
T Consensus 169 ~~~gt~~y~APE~l-~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~~~i-------------~~~~~~~~p 232 (277)
T d1xbba_ 169 HGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAML-------------EKGERMGCP 232 (277)
T ss_dssp --CCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH-------------HTTCCCCCC
T ss_pred ccCCCceecCchhh-cCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HHHHH-------------HcCCCCCCC
Confidence 56789999999988 56678999999999999999998 899997554321 11111 122234556
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
..++.++.+++.+||+.||++|||+++|+++|+.+.
T Consensus 233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 777889999999999999999999999999998753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=414.52 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=212.3
Q ss_pred hccCCCCccCCCCceEEEEEEeCC-C-----cEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCce
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD-G-----RSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 754 (967)
+.|+..+.||+|+||+||+|+... + ..||||.+...........+.+|+.++.++ +|||||++++++.+++..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 346778899999999999999643 2 369999987655445567899999999998 899999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEE
Q 002094 755 LLIYEFISSGSLYKHLHDGSSR--------------------NCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVL 814 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~--------------------~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nil 814 (967)
++||||+++|+|.++++..... ..+++..++.++.||+.||+|||+++|+||||||+||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 9999999999999999765321 24889999999999999999999999999999999999
Q ss_pred eCCCCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchH
Q 002094 815 IDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVV 893 (967)
Q Consensus 815 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~ 893 (967)
++.++.+||+|||+|+...............||+.|+|||.+ ....++.++|||||||++|||+| |+.||........
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH-cCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999876554444445567789999999988 66789999999999999999998 8999975544322
Q ss_pred hHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 002094 894 VLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILE 954 (967)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 954 (967)
+..++. ...+.+.|..++.++.++|.+||+.||++|||++|+++.|.
T Consensus 276 -~~~~~~-------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 276 -FYKLIQ-------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -HHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHHh-------------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 222222 22334556777888999999999999999999999999996
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-47 Score=401.17 Aligned_cols=261 Identities=29% Similarity=0.379 Sum_probs=210.0
Q ss_pred hccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
+.|+..+.||+|+||.||+|+.++++.||||++.... ...+.|.+|+.++++++|||||+++|++. .+..++||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 3478889999999999999999988899999997554 45678999999999999999999999985 45689999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
++|+|..++...... .++|.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 94 ~~g~l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-~~~~~ 171 (285)
T d1fmka3 94 SKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTAR 171 (285)
T ss_dssp TTCBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CCCchhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC-Cceee
Confidence 999999998764332 2899999999999999999999999999999999999999999999999999876432 22233
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
....||+.|+|||++ ..+.++.++||||||+++|||++|..|+.........+. .+. ...+.+.+
T Consensus 172 ~~~~gt~~y~aPE~~-~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~-~i~-------------~~~~~~~~ 236 (285)
T d1fmka3 172 QGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVE-------------RGYRMPCP 236 (285)
T ss_dssp ----CCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHH-------------TTCCCCCC
T ss_pred ccccccccccChHHH-hCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHH-HHH-------------hcCCCCCC
Confidence 456789999999998 667899999999999999999997666544333322221 111 12234456
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDG 962 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 962 (967)
..++.++.+++.+||+.||++||||++|+++|+.+....++
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 67778899999999999999999999999999987755444
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=401.45 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=207.7
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
++|+..+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 45788889999999999999965 68999999997654 34557799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+++|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... ....
T Consensus 91 ~~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~ 166 (288)
T d2jfla1 91 CAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQR 166 (288)
T ss_dssp CTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHHH
T ss_pred CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC--Cccc
Confidence 999999999765332 389999999999999999999999999999999999999999999999999976532 1122
Q ss_pred cccccccccccCccccc----CcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 841 SSKIQSALGYMAPEFAC----RTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~----~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
.....||+.|+|||++. ....++.++||||+||++|||++|+.||...... ..+..+.... ..
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-~~~~~i~~~~------------~~ 233 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-RVLLKIAKSE------------PP 233 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GHHHHHHHSC------------CC
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCC------------CC
Confidence 34567999999999873 2456789999999999999999999999754432 2222222111 00
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
....+...+.++.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11234556778999999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=400.26 Aligned_cols=251 Identities=21% Similarity=0.337 Sum_probs=194.6
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEc--CCceeEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWT--PSLQLLIY 758 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 758 (967)
.|+..+.||+|+||+||+|+.+ +|+.||||.+..... ....+.+.+|++++++++|||||++++++.+ .+..++||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 4678899999999999999965 689999999976643 3345678999999999999999999999865 45678999
Q ss_pred EecCCCchhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCCCCEEeCCCCCeEEeeccccccc
Q 002094 759 EFISSGSLYKHLHDGS-SRNCLSWRQRFNIILGMAKGLAYLHHTN-----IIHYNLKSTNVLIDSSGEPKVGDFGLARLL 832 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~-----ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 832 (967)
||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 9999999999986532 1224899999999999999999999876 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhc
Q 002094 833 PMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCV 912 (967)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (967)
... ........||+.|+|||++ .+..++.++||||+||++|||++|+.||...... .....+.. +
T Consensus 165 ~~~--~~~~~~~~gt~~Y~APE~l-~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-~~~~~i~~-----~------ 229 (269)
T d2java1 165 NHD--TSFAKAFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAGKIRE-----G------ 229 (269)
T ss_dssp -------------CCCSCCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH-----T------
T ss_pred ccC--CCccccCCCCcccCCHHHH-cCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-HHHHHHHc-----C------
Confidence 432 2223457789999999998 6668999999999999999999999999754332 11111111 1
Q ss_pred chhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 913 DARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 913 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+...+.++.+++.+|++.||++|||++|+++
T Consensus 230 ---~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 230 ---KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112244556778999999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-46 Score=402.74 Aligned_cols=261 Identities=25% Similarity=0.368 Sum_probs=215.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
+.|+..+.||+|+||+||+|+.+ +++.||||++.........++|.+|++++++++||||+++++++...+..+
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence 34688899999999999999864 457899999987665555678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEE
Q 002094 756 LIYEFISSGSLYKHLHDGSS---------------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVL 814 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nil 814 (967)
+||||+++|+|.++++.... ...+++..+..++.|++.||+|||+++||||||||+||+
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL 172 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 172 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence 99999999999999975322 123789999999999999999999999999999999999
Q ss_pred eCCCCCeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCC-CCCCCCccchH
Q 002094 815 IDSSGEPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK-RPVEYMEDDVV 893 (967)
Q Consensus 815 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~-~p~~~~~~~~~ 893 (967)
+|.++.+||+|||+|+...........+...|++.|+|||.+ ....++.++|||||||++|||++|. +||...... .
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~-e 250 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-E 250 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-H
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH-ccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH-H
Confidence 999999999999999876554444445567788999999998 6678999999999999999999985 677644332 1
Q ss_pred hHHHHHHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 894 VLCDMVRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.. ..+ . ...+...+.+.+.++.+++.+||+.||++||||.||+++|+++.+
T Consensus 251 ~~-~~v----~---------~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 251 VI-YYV----R---------DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HH-HHH----H---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HH-HHH----H---------cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 111 1 111233466777889999999999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=392.74 Aligned_cols=246 Identities=28% Similarity=0.416 Sum_probs=198.6
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEc----CCceeEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWT----PSLQLLI 757 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv 757 (967)
|+..++||+|+||+||+|+.. +++.||+|++..... ....+.+.+|++++++++|||||++++++.. +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 455668999999999999965 688999999976543 3345679999999999999999999999864 3457899
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCCCCEEeC-CCCCeEEeecccccccCC
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTN--IIHYNLKSTNVLID-SSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~--ivH~Dik~~Nill~-~~~~~kl~Dfg~a~~~~~ 834 (967)
|||+++|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+|+....
T Consensus 91 mE~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHhcccc---ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999976543 899999999999999999999998 99999999999996 578999999999976432
Q ss_pred CccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 835 LDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
.......||+.|+|||++ .+ .++.++||||+||++|||++|+.||............ + ..+..
T Consensus 168 ----~~~~~~~GT~~Y~aPE~~-~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~-i----~~~~~------ 230 (270)
T d1t4ha_ 168 ----SFAKAVIGTPEFMAPEMY-EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-V----TSGVK------ 230 (270)
T ss_dssp ----TSBEESCSSCCCCCGGGG-GT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH-H----TTTCC------
T ss_pred ----CccCCcccCccccCHHHh-CC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH-H----HcCCC------
Confidence 123356799999999988 33 5899999999999999999999999754433222111 1 11100
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...++...+.++.+++.+|+++||++|||++|+++
T Consensus 231 --~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 --PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11123344567999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=399.84 Aligned_cols=249 Identities=20% Similarity=0.262 Sum_probs=205.6
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||+||+|+.+ +|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 4788899999999999999964 689999999975432 2345789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|++||+|.+++..... +++..+..++.|++.||+|||++||+||||||+||++++++.+||+|||+|+.........
T Consensus 89 y~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ccCCCCHHHhhhccCC---CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 9999999999886544 8999999999999999999999999999999999999999999999999998775444444
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......||+.|+|||++ .+..++.++||||+||++|||++|+.||...... .....+.. ....
T Consensus 166 ~~~~~~GT~~Y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~---------------~~~~ 228 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-LIFQKIIK---------------LEYD 228 (288)
T ss_dssp ----CCCCGGGCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHT---------------TCCC
T ss_pred ccccccCCccccCceee-ccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-HHHHHHHc---------------CCCC
Confidence 44566799999999998 5667899999999999999999999999754322 21111111 1123
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
++...+.++.++|.+|++.||++|||++|+++
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 45566778999999999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-46 Score=400.13 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=191.6
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||+||+|+.+ +|+.||||++.........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45788899999999999999965 68999999998765444556789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC---CCCCeEEeecccccccCCCcc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID---SSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~---~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
++||+|.+++..... +++..+..++.||+.||+|||++||+||||||+||++. +++.+||+|||+|+.....
T Consensus 89 ~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-- 163 (307)
T d1a06a_ 89 VSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-- 163 (307)
T ss_dssp CCSCBHHHHHHTCSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred cCCCcHHHhhhcccC---CCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC--
Confidence 999999999976543 89999999999999999999999999999999999994 5789999999999866432
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.......||+.|+|||++ .+..++.++||||+||++|||++|+.||...... .....+.... ....
T Consensus 164 -~~~~~~~GT~~y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~~~-----------~~~~ 229 (307)
T d1a06a_ 164 -SVLSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLFEQILKAE-----------YEFD 229 (307)
T ss_dssp ----------CTTSCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHTTC-----------CCCC
T ss_pred -CeeeeeeeCccccCcHHH-cCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHhccC-----------CCCC
Confidence 223356799999999998 6667899999999999999999999999754332 1111111110 0111
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+.+.+.++.+++.+|++.||++|||++|+++
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 2234456778999999999999999999999976
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-46 Score=400.23 Aligned_cols=246 Identities=27% Similarity=0.396 Sum_probs=203.0
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||+||+|+.. +|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4688889999999999999954 688999999976543 2334678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
||++|++..++..... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 96 ~~~~g~l~~~~~~~~~---l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred ecCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 9999999877665433 89999999999999999999999999999999999999999999999999986532
Q ss_pred ccccccccccccCcccccC--cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 840 LSSKIQSALGYMAPEFACR--TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~--~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.....||+.|+|||++.. .+.++.++||||+||++|||++|+.||...... ..+...... ...
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~~~i~~~-------------~~~ 232 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQN-------------ESP 232 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHS-------------CCC
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhC-------------CCC
Confidence 234679999999998743 356899999999999999999999999754332 111111111 011
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...+...+.++.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1123345678999999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=406.07 Aligned_cols=263 Identities=21% Similarity=0.348 Sum_probs=206.4
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
++.|+..+.||+|+||+||+|+.. +|+.||+|+++..........+.+|++++++++|||||++++++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 345788899999999999999964 6899999999876545556789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHT-NIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
|++||+|.+++.+... +++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~~~---l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 157 (322)
T ss_dssp CCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----
T ss_pred cCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC----
Confidence 9999999999986543 89999999999999999999975 999999999999999999999999999986532
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHH--Hhhhc------------
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMV--RGALE------------ 904 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~--~~~~~------------ 904 (967)
.......||+.|+|||++ .+..++.++||||+||++|||++|+.||.............. .+...
T Consensus 158 ~~~~~~~GT~~Y~APEvl-~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 SMANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp HTC---CCSSCCCCHHHH-HCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred CccccccCCccccCchHH-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 123356799999999999 566899999999999999999999999975443322111000 00000
Q ss_pred ----------cCCchhhcchhhc---CCCC-hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 905 ----------DGRVEDCVDARLR---GNFP-ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 905 ----------~~~~~~~~~~~~~---~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+..+.... ...+ ...+.++.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000000010000 0111 123567999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=390.60 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=201.7
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEc-CCceeEEEEecC
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT-PSLQLLIYEFIS 762 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~ 762 (967)
|+..+.||+|+||.||+|+++ |+.||||+++... ..+.+.+|++++++++|||||+++|++.+ ++..++||||++
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred eEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 466788999999999999985 7899999997543 45779999999999999999999999865 456799999999
Q ss_pred CCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccccc
Q 002094 763 SGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILSS 842 (967)
Q Consensus 763 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 842 (967)
+|+|.+++...... .+++..+++++.||+.||+|||+.+|+||||||+||+++.++.+|++|||+++.... ...
T Consensus 85 ~g~L~~~l~~~~~~-~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----~~~ 158 (262)
T d1byga_ 85 KGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQD 158 (262)
T ss_dssp TEEHHHHHHHHHHH-HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-----CCc
Confidence 99999999754322 379999999999999999999999999999999999999999999999999986532 223
Q ss_pred cccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCCCC
Q 002094 843 KIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGNFP 921 (967)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (967)
...+++.|+|||++ .++.++.++||||||+++|||+| |++||....... ....+ ....+.+.+
T Consensus 159 ~~~~~~~y~aPE~l-~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i-------------~~~~~~~~~ 222 (262)
T d1byga_ 159 TGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRV-------------EKGYKMDAP 222 (262)
T ss_dssp ---CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHH-------------TTTCCCCCC
T ss_pred cccccccCCChHHH-hCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHHH-------------HcCCCCCCC
Confidence 44578889999998 56689999999999999999998 788887544321 11111 223345567
Q ss_pred hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 922 ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 922 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
...+.++.+++.+||+.||++||||.|++++|++++.
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 7778889999999999999999999999999998863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=393.16 Aligned_cols=257 Identities=26% Similarity=0.352 Sum_probs=202.1
Q ss_pred hccCCCCccCCCCceEEEEEEeCC----CcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD----GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|+..+.||+|+||.||+|++.. +..||||.++........+.+.+|++++++++|||||+++|++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 346778899999999999998643 45789999876554555678999999999999999999999985 5678999
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
|||+++|++.+++..... .+++..+..++.||++||+|||+++|+||||||+||+++.++.+||+|||+|+..... .
T Consensus 86 ~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~-~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-T 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC-c
Confidence 999999999998775443 3899999999999999999999999999999999999999999999999999876432 2
Q ss_pred ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhh
Q 002094 838 CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARL 916 (967)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (967)
........||+.|+|||.+ ....++.++|||||||++|||++ |.+||........ .. .+. ...
T Consensus 163 ~~~~~~~~gt~~y~apE~l-~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~-~~-~i~-------------~~~ 226 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-IG-RIE-------------NGE 226 (273)
T ss_dssp --------CCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HH-HHH-------------TTC
T ss_pred ceeccceecCcccchhhHh-ccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH-HH-HHH-------------cCC
Confidence 2334456688999999998 66689999999999999999998 8999976544321 11 111 112
Q ss_pred cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 917 RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 917 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
+.+.+...+.++.++|.+||+.||++|||++|+++.|+.+.+
T Consensus 227 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 234566778889999999999999999999999999998864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=400.56 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=206.8
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCc----EEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGR----SVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
|+..+.||+|+||+||+|++. +|+ +||||++......+..++|.+|++++++++|||||+++|++.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 678889999999999999965 343 68999987665556678899999999999999999999999865 567889
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+.+|+|.+++..... .+++..+++++.|||.||+|||+++|+||||||+||+++.++.+||+|||+|+........
T Consensus 90 e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~ 167 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167 (317)
T ss_dssp ECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred EeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence 99999999998876543 3899999999999999999999999999999999999999999999999999877654444
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhc
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLR 917 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (967)
.......||+.|+|||.+ ..+.++.++|||||||++|||+| |++||+...... +... +....+
T Consensus 168 ~~~~~~~gt~~y~APE~l-~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~-------------i~~~~~ 231 (317)
T d1xkka_ 168 YHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI-------------LEKGER 231 (317)
T ss_dssp -------CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHH-------------HHHTCC
T ss_pred ccccccccCccccChHHH-hcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHH-------------HHcCCC
Confidence 444456789999999988 56689999999999999999998 899997554332 1111 222234
Q ss_pred CCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 918 GNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 918 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
...+..++.++.+++.+||+.||++|||++|+++.|+.+.
T Consensus 232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 4566778889999999999999999999999999998774
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=391.21 Aligned_cols=260 Identities=26% Similarity=0.342 Sum_probs=211.0
Q ss_pred CCccCCCCceEEEEEEeCCC----cEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEc-CCceeEEEEec
Q 002094 687 DCELGRGGFGVVYRTILQDG----RSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWT-PSLQLLIYEFI 761 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 761 (967)
.++||+|+||+||+|++.++ ..||||++.........++|.+|++++++++|||||+++|++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999996542 36899999765545566889999999999999999999999865 56789999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc--cc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR--CI 839 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~ 839 (967)
++|+|.++++..... .++..+.+++.|++.||+|+|+.+|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 112 ~~g~l~~~~~~~~~~--~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~ 189 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189 (311)
T ss_dssp TTCBHHHHHHCTTCC--CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred ecCchhhhhcccccc--chHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence 999999998865443 77889999999999999999999999999999999999999999999999987643222 12
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......||+.|+|||.+ ....++.++||||||+++|||++|+.||......... ...+ ....+..
T Consensus 190 ~~~~~~gt~~y~aPE~~-~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~-~~~i-------------~~g~~~~ 254 (311)
T d1r0pa_ 190 NKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TVYL-------------LQGRRLL 254 (311)
T ss_dssp CTTCSSCCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C-HHHH-------------HTTCCCC
T ss_pred ecccccccccccChHHH-hcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH-HHHH-------------HcCCCCC
Confidence 23346789999999998 6678999999999999999999988887543222111 1111 1112334
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCc
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPLDGQ 963 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~ 963 (967)
.|..++.++.+++.+||+.||++||||+||++.|+++.+.+...
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 45667788999999999999999999999999999999876653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=395.21 Aligned_cols=262 Identities=28% Similarity=0.366 Sum_probs=205.8
Q ss_pred hccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcC-Cc
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTP-SL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~ 753 (967)
+.|+..+.||+|+||.||+|+.. +++.||||+++........+.+.+|...+.++ +|+|||.+++++.++ ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 45788899999999999999853 34689999998665555567788888888777 689999999998765 46
Q ss_pred eeEEEEecCCCchhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSS-------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGE 820 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~ 820 (967)
.++|||||++|+|.++++.... ...+++.++..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence 7899999999999999975432 224889999999999999999999999999999999999999999
Q ss_pred eEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcC-CCCCCCCccchHhHHHHH
Q 002094 821 PKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTG-KRPVEYMEDDVVVLCDMV 899 (967)
Q Consensus 821 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg-~~p~~~~~~~~~~~~~~~ 899 (967)
+||+|||+|+...............||+.|+|||.+ .+..++.++|||||||++|||++| .+||........ +...+
T Consensus 173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l-~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-~~~~~ 250 (299)
T d1ywna1 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRL 250 (299)
T ss_dssp EEECC------CCSCTTSCCTTSCCCGGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-HHHHH
T ss_pred EEEccCcchhhccccccccccCceeeCccccchhHh-hcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-HHHHH
Confidence 999999999876554444445567899999999998 667899999999999999999986 567865443322 11111
Q ss_pred HhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 900 RGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
....+...+...+.++.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 251 -------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 251 -------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp -------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------hcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1222334566677889999999999999999999999999998864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=395.78 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=220.0
Q ss_pred hccCCCCccCCCCceEEEEEEe------CCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCce
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL------QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 754 (967)
+.|+..+.||+|+||.||+|++ .+++.||||+++.........++.+|+.+++++ +|||||++++++.+++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 3467788999999999999985 246789999998766555667899999999999 699999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSS---------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG 819 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~ 819 (967)
++||||+++|+|.++++.... ...+++..+.+++.||+.|++|||+++++||||||+||+++.++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence 999999999999999976432 12488999999999999999999999999999999999999999
Q ss_pred CeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHH
Q 002094 820 EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDM 898 (967)
Q Consensus 820 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~ 898 (967)
.+|++|||.++...........+...||+.|+|||.+ ....++.++|||||||++|||+| |.+||....... .+..+
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~-~~~~~ 260 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-KFYKM 260 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-HHHHH
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHh-cCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH-HHHHH
Confidence 9999999999987665555556678899999999998 66789999999999999999999 556665443322 22222
Q ss_pred HHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 899 VRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
++...+...+...+.++.++|.+||+.||++||||+|++++|+++.+
T Consensus 261 -------------i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 261 -------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp -------------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 22334445566677889999999999999999999999999987654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-45 Score=391.19 Aligned_cols=261 Identities=28% Similarity=0.373 Sum_probs=214.2
Q ss_pred hccCCCCccCCCCceEEEEEEeCC--------CcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCC
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD--------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPS 752 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 752 (967)
+.|+..+.||+|+||.||+|+... +..||||+++.........++.+|...+.++ +|||||++++++.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 456778899999999999998532 3479999998776555668899999999888 7999999999999999
Q ss_pred ceeEEEEecCCCchhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC
Q 002094 753 LQLLIYEFISSGSLYKHLHDGSS-------------RNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG 819 (967)
Q Consensus 753 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~ 819 (967)
..++||||+++|+|.+++..... ...+++.++++++.||+.||+|||+++||||||||+|||++.++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence 99999999999999999976542 12489999999999999999999999999999999999999999
Q ss_pred CeEEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHH
Q 002094 820 EPKVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDM 898 (967)
Q Consensus 820 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~ 898 (967)
.+||+|||+++...............+++.|+|||.+ ..+.++.++||||||+++|||++ |++||.....+. ..+
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l-~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--~~~- 248 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LFK- 248 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH-
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHh-cCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--HHH-
Confidence 9999999999877654444445567789999999998 66789999999999999999998 788886544321 111
Q ss_pred HHhhhccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 899 VRGALEDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
.+....+...+...+.++.+++.+||+.||++|||++||++.|+++..
T Consensus 249 ------------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 249 ------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ------------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 112233445566777889999999999999999999999999998853
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=389.45 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=206.9
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-----cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCce
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-----IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQ 754 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 754 (967)
.+.|+..+.||+|+||+||+|+.+ +|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 356788999999999999999964 689999999975432 22467899999999999999999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC----CeEEeeccccc
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG----EPKVGDFGLAR 830 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~----~~kl~Dfg~a~ 830 (967)
++|||||++|+|.+++..... +++..+..++.|++.||+|||+++|+||||||+||+++.++ .+|++|||+|.
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~---l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhccccc---cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999976543 89999999999999999999999999999999999998776 59999999998
Q ss_pred ccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchh
Q 002094 831 LLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVED 910 (967)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (967)
..... .......||+.|+|||++ ....++.++||||+||++|||++|+.||...... ..+..+......
T Consensus 166 ~~~~~---~~~~~~~~t~~y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~~~~~------ 234 (293)
T d1jksa_ 166 KIDFG---NEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVSAVNYE------ 234 (293)
T ss_dssp ECTTS---CBCSCCCCCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHTTCCC------
T ss_pred hcCCC---ccccccCCCCcccCHHHH-cCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-HHHHHHHhcCCC------
Confidence 76432 223456789999999998 6667899999999999999999999999754332 212221111000
Q ss_pred hcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 911 CVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 911 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+...+.++.+++.+|++.||++|||++|+++
T Consensus 235 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 -----FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000112345567899999999999999999999876
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-44 Score=395.56 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=208.0
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++|||||++++++.+++..++||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45788899999999999999964 69999999997654 33456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC--CCCCeEEeecccccccCCCccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID--SSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~--~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
|+||+|.+++..... .+++.++..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|......
T Consensus 108 ~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--- 182 (352)
T d1koba_ 108 LSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--- 182 (352)
T ss_dssp CCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---
T ss_pred CCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC---
Confidence 999999988765432 389999999999999999999999999999999999998 5789999999999877532
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......||+.|+|||++ .+..++.++||||+||++|||++|+.||...... ..+..+.... .....
T Consensus 183 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~-----------~~~~~ 249 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCD-----------WEFDE 249 (352)
T ss_dssp SCEEEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCC-----------CCCCS
T ss_pred CceeeccCcccccCHHHH-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC-----------CCCCc
Confidence 223456789999999998 6668999999999999999999999999754332 2222221111 01112
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
......+.++.+++.+|++.||++|||++|+++
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233456678999999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=387.70 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=198.8
Q ss_pred ccCCCCccCCCCceEEEEEEeC--C--CcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ--D--GRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLL 756 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~--~--~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 756 (967)
.|+..+.||+|+||.||+|+.. + ...||||++..... .+..++|.+|++++++++|||||+++|++.+ +..++
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence 3577889999999999999853 2 24789999876533 2335689999999999999999999999965 46789
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCc
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 836 (967)
||||+++|++.+++..... .+++..+..++.|||.||+|||+++|+||||||+||+++.++.+||+|||+++......
T Consensus 88 v~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 9999999999998875433 38999999999999999999999999999999999999999999999999998775432
Q ss_pred c-ccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHc-CCCCCCCCccchHhHHHHHHhhhccCCchhhcch
Q 002094 837 R-CILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVT-GKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA 914 (967)
Q Consensus 837 ~-~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (967)
. ........|+..|+|||.+ ....++.++||||||+++|||+| |++||........ .. .+ . ..
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~-~~-~i---~---------~~ 230 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESL-KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-LH-KI---D---------KE 230 (273)
T ss_dssp CEEEC-----CCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HH-HH---H---------TS
T ss_pred CcceecCccccCcccCCHHHH-hCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH-HH-HH---H---------hC
Confidence 2 2233455678899999998 56789999999999999999998 8999975543321 11 11 1 11
Q ss_pred hhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 002094 915 RLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELI 956 (967)
Q Consensus 915 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~ 956 (967)
..+.+.+...+.++.+++.+||+.||++||||+|+.+.|++.
T Consensus 231 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 223344566778899999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-44 Score=396.78 Aligned_cols=250 Identities=25% Similarity=0.347 Sum_probs=206.3
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4788899999999999999964 68999999997654 344678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeC--CCCCeEEeecccccccCCCcccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLID--SSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~--~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
+||+|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++..... .
T Consensus 106 ~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~---~ 180 (350)
T d1koaa2 106 SGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---Q 180 (350)
T ss_dssp CSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT---S
T ss_pred CCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc---c
Confidence 99999999965433 389999999999999999999999999999999999996 4678999999999876432 2
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
......||+.|+|||++ .+..++.++||||+||++|||++|+.||...... ..+..+...... ....
T Consensus 181 ~~~~~~gT~~Y~aPEv~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~-----------~~~~ 247 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVA-EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWN-----------MDDS 247 (350)
T ss_dssp CEEEECSCTTTCCHHHH-HTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCC-----------SCCG
T ss_pred ccceecCcccccCHHHH-cCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC-----------CCcc
Confidence 23456789999999998 5667899999999999999999999999754332 222222211110 0111
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+.++.+++.+|++.||++|||++|+++
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22345667999999999999999999999976
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=392.30 Aligned_cols=258 Identities=25% Similarity=0.368 Sum_probs=207.5
Q ss_pred hccCCCCccCCCCceEEEEEEeCC-Cc--EEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEcCCceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQD-GR--SVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 757 (967)
+.|+..++||+|+||.||+|++++ |. .||||++.........++|.+|+++++++ +|||||+++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 345777899999999999999754 43 57888887655445567899999999999 799999999999999999999
Q ss_pred EEecCCCchhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEe
Q 002094 758 YEFISSGSLYKHLHDGS-------------SRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVG 824 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~ 824 (967)
|||+++|+|.++++... ....+++..+++++.|||.||+|+|+++|+||||||+|||++.++.+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 99999999999997642 22358999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCC-CCCCCCccchHhHHHHHHhhh
Q 002094 825 DFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK-RPVEYMEDDVVVLCDMVRGAL 903 (967)
Q Consensus 825 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~ 903 (967)
|||+++.... ........||+.|+|||.+ ....++.++|||||||++|||++|. +||....... +.+.
T Consensus 170 DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l-~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--~~~~----- 238 (309)
T d1fvra_ 170 DFGLSRGQEV---YVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEK----- 238 (309)
T ss_dssp CTTCEESSCE---ECCC----CCTTTCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH-----
T ss_pred cccccccccc---cccccceecCCcccchHHh-ccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--HHHH-----
Confidence 9999976532 2223345688999999998 6668999999999999999999965 5675443221 1111
Q ss_pred ccCCchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 904 EDGRVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
+....+.+.+...+.++.++|.+||+.||++||||+|+++.|+++.+
T Consensus 239 --------i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 239 --------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp --------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11223445566778899999999999999999999999999998874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=388.89 Aligned_cols=248 Identities=22% Similarity=0.280 Sum_probs=208.4
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+..+.||+|+||+||+|+. .+|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 3468889999999999999996 4799999999975432 234678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||++||+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... .
T Consensus 85 ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--G 159 (337)
T ss_dssp ECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--T
T ss_pred eccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC--C
Confidence 99999999999987554 889999999999999999999999999999999999999999999999999865432 2
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......||+.|+|||++ .+..++.++||||+||++|||++|++||...... .....+... ..
T Consensus 160 ~~~~~~~GT~~Y~aPE~~-~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-~~~~~i~~~---------------~~ 222 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILME---------------EI 222 (337)
T ss_dssp CCBCCCEECGGGCCGGGG-SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHC---------------CC
T ss_pred cccccceeCHHHhhhhhc-cCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-HHHHHHhcC---------------CC
Confidence 233457799999999998 6667899999999999999999999999754432 111111111 12
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPD-----MEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~ 951 (967)
.+|...+.++.++|.+|+++||++||+ ++|+++
T Consensus 223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 345667778999999999999999995 777765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=388.36 Aligned_cols=263 Identities=24% Similarity=0.349 Sum_probs=217.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC------CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ------DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
+.|+..+.||+|+||.||+|.++ +++.||||+++..........|.+|++++++++|||||++++++..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 34677889999999999999863 357899999986655555677999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeeccc
Q 002094 756 LIYEFISSGSLYKHLHDG-------SSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGL 828 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~ 828 (967)
+||||+++|+|.++++.. .....+++..+.+++.|+|+||+|||+++|+||||||+|||+++++.+||+|||+
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeeccc
Confidence 999999999999998642 1222378999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCC-CCCCCCccchHhHHHHHHhhhccCC
Q 002094 829 ARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGK-RPVEYMEDDVVVLCDMVRGALEDGR 907 (967)
Q Consensus 829 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 907 (967)
++...............||+.|+|||.+ ....++.++||||||+++|||+||. .||...... ..+..+.
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l-~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-~~~~~i~-------- 249 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVM-------- 249 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-HHHHHHH--------
T ss_pred ceeccCCcceeeccceecccccCCHHHH-ccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH--------
Confidence 9877554444445566789999999998 6668899999999999999999984 777644332 1111111
Q ss_pred chhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 002094 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSPL 960 (967)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 960 (967)
...+...+..++..+.+++.+||+.||++||||+|++++|++..++.
T Consensus 250 ------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 250 ------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp ------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred ------hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 11223345667788999999999999999999999999999876644
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8e-44 Score=384.85 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=206.3
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||+||+|+.+ +|+.||||+++.... ....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 3678899999999999999964 689999999975432 3446789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|++||++..++..... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 85 YIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp CCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred ecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 9999999999987655 788999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
.....||+.|+|||++ .+..++.++||||+||++|||++|+.||...... .....+... ...
T Consensus 158 -~~~~~Gt~~Y~APE~l-~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~---------------~~~ 219 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNA---------------ELR 219 (316)
T ss_dssp -BCCCCSCTTTCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHC---------------CCC
T ss_pred -cccccCcccccCHHHH-cCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-HHHHHHHcC---------------CCC
Confidence 2356799999999998 6667899999999999999999999999754332 111111111 123
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
++...+.++.+++.+|+..||.+|+ |++|+++
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 4556677899999999999999996 8999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.7e-44 Score=382.30 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=204.0
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC----ce
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS----LQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~ 754 (967)
+.|+..+.||+|+||.||+|+. .+|+.||||+++.... ....+.+.+|++++++++|||||++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 4578889999999999999996 4799999999976543 233467999999999999999999999987643 37
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
|+||||++|++|.+++..... +++.++..++.||+.||+|||++||+||||||+||+++.++.++++|||.+.....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhcccCC---CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 899999999999999876544 89999999999999999999999999999999999999999999999999876533
Q ss_pred Cc-cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcc
Q 002094 835 LD-RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913 (967)
Q Consensus 835 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (967)
.. .........||+.|+|||++ .+..++.++||||+||++|||+||++||...... ...... +......
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~~----~~~~~~~---- 233 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQH----VREDPIP---- 233 (277)
T ss_dssp ---------------TTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH----HHCCCCC----
T ss_pred ccccccccccccCcccccCHHHH-cCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-HHHHHH----HhcCCCC----
Confidence 22 22234456799999999998 6668899999999999999999999999754332 212222 2111110
Q ss_pred hhhcCCCChhhHHHHHHHHHhhccCCCCCCC-CHHHHHHHHHhhcC
Q 002094 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRP-DMEEVVNILELIQS 958 (967)
Q Consensus 914 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~evl~~L~~~~~ 958 (967)
......+.+.++.+++.+|+++||++|| |++|+.+.|.+++.
T Consensus 234 ---~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 234 ---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp ---GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ---CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 1112344567799999999999999999 89999999988764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-43 Score=375.60 Aligned_cols=252 Identities=25% Similarity=0.326 Sum_probs=206.1
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCcc--------ccHHHHHHHHHHHcCCC-CCceeeeeeEEEcC
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLI--------KSQEDFEKEMKTLGKIR-HHNLVALEGYYWTP 751 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 751 (967)
+.|+..+.||+|+||+||+|+. .+|+.||||++...... ...+.+.+|++++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 3467889999999999999996 47899999999765321 12346889999999996 99999999999999
Q ss_pred CceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 752 SLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
+..++||||+++|+|.++++.... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 999999999999999999976443 89999999999999999999999999999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcccccC-----cccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccC
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACR-----TVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDG 906 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 906 (967)
.... .......||+.|+|||.+.. ...++.++||||+||++|||++|+.||...... .....+..+..
T Consensus 160 ~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-~~~~~i~~~~~--- 232 (277)
T d1phka_ 160 LDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMSGNY--- 232 (277)
T ss_dssp CCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC---
T ss_pred ccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-HHHHHHHhCCC---
Confidence 7542 22345679999999998732 334688999999999999999999999754432 12222221111
Q ss_pred CchhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 907 RVEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..........+.++.+++.+|++.||++|||++|+++
T Consensus 233 --------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 233 --------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1112223456778999999999999999999999865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.6e-43 Score=388.34 Aligned_cols=250 Identities=21% Similarity=0.281 Sum_probs=202.5
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHH---HHHHHHHcCCCCCceeeeeeEEEcCCcee
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDF---EKEMKTLGKIRHHNLVALEGYYWTPSLQL 755 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 755 (967)
+.|+..+.||+|+||.||+|+.. +|+.||||++..... ......+ ..|+++++.++|||||++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 34688899999999999999965 689999999865332 1222333 34577888889999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCC
Q 002094 756 LIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPML 835 (967)
Q Consensus 756 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 835 (967)
+||||++||+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999999976543 789999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh
Q 002094 836 DRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR 915 (967)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (967)
......||+.|+|||++..+..++.++||||+||++|||++|+.||........ ....+... .
T Consensus 161 ----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~~-----------~ 223 (364)
T d1omwa3 161 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTL-----------T 223 (364)
T ss_dssp ----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHHHSS-----------S
T ss_pred ----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcc-----------c
Confidence 234567999999999985566789999999999999999999999975433211 11111111 1
Q ss_pred hcCCCChhhHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 002094 916 LRGNFPADEAIPVIKLGLICASQVPSNRPD-----MEEVVN 951 (967)
Q Consensus 916 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~ 951 (967)
.....+...+.++.++|.+|++.||++||| ++|+++
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 122345566778999999999999999999 677764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-43 Score=384.86 Aligned_cols=244 Identities=23% Similarity=0.305 Sum_probs=206.2
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 759 (967)
.|+..+.||+|+||.||+|+.+ +|+.||||++..... ....+.+.+|+++++.++|||||++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 4688899999999999999964 699999999975432 2345779999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCI 839 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 839 (967)
|+.+|+|.+++..... +++..+..++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+.....
T Consensus 122 ~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred cccccchhhhHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 9999999999976543 899999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcCC
Q 002094 840 LSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRGN 919 (967)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (967)
.....||+.|+|||++ .+..++.++||||+||++|||++|+.||...... .....+... ...
T Consensus 195 -~~~~~Gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~---------------~~~ 256 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEII-LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSG---------------KVR 256 (350)
T ss_dssp -BCCCEECGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHC---------------CCC
T ss_pred -cccccCccccCCHHHH-cCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-HHHHHHhcC---------------CCC
Confidence 2356799999999998 5667899999999999999999999999754322 212211111 122
Q ss_pred CChhhHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 920 FPADEAIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 920 ~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
.+...+.++.+++.+|++.||++|+ |++|+++
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 3455677899999999999999994 8999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=384.44 Aligned_cols=265 Identities=24% Similarity=0.321 Sum_probs=197.8
Q ss_pred cCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC----ceeEEEE
Q 002094 684 LNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS----LQLLIYE 759 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e 759 (967)
|...+.||+|+||.||+|+. +|+.||||++.... ......+.|+..+.+++|||||++++++.+++ ..++|||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 45667899999999999997 48999999986543 22223344555667789999999999997654 5689999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc--------CCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH--------TNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~--------~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
|+++|+|.+++++.. ++|..+++++.|+|.||+|+|+ +||+||||||+|||++.++.+||+|||+++.
T Consensus 82 y~~~g~L~~~l~~~~----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 82 YHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cccCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999998642 8999999999999999999996 5999999999999999999999999999987
Q ss_pred cCCCccc--cccccccccccccCcccccCc-----ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc
Q 002094 832 LPMLDRC--ILSSKIQSALGYMAPEFACRT-----VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE 904 (967)
Q Consensus 832 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-----~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 904 (967)
....... .......||+.|+|||++... ..++.++|||||||++|||+||..||...........+... .
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~---~ 234 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP---S 234 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC---S
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc---c
Confidence 6543222 123456799999999987332 23677999999999999999999887643222111000000 0
Q ss_pred cCCch----hhcchhhcCCCC-----hhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 002094 905 DGRVE----DCVDARLRGNFP-----ADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQS 958 (967)
Q Consensus 905 ~~~~~----~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~ 958 (967)
..... ...+..+++..+ .+....+.+++.+||+.||++|||+.||++.|+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 00000 111122222222 2345679999999999999999999999999998874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=380.52 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=204.3
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
+.|+..+.||+|+||+||+|..+ +|+.||||.++... .....+.+|++++++++|||||++++++.+++..|+||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 34678889999999999999965 68899999997654 3456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCC--CCeEEeecccccccCCCccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSS--GEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~--~~~kl~Dfg~a~~~~~~~~~ 838 (967)
|+||+|.+++..... .+++.++..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--- 157 (321)
T d1tkia_ 83 ISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--- 157 (321)
T ss_dssp CCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---
T ss_pred CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC---
Confidence 999999999976542 38999999999999999999999999999999999999854 58999999999876432
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......+|+.|+|||.. ....++.++||||+||++|||++|+.||...... ..+..+...... ....
T Consensus 158 ~~~~~~~~t~~y~ape~~-~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~~~~i~~~~~~-------~~~~--- 225 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVH-QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYT-------FDEE--- 225 (321)
T ss_dssp CEEEEEESCGGGSCHHHH-TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCC-------CCHH---
T ss_pred Ccccccccccccccchhc-cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC-------CChh---
Confidence 223456788999999988 6667899999999999999999999999754432 222222211110 0000
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.....+.++.+++.+|+..||++|||++|+++
T Consensus 226 -~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 -AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01234567899999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-43 Score=377.41 Aligned_cols=258 Identities=22% Similarity=0.232 Sum_probs=197.2
Q ss_pred CCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcccc----HHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 687 DCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKS----QEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.+.||+|+||+||+|+.+ +|+.||||+++....... .+.+.+|++++++++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 357999999999999964 689999999975542211 246889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
.++++........ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 83 ~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~~ 157 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAY 157 (299)
T ss_dssp SEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCC
T ss_pred cchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc--ccc
Confidence 9987776655433 38889999999999999999999999999999999999999999999999998664322 223
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchh------
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDAR------ 915 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 915 (967)
....||+.|+|||++.....++.++||||+||++|||++|++||....+. ..+..+... ...+....+.+..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~-~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFET-LGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH-HCCCCTTTSSSTTSSTTCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHh-cCCCChhhccchhccchhh
Confidence 34578999999999866667899999999999999999999999754432 222222221 1111111111000
Q ss_pred ---hcCCC-----ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 916 ---LRGNF-----PADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 916 ---~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..... ....+.++.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00001 1234567999999999999999999999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=380.90 Aligned_cols=246 Identities=21% Similarity=0.304 Sum_probs=203.3
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc--cccHHHHHHHHHHHc-CCCCCceeeeeeEEEcCCceeEEE
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL--IKSQEDFEKEMKTLG-KIRHHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~ 758 (967)
.|+..+.||+|+||+||+|+.+ +|+.||||+++.... ....+.+..|..++. .++|||||++++++.+++..|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 3677889999999999999965 689999999975431 234556777777665 689999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccc
Q 002094 759 EFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRC 838 (967)
Q Consensus 759 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 838 (967)
||+++|+|.++++.... +++.++..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++..... .
T Consensus 83 Ey~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--~ 157 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--D 157 (320)
T ss_dssp ECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--T
T ss_pred eecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc--c
Confidence 99999999999986544 889999999999999999999999999999999999999999999999999865432 2
Q ss_pred cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcchhhcC
Q 002094 839 ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDARLRG 918 (967)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (967)
.......||+.|+|||++ ....++.++||||+||++|||++|+.||...... .....+. .. ..
T Consensus 158 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i~-----~~----------~~ 220 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFHSIR-----MD----------NP 220 (320)
T ss_dssp CCBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH-----HC----------CC
T ss_pred ccccccCCCCCcCCHHHH-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHH-----cC----------CC
Confidence 334456799999999999 6668999999999999999999999999754432 1111111 10 22
Q ss_pred CCChhhHHHHHHHHHhhccCCCCCCCCHH-HHH
Q 002094 919 NFPADEAIPVIKLGLICASQVPSNRPDME-EVV 950 (967)
Q Consensus 919 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-evl 950 (967)
.+|...+.++.+++.+|++.||++|||+. |++
T Consensus 221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 34556677899999999999999999995 664
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.3e-43 Score=374.04 Aligned_cols=262 Identities=22% Similarity=0.288 Sum_probs=204.2
Q ss_pred ccCCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEec
Q 002094 683 LLNKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEFI 761 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 761 (967)
.|+..+.||+|+||+||+|+.++|+.||||++..... ....+.+.+|+.++++++|||||++++++..++..+++|||+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 4677889999999999999999999999999976543 233578999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcccccc
Q 002094 762 SSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCILS 841 (967)
Q Consensus 762 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 841 (967)
.++.+..+..... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+|++|||.+...... ....
T Consensus 83 ~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 157 (286)
T d1ob3a_ 83 DQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKY 157 (286)
T ss_dssp SEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred hhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC--cccc
Confidence 8877766655443 3899999999999999999999999999999999999999999999999999876432 2223
Q ss_pred ccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcch----h--
Q 002094 842 SKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVDA----R-- 915 (967)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~-- 915 (967)
....+++.|+|||.+.....++.++||||+||++|||++|+.||...... ..+.++.... .......+.+. +
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-~~~~~i~~~~-~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRIL-GTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHH-CCCCTTTSTTGGGSTTCC
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH-HHHHHHHHhh-CCCChhhccchhhhhhcc
Confidence 34568889999999866777899999999999999999999999754432 2222222211 11111110000 0
Q ss_pred ---------hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 916 ---------LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 916 ---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.........+..+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001123345677999999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=373.38 Aligned_cols=272 Identities=22% Similarity=0.284 Sum_probs=205.3
Q ss_pred ccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|+..+.||+|+||+||+|+. .+|+.||||+++.... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 467788999999999999996 5689999999965542 22356799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+.++ +.+++...... .+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||.|+..... ...
T Consensus 83 ~~~~-~~~~~~~~~~~-~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~~~ 158 (298)
T d1gz8a_ 83 LHQD-LKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 158 (298)
T ss_dssp CSEE-HHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--SBC
T ss_pred cCCc-hhhhhhhhccc-CCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC--ccc
Confidence 9764 44444333222 3899999999999999999999999999999999999999999999999999876432 223
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhcc--CCchhhcc-hhhc
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALED--GRVEDCVD-ARLR 917 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~ 917 (967)
.....||+.|+|||........+.++|+||+||++|+|++|+.||....... .+.......... ........ ....
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhccccccccccc
Confidence 4456789999999988666667899999999999999999999997544322 222222211110 00000000 0000
Q ss_pred CCC-----------ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH--HHhhcCC
Q 002094 918 GNF-----------PADEAIPVIKLGLICASQVPSNRPDMEEVVNI--LELIQSP 959 (967)
Q Consensus 918 ~~~-----------~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~~~~~ 959 (967)
..+ ....+.++.+++.+|++.||++|||++|+++- ++++.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 000 12334678999999999999999999999874 5555443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.9e-42 Score=377.36 Aligned_cols=295 Identities=31% Similarity=0.499 Sum_probs=265.7
Q ss_pred CChhHHHHHHHHHhcCCCCccccCCCCCCCCCCC--ccceEEeCCCC--CeeeeeeecCCCCCc--cccccccCCCCCCe
Q 002094 24 TFNDDVLGLIVFKAGLEDPKEKLTSWSEDDDNPC--NWVGVKCDPKT--KRVVGLTLDGFSLSG--HIGRGLLRLQFLQV 97 (967)
Q Consensus 24 ~~~~d~~all~~k~~~~~~~~~l~sw~~~~~~~c--~w~gv~c~~~~--~~v~~l~l~~~~l~~--~~~~~l~~l~~L~~ 97 (967)
|+++|++||++||+++.||. .++||..++ +|| .|+||+|++.+ .||++|+|.+++++| .+|+.+++|++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~-d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPTT-DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTTS-CTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCCCC-CCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 67899999999999999985 699998665 578 59999998753 489999999999998 57899999999999
Q ss_pred EecCC-CccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeeccc
Q 002094 98 LSLSN-NNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSN 176 (967)
Q Consensus 98 L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N 176 (967)
|+|++ |+++|.+|..|+++++|++|+|++|++.+..+. .+..+.+|+++++++|++.+.+|..++.+++|+++++++|
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~-~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD-FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCG-GGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred cccccccccccccccccccccccchhhhccccccccccc-cccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 99997 899999999999999999999999999976665 4689999999999999999999999999999999999999
Q ss_pred ccccccCccccccccC-CeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCC
Q 002094 177 RLSGQLPYGIWFLRSL-QSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLP 255 (967)
Q Consensus 177 ~l~~~~p~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 255 (967)
++++.+|..+..+.++ +.+++++|++++..+..+.++..+ .+++++|.+.+.+|..++.+++|+.+++++|.+.+.+|
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~ 238 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence 9999999999888886 889999999999999988888554 79999999999999999999999999999999987654
Q ss_pred hhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCc-CCC
Q 002094 256 DSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQ-FTG 324 (967)
Q Consensus 256 ~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~ 324 (967)
.+..+++|+.|+|++|+++|.+|..|+++++|++|+|++|+++|.+|. ++++++|+.+++++|+ +.|
T Consensus 239 -~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 239 -KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp -GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEES
T ss_pred -ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccC
Confidence 688889999999999999999999999999999999999999988884 6888999999999987 454
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=378.53 Aligned_cols=249 Identities=20% Similarity=0.284 Sum_probs=194.4
Q ss_pred cCCC-CccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCC-CCCceeeeeeEEEc----CCceeE
Q 002094 684 LNKD-CELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKI-RHHNLVALEGYYWT----PSLQLL 756 (967)
Q Consensus 684 ~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~l 756 (967)
|.+. +.||+|+||+||+|+. .+++.||||+++. ...+.+|++++.++ +|||||++++++.+ ....|+
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 4554 4699999999999996 5689999999863 24578899986554 89999999999864 456799
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC---CCCeEEeecccccccC
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS---SGEPKVGDFGLARLLP 833 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~---~~~~kl~Dfg~a~~~~ 833 (967)
|||||+||+|.+++...... .+++.++..++.||+.||+|||++||+||||||+||+++. ++.+||+|||+|+...
T Consensus 87 vmEy~~gg~L~~~i~~~~~~-~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp EEECCCSEEHHHHHHSCSCC-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred EEECCCCCcHHHHHHhcCCC-CcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence 99999999999999865332 3899999999999999999999999999999999999985 5679999999998764
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcc
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (967)
... ......||+.|+|||++ ....++.++||||+||++|||+||+.||........ ... +...+.....
T Consensus 166 ~~~---~~~~~~gt~~y~aPE~~-~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~-~~~~i~~~~~----- 234 (335)
T d2ozaa1 166 SHN---SLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPG-MKTRIRMGQY----- 234 (335)
T ss_dssp CCC---CCCCCSCCCSSCCCCCC-CGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCSS-----
T ss_pred CCC---ccccccCCcccCCcHHH-cCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHH-HHHHHhcCCC-----
Confidence 322 23456799999999998 667899999999999999999999999974332211 000 1111100000
Q ss_pred hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 914 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
..........+.++.+++.+|++.||++|||+.|+++
T Consensus 235 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 -EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000111245678999999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=372.87 Aligned_cols=241 Identities=26% Similarity=0.391 Sum_probs=197.7
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCcc-----ccHHHHHHHHHHHcCCC--CCceeeeeeEEEcCCc
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLI-----KSQEDFEKEMKTLGKIR--HHNLVALEGYYWTPSL 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~ 753 (967)
+.|+..+.||+|+||+||+|+.. +|+.||||++...... ....++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 45788899999999999999964 6899999999754321 12234778999999886 8999999999999999
Q ss_pred eeEEEEecCC-CchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC-CCCeEEeecccccc
Q 002094 754 QLLIYEFISS-GSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS-SGEPKVGDFGLARL 831 (967)
Q Consensus 754 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~-~~~~kl~Dfg~a~~ 831 (967)
.++||||+.+ +++.+++..... +++.++..++.||+.||+|||++||+||||||+||+++. ++.+||+|||+|+.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~---l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999976 678888766443 899999999999999999999999999999999999985 47899999999986
Q ss_pred cCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh
Q 002094 832 LPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC 911 (967)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (967)
.... ......||+.|+|||++.....++.++||||+||++|||++|+.||.... +..+.
T Consensus 161 ~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~---------- 219 (273)
T d1xwsa_ 161 LKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRG---------- 219 (273)
T ss_dssp CCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHC----------
T ss_pred cccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhc----------
Confidence 5432 23456799999999998545455778999999999999999999996321 11111
Q ss_pred cchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 912 VDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 912 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...++...+.++.+++.+|++.||++|||++|+++
T Consensus 220 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 -----QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11234455677999999999999999999999876
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=367.84 Aligned_cols=263 Identities=22% Similarity=0.274 Sum_probs=197.9
Q ss_pred hhccCCCCccCCCCceEEEEEEeC-C-CcEEEEEEeecCCc-cccHHHHHHHHHHHcCC---CCCceeeeeeEEEc----
Q 002094 681 NALLNKDCELGRGGFGVVYRTILQ-D-GRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKI---RHHNLVALEGYYWT---- 750 (967)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~---- 750 (967)
++.|+..+.||+|+||+||+|+.. + ++.||||+++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 356788999999999999999963 4 56799999975432 12233466777776655 89999999999853
Q ss_pred -CCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccc
Q 002094 751 -PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLA 829 (967)
Q Consensus 751 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a 829 (967)
....+++|||++++++......... .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cCceEEEEEEeccCCchhhhhhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 3467899999998776555443322 3889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch
Q 002094 830 RLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE 909 (967)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (967)
..... ........||+.|+|||++ ....++.++||||+||++|||++|++||...... ..+..+..... .....
T Consensus 164 ~~~~~---~~~~~~~~gT~~Y~APE~~-~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~-~~~~~ 237 (305)
T d1blxa_ 164 RIYSF---QMALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIG-LPGEE 237 (305)
T ss_dssp CCCCG---GGGGCCCCCCCTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHC-CCCGG
T ss_pred hhhcc---cccCCCcccChhhcCcchh-cCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhC-CCchh
Confidence 76532 2334567799999999998 5678999999999999999999999999754432 22333322111 11000
Q ss_pred hhcc------hh-------hcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 910 DCVD------AR-------LRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 910 ~~~~------~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.+.. .. ....+....+..+.+|+.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 00 011123445677899999999999999999999876
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-41 Score=368.80 Aligned_cols=264 Identities=21% Similarity=0.281 Sum_probs=198.5
Q ss_pred cCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcC------CceeE
Q 002094 684 LNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP------SLQLL 756 (967)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l 756 (967)
|+..++||+|+||+||+|+.. +|+.||||++..... ...+|++++++++|||||++++++... ...++
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 677889999999999999965 689999999976542 234799999999999999999998543 34689
Q ss_pred EEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC-CeEEeecccccccCCC
Q 002094 757 IYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG-EPKVGDFGLARLLPML 835 (967)
Q Consensus 757 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~~~~ 835 (967)
||||++++.+....+.......+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 999998765444433222333489999999999999999999999999999999999999775 8999999999876432
Q ss_pred ccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCC--------
Q 002094 836 DRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGR-------- 907 (967)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 907 (967)
. ......|++.|+|||.+.....++.++||||+||++|||++|+.||...... ..+..+++.. ....
T Consensus 177 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~-g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 177 E---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVL-GTPTREQIREMN 251 (350)
T ss_dssp S---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHH-CCCCHHHHHHHC
T ss_pred c---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHh-CCChHHhhhhhc
Confidence 2 2334678999999998866778999999999999999999999999754432 2222222211 0000
Q ss_pred -------chhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH--HHHhhc
Q 002094 908 -------VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN--ILELIQ 957 (967)
Q Consensus 908 -------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~--~L~~~~ 957 (967)
.................+.++.+|+.+|++.||++|||++|+++ .++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00000000011122345677999999999999999999999986 355544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-40 Score=361.95 Aligned_cols=264 Identities=21% Similarity=0.302 Sum_probs=199.7
Q ss_pred ccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC----ceeEE
Q 002094 683 LLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS----LQLLI 757 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv 757 (967)
.|+..+.||+|+||+||+|+. .+|+.||||++.........+.+.+|++++++++||||+++++++..+. ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 467888999999999999985 4799999999976554445678999999999999999999999987543 33566
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCcc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDR 837 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 837 (967)
++|+.+|+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 89 ~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 89 VTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 6778899999999754 289999999999999999999999999999999999999999999999999987643222
Q ss_pred c-cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhh-----
Q 002094 838 C-ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDC----- 911 (967)
Q Consensus 838 ~-~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 911 (967)
. .......||+.|+|||.+.....++.++||||+||++|||++|+.||......... ..... ..........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-NHILG-ILGSPSQEDLNCIIN 242 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHH-HHCSCCHHHHHTCCC
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH-HHHhh-hccCCChhhhhhhhh
Confidence 1 22345678999999999866667899999999999999999999999754432211 11111 1111100000
Q ss_pred ---cc--hhh--cCCC-----ChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 002094 912 ---VD--ARL--RGNF-----PADEAIPVIKLGLICASQVPSNRPDMEEVVNI 952 (967)
Q Consensus 912 ---~~--~~~--~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 952 (967)
.. ... .... ....+.++.+++.+|++.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000 0000 12334578999999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=354.81 Aligned_cols=264 Identities=21% Similarity=0.235 Sum_probs=207.6
Q ss_pred ccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCCceeEEEEe
Q 002094 683 LLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPSLQLLIYEF 760 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 760 (967)
.|+..+.||+|+||+||+|+. .+++.||||+++.... ......+.+|+.+++.++||||+++++++.++...++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 467788999999999999996 4789999999976543 33467899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCCCccccc
Q 002094 761 ISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPMLDRCIL 840 (967)
Q Consensus 761 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 840 (967)
+.++++..++..... +++..+..++.|++.||+|||++||+||||||+||+++.++.+|++|||.+....... ..
T Consensus 83 ~~~~~l~~~~~~~~~---~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~--~~ 157 (292)
T d1unla_ 83 CDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RC 157 (292)
T ss_dssp CSEEHHHHHHHTTTC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--SC
T ss_pred ccccccccccccccc---cchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC--cc
Confidence 999999888776543 7899999999999999999999999999999999999999999999999998765322 22
Q ss_pred cccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhcc--CCchh---hcc--
Q 002094 841 SSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALED--GRVED---CVD-- 913 (967)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~-- 913 (967)
.....+++.|+|||.+.....++.++||||+||++|||++|+.||....+.......+....... ..... ..+
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 33455677899999886666689999999999999999999999865444333222222111110 00000 000
Q ss_pred -------hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 914 -------ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 914 -------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
...........+..+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111123445677899999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-40 Score=358.29 Aligned_cols=266 Identities=21% Similarity=0.244 Sum_probs=196.2
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEc--------C
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWT--------P 751 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~ 751 (967)
+.|+..+.||+|+||+||+|+. ++|+.||||++..... .....++.+|++++++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 4578889999999999999996 4799999999865533 2345678999999999999999999998865 3
Q ss_pred CceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccc
Q 002094 752 SLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARL 831 (967)
Q Consensus 752 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 831 (967)
+..++||||+.++.+........ .++...+..++.||+.||+|||++||+||||||+||+++.++.+|++|||++..
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 45789999998877665544333 288899999999999999999999999999999999999999999999999987
Q ss_pred cCCCccc--cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc--cCC
Q 002094 832 LPMLDRC--ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE--DGR 907 (967)
Q Consensus 832 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~ 907 (967)
....... .......||+.|+|||.+.....++.++||||+||++|||++|+.||....+. .....+.+.... ...
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSITPEV 245 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-HHHHHHHHhcCCCChhh
Confidence 6542222 12234568999999999866667899999999999999999999999754332 222222221111 000
Q ss_pred chhhcchhhc--------CCCC-------hhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 908 VEDCVDARLR--------GNFP-------ADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 908 ~~~~~~~~~~--------~~~~-------~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.......... .... ......+.+|+.+|++.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0000000000 0000 112345788999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.7e-40 Score=357.83 Aligned_cols=257 Identities=18% Similarity=0.212 Sum_probs=199.4
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcC--CceeEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTP--SLQLLI 757 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv 757 (967)
+.|+..+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|++++++++ ||||+++++++..+ ...++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 4578889999999999999996 46899999998643 3567899999999995 99999999998743 568899
Q ss_pred EEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCC-CeEEeecccccccCCCc
Q 002094 758 YEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSG-EPKVGDFGLARLLPMLD 836 (967)
Q Consensus 758 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~~~~~ 836 (967)
|||+++++|..+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 111 ~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp EECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred EeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence 99999999977643 288999999999999999999999999999999999998655 5899999999876432
Q ss_pred cccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHh--------hhc---c
Q 002094 837 RCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRG--------ALE---D 905 (967)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~--------~~~---~ 905 (967)
.......+|+.|+|||.+.....++.++||||+||++|||++|+.||....+.......+... ... .
T Consensus 184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred --CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 223456789999999998666678999999999999999999999997554432222211110 000 0
Q ss_pred CCchhhcc-----------hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 906 GRVEDCVD-----------ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 906 ~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.......+ ...........+.++.+|+.+|++.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 00111122345667999999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=363.01 Aligned_cols=264 Identities=23% Similarity=0.267 Sum_probs=197.7
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcCC------c
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTPS------L 753 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~ 753 (967)
+.|+..+.||+|+||+||+|+.+ +|+.||||+++.... ....+.+.+|++++++++|||||++++++...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 45778889999999999999964 699999999976532 234567899999999999999999999997654 4
Q ss_pred eeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccC
Q 002094 754 QLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLP 833 (967)
Q Consensus 754 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 833 (967)
.++||||+ +.+|..+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||.|+...
T Consensus 98 ~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 68999999 56787777543 28999999999999999999999999999999999999999999999999998654
Q ss_pred CCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhcc-------C
Q 002094 834 MLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALED-------G 906 (967)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~ 906 (967)
. ......||+.|+|||.+.....++.++||||+||++|||++|++||...... ..+..+....... .
T Consensus 173 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 173 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHTC
T ss_pred C-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhccCCCcHHHHhhh
Confidence 3 2345678999999999866667899999999999999999999999754332 2222222111000 0
Q ss_pred Cchhhc--chhh-------cCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHH--HHhh
Q 002094 907 RVEDCV--DARL-------RGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNI--LELI 956 (967)
Q Consensus 907 ~~~~~~--~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~--L~~~ 956 (967)
...... .... ........+..+.+|+.+|+..||++|||++|+++. ++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000000 0000 001123445678999999999999999999999874 4443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-39 Score=348.89 Aligned_cols=261 Identities=14% Similarity=0.134 Sum_probs=205.8
Q ss_pred hccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCccccHHHHHHHHHHHcCCCC-CceeeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRH-HNLVALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 759 (967)
+.|+..+.||+|+||+||+|+.. +|+.||||++..... ...+.+|++.++.++| +|++.+++++.+....++|||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 45788899999999999999965 689999998865442 2347788888888865 899999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC-----CCCeEEeecccccccCC
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS-----SGEPKVGDFGLARLLPM 834 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~-----~~~~kl~Dfg~a~~~~~ 834 (967)
|+ +++|.+++..... .+++.++..++.|++.||+|||++||+||||||+||+++. ++.+||+|||+|+.+..
T Consensus 82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred ec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 99 6799999876543 3899999999999999999999999999999999999974 57899999999987643
Q ss_pred Cccc-----cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchH--hHHHHHHhhhccCC
Q 002094 835 LDRC-----ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVV--VLCDMVRGALEDGR 907 (967)
Q Consensus 835 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~ 907 (967)
.... .......||+.|+|||.+ .+..++.++||||+||++|||++|+.||........ ....+..... ...
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~-~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-~~~ 236 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STP 236 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSC
T ss_pred CccccceeecccCceEEchhhcCHHHh-cCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-CCC
Confidence 2111 123356799999999998 667899999999999999999999999975433211 1111111111 000
Q ss_pred chhhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 002094 908 VEDCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQSP 959 (967)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~~~ 959 (967)
. .. .....+.++.+++..|++.+|++||+++.+.+.|+++.+.
T Consensus 237 ~-----~~----l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 237 L-----RE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp H-----HH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred h-----HH----hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 1 11 1233456799999999999999999999999999887643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-39 Score=351.40 Aligned_cols=259 Identities=16% Similarity=0.165 Sum_probs=197.6
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCce-eeeeeEEEcCCceeEEEE
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHNL-VALEGYYWTPSLQLLIYE 759 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 759 (967)
+.|+..+.||+|+||.||+|+. .+|+.||||++..... ..++..|+++++.++|+++ +.+.+++.+.+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 3478889999999999999996 4689999999876542 2357899999999987665 455556677888899999
Q ss_pred ecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCC---CCCeEEeecccccccCCCc
Q 002094 760 FISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDS---SGEPKVGDFGLARLLPMLD 836 (967)
Q Consensus 760 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~---~~~~kl~Dfg~a~~~~~~~ 836 (967)
|+. +++...+..... .+++..+..++.|++.||+|||++||+||||||+||+++. +..++++|||+|+......
T Consensus 84 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 84 LLG-PSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CCC-CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EcC-CchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 995 566666654333 2899999999999999999999999999999999999863 4579999999998775422
Q ss_pred cc-----cccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHh--HHHHHHhhhccCCch
Q 002094 837 RC-----ILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVV--LCDMVRGALEDGRVE 909 (967)
Q Consensus 837 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 909 (967)
.. .......||+.|+|||.+ .+..++.++|||||||++|||++|+.||......... ...+.......
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~---- 235 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTH-LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---- 235 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHH-TTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS----
T ss_pred cccceeccccCCcCCCccccCHHHH-hCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC----
Confidence 21 223456799999999998 6667999999999999999999999999754332111 11111111000
Q ss_pred hhcchhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 002094 910 DCVDARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEVVNILELIQ 957 (967)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~~~ 957 (967)
..+. .....+.++.+++.+|++.+|++||+++++.+.|+.+.
T Consensus 236 --~~~~----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 236 --PIEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp --CHHH----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred --ChhH----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0011 12345667999999999999999999999999998764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-40 Score=354.91 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=203.4
Q ss_pred ccCCCCccCCCCceEEEEEEeC----CCcEEEEEEeecCCc---cccHHHHHHHHHHHcCCCC-CceeeeeeEEEcCCce
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ----DGRSVAIKKLTVSGL---IKSQEDFEKEMKTLGKIRH-HNLVALEGYYWTPSLQ 754 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~ 754 (967)
.|+..+.||+|+||+||+|+.. +|+.||||.++.... ....+.+.+|++++++++| |||+++++++.++...
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 3688899999999999999842 488999999865432 2335678899999999976 8999999999999999
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
++||||+.+|+|.+++..... .....+..++.||+.|++|+|+++|+||||||+||+++.++.+||+|||+++.+..
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999999999987654 67889999999999999999999999999999999999999999999999987654
Q ss_pred CccccccccccccccccCcccccCc-ccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCchhhcc
Q 002094 835 LDRCILSSKIQSALGYMAPEFACRT-VKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVEDCVD 913 (967)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (967)
.. ........|++.|+|||.+... ..++.++||||+||++|||++|+.||....... ..........
T Consensus 182 ~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-~~~~i~~~~~---------- 249 (322)
T d1vzoa_ 182 DE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRIL---------- 249 (322)
T ss_dssp GG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHH----------
T ss_pred cc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcc----------
Confidence 22 2233456789999999988433 357889999999999999999999997543221 1111222111
Q ss_pred hhhcCCCChhhHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 002094 914 ARLRGNFPADEAIPVIKLGLICASQVPSNRP-----DMEEVVN 951 (967)
Q Consensus 914 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 951 (967)
.....++...+.++.+++.+|+++||++|| |++|+++
T Consensus 250 -~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 -KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 112335567788899999999999999999 4788865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-39 Score=356.97 Aligned_cols=265 Identities=19% Similarity=0.241 Sum_probs=200.0
Q ss_pred hccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC-----Cce
Q 002094 682 ALLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP-----SLQ 754 (967)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 754 (967)
+.|+..+.||+|+||+||+|+. .+|+.||||++..... ....+++.+|++++++++|||||++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 3478889999999999999995 4799999999976542 23456789999999999999999999998643 345
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
+++|+|+.+|+|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+|++|||.+.....
T Consensus 98 ~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc
Confidence 7778888999999998653 289999999999999999999999999999999999999999999999999975432
Q ss_pred CccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhccCCch-----
Q 002094 835 LDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALEDGRVE----- 909 (967)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 909 (967)
......|++.|+|||.......++.++||||+||++|+|++|+.||...... .....+..... .....
T Consensus 174 -----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-~~~~~i~~~~~-~~~~~~~~~~ 246 (348)
T d2gfsa1 174 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVG-TPGAELLKKI 246 (348)
T ss_dssp -----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHC-CCCHHHHTTC
T ss_pred -----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcC-CCChHHhhhc
Confidence 2345678899999998756667899999999999999999999999754322 22222222111 10000
Q ss_pred ------hhcchhhc-CCC-----ChhhHHHHHHHHHhhccCCCCCCCCHHHHHH--HHHhhc
Q 002094 910 ------DCVDARLR-GNF-----PADEAIPVIKLGLICASQVPSNRPDMEEVVN--ILELIQ 957 (967)
Q Consensus 910 ------~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~--~L~~~~ 957 (967)
........ ... ....+.++.+|+.+|++.||++|||++|+++ -++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 00000000 000 1234567899999999999999999999987 344443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=350.16 Aligned_cols=258 Identities=20% Similarity=0.209 Sum_probs=187.9
Q ss_pred ccCCCCccCCCCceEEEEEEeC-CCcEEEEEEeecCCc-cccHHHHHHHHHHHcCCCCCceeeeeeEEEcC------Cce
Q 002094 683 LLNKDCELGRGGFGVVYRTILQ-DGRSVAIKKLTVSGL-IKSQEDFEKEMKTLGKIRHHNLVALEGYYWTP------SLQ 754 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 754 (967)
.|++.+.||+|+||+||+|+.. +|+.||||++..... .....++.+|+.++++++|||||++++++... ...
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 4788889999999999999965 699999999976543 23446789999999999999999999999643 577
Q ss_pred eEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecccccccCC
Q 002094 755 LLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFGLARLLPM 834 (967)
Q Consensus 755 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 834 (967)
|+||||+.++.+ +.+.. .+++..++.++.||+.||+|||++||+||||||+||+++.++.++++|||.++....
T Consensus 98 ~iv~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 98 YLVMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp EEEEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 999999977554 44432 278999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccchHhHHHHHHhhhc----------
Q 002094 835 LDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDDVVVLCDMVRGALE---------- 904 (967)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~---------- 904 (967)
........+|+.|+|||++ .+..++.++||||+||++|||++|+.||...... .....++.....
T Consensus 172 ---~~~~~~~~~t~~y~aPE~l-~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 172 ---SFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp ------------CCTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHTTSC
T ss_pred ---ccccccccccccccChhhh-cCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhccCCCHHHHHHhh
Confidence 2334466789999999998 5568899999999999999999999999644322 111222111100
Q ss_pred --------cC------CchhhcchhhcCC---CChhhHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 002094 905 --------DG------RVEDCVDARLRGN---FPADEAIPVIKLGLICASQVPSNRPDMEEVVN 951 (967)
Q Consensus 905 --------~~------~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 951 (967)
.. ............. .....+.++.+|+.+|++.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 0000000001000 11234667899999999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-34 Score=319.49 Aligned_cols=261 Identities=21% Similarity=0.212 Sum_probs=189.4
Q ss_pred ccCCCCccCCCCceEEEEEEe-CCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-----------CCceeeeeeEEEc
Q 002094 683 LLNKDCELGRGGFGVVYRTIL-QDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-----------HHNLVALEGYYWT 750 (967)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 750 (967)
.|+..++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 478899999999999999996 479999999997553 23457788998887764 5789999998764
Q ss_pred --CCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCCCEEeCCCCC------e
Q 002094 751 --PSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHH-TNIIHYNLKSTNVLIDSSGE------P 821 (967)
Q Consensus 751 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~ivH~Dik~~Nill~~~~~------~ 821 (967)
....+++|+++..+..............+++..+..++.||+.|++|||+ +||+||||||+|||++.++. +
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 35566777776555443333333333348899999999999999999998 89999999999999986553 8
Q ss_pred EEeecccccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHHHHHHcCCCCCCCCccc-----hHhHH
Q 002094 822 KVGDFGLARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKRPVEYMEDD-----VVVLC 896 (967)
Q Consensus 822 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll~elltg~~p~~~~~~~-----~~~~~ 896 (967)
+++|||.+..... ......||+.|+|||.+ ....++.++|+||+||+++||++|+.||...... .....
T Consensus 172 kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 172 KIADLGNACWYDE-----HYTNSIQTREYRSPEVL-LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EECCCTTCEETTB-----CCCSCCSCGGGCCHHHH-HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eEeeccccccccc-----ccccccccccccChhhc-cccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 9999999975532 23456799999999988 4567899999999999999999999999743221 11111
Q ss_pred HHHHhhhc--------cCCchhhcc-------------------hhhcCCCChhhHHHHHHHHHhhccCCCCCCCCHHHH
Q 002094 897 DMVRGALE--------DGRVEDCVD-------------------ARLRGNFPADEAIPVIKLGLICASQVPSNRPDMEEV 949 (967)
Q Consensus 897 ~~~~~~~~--------~~~~~~~~~-------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev 949 (967)
.++...-. ........+ .......+...+.++.+|+.+|++.||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 11111000 000000000 001223456678889999999999999999999998
Q ss_pred HH
Q 002094 950 VN 951 (967)
Q Consensus 950 l~ 951 (967)
++
T Consensus 326 L~ 327 (362)
T d1q8ya_ 326 VN 327 (362)
T ss_dssp HT
T ss_pred hc
Confidence 76
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.6e-31 Score=290.28 Aligned_cols=258 Identities=31% Similarity=0.495 Sum_probs=186.8
Q ss_pred CCCEEEccCCCCCCc--Cchhhccccccccccccc-cccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEE
Q 002094 263 SCSSLSLKGNSFTGE--VPDWIGKLANLESLDLSL-NQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAI 339 (967)
Q Consensus 263 ~L~~L~L~~n~l~~~--~~~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 339 (967)
+++.|+|++|.+++. +|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~------ 124 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI------ 124 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGC------
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccch------
Confidence 344555555555542 344555555555555543 44544445445555555555555554444444444433
Q ss_pred EccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccc
Q 002094 340 DVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSM 419 (967)
Q Consensus 340 ~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 419 (967)
.+|+.+++++|.+.+.+|..+.+++.|+.+++++
T Consensus 125 ----------------------------------------------~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~ 158 (313)
T d1ogqa_ 125 ----------------------------------------------KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp ----------------------------------------------TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred ----------------------------------------------hhhcccccccccccccCchhhccCcccceeeccc
Confidence 4455566666666666666777777777777777
Q ss_pred cccccccCCCcCCcccc-cEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCcc
Q 002094 420 NYLFGSIPASIGKLKAI-QVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPV 498 (967)
Q Consensus 420 N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 498 (967)
|.+.+.+|..+..+..+ +.+++++|++++..|..+..+.. ..+++++|.+.+.+|..+..+++|+.|++++|.+++.+
T Consensus 159 n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~ 237 (313)
T d1ogqa_ 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence 77777777777777665 77888888888888887777644 47888888888888888888999999999999998765
Q ss_pred chhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCCCCCCCCccCCCcccCCCCCCCccccCCC
Q 002094 499 PAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELPVGGFFNTISPSSVSGNPSLCGSVVNRSC 575 (967)
Q Consensus 499 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~c 575 (967)
| .++.+++|++|||++|+++|.+|..|.++++|+.|+|++|+|+|.+|..+.+..+....+.||+.+||.|+ +.|
T Consensus 238 ~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl-p~c 312 (313)
T d1ogqa_ 238 G-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL-PAC 312 (313)
T ss_dssp G-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS-SCC
T ss_pred c-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC-CCC
Confidence 5 68888999999999999999999999999999999999999999999877777888888999999999887 455
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=2.5e-29 Score=281.64 Aligned_cols=145 Identities=26% Similarity=0.422 Sum_probs=108.4
Q ss_pred CCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEE
Q 002094 384 SYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKEL 463 (967)
Q Consensus 384 ~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 463 (967)
.+++|+.|++++|++++..+ +..+++|+.|++++|++.+.. .+..+..++.+++++|++++ ...+..+++++.|
T Consensus 239 ~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L 312 (384)
T d2omza2 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYL 312 (384)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEE
T ss_pred cccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeE
Confidence 34566666666666665433 566677777777777776433 26667778888888888874 2347778888888
Q ss_pred EcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCC
Q 002094 464 KLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHN 540 (967)
Q Consensus 464 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N 540 (967)
++++|++++.. .+..+++|+.|+|++|+|++ ++ .|.++++|++||+++|+|++..| +.++++|+.|+|++|
T Consensus 313 ~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 313 TLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp ECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 88888888643 37888889999999998885 34 58888999999999999887665 788889999999887
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=5.8e-29 Score=278.60 Aligned_cols=211 Identities=26% Similarity=0.362 Sum_probs=136.3
Q ss_pred cCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEE
Q 002094 260 RLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAI 339 (967)
Q Consensus 260 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 339 (967)
............|... ....+..+++++.|++++|.+++..| +..+++|++|++++|++++. ..+..+++|+.|
T Consensus 173 ~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 246 (384)
T d2omza2 173 NLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDL 246 (384)
T ss_dssp TCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchh
Confidence 3334444444444433 22334555666666666666654432 34455666666666666532 345566666666
Q ss_pred EccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccc
Q 002094 340 DVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSM 419 (967)
Q Consensus 340 ~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 419 (967)
++++|++++..+ +..+++|++|++++|++++..+ +..++.++.+.++.
T Consensus 247 ~l~~n~l~~~~~------------------------------~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~ 294 (384)
T d2omza2 247 DLANNQISNLAP------------------------------LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE 294 (384)
T ss_dssp ECCSSCCCCCGG------------------------------GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCS
T ss_pred ccccCccCCCCc------------------------------ccccccCCEeeccCcccCCCCc--cccccccccccccc
Confidence 666666653211 1123556666666666664432 55666677777777
Q ss_pred cccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccc
Q 002094 420 NYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVP 499 (967)
Q Consensus 420 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 499 (967)
|.+.+ ...+..+++++.|++++|++++.. .+..+++|++|++++|+|++ ++ .++++++|++|+|++|+|++..|
T Consensus 295 n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 295 NQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp SCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred ccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence 77654 234677778888888888887643 37788889999999998874 44 58889999999999999987655
Q ss_pred hhhhcccCccEEeccCC
Q 002094 500 AAIANLSNLKYVDLSFN 516 (967)
Q Consensus 500 ~~~~~l~~L~~L~Ls~N 516 (967)
+.++++|+.|+|++|
T Consensus 369 --l~~l~~L~~L~L~~N 383 (384)
T d2omza2 369 --LANLTRITQLGLNDQ 383 (384)
T ss_dssp --GTTCTTCSEEECCCE
T ss_pred --hccCCCCCEeeCCCC
Confidence 888999999999988
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.1e-25 Score=242.93 Aligned_cols=248 Identities=22% Similarity=0.325 Sum_probs=136.9
Q ss_pred CCCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCC
Q 002094 55 NPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIP 134 (967)
Q Consensus 55 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip 134 (967)
|-|.|++|.|+.. +++ .+|+.+. +.+++|+|++|+|+...+..|.++++|++|++++|.+.. ++
T Consensus 8 c~c~~~~~~C~~~------------~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~-i~ 71 (305)
T d1xkua_ 8 CQCHLRVVQCSDL------------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-IS 71 (305)
T ss_dssp CEEETTEEECTTS------------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC-BC
T ss_pred CEecCCEEEecCC------------CCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccc-cc
Confidence 3488999999742 222 2344442 467777777777775555566666666666666666663 33
Q ss_pred chhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCC
Q 002094 135 DEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLY 214 (967)
Q Consensus 135 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 214 (967)
...|.++++|++|++++|+++. +|..+ ...|+.|++++|.+.+..+..+.....++.++...|....
T Consensus 72 ~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~---------- 138 (305)
T d1xkua_ 72 PGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS---------- 138 (305)
T ss_dssp TTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG----------
T ss_pred hhhhhCCCccCEecccCCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccc----------
Confidence 3345666666666666666663 33222 2345555555555554444444444445555554443221
Q ss_pred CCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccccccc
Q 002094 215 DLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLS 294 (967)
Q Consensus 215 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 294 (967)
....+..+..+++|+++++++|.++. +|..+ +++|+.|++++|.+++..+..|.+++.+++|+++
T Consensus 139 ------------~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s 203 (305)
T d1xkua_ 139 ------------SGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203 (305)
T ss_dssp ------------GGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECC
T ss_pred ------------cCCCccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccc
Confidence 12223344445555555555555542 22221 3455555555555555555555555666666666
Q ss_pred ccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCc
Q 002094 295 LNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLT 347 (967)
Q Consensus 295 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 347 (967)
+|.+.+..+..+.++++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|+
T Consensus 204 ~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 204 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp SSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred cccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence 66665555555555666666666666665 34555666666666666666655
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=3.3e-25 Score=239.08 Aligned_cols=272 Identities=19% Similarity=0.273 Sum_probs=136.1
Q ss_pred CeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccccccccc
Q 002094 217 RAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLN 296 (967)
Q Consensus 217 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N 296 (967)
+.++-++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++++|
T Consensus 13 ~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 13 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp TEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 33444444444 3343332 34555555555555433345555555555555555555555555556666666666666
Q ss_pred ccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCCCCCC
Q 002094 297 QFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGESMQYP 376 (967)
Q Consensus 297 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~~~~ 376 (967)
+++ .+|..+ ...++.|.+.+|.+.+..+..+.....+..++...|......
T Consensus 90 ~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~-------------------------- 140 (305)
T d1xkua_ 90 QLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG-------------------------- 140 (305)
T ss_dssp CCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG--------------------------
T ss_pred ccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccC--------------------------
Confidence 655 233222 234555666666666555555555555555555555432100
Q ss_pred cccccccCCCCccEEEccCCcccCCCCCCcccccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccC
Q 002094 377 SFASMKDSYQGLQVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGG 456 (967)
Q Consensus 377 ~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 456 (967)
.....+..+++|+.+++++|.+... |. .+ +++|+.|++++|..++..+..+.+
T Consensus 141 ~~~~~~~~l~~L~~l~l~~n~l~~l-~~------------------------~~--~~~L~~L~l~~n~~~~~~~~~~~~ 193 (305)
T d1xkua_ 141 IENGAFQGMKKLSYIRIADTNITTI-PQ------------------------GL--PPSLTELHLDGNKITKVDAASLKG 193 (305)
T ss_dssp BCTTGGGGCTTCCEEECCSSCCCSC-CS------------------------SC--CTTCSEEECTTSCCCEECTGGGTT
T ss_pred CCccccccccccCccccccCCcccc-Cc------------------------cc--CCccCEEECCCCcCCCCChhHhhc
Confidence 0011122334455555555554422 21 11 234445555555555444555555
Q ss_pred CCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchh------hhhcc
Q 002094 457 AVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKE------LINLS 530 (967)
Q Consensus 457 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~------l~~l~ 530 (967)
++.++.|++++|.+.+..+..+.++++|++|+|++|+|+ .+|.+|.++++|++|+|++|+|+.+.... +..+.
T Consensus 194 ~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~ 272 (305)
T d1xkua_ 194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKA 272 (305)
T ss_dssp CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSC
T ss_pred cccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccC
Confidence 555555555555555545555555555555555555555 34555555555555555555555432222 23455
Q ss_pred CCceEEecCCccc-ccCCC
Q 002094 531 HLLSFNISHNHLH-GELPV 548 (967)
Q Consensus 531 ~L~~L~l~~N~l~-~~~p~ 548 (967)
+|+.|+|++|+++ ..++.
T Consensus 273 ~L~~L~L~~N~~~~~~~~~ 291 (305)
T d1xkua_ 273 SYSGVSLFSNPVQYWEIQP 291 (305)
T ss_dssp CCSEEECCSSSSCGGGSCG
T ss_pred CCCEEECCCCcCccCcCCH
Confidence 5666666666664 34443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=7.3e-26 Score=241.38 Aligned_cols=227 Identities=20% Similarity=0.198 Sum_probs=183.9
Q ss_pred EEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeec-CC
Q 002094 122 VDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLS-NN 200 (967)
Q Consensus 122 L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~n 200 (967)
++.++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|++....+..+..+..++.++.. .|
T Consensus 16 v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 344444444 4554432 456777777777776666677777777777777777777777777777777777654 55
Q ss_pred cCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCch
Q 002094 201 LLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPD 280 (967)
Q Consensus 201 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 280 (967)
.++...+..|+++++|++|++++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|++++|++++..+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 67767777888888888888888888777777888888899999999999877778888899999999999999988888
Q ss_pred hhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcCCCCh
Q 002094 281 WIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTGNIPT 352 (967)
Q Consensus 281 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 352 (967)
+|.++++|+++++++|++++..|..|..+++|++|++++|++.+..+..|..+++|+.|++++|++.+..+.
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc
Confidence 999999999999999999988899999999999999999999998889999999999999999999876553
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=6.4e-26 Score=241.80 Aligned_cols=263 Identities=19% Similarity=0.182 Sum_probs=214.2
Q ss_pred cCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEecc-ccccC
Q 002094 77 DGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFA-NNNLT 155 (967)
Q Consensus 77 ~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~-~n~l~ 155 (967)
++.+++ .+|..+. +.+++|+|++|+|+...+..|.++++|++|++++|++. .++...+..+..++.++.. .|.++
T Consensus 19 ~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~-~i~~~~~~~~~~~~~l~~~~~~~~~ 94 (284)
T d1ozna_ 19 PQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLR 94 (284)
T ss_dssp CSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSCTTCC
T ss_pred CCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccc-ccccccccccccccccccccccccc
Confidence 334444 3444433 56899999999999887788999999999999999998 4566677889999998765 67788
Q ss_pred CCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCcc
Q 002094 156 GPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIG 235 (967)
Q Consensus 156 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 235 (967)
...+..|+++++|++|++++|.+....+..+...++|+.+++++|+++++++..|..+++|++|++++|++++..+..|.
T Consensus 95 ~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~ 174 (284)
T d1ozna_ 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174 (284)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhc
Confidence 77788999999999999999999877778888899999999999999988888999999999999999999988889999
Q ss_pred CCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceE
Q 002094 236 GCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKEL 315 (967)
Q Consensus 236 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 315 (967)
++++|+++++++|++++..|..|.++++|++|++++|++++..+..|..+++|++|+|++|++...-+ ...-...++.+
T Consensus 175 ~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~ 253 (284)
T d1ozna_ 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKF 253 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHC
T ss_pred cccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhC
Confidence 99999999999999998889999999999999999999998888999999999999999999875432 11112346667
Q ss_pred EcccCcCCCCCChhhhcCCCCcEEEccCCcCc
Q 002094 316 NISMNQFTGGLPESMMNCGNLLAIDVSQNKLT 347 (967)
Q Consensus 316 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 347 (967)
....+++....|..+.+ ....+++.+.++
T Consensus 254 ~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~ 282 (284)
T d1ozna_ 254 RGSSSEVPCSLPQRLAG---RDLKRLAANDLQ 282 (284)
T ss_dssp CSEECCCBEEESGGGTT---CBGGGSCGGGSC
T ss_pred cCCCCceEeCCchHHcC---CccccCCHHHCC
Confidence 77777776666665543 233334444443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=9.9e-23 Score=214.31 Aligned_cols=202 Identities=21% Similarity=0.211 Sum_probs=121.7
Q ss_pred CCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCe
Q 002094 115 SFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQS 194 (967)
Q Consensus 115 ~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 194 (967)
....+.++|.++++++ .+|..+. ++|++|+|++|+|++..+.+|.++++|++|+|++|+|+. +| .++.++
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~---- 77 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLP---- 77 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCT----
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccc----
Confidence 3444555566666665 4554431 345555555555554444455555555555555555542 22 123444
Q ss_pred EeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCC
Q 002094 195 LDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSF 274 (967)
Q Consensus 195 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 274 (967)
+|++|+|++|+++. .+..+.++++|++|++++|.+....+..+..+.+++.|++++|.+
T Consensus 78 --------------------~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l 136 (266)
T d1p9ag_ 78 --------------------VLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136 (266)
T ss_dssp --------------------TCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCC
T ss_pred --------------------cccccccccccccc-cccccccccccccccccccccceeecccccccccccccccccccc
Confidence 44444444444442 344555566666666666666655556666666666666666666
Q ss_pred CCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCcC
Q 002094 275 TGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLTG 348 (967)
Q Consensus 275 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 348 (967)
+...+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|++..
T Consensus 137 ~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 6666666666777777777777777666666777777777777777777 566666677777777777777764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=7.8e-23 Score=215.12 Aligned_cols=201 Identities=21% Similarity=0.201 Sum_probs=151.6
Q ss_pred cCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccc
Q 002094 90 LRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLE 169 (967)
Q Consensus 90 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 169 (967)
.+...+.+.+.++++++. +|+.+. ++|++|+|++|+|+ .+|...|.++++|++|+|++|+|+. +| .++.+++|+
T Consensus 7 ~~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~ 80 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLG 80 (266)
T ss_dssp ECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCC
T ss_pred cccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCC-CcCHHHhhccccccccccccccccc-cc-ccccccccc
Confidence 355667788999999995 676664 58999999999998 5777778999999999999999995 34 468899999
Q ss_pred eeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccc
Q 002094 170 SVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNS 249 (967)
Q Consensus 170 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 249 (967)
+|+|++|+++ ..+..+..+++|++|++++|.+.+..+..+..+.++++|++++|.++...+..+..+++|++|++++|+
T Consensus 81 ~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~ 159 (266)
T d1p9ag_ 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (266)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred cccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence 9999999998 456678888999999999988887777777777777777777777776666666666666666666666
Q ss_pred cCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccccccccccc
Q 002094 250 LSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQF 298 (967)
Q Consensus 250 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l 298 (967)
|++..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|.+
T Consensus 160 l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred ccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 66555555666666666666666665 4454455555555555555544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=1.9e-19 Score=197.74 Aligned_cols=95 Identities=28% Similarity=0.327 Sum_probs=51.1
Q ss_pred CCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeee
Q 002094 94 FLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNF 173 (967)
Q Consensus 94 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 173 (967)
++++|||++|+++. +|+. +++|++|+|++|+|+ .+|.. +.+|++|++++|+++. ++. + .+.|++|++
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~~-l~~-l--p~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLKA-LSD-L--PPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSC-CCS-C--CTTCCEEEC
T ss_pred CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccch-hhh-h--ccccccccc
Confidence 56777777777763 4432 356666777777666 45542 3456666666666652 221 1 123555555
Q ss_pred cccccccccCccccccccCCeEeecCCcCC
Q 002094 174 SSNRLSGQLPYGIWFLRSLQSLDLSNNLLE 203 (967)
Q Consensus 174 ~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~ 203 (967)
++|+++ .+|. ++.+++|+.|++++|.+.
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred cccccc-cccc-hhhhccceeecccccccc
Confidence 555554 2332 344555555555555443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=5.3e-22 Score=197.18 Aligned_cols=170 Identities=14% Similarity=0.113 Sum_probs=120.0
Q ss_pred CCCCccCCCCceEEEEEEeCCCcEEEEEEeecCCcc-----------------ccHHHHHHHHHHHcCCCCCceeeeeeE
Q 002094 685 NKDCELGRGGFGVVYRTILQDGRSVAIKKLTVSGLI-----------------KSQEDFEKEMKTLGKIRHHNLVALEGY 747 (967)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~~~~~ 747 (967)
..++.||+|+||+||+|+..+|+.||||+++..... ........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 346789999999999999889999999987542110 012345678888999999999988766
Q ss_pred EEcCCceeEEEEecCCCchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCCCCEEeCCCCCeEEeecc
Q 002094 748 YWTPSLQLLIYEFISSGSLYKHLHDGSSRNCLSWRQRFNIILGMAKGLAYLHHTNIIHYNLKSTNVLIDSSGEPKVGDFG 827 (967)
Q Consensus 748 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ivH~Dik~~Nill~~~~~~kl~Dfg 827 (967)
. ..+++|||++++.+.+ ++...+..++.|++.|++|||++||+||||||+|||++++ .++++|||
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECC
Confidence 3 2379999998865533 2234456799999999999999999999999999999865 48999999
Q ss_pred cccccCCCccccccccccccccccCcccccCcccCCcccchhhHHHHH
Q 002094 828 LARLLPMLDRCILSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLV 875 (967)
Q Consensus 828 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~t~~~Dv~slGvll 875 (967)
.|.......... ....+.. .-.|++ .+.++.++|+||..--+
T Consensus 148 ~a~~~~~~~~~~---~l~rd~~-~~~~~f--~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWRE---ILERDVR-NIITYF--SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHHH---HHHHHHH-HHHHHH--HHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcHH---HHHHHHH-HHHHHH--cCCCCCcccHHHHHHHH
Confidence 997553211100 0000000 001222 24578899999976543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=5.6e-19 Score=193.87 Aligned_cols=179 Identities=27% Similarity=0.316 Sum_probs=105.6
Q ss_pred CCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCC-CCCCeee
Q 002094 142 GSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNL-YDLRAIK 220 (967)
Q Consensus 142 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~ 220 (967)
.+|++|+|++|+++ .+|+. +++|++|+|++|+|+ .+|.. +.+|+.|++++|+++... .+ +.|++|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l~-----~lp~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKALS-----DLPPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCC-----SCCTTCCEEE
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchhh-----hhcccccccc
Confidence 46888999999888 46653 467888889888888 66754 457888888888877321 22 3477777
Q ss_pred ccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhcccccccccccccccccc
Q 002094 221 LGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSG 300 (967)
Q Consensus 221 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 300 (967)
+++|++.. +| .++.+++|++|++++|.+... +. ....+..+.+..+.... ...+..++.++.|++++|.+..
T Consensus 105 L~~n~l~~-lp-~~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~ 176 (353)
T d1jl5a_ 105 VSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKK 176 (353)
T ss_dssp CCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSS
T ss_pred cccccccc-cc-chhhhccceeecccccccccc-cc---ccccccchhhccccccc--cccccccccceecccccccccc
Confidence 77777763 34 356677777777777766532 21 23445555555554432 2334556666666666666552
Q ss_pred ccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccCCcCc
Q 002094 301 RIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQNKLT 347 (967)
Q Consensus 301 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 347 (967)
++.. ....+.+...++.+. ..+ .+..++.|+.+++++|...
T Consensus 177 -~~~~---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~ 217 (353)
T d1jl5a_ 177 -LPDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK 217 (353)
T ss_dssp -CCCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS
T ss_pred -cccc---ccccccccccccccc-ccc-ccccccccccccccccccc
Confidence 2211 122344444444443 222 2345555666666655544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=1.7e-22 Score=231.03 Aligned_cols=125 Identities=18% Similarity=0.094 Sum_probs=80.1
Q ss_pred ccchhcccccccccccC----CCcCCcccccEEEecCCccccc----Cccccc-CCCCCCEEEcCCCCCCCc----CCcc
Q 002094 411 SLMLLNMSMNYLFGSIP----ASIGKLKAIQVLDFSDNWLNGT----IPPQIG-GAVSLKELKLEKNFLSGR----IPSQ 477 (967)
Q Consensus 411 ~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l~~~----~p~~ 477 (967)
.|+.+++++|.+..... ..+...++|++|+|++|++++. ++..+. ....|++|+|++|.|+.. ++..
T Consensus 313 ~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 392 (460)
T d1z7xw1 313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 392 (460)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred ccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHH
Confidence 45555555555543221 2233455788888888887643 233332 345688999999988743 4455
Q ss_pred ccccCccceeeccCCcCcCccchhhh-----cccCccEEeccCCccccCCchhh----hhccCCceE
Q 002094 478 IKNCSSLTSLILSQNNLTGPVPAAIA-----NLSNLKYVDLSFNDLSGILPKEL----INLSHLLSF 535 (967)
Q Consensus 478 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~~l----~~l~~L~~L 535 (967)
+..+++|++|+|++|+|+......|. +...|+.|++++|++.......+ ...++|+.|
T Consensus 393 l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l~~l~~~~~~l~~~ 459 (460)
T d1z7xw1 393 LLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459 (460)
T ss_dssp HHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHHHHHHHHCTTSEEE
T ss_pred HhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHHHHHHHhCCCCEEe
Confidence 67788999999999999865444442 23479999999999886555544 344555554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.1e-21 Score=224.13 Aligned_cols=380 Identities=16% Similarity=0.109 Sum_probs=205.6
Q ss_pred CCceEeccccccCCCC-ccccccccccceeeeccccccc----ccCccccccccCCeEeecCCcCCCcccccc----c-C
Q 002094 143 SLREVSFANNNLTGPI-PESLSFCSSLESVNFSSNRLSG----QLPYGIWFLRSLQSLDLSNNLLEGEIVKGI----S-N 212 (967)
Q Consensus 143 ~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~----~-~ 212 (967)
+|++||+++|++++.. ...+..+++|++|+|++|+|+. .++..+..+++|++|||++|.|+......+ . .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5777777777777532 2335567777777777777763 233445566777777777777653222222 1 1
Q ss_pred CCCCCeeeccCcccccc----CCcCccCCCCccEEeccccccCCCCChhhh-----cCCCCCEEEccCCCCCCcC----c
Q 002094 213 LYDLRAIKLGKNKFSGQ----LPEDIGGCSMLKVLDFGVNSLSGSLPDSLQ-----RLNSCSSLSLKGNSFTGEV----P 279 (967)
Q Consensus 213 l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~-----~l~~L~~L~L~~n~l~~~~----~ 279 (967)
..+|++|+|++|+++.. ++..+..+++|++|++++|.++......+. .......+......+.... .
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 23566667766666532 234455566666666666665532111111 1122233333333322111 1
Q ss_pred hhhccccccccccccccccccccCCC----C-CcccccceEEcccCcCCCCC----ChhhhcCCCCcEEEccCCcCcCCC
Q 002094 280 DWIGKLANLESLDLSLNQFSGRIPSS----I-GNLVFLKELNISMNQFTGGL----PESMMNCGNLLAIDVSQNKLTGNI 350 (967)
Q Consensus 280 ~~l~~l~~L~~L~L~~N~l~~~~~~~----~-~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~ 350 (967)
..+.....++.++++++.+....-.. + ........+.+..+.+.... ...+...+.++.+++++|++.
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~--- 239 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG--- 239 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccc---
Confidence 11222334444444444432110000 0 00112334444444333111 112233444444444444432
Q ss_pred ChhhhcccccEEeccCCCCCCCCCCCcccccccCCCCccEEEccCCcccCCC----CCCcccccccchhccccccccccc
Q 002094 351 PTWIFKMGLQTVSLSGNRLGESMQYPSFASMKDSYQGLQVLDLSSNALSGVI----PSNIGDLSSLMLLNMSMNYLFGSI 426 (967)
Q Consensus 351 p~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~ 426 (967)
.................++.+++++|.+.... ...+...+.++.+++++|.+....
T Consensus 240 --------------------~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~ 299 (460)
T d1z7xw1 240 --------------------DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 299 (460)
T ss_dssp --------------------HHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHH
T ss_pred --------------------ccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 21111111222333456777777777665321 222344566777777777765322
Q ss_pred CCCc-----CCcccccEEEecCCcccccCcccc----cCCCCCCEEEcCCCCCCCc----CCcccc-ccCccceeeccCC
Q 002094 427 PASI-----GKLKAIQVLDFSDNWLNGTIPPQI----GGAVSLKELKLEKNFLSGR----IPSQIK-NCSSLTSLILSQN 492 (967)
Q Consensus 427 p~~~-----~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~Ls~N 492 (967)
...+ .....|+.+++++|.+.......+ ....+|++|+|++|+|+.. ++..+. ..+.|+.|+|++|
T Consensus 300 ~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n 379 (460)
T d1z7xw1 300 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 379 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCC
Confidence 2111 234578999999998875433333 3456899999999998643 333333 4677999999999
Q ss_pred cCcCc----cchhhhcccCccEEeccCCccccCCchhhh-----hccCCceEEecCCccccc
Q 002094 493 NLTGP----VPAAIANLSNLKYVDLSFNDLSGILPKELI-----NLSHLLSFNISHNHLHGE 545 (967)
Q Consensus 493 ~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-----~l~~L~~L~l~~N~l~~~ 545 (967)
+|+.. +...+..+++|++|||++|+|+..-...|. +...|+.|++.+|.+...
T Consensus 380 ~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 380 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp CCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred CCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 99753 445567789999999999999854444332 234699999999988753
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=4.3e-19 Score=183.61 Aligned_cols=226 Identities=15% Similarity=0.119 Sum_probs=164.6
Q ss_pred CCCccceEEeCCCCCeeeeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCC
Q 002094 55 NPCNWVGVKCDPKTKRVVGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIP 134 (967)
Q Consensus 55 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip 134 (967)
|-|.++.|.|... +++ .+|+.+. +++++|+|++|+|+...+.+|.++++|++|+|++|.+.+.++
T Consensus 6 C~C~~~~i~c~~~------------~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~ 70 (242)
T d1xwdc1 6 CHCSNRVFLCQES------------KVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 70 (242)
T ss_dssp EEECSSEEEEESC------------SCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEEC
T ss_pred CCCcCCEEEEeCC------------CCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceee
Confidence 3477778888532 233 3444442 478999999999997777789999999999999999987788
Q ss_pred chhhhcCCCCceEecc-ccccCCCCccccccccccceeeecccccccccCc-cccccccCCeEeecCCcCCCcccccccC
Q 002094 135 DEFFRQCGSLREVSFA-NNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPY-GIWFLRSLQSLDLSNNLLEGEIVKGISN 212 (967)
Q Consensus 135 ~~~~~~l~~L~~L~L~-~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 212 (967)
...|..++++++|.+. .|++....+..|.++++|++|++++|+++...+. .+..+..+..+..+++.+....+..|.+
T Consensus 71 ~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~ 150 (242)
T d1xwdc1 71 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 150 (242)
T ss_dssp SSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccc
Confidence 8788899999999876 4678878888889999999999999998744332 2344566666667777787777777776
Q ss_pred CC-CCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccc
Q 002094 213 LY-DLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESL 291 (967)
Q Consensus 213 l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 291 (967)
++ .++.|++++|+++...+..|.....++.+++++|+++...+..|.++++|++|+|++|+|+...+..|.++++|+.|
T Consensus 151 ~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l 230 (242)
T d1xwdc1 151 LSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR 230 (242)
T ss_dssp SBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESS
T ss_pred ccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccC
Confidence 64 67888888888885555444433333444567777775555567778888888888888776656667777777777
Q ss_pred cccc
Q 002094 292 DLSL 295 (967)
Q Consensus 292 ~L~~ 295 (967)
++.+
T Consensus 231 ~~~~ 234 (242)
T d1xwdc1 231 STYN 234 (242)
T ss_dssp SEES
T ss_pred cCCC
Confidence 6643
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=6.2e-19 Score=180.25 Aligned_cols=204 Identities=17% Similarity=0.287 Sum_probs=100.2
Q ss_pred eeeeecCCCCCccccccccCCCCCCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccc
Q 002094 72 VGLTLDGFSLSGHIGRGLLRLQFLQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFAN 151 (967)
Q Consensus 72 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~ 151 (967)
+.+++....+++.+ .++.|.+|+.|++++|+++.. +.+..+++|++|+|++|++++..| +..+++|+++++++
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~---l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP---LKNLTKITELELSG 94 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG---GTTCCSCCEEECCS
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc---cccccccccccccc
Confidence 33444444444432 334455555555555555532 234555555555555555543211 34455555555555
Q ss_pred cccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCC
Q 002094 152 NNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLP 231 (967)
Q Consensus 152 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 231 (967)
|.++. + ..+.++++|++++++++...+. ..+...+.++.+.++.+.+...
T Consensus 95 n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--------------------------~~~~~~~~~~~l~~~~~~~~~~-- 144 (227)
T d1h6ua2 95 NPLKN-V-SAIAGLQSIKTLDLTSTQITDV--------------------------TPLAGLSNLQVLYLDLNQITNI-- 144 (227)
T ss_dssp CCCSC-C-GGGTTCTTCCEEECTTSCCCCC--------------------------GGGTTCTTCCEEECCSSCCCCC--
T ss_pred ccccc-c-cccccccccccccccccccccc--------------------------chhccccchhhhhchhhhhchh--
Confidence 54442 1 1344444555555544444322 2233444445555555544422
Q ss_pred cCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccc
Q 002094 232 EDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVF 311 (967)
Q Consensus 232 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 311 (967)
..+.++++|++|++++|.+... ..+.++++|+.|+|++|++++. + .++++++|++|+|++|++++.. .+.++++
T Consensus 145 ~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~ 218 (227)
T d1h6ua2 145 SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVS--PLANTSN 218 (227)
T ss_dssp GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG--GGTTCTT
T ss_pred hhhccccccccccccccccccc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc--ccccCCC
Confidence 2244455555555555555432 2255566666666666666542 2 2556666666666666666432 2556666
Q ss_pred cceEEcc
Q 002094 312 LKELNIS 318 (967)
Q Consensus 312 L~~L~L~ 318 (967)
|+.|+++
T Consensus 219 L~~L~ls 225 (227)
T d1h6ua2 219 LFIVTLT 225 (227)
T ss_dssp CCEEEEE
T ss_pred CCEEEee
Confidence 6666665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.1e-18 Score=178.47 Aligned_cols=207 Identities=19% Similarity=0.298 Sum_probs=152.3
Q ss_pred CCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEee
Q 002094 118 TLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDL 197 (967)
Q Consensus 118 ~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (967)
++..++++.+++++.++ ++.+.+|++|++.+|+|+.. +.+..+++|++|++++|++++..| +..+++|++|++
T Consensus 20 ~~~~~~l~~~~~~d~~~---~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~ 92 (227)
T d1h6ua2 20 NAIKIAAGKSNVTDTVT---QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELEL 92 (227)
T ss_dssp HHHHHHTTCSSTTSEEC---HHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEEC
T ss_pred HHHHHHhCCCCcCCcCC---HHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccc
Confidence 33445566666665432 35667777777777777743 347778888888888888775443 677888888888
Q ss_pred cCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCc
Q 002094 198 SNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGE 277 (967)
Q Consensus 198 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 277 (967)
++|.++.. +.+.++++|+.+++++|+..+. ..+...+.++.+.++.+.+... ..+.+.++|+.|++++|.++..
T Consensus 93 ~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~ 166 (227)
T d1h6ua2 93 SGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL 166 (227)
T ss_dssp CSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC
T ss_pred cccccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc
Confidence 88877643 3577888888888888887643 3466778888889888888743 3477888899999999888744
Q ss_pred CchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCcEEEccC
Q 002094 278 VPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLLAIDVSQ 343 (967)
Q Consensus 278 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 343 (967)
. .++++++|+.|+|++|++++. + .++++++|++|+|++|++++.. .+.++++|+.|++++
T Consensus 167 ~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 167 T--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp G--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred h--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 3 378888899999999888753 3 3788888999999999888543 378888888888863
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=6.7e-19 Score=182.17 Aligned_cols=219 Identities=17% Similarity=0.062 Sum_probs=101.0
Q ss_pred CeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCC-ccccccccccceeeec
Q 002094 96 QVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPI-PESLSFCSSLESVNFS 174 (967)
Q Consensus 96 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~ 174 (967)
+.++.++++++ .+|+.+. +++++|||++|+|+ .+|...|.++++|++|+|++|.+...+ +..|.+++++++|.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 35555555555 3343332 34555555555554 344444555555555555555554322 2344555555555543
Q ss_pred c-cccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCC
Q 002094 175 S-NRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGS 253 (967)
Q Consensus 175 ~-N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 253 (967)
. |++....+..|.++++|++|++++|.+....+.. .+..++.+..+..+++.+...
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~-----------------------~~~~l~~l~~~~~~n~~l~~i 143 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH-----------------------KIHSLQKVLLDIQDNINIHTI 143 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCT-----------------------TTCBSSCEEEEEESCTTCCEE
T ss_pred ccccccccccccccccccccccccchhhhccccccc-----------------------ccccccccccccccccccccc
Confidence 2 4444444444555555555555555544322111 122233333444444444433
Q ss_pred CChhhhcCC-CCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhc
Q 002094 254 LPDSLQRLN-SCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMN 332 (967)
Q Consensus 254 ~~~~l~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 332 (967)
.+..|.+++ .++.|++++|+++...+..+.....++.+++++|+++...+..|.++++|++|+|++|+|+...+..|.+
T Consensus 144 ~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~ 223 (242)
T d1xwdc1 144 ERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223 (242)
T ss_dssp CTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTT
T ss_pred cccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcC
Confidence 333343332 4445555555555333333322222223344555555333334555556666666666655444444555
Q ss_pred CCCCcEEEc
Q 002094 333 CGNLLAIDV 341 (967)
Q Consensus 333 l~~L~~L~l 341 (967)
+++|+.+++
T Consensus 224 l~~L~~l~~ 232 (242)
T d1xwdc1 224 LKKLRARST 232 (242)
T ss_dssp CCEEESSSE
T ss_pred CcccccCcC
Confidence 555544444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=7.1e-19 Score=174.43 Aligned_cols=110 Identities=20% Similarity=0.318 Sum_probs=59.1
Q ss_pred CCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEee
Q 002094 118 TLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDL 197 (967)
Q Consensus 118 ~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (967)
++++|+|++|+|++.++...|.++++|++|+|++|++.+..+..|..+++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence 44444444444444444444555555555555555555555555555555555555555555554555555555555555
Q ss_pred cCCcCCCcccccccCCCCCCeeeccCcccc
Q 002094 198 SNNLLEGEIVKGISNLYDLRAIKLGKNKFS 227 (967)
Q Consensus 198 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 227 (967)
++|+|++..+..|..+++|++|+|++|.+.
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCccccccCHHHhcCCcccccccccccccc
Confidence 555555555555555555555555555544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=3.3e-18 Score=169.56 Aligned_cols=177 Identities=19% Similarity=0.216 Sum_probs=117.0
Q ss_pred cEEEccCCcccCCCCCCcccccccchhcccccccccc-cCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCC
Q 002094 389 QVLDLSSNALSGVIPSNIGDLSSLMLLNMSMNYLFGS-IPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEK 467 (967)
Q Consensus 389 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 467 (967)
+.++.++++++. +|..+. +++++|+|++|+|++. .+..|.++++|+.|+|++|++.+..+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 466777777773 444432 4677777777777653 355667777777777777777777777777777788888888
Q ss_pred CCCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCchhhhhccCCceEEecCCcccccCC
Q 002094 468 NFLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPKELINLSHLLSFNISHNHLHGELP 547 (967)
Q Consensus 468 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 547 (967)
|+|+...|..|.++++|+.|+|++|+|++..|.+|..+++|++|+|++|.+....+.. .-...++.+.+..|.+.+..|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCCC
Confidence 8777767777777888888888888887777777777888888888888776443321 112335566677777776666
Q ss_pred CCCCCCccCCCcccCCCCCCCccc
Q 002094 548 VGGFFNTISPSSVSGNPSLCGSVV 571 (967)
Q Consensus 548 ~~~~~~~~~~~~~~~n~~lc~~~~ 571 (967)
.. +.......+..|...|.++-
T Consensus 167 ~~--l~~~~l~~L~~n~l~C~~~~ 188 (192)
T d1w8aa_ 167 SK--VRDVQIKDLPHSEFKCSSEN 188 (192)
T ss_dssp TT--TTTSBGGGSCTTTCCCCCC-
T ss_pred hh--hcCCEeeecCHhhCcCCCCC
Confidence 42 22333334555555565443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=7.9e-18 Score=169.30 Aligned_cols=79 Identities=28% Similarity=0.369 Sum_probs=34.8
Q ss_pred hhcCCCCCEEEccCCCCCCcCchhhccccccccccccccccccccCCCCCcccccceEEcccCcCCCCCChhhhcCCCCc
Q 002094 258 LQRLNSCSSLSLKGNSFTGEVPDWIGKLANLESLDLSLNQFSGRIPSSIGNLVFLKELNISMNQFTGGLPESMMNCGNLL 337 (967)
Q Consensus 258 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 337 (967)
+..+++++.+++++|.+++. ..+..+++|+++++++|++++.. .+.++++|+.|+|++|+|++ ++ .+.++++|+
T Consensus 130 l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~ 203 (210)
T d1h6ta2 130 LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLD 203 (210)
T ss_dssp GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCS
T ss_pred cccccccccccccccccccc--ccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCC
Confidence 34444444444444444321 22334444444444444444321 14444555555555555442 22 344555555
Q ss_pred EEEcc
Q 002094 338 AIDVS 342 (967)
Q Consensus 338 ~L~l~ 342 (967)
+|+|+
T Consensus 204 ~L~Ls 208 (210)
T d1h6ta2 204 VLELF 208 (210)
T ss_dssp EEEEE
T ss_pred EEEcc
Confidence 55543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=1.3e-17 Score=167.59 Aligned_cols=101 Identities=27% Similarity=0.357 Sum_probs=45.9
Q ss_pred ccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccccccc
Q 002094 210 ISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKLANLE 289 (967)
Q Consensus 210 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 289 (967)
+.++++|+.|++++|.+.. ...+..++.|+.+++++|.+++ +..+..+++|+.+++++|++++.. .+.++++|+
T Consensus 108 l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~ 181 (210)
T d1h6ta2 108 LKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQ 181 (210)
T ss_dssp GTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCC
T ss_pred ccccccccccccccccccc--cccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCC
Confidence 3334444444444443331 1234444444444444444442 223444455555555555554322 145555555
Q ss_pred cccccccccccccCCCCCcccccceEEcc
Q 002094 290 SLDLSLNQFSGRIPSSIGNLVFLKELNIS 318 (967)
Q Consensus 290 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 318 (967)
+|+|++|++++ ++ .+.++++|++|+|+
T Consensus 182 ~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 182 NLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp EEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred EEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 55555555542 22 35555555555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=2.3e-17 Score=164.40 Aligned_cols=18 Identities=39% Similarity=0.600 Sum_probs=7.4
Q ss_pred CCcccccceEEcccCcCC
Q 002094 306 IGNLVFLKELNISMNQFT 323 (967)
Q Consensus 306 ~~~l~~L~~L~L~~N~l~ 323 (967)
++++++|++|++++|+++
T Consensus 168 l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 168 LANLTTLERLDISSNKVS 185 (199)
T ss_dssp GTTCTTCCEEECCSSCCC
T ss_pred ccCCCCCCEEECCCCCCC
Confidence 333444444444444443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=3.6e-17 Score=162.97 Aligned_cols=147 Identities=22% Similarity=0.351 Sum_probs=58.4
Q ss_pred CCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeE
Q 002094 116 FGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSL 195 (967)
Q Consensus 116 l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 195 (967)
+.+|++|++++|.++. ++. ++.+++|++|+|++|++++..| ++++++|++|++++|.+... + .+.++++|+.|
T Consensus 39 l~~l~~L~l~~~~i~~-l~~--l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L 111 (199)
T d2omxa2 39 LDQVTTLQADRLGIKS-IDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGL 111 (199)
T ss_dssp HTTCCEEECTTSCCCC-CTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEE
T ss_pred hcCCCEEECCCCCCCC-ccc--cccCCCcCcCccccccccCccc--ccCCcccccccccccccccc-c-ccccccccccc
Confidence 3444444444444431 211 2344444444444444443221 44444444444444444321 1 23344444444
Q ss_pred eecCCcCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCC
Q 002094 196 DLSNNLLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFT 275 (967)
Q Consensus 196 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 275 (967)
++++|.+... ..+..+++|+.|++++|++.. ...+..+++|++|++++|++++. ..+.++++|++|++++|+++
T Consensus 112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~--~~~l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVS 185 (199)
T ss_dssp ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC--CGGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCC
T ss_pred cccccccccc--cccchhhhhHHhhhhhhhhcc--cccccccccccccccccccccCC--ccccCCCCCCEEECCCCCCC
Confidence 4444443321 123334444444444444331 11233344444444444444321 12334444444444444443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=1.6e-16 Score=167.70 Aligned_cols=203 Identities=18% Similarity=0.167 Sum_probs=101.5
Q ss_pred CCeEecCCCccCccccccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeec
Q 002094 95 LQVLSLSNNNFTGTINADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFS 174 (967)
Q Consensus 95 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 174 (967)
+..+.++...+...+.. .....+|++|||++|.+++.....++..+++|++|+|++|++++..+..++.+++|++|+|+
T Consensus 25 ~~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls 103 (284)
T d2astb2 25 VIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103 (284)
T ss_dssp CSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEeeccccccccchhh-hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence 34555555444432222 23344677777777766544444456666777777777776666556666666777777776
Q ss_pred cc-cccccc-CccccccccCCeEeecCC-cCCCcc-cccccC-CCCCCeeeccCccccccCCcCccCCCCccEEeccccc
Q 002094 175 SN-RLSGQL-PYGIWFLRSLQSLDLSNN-LLEGEI-VKGISN-LYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNS 249 (967)
Q Consensus 175 ~N-~l~~~~-p~~~~~l~~L~~L~L~~n-~l~~~~-~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 249 (967)
++ .++... ...+..+++|++|+|++| .+++.. ...+.. .++|+.|+++++. +.
T Consensus 104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~----------------------~~ 161 (284)
T d2astb2 104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR----------------------KN 161 (284)
T ss_dssp TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG----------------------GG
T ss_pred ccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccc----------------------cc
Confidence 63 454221 112234566666666664 233211 111222 2345555554331 11
Q ss_pred cCCC-CChhhhcCCCCCEEEccCC-CCCCcCchhhccccccccccccc-cccccccCCCCCcccccceEEcccC
Q 002094 250 LSGS-LPDSLQRLNSCSSLSLKGN-SFTGEVPDWIGKLANLESLDLSL-NQFSGRIPSSIGNLVFLKELNISMN 320 (967)
Q Consensus 250 l~~~-~~~~l~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N 320 (967)
++.. +...+.++++|++|++++| .+++.....+..+++|++|+|++ +.+++.....++++++|+.|+++++
T Consensus 162 i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 162 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp SCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 2211 1112234455555555543 34444444455555555555555 2444444444555556666666555
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=5.2e-16 Score=163.64 Aligned_cols=206 Identities=17% Similarity=0.179 Sum_probs=131.8
Q ss_pred ccccceeeecccccccc-cCccccccccCCeEeecCCcCCCcccccccCCCCCCeeeccCc-cccccC-CcCccCCCCcc
Q 002094 165 CSSLESVNFSSNRLSGQ-LPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRAIKLGKN-KFSGQL-PEDIGGCSMLK 241 (967)
Q Consensus 165 l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~-~~~~~~l~~L~ 241 (967)
..+|++|||+++.++.. +...+..+++|++|+|++|.+++..+..++.+++|++|+|+++ .++... ...+.++++|+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcc
Confidence 34566666665555432 2233455666666666666666555566666666666666663 343221 12234567888
Q ss_pred EEecccc-ccCCC-CChhhhc-CCCCCEEEccCC--CCCCc-Cchhhcccccccccccccc-ccccccCCCCCcccccce
Q 002094 242 VLDFGVN-SLSGS-LPDSLQR-LNSCSSLSLKGN--SFTGE-VPDWIGKLANLESLDLSLN-QFSGRIPSSIGNLVFLKE 314 (967)
Q Consensus 242 ~L~l~~n-~l~~~-~~~~l~~-l~~L~~L~L~~n--~l~~~-~~~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~ 314 (967)
+|+++++ .++.. +...+.. .++|+.|+++++ .++.. +...+.++++|++|++++| .+++.....+..+++|++
T Consensus 125 ~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~ 204 (284)
T d2astb2 125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 204 (284)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred ccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCE
Confidence 8888775 34321 2233444 478999999975 34432 2334467899999999986 577777778899999999
Q ss_pred EEcccC-cCCCCCChhhhcCCCCcEEEccCCcCcCCCChhhhcccccEEeccCCCCCCC
Q 002094 315 LNISMN-QFTGGLPESMMNCGNLLAIDVSQNKLTGNIPTWIFKMGLQTVSLSGNRLGES 372 (967)
Q Consensus 315 L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~ 372 (967)
|+|++| .+++.....+.++++|+.|+++++ ++...-..+ ...+..|.+..++++..
T Consensus 205 L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l-~~~lp~L~i~~~~ls~~ 261 (284)
T d2astb2 205 LSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLL-KEALPHLQINCSHFTTI 261 (284)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHH-HHHSTTSEESCCCSCCT
T ss_pred EECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHH-HHhCccccccCccCCCC
Confidence 999995 688777788999999999999988 332111111 12455666777776543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.51 E-value=1.5e-15 Score=165.52 Aligned_cols=244 Identities=22% Similarity=0.264 Sum_probs=135.6
Q ss_pred ccccccCCCCCCeEecCCCccCcc----ccccccCCCCCcEEEcCCCCCCCC---CCc------hhhhcCCCCceEeccc
Q 002094 85 IGRGLLRLQFLQVLSLSNNNFTGT----INADLASFGTLQVVDFSENNLSGL---IPD------EFFRQCGSLREVSFAN 151 (967)
Q Consensus 85 ~~~~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~n~~~~~---ip~------~~~~~l~~L~~L~L~~ 151 (967)
+...+...+.|+.|+|++|.+... +...+...++|+.|+++++..... .+. ..+..+++|++|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 345567788899999999988653 345567778899999988765421 111 1134567788888888
Q ss_pred cccCCCC----ccccccccccceeeecccccccccCccc-------------cccccCCeEeecCCcCCCcccc----cc
Q 002094 152 NNLTGPI----PESLSFCSSLESVNFSSNRLSGQLPYGI-------------WFLRSLQSLDLSNNLLEGEIVK----GI 210 (967)
Q Consensus 152 n~l~~~~----p~~l~~l~~L~~L~L~~N~l~~~~p~~~-------------~~l~~L~~L~L~~n~l~~~~~~----~~ 210 (967)
|.++... ...+..+++|++|++++|.+.......+ ...+.|+.|++++|.++..... .+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l 182 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence 8877642 2334566778888888887653211111 1244566666666666532222 23
Q ss_pred cCCCCCCeeeccCcccccc-----CCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCcCchhhccc
Q 002094 211 SNLYDLRAIKLGKNKFSGQ-----LPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGEVPDWIGKL 285 (967)
Q Consensus 211 ~~l~~L~~L~L~~n~l~~~-----~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l 285 (967)
...+.|+.|+|++|+++.. +...+..+++|++|++++|.++..... .+...+..+
T Consensus 183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~--------------------~L~~~l~~~ 242 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS--------------------ALAIALKSW 242 (344)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHH--------------------HHHHHGGGC
T ss_pred hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccc--------------------ccccccccc
Confidence 3445555666655555421 222344445555555555554321000 012233344
Q ss_pred cccccccccccccccccCCCC----C--cccccceEEcccCcCCCCC----Chhhh-cCCCCcEEEccCCcCcC
Q 002094 286 ANLESLDLSLNQFSGRIPSSI----G--NLVFLKELNISMNQFTGGL----PESMM-NCGNLLAIDVSQNKLTG 348 (967)
Q Consensus 286 ~~L~~L~L~~N~l~~~~~~~~----~--~l~~L~~L~L~~N~l~~~~----~~~~~-~l~~L~~L~l~~N~l~~ 348 (967)
++|++|+|++|.|++.....+ . ..+.|++|++++|+|+... ...+. ++++|+.|++++|++..
T Consensus 243 ~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 445555555554443211111 1 1245777777777776422 23332 56788888888888864
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=1.2e-14 Score=138.31 Aligned_cols=126 Identities=19% Similarity=0.162 Sum_probs=67.9
Q ss_pred cccccchhcccccccccccCCCcCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCcccee
Q 002094 408 DLSSLMLLNMSMNYLFGSIPASIGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSL 487 (967)
Q Consensus 408 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 487 (967)
+..+|++|+|++|+|+ .++..+..+++|+.|+|++|+++. + +.+..+++|++|++++|+++...+..+..+++|+.|
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccccccc
Confidence 3334444455555443 223334445555555555555552 2 235555666666666666654444445556666666
Q ss_pred eccCCcCcCccc-hhhhcccCccEEeccCCccccCC---chhhhhccCCceEE
Q 002094 488 ILSQNNLTGPVP-AAIANLSNLKYVDLSFNDLSGIL---PKELINLSHLLSFN 536 (967)
Q Consensus 488 ~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~---p~~l~~l~~L~~L~ 536 (967)
+|++|+|+.... ..+..+++|++|++++|+++... +..+..+++|+.||
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred eeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 666666653221 34566666666666666665332 12456666666665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=3.9e-14 Score=127.98 Aligned_cols=87 Identities=25% Similarity=0.395 Sum_probs=37.6
Q ss_pred cCCcccccEEEecCCcccccCcccccCCCCCCEEEcCCCCCCCcCCccccccCccceeeccCCcCcCcc-chhhhcccCc
Q 002094 430 IGKLKAIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKNFLSGRIPSQIKNCSSLTSLILSQNNLTGPV-PAAIANLSNL 508 (967)
Q Consensus 430 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L 508 (967)
+..+++|++|++++|+++ .+|+.++.+++|+.|++++|+|+. +| .++.+++|+.|++++|+|+... ...+..+++|
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L 92 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 92 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCC
Confidence 333444444444444443 233344444444444444444442 22 2444444444444444444321 1234444445
Q ss_pred cEEeccCCccc
Q 002094 509 KYVDLSFNDLS 519 (967)
Q Consensus 509 ~~L~Ls~N~l~ 519 (967)
++|++++|+++
T Consensus 93 ~~L~l~~N~i~ 103 (124)
T d1dcea3 93 VLLNLQGNSLC 103 (124)
T ss_dssp CEEECTTSGGG
T ss_pred CEEECCCCcCC
Confidence 55555554443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=1.7e-14 Score=137.30 Aligned_cols=86 Identities=22% Similarity=0.226 Sum_probs=43.8
Q ss_pred hcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCCe
Q 002094 139 RQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLRA 218 (967)
Q Consensus 139 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 218 (967)
.+..+|++|+|++|+|+. ++..+..+++|++|+|++|+|+. ++ .|..+++|++|+|++|+++...+..+..+++|++
T Consensus 15 ~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp ECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred cCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccccc
Confidence 455556666666666653 34444555556666666665552 22 3445555555555555555433333444444444
Q ss_pred eeccCcccc
Q 002094 219 IKLGKNKFS 227 (967)
Q Consensus 219 L~L~~n~l~ 227 (967)
|++++|+++
T Consensus 92 L~L~~N~i~ 100 (162)
T d1a9na_ 92 LILTNNSLV 100 (162)
T ss_dssp EECCSCCCC
T ss_pred ceecccccc
Confidence 444444443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.49 E-value=1.2e-15 Score=166.19 Aligned_cols=199 Identities=17% Similarity=0.165 Sum_probs=95.1
Q ss_pred hhcCCCCceEeccccccCCCC----ccccccccccceeeeccccccc---cc-------CccccccccCCeEeecCCcCC
Q 002094 138 FRQCGSLREVSFANNNLTGPI----PESLSFCSSLESVNFSSNRLSG---QL-------PYGIWFLRSLQSLDLSNNLLE 203 (967)
Q Consensus 138 ~~~l~~L~~L~L~~n~l~~~~----p~~l~~l~~L~~L~L~~N~l~~---~~-------p~~~~~l~~L~~L~L~~n~l~ 203 (967)
+.....|++|+|++|.+.... ...+...++|+.|+++++.+.. .. ...+...++|+.|+|++|.++
T Consensus 27 L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 106 (344)
T d2ca6a1 27 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 106 (344)
T ss_dssp HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred HhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccc
Confidence 466677888888877775422 2334556777777777654331 11 122334556666666666665
Q ss_pred Cccc----ccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccccccCCCCChhhhcCCCCCEEEccCCCCCCc--
Q 002094 204 GEIV----KGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGVNSLSGSLPDSLQRLNSCSSLSLKGNSFTGE-- 277 (967)
Q Consensus 204 ~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-- 277 (967)
.... ..+...++|++|++++|.+.......++. .|..+. ........+.|+.|++++|.++..
T Consensus 107 ~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~~---------~~~~~~~~~~L~~l~l~~n~i~~~~~ 175 (344)
T d2ca6a1 107 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQELA---------VNKKAKNAPPLRSIICGRNRLENGSM 175 (344)
T ss_dssp TTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHHH---------HHHHHHTCCCCCEEECCSSCCTGGGH
T ss_pred cccccchhhhhcccccchheecccccccccccccccc--cccccc---------cccccccCcccceeeccccccccccc
Confidence 4322 22334556666666666553211111100 000000 000012234455555555554422
Q ss_pred --Cchhhccccccccccccccccccc-----cCCCCCcccccceEEcccCcCCCC----CChhhhcCCCCcEEEccCCcC
Q 002094 278 --VPDWIGKLANLESLDLSLNQFSGR-----IPSSIGNLVFLKELNISMNQFTGG----LPESMMNCGNLLAIDVSQNKL 346 (967)
Q Consensus 278 --~~~~l~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l 346 (967)
+...+...+.|+.|+|++|++... +...+..+++|+.|+|++|.++.. +...+..+++|+.|++++|.|
T Consensus 176 ~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i 255 (344)
T d2ca6a1 176 KEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 255 (344)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred ccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCcc
Confidence 122233444555555555554321 223344555566666666655432 223445566666666666665
Q ss_pred c
Q 002094 347 T 347 (967)
Q Consensus 347 ~ 347 (967)
.
T Consensus 256 ~ 256 (344)
T d2ca6a1 256 S 256 (344)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=6.1e-14 Score=126.69 Aligned_cols=77 Identities=27% Similarity=0.385 Sum_probs=34.5
Q ss_pred EEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCC
Q 002094 121 VVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNN 200 (967)
Q Consensus 121 ~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n 200 (967)
+|||++|+++ .++. ++.+++|++|++++|+|+ .+|+.++.+++|++|++++|+|++. | .+..+++|++|++++|
T Consensus 2 ~L~Ls~n~l~-~l~~--l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCS-SCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred EEEcCCCCCC-CCcc--cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 4555555554 2332 344455555555555554 2333444444444444444444421 2 2344444444444444
Q ss_pred cCC
Q 002094 201 LLE 203 (967)
Q Consensus 201 ~l~ 203 (967)
+++
T Consensus 76 ~i~ 78 (124)
T d1dcea3 76 RLQ 78 (124)
T ss_dssp CCC
T ss_pred ccC
Confidence 443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.38 E-value=2.2e-14 Score=141.64 Aligned_cols=113 Identities=24% Similarity=0.273 Sum_probs=67.1
Q ss_pred cccccCCCCCcEEEcCCCCCCCCCCchhhhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCcccccc
Q 002094 110 NADLASFGTLQVVDFSENNLSGLIPDEFFRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFL 189 (967)
Q Consensus 110 ~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 189 (967)
+..++.+++|++|+|++|+|+ .++. +..+++|++|+|++|+|+ .+|..+..+++|++|++++|+|+.. ..+..+
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~-~i~~--l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l 114 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIE-KISS--LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL 114 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEES-CCCC--HHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred hhHHhcccccceeECcccCCC-Cccc--ccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccc
Confidence 344555566666666666665 3432 456666666666666666 3444445555666777777666632 235566
Q ss_pred ccCCeEeecCCcCCCccc-ccccCCCCCCeeeccCccccc
Q 002094 190 RSLQSLDLSNNLLEGEIV-KGISNLYDLRAIKLGKNKFSG 228 (967)
Q Consensus 190 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~ 228 (967)
++|++|+|++|++++... ..+..+++|+.|+|++|++..
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 667777777776664322 456666666666666666653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.32 E-value=7e-14 Score=137.96 Aligned_cols=109 Identities=20% Similarity=0.238 Sum_probs=78.0
Q ss_pred hhcCCCCceEeccccccCCCCccccccccccceeeecccccccccCccccccccCCeEeecCCcCCCcccccccCCCCCC
Q 002094 138 FRQCGSLREVSFANNNLTGPIPESLSFCSSLESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNNLLEGEIVKGISNLYDLR 217 (967)
Q Consensus 138 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 217 (967)
+..+++|++|+|++|+|+.. + .|..+++|++|+|++|+|+ .+|..+..+++|++|++++|.++.. +.+..+++|+
T Consensus 44 l~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~ 118 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLR 118 (198)
T ss_dssp HHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSS
T ss_pred HhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccccccc
Confidence 57888888888888888843 3 4888888888888888887 4565556667788888888888753 3466777777
Q ss_pred eeeccCccccccCC-cCccCCCCccEEeccccccC
Q 002094 218 AIKLGKNKFSGQLP-EDIGGCSMLKVLDFGVNSLS 251 (967)
Q Consensus 218 ~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~ 251 (967)
.|+|++|+++.... ..+..+++|++|++++|.+.
T Consensus 119 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccchhccccccccccCCCccceeecCCCccc
Confidence 77777777764321 34566666666666666654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=4.6e-12 Score=119.34 Aligned_cols=110 Identities=24% Similarity=0.242 Sum_probs=83.4
Q ss_pred cccEEEecCCcccccCcccccCCCCCCEEEcCCC-CCCCcCCccccccCccceeeccCCcCcCccchhhhcccCccEEec
Q 002094 435 AIQVLDFSDNWLNGTIPPQIGGAVSLKELKLEKN-FLSGRIPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDL 513 (967)
Q Consensus 435 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 513 (967)
..+.++.+++.+. ..|..+.++++|++|++++| .|+...+..|.++++|+.|+|++|+|+++.|.+|..+++|++|||
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3455777777776 45677777888888888765 477666677888888888888888888777888888888888888
Q ss_pred cCCccccCCchhhhhccCCceEEecCCcccccC
Q 002094 514 SFNDLSGILPKELINLSHLLSFNISHNHLHGEL 546 (967)
Q Consensus 514 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 546 (967)
++|+|+...+..|..+ .|+.|+|++|+|.+..
T Consensus 88 s~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 88 SFNALESLSWKTVQGL-SLQELVLSGNPLHCSC 119 (156)
T ss_dssp CSSCCSCCCSTTTCSC-CCCEEECCSSCCCCCG
T ss_pred cCCCCcccChhhhccc-cccccccCCCcccCCc
Confidence 8888885555555544 6888888888886544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=9.2e-12 Score=117.21 Aligned_cols=105 Identities=19% Similarity=0.187 Sum_probs=58.8
Q ss_pred ceeeecccccccccCccccccccCCeEeecCC-cCCCcccccccCCCCCCeeeccCccccccCCcCccCCCCccEEeccc
Q 002094 169 ESVNFSSNRLSGQLPYGIWFLRSLQSLDLSNN-LLEGEIVKGISNLYDLRAIKLGKNKFSGQLPEDIGGCSMLKVLDFGV 247 (967)
Q Consensus 169 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 247 (967)
+.++++++.+. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+.+|.++++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34444444444 33444455555555555443 35555555566666666666666666655556666666666666666
Q ss_pred cccCCCCChhhhcCCCCCEEEccCCCCC
Q 002094 248 NSLSGSLPDSLQRLNSCSSLSLKGNSFT 275 (967)
Q Consensus 248 n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 275 (967)
|+|+...+..|..+ +|+.|+|++|.+.
T Consensus 90 N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp SCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCCcccChhhhccc-cccccccCCCccc
Confidence 66664333334333 5667777777664
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.52 E-value=5.7e-09 Score=98.42 Aligned_cols=82 Identities=23% Similarity=0.174 Sum_probs=53.4
Q ss_pred cCCCCCCEEEcCCCCCCCc--CCccccccCccceeeccCCcCcCccchhhhcccCccEEeccCCccccCCch-------h
Q 002094 455 GGAVSLKELKLEKNFLSGR--IPSQIKNCSSLTSLILSQNNLTGPVPAAIANLSNLKYVDLSFNDLSGILPK-------E 525 (967)
Q Consensus 455 ~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-------~ 525 (967)
..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|++++.... .
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i 141 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence 4456666666666666643 234566777888888888888754444455556678888888887755442 2
Q ss_pred hhhccCCceEE
Q 002094 526 LINLSHLLSFN 536 (967)
Q Consensus 526 l~~l~~L~~L~ 536 (967)
+..+|+|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
Confidence 55677777765
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.45 E-value=1.8e-08 Score=94.92 Aligned_cols=41 Identities=27% Similarity=0.224 Sum_probs=17.8
Q ss_pred cccccCCeEeecCCcCCCcc--cccccCCCCCCeeeccCcccc
Q 002094 187 WFLRSLQSLDLSNNLLEGEI--VKGISNLYDLRAIKLGKNKFS 227 (967)
Q Consensus 187 ~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~ 227 (967)
..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence 34455555555555554321 122333444444444444444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.09 E-value=2.8e-06 Score=86.73 Aligned_cols=128 Identities=13% Similarity=0.092 Sum_probs=85.1
Q ss_pred CCceEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCceeEEEEecCCCchhhhhh
Q 002094 693 GGFGVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQLLIYEFISSGSLYKHLH 771 (967)
Q Consensus 693 G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 771 (967)
++.+.||+... +++.++||+..... ......+.+|...++.+. +--+.+++.+...++..++||++++|.++.+...
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc
Confidence 33468999865 46677888775443 223345677888776653 3335677778888888999999999987765442
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------------
Q 002094 772 DGSSRNCLSWRQRFNIILGMAKGLAYLHHT-------------------------------------------------- 801 (967)
Q Consensus 772 ~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-------------------------------------------------- 801 (967)
... ....++.++++.++.||+.
T Consensus 103 ~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 103 DEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp TCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred ccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 211 1122344444444444421
Q ss_pred ---------CcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 802 ---------NIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 802 ---------~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
.++|+|+.|.||++++++.+-++||+.+.
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 25899999999999877666799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.87 E-value=1.4e-05 Score=80.77 Aligned_cols=75 Identities=13% Similarity=0.083 Sum_probs=53.0
Q ss_pred ccCCCCc-eEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCC--CCceeeeeeEEEcCCceeEEEEecCCCc
Q 002094 689 ELGRGGF-GVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR--HHNLVALEGYYWTPSLQLLIYEFISSGS 765 (967)
Q Consensus 689 ~lG~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gs 765 (967)
.+..|.. +.||+....++..+++|...... ...+..|++.++.+. .-.+.+++.+..+++..++||+|++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3445554 67999998888888999765433 234667777766553 2336677888888888999999999866
Q ss_pred hh
Q 002094 766 LY 767 (967)
Q Consensus 766 L~ 767 (967)
+.
T Consensus 93 ~~ 94 (255)
T d1nd4a_ 93 LL 94 (255)
T ss_dssp TT
T ss_pred cc
Confidence 53
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.61 E-value=7.2e-06 Score=76.94 Aligned_cols=43 Identities=19% Similarity=0.167 Sum_probs=21.6
Q ss_pred cccccccceeeecccccccccC----ccccccccCCeEeecCCcCCC
Q 002094 162 LSFCSSLESVNFSSNRLSGQLP----YGIWFLRSLQSLDLSNNLLEG 204 (967)
Q Consensus 162 l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~n~l~~ 204 (967)
+...+.|++|+|++|.+..... ..+...+.|++|+|++|.++.
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~ 86 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 86 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcch
Confidence 3444555666666655543222 222334556666666665553
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.59 E-value=2.3e-05 Score=73.29 Aligned_cols=88 Identities=16% Similarity=0.127 Sum_probs=45.6
Q ss_pred ccCCCCCCEEEcCCCCCCCc----CCccccccCccceeeccCCcCcCccc----hhhhcccCccEEeccCCccccC----
Q 002094 454 IGGAVSLKELKLEKNFLSGR----IPSQIKNCSSLTSLILSQNNLTGPVP----AAIANLSNLKYVDLSFNDLSGI---- 521 (967)
Q Consensus 454 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~---- 521 (967)
+...+.|++|+|++|.+... +...+...+.|+.|+|++|.|+.... ..+...+.|++|+|++|.+...
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~ 119 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV 119 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHH
Confidence 33444555555555555422 22234445666666666666654322 2334445666777766654421
Q ss_pred ---CchhhhhccCCceEEecCCc
Q 002094 522 ---LPKELINLSHLLSFNISHNH 541 (967)
Q Consensus 522 ---~p~~l~~l~~L~~L~l~~N~ 541 (967)
+...+..-+.|+.|+++++.
T Consensus 120 ~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 120 EMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHHHhCCCccEeeCcCCC
Confidence 23344455666666665543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.53 E-value=0.0001 Score=79.38 Aligned_cols=76 Identities=18% Similarity=0.183 Sum_probs=48.7
Q ss_pred CccCCCCceEEEEEEeCC-CcEEEEEEeecC------CccccHHHHHHHHHHHcCC-CC--CceeeeeeEEEcCCceeEE
Q 002094 688 CELGRGGFGVVYRTILQD-GRSVAIKKLTVS------GLIKSQEDFEKEMKTLGKI-RH--HNLVALEGYYWTPSLQLLI 757 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~------~~~~~~~~~~~E~~~l~~l-~h--~niv~~~~~~~~~~~~~lv 757 (967)
+.||.|....||++...+ ++.|+||.-... ..+....+...|.+.++.+ .+ ..+++++.+ ++...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998654 678999975431 1122334556677777665 22 345556554 45567899
Q ss_pred EEecCCCc
Q 002094 758 YEFISSGS 765 (967)
Q Consensus 758 ~e~~~~gs 765 (967)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.11 E-value=3.6e-05 Score=71.98 Aligned_cols=67 Identities=12% Similarity=0.106 Sum_probs=36.9
Q ss_pred ccCCCCCCeEecCC-CccCcc----ccccccCCCCCcEEEcCCCCCCCCCCc---hhhhcCCCCceEeccccccC
Q 002094 89 LLRLQFLQVLSLSN-NNFTGT----INADLASFGTLQVVDFSENNLSGLIPD---EFFRQCGSLREVSFANNNLT 155 (967)
Q Consensus 89 l~~l~~L~~L~L~~-n~l~~~----~~~~~~~l~~L~~L~Ls~n~~~~~ip~---~~~~~l~~L~~L~L~~n~l~ 155 (967)
..+.+.|++|+|++ +.++.. +-.++...++|++|+|++|.++...-. ..+...+.++.|++++|.++
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 34557777777776 456532 233445566677777777766532111 12344455566665555554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.93 E-value=0.00018 Score=67.03 Aligned_cols=87 Identities=17% Similarity=0.185 Sum_probs=42.7
Q ss_pred CCCCCCEEEcCCCCCCCc----CCccccccCccceeeccCCcCcCcc----chhhhcccCccEE--eccCCcccc----C
Q 002094 456 GAVSLKELKLEKNFLSGR----IPSQIKNCSSLTSLILSQNNLTGPV----PAAIANLSNLKYV--DLSFNDLSG----I 521 (967)
Q Consensus 456 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L--~Ls~N~l~~----~ 521 (967)
..+.|++|+|++|.++.. +-..+...+.++.+++++|.++... -..+...++|+.+ ++++|.+.. .
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~ 123 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME 123 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence 444555555555555432 2223344556666666666654322 1334445556543 334455542 2
Q ss_pred CchhhhhccCCceEEecCCcc
Q 002094 522 LPKELINLSHLLSFNISHNHL 542 (967)
Q Consensus 522 ~p~~l~~l~~L~~L~l~~N~l 542 (967)
+...+...+.|+.|+++.|..
T Consensus 124 La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 124 IANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCCCcCEEeCcCCCC
Confidence 333444556666666665543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.91 E-value=0.0012 Score=68.69 Aligned_cols=68 Identities=10% Similarity=0.097 Sum_probs=45.7
Q ss_pred eEEEEEEeCCCcEEEEEEeecCCccccHHHHHHHHHHHcCCCCCc--eeeee-----eEEEcCCceeEEEEecCCCc
Q 002094 696 GVVYRTILQDGRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIRHHN--LVALE-----GYYWTPSLQLLIYEFISSGS 765 (967)
Q Consensus 696 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~-----~~~~~~~~~~lv~e~~~~gs 765 (967)
-.||++..++|+.|++|+.+... .+.+++..|.+.+..+.... ++..+ ..+...+..+.++++++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 47999999999999999987653 35677888888776663211 11111 12234566788999998743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.54 E-value=0.013 Score=62.46 Aligned_cols=72 Identities=15% Similarity=0.160 Sum_probs=47.6
Q ss_pred CccCCCCceEEEEEEeCC--------CcEEEEEEeecCCccccHHHHHHHHHHHcCCC-CCceeeeeeEEEcCCceeEEE
Q 002094 688 CELGRGGFGVVYRTILQD--------GRSVAIKKLTVSGLIKSQEDFEKEMKTLGKIR-HHNLVALEGYYWTPSLQLLIY 758 (967)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 758 (967)
+.|+-|-.=.+|++...+ ...|.+++... . .......+|.++++.+. +.-..++++++.. ..||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 457778888999998654 34566665542 2 23445678888888774 4334567776632 6899
Q ss_pred EecCCCch
Q 002094 759 EFISSGSL 766 (967)
Q Consensus 759 e~~~~gsL 766 (967)
||++|..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.61 E-value=0.068 Score=54.47 Aligned_cols=30 Identities=27% Similarity=0.279 Sum_probs=26.7
Q ss_pred CCcccCCCCCCCEEeCCCCCeEEeeccccc
Q 002094 801 TNIIHYNLKSTNVLIDSSGEPKVGDFGLAR 830 (967)
Q Consensus 801 ~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 830 (967)
.|+||+|+.+.||+++.+...-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999988777899999875
|